data_2m70_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2m70 _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.454 -0.243 0 N-CA-C 109.772 -0.455 . . . . 0.0 109.772 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 56.8 tp -71.8 97.02 1.71 Allowed 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.177 0.513 . . . . 0.0 110.35 179.547 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . 0.442 ' C ' ' H ' ' A' ' 45' ' ' MET . 0.7 OUTLIER -150.13 147.92 28.34 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.655 -0.702 . . . . 0.0 109.582 -179.986 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -73.79 20.35 0.1 Allowed 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.623 -179.723 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' MET . . . . . 0.442 ' H ' ' C ' ' A' ' 43' ' ' ARG . 19.5 ptt? -83.86 8.1 15.98 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.026 0.441 . . . . 0.0 110.63 -179.854 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 87.7 mt-30 -66.1 -22.75 66.41 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.179 0.514 . . . . 0.0 110.477 179.361 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -80.37 -7.43 59.09 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.149 0.499 . . . . 0.0 110.681 179.648 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 18.7 ttmm -77.91 -6.28 53.81 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.539 -179.795 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 14.8 p -56.2 -28.57 25.83 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.32 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.596 -179.474 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 26.7 mt-10 -62.22 -31.36 71.89 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.91 0.386 . . . . 0.0 111.294 -179.359 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 37.6 mtmt -96.68 -41.18 8.63 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.609 -179.966 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 27.6 mm-40 -61.39 -29.6 70.02 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.71 -179.502 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 15.2 ptt? -62.62 -24.9 67.83 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-O 120.87 0.367 . . . . 0.0 110.629 179.797 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -94.3 -9.48 59.14 Favored Glycine 0 N--CA 1.447 -0.598 0 C-N-CA 120.699 -0.762 . . . . 0.0 111.483 179.463 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.326 -0.452 0 CA-C-O 120.909 0.385 . . . . 0.0 110.747 -179.753 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.225 -0.187 0 CA-C-O 120.901 0.382 . . . . 0.0 110.213 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -74.6 -0.08 16.63 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.048 0.452 . . . . 0.0 111.14 179.909 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 21.9 tp60 -119.47 -48.69 2.39 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.998 179.698 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -89.36 -52.94 4.78 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.864 0.364 . . . . 0.0 111.904 -179.236 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . 0.411 ' O ' HG23 ' A' ' 72' ' ' VAL . 6.4 tt0 -68.68 -26.1 65.13 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.143 0.497 . . . . 0.0 110.549 -179.094 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 51.2 tptt -58.91 -27.89 65.69 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.886 179.511 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 52.6 mt-10 -63.76 -21.94 66.66 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-O 121.443 0.64 . . . . 0.0 110.99 179.758 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . 0.525 ' O ' ' HD3' ' A' ' 75' ' ' ARG . 13.2 tp10 -94.8 -44.56 7.71 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 115.521 -0.763 . . . . 0.0 108.951 178.307 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . 0.411 HG23 ' O ' ' A' ' 68' ' ' GLU . 26.7 t -62.78 -40.45 88.69 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-N 115.351 -0.84 . . . . 0.0 112.883 -178.496 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 9.9 p-10 -70.86 -20.83 62.49 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-O 121.091 0.472 . . . . 0.0 111.64 -178.933 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 18.0 m -100.89 -5.05 26.61 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-O 121.335 0.588 . . . . 0.0 110.192 179.888 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . 0.525 ' HD3' ' O ' ' A' ' 71' ' ' GLU . 1.9 mpt_? -113.9 39.43 2.7 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.593 -0.73 . . . . 0.0 109.545 -179.92 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -119.26 173.83 6.71 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.381 -0.827 . . . . 0.0 110.886 -179.926 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 7.0 pt -133.31 140.41 47.03 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.067 178.585 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 71.0 t80 -96.53 126.52 41.77 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 109.624 -0.51 . . . . 0.0 109.624 179.815 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 5.1 t -108.09 114.33 46.23 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.983 -179.381 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -120.38 169.45 14.06 Favored Glycine 0 N--CA 1.448 -0.513 0 N-CA-C 111.192 -0.763 . . . . 0.0 111.192 179.36 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 93.8 m-20 60.06 38.66 20.47 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-O 121.073 0.463 . . . . 0.0 110.754 -179.712 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 2.4 t -81.82 164.44 2.91 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.753 -179.145 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . 0.4 ' O ' ' HB2' ' A' ' 86' ' ' CYS . 9.7 t70 -67.3 137.01 55.75 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 109.676 -0.491 . . . . 0.0 109.676 179.414 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 30.5 p90 -64.27 -18.46 64.59 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.897 -178.647 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -113.23 24.92 11.81 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 121.037 0.446 . . . . 0.0 110.747 179.851 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' CYS . . . . . 0.4 ' HB2' ' O ' ' A' ' 83' ' ' ASP . 0.1 OUTLIER -85.85 156.45 20.55 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.397 0.618 . . . . 0.0 111.549 -179.966 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' THR . . . . . 0.47 ' O ' ' HG2' ' A' ' 90' ' ' GLU . 0.0 OUTLIER -119.31 146.64 41.35 Favored Pre-proline 0 C--N 1.322 -0.601 0 CA-C-N 115.432 -0.804 . . . . 0.0 110.343 -179.941 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 15.0 Cg_endo -56.7 -40.2 86.04 Favored 'Trans proline' 0 C--N 1.344 0.319 0 C-N-CA 122.83 2.353 . . . . 0.0 112.734 -178.867 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 60.1 mm-40 -60.42 -50.49 73.36 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.531 -179.097 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . 0.705 ' O ' ' HB2' ' A' ' 94' ' ' HIS . 6.6 pt-20 -63.91 -24.6 67.8 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.624 -0.262 . . . . 0.0 111.143 -178.706 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 70.0 t -80.76 -48.66 19.3 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.04 -179.343 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 2.3 pt20 -70.92 -34.03 71.12 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 112.1 0.407 . . . . 0.0 112.1 -178.167 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 18.5 pt20 -79.19 -23.8 43.61 Favored 'General case' 0 C--N 1.329 -0.285 0 C-N-CA 120.496 -0.481 . . . . 0.0 110.896 -179.502 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' HIS . . . . . 0.705 ' HB2' ' O ' ' A' ' 90' ' ' GLU . 0.4 OUTLIER -74.48 -43.66 55.0 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.048 0.452 . . . . 0.0 110.067 179.684 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 21.8 m-30 -78.17 -12.52 60.0 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.521 -179.873 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . 0.592 ' HA ' ' O ' ' A' ' 99' ' ' GLY . 15.8 tt0 -65.08 -19.72 66.13 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.378 -179.959 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 12.3 m -66.54 -26.82 67.32 Favored 'General case' 0 N--CA 1.451 -0.401 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.272 179.217 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 5.9 m -97.02 -42.97 7.64 Favored 'General case' 0 N--CA 1.453 -0.324 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.168 179.365 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . 0.592 ' O ' ' HA ' ' A' ' 96' ' ' GLN . . . -150.65 142.16 9.35 Favored Glycine 0 N--CA 1.445 -0.712 0 C-N-CA 120.875 -0.679 . . . . 0.0 111.768 179.855 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' THR . . . . . 0.414 ' HB ' ' CZ ' ' A' ' 122' ' ' PHE . 0.2 OUTLIER -62.68 150.03 42.09 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 120.937 0.398 . . . . 0.0 111.524 -179.924 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 2.2 p -119.54 129.26 75.55 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.754 -179.762 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 55.7 t30 -98.24 -39.51 8.81 Favored 'General case' 0 N--CA 1.463 0.175 0 CA-C-O 121.145 0.498 . . . . 0.0 110.274 179.385 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 2.2 tpt180 -145.93 153.29 40.66 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.223 -179.883 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 5.8 p -151.22 133.09 5.39 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.07 179.763 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 1.5 m -121.27 122.88 40.89 Favored 'General case' 0 C--N 1.32 -0.674 0 N-CA-C 110.129 -0.323 . . . . 0.0 110.129 179.612 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' ILE . . . . . 0.434 HD13 ' HA2' ' A' ' 116' ' ' GLY . 21.0 tt -113.49 144.36 21.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 120.935 0.398 . . . . 0.0 110.729 -179.514 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 27.0 tp -132.45 128.7 38.02 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.305 179.662 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -86.91 114.56 23.65 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.715 179.7 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . 0.408 ' O ' ' HG2' ' A' ' 115' ' ' LYS . 15.0 t70 -75.39 140.93 43.28 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.872 0.367 . . . . 0.0 110.796 -179.74 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -132.31 28.7 4.36 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 109.352 -0.61 . . . . 0.0 109.352 179.159 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 5.1 t80 -109.82 -2.37 17.32 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.589 -0.732 . . . . 0.0 109.707 179.919 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 106.89 6.29 34.81 Favored Glycine 0 N--CA 1.448 -0.51 0 CA-C-N 115.527 -0.76 . . . . 0.0 112.52 179.98 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 36.3 mt-30 -94.87 158.74 34.61 Favored Pre-proline 0 C--N 1.324 -0.511 0 N-CA-C 109.407 -0.59 . . . . 0.0 109.407 179.593 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 15.2 Cg_endo -58.11 119.3 6.47 Favored 'Trans proline' 0 C--N 1.345 0.388 0 C-N-CA 122.105 1.87 . . . . 0.0 110.88 178.886 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . 0.408 ' HG2' ' O ' ' A' ' 109' ' ' ASP . 58.3 mttt -74.4 173.37 10.38 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 109.976 -0.379 . . . . 0.0 109.976 -179.499 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . 0.434 ' HA2' HD13 ' A' ' 106' ' ' ILE . . . 98.32 3.27 57.68 Favored Glycine 0 N--CA 1.443 -0.844 0 C-N-CA 120.178 -1.01 . . . . 0.0 112.165 179.626 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 5.2 m-30 -54.82 117.56 3.51 Favored 'General case' 0 N--CA 1.463 0.206 0 N-CA-C 110.188 -0.301 . . . . 0.0 110.188 179.582 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -147.29 168.42 21.79 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.046 0.45 . . . . 0.0 111.451 -178.811 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 34.5 p90 -148.24 129.84 14.98 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.643 -0.708 . . . . 0.0 109.722 178.41 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 6.4 m -105.3 145.95 12.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 N-CA-C 109.742 -0.466 . . . . 0.0 109.742 179.781 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 6.1 pt-20 -133.9 152.58 51.91 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 120.657 0.265 . . . . 0.0 111.005 -179.701 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 122' ' ' PHE . . . . . 0.414 ' CZ ' ' HB ' ' A' ' 100' ' ' THR . 13.0 t80 -148.64 167.01 26.6 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.124 179.525 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 10.1 t -83.44 -41.92 17.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.488 -0.324 . . . . 0.0 111.535 -179.286 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 43.6 mm-40 -74.02 132.12 42.06 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.121 0.486 . . . . 0.0 111.593 -179.087 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 2.4 mp -74.71 -35.51 37.44 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.444 -179.657 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -59.25 -33.49 71.1 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.151 0.5 . . . . 0.0 110.937 -179.692 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -65.56 -54.97 20.52 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.926 179.958 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 10.3 p -66.49 -29.6 47.06 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.804 -179.564 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 8.3 tt0 -60.39 -42.62 96.28 Favored 'General case' 0 C--N 1.333 -0.142 0 CA-C-O 120.909 0.385 . . . . 0.0 110.431 179.619 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 29.3 m-80 -73.59 -31.0 63.35 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.119 179.282 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -67.93 -52.44 36.08 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.664 -0.698 . . . . 0.0 111.274 -179.885 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 4.0 pp -64.23 -22.22 66.87 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.85 0.357 . . . . 0.0 111.015 -179.802 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 5.5 tp -77.55 -55.72 5.13 Favored 'General case' 0 N--CA 1.451 -0.403 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.46 179.556 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 33.7 mt -123.74 103.04 8.14 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.078 -179.836 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -145.42 -71.25 0.26 Allowed 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 120.788 0.328 . . . . 0.0 111.56 -179.316 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 4.1 pt-20 -66.61 110.35 3.16 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.268 0.556 . . . . 0.0 111.268 -179.224 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 14.0 m -153.45 -58.14 0.13 Allowed 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.787 -0.642 . . . . 0.0 109.726 179.334 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -163.88 122.15 1.88 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.1 -0.5 . . . . 0.0 109.978 179.174 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -138.83 115.61 10.74 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 109.189 -0.671 . . . . 0.0 109.189 179.425 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 3.3 t60 64.83 16.45 10.47 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-O 120.896 0.379 . . . . 0.0 110.853 179.883 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 91.39 6.28 66.42 Favored Glycine 0 N--CA 1.448 -0.522 0 C-N-CA 120.893 -0.67 . . . . 0.0 111.761 -179.034 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -119.99 160.45 22.73 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 110.204 -0.295 . . . . 0.0 110.204 179.794 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 14.2 pt20 -108.22 126.5 52.87 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 109.443 -0.577 . . . . 0.0 109.443 178.573 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -112.47 175.43 5.44 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.688 -179.553 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 78.4 tttt -116.97 124.04 48.41 Favored 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 109.461 -0.57 . . . . 0.0 109.461 178.73 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 99.1 t -116.01 125.24 73.03 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.639 0 CA-C-O 120.941 0.4 . . . . 0.0 110.448 179.862 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 11.9 t -127.36 149.58 49.99 Favored 'General case' 0 N--CA 1.447 -0.624 0 N-CA-C 109.583 -0.525 . . . . 0.0 109.583 179.927 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -65.58 127.26 31.17 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.55 -0.295 . . . . 0.0 110.964 -179.829 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 19.9 ttpt -91.2 66.42 5.66 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.376 0.607 . . . . 0.0 109.683 179.88 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 150' ' ' ARG . . . . . 0.484 ' C ' ' HD2' ' A' ' 150' ' ' ARG . 0.0 OUTLIER . . . . . 0 C--N 1.322 -0.612 0 N-CA-C 109.439 -0.578 . . . . 0.0 109.439 179.819 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.177 0 CA-C-O 120.434 0.159 . . . . 0.0 110.623 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 64.7 tp -75.33 92.63 2.8 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-O 121.225 0.536 . . . . 0.0 110.569 179.696 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 4.3 ttp180 -155.84 159.73 39.62 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.836 -0.62 . . . . 0.0 109.675 -179.673 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 16.9 mt-10 -86.17 23.47 1.53 Allowed 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.371 0.605 . . . . 0.0 111.185 179.91 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 6.4 ptm -83.56 14.18 3.98 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.061 179.39 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 45.4 mt-30 -73.23 -27.53 61.65 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.837 -0.619 . . . . 0.0 109.713 179.408 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -75.8 -12.27 60.14 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.509 -0.769 . . . . 0.0 110.146 179.136 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 3.4 tmmt? -74.89 -2.62 27.69 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.214 -0.903 . . . . 0.0 110.21 179.681 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 8.1 p -60.5 -23.95 29.96 Favored 'Isoleucine or valine' 0 C--O 1.235 0.302 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.831 179.337 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 26.1 mm-40 -59.46 -27.28 65.95 Favored 'General case' 0 N--CA 1.457 -0.087 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.285 179.187 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 12.7 mtmm -97.85 -37.25 9.91 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.945 -0.571 . . . . 0.0 110.441 178.455 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -59.38 -22.32 61.19 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.687 -179.748 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 17.9 ptt? -58.47 -23.09 56.83 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.767 0.317 . . . . 0.0 110.859 179.814 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -105.86 4.37 39.18 Favored Glycine 0 N--CA 1.447 -0.592 0 C-N-CA 120.668 -0.777 . . . . 0.0 111.711 179.258 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.3 0 CA-C-O 121.139 0.495 . . . . 0.0 110.635 -179.829 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.453 -0.318 0 CA-C-O 120.867 0.365 . . . . 0.0 110.175 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -76.12 0.82 17.51 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.984 0.421 . . . . 0.0 111.243 179.826 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 57.1 tp60 -120.44 -50.52 2.22 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.972 179.679 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -85.04 -57.18 3.2 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 111.927 0.343 . . . . 0.0 111.927 -179.384 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 2.1 tp10 -63.09 -29.23 70.65 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-O 121.344 0.592 . . . . 0.0 110.211 -179.62 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 52.7 tptt -58.98 -28.59 66.49 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.459 -0.792 . . . . 0.0 111.251 179.453 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 63.4 mt-10 -62.43 -24.32 67.36 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-O 120.906 0.384 . . . . 0.0 111.174 -179.786 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 11.9 tp10 -96.83 -35.69 10.86 Favored 'General case' 0 C--N 1.318 -0.797 0 N-CA-C 109.841 -0.429 . . . . 0.0 109.841 178.423 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . 0.415 ' HA ' ' O ' ' A' ' 122' ' ' PHE . 57.5 t -65.98 -42.31 91.5 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.878 -179.337 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 24.9 p-10 -71.33 -14.71 62.28 Favored 'General case' 0 N--CA 1.466 0.325 0 CA-C-O 121.118 0.485 . . . . 0.0 110.864 -179.726 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' SER . . . . . 0.4 ' OG ' ' HD3' ' A' ' 75' ' ' ARG . 12.4 p -97.89 -14.61 20.59 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.093 178.894 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . 0.459 ' CZ ' HG12 ' A' ' 125' ' ' ILE . 0.1 OUTLIER -111.23 46.47 1.08 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.423 -0.808 . . . . 0.0 110.401 -178.85 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -122.25 172.42 8.31 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.456 179.921 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 10.4 pt -130.83 140.71 48.02 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.61 179.394 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 87.2 t80 -95.54 123.07 38.91 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.839 -0.619 . . . . 0.0 109.836 179.908 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 3.9 t -106.48 113.18 42.43 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.849 -179.426 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -120.45 165.68 13.79 Favored Glycine 0 N--CA 1.448 -0.516 0 C-N-CA 120.937 -0.649 . . . . 0.0 111.801 179.938 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 2.6 m-20 61.79 39.44 13.96 Favored 'General case' 0 N--CA 1.471 0.598 0 CA-C-O 121.112 0.482 . . . . 0.0 111.014 -179.602 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 2.3 t -81.4 162.99 3.39 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.693 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.331 -179.417 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . 0.731 ' OD2' ' HB2' ' A' ' 142' ' ' ARG . 0.3 OUTLIER -63.87 138.52 58.51 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 109.845 -0.428 . . . . 0.0 109.845 179.445 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 30.5 p90 -62.67 -12.44 23.55 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.107 -0.497 . . . . 0.0 112.057 -179.443 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -123.24 27.74 7.41 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.744 0.307 . . . . 0.0 110.948 -179.485 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -86.08 147.55 26.12 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 116.444 -0.344 . . . . 0.0 110.783 -179.975 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' THR . . . . . 0.478 ' HB ' ' OE1' ' A' ' 89' ' ' GLU . 15.5 p -108.88 146.82 34.59 Favored Pre-proline 0 C--N 1.325 -0.487 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.894 179.658 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 16.1 Cg_endo -57.41 -37.43 97.45 Favored 'Trans proline' 0 C--N 1.344 0.29 0 C-N-CA 122.663 2.242 . . . . 0.0 113.2 -179.083 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . 0.478 ' OE1' ' HB ' ' A' ' 87' ' ' THR . 5.4 mp0 -64.75 -47.46 78.12 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.912 -178.347 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . 0.411 ' HG2' ' O ' ' A' ' 87' ' ' THR . 7.4 pt-20 -67.01 -24.19 66.0 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.843 0.354 . . . . 0.0 111.157 -178.958 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 75.0 t -79.97 -47.99 20.91 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.96 -179.535 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -69.43 -33.76 73.44 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.569 -0.287 . . . . 0.0 111.593 -178.356 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 11.1 pt20 -76.65 -30.17 56.72 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 120.516 -0.474 . . . . 0.0 111.143 -179.176 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 8.1 t60 -73.13 -40.04 65.23 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.053 0.454 . . . . 0.0 109.976 179.898 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 18.6 m-30 -78.35 -14.57 59.35 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.301 179.751 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . 0.588 ' HA ' ' O ' ' A' ' 99' ' ' GLY . 28.2 tt0 -67.57 -20.85 65.44 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.401 -0.818 . . . . 0.0 110.257 179.699 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 5.1 m -69.18 -23.09 63.88 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.648 -0.706 . . . . 0.0 110.173 179.241 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 26.5 m -99.91 -42.17 6.9 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.76 -0.655 . . . . 0.0 110.324 179.276 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . 0.588 ' O ' ' HA ' ' A' ' 96' ' ' GLN . . . -150.63 144.72 12.18 Favored Glycine 0 N--CA 1.442 -0.95 0 CA-C-N 115.906 -0.588 . . . . 0.0 111.84 179.897 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -63.25 146.5 53.29 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 120.993 0.425 . . . . 0.0 111.304 179.857 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 2.0 p -115.73 126.47 73.28 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.777 -179.533 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 5.5 t30 -94.57 -39.07 10.57 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 121.179 0.514 . . . . 0.0 110.047 179.309 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 3.0 tpt180 -150.01 151.98 34.17 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.121 -179.872 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 4.0 p -148.59 128.97 4.53 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-O 121.09 0.472 . . . . 0.0 110.122 179.483 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' THR . . . . . 0.59 ' HB ' ' CE1' ' A' ' 119' ' ' TYR . 4.9 m -121.47 122.38 39.63 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 116.473 -0.33 . . . . 0.0 110.573 179.845 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 19.6 tt -108.87 148.54 12.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 O-C-N 123.206 0.316 . . . . 0.0 110.408 179.741 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 17.6 tp -136.75 124.89 22.99 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.386 -179.914 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -89.0 117.37 27.97 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 120.81 0.338 . . . . 0.0 110.651 179.434 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 4.7 t70 -77.94 139.64 39.21 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.698 0.285 . . . . 0.0 110.762 179.596 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -123.34 32.6 5.6 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 121.061 0.457 . . . . 0.0 110.261 179.274 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 1.7 t80 -113.73 -3.06 13.57 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.302 -179.889 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 106.65 6.7 35.06 Favored Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 120.828 -0.701 . . . . 0.0 112.738 -179.565 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 113' ' ' GLN . . . . . 0.4 ' HB3' ' HD2' ' A' ' 114' ' ' PRO . 27.5 mt-30 -92.02 158.81 38.96 Favored Pre-proline 0 C--N 1.323 -0.568 0 N-CA-C 109.564 -0.532 . . . . 0.0 109.564 -179.939 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 114' ' ' PRO . . . . . 0.4 ' HD2' ' HB3' ' A' ' 113' ' ' GLN . 18.0 Cg_endo -59.7 106.45 0.32 Allowed 'Trans proline' 0 C--N 1.347 0.466 0 C-N-CA 122.411 2.074 . . . . 0.0 111.528 179.148 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 5.2 mttp -68.3 175.46 3.29 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.07 -0.513 . . . . 0.0 110.588 -179.475 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 98.51 4.02 57.28 Favored Glycine 0 N--CA 1.441 -0.993 0 C-N-CA 120.04 -1.076 . . . . 0.0 111.658 -179.628 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 30.0 m-85 -52.82 116.06 2.14 Favored 'General case' 0 CA--C 1.521 -0.152 0 O-C-N 123.776 0.339 . . . . 0.0 110.364 179.86 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -144.05 176.19 9.48 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 121.057 0.456 . . . . 0.0 111.236 -179.255 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 119' ' ' TYR . . . . . 0.59 ' CE1' ' HB ' ' A' ' 105' ' ' THR . 50.0 p90 -159.93 137.34 9.64 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.497 -0.774 . . . . 0.0 109.171 178.93 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 10.9 m -111.01 143.57 20.63 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 178.925 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 4.4 pt-20 -128.8 157.05 42.56 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 116.562 -0.29 . . . . 0.0 111.054 -179.207 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 122' ' ' PHE . . . . . 0.415 ' O ' ' HA ' ' A' ' 72' ' ' VAL . 11.9 t80 -161.37 168.99 22.85 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 109.691 -0.485 . . . . 0.0 109.691 179.491 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 1.8 t -85.54 -48.38 16.21 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-O 120.921 0.391 . . . . 0.0 111.342 -179.182 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 11.0 mt-10 -62.44 130.31 44.6 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.956 -0.565 . . . . 0.0 111.795 -178.971 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . 0.459 HG12 ' CZ ' ' A' ' 75' ' ' ARG . 2.3 mp -76.06 -32.4 23.0 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.468 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.63 -179.795 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 13.2 t70 -60.43 -39.49 87.64 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.102 0.477 . . . . 0.0 110.232 179.333 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -61.36 -53.64 54.04 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.523 -0.762 . . . . 0.0 111.545 179.963 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 7.3 p -68.74 -28.11 38.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.127 -179.511 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 25.5 tt0 -58.86 -47.6 84.32 Favored 'General case' 0 C--N 1.334 -0.096 0 CA-C-O 121.023 0.439 . . . . 0.0 110.32 179.629 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 76.8 m-20 -70.9 -33.29 70.42 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.741 -0.663 . . . . 0.0 109.864 179.533 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -66.06 -40.52 90.98 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.542 -0.754 . . . . 0.0 112.219 -179.408 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 3.9 pp -79.49 -16.84 55.35 Favored 'General case' 0 C--N 1.329 -0.325 0 O-C-N 122.128 -0.358 . . . . 0.0 110.959 179.905 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 5.2 tp -86.12 -50.15 7.23 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.283 -179.529 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 28.3 mt -132.47 112.68 12.33 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.501 -0.318 . . . . 0.0 110.944 -179.208 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 3.5 m-20 -168.95 -49.41 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.336 179.664 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 1.9 pt-20 -75.09 79.48 2.25 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.58 -0.737 . . . . 0.0 111.206 179.737 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 6.5 m -135.4 -59.93 0.76 Allowed 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.912 -0.586 . . . . 0.0 110.188 179.224 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 7.9 tm-20 -149.31 128.05 12.48 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 109.606 -0.516 . . . . 0.0 109.606 179.959 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -149.78 121.04 7.82 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 179.329 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 140' ' ' HIS . . . . . 0.655 ' HB3' ' OD2' ' A' ' 83' ' ' ASP . 5.4 t60 60.83 13.47 4.46 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-O 121.076 0.465 . . . . 0.0 111.614 178.742 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 98.58 -6.11 60.7 Favored Glycine 0 N--CA 1.447 -0.611 0 C-N-CA 120.803 -0.713 . . . . 0.0 112.216 -179.621 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 142' ' ' ARG . . . . . 0.731 ' HB2' ' OD2' ' A' ' 83' ' ' ASP . 2.1 mpt_? -114.01 -169.32 1.5 Allowed 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.008 0.432 . . . . 0.0 110.187 179.347 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 15.3 pt20 -131.65 138.74 48.88 Favored 'General case' 0 C--N 1.319 -0.754 0 N-CA-C 109.254 -0.647 . . . . 0.0 109.254 178.796 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -123.2 177.79 5.41 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-N 115.867 -0.606 . . . . 0.0 109.935 -179.528 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 1.7 tmtp? -117.27 121.8 42.17 Favored 'General case' 0 C--N 1.315 -0.907 0 N-CA-C 109.588 -0.523 . . . . 0.0 109.588 179.09 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 98.8 t -114.82 119.78 62.61 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-O 120.827 0.346 . . . . 0.0 110.911 -179.427 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 5.1 t -122.09 153.15 39.05 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.022 179.665 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -70.83 125.61 27.33 Favored 'General case' 0 N--CA 1.445 -0.713 0 CA-C-O 120.858 0.361 . . . . 0.0 111.187 179.956 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 18.9 ttpp -90.88 68.95 6.38 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.502 0.668 . . . . 0.0 109.29 179.909 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 13.0 tpt180 . . . . . 0 C--N 1.319 -0.724 0 CA-C-N 115.731 -0.668 . . . . 0.0 109.965 -179.999 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.233 0.228 0 N-CA-C 110.374 -0.232 . . . . 0.0 110.374 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 29.4 tp -73.81 84.43 1.67 Allowed 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.226 0.536 . . . . 0.0 110.387 179.741 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 17.0 tpt180 -130.8 151.83 50.8 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.161 -179.623 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 26.8 mm-40 -82.45 19.49 1.24 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.301 -179.825 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 11.9 ptm -83.7 4.37 29.0 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.735 -179.431 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 43.5 mt-30 -66.19 -22.03 66.33 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.945 -0.571 . . . . 0.0 110.578 179.911 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -78.89 -8.69 59.07 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.601 -0.727 . . . . 0.0 111.446 -179.763 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . 0.449 ' O ' ' HG2' ' A' ' 52' ' ' GLU . 10.3 ttpt -78.23 -6.31 54.54 Favored 'General case' 0 C--O 1.234 0.28 0 CA-C-O 120.991 0.424 . . . . 0.0 110.345 -179.869 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 8.4 p -59.32 -25.65 31.4 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.325 0 CA-C-N 115.936 -0.575 . . . . 0.0 111.581 -179.48 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 39.5 mt-10 -61.47 -30.61 70.71 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 121.008 0.432 . . . . 0.0 110.922 -179.876 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 15.3 mtmm -95.83 -36.27 11.19 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.244 -179.532 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . 0.449 ' HG2' ' O ' ' A' ' 48' ' ' LYS . 3.0 mm-40 -75.63 -16.99 60.14 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.936 -178.337 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 25.7 ptm -64.47 -24.11 67.51 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.178 0.513 . . . . 0.0 110.117 178.731 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -97.83 1.06 59.49 Favored Glycine 0 N--CA 1.446 -0.69 0 N-CA-C 110.885 -0.886 . . . . 0.0 110.885 178.595 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.327 -0.373 0 CA-C-O 121.235 0.54 . . . . 0.0 110.215 179.931 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.52 -0.195 0 CA-C-O 120.877 0.37 . . . . 0.0 110.53 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -80.59 5.75 14.54 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.012 0.434 . . . . 0.0 111.136 -179.762 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 49.7 tp60 -125.16 -40.38 2.15 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.448 -0.342 . . . . 0.0 111.006 179.616 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -94.1 -53.45 3.96 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.917 0.389 . . . . 0.0 111.341 179.826 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 3.2 tp10 -70.12 -30.36 67.53 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.032 -179.421 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.11 -25.76 64.11 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.542 -179.886 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 39.9 mt-10 -62.98 -23.77 67.59 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.186 0.517 . . . . 0.0 110.925 179.883 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . 0.607 ' O ' ' HD3' ' A' ' 75' ' ' ARG . 8.3 tp10 -96.66 -43.59 7.49 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.992 -0.549 . . . . 0.0 109.572 178.225 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 41.3 t -61.15 -44.13 97.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 115.467 -0.788 . . . . 0.0 112.459 -178.709 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 8.5 p-10 -63.29 -27.57 69.42 Favored 'General case' 0 N--CA 1.471 0.624 0 N-CA-C 111.921 0.341 . . . . 0.0 111.921 -179.31 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 40.0 t -95.54 -2.27 48.84 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-O 120.909 0.385 . . . . 0.0 110.741 179.772 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . 0.607 ' HD3' ' O ' ' A' ' 71' ' ' GLU . 2.2 mpt_? -115.26 46.95 1.37 Allowed 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.389 0.614 . . . . 0.0 109.582 -179.473 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -125.43 174.48 8.16 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.188 -0.914 . . . . 0.0 110.436 179.874 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 7.4 pt -131.02 140.48 48.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-O 120.742 0.306 . . . . 0.0 110.794 179.141 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 13.7 t80 -92.75 118.72 31.38 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.616 -0.72 . . . . 0.0 109.361 179.636 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 6.8 t -104.01 109.51 27.46 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-N 116.332 -0.395 . . . . 0.0 109.974 179.452 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -118.03 165.85 12.74 Favored Glycine 0 N--CA 1.447 -0.576 0 C-N-CA 120.773 -0.727 . . . . 0.0 111.995 -179.262 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 9.9 m120 59.21 41.12 20.69 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-O 121.043 0.449 . . . . 0.0 110.741 -179.621 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 2.1 t -80.02 167.56 2.15 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-N 115.566 -0.743 . . . . 0.0 110.41 -179.172 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . 0.459 ' OD1' ' HD3' ' A' ' 142' ' ' ARG . 33.0 t70 -75.03 141.34 43.91 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.043 0.449 . . . . 0.0 110.627 179.901 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 29.2 p90 -63.09 -17.02 61.84 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.673 -0.694 . . . . 0.0 112.613 -178.743 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -110.42 8.27 23.13 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.828 0.346 . . . . 0.0 111.481 -179.592 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' CYS . . . . . 0.485 ' SG ' ' HB2' ' A' ' 140' ' ' HIS . 1.0 OUTLIER -73.27 142.42 47.22 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.154 0.502 . . . . 0.0 111.299 -179.893 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' THR . . . . . 0.493 ' O ' ' HG2' ' A' ' 90' ' ' GLU . 12.2 p -109.73 154.12 42.64 Favored Pre-proline 0 C--N 1.322 -0.602 0 CA-C-N 115.464 -0.789 . . . . 0.0 109.856 178.997 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . 0.546 ' O ' ' HG2' ' A' ' 92' ' ' GLN . 14.0 Cg_endo -57.25 -36.83 99.07 Favored 'Trans proline' 0 C--O 1.233 0.236 0 C-N-CA 122.391 2.061 . . . . 0.0 112.274 -179.726 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . 0.438 ' O ' ' HG2' ' A' ' 93' ' ' GLN . 28.2 mp0 -62.93 -51.51 66.64 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.781 -179.42 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . 0.495 ' O ' ' HB2' ' A' ' 94' ' ' HIS . 8.3 pt-20 -63.96 -22.68 67.03 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.615 0.245 . . . . 0.0 111.344 -178.751 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 66.5 t -82.98 -48.05 17.97 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.521 -179.583 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' GLN . . . . . 0.546 ' HG2' ' O ' ' A' ' 88' ' ' PRO . 16.4 pt20 -71.86 -33.56 68.51 Favored 'General case' 0 N--CA 1.465 0.284 0 N-CA-C 111.881 0.326 . . . . 0.0 111.881 -178.397 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . 0.438 ' HG2' ' O ' ' A' ' 89' ' ' GLU . 0.8 OUTLIER -77.27 -27.87 53.29 Favored 'General case' 0 C--N 1.329 -0.32 0 C-N-CA 120.464 -0.494 . . . . 0.0 110.636 -179.515 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' HIS . . . . . 0.495 ' HB2' ' O ' ' A' ' 90' ' ' GLU . 0.1 OUTLIER -71.9 -43.33 65.52 Favored 'General case' 0 CA--C 1.517 -0.295 0 CA-C-O 121.11 0.481 . . . . 0.0 110.276 179.719 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 21.0 m-30 -79.13 -15.36 58.25 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.93 -179.453 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . 0.501 ' HA ' ' O ' ' A' ' 99' ' ' GLY . 33.6 tt0 -64.64 -23.5 67.28 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.558 179.967 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 13.4 m -65.72 -33.41 75.8 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.409 179.454 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 11.1 m -94.95 -40.78 9.5 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.368 179.871 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . 0.501 ' O ' ' HA ' ' A' ' 96' ' ' GLN . . . -146.46 130.39 3.66 Favored Glycine 0 N--CA 1.444 -0.829 0 C-N-CA 120.688 -0.768 . . . . 0.0 111.742 -179.916 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' THR . . . . . 0.416 ' HB ' ' CZ ' ' A' ' 122' ' ' PHE . 0.2 OUTLIER -58.56 146.45 35.7 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 120.984 0.421 . . . . 0.0 111.539 179.894 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 2.4 p -111.99 131.43 63.43 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.112 -179.133 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 23.1 t-20 -99.19 -45.02 6.04 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 178.566 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 18.5 mmt180 -141.55 150.23 41.84 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-N 115.509 -0.769 . . . . 0.0 110.088 179.473 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 6.1 p -146.17 136.53 18.2 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-O 121.013 0.435 . . . . 0.0 110.191 179.385 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' THR . . . . . 0.513 ' HB ' ' CE1' ' A' ' 119' ' ' TYR . 1.4 m -128.15 129.4 46.47 Favored 'General case' 0 C--N 1.319 -0.722 0 N-CA-C 109.731 -0.47 . . . . 0.0 109.731 179.309 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 20.1 tt -120.47 147.47 24.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-O 120.953 0.406 . . . . 0.0 111.294 -179.298 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 15.3 tp -133.11 143.52 49.34 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.25 179.361 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -104.5 119.34 38.76 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 120.588 0.232 . . . . 0.0 110.662 179.463 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 8.5 t70 -80.08 130.41 35.23 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.992 0.425 . . . . 0.0 111.245 -179.76 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 10.8 mmmm -114.66 20.51 15.23 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.272 -179.799 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 63.9 t80 -98.68 -11.26 22.18 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.491 0.662 . . . . 0.0 109.913 -179.446 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 111.15 8.56 23.49 Favored Glycine 0 N--CA 1.448 -0.534 0 CA-C-N 115.557 -0.747 . . . . 0.0 112.394 -179.269 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 113' ' ' GLN . . . . . 0.424 ' HB3' ' HD2' ' A' ' 114' ' ' PRO . 24.4 mt-30 -94.42 160.58 31.44 Favored Pre-proline 0 C--N 1.323 -0.553 0 N-CA-C 109.188 -0.671 . . . . 0.0 109.188 179.663 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 114' ' ' PRO . . . . . 0.424 ' HD2' ' HB3' ' A' ' 113' ' ' GLN . 14.4 Cg_endo -57.37 114.2 1.84 Allowed 'Trans proline' 0 C--N 1.346 0.415 0 C-N-CA 122.357 2.038 . . . . 0.0 111.686 179.119 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 6.3 mttp -76.98 179.3 6.3 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.403 -179.897 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 94.99 1.45 63.1 Favored Glycine 0 N--CA 1.445 -0.718 0 C-N-CA 120.056 -1.068 . . . . 0.0 111.488 -179.884 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 6.8 t80 -53.74 117.31 3.06 Favored 'General case' 0 C--O 1.234 0.278 0 O-C-N 123.806 0.357 . . . . 0.0 110.125 179.744 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -145.32 175.34 10.37 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.781 -179.356 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 119' ' ' TYR . . . . . 0.513 ' CE1' ' HB ' ' A' ' 105' ' ' THR . 51.7 p90 -157.48 134.16 9.93 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.561 -0.745 . . . . 0.0 109.292 179.047 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 14.7 m -110.49 140.15 30.88 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 N-CA-C 109.766 -0.457 . . . . 0.0 109.766 179.705 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 7.9 pt-20 -124.45 154.22 40.81 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 116.596 -0.275 . . . . 0.0 110.642 -179.993 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 122' ' ' PHE . . . . . 0.416 ' CZ ' ' HB ' ' A' ' 100' ' ' THR . 11.0 t80 -149.29 164.84 33.71 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.203 179.94 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 11.8 t -81.56 -42.64 19.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.317 -179.579 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 81.9 mt-10 -76.38 138.73 40.6 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.043 0.449 . . . . 0.0 111.171 -179.541 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 2.5 mp -75.87 -30.55 21.2 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-N 115.745 -0.661 . . . . 0.0 110.029 179.572 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -54.15 -47.21 72.18 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 115.802 -0.636 . . . . 0.0 111.17 179.596 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -56.26 -58.0 9.84 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.396 -0.82 . . . . 0.0 111.488 -179.362 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 8.9 p -66.04 -32.8 59.73 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-N 116.31 -0.404 . . . . 0.0 111.676 -179.049 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 44.9 tt0 -60.99 -41.11 95.85 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.817 0.341 . . . . 0.0 110.88 -179.579 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 94.4 m-20 -79.4 -28.9 41.83 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.148 0.499 . . . . 0.0 110.01 179.36 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -70.12 -39.13 75.63 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.651 -0.704 . . . . 0.0 112.045 -179.414 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 4.2 pp -75.89 -11.47 59.97 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.938 0.399 . . . . 0.0 110.809 -179.901 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -88.84 -58.94 2.37 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.841 -0.618 . . . . 0.0 111.063 -179.923 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 75.8 mt -125.53 108.27 11.44 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.681 -178.864 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 2.8 m-20 -162.99 -50.66 0.04 OUTLIER 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.771 -0.65 . . . . 0.0 110.801 179.876 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 5.0 pt-20 -73.35 85.11 1.45 Allowed 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.779 -0.646 . . . . 0.0 111.448 -179.917 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 6.3 m -137.97 -59.32 0.65 Allowed 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.58 -0.736 . . . . 0.0 110.154 179.091 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 22.7 tt0 -153.79 127.94 9.04 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.217 -179.816 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -145.57 115.61 7.42 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 108.764 -0.828 . . . . 0.0 108.764 179.101 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 140' ' ' HIS . . . . . 0.485 ' HB2' ' SG ' ' A' ' 86' ' ' CYS . 2.8 t60 65.83 21.09 11.47 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-O 121.058 0.456 . . . . 0.0 110.373 -179.596 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 87.53 4.4 80.13 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.213 -179.601 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 142' ' ' ARG . . . . . 0.459 ' HD3' ' OD1' ' A' ' 83' ' ' ASP . 0.8 OUTLIER -125.66 165.19 19.02 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 109.945 -0.391 . . . . 0.0 109.945 179.838 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 12.9 pt20 -107.85 139.61 42.18 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-O 120.982 0.42 . . . . 0.0 110.697 179.656 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -121.68 178.08 4.99 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.037 -179.97 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 28.5 ttpt -116.22 122.41 44.93 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 109.912 -0.403 . . . . 0.0 109.912 179.063 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 95.7 t -113.92 123.13 69.28 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-O 120.968 0.413 . . . . 0.0 110.525 179.713 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 30.5 t -125.05 149.37 47.86 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 109.507 -0.553 . . . . 0.0 109.507 179.892 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -68.83 127.55 33.48 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 110.56 -0.163 . . . . 0.0 110.56 179.687 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 64.8 tttp -90.94 83.15 5.62 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.294 0.569 . . . . 0.0 110.505 -179.74 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 23.8 tpt180 . . . . . 0 C--N 1.319 -0.751 0 CA-C-N 115.741 -0.663 . . . . 0.0 109.36 179.01 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.233 0.233 0 N-CA-C 110.085 -0.339 . . . . 0.0 110.085 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 18.6 tp -81.56 85.88 6.45 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.17 0.51 . . . . 0.0 110.067 179.622 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 13.4 tpp180 -145.95 132.36 19.65 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.899 -0.591 . . . . 0.0 109.652 179.96 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 3.3 tp10 -82.79 39.26 0.61 Allowed 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.559 0.695 . . . . 0.0 110.911 -179.742 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 17.6 ptt? -87.83 11.66 14.98 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.656 -0.702 . . . . 0.0 109.538 179.089 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 19.4 mm-40 -66.87 -22.5 65.98 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.277 -0.874 . . . . 0.0 111.101 -179.682 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -68.8 -14.4 63.0 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 121.348 0.594 . . . . 0.0 110.6 179.54 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 20.2 ttpp -83.24 1.05 42.73 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.589 -0.732 . . . . 0.0 110.33 179.814 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 8.3 p -59.48 -26.2 33.6 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.205 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.971 -179.912 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 26.6 mt-10 -67.14 -24.67 65.93 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 115.912 -0.586 . . . . 0.0 110.344 179.534 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 11.4 mtmm -97.22 -29.74 13.4 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.579 -0.737 . . . . 0.0 110.594 179.331 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 38.0 mm-40 -80.96 -5.32 57.36 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.677 -179.661 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 10.7 ptp -62.33 -30.83 71.44 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.891 0.377 . . . . 0.0 110.652 -179.932 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -91.55 3.89 79.17 Favored Glycine 0 N--CA 1.447 -0.594 0 C-N-CA 120.722 -0.751 . . . . 0.0 111.319 178.838 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.325 -0.461 0 CA-C-N 115.432 -0.384 . . . . 0.0 110.275 -179.802 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.453 -0.285 0 CA-C-O 120.939 0.399 . . . . 0.0 110.488 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -76.44 -2.12 30.45 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.25 0.548 . . . . 0.0 110.793 179.865 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 64.7 tt0 -114.39 -54.71 2.56 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.923 179.924 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -85.49 -56.09 3.69 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.793 -178.509 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . 0.451 ' O ' HG23 ' A' ' 72' ' ' VAL . 1.2 tt0 -62.65 -31.48 72.35 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.952 0.406 . . . . 0.0 110.896 -179.61 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 48.7 tptt -55.55 -30.01 59.99 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.587 -0.733 . . . . 0.0 111.299 179.937 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 99.3 mt-10 -58.63 -41.6 86.32 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.027 0.441 . . . . 0.0 110.455 179.469 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . 0.415 ' O ' ' HD2' ' A' ' 75' ' ' ARG . 7.4 tp10 -76.86 -43.37 36.38 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.057 -0.519 . . . . 0.0 109.871 179.308 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . 0.451 HG23 ' O ' ' A' ' 68' ' ' GLU . 43.8 t -60.75 -40.34 84.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 115.648 -0.705 . . . . 0.0 111.624 -179.241 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 7.5 t0 -68.23 -23.26 64.78 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-O 121.318 0.58 . . . . 0.0 110.723 -179.934 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 1.2 t -95.29 -9.9 31.77 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 121.686 0.755 . . . . 0.0 109.782 179.705 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . 0.415 ' HD2' ' O ' ' A' ' 71' ' ' GLU . 0.0 OUTLIER -111.75 44.77 1.32 Allowed 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.396 -0.82 . . . . 0.0 110.659 -179.259 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' SER . . . . . 0.461 ' OG ' ' HE2' ' A' ' 149' ' ' LYS . 0.0 OUTLIER -126.92 171.69 11.07 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.818 179.367 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 13.8 pt -131.01 136.95 56.97 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-N 116.465 -0.334 . . . . 0.0 110.198 178.64 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' TYR . . . . . 0.449 ' O ' ' HA ' ' A' ' 146' ' ' VAL . 43.0 t80 -91.12 123.29 34.47 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.142 -179.896 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 10.4 t -107.04 111.92 37.72 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.658 -179.749 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -121.48 170.8 14.84 Favored Glycine 0 N--CA 1.446 -0.682 0 N-CA-C 111.362 -0.695 . . . . 0.0 111.362 179.974 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 13.1 m120 58.39 44.24 18.6 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-O 121.294 0.569 . . . . 0.0 110.441 -179.627 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.477 HG11 ' H ' ' A' ' 83' ' ' ASP . 1.7 t -90.07 172.1 1.03 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 CA-C-N 115.338 -0.846 . . . . 0.0 110.615 -179.011 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . 0.477 ' H ' HG11 ' A' ' 82' ' ' VAL . 9.2 t0 -68.74 137.25 53.91 Favored 'General case' 0 N--CA 1.451 -0.395 0 N-CA-C 109.666 -0.494 . . . . 0.0 109.666 179.476 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 34.9 p90 -61.71 -18.14 58.51 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.459 -179.28 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -118.15 20.59 13.14 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.511 -0.313 . . . . 0.0 111.332 179.942 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' CYS . . . . . 0.437 ' SG ' ' HB3' ' A' ' 83' ' ' ASP . 0.5 OUTLIER -77.16 145.25 37.83 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.984 0.421 . . . . 0.0 110.869 179.603 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' THR . . . . . 0.46 ' O ' ' HG2' ' A' ' 90' ' ' GLU . 55.9 p -103.08 151.22 38.43 Favored Pre-proline 0 C--N 1.323 -0.57 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.261 179.637 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -61.77 -29.2 82.84 Favored 'Trans proline' 0 C--O 1.233 0.24 0 C-N-CA 122.3 2.0 . . . . 0.0 111.93 179.835 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . 0.511 ' O ' ' HG2' ' A' ' 93' ' ' GLN . 27.8 mt-10 -66.27 -53.26 38.94 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.343 -0.844 . . . . 0.0 111.933 -178.837 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . 0.46 ' HG2' ' O ' ' A' ' 87' ' ' THR . 9.2 pt-20 -61.71 -24.98 67.13 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.967 0.413 . . . . 0.0 111.24 -179.268 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 69.3 t -79.84 -48.57 20.41 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.275 -179.106 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' GLN . . . . . 0.4 ' O ' ' HB2' ' A' ' 96' ' ' GLN . 0.0 OUTLIER -70.29 -32.88 70.85 Favored 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 112.196 0.443 . . . . 0.0 112.196 -178.183 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . 0.511 ' HG2' ' O ' ' A' ' 89' ' ' GLU . 9.6 pt20 -79.79 -28.77 40.25 Favored 'General case' 0 C--N 1.325 -0.491 0 C-N-CA 120.061 -0.656 . . . . 0.0 111.19 -179.331 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 58.7 t-80 -68.92 -45.22 71.4 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.808 0.337 . . . . 0.0 110.57 179.989 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 23.9 m-85 -78.53 -11.8 59.98 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.68 -179.388 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . 0.56 ' HA ' ' O ' ' A' ' 99' ' ' GLY . 8.2 tt0 -68.9 -21.7 64.22 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 121.23 0.538 . . . . 0.0 109.958 179.802 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 4.5 m -66.52 -32.24 73.47 Favored 'General case' 0 N--CA 1.452 -0.347 0 CA-C-N 115.673 -0.694 . . . . 0.0 109.531 178.545 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 2.1 m -88.25 -47.83 8.14 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.546 -0.752 . . . . 0.0 110.075 179.575 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . 0.56 ' O ' ' HA ' ' A' ' 96' ' ' GLN . . . -147.07 142.35 10.23 Favored Glycine 0 N--CA 1.447 -0.603 0 C-N-CA 121.023 -0.608 . . . . 0.0 111.751 179.801 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -60.07 144.03 50.56 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 120.827 0.346 . . . . 0.0 111.503 -179.639 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 2.3 p -114.86 127.76 72.27 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.289 179.832 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 20.1 t-20 -95.1 -40.99 9.34 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.145 0.498 . . . . 0.0 110.098 179.649 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 3.2 tpp180 -144.87 155.91 43.72 Favored 'General case' 0 N--CA 1.45 -0.425 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.263 -179.487 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 5.7 p -154.32 133.95 3.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.109 179.804 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -126.13 127.74 46.23 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 109.736 -0.468 . . . . 0.0 109.736 179.006 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' ILE . . . . . 0.408 HD13 ' HA2' ' A' ' 116' ' ' GLY . 20.1 tt -111.04 146.07 16.54 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-O 121.017 0.437 . . . . 0.0 110.951 -179.368 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 43.3 tp -130.15 138.32 50.58 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.26 179.816 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -103.64 113.68 27.38 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 109.963 -0.384 . . . . 0.0 109.963 179.453 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 6.4 t70 -72.3 133.32 44.94 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.054 0.454 . . . . 0.0 111.367 -179.677 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 11.2 mmmt -111.31 19.22 18.5 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.722 -179.868 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 3.0 t80 -101.0 -9.93 21.0 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.973 0.416 . . . . 0.0 110.324 -179.372 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 110.83 -0.53 28.8 Favored Glycine 0 N--CA 1.449 -0.441 0 CA-C-N 115.788 -0.642 . . . . 0.0 112.227 -179.808 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 3.5 mt-30 -81.28 158.63 69.13 Favored Pre-proline 0 C--N 1.323 -0.581 0 N-CA-C 110.332 -0.247 . . . . 0.0 110.332 -179.911 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 13.5 Cg_endo -56.57 103.77 0.13 Allowed 'Trans proline' 0 C--N 1.347 0.486 0 C-N-CA 122.687 2.258 . . . . 0.0 111.319 178.419 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 7.8 mttp -68.84 176.67 2.94 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.606 -0.725 . . . . 0.0 110.776 -178.444 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . 0.408 ' HA2' HD13 ' A' ' 106' ' ' ILE . . . 99.92 4.52 55.53 Favored Glycine 0 N--CA 1.441 -0.998 0 C-N-CA 120.398 -0.906 . . . . 0.0 111.187 -179.54 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 59.2 m-85 -52.27 118.3 3.43 Favored 'General case' 0 CA--C 1.522 -0.098 0 C-N-CA 122.63 0.372 . . . . 0.0 110.121 179.401 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -146.23 176.33 9.84 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 121.052 0.453 . . . . 0.0 111.234 -178.916 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 43.5 p90 -156.56 133.95 10.7 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.418 -0.81 . . . . 0.0 109.706 179.155 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 15.7 m -108.42 142.5 20.89 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 N-CA-C 109.108 -0.701 . . . . 0.0 109.108 178.62 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . 0.405 ' HB2' HG12 ' A' ' 72' ' ' VAL . 5.9 pt-20 -131.39 156.18 46.0 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 120.927 0.394 . . . . 0.0 111.884 -178.901 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 13.8 t80 -152.08 166.64 30.99 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.796 -0.638 . . . . 0.0 109.755 179.134 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 13.0 t -83.96 -52.94 12.16 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-O 120.76 0.314 . . . . 0.0 111.242 -179.52 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 38.6 mt-10 -67.88 131.7 45.99 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.832 -179.66 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 2.2 mp -70.91 -31.07 44.25 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.88 -179.161 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -54.47 -40.48 68.47 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-O 121.15 0.5 . . . . 0.0 111.228 179.327 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -62.76 -57.05 12.29 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.837 -0.62 . . . . 0.0 111.273 -179.877 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 9.9 p -65.91 -27.97 42.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.192 -179.503 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 18.6 tp60 -59.08 -44.58 91.92 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.902 0.382 . . . . 0.0 110.247 179.506 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 52.9 m-80 -77.31 -29.66 53.72 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.919 -0.582 . . . . 0.0 109.72 179.209 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -67.38 -41.6 84.75 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.799 -0.637 . . . . 0.0 111.342 179.821 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 4.2 pp -77.96 -10.31 59.53 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.915 0.388 . . . . 0.0 110.605 179.482 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -86.7 -52.51 5.48 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.928 -0.578 . . . . 0.0 109.648 179.257 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 27.7 mt -117.46 102.83 9.53 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.598 -0.728 . . . . 0.0 109.647 179.919 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 135' ' ' ASN . . . . . 0.531 ' OD1' ' HB ' ' A' ' 146' ' ' VAL . 1.3 p30 -142.96 -78.1 0.23 Allowed 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 112.422 0.527 . . . . 0.0 112.422 -178.46 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -68.76 109.99 4.11 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.432 0.634 . . . . 0.0 111.549 -178.67 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 56.2 m -152.43 -61.53 0.16 Allowed 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.709 -0.678 . . . . 0.0 109.666 179.0 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 -157.76 120.36 3.84 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 116.699 -0.228 . . . . 0.0 110.943 179.225 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -140.6 116.66 10.49 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 109.555 -0.535 . . . . 0.0 109.555 179.482 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 1.3 t60 61.69 17.21 8.48 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-O 120.992 0.425 . . . . 0.0 110.863 -179.866 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 96.34 -7.38 66.36 Favored Glycine 0 N--CA 1.448 -0.556 0 C-N-CA 120.992 -0.623 . . . . 0.0 112.173 -179.76 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 3.8 mpt_? -112.26 160.61 17.47 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.938 0.399 . . . . 0.0 111.443 -179.39 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 16.3 pt20 -104.79 116.9 32.8 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 109.387 -0.597 . . . . 0.0 109.387 178.641 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -95.32 176.73 6.09 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.081 -179.16 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 1.8 tmtp? -117.64 120.94 39.55 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 109.679 -0.489 . . . . 0.0 109.679 179.599 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 146' ' ' VAL . . . . . 0.531 ' HB ' ' OD1' ' A' ' 135' ' ' ASN . 99.3 t -119.34 133.02 67.5 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-O 120.879 0.371 . . . . 0.0 111.26 -179.336 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 5.3 m -135.24 142.86 46.06 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.114 -0.494 . . . . 0.0 109.954 178.92 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -58.87 124.98 21.65 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.846 0.355 . . . . 0.0 110.844 179.766 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 149' ' ' LYS . . . . . 0.461 ' HE2' ' OG ' ' A' ' 76' ' ' SER . 23.7 ttpt -91.17 63.33 5.01 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.562 0.696 . . . . 0.0 109.189 -179.877 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.32 -0.712 0 CA-C-N 115.405 -0.816 . . . . 0.0 109.81 -179.872 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.236 0.344 0 CA-C-O 120.742 0.306 . . . . 0.0 110.953 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 32.0 tp -79.82 79.55 6.32 Favored 'General case' 0 N--CA 1.45 -0.436 0 CA-C-O 121.796 0.808 . . . . 0.0 110.079 179.959 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . 0.42 ' C ' ' H ' ' A' ' 45' ' ' MET . 65.5 ttt180 -161.62 159.37 27.49 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 114.739 -1.119 . . . . 0.0 109.382 -179.787 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 4.5 tt0 -78.62 19.89 0.47 Allowed 'General case' 0 N--CA 1.465 0.316 0 CA-C-O 121.325 0.583 . . . . 0.0 110.922 179.988 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' MET . . . . . 0.42 ' H ' ' C ' ' A' ' 43' ' ' ARG . 13.6 ptm -88.16 6.0 38.68 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.717 -179.819 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 49.5 mt-30 -70.77 -23.03 62.32 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.581 179.999 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -75.51 -13.9 60.39 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.361 0.601 . . . . 0.0 110.623 179.33 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 6.1 ttmm -74.0 -2.28 23.48 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.683 -0.69 . . . . 0.0 111.09 -179.523 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 9.5 p -57.64 -24.4 22.33 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.275 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.155 -179.87 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 4.6 mm-40 -62.14 -27.99 69.33 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-O 121.107 0.48 . . . . 0.0 110.341 179.552 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 5.8 mtmm -106.76 -42.57 4.92 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.747 -0.66 . . . . 0.0 110.994 179.619 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 78.9 mm-40 -64.87 -6.09 7.5 Favored 'General case' 0 N--CA 1.467 0.397 0 N-CA-C 112.304 0.483 . . . . 0.0 112.304 -179.089 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 3.0 ptt? -65.76 -23.9 66.83 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.112 0.482 . . . . 0.0 109.937 178.777 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -96.78 5.42 64.06 Favored Glycine 0 N--CA 1.451 -0.332 0 N-CA-C 110.708 -0.957 . . . . 0.0 110.708 178.337 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.359 0 CA-C-N 115.284 -0.458 . . . . 0.0 110.134 -179.85 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.518 -0.265 0 CA-C-O 120.986 0.422 . . . . 0.0 110.215 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -82.36 7.21 14.67 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.439 0.638 . . . . 0.0 110.2 179.499 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 1.1 tp-100 -124.88 -55.34 1.6 Allowed 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.705 -0.68 . . . . 0.0 111.357 -179.795 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -85.16 -51.48 6.6 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.54 -179.275 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 4.8 tp10 -72.3 -24.27 61.3 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.102 0.477 . . . . 0.0 110.312 -179.549 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 2.2 tptm -64.23 -24.64 67.74 Favored 'General case' 0 N--CA 1.453 -0.317 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.611 178.902 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -63.55 -17.75 63.14 Favored 'General case' 0 C--O 1.232 0.141 0 CA-C-O 121.543 0.687 . . . . 0.0 109.927 178.882 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . 0.444 ' O ' ' HD2' ' A' ' 75' ' ' ARG . 6.6 tp10 -97.37 -47.17 5.8 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.147 -0.933 . . . . 0.0 109.208 177.744 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 94.7 t -60.36 -39.37 80.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 115.449 -0.796 . . . . 0.0 112.332 -178.943 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 17.5 p-10 -68.8 -21.31 64.33 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-O 120.754 0.311 . . . . 0.0 111.47 -178.596 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 39.1 t -101.32 -0.07 36.27 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 109.451 -0.574 . . . . 0.0 109.451 178.66 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . 0.444 ' HD2' ' O ' ' A' ' 71' ' ' GLU . 0.0 OUTLIER -117.91 44.15 2.25 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.551 -0.75 . . . . 0.0 110.309 -179.749 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -123.43 172.25 8.85 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.675 179.499 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 8.3 pt -132.99 137.46 53.7 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 N-CA-C 109.864 -0.421 . . . . 0.0 109.864 178.604 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 85.4 t80 -96.06 125.61 40.72 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 116.148 -0.478 . . . . 0.0 109.849 -179.775 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 4.6 t -105.24 114.32 44.49 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.057 -179.346 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -117.97 168.0 12.97 Favored Glycine 0 N--CA 1.448 -0.504 0 N-CA-C 111.123 -0.791 . . . . 0.0 111.123 179.502 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 4.3 m-20 58.61 41.4 22.27 Favored 'General case' 0 N--CA 1.472 0.662 0 CA-C-O 121.118 0.485 . . . . 0.0 110.844 -179.328 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 2.0 t -85.66 166.38 2.04 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.954 -179.245 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . 0.616 ' OD2' ' HD3' ' A' ' 142' ' ' ARG . 9.9 t70 -67.83 136.63 54.42 Favored 'General case' 0 CA--C 1.519 -0.243 0 N-CA-C 109.587 -0.523 . . . . 0.0 109.587 179.526 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 32.4 p90 -62.09 -19.71 63.26 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.944 -0.571 . . . . 0.0 112.493 -178.597 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -112.71 17.61 18.95 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 120.534 0.207 . . . . 0.0 111.508 -179.382 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' CYS . . . . . 0.425 ' SG ' ' HB3' ' A' ' 83' ' ' ASP . 0.7 OUTLIER -77.51 144.58 37.57 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.196 0.522 . . . . 0.0 111.41 -179.779 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' THR . . . . . 0.488 ' O ' ' HG2' ' A' ' 90' ' ' GLU . 20.5 p -105.44 152.92 40.04 Favored Pre-proline 0 C--N 1.323 -0.554 0 CA-C-N 115.496 -0.775 . . . . 0.0 110.008 179.222 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 21.0 Cg_endo -61.32 -32.04 89.44 Favored 'Trans proline' 0 C--N 1.342 0.221 0 C-N-CA 122.342 2.028 . . . . 0.0 112.554 -179.071 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 12.3 mt-10 -64.54 -54.42 32.56 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.737 -0.665 . . . . 0.0 111.731 -178.862 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . 0.551 ' O ' ' HB2' ' A' ' 94' ' ' HIS . 11.3 pt-20 -60.72 -26.25 67.03 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.032 0.444 . . . . 0.0 111.299 -178.75 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 51.8 t -78.92 -48.97 20.96 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.319 -179.244 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -71.19 -32.47 68.9 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 111.794 0.294 . . . . 0.0 111.794 -178.585 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 16.7 pt20 -79.45 -25.99 41.85 Favored 'General case' 0 C--N 1.33 -0.243 0 C-N-CA 120.774 -0.37 . . . . 0.0 111.323 -179.117 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' HIS . . . . . 0.551 ' HB2' ' O ' ' A' ' 90' ' ' GLU . 2.3 t60 -76.34 -38.6 55.67 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.838 0.352 . . . . 0.0 110.414 -179.988 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 21.2 m-30 -81.23 -15.08 56.67 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.497 179.827 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . 0.526 ' HA ' ' O ' ' A' ' 99' ' ' GLY . 48.7 tt0 -65.72 -21.83 66.56 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.718 -0.674 . . . . 0.0 110.621 -179.977 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 17.3 m -68.58 -20.14 64.5 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.877 -0.602 . . . . 0.0 110.377 179.132 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 32.3 m -102.69 -46.42 4.73 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.005 179.188 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . 0.526 ' O ' ' HA ' ' A' ' 96' ' ' GLN . . . -145.2 142.29 10.66 Favored Glycine 0 N--CA 1.445 -0.76 0 N-CA-C 111.506 -0.637 . . . . 0.0 111.506 179.781 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' THR . . . . . 0.401 ' HB ' ' CZ ' ' A' ' 122' ' ' PHE . 0.2 OUTLIER -62.29 148.37 45.21 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-O 120.889 0.376 . . . . 0.0 111.305 -179.715 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 2.4 p -117.79 130.89 71.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.916 -179.652 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 16.6 t30 -98.46 -45.56 6.08 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.292 0.568 . . . . 0.0 109.868 179.123 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -142.54 150.78 40.86 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.756 -0.656 . . . . 0.0 109.668 179.844 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 3.5 p -146.04 129.54 10.22 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 N-CA-C 109.89 -0.411 . . . . 0.0 109.89 179.734 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 7.8 m -120.48 125.98 49.24 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 110.268 -0.271 . . . . 0.0 110.268 179.924 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 19.8 tt -112.36 146.18 17.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.434 -179.944 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 16.4 tp -131.81 132.47 43.78 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.511 179.765 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -96.85 121.59 38.88 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 116.201 -0.454 . . . . 0.0 109.867 179.208 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -88.56 136.22 33.1 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.788 0.327 . . . . 0.0 110.592 179.968 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . 0.418 ' N ' ' HD3' ' A' ' 110' ' ' LYS . 0.0 OUTLIER -121.64 21.66 10.79 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 120.986 0.422 . . . . 0.0 110.474 179.819 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 17.3 t80 -101.68 -5.34 25.13 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.26 0.552 . . . . 0.0 110.277 -179.879 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 112.42 2.21 26.1 Favored Glycine 0 N--CA 1.447 -0.631 0 C-N-CA 120.879 -0.677 . . . . 0.0 112.392 179.733 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 19.4 mt-30 -89.52 154.89 48.67 Favored Pre-proline 0 C--N 1.326 -0.424 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 179.565 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -55.23 121.54 10.1 Favored 'Trans proline' 0 N--CA 1.46 -0.441 0 C-N-CA 121.737 1.625 . . . . 0.0 110.971 178.773 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 54.6 mttt -76.64 176.1 8.7 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 -179.352 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 94.95 6.9 60.14 Favored Glycine 0 N--CA 1.446 -0.634 0 C-N-CA 120.129 -1.034 . . . . 0.0 112.355 179.648 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 4.4 m-30 -58.75 103.94 0.19 Allowed 'General case' 0 C--N 1.332 -0.169 0 N-CA-C 109.815 -0.439 . . . . 0.0 109.815 179.607 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -132.18 177.25 7.71 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-O 121.085 0.469 . . . . 0.0 111.324 -179.059 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 2.0 p90 -158.56 139.58 13.03 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.372 -0.831 . . . . 0.0 109.379 179.179 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 13.8 m -112.49 142.87 23.5 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 N-CA-C 109.555 -0.535 . . . . 0.0 109.555 178.35 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 5.0 pt-20 -129.38 150.13 50.87 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.787 -179.671 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 122' ' ' PHE . . . . . 0.401 ' CZ ' ' HB ' ' A' ' 100' ' ' THR . 16.3 t80 -151.73 168.93 23.48 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.336 179.61 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 4.1 t -82.8 -54.21 9.9 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-O 120.836 0.35 . . . . 0.0 111.496 -179.359 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 56.7 mt-10 -60.61 126.52 27.73 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.958 -0.565 . . . . 0.0 111.586 -179.105 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 2.2 mp -71.69 -33.62 49.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 115.703 -0.681 . . . . 0.0 109.864 179.567 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -60.37 -38.05 82.65 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.466 -0.788 . . . . 0.0 110.707 179.585 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -63.95 -56.13 17.42 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.783 -0.644 . . . . 0.0 111.119 -179.986 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 9.9 p -64.12 -27.77 43.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-O 120.812 0.339 . . . . 0.0 110.561 179.774 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 129' ' ' GLN . . . . . 0.429 HE21 ' HB3' ' A' ' 129' ' ' GLN . 1.7 tt0 -62.29 -47.25 85.16 Favored 'General case' 0 C--N 1.333 -0.121 0 CA-C-O 121.066 0.46 . . . . 0.0 109.876 178.853 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 88.4 m-20 -66.69 -31.95 72.95 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.337 0.589 . . . . 0.0 109.579 179.349 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 131' ' ' ALA . . . . . 0.444 ' O ' ' HB2' ' A' ' 135' ' ' ASN . . . -67.27 -51.93 46.97 Favored 'General case' 0 N--CA 1.452 -0.358 0 CA-C-N 115.267 -0.879 . . . . 0.0 110.986 179.684 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 4.3 pp -66.22 -21.49 66.3 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.142 0.496 . . . . 0.0 110.693 179.898 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 5.6 tp -76.78 -51.45 11.35 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.115 179.16 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 94.4 mt -125.83 99.86 6.14 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.286 179.953 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 135' ' ' ASN . . . . . 0.444 ' HB2' ' O ' ' A' ' 131' ' ' ALA . 0.4 OUTLIER -146.77 -70.1 0.25 Allowed 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.491 -179.112 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 136' ' ' GLU . . . . . 0.412 ' HB2' ' O ' ' A' ' 144' ' ' LEU . 9.3 pt-20 -69.86 103.21 2.14 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.601 0.715 . . . . 0.0 111.277 -179.234 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 13.1 m -152.33 -57.54 0.14 Allowed 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.831 -0.622 . . . . 0.0 109.667 179.246 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 28.8 tt0 -160.0 122.32 3.34 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.152 -179.854 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -143.64 115.28 8.15 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 109.368 -0.604 . . . . 0.0 109.368 179.62 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 2.4 t60 64.82 14.03 8.9 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-O 121.255 0.55 . . . . 0.0 110.586 -179.869 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 95.71 -0.49 63.02 Favored Glycine 0 N--CA 1.446 -0.675 0 C-N-CA 120.786 -0.721 . . . . 0.0 111.913 -179.207 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 142' ' ' ARG . . . . . 0.616 ' HD3' ' OD2' ' A' ' 83' ' ' ASP . 2.4 mpt_? -115.59 158.81 22.12 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 120.917 0.389 . . . . 0.0 110.595 179.614 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 15.3 pt20 -105.06 119.07 38.13 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 178.411 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . 0.412 ' O ' ' HB2' ' A' ' 136' ' ' GLU . 0.5 OUTLIER -103.29 176.74 5.05 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.04 -178.966 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 73.8 tttt -115.57 121.9 44.02 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 109.253 -0.647 . . . . 0.0 109.253 178.996 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 89.2 t -115.34 119.3 61.44 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-O 120.902 0.382 . . . . 0.0 111.039 -179.803 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 36.3 t -121.54 139.47 53.46 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 116.142 -0.481 . . . . 0.0 109.81 179.943 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -58.84 132.12 53.0 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 109.926 -0.398 . . . . 0.0 109.926 179.213 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 57.5 tttp -93.12 78.16 4.58 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-O 121.479 0.657 . . . . 0.0 109.942 -179.382 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 21.5 tpt180 . . . . . 0 C--N 1.317 -0.809 0 CA-C-N 115.371 -0.831 . . . . 0.0 109.281 179.435 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.235 0.337 0 CA-C-O 120.725 0.298 . . . . 0.0 110.853 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 25.4 tp -79.17 84.33 5.14 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.28 0.562 . . . . 0.0 110.52 179.562 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . 0.406 ' C ' ' H ' ' A' ' 45' ' ' MET . 31.3 ttm180 -147.12 146.92 30.09 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.843 -0.617 . . . . 0.0 109.601 179.824 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -77.97 40.49 0.33 Allowed 'General case' 0 N--CA 1.463 0.214 0 CA-C-O 121.407 0.622 . . . . 0.0 111.079 179.989 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' MET . . . . . 0.406 ' H ' ' C ' ' A' ' 43' ' ' ARG . 15.8 ptt? -92.51 6.12 48.31 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 115.771 -0.65 . . . . 0.0 110.342 -179.904 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 25.3 mt-30 -64.49 -25.27 67.92 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.942 -179.764 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -66.72 -16.43 64.22 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 121.125 0.488 . . . . 0.0 111.303 -179.875 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 24.4 ttpp -72.19 -10.01 59.21 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.564 179.976 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 5.6 p -59.99 -23.96 28.49 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.169 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.039 179.844 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 38.6 mt-10 -64.63 -21.68 66.78 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.253 0.549 . . . . 0.0 110.701 179.261 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 10.3 mtmm -102.77 -40.95 6.36 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.366 179.182 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -72.8 -3.85 27.96 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.0 -0.545 . . . . 0.0 111.723 -179.84 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -67.14 -27.65 67.48 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 109.304 -0.628 . . . . 0.0 109.304 178.392 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -89.87 2.56 82.2 Favored Glycine 0 N--CA 1.446 -0.675 0 N-CA-C 110.831 -0.908 . . . . 0.0 110.831 178.57 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.376 0 CA-C-O 121.034 0.445 . . . . 0.0 110.055 -179.974 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.456 -0.162 0 CA-C-O 120.783 0.325 . . . . 0.0 110.585 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -77.32 -1.73 31.32 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.637 -179.486 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 8.2 pt20 -121.36 -31.23 4.11 Favored 'General case' 0 C--N 1.328 -0.353 0 C-N-CA 120.613 -0.435 . . . . 0.0 111.181 179.396 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -99.65 -57.21 2.2 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.956 0.407 . . . . 0.0 111.39 -179.932 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 5.1 tp10 -71.74 -21.39 61.76 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 120.891 0.376 . . . . 0.0 110.866 -179.317 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -63.27 -24.51 67.9 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.659 -0.246 . . . . 0.0 110.736 179.318 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 51.4 mt-10 -63.52 -23.18 67.28 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.478 0.656 . . . . 0.0 109.412 178.754 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 6.6 tp10 -94.94 -45.57 7.22 Favored 'General case' 0 N--CA 1.45 -0.466 0 CA-C-N 115.217 -0.901 . . . . 0.0 109.937 178.647 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . 0.464 ' HA ' ' O ' ' A' ' 122' ' ' PHE . 84.2 t -61.17 -42.67 94.24 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.342 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.583 -179.234 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -68.18 -21.37 64.88 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-O 121.188 0.518 . . . . 0.0 110.892 -179.6 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 11.1 t -98.49 -4.66 33.9 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.625 -0.716 . . . . 0.0 109.737 179.811 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -116.56 40.65 2.86 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.485 -0.78 . . . . 0.0 110.321 -179.499 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -119.02 170.99 8.57 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.622 179.81 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 10.4 pt -127.78 137.91 56.24 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-O 120.763 0.316 . . . . 0.0 110.357 178.982 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 76.6 t80 -92.78 116.53 29.11 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 116.023 -0.535 . . . . 0.0 109.736 -179.753 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 10.9 t -105.2 113.97 43.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-O 120.914 0.387 . . . . 0.0 110.886 -179.102 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -122.52 170.56 15.25 Favored Glycine 0 N--CA 1.449 -0.49 0 N-CA-C 111.664 -0.574 . . . . 0.0 111.664 179.833 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 5.4 m-20 58.43 40.5 24.07 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-O 121.27 0.557 . . . . 0.0 110.775 -179.929 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 2.5 t -82.83 165.18 2.59 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 CA-C-N 115.364 -0.834 . . . . 0.0 110.41 -179.408 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . 0.589 ' HB3' ' SG ' ' A' ' 86' ' ' CYS . 13.6 t0 -67.23 140.88 57.42 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 109.96 -0.385 . . . . 0.0 109.96 179.316 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 34.6 p90 -68.49 -11.77 60.28 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.703 -179.13 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -113.46 14.38 19.06 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 120.739 0.304 . . . . 0.0 111.477 -179.803 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' CYS . . . . . 0.589 ' SG ' ' HB3' ' A' ' 83' ' ' ASP . 1.2 m -81.34 150.23 28.54 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.354 0.597 . . . . 0.0 111.747 -179.594 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' THR . . . . . 0.518 ' O ' ' HG2' ' A' ' 90' ' ' GLU . 1.2 p -116.02 155.75 47.58 Favored Pre-proline 0 C--N 1.323 -0.547 0 CA-C-N 115.513 -0.767 . . . . 0.0 109.933 179.235 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 25.6 Cg_endo -60.51 -34.52 92.68 Favored 'Trans proline' 0 C--N 1.344 0.31 0 C-N-CA 122.464 2.109 . . . . 0.0 113.054 -178.599 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 8.4 mt-10 -63.4 -51.85 64.07 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.646 -178.94 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . 0.672 ' O ' ' HB2' ' A' ' 94' ' ' HIS . 8.8 pt-20 -61.73 -28.82 69.7 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.924 -179.201 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 79.6 t -76.96 -48.53 25.16 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.178 -179.003 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' GLN . . . . . 0.431 ' O ' ' HB2' ' A' ' 96' ' ' GLN . 0.0 OUTLIER -69.87 -32.64 71.1 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.57 -0.287 . . . . 0.0 111.474 -178.084 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 1.7 pt20 -80.97 -26.44 36.58 Favored 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 120.883 -0.327 . . . . 0.0 110.994 -179.239 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' HIS . . . . . 0.672 ' HB2' ' O ' ' A' ' 90' ' ' GLU . 0.9 OUTLIER -71.5 -39.15 71.02 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.961 0.41 . . . . 0.0 110.316 -179.777 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 15.4 m-85 -88.46 -13.98 39.02 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.974 -179.479 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . 0.467 ' HA ' ' O ' ' A' ' 99' ' ' GLY . 41.6 tt0 -63.22 -22.18 66.7 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.802 -179.904 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 35.7 m -72.74 -21.9 60.95 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.54 179.505 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 3.6 m -96.67 -44.15 7.24 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.202 0.525 . . . . 0.0 109.629 178.957 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . 0.467 ' O ' ' HA ' ' A' ' 96' ' ' GLN . . . -147.35 139.03 7.58 Favored Glycine 0 N--CA 1.442 -0.916 0 CA-C-N 115.516 -0.766 . . . . 0.0 111.229 179.529 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 2.3 m -62.73 143.14 57.75 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 120.819 0.342 . . . . 0.0 110.957 179.975 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 2.6 p -108.12 132.68 55.22 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.928 -179.365 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 10.7 t30 -93.68 -41.36 9.74 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 109.615 -0.513 . . . . 0.0 109.615 178.655 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -156.41 159.11 38.41 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.285 -0.87 . . . . 0.0 109.512 179.549 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 6.2 p -148.6 136.34 14.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-O 120.909 0.385 . . . . 0.0 110.581 -179.882 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' THR . . . . . 0.483 ' HB ' ' CE1' ' A' ' 119' ' ' TYR . 2.0 m -122.91 130.82 53.32 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.259 178.945 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' ILE . . . . . 0.4 HD13 ' HA2' ' A' ' 116' ' ' GLY . 21.1 tt -118.73 146.11 23.8 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-O 120.703 0.287 . . . . 0.0 110.535 -179.849 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 43.2 tp -135.46 127.29 29.32 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.36 179.855 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -87.59 124.32 33.38 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.6 179.759 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -86.98 137.44 32.35 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.033 0.444 . . . . 0.0 110.774 179.807 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 5.3 mmmm -121.24 17.38 11.52 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.669 -179.616 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 5.7 t80 -101.61 -0.64 34.45 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.075 0.464 . . . . 0.0 110.706 -179.172 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 105.38 5.41 39.95 Favored Glycine 0 N--CA 1.446 -0.679 0 C-N-CA 120.654 -0.784 . . . . 0.0 112.53 179.535 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 113' ' ' GLN . . . . . 0.433 ' HB3' ' HD2' ' A' ' 114' ' ' PRO . 7.7 mt-30 -91.25 160.03 38.14 Favored Pre-proline 0 C--N 1.322 -0.609 0 N-CA-C 109.018 -0.734 . . . . 0.0 109.018 179.677 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 114' ' ' PRO . . . . . 0.433 ' HD2' ' HB3' ' A' ' 113' ' ' GLN . 14.1 Cg_endo -57.42 117.45 4.15 Favored 'Trans proline' 0 C--N 1.345 0.379 0 C-N-CA 122.038 1.825 . . . . 0.0 111.577 179.333 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 63.9 mttt -76.55 179.49 5.91 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 109.071 -0.714 . . . . 0.0 109.071 179.975 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . 0.4 ' HA2' HD13 ' A' ' 106' ' ' ILE . . . 91.64 -0.79 74.41 Favored Glycine 0 N--CA 1.448 -0.515 0 C-N-CA 120.258 -0.973 . . . . 0.0 111.869 179.69 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 2.0 t80 -54.25 121.34 8.0 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.856 0.36 . . . . 0.0 110.153 179.809 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -149.95 175.45 11.66 Favored 'General case' 0 N--CA 1.448 -0.558 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.754 -179.216 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 119' ' ' TYR . . . . . 0.483 ' CE1' ' HB ' ' A' ' 105' ' ' THR . 35.2 p90 -157.49 134.46 10.13 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.985 -0.552 . . . . 0.0 109.615 179.068 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 11.8 m -106.41 149.33 9.93 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 N-CA-C 109.677 -0.49 . . . . 0.0 109.677 179.385 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . 0.424 ' HB2' HG12 ' A' ' 72' ' ' VAL . 0.7 OUTLIER -133.73 156.13 48.52 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.927 -178.789 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 122' ' ' PHE . . . . . 0.464 ' O ' ' HA ' ' A' ' 72' ' ' VAL . 13.2 t80 -155.1 165.63 36.11 Favored 'General case' 0 C--N 1.333 -0.116 0 CA-C-O 120.927 0.394 . . . . 0.0 111.126 179.275 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 12.2 t -82.14 -45.26 19.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 115.694 -0.685 . . . . 0.0 112.226 -178.869 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 20.0 mm-40 -76.26 136.88 39.66 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.12 0.486 . . . . 0.0 111.306 -178.865 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 2.7 mp -74.82 -35.89 37.87 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.675 -179.493 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -55.79 -38.79 70.4 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.106 179.597 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -61.5 -57.05 13.68 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.018 179.971 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 10.0 p -66.36 -29.06 45.41 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.002 -179.544 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 19.6 tt0 -61.54 -39.46 91.17 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.666 179.804 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 46.4 m-80 -78.77 -31.12 45.99 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.142 0.496 . . . . 0.0 109.706 178.738 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -66.44 -51.07 60.79 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.657 -0.701 . . . . 0.0 111.221 179.996 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 4.2 pp -65.66 -16.08 63.4 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-O 121.036 0.446 . . . . 0.0 110.859 -179.868 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 3.8 tp -84.04 -52.89 5.95 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.014 179.237 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 69.5 mt -121.41 101.4 7.6 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.915 -0.584 . . . . 0.0 109.85 179.693 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -146.66 -70.53 0.24 Allowed 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.84 0.352 . . . . 0.0 111.706 -179.331 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -70.48 105.35 3.04 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.546 0.689 . . . . 0.0 111.598 -179.051 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 15.2 m -147.59 -58.49 0.26 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.573 -0.74 . . . . 0.0 109.41 178.769 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -161.32 127.75 3.89 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.976 -0.556 . . . . 0.0 109.839 179.433 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -142.82 111.93 6.56 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.16 -0.473 . . . . 0.0 109.861 179.794 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 140' ' ' HIS . . . . . 0.429 ' HB2' ' SG ' ' A' ' 86' ' ' CYS . 1.3 t60 62.81 25.41 15.08 Favored 'General case' 0 N--CA 1.466 0.33 0 O-C-N 123.41 0.444 . . . . 0.0 110.839 179.189 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 86.66 3.45 83.74 Favored Glycine 0 N--CA 1.45 -0.429 0 C-N-CA 120.871 -0.681 . . . . 0.0 112.029 -179.57 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -116.86 170.57 8.51 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 110.072 -0.344 . . . . 0.0 110.072 179.989 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 8.1 pt20 -120.53 117.03 26.56 Favored 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 109.486 -0.561 . . . . 0.0 109.486 178.957 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -99.62 175.22 5.9 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.934 0.397 . . . . 0.0 111.336 -178.934 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 145' ' ' LYS . . . . . 0.498 ' HE3' ' OG ' ' A' ' 147' ' ' SER . 1.2 tmtp? -116.37 123.19 46.99 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.645 -0.707 . . . . 0.0 109.413 179.34 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 90.8 t -120.55 137.28 54.85 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-O 120.771 0.32 . . . . 0.0 110.68 -179.303 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 147' ' ' SER . . . . . 0.498 ' OG ' ' HE3' ' A' ' 145' ' ' LYS . 66.9 m -144.62 149.23 35.41 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.284 -0.417 . . . . 0.0 109.911 178.902 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -61.74 123.55 18.27 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.757 0.313 . . . . 0.0 111.338 -179.794 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 12.5 ttpp -86.86 73.67 9.92 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.498 0.666 . . . . 0.0 109.755 -179.982 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 14.1 tpt180 . . . . . 0 C--N 1.32 -0.713 0 CA-C-N 115.69 -0.686 . . . . 0.0 110.716 -179.904 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.233 0.2 0 N-CA-C 109.837 -0.431 . . . . 0.0 109.837 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 29.0 tp -74.97 88.63 2.37 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.987 0.423 . . . . 0.0 110.079 179.734 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 20.0 ttp180 -138.74 158.42 44.26 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.249 -0.432 . . . . 0.0 109.852 -179.469 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 52.3 mt-10 -79.66 25.18 0.35 Allowed 'General case' 0 N--CA 1.464 0.267 0 CA-C-O 121.023 0.439 . . . . 0.0 111.311 -179.807 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 11.3 ptt? -79.89 4.05 17.92 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 120.811 0.338 . . . . 0.0 110.584 -178.961 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 14.2 mt-30 -71.83 -22.31 61.57 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.214 0.531 . . . . 0.0 110.011 179.424 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -78.44 -15.26 58.84 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.707 -0.679 . . . . 0.0 110.113 179.033 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . 0.524 ' O ' ' HG2' ' A' ' 52' ' ' GLU . 6.7 ttpp -76.93 2.85 13.53 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.458 -0.792 . . . . 0.0 110.309 -179.802 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 9.2 p -55.71 -24.21 16.15 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.142 0 CA-C-N 115.481 -0.781 . . . . 0.0 111.86 -179.541 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . 0.407 ' H ' ' HG3' ' A' ' 50' ' ' GLU . 0.1 OUTLIER -60.54 -32.25 71.31 Favored 'General case' 0 CA--C 1.52 -0.195 0 CA-C-O 121.43 0.633 . . . . 0.0 109.735 179.494 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 9.0 mtmm -103.22 -40.69 6.32 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.471 -0.786 . . . . 0.0 111.354 -179.645 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . 0.524 ' HG2' ' O ' ' A' ' 48' ' ' LYS . 44.1 mm-40 -64.63 -8.4 14.19 Favored 'General case' 0 N--CA 1.468 0.469 0 N-CA-C 112.421 0.526 . . . . 0.0 112.421 -179.356 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 9.2 ptp -57.98 -33.13 68.56 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.741 0.305 . . . . 0.0 111.257 179.604 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -91.04 -19.88 41.27 Favored Glycine 0 N--CA 1.449 -0.477 0 C-N-CA 120.573 -0.822 . . . . 0.0 111.214 179.082 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.323 -0.547 0 CA-C-N 115.125 -0.538 . . . . 0.0 110.899 -179.263 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.455 -0.184 0 CA-C-O 120.945 0.403 . . . . 0.0 110.047 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 1.2 m -76.15 5.35 6.94 Favored 'General case' 0 CA--C 1.533 0.299 0 CA-C-O 121.343 0.592 . . . . 0.0 110.98 179.731 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 7.3 tp-100 -124.81 -54.99 1.62 Allowed 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.916 -0.583 . . . . 0.0 110.398 179.21 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -78.89 -56.28 4.52 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.362 -179.427 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 1.7 tp10 -66.32 -28.72 68.9 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-O 121.325 0.583 . . . . 0.0 109.935 179.937 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 48.8 tptt -59.96 -29.17 68.24 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.437 -0.802 . . . . 0.0 111.268 179.487 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 48.8 mt-10 -61.69 -24.04 66.5 Favored 'General case' 0 N--CA 1.463 0.207 0 CA-C-O 120.977 0.418 . . . . 0.0 110.654 179.669 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 6.9 tp10 -95.19 -39.16 10.24 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.787 -0.642 . . . . 0.0 109.711 178.814 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . 0.447 ' HA ' ' O ' ' A' ' 122' ' ' PHE . 89.4 t -63.03 -44.65 99.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 115.795 -0.639 . . . . 0.0 112.127 -179.302 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -69.22 -23.11 63.85 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-O 121.17 0.51 . . . . 0.0 110.968 -179.129 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 49.9 m -90.6 -9.65 46.27 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.451 -0.795 . . . . 0.0 109.765 179.154 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -113.98 36.06 3.85 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 114.993 -1.003 . . . . 0.0 110.005 -179.839 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -111.89 169.27 8.95 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.04 179.425 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 7.6 pt -129.28 136.48 59.37 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 N-CA-C 110.029 -0.36 . . . . 0.0 110.029 178.748 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' TYR . . . . . 0.402 ' O ' ' HA ' ' A' ' 146' ' ' VAL . 68.8 t80 -90.42 120.83 31.86 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 116.042 -0.526 . . . . 0.0 109.808 -179.706 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 6.7 t -107.46 111.63 36.61 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-O 120.832 0.348 . . . . 0.0 110.593 -179.164 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -119.26 168.67 13.46 Favored Glycine 0 N--CA 1.449 -0.486 0 N-CA-C 111.683 -0.567 . . . . 0.0 111.683 179.708 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 96.8 m-20 60.93 34.38 19.51 Favored 'General case' 0 N--CA 1.47 0.535 0 CA-C-O 120.964 0.411 . . . . 0.0 111.262 -179.792 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 2.5 t -75.8 166.38 2.76 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.597 -179.768 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 22.0 t0 -73.08 145.36 46.57 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.854 0.359 . . . . 0.0 110.34 179.714 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 3.0 p90 -66.27 -19.97 65.97 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.732 -0.667 . . . . 0.0 111.712 -178.934 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -109.84 20.12 18.37 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 111.742 0.275 . . . . 0.0 111.742 -179.323 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' CYS . . . . . 0.458 ' SG ' ' HB2' ' A' ' 140' ' ' HIS . 0.8 OUTLIER -87.84 141.71 28.38 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.07 0.462 . . . . 0.0 111.286 -179.829 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' THR . . . . . 0.453 ' O ' ' HG2' ' A' ' 90' ' ' GLU . 41.7 p -107.1 155.61 38.97 Favored Pre-proline 0 C--N 1.328 -0.367 0 CA-C-N 115.593 -0.73 . . . . 0.0 110.343 179.562 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -59.12 -35.35 98.14 Favored 'Trans proline' 0 C--N 1.342 0.213 0 C-N-CA 122.457 2.104 . . . . 0.0 112.556 -179.576 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 28.8 mt-10 -65.02 -50.04 67.8 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.688 -0.687 . . . . 0.0 112.096 -178.861 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . 0.563 ' O ' ' HB2' ' A' ' 94' ' ' HIS . 10.9 pt-20 -67.24 -18.6 65.29 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.835 0.35 . . . . 0.0 111.193 -179.102 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 51.3 t -85.26 -49.66 15.37 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.115 -179.897 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 6.9 pt20 -68.81 -35.92 77.6 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.696 -0.229 . . . . 0.0 111.561 -178.098 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 16.0 pt20 -74.48 -28.71 61.13 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.939 0.4 . . . . 0.0 110.37 -179.5 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' HIS . . . . . 0.563 ' HB2' ' O ' ' A' ' 90' ' ' GLU . 0.1 OUTLIER -70.81 -42.5 70.18 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.652 -179.796 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 20.7 m-30 -80.04 -14.59 58.43 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.87 -0.604 . . . . 0.0 110.647 -179.511 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . 0.618 ' HA ' ' O ' ' A' ' 99' ' ' GLY . 10.9 tt0 -66.0 -19.15 65.76 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.131 179.513 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 13.9 m -66.84 -28.57 68.46 Favored 'General case' 0 N--CA 1.451 -0.384 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.257 178.871 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 4.9 m -100.33 -43.26 6.32 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.401 179.661 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . 0.618 ' O ' ' HA ' ' A' ' 96' ' ' GLN . . . -144.59 139.73 8.74 Favored Glycine 0 N--CA 1.447 -0.62 0 C-N-CA 120.88 -0.676 . . . . 0.0 111.904 -179.896 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -63.02 147.72 49.84 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 120.914 0.388 . . . . 0.0 111.601 -179.901 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 2.4 p -116.52 132.93 64.71 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.095 -179.458 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 27.4 t-20 -102.2 -43.64 5.66 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.068 0.461 . . . . 0.0 110.282 178.956 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -141.03 148.68 40.64 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.055 -0.521 . . . . 0.0 109.888 -179.872 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 4.5 p -146.94 134.99 15.12 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 N-CA-C 109.936 -0.394 . . . . 0.0 109.936 179.197 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' THR . . . . . 0.453 ' HB ' ' CE1' ' A' ' 119' ' ' TYR . 0.7 OUTLIER -128.16 126.13 40.45 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.236 179.376 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 18.6 tt -112.55 148.3 15.69 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-O 120.862 0.363 . . . . 0.0 110.867 -179.941 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 18.0 tp -136.83 129.96 31.11 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.155 179.56 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -88.42 123.24 32.77 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 109.708 -0.479 . . . . 0.0 109.708 179.542 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . 0.428 ' O ' ' HB2' ' A' ' 110' ' ' LYS . 29.2 t70 -70.93 -80.17 0.06 Allowed 'General case' 0 CA--C 1.531 0.247 0 N-CA-C 112.628 0.603 . . . . 0.0 112.628 -178.239 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . 0.428 ' HB2' ' O ' ' A' ' 109' ' ' ASP . 1.7 mtpp 70.34 20.66 6.03 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 122.828 0.451 . . . . 0.0 111.621 -179.901 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 6.6 t80 -115.41 17.92 16.24 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-O 121.274 0.559 . . . . 0.0 109.955 -179.749 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 103.99 0.37 45.02 Favored Glycine 0 N--CA 1.449 -0.5 0 C-N-CA 120.768 -0.729 . . . . 0.0 112.158 179.952 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 4.3 mt-30 -111.34 157.72 38.24 Favored Pre-proline 0 C--N 1.322 -0.596 0 N-CA-C 109.588 -0.523 . . . . 0.0 109.588 179.599 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -59.77 129.7 31.84 Favored 'Trans proline' 0 N--CA 1.462 -0.335 0 C-N-CA 122.124 1.883 . . . . 0.0 111.366 178.827 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 15.6 mttp -82.8 -179.41 7.43 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 109.196 -0.668 . . . . 0.0 109.196 179.963 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 92.36 2.53 68.02 Favored Glycine 0 N--CA 1.446 -0.645 0 C-N-CA 120.064 -1.065 . . . . 0.0 112.32 179.168 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 2.2 t80 -54.51 119.52 5.36 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-O 120.732 0.301 . . . . 0.0 110.278 179.793 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -146.56 177.89 8.71 Favored 'General case' 0 N--CA 1.45 -0.427 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.846 -179.316 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 119' ' ' TYR . . . . . 0.453 ' CE1' ' HB ' ' A' ' 105' ' ' THR . 43.6 p90 -161.1 134.84 6.75 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.521 -0.763 . . . . 0.0 109.225 179.045 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 15.1 m -108.74 147.07 13.69 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 N-CA-C 109.529 -0.545 . . . . 0.0 109.529 178.824 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . 0.417 ' HB2' HG12 ' A' ' 72' ' ' VAL . 7.2 pt-20 -131.7 155.91 46.82 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 116.389 -0.368 . . . . 0.0 111.022 -179.217 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 122' ' ' PHE . . . . . 0.447 ' O ' ' HA ' ' A' ' 72' ' ' VAL . 10.8 t80 -157.2 166.66 32.59 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.147 -179.943 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 5.1 t -84.82 -49.23 15.99 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-O 120.854 0.359 . . . . 0.0 111.708 -178.995 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 47.8 mm-40 -66.27 127.87 33.91 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.002 -0.545 . . . . 0.0 111.844 -178.608 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 2.3 mp -72.05 -29.4 32.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 115.6 -0.727 . . . . 0.0 109.643 179.516 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 16.7 t70 -58.1 -42.25 85.29 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.265 -0.88 . . . . 0.0 110.56 179.322 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -64.81 -52.98 53.9 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.731 -0.668 . . . . 0.0 111.532 -179.597 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 8.8 p -65.85 -27.05 40.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 116.636 -0.256 . . . . 0.0 111.43 -179.27 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 24.4 tt0 -60.31 -48.52 81.4 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.806 0.336 . . . . 0.0 110.404 179.898 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 86.6 m-20 -69.61 -32.41 71.11 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 121.021 0.439 . . . . 0.0 110.248 179.611 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 131' ' ' ALA . . . . . 0.428 ' O ' ' HB2' ' A' ' 135' ' ' ASN . . . -64.84 -53.16 51.13 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.604 -0.725 . . . . 0.0 111.254 -179.787 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 4.1 pp -65.23 -23.94 67.21 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.9 0.381 . . . . 0.0 110.888 -179.796 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 5.6 tp -76.42 -54.34 6.87 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.652 179.699 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 26.9 mt -122.38 103.04 8.47 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.091 -0.504 . . . . 0.0 109.878 -179.998 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 135' ' ' ASN . . . . . 0.428 ' HB2' ' O ' ' A' ' 131' ' ' ALA . 0.2 OUTLIER -150.23 -66.87 0.2 Allowed 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 120.977 0.418 . . . . 0.0 111.551 -179.22 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 3.3 pt-20 -69.73 101.18 1.63 Allowed 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.882 -0.599 . . . . 0.0 111.417 -179.188 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 23.7 m -151.31 -59.32 0.17 Allowed 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.909 -0.587 . . . . 0.0 109.966 178.93 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 6.0 tm-20 -154.78 127.68 8.17 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.457 179.755 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -147.72 111.27 4.98 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 178.774 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 140' ' ' HIS . . . . . 0.458 ' HB2' ' SG ' ' A' ' 86' ' ' CYS . 2.1 t60 64.6 28.22 13.25 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-O 121.241 0.543 . . . . 0.0 109.725 -179.585 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 79.23 1.27 85.5 Favored Glycine 0 CA--C 1.52 0.371 0 C-N-CA 121.012 -0.613 . . . . 0.0 112.485 -179.353 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 7.3 mpt_? -113.11 170.94 7.85 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 120.662 0.267 . . . . 0.0 110.437 -179.907 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 12.7 pt20 -115.11 137.55 51.89 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.114 -0.494 . . . . 0.0 109.83 179.162 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -125.58 174.48 8.22 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.135 179.951 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 76.7 tttt -116.91 122.33 44.0 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 109.775 -0.454 . . . . 0.0 109.775 179.371 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 146' ' ' VAL . . . . . 0.402 ' HA ' ' O ' ' A' ' 78' ' ' TYR . 77.6 t -115.88 125.21 72.93 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-O 120.843 0.354 . . . . 0.0 110.739 179.811 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 5.4 t -126.87 148.46 50.0 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 109.848 -0.427 . . . . 0.0 109.848 179.944 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -66.62 122.66 18.11 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.595 -0.275 . . . . 0.0 110.636 -179.737 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 14.0 ttpp -88.14 61.99 6.55 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.456 0.646 . . . . 0.0 109.63 -179.823 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.322 -0.618 0 CA-C-N 115.806 -0.634 . . . . 0.0 109.561 179.453 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.236 0.35 0 N-CA-C 110.467 -0.198 . . . . 0.0 110.467 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 37.9 tp -74.29 84.32 1.91 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.08 0.467 . . . . 0.0 109.897 179.346 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . 0.523 ' HA ' ' NE ' ' A' ' 43' ' ' ARG . 1.5 tpm_? -132.63 142.3 49.05 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.746 -179.376 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 21.5 mp0 -77.27 47.04 0.54 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.249 0.547 . . . . 0.0 110.278 179.252 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 9.1 ptt? -108.65 -0.41 20.18 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.498 -179.548 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 24.6 mt-30 -59.86 -22.68 62.62 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-O 120.889 0.376 . . . . 0.0 111.325 -179.048 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -68.03 -16.96 64.26 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.787 -179.914 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 3.4 ptmm? -73.82 3.59 6.39 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-O 120.635 0.255 . . . . 0.0 111.323 -179.383 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 11.0 p -54.73 -25.09 14.61 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.25 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.307 179.63 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . 0.423 ' H ' ' HG3' ' A' ' 50' ' ' GLU . 0.7 OUTLIER -59.46 -37.03 77.1 Favored 'General case' 0 C--N 1.334 -0.095 0 CA-C-O 121.185 0.517 . . . . 0.0 110.152 179.134 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 10.7 mtmm -85.57 -41.14 15.53 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.804 -0.634 . . . . 0.0 110.328 -179.369 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 16.9 mm-40 -60.33 -38.05 82.53 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.519 -0.764 . . . . 0.0 111.991 -179.013 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 17.3 ptp -64.67 -25.94 68.17 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.679 0.276 . . . . 0.0 110.973 -179.607 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -95.61 -9.94 57.17 Favored Glycine 0 N--CA 1.448 -0.514 0 C-N-CA 120.812 -0.709 . . . . 0.0 111.539 179.433 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.325 -0.463 0 CA-C-O 121.029 0.442 . . . . 0.0 110.629 -179.458 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.456 -0.144 0 CA-C-O 120.717 0.294 . . . . 0.0 110.483 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -76.98 4.3 10.32 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.321 0.582 . . . . 0.0 110.605 179.772 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 46.3 tp60 -122.5 -54.9 1.86 Allowed 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.811 -0.632 . . . . 0.0 110.524 179.277 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -79.8 -54.42 5.86 Favored 'General case' 0 C--N 1.326 -0.413 0 N-CA-C 112.174 0.435 . . . . 0.0 112.174 -178.603 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 14.0 tp10 -69.58 -27.1 64.83 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.069 0.461 . . . . 0.0 110.963 -179.224 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . 0.464 ' HZ3' ' CD ' ' A' ' 121' ' ' GLU . 15.5 tptp -59.9 -27.2 66.52 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.995 179.303 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 94.8 mt-10 -62.74 -22.28 66.43 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-O 121.375 0.607 . . . . 0.0 111.009 179.583 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . 0.433 ' O ' ' HD2' ' A' ' 75' ' ' ARG . 7.0 tp10 -96.97 -40.01 9.09 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 115.727 -0.669 . . . . 0.0 109.596 178.007 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . 0.414 ' HA ' ' O ' ' A' ' 122' ' ' PHE . 59.0 t -65.27 -37.89 81.25 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-N 115.728 -0.669 . . . . 0.0 112.586 -179.034 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -72.98 -17.13 61.49 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-O 120.889 0.376 . . . . 0.0 111.148 -179.227 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -97.77 -18.56 18.72 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.964 -0.562 . . . . 0.0 109.952 177.831 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . 0.433 ' HD2' ' O ' ' A' ' 71' ' ' GLU . 0.0 OUTLIER -103.05 49.76 0.83 Allowed 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.353 -179.334 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' SER . . . . . 0.479 ' HB3' ' HB3' ' A' ' 121' ' ' GLU . 0.0 OUTLIER -128.04 170.57 12.76 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.542 -0.754 . . . . 0.0 110.313 179.703 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 4.8 pt -134.98 137.33 50.8 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.787 0 N-CA-C 109.795 -0.446 . . . . 0.0 109.795 178.88 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 67.0 t80 -95.81 128.18 42.48 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.151 -179.58 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 2.7 t -105.18 111.8 36.13 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.362 -179.861 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -116.93 162.98 12.57 Favored Glycine 0 N--CA 1.449 -0.498 0 C-N-CA 120.925 -0.655 . . . . 0.0 111.599 -179.859 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 9.9 m120 60.28 42.45 15.02 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-O 121.32 0.581 . . . . 0.0 110.542 -179.559 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.464 HG11 ' H ' ' A' ' 83' ' ' ASP . 2.0 t -83.26 172.9 1.0 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.656 0 CA-C-N 115.521 -0.763 . . . . 0.0 110.31 -179.375 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . 0.634 ' OD2' ' HD3' ' A' ' 142' ' ' ARG . 11.6 t0 -73.62 135.4 43.82 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 109.756 -0.461 . . . . 0.0 109.756 179.451 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 5.4 p90 -60.77 -21.4 63.01 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.88 -0.6 . . . . 0.0 111.924 -179.662 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -110.85 19.19 18.81 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.774 0.321 . . . . 0.0 111.237 -179.855 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' CYS . . . . . 0.421 ' SG ' ' HB3' ' A' ' 83' ' ' ASP . 0.5 OUTLIER -80.64 148.32 30.3 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.375 0.607 . . . . 0.0 110.993 -179.898 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' THR . . . . . 0.516 ' O ' ' HG2' ' A' ' 90' ' ' GLU . 40.1 p -109.97 152.38 43.0 Favored Pre-proline 0 C--N 1.321 -0.649 0 CA-C-N 115.338 -0.846 . . . . 0.0 110.194 179.409 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -60.14 -32.39 94.52 Favored 'Trans proline' 0 C--N 1.344 0.338 0 C-N-CA 122.414 2.076 . . . . 0.0 112.593 -179.543 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 7.8 mm-40 -64.6 -53.09 53.21 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.731 -0.668 . . . . 0.0 111.96 -179.165 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . 0.516 ' HG2' ' O ' ' A' ' 87' ' ' THR . 10.7 pt-20 -62.42 -23.93 67.13 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.966 0.412 . . . . 0.0 111.413 -178.904 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 76.6 t -79.86 -48.78 20.16 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.059 -179.86 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' GLN . . . . . 0.417 ' O ' ' HB2' ' A' ' 96' ' ' GLN . 1.6 pp0? -71.97 -33.63 68.32 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.708 -0.224 . . . . 0.0 111.372 -178.455 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 8.6 pt20 -74.21 -31.79 62.76 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.911 0.386 . . . . 0.0 111.068 -179.475 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 65.0 t-80 -73.79 -41.85 61.82 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.734 -179.431 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 18.1 m-30 -78.19 -12.97 60.03 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.124 -179.162 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . 0.538 ' HA ' ' O ' ' A' ' 99' ' ' GLY . 7.5 tt0 -70.06 -20.17 63.24 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.687 -0.688 . . . . 0.0 109.988 179.669 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 1.4 m -65.17 -36.41 84.14 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.496 -0.775 . . . . 0.0 110.692 179.555 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 0.2 OUTLIER -89.81 -46.43 8.59 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.304 -179.988 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . 0.538 ' O ' ' HA ' ' A' ' 96' ' ' GLN . . . -144.27 145.21 14.55 Favored Glycine 0 N--CA 1.445 -0.766 0 C-N-CA 120.672 -0.775 . . . . 0.0 111.801 179.792 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -64.12 145.91 55.12 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 121.033 0.444 . . . . 0.0 111.337 -179.781 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 1.2 p -118.65 121.79 67.86 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.259 -179.949 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . 0.472 ' OD1' ' HG2' ' A' ' 103' ' ' ARG . 26.6 t-20 -91.07 -44.83 9.04 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 109.859 -0.423 . . . . 0.0 109.859 179.733 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' ARG . . . . . 0.472 ' HG2' ' OD1' ' A' ' 102' ' ' ASN . 10.3 mmm180 -136.99 149.16 47.34 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.534 179.967 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 4.0 p -148.2 131.39 7.9 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.587 0 CA-C-N 115.919 -0.582 . . . . 0.0 109.473 179.711 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' THR . . . . . 0.415 ' HB ' ' CE1' ' A' ' 119' ' ' TYR . 0.7 OUTLIER -124.89 126.53 45.68 Favored 'General case' 0 C--N 1.32 -0.69 0 N-CA-C 110.08 -0.341 . . . . 0.0 110.08 179.237 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 21.1 tt -113.26 143.62 22.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-O 120.895 0.379 . . . . 0.0 110.889 -179.598 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 51.4 tp -129.66 127.75 41.17 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.062 179.372 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -94.76 114.65 26.58 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.546 -0.297 . . . . 0.0 110.411 179.73 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . 0.459 ' C ' ' HD2' ' A' ' 110' ' ' LYS . 3.1 t70 -75.24 134.07 41.23 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.771 0.32 . . . . 0.0 110.899 -179.948 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . 0.459 ' HD2' ' C ' ' A' ' 109' ' ' ASP . 8.0 mmmm -116.66 30.17 7.5 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 120.94 0.4 . . . . 0.0 110.094 -179.906 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 8.5 t80 -112.72 -2.85 14.37 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.848 0.356 . . . . 0.0 110.81 -179.6 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 108.33 8.78 28.53 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.844 -0.693 . . . . 0.0 113.141 179.717 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 30.2 mt-30 -94.58 157.18 37.55 Favored Pre-proline 0 C--N 1.322 -0.596 0 N-CA-C 109.646 -0.502 . . . . 0.0 109.646 179.84 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -58.64 105.59 0.23 Allowed 'Trans proline' 0 C--N 1.348 0.502 0 C-N-CA 122.216 1.944 . . . . 0.0 110.819 178.998 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 3.3 mttp -68.22 177.34 2.32 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.68 -179.074 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 99.54 2.93 56.46 Favored Glycine 0 N--CA 1.445 -0.729 0 C-N-CA 120.339 -0.934 . . . . 0.0 111.308 -179.73 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 39.9 m-85 -53.13 117.55 3.09 Favored 'General case' 0 C--N 1.331 -0.205 0 O-C-N 123.821 0.366 . . . . 0.0 110.097 179.505 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -147.15 173.49 12.46 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 121.154 0.502 . . . . 0.0 111.205 -179.099 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 119' ' ' TYR . . . . . 0.415 ' CE1' ' HB ' ' A' ' 105' ' ' THR . 39.2 p90 -156.14 134.6 11.58 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 115.436 -0.802 . . . . 0.0 109.0 178.642 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 14.4 m -109.43 139.24 33.18 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 N-CA-C 109.319 -0.623 . . . . 0.0 109.319 179.055 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . 0.479 ' HB3' ' HB3' ' A' ' 76' ' ' SER . 9.0 pt-20 -127.67 154.6 45.1 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 120.921 0.391 . . . . 0.0 111.334 -179.684 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 122' ' ' PHE . . . . . 0.414 ' O ' ' HA ' ' A' ' 72' ' ' VAL . 17.6 t80 -154.56 171.14 19.91 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.748 -0.66 . . . . 0.0 109.819 -179.821 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 3.8 t -84.65 -52.01 13.06 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-O 120.772 0.32 . . . . 0.0 111.551 -179.463 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -62.43 132.7 53.42 Favored 'General case' 0 C--O 1.236 0.346 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.674 -179.032 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 2.3 mp -76.04 -32.45 23.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 115.937 -0.574 . . . . 0.0 109.629 179.463 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 6.4 t70 -58.67 -39.16 79.88 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.358 -0.837 . . . . 0.0 110.632 179.324 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -62.59 -57.56 10.66 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.781 -0.645 . . . . 0.0 111.118 -179.829 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 7.6 p -65.2 -29.48 47.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.428 -0.351 . . . . 0.0 111.371 -179.449 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 40.6 tt0 -59.24 -47.17 86.36 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.284 0.564 . . . . 0.0 110.673 179.752 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 44.7 m-80 -70.68 -31.24 68.06 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.804 -0.635 . . . . 0.0 110.029 179.608 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -68.47 -47.91 65.87 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.58 -0.736 . . . . 0.0 111.672 -179.601 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 4.1 pp -68.02 -24.0 65.06 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.74 0.305 . . . . 0.0 110.9 -179.746 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 5.4 tp -74.24 -53.45 9.74 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.722 -179.354 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 61.9 mt -131.64 98.41 4.48 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 112.087 0.403 . . . . 0.0 112.087 -178.939 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 3.4 m-20 -149.9 -52.25 0.15 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.318 179.111 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 2.9 pt-20 -73.03 93.55 1.78 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.619 0.723 . . . . 0.0 110.708 179.614 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 4.6 m -142.38 -59.85 0.45 Allowed 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.544 -0.753 . . . . 0.0 110.354 179.376 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -156.47 127.41 6.86 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.216 179.894 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -146.95 122.99 10.77 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 109.481 -0.562 . . . . 0.0 109.481 179.691 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 2.0 t60 63.93 17.34 10.5 Favored 'General case' 0 N--CA 1.465 0.306 0 C-N-CA 122.71 0.404 . . . . 0.0 111.015 179.59 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 93.39 -1.59 69.73 Favored Glycine 0 N--CA 1.443 -0.843 0 C-N-CA 120.77 -0.728 . . . . 0.0 112.366 -179.465 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 142' ' ' ARG . . . . . 0.634 ' HD3' ' OD2' ' A' ' 83' ' ' ASP . 4.3 mpt_? -121.38 -173.7 2.68 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 110.127 -0.323 . . . . 0.0 110.127 179.861 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 20.7 pt20 -124.12 150.98 44.46 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 120.794 0.331 . . . . 0.0 110.402 179.735 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -133.54 177.89 7.35 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.472 -179.783 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 42.0 tttt -117.72 123.46 46.09 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 109.793 -0.447 . . . . 0.0 109.793 178.449 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 82.8 t -117.61 121.52 67.68 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-O 120.982 0.42 . . . . 0.0 110.451 179.875 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 56.8 m -127.44 147.63 50.29 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 116.33 -0.396 . . . . 0.0 110.185 179.51 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -65.23 126.79 29.25 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.903 0.382 . . . . 0.0 111.133 -179.479 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 19.8 ttpp -89.38 55.45 3.26 Favored 'General case' 0 N--CA 1.448 -0.533 0 CA-C-O 121.463 0.649 . . . . 0.0 109.302 -179.807 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.327 -0.383 0 CA-C-N 115.781 -0.645 . . . . 0.0 109.909 179.912 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.453 -0.302 0 N-CA-C 110.291 -0.263 . . . . 0.0 110.291 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 14.4 tp -75.21 77.23 2.34 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.395 0.617 . . . . 0.0 109.84 178.955 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . 0.45 ' C ' ' H ' ' A' ' 45' ' ' MET . 29.0 ttt180 -136.33 145.67 45.71 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.127 -179.333 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -75.45 37.32 0.13 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.23 0.538 . . . . 0.0 111.199 179.97 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' MET . . . . . 0.45 ' H ' ' C ' ' A' ' 43' ' ' ARG . 22.1 ptt? -100.29 8.38 43.76 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.05 -179.843 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 73.2 mm-40 -66.07 -26.5 67.52 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.368 179.753 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -72.86 -8.4 55.37 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.832 -0.622 . . . . 0.0 111.345 179.953 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 13.5 ttpt -75.14 -8.5 56.74 Favored 'General case' 0 C--O 1.236 0.363 0 CA-C-O 121.19 0.519 . . . . 0.0 110.04 179.947 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 9.9 p -58.86 -25.04 28.02 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.204 0 CA-C-N 115.747 -0.66 . . . . 0.0 111.122 179.646 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -61.1 -27.18 68.18 Favored 'General case' 0 C--N 1.333 -0.131 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.019 179.794 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 11.8 mtmt -101.55 -35.47 9.14 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.398 179.903 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 76.5 mm-40 -70.38 -21.32 62.88 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.591 -0.277 . . . . 0.0 111.188 179.986 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 13.7 ptp -62.8 -29.36 70.65 Favored 'General case' 0 N--CA 1.462 0.169 0 CA-C-O 120.829 0.347 . . . . 0.0 110.435 179.566 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -90.66 -10.97 62.69 Favored Glycine 0 N--CA 1.447 -0.602 0 N-CA-C 111.008 -0.837 . . . . 0.0 111.008 178.909 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.529 0 CA-C-O 120.805 0.336 . . . . 0.0 110.431 -179.838 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.328 0 N-CA-C 109.61 -0.515 . . . . 0.0 109.61 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -76.4 4.12 9.66 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.225 0.536 . . . . 0.0 110.521 179.312 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 46.4 tt0 -118.27 -52.55 2.38 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.607 179.674 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -85.98 -57.82 2.89 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.812 -179.488 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 3.7 tp10 -63.79 -27.51 69.24 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 120.838 0.352 . . . . 0.0 110.751 -179.717 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 2.3 tptm -61.0 -23.72 65.6 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.199 179.952 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 35.1 mt-10 -62.1 -23.97 66.84 Favored 'General case' 0 N--CA 1.461 0.12 0 CA-C-O 121.176 0.512 . . . . 0.0 110.496 179.02 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 7.2 tp10 -95.46 -38.71 10.34 Favored 'General case' 0 C--N 1.319 -0.751 0 N-CA-C 109.212 -0.662 . . . . 0.0 109.212 177.747 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . 0.441 ' HA ' ' O ' ' A' ' 122' ' ' PHE . 58.4 t -65.04 -42.18 93.93 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.331 0 CA-C-N 115.913 -0.585 . . . . 0.0 112.191 -179.209 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 51.3 p30 -69.4 -15.21 63.25 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-O 121.125 0.488 . . . . 0.0 111.057 -179.223 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 24.5 m -105.51 -3.88 21.93 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.54 179.826 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -116.19 47.77 1.35 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.652 -0.704 . . . . 0.0 110.255 -179.193 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -126.3 172.81 9.79 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.866 -179.839 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 8.7 pt -131.17 136.75 57.19 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 N-CA-C 109.92 -0.4 . . . . 0.0 109.92 178.392 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' TYR . . . . . 0.539 ' O ' ' HA ' ' A' ' 146' ' ' VAL . 36.8 t80 -91.63 124.3 35.68 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.62 -179.465 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 6.9 t -105.98 110.23 30.62 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 N-CA-C 110.103 -0.332 . . . . 0.0 110.103 179.759 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -118.4 167.24 12.95 Favored Glycine 0 N--CA 1.45 -0.37 0 N-CA-C 111.745 -0.542 . . . . 0.0 111.745 -179.857 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 4.6 m-20 59.25 40.77 21.03 Favored 'General case' 0 N--CA 1.468 0.471 0 CA-C-O 121.289 0.566 . . . . 0.0 110.794 -179.583 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 2.1 t -83.46 169.1 1.61 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-N 115.354 -0.839 . . . . 0.0 109.851 -179.471 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . 0.459 ' HB3' ' SG ' ' A' ' 86' ' ' CYS . 29.8 t70 -73.2 143.14 47.28 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 120.901 0.381 . . . . 0.0 110.73 179.916 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 34.1 p90 -64.77 -13.53 55.61 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.799 -0.637 . . . . 0.0 112.549 -178.693 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -117.21 15.95 14.91 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.81 0.338 . . . . 0.0 111.019 179.923 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' CYS . . . . . 0.459 ' SG ' ' HB3' ' A' ' 83' ' ' ASP . 1.0 OUTLIER -78.68 142.55 37.05 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.113 0.483 . . . . 0.0 110.885 179.945 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' THR . . . . . 0.47 ' O ' ' HG2' ' A' ' 90' ' ' GLU . 70.2 p -106.12 155.41 38.55 Favored Pre-proline 0 C--N 1.321 -0.672 0 CA-C-N 115.444 -0.798 . . . . 0.0 110.272 -179.994 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 20.8 Cg_endo -61.46 -29.29 84.88 Favored 'Trans proline' 0 C--N 1.344 0.32 0 C-N-CA 122.219 1.946 . . . . 0.0 112.401 -179.788 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 14.0 mt-10 -65.31 -55.3 19.07 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.665 -179.073 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . 0.47 ' HG2' ' O ' ' A' ' 87' ' ' THR . 9.6 pt-20 -60.89 -25.53 66.78 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.921 0.391 . . . . 0.0 111.258 -178.634 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 69.2 t -78.24 -47.37 24.62 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.274 -179.286 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' GLN . . . . . 0.462 ' O ' ' HB2' ' A' ' 96' ' ' GLN . 13.9 pt20 -74.0 -31.75 63.1 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 112.172 0.434 . . . . 0.0 112.172 -178.212 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 1.5 pp0? -77.53 -27.85 51.8 Favored 'General case' 0 N--CA 1.467 0.419 0 C-N-CA 120.305 -0.558 . . . . 0.0 111.743 -179.155 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 1.5 m-70 -71.71 -44.46 64.14 Favored 'General case' 0 C--N 1.328 -0.349 0 C-N-CA 120.832 -0.347 . . . . 0.0 111.009 -179.571 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 23.0 m-85 -81.18 -11.72 59.36 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.682 0.277 . . . . 0.0 110.884 -179.707 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . 0.462 ' HB2' ' O ' ' A' ' 92' ' ' GLN . 43.3 tt0 -62.64 -28.56 70.0 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.002 -0.544 . . . . 0.0 110.59 -179.483 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 12.1 m -64.85 -38.95 92.7 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.305 179.263 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 6.1 m -81.01 -40.01 24.96 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.005 179.321 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . 0.448 ' O ' ' HA ' ' A' ' 96' ' ' GLN . . . -153.8 129.37 2.64 Favored Glycine 0 N--CA 1.442 -0.91 0 CA-C-N 115.76 -0.655 . . . . 0.0 111.516 179.487 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -58.97 140.84 55.18 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.259 0.552 . . . . 0.0 110.748 179.868 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . 0.447 HG12 ' HB2' ' A' ' 92' ' ' GLN . 1.3 p -107.55 128.37 62.73 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 115.754 -0.657 . . . . 0.0 111.996 -178.057 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . 0.469 ' O ' ' HD2' ' A' ' 103' ' ' ARG . 6.3 t30 -86.39 -53.36 5.05 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 109.229 -0.656 . . . . 0.0 109.229 178.553 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' ARG . . . . . 0.469 ' HD2' ' O ' ' A' ' 102' ' ' ASN . 3.4 mpt_? -138.93 153.49 48.24 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 116.001 -0.545 . . . . 0.0 109.62 179.963 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 4.8 p -142.74 126.93 15.22 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 N-CA-C 109.787 -0.449 . . . . 0.0 109.787 179.669 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' THR . . . . . 0.401 ' O ' ' HA ' ' A' ' 118' ' ' ALA . 0.8 OUTLIER -114.75 127.19 55.6 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 110.308 -0.256 . . . . 0.0 110.308 179.847 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 20.0 tt -117.8 144.55 25.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-O 120.708 0.29 . . . . 0.0 110.597 -179.77 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 26.6 tp -133.45 121.97 23.01 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.557 179.84 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -84.09 114.53 21.82 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.543 -0.299 . . . . 0.0 110.318 179.258 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -78.54 134.21 37.29 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.182 0.515 . . . . 0.0 111.516 -179.698 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -119.94 22.85 11.33 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.167 179.33 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 4.0 t80 -101.07 1.39 39.35 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.113 -179.56 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 100.87 12.15 38.08 Favored Glycine 0 N--CA 1.449 -0.455 0 C-N-CA 120.796 -0.716 . . . . 0.0 112.361 179.898 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 7.2 mt-30 -100.11 157.61 33.53 Favored Pre-proline 0 C--N 1.325 -0.485 0 N-CA-C 109.37 -0.604 . . . . 0.0 109.37 179.372 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -58.53 112.76 1.29 Allowed 'Trans proline' 0 C--N 1.345 0.37 0 C-N-CA 122.433 2.089 . . . . 0.0 111.488 178.889 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 7.9 mttp -69.58 176.87 3.23 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.662 -179.745 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 99.06 2.96 56.93 Favored Glycine 0 N--CA 1.439 -1.139 0 C-N-CA 120.164 -1.017 . . . . 0.0 111.768 -179.801 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 29.1 m-85 -54.95 113.35 1.31 Allowed 'General case' 0 C--O 1.231 0.118 0 N-CA-C 110.12 -0.326 . . . . 0.0 110.12 179.53 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . 0.401 ' HA ' ' O ' ' A' ' 105' ' ' THR . . . -144.59 173.07 12.14 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 120.931 0.396 . . . . 0.0 110.87 -178.977 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 2.3 p90 -157.75 136.75 11.59 Favored 'General case' 0 N--CA 1.445 -0.676 0 CA-C-N 115.891 -0.595 . . . . 0.0 109.552 178.874 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 15.0 m -105.91 140.7 23.16 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 N-CA-C 109.489 -0.56 . . . . 0.0 109.489 178.985 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 6.4 pt-20 -126.4 154.2 43.93 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.045 -179.287 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 122' ' ' PHE . . . . . 0.441 ' O ' ' HA ' ' A' ' 72' ' ' VAL . 14.3 t80 -154.65 167.87 28.7 Favored 'General case' 0 C--O 1.226 -0.15 0 CA-C-O 120.796 0.331 . . . . 0.0 110.637 179.306 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 6.3 t -82.73 -50.32 15.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 115.715 -0.675 . . . . 0.0 111.626 -179.126 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 33.1 mt-10 -70.97 137.42 49.12 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.044 -0.526 . . . . 0.0 111.934 -178.748 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 2.9 mp -74.99 -32.46 27.17 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.313 179.707 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 37.8 t70 -58.0 -43.54 86.67 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-O 120.982 0.42 . . . . 0.0 111.003 -179.833 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -58.05 -57.37 13.15 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.872 -0.604 . . . . 0.0 111.471 -179.682 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 12.2 p -67.62 -29.52 45.6 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 116.477 -0.329 . . . . 0.0 111.608 -179.177 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 129' ' ' GLN . . . . . 0.45 ' O ' ' HG ' ' A' ' 132' ' ' LEU . 29.4 tt0 -63.16 -46.43 87.2 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.901 0.381 . . . . 0.0 110.308 179.889 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 48.6 m-80 -72.02 -27.15 62.53 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.216 0.532 . . . . 0.0 109.688 179.125 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -72.15 -40.73 67.8 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.561 -0.745 . . . . 0.0 111.317 179.892 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 132' ' ' LEU . . . . . 0.583 ' HA ' ' ND2' ' A' ' 135' ' ' ASN . 4.4 pp -74.7 -19.1 60.39 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.924 0.392 . . . . 0.0 110.789 179.861 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 5.3 tp -76.34 -47.48 23.31 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.383 -179.906 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 40.1 mt -126.19 95.28 4.34 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.973 -0.558 . . . . 0.0 109.818 179.959 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 135' ' ' ASN . . . . . 0.583 ' ND2' ' HA ' ' A' ' 132' ' ' LEU . 2.8 p30 -135.75 -74.74 0.45 Allowed 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 112.431 0.53 . . . . 0.0 112.431 -179.083 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 5.8 pt-20 -69.25 100.57 1.33 Allowed 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.505 0.669 . . . . 0.0 111.632 -178.708 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 26.5 m -142.68 -58.3 0.44 Allowed 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.577 -0.738 . . . . 0.0 109.929 178.815 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 3.0 tm-20 -162.17 124.51 2.85 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.151 -0.477 . . . . 0.0 109.961 179.491 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -144.51 119.11 9.75 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 109.374 -0.602 . . . . 0.0 109.374 179.448 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 2.5 t60 64.67 20.52 12.16 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-O 121.108 0.48 . . . . 0.0 110.386 179.541 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 85.15 5.61 85.48 Favored Glycine 0 N--CA 1.448 -0.543 0 C-N-CA 120.922 -0.656 . . . . 0.0 112.149 -179.303 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -120.34 173.33 7.2 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 109.98 -0.378 . . . . 0.0 109.98 179.994 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 10.3 pt20 -118.84 125.43 49.52 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 109.761 -0.459 . . . . 0.0 109.761 179.271 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -110.36 178.3 4.43 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.86 -178.9 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -118.67 118.64 32.2 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 109.394 -0.595 . . . . 0.0 109.394 179.22 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 146' ' ' VAL . . . . . 0.539 ' HA ' ' O ' ' A' ' 78' ' ' TYR . 42.0 t -122.03 119.56 58.91 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-O 120.753 0.311 . . . . 0.0 111.144 -179.065 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 60.0 m -124.16 152.49 42.77 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 109.901 -0.407 . . . . 0.0 109.901 179.499 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -61.49 130.31 45.4 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.939 0.399 . . . . 0.0 110.796 179.984 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 42.7 tttp -92.94 71.19 4.69 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 109.079 -0.711 . . . . 0.0 109.079 179.958 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 3.6 tpt180 . . . . . 0 C--N 1.32 -0.706 0 CA-C-N 115.679 -0.692 . . . . 0.0 110.034 -179.563 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.165 0 N-CA-C 110.107 -0.331 . . . . 0.0 110.107 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 20.2 tp -83.75 79.39 9.48 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.147 0.499 . . . . 0.0 110.297 179.919 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 28.6 ttm180 -144.22 140.79 29.48 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.797 -0.638 . . . . 0.0 109.632 179.781 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -71.97 84.08 0.96 Allowed 'General case' 0 C--O 1.235 0.305 0 CA-C-O 120.972 0.415 . . . . 0.0 110.112 179.398 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 14.9 ptt? -132.53 12.05 4.48 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.772 -179.244 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 1.7 mp0 -65.57 -11.64 45.91 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.834 -178.929 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -70.31 -17.43 63.08 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.963 0.411 . . . . 0.0 111.331 179.852 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 19.3 pttp -70.71 -13.22 61.99 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.49 -179.411 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 5.3 p -65.11 -20.53 27.72 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.317 0 CA-C-O 121.208 0.528 . . . . 0.0 110.952 -179.66 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 49.3 mt-10 -82.5 -12.0 58.09 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.284 179.673 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 28.7 ttmt -107.43 -32.71 7.62 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.18 0.514 . . . . 0.0 109.682 179.228 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 71.1 mt-10 -78.74 7.54 6.8 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.548 -0.751 . . . . 0.0 111.265 179.754 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -62.3 -29.21 70.27 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 109.944 -0.391 . . . . 0.0 109.944 178.988 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -96.78 3.27 62.69 Favored Glycine 0 N--CA 1.449 -0.449 0 N-CA-C 110.733 -0.947 . . . . 0.0 110.733 178.526 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.302 0 CA-C-O 121.113 0.482 . . . . 0.0 110.321 -179.388 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.153 0 CA-C-O 120.897 0.379 . . . . 0.0 110.799 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -78.24 6.19 8.71 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.374 -0.376 . . . . 0.0 111.179 179.754 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 4.2 tp-100 -119.43 -51.63 2.29 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.494 179.763 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -82.1 -62.1 1.72 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.364 -179.432 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . 0.497 ' O ' HG22 ' A' ' 72' ' ' VAL . 0.7 OUTLIER -58.52 -33.89 70.36 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.464 -179.101 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 32.6 tptt -53.25 -34.21 56.25 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 116.198 -0.455 . . . . 0.0 112.165 -179.577 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 2.5 mm-40 -61.0 -34.68 75.19 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.042 0.448 . . . . 0.0 110.764 -179.793 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 10.2 tp10 -88.42 -38.19 15.26 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.493 179.829 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . 0.497 HG22 ' O ' ' A' ' 68' ' ' GLU . 61.4 t -64.7 -41.84 93.35 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.059 -179.589 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 4.6 t70 -68.04 -33.19 74.12 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.333 -179.357 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' SER . . . . . 0.437 ' HB2' ' HE ' ' A' ' 150' ' ' ARG . 11.5 p -82.47 -17.25 45.89 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 121.284 0.564 . . . . 0.0 109.964 179.908 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -101.79 48.19 0.89 Allowed 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.836 0.827 . . . . 0.0 108.849 178.717 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 28.0 t -125.0 158.8 32.78 Favored 'General case' 0 N--CA 1.446 -0.643 0 CA-C-N 114.726 -1.125 . . . . 0.0 110.22 -179.085 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 5.4 pt -126.94 134.8 65.37 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.138 178.895 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 61.2 t80 -92.19 130.27 37.94 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.323 -179.668 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 8.0 t -104.23 108.2 24.14 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.742 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.35 -179.947 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -112.88 170.24 13.32 Favored Glycine 0 N--CA 1.442 -0.961 0 N-CA-C 111.022 -0.831 . . . . 0.0 111.022 179.468 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 9.9 m-20 58.51 38.5 25.45 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-N 116.97 0.385 . . . . 0.0 110.557 -179.76 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.463 HG11 ' H ' ' A' ' 83' ' ' ASP . 1.4 t -79.35 171.81 1.23 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.971 -178.993 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . 0.549 ' OD1' ' HD2' ' A' ' 142' ' ' ARG . 30.2 t70 -81.24 141.71 33.87 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.287 -0.415 . . . . 0.0 109.906 179.476 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 55.2 p90 -65.01 -16.3 63.28 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 112.708 0.633 . . . . 0.0 112.708 -178.113 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -110.22 9.26 23.84 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.698 0.285 . . . . 0.0 111.327 -179.953 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' CYS . . . . . 0.418 ' SG ' ' HB2' ' A' ' 140' ' ' HIS . 0.9 OUTLIER -73.88 135.7 43.36 Favored 'General case' 0 C--O 1.235 0.294 0 CA-C-O 121.118 0.485 . . . . 0.0 111.336 179.888 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' THR . . . . . 0.57 ' O ' ' HG2' ' A' ' 90' ' ' GLU . 9.0 p -103.01 153.16 38.49 Favored Pre-proline 0 C--N 1.324 -0.514 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.19 179.337 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 15.2 Cg_endo -58.82 -37.86 91.64 Favored 'Trans proline' 0 CA--C 1.531 0.335 0 C-N-CA 122.48 2.12 . . . . 0.0 112.827 -179.426 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 7.5 mp0 -63.79 -46.3 85.83 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.756 -179.361 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . 0.57 ' HG2' ' O ' ' A' ' 87' ' ' THR . 7.7 pt-20 -65.65 -26.4 67.79 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.807 0.337 . . . . 0.0 111.069 -179.114 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 62.2 t -74.61 -55.51 11.74 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.874 -179.953 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 2.7 pt20 -62.51 -36.12 81.54 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 112.405 0.52 . . . . 0.0 112.405 -178.516 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 2.9 pt20 -76.35 -24.07 54.22 Favored 'General case' 0 N--CA 1.463 0.185 0 C-N-CA 120.792 -0.363 . . . . 0.0 111.605 -178.947 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -80.02 -39.25 30.3 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.856 0.36 . . . . 0.0 111.193 -179.494 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 21.1 m-30 -81.3 -17.92 47.62 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.955 -179.22 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . 0.521 ' HA ' ' O ' ' A' ' 99' ' ' GLY . 1.9 tt0 -61.36 -23.78 66.01 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.801 179.702 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 2.7 m -63.11 -31.21 72.3 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.641 -0.708 . . . . 0.0 110.594 179.47 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 27.7 m -99.61 -44.96 5.95 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.213 179.547 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . 0.521 ' O ' ' HA ' ' A' ' 96' ' ' GLN . . . -141.52 132.24 5.2 Favored Glycine 0 N--CA 1.446 -0.646 0 C-N-CA 120.793 -0.718 . . . . 0.0 112.012 -179.815 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 2.5 m -68.0 147.23 52.69 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 120.728 0.299 . . . . 0.0 110.481 179.905 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 2.0 p -125.9 135.2 64.62 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-O 120.832 0.349 . . . . 0.0 111.325 -179.088 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 28.3 t-20 -104.78 -43.78 5.02 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.298 179.268 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 5.3 mpt_? -119.4 137.15 53.94 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.345 -0.388 . . . . 0.0 109.999 179.539 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 12.3 p -144.47 145.84 20.99 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.109 -179.948 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' THR . . . . . 0.581 ' HB ' ' CE2' ' A' ' 119' ' ' TYR . 4.2 m -146.13 137.83 24.9 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 110.036 -0.357 . . . . 0.0 110.036 179.358 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 14.9 tt -121.38 144.96 28.74 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-O 120.824 0.345 . . . . 0.0 110.631 -179.78 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 18.6 tp -123.22 127.64 48.89 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 116.438 -0.346 . . . . 0.0 110.469 -179.959 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -90.1 121.69 32.39 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.378 179.162 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 20.5 t70 -92.76 144.39 25.34 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 120.98 0.419 . . . . 0.0 111.174 -179.69 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -135.81 30.53 3.1 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 179.131 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 40.0 t80 -111.5 -12.24 13.99 Favored 'General case' 0 N--CA 1.452 -0.329 0 CA-C-N 115.19 -0.914 . . . . 0.0 110.029 -179.253 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 112.17 9.49 19.97 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.706 -179.466 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 32.6 mt-30 -91.81 157.59 41.29 Favored Pre-proline 0 C--N 1.325 -0.497 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 179.256 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 13.9 Cg_endo -58.1 99.09 0.09 OUTLIER 'Trans proline' 0 C--N 1.345 0.388 0 C-N-CA 122.095 1.863 . . . . 0.0 111.713 179.024 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 73.9 mttt -58.5 163.3 3.22 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.624 -0.717 . . . . 0.0 111.122 -179.196 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 102.55 6.12 47.57 Favored Glycine 0 N--CA 1.445 -0.75 0 C-N-CA 120.705 -0.76 . . . . 0.0 112.015 -179.811 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 46.5 m-85 -51.96 119.36 4.21 Favored 'General case' 0 CA--C 1.519 -0.236 0 CA-C-O 120.585 0.231 . . . . 0.0 110.473 179.56 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -146.79 172.94 12.87 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-O 121.034 0.445 . . . . 0.0 111.028 -179.136 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 119' ' ' TYR . . . . . 0.581 ' CE2' ' HB ' ' A' ' 105' ' ' THR . 50.5 p90 -154.2 148.75 26.28 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 115.791 -0.64 . . . . 0.0 109.471 179.02 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 30.6 m -124.64 136.31 61.07 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-N 116.476 -0.329 . . . . 0.0 110.314 179.566 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -128.38 149.09 50.69 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 120.898 0.38 . . . . 0.0 111.06 -179.844 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 7.7 t80 -148.87 167.96 24.3 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.535 -179.942 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 8.0 t -82.62 -42.27 18.19 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.177 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.446 -179.501 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -71.15 126.91 30.86 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.327 0.584 . . . . 0.0 111.292 -179.165 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 4.7 mp -67.87 -44.11 85.55 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-N 115.244 -0.889 . . . . 0.0 111.262 -178.845 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . 0.412 ' HA ' ' HB3' ' A' ' 129' ' ' GLN . 0.2 OUTLIER -62.34 -27.58 69.15 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.574 -0.284 . . . . 0.0 111.698 -179.132 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -63.66 -57.95 8.43 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.893 0.378 . . . . 0.0 110.23 179.423 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 11.5 p -69.26 -27.09 33.39 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 116.343 -0.389 . . . . 0.0 110.726 179.748 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 129' ' ' GLN . . . . . 0.412 ' HB3' ' HA ' ' A' ' 126' ' ' ASP . 16.1 tt0 -62.24 -45.4 93.48 Favored 'General case' 0 C--N 1.333 -0.121 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.493 179.504 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 37.6 m-80 -73.4 -26.84 61.15 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.246 0.546 . . . . 0.0 109.914 179.417 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 131' ' ' ALA . . . . . 0.458 ' O ' ' HB2' ' A' ' 135' ' ' ASN . . . -69.62 -49.72 51.2 Favored 'General case' 0 N--CA 1.45 -0.456 0 CA-C-N 115.661 -0.699 . . . . 0.0 110.792 179.623 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 3.9 pp -65.74 -16.08 63.44 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-O 120.884 0.373 . . . . 0.0 111.223 179.99 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 51.2 tp -82.39 -54.19 5.41 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.014 179.344 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 89.8 mt -120.43 93.64 4.11 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.298 179.827 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 135' ' ' ASN . . . . . 0.458 ' HB2' ' O ' ' A' ' 131' ' ' ALA . 0.2 OUTLIER -145.98 -57.31 0.3 Allowed 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.978 -0.556 . . . . 0.0 111.054 -179.522 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 1.2 pt-20 -73.44 87.71 1.58 Allowed 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.854 -0.612 . . . . 0.0 111.19 -179.462 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 6.6 m -138.28 -65.87 0.5 Allowed 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.21 179.278 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 6.2 tm-20 -157.96 136.22 10.96 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.309 -179.576 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -152.23 119.23 5.83 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 109.071 -0.715 . . . . 0.0 109.071 179.181 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 140' ' ' HIS . . . . . 0.418 ' HB2' ' SG ' ' A' ' 86' ' ' CYS . 2.2 t60 65.45 19.07 11.51 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-O 121.147 0.499 . . . . 0.0 110.658 179.63 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 88.78 -5.84 84.21 Favored Glycine 0 N--CA 1.447 -0.589 0 C-N-CA 120.864 -0.684 . . . . 0.0 111.814 -179.189 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 142' ' ' ARG . . . . . 0.549 ' HD2' ' OD1' ' A' ' 83' ' ' ASP . 0.0 OUTLIER -108.1 175.56 5.43 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 120.798 0.332 . . . . 0.0 110.154 -179.676 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 10.8 pt20 -113.9 148.94 35.9 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 109.584 -0.525 . . . . 0.0 109.584 179.257 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -137.12 175.23 9.8 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 120.789 0.328 . . . . 0.0 110.897 -179.905 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 84.0 tttt -123.96 127.46 47.99 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.758 -0.655 . . . . 0.0 109.77 -179.873 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 99.2 t -115.72 126.42 73.24 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 CA-C-O 120.801 0.334 . . . . 0.0 110.975 -179.073 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 3.8 m -121.81 153.27 38.56 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.673 -179.69 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -74.84 117.17 16.38 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.721 0.296 . . . . 0.0 110.489 179.386 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 11.6 ttpp -92.97 47.48 1.28 Allowed 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.728 -179.232 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 150' ' ' ARG . . . . . 0.437 ' HE ' ' HB2' ' A' ' 74' ' ' SER . 0.0 OUTLIER . . . . . 0 C--N 1.326 -0.438 0 N-CA-C 109.892 -0.41 . . . . 0.0 109.892 179.517 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.236 0.371 0 CA-C-O 120.59 0.233 . . . . 0.0 110.471 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 12.1 tp -77.5 86.07 3.86 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.247 0.546 . . . . 0.0 110.369 -179.811 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 22.0 ttm-85 -148.43 149.65 32.1 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.031 -179.636 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -79.76 56.11 2.2 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.582 0.706 . . . . 0.0 110.485 -179.86 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 27.4 ptm -106.54 12.62 29.3 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.42 -0.809 . . . . 0.0 109.968 179.752 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 28.9 mm-40 -73.91 -26.45 60.53 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.531 -179.307 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -70.29 -6.37 34.54 Favored 'General case' 0 C--O 1.236 0.347 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.679 179.501 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 13.9 ttpp -86.57 2.1 49.34 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.207 179.599 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 8.3 p -55.74 -30.32 27.16 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.331 0 CA-C-N 116.052 -0.522 . . . . 0.0 112.005 -179.233 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 17.1 pt-20 -67.19 -28.45 68.11 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.862 0.363 . . . . 0.0 110.9 -179.928 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 37.4 mttm -86.63 -32.55 20.52 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 109.342 -0.614 . . . . 0.0 109.342 179.515 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 15.8 mm-40 -77.23 -3.62 40.61 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.691 -0.686 . . . . 0.0 111.197 -179.427 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 21.3 ttt -59.11 -38.58 79.91 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.174 0.511 . . . . 0.0 110.064 179.059 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -88.57 1.75 84.15 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.678 -0.772 . . . . 0.0 112.125 179.72 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.324 -0.524 0 CA-C-O 121.252 0.548 . . . . 0.0 110.937 -179.693 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.457 -0.096 0 CA-C-O 120.787 0.327 . . . . 0.0 111.588 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 4.3 m -81.21 -4.95 57.1 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 120.894 0.378 . . . . 0.0 111.511 -179.18 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 20.1 tp60 -111.94 -65.52 1.17 Allowed 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 112.171 0.434 . . . . 0.0 112.171 -179.947 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -77.7 -54.58 6.2 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.774 0.321 . . . . 0.0 111.802 -178.276 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . 0.437 ' O ' HG21 ' A' ' 72' ' ' VAL . 1.0 OUTLIER -62.05 -25.86 67.92 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.323 -0.398 . . . . 0.0 110.756 -179.518 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . 0.42 ' HG3' ' OD2' ' A' ' 73' ' ' ASP . 0.1 OUTLIER -49.48 -42.91 44.67 Favored 'General case' 0 C--O 1.232 0.139 0 CA-C-N 115.998 -0.546 . . . . 0.0 112.036 -179.293 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 28.2 mt-10 -52.23 -35.84 50.66 Favored 'General case' 0 N--CA 1.465 0.301 0 O-C-N 123.696 0.622 . . . . 0.0 112.138 -179.243 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 5.7 tp10 -83.52 -32.96 25.62 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 116.564 -0.289 . . . . 0.0 111.56 -178.755 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . 0.525 ' HA ' ' O ' ' A' ' 122' ' ' PHE . 0.6 OUTLIER -69.05 -40.95 81.4 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 116.583 -0.28 . . . . 0.0 111.518 -178.786 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . 0.42 ' OD2' ' HG3' ' A' ' 69' ' ' LYS . 0.8 OUTLIER -83.53 -11.44 57.41 Favored 'General case' 0 N--CA 1.463 0.204 0 C-N-CA 119.819 -0.753 . . . . 0.0 111.353 -179.961 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 46.4 m -87.28 -20.23 27.13 Favored 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 176.729 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -116.66 53.86 0.87 Allowed 'General case' 0 N--CA 1.454 -0.269 0 CA-C-N 115.108 -0.951 . . . . 0.0 110.468 -179.969 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -124.24 159.57 29.87 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 120.942 0.401 . . . . 0.0 110.606 179.368 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 4.5 pt -127.29 138.18 55.56 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.231 179.048 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 34.7 t80 -104.4 126.96 51.96 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 116.128 -0.487 . . . . 0.0 109.841 -179.697 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 4.6 t -98.89 112.65 31.54 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 CA-C-O 121.072 0.463 . . . . 0.0 110.464 -179.718 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -111.02 153.28 17.25 Favored Glycine 0 N--CA 1.444 -0.78 0 CA-C-N 115.74 -0.663 . . . . 0.0 111.793 179.864 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 11.2 m-80 61.01 53.08 3.8 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-O 121.083 0.468 . . . . 0.0 110.621 -179.643 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.421 HG13 ' H ' ' A' ' 83' ' ' ASP . 1.1 t -89.46 169.08 1.43 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.221 -179.693 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . 0.499 ' OD1' ' HD2' ' A' ' 142' ' ' ARG . 28.4 t70 -73.99 140.35 45.43 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.877 0.37 . . . . 0.0 110.403 -179.958 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 1.1 p90 -63.97 -25.71 68.26 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.794 -0.639 . . . . 0.0 111.905 -178.907 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -96.72 10.43 38.74 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.728 0.299 . . . . 0.0 111.443 -179.595 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' CYS . . . . . 0.429 ' HB2' ' O ' ' A' ' 83' ' ' ASP . 0.8 OUTLIER -84.64 149.31 25.93 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.152 0.501 . . . . 0.0 111.15 179.823 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' THR . . . . . 0.454 ' O ' ' HG2' ' A' ' 90' ' ' GLU . 2.5 p -120.18 157.73 52.48 Favored Pre-proline 0 C--N 1.322 -0.622 0 CA-C-N 115.73 -0.668 . . . . 0.0 109.949 179.4 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -59.09 -36.56 95.9 Favored 'Trans proline' 0 C--N 1.345 0.392 0 C-N-CA 122.366 2.044 . . . . 0.0 112.647 -179.009 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . 0.405 ' O ' ' HG3' ' A' ' 92' ' ' GLN . 56.2 mp0 -63.83 -53.11 55.9 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.67 -179.176 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . 0.454 ' HG2' ' O ' ' A' ' 87' ' ' THR . 8.9 pt-20 -62.92 -24.71 67.98 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.79 0.328 . . . . 0.0 111.853 -178.743 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 52.5 t -78.3 -49.3 21.4 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.587 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.917 -179.932 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' GLN . . . . . 0.405 ' HG3' ' O ' ' A' ' 89' ' ' GLU . 0.0 OUTLIER -67.8 -37.59 82.2 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 112.382 0.512 . . . . 0.0 112.382 -178.582 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -71.86 -26.34 62.31 Favored 'General case' 0 N--CA 1.464 0.231 0 C-N-CA 120.836 -0.346 . . . . 0.0 111.325 -179.258 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 1.6 m80 -79.26 -37.34 38.18 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.064 0.459 . . . . 0.0 110.671 179.96 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 16.7 m-30 -81.26 -14.75 57.11 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.402 -179.631 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . 0.542 ' HA ' ' O ' ' A' ' 99' ' ' GLY . 52.4 tt0 -64.1 -23.22 67.24 Favored 'General case' 0 C--N 1.333 -0.113 0 CA-C-N 115.94 -0.573 . . . . 0.0 109.898 179.215 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 1.1 m -68.79 -26.25 65.11 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.229 178.942 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 5.6 m -91.6 -47.37 7.43 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 178.864 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . 0.542 ' O ' ' HA ' ' A' ' 96' ' ' GLN . . . -150.16 143.24 10.47 Favored Glycine 0 N--CA 1.443 -0.896 0 CA-C-N 115.485 -0.779 . . . . 0.0 111.155 179.344 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 100' ' ' THR . . . . . 0.508 ' HB ' ' CZ ' ' A' ' 122' ' ' PHE . 0.9 OUTLIER -62.09 139.22 58.46 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 116.881 0.34 . . . . 0.0 110.565 -179.832 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 7.6 p -101.78 145.26 11.97 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 116.308 -0.406 . . . . 0.0 111.424 -179.275 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . 0.463 ' HB3' ' O ' ' A' ' 121' ' ' GLU . 17.9 t30 -113.74 -62.05 1.65 Allowed 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 109.687 -0.486 . . . . 0.0 109.687 178.789 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 1.2 mpp_? -120.62 145.62 47.21 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.107 179.236 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 5.4 p -137.12 128.92 42.67 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-O 121.238 0.542 . . . . 0.0 110.611 179.776 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 2.8 m -129.53 134.41 47.75 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.243 179.455 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 10.6 tt -125.02 148.9 29.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 120.697 0.284 . . . . 0.0 110.674 -179.718 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 30.2 tp -134.01 118.92 18.37 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.084 -0.507 . . . . 0.0 109.979 179.351 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -89.27 109.77 20.62 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 120.716 0.294 . . . . 0.0 110.31 179.502 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -74.03 146.89 43.38 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.15 -179.785 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 7.2 mptt -133.04 31.65 3.84 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.898 -0.592 . . . . 0.0 109.442 178.906 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -120.3 -3.69 9.98 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.628 -179.153 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 115.32 9.48 13.05 Favored Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.147 -1.025 . . . . 0.0 114.101 179.256 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 36.7 mt-30 -98.18 155.07 37.37 Favored Pre-proline 0 C--N 1.323 -0.562 0 CA-C-N 117.467 0.633 . . . . 0.0 109.382 179.206 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -53.65 98.84 0.05 OUTLIER 'Trans proline' 0 C--N 1.348 0.523 0 C-N-CA 122.887 2.392 . . . . 0.0 111.598 178.859 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 86.2 mttt -59.39 151.75 23.0 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.408 -0.815 . . . . 0.0 111.195 -179.302 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 110.36 6.22 27.58 Favored Glycine 0 N--CA 1.447 -0.625 0 C-N-CA 120.368 -0.92 . . . . 0.0 112.468 -179.698 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 51.8 m-85 -51.89 119.13 3.95 Favored 'General case' 0 CA--C 1.521 -0.169 0 CA-C-O 120.592 0.234 . . . . 0.0 110.425 179.185 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -143.49 161.65 37.87 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-O 120.806 0.336 . . . . 0.0 110.859 -179.263 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 15.1 p90 -151.19 145.26 25.29 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 109.517 -0.549 . . . . 0.0 109.517 178.878 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 28.3 m -124.28 144.1 35.31 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.363 -179.794 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . 0.463 ' O ' ' HB3' ' A' ' 102' ' ' ASN . 7.4 pt-20 -124.56 144.57 50.06 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.703 -179.851 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 122' ' ' PHE . . . . . 0.525 ' O ' ' HA ' ' A' ' 72' ' ' VAL . 4.8 t80 -140.73 168.54 19.55 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.19 -0.459 . . . . 0.0 109.898 179.496 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -99.59 -24.77 4.07 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.241 0 N-CA-C 112.092 0.405 . . . . 0.0 112.092 -178.798 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 59.9 mm-40 -85.3 119.52 25.76 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.92 0.39 . . . . 0.0 110.496 -179.826 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 15.0 mt -64.48 -42.49 95.38 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 115.68 -0.691 . . . . 0.0 111.495 -179.132 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -57.48 -42.43 82.61 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.777 0.322 . . . . 0.0 111.599 -179.56 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -60.34 -51.86 67.71 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.634 -179.358 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 3.4 p -68.44 -24.26 29.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-O 120.856 0.36 . . . . 0.0 111.081 -179.328 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 45.3 tt0 -63.87 -41.44 97.76 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.747 179.921 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 19.7 t-20 -66.63 -33.89 76.65 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.046 179.972 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 131' ' ' ALA . . . . . 0.561 ' O ' ' HB2' ' A' ' 135' ' ' ASN . . . -73.05 -25.29 60.88 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.532 179.543 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -74.35 -25.78 59.73 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.233 0.539 . . . . 0.0 109.943 179.034 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 26.3 tp -81.26 -58.17 3.17 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.305 -0.862 . . . . 0.0 110.554 -179.643 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 22.6 mt -127.78 121.14 29.44 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.314 -179.922 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 135' ' ' ASN . . . . . 0.561 ' HB2' ' O ' ' A' ' 131' ' ' ALA . 3.2 t30 -169.33 -53.72 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.163 0.506 . . . . 0.0 110.303 -179.915 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -80.04 71.27 6.76 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.814 -0.63 . . . . 0.0 111.06 179.997 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 2.3 p -112.65 -74.67 0.62 Allowed 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.362 179.012 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 24.3 tt0 -157.68 124.31 4.92 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.183 179.888 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -135.3 126.81 28.73 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 109.493 -0.558 . . . . 0.0 109.493 179.83 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 1.9 t60 64.79 22.16 12.5 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-O 121.331 0.586 . . . . 0.0 110.097 -179.697 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 84.04 -1.14 89.12 Favored Glycine 0 N--CA 1.448 -0.514 0 CA-C-N 115.758 -0.655 . . . . 0.0 112.415 -179.691 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 142' ' ' ARG . . . . . 0.499 ' HD2' ' OD1' ' A' ' 83' ' ' ASP . 0.0 OUTLIER -113.36 154.79 26.32 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.644 0.259 . . . . 0.0 110.323 -179.513 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 7.6 pt20 -95.86 146.64 24.4 Favored 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 109.499 -0.556 . . . . 0.0 109.499 178.75 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -141.05 -179.74 6.26 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.788 0.328 . . . . 0.0 110.608 -179.105 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -126.17 142.33 51.57 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.956 -0.566 . . . . 0.0 110.123 179.793 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 92.3 t -129.11 110.63 21.01 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 N-CA-C 109.789 -0.449 . . . . 0.0 109.789 -179.925 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -108.51 154.3 22.11 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.611 -179.614 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -76.02 116.43 16.71 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.02 0.438 . . . . 0.0 110.524 -179.91 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 3.6 ttpm? -86.51 68.89 10.32 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.974 -0.557 . . . . 0.0 109.684 179.927 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 9.6 tpt180 . . . . . 0 C--N 1.325 -0.479 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.08 -179.392 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.453 -0.286 0 N-CA-C 110.035 -0.358 . . . . 0.0 110.035 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 11.2 tp -85.21 76.85 10.13 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 121.126 0.488 . . . . 0.0 110.399 -179.942 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 23.0 ttt180 -136.6 158.48 44.35 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.683 -179.942 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -82.83 56.34 3.38 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.709 179.957 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -119.49 17.97 12.86 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.343 0.592 . . . . 0.0 110.552 179.68 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 37.9 mm-40 -70.1 -22.83 62.99 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.758 -0.655 . . . . 0.0 110.835 -179.594 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -65.21 -14.59 61.02 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.966 -179.868 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 6.4 ttpp -77.05 -7.77 56.28 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.574 -0.284 . . . . 0.0 111.195 -179.718 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 10.6 p -59.37 -27.65 37.49 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.267 0 CA-C-O 120.98 0.419 . . . . 0.0 111.12 -179.895 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 26.8 mt-10 -66.88 -24.44 66.12 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.943 -0.572 . . . . 0.0 110.363 179.921 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 35.6 ttmt -99.24 -35.38 9.99 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.765 -0.652 . . . . 0.0 109.815 179.235 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 60.3 mm-40 -77.48 2.24 16.82 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.724 -0.671 . . . . 0.0 111.286 -179.965 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 20.0 ptt? -62.76 -28.87 70.27 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.158 0.504 . . . . 0.0 110.245 179.594 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -89.78 0.41 79.66 Favored Glycine 0 N--CA 1.445 -0.732 0 C-N-CA 120.737 -0.744 . . . . 0.0 111.448 179.321 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.325 -0.48 0 CA-C-O 121.269 0.557 . . . . 0.0 110.137 -179.763 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.52 -0.178 0 CA-C-O 120.979 0.419 . . . . 0.0 110.686 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 4.9 m -75.71 -4.52 40.81 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.696 -179.61 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 21.8 tp60 -114.72 -60.69 1.85 Allowed 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 111.962 0.356 . . . . 0.0 111.962 179.936 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -79.91 -56.29 4.36 Favored 'General case' 0 C--N 1.331 -0.215 0 N-CA-C 112.187 0.44 . . . . 0.0 112.187 -178.322 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . 0.614 ' O ' HG21 ' A' ' 72' ' ' VAL . 1.4 tp10 -59.17 -33.51 71.02 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.304 -179.575 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . 0.545 ' HG3' ' OD2' ' A' ' 73' ' ' ASP . 23.5 tptp -50.85 -33.83 25.41 Favored 'General case' 0 N--CA 1.462 0.155 0 CA-C-N 115.422 -0.808 . . . . 0.0 111.875 -179.364 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 34.5 mt-10 -49.38 -39.2 31.44 Favored 'General case' 0 N--CA 1.465 0.277 0 O-C-N 123.551 0.532 . . . . 0.0 111.583 179.911 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 7.7 tp10 -94.99 -31.46 13.62 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.251 -179.438 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . 0.614 HG21 ' O ' ' A' ' 68' ' ' GLU . 22.9 t -58.17 -54.68 29.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 N-CA-C 112.453 0.538 . . . . 0.0 112.453 -178.084 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . 0.545 ' OD2' ' HG3' ' A' ' 69' ' ' LYS . 3.3 p30 -84.58 0.47 49.93 Favored 'General case' 0 N--CA 1.462 0.164 0 C-N-CA 119.676 -0.81 . . . . 0.0 111.588 -179.419 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 6.1 m -91.11 -27.25 18.68 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 108.318 -0.993 . . . . 0.0 108.318 175.562 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -106.54 59.61 0.64 Allowed 'General case' 0 N--CA 1.449 -0.5 0 CA-C-N 114.916 -1.038 . . . . 0.0 109.565 179.701 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -132.36 161.27 34.0 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.848 -179.908 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 15.1 pt -119.68 136.98 55.05 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.312 179.293 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 56.1 t80 -101.15 128.0 47.44 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 179.432 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 2.7 t -108.73 117.75 54.83 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.683 0 CA-C-O 121.074 0.464 . . . . 0.0 111.413 -178.711 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -113.44 164.41 12.05 Favored Glycine 0 N--CA 1.445 -0.719 0 N-CA-C 111.115 -0.794 . . . . 0.0 111.115 179.421 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 2.7 m-20 61.88 44.19 8.65 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-O 121.011 0.434 . . . . 0.0 110.941 179.943 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 10.7 t -85.43 154.27 3.5 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.5 -179.82 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . 0.579 ' HB3' ' SG ' ' A' ' 86' ' ' CYS . 0.8 OUTLIER -72.33 134.66 45.61 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.13 179.51 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 48.7 p90 -63.9 -16.34 61.19 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 113.057 0.762 . . . . 0.0 113.057 -178.015 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -96.46 4.37 52.16 Favored 'General case' 0 C--N 1.324 -0.52 0 C-N-CA 121.054 -0.258 . . . . 0.0 111.665 -179.151 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' CYS . . . . . 0.579 ' SG ' ' HB3' ' A' ' 83' ' ' ASP . 89.6 m -81.18 156.66 25.58 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 121.207 0.527 . . . . 0.0 111.285 179.974 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 48.7 p -124.12 152.74 67.63 Favored Pre-proline 0 C--N 1.325 -0.494 0 CA-C-N 115.616 -0.72 . . . . 0.0 109.637 178.996 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -58.77 -23.07 64.89 Favored 'Trans proline' 0 C--N 1.342 0.226 0 C-N-CA 122.469 2.113 . . . . 0.0 112.599 -179.258 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 34.1 mt-10 -69.96 -58.69 3.55 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.955 -179.811 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -65.12 -23.49 67.16 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.096 0.474 . . . . 0.0 111.008 -179.462 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 6.2 t -72.28 -52.56 23.46 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.667 0 CA-C-N 115.791 -0.64 . . . . 0.0 111.163 -179.967 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 8.7 pt20 -68.69 -36.26 78.25 Favored 'General case' 0 CA--C 1.532 0.258 0 N-CA-C 112.451 0.538 . . . . 0.0 112.451 -178.207 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -68.48 -31.11 70.16 Favored 'General case' 0 C--O 1.234 0.269 0 C-N-CA 120.733 -0.387 . . . . 0.0 111.329 -178.834 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 3.6 m80 -70.33 -38.64 74.93 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.104 0.478 . . . . 0.0 109.729 179.386 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 8.2 m-30 -74.14 -30.76 62.43 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.72 -0.673 . . . . 0.0 109.828 179.765 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . 0.565 ' HA ' ' O ' ' A' ' 99' ' ' GLY . 29.0 tt0 -62.99 -17.66 62.41 Favored 'General case' 0 C--O 1.231 0.131 0 CA-C-N 115.448 -0.796 . . . . 0.0 111.183 -179.79 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 5.2 m -76.09 -22.88 55.08 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.179 0.514 . . . . 0.0 109.878 179.165 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 24.8 m -98.24 -46.03 5.97 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.729 -0.668 . . . . 0.0 109.81 179.42 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . 0.565 ' O ' ' HA ' ' A' ' 96' ' ' GLN . . . -148.49 152.68 24.7 Favored Glycine 0 N--CA 1.449 -0.496 0 N-CA-C 111.546 -0.622 . . . . 0.0 111.546 179.538 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 100' ' ' THR . . . . . 0.544 ' HB ' ' CZ ' ' A' ' 122' ' ' PHE . 0.2 OUTLIER -66.96 146.82 53.98 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 116.799 0.3 . . . . 0.0 110.635 179.918 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 2.7 p -117.21 137.72 50.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 121.015 0.436 . . . . 0.0 111.695 -178.659 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 24.1 t30 -99.13 -64.26 1.05 Allowed 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 109.487 -0.56 . . . . 0.0 109.487 179.331 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -122.88 149.18 44.55 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.486 179.44 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 7.9 p -136.28 139.94 44.57 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.018 179.677 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 105' ' ' THR . . . . . 0.582 ' HB ' ' CE1' ' A' ' 119' ' ' TYR . 4.0 m -138.19 140.69 39.89 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 109.59 -0.522 . . . . 0.0 109.59 179.304 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 20.6 tt -134.03 143.79 37.37 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 O-C-N 123.289 0.368 . . . . 0.0 110.446 -179.733 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 20.4 tp -127.09 134.55 50.23 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 120.998 0.428 . . . . 0.0 111.201 -179.804 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -101.62 114.77 29.1 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.595 179.256 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . 0.513 ' O ' ' HE2' ' A' ' 115' ' ' LYS . 17.3 t70 -85.44 148.54 25.94 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.397 -179.94 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 4.0 mppt? -128.6 23.31 5.86 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.861 179.956 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 3.8 t80 -110.52 -9.71 14.56 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.792 0.33 . . . . 0.0 110.904 -179.721 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 123.6 -3.54 9.4 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.251 -0.976 . . . . 0.0 113.465 179.327 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 34.1 mt-30 -79.22 154.82 77.18 Favored Pre-proline 0 C--N 1.326 -0.44 0 CA-C-N 117.215 0.507 . . . . 0.0 109.787 179.694 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 10.6 Cg_endo -55.72 101.64 0.09 OUTLIER 'Trans proline' 0 C--N 1.346 0.422 0 C-N-CA 122.533 2.155 . . . . 0.0 111.992 179.261 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . 0.513 ' HE2' ' O ' ' A' ' 109' ' ' ASP . 85.9 mttt -61.32 147.45 44.64 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.464 -0.789 . . . . 0.0 110.844 -179.778 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 109.76 11.45 21.0 Favored Glycine 0 N--CA 1.447 -0.627 0 C-N-CA 120.125 -1.035 . . . . 0.0 113.076 179.943 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 32.2 m-85 -54.47 116.69 2.79 Favored 'General case' 0 N--CA 1.465 0.278 0 N-CA-C 109.766 -0.457 . . . . 0.0 109.766 179.032 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -138.83 166.39 24.55 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 121.271 0.558 . . . . 0.0 111.826 -178.591 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 119' ' ' TYR . . . . . 0.582 ' CE1' ' HB ' ' A' ' 105' ' ' THR . 41.4 p90 -157.8 147.73 20.29 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.081 -0.963 . . . . 0.0 109.052 179.085 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 29.8 m -125.59 136.58 60.4 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-N 116.643 -0.253 . . . . 0.0 110.702 -179.944 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 4.2 pt-20 -115.78 152.59 32.99 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.993 179.923 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 122' ' ' PHE . . . . . 0.544 ' CZ ' ' HB ' ' A' ' 100' ' ' THR . 8.7 t80 -152.2 167.14 29.54 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.253 -0.431 . . . . 0.0 109.935 179.498 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 4.5 t -89.07 -38.63 11.6 Favored 'Isoleucine or valine' 0 C--O 1.236 0.354 0 CA-C-O 121.036 0.446 . . . . 0.0 111.392 -179.402 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 63.6 mm-40 -76.8 127.32 32.54 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.363 -179.368 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 32.4 mt -70.81 -38.37 72.45 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-N 115.593 -0.73 . . . . 0.0 111.426 -179.442 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -61.06 -38.52 86.48 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.383 -0.371 . . . . 0.0 111.697 -179.035 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -61.38 -55.8 27.43 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.213 -179.573 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 11.9 p -67.4 -27.77 39.9 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.173 -179.497 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 52.6 tt0 -61.3 -45.51 94.16 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.929 0.395 . . . . 0.0 110.788 179.937 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -64.54 -34.13 77.53 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.908 -179.726 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -77.55 -23.26 50.11 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.178 179.908 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -80.47 -15.78 55.92 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-O 121.358 0.599 . . . . 0.0 110.164 179.833 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 5.1 mp -96.62 -58.9 1.93 Allowed 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.771 179.661 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 78.9 mt -117.38 107.5 14.44 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.664 -179.435 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 65.8 t30 -166.51 -50.96 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.599 -179.799 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 4.0 pt-20 -72.46 87.33 1.18 Allowed 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.299 0.571 . . . . 0.0 111.102 -179.618 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -131.21 -70.29 0.6 Allowed 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.393 179.845 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 2.9 tm-20 -150.11 132.93 15.99 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.228 -179.788 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -143.61 112.46 6.6 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.695 -0.684 . . . . 0.0 109.469 179.483 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 2.0 t60 62.37 27.72 16.51 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.208 179.49 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 90.0 -10.0 75.44 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.821 -0.704 . . . . 0.0 112.42 179.75 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 142' ' ' ARG . . . . . 0.409 HH11 ' HD3' ' A' ' 142' ' ' ARG . 0.4 OUTLIER -109.39 176.33 5.12 Favored 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 110.134 -0.321 . . . . 0.0 110.134 -179.886 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 5.0 pt20 -125.48 141.09 52.24 Favored 'General case' 0 C--N 1.319 -0.722 0 N-CA-C 109.891 -0.411 . . . . 0.0 109.891 179.195 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -125.3 173.83 8.55 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.467 -178.99 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -115.34 126.11 54.04 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.271 -0.422 . . . . 0.0 109.991 179.586 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 94.1 t -104.47 117.18 49.63 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 CA-C-N 115.877 -0.601 . . . . 0.0 109.994 -179.743 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -117.2 156.17 28.15 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.39 -179.589 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -80.19 115.9 19.99 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 109.986 -0.376 . . . . 0.0 109.986 179.713 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 11.5 ttpp -88.52 52.9 2.55 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.219 0.533 . . . . 0.0 109.955 -179.73 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.325 -0.479 0 CA-C-N 115.804 -0.635 . . . . 0.0 110.48 -179.583 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.453 -0.293 0 N-CA-C 109.215 -0.661 . . . . 0.0 109.215 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 24.4 tp -74.86 82.76 2.16 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.405 0.622 . . . . 0.0 110.456 179.649 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . 0.416 ' C ' ' H ' ' A' ' 45' ' ' MET . 9.5 ttp180 -143.03 141.87 31.43 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.688 -0.687 . . . . 0.0 109.676 179.617 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -76.07 41.82 0.24 Allowed 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 121.139 0.495 . . . . 0.0 111.152 -179.749 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' MET . . . . . 0.416 ' H ' ' C ' ' A' ' 43' ' ' ARG . 10.9 ptt? -98.6 5.25 47.94 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.853 -0.612 . . . . 0.0 109.644 179.752 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 84.0 mt-30 -71.43 -20.95 62.04 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.351 -0.84 . . . . 0.0 111.383 -178.811 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -69.26 -17.51 63.76 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.214 0.531 . . . . 0.0 110.602 179.861 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . 0.551 ' O ' ' HG2' ' A' ' 52' ' ' GLU . 20.4 ttpp -72.99 1.48 8.78 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.572 -0.74 . . . . 0.0 110.885 179.72 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 8.1 p -55.38 -27.05 20.0 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.311 0 CA-C-N 116.463 -0.335 . . . . 0.0 111.601 -179.648 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 20.8 mt-10 -64.02 -19.9 65.53 Favored 'General case' 0 N--CA 1.463 0.19 0 CA-C-O 121.337 0.589 . . . . 0.0 110.248 179.377 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 13.1 mtmt -107.95 -37.66 6.03 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.598 -0.728 . . . . 0.0 110.904 178.749 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . 0.551 ' HG2' ' O ' ' A' ' 48' ' ' LYS . 9.2 mm-40 -62.77 -21.64 66.0 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 116.681 -0.236 . . . . 0.0 111.276 179.879 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 4.7 ppp? -59.36 -23.59 62.67 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-O 120.895 0.379 . . . . 0.0 110.994 179.573 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -94.53 -5.14 61.87 Favored Glycine 0 C--O 1.227 -0.324 0 C-N-CA 121.062 -0.59 . . . . 0.0 111.677 179.28 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.326 -0.42 0 CA-C-O 121.335 0.588 . . . . 0.0 110.079 -179.798 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.52 -0.211 0 CA-C-O 120.955 0.407 . . . . 0.0 110.28 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -77.57 0.87 21.38 Favored 'General case' 0 N--CA 1.453 -0.316 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.806 -179.868 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 6.3 tp-100 -118.52 -50.49 2.43 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.441 179.502 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -82.58 -64.5 1.16 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.14 -0.482 . . . . 0.0 112.043 -179.15 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . 0.415 ' O ' HG23 ' A' ' 72' ' ' VAL . 26.0 tp10 -63.83 -26.67 68.72 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.707 0.289 . . . . 0.0 111.466 -178.775 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 36.2 tptt -58.02 -28.12 64.17 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.514 -0.312 . . . . 0.0 111.01 179.842 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 83.1 mt-10 -63.26 -21.35 66.18 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-O 121.388 0.613 . . . . 0.0 110.763 179.354 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . 0.507 ' O ' ' HD2' ' A' ' 75' ' ' ARG . 5.7 tp10 -97.49 -41.23 8.28 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.418 -0.81 . . . . 0.0 109.316 178.158 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . 0.415 HG23 ' O ' ' A' ' 68' ' ' GLU . 42.2 t -62.29 -40.13 86.68 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.379 0 CA-C-N 115.927 -0.578 . . . . 0.0 112.192 -179.25 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 12.9 p-10 -74.83 -14.19 60.66 Favored 'General case' 0 N--CA 1.466 0.375 0 CA-C-O 121.035 0.445 . . . . 0.0 110.867 -179.705 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 45.6 t -99.79 -12.98 19.45 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 121.504 0.669 . . . . 0.0 109.445 177.888 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . 0.507 ' HD2' ' O ' ' A' ' 71' ' ' GLU . 0.0 OUTLIER -107.66 41.05 1.58 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.054 -179.401 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -121.04 169.79 10.15 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 115.649 -0.705 . . . . 0.0 110.492 179.795 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -131.86 136.18 57.37 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 N-CA-C 109.616 -0.513 . . . . 0.0 109.616 178.433 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 71.3 t80 -91.79 123.27 35.05 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.409 -0.359 . . . . 0.0 110.278 -179.617 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 6.4 t -103.96 111.07 32.17 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.286 -179.615 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -119.95 169.66 13.96 Favored Glycine 0 N--CA 1.449 -0.48 0 C-N-CA 120.908 -0.663 . . . . 0.0 111.74 179.896 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 15.2 m120 61.48 35.62 17.5 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-O 121.102 0.477 . . . . 0.0 110.623 -179.742 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 2.1 t -79.79 165.85 2.71 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.674 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.65 -179.125 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -70.42 142.81 51.99 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 110.017 -0.364 . . . . 0.0 110.017 179.35 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 38.2 p90 -67.12 -13.47 61.98 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 112.03 0.381 . . . . 0.0 112.03 -178.723 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -114.06 16.78 18.1 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.787 0.327 . . . . 0.0 111.025 -179.968 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' CYS . . . . . 0.455 ' SG ' ' HB2' ' A' ' 140' ' ' HIS . 0.7 OUTLIER -82.16 142.1 32.5 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.132 0.491 . . . . 0.0 111.164 -179.927 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' THR . . . . . 0.537 ' O ' ' HG2' ' A' ' 90' ' ' GLU . 23.1 p -106.29 154.48 39.72 Favored Pre-proline 0 C--N 1.327 -0.406 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.548 179.705 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -59.19 -35.13 98.22 Favored 'Trans proline' 0 C--N 1.344 0.328 0 C-N-CA 122.769 2.313 . . . . 0.0 112.794 -179.355 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -65.51 -50.62 64.6 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.909 -0.587 . . . . 0.0 112.144 -178.705 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . 0.537 ' HG2' ' O ' ' A' ' 87' ' ' THR . 10.5 pt-20 -61.97 -24.78 67.22 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.888 0.375 . . . . 0.0 111.444 -178.806 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 76.1 t -81.2 -47.78 19.68 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.926 -178.761 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -71.5 -31.11 66.72 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.581 -178.627 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 3.7 pp0? -80.33 -27.91 38.26 Favored 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 120.383 -0.527 . . . . 0.0 111.252 -179.124 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 50.2 t-80 -77.44 -34.13 54.62 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.987 0.423 . . . . 0.0 110.479 -179.792 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 22.5 m-30 -84.38 -10.21 57.76 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.611 -179.987 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . 0.449 ' HA ' ' O ' ' A' ' 99' ' ' GLY . 14.8 tt0 -65.83 -25.4 67.2 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.488 -0.778 . . . . 0.0 109.979 179.804 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 3.6 m -62.95 -30.03 71.25 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.646 -0.706 . . . . 0.0 110.48 179.123 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 3.5 m -92.55 -49.67 6.0 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.346 179.951 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . 0.449 ' O ' ' HA ' ' A' ' 96' ' ' GLN . . . -145.41 144.24 12.8 Favored Glycine 0 N--CA 1.449 -0.473 0 C-N-CA 120.824 -0.703 . . . . 0.0 111.701 179.829 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 100' ' ' THR . . . . . 0.451 ' HB ' ' CZ ' ' A' ' 122' ' ' PHE . 0.2 OUTLIER -64.26 143.81 57.61 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-O 120.837 0.351 . . . . 0.0 110.69 179.945 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 1.7 p -110.72 126.45 68.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.077 -179.387 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 24.8 t-20 -90.91 -50.14 6.04 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 109.455 -0.572 . . . . 0.0 109.455 179.026 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -138.75 156.08 47.67 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.954 -0.567 . . . . 0.0 109.726 179.169 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 5.4 p -152.28 125.73 1.27 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.262 179.972 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 2.6 m -118.14 126.3 51.95 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 110.007 -0.368 . . . . 0.0 110.007 179.795 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 106' ' ' ILE . . . . . 0.489 HD13 ' HA2' ' A' ' 116' ' ' GLY . 20.9 tt -110.68 145.4 17.09 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-O 120.962 0.411 . . . . 0.0 110.794 179.816 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 32.6 tp -129.2 130.3 46.14 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.576 179.934 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -91.83 119.54 31.72 Favored 'General case' 0 N--CA 1.45 -0.47 0 CA-C-N 116.495 -0.32 . . . . 0.0 110.386 179.235 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . 0.416 ' O ' ' HG2' ' A' ' 115' ' ' LYS . 16.4 t70 -85.46 139.14 31.75 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.086 0.47 . . . . 0.0 110.633 179.917 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.3 23.49 5.98 Favored 'General case' 0 C--N 1.319 -0.749 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 179.113 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 1.1 t80 -103.82 1.79 31.97 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.542 -178.927 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 103.86 7.85 40.75 Favored Glycine 0 N--CA 1.448 -0.554 0 C-N-CA 121.066 -0.588 . . . . 0.0 112.701 179.527 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 18.3 mt-30 -98.56 158.19 32.97 Favored Pre-proline 0 C--N 1.324 -0.507 0 N-CA-C 109.489 -0.56 . . . . 0.0 109.489 179.581 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -59.26 118.91 5.87 Favored 'Trans proline' 0 C--N 1.346 0.403 0 C-N-CA 122.12 1.88 . . . . 0.0 111.169 178.665 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . 0.416 ' HG2' ' O ' ' A' ' 109' ' ' ASP . 60.1 mttt -72.93 173.74 8.82 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 109.892 -0.41 . . . . 0.0 109.892 -179.441 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . 0.489 ' HA2' HD13 ' A' ' 106' ' ' ILE . . . 100.28 2.53 55.72 Favored Glycine 0 N--CA 1.444 -0.788 0 C-N-CA 120.309 -0.948 . . . . 0.0 112.326 179.406 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 29.8 m-85 -52.48 115.2 1.65 Allowed 'General case' 0 C--N 1.333 -0.14 0 N-CA-C 110.117 -0.327 . . . . 0.0 110.117 179.445 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -144.6 175.36 10.2 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 121.087 0.47 . . . . 0.0 111.223 -178.913 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 50.8 p90 -159.26 137.75 10.73 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.58 -0.737 . . . . 0.0 109.506 179.002 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 11.3 m -110.31 140.66 28.39 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 N-CA-C 109.446 -0.576 . . . . 0.0 109.446 179.118 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 4.9 pt-20 -126.02 151.57 46.92 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.487 -0.324 . . . . 0.0 110.812 179.887 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 122' ' ' PHE . . . . . 0.451 ' CZ ' ' HB ' ' A' ' 100' ' ' THR . 10.6 t80 -148.87 167.14 26.48 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.662 179.965 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 37.7 t -84.05 -45.37 18.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 115.765 -0.652 . . . . 0.0 111.741 -179.19 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 34.2 mm-40 -73.54 137.03 44.12 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.785 0.326 . . . . 0.0 110.669 -179.24 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 2.9 mp -77.42 -34.83 21.26 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.702 -179.59 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -59.28 -36.23 75.19 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.186 0.517 . . . . 0.0 111.203 -179.786 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -62.95 -57.71 9.81 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.354 -179.818 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 10.7 p -65.03 -28.7 45.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.532 -0.304 . . . . 0.0 111.271 -179.403 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 50.2 tt0 -61.49 -43.35 99.01 Favored 'General case' 0 C--N 1.334 -0.095 0 CA-C-O 120.973 0.416 . . . . 0.0 110.23 179.602 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 46.4 m-80 -72.17 -29.98 64.54 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 121.223 0.535 . . . . 0.0 109.951 179.477 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -67.97 -50.88 53.12 Favored 'General case' 0 N--CA 1.453 -0.285 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.989 179.827 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 4.1 pp -67.41 -17.31 64.67 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.986 0.422 . . . . 0.0 110.882 -179.965 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 1.4 tp -78.06 -50.49 11.96 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.506 -179.965 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 76.5 mt -135.2 104.25 5.83 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.15 179.916 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -148.64 -56.59 0.21 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.243 0.544 . . . . 0.0 111.344 -179.035 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 3.8 pt-20 -75.24 92.6 2.75 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.667 -0.697 . . . . 0.0 111.437 -179.39 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 2.5 m -140.04 -59.31 0.55 Allowed 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.005 179.276 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 11.4 tt0 -157.88 130.06 7.09 Favored 'General case' 0 N--CA 1.45 -0.438 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.482 179.413 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -148.3 120.59 8.4 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 108.82 -0.807 . . . . 0.0 108.82 179.823 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 140' ' ' HIS . . . . . 0.455 ' HB2' ' SG ' ' A' ' 86' ' ' CYS . 1.9 t60 60.48 28.08 17.73 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-O 120.87 0.367 . . . . 0.0 110.609 179.987 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 82.62 -6.0 71.54 Favored Glycine 0 CA--C 1.519 0.299 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.688 -179.845 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 1.4 mpt_? -110.94 -177.72 3.29 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.828 0.347 . . . . 0.0 110.246 -179.951 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 20.4 pt20 -123.15 141.65 51.74 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 179.077 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -125.1 175.87 7.09 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.253 179.953 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -118.06 121.27 40.17 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 109.348 -0.612 . . . . 0.0 109.348 179.61 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 96.8 t -118.73 122.64 69.93 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-O 120.71 0.29 . . . . 0.0 111.62 -178.834 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -125.77 148.26 49.15 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.041 179.196 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -63.65 130.58 44.87 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.768 0.318 . . . . 0.0 110.536 179.464 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 15.3 ttpp -91.46 67.41 5.61 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 121.351 0.596 . . . . 0.0 110.443 -179.642 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 24.3 tpt180 . . . . . 0 C--N 1.323 -0.548 0 N-CA-C 109.366 -0.605 . . . . 0.0 109.366 179.075 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.235 0.312 0 N-CA-C 110.127 -0.323 . . . . 0.0 110.127 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 41.4 tp -78.51 92.43 4.66 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.004 0.43 . . . . 0.0 110.172 179.866 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . 0.428 ' HD3' ' SD ' ' A' ' 45' ' ' MET . 57.7 ttt180 -150.86 143.06 24.15 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.455 -179.738 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 63.3 mt-10 -81.68 39.8 0.56 Allowed 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.956 -0.566 . . . . 0.0 110.757 -179.952 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' MET . . . . . 0.428 ' SD ' ' HD3' ' A' ' 43' ' ' ARG . 17.5 ptt? -97.35 14.85 24.76 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.262 0.554 . . . . 0.0 110.141 -179.611 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 51.5 mt-30 -69.09 -28.93 66.94 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.591 -0.731 . . . . 0.0 110.492 -179.826 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -70.79 -3.01 16.62 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.781 -0.645 . . . . 0.0 111.713 -179.519 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 33.6 ttpt -84.29 -3.25 58.11 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.557 179.871 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 8.9 p -57.97 -28.71 34.37 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.266 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.364 -179.874 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . 0.419 ' O ' ' HG2' ' A' ' 53' ' ' MET . 29.4 mt-10 -67.01 -20.13 65.82 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 121.245 0.545 . . . . 0.0 110.65 179.944 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 10.6 ttmt -98.5 -41.46 7.76 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.895 -0.593 . . . . 0.0 109.627 178.996 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -63.99 -21.63 66.58 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.651 -0.704 . . . . 0.0 111.0 179.629 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' MET . . . . . 0.419 ' HG2' ' O ' ' A' ' 50' ' ' GLU . 8.3 ptt? -61.63 -27.36 68.61 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 120.973 0.416 . . . . 0.0 110.577 179.502 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -98.97 10.72 62.19 Favored Glycine 0 N--CA 1.449 -0.453 0 N-CA-C 111.144 -0.782 . . . . 0.0 111.144 178.965 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.324 -0.519 0 CA-C-N 115.383 -0.408 . . . . 0.0 110.406 179.94 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.453 -0.321 0 CA-C-O 120.851 0.358 . . . . 0.0 110.341 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -76.21 -2.56 31.87 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.117 0.484 . . . . 0.0 111.085 179.515 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 35.3 tt0 -117.44 -50.66 2.53 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.208 -179.817 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -86.59 -58.31 2.66 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 112.105 0.409 . . . . 0.0 112.105 -178.675 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 2.9 tp10 -62.7 -31.0 71.82 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.587 -179.489 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 39.4 tptt -58.6 -28.67 65.81 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.976 -0.556 . . . . 0.0 111.169 179.87 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 49.1 mt-10 -61.98 -23.07 66.17 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-O 120.974 0.416 . . . . 0.0 111.151 -179.854 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 6.8 tp10 -97.77 -38.93 9.28 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 116.067 -0.515 . . . . 0.0 109.729 178.743 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 46.6 t -65.01 -37.15 79.52 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-N 115.687 -0.688 . . . . 0.0 112.415 -178.907 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 52.1 p-10 -74.09 -16.11 61.03 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-O 120.951 0.405 . . . . 0.0 110.886 -179.526 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 42.3 t -101.8 -6.72 23.27 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.954 -0.566 . . . . 0.0 109.857 178.359 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -112.69 42.79 1.78 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.348 0.594 . . . . 0.0 109.96 -179.382 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -122.14 171.95 8.62 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.692 -0.686 . . . . 0.0 110.25 179.71 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -132.02 139.05 51.23 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 N-CA-C 109.987 -0.375 . . . . 0.0 109.987 178.341 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' TYR . . . . . 0.431 ' O ' ' HA ' ' A' ' 146' ' ' VAL . 25.0 t80 -90.13 124.06 34.49 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.868 -0.606 . . . . 0.0 109.929 179.939 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 6.2 t -108.3 109.11 27.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.515 -0.311 . . . . 0.0 110.405 179.461 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -118.62 170.15 13.69 Favored Glycine 0 N--CA 1.447 -0.567 0 C-N-CA 120.996 -0.621 . . . . 0.0 111.7 -179.9 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 92.2 m-20 56.51 42.56 27.17 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-O 121.015 0.436 . . . . 0.0 110.829 -179.477 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 2.3 t -81.98 165.14 2.69 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-N 115.862 -0.608 . . . . 0.0 111.048 -178.998 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . 0.458 ' HB3' ' SG ' ' A' ' 86' ' ' CYS . 37.3 t70 -68.2 137.81 55.11 Favored 'General case' 0 CA--C 1.519 -0.212 0 N-CA-C 109.871 -0.418 . . . . 0.0 109.871 179.597 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 18.1 p90 -66.59 -10.07 41.8 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.901 -178.87 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -118.94 19.43 13.03 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.001 0.429 . . . . 0.0 110.719 179.521 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' CYS . . . . . 0.458 ' SG ' ' HB3' ' A' ' 83' ' ' ASP . 0.7 OUTLIER -79.45 149.28 31.61 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.966 180.0 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' THR . . . . . 0.476 ' O ' ' HG2' ' A' ' 90' ' ' GLU . 2.9 p -112.61 145.92 33.94 Favored Pre-proline 0 C--N 1.326 -0.441 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.659 179.226 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 11.2 Cg_endo -54.29 -42.56 66.45 Favored 'Trans proline' 0 C--N 1.344 0.311 0 C-N-CA 122.942 2.428 . . . . 0.0 113.039 -178.996 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -62.05 -45.7 92.41 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.302 -0.408 . . . . 0.0 112.011 -179.429 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . 0.622 ' O ' ' HB2' ' A' ' 94' ' ' HIS . 4.8 pt-20 -67.68 -21.76 65.32 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.723 0.297 . . . . 0.0 111.24 -178.765 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 76.2 t -82.17 -48.31 18.42 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.734 -179.108 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 2.4 pt20 -71.54 -31.33 66.9 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.441 -0.345 . . . . 0.0 111.451 -178.258 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -80.13 -26.59 39.35 Favored 'General case' 0 C--N 1.327 -0.386 0 C-N-CA 120.53 -0.468 . . . . 0.0 110.586 -179.793 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' HIS . . . . . 0.622 ' HB2' ' O ' ' A' ' 90' ' ' GLU . 0.1 OUTLIER -72.17 -42.1 66.27 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.994 0.426 . . . . 0.0 110.483 -179.959 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 19.9 m-30 -80.63 -15.33 56.84 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.377 179.913 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . 0.542 ' HA ' ' O ' ' A' ' 99' ' ' GLY . 30.1 tt0 -62.77 -28.85 70.27 Favored 'General case' 0 CA--C 1.523 -0.065 0 CA-C-N 115.549 -0.75 . . . . 0.0 109.607 178.704 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 14.2 m -63.4 -23.05 67.24 Favored 'General case' 0 CA--C 1.533 0.291 0 CA-C-N 115.491 -0.777 . . . . 0.0 110.852 179.302 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 7.4 m -100.2 -43.97 6.12 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.169 -0.469 . . . . 0.0 109.807 179.044 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . 0.542 ' O ' ' HA ' ' A' ' 96' ' ' GLN . . . -150.19 139.31 7.25 Favored Glycine 0 N--CA 1.444 -0.81 0 N-CA-C 111.071 -0.811 . . . . 0.0 111.071 179.491 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -60.41 149.92 32.51 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 121.072 0.463 . . . . 0.0 111.564 -179.705 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 2.0 p -114.28 129.36 70.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.352 -178.897 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 8.0 t30 -94.05 -38.33 11.19 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.306 0.574 . . . . 0.0 109.817 179.078 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -155.15 149.32 25.91 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.573 -0.739 . . . . 0.0 110.289 -179.72 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 7.7 p -145.93 135.25 17.36 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 CA-C-N 116.015 -0.538 . . . . 0.0 110.15 179.858 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 105' ' ' THR . . . . . 0.493 ' HB ' ' CE1' ' A' ' 119' ' ' TYR . 2.3 m -126.37 119.74 28.08 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.468 -0.333 . . . . 0.0 110.232 179.62 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 20.1 tt -108.24 143.42 18.67 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-O 120.808 0.337 . . . . 0.0 110.512 179.991 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 36.4 tp -129.39 135.39 48.63 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.713 -179.713 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -94.42 116.62 29.01 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 109.833 -0.432 . . . . 0.0 109.833 179.045 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -84.46 134.06 34.46 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.194 0.521 . . . . 0.0 110.87 -179.676 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 11.2 mmmm -117.77 24.22 11.2 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.742 -0.663 . . . . 0.0 109.703 179.915 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 11.6 t80 -106.87 10.77 30.55 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.208 0.528 . . . . 0.0 110.237 -179.02 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 93.79 6.83 61.88 Favored Glycine 0 N--CA 1.449 -0.461 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.697 179.396 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 27.8 mt-30 -95.47 157.61 35.93 Favored Pre-proline 0 C--N 1.323 -0.586 0 N-CA-C 109.752 -0.462 . . . . 0.0 109.752 179.89 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 11.0 Cg_endo -56.16 117.83 4.54 Favored 'Trans proline' 0 N--CA 1.462 -0.348 0 C-N-CA 122.237 1.958 . . . . 0.0 110.811 178.458 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 47.2 mttt -76.88 172.46 13.1 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 109.63 -0.507 . . . . 0.0 109.63 -179.289 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 98.08 0.67 58.52 Favored Glycine 0 N--CA 1.446 -0.693 0 C-N-CA 120.115 -1.041 . . . . 0.0 112.599 179.596 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 1.8 t80 -52.99 119.28 4.48 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 121.018 0.437 . . . . 0.0 110.08 179.423 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -145.24 177.06 9.08 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.992 -178.845 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 119' ' ' TYR . . . . . 0.493 ' CE1' ' HB ' ' A' ' 105' ' ' THR . 49.9 p90 -158.34 133.91 8.86 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.606 -0.725 . . . . 0.0 109.059 178.905 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 6.8 m -108.97 143.22 19.61 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.659 0 N-CA-C 109.666 -0.494 . . . . 0.0 109.666 178.895 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 7.4 pt-20 -127.7 153.7 46.19 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.43 -0.35 . . . . 0.0 110.753 -179.903 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 8.4 t80 -151.97 169.57 21.99 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.297 179.318 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 3.0 t -89.52 -48.1 14.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 120.844 0.354 . . . . 0.0 111.376 -179.59 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -69.76 127.88 34.46 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.876 0.37 . . . . 0.0 110.86 -179.248 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 2.5 mp -68.03 -33.17 59.54 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.314 -179.075 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -58.09 -42.12 84.93 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.839 0.352 . . . . 0.0 111.465 -179.991 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -56.94 -56.47 21.33 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.171 -179.777 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 8.9 p -68.56 -28.32 39.79 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.363 -179.527 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 3.5 tt0 -63.01 -39.25 94.19 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.977 0.418 . . . . 0.0 110.453 -179.905 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 41.2 m-80 -77.7 -29.66 51.45 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.266 0.555 . . . . 0.0 109.797 179.096 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 131' ' ' ALA . . . . . 0.454 ' O ' ' HB2' ' A' ' 135' ' ' ASN . . . -67.65 -49.6 62.04 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.422 -0.808 . . . . 0.0 111.161 179.829 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 4.4 pp -66.38 -13.27 60.4 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.886 0.374 . . . . 0.0 111.555 -179.578 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 3.9 tp -89.06 -49.9 6.48 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.153 0.501 . . . . 0.0 109.986 179.036 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 25.3 mt -126.69 100.91 6.4 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.057 179.729 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 135' ' ' ASN . . . . . 0.454 ' HB2' ' O ' ' A' ' 131' ' ' ALA . 0.2 OUTLIER -150.62 -58.28 0.18 Allowed 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.239 0.542 . . . . 0.0 111.628 -179.293 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 4.6 pt-20 -77.5 85.98 3.86 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.8 -0.636 . . . . 0.0 111.67 -178.98 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 23.9 m -134.44 -58.88 0.83 Allowed 'General case' 0 N--CA 1.448 -0.526 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.117 179.248 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 6.8 tm-20 -155.02 128.37 8.4 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.906 0.384 . . . . 0.0 111.002 179.646 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -143.45 111.59 6.19 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 178.269 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 140' ' ' HIS . . . . . 0.454 ' HD1' ' CD ' ' A' ' 90' ' ' GLU . 1.7 t60 61.01 28.8 18.57 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.97 0.414 . . . . 0.0 110.7 -179.833 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 85.39 0.94 88.22 Favored Glycine 0 N--CA 1.449 -0.499 0 C-N-CA 120.978 -0.629 . . . . 0.0 113.043 179.779 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 142' ' ' ARG . . . . . 0.412 ' HD3' ' OD1' ' A' ' 83' ' ' ASP . 1.4 mpt_? -117.52 163.66 16.08 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 117.147 0.473 . . . . 0.0 110.868 179.928 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 2.1 pt20 -110.69 121.8 46.22 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 116.256 -0.429 . . . . 0.0 109.932 179.799 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -106.46 178.78 4.46 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.992 -179.025 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 6.1 tttt -115.44 121.78 43.77 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.088 -0.505 . . . . 0.0 109.859 178.893 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 146' ' ' VAL . . . . . 0.431 ' HA ' ' O ' ' A' ' 78' ' ' TYR . 96.9 t -120.98 126.9 75.77 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-O 121.094 0.473 . . . . 0.0 111.212 -179.712 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 39.7 m -134.61 151.73 51.27 Favored 'General case' 0 C--N 1.319 -0.743 0 N-CA-C 109.582 -0.525 . . . . 0.0 109.582 178.91 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -65.0 131.4 46.49 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.128 0.49 . . . . 0.0 111.46 -179.101 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 21.0 ttpt -93.48 80.29 4.35 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 121.363 0.601 . . . . 0.0 109.813 179.611 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 21.5 tpt180 . . . . . 0 C--N 1.321 -0.646 0 CA-C-N 115.346 -0.843 . . . . 0.0 109.483 179.236 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.453 -0.317 0 CA-C-O 120.732 0.301 . . . . 0.0 110.665 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 46.6 tp -72.75 90.1 1.39 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.346 179.699 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 51.2 ttt85 -154.43 147.13 24.25 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.064 -179.817 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 15.7 mt-10 -81.73 29.92 0.38 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.033 0.444 . . . . 0.0 111.111 -179.877 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 13.9 ptt? -83.64 1.83 40.44 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.277 0.56 . . . . 0.0 110.142 -179.924 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 38.6 mt-30 -71.4 -17.01 62.43 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.751 -179.793 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -78.31 -11.62 59.95 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.242 179.374 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 35.5 ttpt -77.8 -0.09 25.81 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.718 -0.674 . . . . 0.0 110.246 179.717 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 8.1 p -59.49 -26.03 33.12 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.237 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.901 179.883 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 25.7 mt-10 -67.37 -24.95 65.75 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.72 179.571 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 4.3 ttmt -98.81 -34.59 10.43 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.454 179.192 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 9.1 mm-40 -66.1 -16.04 63.6 Favored 'General case' 0 C--N 1.333 -0.112 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.22 179.781 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -64.53 -25.44 67.99 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.178 0.513 . . . . 0.0 109.785 178.694 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -97.41 12.04 65.02 Favored Glycine 0 N--CA 1.45 -0.378 0 N-CA-C 110.709 -0.956 . . . . 0.0 110.709 179.044 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.324 -0.533 0 CA-C-N 115.256 -0.472 . . . . 0.0 109.942 179.777 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.455 -0.177 0 CA-C-O 120.908 0.385 . . . . 0.0 110.575 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -74.47 -2.13 24.25 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.466 -179.922 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 22.5 tp60 -118.98 -49.37 2.42 Favored 'General case' 0 N--CA 1.451 -0.404 0 CA-C-O 120.593 0.235 . . . . 0.0 111.315 179.876 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -84.59 -52.68 5.93 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.881 0.372 . . . . 0.0 111.92 -178.549 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . 0.404 ' O ' HG23 ' A' ' 72' ' ' VAL . 1.3 tp10 -69.62 -30.67 68.45 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.989 0.423 . . . . 0.0 110.615 -179.387 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 50.9 tptt -55.81 -33.65 64.62 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.714 179.908 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 54.4 mt-10 -58.85 -25.7 63.51 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-O 121.02 0.438 . . . . 0.0 111.31 179.943 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 4.4 tp10 -93.82 -40.21 10.31 Favored 'General case' 0 N--CA 1.449 -0.517 0 N-CA-C 109.711 -0.477 . . . . 0.0 109.711 178.786 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . 0.404 HG23 ' O ' ' A' ' 68' ' ' GLU . 61.8 t -63.01 -43.45 99.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 115.706 -0.679 . . . . 0.0 112.658 -178.804 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 9.0 p-10 -70.81 -18.89 62.73 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-O 121.154 0.502 . . . . 0.0 110.894 -179.365 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 49.1 m -97.79 -8.69 27.94 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.051 178.272 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -111.41 48.31 0.95 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.562 -0.744 . . . . 0.0 110.11 -179.368 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' SER . . . . . 0.467 ' OG ' ' HE2' ' A' ' 149' ' ' LYS . 0.1 OUTLIER -129.95 172.76 11.37 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.921 -0.581 . . . . 0.0 111.26 179.86 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -131.01 138.14 54.2 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-N 115.847 -0.615 . . . . 0.0 109.573 178.434 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 57.2 t80 -96.64 125.32 41.03 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.405 -179.485 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 2.9 t -104.8 118.41 52.09 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.391 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.843 -179.405 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -124.46 168.18 16.64 Favored Glycine 0 N--CA 1.449 -0.472 0 N-CA-C 110.936 -0.866 . . . . 0.0 110.936 179.521 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 2.4 m-20 59.42 34.75 22.81 Favored 'General case' 0 N--CA 1.474 0.746 0 CA-C-O 120.834 0.35 . . . . 0.0 111.279 -179.39 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 2.2 t -76.4 163.51 3.91 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.724 0 CA-C-N 115.616 -0.72 . . . . 0.0 110.652 -178.975 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . 0.713 ' OD2' ' HB2' ' A' ' 142' ' ' ARG . 0.5 OUTLIER -63.48 137.66 58.22 Favored 'General case' 0 CA--C 1.515 -0.369 0 N-CA-C 109.67 -0.492 . . . . 0.0 109.67 179.015 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 37.2 p90 -66.17 -8.79 26.33 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.07 -179.768 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -120.41 20.54 11.87 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.038 -179.805 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -86.48 146.34 26.44 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.817 0.342 . . . . 0.0 111.052 -179.97 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' THR . . . . . 0.411 ' O ' ' HG2' ' A' ' 90' ' ' GLU . 17.7 p -109.73 155.0 42.2 Favored Pre-proline 0 C--N 1.323 -0.57 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.412 179.841 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -59.05 -38.88 84.9 Favored 'Trans proline' 0 C--N 1.345 0.372 0 C-N-CA 122.709 2.272 . . . . 0.0 112.929 -178.928 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 24.3 mt-10 -62.36 -50.57 71.04 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.766 -0.652 . . . . 0.0 112.348 -178.496 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . 0.411 ' HG2' ' O ' ' A' ' 87' ' ' THR . 11.1 pt-20 -66.31 -16.73 64.28 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.672 0.273 . . . . 0.0 111.535 -178.972 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 56.0 t -86.44 -47.23 16.39 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 CA-C-O 120.93 0.395 . . . . 0.0 110.495 -179.904 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -71.7 -33.39 68.73 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.791 -178.576 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 1.2 pp0? -77.09 -29.03 54.77 Favored 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 120.378 -0.529 . . . . 0.0 111.33 -178.759 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 2.9 m80 -76.7 -40.31 49.19 Favored 'General case' 0 C--N 1.327 -0.376 0 C-N-CA 120.725 -0.39 . . . . 0.0 110.809 -179.635 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 22.0 m-30 -75.61 -16.53 60.21 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.58 179.899 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . 0.624 ' HA ' ' O ' ' A' ' 99' ' ' GLY . 2.7 tt0 -66.89 -21.77 65.99 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-N 115.982 -0.553 . . . . 0.0 110.391 179.22 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 46.7 m -66.14 -24.26 66.63 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-N 115.905 -0.588 . . . . 0.0 110.074 179.015 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 2.6 m -100.59 -48.84 4.39 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.635 -0.711 . . . . 0.0 109.497 179.042 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . 0.624 ' O ' ' HA ' ' A' ' 96' ' ' GLN . . . -142.18 138.4 8.5 Favored Glycine 0 N--CA 1.446 -0.666 0 N-CA-C 111.41 -0.676 . . . . 0.0 111.41 179.766 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -59.81 148.36 34.81 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.735 0.267 . . . . 0.0 111.413 -179.934 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 2.1 p -119.88 129.28 75.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.216 -179.237 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 58.2 t30 -100.42 -43.19 6.32 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.863 0.363 . . . . 0.0 110.182 178.986 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -139.77 148.6 42.45 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.392 179.996 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 5.9 p -148.07 134.33 12.45 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-N 115.856 -0.611 . . . . 0.0 109.854 179.286 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 2.8 m -126.01 122.89 37.17 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 116.479 -0.328 . . . . 0.0 110.341 179.554 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 20.3 tt -112.02 148.0 15.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 120.895 0.379 . . . . 0.0 111.136 -179.61 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 27.5 tp -136.5 128.19 28.94 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.156 178.997 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -90.06 120.69 31.47 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 109.848 -0.427 . . . . 0.0 109.848 179.315 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . 0.429 ' O ' ' HG2' ' A' ' 115' ' ' LYS . 12.8 t70 -79.53 145.1 33.36 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.087 0.47 . . . . 0.0 111.088 -179.992 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . 0.401 ' HD3' ' C ' ' A' ' 109' ' ' ASP . 0.0 OUTLIER -131.59 23.83 4.72 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.8 -0.636 . . . . 0.0 109.286 179.161 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 4.8 t80 -106.62 -5.4 18.7 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.428 -179.126 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 108.39 12.56 21.25 Favored Glycine 0 CA--C 1.519 0.287 0 C-N-CA 120.979 -0.629 . . . . 0.0 112.86 -179.956 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 22.6 mt-30 -99.84 159.19 30.56 Favored Pre-proline 0 C--N 1.323 -0.563 0 N-CA-C 109.662 -0.496 . . . . 0.0 109.662 179.701 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo -58.85 110.04 0.61 Allowed 'Trans proline' 0 C--N 1.346 0.44 0 C-N-CA 122.233 1.955 . . . . 0.0 110.863 178.645 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . 0.429 ' HG2' ' O ' ' A' ' 109' ' ' ASP . 30.5 mttt -69.6 170.9 9.83 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.553 -178.616 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 101.46 4.71 52.7 Favored Glycine 0 N--CA 1.446 -0.646 0 C-N-CA 120.514 -0.851 . . . . 0.0 111.877 -179.841 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 34.1 m-85 -53.01 117.89 3.32 Favored 'General case' 0 C--O 1.232 0.167 0 C-N-CA 122.338 0.255 . . . . 0.0 110.492 179.671 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -149.18 171.54 16.28 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 121.0 0.429 . . . . 0.0 111.13 -179.314 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 17.2 p90 -154.96 132.58 11.31 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 115.501 -0.772 . . . . 0.0 109.645 178.411 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 8.5 m -108.06 142.83 19.71 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 N-CA-C 109.726 -0.472 . . . . 0.0 109.726 179.735 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . 0.424 ' HB3' ' HB3' ' A' ' 76' ' ' SER . 4.5 pt-20 -130.92 153.42 49.18 Favored 'General case' 0 C--O 1.238 0.5 0 CA-C-O 120.944 0.402 . . . . 0.0 111.235 179.987 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 11.5 t80 -148.26 172.67 13.99 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.644 -0.707 . . . . 0.0 110.095 179.834 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 6.3 t -89.37 -41.86 14.09 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-O 121.028 0.442 . . . . 0.0 111.192 -179.742 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 38.7 mm-40 -69.96 128.92 38.02 Favored 'General case' 0 C--O 1.236 0.392 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.937 -179.83 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 2.7 mp -74.57 -33.95 33.78 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.177 -179.869 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -59.85 -37.28 78.81 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.435 179.633 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -63.56 -56.49 15.56 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.641 -0.709 . . . . 0.0 111.256 -179.789 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 11.0 p -65.77 -28.06 43.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.367 -179.367 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 5.9 tt0 -60.38 -43.93 96.12 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-O 121.006 0.431 . . . . 0.0 110.371 179.447 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 92.5 m-20 -72.48 -31.57 65.5 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.053 -0.522 . . . . 0.0 110.05 179.699 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -67.53 -42.86 82.07 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.51 -0.768 . . . . 0.0 111.636 -179.857 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 4.1 pp -74.15 -17.67 60.89 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.915 0.388 . . . . 0.0 110.914 179.976 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 6.2 tp -83.8 -56.39 3.73 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.673 179.939 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 54.1 mt -125.38 103.18 7.77 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.642 -0.254 . . . . 0.0 111.44 -179.113 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 2.4 m-20 -154.49 -53.19 0.1 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.885 0.374 . . . . 0.0 111.15 178.764 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 3.9 pt-20 -75.82 98.22 4.11 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.464 0.65 . . . . 0.0 111.08 -179.888 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 43.3 m -145.92 -57.54 0.31 Allowed 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.669 -0.696 . . . . 0.0 109.821 178.865 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 24.4 tt0 -163.17 130.05 3.44 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 109.436 -0.579 . . . . 0.0 109.436 178.954 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -148.46 122.31 9.34 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 108.603 -0.888 . . . . 0.0 108.603 179.677 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 140' ' ' HIS . . . . . 0.648 ' HB3' ' OD2' ' A' ' 83' ' ' ASP . 5.0 t60 64.43 3.16 1.77 Allowed 'General case' 0 N--CA 1.471 0.623 0 O-C-N 123.544 0.528 . . . . 0.0 111.723 179.005 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 109.65 -9.93 32.56 Favored Glycine 0 N--CA 1.446 -0.637 0 C-N-CA 121.123 -0.56 . . . . 0.0 112.127 -179.704 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 142' ' ' ARG . . . . . 0.713 ' HB2' ' OD2' ' A' ' 83' ' ' ASP . 1.0 OUTLIER -111.7 170.98 7.76 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.154 0.502 . . . . 0.0 110.375 179.876 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 7.4 pt20 -113.0 129.67 56.41 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 179.303 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -113.91 173.27 6.51 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-O 120.907 0.384 . . . . 0.0 110.474 -179.645 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 8.8 ttpt -113.23 118.02 33.5 Favored 'General case' 0 C--N 1.318 -0.775 0 N-CA-C 109.428 -0.582 . . . . 0.0 109.428 179.278 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 96.7 t -114.42 116.95 54.1 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.659 0 CA-C-O 120.756 0.312 . . . . 0.0 110.431 -179.909 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 25.7 m -127.12 146.38 50.41 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 109.393 -0.595 . . . . 0.0 109.393 179.674 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -56.85 130.6 46.46 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 120.978 0.418 . . . . 0.0 111.501 -179.234 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 149' ' ' LYS . . . . . 0.467 ' HE2' ' OG ' ' A' ' 76' ' ' SER . 18.0 ttpt -93.2 63.11 3.59 Favored 'General case' 0 N--CA 1.451 -0.378 0 N-CA-C 108.622 -0.881 . . . . 0.0 108.622 179.508 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 16.4 tpt180 . . . . . 0 C--N 1.321 -0.657 0 CA-C-O 121.31 0.576 . . . . 0.0 110.25 -179.867 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.237 0.444 0 CA-C-O 120.891 0.377 . . . . 0.0 111.547 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 16.2 tp -72.11 80.42 0.96 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.422 -0.808 . . . . 0.0 111.015 179.862 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . 0.436 ' C ' ' H ' ' A' ' 45' ' ' MET . 0.8 OUTLIER -126.6 148.93 49.72 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 115.765 -0.652 . . . . 0.0 109.391 179.449 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -75.98 23.87 0.13 Allowed 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.088 0.471 . . . . 0.0 111.847 -179.58 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' MET . . . . . 0.436 ' H ' ' C ' ' A' ' 43' ' ' ARG . 16.6 ptt? -95.8 5.93 50.13 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.053 0.454 . . . . 0.0 110.127 179.754 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 40.5 mt-30 -67.22 -8.5 32.05 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.409 -179.264 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -82.7 -11.74 58.1 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.483 0.658 . . . . 0.0 109.994 178.722 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . 0.48 ' O ' ' HG2' ' A' ' 52' ' ' GLU . 13.5 ttpp -78.51 5.82 9.97 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.257 -0.883 . . . . 0.0 110.398 -179.806 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 12.6 p -58.04 -24.65 24.25 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.123 -179.866 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 32.0 mt-10 -65.13 -27.8 68.99 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 121.154 0.502 . . . . 0.0 110.247 179.042 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 12.8 mtmt -98.59 -33.7 10.87 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.238 178.711 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . 0.48 ' HG2' ' O ' ' A' ' 48' ' ' LYS . 38.1 mm-40 -83.31 12.14 5.76 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.807 -0.633 . . . . 0.0 111.651 -179.731 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 10.5 ptp -62.03 -30.64 71.1 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-O 120.717 0.294 . . . . 0.0 110.651 179.679 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -96.91 3.96 62.81 Favored Glycine 0 N--CA 1.449 -0.434 0 N-CA-C 111.05 -0.82 . . . . 0.0 111.05 178.474 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.326 -0.441 0 CA-C-O 121.406 0.622 . . . . 0.0 110.389 -179.722 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . 0.463 ' O ' ' HB3' ' A' ' 68' ' ' GLU . . . . . . . . 0 CA--C 1.522 -0.131 0 CA-C-O 121.101 0.477 . . . . 0.0 110.223 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -77.59 3.22 14.26 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-O 121.18 0.514 . . . . 0.0 111.21 -179.795 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 16.5 tp60 -121.81 -45.86 2.26 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.794 178.928 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -87.45 -48.9 7.58 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.513 -0.312 . . . . 0.0 111.343 -179.835 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . 0.463 ' HB3' ' O ' ' A' ' 64' ' ' ALA . 3.0 tp10 -72.54 -31.37 65.25 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 121.114 0.483 . . . . 0.0 109.92 179.795 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . 0.411 ' HE3' ' OE2' ' A' ' 121' ' ' GLU . 0.0 OUTLIER -55.11 -29.98 58.77 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.814 -0.63 . . . . 0.0 111.581 179.726 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 95.4 mt-10 -60.64 -21.48 62.81 Favored 'General case' 0 C--N 1.332 -0.182 0 O-C-N 123.525 0.516 . . . . 0.0 110.787 179.656 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . 0.543 ' O ' ' HD3' ' A' ' 75' ' ' ARG . 36.0 tp10 -98.68 -43.49 6.79 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 109.435 -0.58 . . . . 0.0 109.435 177.432 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . 0.425 HG23 ' O ' ' A' ' 68' ' ' GLU . 21.8 t -60.24 -42.22 89.66 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.244 0 CA-C-N 115.699 -0.682 . . . . 0.0 112.655 -178.613 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 23.4 p-10 -66.93 -18.37 65.35 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-O 121.045 0.45 . . . . 0.0 111.041 -179.928 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' SER . . . . . 0.409 ' C ' ' HD2' ' A' ' 75' ' ' ARG . 28.8 t -101.64 -3.86 27.58 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 121.334 0.588 . . . . 0.0 110.125 179.018 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . 0.543 ' HD3' ' O ' ' A' ' 71' ' ' GLU . 2.6 mpt_? -115.93 49.06 1.14 Allowed 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.694 0.759 . . . . 0.0 109.631 -179.796 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' SER . . . . . 0.477 ' OG ' ' HE2' ' A' ' 149' ' ' LYS . 0.4 OUTLIER -130.38 175.15 9.19 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 115.057 -0.974 . . . . 0.0 110.153 179.958 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -133.96 137.1 52.85 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 N-CA-C 109.977 -0.379 . . . . 0.0 109.977 178.179 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 83.9 t80 -94.82 126.52 40.2 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 109.644 -0.502 . . . . 0.0 109.644 179.877 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 4.0 t -105.95 115.36 47.49 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.138 -179.013 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -118.08 169.32 13.3 Favored Glycine 0 N--CA 1.447 -0.606 0 N-CA-C 110.863 -0.895 . . . . 0.0 110.863 179.255 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 1.6 m-20 59.08 37.8 24.13 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-O 121.177 0.513 . . . . 0.0 110.936 -179.566 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 2.5 t -80.84 162.25 3.65 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.884 -179.319 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . 0.522 ' OD2' ' HD2' ' A' ' 142' ' ' ARG . 9.7 t0 -66.23 135.43 54.46 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 109.607 -0.516 . . . . 0.0 109.607 179.225 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 36.5 p90 -63.96 -14.25 52.44 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.075 -0.511 . . . . 0.0 112.005 -178.616 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -114.19 14.85 18.24 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.72 0.295 . . . . 0.0 111.456 179.753 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' CYS . . . . . 0.484 ' SG ' ' HB2' ' A' ' 140' ' ' HIS . 0.8 OUTLIER -78.1 148.91 33.99 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.103 0.478 . . . . 0.0 111.281 -179.795 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' THR . . . . . 0.492 ' O ' ' HG2' ' A' ' 90' ' ' GLU . 0.2 OUTLIER -110.67 149.71 40.7 Favored Pre-proline 0 C--N 1.325 -0.462 0 CA-C-N 115.743 -0.662 . . . . 0.0 109.921 179.114 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 11.5 Cg_endo -55.32 -38.33 93.87 Favored 'Trans proline' 0 C--N 1.347 0.458 0 C-N-CA 122.83 2.353 . . . . 0.0 112.842 -179.039 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . 0.435 ' O ' ' HG3' ' A' ' 92' ' ' GLN . 3.2 mp0 -62.94 -52.14 64.2 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.485 -0.325 . . . . 0.0 111.802 -179.199 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . 0.492 ' HG2' ' O ' ' A' ' 87' ' ' THR . 6.0 pt-20 -61.04 -20.31 62.4 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-O 120.862 0.363 . . . . 0.0 111.519 -178.806 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 55.5 t -84.61 -47.21 17.45 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.674 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.739 -179.152 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 92' ' ' GLN . . . . . 0.435 ' HG3' ' O ' ' A' ' 89' ' ' GLU . 0.8 OUTLIER -72.17 -33.2 67.51 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.319 -0.401 . . . . 0.0 111.757 -178.423 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -78.04 -27.42 48.75 Favored 'General case' 0 N--CA 1.467 0.384 0 C-N-CA 120.237 -0.585 . . . . 0.0 111.53 -178.919 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 94' ' ' HIS . . . . . 0.485 ' HB2' ' O ' ' A' ' 90' ' ' GLU . 0.2 OUTLIER -75.12 -42.33 56.64 Favored 'General case' 0 C--N 1.325 -0.464 0 C-N-CA 120.819 -0.352 . . . . 0.0 110.721 -179.856 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 20.3 m-30 -76.47 -18.9 58.53 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.464 179.931 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . 0.639 ' HA ' ' O ' ' A' ' 99' ' ' GLY . 0.9 OUTLIER -62.4 -22.09 65.88 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.397 179.342 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 21.5 t -62.91 -28.57 70.15 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.364 179.475 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 5.5 m -97.91 -40.7 8.36 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.23 179.837 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . 0.639 ' O ' ' HA ' ' A' ' 96' ' ' GLN . . . -151.28 141.86 8.99 Favored Glycine 0 N--CA 1.449 -0.484 0 N-CA-C 111.424 -0.671 . . . . 0.0 111.424 179.69 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 100' ' ' THR . . . . . 0.41 ' HB ' ' CE1' ' A' ' 122' ' ' PHE . 0.2 OUTLIER -62.22 154.5 27.32 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.104 0.478 . . . . 0.0 112.09 -179.471 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 2.1 p -118.03 131.19 71.51 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-N 115.747 -0.66 . . . . 0.0 110.91 -179.685 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 26.1 t30 -97.91 -45.0 6.46 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.152 0.501 . . . . 0.0 109.695 179.123 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -142.75 157.32 44.76 Favored 'General case' 0 C--O 1.235 0.318 0 CA-C-N 115.676 -0.693 . . . . 0.0 109.991 179.196 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 7.2 p -155.29 137.59 6.43 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 CA-C-N 115.82 -0.627 . . . . 0.0 109.974 179.59 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 105' ' ' THR . . . . . 0.476 ' HB ' ' CE1' ' A' ' 119' ' ' TYR . 3.5 m -131.59 128.29 38.89 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 109.732 -0.47 . . . . 0.0 109.732 179.317 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 20.3 tt -113.27 137.15 47.31 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-O 121.3 0.571 . . . . 0.0 111.205 -179.804 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 35.0 tp -118.91 124.5 47.24 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.777 -0.647 . . . . 0.0 109.896 179.646 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -90.79 113.62 25.8 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 110.144 -0.317 . . . . 0.0 110.144 179.445 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -72.76 139.73 47.31 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.152 0.501 . . . . 0.0 111.253 -179.469 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -129.61 33.93 4.4 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 115.638 -0.71 . . . . 0.0 109.434 178.751 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 2.6 t80 -118.21 -4.31 10.97 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.618 -179.69 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 110.19 6.98 27.28 Favored Glycine 0 CA--C 1.52 0.353 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.833 179.936 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 113' ' ' GLN . . . . . 0.41 ' HB3' ' HD2' ' A' ' 114' ' ' PRO . 19.0 mt-30 -96.8 161.05 27.82 Favored Pre-proline 0 C--N 1.324 -0.513 0 N-CA-C 109.464 -0.569 . . . . 0.0 109.464 179.951 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 114' ' ' PRO . . . . . 0.41 ' HD2' ' HB3' ' A' ' 113' ' ' GLN . 19.5 Cg_endo -59.75 115.15 2.41 Favored 'Trans proline' 0 C--N 1.347 0.454 0 C-N-CA 122.039 1.826 . . . . 0.0 111.13 178.582 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 53.1 mttt -72.72 172.19 11.18 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 120.771 0.319 . . . . 0.0 110.246 -179.014 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 101.4 3.89 53.29 Favored Glycine 0 N--CA 1.444 -0.781 0 C-N-CA 120.175 -1.012 . . . . 0.0 112.227 179.712 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 26.8 m-85 -52.73 112.66 0.88 Allowed 'General case' 0 N--CA 1.463 0.196 0 N-CA-C 110.094 -0.336 . . . . 0.0 110.094 179.49 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -141.37 174.25 10.72 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 121.191 0.52 . . . . 0.0 111.523 -178.61 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 119' ' ' TYR . . . . . 0.476 ' CE1' ' HB ' ' A' ' 105' ' ' THR . 48.5 p90 -156.48 129.59 7.98 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.34 -0.845 . . . . 0.0 109.81 179.202 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 13.9 m -105.92 142.94 17.78 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.686 0 N-CA-C 109.254 -0.646 . . . . 0.0 109.254 178.976 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . 0.411 ' OE2' ' HE3' ' A' ' 69' ' ' LYS . 7.1 pt-20 -129.92 150.23 51.3 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 120.765 0.317 . . . . 0.0 111.745 -179.68 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 122' ' ' PHE . . . . . 0.41 ' CE1' ' HB ' ' A' ' 100' ' ' THR . 11.5 t80 -145.89 172.44 13.34 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.706 -0.679 . . . . 0.0 109.308 178.796 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 2.9 t -92.64 -57.26 4.45 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 CA-C-O 120.782 0.325 . . . . 0.0 111.281 -178.979 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 93.0 mt-10 -62.65 118.07 7.14 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.451 -179.813 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 2.1 mp -57.29 -32.31 40.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 115.566 -0.743 . . . . 0.0 110.964 -179.435 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 17.6 t70 -53.35 -45.37 69.13 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.374 179.42 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -61.93 -54.82 36.61 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.758 -0.655 . . . . 0.0 111.691 -179.361 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 12.1 p -65.94 -29.65 47.52 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 C-N-CA 120.894 -0.322 . . . . 0.0 111.256 -179.249 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 129' ' ' GLN . . . . . 0.414 ' O ' ' HG ' ' A' ' 132' ' ' LEU . 9.6 tt0 -61.25 -48.59 80.75 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.178 0.513 . . . . 0.0 110.116 179.123 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 87.2 m-20 -69.29 -29.96 67.94 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.721 -0.672 . . . . 0.0 109.717 179.713 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 131' ' ' ALA . . . . . 0.455 ' O ' ' HB2' ' A' ' 135' ' ' ASN . . . -66.86 -52.18 46.63 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.618 -0.719 . . . . 0.0 111.089 179.66 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 132' ' ' LEU . . . . . 0.414 ' HG ' ' O ' ' A' ' 129' ' ' GLN . 4.0 pp -64.94 -23.92 67.37 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.79 0.328 . . . . 0.0 110.636 179.978 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 1.6 tp -72.0 -55.61 7.12 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.204 0.526 . . . . 0.0 110.058 179.597 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 49.4 mt -120.13 101.8 8.08 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.648 -0.705 . . . . 0.0 109.558 179.568 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 135' ' ' ASN . . . . . 0.455 ' HB2' ' O ' ' A' ' 131' ' ' ALA . 0.5 OUTLIER -146.68 -71.26 0.24 Allowed 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 120.87 0.367 . . . . 0.0 111.155 -178.976 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 7.5 pt-20 -69.91 95.12 0.9 Allowed 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.649 0.738 . . . . 0.0 111.849 -179.034 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 8.9 m -137.17 -59.53 0.69 Allowed 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.374 -0.83 . . . . 0.0 109.536 178.92 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 7.4 tt0 -165.4 130.84 2.56 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 109.525 -0.546 . . . . 0.0 109.525 179.222 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -146.0 118.04 8.28 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 109.672 -0.492 . . . . 0.0 109.672 -179.939 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 140' ' ' HIS . . . . . 0.484 ' HB2' ' SG ' ' A' ' 86' ' ' CYS . 3.2 t60 68.77 1.23 2.99 Favored 'General case' 0 N--CA 1.469 0.509 0 O-C-N 123.508 0.505 . . . . 0.0 111.393 178.971 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 113.52 -9.38 24.11 Favored Glycine 0 N--CA 1.447 -0.622 0 C-N-CA 121.038 -0.601 . . . . 0.0 111.743 -179.129 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 142' ' ' ARG . . . . . 0.522 ' HD2' ' OD2' ' A' ' 83' ' ' ASP . 0.0 OUTLIER -111.29 170.88 7.82 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 109.874 -0.417 . . . . 0.0 109.874 179.785 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 13.2 pt20 -115.75 121.45 42.5 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 109.217 -0.66 . . . . 0.0 109.217 178.705 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -99.08 175.65 5.83 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.066 -178.748 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 3.8 tttt -117.1 122.69 44.84 Favored 'General case' 0 C--N 1.317 -0.805 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 179.16 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 146' ' ' VAL . . . . . 0.429 HG21 ' OD1' ' A' ' 135' ' ' ASN . 96.2 t -117.49 137.51 51.17 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.652 0 CA-C-O 121.242 0.544 . . . . 0.0 111.409 -178.971 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 23.6 t -139.13 144.18 38.54 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.845 -0.616 . . . . 0.0 109.516 179.314 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -63.14 128.89 37.93 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 120.714 0.292 . . . . 0.0 110.277 179.47 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 149' ' ' LYS . . . . . 0.477 ' HE2' ' OG ' ' A' ' 76' ' ' SER . 28.3 ttpt -89.15 76.63 7.68 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 121.3 0.571 . . . . 0.0 109.76 -179.643 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 23.9 tpt180 . . . . . 0 C--N 1.324 -0.529 0 CA-C-N 115.654 -0.703 . . . . 0.0 109.802 179.539 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.423 0 N-CA-C 110.066 -0.346 . . . . 0.0 110.066 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 27.4 tp -69.26 90.93 0.51 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.101 0.477 . . . . 0.0 109.896 179.252 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 53.5 ttm-85 -153.69 -6.34 0.17 Allowed 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.861 -0.609 . . . . 0.0 111.177 -178.88 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 17.1 mt-10 65.2 19.71 11.78 Favored 'General case' 0 N--CA 1.468 0.471 0 CA-C-O 121.149 0.499 . . . . 0.0 110.662 -178.767 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 26.5 ptm -83.61 1.35 42.65 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.848 -0.615 . . . . 0.0 110.382 -179.88 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 30.6 mt-30 -72.39 -20.9 61.36 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.147 0.498 . . . . 0.0 110.116 179.72 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -76.5 -8.54 57.4 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 121.555 0.693 . . . . 0.0 109.965 178.788 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 21.6 ttmt -79.26 1.44 24.85 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.321 -0.854 . . . . 0.0 110.499 -179.91 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 7.4 p -58.28 -23.64 22.55 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.251 0 CA-C-N 115.781 -0.645 . . . . 0.0 111.102 179.632 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -63.42 -26.37 68.7 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.512 179.526 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 24.5 mtmt -101.97 -41.52 6.43 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.872 179.444 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 62.6 mm-40 -62.36 -16.65 55.75 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.969 -0.559 . . . . 0.0 111.522 -179.572 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 10.0 ptp -63.32 -25.41 68.29 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.978 0.418 . . . . 0.0 110.042 178.794 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -98.17 -5.08 57.35 Favored Glycine 0 N--CA 1.448 -0.542 0 N-CA-C 110.943 -0.863 . . . . 0.0 110.943 179.0 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.324 -0.519 0 CA-C-O 121.099 0.476 . . . . 0.0 110.154 -179.779 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.456 -0.154 0 CA-C-O 120.82 0.343 . . . . 0.0 110.832 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -76.47 -1.62 28.05 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.09 0.471 . . . . 0.0 110.931 179.802 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 7.0 tp60 -118.05 -51.27 2.45 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.64 179.507 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -83.08 -61.65 1.8 Allowed 'General case' 0 C--N 1.331 -0.201 0 N-CA-C 111.871 0.323 . . . . 0.0 111.871 -179.092 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -60.88 -29.7 69.7 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-O 120.976 0.417 . . . . 0.0 110.671 -179.384 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 51.5 tptt -56.11 -31.35 63.19 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.83 -0.623 . . . . 0.0 111.206 179.582 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 18.7 mt-10 -63.3 -21.15 66.07 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-O 121.18 0.514 . . . . 0.0 111.074 -179.797 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . 0.415 ' O ' ' HD2' ' A' ' 75' ' ' ARG . 13.5 tp10 -94.65 -42.96 8.51 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 115.675 -0.693 . . . . 0.0 109.172 177.98 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 47.9 t -62.34 -43.29 97.93 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-N 115.181 -0.918 . . . . 0.0 112.552 -178.924 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 17.2 p-10 -71.55 -19.68 62.13 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-O 121.025 0.441 . . . . 0.0 111.613 -178.958 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' SER . . . . . 0.572 ' OG ' ' HD3' ' A' ' 150' ' ' ARG . 44.4 t -96.65 -7.33 34.46 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 109.604 -0.517 . . . . 0.0 109.604 178.796 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . 0.415 ' HD2' ' O ' ' A' ' 71' ' ' GLU . 0.0 OUTLIER -114.47 40.94 2.42 Favored 'General case' 0 N--CA 1.452 -0.361 0 CA-C-N 115.505 -0.77 . . . . 0.0 110.185 -179.367 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' SER . . . . . 0.445 ' OG ' ' HE2' ' A' ' 149' ' ' LYS . 0.3 OUTLIER -120.11 174.6 6.39 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.708 179.509 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 6.5 pt -132.3 139.64 49.62 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.262 178.341 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' TYR . . . . . 0.402 ' O ' ' HA ' ' A' ' 146' ' ' VAL . 16.7 t80 -92.58 119.84 32.43 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.615 -0.72 . . . . 0.0 109.761 179.895 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 7.2 t -104.79 109.36 27.34 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-N 116.53 -0.304 . . . . 0.0 110.184 179.86 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -117.82 166.94 12.73 Favored Glycine 0 N--CA 1.448 -0.523 0 C-N-CA 120.815 -0.707 . . . . 0.0 112.278 -179.281 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 3.0 m120 57.01 44.13 23.32 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-O 121.314 0.578 . . . . 0.0 110.853 -179.818 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.417 HG11 ' H ' ' A' ' 83' ' ' ASP . 2.4 t -82.68 167.91 1.9 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 CA-C-N 115.236 -0.893 . . . . 0.0 110.368 -179.361 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . 0.491 ' HB3' ' SG ' ' A' ' 86' ' ' CYS . 24.7 t70 -68.71 140.97 55.41 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.855 0.36 . . . . 0.0 110.337 179.625 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 28.3 p90 -65.49 -12.66 54.69 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.831 -0.622 . . . . 0.0 112.521 -178.694 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -117.85 10.79 13.33 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.617 0.246 . . . . 0.0 111.492 -179.981 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' CYS . . . . . 0.491 ' SG ' ' HB3' ' A' ' 83' ' ' ASP . 0.9 OUTLIER -73.9 144.52 45.33 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.044 0.449 . . . . 0.0 111.001 -179.995 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' THR . . . . . 0.52 ' O ' ' HG2' ' A' ' 90' ' ' GLU . 5.6 p -108.24 157.54 36.07 Favored Pre-proline 0 C--N 1.327 -0.377 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.233 179.379 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 20.8 Cg_endo -60.53 -39.84 61.79 Favored 'Trans proline' 0 C--N 1.344 0.328 0 C-N-CA 122.399 2.066 . . . . 0.0 113.366 -178.979 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . 0.436 ' O ' ' HG2' ' A' ' 93' ' ' GLN . 7.9 mm-40 -64.16 -46.1 85.55 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 112.323 0.49 . . . . 0.0 112.323 -178.603 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . 0.52 ' HG2' ' O ' ' A' ' 87' ' ' THR . 9.8 pt-20 -65.79 -18.29 65.23 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-O 121.028 0.442 . . . . 0.0 111.432 -179.25 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 52.1 t -87.44 -47.36 15.85 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.83 -179.135 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 1.7 pp0? -68.79 -35.44 77.03 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.511 -0.313 . . . . 0.0 111.496 -178.581 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . 0.436 ' HG2' ' O ' ' A' ' 89' ' ' GLU . 3.5 pt20 -77.17 -29.89 54.66 Favored 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 120.372 -0.531 . . . . 0.0 111.337 -179.05 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -69.3 -41.68 76.46 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.853 0.358 . . . . 0.0 110.71 179.931 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 17.0 m-30 -82.47 -13.48 56.65 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 116.387 -0.37 . . . . 0.0 110.968 -179.557 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . 0.567 ' HA ' ' O ' ' A' ' 99' ' ' GLY . 37.3 tt0 -64.33 -23.94 67.47 Favored 'General case' 0 C--O 1.234 0.252 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.483 -179.86 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 15.2 m -67.12 -28.15 67.92 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.712 179.576 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 5.3 m -94.35 -41.62 9.32 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.144 -0.48 . . . . 0.0 109.978 179.542 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . 0.567 ' O ' ' HA ' ' A' ' 96' ' ' GLN . . . -150.55 144.26 11.63 Favored Glycine 0 N--CA 1.445 -0.745 0 CA-C-N 115.864 -0.607 . . . . 0.0 111.701 179.807 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -63.18 146.87 52.44 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 121.029 0.442 . . . . 0.0 111.48 -179.829 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 1.3 p -120.23 128.68 75.99 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.342 -179.878 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 27.2 t-20 -96.98 -46.97 5.99 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.687 0.28 . . . . 0.0 110.669 -179.999 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 2.6 tpt180 -137.44 148.33 46.04 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.571 -179.643 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 7.5 p -148.15 137.83 16.28 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-O 121.004 0.43 . . . . 0.0 110.638 179.265 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 2.3 m -130.24 129.44 43.34 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 116.008 -0.542 . . . . 0.0 109.983 178.961 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 20.5 tt -114.63 148.04 17.66 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-O 120.995 0.426 . . . . 0.0 110.899 -179.494 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 9.1 tp -129.82 140.29 51.05 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.131 179.759 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -105.8 114.3 28.38 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.511 -0.313 . . . . 0.0 110.248 179.552 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 7.5 t70 -75.85 142.64 42.14 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.396 -0.365 . . . . 0.0 110.952 -179.818 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 2.6 mppt? -127.13 20.4 6.89 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.281 0.563 . . . . 0.0 109.906 179.015 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 36.0 t80 -100.92 -6.79 24.13 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.467 -0.788 . . . . 0.0 110.23 -179.608 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 106.36 11.61 26.99 Favored Glycine 0 N--CA 1.448 -0.534 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.443 -179.966 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 113' ' ' GLN . . . . . 0.425 ' HB3' ' HD2' ' A' ' 114' ' ' PRO . 24.5 mt-30 -97.1 160.86 28.04 Favored Pre-proline 0 C--O 1.239 0.535 0 N-CA-C 109.455 -0.572 . . . . 0.0 109.455 -179.972 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 114' ' ' PRO . . . . . 0.425 ' HD2' ' HB3' ' A' ' 113' ' ' GLN . 16.8 Cg_endo -58.7 113.77 1.71 Allowed 'Trans proline' 0 C--N 1.347 0.492 0 C-N-CA 122.207 1.938 . . . . 0.0 111.277 178.628 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 9.6 mttp -78.57 179.74 6.91 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.144 -179.226 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 92.55 2.83 67.24 Favored Glycine 0 N--CA 1.444 -0.804 0 C-N-CA 120.081 -1.057 . . . . 0.0 111.462 179.978 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 5.1 t80 -55.67 124.59 17.91 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.725 0.298 . . . . 0.0 110.393 179.78 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -149.44 171.2 16.96 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.627 -179.374 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 44.9 p90 -152.4 130.41 11.82 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-N 115.656 -0.702 . . . . 0.0 109.204 178.782 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 13.7 m -108.56 142.49 21.04 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.139 179.905 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . 0.441 ' HB3' ' HB3' ' A' ' 76' ' ' SER . 1.3 pt-20 -131.55 154.34 48.91 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 120.923 0.392 . . . . 0.0 111.192 179.637 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 12.1 t80 -146.88 167.61 23.5 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.587 -0.733 . . . . 0.0 110.363 179.689 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 11.0 t -84.45 -41.21 15.97 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-O 120.901 0.381 . . . . 0.0 111.565 -179.432 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 33.3 mm-40 -76.56 131.34 38.89 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.152 -179.429 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 2.1 mp -73.27 -34.53 44.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.018 -179.46 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 17.5 t70 -58.38 -36.1 73.0 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.204 0.526 . . . . 0.0 111.058 -179.763 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -64.13 -57.7 8.81 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.735 -0.666 . . . . 0.0 111.271 -179.893 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 10.9 p -65.27 -27.71 42.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.554 -0.293 . . . . 0.0 111.287 -179.52 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 7.1 tt0 -60.02 -46.77 88.39 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.887 0.375 . . . . 0.0 110.246 179.83 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 50.7 m-80 -74.96 -24.26 58.43 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.143 179.873 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -68.98 -51.78 35.81 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.608 179.344 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 3.8 pp -67.55 -16.89 64.43 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.988 0.423 . . . . 0.0 111.057 179.881 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 1.1 tp -77.41 -53.08 8.09 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.003 179.324 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 87.9 mt -126.36 102.83 7.33 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.742 -0.663 . . . . 0.0 109.687 179.568 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -147.52 -67.02 0.26 Allowed 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.166 0.508 . . . . 0.0 111.948 -178.931 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 4.5 pt-20 -74.12 95.04 2.5 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.629 0.728 . . . . 0.0 111.857 -178.819 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 5.9 m -141.21 -59.75 0.49 Allowed 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.692 -0.686 . . . . 0.0 110.134 178.801 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -154.21 121.36 5.68 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 109.935 -0.395 . . . . 0.0 109.935 179.841 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -141.97 117.04 9.99 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 109.459 -0.571 . . . . 0.0 109.459 179.744 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 140' ' ' HIS . . . . . 0.415 ' HB2' ' SG ' ' A' ' 86' ' ' CYS . 2.2 t60 64.52 21.09 12.36 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-O 120.99 0.424 . . . . 0.0 110.78 179.869 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 86.55 -1.84 87.27 Favored Glycine 0 N--CA 1.449 -0.469 0 C-N-CA 120.715 -0.755 . . . . 0.0 111.533 -179.084 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 1.4 mpt_? -116.17 178.88 4.16 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 109.663 -0.495 . . . . 0.0 109.663 -179.68 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -122.5 141.41 51.68 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-O 120.818 0.342 . . . . 0.0 110.268 179.41 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -123.98 178.72 5.15 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 115.968 -0.56 . . . . 0.0 109.971 -179.821 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -120.81 120.3 35.17 Favored 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 109.595 -0.52 . . . . 0.0 109.595 179.444 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 146' ' ' VAL . . . . . 0.402 ' HA ' ' O ' ' A' ' 78' ' ' TYR . 73.1 t -115.32 129.92 70.76 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-O 120.951 0.405 . . . . 0.0 111.063 -179.092 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 1.6 m -134.22 148.02 50.8 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 179.109 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -61.96 129.47 41.05 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 120.658 0.266 . . . . 0.0 111.246 -179.83 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 149' ' ' LYS . . . . . 0.445 ' HE2' ' OG ' ' A' ' 76' ' ' SER . 25.8 ttpt -90.39 62.19 5.25 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.919 0.866 . . . . 0.0 108.758 179.528 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 150' ' ' ARG . . . . . 0.572 ' HD3' ' OG ' ' A' ' 74' ' ' SER . 0.0 OUTLIER . . . . . 0 C--N 1.321 -0.631 0 CA-C-N 114.959 -1.019 . . . . 0.0 110.064 -179.729 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.454 -0.269 0 N-CA-C 110.127 -0.323 . . . . 0.0 110.127 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 63.9 tp -72.81 91.42 1.5 Allowed 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 109.623 -0.51 . . . . 0.0 109.623 179.06 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . 0.431 ' HD2' ' SD ' ' A' ' 45' ' ' MET . 13.5 ttm-85 -119.28 -16.1 9.07 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.96 -0.564 . . . . 0.0 111.161 -179.292 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 60.07 29.45 19.01 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 121.375 0.607 . . . . 0.0 110.021 -179.317 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' MET . . . . . 0.431 ' SD ' ' HD2' ' A' ' 43' ' ' ARG . 19.9 ptt? -99.63 12.56 36.22 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.182 -0.917 . . . . 0.0 111.167 -179.69 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 9.9 mm100 -71.81 -20.89 61.78 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 120.853 0.359 . . . . 0.0 110.898 -179.361 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -71.77 -14.5 62.01 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.302 0.572 . . . . 0.0 109.866 178.381 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 34.1 ttpt -82.78 7.22 15.7 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.694 -0.684 . . . . 0.0 109.445 178.826 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 7.3 p -57.2 -20.62 13.26 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.202 0 CA-C-N 115.693 -0.685 . . . . 0.0 111.623 -179.923 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 12.7 mm-40 -64.06 -33.23 75.28 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.431 0.634 . . . . 0.0 109.573 178.705 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 23.1 mtmt -97.42 -31.1 12.54 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.247 -0.888 . . . . 0.0 110.827 179.316 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 20.1 mm-40 -88.04 18.48 4.22 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.592 -179.548 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 7.9 ptm -64.76 -30.37 71.38 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.894 0.378 . . . . 0.0 110.813 179.971 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -94.07 -4.86 62.8 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.771 -0.728 . . . . 0.0 111.445 178.883 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.328 -0.343 0 CA-C-O 121.218 0.532 . . . . 0.0 110.166 -179.61 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.457 -0.092 0 CA-C-O 120.874 0.369 . . . . 0.0 110.45 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -75.13 -1.37 22.76 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.967 -0.56 . . . . 0.0 111.684 -179.615 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -118.97 -40.17 2.87 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.873 179.988 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -93.69 -58.97 2.11 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 112.203 0.445 . . . . 0.0 112.203 -179.408 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . 0.528 ' O ' HG23 ' A' ' 72' ' ' VAL . 2.4 tp10 -66.59 -29.34 69.37 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.611 -0.268 . . . . 0.0 110.997 -178.993 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 45.1 tptt -56.36 -27.88 57.39 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.027 179.715 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 24.1 mt-10 -59.23 -34.83 72.67 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-O 120.83 0.347 . . . . 0.0 110.504 179.274 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 6.8 tp10 -89.07 -41.32 12.38 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.173 179.214 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . 0.528 HG23 ' O ' ' A' ' 68' ' ' GLU . 22.1 t -62.68 -42.02 94.5 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.444 0 N-CA-C 112.073 0.397 . . . . 0.0 112.073 -178.964 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 25.4 t0 -66.28 -20.11 66.01 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-O 121.6 0.714 . . . . 0.0 110.192 179.76 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 16.3 m -100.61 -12.95 18.79 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 114.972 -1.013 . . . . 0.0 110.871 179.998 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -109.21 47.39 0.92 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.485 -179.199 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -126.14 170.13 12.11 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.644 179.783 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -133.24 133.62 57.99 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 N-CA-C 109.832 -0.433 . . . . 0.0 109.832 178.851 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 22.4 t80 -88.5 124.67 34.22 Favored 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 109.497 -0.557 . . . . 0.0 109.497 179.952 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 5.2 t -105.89 111.11 33.66 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-N 116.519 -0.31 . . . . 0.0 110.297 179.861 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -117.04 170.57 13.47 Favored Glycine 0 N--CA 1.447 -0.621 0 N-CA-C 111.574 -0.61 . . . . 0.0 111.574 -179.982 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 3.9 m-20 55.91 43.29 27.68 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-O 121.238 0.542 . . . . 0.0 110.933 -179.099 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 2.5 t -85.49 166.38 2.05 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 CA-C-N 115.646 -0.706 . . . . 0.0 110.561 -179.505 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . 0.528 ' OD2' ' HD2' ' A' ' 142' ' ' ARG . 14.7 t70 -69.68 141.34 53.58 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.042 0.448 . . . . 0.0 110.392 179.978 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 14.5 p90 -64.0 -23.04 67.18 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.763 -0.653 . . . . 0.0 112.322 -178.575 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -107.13 16.01 24.57 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 120.874 0.368 . . . . 0.0 111.162 -179.27 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' CYS . . . . . 0.411 ' SG ' ' HB2' ' A' ' 140' ' ' HIS . 0.8 OUTLIER -79.84 145.43 32.76 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 121.207 0.527 . . . . 0.0 110.954 179.971 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 13.2 p -111.25 153.77 43.89 Favored Pre-proline 0 C--N 1.324 -0.524 0 CA-C-N 115.509 -0.769 . . . . 0.0 110.315 179.553 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 16.6 Cg_endo -56.43 -37.7 96.67 Favored 'Trans proline' 0 C--N 1.344 0.336 0 C-N-CA 122.855 2.37 . . . . 0.0 112.556 -179.311 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . 0.485 ' O ' ' HG2' ' A' ' 93' ' ' GLN . 0.0 OUTLIER -63.5 -52.26 62.03 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.9 -0.591 . . . . 0.0 111.886 -178.937 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . 0.409 ' O ' ' HB2' ' A' ' 94' ' ' HIS . 7.9 pt-20 -65.23 -15.3 62.33 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.763 0.316 . . . . 0.0 111.429 -178.475 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 61.7 t -89.65 -46.25 15.17 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 CA-C-N 116.63 -0.259 . . . . 0.0 110.873 -179.806 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 1.7 pt20 -72.35 -34.2 67.84 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 111.817 0.302 . . . . 0.0 111.817 -178.45 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . 0.485 ' HG2' ' O ' ' A' ' 89' ' ' GLU . 26.0 pt20 -80.59 -22.72 40.42 Favored 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 120.33 -0.548 . . . . 0.0 111.249 -179.157 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 94' ' ' HIS . . . . . 0.409 ' HB2' ' O ' ' A' ' 90' ' ' GLU . 0.3 OUTLIER -75.31 -32.42 60.96 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.952 0.405 . . . . 0.0 110.498 179.331 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 23.3 m-30 -89.68 -8.08 53.19 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.175 -179.266 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . 0.554 ' HA ' ' O ' ' A' ' 99' ' ' GLY . 1.3 tt0 -66.49 -22.54 66.19 Favored 'General case' 0 C--O 1.232 0.148 0 CA-C-O 121.163 0.506 . . . . 0.0 109.978 -179.694 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 1.2 m -63.36 -30.71 71.79 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.459 -0.791 . . . . 0.0 110.642 179.147 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 17.4 m -97.27 -46.03 6.27 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.397 179.63 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . 0.554 ' O ' ' HA ' ' A' ' 96' ' ' GLN . . . -144.92 143.35 11.81 Favored Glycine 0 N--CA 1.442 -0.95 0 C-N-CA 120.908 -0.663 . . . . 0.0 111.869 -179.892 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -66.06 145.65 55.6 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 120.574 0.226 . . . . 0.0 111.096 -179.872 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 2.5 p -111.09 129.51 66.23 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-O 120.957 0.408 . . . . 0.0 111.25 -179.335 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . 0.516 ' OD1' ' HD2' ' A' ' 103' ' ' ARG . 26.0 t-20 -100.88 -45.17 5.53 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 109.868 -0.419 . . . . 0.0 109.868 179.327 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 103' ' ' ARG . . . . . 0.516 ' HD2' ' OD1' ' A' ' 102' ' ' ASN . 0.0 OUTLIER -138.44 151.9 47.86 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.156 -0.475 . . . . 0.0 109.972 178.776 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 4.0 p -151.44 119.52 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-O 121.142 0.496 . . . . 0.0 110.299 179.144 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 105' ' ' THR . . . . . 0.424 ' HB ' ' CE1' ' A' ' 119' ' ' TYR . 1.2 m -112.27 120.12 40.66 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.116 179.655 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 106' ' ' ILE . . . . . 0.405 HD13 ' HA2' ' A' ' 116' ' ' GLY . 21.5 tt -108.06 146.38 14.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-O 121.025 0.44 . . . . 0.0 111.166 -179.903 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 26.0 tp -131.93 136.22 47.21 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.213 179.458 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -101.83 116.33 32.48 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 116.544 -0.298 . . . . 0.0 110.533 179.749 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . 0.436 ' O ' ' HG2' ' A' ' 115' ' ' LYS . 12.3 t70 -83.76 136.2 34.25 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.026 0.441 . . . . 0.0 111.155 -179.766 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -126.56 27.42 6.12 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 116.148 -0.478 . . . . 0.0 109.896 179.4 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 10.0 t80 -108.23 -2.01 19.7 Favored 'General case' 0 N--CA 1.45 -0.451 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.282 -179.36 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 114.45 3.2 22.63 Favored Glycine 0 N--CA 1.449 -0.434 0 C-N-CA 120.399 -0.905 . . . . 0.0 112.995 179.617 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 26.6 mt-30 -98.18 156.57 35.7 Favored Pre-proline 0 C--N 1.321 -0.645 0 N-CA-C 109.671 -0.492 . . . . 0.0 109.671 179.858 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 14.2 Cg_endo -57.37 126.71 22.85 Favored 'Trans proline' 0 C--N 1.349 0.566 0 C-N-CA 122.194 1.929 . . . . 0.0 110.894 178.798 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . 0.436 ' HG2' ' O ' ' A' ' 109' ' ' ASP . 10.7 mttp -82.67 177.55 8.64 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 110.008 -0.368 . . . . 0.0 110.008 -179.732 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . 0.405 ' HA2' HD13 ' A' ' 106' ' ' ILE . . . 94.78 2.91 62.66 Favored Glycine 0 N--CA 1.444 -0.774 0 C-N-CA 120.157 -1.02 . . . . 0.0 112.349 179.419 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 9.9 m-30 -55.84 117.73 3.94 Favored 'General case' 0 C--N 1.332 -0.194 0 N-CA-C 110.163 -0.31 . . . . 0.0 110.163 179.992 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -147.03 174.69 11.31 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-O 120.935 0.398 . . . . 0.0 111.145 -179.144 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 119' ' ' TYR . . . . . 0.424 ' CE1' ' HB ' ' A' ' 105' ' ' THR . 36.1 p90 -152.91 134.09 14.19 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.687 -0.688 . . . . 0.0 109.182 178.674 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 14.6 m -107.91 136.64 42.66 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 N-CA-C 109.42 -0.585 . . . . 0.0 109.42 178.906 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -122.61 152.25 40.64 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 120.619 0.247 . . . . 0.0 110.755 -179.728 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 11.9 t80 -148.4 170.07 18.79 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.028 -0.533 . . . . 0.0 109.961 179.421 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 21.4 t -87.49 -50.09 14.08 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-O 120.975 0.417 . . . . 0.0 111.568 -179.452 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 29.0 mt-10 -70.22 134.26 47.87 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.385 -179.128 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 2.6 mp -73.23 -30.97 32.58 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.59 -179.621 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 5.7 t70 -57.24 -40.45 77.59 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.892 -179.771 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -64.04 -54.95 26.13 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.708 -0.678 . . . . 0.0 111.402 -179.413 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 7.3 p -65.59 -30.58 50.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.447 -0.342 . . . . 0.0 111.193 -179.498 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 20.4 tt0 -59.98 -45.82 91.44 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-O 120.939 0.4 . . . . 0.0 110.361 179.539 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 82.8 m-20 -71.25 -32.61 68.94 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.183 179.701 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 131' ' ' ALA . . . . . 0.434 ' O ' ' HB2' ' A' ' 135' ' ' ASN . . . -66.32 -48.06 71.53 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.85 -0.614 . . . . 0.0 111.382 -179.927 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 4.2 pp -71.24 -16.87 62.51 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.784 0.326 . . . . 0.0 110.943 -179.734 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 5.5 tp -82.1 -48.96 10.74 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.068 -179.85 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 79.2 mt -136.98 104.06 5.34 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.398 -0.365 . . . . 0.0 110.503 -179.815 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 135' ' ' ASN . . . . . 0.434 ' HB2' ' O ' ' A' ' 131' ' ' ALA . 1.8 m-20 -152.33 -52.87 0.12 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.564 -0.289 . . . . 0.0 111.54 -179.743 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 5.2 pt-20 -73.83 89.27 1.83 Allowed 'General case' 0 C--N 1.33 -0.283 0 CA-C-O 121.528 0.68 . . . . 0.0 111.039 -179.658 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 6.7 m -130.78 -61.94 0.93 Allowed 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.548 -0.751 . . . . 0.0 110.51 179.672 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 8.0 tm-20 -162.16 127.21 3.36 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.22 -0.445 . . . . 0.0 109.813 -179.867 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -142.35 119.69 11.58 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.929 -0.578 . . . . 0.0 109.616 179.466 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 140' ' ' HIS . . . . . 0.411 ' HB2' ' SG ' ' A' ' 86' ' ' CYS . 3.7 t60 63.75 12.74 6.89 Favored 'General case' 0 N--CA 1.466 0.333 0 C-N-CA 122.717 0.407 . . . . 0.0 111.413 179.594 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 103.76 -8.42 50.79 Favored Glycine 0 N--CA 1.45 -0.398 0 C-N-CA 120.633 -0.794 . . . . 0.0 112.755 -179.59 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 142' ' ' ARG . . . . . 0.528 ' HD2' ' OD2' ' A' ' 83' ' ' ASP . 0.0 OUTLIER -116.2 169.77 9.03 Favored 'General case' 0 C--N 1.324 -0.543 0 O-C-N 122.602 -0.352 . . . . 0.0 110.843 -179.436 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 7.8 pt20 -110.93 125.72 53.97 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 109.544 -0.539 . . . . 0.0 109.544 179.046 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -104.92 177.35 4.87 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 120.734 0.302 . . . . 0.0 111.179 -179.277 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 145' ' ' LYS . . . . . 0.543 ' HE2' ' OG ' ' A' ' 147' ' ' SER . 0.1 OUTLIER -118.04 122.95 44.46 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 109.459 -0.571 . . . . 0.0 109.459 179.305 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 89.0 t -114.18 121.64 66.7 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-O 120.837 0.351 . . . . 0.0 111.226 -179.785 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 147' ' ' SER . . . . . 0.543 ' OG ' ' HE2' ' A' ' 145' ' ' LYS . 0.6 OUTLIER -118.63 141.77 48.28 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.007 179.68 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -67.6 123.51 20.66 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.722 0.296 . . . . 0.0 110.537 179.885 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 15.7 tttp -86.0 74.29 10.15 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.332 0.586 . . . . 0.0 110.312 -179.051 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 11.6 tpt85 . . . . . 0 C--N 1.323 -0.558 0 N-CA-C 109.105 -0.702 . . . . 0.0 109.105 178.944 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.234 0.268 0 N-CA-C 109.846 -0.427 . . . . 0.0 109.846 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 57.4 tp -73.87 91.39 1.97 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.314 0.578 . . . . 0.0 110.234 179.33 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . 0.667 ' HB3' ' SD ' ' A' ' 45' ' ' MET . 49.5 ttt85 -155.87 156.27 34.36 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.785 -0.643 . . . . 0.0 109.785 -179.31 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . 0.418 ' H ' ' HG2' ' A' ' 44' ' ' GLU . 2.0 pt-20 -79.56 39.55 0.41 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.803 0.811 . . . . 0.0 110.016 178.669 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' MET . . . . . 0.667 ' SD ' ' HB3' ' A' ' 43' ' ' ARG . 6.1 ptm -95.36 9.97 37.96 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 114.815 -1.084 . . . . 0.0 110.989 -179.26 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 22.0 mm-40 -69.87 -20.43 63.4 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.251 0.548 . . . . 0.0 110.459 -179.774 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -82.37 -3.26 55.17 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.664 179.173 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . 0.425 ' HZ3' ' CD ' ' A' ' 52' ' ' GLU . 24.0 ttpp -81.87 -4.19 55.94 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.501 -179.794 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 9.9 p -61.85 -22.28 28.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 121.347 0.594 . . . . 0.0 110.238 179.549 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -67.83 -17.9 64.66 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.657 -0.701 . . . . 0.0 110.044 178.619 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 29.4 mtmt -103.86 -41.15 5.98 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.205 -0.907 . . . . 0.0 110.616 179.741 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . 0.425 ' CD ' ' HZ3' ' A' ' 48' ' ' LYS . 8.4 mt-10 -78.82 6.28 9.44 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.901 0.381 . . . . 0.0 111.24 179.752 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -72.74 -32.61 65.81 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 121.315 0.579 . . . . 0.0 109.526 178.142 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -89.37 -9.6 66.81 Favored Glycine 0 N--CA 1.445 -0.703 0 N-CA-C 110.429 -1.068 . . . . 0.0 110.429 179.034 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.322 -0.612 0 CA-C-N 114.654 -0.773 . . . . 0.0 109.838 179.868 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . 0.424 ' O ' ' HB3' ' A' ' 68' ' ' GLU . . . . . . . . 0 C--O 1.227 -0.112 0 CA-C-O 121.312 0.577 . . . . 0.0 110.1 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -81.56 1.76 32.26 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.733 179.814 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 24.3 tp60 -123.4 -50.88 1.87 Allowed 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.723 -0.671 . . . . 0.0 110.569 179.577 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -82.89 -57.85 3.12 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.545 -179.634 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . 0.424 ' HB3' ' O ' ' A' ' 64' ' ' ALA . 28.4 tt0 -64.06 -29.73 70.85 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 121.129 0.49 . . . . 0.0 110.587 -179.817 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 39.4 tptt -57.24 -30.14 64.37 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.785 -0.643 . . . . 0.0 111.265 179.955 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 7.2 mt-10 -61.42 -22.54 65.11 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-O 121.261 0.553 . . . . 0.0 111.25 179.998 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . 0.535 ' O ' ' HD3' ' A' ' 75' ' ' ARG . 42.7 tp10 -97.84 -43.35 7.16 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 115.881 -0.6 . . . . 0.0 109.536 178.481 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 45.3 t -61.84 -40.22 86.24 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-N 115.597 -0.729 . . . . 0.0 112.776 -178.815 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 16.1 p-10 -72.79 -14.21 61.48 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-O 120.742 0.306 . . . . 0.0 111.792 -178.709 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 48.0 t -106.37 -2.02 22.66 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.004 178.323 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . 0.535 ' HD3' ' O ' ' A' ' 71' ' ' GLU . 2.8 mpt_? -116.68 41.16 2.75 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.609 0.719 . . . . 0.0 109.331 -179.74 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -120.73 171.17 8.79 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.223 -0.899 . . . . 0.0 110.474 179.906 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -131.4 136.15 58.05 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 N-CA-C 109.74 -0.467 . . . . 0.0 109.74 178.603 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 79.2 t80 -93.05 124.06 36.75 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.286 -179.142 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 3.4 t -104.5 112.92 40.01 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.808 -179.708 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -119.24 167.69 13.3 Favored Glycine 0 N--CA 1.447 -0.599 0 N-CA-C 111.18 -0.768 . . . . 0.0 111.18 179.479 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 5.3 m-20 61.77 36.71 16.11 Favored 'General case' 0 N--CA 1.472 0.625 0 CA-C-O 121.218 0.532 . . . . 0.0 110.488 -179.702 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 2.5 t -78.55 164.03 3.48 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-N 115.624 -0.716 . . . . 0.0 111.116 -178.897 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . 0.543 ' OD2' ' HD3' ' A' ' 142' ' ' ARG . 10.8 t0 -68.06 136.58 54.01 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.996 -0.547 . . . . 0.0 109.61 179.313 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 25.7 p90 -64.98 -13.89 58.83 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.118 -0.492 . . . . 0.0 112.1 -179.253 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -113.28 14.21 19.26 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.773 0.321 . . . . 0.0 111.24 179.586 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' CYS . . . . . 0.449 ' SG ' ' HB2' ' A' ' 140' ' ' HIS . 0.8 OUTLIER -78.47 150.11 33.05 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.067 0.461 . . . . 0.0 111.521 -179.389 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 5.3 p -111.47 150.91 42.84 Favored Pre-proline 0 C--N 1.323 -0.55 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.259 179.099 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 16.9 Cg_endo -57.89 -35.03 99.01 Favored 'Trans proline' 0 C--N 1.342 0.235 0 C-N-CA 122.462 2.108 . . . . 0.0 111.566 -179.716 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 66.8 mm-40 -64.36 -53.45 48.46 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.549 -0.75 . . . . 0.0 111.89 -179.429 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 -64.16 -18.37 64.4 Favored 'General case' 0 C--N 1.333 -0.133 0 CA-C-O 120.901 0.381 . . . . 0.0 111.472 -178.225 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 55.0 t -83.71 -49.06 16.79 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.518 -179.884 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 92' ' ' GLN . . . . . 0.406 ' O ' ' HB2' ' A' ' 96' ' ' GLN . 2.8 pt20 -73.38 -32.47 64.5 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.472 -0.331 . . . . 0.0 111.611 -178.479 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 7.1 pt20 -77.25 -28.29 53.57 Favored 'General case' 0 C--N 1.33 -0.261 0 C-N-CA 120.618 -0.433 . . . . 0.0 111.048 -179.118 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 60.9 t-80 -74.95 -44.48 48.21 Favored 'General case' 0 CA--C 1.519 -0.248 0 CA-C-O 121.085 0.469 . . . . 0.0 110.165 179.536 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 20.5 m-30 -73.45 -17.78 61.2 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.866 -0.607 . . . . 0.0 110.517 -179.2 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . 0.482 ' HA ' ' O ' ' A' ' 99' ' ' GLY . 7.7 tt0 -64.61 -25.29 67.9 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.494 -0.775 . . . . 0.0 110.631 179.521 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 48.8 m -61.0 -32.18 71.77 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.514 179.682 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 18.2 m -92.35 -50.23 5.75 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.176 0.512 . . . . 0.0 110.078 179.42 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . 0.482 ' O ' ' HA ' ' A' ' 96' ' ' GLN . . . -137.77 133.7 6.53 Favored Glycine 0 N--CA 1.443 -0.854 0 C-N-CA 120.659 -0.782 . . . . 0.0 111.91 179.783 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -59.33 140.0 56.48 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.029 0.443 . . . . 0.0 110.686 179.975 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 2.8 p -105.51 140.18 24.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 115.876 -0.602 . . . . 0.0 112.171 -178.058 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 9.1 t30 -101.95 -50.56 3.63 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 109.431 -0.581 . . . . 0.0 109.431 178.125 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 9.0 mmm180 -141.8 158.32 43.94 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.386 179.698 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 6.6 p -151.54 127.57 1.83 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.104 179.566 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 105' ' ' THR . . . . . 0.408 ' HB ' ' CE1' ' A' ' 119' ' ' TYR . 1.8 m -117.9 119.17 34.04 Favored 'General case' 0 C--N 1.321 -0.669 0 O-C-N 122.263 -0.273 . . . . 0.0 110.441 -179.984 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 106' ' ' ILE . . . . . 0.405 HD13 ' HA2' ' A' ' 116' ' ' GLY . 18.6 tt -107.16 146.64 13.19 Favored 'Isoleucine or valine' 0 C--O 1.235 0.327 0 CA-C-O 120.959 0.409 . . . . 0.0 111.04 -179.592 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 60.4 tp -135.69 126.24 26.97 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.858 -0.61 . . . . 0.0 109.948 179.12 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -89.2 120.02 30.21 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 116.517 -0.311 . . . . 0.0 110.499 179.83 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . 0.531 ' O ' ' HG2' ' A' ' 115' ' ' LYS . 16.8 t70 -81.08 136.9 35.99 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.014 0.435 . . . . 0.0 110.829 -179.883 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -124.93 25.86 7.21 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.896 -0.593 . . . . 0.0 109.763 179.556 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 24.6 t80 -105.99 -3.87 21.19 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.059 -179.483 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 106.83 10.9 27.62 Favored Glycine 0 N--CA 1.449 -0.493 0 C-N-CA 120.678 -0.772 . . . . 0.0 112.536 -179.582 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 113' ' ' GLN . . . . . 0.404 ' HB3' ' HD2' ' A' ' 114' ' ' PRO . 20.9 mt-30 -99.8 159.36 30.14 Favored Pre-proline 0 C--N 1.325 -0.471 0 N-CA-C 109.509 -0.552 . . . . 0.0 109.509 179.388 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 114' ' ' PRO . . . . . 0.404 ' HD2' ' HB3' ' A' ' 113' ' ' GLN . 11.4 Cg_endo -55.77 115.67 2.62 Favored 'Trans proline' 0 C--N 1.344 0.327 0 C-N-CA 122.307 2.005 . . . . 0.0 110.835 178.584 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . 0.531 ' HG2' ' O ' ' A' ' 109' ' ' ASP . 54.9 mttt -75.52 172.27 12.83 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.044 -178.467 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . 0.405 ' HA2' HD13 ' A' ' 106' ' ' ILE . . . 98.55 7.81 55.32 Favored Glycine 0 N--CA 1.444 -0.767 0 C-N-CA 120.351 -0.928 . . . . 0.0 112.286 179.902 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 30.2 m-85 -53.27 115.48 1.92 Allowed 'General case' 0 C--N 1.334 -0.097 0 N-CA-C 110.146 -0.316 . . . . 0.0 110.146 179.749 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -146.23 175.53 10.44 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-O 121.034 0.445 . . . . 0.0 111.165 -179.168 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 119' ' ' TYR . . . . . 0.408 ' CE1' ' HB ' ' A' ' 105' ' ' THR . 51.7 p90 -160.08 135.64 8.29 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.581 -0.736 . . . . 0.0 109.234 178.799 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 17.4 m -105.55 142.0 19.62 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.727 0 N-CA-C 109.69 -0.485 . . . . 0.0 109.69 179.344 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 5.8 pt-20 -127.1 152.94 46.64 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.157 -179.417 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 15.4 t80 -156.46 166.99 31.82 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.476 179.163 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 3.8 t -84.37 -47.61 17.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 120.921 0.391 . . . . 0.0 111.627 -179.317 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 74.9 mm-40 -66.33 126.45 28.82 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.32 -179.394 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 2.5 mp -70.23 -32.92 52.41 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.02 -179.926 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 4.8 t70 -62.66 -36.64 83.5 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.505 179.884 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -61.3 -55.44 31.8 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.636 179.724 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 11.3 p -67.12 -28.86 44.12 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.756 179.729 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 7.0 tt0 -58.56 -46.53 86.68 Favored 'General case' 0 N--CA 1.462 0.165 0 CA-C-O 121.11 0.481 . . . . 0.0 110.399 179.223 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 46.2 m-80 -70.83 -31.16 67.78 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.878 -0.601 . . . . 0.0 109.985 179.913 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -68.03 -48.41 65.76 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.665 -0.698 . . . . 0.0 111.833 -179.537 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 3.8 pp -69.93 -18.97 63.4 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.943 0.401 . . . . 0.0 110.92 -179.666 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 5.4 tp -80.03 -49.91 11.12 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.765 179.858 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 79.1 mt -134.61 107.81 7.7 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.477 -0.329 . . . . 0.0 110.967 -179.609 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 2.8 m-20 -159.81 -52.53 0.06 Allowed 'General case' 0 N--CA 1.465 0.303 0 CA-C-O 121.181 0.515 . . . . 0.0 110.998 179.757 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 4.6 pt-20 -74.73 80.06 2.05 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.433 0.635 . . . . 0.0 111.205 -179.735 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 6.8 m -133.78 -60.58 0.82 Allowed 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.672 -0.695 . . . . 0.0 111.0 179.573 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 1.6 tp10 -150.97 121.25 7.28 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-O 120.532 0.206 . . . . 0.0 110.516 -179.325 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -141.93 111.43 6.55 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 109.867 -0.42 . . . . 0.0 109.867 179.237 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 140' ' ' HIS . . . . . 0.449 ' HB2' ' SG ' ' A' ' 86' ' ' CYS . 2.4 t60 67.34 18.27 10.2 Favored 'General case' 0 N--CA 1.468 0.425 0 CA-C-O 121.142 0.496 . . . . 0.0 110.402 179.582 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 88.9 4.14 75.72 Favored Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.869 -0.681 . . . . 0.0 111.54 -179.212 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 142' ' ' ARG . . . . . 0.543 ' HD3' ' OD2' ' A' ' 83' ' ' ASP . 4.3 mpt_? -121.28 166.49 13.95 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 109.825 -0.435 . . . . 0.0 109.825 179.499 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 18.7 pt20 -110.99 140.08 45.81 Favored 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 109.863 -0.421 . . . . 0.0 109.863 179.2 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -125.6 174.98 7.88 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.547 -179.549 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 15.6 ttpt -111.32 118.79 36.82 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.255 179.791 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 85.9 t -113.37 118.53 58.38 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-O 120.992 0.425 . . . . 0.0 110.005 179.276 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 66.3 m -127.49 143.36 51.2 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 116.116 -0.493 . . . . 0.0 109.921 -179.89 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -59.13 133.49 56.14 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.058 0.456 . . . . 0.0 111.888 -178.747 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 12.1 ttpp -96.0 78.29 3.18 Favored 'General case' 0 N--CA 1.449 -0.476 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.205 179.607 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 21.5 tpt180 . . . . . 0 C--N 1.322 -0.615 0 N-CA-C 109.293 -0.632 . . . . 0.0 109.293 179.329 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.235 0.319 0 N-CA-C 110.05 -0.352 . . . . 0.0 110.05 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 50.7 tp -72.45 94.32 1.64 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.095 0.474 . . . . 0.0 109.825 179.472 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 16.8 ttm180 -149.03 149.58 31.36 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.764 -0.653 . . . . 0.0 109.576 -179.71 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 10.4 tt0 -79.97 48.79 1.0 Allowed 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.272 0.558 . . . . 0.0 110.824 -179.508 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 6.4 ptm -107.35 12.31 28.19 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.441 179.674 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 19.7 mm-40 -69.63 -20.8 63.6 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.056 0.455 . . . . 0.0 111.212 -179.261 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -79.71 -5.44 55.23 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.25 178.913 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 37.1 ttpt -85.34 1.73 47.22 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.78 -0.645 . . . . 0.0 109.775 179.614 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 5.8 p -58.32 -19.44 13.59 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.432 0 CA-C-N 115.261 -0.882 . . . . 0.0 111.094 179.447 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 29.6 mt-10 -70.65 -19.9 62.76 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-O 121.207 0.527 . . . . 0.0 110.369 179.173 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 5.2 mtmt -101.63 -42.52 6.18 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.995 -0.548 . . . . 0.0 109.905 178.749 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 22.0 mt-10 -61.37 -26.6 67.94 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.854 179.391 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 19.5 ptt? -66.55 -16.53 64.22 Favored 'General case' 0 C--O 1.227 -0.116 0 CA-C-O 121.372 0.606 . . . . 0.0 110.024 178.668 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -98.67 -7.93 55.04 Favored Glycine 0 N--CA 1.445 -0.725 0 N-CA-C 110.612 -0.995 . . . . 0.0 110.612 178.509 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.318 -0.785 0 CA-C-O 121.144 0.497 . . . . 0.0 110.055 -179.871 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.453 -0.302 0 CA-C-O 120.879 0.371 . . . . 0.0 110.584 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -81.88 -1.64 48.42 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.993 179.867 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 22.9 tp60 -119.87 -44.75 2.51 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.565 -0.289 . . . . 0.0 111.337 179.811 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -90.86 -61.18 1.73 Allowed 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 120.844 0.354 . . . . 0.0 111.252 -179.415 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . 0.458 ' O ' HG23 ' A' ' 72' ' ' VAL . 0.6 OUTLIER -61.94 -27.86 69.13 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.969 -0.56 . . . . 0.0 111.125 -179.313 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 19.4 tptp -58.4 -29.55 66.14 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.405 -179.727 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 17.7 mt-10 -66.27 -20.39 66.09 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-O 121.396 0.617 . . . . 0.0 110.605 179.722 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . 0.432 ' O ' ' HD2' ' A' ' 75' ' ' ARG . 5.5 tp10 -95.28 -39.88 9.83 Favored 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 109.091 -0.707 . . . . 0.0 109.091 177.176 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . 0.458 HG23 ' O ' ' A' ' 68' ' ' GLU . 54.9 t -63.97 -42.64 96.39 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.374 0 CA-C-N 115.606 -0.724 . . . . 0.0 112.491 -179.464 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 14.5 p-10 -70.69 -18.18 62.82 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-O 120.949 0.404 . . . . 0.0 110.898 -179.076 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 33.6 t -97.41 -13.47 21.8 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.188 178.633 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . 0.432 ' HD2' ' O ' ' A' ' 71' ' ' GLU . 0.0 OUTLIER -106.04 44.95 1.0 Allowed 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.775 -0.648 . . . . 0.0 109.961 -179.498 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' SER . . . . . 0.449 ' CB ' ' HB3' ' A' ' 121' ' ' GLU . 0.3 OUTLIER -124.53 170.99 10.36 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.47 -0.786 . . . . 0.0 110.689 179.971 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 6.7 pt -132.15 135.15 58.73 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.772 0 CA-C-N 115.803 -0.635 . . . . 0.0 109.35 178.445 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 69.6 t80 -91.91 123.04 34.99 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 116.341 -0.39 . . . . 0.0 109.994 -179.883 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 4.6 t -102.78 111.48 32.71 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.493 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.223 -179.516 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -121.42 169.69 14.55 Favored Glycine 0 N--CA 1.447 -0.602 0 C-N-CA 120.828 -0.701 . . . . 0.0 111.57 179.858 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 4.2 m-20 61.01 37.66 17.89 Favored 'General case' 0 N--CA 1.469 0.514 0 CA-C-O 121.251 0.548 . . . . 0.0 110.431 -179.882 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 2.5 t -83.52 164.31 2.72 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-N 115.358 -0.837 . . . . 0.0 110.804 -179.01 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . 0.735 ' OD2' ' HB2' ' A' ' 142' ' ' ARG . 0.1 OUTLIER -66.17 137.3 56.91 Favored 'General case' 0 CA--C 1.517 -0.323 0 N-CA-C 109.707 -0.479 . . . . 0.0 109.707 179.288 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 24.6 p90 -65.64 -8.06 18.43 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 120.917 0.389 . . . . 0.0 111.379 -179.878 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -118.51 19.52 13.29 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.14 -179.743 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -87.01 143.88 27.14 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.707 179.971 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 87' ' ' THR . . . . . 0.427 ' O ' ' HG2' ' A' ' 90' ' ' GLU . 20.7 p -107.79 148.9 38.25 Favored Pre-proline 0 C--N 1.326 -0.429 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.425 179.572 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 11.7 Cg_endo -54.81 -39.65 88.83 Favored 'Trans proline' 0 C--N 1.344 0.339 0 C-N-CA 123.089 2.526 . . . . 0.0 112.977 -179.198 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 3.2 mp0 -65.1 -41.73 94.7 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 112.498 0.555 . . . . 0.0 112.498 -178.486 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . 0.473 ' O ' ' HB2' ' A' ' 94' ' ' HIS . 8.0 pt-20 -73.98 -14.8 61.09 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.97 0.414 . . . . 0.0 111.024 -178.977 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 74.5 t -88.52 -48.35 14.92 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.89 -179.561 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -69.0 -34.13 74.8 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.545 -178.333 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 7.6 pt20 -78.11 -28.97 48.7 Favored 'General case' 0 C--N 1.327 -0.384 0 C-N-CA 120.556 -0.457 . . . . 0.0 111.24 -178.854 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 94' ' ' HIS . . . . . 0.473 ' HB2' ' O ' ' A' ' 90' ' ' GLU . 1.8 t-80 -73.39 -32.19 64.33 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.97 0.414 . . . . 0.0 110.828 -179.664 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 21.4 m-30 -87.7 -11.69 47.54 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.144 179.543 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 26.4 tt0 -62.74 -27.64 69.41 Favored 'General case' 0 C--O 1.234 0.237 0 CA-C-N 115.538 -0.755 . . . . 0.0 110.343 -179.957 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 12.7 m -63.96 -35.5 80.89 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.233 179.085 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 3.8 m -85.29 -52.75 5.68 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.883 -0.599 . . . . 0.0 109.532 179.159 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -140.57 128.16 3.71 Favored Glycine 0 N--CA 1.441 -0.979 0 CA-C-N 115.684 -0.689 . . . . 0.0 111.689 179.752 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -57.33 136.25 56.55 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.853 0.359 . . . . 0.0 110.101 179.418 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 2.0 p -102.01 130.33 51.94 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-N 116.048 -0.524 . . . . 0.0 112.073 -177.913 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . 0.437 ' HB2' ' CD1' ' A' ' 122' ' ' PHE . 29.2 t-20 -99.85 -43.78 6.3 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 109.53 -0.544 . . . . 0.0 109.53 178.449 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 103' ' ' ARG . . . . . 0.412 ' HD3' ' OD1' ' A' ' 102' ' ' ASN . 1.5 mpt_? -135.7 151.24 49.98 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.328 179.657 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 6.1 p -155.46 129.82 1.39 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.552 -0.295 . . . . 0.0 110.211 179.28 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -127.49 124.8 39.19 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.492 -0.322 . . . . 0.0 110.248 179.472 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 20.8 tt -109.26 149.06 12.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 120.857 0.36 . . . . 0.0 111.014 -179.89 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 13.8 tp -130.14 136.22 49.05 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.002 -0.544 . . . . 0.0 109.991 179.516 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -100.8 111.35 23.55 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.488 179.9 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -76.73 146.91 37.68 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.188 0.518 . . . . 0.0 111.13 -179.618 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 3.3 mppt? -135.15 22.99 3.5 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.267 179.446 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 19.0 t80 -107.58 -3.89 18.88 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.222 0.534 . . . . 0.0 110.157 -179.544 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 114.78 0.62 22.96 Favored Glycine 0 N--CA 1.449 -0.474 0 C-N-CA 120.816 -0.707 . . . . 0.0 112.766 179.835 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 26.6 mt-30 -88.35 154.59 51.53 Favored Pre-proline 0 C--N 1.329 -0.315 0 N-CA-C 109.361 -0.607 . . . . 0.0 109.361 179.679 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 14.5 Cg_endo -58.45 115.92 2.88 Favored 'Trans proline' 0 N--CA 1.462 -0.378 0 C-N-CA 122.013 1.809 . . . . 0.0 111.444 178.917 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 60.0 mttt -70.86 167.06 19.77 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 109.558 -0.534 . . . . 0.0 109.558 -179.485 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 105.59 1.83 40.36 Favored Glycine 0 N--CA 1.447 -0.607 0 C-N-CA 120.073 -1.061 . . . . 0.0 112.197 179.914 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 32.4 m-85 -53.69 115.61 2.07 Favored 'General case' 0 C--N 1.333 -0.138 0 N-CA-C 110.269 -0.271 . . . . 0.0 110.269 179.46 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -143.41 173.01 12.0 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 120.915 0.388 . . . . 0.0 111.006 -179.162 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 51.9 p90 -155.21 130.09 9.35 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 115.847 -0.615 . . . . 0.0 109.765 178.681 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 18.6 m -107.21 141.27 22.85 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 N-CA-C 109.695 -0.483 . . . . 0.0 109.695 179.178 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . 0.449 ' HB3' ' CB ' ' A' ' 76' ' ' SER . 1.4 pt-20 -132.04 157.05 45.16 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.916 0.388 . . . . 0.0 111.17 179.723 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 122' ' ' PHE . . . . . 0.437 ' CD1' ' HB2' ' A' ' 102' ' ' ASN . 22.2 t80 -152.29 170.88 18.95 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.535 -0.757 . . . . 0.0 109.771 179.91 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 20.4 t -84.26 -51.6 13.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-O 120.969 0.414 . . . . 0.0 110.461 179.852 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 4.7 mm-40 -60.53 129.66 42.69 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.852 -0.613 . . . . 0.0 111.132 179.886 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 2.9 mp -73.9 -31.03 29.58 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 N-CA-C 109.327 -0.62 . . . . 0.0 109.327 179.516 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -60.53 -37.97 82.92 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.342 179.26 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -60.8 -56.33 22.52 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.537 -0.756 . . . . 0.0 111.107 -179.976 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 11.3 p -67.19 -30.13 48.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.442 -179.654 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 30.1 tt0 -61.31 -44.78 96.64 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 121.038 0.447 . . . . 0.0 110.436 179.653 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 37.9 m-80 -72.3 -29.11 63.55 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.055 -0.52 . . . . 0.0 109.994 179.601 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 131' ' ' ALA . . . . . 0.437 ' O ' ' HB2' ' A' ' 135' ' ' ASN . . . -69.53 -51.65 33.66 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.476 -0.784 . . . . 0.0 111.305 -179.939 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 4.2 pp -65.59 -23.34 66.81 Favored 'General case' 0 N--CA 1.462 0.142 0 CA-C-O 120.794 0.33 . . . . 0.0 110.681 -179.824 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 5.7 tp -73.37 -56.48 5.01 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.961 0.41 . . . . 0.0 110.228 179.595 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 69.1 mt -122.71 104.2 9.16 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.007 -0.542 . . . . 0.0 109.79 179.826 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 135' ' ' ASN . . . . . 0.437 ' HB2' ' O ' ' A' ' 131' ' ' ALA . 0.5 OUTLIER -148.4 -66.84 0.24 Allowed 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.15 0.5 . . . . 0.0 111.122 -179.186 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 5.6 pt-20 -73.68 106.29 5.37 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.563 -0.744 . . . . 0.0 111.414 -179.466 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 21.3 m -150.09 -59.13 0.19 Allowed 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.706 -0.679 . . . . 0.0 109.599 178.997 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 4.9 tt0 -161.55 120.96 2.5 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.813 -0.63 . . . . 0.0 109.572 178.946 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -139.35 123.18 17.63 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 -179.982 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 140' ' ' HIS . . . . . 0.618 ' HB3' ' OD2' ' A' ' 83' ' ' ASP . 6.9 t60 59.07 12.4 2.42 Favored 'General case' 0 CA--C 1.54 0.562 0 O-C-N 123.555 0.534 . . . . 0.0 111.553 179.28 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 101.36 -6.4 55.75 Favored Glycine 0 N--CA 1.449 -0.443 0 C-N-CA 120.904 -0.665 . . . . 0.0 112.754 -179.918 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 142' ' ' ARG . . . . . 0.735 ' HB2' ' OD2' ' A' ' 83' ' ' ASP . 8.0 mpt_? -113.43 173.42 6.42 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 117.023 0.412 . . . . 0.0 110.418 179.58 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 17.4 pt20 -116.87 114.16 23.49 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.093 0.473 . . . . 0.0 109.759 179.531 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -97.97 175.13 6.24 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.174 -179.15 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 6.4 ttpt -117.51 120.81 39.22 Favored 'General case' 0 N--CA 1.45 -0.457 0 CA-C-N 115.905 -0.589 . . . . 0.0 109.495 179.052 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 93.5 t -113.36 119.96 62.07 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.738 0 CA-C-O 120.898 0.38 . . . . 0.0 110.653 -179.635 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 58.2 m -123.25 141.68 51.72 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 116.195 -0.457 . . . . 0.0 109.801 -179.849 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -59.86 128.8 38.67 Favored 'General case' 0 C--O 1.236 0.378 0 CA-C-O 120.828 0.347 . . . . 0.0 111.277 -179.64 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 149' ' ' LYS . . . . . 0.426 ' HE2' ' OG ' ' A' ' 76' ' ' SER . 21.9 ttpt -91.94 67.8 5.25 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.384 0.611 . . . . 0.0 109.999 -179.601 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 24.7 tpt180 . . . . . 0 C--N 1.324 -0.537 0 CA-C-O 121.236 0.541 . . . . 0.0 109.611 179.104 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 18.6 mmt . . . . . 0 N--CA 1.48 1.069 0 N-CA-C 110.224 -0.287 . . . . 0.0 110.224 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 90.47 -61.64 3.18 Favored Glycine 0 N--CA 1.447 -0.598 0 C-N-CA 120.658 -0.782 . . . . 0.0 111.623 -179.711 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 2.2 m -67.35 148.02 52.18 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 120.667 0.27 . . . . 0.0 110.404 179.333 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -82.18 -59.68 2.47 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 120.723 0.297 . . . . 0.0 110.624 -179.896 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 11.4 t60 -160.11 118.1 2.62 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.306 179.88 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 19.1 p-80 -59.64 139.54 57.12 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.925 179.492 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 36.7 m80 -115.37 -155.1 0.56 Allowed 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.343 -0.389 . . . . 0.0 110.232 -179.926 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -134.34 133.1 40.29 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.968 0.413 . . . . 0.0 111.071 179.866 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 31.8 t-80 -121.89 103.25 8.71 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 109.606 -0.516 . . . . 0.0 109.606 179.291 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 3.1 t60 -65.2 122.99 18.37 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.495 -179.818 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -79.21 151.72 31.06 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.252 -179.317 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 35.6 m -92.68 132.48 36.88 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.005 -0.543 . . . . 0.0 109.919 178.824 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -78.79 109.12 2.78 Favored Glycine 0 N--CA 1.448 -0.506 0 C-N-CA 120.691 -0.766 . . . . 0.0 112.491 -179.657 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 42.5 mt -85.41 167.57 15.4 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 120.883 0.373 . . . . 0.0 110.555 179.53 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 12.9 m -95.37 144.44 27.82 Favored Pre-proline 0 C--N 1.325 -0.49 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.498 179.565 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_endo -68.88 145.71 63.17 Favored 'Trans proline' 0 C--O 1.234 0.304 0 C-N-CA 122.681 2.254 . . . . 0.0 112.292 -179.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . 0.408 HH11 ' HD3' ' A' ' 17' ' ' ARG . 6.1 ttt180 -92.09 87.81 6.29 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.287 179.95 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -76.85 86.76 0.96 Allowed Glycine 0 N--CA 1.449 -0.454 0 C-N-CA 120.801 -0.714 . . . . 0.0 111.695 179.68 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 6.0 m -148.13 144.92 28.13 Favored 'General case' 0 C--N 1.323 -0.557 0 O-C-N 122.813 -0.228 . . . . 0.0 110.58 -179.932 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 18.8 p-80 -130.67 111.19 11.96 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 109.729 -0.471 . . . . 0.0 109.729 178.842 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 45.8 mtt -148.98 174.63 12.07 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.174 -179.122 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 145.94 129.0 2.02 Favored Glycine 0 N--CA 1.445 -0.729 0 C-N-CA 120.901 -0.666 . . . . 0.0 112.338 179.564 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 2.8 m -92.32 138.78 31.23 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 120.717 0.294 . . . . 0.0 110.29 179.565 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -101.55 136.62 41.09 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.065 179.897 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 85.1 mt -105.11 120.84 42.5 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 120.983 0.42 . . . . 0.0 111.17 -179.404 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 23.3 mt-10 -93.8 129.46 40.16 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.781 -0.645 . . . . 0.0 109.932 179.372 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -83.56 120.91 26.53 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 110.183 -0.303 . . . . 0.0 110.183 179.694 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 25.8 ptm -163.85 -178.58 5.77 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.159 -179.482 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 37.5 tttm -66.79 136.55 55.63 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.085 179.524 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 16.3 pttm -72.27 144.56 48.35 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 109.719 -0.474 . . . . 0.0 109.719 179.256 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 65.0 mtt180 -114.5 171.36 7.67 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-O 120.962 0.41 . . . . 0.0 110.506 -179.71 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -75.06 97.23 3.38 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.699 -0.682 . . . . 0.0 109.58 179.411 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 20.5 pttp -66.13 118.85 10.45 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.363 0.602 . . . . 0.0 111.35 -179.452 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -96.79 -22.6 16.85 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.61 179.354 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 11.5 tt -95.61 161.47 2.64 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 CA-C-N 115.813 -0.63 . . . . 0.0 110.725 -179.717 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 2.7 pt-20 -72.17 152.47 42.25 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.514 179.313 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -123.6 163.31 21.27 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 109.942 -0.392 . . . . 0.0 109.942 -179.94 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 22.2 mm-40 -79.57 79.6 6.03 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.28 0.562 . . . . 0.0 111.106 -179.424 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -123.42 110.19 14.81 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.781 -0.645 . . . . 0.0 109.777 179.296 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -78.45 106.44 2.32 Favored Glycine 0 N--CA 1.449 -0.498 0 C-N-CA 120.947 -0.644 . . . . 0.0 113.221 -179.187 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -112.54 -170.11 1.6 Allowed 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 109.772 -0.455 . . . . 0.0 109.772 179.128 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 56.8 tp -71.8 97.02 1.71 Allowed 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.177 0.513 . . . . 0.0 110.35 179.547 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . 0.442 ' C ' ' H ' ' A' ' 45' ' ' MET . 0.7 OUTLIER -150.13 147.92 28.34 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.655 -0.702 . . . . 0.0 109.582 -179.986 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -73.79 20.35 0.1 Allowed 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.623 -179.723 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' MET . . . . . 0.442 ' H ' ' C ' ' A' ' 43' ' ' ARG . 19.5 ptt? -83.86 8.1 15.98 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.026 0.441 . . . . 0.0 110.63 -179.854 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 87.7 mt-30 -66.1 -22.75 66.41 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.179 0.514 . . . . 0.0 110.477 179.361 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -80.37 -7.43 59.09 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.149 0.499 . . . . 0.0 110.681 179.648 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 18.7 ttmm -77.91 -6.28 53.81 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.539 -179.795 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 14.8 p -56.2 -28.57 25.83 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.32 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.596 -179.474 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 26.7 mt-10 -62.22 -31.36 71.89 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.91 0.386 . . . . 0.0 111.294 -179.359 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 37.6 mtmt -96.68 -41.18 8.63 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.609 -179.966 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 27.6 mm-40 -61.39 -29.6 70.02 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.71 -179.502 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 15.2 ptt? -62.62 -24.9 67.83 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-O 120.87 0.367 . . . . 0.0 110.629 179.797 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -94.3 -9.48 59.14 Favored Glycine 0 N--CA 1.447 -0.598 0 C-N-CA 120.699 -0.762 . . . . 0.0 111.483 179.463 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -110.79 17.05 20.98 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 120.909 0.385 . . . . 0.0 110.747 -179.753 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 18.0 m -64.31 -13.71 14.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.376 179.797 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 92.6 mt-30 -78.83 -10.98 59.97 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.902 0.382 . . . . 0.0 110.39 179.232 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 26.8 t70 -127.38 -52.39 1.38 Allowed 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.474 179.92 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 7.6 m -71.71 -75.29 0.13 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.241 179.899 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -79.61 39.91 0.43 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.172 0.51 . . . . 0.0 111.135 -179.827 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 45.5 p -80.78 -33.61 34.78 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.597 -179.44 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 1.3 m -67.51 -25.17 65.71 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.958 -0.565 . . . . 0.0 111.006 179.949 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -62.39 -27.61 69.2 Favored 'General case' 0 N--CA 1.449 -0.477 0 CA-C-N 115.771 -0.65 . . . . 0.0 110.492 179.794 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -69.63 -33.41 72.59 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.213 179.454 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -74.6 -0.08 16.63 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.048 0.452 . . . . 0.0 111.14 179.909 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 21.9 tp60 -119.47 -48.69 2.39 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.998 179.698 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -89.36 -52.94 4.78 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.864 0.364 . . . . 0.0 111.904 -179.236 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . 0.411 ' O ' HG23 ' A' ' 72' ' ' VAL . 6.4 tt0 -68.68 -26.1 65.13 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.143 0.497 . . . . 0.0 110.549 -179.094 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 51.2 tptt -58.91 -27.89 65.69 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.886 179.511 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 52.6 mt-10 -63.76 -21.94 66.66 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-O 121.443 0.64 . . . . 0.0 110.99 179.758 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . 0.525 ' O ' ' HD3' ' A' ' 75' ' ' ARG . 13.2 tp10 -94.8 -44.56 7.71 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 115.521 -0.763 . . . . 0.0 108.951 178.307 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.411 HG23 ' O ' ' A' ' 68' ' ' GLU . 26.7 t -62.78 -40.45 88.69 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-N 115.351 -0.84 . . . . 0.0 112.883 -178.496 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 9.9 p-10 -70.86 -20.83 62.49 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-O 121.091 0.472 . . . . 0.0 111.64 -178.933 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 18.0 m -100.89 -5.05 26.61 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-O 121.335 0.588 . . . . 0.0 110.192 179.888 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . 0.525 ' HD3' ' O ' ' A' ' 71' ' ' GLU . 1.9 mpt_? -113.9 39.43 2.7 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.593 -0.73 . . . . 0.0 109.545 -179.92 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -119.26 173.83 6.71 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.381 -0.827 . . . . 0.0 110.886 -179.926 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 7.0 pt -133.31 140.41 47.03 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.067 178.585 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 71.0 t80 -96.53 126.52 41.77 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 109.624 -0.51 . . . . 0.0 109.624 179.815 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 5.1 t -108.09 114.33 46.23 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.983 -179.381 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -120.38 169.45 14.06 Favored Glycine 0 N--CA 1.448 -0.513 0 N-CA-C 111.192 -0.763 . . . . 0.0 111.192 179.36 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 93.8 m-20 60.06 38.66 20.47 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-O 121.073 0.463 . . . . 0.0 110.754 -179.712 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 2.4 t -81.82 164.44 2.91 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.753 -179.145 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . 0.4 ' O ' ' HB2' ' A' ' 86' ' ' CYS . 9.7 t70 -67.3 137.01 55.75 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 109.676 -0.491 . . . . 0.0 109.676 179.414 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 30.5 p90 -64.27 -18.46 64.59 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.897 -178.647 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -113.23 24.92 11.81 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 121.037 0.446 . . . . 0.0 110.747 179.851 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' CYS . . . . . 0.4 ' HB2' ' O ' ' A' ' 83' ' ' ASP . 0.1 OUTLIER -85.85 156.45 20.55 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.397 0.618 . . . . 0.0 111.549 -179.966 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' THR . . . . . 0.47 ' O ' ' HG2' ' A' ' 90' ' ' GLU . 0.0 OUTLIER -119.31 146.64 41.35 Favored Pre-proline 0 C--N 1.322 -0.601 0 CA-C-N 115.432 -0.804 . . . . 0.0 110.343 -179.941 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 15.0 Cg_endo -56.7 -40.2 86.04 Favored 'Trans proline' 0 C--N 1.344 0.319 0 C-N-CA 122.83 2.353 . . . . 0.0 112.734 -178.867 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 60.1 mm-40 -60.42 -50.49 73.36 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.531 -179.097 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . 0.705 ' O ' ' HB2' ' A' ' 94' ' ' HIS . 6.6 pt-20 -63.91 -24.6 67.8 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.624 -0.262 . . . . 0.0 111.143 -178.706 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 70.0 t -80.76 -48.66 19.3 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.04 -179.343 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 2.3 pt20 -70.92 -34.03 71.12 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 112.1 0.407 . . . . 0.0 112.1 -178.167 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 18.5 pt20 -79.19 -23.8 43.61 Favored 'General case' 0 C--N 1.329 -0.285 0 C-N-CA 120.496 -0.481 . . . . 0.0 110.896 -179.502 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' HIS . . . . . 0.705 ' HB2' ' O ' ' A' ' 90' ' ' GLU . 0.4 OUTLIER -74.48 -43.66 55.0 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.048 0.452 . . . . 0.0 110.067 179.684 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 21.8 m-30 -78.17 -12.52 60.0 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.521 -179.873 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . 0.592 ' HA ' ' O ' ' A' ' 99' ' ' GLY . 15.8 tt0 -65.08 -19.72 66.13 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.378 -179.959 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 12.3 m -66.54 -26.82 67.32 Favored 'General case' 0 N--CA 1.451 -0.401 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.272 179.217 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 5.9 m -97.02 -42.97 7.64 Favored 'General case' 0 N--CA 1.453 -0.324 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.168 179.365 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . 0.592 ' O ' ' HA ' ' A' ' 96' ' ' GLN . . . -150.65 142.16 9.35 Favored Glycine 0 N--CA 1.445 -0.712 0 C-N-CA 120.875 -0.679 . . . . 0.0 111.768 179.855 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' THR . . . . . 0.414 ' HB ' ' CZ ' ' A' ' 122' ' ' PHE . 0.2 OUTLIER -62.68 150.03 42.09 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 120.937 0.398 . . . . 0.0 111.524 -179.924 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 2.2 p -119.54 129.26 75.55 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.754 -179.762 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 55.7 t30 -98.24 -39.51 8.81 Favored 'General case' 0 N--CA 1.463 0.175 0 CA-C-O 121.145 0.498 . . . . 0.0 110.274 179.385 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 2.2 tpt180 -145.93 153.29 40.66 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.223 -179.883 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 5.8 p -151.22 133.09 5.39 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.07 179.763 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 1.5 m -121.27 122.88 40.89 Favored 'General case' 0 C--N 1.32 -0.674 0 N-CA-C 110.129 -0.323 . . . . 0.0 110.129 179.612 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' ILE . . . . . 0.434 HD13 ' HA2' ' A' ' 116' ' ' GLY . 21.0 tt -113.49 144.36 21.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 120.935 0.398 . . . . 0.0 110.729 -179.514 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 27.0 tp -132.45 128.7 38.02 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.305 179.662 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -86.91 114.56 23.65 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.715 179.7 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . 0.408 ' O ' ' HG2' ' A' ' 115' ' ' LYS . 15.0 t70 -75.39 140.93 43.28 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.872 0.367 . . . . 0.0 110.796 -179.74 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -132.31 28.7 4.36 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 109.352 -0.61 . . . . 0.0 109.352 179.159 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 5.1 t80 -109.82 -2.37 17.32 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.589 -0.732 . . . . 0.0 109.707 179.919 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 106.89 6.29 34.81 Favored Glycine 0 N--CA 1.448 -0.51 0 CA-C-N 115.527 -0.76 . . . . 0.0 112.52 179.98 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 36.3 mt-30 -94.87 158.74 34.61 Favored Pre-proline 0 C--N 1.324 -0.511 0 N-CA-C 109.407 -0.59 . . . . 0.0 109.407 179.593 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 15.2 Cg_endo -58.11 119.3 6.47 Favored 'Trans proline' 0 C--N 1.345 0.388 0 C-N-CA 122.105 1.87 . . . . 0.0 110.88 178.886 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . 0.408 ' HG2' ' O ' ' A' ' 109' ' ' ASP . 58.3 mttt -74.4 173.37 10.38 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 109.976 -0.379 . . . . 0.0 109.976 -179.499 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . 0.434 ' HA2' HD13 ' A' ' 106' ' ' ILE . . . 98.32 3.27 57.68 Favored Glycine 0 N--CA 1.443 -0.844 0 C-N-CA 120.178 -1.01 . . . . 0.0 112.165 179.626 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 5.2 m-30 -54.82 117.56 3.51 Favored 'General case' 0 N--CA 1.463 0.206 0 N-CA-C 110.188 -0.301 . . . . 0.0 110.188 179.582 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -147.29 168.42 21.79 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.046 0.45 . . . . 0.0 111.451 -178.811 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 34.5 p90 -148.24 129.84 14.98 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.643 -0.708 . . . . 0.0 109.722 178.41 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 6.4 m -105.3 145.95 12.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 N-CA-C 109.742 -0.466 . . . . 0.0 109.742 179.781 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 6.1 pt-20 -133.9 152.58 51.91 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 120.657 0.265 . . . . 0.0 111.005 -179.701 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' PHE . . . . . 0.414 ' CZ ' ' HB ' ' A' ' 100' ' ' THR . 13.0 t80 -148.64 167.01 26.6 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.124 179.525 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 10.1 t -83.44 -41.92 17.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.488 -0.324 . . . . 0.0 111.535 -179.286 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 43.6 mm-40 -74.02 132.12 42.06 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.121 0.486 . . . . 0.0 111.593 -179.087 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 2.4 mp -74.71 -35.51 37.44 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.444 -179.657 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -59.25 -33.49 71.1 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.151 0.5 . . . . 0.0 110.937 -179.692 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -65.56 -54.97 20.52 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.926 179.958 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 10.3 p -66.49 -29.6 47.06 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.804 -179.564 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 8.3 tt0 -60.39 -42.62 96.28 Favored 'General case' 0 C--N 1.333 -0.142 0 CA-C-O 120.909 0.385 . . . . 0.0 110.431 179.619 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 29.3 m-80 -73.59 -31.0 63.35 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.119 179.282 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -67.93 -52.44 36.08 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.664 -0.698 . . . . 0.0 111.274 -179.885 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 4.0 pp -64.23 -22.22 66.87 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.85 0.357 . . . . 0.0 111.015 -179.802 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 5.5 tp -77.55 -55.72 5.13 Favored 'General case' 0 N--CA 1.451 -0.403 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.46 179.556 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 33.7 mt -123.74 103.04 8.14 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.078 -179.836 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -145.42 -71.25 0.26 Allowed 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 120.788 0.328 . . . . 0.0 111.56 -179.316 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 4.1 pt-20 -66.61 110.35 3.16 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.268 0.556 . . . . 0.0 111.268 -179.224 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 14.0 m -153.45 -58.14 0.13 Allowed 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.787 -0.642 . . . . 0.0 109.726 179.334 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -163.88 122.15 1.88 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.1 -0.5 . . . . 0.0 109.978 179.174 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -138.83 115.61 10.74 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 109.189 -0.671 . . . . 0.0 109.189 179.425 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 3.3 t60 64.83 16.45 10.47 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-O 120.896 0.379 . . . . 0.0 110.853 179.883 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 91.39 6.28 66.42 Favored Glycine 0 N--CA 1.448 -0.522 0 C-N-CA 120.893 -0.67 . . . . 0.0 111.761 -179.034 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -119.99 160.45 22.73 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 110.204 -0.295 . . . . 0.0 110.204 179.794 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 14.2 pt20 -108.22 126.5 52.87 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 109.443 -0.577 . . . . 0.0 109.443 178.573 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -112.47 175.43 5.44 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.688 -179.553 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 78.4 tttt -116.97 124.04 48.41 Favored 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 109.461 -0.57 . . . . 0.0 109.461 178.73 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 99.1 t -116.01 125.24 73.03 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.639 0 CA-C-O 120.941 0.4 . . . . 0.0 110.448 179.862 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 11.9 t -127.36 149.58 49.99 Favored 'General case' 0 N--CA 1.447 -0.624 0 N-CA-C 109.583 -0.525 . . . . 0.0 109.583 179.927 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -65.58 127.26 31.17 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.55 -0.295 . . . . 0.0 110.964 -179.829 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 19.9 ttpt -91.2 66.42 5.66 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.376 0.607 . . . . 0.0 109.683 179.88 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 150' ' ' ARG . . . . . 0.484 ' C ' ' HD2' ' A' ' 150' ' ' ARG . 0.0 OUTLIER -88.9 76.16 7.95 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 109.439 -0.578 . . . . 0.0 109.439 179.819 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 8.2 t -62.33 133.84 55.65 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.456 -0.793 . . . . 0.0 111.015 -179.799 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 152' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 -175.68 175.6 2.03 Favored 'General case' 0 C--O 1.235 0.326 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.039 179.995 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 7.7 pt -81.04 153.41 72.22 Favored Pre-proline 0 C--N 1.323 -0.564 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.951 -179.806 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 6.7 Cg_exo -74.08 73.24 3.81 Favored 'Trans proline' 0 C--N 1.346 0.443 0 C-N-CA 123.032 2.488 . . . . 0.0 111.832 179.436 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.443 -0.862 0 N-CA-C 110.803 -0.919 . . . . 0.0 110.803 -179.879 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.481 1.103 0 CA-C-O 120.669 0.271 . . . . 0.0 110.614 . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 133.24 158.8 8.88 Favored Glycine 0 N--CA 1.447 -0.624 0 C-N-CA 120.793 -0.718 . . . . 0.0 111.666 179.71 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 8.4 t -155.25 132.98 11.31 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 120.781 0.324 . . . . 0.0 110.214 -179.965 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -100.83 159.12 15.45 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.132 179.289 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 80.1 m-70 -133.8 155.27 50.12 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 110.417 -0.216 . . . . 0.0 110.417 -179.585 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 2.7 t60 -162.27 131.5 4.37 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.478 179.765 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 34.7 m80 -93.4 -179.79 5.16 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.009 0.433 . . . . 0.0 111.271 -179.623 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 27.7 m80 -144.24 167.66 21.9 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.774 -0.648 . . . . 0.0 109.413 179.387 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 5.7 t60 -150.55 141.18 22.62 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.965 0.412 . . . . 0.0 111.034 -179.781 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 5.2 p80 -144.04 130.04 19.5 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.087 179.645 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 1.2 m -127.26 142.34 51.49 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.557 -179.627 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 15.1 m -126.74 127.2 44.72 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 110.068 -0.345 . . . . 0.0 110.068 179.825 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -81.89 172.46 53.07 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.989 -0.624 . . . . 0.0 113.242 -178.852 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 74.2 mt -103.64 -178.53 3.69 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 120.694 0.283 . . . . 0.0 110.765 -179.776 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 16.1 m -123.9 152.96 67.16 Favored Pre-proline 0 C--N 1.326 -0.417 0 CA-C-N 116.444 -0.344 . . . . 0.0 111.32 -179.719 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -75.31 -171.76 1.1 Allowed 'Trans proline' 0 C--N 1.345 0.378 0 C-N-CA 123.047 2.498 . . . . 0.0 112.499 179.802 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 4.7 mtp85 -130.07 146.97 51.76 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.509 -179.249 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -103.46 168.93 17.93 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 121.09 -0.576 . . . . 0.0 111.716 179.583 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -129.28 160.2 33.74 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.766 0.317 . . . . 0.0 110.824 -179.685 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 8.9 p-80 -131.79 161.33 33.15 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.54 179.616 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -131.78 -178.41 4.87 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.459 -0.337 . . . . 0.0 110.74 179.998 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -157.99 174.48 35.28 Favored Glycine 0 N--CA 1.452 -0.263 0 N-CA-C 111.601 -0.6 . . . . 0.0 111.601 -179.957 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 39.7 m -132.81 157.74 44.23 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 120.912 0.386 . . . . 0.0 111.259 -179.704 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 15.9 p-10 -106.27 -151.91 0.46 Allowed 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.839 -0.618 . . . . 0.0 110.551 179.865 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -148.04 167.69 24.3 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-O 120.651 0.263 . . . . 0.0 110.596 179.88 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 30.1 mt-10 -101.18 -172.81 2.23 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.076 -179.755 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 44.7 t0 -85.27 162.26 19.2 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.692 179.865 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 28.2 ptm -94.29 168.44 10.9 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.851 -179.491 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 21.8 pttm -86.43 -178.14 6.36 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.041 179.971 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -98.02 172.62 7.51 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.967 0.413 . . . . 0.0 111.105 -179.528 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 67.3 ttt180 -114.32 153.26 30.07 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.104 -179.552 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 48.1 tp -62.07 133.28 55.09 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-O 120.937 0.398 . . . . 0.0 110.59 179.342 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 49.0 tttm -130.72 119.31 22.17 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.003 179.839 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 4.6 tp10 -120.06 149.94 41.38 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.965 -0.562 . . . . 0.0 110.315 -179.662 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 19.0 tt -101.07 147.67 7.87 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 CA-C-N 115.877 -0.601 . . . . 0.0 109.943 179.778 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 3.7 mm-40 -125.73 -169.64 2.04 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-O 120.766 0.317 . . . . 0.0 110.868 -179.686 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 4.8 pt-20 -135.32 147.28 49.11 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.741 -0.663 . . . . 0.0 109.272 179.577 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -142.56 149.1 38.61 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.091 0.472 . . . . 0.0 111.361 -178.78 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -122.18 -28.46 4.36 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.516 -0.766 . . . . 0.0 110.271 179.333 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 77.57 98.59 0.2 Allowed Glycine 0 C--N 1.334 0.422 0 CA-C-N 116.011 -0.541 . . . . 0.0 112.634 179.407 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -160.0 -172.22 3.54 Favored 'General case' 0 C--N 1.328 -0.359 0 O-C-N 122.891 -0.182 . . . . 0.0 110.623 179.074 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 64.7 tp -75.33 92.63 2.8 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-O 121.225 0.536 . . . . 0.0 110.569 179.696 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 4.3 ttp180 -155.84 159.73 39.62 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.836 -0.62 . . . . 0.0 109.675 -179.673 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 16.9 mt-10 -86.17 23.47 1.53 Allowed 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.371 0.605 . . . . 0.0 111.185 179.91 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 6.4 ptm -83.56 14.18 3.98 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.061 179.39 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 45.4 mt-30 -73.23 -27.53 61.65 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.837 -0.619 . . . . 0.0 109.713 179.408 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -75.8 -12.27 60.14 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.509 -0.769 . . . . 0.0 110.146 179.136 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 3.4 tmmt? -74.89 -2.62 27.69 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.214 -0.903 . . . . 0.0 110.21 179.681 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 8.1 p -60.5 -23.95 29.96 Favored 'Isoleucine or valine' 0 C--O 1.235 0.302 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.831 179.337 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 26.1 mm-40 -59.46 -27.28 65.95 Favored 'General case' 0 N--CA 1.457 -0.087 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.285 179.187 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 12.7 mtmm -97.85 -37.25 9.91 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.945 -0.571 . . . . 0.0 110.441 178.455 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . 0.457 ' O ' HG11 ' A' ' 56' ' ' VAL . 5.6 mm-40 -59.38 -22.32 61.19 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.687 -179.748 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 17.9 ptt? -58.47 -23.09 56.83 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.767 0.317 . . . . 0.0 110.859 179.814 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -105.86 4.37 39.18 Favored Glycine 0 N--CA 1.447 -0.592 0 C-N-CA 120.668 -0.777 . . . . 0.0 111.711 179.258 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -129.11 21.76 5.74 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.139 0.495 . . . . 0.0 110.635 -179.829 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.457 HG11 ' O ' ' A' ' 52' ' ' GLU . 15.2 m -63.46 -9.83 5.7 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.272 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.666 -179.845 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 84.5 mt-30 -81.81 -9.19 59.68 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.539 179.546 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 17.3 t70 -132.58 -51.89 0.93 Allowed 'General case' 0 CA--C 1.531 0.217 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.44 179.372 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 4.5 m -67.31 -56.57 9.21 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.069 0.462 . . . . 0.0 111.874 -179.591 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -102.29 25.99 8.27 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.602 -178.736 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 2.4 t -72.57 -29.9 63.93 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 120.993 0.425 . . . . 0.0 110.178 -179.738 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -66.4 -26.46 67.25 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.257 179.681 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 2.9 m -64.22 -26.74 68.64 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.106 0.479 . . . . 0.0 110.436 -179.979 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -72.31 -31.11 65.41 Favored 'General case' 0 N--CA 1.453 -0.318 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.175 179.242 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -76.12 0.82 17.51 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.984 0.421 . . . . 0.0 111.243 179.826 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 57.1 tp60 -120.44 -50.52 2.22 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.972 179.679 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -85.04 -57.18 3.2 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 111.927 0.343 . . . . 0.0 111.927 -179.384 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 2.1 tp10 -63.09 -29.23 70.65 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-O 121.344 0.592 . . . . 0.0 110.211 -179.62 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 52.7 tptt -58.98 -28.59 66.49 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.459 -0.792 . . . . 0.0 111.251 179.453 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 63.4 mt-10 -62.43 -24.32 67.36 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-O 120.906 0.384 . . . . 0.0 111.174 -179.786 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 11.9 tp10 -96.83 -35.69 10.86 Favored 'General case' 0 C--N 1.318 -0.797 0 N-CA-C 109.841 -0.429 . . . . 0.0 109.841 178.423 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.415 ' HA ' ' O ' ' A' ' 122' ' ' PHE . 57.5 t -65.98 -42.31 91.5 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.878 -179.337 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 24.9 p-10 -71.33 -14.71 62.28 Favored 'General case' 0 N--CA 1.466 0.325 0 CA-C-O 121.118 0.485 . . . . 0.0 110.864 -179.726 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' SER . . . . . 0.4 ' OG ' ' HD3' ' A' ' 75' ' ' ARG . 12.4 p -97.89 -14.61 20.59 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.093 178.894 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . 0.459 ' CZ ' HG12 ' A' ' 125' ' ' ILE . 0.1 OUTLIER -111.23 46.47 1.08 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.423 -0.808 . . . . 0.0 110.401 -178.85 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -122.25 172.42 8.31 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.456 179.921 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 10.4 pt -130.83 140.71 48.02 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.61 179.394 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 87.2 t80 -95.54 123.07 38.91 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.839 -0.619 . . . . 0.0 109.836 179.908 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 3.9 t -106.48 113.18 42.43 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.849 -179.426 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -120.45 165.68 13.79 Favored Glycine 0 N--CA 1.448 -0.516 0 C-N-CA 120.937 -0.649 . . . . 0.0 111.801 179.938 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 2.6 m-20 61.79 39.44 13.96 Favored 'General case' 0 N--CA 1.471 0.598 0 CA-C-O 121.112 0.482 . . . . 0.0 111.014 -179.602 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 2.3 t -81.4 162.99 3.39 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.693 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.331 -179.417 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . 0.731 ' OD2' ' HB2' ' A' ' 142' ' ' ARG . 0.3 OUTLIER -63.87 138.52 58.51 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 109.845 -0.428 . . . . 0.0 109.845 179.445 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 30.5 p90 -62.67 -12.44 23.55 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.107 -0.497 . . . . 0.0 112.057 -179.443 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -123.24 27.74 7.41 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.744 0.307 . . . . 0.0 110.948 -179.485 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -86.08 147.55 26.12 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 116.444 -0.344 . . . . 0.0 110.783 -179.975 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' THR . . . . . 0.478 ' HB ' ' OE1' ' A' ' 89' ' ' GLU . 15.5 p -108.88 146.82 34.59 Favored Pre-proline 0 C--N 1.325 -0.487 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.894 179.658 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 16.1 Cg_endo -57.41 -37.43 97.45 Favored 'Trans proline' 0 C--N 1.344 0.29 0 C-N-CA 122.663 2.242 . . . . 0.0 113.2 -179.083 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . 0.478 ' OE1' ' HB ' ' A' ' 87' ' ' THR . 5.4 mp0 -64.75 -47.46 78.12 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.912 -178.347 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . 0.411 ' HG2' ' O ' ' A' ' 87' ' ' THR . 7.4 pt-20 -67.01 -24.19 66.0 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.843 0.354 . . . . 0.0 111.157 -178.958 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 75.0 t -79.97 -47.99 20.91 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.96 -179.535 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -69.43 -33.76 73.44 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.569 -0.287 . . . . 0.0 111.593 -178.356 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 11.1 pt20 -76.65 -30.17 56.72 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 120.516 -0.474 . . . . 0.0 111.143 -179.176 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 8.1 t60 -73.13 -40.04 65.23 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.053 0.454 . . . . 0.0 109.976 179.898 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 18.6 m-30 -78.35 -14.57 59.35 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.301 179.751 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . 0.588 ' HA ' ' O ' ' A' ' 99' ' ' GLY . 28.2 tt0 -67.57 -20.85 65.44 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.401 -0.818 . . . . 0.0 110.257 179.699 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 5.1 m -69.18 -23.09 63.88 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.648 -0.706 . . . . 0.0 110.173 179.241 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 26.5 m -99.91 -42.17 6.9 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.76 -0.655 . . . . 0.0 110.324 179.276 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . 0.588 ' O ' ' HA ' ' A' ' 96' ' ' GLN . . . -150.63 144.72 12.18 Favored Glycine 0 N--CA 1.442 -0.95 0 CA-C-N 115.906 -0.588 . . . . 0.0 111.84 179.897 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -63.25 146.5 53.29 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 120.993 0.425 . . . . 0.0 111.304 179.857 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 2.0 p -115.73 126.47 73.28 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.777 -179.533 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 5.5 t30 -94.57 -39.07 10.57 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 121.179 0.514 . . . . 0.0 110.047 179.309 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 3.0 tpt180 -150.01 151.98 34.17 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.121 -179.872 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 4.0 p -148.59 128.97 4.53 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-O 121.09 0.472 . . . . 0.0 110.122 179.483 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' THR . . . . . 0.59 ' HB ' ' CE1' ' A' ' 119' ' ' TYR . 4.9 m -121.47 122.38 39.63 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 116.473 -0.33 . . . . 0.0 110.573 179.845 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 19.6 tt -108.87 148.54 12.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 O-C-N 123.206 0.316 . . . . 0.0 110.408 179.741 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 17.6 tp -136.75 124.89 22.99 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.386 -179.914 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -89.0 117.37 27.97 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 120.81 0.338 . . . . 0.0 110.651 179.434 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 4.7 t70 -77.94 139.64 39.21 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.698 0.285 . . . . 0.0 110.762 179.596 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -123.34 32.6 5.6 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 121.061 0.457 . . . . 0.0 110.261 179.274 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 1.7 t80 -113.73 -3.06 13.57 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.302 -179.889 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 106.65 6.7 35.06 Favored Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 120.828 -0.701 . . . . 0.0 112.738 -179.565 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' GLN . . . . . 0.4 ' HB3' ' HD2' ' A' ' 114' ' ' PRO . 27.5 mt-30 -92.02 158.81 38.96 Favored Pre-proline 0 C--N 1.323 -0.568 0 N-CA-C 109.564 -0.532 . . . . 0.0 109.564 -179.939 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' PRO . . . . . 0.4 ' HD2' ' HB3' ' A' ' 113' ' ' GLN . 18.0 Cg_endo -59.7 106.45 0.32 Allowed 'Trans proline' 0 C--N 1.347 0.466 0 C-N-CA 122.411 2.074 . . . . 0.0 111.528 179.148 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 5.2 mttp -68.3 175.46 3.29 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.07 -0.513 . . . . 0.0 110.588 -179.475 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 98.51 4.02 57.28 Favored Glycine 0 N--CA 1.441 -0.993 0 C-N-CA 120.04 -1.076 . . . . 0.0 111.658 -179.628 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 30.0 m-85 -52.82 116.06 2.14 Favored 'General case' 0 CA--C 1.521 -0.152 0 O-C-N 123.776 0.339 . . . . 0.0 110.364 179.86 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -144.05 176.19 9.48 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 121.057 0.456 . . . . 0.0 111.236 -179.255 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' TYR . . . . . 0.59 ' CE1' ' HB ' ' A' ' 105' ' ' THR . 50.0 p90 -159.93 137.34 9.64 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.497 -0.774 . . . . 0.0 109.171 178.93 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 10.9 m -111.01 143.57 20.63 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 178.925 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 4.4 pt-20 -128.8 157.05 42.56 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 116.562 -0.29 . . . . 0.0 111.054 -179.207 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' PHE . . . . . 0.415 ' O ' ' HA ' ' A' ' 72' ' ' VAL . 11.9 t80 -161.37 168.99 22.85 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 109.691 -0.485 . . . . 0.0 109.691 179.491 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 1.8 t -85.54 -48.38 16.21 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-O 120.921 0.391 . . . . 0.0 111.342 -179.182 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 11.0 mt-10 -62.44 130.31 44.6 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.956 -0.565 . . . . 0.0 111.795 -178.971 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . 0.459 HG12 ' CZ ' ' A' ' 75' ' ' ARG . 2.3 mp -76.06 -32.4 23.0 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.468 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.63 -179.795 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 13.2 t70 -60.43 -39.49 87.64 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.102 0.477 . . . . 0.0 110.232 179.333 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -61.36 -53.64 54.04 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.523 -0.762 . . . . 0.0 111.545 179.963 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 7.3 p -68.74 -28.11 38.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.127 -179.511 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 25.5 tt0 -58.86 -47.6 84.32 Favored 'General case' 0 C--N 1.334 -0.096 0 CA-C-O 121.023 0.439 . . . . 0.0 110.32 179.629 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 76.8 m-20 -70.9 -33.29 70.42 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.741 -0.663 . . . . 0.0 109.864 179.533 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -66.06 -40.52 90.98 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.542 -0.754 . . . . 0.0 112.219 -179.408 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 3.9 pp -79.49 -16.84 55.35 Favored 'General case' 0 C--N 1.329 -0.325 0 O-C-N 122.128 -0.358 . . . . 0.0 110.959 179.905 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 5.2 tp -86.12 -50.15 7.23 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.283 -179.529 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 28.3 mt -132.47 112.68 12.33 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.501 -0.318 . . . . 0.0 110.944 -179.208 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 3.5 m-20 -168.95 -49.41 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.336 179.664 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 1.9 pt-20 -75.09 79.48 2.25 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.58 -0.737 . . . . 0.0 111.206 179.737 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 6.5 m -135.4 -59.93 0.76 Allowed 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.912 -0.586 . . . . 0.0 110.188 179.224 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 7.9 tm-20 -149.31 128.05 12.48 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 109.606 -0.516 . . . . 0.0 109.606 179.959 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -149.78 121.04 7.82 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 179.329 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 140' ' ' HIS . . . . . 0.655 ' HB3' ' OD2' ' A' ' 83' ' ' ASP . 5.4 t60 60.83 13.47 4.46 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-O 121.076 0.465 . . . . 0.0 111.614 178.742 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 98.58 -6.11 60.7 Favored Glycine 0 N--CA 1.447 -0.611 0 C-N-CA 120.803 -0.713 . . . . 0.0 112.216 -179.621 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 142' ' ' ARG . . . . . 0.731 ' HB2' ' OD2' ' A' ' 83' ' ' ASP . 2.1 mpt_? -114.01 -169.32 1.5 Allowed 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.008 0.432 . . . . 0.0 110.187 179.347 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 15.3 pt20 -131.65 138.74 48.88 Favored 'General case' 0 C--N 1.319 -0.754 0 N-CA-C 109.254 -0.647 . . . . 0.0 109.254 178.796 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -123.2 177.79 5.41 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-N 115.867 -0.606 . . . . 0.0 109.935 -179.528 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 1.7 tmtp? -117.27 121.8 42.17 Favored 'General case' 0 C--N 1.315 -0.907 0 N-CA-C 109.588 -0.523 . . . . 0.0 109.588 179.09 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 98.8 t -114.82 119.78 62.61 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-O 120.827 0.346 . . . . 0.0 110.911 -179.427 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 5.1 t -122.09 153.15 39.05 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.022 179.665 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -70.83 125.61 27.33 Favored 'General case' 0 N--CA 1.445 -0.713 0 CA-C-O 120.858 0.361 . . . . 0.0 111.187 179.956 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 18.9 ttpp -90.88 68.95 6.38 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.502 0.668 . . . . 0.0 109.29 179.909 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 13.0 tpt180 -84.92 90.18 7.74 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.731 -0.668 . . . . 0.0 109.965 -179.999 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 6.8 t -74.29 129.8 38.49 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.581 -0.736 . . . . 0.0 109.658 179.69 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 152' ' ' ASN . . . . . . . . . . . . . 28.6 t-20 -174.89 148.23 1.04 Allowed 'General case' 0 C--O 1.235 0.309 0 CA-C-N 116.184 -0.462 . . . . 0.0 109.971 -179.029 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 11.5 pt -68.66 145.45 97.01 Favored Pre-proline 0 CA--C 1.533 0.303 0 O-C-N 123.186 0.304 . . . . 0.0 111.184 -179.806 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 25.9 Cg_exo -63.31 122.91 11.25 Favored 'Trans proline' 0 C--O 1.235 0.373 0 C-N-CA 122.5 2.133 . . . . 0.0 111.965 179.211 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.246 0.874 0 CA-C-O 118.686 -1.063 . . . . 0.0 111.84 179.996 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.7 ttp . . . . . 0 N--CA 1.48 1.072 0 N-CA-C 110.06 -0.348 . . . . 0.0 110.06 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 99.81 172.54 30.4 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.589 -0.815 . . . . 0.0 111.807 179.953 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 3.3 p -142.19 152.69 43.38 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.971 0.386 . . . . 0.0 111.15 -179.583 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -134.3 141.62 47.0 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 109.724 -0.473 . . . . 0.0 109.724 179.605 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -127.56 3.41 6.18 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.667 0.27 . . . . 0.0 111.167 -179.563 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 2.0 p80 -76.43 143.39 40.61 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 116.367 -0.378 . . . . 0.0 111.077 -179.732 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 15.3 p-80 -90.74 -176.5 4.72 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 109.966 -0.383 . . . . 0.0 109.966 179.287 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 49.9 m80 -126.13 173.33 9.31 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.648 0.261 . . . . 0.0 110.953 -179.406 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 52.3 p-80 -153.72 158.39 40.94 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.008 -0.542 . . . . 0.0 109.715 179.501 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -146.22 131.77 18.78 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 120.815 0.341 . . . . 0.0 111.003 -179.764 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 14.5 m -155.95 138.71 15.19 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.268 -0.424 . . . . 0.0 109.971 179.501 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 23.5 m -132.39 139.15 47.97 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.744 0.306 . . . . 0.0 110.816 179.336 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -116.55 118.48 4.19 Favored Glycine 0 N--CA 1.447 -0.6 0 C-N-CA 120.924 -0.655 . . . . 0.0 112.248 -179.502 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -141.64 179.22 6.95 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 109.669 -0.493 . . . . 0.0 109.669 179.678 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 4.7 p -104.94 126.75 30.29 Favored Pre-proline 0 C--N 1.323 -0.557 0 N-CA-C 110.35 -0.241 . . . . 0.0 110.35 179.727 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -70.75 90.2 0.62 Allowed 'Trans proline' 0 N--CA 1.462 -0.324 0 C-N-CA 122.475 2.116 . . . . 0.0 111.383 179.036 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 82.6 mtt-85 -74.9 143.96 43.54 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.617 -0.72 . . . . 0.0 110.403 -179.488 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 153.11 -171.58 32.08 Favored Glycine 0 N--CA 1.444 -0.81 0 C-N-CA 120.654 -0.784 . . . . 0.0 112.261 179.868 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -138.78 174.07 10.91 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 109.907 -0.405 . . . . 0.0 109.907 179.888 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 14.9 m170 -97.33 138.45 34.78 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 120.683 0.278 . . . . 0.0 110.384 179.447 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 28.6 ttt -142.77 132.29 23.7 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 120.984 0.421 . . . . 0.0 110.537 -179.864 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -153.3 -151.45 5.72 Favored Glycine 0 N--CA 1.448 -0.503 0 C-N-CA 120.852 -0.689 . . . . 0.0 111.927 179.847 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -73.96 86.26 1.79 Allowed 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.014 0.435 . . . . 0.0 110.793 -179.915 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 24.1 t0 -82.19 -42.18 19.34 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.928 179.916 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 32.3 mt -118.53 143.43 46.75 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.276 179.942 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -74.09 -171.65 1.18 Allowed 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.696 0.284 . . . . 0.0 110.971 -179.997 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -61.26 -54.97 37.3 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.41 -178.752 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 1.9 mmm 54.14 48.69 20.39 Favored 'General case' 0 N--CA 1.466 0.33 0 O-C-N 123.639 0.587 . . . . 0.0 110.964 -179.597 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 94.8 mttt -69.22 126.82 30.98 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.721 -0.672 . . . . 0.0 111.247 -179.383 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 68.1 tttt -93.76 127.67 39.61 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 121.002 0.43 . . . . 0.0 109.883 179.367 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 18.6 ptt180 -121.62 176.49 5.68 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.116 -179.941 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 35.7 mt -98.01 130.73 44.83 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 120.864 0.364 . . . . 0.0 111.04 -179.685 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 12.5 tmtt? -135.72 60.56 1.68 Allowed 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 179.071 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 35.3 mt-10 -81.94 78.48 8.64 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.933 -0.576 . . . . 0.0 109.865 179.878 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 40.5 mm -113.9 101.5 12.54 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.336 179.972 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 28.5 mt-10 -120.91 88.14 2.88 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.925 -0.579 . . . . 0.0 110.011 179.793 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -158.46 123.83 4.39 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.323 0.583 . . . . 0.0 111.667 -179.72 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -131.14 155.3 47.23 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.468 -0.787 . . . . 0.0 110.043 179.413 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . 0.401 ' HB3' ' SD ' ' A' ' 45' ' ' MET . . . -150.43 169.42 21.5 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 109.817 -0.438 . . . . 0.0 109.817 -179.792 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -144.95 69.23 0.4 Allowed Glycine 0 N--CA 1.449 -0.438 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.564 -179.628 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -152.8 -177.23 6.13 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 110.374 -0.232 . . . . 0.0 110.374 179.713 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 29.4 tp -73.81 84.43 1.67 Allowed 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.226 0.536 . . . . 0.0 110.387 179.741 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 17.0 tpt180 -130.8 151.83 50.8 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.161 -179.623 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 26.8 mm-40 -82.45 19.49 1.24 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.301 -179.825 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' MET . . . . . 0.401 ' SD ' ' HB3' ' A' ' 39' ' ' ALA . 11.9 ptm -83.7 4.37 29.0 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.735 -179.431 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 43.5 mt-30 -66.19 -22.03 66.33 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.945 -0.571 . . . . 0.0 110.578 179.911 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -78.89 -8.69 59.07 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.601 -0.727 . . . . 0.0 111.446 -179.763 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . 0.449 ' O ' ' HG2' ' A' ' 52' ' ' GLU . 10.3 ttpt -78.23 -6.31 54.54 Favored 'General case' 0 C--O 1.234 0.28 0 CA-C-O 120.991 0.424 . . . . 0.0 110.345 -179.869 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 8.4 p -59.32 -25.65 31.4 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.325 0 CA-C-N 115.936 -0.575 . . . . 0.0 111.581 -179.48 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 39.5 mt-10 -61.47 -30.61 70.71 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 121.008 0.432 . . . . 0.0 110.922 -179.876 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 15.3 mtmm -95.83 -36.27 11.19 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.244 -179.532 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . 0.449 ' HG2' ' O ' ' A' ' 48' ' ' LYS . 3.0 mm-40 -75.63 -16.99 60.14 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.936 -178.337 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 25.7 ptm -64.47 -24.11 67.51 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.178 0.513 . . . . 0.0 110.117 178.731 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -97.83 1.06 59.49 Favored Glycine 0 N--CA 1.446 -0.69 0 N-CA-C 110.885 -0.886 . . . . 0.0 110.885 178.595 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -121.23 21.23 11.22 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.235 0.54 . . . . 0.0 110.215 179.931 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 13.6 m -65.88 -8.62 6.78 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 115.739 -0.664 . . . . 0.0 111.809 -179.664 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 23.1 mm-40 -83.67 -7.93 59.39 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 121.142 0.496 . . . . 0.0 109.937 179.756 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -129.73 -53.07 1.15 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.432 -0.804 . . . . 0.0 110.602 -179.804 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 8.0 m -68.75 -62.86 1.2 Allowed 'General case' 0 CA--C 1.531 0.243 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.241 179.954 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -91.23 30.45 1.25 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.213 0.53 . . . . 0.0 110.95 -179.822 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 22.8 t -77.32 -31.24 54.49 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.955 -178.938 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -63.62 -24.52 67.83 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.024 0.44 . . . . 0.0 111.37 -179.941 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 47.1 m -62.28 -25.73 68.01 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.927 -0.578 . . . . 0.0 110.836 179.931 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -70.05 -31.46 69.09 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.53 179.358 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -80.59 5.75 14.54 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.012 0.434 . . . . 0.0 111.136 -179.762 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 49.7 tp60 -125.16 -40.38 2.15 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.448 -0.342 . . . . 0.0 111.006 179.616 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -94.1 -53.45 3.96 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.917 0.389 . . . . 0.0 111.341 179.826 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 3.2 tp10 -70.12 -30.36 67.53 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.032 -179.421 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.11 -25.76 64.11 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.542 -179.886 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 39.9 mt-10 -62.98 -23.77 67.59 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.186 0.517 . . . . 0.0 110.925 179.883 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . 0.607 ' O ' ' HD3' ' A' ' 75' ' ' ARG . 8.3 tp10 -96.66 -43.59 7.49 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.992 -0.549 . . . . 0.0 109.572 178.225 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 41.3 t -61.15 -44.13 97.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 115.467 -0.788 . . . . 0.0 112.459 -178.709 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 8.5 p-10 -63.29 -27.57 69.42 Favored 'General case' 0 N--CA 1.471 0.624 0 N-CA-C 111.921 0.341 . . . . 0.0 111.921 -179.31 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 40.0 t -95.54 -2.27 48.84 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-O 120.909 0.385 . . . . 0.0 110.741 179.772 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . 0.607 ' HD3' ' O ' ' A' ' 71' ' ' GLU . 2.2 mpt_? -115.26 46.95 1.37 Allowed 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.389 0.614 . . . . 0.0 109.582 -179.473 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -125.43 174.48 8.16 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.188 -0.914 . . . . 0.0 110.436 179.874 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 7.4 pt -131.02 140.48 48.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-O 120.742 0.306 . . . . 0.0 110.794 179.141 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 13.7 t80 -92.75 118.72 31.38 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.616 -0.72 . . . . 0.0 109.361 179.636 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 6.8 t -104.01 109.51 27.46 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-N 116.332 -0.395 . . . . 0.0 109.974 179.452 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -118.03 165.85 12.74 Favored Glycine 0 N--CA 1.447 -0.576 0 C-N-CA 120.773 -0.727 . . . . 0.0 111.995 -179.262 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 9.9 m120 59.21 41.12 20.69 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-O 121.043 0.449 . . . . 0.0 110.741 -179.621 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 2.1 t -80.02 167.56 2.15 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-N 115.566 -0.743 . . . . 0.0 110.41 -179.172 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . 0.459 ' OD1' ' HD3' ' A' ' 142' ' ' ARG . 33.0 t70 -75.03 141.34 43.91 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.043 0.449 . . . . 0.0 110.627 179.901 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 29.2 p90 -63.09 -17.02 61.84 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.673 -0.694 . . . . 0.0 112.613 -178.743 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -110.42 8.27 23.13 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.828 0.346 . . . . 0.0 111.481 -179.592 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' CYS . . . . . 0.485 ' SG ' ' HB2' ' A' ' 140' ' ' HIS . 1.0 OUTLIER -73.27 142.42 47.22 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.154 0.502 . . . . 0.0 111.299 -179.893 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' THR . . . . . 0.493 ' O ' ' HG2' ' A' ' 90' ' ' GLU . 12.2 p -109.73 154.12 42.64 Favored Pre-proline 0 C--N 1.322 -0.602 0 CA-C-N 115.464 -0.789 . . . . 0.0 109.856 178.997 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . 0.546 ' O ' ' HG2' ' A' ' 92' ' ' GLN . 14.0 Cg_endo -57.25 -36.83 99.07 Favored 'Trans proline' 0 C--O 1.233 0.236 0 C-N-CA 122.391 2.061 . . . . 0.0 112.274 -179.726 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . 0.438 ' O ' ' HG2' ' A' ' 93' ' ' GLN . 28.2 mp0 -62.93 -51.51 66.64 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.781 -179.42 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . 0.495 ' O ' ' HB2' ' A' ' 94' ' ' HIS . 8.3 pt-20 -63.96 -22.68 67.03 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.615 0.245 . . . . 0.0 111.344 -178.751 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 66.5 t -82.98 -48.05 17.97 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.521 -179.583 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . 0.546 ' HG2' ' O ' ' A' ' 88' ' ' PRO . 16.4 pt20 -71.86 -33.56 68.51 Favored 'General case' 0 N--CA 1.465 0.284 0 N-CA-C 111.881 0.326 . . . . 0.0 111.881 -178.397 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . 0.438 ' HG2' ' O ' ' A' ' 89' ' ' GLU . 0.8 OUTLIER -77.27 -27.87 53.29 Favored 'General case' 0 C--N 1.329 -0.32 0 C-N-CA 120.464 -0.494 . . . . 0.0 110.636 -179.515 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' HIS . . . . . 0.495 ' HB2' ' O ' ' A' ' 90' ' ' GLU . 0.1 OUTLIER -71.9 -43.33 65.52 Favored 'General case' 0 CA--C 1.517 -0.295 0 CA-C-O 121.11 0.481 . . . . 0.0 110.276 179.719 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 21.0 m-30 -79.13 -15.36 58.25 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.93 -179.453 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . 0.501 ' HA ' ' O ' ' A' ' 99' ' ' GLY . 33.6 tt0 -64.64 -23.5 67.28 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.558 179.967 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 13.4 m -65.72 -33.41 75.8 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.409 179.454 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 11.1 m -94.95 -40.78 9.5 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.368 179.871 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . 0.501 ' O ' ' HA ' ' A' ' 96' ' ' GLN . . . -146.46 130.39 3.66 Favored Glycine 0 N--CA 1.444 -0.829 0 C-N-CA 120.688 -0.768 . . . . 0.0 111.742 -179.916 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' THR . . . . . 0.416 ' HB ' ' CZ ' ' A' ' 122' ' ' PHE . 0.2 OUTLIER -58.56 146.45 35.7 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 120.984 0.421 . . . . 0.0 111.539 179.894 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 2.4 p -111.99 131.43 63.43 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.112 -179.133 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 23.1 t-20 -99.19 -45.02 6.04 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 178.566 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 18.5 mmt180 -141.55 150.23 41.84 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-N 115.509 -0.769 . . . . 0.0 110.088 179.473 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 6.1 p -146.17 136.53 18.2 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-O 121.013 0.435 . . . . 0.0 110.191 179.385 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' THR . . . . . 0.513 ' HB ' ' CE1' ' A' ' 119' ' ' TYR . 1.4 m -128.15 129.4 46.47 Favored 'General case' 0 C--N 1.319 -0.722 0 N-CA-C 109.731 -0.47 . . . . 0.0 109.731 179.309 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 20.1 tt -120.47 147.47 24.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-O 120.953 0.406 . . . . 0.0 111.294 -179.298 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 15.3 tp -133.11 143.52 49.34 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.25 179.361 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -104.5 119.34 38.76 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 120.588 0.232 . . . . 0.0 110.662 179.463 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 8.5 t70 -80.08 130.41 35.23 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.992 0.425 . . . . 0.0 111.245 -179.76 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 10.8 mmmm -114.66 20.51 15.23 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.272 -179.799 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 63.9 t80 -98.68 -11.26 22.18 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.491 0.662 . . . . 0.0 109.913 -179.446 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 111.15 8.56 23.49 Favored Glycine 0 N--CA 1.448 -0.534 0 CA-C-N 115.557 -0.747 . . . . 0.0 112.394 -179.269 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' GLN . . . . . 0.424 ' HB3' ' HD2' ' A' ' 114' ' ' PRO . 24.4 mt-30 -94.42 160.58 31.44 Favored Pre-proline 0 C--N 1.323 -0.553 0 N-CA-C 109.188 -0.671 . . . . 0.0 109.188 179.663 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' PRO . . . . . 0.424 ' HD2' ' HB3' ' A' ' 113' ' ' GLN . 14.4 Cg_endo -57.37 114.2 1.84 Allowed 'Trans proline' 0 C--N 1.346 0.415 0 C-N-CA 122.357 2.038 . . . . 0.0 111.686 179.119 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 6.3 mttp -76.98 179.3 6.3 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.403 -179.897 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 94.99 1.45 63.1 Favored Glycine 0 N--CA 1.445 -0.718 0 C-N-CA 120.056 -1.068 . . . . 0.0 111.488 -179.884 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 6.8 t80 -53.74 117.31 3.06 Favored 'General case' 0 C--O 1.234 0.278 0 O-C-N 123.806 0.357 . . . . 0.0 110.125 179.744 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -145.32 175.34 10.37 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.781 -179.356 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' TYR . . . . . 0.513 ' CE1' ' HB ' ' A' ' 105' ' ' THR . 51.7 p90 -157.48 134.16 9.93 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.561 -0.745 . . . . 0.0 109.292 179.047 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 14.7 m -110.49 140.15 30.88 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 N-CA-C 109.766 -0.457 . . . . 0.0 109.766 179.705 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 7.9 pt-20 -124.45 154.22 40.81 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 116.596 -0.275 . . . . 0.0 110.642 -179.993 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 122' ' ' PHE . . . . . 0.416 ' CZ ' ' HB ' ' A' ' 100' ' ' THR . 11.0 t80 -149.29 164.84 33.71 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.203 179.94 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 11.8 t -81.56 -42.64 19.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.317 -179.579 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 81.9 mt-10 -76.38 138.73 40.6 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.043 0.449 . . . . 0.0 111.171 -179.541 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 2.5 mp -75.87 -30.55 21.2 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-N 115.745 -0.661 . . . . 0.0 110.029 179.572 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -54.15 -47.21 72.18 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 115.802 -0.636 . . . . 0.0 111.17 179.596 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -56.26 -58.0 9.84 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.396 -0.82 . . . . 0.0 111.488 -179.362 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 8.9 p -66.04 -32.8 59.73 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-N 116.31 -0.404 . . . . 0.0 111.676 -179.049 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 44.9 tt0 -60.99 -41.11 95.85 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.817 0.341 . . . . 0.0 110.88 -179.579 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 94.4 m-20 -79.4 -28.9 41.83 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.148 0.499 . . . . 0.0 110.01 179.36 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -70.12 -39.13 75.63 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.651 -0.704 . . . . 0.0 112.045 -179.414 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 4.2 pp -75.89 -11.47 59.97 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.938 0.399 . . . . 0.0 110.809 -179.901 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -88.84 -58.94 2.37 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.841 -0.618 . . . . 0.0 111.063 -179.923 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 75.8 mt -125.53 108.27 11.44 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.681 -178.864 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 2.8 m-20 -162.99 -50.66 0.04 OUTLIER 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.771 -0.65 . . . . 0.0 110.801 179.876 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 5.0 pt-20 -73.35 85.11 1.45 Allowed 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.779 -0.646 . . . . 0.0 111.448 -179.917 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 6.3 m -137.97 -59.32 0.65 Allowed 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.58 -0.736 . . . . 0.0 110.154 179.091 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 22.7 tt0 -153.79 127.94 9.04 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.217 -179.816 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -145.57 115.61 7.42 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 108.764 -0.828 . . . . 0.0 108.764 179.101 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 140' ' ' HIS . . . . . 0.485 ' HB2' ' SG ' ' A' ' 86' ' ' CYS . 2.8 t60 65.83 21.09 11.47 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-O 121.058 0.456 . . . . 0.0 110.373 -179.596 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 87.53 4.4 80.13 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.213 -179.601 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 142' ' ' ARG . . . . . 0.459 ' HD3' ' OD1' ' A' ' 83' ' ' ASP . 0.8 OUTLIER -125.66 165.19 19.02 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 109.945 -0.391 . . . . 0.0 109.945 179.838 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 12.9 pt20 -107.85 139.61 42.18 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-O 120.982 0.42 . . . . 0.0 110.697 179.656 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -121.68 178.08 4.99 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.037 -179.97 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 28.5 ttpt -116.22 122.41 44.93 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 109.912 -0.403 . . . . 0.0 109.912 179.063 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 95.7 t -113.92 123.13 69.28 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-O 120.968 0.413 . . . . 0.0 110.525 179.713 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 30.5 t -125.05 149.37 47.86 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 109.507 -0.553 . . . . 0.0 109.507 179.892 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -68.83 127.55 33.48 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 110.56 -0.163 . . . . 0.0 110.56 179.687 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 64.8 tttp -90.94 83.15 5.62 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.294 0.569 . . . . 0.0 110.505 -179.74 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 23.8 tpt180 -96.32 98.69 10.48 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 115.741 -0.663 . . . . 0.0 109.36 179.01 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 4.9 t -103.03 127.46 50.27 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.083 179.867 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 152' ' ' ASN . . . . . . . . . . . . . 5.2 t-20 -169.69 153.76 5.14 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.227 -179.857 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 153' ' ' ILE . . . . . 0.418 ' HA ' ' HD3' ' A' ' 154' ' ' PRO . 8.9 pt -62.24 127.98 90.42 Favored Pre-proline 0 C--N 1.327 -0.402 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.075 179.727 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 154' ' ' PRO . . . . . 0.418 ' HD3' ' HA ' ' A' ' 153' ' ' ILE . 4.3 Cg_exo -75.32 74.13 4.27 Favored 'Trans proline' 0 C--N 1.345 0.373 0 C-N-CA 122.559 2.173 . . . . 0.0 112.494 179.787 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 0.98 0 CA-C-O 118.924 -0.931 . . . . 0.0 111.331 179.874 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 15.3 tpt . . . . . 0 N--CA 1.482 1.163 0 CA-C-O 120.66 0.267 . . . . 0.0 110.669 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -131.5 -171.47 12.86 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.855 -0.688 . . . . 0.0 111.722 179.869 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 40.2 m 60.37 45.65 10.86 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-O 121.395 0.617 . . . . 0.0 111.062 179.936 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 1.1 m -89.33 170.76 10.29 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.381 -0.827 . . . . 0.0 110.532 179.953 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 37.4 m170 -73.77 143.47 46.03 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.74 0.305 . . . . 0.0 110.588 179.835 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 41.7 m-70 -101.03 -61.58 1.35 Allowed 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.398 -0.365 . . . . 0.0 111.262 -179.318 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 1.3 p-80 -162.06 157.06 22.9 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.746 0.307 . . . . 0.0 111.19 -178.735 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 33.0 p80 -167.38 142.62 3.98 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 109.193 -0.669 . . . . 0.0 109.193 178.865 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 19.2 p80 -165.12 150.82 9.69 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.024 0.44 . . . . 0.0 110.972 179.992 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 29.9 t-80 -138.99 145.16 39.36 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.661 -0.7 . . . . 0.0 109.375 179.407 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 1.2 p -126.77 148.58 49.9 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 120.853 0.358 . . . . 0.0 111.251 -179.879 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -102.2 172.39 6.92 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.619 179.667 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -88.91 -167.54 43.17 Favored Glycine 0 CA--C 1.518 0.234 0 C-N-CA 120.709 -0.757 . . . . 0.0 112.325 179.863 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 2.0 pt? -138.5 161.87 35.96 Favored 'General case' 0 C--N 1.326 -0.415 0 O-C-N 122.576 -0.367 . . . . 0.0 110.509 -179.904 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 1.6 p -134.04 102.37 12.16 Favored Pre-proline 0 C--N 1.325 -0.496 0 CA-C-O 121.391 0.615 . . . . 0.0 110.543 -179.825 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 94.5 Cg_endo -89.95 -176.85 1.24 Allowed 'Trans proline' 0 N--CA 1.456 -0.734 0 C-N-CA 122.818 2.345 . . . . 0.0 112.582 179.79 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 32.8 mtp180 -109.18 124.18 50.42 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.364 179.628 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -92.4 -167.79 39.78 Favored Glycine 0 N--CA 1.445 -0.749 0 C-N-CA 120.638 -0.792 . . . . 0.0 112.695 -179.621 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 51.3 m -151.21 146.87 26.39 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 110.273 -0.269 . . . . 0.0 110.273 179.661 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 9.3 p-80 -99.5 166.2 11.27 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.5 -179.857 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 31.9 mtt -83.46 152.03 25.17 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.607 -0.27 . . . . 0.0 110.389 -179.732 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -177.78 162.11 29.66 Favored Glycine 0 N--CA 1.447 -0.604 0 C-N-CA 120.773 -0.727 . . . . 0.0 111.883 -179.977 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -144.93 160.3 41.54 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.756 0.278 . . . . 0.0 110.634 -179.958 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 30.9 t0 -116.37 164.75 14.07 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.459 -0.337 . . . . 0.0 110.212 -179.863 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -105.83 -156.95 0.59 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.634 -0.257 . . . . 0.0 111.128 -179.385 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 15.9 pt-20 -129.96 -172.68 2.84 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.882 0.373 . . . . 0.0 111.102 -179.727 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 26.8 t70 -153.4 148.83 27.14 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.414 -179.681 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 21.3 ttt -120.69 136.97 54.7 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 109.734 -0.469 . . . . 0.0 109.734 179.505 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 20.5 tptt -129.53 154.92 46.56 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.757 0.313 . . . . 0.0 111.739 -179.033 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 96.9 mttt -130.77 169.2 16.02 Favored 'General case' 0 C--O 1.235 0.308 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.251 179.636 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 5.2 ptp180 -165.53 139.75 4.72 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 116.541 -0.3 . . . . 0.0 110.712 179.765 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -144.93 156.68 44.11 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 110.209 -0.293 . . . . 0.0 110.209 179.68 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 16.1 ttmt -151.21 114.7 4.86 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.907 0.384 . . . . 0.0 111.032 -179.97 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 6.4 mt-10 -128.66 84.13 2.21 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.059 179.381 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 39.2 pt -129.23 147.37 33.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 116.712 -0.222 . . . . 0.0 111.484 -179.055 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 22.1 mm-40 43.89 62.82 1.8 Allowed 'General case' 0 N--CA 1.468 0.473 0 O-C-N 124.249 0.968 . . . . 0.0 112.824 178.891 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 10.7 tt0 -82.75 -17.12 45.39 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.257 0.551 . . . . 0.0 109.936 179.732 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -130.06 110.26 11.49 Favored 'General case' 0 C--O 1.236 0.348 0 CA-C-N 115.619 -0.718 . . . . 0.0 110.995 -179.743 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -161.43 122.29 2.76 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.877 179.797 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 165.33 138.89 2.52 Favored Glycine 0 N--CA 1.449 -0.464 0 C-N-CA 120.876 -0.678 . . . . 0.0 112.234 179.693 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -164.1 -164.06 0.83 Allowed 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 110.085 -0.339 . . . . 0.0 110.085 -179.75 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 18.6 tp -81.56 85.88 6.45 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.17 0.51 . . . . 0.0 110.067 179.622 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 13.4 tpp180 -145.95 132.36 19.65 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.899 -0.591 . . . . 0.0 109.652 179.96 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 3.3 tp10 -82.79 39.26 0.61 Allowed 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.559 0.695 . . . . 0.0 110.911 -179.742 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 17.6 ptt? -87.83 11.66 14.98 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.656 -0.702 . . . . 0.0 109.538 179.089 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 19.4 mm-40 -66.87 -22.5 65.98 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.277 -0.874 . . . . 0.0 111.101 -179.682 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -68.8 -14.4 63.0 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 121.348 0.594 . . . . 0.0 110.6 179.54 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 20.2 ttpp -83.24 1.05 42.73 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.589 -0.732 . . . . 0.0 110.33 179.814 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 8.3 p -59.48 -26.2 33.6 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.205 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.971 -179.912 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 26.6 mt-10 -67.14 -24.67 65.93 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 115.912 -0.586 . . . . 0.0 110.344 179.534 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 11.4 mtmm -97.22 -29.74 13.4 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.579 -0.737 . . . . 0.0 110.594 179.331 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 38.0 mm-40 -80.96 -5.32 57.36 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.677 -179.661 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 10.7 ptp -62.33 -30.83 71.44 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.891 0.377 . . . . 0.0 110.652 -179.932 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -91.55 3.89 79.17 Favored Glycine 0 N--CA 1.447 -0.594 0 C-N-CA 120.722 -0.751 . . . . 0.0 111.319 178.838 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -130.41 26.66 5.08 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.432 -0.384 . . . . 0.0 110.275 -179.802 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 18.4 m -71.03 -4.33 4.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 120.773 0.32 . . . . 0.0 111.497 -179.489 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 28.7 mt-30 -94.25 -4.17 49.35 Favored 'General case' 0 CA--C 1.505 -0.785 0 N-CA-C 108.108 -1.071 . . . . 0.0 108.108 179.778 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -124.51 -60.64 1.38 Allowed 'General case' 0 C--N 1.31 -1.113 0 CA-C-N 113.399 -1.728 . . . . 0.0 110.023 -177.239 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 10.1 m -72.75 -70.1 0.37 Allowed 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.091 -0.959 . . . . 0.0 111.844 -179.36 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -85.08 33.7 0.54 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.816 0.341 . . . . 0.0 111.455 -178.931 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 3.6 t -75.74 -27.87 58.3 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 109.675 -0.491 . . . . 0.0 109.675 -179.812 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 1.3 m -65.61 -25.83 67.56 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-O 121.238 0.542 . . . . 0.0 110.681 178.857 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 18.1 m -60.88 -28.15 68.66 Favored 'General case' 0 N--CA 1.45 -0.46 0 CA-C-N 115.63 -0.714 . . . . 0.0 110.63 179.989 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -72.62 -33.45 66.66 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.488 179.15 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -76.44 -2.12 30.45 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.25 0.548 . . . . 0.0 110.793 179.865 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 64.7 tt0 -114.39 -54.71 2.56 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.923 179.924 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -85.49 -56.09 3.69 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.793 -178.509 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . 0.451 ' O ' HG23 ' A' ' 72' ' ' VAL . 1.2 tt0 -62.65 -31.48 72.35 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.952 0.406 . . . . 0.0 110.896 -179.61 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 48.7 tptt -55.55 -30.01 59.99 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.587 -0.733 . . . . 0.0 111.299 179.937 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 99.3 mt-10 -58.63 -41.6 86.32 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.027 0.441 . . . . 0.0 110.455 179.469 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . 0.415 ' O ' ' HD2' ' A' ' 75' ' ' ARG . 7.4 tp10 -76.86 -43.37 36.38 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.057 -0.519 . . . . 0.0 109.871 179.308 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.451 HG23 ' O ' ' A' ' 68' ' ' GLU . 43.8 t -60.75 -40.34 84.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 115.648 -0.705 . . . . 0.0 111.624 -179.241 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 7.5 t0 -68.23 -23.26 64.78 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-O 121.318 0.58 . . . . 0.0 110.723 -179.934 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 1.2 t -95.29 -9.9 31.77 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 121.686 0.755 . . . . 0.0 109.782 179.705 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . 0.415 ' HD2' ' O ' ' A' ' 71' ' ' GLU . 0.0 OUTLIER -111.75 44.77 1.32 Allowed 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.396 -0.82 . . . . 0.0 110.659 -179.259 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' SER . . . . . 0.461 ' OG ' ' HE2' ' A' ' 149' ' ' LYS . 0.0 OUTLIER -126.92 171.69 11.07 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.818 179.367 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 13.8 pt -131.01 136.95 56.97 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-N 116.465 -0.334 . . . . 0.0 110.198 178.64 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' TYR . . . . . 0.449 ' O ' ' HA ' ' A' ' 146' ' ' VAL . 43.0 t80 -91.12 123.29 34.47 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.142 -179.896 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 10.4 t -107.04 111.92 37.72 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.658 -179.749 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -121.48 170.8 14.84 Favored Glycine 0 N--CA 1.446 -0.682 0 N-CA-C 111.362 -0.695 . . . . 0.0 111.362 179.974 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 13.1 m120 58.39 44.24 18.6 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-O 121.294 0.569 . . . . 0.0 110.441 -179.627 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.477 HG11 ' H ' ' A' ' 83' ' ' ASP . 1.7 t -90.07 172.1 1.03 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 CA-C-N 115.338 -0.846 . . . . 0.0 110.615 -179.011 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . 0.477 ' H ' HG11 ' A' ' 82' ' ' VAL . 9.2 t0 -68.74 137.25 53.91 Favored 'General case' 0 N--CA 1.451 -0.395 0 N-CA-C 109.666 -0.494 . . . . 0.0 109.666 179.476 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 34.9 p90 -61.71 -18.14 58.51 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.459 -179.28 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -118.15 20.59 13.14 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.511 -0.313 . . . . 0.0 111.332 179.942 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' CYS . . . . . 0.437 ' SG ' ' HB3' ' A' ' 83' ' ' ASP . 0.5 OUTLIER -77.16 145.25 37.83 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.984 0.421 . . . . 0.0 110.869 179.603 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' THR . . . . . 0.46 ' O ' ' HG2' ' A' ' 90' ' ' GLU . 55.9 p -103.08 151.22 38.43 Favored Pre-proline 0 C--N 1.323 -0.57 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.261 179.637 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -61.77 -29.2 82.84 Favored 'Trans proline' 0 C--O 1.233 0.24 0 C-N-CA 122.3 2.0 . . . . 0.0 111.93 179.835 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . 0.511 ' O ' ' HG2' ' A' ' 93' ' ' GLN . 27.8 mt-10 -66.27 -53.26 38.94 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.343 -0.844 . . . . 0.0 111.933 -178.837 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . 0.46 ' HG2' ' O ' ' A' ' 87' ' ' THR . 9.2 pt-20 -61.71 -24.98 67.13 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.967 0.413 . . . . 0.0 111.24 -179.268 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 69.3 t -79.84 -48.57 20.41 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.275 -179.106 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . 0.4 ' O ' ' HB2' ' A' ' 96' ' ' GLN . 0.0 OUTLIER -70.29 -32.88 70.85 Favored 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 112.196 0.443 . . . . 0.0 112.196 -178.183 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . 0.511 ' HG2' ' O ' ' A' ' 89' ' ' GLU . 9.6 pt20 -79.79 -28.77 40.25 Favored 'General case' 0 C--N 1.325 -0.491 0 C-N-CA 120.061 -0.656 . . . . 0.0 111.19 -179.331 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 58.7 t-80 -68.92 -45.22 71.4 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.808 0.337 . . . . 0.0 110.57 179.989 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 23.9 m-85 -78.53 -11.8 59.98 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.68 -179.388 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . 0.56 ' HA ' ' O ' ' A' ' 99' ' ' GLY . 8.2 tt0 -68.9 -21.7 64.22 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 121.23 0.538 . . . . 0.0 109.958 179.802 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 4.5 m -66.52 -32.24 73.47 Favored 'General case' 0 N--CA 1.452 -0.347 0 CA-C-N 115.673 -0.694 . . . . 0.0 109.531 178.545 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 2.1 m -88.25 -47.83 8.14 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.546 -0.752 . . . . 0.0 110.075 179.575 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . 0.56 ' O ' ' HA ' ' A' ' 96' ' ' GLN . . . -147.07 142.35 10.23 Favored Glycine 0 N--CA 1.447 -0.603 0 C-N-CA 121.023 -0.608 . . . . 0.0 111.751 179.801 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -60.07 144.03 50.56 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 120.827 0.346 . . . . 0.0 111.503 -179.639 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 2.3 p -114.86 127.76 72.27 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.289 179.832 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 20.1 t-20 -95.1 -40.99 9.34 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.145 0.498 . . . . 0.0 110.098 179.649 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 3.2 tpp180 -144.87 155.91 43.72 Favored 'General case' 0 N--CA 1.45 -0.425 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.263 -179.487 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 5.7 p -154.32 133.95 3.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.109 179.804 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -126.13 127.74 46.23 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 109.736 -0.468 . . . . 0.0 109.736 179.006 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' ILE . . . . . 0.408 HD13 ' HA2' ' A' ' 116' ' ' GLY . 20.1 tt -111.04 146.07 16.54 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-O 121.017 0.437 . . . . 0.0 110.951 -179.368 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 43.3 tp -130.15 138.32 50.58 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.26 179.816 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -103.64 113.68 27.38 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 109.963 -0.384 . . . . 0.0 109.963 179.453 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 6.4 t70 -72.3 133.32 44.94 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.054 0.454 . . . . 0.0 111.367 -179.677 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 11.2 mmmt -111.31 19.22 18.5 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.722 -179.868 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 3.0 t80 -101.0 -9.93 21.0 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.973 0.416 . . . . 0.0 110.324 -179.372 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 110.83 -0.53 28.8 Favored Glycine 0 N--CA 1.449 -0.441 0 CA-C-N 115.788 -0.642 . . . . 0.0 112.227 -179.808 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 3.5 mt-30 -81.28 158.63 69.13 Favored Pre-proline 0 C--N 1.323 -0.581 0 N-CA-C 110.332 -0.247 . . . . 0.0 110.332 -179.911 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 13.5 Cg_endo -56.57 103.77 0.13 Allowed 'Trans proline' 0 C--N 1.347 0.486 0 C-N-CA 122.687 2.258 . . . . 0.0 111.319 178.419 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 7.8 mttp -68.84 176.67 2.94 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.606 -0.725 . . . . 0.0 110.776 -178.444 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . 0.408 ' HA2' HD13 ' A' ' 106' ' ' ILE . . . 99.92 4.52 55.53 Favored Glycine 0 N--CA 1.441 -0.998 0 C-N-CA 120.398 -0.906 . . . . 0.0 111.187 -179.54 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 59.2 m-85 -52.27 118.3 3.43 Favored 'General case' 0 CA--C 1.522 -0.098 0 C-N-CA 122.63 0.372 . . . . 0.0 110.121 179.401 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -146.23 176.33 9.84 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 121.052 0.453 . . . . 0.0 111.234 -178.916 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 43.5 p90 -156.56 133.95 10.7 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.418 -0.81 . . . . 0.0 109.706 179.155 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 15.7 m -108.42 142.5 20.89 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 N-CA-C 109.108 -0.701 . . . . 0.0 109.108 178.62 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . 0.405 ' HB2' HG12 ' A' ' 72' ' ' VAL . 5.9 pt-20 -131.39 156.18 46.0 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 120.927 0.394 . . . . 0.0 111.884 -178.901 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 13.8 t80 -152.08 166.64 30.99 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.796 -0.638 . . . . 0.0 109.755 179.134 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 13.0 t -83.96 -52.94 12.16 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-O 120.76 0.314 . . . . 0.0 111.242 -179.52 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 38.6 mt-10 -67.88 131.7 45.99 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.832 -179.66 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 2.2 mp -70.91 -31.07 44.25 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.88 -179.161 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -54.47 -40.48 68.47 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-O 121.15 0.5 . . . . 0.0 111.228 179.327 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -62.76 -57.05 12.29 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.837 -0.62 . . . . 0.0 111.273 -179.877 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 9.9 p -65.91 -27.97 42.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.192 -179.503 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 18.6 tp60 -59.08 -44.58 91.92 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.902 0.382 . . . . 0.0 110.247 179.506 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 52.9 m-80 -77.31 -29.66 53.72 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.919 -0.582 . . . . 0.0 109.72 179.209 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -67.38 -41.6 84.75 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.799 -0.637 . . . . 0.0 111.342 179.821 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 4.2 pp -77.96 -10.31 59.53 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.915 0.388 . . . . 0.0 110.605 179.482 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -86.7 -52.51 5.48 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.928 -0.578 . . . . 0.0 109.648 179.257 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 27.7 mt -117.46 102.83 9.53 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.598 -0.728 . . . . 0.0 109.647 179.919 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 135' ' ' ASN . . . . . 0.531 ' OD1' ' HB ' ' A' ' 146' ' ' VAL . 1.3 p30 -142.96 -78.1 0.23 Allowed 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 112.422 0.527 . . . . 0.0 112.422 -178.46 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -68.76 109.99 4.11 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.432 0.634 . . . . 0.0 111.549 -178.67 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 56.2 m -152.43 -61.53 0.16 Allowed 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.709 -0.678 . . . . 0.0 109.666 179.0 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 -157.76 120.36 3.84 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 116.699 -0.228 . . . . 0.0 110.943 179.225 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -140.6 116.66 10.49 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 109.555 -0.535 . . . . 0.0 109.555 179.482 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 1.3 t60 61.69 17.21 8.48 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-O 120.992 0.425 . . . . 0.0 110.863 -179.866 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 96.34 -7.38 66.36 Favored Glycine 0 N--CA 1.448 -0.556 0 C-N-CA 120.992 -0.623 . . . . 0.0 112.173 -179.76 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 3.8 mpt_? -112.26 160.61 17.47 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.938 0.399 . . . . 0.0 111.443 -179.39 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 16.3 pt20 -104.79 116.9 32.8 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 109.387 -0.597 . . . . 0.0 109.387 178.641 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -95.32 176.73 6.09 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.081 -179.16 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 1.8 tmtp? -117.64 120.94 39.55 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 109.679 -0.489 . . . . 0.0 109.679 179.599 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 146' ' ' VAL . . . . . 0.531 ' HB ' ' OD1' ' A' ' 135' ' ' ASN . 99.3 t -119.34 133.02 67.5 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-O 120.879 0.371 . . . . 0.0 111.26 -179.336 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 5.3 m -135.24 142.86 46.06 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.114 -0.494 . . . . 0.0 109.954 178.92 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -58.87 124.98 21.65 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.846 0.355 . . . . 0.0 110.844 179.766 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 149' ' ' LYS . . . . . 0.461 ' HE2' ' OG ' ' A' ' 76' ' ' SER . 23.7 ttpt -91.17 63.33 5.01 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.562 0.696 . . . . 0.0 109.189 -179.877 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -84.5 81.51 8.81 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.405 -0.816 . . . . 0.0 109.81 -179.872 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 13.0 t -61.24 129.03 39.28 Favored 'General case' 0 N--CA 1.45 -0.432 0 CA-C-N 115.926 -0.579 . . . . 0.0 109.614 179.204 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 152' ' ' ASN . . . . . . . . . . . . . 64.3 t30 -161.97 155.3 20.83 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 109.643 -0.503 . . . . 0.0 109.643 -179.295 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 153' ' ' ILE . . . . . 0.434 ' HA ' ' HD3' ' A' ' 154' ' ' PRO . 15.1 pt -74.68 137.25 73.86 Favored Pre-proline 0 C--N 1.322 -0.606 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.621 -179.956 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 154' ' ' PRO . . . . . 0.434 ' HD3' ' HA ' ' A' ' 153' ' ' ILE . 26.3 Cg_exo -62.65 140.48 81.21 Favored 'Trans proline' 0 C--N 1.343 0.289 0 C-N-CA 122.476 2.117 . . . . 0.0 112.111 179.729 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.244 0.746 0 CA-C-O 118.994 -0.892 . . . . 0.0 111.701 -179.647 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 37.7 mtt . . . . . 0 N--CA 1.479 0.977 0 N-CA-C 110.13 -0.322 . . . . 0.0 110.13 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 105.21 62.28 0.64 Allowed Glycine 0 N--CA 1.447 -0.568 0 C-N-CA 120.773 -0.727 . . . . 0.0 111.718 -179.311 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 2.0 m -96.94 89.48 4.86 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 120.958 0.408 . . . . 0.0 111.313 -179.261 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 1.1 m -130.66 93.34 3.41 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.119 -0.491 . . . . 0.0 109.965 179.38 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -154.03 138.48 16.77 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.681 0.277 . . . . 0.0 111.042 -179.437 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 27.3 t-80 -154.98 148.97 25.77 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 109.374 -0.602 . . . . 0.0 109.374 179.077 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 11.4 p80 -149.73 179.88 7.66 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.673 0.273 . . . . 0.0 110.539 -179.549 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 36.0 t60 -124.58 153.77 41.66 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 109.494 -0.558 . . . . 0.0 109.494 179.953 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 17.9 p-80 -83.13 156.13 23.43 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.724 0.297 . . . . 0.0 110.873 179.769 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 23.3 t-80 -105.97 142.1 36.25 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 109.836 -0.431 . . . . 0.0 109.836 179.197 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -130.02 150.63 51.21 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.327 179.644 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -134.21 152.45 51.83 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 120.899 0.38 . . . . 0.0 110.785 -179.83 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -97.48 -123.26 4.59 Favored Glycine 0 N--CA 1.448 -0.527 0 C-N-CA 120.614 -0.803 . . . . 0.0 112.541 -179.665 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -162.71 175.29 11.48 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 110.111 -0.329 . . . . 0.0 110.111 179.883 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . 0.428 ' HA ' ' HD3' ' A' ' 16' ' ' PRO . 2.7 p -150.48 110.03 3.17 Favored Pre-proline 0 C--N 1.324 -0.518 0 CA-C-O 120.823 0.344 . . . . 0.0 110.66 179.69 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . 0.428 ' HD3' ' HA ' ' A' ' 15' ' ' VAL . 2.5 Cg_endo -84.3 -166.05 0.34 Allowed 'Trans proline' 0 N--CA 1.459 -0.547 0 C-N-CA 122.867 2.378 . . . . 0.0 111.936 179.474 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 31.1 mmm180 -113.42 -171.75 1.94 Allowed 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.407 -0.36 . . . . 0.0 110.141 179.734 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -148.31 169.4 28.96 Favored Glycine 0 N--CA 1.447 -0.605 0 C-N-CA 120.455 -0.878 . . . . 0.0 112.308 -179.798 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 2.3 t -144.98 170.69 15.66 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 109.956 -0.387 . . . . 0.0 109.956 -179.973 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 35.8 p-80 -160.63 144.76 13.88 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.549 -0.296 . . . . 0.0 110.379 -179.633 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' MET . . . . . 0.519 ' HB2' ' HG3' ' A' ' 36' ' ' GLU . 6.2 tpt -146.93 177.51 9.08 Favored 'General case' 0 C--N 1.326 -0.413 0 N-CA-C 109.607 -0.516 . . . . 0.0 109.607 179.838 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . 0.456 ' H ' ' HG3' ' A' ' 21' ' ' MET . . . -104.18 81.55 0.34 Allowed Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.699 -0.763 . . . . 0.0 112.561 -179.889 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 4.7 m -63.33 141.57 58.72 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.73 0.3 . . . . 0.0 111.571 179.808 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 15.5 p-10 -115.16 -154.25 0.54 Allowed 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.464 179.625 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 1.4 mm? -80.43 135.81 36.22 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.0 0.428 . . . . 0.0 111.753 -179.18 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . 0.459 ' CD ' ' HG ' ' A' ' 63' ' ' SER . 0.2 OUTLIER -134.44 -147.14 0.27 Allowed 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 109.009 -0.737 . . . . 0.0 109.009 179.276 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 28.0 t0 -91.73 157.45 16.91 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.783 0.325 . . . . 0.0 110.126 179.362 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -99.2 91.67 5.09 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 120.976 0.417 . . . . 0.0 111.155 -179.291 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.488 ' HD3' ' OG ' ' A' ' 63' ' ' SER . 0.0 OUTLIER -139.43 159.79 41.34 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.474 179.608 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 36.9 mmtt -83.0 106.39 14.78 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.323 -0.398 . . . . 0.0 110.323 179.713 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 6.3 tpp180 -162.07 128.92 3.76 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.018 -0.537 . . . . 0.0 109.975 179.967 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 51.7 tp -113.08 112.71 24.31 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.899 -179.958 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -164.78 132.84 3.29 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.215 179.198 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -108.73 128.31 54.76 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.189 -179.636 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 9.2 tt 179.31 166.11 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 115.947 -0.569 . . . . 0.0 109.694 179.334 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . 0.519 ' HG3' ' HB2' ' A' ' 21' ' ' MET . 1.3 mp0 -77.5 144.05 38.0 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.765 0.317 . . . . 0.0 110.22 179.14 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -120.07 -174.69 2.83 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.378 -178.761 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 28.5 mt-10 -125.88 -100.71 0.38 Allowed 'General case' 0 C--O 1.236 0.354 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.352 179.499 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -168.68 164.85 12.2 Favored 'General case' 0 C--O 1.235 0.313 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.269 -179.851 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 139.89 71.8 0.04 OUTLIER Glycine 0 C--N 1.332 0.358 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.953 179.655 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -113.47 -63.5 1.44 Allowed 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.742 0.306 . . . . 0.0 110.953 179.88 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 32.0 tp -79.82 79.55 6.32 Favored 'General case' 0 N--CA 1.45 -0.436 0 CA-C-O 121.796 0.808 . . . . 0.0 110.079 179.959 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . 0.42 ' C ' ' H ' ' A' ' 45' ' ' MET . 65.5 ttt180 -161.62 159.37 27.49 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 114.739 -1.119 . . . . 0.0 109.382 -179.787 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 4.5 tt0 -78.62 19.89 0.47 Allowed 'General case' 0 N--CA 1.465 0.316 0 CA-C-O 121.325 0.583 . . . . 0.0 110.922 179.988 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' MET . . . . . 0.42 ' H ' ' C ' ' A' ' 43' ' ' ARG . 13.6 ptm -88.16 6.0 38.68 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.717 -179.819 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 49.5 mt-30 -70.77 -23.03 62.32 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.581 179.999 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -75.51 -13.9 60.39 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.361 0.601 . . . . 0.0 110.623 179.33 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 6.1 ttmm -74.0 -2.28 23.48 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.683 -0.69 . . . . 0.0 111.09 -179.523 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 9.5 p -57.64 -24.4 22.33 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.275 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.155 -179.87 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 4.6 mm-40 -62.14 -27.99 69.33 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-O 121.107 0.48 . . . . 0.0 110.341 179.552 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 5.8 mtmm -106.76 -42.57 4.92 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.747 -0.66 . . . . 0.0 110.994 179.619 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 78.9 mm-40 -64.87 -6.09 7.5 Favored 'General case' 0 N--CA 1.467 0.397 0 N-CA-C 112.304 0.483 . . . . 0.0 112.304 -179.089 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 3.0 ptt? -65.76 -23.9 66.83 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.112 0.482 . . . . 0.0 109.937 178.777 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -96.78 5.42 64.06 Favored Glycine 0 N--CA 1.451 -0.332 0 N-CA-C 110.708 -0.957 . . . . 0.0 110.708 178.337 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -128.31 19.28 6.37 Favored 'General case' 0 N--CA 1.452 -0.359 0 CA-C-N 115.284 -0.458 . . . . 0.0 110.134 -179.85 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 11.8 m -67.01 -12.19 14.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-O 121.234 0.54 . . . . 0.0 110.657 -179.735 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -83.08 -4.14 58.04 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.7 179.712 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -130.83 -53.09 1.06 Allowed 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.593 -0.731 . . . . 0.0 110.304 -179.946 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 3.5 m -73.28 -71.0 0.33 Allowed 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.394 -0.821 . . . . 0.0 111.646 -179.428 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -85.06 38.16 0.7 Allowed 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.178 0.514 . . . . 0.0 111.226 -179.254 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 7.0 t -85.69 -18.59 32.71 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 109.191 -0.67 . . . . 0.0 109.191 179.243 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 2.0 m -69.42 -24.59 63.85 Favored 'General case' 0 C--O 1.234 0.286 0 CA-C-N 115.364 -0.835 . . . . 0.0 109.599 179.125 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' SER . . . . . 0.488 ' OG ' ' HD3' ' A' ' 29' ' ' LYS . 71.9 m -58.25 -28.08 64.59 Favored 'General case' 0 N--CA 1.448 -0.559 0 CA-C-N 115.039 -0.982 . . . . 0.0 111.287 179.299 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -71.24 -31.57 67.7 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.986 0.422 . . . . 0.0 110.215 179.327 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -82.36 7.21 14.67 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.439 0.638 . . . . 0.0 110.2 179.499 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 1.1 tp-100 -124.88 -55.34 1.6 Allowed 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.705 -0.68 . . . . 0.0 111.357 -179.795 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -85.16 -51.48 6.6 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.54 -179.275 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 4.8 tp10 -72.3 -24.27 61.3 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.102 0.477 . . . . 0.0 110.312 -179.549 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 2.2 tptm -64.23 -24.64 67.74 Favored 'General case' 0 N--CA 1.453 -0.317 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.611 178.902 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -63.55 -17.75 63.14 Favored 'General case' 0 C--O 1.232 0.141 0 CA-C-O 121.543 0.687 . . . . 0.0 109.927 178.882 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . 0.444 ' O ' ' HD2' ' A' ' 75' ' ' ARG . 6.6 tp10 -97.37 -47.17 5.8 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.147 -0.933 . . . . 0.0 109.208 177.744 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 94.7 t -60.36 -39.37 80.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 115.449 -0.796 . . . . 0.0 112.332 -178.943 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 17.5 p-10 -68.8 -21.31 64.33 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-O 120.754 0.311 . . . . 0.0 111.47 -178.596 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 39.1 t -101.32 -0.07 36.27 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 109.451 -0.574 . . . . 0.0 109.451 178.66 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . 0.444 ' HD2' ' O ' ' A' ' 71' ' ' GLU . 0.0 OUTLIER -117.91 44.15 2.25 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.551 -0.75 . . . . 0.0 110.309 -179.749 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -123.43 172.25 8.85 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.675 179.499 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 8.3 pt -132.99 137.46 53.7 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 N-CA-C 109.864 -0.421 . . . . 0.0 109.864 178.604 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 85.4 t80 -96.06 125.61 40.72 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 116.148 -0.478 . . . . 0.0 109.849 -179.775 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 4.6 t -105.24 114.32 44.49 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.057 -179.346 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -117.97 168.0 12.97 Favored Glycine 0 N--CA 1.448 -0.504 0 N-CA-C 111.123 -0.791 . . . . 0.0 111.123 179.502 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 4.3 m-20 58.61 41.4 22.27 Favored 'General case' 0 N--CA 1.472 0.662 0 CA-C-O 121.118 0.485 . . . . 0.0 110.844 -179.328 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 2.0 t -85.66 166.38 2.04 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.954 -179.245 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . 0.616 ' OD2' ' HD3' ' A' ' 142' ' ' ARG . 9.9 t70 -67.83 136.63 54.42 Favored 'General case' 0 CA--C 1.519 -0.243 0 N-CA-C 109.587 -0.523 . . . . 0.0 109.587 179.526 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 32.4 p90 -62.09 -19.71 63.26 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.944 -0.571 . . . . 0.0 112.493 -178.597 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -112.71 17.61 18.95 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 120.534 0.207 . . . . 0.0 111.508 -179.382 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' CYS . . . . . 0.425 ' SG ' ' HB3' ' A' ' 83' ' ' ASP . 0.7 OUTLIER -77.51 144.58 37.57 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.196 0.522 . . . . 0.0 111.41 -179.779 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' THR . . . . . 0.488 ' O ' ' HG2' ' A' ' 90' ' ' GLU . 20.5 p -105.44 152.92 40.04 Favored Pre-proline 0 C--N 1.323 -0.554 0 CA-C-N 115.496 -0.775 . . . . 0.0 110.008 179.222 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 21.0 Cg_endo -61.32 -32.04 89.44 Favored 'Trans proline' 0 C--N 1.342 0.221 0 C-N-CA 122.342 2.028 . . . . 0.0 112.554 -179.071 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 12.3 mt-10 -64.54 -54.42 32.56 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.737 -0.665 . . . . 0.0 111.731 -178.862 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . 0.551 ' O ' ' HB2' ' A' ' 94' ' ' HIS . 11.3 pt-20 -60.72 -26.25 67.03 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.032 0.444 . . . . 0.0 111.299 -178.75 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 51.8 t -78.92 -48.97 20.96 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.319 -179.244 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -71.19 -32.47 68.9 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 111.794 0.294 . . . . 0.0 111.794 -178.585 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 16.7 pt20 -79.45 -25.99 41.85 Favored 'General case' 0 C--N 1.33 -0.243 0 C-N-CA 120.774 -0.37 . . . . 0.0 111.323 -179.117 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' HIS . . . . . 0.551 ' HB2' ' O ' ' A' ' 90' ' ' GLU . 2.3 t60 -76.34 -38.6 55.67 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.838 0.352 . . . . 0.0 110.414 -179.988 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 21.2 m-30 -81.23 -15.08 56.67 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.497 179.827 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . 0.526 ' HA ' ' O ' ' A' ' 99' ' ' GLY . 48.7 tt0 -65.72 -21.83 66.56 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.718 -0.674 . . . . 0.0 110.621 -179.977 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 17.3 m -68.58 -20.14 64.5 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.877 -0.602 . . . . 0.0 110.377 179.132 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 32.3 m -102.69 -46.42 4.73 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.005 179.188 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . 0.526 ' O ' ' HA ' ' A' ' 96' ' ' GLN . . . -145.2 142.29 10.66 Favored Glycine 0 N--CA 1.445 -0.76 0 N-CA-C 111.506 -0.637 . . . . 0.0 111.506 179.781 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' THR . . . . . 0.401 ' HB ' ' CZ ' ' A' ' 122' ' ' PHE . 0.2 OUTLIER -62.29 148.37 45.21 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-O 120.889 0.376 . . . . 0.0 111.305 -179.715 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 2.4 p -117.79 130.89 71.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.916 -179.652 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 16.6 t30 -98.46 -45.56 6.08 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.292 0.568 . . . . 0.0 109.868 179.123 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -142.54 150.78 40.86 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.756 -0.656 . . . . 0.0 109.668 179.844 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 3.5 p -146.04 129.54 10.22 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 N-CA-C 109.89 -0.411 . . . . 0.0 109.89 179.734 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 7.8 m -120.48 125.98 49.24 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 110.268 -0.271 . . . . 0.0 110.268 179.924 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 19.8 tt -112.36 146.18 17.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.434 -179.944 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 16.4 tp -131.81 132.47 43.78 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.511 179.765 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -96.85 121.59 38.88 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 116.201 -0.454 . . . . 0.0 109.867 179.208 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -88.56 136.22 33.1 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.788 0.327 . . . . 0.0 110.592 179.968 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . 0.418 ' N ' ' HD3' ' A' ' 110' ' ' LYS . 0.0 OUTLIER -121.64 21.66 10.79 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 120.986 0.422 . . . . 0.0 110.474 179.819 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 17.3 t80 -101.68 -5.34 25.13 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.26 0.552 . . . . 0.0 110.277 -179.879 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 112.42 2.21 26.1 Favored Glycine 0 N--CA 1.447 -0.631 0 C-N-CA 120.879 -0.677 . . . . 0.0 112.392 179.733 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 19.4 mt-30 -89.52 154.89 48.67 Favored Pre-proline 0 C--N 1.326 -0.424 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 179.565 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -55.23 121.54 10.1 Favored 'Trans proline' 0 N--CA 1.46 -0.441 0 C-N-CA 121.737 1.625 . . . . 0.0 110.971 178.773 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 54.6 mttt -76.64 176.1 8.7 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 -179.352 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 94.95 6.9 60.14 Favored Glycine 0 N--CA 1.446 -0.634 0 C-N-CA 120.129 -1.034 . . . . 0.0 112.355 179.648 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 4.4 m-30 -58.75 103.94 0.19 Allowed 'General case' 0 C--N 1.332 -0.169 0 N-CA-C 109.815 -0.439 . . . . 0.0 109.815 179.607 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -132.18 177.25 7.71 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-O 121.085 0.469 . . . . 0.0 111.324 -179.059 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 2.0 p90 -158.56 139.58 13.03 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.372 -0.831 . . . . 0.0 109.379 179.179 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 13.8 m -112.49 142.87 23.5 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 N-CA-C 109.555 -0.535 . . . . 0.0 109.555 178.35 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 5.0 pt-20 -129.38 150.13 50.87 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.787 -179.671 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 122' ' ' PHE . . . . . 0.401 ' CZ ' ' HB ' ' A' ' 100' ' ' THR . 16.3 t80 -151.73 168.93 23.48 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.336 179.61 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 4.1 t -82.8 -54.21 9.9 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-O 120.836 0.35 . . . . 0.0 111.496 -179.359 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 56.7 mt-10 -60.61 126.52 27.73 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.958 -0.565 . . . . 0.0 111.586 -179.105 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 2.2 mp -71.69 -33.62 49.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 115.703 -0.681 . . . . 0.0 109.864 179.567 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -60.37 -38.05 82.65 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.466 -0.788 . . . . 0.0 110.707 179.585 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -63.95 -56.13 17.42 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.783 -0.644 . . . . 0.0 111.119 -179.986 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 9.9 p -64.12 -27.77 43.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-O 120.812 0.339 . . . . 0.0 110.561 179.774 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 129' ' ' GLN . . . . . 0.429 HE21 ' HB3' ' A' ' 129' ' ' GLN . 1.7 tt0 -62.29 -47.25 85.16 Favored 'General case' 0 C--N 1.333 -0.121 0 CA-C-O 121.066 0.46 . . . . 0.0 109.876 178.853 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 88.4 m-20 -66.69 -31.95 72.95 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.337 0.589 . . . . 0.0 109.579 179.349 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . 0.444 ' O ' ' HB2' ' A' ' 135' ' ' ASN . . . -67.27 -51.93 46.97 Favored 'General case' 0 N--CA 1.452 -0.358 0 CA-C-N 115.267 -0.879 . . . . 0.0 110.986 179.684 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 4.3 pp -66.22 -21.49 66.3 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.142 0.496 . . . . 0.0 110.693 179.898 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 5.6 tp -76.78 -51.45 11.35 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.115 179.16 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 94.4 mt -125.83 99.86 6.14 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.286 179.953 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 135' ' ' ASN . . . . . 0.444 ' HB2' ' O ' ' A' ' 131' ' ' ALA . 0.4 OUTLIER -146.77 -70.1 0.25 Allowed 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.491 -179.112 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . 0.412 ' HB2' ' O ' ' A' ' 144' ' ' LEU . 9.3 pt-20 -69.86 103.21 2.14 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.601 0.715 . . . . 0.0 111.277 -179.234 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 13.1 m -152.33 -57.54 0.14 Allowed 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.831 -0.622 . . . . 0.0 109.667 179.246 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 28.8 tt0 -160.0 122.32 3.34 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.152 -179.854 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -143.64 115.28 8.15 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 109.368 -0.604 . . . . 0.0 109.368 179.62 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 2.4 t60 64.82 14.03 8.9 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-O 121.255 0.55 . . . . 0.0 110.586 -179.869 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 95.71 -0.49 63.02 Favored Glycine 0 N--CA 1.446 -0.675 0 C-N-CA 120.786 -0.721 . . . . 0.0 111.913 -179.207 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 142' ' ' ARG . . . . . 0.616 ' HD3' ' OD2' ' A' ' 83' ' ' ASP . 2.4 mpt_? -115.59 158.81 22.12 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 120.917 0.389 . . . . 0.0 110.595 179.614 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 15.3 pt20 -105.06 119.07 38.13 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 178.411 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . 0.412 ' O ' ' HB2' ' A' ' 136' ' ' GLU . 0.5 OUTLIER -103.29 176.74 5.05 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.04 -178.966 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 73.8 tttt -115.57 121.9 44.02 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 109.253 -0.647 . . . . 0.0 109.253 178.996 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 89.2 t -115.34 119.3 61.44 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-O 120.902 0.382 . . . . 0.0 111.039 -179.803 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 36.3 t -121.54 139.47 53.46 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 116.142 -0.481 . . . . 0.0 109.81 179.943 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -58.84 132.12 53.0 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 109.926 -0.398 . . . . 0.0 109.926 179.213 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 57.5 tttp -93.12 78.16 4.58 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-O 121.479 0.657 . . . . 0.0 109.942 -179.382 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 21.5 tpt180 -92.31 93.46 8.65 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 115.371 -0.831 . . . . 0.0 109.281 179.435 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 8.8 t -72.79 133.08 44.34 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.288 -0.869 . . . . 0.0 109.656 179.562 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 152' ' ' ASN . . . . . . . . . . . . . 66.6 t30 -171.84 164.52 6.45 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 109.778 -0.452 . . . . 0.0 109.778 -179.449 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 7.2 pt -71.9 144.55 88.08 Favored Pre-proline 0 C--N 1.323 -0.583 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.285 179.301 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -75.65 59.44 5.61 Favored 'Trans proline' 0 CA--C 1.53 0.289 0 C-N-CA 122.828 2.352 . . . . 0.0 112.501 179.774 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.968 0 CA-C-O 119.007 -0.885 . . . . 0.0 111.483 179.938 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.2 mpt? . . . . . 0 N--CA 1.479 1.012 0 N-CA-C 110.137 -0.32 . . . . 0.0 110.137 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -123.04 122.59 5.04 Favored Glycine 0 N--CA 1.448 -0.566 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.422 -179.699 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 1.9 m -110.68 135.06 51.86 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 110.241 -0.281 . . . . 0.0 110.241 179.803 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 53.6 m -94.5 165.82 12.35 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 121.016 0.436 . . . . 0.0 111.026 -179.712 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 2.6 p-80 -148.45 150.35 33.31 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.207 -179.547 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 1.2 t-80 -139.33 141.35 37.68 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 109.538 -0.542 . . . . 0.0 109.538 179.892 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 89.8 m-70 -138.62 164.82 28.5 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 120.78 0.324 . . . . 0.0 110.753 -179.543 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 6.3 p80 -144.54 151.75 39.56 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.008 -0.542 . . . . 0.0 109.978 179.552 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 8.6 t-80 -149.2 154.58 39.34 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 109.532 -0.544 . . . . 0.0 109.532 -179.816 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 18.7 p80 -135.02 176.1 8.98 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 110.148 -0.316 . . . . 0.0 110.148 179.899 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 44.2 m -151.96 140.28 20.44 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.878 0.371 . . . . 0.0 110.807 -179.647 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 19.4 m -127.92 138.05 52.51 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.354 179.585 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -150.51 140.54 8.03 Favored Glycine 0 N--CA 1.447 -0.574 0 N-CA-C 111.119 -0.793 . . . . 0.0 111.119 -179.97 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -128.32 163.23 25.24 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 120.88 0.371 . . . . 0.0 111.095 -179.279 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -129.3 102.84 18.37 Favored Pre-proline 0 C--N 1.322 -0.592 0 CA-C-N 115.598 -0.728 . . . . 0.0 110.653 179.764 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 76.4 Cg_endo -82.22 158.71 17.6 Favored 'Trans proline' 0 N--CA 1.459 -0.543 0 C-N-CA 122.441 2.094 . . . . 0.0 112.346 179.737 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 11.2 ptt180 -138.33 131.85 30.68 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.191 179.918 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -163.46 107.39 0.3 Allowed Glycine 0 N--CA 1.447 -0.575 0 C-N-CA 120.673 -0.775 . . . . 0.0 112.568 -179.898 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 1.1 m -85.69 143.19 28.52 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 120.72 0.295 . . . . 0.0 110.46 179.758 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 47.7 t-80 -112.51 128.79 56.44 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 109.761 -0.459 . . . . 0.0 109.761 179.587 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 12.2 ptt? -153.17 154.46 34.79 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 120.84 0.352 . . . . 0.0 111.071 -179.644 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -119.73 163.51 13.68 Favored Glycine 0 N--CA 1.447 -0.632 0 N-CA-C 111.604 -0.598 . . . . 0.0 111.604 179.523 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -145.32 172.69 12.79 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 110.268 -0.271 . . . . 0.0 110.268 -179.887 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 1.5 t0 -110.79 176.39 5.05 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 110.088 -0.338 . . . . 0.0 110.088 179.466 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 27.8 mt -131.82 -176.58 4.1 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 116.439 -0.346 . . . . 0.0 110.563 -179.236 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 5.5 tp10 -72.93 153.0 41.16 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.66 -179.757 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 -112.76 167.32 10.59 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.346 179.77 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 23.9 mmt -107.25 129.59 54.86 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.069 -179.401 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 20.4 pttm -68.53 157.74 35.36 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.06 179.948 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 13.4 tptt -122.28 157.62 31.3 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.087 -179.294 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 53.4 ttm-85 -136.59 141.79 43.31 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 109.35 -0.611 . . . . 0.0 109.35 179.171 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -105.73 163.18 12.9 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 110.06 -0.348 . . . . 0.0 110.06 179.68 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -124.4 161.24 26.39 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.481 -0.327 . . . . 0.0 110.172 179.855 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 34.2 mt-10 -99.81 177.18 5.2 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.989 0.423 . . . . 0.0 111.703 -178.392 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 24.5 pt -74.67 157.11 6.17 Favored 'Isoleucine or valine' 0 C--O 1.234 0.281 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.601 -179.271 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . 0.422 ' HB3' ' H ' ' A' ' 37' ' ' GLU . 8.5 mm-40 -118.3 -162.29 0.88 Allowed 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.94 -179.52 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . 0.422 ' H ' ' HB3' ' A' ' 36' ' ' GLU . 15.3 pt-20 -74.06 159.29 32.87 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.869 -179.378 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . 0.414 ' HB2' ' H ' ' A' ' 39' ' ' ALA . 0.0 OUTLIER -144.7 -119.88 0.08 Allowed 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.508 -0.769 . . . . 0.0 109.797 179.661 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . 0.414 ' H ' ' HB2' ' A' ' 38' ' ' GLU . . . 55.57 81.95 0.11 Allowed 'General case' 0 C--O 1.234 0.259 0 C-N-CA 122.892 0.477 . . . . 0.0 112.206 179.293 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -80.66 134.03 12.9 Favored Glycine 0 N--CA 1.45 -0.406 0 C-N-CA 120.793 -0.717 . . . . 0.0 111.834 179.918 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -98.89 175.39 5.96 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 120.725 0.298 . . . . 0.0 110.853 -179.688 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 25.4 tp -79.17 84.33 5.14 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.28 0.562 . . . . 0.0 110.52 179.562 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . 0.406 ' C ' ' H ' ' A' ' 45' ' ' MET . 31.3 ttm180 -147.12 146.92 30.09 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.843 -0.617 . . . . 0.0 109.601 179.824 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -77.97 40.49 0.33 Allowed 'General case' 0 N--CA 1.463 0.214 0 CA-C-O 121.407 0.622 . . . . 0.0 111.079 179.989 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' MET . . . . . 0.406 ' H ' ' C ' ' A' ' 43' ' ' ARG . 15.8 ptt? -92.51 6.12 48.31 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 115.771 -0.65 . . . . 0.0 110.342 -179.904 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 25.3 mt-30 -64.49 -25.27 67.92 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.942 -179.764 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -66.72 -16.43 64.22 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 121.125 0.488 . . . . 0.0 111.303 -179.875 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 24.4 ttpp -72.19 -10.01 59.21 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.564 179.976 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 5.6 p -59.99 -23.96 28.49 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.169 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.039 179.844 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 38.6 mt-10 -64.63 -21.68 66.78 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.253 0.549 . . . . 0.0 110.701 179.261 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 10.3 mtmm -102.77 -40.95 6.36 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.366 179.182 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -72.8 -3.85 27.96 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.0 -0.545 . . . . 0.0 111.723 -179.84 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -67.14 -27.65 67.48 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 109.304 -0.628 . . . . 0.0 109.304 178.392 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -89.87 2.56 82.2 Favored Glycine 0 N--CA 1.446 -0.675 0 N-CA-C 110.831 -0.908 . . . . 0.0 110.831 178.57 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -131.08 27.68 4.83 Favored 'General case' 0 N--CA 1.451 -0.376 0 CA-C-O 121.034 0.445 . . . . 0.0 110.055 -179.974 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 16.0 m -63.47 -21.8 29.34 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.287 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.456 -179.762 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 20.1 mm-40 -72.75 -9.83 59.09 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.564 0.697 . . . . 0.0 109.731 179.036 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 6.8 t70 -120.15 -60.46 1.69 Allowed 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.491 -0.777 . . . . 0.0 110.91 -179.313 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 66.4 m -69.89 -75.81 0.11 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.776 -179.546 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -79.01 41.97 0.46 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.103 0.478 . . . . 0.0 111.207 -179.278 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 36.3 p -80.91 -31.68 35.01 Favored 'General case' 0 N--CA 1.448 -0.558 0 CA-C-O 121.282 0.563 . . . . 0.0 110.096 -179.356 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -69.81 -20.66 63.44 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.529 -0.76 . . . . 0.0 111.212 179.681 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' SER . . . . . 0.478 ' O ' ' HG2' ' A' ' 66' ' ' GLN . 3.8 m -62.07 -25.03 67.46 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.07 -179.604 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -69.92 -31.55 69.37 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.452 -0.34 . . . . 0.0 110.585 179.357 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -77.32 -1.73 31.32 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.637 -179.486 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' GLN . . . . . 0.478 ' HG2' ' O ' ' A' ' 63' ' ' SER . 8.2 pt20 -121.36 -31.23 4.11 Favored 'General case' 0 C--N 1.328 -0.353 0 C-N-CA 120.613 -0.435 . . . . 0.0 111.181 179.396 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -99.65 -57.21 2.2 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.956 0.407 . . . . 0.0 111.39 -179.932 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 5.1 tp10 -71.74 -21.39 61.76 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 120.891 0.376 . . . . 0.0 110.866 -179.317 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -63.27 -24.51 67.9 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.659 -0.246 . . . . 0.0 110.736 179.318 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 51.4 mt-10 -63.52 -23.18 67.28 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.478 0.656 . . . . 0.0 109.412 178.754 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 6.6 tp10 -94.94 -45.57 7.22 Favored 'General case' 0 N--CA 1.45 -0.466 0 CA-C-N 115.217 -0.901 . . . . 0.0 109.937 178.647 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.464 ' HA ' ' O ' ' A' ' 122' ' ' PHE . 84.2 t -61.17 -42.67 94.24 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.342 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.583 -179.234 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -68.18 -21.37 64.88 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-O 121.188 0.518 . . . . 0.0 110.892 -179.6 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 11.1 t -98.49 -4.66 33.9 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.625 -0.716 . . . . 0.0 109.737 179.811 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -116.56 40.65 2.86 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.485 -0.78 . . . . 0.0 110.321 -179.499 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -119.02 170.99 8.57 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.622 179.81 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 10.4 pt -127.78 137.91 56.24 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-O 120.763 0.316 . . . . 0.0 110.357 178.982 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 76.6 t80 -92.78 116.53 29.11 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 116.023 -0.535 . . . . 0.0 109.736 -179.753 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 10.9 t -105.2 113.97 43.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-O 120.914 0.387 . . . . 0.0 110.886 -179.102 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -122.52 170.56 15.25 Favored Glycine 0 N--CA 1.449 -0.49 0 N-CA-C 111.664 -0.574 . . . . 0.0 111.664 179.833 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 5.4 m-20 58.43 40.5 24.07 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-O 121.27 0.557 . . . . 0.0 110.775 -179.929 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 2.5 t -82.83 165.18 2.59 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 CA-C-N 115.364 -0.834 . . . . 0.0 110.41 -179.408 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . 0.589 ' HB3' ' SG ' ' A' ' 86' ' ' CYS . 13.6 t0 -67.23 140.88 57.42 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 109.96 -0.385 . . . . 0.0 109.96 179.316 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 34.6 p90 -68.49 -11.77 60.28 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.703 -179.13 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -113.46 14.38 19.06 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 120.739 0.304 . . . . 0.0 111.477 -179.803 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' CYS . . . . . 0.589 ' SG ' ' HB3' ' A' ' 83' ' ' ASP . 1.2 m -81.34 150.23 28.54 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.354 0.597 . . . . 0.0 111.747 -179.594 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' THR . . . . . 0.518 ' O ' ' HG2' ' A' ' 90' ' ' GLU . 1.2 p -116.02 155.75 47.58 Favored Pre-proline 0 C--N 1.323 -0.547 0 CA-C-N 115.513 -0.767 . . . . 0.0 109.933 179.235 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 25.6 Cg_endo -60.51 -34.52 92.68 Favored 'Trans proline' 0 C--N 1.344 0.31 0 C-N-CA 122.464 2.109 . . . . 0.0 113.054 -178.599 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 8.4 mt-10 -63.4 -51.85 64.07 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.646 -178.94 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . 0.672 ' O ' ' HB2' ' A' ' 94' ' ' HIS . 8.8 pt-20 -61.73 -28.82 69.7 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.924 -179.201 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 79.6 t -76.96 -48.53 25.16 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.178 -179.003 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . 0.431 ' O ' ' HB2' ' A' ' 96' ' ' GLN . 0.0 OUTLIER -69.87 -32.64 71.1 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.57 -0.287 . . . . 0.0 111.474 -178.084 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 1.7 pt20 -80.97 -26.44 36.58 Favored 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 120.883 -0.327 . . . . 0.0 110.994 -179.239 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' HIS . . . . . 0.672 ' HB2' ' O ' ' A' ' 90' ' ' GLU . 0.9 OUTLIER -71.5 -39.15 71.02 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.961 0.41 . . . . 0.0 110.316 -179.777 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 15.4 m-85 -88.46 -13.98 39.02 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.974 -179.479 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . 0.467 ' HA ' ' O ' ' A' ' 99' ' ' GLY . 41.6 tt0 -63.22 -22.18 66.7 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.802 -179.904 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 35.7 m -72.74 -21.9 60.95 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.54 179.505 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 3.6 m -96.67 -44.15 7.24 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.202 0.525 . . . . 0.0 109.629 178.957 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . 0.467 ' O ' ' HA ' ' A' ' 96' ' ' GLN . . . -147.35 139.03 7.58 Favored Glycine 0 N--CA 1.442 -0.916 0 CA-C-N 115.516 -0.766 . . . . 0.0 111.229 179.529 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 2.3 m -62.73 143.14 57.75 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 120.819 0.342 . . . . 0.0 110.957 179.975 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 2.6 p -108.12 132.68 55.22 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.928 -179.365 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 10.7 t30 -93.68 -41.36 9.74 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 109.615 -0.513 . . . . 0.0 109.615 178.655 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -156.41 159.11 38.41 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.285 -0.87 . . . . 0.0 109.512 179.549 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 6.2 p -148.6 136.34 14.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-O 120.909 0.385 . . . . 0.0 110.581 -179.882 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' THR . . . . . 0.483 ' HB ' ' CE1' ' A' ' 119' ' ' TYR . 2.0 m -122.91 130.82 53.32 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.259 178.945 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' ILE . . . . . 0.4 HD13 ' HA2' ' A' ' 116' ' ' GLY . 21.1 tt -118.73 146.11 23.8 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-O 120.703 0.287 . . . . 0.0 110.535 -179.849 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 43.2 tp -135.46 127.29 29.32 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.36 179.855 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -87.59 124.32 33.38 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.6 179.759 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -86.98 137.44 32.35 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.033 0.444 . . . . 0.0 110.774 179.807 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 5.3 mmmm -121.24 17.38 11.52 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.669 -179.616 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 5.7 t80 -101.61 -0.64 34.45 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.075 0.464 . . . . 0.0 110.706 -179.172 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 105.38 5.41 39.95 Favored Glycine 0 N--CA 1.446 -0.679 0 C-N-CA 120.654 -0.784 . . . . 0.0 112.53 179.535 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' GLN . . . . . 0.433 ' HB3' ' HD2' ' A' ' 114' ' ' PRO . 7.7 mt-30 -91.25 160.03 38.14 Favored Pre-proline 0 C--N 1.322 -0.609 0 N-CA-C 109.018 -0.734 . . . . 0.0 109.018 179.677 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' PRO . . . . . 0.433 ' HD2' ' HB3' ' A' ' 113' ' ' GLN . 14.1 Cg_endo -57.42 117.45 4.15 Favored 'Trans proline' 0 C--N 1.345 0.379 0 C-N-CA 122.038 1.825 . . . . 0.0 111.577 179.333 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 63.9 mttt -76.55 179.49 5.91 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 109.071 -0.714 . . . . 0.0 109.071 179.975 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . 0.4 ' HA2' HD13 ' A' ' 106' ' ' ILE . . . 91.64 -0.79 74.41 Favored Glycine 0 N--CA 1.448 -0.515 0 C-N-CA 120.258 -0.973 . . . . 0.0 111.869 179.69 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 2.0 t80 -54.25 121.34 8.0 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.856 0.36 . . . . 0.0 110.153 179.809 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -149.95 175.45 11.66 Favored 'General case' 0 N--CA 1.448 -0.558 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.754 -179.216 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' TYR . . . . . 0.483 ' CE1' ' HB ' ' A' ' 105' ' ' THR . 35.2 p90 -157.49 134.46 10.13 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.985 -0.552 . . . . 0.0 109.615 179.068 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 11.8 m -106.41 149.33 9.93 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 N-CA-C 109.677 -0.49 . . . . 0.0 109.677 179.385 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . 0.424 ' HB2' HG12 ' A' ' 72' ' ' VAL . 0.7 OUTLIER -133.73 156.13 48.52 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.927 -178.789 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 122' ' ' PHE . . . . . 0.464 ' O ' ' HA ' ' A' ' 72' ' ' VAL . 13.2 t80 -155.1 165.63 36.11 Favored 'General case' 0 C--N 1.333 -0.116 0 CA-C-O 120.927 0.394 . . . . 0.0 111.126 179.275 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 12.2 t -82.14 -45.26 19.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 115.694 -0.685 . . . . 0.0 112.226 -178.869 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 20.0 mm-40 -76.26 136.88 39.66 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.12 0.486 . . . . 0.0 111.306 -178.865 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 2.7 mp -74.82 -35.89 37.87 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.675 -179.493 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -55.79 -38.79 70.4 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.106 179.597 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -61.5 -57.05 13.68 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.018 179.971 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 10.0 p -66.36 -29.06 45.41 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.002 -179.544 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 19.6 tt0 -61.54 -39.46 91.17 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.666 179.804 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 46.4 m-80 -78.77 -31.12 45.99 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.142 0.496 . . . . 0.0 109.706 178.738 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -66.44 -51.07 60.79 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.657 -0.701 . . . . 0.0 111.221 179.996 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 4.2 pp -65.66 -16.08 63.4 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-O 121.036 0.446 . . . . 0.0 110.859 -179.868 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 3.8 tp -84.04 -52.89 5.95 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.014 179.237 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 69.5 mt -121.41 101.4 7.6 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.915 -0.584 . . . . 0.0 109.85 179.693 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -146.66 -70.53 0.24 Allowed 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.84 0.352 . . . . 0.0 111.706 -179.331 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -70.48 105.35 3.04 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.546 0.689 . . . . 0.0 111.598 -179.051 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 15.2 m -147.59 -58.49 0.26 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.573 -0.74 . . . . 0.0 109.41 178.769 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -161.32 127.75 3.89 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.976 -0.556 . . . . 0.0 109.839 179.433 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -142.82 111.93 6.56 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.16 -0.473 . . . . 0.0 109.861 179.794 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 140' ' ' HIS . . . . . 0.429 ' HB2' ' SG ' ' A' ' 86' ' ' CYS . 1.3 t60 62.81 25.41 15.08 Favored 'General case' 0 N--CA 1.466 0.33 0 O-C-N 123.41 0.444 . . . . 0.0 110.839 179.189 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 86.66 3.45 83.74 Favored Glycine 0 N--CA 1.45 -0.429 0 C-N-CA 120.871 -0.681 . . . . 0.0 112.029 -179.57 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -116.86 170.57 8.51 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 110.072 -0.344 . . . . 0.0 110.072 179.989 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 8.1 pt20 -120.53 117.03 26.56 Favored 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 109.486 -0.561 . . . . 0.0 109.486 178.957 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -99.62 175.22 5.9 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.934 0.397 . . . . 0.0 111.336 -178.934 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 145' ' ' LYS . . . . . 0.498 ' HE3' ' OG ' ' A' ' 147' ' ' SER . 1.2 tmtp? -116.37 123.19 46.99 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.645 -0.707 . . . . 0.0 109.413 179.34 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 90.8 t -120.55 137.28 54.85 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-O 120.771 0.32 . . . . 0.0 110.68 -179.303 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 147' ' ' SER . . . . . 0.498 ' OG ' ' HE3' ' A' ' 145' ' ' LYS . 66.9 m -144.62 149.23 35.41 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.284 -0.417 . . . . 0.0 109.911 178.902 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -61.74 123.55 18.27 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.757 0.313 . . . . 0.0 111.338 -179.794 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 12.5 ttpp -86.86 73.67 9.92 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.498 0.666 . . . . 0.0 109.755 -179.982 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 14.1 tpt180 -83.5 96.62 8.65 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.69 -0.686 . . . . 0.0 110.716 -179.904 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 151' ' ' THR . . . . . 0.427 ' O ' HG21 ' A' ' 151' ' ' THR . 12.4 t -84.08 124.15 30.8 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 179.002 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 152' ' ' ASN . . . . . . . . . . . . . 57.0 t30 -169.29 152.55 4.98 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 110.207 -0.294 . . . . 0.0 110.207 -178.872 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 14.9 pt -76.93 150.95 81.77 Favored Pre-proline 0 C--N 1.323 -0.557 0 CA-C-N 116.155 -0.475 . . . . 0.0 109.897 179.12 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 28.1 Cg_endo -64.08 108.13 0.9 Allowed 'Trans proline' 0 C--O 1.234 0.309 0 C-N-CA 122.351 2.034 . . . . 0.0 112.198 179.859 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.914 0 CA-C-O 118.421 -1.21 . . . . 0.0 111.56 179.844 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.5 ptt? . . . . . 0 N--CA 1.479 1.009 0 CA-C-O 120.773 0.321 . . . . 0.0 110.443 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 160.26 156.23 8.08 Favored Glycine 0 N--CA 1.448 -0.522 0 N-CA-C 111.63 -0.588 . . . . 0.0 111.63 -179.687 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 18.4 m -139.25 137.67 36.13 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.852 0.326 . . . . 0.0 111.226 -179.859 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 1.2 m -129.87 145.63 51.6 Favored 'General case' 0 CA--C 1.532 0.27 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.429 179.94 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 10.8 p80 -168.29 133.05 1.7 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.451 -0.341 . . . . 0.0 110.366 179.883 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 8.8 p80 -160.84 102.29 1.31 Allowed 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.966 0.412 . . . . 0.0 111.271 -179.732 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 7.1 p80 -168.36 152.19 5.86 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.227 179.468 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 82.6 t60 -164.3 140.77 6.36 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.669 -0.242 . . . . 0.0 110.37 179.606 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 80.5 t60 -132.39 143.55 49.91 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.438 -0.346 . . . . 0.0 110.373 179.939 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 52.2 t60 -162.52 124.94 2.77 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.478 -0.328 . . . . 0.0 110.478 179.32 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 71.0 m -134.6 151.96 51.44 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.463 -0.335 . . . . 0.0 110.328 179.631 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 32.2 m -151.62 162.06 41.62 Favored 'General case' 0 C--O 1.236 0.392 0 CA-C-O 120.84 0.353 . . . . 0.0 110.873 -179.993 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -164.32 124.42 1.26 Allowed Glycine 0 N--CA 1.451 -0.31 0 N-CA-C 111.543 -0.623 . . . . 0.0 111.543 179.705 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 64.4 mt -136.21 164.36 28.25 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.91 0.386 . . . . 0.0 111.327 -179.268 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 4.2 p -150.07 124.5 4.64 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-N 115.663 -0.699 . . . . 0.0 109.752 179.365 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -75.78 -173.72 1.76 Allowed 'Trans proline' 0 C--N 1.343 0.287 0 C-N-CA 122.814 2.343 . . . . 0.0 112.917 -179.247 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 7.9 tpp85 -162.12 145.96 12.12 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.7 179.667 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -108.46 -163.45 20.81 Favored Glycine 0 N--CA 1.449 -0.436 0 C-N-CA 120.948 -0.644 . . . . 0.0 111.69 179.337 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 41.4 m -152.02 158.26 42.82 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.757 0.278 . . . . 0.0 110.288 179.59 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 13.3 p80 -146.31 131.06 17.97 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.813 0.34 . . . . 0.0 110.963 -179.989 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 1.7 tmm? -163.49 147.77 10.71 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 179.279 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -167.31 122.04 1.02 Allowed Glycine 0 N--CA 1.447 -0.614 0 C-N-CA 120.467 -0.873 . . . . 0.0 112.782 -179.873 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 3.7 p -139.76 93.6 2.68 Favored 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 108.932 -0.766 . . . . 0.0 108.932 178.907 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -91.23 178.23 6.03 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.672 -0.694 . . . . 0.0 111.999 -178.249 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 54.5 mt -136.27 159.06 42.88 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.062 -0.972 . . . . 0.0 108.395 179.41 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -113.08 116.88 30.58 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 121.091 0.472 . . . . 0.0 111.22 -179.273 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -152.24 152.47 32.24 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.496 -0.774 . . . . 0.0 109.669 -179.844 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 74.8 mtp -118.55 156.5 29.04 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 110.272 -0.27 . . . . 0.0 110.272 -179.73 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -133.74 171.09 14.61 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.824 0.345 . . . . 0.0 111.417 -178.276 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 20.3 ptmt -105.19 9.32 34.15 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.123 0.487 . . . . 0.0 110.703 -179.921 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . 0.425 HH11 ' HD3' ' A' ' 31' ' ' ARG . 27.9 mtm180 -100.85 112.14 24.51 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.672 -179.488 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 13.2 tp -169.47 33.06 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.377 -179.899 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.435 ' HE3' ' OE2' ' A' ' 68' ' ' GLU . 0.7 OUTLIER -164.93 37.6 0.07 Allowed 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.48 0.657 . . . . 0.0 109.816 -179.262 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 5.2 mp0 -86.97 -75.47 0.4 Allowed 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.55 -0.75 . . . . 0.0 111.842 -178.315 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 11.4 pt -141.02 175.92 5.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-O 120.613 0.244 . . . . 0.0 110.875 -179.282 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 67.1 mt-10 -125.23 113.64 17.91 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 109.513 -0.551 . . . . 0.0 109.513 178.682 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 2.9 mm-40 -124.04 -77.05 0.59 Allowed 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.004 0.431 . . . . 0.0 111.772 -178.508 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 4.7 tp10 -72.32 150.85 43.16 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.998 -0.546 . . . . 0.0 111.022 -178.97 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . 0.413 ' O ' HG23 ' A' ' 62' ' ' THR . . . -101.99 -34.61 9.28 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.186 0.517 . . . . 0.0 110.267 179.233 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 84.66 167.7 43.3 Favored Glycine 0 N--CA 1.448 -0.515 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.489 179.467 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -161.5 178.01 9.51 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 109.837 -0.431 . . . . 0.0 109.837 -179.57 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 29.0 tp -74.97 88.63 2.37 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.987 0.423 . . . . 0.0 110.079 179.734 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 20.0 ttp180 -138.74 158.42 44.26 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.249 -0.432 . . . . 0.0 109.852 -179.469 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 52.3 mt-10 -79.66 25.18 0.35 Allowed 'General case' 0 N--CA 1.464 0.267 0 CA-C-O 121.023 0.439 . . . . 0.0 111.311 -179.807 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 11.3 ptt? -79.89 4.05 17.92 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 120.811 0.338 . . . . 0.0 110.584 -178.961 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 14.2 mt-30 -71.83 -22.31 61.57 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.214 0.531 . . . . 0.0 110.011 179.424 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -78.44 -15.26 58.84 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.707 -0.679 . . . . 0.0 110.113 179.033 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . 0.524 ' O ' ' HG2' ' A' ' 52' ' ' GLU . 6.7 ttpp -76.93 2.85 13.53 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.458 -0.792 . . . . 0.0 110.309 -179.802 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 9.2 p -55.71 -24.21 16.15 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.142 0 CA-C-N 115.481 -0.781 . . . . 0.0 111.86 -179.541 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . 0.407 ' H ' ' HG3' ' A' ' 50' ' ' GLU . 0.1 OUTLIER -60.54 -32.25 71.31 Favored 'General case' 0 CA--C 1.52 -0.195 0 CA-C-O 121.43 0.633 . . . . 0.0 109.735 179.494 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 9.0 mtmm -103.22 -40.69 6.32 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.471 -0.786 . . . . 0.0 111.354 -179.645 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . 0.524 ' HG2' ' O ' ' A' ' 48' ' ' LYS . 44.1 mm-40 -64.63 -8.4 14.19 Favored 'General case' 0 N--CA 1.468 0.469 0 N-CA-C 112.421 0.526 . . . . 0.0 112.421 -179.356 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' MET . . . . . 0.403 ' O ' HG13 ' A' ' 56' ' ' VAL . 9.2 ptp -57.98 -33.13 68.56 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.741 0.305 . . . . 0.0 111.257 179.604 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -91.04 -19.88 41.27 Favored Glycine 0 N--CA 1.449 -0.477 0 C-N-CA 120.573 -0.822 . . . . 0.0 111.214 179.082 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -98.57 23.21 8.87 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.125 -0.538 . . . . 0.0 110.899 -179.263 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.403 HG13 ' O ' ' A' ' 53' ' ' MET . 15.7 m -64.95 -9.24 6.69 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.38 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.48 179.557 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 37.2 mt-30 -86.4 -2.74 58.7 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.338 0.589 . . . . 0.0 110.14 179.531 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 11.2 t70 -133.0 -52.29 0.9 Allowed 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.41 -0.813 . . . . 0.0 110.234 179.625 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 3.3 m -74.24 -63.49 1.22 Allowed 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.374 -0.83 . . . . 0.0 112.657 -179.008 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -87.88 15.21 7.42 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.522 -0.308 . . . . 0.0 111.363 -178.489 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -73.87 -26.42 60.56 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.019 0.438 . . . . 0.0 110.089 -179.905 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' THR . . . . . 0.413 HG23 ' O ' ' A' ' 39' ' ' ALA . 0.2 OUTLIER -69.86 -23.68 63.31 Favored 'General case' 0 N--CA 1.447 -0.602 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.409 179.325 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 2.9 m -62.26 -23.07 66.48 Favored 'General case' 0 N--CA 1.448 -0.555 0 CA-C-N 115.601 -0.727 . . . . 0.0 109.939 179.814 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -71.52 -33.25 69.04 Favored 'General case' 0 N--CA 1.455 -0.184 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.047 178.812 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 1.2 m -76.15 5.35 6.94 Favored 'General case' 0 CA--C 1.533 0.299 0 CA-C-O 121.343 0.592 . . . . 0.0 110.98 179.731 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 7.3 tp-100 -124.81 -54.99 1.62 Allowed 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.916 -0.583 . . . . 0.0 110.398 179.21 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -78.89 -56.28 4.52 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.362 -179.427 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . 0.435 ' OE2' ' HE3' ' A' ' 33' ' ' LYS . 1.7 tp10 -66.32 -28.72 68.9 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-O 121.325 0.583 . . . . 0.0 109.935 179.937 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 48.8 tptt -59.96 -29.17 68.24 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.437 -0.802 . . . . 0.0 111.268 179.487 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 48.8 mt-10 -61.69 -24.04 66.5 Favored 'General case' 0 N--CA 1.463 0.207 0 CA-C-O 120.977 0.418 . . . . 0.0 110.654 179.669 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 6.9 tp10 -95.19 -39.16 10.24 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.787 -0.642 . . . . 0.0 109.711 178.814 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.447 ' HA ' ' O ' ' A' ' 122' ' ' PHE . 89.4 t -63.03 -44.65 99.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 115.795 -0.639 . . . . 0.0 112.127 -179.302 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -69.22 -23.11 63.85 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-O 121.17 0.51 . . . . 0.0 110.968 -179.129 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 49.9 m -90.6 -9.65 46.27 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.451 -0.795 . . . . 0.0 109.765 179.154 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -113.98 36.06 3.85 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 114.993 -1.003 . . . . 0.0 110.005 -179.839 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -111.89 169.27 8.95 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.04 179.425 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 7.6 pt -129.28 136.48 59.37 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 N-CA-C 110.029 -0.36 . . . . 0.0 110.029 178.748 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' TYR . . . . . 0.402 ' O ' ' HA ' ' A' ' 146' ' ' VAL . 68.8 t80 -90.42 120.83 31.86 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 116.042 -0.526 . . . . 0.0 109.808 -179.706 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 6.7 t -107.46 111.63 36.61 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-O 120.832 0.348 . . . . 0.0 110.593 -179.164 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -119.26 168.67 13.46 Favored Glycine 0 N--CA 1.449 -0.486 0 N-CA-C 111.683 -0.567 . . . . 0.0 111.683 179.708 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 96.8 m-20 60.93 34.38 19.51 Favored 'General case' 0 N--CA 1.47 0.535 0 CA-C-O 120.964 0.411 . . . . 0.0 111.262 -179.792 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 2.5 t -75.8 166.38 2.76 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.597 -179.768 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 22.0 t0 -73.08 145.36 46.57 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.854 0.359 . . . . 0.0 110.34 179.714 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 3.0 p90 -66.27 -19.97 65.97 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.732 -0.667 . . . . 0.0 111.712 -178.934 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -109.84 20.12 18.37 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 111.742 0.275 . . . . 0.0 111.742 -179.323 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' CYS . . . . . 0.458 ' SG ' ' HB2' ' A' ' 140' ' ' HIS . 0.8 OUTLIER -87.84 141.71 28.38 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.07 0.462 . . . . 0.0 111.286 -179.829 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' THR . . . . . 0.453 ' O ' ' HG2' ' A' ' 90' ' ' GLU . 41.7 p -107.1 155.61 38.97 Favored Pre-proline 0 C--N 1.328 -0.367 0 CA-C-N 115.593 -0.73 . . . . 0.0 110.343 179.562 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -59.12 -35.35 98.14 Favored 'Trans proline' 0 C--N 1.342 0.213 0 C-N-CA 122.457 2.104 . . . . 0.0 112.556 -179.576 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 28.8 mt-10 -65.02 -50.04 67.8 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.688 -0.687 . . . . 0.0 112.096 -178.861 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . 0.563 ' O ' ' HB2' ' A' ' 94' ' ' HIS . 10.9 pt-20 -67.24 -18.6 65.29 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.835 0.35 . . . . 0.0 111.193 -179.102 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 51.3 t -85.26 -49.66 15.37 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.115 -179.897 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 6.9 pt20 -68.81 -35.92 77.6 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.696 -0.229 . . . . 0.0 111.561 -178.098 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 16.0 pt20 -74.48 -28.71 61.13 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.939 0.4 . . . . 0.0 110.37 -179.5 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' HIS . . . . . 0.563 ' HB2' ' O ' ' A' ' 90' ' ' GLU . 0.1 OUTLIER -70.81 -42.5 70.18 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.652 -179.796 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 20.7 m-30 -80.04 -14.59 58.43 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.87 -0.604 . . . . 0.0 110.647 -179.511 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . 0.618 ' HA ' ' O ' ' A' ' 99' ' ' GLY . 10.9 tt0 -66.0 -19.15 65.76 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.131 179.513 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 13.9 m -66.84 -28.57 68.46 Favored 'General case' 0 N--CA 1.451 -0.384 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.257 178.871 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 4.9 m -100.33 -43.26 6.32 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.401 179.661 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . 0.618 ' O ' ' HA ' ' A' ' 96' ' ' GLN . . . -144.59 139.73 8.74 Favored Glycine 0 N--CA 1.447 -0.62 0 C-N-CA 120.88 -0.676 . . . . 0.0 111.904 -179.896 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -63.02 147.72 49.84 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 120.914 0.388 . . . . 0.0 111.601 -179.901 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 2.4 p -116.52 132.93 64.71 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.095 -179.458 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 27.4 t-20 -102.2 -43.64 5.66 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.068 0.461 . . . . 0.0 110.282 178.956 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -141.03 148.68 40.64 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.055 -0.521 . . . . 0.0 109.888 -179.872 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 4.5 p -146.94 134.99 15.12 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 N-CA-C 109.936 -0.394 . . . . 0.0 109.936 179.197 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' THR . . . . . 0.453 ' HB ' ' CE1' ' A' ' 119' ' ' TYR . 0.7 OUTLIER -128.16 126.13 40.45 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.236 179.376 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 18.6 tt -112.55 148.3 15.69 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-O 120.862 0.363 . . . . 0.0 110.867 -179.941 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 18.0 tp -136.83 129.96 31.11 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.155 179.56 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -88.42 123.24 32.77 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 109.708 -0.479 . . . . 0.0 109.708 179.542 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . 0.428 ' O ' ' HB2' ' A' ' 110' ' ' LYS . 29.2 t70 -70.93 -80.17 0.06 Allowed 'General case' 0 CA--C 1.531 0.247 0 N-CA-C 112.628 0.603 . . . . 0.0 112.628 -178.239 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . 0.428 ' HB2' ' O ' ' A' ' 109' ' ' ASP . 1.7 mtpp 70.34 20.66 6.03 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 122.828 0.451 . . . . 0.0 111.621 -179.901 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 6.6 t80 -115.41 17.92 16.24 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-O 121.274 0.559 . . . . 0.0 109.955 -179.749 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 103.99 0.37 45.02 Favored Glycine 0 N--CA 1.449 -0.5 0 C-N-CA 120.768 -0.729 . . . . 0.0 112.158 179.952 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 4.3 mt-30 -111.34 157.72 38.24 Favored Pre-proline 0 C--N 1.322 -0.596 0 N-CA-C 109.588 -0.523 . . . . 0.0 109.588 179.599 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -59.77 129.7 31.84 Favored 'Trans proline' 0 N--CA 1.462 -0.335 0 C-N-CA 122.124 1.883 . . . . 0.0 111.366 178.827 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 15.6 mttp -82.8 -179.41 7.43 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 109.196 -0.668 . . . . 0.0 109.196 179.963 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 92.36 2.53 68.02 Favored Glycine 0 N--CA 1.446 -0.645 0 C-N-CA 120.064 -1.065 . . . . 0.0 112.32 179.168 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 2.2 t80 -54.51 119.52 5.36 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-O 120.732 0.301 . . . . 0.0 110.278 179.793 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -146.56 177.89 8.71 Favored 'General case' 0 N--CA 1.45 -0.427 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.846 -179.316 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' TYR . . . . . 0.453 ' CE1' ' HB ' ' A' ' 105' ' ' THR . 43.6 p90 -161.1 134.84 6.75 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.521 -0.763 . . . . 0.0 109.225 179.045 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 15.1 m -108.74 147.07 13.69 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 N-CA-C 109.529 -0.545 . . . . 0.0 109.529 178.824 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . 0.417 ' HB2' HG12 ' A' ' 72' ' ' VAL . 7.2 pt-20 -131.7 155.91 46.82 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 116.389 -0.368 . . . . 0.0 111.022 -179.217 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 122' ' ' PHE . . . . . 0.447 ' O ' ' HA ' ' A' ' 72' ' ' VAL . 10.8 t80 -157.2 166.66 32.59 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.147 -179.943 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 5.1 t -84.82 -49.23 15.99 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-O 120.854 0.359 . . . . 0.0 111.708 -178.995 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 47.8 mm-40 -66.27 127.87 33.91 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.002 -0.545 . . . . 0.0 111.844 -178.608 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 2.3 mp -72.05 -29.4 32.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 115.6 -0.727 . . . . 0.0 109.643 179.516 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 16.7 t70 -58.1 -42.25 85.29 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.265 -0.88 . . . . 0.0 110.56 179.322 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -64.81 -52.98 53.9 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.731 -0.668 . . . . 0.0 111.532 -179.597 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 8.8 p -65.85 -27.05 40.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 116.636 -0.256 . . . . 0.0 111.43 -179.27 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 24.4 tt0 -60.31 -48.52 81.4 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.806 0.336 . . . . 0.0 110.404 179.898 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 86.6 m-20 -69.61 -32.41 71.11 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 121.021 0.439 . . . . 0.0 110.248 179.611 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . 0.428 ' O ' ' HB2' ' A' ' 135' ' ' ASN . . . -64.84 -53.16 51.13 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.604 -0.725 . . . . 0.0 111.254 -179.787 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 4.1 pp -65.23 -23.94 67.21 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.9 0.381 . . . . 0.0 110.888 -179.796 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 5.6 tp -76.42 -54.34 6.87 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.652 179.699 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 26.9 mt -122.38 103.04 8.47 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.091 -0.504 . . . . 0.0 109.878 -179.998 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 135' ' ' ASN . . . . . 0.428 ' HB2' ' O ' ' A' ' 131' ' ' ALA . 0.2 OUTLIER -150.23 -66.87 0.2 Allowed 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 120.977 0.418 . . . . 0.0 111.551 -179.22 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 3.3 pt-20 -69.73 101.18 1.63 Allowed 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.882 -0.599 . . . . 0.0 111.417 -179.188 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 23.7 m -151.31 -59.32 0.17 Allowed 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.909 -0.587 . . . . 0.0 109.966 178.93 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 6.0 tm-20 -154.78 127.68 8.17 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.457 179.755 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -147.72 111.27 4.98 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 178.774 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 140' ' ' HIS . . . . . 0.458 ' HB2' ' SG ' ' A' ' 86' ' ' CYS . 2.1 t60 64.6 28.22 13.25 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-O 121.241 0.543 . . . . 0.0 109.725 -179.585 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 79.23 1.27 85.5 Favored Glycine 0 CA--C 1.52 0.371 0 C-N-CA 121.012 -0.613 . . . . 0.0 112.485 -179.353 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 7.3 mpt_? -113.11 170.94 7.85 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 120.662 0.267 . . . . 0.0 110.437 -179.907 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 12.7 pt20 -115.11 137.55 51.89 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.114 -0.494 . . . . 0.0 109.83 179.162 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -125.58 174.48 8.22 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.135 179.951 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 76.7 tttt -116.91 122.33 44.0 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 109.775 -0.454 . . . . 0.0 109.775 179.371 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 146' ' ' VAL . . . . . 0.402 ' HA ' ' O ' ' A' ' 78' ' ' TYR . 77.6 t -115.88 125.21 72.93 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-O 120.843 0.354 . . . . 0.0 110.739 179.811 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 5.4 t -126.87 148.46 50.0 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 109.848 -0.427 . . . . 0.0 109.848 179.944 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -66.62 122.66 18.11 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.595 -0.275 . . . . 0.0 110.636 -179.737 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 14.0 ttpp -88.14 61.99 6.55 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.456 0.646 . . . . 0.0 109.63 -179.823 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -82.42 77.94 9.13 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.806 -0.634 . . . . 0.0 109.561 179.453 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 2.9 t -70.84 129.21 38.49 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-N 115.116 -0.947 . . . . 0.0 110.95 179.972 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 152' ' ' ASN . . . . . . . . . . . . . 6.8 t-20 -171.45 156.97 4.69 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.198 -0.455 . . . . 0.0 109.984 179.748 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 8.3 pt -60.72 151.04 73.76 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-O 120.841 0.353 . . . . 0.0 111.421 179.966 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 96.1 Cg_endo -78.78 48.5 2.8 Favored 'Trans proline' 0 CA--C 1.53 0.278 0 C-N-CA 123.201 2.601 . . . . 0.0 112.695 179.929 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.934 0 CA-C-O 118.842 -0.976 . . . . 0.0 111.973 -179.95 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.5 mpt? . . . . . 0 N--CA 1.478 0.925 0 N-CA-C 109.791 -0.448 . . . . 0.0 109.791 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -159.61 152.46 23.39 Favored Glycine 0 N--CA 1.447 -0.614 0 C-N-CA 120.654 -0.784 . . . . 0.0 112.219 -179.465 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -114.62 150.66 34.75 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 110.172 -0.307 . . . . 0.0 110.172 179.929 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 2.1 p -143.64 137.9 28.61 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.559 -0.291 . . . . 0.0 110.715 -179.946 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -149.06 138.48 21.67 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.597 -0.274 . . . . 0.0 110.599 179.417 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 39.9 m80 -94.47 163.71 13.29 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.914 -179.701 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 7.1 p80 -173.55 153.19 2.26 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.758 -0.656 . . . . 0.0 109.673 179.713 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 38.0 t-80 -143.53 134.43 25.39 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 120.789 0.328 . . . . 0.0 110.341 179.808 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 4.9 t-80 -144.43 119.43 10.01 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 109.421 -0.585 . . . . 0.0 109.421 179.596 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 17.1 t-80 -112.7 111.16 21.76 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 120.869 0.366 . . . . 0.0 111.228 -179.286 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 4.0 m -67.83 152.78 45.03 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.933 -0.576 . . . . 0.0 109.648 178.728 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 15.6 m -134.04 114.44 13.2 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-O 120.99 0.424 . . . . 0.0 110.906 -179.123 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -100.15 -162.59 28.56 Favored Glycine 0 N--CA 1.444 -0.828 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.245 179.95 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -131.67 159.29 38.77 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 110.402 -0.222 . . . . 0.0 110.402 -179.828 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 2.4 p -130.94 119.11 17.82 Favored Pre-proline 0 C--N 1.325 -0.477 0 CA-C-O 121.028 0.442 . . . . 0.0 110.892 179.821 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 70.0 Cg_endo -77.87 120.37 5.05 Favored 'Trans proline' 0 N--CA 1.458 -0.571 0 C-N-CA 122.65 2.234 . . . . 0.0 111.491 178.948 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 1.1 tpm_? -119.0 145.72 45.61 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.25 -179.357 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -138.65 121.5 2.16 Favored Glycine 0 N--CA 1.45 -0.425 0 C-N-CA 121.12 -0.562 . . . . 0.0 111.892 179.841 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 4.7 m -82.32 140.57 33.49 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 120.847 0.356 . . . . 0.0 111.051 -179.445 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 54.2 t-80 -90.48 140.99 29.21 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.188 -179.972 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 19.2 ptt? -137.16 -179.19 5.57 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.776 -179.624 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 148.59 119.99 1.07 Allowed Glycine 0 N--CA 1.45 -0.373 0 N-CA-C 111.723 -0.551 . . . . 0.0 111.723 -179.93 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 1.2 m -109.16 123.4 49.14 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 120.783 0.325 . . . . 0.0 111.383 -179.516 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 36.9 t0 -87.97 153.47 21.26 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.021 179.738 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 3.0 tp -114.63 139.9 49.25 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 116.683 -0.235 . . . . 0.0 110.866 -179.018 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 23.5 mm-40 -68.37 131.92 46.15 Favored 'General case' 0 C--N 1.332 -0.177 0 N-CA-C 110.347 -0.242 . . . . 0.0 110.347 179.593 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -109.0 141.07 41.64 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.982 -179.531 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 32.6 tpp -144.06 127.77 17.18 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.546 179.679 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 19.5 mmtp -131.3 166.13 21.88 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.606 -0.27 . . . . 0.0 110.721 -179.615 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 1.3 ptmm? -157.8 -175.08 5.17 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.27 179.52 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 12.4 ptt180 -150.82 174.17 13.38 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 109.654 -0.498 . . . . 0.0 109.654 179.504 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -150.67 144.74 25.39 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.682 0.277 . . . . 0.0 110.377 -179.534 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 17.7 ttmm -100.81 125.0 47.28 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.71 -179.957 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 32.3 tt0 -84.61 126.0 32.96 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.136 179.453 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 10.6 pt -135.67 130.3 49.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-O 120.816 0.341 . . . . 0.0 110.982 -179.904 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 6.4 tp10 -147.37 153.54 39.78 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.521 -0.309 . . . . 0.0 110.414 179.549 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 1.5 mm-40 -114.4 176.08 5.2 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.004 0.43 . . . . 0.0 111.506 -179.443 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 7.9 mt-10 -115.49 145.98 42.1 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.643 -0.708 . . . . 0.0 109.948 179.551 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -145.18 124.68 13.15 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 120.901 0.382 . . . . 0.0 111.347 -179.667 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -96.93 77.87 0.69 Allowed Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.726 -0.749 . . . . 0.0 111.895 179.687 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -141.77 177.43 8.18 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 110.467 -0.198 . . . . 0.0 110.467 -179.245 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 37.9 tp -74.29 84.32 1.91 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.08 0.467 . . . . 0.0 109.897 179.346 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . 0.523 ' HA ' ' NE ' ' A' ' 43' ' ' ARG . 1.5 tpm_? -132.63 142.3 49.05 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.746 -179.376 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 21.5 mp0 -77.27 47.04 0.54 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.249 0.547 . . . . 0.0 110.278 179.252 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 9.1 ptt? -108.65 -0.41 20.18 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.498 -179.548 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 24.6 mt-30 -59.86 -22.68 62.62 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-O 120.889 0.376 . . . . 0.0 111.325 -179.048 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -68.03 -16.96 64.26 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.787 -179.914 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 3.4 ptmm? -73.82 3.59 6.39 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-O 120.635 0.255 . . . . 0.0 111.323 -179.383 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 11.0 p -54.73 -25.09 14.61 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.25 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.307 179.63 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . 0.423 ' H ' ' HG3' ' A' ' 50' ' ' GLU . 0.7 OUTLIER -59.46 -37.03 77.1 Favored 'General case' 0 C--N 1.334 -0.095 0 CA-C-O 121.185 0.517 . . . . 0.0 110.152 179.134 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 10.7 mtmm -85.57 -41.14 15.53 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.804 -0.634 . . . . 0.0 110.328 -179.369 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 16.9 mm-40 -60.33 -38.05 82.53 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.519 -0.764 . . . . 0.0 111.991 -179.013 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 17.3 ptp -64.67 -25.94 68.17 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.679 0.276 . . . . 0.0 110.973 -179.607 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -95.61 -9.94 57.17 Favored Glycine 0 N--CA 1.448 -0.514 0 C-N-CA 120.812 -0.709 . . . . 0.0 111.539 179.433 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -112.86 23.79 13.08 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.029 0.442 . . . . 0.0 110.629 -179.458 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 7.7 m -64.18 -14.36 15.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.835 -179.863 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 17.7 mm-40 -81.09 -11.59 59.46 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.838 0.352 . . . . 0.0 110.544 179.561 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -121.61 -51.97 2.04 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.105 -179.785 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 13.6 m -72.76 -71.8 0.28 Allowed 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.011 -0.541 . . . . 0.0 111.295 -179.959 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -83.56 32.33 0.46 Allowed 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.798 -178.861 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 1.4 t -80.23 -31.38 38.58 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 121.042 0.449 . . . . 0.0 109.948 -179.57 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -66.47 -25.68 66.83 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.914 -0.585 . . . . 0.0 111.212 179.777 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 1.4 m -61.15 -24.53 66.36 Favored 'General case' 0 N--CA 1.449 -0.495 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.079 -179.653 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -71.7 -31.24 66.55 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.527 -0.306 . . . . 0.0 110.483 179.026 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -76.98 4.3 10.32 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.321 0.582 . . . . 0.0 110.605 179.772 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 46.3 tp60 -122.5 -54.9 1.86 Allowed 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.811 -0.632 . . . . 0.0 110.524 179.277 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -79.8 -54.42 5.86 Favored 'General case' 0 C--N 1.326 -0.413 0 N-CA-C 112.174 0.435 . . . . 0.0 112.174 -178.603 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 14.0 tp10 -69.58 -27.1 64.83 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.069 0.461 . . . . 0.0 110.963 -179.224 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . 0.464 ' HZ3' ' CD ' ' A' ' 121' ' ' GLU . 15.5 tptp -59.9 -27.2 66.52 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.995 179.303 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 94.8 mt-10 -62.74 -22.28 66.43 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-O 121.375 0.607 . . . . 0.0 111.009 179.583 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . 0.433 ' O ' ' HD2' ' A' ' 75' ' ' ARG . 7.0 tp10 -96.97 -40.01 9.09 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 115.727 -0.669 . . . . 0.0 109.596 178.007 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.414 ' HA ' ' O ' ' A' ' 122' ' ' PHE . 59.0 t -65.27 -37.89 81.25 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-N 115.728 -0.669 . . . . 0.0 112.586 -179.034 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -72.98 -17.13 61.49 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-O 120.889 0.376 . . . . 0.0 111.148 -179.227 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -97.77 -18.56 18.72 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.964 -0.562 . . . . 0.0 109.952 177.831 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . 0.433 ' HD2' ' O ' ' A' ' 71' ' ' GLU . 0.0 OUTLIER -103.05 49.76 0.83 Allowed 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.353 -179.334 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' SER . . . . . 0.479 ' HB3' ' HB3' ' A' ' 121' ' ' GLU . 0.0 OUTLIER -128.04 170.57 12.76 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.542 -0.754 . . . . 0.0 110.313 179.703 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 4.8 pt -134.98 137.33 50.8 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.787 0 N-CA-C 109.795 -0.446 . . . . 0.0 109.795 178.88 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 67.0 t80 -95.81 128.18 42.48 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.151 -179.58 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 2.7 t -105.18 111.8 36.13 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.362 -179.861 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -116.93 162.98 12.57 Favored Glycine 0 N--CA 1.449 -0.498 0 C-N-CA 120.925 -0.655 . . . . 0.0 111.599 -179.859 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 9.9 m120 60.28 42.45 15.02 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-O 121.32 0.581 . . . . 0.0 110.542 -179.559 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.464 HG11 ' H ' ' A' ' 83' ' ' ASP . 2.0 t -83.26 172.9 1.0 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.656 0 CA-C-N 115.521 -0.763 . . . . 0.0 110.31 -179.375 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . 0.634 ' OD2' ' HD3' ' A' ' 142' ' ' ARG . 11.6 t0 -73.62 135.4 43.82 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 109.756 -0.461 . . . . 0.0 109.756 179.451 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 5.4 p90 -60.77 -21.4 63.01 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.88 -0.6 . . . . 0.0 111.924 -179.662 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -110.85 19.19 18.81 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.774 0.321 . . . . 0.0 111.237 -179.855 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' CYS . . . . . 0.421 ' SG ' ' HB3' ' A' ' 83' ' ' ASP . 0.5 OUTLIER -80.64 148.32 30.3 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.375 0.607 . . . . 0.0 110.993 -179.898 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' THR . . . . . 0.516 ' O ' ' HG2' ' A' ' 90' ' ' GLU . 40.1 p -109.97 152.38 43.0 Favored Pre-proline 0 C--N 1.321 -0.649 0 CA-C-N 115.338 -0.846 . . . . 0.0 110.194 179.409 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -60.14 -32.39 94.52 Favored 'Trans proline' 0 C--N 1.344 0.338 0 C-N-CA 122.414 2.076 . . . . 0.0 112.593 -179.543 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 7.8 mm-40 -64.6 -53.09 53.21 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.731 -0.668 . . . . 0.0 111.96 -179.165 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . 0.516 ' HG2' ' O ' ' A' ' 87' ' ' THR . 10.7 pt-20 -62.42 -23.93 67.13 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.966 0.412 . . . . 0.0 111.413 -178.904 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 76.6 t -79.86 -48.78 20.16 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.059 -179.86 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . 0.417 ' O ' ' HB2' ' A' ' 96' ' ' GLN . 1.6 pp0? -71.97 -33.63 68.32 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.708 -0.224 . . . . 0.0 111.372 -178.455 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 8.6 pt20 -74.21 -31.79 62.76 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.911 0.386 . . . . 0.0 111.068 -179.475 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 65.0 t-80 -73.79 -41.85 61.82 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.734 -179.431 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 18.1 m-30 -78.19 -12.97 60.03 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.124 -179.162 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . 0.538 ' HA ' ' O ' ' A' ' 99' ' ' GLY . 7.5 tt0 -70.06 -20.17 63.24 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.687 -0.688 . . . . 0.0 109.988 179.669 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 1.4 m -65.17 -36.41 84.14 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.496 -0.775 . . . . 0.0 110.692 179.555 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 0.2 OUTLIER -89.81 -46.43 8.59 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.304 -179.988 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . 0.538 ' O ' ' HA ' ' A' ' 96' ' ' GLN . . . -144.27 145.21 14.55 Favored Glycine 0 N--CA 1.445 -0.766 0 C-N-CA 120.672 -0.775 . . . . 0.0 111.801 179.792 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -64.12 145.91 55.12 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 121.033 0.444 . . . . 0.0 111.337 -179.781 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 1.2 p -118.65 121.79 67.86 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.259 -179.949 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . 0.472 ' OD1' ' HG2' ' A' ' 103' ' ' ARG . 26.6 t-20 -91.07 -44.83 9.04 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 109.859 -0.423 . . . . 0.0 109.859 179.733 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . 0.472 ' HG2' ' OD1' ' A' ' 102' ' ' ASN . 10.3 mmm180 -136.99 149.16 47.34 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.534 179.967 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 4.0 p -148.2 131.39 7.9 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.587 0 CA-C-N 115.919 -0.582 . . . . 0.0 109.473 179.711 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' THR . . . . . 0.415 ' HB ' ' CE1' ' A' ' 119' ' ' TYR . 0.7 OUTLIER -124.89 126.53 45.68 Favored 'General case' 0 C--N 1.32 -0.69 0 N-CA-C 110.08 -0.341 . . . . 0.0 110.08 179.237 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 21.1 tt -113.26 143.62 22.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-O 120.895 0.379 . . . . 0.0 110.889 -179.598 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 51.4 tp -129.66 127.75 41.17 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.062 179.372 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -94.76 114.65 26.58 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.546 -0.297 . . . . 0.0 110.411 179.73 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . 0.459 ' C ' ' HD2' ' A' ' 110' ' ' LYS . 3.1 t70 -75.24 134.07 41.23 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.771 0.32 . . . . 0.0 110.899 -179.948 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . 0.459 ' HD2' ' C ' ' A' ' 109' ' ' ASP . 8.0 mmmm -116.66 30.17 7.5 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 120.94 0.4 . . . . 0.0 110.094 -179.906 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 8.5 t80 -112.72 -2.85 14.37 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.848 0.356 . . . . 0.0 110.81 -179.6 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 108.33 8.78 28.53 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.844 -0.693 . . . . 0.0 113.141 179.717 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 30.2 mt-30 -94.58 157.18 37.55 Favored Pre-proline 0 C--N 1.322 -0.596 0 N-CA-C 109.646 -0.502 . . . . 0.0 109.646 179.84 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -58.64 105.59 0.23 Allowed 'Trans proline' 0 C--N 1.348 0.502 0 C-N-CA 122.216 1.944 . . . . 0.0 110.819 178.998 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 3.3 mttp -68.22 177.34 2.32 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.68 -179.074 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 99.54 2.93 56.46 Favored Glycine 0 N--CA 1.445 -0.729 0 C-N-CA 120.339 -0.934 . . . . 0.0 111.308 -179.73 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 39.9 m-85 -53.13 117.55 3.09 Favored 'General case' 0 C--N 1.331 -0.205 0 O-C-N 123.821 0.366 . . . . 0.0 110.097 179.505 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -147.15 173.49 12.46 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 121.154 0.502 . . . . 0.0 111.205 -179.099 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' TYR . . . . . 0.415 ' CE1' ' HB ' ' A' ' 105' ' ' THR . 39.2 p90 -156.14 134.6 11.58 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 115.436 -0.802 . . . . 0.0 109.0 178.642 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 14.4 m -109.43 139.24 33.18 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 N-CA-C 109.319 -0.623 . . . . 0.0 109.319 179.055 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . 0.479 ' HB3' ' HB3' ' A' ' 76' ' ' SER . 9.0 pt-20 -127.67 154.6 45.1 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 120.921 0.391 . . . . 0.0 111.334 -179.684 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 122' ' ' PHE . . . . . 0.414 ' O ' ' HA ' ' A' ' 72' ' ' VAL . 17.6 t80 -154.56 171.14 19.91 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.748 -0.66 . . . . 0.0 109.819 -179.821 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 3.8 t -84.65 -52.01 13.06 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-O 120.772 0.32 . . . . 0.0 111.551 -179.463 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -62.43 132.7 53.42 Favored 'General case' 0 C--O 1.236 0.346 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.674 -179.032 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 2.3 mp -76.04 -32.45 23.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 115.937 -0.574 . . . . 0.0 109.629 179.463 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 6.4 t70 -58.67 -39.16 79.88 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.358 -0.837 . . . . 0.0 110.632 179.324 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -62.59 -57.56 10.66 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.781 -0.645 . . . . 0.0 111.118 -179.829 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 7.6 p -65.2 -29.48 47.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.428 -0.351 . . . . 0.0 111.371 -179.449 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 40.6 tt0 -59.24 -47.17 86.36 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.284 0.564 . . . . 0.0 110.673 179.752 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 44.7 m-80 -70.68 -31.24 68.06 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.804 -0.635 . . . . 0.0 110.029 179.608 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -68.47 -47.91 65.87 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.58 -0.736 . . . . 0.0 111.672 -179.601 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 4.1 pp -68.02 -24.0 65.06 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.74 0.305 . . . . 0.0 110.9 -179.746 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 5.4 tp -74.24 -53.45 9.74 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.722 -179.354 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 61.9 mt -131.64 98.41 4.48 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 112.087 0.403 . . . . 0.0 112.087 -178.939 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 3.4 m-20 -149.9 -52.25 0.15 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.318 179.111 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 2.9 pt-20 -73.03 93.55 1.78 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.619 0.723 . . . . 0.0 110.708 179.614 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 4.6 m -142.38 -59.85 0.45 Allowed 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.544 -0.753 . . . . 0.0 110.354 179.376 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -156.47 127.41 6.86 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.216 179.894 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -146.95 122.99 10.77 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 109.481 -0.562 . . . . 0.0 109.481 179.691 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 2.0 t60 63.93 17.34 10.5 Favored 'General case' 0 N--CA 1.465 0.306 0 C-N-CA 122.71 0.404 . . . . 0.0 111.015 179.59 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 93.39 -1.59 69.73 Favored Glycine 0 N--CA 1.443 -0.843 0 C-N-CA 120.77 -0.728 . . . . 0.0 112.366 -179.465 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 142' ' ' ARG . . . . . 0.634 ' HD3' ' OD2' ' A' ' 83' ' ' ASP . 4.3 mpt_? -121.38 -173.7 2.68 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 110.127 -0.323 . . . . 0.0 110.127 179.861 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 20.7 pt20 -124.12 150.98 44.46 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 120.794 0.331 . . . . 0.0 110.402 179.735 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -133.54 177.89 7.35 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.472 -179.783 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 42.0 tttt -117.72 123.46 46.09 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 109.793 -0.447 . . . . 0.0 109.793 178.449 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 82.8 t -117.61 121.52 67.68 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-O 120.982 0.42 . . . . 0.0 110.451 179.875 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 56.8 m -127.44 147.63 50.29 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 116.33 -0.396 . . . . 0.0 110.185 179.51 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -65.23 126.79 29.25 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.903 0.382 . . . . 0.0 111.133 -179.479 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 19.8 ttpp -89.38 55.45 3.26 Favored 'General case' 0 N--CA 1.448 -0.533 0 CA-C-O 121.463 0.649 . . . . 0.0 109.302 -179.807 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.99 84.74 2.26 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.781 -0.645 . . . . 0.0 109.909 179.912 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 11.1 t -67.04 139.75 57.63 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.564 -0.744 . . . . 0.0 110.248 179.58 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 152' ' ' ASN . . . . . . . . . . . . . 7.5 t-20 -177.22 167.07 2.38 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 109.166 -0.679 . . . . 0.0 109.166 -179.915 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 14.1 pt -74.87 119.85 78.78 Favored Pre-proline 0 C--N 1.323 -0.562 0 CA-C-O 120.919 0.39 . . . . 0.0 110.09 179.588 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -60.36 124.17 14.6 Favored 'Trans proline' 0 C--O 1.236 0.421 0 C-N-CA 122.758 2.305 . . . . 0.0 112.929 -178.71 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.246 0.9 0 CA-C-O 118.869 -0.962 . . . . 0.0 111.63 179.554 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 59.1 tpp . . . . . 0 N--CA 1.481 1.094 0 CA-C-O 120.662 0.268 . . . . 0.0 110.324 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 124.78 122.26 2.63 Favored Glycine 0 N--CA 1.448 -0.562 0 C-N-CA 120.915 -0.659 . . . . 0.0 111.871 -179.725 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 1.1 m -65.72 -59.32 4.03 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 120.951 0.405 . . . . 0.0 110.78 -179.89 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -78.02 100.98 6.71 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.104 0.478 . . . . 0.0 110.287 179.826 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 46.8 p-80 -124.48 114.94 20.11 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.48 -179.519 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -137.38 109.52 7.26 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.113 179.867 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 2.2 t60 60.91 37.52 18.32 Favored 'General case' 0 N--CA 1.464 0.262 0 O-C-N 123.497 0.498 . . . . 0.0 110.703 179.516 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 28.0 t-80 -107.79 75.2 0.99 Allowed 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.146 0.498 . . . . 0.0 111.018 -178.997 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 15.2 p80 -78.04 167.25 21.74 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.882 179.674 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 8.7 m170 -98.14 165.22 11.99 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.648 -179.965 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 5.0 m -87.6 87.82 7.5 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 120.795 0.331 . . . . 0.0 110.466 179.459 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 3.4 t -167.64 152.93 7.11 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.176 -0.466 . . . . 0.0 109.839 179.455 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -174.61 -179.69 45.37 Favored Glycine 0 N--CA 1.444 -0.827 0 C-N-CA 120.936 -0.649 . . . . 0.0 111.75 -179.976 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 19.6 tp -131.24 121.49 24.87 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 110.08 -0.341 . . . . 0.0 110.08 179.922 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 6.6 p -91.82 127.27 50.62 Favored Pre-proline 0 C--N 1.321 -0.642 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.745 -179.957 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -71.23 155.31 60.98 Favored 'Trans proline' 0 C--N 1.346 0.418 0 C-N-CA 122.383 2.056 . . . . 0.0 111.833 179.207 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 25.3 ptt180 -72.54 137.71 46.43 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.099 0.476 . . . . 0.0 110.62 -179.883 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -177.1 72.92 0.08 OUTLIER Glycine 0 N--CA 1.445 -0.71 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.094 -179.46 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 16.1 m -123.65 139.67 53.77 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 110.348 -0.242 . . . . 0.0 110.348 179.872 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 48.9 p-80 -159.57 132.97 7.08 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 109.835 -0.432 . . . . 0.0 109.835 -179.757 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 51.2 ttp -166.53 104.65 0.61 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.845 0.355 . . . . 0.0 110.686 -179.848 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -147.87 51.53 0.56 Allowed Glycine 0 N--CA 1.448 -0.503 0 C-N-CA 120.813 -0.708 . . . . 0.0 112.001 179.737 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 24.5 m -133.89 129.83 36.95 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 110.535 -0.172 . . . . 0.0 110.535 -179.775 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -116.61 142.25 47.14 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 109.873 -0.418 . . . . 0.0 109.873 179.565 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 39.3 mt -113.83 168.56 9.68 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.581 -179.204 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 17.7 mm-40 -76.9 -178.04 4.69 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.515 179.458 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -148.53 -172.67 4.14 Favored 'General case' 0 C--N 1.325 -0.465 0 C-N-CA 121.125 -0.23 . . . . 0.0 110.901 -179.868 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 22.2 ptp -79.48 154.68 28.71 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.503 179.717 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 2.3 mtmm -95.18 148.09 22.76 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.5 -0.318 . . . . 0.0 110.274 179.6 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -68.84 174.01 4.78 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.923 -0.58 . . . . 0.0 111.618 -179.782 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 2.6 tmt_? -62.26 142.47 57.7 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.123 179.596 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 1.3 mm? -59.78 102.32 0.15 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.103 0.478 . . . . 0.0 110.867 179.811 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 23.7 tptm -170.94 91.26 0.15 Allowed 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.349 -0.841 . . . . 0.0 108.79 -179.852 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 24.9 mm-40 -100.57 -77.19 0.54 Allowed 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.34 -179.028 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 16.8 mm 58.8 53.16 0.3 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.185 0 CA-C-O 121.745 0.784 . . . . 0.0 109.544 -179.101 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 61.1 mm-40 -111.96 143.96 42.08 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.375 -0.829 . . . . 0.0 109.883 -179.672 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 77.9 mt-10 -79.4 76.12 5.98 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.204 0.526 . . . . 0.0 110.657 179.99 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 32.7 mt-10 -76.23 152.91 36.42 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.604 -0.725 . . . . 0.0 110.507 -179.817 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -107.72 168.08 9.51 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.076 -179.127 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -72.36 128.7 13.68 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.865 -0.683 . . . . 0.0 112.348 179.999 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -156.97 168.94 25.99 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 110.291 -0.263 . . . . 0.0 110.291 -179.697 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 14.4 tp -75.21 77.23 2.34 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.395 0.617 . . . . 0.0 109.84 178.955 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . 0.45 ' C ' ' H ' ' A' ' 45' ' ' MET . 29.0 ttt180 -136.33 145.67 45.71 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.127 -179.333 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -75.45 37.32 0.13 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.23 0.538 . . . . 0.0 111.199 179.97 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' MET . . . . . 0.45 ' H ' ' C ' ' A' ' 43' ' ' ARG . 22.1 ptt? -100.29 8.38 43.76 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.05 -179.843 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 73.2 mm-40 -66.07 -26.5 67.52 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.368 179.753 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -72.86 -8.4 55.37 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.832 -0.622 . . . . 0.0 111.345 179.953 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 13.5 ttpt -75.14 -8.5 56.74 Favored 'General case' 0 C--O 1.236 0.363 0 CA-C-O 121.19 0.519 . . . . 0.0 110.04 179.947 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 9.9 p -58.86 -25.04 28.02 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.204 0 CA-C-N 115.747 -0.66 . . . . 0.0 111.122 179.646 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -61.1 -27.18 68.18 Favored 'General case' 0 C--N 1.333 -0.131 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.019 179.794 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 11.8 mtmt -101.55 -35.47 9.14 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.398 179.903 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 76.5 mm-40 -70.38 -21.32 62.88 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.591 -0.277 . . . . 0.0 111.188 179.986 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 13.7 ptp -62.8 -29.36 70.65 Favored 'General case' 0 N--CA 1.462 0.169 0 CA-C-O 120.829 0.347 . . . . 0.0 110.435 179.566 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -90.66 -10.97 62.69 Favored Glycine 0 N--CA 1.447 -0.602 0 N-CA-C 111.008 -0.837 . . . . 0.0 111.008 178.909 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -105.22 14.2 29.39 Favored 'General case' 0 N--CA 1.448 -0.529 0 CA-C-O 120.805 0.336 . . . . 0.0 110.431 -179.838 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 26.8 m -62.46 -16.17 16.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.904 179.473 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 26.9 mt-30 -79.24 -3.77 47.44 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 121.42 0.628 . . . . 0.0 109.887 179.223 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 7.1 t0 -132.02 -63.16 0.82 Allowed 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.43 -0.804 . . . . 0.0 110.333 179.836 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 5.0 m -59.49 -61.61 2.49 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.728 -0.669 . . . . 0.0 111.655 -179.604 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -94.8 25.16 4.22 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.819 -0.628 . . . . 0.0 111.589 -178.934 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 5.7 t -76.9 -26.14 53.79 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 120.966 0.412 . . . . 0.0 110.664 -179.583 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 1.3 m -67.9 -23.75 65.14 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-O 121.105 0.479 . . . . 0.0 110.276 179.49 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 18.8 m -63.42 -27.36 69.24 Favored 'General case' 0 N--CA 1.449 -0.495 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.446 179.676 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -68.53 -33.48 74.19 Favored 'General case' 0 N--CA 1.452 -0.328 0 N-CA-C 109.61 -0.515 . . . . 0.0 109.61 179.08 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -76.4 4.12 9.66 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.225 0.536 . . . . 0.0 110.521 179.312 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 46.4 tt0 -118.27 -52.55 2.38 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.607 179.674 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -85.98 -57.82 2.89 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.812 -179.488 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 3.7 tp10 -63.79 -27.51 69.24 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 120.838 0.352 . . . . 0.0 110.751 -179.717 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 2.3 tptm -61.0 -23.72 65.6 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.199 179.952 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 35.1 mt-10 -62.1 -23.97 66.84 Favored 'General case' 0 N--CA 1.461 0.12 0 CA-C-O 121.176 0.512 . . . . 0.0 110.496 179.02 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 7.2 tp10 -95.46 -38.71 10.34 Favored 'General case' 0 C--N 1.319 -0.751 0 N-CA-C 109.212 -0.662 . . . . 0.0 109.212 177.747 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.441 ' HA ' ' O ' ' A' ' 122' ' ' PHE . 58.4 t -65.04 -42.18 93.93 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.331 0 CA-C-N 115.913 -0.585 . . . . 0.0 112.191 -179.209 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 51.3 p30 -69.4 -15.21 63.25 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-O 121.125 0.488 . . . . 0.0 111.057 -179.223 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 24.5 m -105.51 -3.88 21.93 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.54 179.826 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -116.19 47.77 1.35 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.652 -0.704 . . . . 0.0 110.255 -179.193 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -126.3 172.81 9.79 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.866 -179.839 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 8.7 pt -131.17 136.75 57.19 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 N-CA-C 109.92 -0.4 . . . . 0.0 109.92 178.392 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' TYR . . . . . 0.539 ' O ' ' HA ' ' A' ' 146' ' ' VAL . 36.8 t80 -91.63 124.3 35.68 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.62 -179.465 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 6.9 t -105.98 110.23 30.62 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 N-CA-C 110.103 -0.332 . . . . 0.0 110.103 179.759 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -118.4 167.24 12.95 Favored Glycine 0 N--CA 1.45 -0.37 0 N-CA-C 111.745 -0.542 . . . . 0.0 111.745 -179.857 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 4.6 m-20 59.25 40.77 21.03 Favored 'General case' 0 N--CA 1.468 0.471 0 CA-C-O 121.289 0.566 . . . . 0.0 110.794 -179.583 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 2.1 t -83.46 169.1 1.61 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-N 115.354 -0.839 . . . . 0.0 109.851 -179.471 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . 0.459 ' HB3' ' SG ' ' A' ' 86' ' ' CYS . 29.8 t70 -73.2 143.14 47.28 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 120.901 0.381 . . . . 0.0 110.73 179.916 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 34.1 p90 -64.77 -13.53 55.61 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.799 -0.637 . . . . 0.0 112.549 -178.693 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -117.21 15.95 14.91 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.81 0.338 . . . . 0.0 111.019 179.923 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' CYS . . . . . 0.459 ' SG ' ' HB3' ' A' ' 83' ' ' ASP . 1.0 OUTLIER -78.68 142.55 37.05 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.113 0.483 . . . . 0.0 110.885 179.945 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' THR . . . . . 0.47 ' O ' ' HG2' ' A' ' 90' ' ' GLU . 70.2 p -106.12 155.41 38.55 Favored Pre-proline 0 C--N 1.321 -0.672 0 CA-C-N 115.444 -0.798 . . . . 0.0 110.272 -179.994 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 20.8 Cg_endo -61.46 -29.29 84.88 Favored 'Trans proline' 0 C--N 1.344 0.32 0 C-N-CA 122.219 1.946 . . . . 0.0 112.401 -179.788 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 14.0 mt-10 -65.31 -55.3 19.07 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.665 -179.073 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . 0.47 ' HG2' ' O ' ' A' ' 87' ' ' THR . 9.6 pt-20 -60.89 -25.53 66.78 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.921 0.391 . . . . 0.0 111.258 -178.634 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 69.2 t -78.24 -47.37 24.62 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.274 -179.286 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . 0.462 ' O ' ' HB2' ' A' ' 96' ' ' GLN . 13.9 pt20 -74.0 -31.75 63.1 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 112.172 0.434 . . . . 0.0 112.172 -178.212 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 1.5 pp0? -77.53 -27.85 51.8 Favored 'General case' 0 N--CA 1.467 0.419 0 C-N-CA 120.305 -0.558 . . . . 0.0 111.743 -179.155 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 1.5 m-70 -71.71 -44.46 64.14 Favored 'General case' 0 C--N 1.328 -0.349 0 C-N-CA 120.832 -0.347 . . . . 0.0 111.009 -179.571 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 23.0 m-85 -81.18 -11.72 59.36 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.682 0.277 . . . . 0.0 110.884 -179.707 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . 0.462 ' HB2' ' O ' ' A' ' 92' ' ' GLN . 43.3 tt0 -62.64 -28.56 70.0 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.002 -0.544 . . . . 0.0 110.59 -179.483 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 12.1 m -64.85 -38.95 92.7 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.305 179.263 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 6.1 m -81.01 -40.01 24.96 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.005 179.321 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . 0.448 ' O ' ' HA ' ' A' ' 96' ' ' GLN . . . -153.8 129.37 2.64 Favored Glycine 0 N--CA 1.442 -0.91 0 CA-C-N 115.76 -0.655 . . . . 0.0 111.516 179.487 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -58.97 140.84 55.18 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.259 0.552 . . . . 0.0 110.748 179.868 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . 0.447 HG12 ' HB2' ' A' ' 92' ' ' GLN . 1.3 p -107.55 128.37 62.73 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 115.754 -0.657 . . . . 0.0 111.996 -178.057 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . 0.469 ' O ' ' HD2' ' A' ' 103' ' ' ARG . 6.3 t30 -86.39 -53.36 5.05 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 109.229 -0.656 . . . . 0.0 109.229 178.553 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . 0.469 ' HD2' ' O ' ' A' ' 102' ' ' ASN . 3.4 mpt_? -138.93 153.49 48.24 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 116.001 -0.545 . . . . 0.0 109.62 179.963 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 4.8 p -142.74 126.93 15.22 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 N-CA-C 109.787 -0.449 . . . . 0.0 109.787 179.669 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' THR . . . . . 0.401 ' O ' ' HA ' ' A' ' 118' ' ' ALA . 0.8 OUTLIER -114.75 127.19 55.6 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 110.308 -0.256 . . . . 0.0 110.308 179.847 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 20.0 tt -117.8 144.55 25.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-O 120.708 0.29 . . . . 0.0 110.597 -179.77 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 26.6 tp -133.45 121.97 23.01 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.557 179.84 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -84.09 114.53 21.82 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.543 -0.299 . . . . 0.0 110.318 179.258 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -78.54 134.21 37.29 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.182 0.515 . . . . 0.0 111.516 -179.698 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -119.94 22.85 11.33 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.167 179.33 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 4.0 t80 -101.07 1.39 39.35 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.113 -179.56 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 100.87 12.15 38.08 Favored Glycine 0 N--CA 1.449 -0.455 0 C-N-CA 120.796 -0.716 . . . . 0.0 112.361 179.898 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 7.2 mt-30 -100.11 157.61 33.53 Favored Pre-proline 0 C--N 1.325 -0.485 0 N-CA-C 109.37 -0.604 . . . . 0.0 109.37 179.372 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -58.53 112.76 1.29 Allowed 'Trans proline' 0 C--N 1.345 0.37 0 C-N-CA 122.433 2.089 . . . . 0.0 111.488 178.889 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 7.9 mttp -69.58 176.87 3.23 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.662 -179.745 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 99.06 2.96 56.93 Favored Glycine 0 N--CA 1.439 -1.139 0 C-N-CA 120.164 -1.017 . . . . 0.0 111.768 -179.801 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 29.1 m-85 -54.95 113.35 1.31 Allowed 'General case' 0 C--O 1.231 0.118 0 N-CA-C 110.12 -0.326 . . . . 0.0 110.12 179.53 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . 0.401 ' HA ' ' O ' ' A' ' 105' ' ' THR . . . -144.59 173.07 12.14 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 120.931 0.396 . . . . 0.0 110.87 -178.977 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 2.3 p90 -157.75 136.75 11.59 Favored 'General case' 0 N--CA 1.445 -0.676 0 CA-C-N 115.891 -0.595 . . . . 0.0 109.552 178.874 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 15.0 m -105.91 140.7 23.16 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 N-CA-C 109.489 -0.56 . . . . 0.0 109.489 178.985 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 6.4 pt-20 -126.4 154.2 43.93 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.045 -179.287 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 122' ' ' PHE . . . . . 0.441 ' O ' ' HA ' ' A' ' 72' ' ' VAL . 14.3 t80 -154.65 167.87 28.7 Favored 'General case' 0 C--O 1.226 -0.15 0 CA-C-O 120.796 0.331 . . . . 0.0 110.637 179.306 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 6.3 t -82.73 -50.32 15.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 115.715 -0.675 . . . . 0.0 111.626 -179.126 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 33.1 mt-10 -70.97 137.42 49.12 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.044 -0.526 . . . . 0.0 111.934 -178.748 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 2.9 mp -74.99 -32.46 27.17 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.313 179.707 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 37.8 t70 -58.0 -43.54 86.67 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-O 120.982 0.42 . . . . 0.0 111.003 -179.833 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -58.05 -57.37 13.15 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.872 -0.604 . . . . 0.0 111.471 -179.682 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 12.2 p -67.62 -29.52 45.6 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 116.477 -0.329 . . . . 0.0 111.608 -179.177 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 129' ' ' GLN . . . . . 0.45 ' O ' ' HG ' ' A' ' 132' ' ' LEU . 29.4 tt0 -63.16 -46.43 87.2 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.901 0.381 . . . . 0.0 110.308 179.889 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 48.6 m-80 -72.02 -27.15 62.53 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.216 0.532 . . . . 0.0 109.688 179.125 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -72.15 -40.73 67.8 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.561 -0.745 . . . . 0.0 111.317 179.892 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 132' ' ' LEU . . . . . 0.583 ' HA ' ' ND2' ' A' ' 135' ' ' ASN . 4.4 pp -74.7 -19.1 60.39 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.924 0.392 . . . . 0.0 110.789 179.861 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 5.3 tp -76.34 -47.48 23.31 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.383 -179.906 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 40.1 mt -126.19 95.28 4.34 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.973 -0.558 . . . . 0.0 109.818 179.959 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 135' ' ' ASN . . . . . 0.583 ' ND2' ' HA ' ' A' ' 132' ' ' LEU . 2.8 p30 -135.75 -74.74 0.45 Allowed 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 112.431 0.53 . . . . 0.0 112.431 -179.083 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 5.8 pt-20 -69.25 100.57 1.33 Allowed 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.505 0.669 . . . . 0.0 111.632 -178.708 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 26.5 m -142.68 -58.3 0.44 Allowed 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.577 -0.738 . . . . 0.0 109.929 178.815 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 3.0 tm-20 -162.17 124.51 2.85 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.151 -0.477 . . . . 0.0 109.961 179.491 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -144.51 119.11 9.75 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 109.374 -0.602 . . . . 0.0 109.374 179.448 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 2.5 t60 64.67 20.52 12.16 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-O 121.108 0.48 . . . . 0.0 110.386 179.541 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 85.15 5.61 85.48 Favored Glycine 0 N--CA 1.448 -0.543 0 C-N-CA 120.922 -0.656 . . . . 0.0 112.149 -179.303 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -120.34 173.33 7.2 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 109.98 -0.378 . . . . 0.0 109.98 179.994 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 10.3 pt20 -118.84 125.43 49.52 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 109.761 -0.459 . . . . 0.0 109.761 179.271 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -110.36 178.3 4.43 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.86 -178.9 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -118.67 118.64 32.2 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 109.394 -0.595 . . . . 0.0 109.394 179.22 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 146' ' ' VAL . . . . . 0.539 ' HA ' ' O ' ' A' ' 78' ' ' TYR . 42.0 t -122.03 119.56 58.91 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-O 120.753 0.311 . . . . 0.0 111.144 -179.065 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 60.0 m -124.16 152.49 42.77 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 109.901 -0.407 . . . . 0.0 109.901 179.499 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -61.49 130.31 45.4 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.939 0.399 . . . . 0.0 110.796 179.984 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 42.7 tttp -92.94 71.19 4.69 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 109.079 -0.711 . . . . 0.0 109.079 179.958 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 3.6 tpt180 -90.79 86.74 6.42 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.679 -0.692 . . . . 0.0 110.034 -179.563 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 9.0 t -68.01 138.14 55.63 Favored 'General case' 0 N--CA 1.447 -0.591 0 CA-C-N 115.66 -0.7 . . . . 0.0 109.927 179.659 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 152' ' ' ASN . . . . . . . . . . . . . 64.3 t30 -168.55 152.5 5.76 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 109.066 -0.716 . . . . 0.0 109.066 -179.779 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 18.8 pt -63.73 139.01 97.55 Favored Pre-proline 0 C--N 1.327 -0.381 0 O-C-N 123.153 0.283 . . . . 0.0 110.869 179.951 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 28.5 Cg_endo -63.82 115.89 3.35 Favored 'Trans proline' 0 CA--C 1.528 0.22 0 C-N-CA 122.891 2.394 . . . . 0.0 112.676 -179.824 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.255 1.427 0 CA-C-O 118.241 -1.31 . . . . 0.0 111.365 179.822 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 68.3 mtt . . . . . 0 N--CA 1.482 1.172 0 CA-C-O 120.77 0.319 . . . . 0.0 110.732 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 100.52 117.58 4.13 Favored Glycine 0 N--CA 1.449 -0.452 0 C-N-CA 120.915 -0.66 . . . . 0.0 111.933 179.872 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 36.5 m -129.9 128.04 41.39 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 122.665 -0.314 . . . . 0.0 111.146 -179.604 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -122.49 137.23 54.94 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.328 -0.396 . . . . 0.0 109.971 179.682 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 12.7 p-80 -155.35 125.09 6.48 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.582 -0.281 . . . . 0.0 110.735 -179.39 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -164.27 112.88 1.15 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.444 -0.344 . . . . 0.0 111.074 179.559 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 2.7 p80 -164.24 138.95 5.7 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.96 -0.564 . . . . 0.0 109.906 179.763 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 51.7 p-80 -169.12 136.96 1.9 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.818 0.342 . . . . 0.0 110.612 179.418 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 20.6 p80 -146.9 151.5 37.14 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.684 -179.505 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 72.4 t60 -161.26 115.51 2.02 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.221 -0.445 . . . . 0.0 109.851 179.235 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 2.7 p -134.12 131.72 39.05 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 120.568 0.223 . . . . 0.0 111.124 -179.391 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 19.0 m -157.97 -178.24 7.16 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 110.03 -0.359 . . . . 0.0 110.03 179.772 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 131.3 78.56 0.17 Allowed Glycine 0 N--CA 1.45 -0.432 0 C-N-CA 120.308 -0.949 . . . . 0.0 113.334 179.324 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 33.4 tp -157.15 132.55 9.15 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 120.657 0.265 . . . . 0.0 110.517 179.153 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 2.8 m -137.24 149.95 67.51 Favored Pre-proline 0 C--N 1.327 -0.375 0 CA-C-N 116.485 -0.325 . . . . 0.0 110.256 179.692 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 89.7 Cg_endo -83.19 178.7 5.64 Favored 'Trans proline' 0 C--O 1.238 0.499 0 C-N-CA 122.781 2.321 . . . . 0.0 112.688 179.545 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 37.4 ttm180 -164.94 158.09 16.75 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.196 -179.797 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 143.12 123.26 1.77 Allowed Glycine 0 C--N 1.331 0.284 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.743 179.205 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 62.4 m -155.63 143.23 19.59 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 110.207 -0.294 . . . . 0.0 110.207 179.202 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -158.72 128.12 5.63 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.576 -0.283 . . . . 0.0 110.463 -179.563 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -170.04 170.93 7.28 Favored 'General case' 0 C--O 1.236 0.344 0 O-C-N 123.103 0.252 . . . . 0.0 110.935 179.817 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 162.88 162.05 13.17 Favored Glycine 0 C--N 1.33 0.228 0 C-N-CA 120.843 -0.694 . . . . 0.0 112.422 179.656 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 19.3 m -157.7 154.9 29.03 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 116.778 0.289 . . . . 0.0 110.517 179.874 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -143.93 169.68 17.34 Favored 'General case' 0 C--O 1.235 0.331 0 CA-C-N 116.576 -0.284 . . . . 0.0 110.388 179.855 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 29.3 tp -153.76 147.73 25.55 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-O 120.7 0.285 . . . . 0.0 110.896 -179.898 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 14.7 tt0 -108.27 154.38 21.88 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.383 -0.372 . . . . 0.0 110.615 179.686 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 14.5 p-10 -114.99 -168.0 1.32 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.516 -0.311 . . . . 0.0 110.878 -179.83 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 46.2 ttm -156.53 142.89 18.32 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-N 116.506 -0.316 . . . . 0.0 110.559 -179.584 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -118.71 168.87 10.32 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.621 0.248 . . . . 0.0 110.671 179.329 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 51.0 mttt -132.34 172.76 12.04 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.465 -0.334 . . . . 0.0 110.88 -179.654 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 86.3 mtt180 -132.56 172.98 11.8 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.992 -179.613 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 16.5 mt -102.77 -160.47 0.78 Allowed 'General case' 0 C--O 1.236 0.344 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.046 179.858 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.514 ' NZ ' ' HG3' ' A' ' 36' ' ' GLU . 35.2 mtpt -124.58 -178.01 4.0 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.633 -0.258 . . . . 0.0 110.733 179.92 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 15.7 mm-40 -101.38 56.1 0.84 Allowed 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.504 -0.316 . . . . 0.0 111.144 -179.215 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 4.3 pt 30.78 85.38 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.48 1.05 0 C-N-CA 124.406 1.082 . . . . 0.0 113.134 179.764 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . 0.514 ' HG3' ' NZ ' ' A' ' 33' ' ' LYS . 9.1 mm-40 -78.96 -76.28 0.21 Allowed 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.48 -0.782 . . . . 0.0 112.042 -178.828 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 24.2 mt-10 59.9 73.04 0.5 Allowed 'General case' 0 N--CA 1.466 0.327 0 O-C-N 123.473 0.483 . . . . 0.0 111.167 -179.158 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 1.1 pp20? -81.96 173.49 12.16 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.939 179.975 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -94.53 -66.8 0.89 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.784 0.326 . . . . 0.0 111.188 -179.138 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 116.75 96.79 1.96 Allowed Glycine 0 N--CA 1.449 -0.488 0 C-N-CA 120.629 -0.796 . . . . 0.0 113.042 179.763 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -104.09 -172.34 2.09 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 110.107 -0.331 . . . . 0.0 110.107 179.229 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 20.2 tp -83.75 79.39 9.48 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.147 0.499 . . . . 0.0 110.297 179.919 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 28.6 ttm180 -144.22 140.79 29.48 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.797 -0.638 . . . . 0.0 109.632 179.781 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -71.97 84.08 0.96 Allowed 'General case' 0 C--O 1.235 0.305 0 CA-C-O 120.972 0.415 . . . . 0.0 110.112 179.398 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 14.9 ptt? -132.53 12.05 4.48 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.772 -179.244 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 1.7 mp0 -65.57 -11.64 45.91 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.834 -178.929 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -70.31 -17.43 63.08 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.963 0.411 . . . . 0.0 111.331 179.852 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 19.3 pttp -70.71 -13.22 61.99 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.49 -179.411 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 5.3 p -65.11 -20.53 27.72 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.317 0 CA-C-O 121.208 0.528 . . . . 0.0 110.952 -179.66 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 49.3 mt-10 -82.5 -12.0 58.09 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.284 179.673 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 28.7 ttmt -107.43 -32.71 7.62 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.18 0.514 . . . . 0.0 109.682 179.228 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 71.1 mt-10 -78.74 7.54 6.8 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.548 -0.751 . . . . 0.0 111.265 179.754 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -62.3 -29.21 70.27 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 109.944 -0.391 . . . . 0.0 109.944 178.988 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -96.78 3.27 62.69 Favored Glycine 0 N--CA 1.449 -0.449 0 N-CA-C 110.733 -0.947 . . . . 0.0 110.733 178.526 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -101.47 23.3 11.28 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.113 0.482 . . . . 0.0 110.321 -179.388 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 10.8 m -65.72 -17.63 22.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.762 179.58 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 10.1 mm-40 -105.28 14.24 29.25 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.066 179.057 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -125.82 -59.39 1.35 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.968 -179.729 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 64.7 m -109.86 -45.08 3.69 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 111.978 0.362 . . . . 0.0 111.978 -179.062 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -79.85 29.77 0.26 Allowed 'General case' 0 CA--C 1.533 0.323 0 N-CA-C 112.243 0.46 . . . . 0.0 112.243 -178.884 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 7.7 m -92.46 -29.17 16.39 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.935 0.398 . . . . 0.0 110.454 179.932 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -65.19 -22.8 66.95 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.883 -0.599 . . . . 0.0 111.46 -179.562 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -66.89 -31.08 71.44 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.111 0.481 . . . . 0.0 110.431 179.324 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -70.22 -36.23 74.4 Favored 'General case' 0 C--O 1.232 0.153 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.799 -179.932 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -78.24 6.19 8.71 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.374 -0.376 . . . . 0.0 111.179 179.754 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 4.2 tp-100 -119.43 -51.63 2.29 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.494 179.763 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -82.1 -62.1 1.72 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.364 -179.432 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . 0.497 ' O ' HG22 ' A' ' 72' ' ' VAL . 0.7 OUTLIER -58.52 -33.89 70.36 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.464 -179.101 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 32.6 tptt -53.25 -34.21 56.25 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 116.198 -0.455 . . . . 0.0 112.165 -179.577 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 2.5 mm-40 -61.0 -34.68 75.19 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.042 0.448 . . . . 0.0 110.764 -179.793 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 10.2 tp10 -88.42 -38.19 15.26 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.493 179.829 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.497 HG22 ' O ' ' A' ' 68' ' ' GLU . 61.4 t -64.7 -41.84 93.35 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.059 -179.589 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 4.6 t70 -68.04 -33.19 74.12 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.333 -179.357 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' SER . . . . . 0.437 ' HB2' ' HE ' ' A' ' 150' ' ' ARG . 11.5 p -82.47 -17.25 45.89 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 121.284 0.564 . . . . 0.0 109.964 179.908 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -101.79 48.19 0.89 Allowed 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.836 0.827 . . . . 0.0 108.849 178.717 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 28.0 t -125.0 158.8 32.78 Favored 'General case' 0 N--CA 1.446 -0.643 0 CA-C-N 114.726 -1.125 . . . . 0.0 110.22 -179.085 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 5.4 pt -126.94 134.8 65.37 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.138 178.895 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 61.2 t80 -92.19 130.27 37.94 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.323 -179.668 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 8.0 t -104.23 108.2 24.14 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.742 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.35 -179.947 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -112.88 170.24 13.32 Favored Glycine 0 N--CA 1.442 -0.961 0 N-CA-C 111.022 -0.831 . . . . 0.0 111.022 179.468 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 9.9 m-20 58.51 38.5 25.45 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-N 116.97 0.385 . . . . 0.0 110.557 -179.76 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.463 HG11 ' H ' ' A' ' 83' ' ' ASP . 1.4 t -79.35 171.81 1.23 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.971 -178.993 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . 0.549 ' OD1' ' HD2' ' A' ' 142' ' ' ARG . 30.2 t70 -81.24 141.71 33.87 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.287 -0.415 . . . . 0.0 109.906 179.476 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 55.2 p90 -65.01 -16.3 63.28 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 112.708 0.633 . . . . 0.0 112.708 -178.113 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -110.22 9.26 23.84 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.698 0.285 . . . . 0.0 111.327 -179.953 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' CYS . . . . . 0.418 ' SG ' ' HB2' ' A' ' 140' ' ' HIS . 0.9 OUTLIER -73.88 135.7 43.36 Favored 'General case' 0 C--O 1.235 0.294 0 CA-C-O 121.118 0.485 . . . . 0.0 111.336 179.888 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' THR . . . . . 0.57 ' O ' ' HG2' ' A' ' 90' ' ' GLU . 9.0 p -103.01 153.16 38.49 Favored Pre-proline 0 C--N 1.324 -0.514 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.19 179.337 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 15.2 Cg_endo -58.82 -37.86 91.64 Favored 'Trans proline' 0 CA--C 1.531 0.335 0 C-N-CA 122.48 2.12 . . . . 0.0 112.827 -179.426 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 7.5 mp0 -63.79 -46.3 85.83 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.756 -179.361 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . 0.57 ' HG2' ' O ' ' A' ' 87' ' ' THR . 7.7 pt-20 -65.65 -26.4 67.79 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.807 0.337 . . . . 0.0 111.069 -179.114 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 62.2 t -74.61 -55.51 11.74 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.874 -179.953 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 2.7 pt20 -62.51 -36.12 81.54 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 112.405 0.52 . . . . 0.0 112.405 -178.516 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 2.9 pt20 -76.35 -24.07 54.22 Favored 'General case' 0 N--CA 1.463 0.185 0 C-N-CA 120.792 -0.363 . . . . 0.0 111.605 -178.947 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -80.02 -39.25 30.3 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.856 0.36 . . . . 0.0 111.193 -179.494 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 21.1 m-30 -81.3 -17.92 47.62 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.955 -179.22 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . 0.521 ' HA ' ' O ' ' A' ' 99' ' ' GLY . 1.9 tt0 -61.36 -23.78 66.01 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.801 179.702 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 2.7 m -63.11 -31.21 72.3 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.641 -0.708 . . . . 0.0 110.594 179.47 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 27.7 m -99.61 -44.96 5.95 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.213 179.547 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . 0.521 ' O ' ' HA ' ' A' ' 96' ' ' GLN . . . -141.52 132.24 5.2 Favored Glycine 0 N--CA 1.446 -0.646 0 C-N-CA 120.793 -0.718 . . . . 0.0 112.012 -179.815 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 2.5 m -68.0 147.23 52.69 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 120.728 0.299 . . . . 0.0 110.481 179.905 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 2.0 p -125.9 135.2 64.62 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-O 120.832 0.349 . . . . 0.0 111.325 -179.088 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 28.3 t-20 -104.78 -43.78 5.02 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.298 179.268 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 5.3 mpt_? -119.4 137.15 53.94 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.345 -0.388 . . . . 0.0 109.999 179.539 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 12.3 p -144.47 145.84 20.99 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.109 -179.948 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' THR . . . . . 0.581 ' HB ' ' CE2' ' A' ' 119' ' ' TYR . 4.2 m -146.13 137.83 24.9 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 110.036 -0.357 . . . . 0.0 110.036 179.358 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 14.9 tt -121.38 144.96 28.74 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-O 120.824 0.345 . . . . 0.0 110.631 -179.78 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 18.6 tp -123.22 127.64 48.89 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 116.438 -0.346 . . . . 0.0 110.469 -179.959 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -90.1 121.69 32.39 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.378 179.162 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 20.5 t70 -92.76 144.39 25.34 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 120.98 0.419 . . . . 0.0 111.174 -179.69 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -135.81 30.53 3.1 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 179.131 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 40.0 t80 -111.5 -12.24 13.99 Favored 'General case' 0 N--CA 1.452 -0.329 0 CA-C-N 115.19 -0.914 . . . . 0.0 110.029 -179.253 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 112.17 9.49 19.97 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.706 -179.466 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 32.6 mt-30 -91.81 157.59 41.29 Favored Pre-proline 0 C--N 1.325 -0.497 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 179.256 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 13.9 Cg_endo -58.1 99.09 0.09 OUTLIER 'Trans proline' 0 C--N 1.345 0.388 0 C-N-CA 122.095 1.863 . . . . 0.0 111.713 179.024 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 73.9 mttt -58.5 163.3 3.22 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.624 -0.717 . . . . 0.0 111.122 -179.196 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 102.55 6.12 47.57 Favored Glycine 0 N--CA 1.445 -0.75 0 C-N-CA 120.705 -0.76 . . . . 0.0 112.015 -179.811 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 46.5 m-85 -51.96 119.36 4.21 Favored 'General case' 0 CA--C 1.519 -0.236 0 CA-C-O 120.585 0.231 . . . . 0.0 110.473 179.56 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -146.79 172.94 12.87 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-O 121.034 0.445 . . . . 0.0 111.028 -179.136 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' TYR . . . . . 0.581 ' CE2' ' HB ' ' A' ' 105' ' ' THR . 50.5 p90 -154.2 148.75 26.28 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 115.791 -0.64 . . . . 0.0 109.471 179.02 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 30.6 m -124.64 136.31 61.07 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-N 116.476 -0.329 . . . . 0.0 110.314 179.566 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -128.38 149.09 50.69 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 120.898 0.38 . . . . 0.0 111.06 -179.844 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 7.7 t80 -148.87 167.96 24.3 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.535 -179.942 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 8.0 t -82.62 -42.27 18.19 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.177 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.446 -179.501 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -71.15 126.91 30.86 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.327 0.584 . . . . 0.0 111.292 -179.165 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 4.7 mp -67.87 -44.11 85.55 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-N 115.244 -0.889 . . . . 0.0 111.262 -178.845 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . 0.412 ' HA ' ' HB3' ' A' ' 129' ' ' GLN . 0.2 OUTLIER -62.34 -27.58 69.15 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.574 -0.284 . . . . 0.0 111.698 -179.132 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -63.66 -57.95 8.43 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.893 0.378 . . . . 0.0 110.23 179.423 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 11.5 p -69.26 -27.09 33.39 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 116.343 -0.389 . . . . 0.0 110.726 179.748 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 129' ' ' GLN . . . . . 0.412 ' HB3' ' HA ' ' A' ' 126' ' ' ASP . 16.1 tt0 -62.24 -45.4 93.48 Favored 'General case' 0 C--N 1.333 -0.121 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.493 179.504 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 37.6 m-80 -73.4 -26.84 61.15 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.246 0.546 . . . . 0.0 109.914 179.417 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . 0.458 ' O ' ' HB2' ' A' ' 135' ' ' ASN . . . -69.62 -49.72 51.2 Favored 'General case' 0 N--CA 1.45 -0.456 0 CA-C-N 115.661 -0.699 . . . . 0.0 110.792 179.623 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 3.9 pp -65.74 -16.08 63.44 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-O 120.884 0.373 . . . . 0.0 111.223 179.99 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 51.2 tp -82.39 -54.19 5.41 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.014 179.344 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 89.8 mt -120.43 93.64 4.11 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.298 179.827 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 135' ' ' ASN . . . . . 0.458 ' HB2' ' O ' ' A' ' 131' ' ' ALA . 0.2 OUTLIER -145.98 -57.31 0.3 Allowed 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.978 -0.556 . . . . 0.0 111.054 -179.522 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 1.2 pt-20 -73.44 87.71 1.58 Allowed 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.854 -0.612 . . . . 0.0 111.19 -179.462 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 6.6 m -138.28 -65.87 0.5 Allowed 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.21 179.278 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 6.2 tm-20 -157.96 136.22 10.96 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.309 -179.576 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -152.23 119.23 5.83 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 109.071 -0.715 . . . . 0.0 109.071 179.181 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 140' ' ' HIS . . . . . 0.418 ' HB2' ' SG ' ' A' ' 86' ' ' CYS . 2.2 t60 65.45 19.07 11.51 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-O 121.147 0.499 . . . . 0.0 110.658 179.63 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 88.78 -5.84 84.21 Favored Glycine 0 N--CA 1.447 -0.589 0 C-N-CA 120.864 -0.684 . . . . 0.0 111.814 -179.189 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 142' ' ' ARG . . . . . 0.549 ' HD2' ' OD1' ' A' ' 83' ' ' ASP . 0.0 OUTLIER -108.1 175.56 5.43 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 120.798 0.332 . . . . 0.0 110.154 -179.676 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 10.8 pt20 -113.9 148.94 35.9 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 109.584 -0.525 . . . . 0.0 109.584 179.257 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -137.12 175.23 9.8 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 120.789 0.328 . . . . 0.0 110.897 -179.905 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 84.0 tttt -123.96 127.46 47.99 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.758 -0.655 . . . . 0.0 109.77 -179.873 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 99.2 t -115.72 126.42 73.24 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 CA-C-O 120.801 0.334 . . . . 0.0 110.975 -179.073 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 3.8 m -121.81 153.27 38.56 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.673 -179.69 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -74.84 117.17 16.38 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.721 0.296 . . . . 0.0 110.489 179.386 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 11.6 ttpp -92.97 47.48 1.28 Allowed 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.728 -179.232 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 150' ' ' ARG . . . . . 0.437 ' HE ' ' HB2' ' A' ' 74' ' ' SER . 0.0 OUTLIER -74.46 95.66 2.77 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 109.892 -0.41 . . . . 0.0 109.892 179.517 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 13.5 t -62.31 144.4 55.72 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.836 -179.815 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 152' ' ' ASN . . . . . . . . . . . . . 1.9 t-20 -163.85 -165.65 1.05 Allowed 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.769 -0.65 . . . . 0.0 109.459 -179.762 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 19.0 pt -112.4 150.94 43.36 Favored Pre-proline 0 C--N 1.325 -0.496 0 N-CA-C 110.284 -0.265 . . . . 0.0 110.284 179.787 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -60.14 101.64 0.16 Allowed 'Trans proline' 0 C--N 1.346 0.422 0 C-N-CA 122.776 2.317 . . . . 0.0 112.171 179.733 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.244 0 CA-C-O 118.309 -1.273 . . . . 0.0 111.046 -179.661 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 19.7 mmt . . . . . 0 N--CA 1.48 1.047 0 N-CA-C 110.071 -0.344 . . . . 0.0 110.071 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 122.56 120.19 2.61 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 121.003 -0.618 . . . . 0.0 112.112 179.914 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 66.7 m -115.09 152.98 31.57 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 120.68 0.276 . . . . 0.0 110.708 -179.932 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -126.14 158.48 35.41 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.612 -179.575 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 2.5 t60 -146.78 139.51 25.14 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.646 0.26 . . . . 0.0 110.507 -179.944 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 19.3 p80 -150.83 168.57 24.04 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.782 0.325 . . . . 0.0 111.014 -179.444 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 6.8 p80 -155.41 173.53 16.53 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.144 -0.48 . . . . 0.0 109.979 179.93 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 28.4 p80 -144.93 174.23 11.2 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 110.167 -0.309 . . . . 0.0 110.167 179.558 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 30.4 p-80 -101.16 178.61 4.61 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.896 0.379 . . . . 0.0 111.374 -179.143 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 10.5 p-80 -146.54 141.18 26.74 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.316 -179.957 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 2.4 m -138.13 154.07 49.21 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.661 0.267 . . . . 0.0 111.056 -179.981 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 42.2 m -149.59 -178.83 6.66 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.511 -0.313 . . . . 0.0 110.613 -179.738 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -168.51 156.39 27.8 Favored Glycine 0 C--N 1.331 0.269 0 C-N-CA 121.02 -0.609 . . . . 0.0 112.281 179.809 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 69.1 mt -103.09 173.47 6.29 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.689 0.281 . . . . 0.0 110.856 -179.987 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 24.4 m -123.42 161.03 47.85 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-N 116.663 -0.244 . . . . 0.0 111.021 179.963 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_exo -78.65 -177.35 3.83 Favored 'Trans proline' 0 C--N 1.35 0.625 0 C-N-CA 123.167 2.578 . . . . 0.0 112.561 179.885 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 53.9 mtm180 -126.14 -172.49 2.63 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.657 -179.624 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -147.42 168.5 28.45 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.89 -0.672 . . . . 0.0 111.755 179.767 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 1.4 m -125.27 178.56 5.52 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.742 0.271 . . . . 0.0 110.894 -179.877 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -155.24 144.06 20.67 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 109.977 -0.379 . . . . 0.0 109.977 179.804 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -138.47 164.51 29.19 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 110.355 -0.239 . . . . 0.0 110.355 -179.928 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -116.14 -158.49 11.5 Favored Glycine 0 N--CA 1.449 -0.45 0 C-N-CA 120.682 -0.77 . . . . 0.0 113.067 -179.702 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 6.6 m -131.2 179.94 5.72 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 120.812 0.339 . . . . 0.0 110.846 -179.644 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 8.6 p-10 -106.77 164.99 11.65 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.824 -179.812 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 3.1 tt -148.41 123.09 9.86 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 109.576 -0.527 . . . . 0.0 109.576 -179.947 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 1.7 pt-20 -76.39 121.37 22.94 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.1 0.476 . . . . 0.0 112.049 -178.969 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 5.2 t70 -133.22 -159.52 0.97 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.601 -0.727 . . . . 0.0 109.463 179.319 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 23.6 ttp -155.47 3.02 0.18 Allowed 'General case' 0 CA--C 1.536 0.418 0 N-CA-C 112.251 0.463 . . . . 0.0 112.251 -179.525 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 27.6 mmtp -94.83 127.54 40.91 Favored 'General case' 0 C--N 1.327 -0.371 0 O-C-N 122.015 -0.428 . . . . 0.0 111.484 -179.812 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 49.0 mtmt -143.02 124.44 14.72 Favored 'General case' 0 C--O 1.238 0.462 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.195 179.637 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -177.07 14.25 0.0 OUTLIER 'General case' 0 CA--C 1.536 0.415 0 N-CA-C 111.887 0.328 . . . . 0.0 111.887 -179.733 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 34.1 mt -129.65 -179.38 5.15 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.789 0.328 . . . . 0.0 110.909 -179.235 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.444 ' HB3' ' HZ2' ' A' ' 33' ' ' LYS . 0.0 OUTLIER -162.99 31.77 0.1 Allowed 'General case' 0 CA--C 1.532 0.28 0 O-C-N 122.203 -0.311 . . . . 0.0 111.433 -179.992 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 1.5 pm0 -117.33 -175.3 2.78 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.895 0.379 . . . . 0.0 111.27 -179.331 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -133.37 130.41 57.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 115.618 -0.719 . . . . 0.0 109.564 178.979 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . 0.643 ' CD ' ' HA ' ' A' ' 62' ' ' THR . 0.0 OUTLIER -139.61 -159.74 0.99 Allowed 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 116.613 -0.267 . . . . 0.0 110.85 -178.987 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 -135.66 168.23 19.66 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.914 0.388 . . . . 0.0 110.91 179.523 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -68.44 127.27 32.37 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.505 -0.771 . . . . 0.0 111.272 -179.229 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -145.83 38.67 1.11 Allowed 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.971 0.415 . . . . 0.0 110.799 179.741 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -107.49 151.25 16.92 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.821 -0.704 . . . . 0.0 112.133 -179.705 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -145.98 162.38 37.96 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.59 0.233 . . . . 0.0 110.471 -179.778 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 12.1 tp -77.5 86.07 3.86 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.247 0.546 . . . . 0.0 110.369 -179.811 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 22.0 ttm-85 -148.43 149.65 32.1 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.031 -179.636 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -79.76 56.11 2.2 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.582 0.706 . . . . 0.0 110.485 -179.86 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 27.4 ptm -106.54 12.62 29.3 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.42 -0.809 . . . . 0.0 109.968 179.752 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 28.9 mm-40 -73.91 -26.45 60.53 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.531 -179.307 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -70.29 -6.37 34.54 Favored 'General case' 0 C--O 1.236 0.347 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.679 179.501 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 13.9 ttpp -86.57 2.1 49.34 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.207 179.599 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 8.3 p -55.74 -30.32 27.16 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.331 0 CA-C-N 116.052 -0.522 . . . . 0.0 112.005 -179.233 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 17.1 pt-20 -67.19 -28.45 68.11 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.862 0.363 . . . . 0.0 110.9 -179.928 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 37.4 mttm -86.63 -32.55 20.52 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 109.342 -0.614 . . . . 0.0 109.342 179.515 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 15.8 mm-40 -77.23 -3.62 40.61 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.691 -0.686 . . . . 0.0 111.197 -179.427 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 21.3 ttt -59.11 -38.58 79.91 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.174 0.511 . . . . 0.0 110.064 179.059 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -88.57 1.75 84.15 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.678 -0.772 . . . . 0.0 112.125 179.72 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -127.39 29.75 5.49 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 121.252 0.548 . . . . 0.0 110.937 -179.693 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 6.8 m -64.33 -17.44 21.05 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.206 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.937 179.704 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 5.5 mp0 -101.67 12.76 36.61 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.634 179.557 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 21.2 t70 -130.61 -54.06 1.08 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.588 -0.278 . . . . 0.0 111.43 179.724 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -99.36 -37.46 9.23 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 112.259 0.466 . . . . 0.0 112.259 -179.314 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -98.06 20.07 12.94 Favored 'General case' 0 C--O 1.237 0.399 0 N-CA-C 111.768 0.285 . . . . 0.0 111.768 -178.609 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -71.95 -17.25 62.09 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 111.818 0.303 . . . . 0.0 111.818 -179.594 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' THR . . . . . 0.643 ' HA ' ' CD ' ' A' ' 36' ' ' GLU . 0.7 OUTLIER -56.64 -19.2 15.1 Favored 'General case' 0 CA--C 1.533 0.301 0 N-CA-C 112.693 0.627 . . . . 0.0 112.693 -179.095 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -69.52 -16.01 63.36 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.354 -0.384 . . . . 0.0 110.884 179.499 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -75.54 -48.9 20.44 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.588 -179.42 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 4.3 m -81.21 -4.95 57.1 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 120.894 0.378 . . . . 0.0 111.511 -179.18 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 20.1 tp60 -111.94 -65.52 1.17 Allowed 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 112.171 0.434 . . . . 0.0 112.171 -179.947 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -77.7 -54.58 6.2 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.774 0.321 . . . . 0.0 111.802 -178.276 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . 0.437 ' O ' HG21 ' A' ' 72' ' ' VAL . 1.0 OUTLIER -62.05 -25.86 67.92 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.323 -0.398 . . . . 0.0 110.756 -179.518 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . 0.42 ' HG3' ' OD2' ' A' ' 73' ' ' ASP . 0.1 OUTLIER -49.48 -42.91 44.67 Favored 'General case' 0 C--O 1.232 0.139 0 CA-C-N 115.998 -0.546 . . . . 0.0 112.036 -179.293 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 28.2 mt-10 -52.23 -35.84 50.66 Favored 'General case' 0 N--CA 1.465 0.301 0 O-C-N 123.696 0.622 . . . . 0.0 112.138 -179.243 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 5.7 tp10 -83.52 -32.96 25.62 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 116.564 -0.289 . . . . 0.0 111.56 -178.755 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.525 ' HA ' ' O ' ' A' ' 122' ' ' PHE . 0.6 OUTLIER -69.05 -40.95 81.4 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 116.583 -0.28 . . . . 0.0 111.518 -178.786 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . 0.42 ' OD2' ' HG3' ' A' ' 69' ' ' LYS . 0.8 OUTLIER -83.53 -11.44 57.41 Favored 'General case' 0 N--CA 1.463 0.204 0 C-N-CA 119.819 -0.753 . . . . 0.0 111.353 -179.961 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 46.4 m -87.28 -20.23 27.13 Favored 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 176.729 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -116.66 53.86 0.87 Allowed 'General case' 0 N--CA 1.454 -0.269 0 CA-C-N 115.108 -0.951 . . . . 0.0 110.468 -179.969 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -124.24 159.57 29.87 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 120.942 0.401 . . . . 0.0 110.606 179.368 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 4.5 pt -127.29 138.18 55.56 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.231 179.048 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 34.7 t80 -104.4 126.96 51.96 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 116.128 -0.487 . . . . 0.0 109.841 -179.697 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 4.6 t -98.89 112.65 31.54 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 CA-C-O 121.072 0.463 . . . . 0.0 110.464 -179.718 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -111.02 153.28 17.25 Favored Glycine 0 N--CA 1.444 -0.78 0 CA-C-N 115.74 -0.663 . . . . 0.0 111.793 179.864 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 11.2 m-80 61.01 53.08 3.8 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-O 121.083 0.468 . . . . 0.0 110.621 -179.643 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.421 HG13 ' H ' ' A' ' 83' ' ' ASP . 1.1 t -89.46 169.08 1.43 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.221 -179.693 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . 0.499 ' OD1' ' HD2' ' A' ' 142' ' ' ARG . 28.4 t70 -73.99 140.35 45.43 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.877 0.37 . . . . 0.0 110.403 -179.958 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 1.1 p90 -63.97 -25.71 68.26 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.794 -0.639 . . . . 0.0 111.905 -178.907 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -96.72 10.43 38.74 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.728 0.299 . . . . 0.0 111.443 -179.595 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' CYS . . . . . 0.429 ' HB2' ' O ' ' A' ' 83' ' ' ASP . 0.8 OUTLIER -84.64 149.31 25.93 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.152 0.501 . . . . 0.0 111.15 179.823 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' THR . . . . . 0.454 ' O ' ' HG2' ' A' ' 90' ' ' GLU . 2.5 p -120.18 157.73 52.48 Favored Pre-proline 0 C--N 1.322 -0.622 0 CA-C-N 115.73 -0.668 . . . . 0.0 109.949 179.4 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -59.09 -36.56 95.9 Favored 'Trans proline' 0 C--N 1.345 0.392 0 C-N-CA 122.366 2.044 . . . . 0.0 112.647 -179.009 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . 0.405 ' O ' ' HG3' ' A' ' 92' ' ' GLN . 56.2 mp0 -63.83 -53.11 55.9 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.67 -179.176 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . 0.454 ' HG2' ' O ' ' A' ' 87' ' ' THR . 8.9 pt-20 -62.92 -24.71 67.98 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.79 0.328 . . . . 0.0 111.853 -178.743 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 52.5 t -78.3 -49.3 21.4 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.587 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.917 -179.932 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . 0.405 ' HG3' ' O ' ' A' ' 89' ' ' GLU . 0.0 OUTLIER -67.8 -37.59 82.2 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 112.382 0.512 . . . . 0.0 112.382 -178.582 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -71.86 -26.34 62.31 Favored 'General case' 0 N--CA 1.464 0.231 0 C-N-CA 120.836 -0.346 . . . . 0.0 111.325 -179.258 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 1.6 m80 -79.26 -37.34 38.18 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.064 0.459 . . . . 0.0 110.671 179.96 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 16.7 m-30 -81.26 -14.75 57.11 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.402 -179.631 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . 0.542 ' HA ' ' O ' ' A' ' 99' ' ' GLY . 52.4 tt0 -64.1 -23.22 67.24 Favored 'General case' 0 C--N 1.333 -0.113 0 CA-C-N 115.94 -0.573 . . . . 0.0 109.898 179.215 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 1.1 m -68.79 -26.25 65.11 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.229 178.942 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 5.6 m -91.6 -47.37 7.43 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 178.864 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . 0.542 ' O ' ' HA ' ' A' ' 96' ' ' GLN . . . -150.16 143.24 10.47 Favored Glycine 0 N--CA 1.443 -0.896 0 CA-C-N 115.485 -0.779 . . . . 0.0 111.155 179.344 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' THR . . . . . 0.508 ' HB ' ' CZ ' ' A' ' 122' ' ' PHE . 0.9 OUTLIER -62.09 139.22 58.46 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 116.881 0.34 . . . . 0.0 110.565 -179.832 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 7.6 p -101.78 145.26 11.97 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 116.308 -0.406 . . . . 0.0 111.424 -179.275 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . 0.463 ' HB3' ' O ' ' A' ' 121' ' ' GLU . 17.9 t30 -113.74 -62.05 1.65 Allowed 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 109.687 -0.486 . . . . 0.0 109.687 178.789 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 1.2 mpp_? -120.62 145.62 47.21 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.107 179.236 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 5.4 p -137.12 128.92 42.67 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-O 121.238 0.542 . . . . 0.0 110.611 179.776 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 2.8 m -129.53 134.41 47.75 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.243 179.455 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 10.6 tt -125.02 148.9 29.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 120.697 0.284 . . . . 0.0 110.674 -179.718 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 30.2 tp -134.01 118.92 18.37 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.084 -0.507 . . . . 0.0 109.979 179.351 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -89.27 109.77 20.62 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 120.716 0.294 . . . . 0.0 110.31 179.502 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -74.03 146.89 43.38 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.15 -179.785 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 7.2 mptt -133.04 31.65 3.84 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.898 -0.592 . . . . 0.0 109.442 178.906 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -120.3 -3.69 9.98 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.628 -179.153 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 115.32 9.48 13.05 Favored Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.147 -1.025 . . . . 0.0 114.101 179.256 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 36.7 mt-30 -98.18 155.07 37.37 Favored Pre-proline 0 C--N 1.323 -0.562 0 CA-C-N 117.467 0.633 . . . . 0.0 109.382 179.206 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -53.65 98.84 0.05 OUTLIER 'Trans proline' 0 C--N 1.348 0.523 0 C-N-CA 122.887 2.392 . . . . 0.0 111.598 178.859 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 86.2 mttt -59.39 151.75 23.0 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.408 -0.815 . . . . 0.0 111.195 -179.302 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 110.36 6.22 27.58 Favored Glycine 0 N--CA 1.447 -0.625 0 C-N-CA 120.368 -0.92 . . . . 0.0 112.468 -179.698 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 51.8 m-85 -51.89 119.13 3.95 Favored 'General case' 0 CA--C 1.521 -0.169 0 CA-C-O 120.592 0.234 . . . . 0.0 110.425 179.185 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -143.49 161.65 37.87 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-O 120.806 0.336 . . . . 0.0 110.859 -179.263 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 15.1 p90 -151.19 145.26 25.29 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 109.517 -0.549 . . . . 0.0 109.517 178.878 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 28.3 m -124.28 144.1 35.31 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.363 -179.794 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . 0.463 ' O ' ' HB3' ' A' ' 102' ' ' ASN . 7.4 pt-20 -124.56 144.57 50.06 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.703 -179.851 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 122' ' ' PHE . . . . . 0.525 ' O ' ' HA ' ' A' ' 72' ' ' VAL . 4.8 t80 -140.73 168.54 19.55 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.19 -0.459 . . . . 0.0 109.898 179.496 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -99.59 -24.77 4.07 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.241 0 N-CA-C 112.092 0.405 . . . . 0.0 112.092 -178.798 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 59.9 mm-40 -85.3 119.52 25.76 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.92 0.39 . . . . 0.0 110.496 -179.826 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 15.0 mt -64.48 -42.49 95.38 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 115.68 -0.691 . . . . 0.0 111.495 -179.132 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -57.48 -42.43 82.61 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.777 0.322 . . . . 0.0 111.599 -179.56 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -60.34 -51.86 67.71 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.634 -179.358 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 3.4 p -68.44 -24.26 29.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-O 120.856 0.36 . . . . 0.0 111.081 -179.328 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 45.3 tt0 -63.87 -41.44 97.76 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.747 179.921 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 19.7 t-20 -66.63 -33.89 76.65 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.046 179.972 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . 0.561 ' O ' ' HB2' ' A' ' 135' ' ' ASN . . . -73.05 -25.29 60.88 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.532 179.543 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -74.35 -25.78 59.73 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.233 0.539 . . . . 0.0 109.943 179.034 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 26.3 tp -81.26 -58.17 3.17 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.305 -0.862 . . . . 0.0 110.554 -179.643 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 22.6 mt -127.78 121.14 29.44 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.314 -179.922 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 135' ' ' ASN . . . . . 0.561 ' HB2' ' O ' ' A' ' 131' ' ' ALA . 3.2 t30 -169.33 -53.72 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.163 0.506 . . . . 0.0 110.303 -179.915 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -80.04 71.27 6.76 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.814 -0.63 . . . . 0.0 111.06 179.997 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 2.3 p -112.65 -74.67 0.62 Allowed 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.362 179.012 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 24.3 tt0 -157.68 124.31 4.92 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.183 179.888 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -135.3 126.81 28.73 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 109.493 -0.558 . . . . 0.0 109.493 179.83 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 1.9 t60 64.79 22.16 12.5 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-O 121.331 0.586 . . . . 0.0 110.097 -179.697 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 84.04 -1.14 89.12 Favored Glycine 0 N--CA 1.448 -0.514 0 CA-C-N 115.758 -0.655 . . . . 0.0 112.415 -179.691 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 142' ' ' ARG . . . . . 0.499 ' HD2' ' OD1' ' A' ' 83' ' ' ASP . 0.0 OUTLIER -113.36 154.79 26.32 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.644 0.259 . . . . 0.0 110.323 -179.513 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 7.6 pt20 -95.86 146.64 24.4 Favored 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 109.499 -0.556 . . . . 0.0 109.499 178.75 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -141.05 -179.74 6.26 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.788 0.328 . . . . 0.0 110.608 -179.105 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -126.17 142.33 51.57 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.956 -0.566 . . . . 0.0 110.123 179.793 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 92.3 t -129.11 110.63 21.01 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 N-CA-C 109.789 -0.449 . . . . 0.0 109.789 -179.925 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -108.51 154.3 22.11 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.611 -179.614 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -76.02 116.43 16.71 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.02 0.438 . . . . 0.0 110.524 -179.91 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 3.6 ttpm? -86.51 68.89 10.32 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.974 -0.557 . . . . 0.0 109.684 179.927 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 9.6 tpt180 -77.24 96.84 4.65 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.08 -179.392 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 95.4 m -71.1 103.99 2.9 Favored 'General case' 0 N--CA 1.453 -0.315 0 N-CA-C 109.671 -0.492 . . . . 0.0 109.671 178.738 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 152' ' ' ASN . . . . . . . . . . . . . 12.3 t-20 -148.83 151.51 34.88 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.773 -179.03 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 48.2 pt -77.04 151.46 81.79 Favored Pre-proline 0 C--N 1.324 -0.519 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.356 179.579 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 16.6 Cg_exo -66.96 99.96 0.49 Allowed 'Trans proline' 0 N--CA 1.462 -0.359 0 C-N-CA 122.438 2.092 . . . . 0.0 111.422 179.633 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.242 0 CA-C-O 118.312 -1.271 . . . . 0.0 111.456 -179.948 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 20.7 mmt . . . . . 0 N--CA 1.479 1.009 0 N-CA-C 109.882 -0.414 . . . . 0.0 109.882 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 119.0 168.82 14.2 Favored Glycine 0 N--CA 1.45 -0.427 0 C-N-CA 120.818 -0.706 . . . . 0.0 112.044 179.877 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 75.6 m -148.51 156.65 42.73 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 120.881 0.372 . . . . 0.0 110.858 -179.977 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -119.33 169.88 9.6 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.352 179.808 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 22.2 t60 -148.98 136.7 20.49 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 109.719 -0.474 . . . . 0.0 109.719 179.832 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -131.97 174.46 10.15 Favored 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 121.275 -0.17 . . . . 0.0 110.635 179.745 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 48.5 p-80 -149.23 169.12 21.48 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.392 0.139 . . . . 0.0 110.926 -179.714 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 1.8 p80 -160.66 173.52 15.34 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.585 -179.628 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 17.0 p-80 -150.26 163.69 37.63 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.549 -0.296 . . . . 0.0 110.473 -179.926 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 24.0 p-80 -145.56 152.36 39.59 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.844 -0.162 . . . . 0.0 110.606 179.623 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 2.4 m -109.05 -179.2 3.78 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.477 -0.329 . . . . 0.0 110.752 -179.742 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 8.5 t -146.92 166.02 28.01 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 109.879 -0.415 . . . . 0.0 109.879 179.824 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -158.86 167.03 34.68 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.916 -0.659 . . . . 0.0 112.414 -179.649 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 90.8 mt -132.81 175.31 9.46 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.712 0.291 . . . . 0.0 110.733 -179.809 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 17.3 m -127.23 155.76 75.77 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.667 -179.682 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 69.3 Cg_endo -74.59 -177.79 3.6 Favored 'Trans proline' 0 C--N 1.346 0.435 0 C-N-CA 122.762 2.308 . . . . 0.0 112.731 179.82 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 79.8 mtm180 -124.71 176.34 6.64 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.051 -179.744 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -136.81 150.65 20.65 Favored Glycine 0 N--CA 1.448 -0.535 0 C-N-CA 120.902 -0.666 . . . . 0.0 112.149 -179.776 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 1.4 m -106.74 155.08 20.07 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 110.4 -0.222 . . . . 0.0 110.4 -179.67 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 6.6 m170 -112.8 169.24 9.05 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.724 0.297 . . . . 0.0 110.891 -179.8 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 1.3 pmm? -147.53 172.94 13.19 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.183 -0.462 . . . . 0.0 109.994 -179.985 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -141.71 -176.75 16.23 Favored Glycine 0 N--CA 1.453 -0.226 0 C-N-CA 120.94 -0.648 . . . . 0.0 111.946 179.903 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 19.3 m -121.32 161.17 22.52 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.802 0.334 . . . . 0.0 111.019 -179.832 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -94.2 177.9 5.81 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.994 179.928 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 22.9 tp -157.57 147.5 20.47 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 109.358 -0.608 . . . . 0.0 109.358 179.763 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 13.5 mt-10 -101.34 126.59 48.11 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.038 0.447 . . . . 0.0 111.535 -179.558 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . 0.426 ' OD1' ' HG2' ' A' ' 29' ' ' LYS . 4.8 t70 -140.86 -167.77 2.44 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.78 -0.645 . . . . 0.0 109.488 178.992 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 85.9 mtp -130.31 -9.29 4.21 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 111.619 0.229 . . . . 0.0 111.619 -179.417 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.426 ' HG2' ' OD1' ' A' ' 27' ' ' ASP . 0.3 OUTLIER -63.04 133.5 54.63 Favored 'General case' 0 N--CA 1.466 0.356 0 CA-C-N 116.52 -0.309 . . . . 0.0 111.451 -179.473 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . 0.46 ' O ' ' HB2' ' A' ' 31' ' ' ARG . 25.6 mttt -159.23 104.48 1.67 Allowed 'General case' 0 C--O 1.236 0.361 0 CA-C-N 116.385 -0.37 . . . . 0.0 111.03 -179.975 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . 0.619 ' HA ' ' NE ' ' A' ' 31' ' ' ARG . 0.0 OUTLIER 172.17 23.6 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.506 0 O-C-N 123.584 0.552 . . . . 0.0 111.696 179.111 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 32.8 mt -134.37 168.16 19.41 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.747 0.308 . . . . 0.0 111.134 -179.464 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 2.3 ttmt -157.13 41.78 0.33 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.094 0.474 . . . . 0.0 110.085 -179.759 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -102.46 174.13 6.04 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.155 -178.718 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.433 HG12 HH11 ' A' ' 103' ' ' ARG . 0.0 OUTLIER -136.41 106.12 5.11 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.206 0 N-CA-C 108.919 -0.771 . . . . 0.0 108.919 179.144 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . 0.535 ' OE1' ' HB2' ' A' ' 61' ' ' SER . 0.2 OUTLIER -142.61 -171.58 3.45 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 121.036 0.445 . . . . 0.0 111.421 -178.381 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 64.0 mt-10 -120.87 -173.57 2.63 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.881 -179.822 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 3.2 mp0 -70.62 144.92 51.0 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.544 -179.833 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -155.96 24.78 0.38 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.902 -179.965 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -111.92 154.71 16.63 Favored Glycine 0 N--CA 1.449 -0.463 0 C-N-CA 120.814 -0.708 . . . . 0.0 112.674 -179.303 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -140.75 168.06 20.69 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 110.035 -0.358 . . . . 0.0 110.035 -179.683 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 11.2 tp -85.21 76.85 10.13 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 121.126 0.488 . . . . 0.0 110.399 -179.942 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 23.0 ttt180 -136.6 158.48 44.35 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.683 -179.942 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -82.83 56.34 3.38 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.709 179.957 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -119.49 17.97 12.86 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.343 0.592 . . . . 0.0 110.552 179.68 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 37.9 mm-40 -70.1 -22.83 62.99 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.758 -0.655 . . . . 0.0 110.835 -179.594 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -65.21 -14.59 61.02 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.966 -179.868 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 6.4 ttpp -77.05 -7.77 56.28 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.574 -0.284 . . . . 0.0 111.195 -179.718 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 10.6 p -59.37 -27.65 37.49 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.267 0 CA-C-O 120.98 0.419 . . . . 0.0 111.12 -179.895 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 26.8 mt-10 -66.88 -24.44 66.12 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.943 -0.572 . . . . 0.0 110.363 179.921 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 35.6 ttmt -99.24 -35.38 9.99 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.765 -0.652 . . . . 0.0 109.815 179.235 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 60.3 mm-40 -77.48 2.24 16.82 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.724 -0.671 . . . . 0.0 111.286 -179.965 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 20.0 ptt? -62.76 -28.87 70.27 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.158 0.504 . . . . 0.0 110.245 179.594 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -89.78 0.41 79.66 Favored Glycine 0 N--CA 1.445 -0.732 0 C-N-CA 120.737 -0.744 . . . . 0.0 111.448 179.321 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -125.48 32.96 5.22 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.269 0.557 . . . . 0.0 110.137 -179.763 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 5.8 m -64.52 -11.44 10.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 115.593 -0.731 . . . . 0.0 111.588 -179.668 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 14.1 mp0 -89.67 3.34 52.97 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.717 179.594 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 38.3 t70 -142.82 -44.17 0.31 Allowed 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 112.141 0.422 . . . . 0.0 112.141 -179.903 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 2.6 m -86.77 -26.76 23.98 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 120.788 0.328 . . . . 0.0 111.769 -179.303 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 11.4 t -127.23 22.03 6.64 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 120.942 0.401 . . . . 0.0 110.444 -179.526 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' SER . . . . . 0.535 ' HB2' ' OE1' ' A' ' 36' ' ' GLU . 0.3 OUTLIER -67.88 -29.86 69.07 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.091 -179.332 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' THR . . . . . 0.492 ' HA ' ' OE2' ' A' ' 36' ' ' GLU . 1.3 m -54.59 -23.04 15.17 Favored 'General case' 0 CA--C 1.532 0.275 0 CA-C-N 116.037 -0.529 . . . . 0.0 112.028 -179.39 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 4.2 m -66.79 -17.29 64.8 Favored 'General case' 0 N--CA 1.452 -0.352 0 CA-C-O 120.735 0.302 . . . . 0.0 110.708 179.568 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -78.03 -47.94 17.26 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.979 0.419 . . . . 0.0 110.686 179.728 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 4.9 m -75.71 -4.52 40.81 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.696 -179.61 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 21.8 tp60 -114.72 -60.69 1.85 Allowed 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 111.962 0.356 . . . . 0.0 111.962 179.936 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -79.91 -56.29 4.36 Favored 'General case' 0 C--N 1.331 -0.215 0 N-CA-C 112.187 0.44 . . . . 0.0 112.187 -178.322 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . 0.614 ' O ' HG21 ' A' ' 72' ' ' VAL . 1.4 tp10 -59.17 -33.51 71.02 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.304 -179.575 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . 0.545 ' HG3' ' OD2' ' A' ' 73' ' ' ASP . 23.5 tptp -50.85 -33.83 25.41 Favored 'General case' 0 N--CA 1.462 0.155 0 CA-C-N 115.422 -0.808 . . . . 0.0 111.875 -179.364 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 34.5 mt-10 -49.38 -39.2 31.44 Favored 'General case' 0 N--CA 1.465 0.277 0 O-C-N 123.551 0.532 . . . . 0.0 111.583 179.911 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 7.7 tp10 -94.99 -31.46 13.62 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.251 -179.438 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.614 HG21 ' O ' ' A' ' 68' ' ' GLU . 22.9 t -58.17 -54.68 29.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 N-CA-C 112.453 0.538 . . . . 0.0 112.453 -178.084 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . 0.545 ' OD2' ' HG3' ' A' ' 69' ' ' LYS . 3.3 p30 -84.58 0.47 49.93 Favored 'General case' 0 N--CA 1.462 0.164 0 C-N-CA 119.676 -0.81 . . . . 0.0 111.588 -179.419 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 6.1 m -91.11 -27.25 18.68 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 108.318 -0.993 . . . . 0.0 108.318 175.562 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -106.54 59.61 0.64 Allowed 'General case' 0 N--CA 1.449 -0.5 0 CA-C-N 114.916 -1.038 . . . . 0.0 109.565 179.701 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -132.36 161.27 34.0 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.848 -179.908 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 15.1 pt -119.68 136.98 55.05 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.312 179.293 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 56.1 t80 -101.15 128.0 47.44 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 179.432 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 2.7 t -108.73 117.75 54.83 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.683 0 CA-C-O 121.074 0.464 . . . . 0.0 111.413 -178.711 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -113.44 164.41 12.05 Favored Glycine 0 N--CA 1.445 -0.719 0 N-CA-C 111.115 -0.794 . . . . 0.0 111.115 179.421 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 2.7 m-20 61.88 44.19 8.65 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-O 121.011 0.434 . . . . 0.0 110.941 179.943 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 10.7 t -85.43 154.27 3.5 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.5 -179.82 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . 0.579 ' HB3' ' SG ' ' A' ' 86' ' ' CYS . 0.8 OUTLIER -72.33 134.66 45.61 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.13 179.51 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 48.7 p90 -63.9 -16.34 61.19 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 113.057 0.762 . . . . 0.0 113.057 -178.015 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -96.46 4.37 52.16 Favored 'General case' 0 C--N 1.324 -0.52 0 C-N-CA 121.054 -0.258 . . . . 0.0 111.665 -179.151 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' CYS . . . . . 0.579 ' SG ' ' HB3' ' A' ' 83' ' ' ASP . 89.6 m -81.18 156.66 25.58 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 121.207 0.527 . . . . 0.0 111.285 179.974 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 48.7 p -124.12 152.74 67.63 Favored Pre-proline 0 C--N 1.325 -0.494 0 CA-C-N 115.616 -0.72 . . . . 0.0 109.637 178.996 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -58.77 -23.07 64.89 Favored 'Trans proline' 0 C--N 1.342 0.226 0 C-N-CA 122.469 2.113 . . . . 0.0 112.599 -179.258 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 34.1 mt-10 -69.96 -58.69 3.55 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.955 -179.811 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -65.12 -23.49 67.16 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.096 0.474 . . . . 0.0 111.008 -179.462 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 6.2 t -72.28 -52.56 23.46 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.667 0 CA-C-N 115.791 -0.64 . . . . 0.0 111.163 -179.967 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 8.7 pt20 -68.69 -36.26 78.25 Favored 'General case' 0 CA--C 1.532 0.258 0 N-CA-C 112.451 0.538 . . . . 0.0 112.451 -178.207 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -68.48 -31.11 70.16 Favored 'General case' 0 C--O 1.234 0.269 0 C-N-CA 120.733 -0.387 . . . . 0.0 111.329 -178.834 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 3.6 m80 -70.33 -38.64 74.93 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.104 0.478 . . . . 0.0 109.729 179.386 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 8.2 m-30 -74.14 -30.76 62.43 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.72 -0.673 . . . . 0.0 109.828 179.765 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . 0.565 ' HA ' ' O ' ' A' ' 99' ' ' GLY . 29.0 tt0 -62.99 -17.66 62.41 Favored 'General case' 0 C--O 1.231 0.131 0 CA-C-N 115.448 -0.796 . . . . 0.0 111.183 -179.79 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 5.2 m -76.09 -22.88 55.08 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.179 0.514 . . . . 0.0 109.878 179.165 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 24.8 m -98.24 -46.03 5.97 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.729 -0.668 . . . . 0.0 109.81 179.42 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . 0.565 ' O ' ' HA ' ' A' ' 96' ' ' GLN . . . -148.49 152.68 24.7 Favored Glycine 0 N--CA 1.449 -0.496 0 N-CA-C 111.546 -0.622 . . . . 0.0 111.546 179.538 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' THR . . . . . 0.544 ' HB ' ' CZ ' ' A' ' 122' ' ' PHE . 0.2 OUTLIER -66.96 146.82 53.98 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 116.799 0.3 . . . . 0.0 110.635 179.918 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 2.7 p -117.21 137.72 50.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 121.015 0.436 . . . . 0.0 111.695 -178.659 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 24.1 t30 -99.13 -64.26 1.05 Allowed 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 109.487 -0.56 . . . . 0.0 109.487 179.331 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . 0.433 HH11 HG12 ' A' ' 35' ' ' ILE . 0.9 OUTLIER -122.88 149.18 44.55 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.486 179.44 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 7.9 p -136.28 139.94 44.57 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.018 179.677 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' THR . . . . . 0.582 ' HB ' ' CE1' ' A' ' 119' ' ' TYR . 4.0 m -138.19 140.69 39.89 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 109.59 -0.522 . . . . 0.0 109.59 179.304 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 20.6 tt -134.03 143.79 37.37 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 O-C-N 123.289 0.368 . . . . 0.0 110.446 -179.733 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 20.4 tp -127.09 134.55 50.23 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 120.998 0.428 . . . . 0.0 111.201 -179.804 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -101.62 114.77 29.1 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.595 179.256 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . 0.513 ' O ' ' HE2' ' A' ' 115' ' ' LYS . 17.3 t70 -85.44 148.54 25.94 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.397 -179.94 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 4.0 mppt? -128.6 23.31 5.86 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.861 179.956 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 3.8 t80 -110.52 -9.71 14.56 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.792 0.33 . . . . 0.0 110.904 -179.721 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 123.6 -3.54 9.4 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.251 -0.976 . . . . 0.0 113.465 179.327 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 34.1 mt-30 -79.22 154.82 77.18 Favored Pre-proline 0 C--N 1.326 -0.44 0 CA-C-N 117.215 0.507 . . . . 0.0 109.787 179.694 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 10.6 Cg_endo -55.72 101.64 0.09 OUTLIER 'Trans proline' 0 C--N 1.346 0.422 0 C-N-CA 122.533 2.155 . . . . 0.0 111.992 179.261 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . 0.513 ' HE2' ' O ' ' A' ' 109' ' ' ASP . 85.9 mttt -61.32 147.45 44.64 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.464 -0.789 . . . . 0.0 110.844 -179.778 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 109.76 11.45 21.0 Favored Glycine 0 N--CA 1.447 -0.627 0 C-N-CA 120.125 -1.035 . . . . 0.0 113.076 179.943 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 32.2 m-85 -54.47 116.69 2.79 Favored 'General case' 0 N--CA 1.465 0.278 0 N-CA-C 109.766 -0.457 . . . . 0.0 109.766 179.032 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -138.83 166.39 24.55 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 121.271 0.558 . . . . 0.0 111.826 -178.591 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 119' ' ' TYR . . . . . 0.582 ' CE1' ' HB ' ' A' ' 105' ' ' THR . 41.4 p90 -157.8 147.73 20.29 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.081 -0.963 . . . . 0.0 109.052 179.085 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 29.8 m -125.59 136.58 60.4 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-N 116.643 -0.253 . . . . 0.0 110.702 -179.944 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 4.2 pt-20 -115.78 152.59 32.99 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.993 179.923 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 122' ' ' PHE . . . . . 0.544 ' CZ ' ' HB ' ' A' ' 100' ' ' THR . 8.7 t80 -152.2 167.14 29.54 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.253 -0.431 . . . . 0.0 109.935 179.498 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 4.5 t -89.07 -38.63 11.6 Favored 'Isoleucine or valine' 0 C--O 1.236 0.354 0 CA-C-O 121.036 0.446 . . . . 0.0 111.392 -179.402 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 63.6 mm-40 -76.8 127.32 32.54 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.363 -179.368 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 32.4 mt -70.81 -38.37 72.45 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-N 115.593 -0.73 . . . . 0.0 111.426 -179.442 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -61.06 -38.52 86.48 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.383 -0.371 . . . . 0.0 111.697 -179.035 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -61.38 -55.8 27.43 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.213 -179.573 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 11.9 p -67.4 -27.77 39.9 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.173 -179.497 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 52.6 tt0 -61.3 -45.51 94.16 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.929 0.395 . . . . 0.0 110.788 179.937 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -64.54 -34.13 77.53 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.908 -179.726 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -77.55 -23.26 50.11 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.178 179.908 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -80.47 -15.78 55.92 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-O 121.358 0.599 . . . . 0.0 110.164 179.833 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 5.1 mp -96.62 -58.9 1.93 Allowed 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.771 179.661 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 78.9 mt -117.38 107.5 14.44 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.664 -179.435 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 65.8 t30 -166.51 -50.96 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.599 -179.799 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 4.0 pt-20 -72.46 87.33 1.18 Allowed 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.299 0.571 . . . . 0.0 111.102 -179.618 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -131.21 -70.29 0.6 Allowed 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.393 179.845 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 2.9 tm-20 -150.11 132.93 15.99 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.228 -179.788 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -143.61 112.46 6.6 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.695 -0.684 . . . . 0.0 109.469 179.483 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 2.0 t60 62.37 27.72 16.51 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.208 179.49 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 90.0 -10.0 75.44 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.821 -0.704 . . . . 0.0 112.42 179.75 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 142' ' ' ARG . . . . . 0.409 HH11 ' HD3' ' A' ' 142' ' ' ARG . 0.4 OUTLIER -109.39 176.33 5.12 Favored 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 110.134 -0.321 . . . . 0.0 110.134 -179.886 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 5.0 pt20 -125.48 141.09 52.24 Favored 'General case' 0 C--N 1.319 -0.722 0 N-CA-C 109.891 -0.411 . . . . 0.0 109.891 179.195 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -125.3 173.83 8.55 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.467 -178.99 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -115.34 126.11 54.04 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.271 -0.422 . . . . 0.0 109.991 179.586 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 94.1 t -104.47 117.18 49.63 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 CA-C-N 115.877 -0.601 . . . . 0.0 109.994 -179.743 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -117.2 156.17 28.15 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.39 -179.589 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -80.19 115.9 19.99 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 109.986 -0.376 . . . . 0.0 109.986 179.713 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 11.5 ttpp -88.52 52.9 2.55 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.219 0.533 . . . . 0.0 109.955 -179.73 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -76.13 96.13 3.8 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.804 -0.635 . . . . 0.0 110.48 -179.583 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 151' ' ' THR . . . . . 0.408 HG22 ' OD1' ' A' ' 73' ' ' ASP . 6.8 t -65.53 145.0 56.63 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.992 -0.549 . . . . 0.0 109.935 179.135 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 152' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 -168.7 179.42 4.25 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 109.001 -0.74 . . . . 0.0 109.001 -179.346 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 20.8 pt -96.56 154.8 38.41 Favored Pre-proline 0 C--N 1.317 -0.836 0 N-CA-C 109.451 -0.574 . . . . 0.0 109.451 179.228 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -74.88 58.7 4.89 Favored 'Trans proline' 0 C--O 1.235 0.372 0 C-N-CA 122.621 2.214 . . . . 0.0 112.141 179.62 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.048 0 CA-C-O 118.34 -1.256 . . . . 0.0 111.242 -179.769 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 63.4 mtt . . . . . 0 N--CA 1.481 1.104 0 N-CA-C 110.046 -0.353 . . . . 0.0 110.046 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 136.4 165.16 10.46 Favored Glycine 0 N--CA 1.445 -0.711 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.362 179.773 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -145.19 96.38 2.83 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-O 121.089 0.471 . . . . 0.0 110.126 179.339 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -84.49 140.72 31.28 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.969 -179.44 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 25.1 m-70 -117.17 147.07 42.78 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.554 179.779 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 2.4 t60 -123.68 118.03 26.33 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.158 -179.494 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -166.8 144.28 4.92 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.465 0.174 . . . . 0.0 111.025 -179.611 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 8.5 p80 -155.85 159.2 39.15 Favored 'General case' 0 N--CA 1.464 0.231 0 N-CA-C 109.653 -0.499 . . . . 0.0 109.653 179.637 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 30.1 t60 -158.21 145.57 18.06 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.534 0.207 . . . . 0.0 111.074 -179.267 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 25.7 p80 -148.76 136.46 20.57 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 116.438 -0.346 . . . . 0.0 110.494 179.232 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -159.08 137.32 10.6 Favored 'General case' 0 C--O 1.235 0.335 0 CA-C-N 116.511 -0.313 . . . . 0.0 110.709 -179.791 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 2.7 t -160.06 177.39 10.77 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.094 179.745 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 135.6 145.08 5.05 Favored Glycine 0 N--CA 1.449 -0.456 0 C-N-CA 120.802 -0.713 . . . . 0.0 112.814 179.516 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 1.8 pt? -151.24 148.38 28.14 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 109.744 -0.465 . . . . 0.0 109.744 179.593 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 22.0 t -126.41 107.95 23.76 Favored Pre-proline 0 C--N 1.328 -0.351 0 CA-C-N 116.711 -0.222 . . . . 0.0 110.991 -179.431 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 6.4 Cg_exo -74.18 171.66 17.56 Favored 'Trans proline' 0 C--N 1.345 0.365 0 C-N-CA 122.732 2.288 . . . . 0.0 112.211 179.527 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -132.48 125.24 30.2 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.463 -0.335 . . . . 0.0 110.217 179.76 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -160.88 98.45 0.17 Allowed Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.428 -0.891 . . . . 0.0 112.888 179.976 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 19.6 m -143.69 126.94 16.63 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 120.938 0.399 . . . . 0.0 110.02 179.152 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 1.8 t-80 -122.75 120.07 32.53 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.084 -179.756 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 26.7 ptm -136.74 164.11 29.02 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.226 -0.443 . . . . 0.0 109.996 -179.898 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 146.86 155.44 6.54 Favored Glycine 0 N--CA 1.447 -0.606 0 C-N-CA 120.316 -0.945 . . . . 0.0 112.79 179.602 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -153.04 81.62 1.2 Allowed 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.264 0.554 . . . . 0.0 109.731 179.599 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -101.51 115.88 31.51 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.147 -179.974 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.436 ' HA ' ' OE1' ' A' ' 66' ' ' GLN . 33.1 tp -129.02 91.96 3.3 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.751 -179.46 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 24.9 tt0 -175.86 128.34 0.24 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.882 -0.599 . . . . 0.0 109.82 179.4 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 18.5 t0 -85.99 152.63 22.77 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 120.782 0.325 . . . . 0.0 110.367 179.805 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 35.6 mtm -130.79 -13.7 3.65 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.612 -179.344 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 9.4 tppt? -170.12 133.95 1.2 Allowed 'General case' 0 C--N 1.332 -0.16 0 CA-C-O 120.968 0.413 . . . . 0.0 111.199 -179.293 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 62.0 tttt -78.53 70.11 4.82 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.169 179.348 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 2.4 tpt180 -132.05 131.27 42.29 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.433 -179.659 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -126.64 115.29 19.24 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.052 179.783 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.433 ' HB3' ' H ' ' A' ' 34' ' ' GLU . 23.0 tptt -149.85 -87.34 0.08 Allowed 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.606 -0.27 . . . . 0.0 110.886 -179.637 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.433 ' H ' ' HB3' ' A' ' 33' ' ' LYS . 48.8 mm-40 -123.88 -155.15 0.65 Allowed 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 109.742 -0.466 . . . . 0.0 109.742 -179.405 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.447 HG21 ' HG1' ' A' ' 65' ' ' THR . 13.1 pt -140.83 135.78 34.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.744 -0.207 . . . . 0.0 110.767 179.632 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 6.0 tp10 -140.29 -115.28 0.13 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.809 -0.178 . . . . 0.0 111.0 179.859 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 33.6 mt-10 -122.43 157.29 32.24 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-O 121.223 0.535 . . . . 0.0 111.867 -178.552 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -87.75 121.76 30.56 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.846 -0.615 . . . . 0.0 110.53 179.618 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -132.51 82.18 1.99 Allowed 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.414 179.494 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -142.9 138.17 8.16 Favored Glycine 0 N--CA 1.444 -0.775 0 C-N-CA 120.669 -0.777 . . . . 0.0 112.255 -179.604 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -164.85 168.56 17.6 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 109.215 -0.661 . . . . 0.0 109.215 179.678 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 24.4 tp -74.86 82.76 2.16 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.405 0.622 . . . . 0.0 110.456 179.649 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . 0.416 ' C ' ' H ' ' A' ' 45' ' ' MET . 9.5 ttp180 -143.03 141.87 31.43 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.688 -0.687 . . . . 0.0 109.676 179.617 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -76.07 41.82 0.24 Allowed 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 121.139 0.495 . . . . 0.0 111.152 -179.749 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' MET . . . . . 0.416 ' H ' ' C ' ' A' ' 43' ' ' ARG . 10.9 ptt? -98.6 5.25 47.94 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.853 -0.612 . . . . 0.0 109.644 179.752 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 84.0 mt-30 -71.43 -20.95 62.04 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.351 -0.84 . . . . 0.0 111.383 -178.811 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -69.26 -17.51 63.76 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.214 0.531 . . . . 0.0 110.602 179.861 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . 0.551 ' O ' ' HG2' ' A' ' 52' ' ' GLU . 20.4 ttpp -72.99 1.48 8.78 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.572 -0.74 . . . . 0.0 110.885 179.72 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 8.1 p -55.38 -27.05 20.0 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.311 0 CA-C-N 116.463 -0.335 . . . . 0.0 111.601 -179.648 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 20.8 mt-10 -64.02 -19.9 65.53 Favored 'General case' 0 N--CA 1.463 0.19 0 CA-C-O 121.337 0.589 . . . . 0.0 110.248 179.377 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 13.1 mtmt -107.95 -37.66 6.03 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.598 -0.728 . . . . 0.0 110.904 178.749 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . 0.551 ' HG2' ' O ' ' A' ' 48' ' ' LYS . 9.2 mm-40 -62.77 -21.64 66.0 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 116.681 -0.236 . . . . 0.0 111.276 179.879 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 4.7 ppp? -59.36 -23.59 62.67 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-O 120.895 0.379 . . . . 0.0 110.994 179.573 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -94.53 -5.14 61.87 Favored Glycine 0 C--O 1.227 -0.324 0 C-N-CA 121.062 -0.59 . . . . 0.0 111.677 179.28 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -121.96 24.08 9.74 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.335 0.588 . . . . 0.0 110.079 -179.798 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 20.8 m -66.4 -11.42 13.03 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 115.799 -0.637 . . . . 0.0 111.817 -179.458 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 72.6 mt-30 -84.29 -9.61 58.34 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.258 0.552 . . . . 0.0 109.955 179.15 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 6.6 t70 -119.94 -55.01 2.11 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.362 -0.835 . . . . 0.0 110.246 -179.778 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 17.9 m -77.86 -72.35 0.37 Allowed 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.297 -0.865 . . . . 0.0 111.915 -178.834 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -79.36 29.33 0.23 Allowed 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 112.617 0.599 . . . . 0.0 112.617 -178.315 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -88.85 -39.99 13.45 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 109.327 -0.62 . . . . 0.0 109.327 179.066 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -59.9 -18.9 48.37 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.287 -0.87 . . . . 0.0 112.262 -179.559 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -63.6 -26.95 68.92 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 121.197 0.522 . . . . 0.0 110.343 179.221 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -65.16 -29.99 70.87 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.28 179.102 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' THR . . . . . 0.447 ' HG1' HG21 ' A' ' 35' ' ' ILE . 0.2 OUTLIER -77.57 0.87 21.38 Favored 'General case' 0 N--CA 1.453 -0.316 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.806 -179.868 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' GLN . . . . . 0.436 ' OE1' ' HA ' ' A' ' 25' ' ' LEU . 6.3 tp-100 -118.52 -50.49 2.43 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.441 179.502 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -82.58 -64.5 1.16 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.14 -0.482 . . . . 0.0 112.043 -179.15 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . 0.415 ' O ' HG23 ' A' ' 72' ' ' VAL . 26.0 tp10 -63.83 -26.67 68.72 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.707 0.289 . . . . 0.0 111.466 -178.775 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 36.2 tptt -58.02 -28.12 64.17 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.514 -0.312 . . . . 0.0 111.01 179.842 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 83.1 mt-10 -63.26 -21.35 66.18 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-O 121.388 0.613 . . . . 0.0 110.763 179.354 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . 0.507 ' O ' ' HD2' ' A' ' 75' ' ' ARG . 5.7 tp10 -97.49 -41.23 8.28 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.418 -0.81 . . . . 0.0 109.316 178.158 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.415 HG23 ' O ' ' A' ' 68' ' ' GLU . 42.2 t -62.29 -40.13 86.68 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.379 0 CA-C-N 115.927 -0.578 . . . . 0.0 112.192 -179.25 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 12.9 p-10 -74.83 -14.19 60.66 Favored 'General case' 0 N--CA 1.466 0.375 0 CA-C-O 121.035 0.445 . . . . 0.0 110.867 -179.705 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 45.6 t -99.79 -12.98 19.45 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 121.504 0.669 . . . . 0.0 109.445 177.888 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . 0.507 ' HD2' ' O ' ' A' ' 71' ' ' GLU . 0.0 OUTLIER -107.66 41.05 1.58 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.054 -179.401 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -121.04 169.79 10.15 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 115.649 -0.705 . . . . 0.0 110.492 179.795 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -131.86 136.18 57.37 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 N-CA-C 109.616 -0.513 . . . . 0.0 109.616 178.433 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 71.3 t80 -91.79 123.27 35.05 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.409 -0.359 . . . . 0.0 110.278 -179.617 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 6.4 t -103.96 111.07 32.17 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.286 -179.615 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -119.95 169.66 13.96 Favored Glycine 0 N--CA 1.449 -0.48 0 C-N-CA 120.908 -0.663 . . . . 0.0 111.74 179.896 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 15.2 m120 61.48 35.62 17.5 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-O 121.102 0.477 . . . . 0.0 110.623 -179.742 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 2.1 t -79.79 165.85 2.71 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.674 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.65 -179.125 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -70.42 142.81 51.99 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 110.017 -0.364 . . . . 0.0 110.017 179.35 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 38.2 p90 -67.12 -13.47 61.98 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 112.03 0.381 . . . . 0.0 112.03 -178.723 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -114.06 16.78 18.1 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.787 0.327 . . . . 0.0 111.025 -179.968 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' CYS . . . . . 0.455 ' SG ' ' HB2' ' A' ' 140' ' ' HIS . 0.7 OUTLIER -82.16 142.1 32.5 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.132 0.491 . . . . 0.0 111.164 -179.927 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' THR . . . . . 0.537 ' O ' ' HG2' ' A' ' 90' ' ' GLU . 23.1 p -106.29 154.48 39.72 Favored Pre-proline 0 C--N 1.327 -0.406 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.548 179.705 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -59.19 -35.13 98.22 Favored 'Trans proline' 0 C--N 1.344 0.328 0 C-N-CA 122.769 2.313 . . . . 0.0 112.794 -179.355 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -65.51 -50.62 64.6 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.909 -0.587 . . . . 0.0 112.144 -178.705 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . 0.537 ' HG2' ' O ' ' A' ' 87' ' ' THR . 10.5 pt-20 -61.97 -24.78 67.22 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.888 0.375 . . . . 0.0 111.444 -178.806 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 76.1 t -81.2 -47.78 19.68 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.926 -178.761 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -71.5 -31.11 66.72 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.581 -178.627 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 3.7 pp0? -80.33 -27.91 38.26 Favored 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 120.383 -0.527 . . . . 0.0 111.252 -179.124 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 50.2 t-80 -77.44 -34.13 54.62 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.987 0.423 . . . . 0.0 110.479 -179.792 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 22.5 m-30 -84.38 -10.21 57.76 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.611 -179.987 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . 0.449 ' HA ' ' O ' ' A' ' 99' ' ' GLY . 14.8 tt0 -65.83 -25.4 67.2 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.488 -0.778 . . . . 0.0 109.979 179.804 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 3.6 m -62.95 -30.03 71.25 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.646 -0.706 . . . . 0.0 110.48 179.123 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 3.5 m -92.55 -49.67 6.0 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.346 179.951 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . 0.449 ' O ' ' HA ' ' A' ' 96' ' ' GLN . . . -145.41 144.24 12.8 Favored Glycine 0 N--CA 1.449 -0.473 0 C-N-CA 120.824 -0.703 . . . . 0.0 111.701 179.829 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' THR . . . . . 0.451 ' HB ' ' CZ ' ' A' ' 122' ' ' PHE . 0.2 OUTLIER -64.26 143.81 57.61 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-O 120.837 0.351 . . . . 0.0 110.69 179.945 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 1.7 p -110.72 126.45 68.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.077 -179.387 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 24.8 t-20 -90.91 -50.14 6.04 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 109.455 -0.572 . . . . 0.0 109.455 179.026 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -138.75 156.08 47.67 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.954 -0.567 . . . . 0.0 109.726 179.169 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 5.4 p -152.28 125.73 1.27 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.262 179.972 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 2.6 m -118.14 126.3 51.95 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 110.007 -0.368 . . . . 0.0 110.007 179.795 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' ILE . . . . . 0.489 HD13 ' HA2' ' A' ' 116' ' ' GLY . 20.9 tt -110.68 145.4 17.09 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-O 120.962 0.411 . . . . 0.0 110.794 179.816 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 32.6 tp -129.2 130.3 46.14 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.576 179.934 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -91.83 119.54 31.72 Favored 'General case' 0 N--CA 1.45 -0.47 0 CA-C-N 116.495 -0.32 . . . . 0.0 110.386 179.235 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . 0.416 ' O ' ' HG2' ' A' ' 115' ' ' LYS . 16.4 t70 -85.46 139.14 31.75 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.086 0.47 . . . . 0.0 110.633 179.917 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.3 23.49 5.98 Favored 'General case' 0 C--N 1.319 -0.749 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 179.113 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 1.1 t80 -103.82 1.79 31.97 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.542 -178.927 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 103.86 7.85 40.75 Favored Glycine 0 N--CA 1.448 -0.554 0 C-N-CA 121.066 -0.588 . . . . 0.0 112.701 179.527 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 18.3 mt-30 -98.56 158.19 32.97 Favored Pre-proline 0 C--N 1.324 -0.507 0 N-CA-C 109.489 -0.56 . . . . 0.0 109.489 179.581 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -59.26 118.91 5.87 Favored 'Trans proline' 0 C--N 1.346 0.403 0 C-N-CA 122.12 1.88 . . . . 0.0 111.169 178.665 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . 0.416 ' HG2' ' O ' ' A' ' 109' ' ' ASP . 60.1 mttt -72.93 173.74 8.82 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 109.892 -0.41 . . . . 0.0 109.892 -179.441 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . 0.489 ' HA2' HD13 ' A' ' 106' ' ' ILE . . . 100.28 2.53 55.72 Favored Glycine 0 N--CA 1.444 -0.788 0 C-N-CA 120.309 -0.948 . . . . 0.0 112.326 179.406 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 29.8 m-85 -52.48 115.2 1.65 Allowed 'General case' 0 C--N 1.333 -0.14 0 N-CA-C 110.117 -0.327 . . . . 0.0 110.117 179.445 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -144.6 175.36 10.2 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 121.087 0.47 . . . . 0.0 111.223 -178.913 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 50.8 p90 -159.26 137.75 10.73 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.58 -0.737 . . . . 0.0 109.506 179.002 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 11.3 m -110.31 140.66 28.39 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 N-CA-C 109.446 -0.576 . . . . 0.0 109.446 179.118 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 4.9 pt-20 -126.02 151.57 46.92 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.487 -0.324 . . . . 0.0 110.812 179.887 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 122' ' ' PHE . . . . . 0.451 ' CZ ' ' HB ' ' A' ' 100' ' ' THR . 10.6 t80 -148.87 167.14 26.48 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.662 179.965 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 37.7 t -84.05 -45.37 18.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 115.765 -0.652 . . . . 0.0 111.741 -179.19 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 34.2 mm-40 -73.54 137.03 44.12 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.785 0.326 . . . . 0.0 110.669 -179.24 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 2.9 mp -77.42 -34.83 21.26 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.702 -179.59 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -59.28 -36.23 75.19 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.186 0.517 . . . . 0.0 111.203 -179.786 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -62.95 -57.71 9.81 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.354 -179.818 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 10.7 p -65.03 -28.7 45.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.532 -0.304 . . . . 0.0 111.271 -179.403 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 50.2 tt0 -61.49 -43.35 99.01 Favored 'General case' 0 C--N 1.334 -0.095 0 CA-C-O 120.973 0.416 . . . . 0.0 110.23 179.602 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 46.4 m-80 -72.17 -29.98 64.54 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 121.223 0.535 . . . . 0.0 109.951 179.477 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -67.97 -50.88 53.12 Favored 'General case' 0 N--CA 1.453 -0.285 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.989 179.827 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 4.1 pp -67.41 -17.31 64.67 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.986 0.422 . . . . 0.0 110.882 -179.965 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 1.4 tp -78.06 -50.49 11.96 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.506 -179.965 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 76.5 mt -135.2 104.25 5.83 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.15 179.916 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -148.64 -56.59 0.21 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.243 0.544 . . . . 0.0 111.344 -179.035 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 3.8 pt-20 -75.24 92.6 2.75 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.667 -0.697 . . . . 0.0 111.437 -179.39 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 2.5 m -140.04 -59.31 0.55 Allowed 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.005 179.276 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 11.4 tt0 -157.88 130.06 7.09 Favored 'General case' 0 N--CA 1.45 -0.438 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.482 179.413 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -148.3 120.59 8.4 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 108.82 -0.807 . . . . 0.0 108.82 179.823 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 140' ' ' HIS . . . . . 0.455 ' HB2' ' SG ' ' A' ' 86' ' ' CYS . 1.9 t60 60.48 28.08 17.73 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-O 120.87 0.367 . . . . 0.0 110.609 179.987 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 82.62 -6.0 71.54 Favored Glycine 0 CA--C 1.519 0.299 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.688 -179.845 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 1.4 mpt_? -110.94 -177.72 3.29 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.828 0.347 . . . . 0.0 110.246 -179.951 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 20.4 pt20 -123.15 141.65 51.74 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 179.077 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -125.1 175.87 7.09 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.253 179.953 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -118.06 121.27 40.17 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 109.348 -0.612 . . . . 0.0 109.348 179.61 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 96.8 t -118.73 122.64 69.93 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-O 120.71 0.29 . . . . 0.0 111.62 -178.834 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -125.77 148.26 49.15 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.041 179.196 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -63.65 130.58 44.87 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.768 0.318 . . . . 0.0 110.536 179.464 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 15.3 ttpp -91.46 67.41 5.61 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 121.351 0.596 . . . . 0.0 110.443 -179.642 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 24.3 tpt180 -81.95 100.66 9.79 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 109.366 -0.605 . . . . 0.0 109.366 179.075 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 6.5 t -87.88 121.32 30.16 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 116.028 -0.533 . . . . 0.0 109.985 179.96 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 152' ' ' ASN . . . . . . . . . . . . . 60.6 t30 -161.15 155.22 22.6 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 109.621 -0.511 . . . . 0.0 109.621 -179.434 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 26.1 pt -81.15 146.77 59.31 Favored Pre-proline 0 C--N 1.321 -0.653 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.105 179.613 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -60.78 -33.26 93.17 Favored 'Trans proline' 0 CA--C 1.531 0.366 0 C-N-CA 122.493 2.128 . . . . 0.0 111.984 179.767 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.246 0.859 0 CA-C-O 118.598 -1.112 . . . . 0.0 111.921 179.791 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.478 0.969 0 CA-C-O 120.81 0.338 . . . . 0.0 110.289 . . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 104.38 179.93 24.81 Favored Glycine 0 N--CA 1.449 -0.464 0 C-N-CA 120.614 -0.803 . . . . 0.0 112.146 179.905 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 2.0 t -164.34 179.03 7.05 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 109.709 -0.478 . . . . 0.0 109.709 -179.85 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 8.6 t -87.25 -173.27 4.32 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 120.885 0.374 . . . . 0.0 110.436 179.857 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 22.6 p-80 -146.09 137.17 24.54 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.012 -179.836 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 4.4 m-70 -143.46 136.23 27.5 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.378 -0.373 . . . . 0.0 110.527 -179.64 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 36.3 p-80 -135.65 150.21 49.54 Favored 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 109.89 -0.411 . . . . 0.0 109.89 179.113 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 57.5 t60 -123.59 145.61 48.78 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-O 120.876 0.369 . . . . 0.0 110.836 -179.2 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -113.22 136.25 52.94 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.561 -179.944 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 5.6 p80 -161.56 139.21 8.98 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.296 179.761 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 3.8 m -130.78 155.66 46.29 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.482 -0.326 . . . . 0.0 110.174 179.856 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 47.5 m -149.47 163.96 36.36 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.59 -0.277 . . . . 0.0 110.776 -179.56 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -149.44 172.23 29.48 Favored Glycine 0 N--CA 1.449 -0.469 0 C-N-CA 121.101 -0.571 . . . . 0.0 111.694 -179.897 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -142.88 125.49 15.84 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.888 0.375 . . . . 0.0 111.035 -179.964 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 39.6 t -124.78 105.92 29.56 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.567 179.776 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 91.2 Cg_endo -88.11 165.46 7.04 Favored 'Trans proline' 0 N--CA 1.458 -0.586 0 C-N-CA 122.854 2.369 . . . . 0.0 112.116 179.143 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -146.85 156.1 42.85 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 120.678 0.275 . . . . 0.0 110.453 179.431 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -92.22 -164.74 38.57 Favored Glycine 0 N--CA 1.445 -0.705 0 C-N-CA 121.092 -0.575 . . . . 0.0 112.707 -179.626 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 4.4 t -129.42 -172.45 2.75 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 110.365 -0.235 . . . . 0.0 110.365 -179.849 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 18.3 p80 -126.86 127.74 45.42 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.719 -179.884 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 26.2 ptt? -88.78 179.72 6.16 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.555 179.97 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -129.37 -160.08 10.09 Favored Glycine 0 N--CA 1.446 -0.634 0 C-N-CA 121.061 -0.59 . . . . 0.0 112.2 179.583 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 3.4 m -120.08 168.61 11.01 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 120.828 0.347 . . . . 0.0 110.894 -179.803 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 44.4 t0 -104.39 167.79 9.51 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.131 -0.486 . . . . 0.0 109.755 179.82 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 3.5 mp -122.66 150.97 41.97 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 120.743 0.306 . . . . 0.0 111.464 -178.949 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -92.43 -172.15 3.0 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.111 179.009 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 2.4 p-10 -123.81 173.44 8.16 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.656 -0.247 . . . . 0.0 110.62 -179.853 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 21.9 ttt -156.26 144.43 19.76 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.776 -179.713 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 73.9 mttt -82.77 146.46 28.97 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 110.115 -0.328 . . . . 0.0 110.115 179.368 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 43.1 mttt -117.49 176.63 5.08 Favored 'General case' 0 C--O 1.236 0.362 0 CA-C-O 121.257 0.551 . . . . 0.0 111.779 -179.084 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 22.7 mmt180 -121.37 121.32 37.36 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.394 -0.821 . . . . 0.0 110.077 179.603 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 49.5 tp -85.45 139.9 31.14 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.42 -179.119 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.455 ' HG2' ' H ' ' A' ' 34' ' ' GLU . 26.8 tttm -157.54 -157.09 0.64 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.115 178.969 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.455 ' H ' ' HG2' ' A' ' 33' ' ' LYS . 6.9 mm-40 -65.32 144.54 57.05 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.972 0.415 . . . . 0.0 111.847 -179.267 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 34.5 mm -88.64 131.54 35.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.817 -179.374 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 5.5 tp10 -126.15 175.88 7.45 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.022 179.88 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -98.64 151.72 20.39 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.952 -179.828 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 7.8 tp10 -155.61 158.71 38.8 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.911 -0.586 . . . . 0.0 109.786 179.907 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -138.94 163.51 32.14 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.836 0.351 . . . . 0.0 111.137 -179.793 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -140.57 141.81 11.75 Favored Glycine 0 N--CA 1.449 -0.47 0 C-N-CA 120.888 -0.672 . . . . 0.0 112.308 179.617 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -157.15 -170.24 3.2 Favored 'General case' 0 C--O 1.235 0.312 0 N-CA-C 110.127 -0.323 . . . . 0.0 110.127 179.944 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 41.4 tp -78.51 92.43 4.66 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.004 0.43 . . . . 0.0 110.172 179.866 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . 0.428 ' HD3' ' SD ' ' A' ' 45' ' ' MET . 57.7 ttt180 -150.86 143.06 24.15 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.455 -179.738 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 63.3 mt-10 -81.68 39.8 0.56 Allowed 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.956 -0.566 . . . . 0.0 110.757 -179.952 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' MET . . . . . 0.428 ' SD ' ' HD3' ' A' ' 43' ' ' ARG . 17.5 ptt? -97.35 14.85 24.76 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.262 0.554 . . . . 0.0 110.141 -179.611 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 51.5 mt-30 -69.09 -28.93 66.94 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.591 -0.731 . . . . 0.0 110.492 -179.826 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -70.79 -3.01 16.62 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.781 -0.645 . . . . 0.0 111.713 -179.519 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 33.6 ttpt -84.29 -3.25 58.11 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.557 179.871 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 8.9 p -57.97 -28.71 34.37 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.266 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.364 -179.874 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . 0.419 ' O ' ' HG2' ' A' ' 53' ' ' MET . 29.4 mt-10 -67.01 -20.13 65.82 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 121.245 0.545 . . . . 0.0 110.65 179.944 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 10.6 ttmt -98.5 -41.46 7.76 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.895 -0.593 . . . . 0.0 109.627 178.996 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -63.99 -21.63 66.58 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.651 -0.704 . . . . 0.0 111.0 179.629 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' MET . . . . . 0.419 ' HG2' ' O ' ' A' ' 50' ' ' GLU . 8.3 ptt? -61.63 -27.36 68.61 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 120.973 0.416 . . . . 0.0 110.577 179.502 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -98.97 10.72 62.19 Favored Glycine 0 N--CA 1.449 -0.453 0 N-CA-C 111.144 -0.782 . . . . 0.0 111.144 178.965 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -134.7 19.68 3.56 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.383 -0.408 . . . . 0.0 110.406 179.94 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 18.1 m -65.64 -15.4 18.62 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.411 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.796 -179.888 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 14.5 mp0 -80.22 -2.58 45.55 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.489 0.661 . . . . 0.0 110.442 179.343 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -134.24 -59.47 0.83 Allowed 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.424 -0.807 . . . . 0.0 110.22 179.62 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 4.6 m -65.09 -67.85 0.41 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.589 -179.433 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -86.76 21.83 2.12 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.972 -178.705 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 3.2 t -71.56 -28.14 63.65 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 120.874 0.368 . . . . 0.0 110.926 -179.243 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -65.84 -15.52 62.98 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 112.005 0.372 . . . . 0.0 112.005 -179.502 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 93.6 p -68.31 -25.85 65.33 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.018 0.437 . . . . 0.0 110.112 179.51 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -69.21 -32.57 71.92 Favored 'General case' 0 N--CA 1.453 -0.321 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.341 179.886 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -76.21 -2.56 31.87 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.117 0.484 . . . . 0.0 111.085 179.515 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 35.3 tt0 -117.44 -50.66 2.53 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.208 -179.817 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -86.59 -58.31 2.66 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 112.105 0.409 . . . . 0.0 112.105 -178.675 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 2.9 tp10 -62.7 -31.0 71.82 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.587 -179.489 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 39.4 tptt -58.6 -28.67 65.81 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.976 -0.556 . . . . 0.0 111.169 179.87 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 49.1 mt-10 -61.98 -23.07 66.17 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-O 120.974 0.416 . . . . 0.0 111.151 -179.854 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 6.8 tp10 -97.77 -38.93 9.28 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 116.067 -0.515 . . . . 0.0 109.729 178.743 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 46.6 t -65.01 -37.15 79.52 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-N 115.687 -0.688 . . . . 0.0 112.415 -178.907 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 52.1 p-10 -74.09 -16.11 61.03 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-O 120.951 0.405 . . . . 0.0 110.886 -179.526 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 42.3 t -101.8 -6.72 23.27 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.954 -0.566 . . . . 0.0 109.857 178.359 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -112.69 42.79 1.78 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.348 0.594 . . . . 0.0 109.96 -179.382 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -122.14 171.95 8.62 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.692 -0.686 . . . . 0.0 110.25 179.71 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -132.02 139.05 51.23 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 N-CA-C 109.987 -0.375 . . . . 0.0 109.987 178.341 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' TYR . . . . . 0.431 ' O ' ' HA ' ' A' ' 146' ' ' VAL . 25.0 t80 -90.13 124.06 34.49 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.868 -0.606 . . . . 0.0 109.929 179.939 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 6.2 t -108.3 109.11 27.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.515 -0.311 . . . . 0.0 110.405 179.461 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -118.62 170.15 13.69 Favored Glycine 0 N--CA 1.447 -0.567 0 C-N-CA 120.996 -0.621 . . . . 0.0 111.7 -179.9 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 92.2 m-20 56.51 42.56 27.17 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-O 121.015 0.436 . . . . 0.0 110.829 -179.477 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 2.3 t -81.98 165.14 2.69 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-N 115.862 -0.608 . . . . 0.0 111.048 -178.998 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . 0.458 ' HB3' ' SG ' ' A' ' 86' ' ' CYS . 37.3 t70 -68.2 137.81 55.11 Favored 'General case' 0 CA--C 1.519 -0.212 0 N-CA-C 109.871 -0.418 . . . . 0.0 109.871 179.597 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 18.1 p90 -66.59 -10.07 41.8 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.901 -178.87 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -118.94 19.43 13.03 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.001 0.429 . . . . 0.0 110.719 179.521 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' CYS . . . . . 0.458 ' SG ' ' HB3' ' A' ' 83' ' ' ASP . 0.7 OUTLIER -79.45 149.28 31.61 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.966 180.0 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' THR . . . . . 0.476 ' O ' ' HG2' ' A' ' 90' ' ' GLU . 2.9 p -112.61 145.92 33.94 Favored Pre-proline 0 C--N 1.326 -0.441 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.659 179.226 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 11.2 Cg_endo -54.29 -42.56 66.45 Favored 'Trans proline' 0 C--N 1.344 0.311 0 C-N-CA 122.942 2.428 . . . . 0.0 113.039 -178.996 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -62.05 -45.7 92.41 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.302 -0.408 . . . . 0.0 112.011 -179.429 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . 0.622 ' O ' ' HB2' ' A' ' 94' ' ' HIS . 4.8 pt-20 -67.68 -21.76 65.32 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.723 0.297 . . . . 0.0 111.24 -178.765 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 76.2 t -82.17 -48.31 18.42 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.734 -179.108 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 2.4 pt20 -71.54 -31.33 66.9 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.441 -0.345 . . . . 0.0 111.451 -178.258 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -80.13 -26.59 39.35 Favored 'General case' 0 C--N 1.327 -0.386 0 C-N-CA 120.53 -0.468 . . . . 0.0 110.586 -179.793 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' HIS . . . . . 0.622 ' HB2' ' O ' ' A' ' 90' ' ' GLU . 0.1 OUTLIER -72.17 -42.1 66.27 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.994 0.426 . . . . 0.0 110.483 -179.959 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 19.9 m-30 -80.63 -15.33 56.84 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.377 179.913 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . 0.542 ' HA ' ' O ' ' A' ' 99' ' ' GLY . 30.1 tt0 -62.77 -28.85 70.27 Favored 'General case' 0 CA--C 1.523 -0.065 0 CA-C-N 115.549 -0.75 . . . . 0.0 109.607 178.704 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 14.2 m -63.4 -23.05 67.24 Favored 'General case' 0 CA--C 1.533 0.291 0 CA-C-N 115.491 -0.777 . . . . 0.0 110.852 179.302 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 7.4 m -100.2 -43.97 6.12 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.169 -0.469 . . . . 0.0 109.807 179.044 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . 0.542 ' O ' ' HA ' ' A' ' 96' ' ' GLN . . . -150.19 139.31 7.25 Favored Glycine 0 N--CA 1.444 -0.81 0 N-CA-C 111.071 -0.811 . . . . 0.0 111.071 179.491 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -60.41 149.92 32.51 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 121.072 0.463 . . . . 0.0 111.564 -179.705 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 2.0 p -114.28 129.36 70.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.352 -178.897 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 8.0 t30 -94.05 -38.33 11.19 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.306 0.574 . . . . 0.0 109.817 179.078 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -155.15 149.32 25.91 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.573 -0.739 . . . . 0.0 110.289 -179.72 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 7.7 p -145.93 135.25 17.36 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 CA-C-N 116.015 -0.538 . . . . 0.0 110.15 179.858 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' THR . . . . . 0.493 ' HB ' ' CE1' ' A' ' 119' ' ' TYR . 2.3 m -126.37 119.74 28.08 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.468 -0.333 . . . . 0.0 110.232 179.62 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 20.1 tt -108.24 143.42 18.67 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-O 120.808 0.337 . . . . 0.0 110.512 179.991 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 36.4 tp -129.39 135.39 48.63 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.713 -179.713 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -94.42 116.62 29.01 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 109.833 -0.432 . . . . 0.0 109.833 179.045 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -84.46 134.06 34.46 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.194 0.521 . . . . 0.0 110.87 -179.676 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 11.2 mmmm -117.77 24.22 11.2 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.742 -0.663 . . . . 0.0 109.703 179.915 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 11.6 t80 -106.87 10.77 30.55 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.208 0.528 . . . . 0.0 110.237 -179.02 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 93.79 6.83 61.88 Favored Glycine 0 N--CA 1.449 -0.461 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.697 179.396 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 27.8 mt-30 -95.47 157.61 35.93 Favored Pre-proline 0 C--N 1.323 -0.586 0 N-CA-C 109.752 -0.462 . . . . 0.0 109.752 179.89 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 11.0 Cg_endo -56.16 117.83 4.54 Favored 'Trans proline' 0 N--CA 1.462 -0.348 0 C-N-CA 122.237 1.958 . . . . 0.0 110.811 178.458 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 47.2 mttt -76.88 172.46 13.1 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 109.63 -0.507 . . . . 0.0 109.63 -179.289 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 98.08 0.67 58.52 Favored Glycine 0 N--CA 1.446 -0.693 0 C-N-CA 120.115 -1.041 . . . . 0.0 112.599 179.596 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 1.8 t80 -52.99 119.28 4.48 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 121.018 0.437 . . . . 0.0 110.08 179.423 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -145.24 177.06 9.08 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.992 -178.845 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 119' ' ' TYR . . . . . 0.493 ' CE1' ' HB ' ' A' ' 105' ' ' THR . 49.9 p90 -158.34 133.91 8.86 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.606 -0.725 . . . . 0.0 109.059 178.905 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 6.8 m -108.97 143.22 19.61 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.659 0 N-CA-C 109.666 -0.494 . . . . 0.0 109.666 178.895 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 7.4 pt-20 -127.7 153.7 46.19 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.43 -0.35 . . . . 0.0 110.753 -179.903 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 8.4 t80 -151.97 169.57 21.99 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.297 179.318 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 3.0 t -89.52 -48.1 14.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 120.844 0.354 . . . . 0.0 111.376 -179.59 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -69.76 127.88 34.46 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.876 0.37 . . . . 0.0 110.86 -179.248 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 2.5 mp -68.03 -33.17 59.54 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.314 -179.075 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -58.09 -42.12 84.93 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.839 0.352 . . . . 0.0 111.465 -179.991 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -56.94 -56.47 21.33 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.171 -179.777 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 8.9 p -68.56 -28.32 39.79 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.363 -179.527 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 3.5 tt0 -63.01 -39.25 94.19 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.977 0.418 . . . . 0.0 110.453 -179.905 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 41.2 m-80 -77.7 -29.66 51.45 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.266 0.555 . . . . 0.0 109.797 179.096 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . 0.454 ' O ' ' HB2' ' A' ' 135' ' ' ASN . . . -67.65 -49.6 62.04 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.422 -0.808 . . . . 0.0 111.161 179.829 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 4.4 pp -66.38 -13.27 60.4 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.886 0.374 . . . . 0.0 111.555 -179.578 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 3.9 tp -89.06 -49.9 6.48 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.153 0.501 . . . . 0.0 109.986 179.036 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 25.3 mt -126.69 100.91 6.4 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.057 179.729 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 135' ' ' ASN . . . . . 0.454 ' HB2' ' O ' ' A' ' 131' ' ' ALA . 0.2 OUTLIER -150.62 -58.28 0.18 Allowed 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.239 0.542 . . . . 0.0 111.628 -179.293 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 4.6 pt-20 -77.5 85.98 3.86 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.8 -0.636 . . . . 0.0 111.67 -178.98 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 23.9 m -134.44 -58.88 0.83 Allowed 'General case' 0 N--CA 1.448 -0.526 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.117 179.248 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 6.8 tm-20 -155.02 128.37 8.4 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.906 0.384 . . . . 0.0 111.002 179.646 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -143.45 111.59 6.19 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 178.269 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 140' ' ' HIS . . . . . 0.454 ' HD1' ' CD ' ' A' ' 90' ' ' GLU . 1.7 t60 61.01 28.8 18.57 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.97 0.414 . . . . 0.0 110.7 -179.833 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 85.39 0.94 88.22 Favored Glycine 0 N--CA 1.449 -0.499 0 C-N-CA 120.978 -0.629 . . . . 0.0 113.043 179.779 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 142' ' ' ARG . . . . . 0.412 ' HD3' ' OD1' ' A' ' 83' ' ' ASP . 1.4 mpt_? -117.52 163.66 16.08 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 117.147 0.473 . . . . 0.0 110.868 179.928 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 2.1 pt20 -110.69 121.8 46.22 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 116.256 -0.429 . . . . 0.0 109.932 179.799 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -106.46 178.78 4.46 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.992 -179.025 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 6.1 tttt -115.44 121.78 43.77 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.088 -0.505 . . . . 0.0 109.859 178.893 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 146' ' ' VAL . . . . . 0.431 ' HA ' ' O ' ' A' ' 78' ' ' TYR . 96.9 t -120.98 126.9 75.77 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-O 121.094 0.473 . . . . 0.0 111.212 -179.712 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 39.7 m -134.61 151.73 51.27 Favored 'General case' 0 C--N 1.319 -0.743 0 N-CA-C 109.582 -0.525 . . . . 0.0 109.582 178.91 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -65.0 131.4 46.49 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.128 0.49 . . . . 0.0 111.46 -179.101 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 21.0 ttpt -93.48 80.29 4.35 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 121.363 0.601 . . . . 0.0 109.813 179.611 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 21.5 tpt180 -93.64 104.65 16.74 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.346 -0.843 . . . . 0.0 109.483 179.236 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 9.6 t -89.07 136.97 32.73 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 116.083 -0.508 . . . . 0.0 109.803 179.262 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 152' ' ' ASN . . . . . . . . . . . . . 59.8 t30 -172.51 154.87 3.24 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 108.89 -0.782 . . . . 0.0 108.89 -179.864 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 24.1 pt -71.39 139.23 84.1 Favored Pre-proline 0 C--N 1.32 -0.705 0 CA-C-O 120.635 0.255 . . . . 0.0 110.375 179.763 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 20.7 Cg_endo -61.9 119.16 6.14 Favored 'Trans proline' 0 N--CA 1.462 -0.328 0 C-N-CA 122.549 2.166 . . . . 0.0 112.169 179.954 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.063 0 CA-C-O 118.822 -0.988 . . . . 0.0 111.397 179.994 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.2 mpp? . . . . . 0 N--CA 1.481 1.122 0 N-CA-C 110.206 -0.294 . . . . 0.0 110.206 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -139.76 138.78 9.43 Favored Glycine 0 N--CA 1.445 -0.765 0 C-N-CA 120.858 -0.687 . . . . 0.0 111.763 179.557 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 16.7 m -145.24 126.36 14.67 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 120.761 0.315 . . . . 0.0 110.2 179.985 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 46.9 m -154.45 120.42 5.26 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.709 -179.439 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -160.07 124.41 3.77 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.25 179.802 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -152.62 126.82 9.17 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.43 -0.35 . . . . 0.0 110.23 -179.948 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 6.5 p80 -141.37 147.02 37.38 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 109.964 -0.384 . . . . 0.0 109.964 179.947 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 57.4 t60 -171.8 112.93 0.33 Allowed 'General case' 0 C--N 1.328 -0.333 0 O-C-N 123.182 0.301 . . . . 0.0 111.061 -179.5 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 7.9 t-80 -167.19 114.52 0.79 Allowed 'General case' 0 N--CA 1.464 0.241 0 CA-C-O 120.723 0.297 . . . . 0.0 111.021 178.998 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 1.5 m-70 -156.76 122.04 4.67 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.671 179.954 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -129.62 147.72 51.45 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.48 -0.327 . . . . 0.0 110.595 179.159 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -147.33 164.88 31.85 Favored 'General case' 0 C--O 1.237 0.436 0 CA-C-N 116.58 -0.282 . . . . 0.0 111.051 179.852 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -174.62 161.17 30.8 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.819 -0.705 . . . . 0.0 112.561 -179.976 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 15.2 tp -118.84 140.96 49.11 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.64 0.257 . . . . 0.0 110.606 179.851 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -117.51 109.56 41.77 Favored Pre-proline 0 C--N 1.325 -0.478 0 CA-C-O 120.91 0.386 . . . . 0.0 110.586 179.421 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 87.2 Cg_endo -84.44 -175.49 2.17 Favored 'Trans proline' 0 N--CA 1.461 -0.388 0 C-N-CA 122.829 2.353 . . . . 0.0 112.913 -179.743 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -143.06 121.26 12.2 Favored 'General case' 0 N--CA 1.452 -0.343 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.114 -179.807 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 173.35 87.37 0.07 OUTLIER Glycine 0 N--CA 1.448 -0.538 0 C-N-CA 120.842 -0.695 . . . . 0.0 111.905 -179.923 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 6.0 m -138.42 157.77 45.57 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 110.305 -0.257 . . . . 0.0 110.305 179.615 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 14.4 p80 -145.24 163.12 35.41 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 116.498 -0.319 . . . . 0.0 110.207 179.475 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 3.5 mpp? -108.06 -179.04 3.78 Favored 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 109.482 -0.562 . . . . 0.0 109.482 179.336 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 132.03 93.52 0.58 Allowed Glycine 0 N--CA 1.446 -0.653 0 C-N-CA 120.228 -0.986 . . . . 0.0 112.719 179.645 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 3.4 p -131.05 99.13 4.78 Favored 'General case' 0 C--N 1.32 -0.704 0 N-CA-C 110.079 -0.341 . . . . 0.0 110.079 179.815 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -146.61 97.4 2.91 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.546 -0.297 . . . . 0.0 110.367 179.782 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 4.0 mt -165.72 -167.39 1.1 Allowed 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.925 -0.579 . . . . 0.0 109.83 179.925 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 8.7 mm-40 -80.18 179.82 7.45 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.864 0.364 . . . . 0.0 111.071 179.771 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -134.16 171.86 13.66 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.656 -178.653 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 8.8 ttm -113.18 150.55 32.12 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 178.387 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 31.8 mmmt -61.52 -79.41 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.199 0 N-CA-C 110.434 -0.21 . . . . 0.0 110.434 -179.897 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 47.5 pttt -167.93 128.47 1.37 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.97 0.414 . . . . 0.0 110.789 178.956 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -109.26 1.92 20.51 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.641 -0.709 . . . . 0.0 109.969 179.375 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 16.6 tp 60.35 70.38 0.63 Allowed 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.247 -0.888 . . . . 0.0 110.952 179.787 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 15.6 ptpt -159.49 159.25 33.26 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.797 -0.638 . . . . 0.0 109.857 179.574 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 26.7 tt0 -161.58 87.65 0.69 Allowed 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 120.839 0.352 . . . . 0.0 110.157 -179.68 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 19.3 tt -147.36 149.5 15.5 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-O 120.766 0.317 . . . . 0.0 110.566 -179.307 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -119.44 175.4 5.85 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.173 179.317 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 5.2 tt0 -144.39 -160.62 1.15 Allowed 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.396 179.869 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 4.4 mm-40 -94.15 152.44 18.74 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 116.62 -0.264 . . . . 0.0 110.395 179.916 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -70.32 158.6 35.63 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.361 -179.226 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -82.3 -158.99 24.66 Favored Glycine 0 N--CA 1.448 -0.535 0 C-N-CA 121.027 -0.606 . . . . 0.0 112.438 179.783 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -152.73 -150.8 0.35 Allowed 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 120.732 0.301 . . . . 0.0 110.665 -179.875 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 46.6 tp -72.75 90.1 1.39 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.346 179.699 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 51.2 ttt85 -154.43 147.13 24.25 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.064 -179.817 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 15.7 mt-10 -81.73 29.92 0.38 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.033 0.444 . . . . 0.0 111.111 -179.877 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 13.9 ptt? -83.64 1.83 40.44 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.277 0.56 . . . . 0.0 110.142 -179.924 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 38.6 mt-30 -71.4 -17.01 62.43 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.751 -179.793 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -78.31 -11.62 59.95 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.242 179.374 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 35.5 ttpt -77.8 -0.09 25.81 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.718 -0.674 . . . . 0.0 110.246 179.717 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 8.1 p -59.49 -26.03 33.12 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.237 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.901 179.883 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 25.7 mt-10 -67.37 -24.95 65.75 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.72 179.571 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 4.3 ttmt -98.81 -34.59 10.43 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.454 179.192 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 9.1 mm-40 -66.1 -16.04 63.6 Favored 'General case' 0 C--N 1.333 -0.112 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.22 179.781 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -64.53 -25.44 67.99 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.178 0.513 . . . . 0.0 109.785 178.694 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -97.41 12.04 65.02 Favored Glycine 0 N--CA 1.45 -0.378 0 N-CA-C 110.709 -0.956 . . . . 0.0 110.709 179.044 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -138.92 26.34 2.47 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.256 -0.472 . . . . 0.0 109.942 179.777 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 16.0 m -63.32 -20.17 25.46 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.419 0 CA-C-N 116.094 -0.503 . . . . 0.0 112.073 -179.65 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 16.4 mt-30 -80.22 -5.1 55.59 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.233 0.54 . . . . 0.0 110.437 179.534 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -123.88 -48.35 1.89 Allowed 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.534 -0.757 . . . . 0.0 110.974 -179.799 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 16.5 m -81.86 -56.98 3.63 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.735 -0.666 . . . . 0.0 112.595 -178.675 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -98.81 27.18 5.09 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.068 0.461 . . . . 0.0 111.344 -178.576 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 7.6 t -70.22 -31.54 69.01 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-O 121.157 0.503 . . . . 0.0 110.316 -179.742 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -68.52 -22.77 64.5 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.854 -0.612 . . . . 0.0 111.474 179.968 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 3.5 m -63.13 -26.91 69.04 Favored 'General case' 0 N--CA 1.449 -0.499 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.823 -179.275 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -71.72 -32.77 68.12 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.908 0.385 . . . . 0.0 110.575 179.559 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -74.47 -2.13 24.25 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.466 -179.922 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 22.5 tp60 -118.98 -49.37 2.42 Favored 'General case' 0 N--CA 1.451 -0.404 0 CA-C-O 120.593 0.235 . . . . 0.0 111.315 179.876 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -84.59 -52.68 5.93 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.881 0.372 . . . . 0.0 111.92 -178.549 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . 0.404 ' O ' HG23 ' A' ' 72' ' ' VAL . 1.3 tp10 -69.62 -30.67 68.45 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.989 0.423 . . . . 0.0 110.615 -179.387 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 50.9 tptt -55.81 -33.65 64.62 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.714 179.908 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 54.4 mt-10 -58.85 -25.7 63.51 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-O 121.02 0.438 . . . . 0.0 111.31 179.943 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 4.4 tp10 -93.82 -40.21 10.31 Favored 'General case' 0 N--CA 1.449 -0.517 0 N-CA-C 109.711 -0.477 . . . . 0.0 109.711 178.786 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.404 HG23 ' O ' ' A' ' 68' ' ' GLU . 61.8 t -63.01 -43.45 99.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 115.706 -0.679 . . . . 0.0 112.658 -178.804 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 9.0 p-10 -70.81 -18.89 62.73 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-O 121.154 0.502 . . . . 0.0 110.894 -179.365 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 49.1 m -97.79 -8.69 27.94 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.051 178.272 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -111.41 48.31 0.95 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.562 -0.744 . . . . 0.0 110.11 -179.368 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' SER . . . . . 0.467 ' OG ' ' HE2' ' A' ' 149' ' ' LYS . 0.1 OUTLIER -129.95 172.76 11.37 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.921 -0.581 . . . . 0.0 111.26 179.86 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -131.01 138.14 54.2 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-N 115.847 -0.615 . . . . 0.0 109.573 178.434 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 57.2 t80 -96.64 125.32 41.03 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.405 -179.485 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 2.9 t -104.8 118.41 52.09 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.391 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.843 -179.405 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -124.46 168.18 16.64 Favored Glycine 0 N--CA 1.449 -0.472 0 N-CA-C 110.936 -0.866 . . . . 0.0 110.936 179.521 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 2.4 m-20 59.42 34.75 22.81 Favored 'General case' 0 N--CA 1.474 0.746 0 CA-C-O 120.834 0.35 . . . . 0.0 111.279 -179.39 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 2.2 t -76.4 163.51 3.91 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.724 0 CA-C-N 115.616 -0.72 . . . . 0.0 110.652 -178.975 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . 0.713 ' OD2' ' HB2' ' A' ' 142' ' ' ARG . 0.5 OUTLIER -63.48 137.66 58.22 Favored 'General case' 0 CA--C 1.515 -0.369 0 N-CA-C 109.67 -0.492 . . . . 0.0 109.67 179.015 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 37.2 p90 -66.17 -8.79 26.33 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.07 -179.768 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -120.41 20.54 11.87 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.038 -179.805 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -86.48 146.34 26.44 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.817 0.342 . . . . 0.0 111.052 -179.97 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' THR . . . . . 0.411 ' O ' ' HG2' ' A' ' 90' ' ' GLU . 17.7 p -109.73 155.0 42.2 Favored Pre-proline 0 C--N 1.323 -0.57 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.412 179.841 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -59.05 -38.88 84.9 Favored 'Trans proline' 0 C--N 1.345 0.372 0 C-N-CA 122.709 2.272 . . . . 0.0 112.929 -178.928 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 24.3 mt-10 -62.36 -50.57 71.04 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.766 -0.652 . . . . 0.0 112.348 -178.496 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . 0.411 ' HG2' ' O ' ' A' ' 87' ' ' THR . 11.1 pt-20 -66.31 -16.73 64.28 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.672 0.273 . . . . 0.0 111.535 -178.972 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 56.0 t -86.44 -47.23 16.39 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 CA-C-O 120.93 0.395 . . . . 0.0 110.495 -179.904 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -71.7 -33.39 68.73 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.791 -178.576 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 1.2 pp0? -77.09 -29.03 54.77 Favored 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 120.378 -0.529 . . . . 0.0 111.33 -178.759 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 2.9 m80 -76.7 -40.31 49.19 Favored 'General case' 0 C--N 1.327 -0.376 0 C-N-CA 120.725 -0.39 . . . . 0.0 110.809 -179.635 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 22.0 m-30 -75.61 -16.53 60.21 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.58 179.899 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . 0.624 ' HA ' ' O ' ' A' ' 99' ' ' GLY . 2.7 tt0 -66.89 -21.77 65.99 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-N 115.982 -0.553 . . . . 0.0 110.391 179.22 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 46.7 m -66.14 -24.26 66.63 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-N 115.905 -0.588 . . . . 0.0 110.074 179.015 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 2.6 m -100.59 -48.84 4.39 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.635 -0.711 . . . . 0.0 109.497 179.042 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . 0.624 ' O ' ' HA ' ' A' ' 96' ' ' GLN . . . -142.18 138.4 8.5 Favored Glycine 0 N--CA 1.446 -0.666 0 N-CA-C 111.41 -0.676 . . . . 0.0 111.41 179.766 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -59.81 148.36 34.81 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.735 0.267 . . . . 0.0 111.413 -179.934 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 2.1 p -119.88 129.28 75.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.216 -179.237 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 58.2 t30 -100.42 -43.19 6.32 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.863 0.363 . . . . 0.0 110.182 178.986 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -139.77 148.6 42.45 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.392 179.996 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 5.9 p -148.07 134.33 12.45 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-N 115.856 -0.611 . . . . 0.0 109.854 179.286 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 2.8 m -126.01 122.89 37.17 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 116.479 -0.328 . . . . 0.0 110.341 179.554 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 20.3 tt -112.02 148.0 15.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 120.895 0.379 . . . . 0.0 111.136 -179.61 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 27.5 tp -136.5 128.19 28.94 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.156 178.997 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -90.06 120.69 31.47 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 109.848 -0.427 . . . . 0.0 109.848 179.315 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . 0.429 ' O ' ' HG2' ' A' ' 115' ' ' LYS . 12.8 t70 -79.53 145.1 33.36 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.087 0.47 . . . . 0.0 111.088 -179.992 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . 0.401 ' HD3' ' C ' ' A' ' 109' ' ' ASP . 0.0 OUTLIER -131.59 23.83 4.72 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.8 -0.636 . . . . 0.0 109.286 179.161 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 4.8 t80 -106.62 -5.4 18.7 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.428 -179.126 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 108.39 12.56 21.25 Favored Glycine 0 CA--C 1.519 0.287 0 C-N-CA 120.979 -0.629 . . . . 0.0 112.86 -179.956 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 22.6 mt-30 -99.84 159.19 30.56 Favored Pre-proline 0 C--N 1.323 -0.563 0 N-CA-C 109.662 -0.496 . . . . 0.0 109.662 179.701 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo -58.85 110.04 0.61 Allowed 'Trans proline' 0 C--N 1.346 0.44 0 C-N-CA 122.233 1.955 . . . . 0.0 110.863 178.645 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . 0.429 ' HG2' ' O ' ' A' ' 109' ' ' ASP . 30.5 mttt -69.6 170.9 9.83 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.553 -178.616 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 101.46 4.71 52.7 Favored Glycine 0 N--CA 1.446 -0.646 0 C-N-CA 120.514 -0.851 . . . . 0.0 111.877 -179.841 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 34.1 m-85 -53.01 117.89 3.32 Favored 'General case' 0 C--O 1.232 0.167 0 C-N-CA 122.338 0.255 . . . . 0.0 110.492 179.671 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -149.18 171.54 16.28 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 121.0 0.429 . . . . 0.0 111.13 -179.314 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 17.2 p90 -154.96 132.58 11.31 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 115.501 -0.772 . . . . 0.0 109.645 178.411 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 8.5 m -108.06 142.83 19.71 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 N-CA-C 109.726 -0.472 . . . . 0.0 109.726 179.735 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . 0.424 ' HB3' ' HB3' ' A' ' 76' ' ' SER . 4.5 pt-20 -130.92 153.42 49.18 Favored 'General case' 0 C--O 1.238 0.5 0 CA-C-O 120.944 0.402 . . . . 0.0 111.235 179.987 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 11.5 t80 -148.26 172.67 13.99 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.644 -0.707 . . . . 0.0 110.095 179.834 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 6.3 t -89.37 -41.86 14.09 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-O 121.028 0.442 . . . . 0.0 111.192 -179.742 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 38.7 mm-40 -69.96 128.92 38.02 Favored 'General case' 0 C--O 1.236 0.392 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.937 -179.83 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 2.7 mp -74.57 -33.95 33.78 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.177 -179.869 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -59.85 -37.28 78.81 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.435 179.633 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -63.56 -56.49 15.56 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.641 -0.709 . . . . 0.0 111.256 -179.789 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 11.0 p -65.77 -28.06 43.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.367 -179.367 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 5.9 tt0 -60.38 -43.93 96.12 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-O 121.006 0.431 . . . . 0.0 110.371 179.447 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 92.5 m-20 -72.48 -31.57 65.5 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.053 -0.522 . . . . 0.0 110.05 179.699 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -67.53 -42.86 82.07 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.51 -0.768 . . . . 0.0 111.636 -179.857 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 4.1 pp -74.15 -17.67 60.89 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.915 0.388 . . . . 0.0 110.914 179.976 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 6.2 tp -83.8 -56.39 3.73 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.673 179.939 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 54.1 mt -125.38 103.18 7.77 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.642 -0.254 . . . . 0.0 111.44 -179.113 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 2.4 m-20 -154.49 -53.19 0.1 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.885 0.374 . . . . 0.0 111.15 178.764 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 3.9 pt-20 -75.82 98.22 4.11 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.464 0.65 . . . . 0.0 111.08 -179.888 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 43.3 m -145.92 -57.54 0.31 Allowed 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.669 -0.696 . . . . 0.0 109.821 178.865 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 24.4 tt0 -163.17 130.05 3.44 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 109.436 -0.579 . . . . 0.0 109.436 178.954 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -148.46 122.31 9.34 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 108.603 -0.888 . . . . 0.0 108.603 179.677 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 140' ' ' HIS . . . . . 0.648 ' HB3' ' OD2' ' A' ' 83' ' ' ASP . 5.0 t60 64.43 3.16 1.77 Allowed 'General case' 0 N--CA 1.471 0.623 0 O-C-N 123.544 0.528 . . . . 0.0 111.723 179.005 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 109.65 -9.93 32.56 Favored Glycine 0 N--CA 1.446 -0.637 0 C-N-CA 121.123 -0.56 . . . . 0.0 112.127 -179.704 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 142' ' ' ARG . . . . . 0.713 ' HB2' ' OD2' ' A' ' 83' ' ' ASP . 1.0 OUTLIER -111.7 170.98 7.76 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.154 0.502 . . . . 0.0 110.375 179.876 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 7.4 pt20 -113.0 129.67 56.41 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 179.303 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -113.91 173.27 6.51 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-O 120.907 0.384 . . . . 0.0 110.474 -179.645 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 8.8 ttpt -113.23 118.02 33.5 Favored 'General case' 0 C--N 1.318 -0.775 0 N-CA-C 109.428 -0.582 . . . . 0.0 109.428 179.278 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 96.7 t -114.42 116.95 54.1 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.659 0 CA-C-O 120.756 0.312 . . . . 0.0 110.431 -179.909 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 25.7 m -127.12 146.38 50.41 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 109.393 -0.595 . . . . 0.0 109.393 179.674 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -56.85 130.6 46.46 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 120.978 0.418 . . . . 0.0 111.501 -179.234 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 149' ' ' LYS . . . . . 0.467 ' HE2' ' OG ' ' A' ' 76' ' ' SER . 18.0 ttpt -93.2 63.11 3.59 Favored 'General case' 0 N--CA 1.451 -0.378 0 N-CA-C 108.622 -0.881 . . . . 0.0 108.622 179.508 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 16.4 tpt180 -84.99 90.76 7.91 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 121.31 0.576 . . . . 0.0 110.25 -179.867 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 13.7 t -74.75 141.19 44.44 Favored 'General case' 0 N--CA 1.44 -0.927 0 N-CA-C 108.622 -0.881 . . . . 0.0 108.622 178.442 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 152' ' ' ASN . . . . . . . . . . . . . 64.3 t30 -172.04 166.34 6.19 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 120.64 0.257 . . . . 0.0 110.551 -178.953 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 23.5 pt -79.58 152.29 75.22 Favored Pre-proline 0 C--N 1.325 -0.469 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.041 179.087 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -76.02 55.95 4.67 Favored 'Trans proline' 0 C--N 1.345 0.359 0 C-N-CA 122.55 2.167 . . . . 0.0 112.478 179.917 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.166 0 CA-C-O 118.491 -1.172 . . . . 0.0 111.927 -179.71 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 5.2 mpp? . . . . . 0 N--CA 1.481 1.085 0 CA-C-O 120.792 0.33 . . . . 0.0 110.141 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 155.67 128.52 1.13 Allowed Glycine 0 N--CA 1.448 -0.552 0 C-N-CA 120.933 -0.651 . . . . 0.0 112.292 -179.608 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 31.4 m -134.95 140.29 45.59 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 110.291 -0.263 . . . . 0.0 110.291 -179.971 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 8.1 m -107.15 154.4 21.24 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 120.514 0.197 . . . . 0.0 110.532 -179.804 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 7.7 p80 -165.09 138.81 4.78 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.705 -0.225 . . . . 0.0 110.657 -179.629 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 41.9 t-80 -161.58 138.12 8.28 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.444 179.619 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 1.9 m-70 -129.4 164.66 23.16 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.172 179.374 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -145.56 142.08 28.81 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.473 -0.33 . . . . 0.0 110.684 179.81 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 12.3 p-80 -143.19 162.22 36.19 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.724 0.297 . . . . 0.0 110.929 179.721 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 46.2 t-80 -155.33 148.73 25.0 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 109.73 -0.471 . . . . 0.0 109.73 179.826 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 3.1 m -88.1 174.59 8.17 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 120.687 0.279 . . . . 0.0 111.01 179.863 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 45.3 m -120.85 -162.31 0.95 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.951 179.801 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -146.62 173.87 26.69 Favored Glycine 0 N--CA 1.449 -0.45 0 N-CA-C 111.537 -0.625 . . . . 0.0 111.537 -179.771 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 23.3 tp -60.17 137.29 58.14 Favored 'General case' 0 C--O 1.238 0.45 0 CA-C-O 120.953 0.406 . . . . 0.0 111.376 -179.591 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . 0.439 ' HB ' ' CE ' ' A' ' 33' ' ' LYS . 10.2 m -138.86 148.48 58.25 Favored Pre-proline 0 C--N 1.324 -0.505 0 CA-C-N 115.806 -0.634 . . . . 0.0 111.038 -179.744 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 70.6 Cg_endo -76.94 131.31 12.0 Favored 'Trans proline' 0 C--N 1.346 0.438 0 C-N-CA 122.61 2.206 . . . . 0.0 110.954 178.183 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . 0.506 ' HA ' ' OE2' ' A' ' 68' ' ' GLU . 2.0 mpt_? -86.11 150.76 24.2 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.094 0.473 . . . . 0.0 111.933 -178.411 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -139.99 -149.88 5.4 Favored Glycine 0 CA--C 1.522 0.503 0 CA-C-N 115.549 -0.75 . . . . 0.0 112.129 179.198 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' SER . . . . . 0.409 ' N ' HG12 ' A' ' 35' ' ' ILE . 0.0 OUTLIER -150.28 133.7 16.47 Favored 'General case' 0 CA--C 1.532 0.285 0 CA-C-N 116.847 0.324 . . . . 0.0 111.299 179.899 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . 0.455 ' CE1' ' HA ' ' A' ' 37' ' ' GLU . 0.2 OUTLIER -174.17 167.49 4.13 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 122.353 0.261 . . . . 0.0 110.326 179.311 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 92.8 mtp -120.7 145.78 47.12 Favored 'General case' 0 C--O 1.235 0.321 0 N-CA-C 108.751 -0.833 . . . . 0.0 108.751 178.217 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -169.73 -139.94 2.85 Favored Glycine 0 C--N 1.331 0.302 0 C-N-CA 119.939 -1.124 . . . . 0.0 113.893 -179.287 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 46.5 m -127.98 -155.8 0.72 Allowed 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 122.297 0.239 . . . . 0.0 110.749 -178.925 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 12.0 t70 -124.5 142.31 51.43 Favored 'General case' 0 C--N 1.328 -0.345 0 O-C-N 122.068 -0.395 . . . . 0.0 110.872 -179.9 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 42.9 tp -171.42 107.63 0.25 Allowed 'General case' 0 CA--C 1.532 0.259 0 CA-C-O 120.952 0.406 . . . . 0.0 110.894 -179.621 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 4.3 tt0 -94.25 131.42 39.86 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.352 179.5 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 4.1 t70 -146.12 -145.05 0.16 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.625 -0.261 . . . . 0.0 110.443 -179.944 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -70.79 161.98 29.95 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.992 0.425 . . . . 0.0 111.202 -179.874 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 44.5 mttm -99.21 108.58 21.19 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.09 -178.917 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 10.4 mptt -128.15 151.96 48.6 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.539 179.517 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -102.72 -170.19 1.77 Allowed 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.879 -0.601 . . . . 0.0 109.755 179.096 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER 63.56 68.62 0.59 Allowed 'General case' 0 N--CA 1.465 0.302 0 CA-C-O 121.255 0.55 . . . . 0.0 111.081 -179.677 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.514 ' HZ2' ' CD ' ' A' ' 68' ' ' GLU . 0.5 OUTLIER -141.74 163.66 32.3 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.734 -0.666 . . . . 0.0 109.554 179.84 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -110.88 -81.22 0.58 Allowed 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 109.879 -0.415 . . . . 0.0 109.879 179.502 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.428 HD13 HG23 ' A' ' 123' ' ' VAL . 8.6 tp -174.59 47.3 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-O 122.398 1.094 . . . . 0.0 110.643 -179.591 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 1.3 pm0 -87.14 -173.01 4.22 Favored 'General case' 0 C--N 1.314 -0.944 0 CA-C-N 115.472 -0.785 . . . . 0.0 110.607 179.964 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . 0.455 ' HA ' ' CE1' ' A' ' 20' ' ' HIS . 26.9 mt-10 -77.62 -150.89 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.662 -0.244 . . . . 0.0 111.184 -179.508 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . 0.68 ' HB3' ' OG1' ' A' ' 65' ' ' THR . 1.6 pm0 -139.82 126.7 20.77 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.72 0.295 . . . . 0.0 111.096 -179.728 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -168.21 100.76 0.44 Allowed 'General case' 0 C--O 1.232 0.155 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.82 -179.844 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 177.29 -179.72 47.95 Favored Glycine 0 N--CA 1.448 -0.519 0 N-CA-C 111.559 -0.616 . . . . 0.0 111.559 -179.787 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -149.15 170.91 17.35 Favored 'General case' 0 C--O 1.237 0.444 0 CA-C-O 120.891 0.377 . . . . 0.0 111.547 -179.596 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 16.2 tp -72.11 80.42 0.96 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.422 -0.808 . . . . 0.0 111.015 179.862 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . 0.436 ' C ' ' H ' ' A' ' 45' ' ' MET . 0.8 OUTLIER -126.6 148.93 49.72 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 115.765 -0.652 . . . . 0.0 109.391 179.449 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -75.98 23.87 0.13 Allowed 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.088 0.471 . . . . 0.0 111.847 -179.58 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' MET . . . . . 0.436 ' H ' ' C ' ' A' ' 43' ' ' ARG . 16.6 ptt? -95.8 5.93 50.13 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.053 0.454 . . . . 0.0 110.127 179.754 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 40.5 mt-30 -67.22 -8.5 32.05 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.409 -179.264 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -82.7 -11.74 58.1 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.483 0.658 . . . . 0.0 109.994 178.722 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . 0.48 ' O ' ' HG2' ' A' ' 52' ' ' GLU . 13.5 ttpp -78.51 5.82 9.97 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.257 -0.883 . . . . 0.0 110.398 -179.806 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 12.6 p -58.04 -24.65 24.25 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.123 -179.866 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 32.0 mt-10 -65.13 -27.8 68.99 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 121.154 0.502 . . . . 0.0 110.247 179.042 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 12.8 mtmt -98.59 -33.7 10.87 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.238 178.711 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . 0.48 ' HG2' ' O ' ' A' ' 48' ' ' LYS . 38.1 mm-40 -83.31 12.14 5.76 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.807 -0.633 . . . . 0.0 111.651 -179.731 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 10.5 ptp -62.03 -30.64 71.1 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-O 120.717 0.294 . . . . 0.0 110.651 179.679 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -96.91 3.96 62.81 Favored Glycine 0 N--CA 1.449 -0.434 0 N-CA-C 111.05 -0.82 . . . . 0.0 111.05 178.474 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -129.66 29.49 5.02 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.406 0.622 . . . . 0.0 110.389 -179.722 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 17.3 m -65.88 -19.73 26.15 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.483 0 CA-C-N 115.817 -0.629 . . . . 0.0 111.355 -179.548 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 45.6 mt-30 -79.55 -2.18 41.18 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.15 0.5 . . . . 0.0 111.034 179.765 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 15.8 t70 -129.84 -41.9 1.29 Allowed 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.991 179.741 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' SER . . . . . 0.407 ' C ' ' H ' ' A' ' 61' ' ' SER . 24.0 m -90.23 -70.18 0.68 Allowed 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.91 -179.307 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -81.43 30.69 0.35 Allowed 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.3 0.571 . . . . 0.0 110.988 -179.609 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' SER . . . . . 0.407 ' H ' ' C ' ' A' ' 59' ' ' SER . 1.8 t -77.02 -43.54 34.28 Favored 'General case' 0 N--CA 1.449 -0.516 0 CA-C-N 115.512 -0.767 . . . . 0.0 110.834 -178.898 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -56.03 -22.57 27.96 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 112.604 0.594 . . . . 0.0 112.604 -178.794 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 19.5 m -61.73 -22.56 65.49 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.381 -179.708 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . 0.463 ' O ' ' HB3' ' A' ' 68' ' ' GLU . . . -73.73 -34.69 64.88 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.101 0.477 . . . . 0.0 110.223 178.958 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' THR . . . . . 0.68 ' OG1' ' HB3' ' A' ' 38' ' ' GLU . 0.2 OUTLIER -77.59 3.22 14.26 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-O 121.18 0.514 . . . . 0.0 111.21 -179.795 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 16.5 tp60 -121.81 -45.86 2.26 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.794 178.928 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -87.45 -48.9 7.58 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.513 -0.312 . . . . 0.0 111.343 -179.835 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . 0.514 ' CD ' ' HZ2' ' A' ' 33' ' ' LYS . 3.0 tp10 -72.54 -31.37 65.25 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 121.114 0.483 . . . . 0.0 109.92 179.795 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . 0.411 ' HE3' ' OE2' ' A' ' 121' ' ' GLU . 0.0 OUTLIER -55.11 -29.98 58.77 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.814 -0.63 . . . . 0.0 111.581 179.726 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 95.4 mt-10 -60.64 -21.48 62.81 Favored 'General case' 0 C--N 1.332 -0.182 0 O-C-N 123.525 0.516 . . . . 0.0 110.787 179.656 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . 0.543 ' O ' ' HD3' ' A' ' 75' ' ' ARG . 36.0 tp10 -98.68 -43.49 6.79 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 109.435 -0.58 . . . . 0.0 109.435 177.432 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.425 HG23 ' O ' ' A' ' 68' ' ' GLU . 21.8 t -60.24 -42.22 89.66 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.244 0 CA-C-N 115.699 -0.682 . . . . 0.0 112.655 -178.613 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 23.4 p-10 -66.93 -18.37 65.35 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-O 121.045 0.45 . . . . 0.0 111.041 -179.928 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' SER . . . . . 0.409 ' C ' ' HD2' ' A' ' 75' ' ' ARG . 28.8 t -101.64 -3.86 27.58 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 121.334 0.588 . . . . 0.0 110.125 179.018 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . 0.543 ' HD3' ' O ' ' A' ' 71' ' ' GLU . 2.6 mpt_? -115.93 49.06 1.14 Allowed 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.694 0.759 . . . . 0.0 109.631 -179.796 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' SER . . . . . 0.477 ' OG ' ' HE2' ' A' ' 149' ' ' LYS . 0.4 OUTLIER -130.38 175.15 9.19 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 115.057 -0.974 . . . . 0.0 110.153 179.958 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -133.96 137.1 52.85 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 N-CA-C 109.977 -0.379 . . . . 0.0 109.977 178.179 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 83.9 t80 -94.82 126.52 40.2 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 109.644 -0.502 . . . . 0.0 109.644 179.877 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 4.0 t -105.95 115.36 47.49 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.138 -179.013 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -118.08 169.32 13.3 Favored Glycine 0 N--CA 1.447 -0.606 0 N-CA-C 110.863 -0.895 . . . . 0.0 110.863 179.255 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 1.6 m-20 59.08 37.8 24.13 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-O 121.177 0.513 . . . . 0.0 110.936 -179.566 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 2.5 t -80.84 162.25 3.65 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.884 -179.319 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . 0.522 ' OD2' ' HD2' ' A' ' 142' ' ' ARG . 9.7 t0 -66.23 135.43 54.46 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 109.607 -0.516 . . . . 0.0 109.607 179.225 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 36.5 p90 -63.96 -14.25 52.44 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.075 -0.511 . . . . 0.0 112.005 -178.616 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -114.19 14.85 18.24 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.72 0.295 . . . . 0.0 111.456 179.753 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' CYS . . . . . 0.484 ' SG ' ' HB2' ' A' ' 140' ' ' HIS . 0.8 OUTLIER -78.1 148.91 33.99 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.103 0.478 . . . . 0.0 111.281 -179.795 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' THR . . . . . 0.492 ' O ' ' HG2' ' A' ' 90' ' ' GLU . 0.2 OUTLIER -110.67 149.71 40.7 Favored Pre-proline 0 C--N 1.325 -0.462 0 CA-C-N 115.743 -0.662 . . . . 0.0 109.921 179.114 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 11.5 Cg_endo -55.32 -38.33 93.87 Favored 'Trans proline' 0 C--N 1.347 0.458 0 C-N-CA 122.83 2.353 . . . . 0.0 112.842 -179.039 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . 0.435 ' O ' ' HG3' ' A' ' 92' ' ' GLN . 3.2 mp0 -62.94 -52.14 64.2 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.485 -0.325 . . . . 0.0 111.802 -179.199 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . 0.492 ' HG2' ' O ' ' A' ' 87' ' ' THR . 6.0 pt-20 -61.04 -20.31 62.4 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-O 120.862 0.363 . . . . 0.0 111.519 -178.806 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 55.5 t -84.61 -47.21 17.45 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.674 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.739 -179.152 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . 0.435 ' HG3' ' O ' ' A' ' 89' ' ' GLU . 0.8 OUTLIER -72.17 -33.2 67.51 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.319 -0.401 . . . . 0.0 111.757 -178.423 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -78.04 -27.42 48.75 Favored 'General case' 0 N--CA 1.467 0.384 0 C-N-CA 120.237 -0.585 . . . . 0.0 111.53 -178.919 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' HIS . . . . . 0.485 ' HB2' ' O ' ' A' ' 90' ' ' GLU . 0.2 OUTLIER -75.12 -42.33 56.64 Favored 'General case' 0 C--N 1.325 -0.464 0 C-N-CA 120.819 -0.352 . . . . 0.0 110.721 -179.856 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 20.3 m-30 -76.47 -18.9 58.53 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.464 179.931 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . 0.639 ' HA ' ' O ' ' A' ' 99' ' ' GLY . 0.9 OUTLIER -62.4 -22.09 65.88 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.397 179.342 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 21.5 t -62.91 -28.57 70.15 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.364 179.475 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 5.5 m -97.91 -40.7 8.36 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.23 179.837 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . 0.639 ' O ' ' HA ' ' A' ' 96' ' ' GLN . . . -151.28 141.86 8.99 Favored Glycine 0 N--CA 1.449 -0.484 0 N-CA-C 111.424 -0.671 . . . . 0.0 111.424 179.69 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' THR . . . . . 0.41 ' HB ' ' CE1' ' A' ' 122' ' ' PHE . 0.2 OUTLIER -62.22 154.5 27.32 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.104 0.478 . . . . 0.0 112.09 -179.471 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 2.1 p -118.03 131.19 71.51 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-N 115.747 -0.66 . . . . 0.0 110.91 -179.685 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 26.1 t30 -97.91 -45.0 6.46 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.152 0.501 . . . . 0.0 109.695 179.123 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -142.75 157.32 44.76 Favored 'General case' 0 C--O 1.235 0.318 0 CA-C-N 115.676 -0.693 . . . . 0.0 109.991 179.196 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 7.2 p -155.29 137.59 6.43 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 CA-C-N 115.82 -0.627 . . . . 0.0 109.974 179.59 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 105' ' ' THR . . . . . 0.476 ' HB ' ' CE1' ' A' ' 119' ' ' TYR . 3.5 m -131.59 128.29 38.89 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 109.732 -0.47 . . . . 0.0 109.732 179.317 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 20.3 tt -113.27 137.15 47.31 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-O 121.3 0.571 . . . . 0.0 111.205 -179.804 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 35.0 tp -118.91 124.5 47.24 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.777 -0.647 . . . . 0.0 109.896 179.646 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -90.79 113.62 25.8 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 110.144 -0.317 . . . . 0.0 110.144 179.445 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -72.76 139.73 47.31 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.152 0.501 . . . . 0.0 111.253 -179.469 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -129.61 33.93 4.4 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 115.638 -0.71 . . . . 0.0 109.434 178.751 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 2.6 t80 -118.21 -4.31 10.97 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.618 -179.69 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 110.19 6.98 27.28 Favored Glycine 0 CA--C 1.52 0.353 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.833 179.936 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 113' ' ' GLN . . . . . 0.41 ' HB3' ' HD2' ' A' ' 114' ' ' PRO . 19.0 mt-30 -96.8 161.05 27.82 Favored Pre-proline 0 C--N 1.324 -0.513 0 N-CA-C 109.464 -0.569 . . . . 0.0 109.464 179.951 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 114' ' ' PRO . . . . . 0.41 ' HD2' ' HB3' ' A' ' 113' ' ' GLN . 19.5 Cg_endo -59.75 115.15 2.41 Favored 'Trans proline' 0 C--N 1.347 0.454 0 C-N-CA 122.039 1.826 . . . . 0.0 111.13 178.582 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 53.1 mttt -72.72 172.19 11.18 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 120.771 0.319 . . . . 0.0 110.246 -179.014 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 101.4 3.89 53.29 Favored Glycine 0 N--CA 1.444 -0.781 0 C-N-CA 120.175 -1.012 . . . . 0.0 112.227 179.712 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 26.8 m-85 -52.73 112.66 0.88 Allowed 'General case' 0 N--CA 1.463 0.196 0 N-CA-C 110.094 -0.336 . . . . 0.0 110.094 179.49 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -141.37 174.25 10.72 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 121.191 0.52 . . . . 0.0 111.523 -178.61 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 119' ' ' TYR . . . . . 0.476 ' CE1' ' HB ' ' A' ' 105' ' ' THR . 48.5 p90 -156.48 129.59 7.98 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.34 -0.845 . . . . 0.0 109.81 179.202 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 13.9 m -105.92 142.94 17.78 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.686 0 N-CA-C 109.254 -0.646 . . . . 0.0 109.254 178.976 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . 0.411 ' OE2' ' HE3' ' A' ' 69' ' ' LYS . 7.1 pt-20 -129.92 150.23 51.3 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 120.765 0.317 . . . . 0.0 111.745 -179.68 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 122' ' ' PHE . . . . . 0.41 ' CE1' ' HB ' ' A' ' 100' ' ' THR . 11.5 t80 -145.89 172.44 13.34 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.706 -0.679 . . . . 0.0 109.308 178.796 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . 0.428 HG23 HD13 ' A' ' 35' ' ' ILE . 2.9 t -92.64 -57.26 4.45 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 CA-C-O 120.782 0.325 . . . . 0.0 111.281 -178.979 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 93.0 mt-10 -62.65 118.07 7.14 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.451 -179.813 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 2.1 mp -57.29 -32.31 40.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 115.566 -0.743 . . . . 0.0 110.964 -179.435 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 17.6 t70 -53.35 -45.37 69.13 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.374 179.42 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -61.93 -54.82 36.61 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.758 -0.655 . . . . 0.0 111.691 -179.361 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 12.1 p -65.94 -29.65 47.52 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 C-N-CA 120.894 -0.322 . . . . 0.0 111.256 -179.249 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 129' ' ' GLN . . . . . 0.414 ' O ' ' HG ' ' A' ' 132' ' ' LEU . 9.6 tt0 -61.25 -48.59 80.75 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.178 0.513 . . . . 0.0 110.116 179.123 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 87.2 m-20 -69.29 -29.96 67.94 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.721 -0.672 . . . . 0.0 109.717 179.713 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . 0.455 ' O ' ' HB2' ' A' ' 135' ' ' ASN . . . -66.86 -52.18 46.63 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.618 -0.719 . . . . 0.0 111.089 179.66 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 132' ' ' LEU . . . . . 0.414 ' HG ' ' O ' ' A' ' 129' ' ' GLN . 4.0 pp -64.94 -23.92 67.37 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.79 0.328 . . . . 0.0 110.636 179.978 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 1.6 tp -72.0 -55.61 7.12 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.204 0.526 . . . . 0.0 110.058 179.597 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 49.4 mt -120.13 101.8 8.08 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.648 -0.705 . . . . 0.0 109.558 179.568 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 135' ' ' ASN . . . . . 0.455 ' HB2' ' O ' ' A' ' 131' ' ' ALA . 0.5 OUTLIER -146.68 -71.26 0.24 Allowed 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 120.87 0.367 . . . . 0.0 111.155 -178.976 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 7.5 pt-20 -69.91 95.12 0.9 Allowed 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.649 0.738 . . . . 0.0 111.849 -179.034 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 8.9 m -137.17 -59.53 0.69 Allowed 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.374 -0.83 . . . . 0.0 109.536 178.92 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 7.4 tt0 -165.4 130.84 2.56 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 109.525 -0.546 . . . . 0.0 109.525 179.222 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -146.0 118.04 8.28 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 109.672 -0.492 . . . . 0.0 109.672 -179.939 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 140' ' ' HIS . . . . . 0.484 ' HB2' ' SG ' ' A' ' 86' ' ' CYS . 3.2 t60 68.77 1.23 2.99 Favored 'General case' 0 N--CA 1.469 0.509 0 O-C-N 123.508 0.505 . . . . 0.0 111.393 178.971 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 113.52 -9.38 24.11 Favored Glycine 0 N--CA 1.447 -0.622 0 C-N-CA 121.038 -0.601 . . . . 0.0 111.743 -179.129 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 142' ' ' ARG . . . . . 0.522 ' HD2' ' OD2' ' A' ' 83' ' ' ASP . 0.0 OUTLIER -111.29 170.88 7.82 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 109.874 -0.417 . . . . 0.0 109.874 179.785 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 13.2 pt20 -115.75 121.45 42.5 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 109.217 -0.66 . . . . 0.0 109.217 178.705 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -99.08 175.65 5.83 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.066 -178.748 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 3.8 tttt -117.1 122.69 44.84 Favored 'General case' 0 C--N 1.317 -0.805 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 179.16 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 146' ' ' VAL . . . . . 0.429 HG21 ' OD1' ' A' ' 135' ' ' ASN . 96.2 t -117.49 137.51 51.17 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.652 0 CA-C-O 121.242 0.544 . . . . 0.0 111.409 -178.971 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 23.6 t -139.13 144.18 38.54 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.845 -0.616 . . . . 0.0 109.516 179.314 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -63.14 128.89 37.93 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 120.714 0.292 . . . . 0.0 110.277 179.47 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 149' ' ' LYS . . . . . 0.477 ' HE2' ' OG ' ' A' ' 76' ' ' SER . 28.3 ttpt -89.15 76.63 7.68 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 121.3 0.571 . . . . 0.0 109.76 -179.643 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 23.9 tpt180 -95.01 95.42 8.59 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.654 -0.703 . . . . 0.0 109.802 179.539 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 7.0 t -84.24 137.69 33.34 Favored 'General case' 0 N--CA 1.445 -0.723 0 CA-C-N 115.375 -0.83 . . . . 0.0 109.992 179.467 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 152' ' ' ASN . . . . . . . . . . . . . 58.6 t30 -171.2 157.78 5.21 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 109.449 -0.575 . . . . 0.0 109.449 -179.721 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 25.1 pt -68.94 150.65 97.55 Favored Pre-proline 0 C--N 1.325 -0.493 0 N-CA-C 109.955 -0.387 . . . . 0.0 109.955 179.266 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_endo -66.0 83.97 0.25 Allowed 'Trans proline' 0 C--O 1.233 0.268 0 C-N-CA 122.479 2.12 . . . . 0.0 112.182 179.786 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.084 0 CA-C-O 118.181 -1.344 . . . . 0.0 111.082 179.696 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.6 ptm . . . . . 0 N--CA 1.482 1.132 0 N-CA-C 110.158 -0.312 . . . . 0.0 110.158 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 91.52 66.88 1.15 Allowed Glycine 0 N--CA 1.448 -0.534 0 C-N-CA 120.987 -0.625 . . . . 0.0 112.018 -179.887 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 25.0 m -112.88 88.38 2.81 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 121.013 0.435 . . . . 0.0 111.875 -179.39 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 10.6 t -91.9 156.1 17.71 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 109.941 -0.392 . . . . 0.0 109.941 179.09 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 14.1 p-80 -169.77 142.82 2.53 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.493 -0.321 . . . . 0.0 110.804 -179.46 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 26.3 p80 -167.96 145.26 4.25 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.197 -0.456 . . . . 0.0 109.954 179.217 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 16.3 p-80 -146.4 150.68 36.12 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.557 -0.292 . . . . 0.0 110.669 -179.859 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -142.35 -175.5 4.47 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.222 -179.943 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 8.6 p80 -163.4 151.19 13.15 Favored 'General case' 0 C--N 1.332 -0.196 0 N-CA-C 109.886 -0.413 . . . . 0.0 109.886 -179.498 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 77.4 t60 -160.57 111.51 1.85 Allowed 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 120.727 0.299 . . . . 0.0 110.812 179.35 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -80.19 168.51 19.0 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.411 179.561 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 14.4 m -154.58 119.89 5.05 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.757 0.313 . . . . 0.0 110.879 -179.782 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -86.26 123.54 6.5 Favored Glycine 0 N--CA 1.448 -0.511 0 C-N-CA 121.011 -0.614 . . . . 0.0 111.736 179.352 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 8.9 mt -92.87 131.15 38.15 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.15 0.5 . . . . 0.0 111.815 -179.433 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 2.5 p -149.14 92.78 4.25 Favored Pre-proline 0 C--N 1.322 -0.616 0 CA-C-N 115.543 -0.753 . . . . 0.0 109.919 179.031 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 16.2 Cg_exo -67.93 133.34 28.88 Favored 'Trans proline' 0 N--CA 1.464 -0.214 0 C-N-CA 122.81 2.34 . . . . 0.0 112.033 -179.6 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -118.26 120.13 36.74 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 116.322 -0.399 . . . . 0.0 109.975 179.298 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -134.61 -177.14 14.74 Favored Glycine 0 N--CA 1.447 -0.608 0 C-N-CA 120.839 -0.696 . . . . 0.0 111.766 -179.993 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 61.2 m -154.93 129.08 8.89 Favored 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 110.403 -0.221 . . . . 0.0 110.403 179.94 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 28.6 p-80 -74.0 148.68 41.82 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 109.819 -0.437 . . . . 0.0 109.819 179.461 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -87.77 148.27 24.79 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 120.813 0.339 . . . . 0.0 110.144 -179.869 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -97.94 -171.74 32.76 Favored Glycine 0 N--CA 1.446 -0.68 0 CA-C-N 115.828 -0.624 . . . . 0.0 111.911 179.817 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -139.24 150.03 45.02 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 120.615 0.245 . . . . 0.0 110.396 -179.988 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 2.4 p-10 -76.37 137.67 39.93 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.307 -0.406 . . . . 0.0 109.919 179.174 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 12.8 tp -163.41 165.34 24.03 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.191 -179.634 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 15.4 mp0 -69.23 137.82 53.47 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.901 -0.59 . . . . 0.0 109.971 179.915 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 21.6 t0 -116.34 129.05 56.06 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.576 -179.876 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 15.9 tpt -100.97 127.62 47.37 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.205 -179.703 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 1.3 ptpt -147.65 148.21 30.82 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 120.636 0.255 . . . . 0.0 110.496 179.926 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 57.1 mttp -92.24 87.92 6.27 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.272 179.875 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -138.12 -167.77 2.23 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.114 -179.987 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 83.4 mt 69.69 -170.95 0.17 Allowed 'General case' 0 C--O 1.233 0.237 0 O-C-N 123.794 0.684 . . . . 0.0 111.162 179.5 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 48.6 mtpt -122.61 146.99 46.94 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.692 -179.313 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 29.2 mt-10 -79.88 135.89 36.55 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.825 -179.365 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.461 HG22 ' OD1' ' A' ' 58' ' ' ASP . 80.1 mt -123.71 117.47 51.26 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.386 -179.698 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 16.6 tt0 -178.82 126.0 0.1 Allowed 'General case' 0 C--N 1.331 -0.211 0 O-C-N 123.442 0.464 . . . . 0.0 110.469 -179.602 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -114.59 130.66 56.8 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.038 0.447 . . . . 0.0 110.467 179.613 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 49.9 mt-10 -116.01 152.64 33.15 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.006 179.368 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -93.81 160.37 14.78 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 120.921 0.391 . . . . 0.0 111.198 -179.455 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -68.66 120.98 11.8 Favored Glycine 0 N--CA 1.446 -0.693 0 CA-C-N 115.745 -0.661 . . . . 0.0 112.343 179.982 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -144.47 172.85 12.38 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 110.066 -0.346 . . . . 0.0 110.066 179.754 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 27.4 tp -69.26 90.93 0.51 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.101 0.477 . . . . 0.0 109.896 179.252 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 53.5 ttm-85 -153.69 -6.34 0.17 Allowed 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.861 -0.609 . . . . 0.0 111.177 -178.88 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 17.1 mt-10 65.2 19.71 11.78 Favored 'General case' 0 N--CA 1.468 0.471 0 CA-C-O 121.149 0.499 . . . . 0.0 110.662 -178.767 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 26.5 ptm -83.61 1.35 42.65 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.848 -0.615 . . . . 0.0 110.382 -179.88 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 30.6 mt-30 -72.39 -20.9 61.36 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.147 0.498 . . . . 0.0 110.116 179.72 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -76.5 -8.54 57.4 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 121.555 0.693 . . . . 0.0 109.965 178.788 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 21.6 ttmt -79.26 1.44 24.85 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.321 -0.854 . . . . 0.0 110.499 -179.91 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 7.4 p -58.28 -23.64 22.55 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.251 0 CA-C-N 115.781 -0.645 . . . . 0.0 111.102 179.632 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -63.42 -26.37 68.7 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.512 179.526 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 24.5 mtmt -101.97 -41.52 6.43 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.872 179.444 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 62.6 mm-40 -62.36 -16.65 55.75 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.969 -0.559 . . . . 0.0 111.522 -179.572 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 10.0 ptp -63.32 -25.41 68.29 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.978 0.418 . . . . 0.0 110.042 178.794 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -98.17 -5.08 57.35 Favored Glycine 0 N--CA 1.448 -0.542 0 N-CA-C 110.943 -0.863 . . . . 0.0 110.943 179.0 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -109.6 13.35 23.92 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.099 0.476 . . . . 0.0 110.154 -179.779 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 28.2 m -61.64 -16.81 15.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.769 179.767 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 20.5 mm-40 -77.8 -9.03 58.82 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.997 0.427 . . . . 0.0 110.588 179.884 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . 0.461 ' OD1' HG22 ' A' ' 35' ' ' ILE . 38.4 t70 -127.5 -58.87 1.24 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.176 179.22 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 4.8 m -65.69 -62.98 1.2 Allowed 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.8 0.809 . . . . 0.0 111.574 -179.606 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -85.15 19.42 2.22 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-N 114.95 -1.023 . . . . 0.0 111.774 -178.344 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -79.79 -33.43 40.51 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 121.028 0.442 . . . . 0.0 110.824 -179.136 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -65.33 -22.62 66.84 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 121.008 0.432 . . . . 0.0 111.663 -179.957 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -64.3 -26.82 68.66 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.113 0.482 . . . . 0.0 110.556 179.655 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -70.58 -30.13 66.75 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.832 179.582 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -76.47 -1.62 28.05 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.09 0.471 . . . . 0.0 110.931 179.802 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 7.0 tp60 -118.05 -51.27 2.45 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.64 179.507 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -83.08 -61.65 1.8 Allowed 'General case' 0 C--N 1.331 -0.201 0 N-CA-C 111.871 0.323 . . . . 0.0 111.871 -179.092 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -60.88 -29.7 69.7 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-O 120.976 0.417 . . . . 0.0 110.671 -179.384 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 51.5 tptt -56.11 -31.35 63.19 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.83 -0.623 . . . . 0.0 111.206 179.582 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 18.7 mt-10 -63.3 -21.15 66.07 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-O 121.18 0.514 . . . . 0.0 111.074 -179.797 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . 0.415 ' O ' ' HD2' ' A' ' 75' ' ' ARG . 13.5 tp10 -94.65 -42.96 8.51 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 115.675 -0.693 . . . . 0.0 109.172 177.98 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 47.9 t -62.34 -43.29 97.93 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-N 115.181 -0.918 . . . . 0.0 112.552 -178.924 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 17.2 p-10 -71.55 -19.68 62.13 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-O 121.025 0.441 . . . . 0.0 111.613 -178.958 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' SER . . . . . 0.572 ' OG ' ' HD3' ' A' ' 150' ' ' ARG . 44.4 t -96.65 -7.33 34.46 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 109.604 -0.517 . . . . 0.0 109.604 178.796 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . 0.415 ' HD2' ' O ' ' A' ' 71' ' ' GLU . 0.0 OUTLIER -114.47 40.94 2.42 Favored 'General case' 0 N--CA 1.452 -0.361 0 CA-C-N 115.505 -0.77 . . . . 0.0 110.185 -179.367 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' SER . . . . . 0.445 ' OG ' ' HE2' ' A' ' 149' ' ' LYS . 0.3 OUTLIER -120.11 174.6 6.39 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.708 179.509 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 6.5 pt -132.3 139.64 49.62 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.262 178.341 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' TYR . . . . . 0.402 ' O ' ' HA ' ' A' ' 146' ' ' VAL . 16.7 t80 -92.58 119.84 32.43 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.615 -0.72 . . . . 0.0 109.761 179.895 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 7.2 t -104.79 109.36 27.34 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-N 116.53 -0.304 . . . . 0.0 110.184 179.86 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -117.82 166.94 12.73 Favored Glycine 0 N--CA 1.448 -0.523 0 C-N-CA 120.815 -0.707 . . . . 0.0 112.278 -179.281 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 3.0 m120 57.01 44.13 23.32 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-O 121.314 0.578 . . . . 0.0 110.853 -179.818 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.417 HG11 ' H ' ' A' ' 83' ' ' ASP . 2.4 t -82.68 167.91 1.9 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 CA-C-N 115.236 -0.893 . . . . 0.0 110.368 -179.361 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . 0.491 ' HB3' ' SG ' ' A' ' 86' ' ' CYS . 24.7 t70 -68.71 140.97 55.41 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.855 0.36 . . . . 0.0 110.337 179.625 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 28.3 p90 -65.49 -12.66 54.69 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.831 -0.622 . . . . 0.0 112.521 -178.694 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -117.85 10.79 13.33 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.617 0.246 . . . . 0.0 111.492 -179.981 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' CYS . . . . . 0.491 ' SG ' ' HB3' ' A' ' 83' ' ' ASP . 0.9 OUTLIER -73.9 144.52 45.33 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.044 0.449 . . . . 0.0 111.001 -179.995 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' THR . . . . . 0.52 ' O ' ' HG2' ' A' ' 90' ' ' GLU . 5.6 p -108.24 157.54 36.07 Favored Pre-proline 0 C--N 1.327 -0.377 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.233 179.379 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 20.8 Cg_endo -60.53 -39.84 61.79 Favored 'Trans proline' 0 C--N 1.344 0.328 0 C-N-CA 122.399 2.066 . . . . 0.0 113.366 -178.979 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . 0.436 ' O ' ' HG2' ' A' ' 93' ' ' GLN . 7.9 mm-40 -64.16 -46.1 85.55 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 112.323 0.49 . . . . 0.0 112.323 -178.603 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . 0.52 ' HG2' ' O ' ' A' ' 87' ' ' THR . 9.8 pt-20 -65.79 -18.29 65.23 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-O 121.028 0.442 . . . . 0.0 111.432 -179.25 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 52.1 t -87.44 -47.36 15.85 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.83 -179.135 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 1.7 pp0? -68.79 -35.44 77.03 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.511 -0.313 . . . . 0.0 111.496 -178.581 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . 0.436 ' HG2' ' O ' ' A' ' 89' ' ' GLU . 3.5 pt20 -77.17 -29.89 54.66 Favored 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 120.372 -0.531 . . . . 0.0 111.337 -179.05 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -69.3 -41.68 76.46 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.853 0.358 . . . . 0.0 110.71 179.931 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 17.0 m-30 -82.47 -13.48 56.65 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 116.387 -0.37 . . . . 0.0 110.968 -179.557 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . 0.567 ' HA ' ' O ' ' A' ' 99' ' ' GLY . 37.3 tt0 -64.33 -23.94 67.47 Favored 'General case' 0 C--O 1.234 0.252 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.483 -179.86 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 15.2 m -67.12 -28.15 67.92 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.712 179.576 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 5.3 m -94.35 -41.62 9.32 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.144 -0.48 . . . . 0.0 109.978 179.542 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . 0.567 ' O ' ' HA ' ' A' ' 96' ' ' GLN . . . -150.55 144.26 11.63 Favored Glycine 0 N--CA 1.445 -0.745 0 CA-C-N 115.864 -0.607 . . . . 0.0 111.701 179.807 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -63.18 146.87 52.44 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 121.029 0.442 . . . . 0.0 111.48 -179.829 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 1.3 p -120.23 128.68 75.99 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.342 -179.878 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 27.2 t-20 -96.98 -46.97 5.99 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.687 0.28 . . . . 0.0 110.669 -179.999 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 2.6 tpt180 -137.44 148.33 46.04 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.571 -179.643 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 7.5 p -148.15 137.83 16.28 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-O 121.004 0.43 . . . . 0.0 110.638 179.265 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 2.3 m -130.24 129.44 43.34 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 116.008 -0.542 . . . . 0.0 109.983 178.961 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 20.5 tt -114.63 148.04 17.66 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-O 120.995 0.426 . . . . 0.0 110.899 -179.494 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 9.1 tp -129.82 140.29 51.05 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.131 179.759 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -105.8 114.3 28.38 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.511 -0.313 . . . . 0.0 110.248 179.552 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 7.5 t70 -75.85 142.64 42.14 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.396 -0.365 . . . . 0.0 110.952 -179.818 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 2.6 mppt? -127.13 20.4 6.89 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.281 0.563 . . . . 0.0 109.906 179.015 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 36.0 t80 -100.92 -6.79 24.13 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.467 -0.788 . . . . 0.0 110.23 -179.608 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 106.36 11.61 26.99 Favored Glycine 0 N--CA 1.448 -0.534 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.443 -179.966 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 113' ' ' GLN . . . . . 0.425 ' HB3' ' HD2' ' A' ' 114' ' ' PRO . 24.5 mt-30 -97.1 160.86 28.04 Favored Pre-proline 0 C--O 1.239 0.535 0 N-CA-C 109.455 -0.572 . . . . 0.0 109.455 -179.972 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 114' ' ' PRO . . . . . 0.425 ' HD2' ' HB3' ' A' ' 113' ' ' GLN . 16.8 Cg_endo -58.7 113.77 1.71 Allowed 'Trans proline' 0 C--N 1.347 0.492 0 C-N-CA 122.207 1.938 . . . . 0.0 111.277 178.628 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 9.6 mttp -78.57 179.74 6.91 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.144 -179.226 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 92.55 2.83 67.24 Favored Glycine 0 N--CA 1.444 -0.804 0 C-N-CA 120.081 -1.057 . . . . 0.0 111.462 179.978 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 5.1 t80 -55.67 124.59 17.91 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.725 0.298 . . . . 0.0 110.393 179.78 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -149.44 171.2 16.96 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.627 -179.374 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 44.9 p90 -152.4 130.41 11.82 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-N 115.656 -0.702 . . . . 0.0 109.204 178.782 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 13.7 m -108.56 142.49 21.04 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.139 179.905 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . 0.441 ' HB3' ' HB3' ' A' ' 76' ' ' SER . 1.3 pt-20 -131.55 154.34 48.91 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 120.923 0.392 . . . . 0.0 111.192 179.637 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 12.1 t80 -146.88 167.61 23.5 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.587 -0.733 . . . . 0.0 110.363 179.689 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 11.0 t -84.45 -41.21 15.97 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-O 120.901 0.381 . . . . 0.0 111.565 -179.432 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 33.3 mm-40 -76.56 131.34 38.89 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.152 -179.429 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 2.1 mp -73.27 -34.53 44.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.018 -179.46 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 17.5 t70 -58.38 -36.1 73.0 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.204 0.526 . . . . 0.0 111.058 -179.763 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -64.13 -57.7 8.81 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.735 -0.666 . . . . 0.0 111.271 -179.893 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 10.9 p -65.27 -27.71 42.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.554 -0.293 . . . . 0.0 111.287 -179.52 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 7.1 tt0 -60.02 -46.77 88.39 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.887 0.375 . . . . 0.0 110.246 179.83 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 50.7 m-80 -74.96 -24.26 58.43 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.143 179.873 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -68.98 -51.78 35.81 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.608 179.344 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 3.8 pp -67.55 -16.89 64.43 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.988 0.423 . . . . 0.0 111.057 179.881 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 1.1 tp -77.41 -53.08 8.09 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.003 179.324 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 87.9 mt -126.36 102.83 7.33 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.742 -0.663 . . . . 0.0 109.687 179.568 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -147.52 -67.02 0.26 Allowed 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.166 0.508 . . . . 0.0 111.948 -178.931 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 4.5 pt-20 -74.12 95.04 2.5 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.629 0.728 . . . . 0.0 111.857 -178.819 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 5.9 m -141.21 -59.75 0.49 Allowed 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.692 -0.686 . . . . 0.0 110.134 178.801 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -154.21 121.36 5.68 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 109.935 -0.395 . . . . 0.0 109.935 179.841 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -141.97 117.04 9.99 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 109.459 -0.571 . . . . 0.0 109.459 179.744 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 140' ' ' HIS . . . . . 0.415 ' HB2' ' SG ' ' A' ' 86' ' ' CYS . 2.2 t60 64.52 21.09 12.36 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-O 120.99 0.424 . . . . 0.0 110.78 179.869 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 86.55 -1.84 87.27 Favored Glycine 0 N--CA 1.449 -0.469 0 C-N-CA 120.715 -0.755 . . . . 0.0 111.533 -179.084 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 1.4 mpt_? -116.17 178.88 4.16 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 109.663 -0.495 . . . . 0.0 109.663 -179.68 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -122.5 141.41 51.68 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-O 120.818 0.342 . . . . 0.0 110.268 179.41 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -123.98 178.72 5.15 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 115.968 -0.56 . . . . 0.0 109.971 -179.821 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -120.81 120.3 35.17 Favored 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 109.595 -0.52 . . . . 0.0 109.595 179.444 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 146' ' ' VAL . . . . . 0.402 ' HA ' ' O ' ' A' ' 78' ' ' TYR . 73.1 t -115.32 129.92 70.76 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-O 120.951 0.405 . . . . 0.0 111.063 -179.092 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 1.6 m -134.22 148.02 50.8 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 179.109 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -61.96 129.47 41.05 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 120.658 0.266 . . . . 0.0 111.246 -179.83 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 149' ' ' LYS . . . . . 0.445 ' HE2' ' OG ' ' A' ' 76' ' ' SER . 25.8 ttpt -90.39 62.19 5.25 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.919 0.866 . . . . 0.0 108.758 179.528 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 150' ' ' ARG . . . . . 0.572 ' HD3' ' OG ' ' A' ' 74' ' ' SER . 0.0 OUTLIER -81.93 81.85 7.77 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 114.959 -1.019 . . . . 0.0 110.064 -179.729 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 8.7 t -69.28 122.76 19.52 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.359 179.937 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 152' ' ' ASN . . . . . . . . . . . . . 4.8 t30 -163.15 151.39 13.83 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.086 -179.88 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 13.1 pt -69.97 148.3 96.18 Favored Pre-proline 0 C--N 1.321 -0.657 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.847 179.752 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -73.0 103.76 1.65 Allowed 'Trans proline' 0 N--CA 1.464 -0.262 0 C-N-CA 122.34 2.027 . . . . 0.0 111.884 179.328 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.914 0 CA-C-O 118.757 -1.024 . . . . 0.0 111.937 -179.784 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.1 mpt? . . . . . 0 N--CA 1.48 1.038 0 N-CA-C 110.351 -0.24 . . . . 0.0 110.351 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 144.12 148.28 4.85 Favored Glycine 0 N--CA 1.449 -0.472 0 C-N-CA 120.538 -0.839 . . . . 0.0 112.459 179.886 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 8.1 m -136.13 152.0 50.37 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.615 0.245 . . . . 0.0 110.387 179.768 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 2.1 m -131.91 161.72 32.37 Favored 'General case' 0 C--O 1.237 0.398 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.601 179.85 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -157.88 121.91 4.15 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.583 179.377 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 1.3 t60 -159.99 124.87 3.92 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.506 -0.315 . . . . 0.0 110.853 -179.987 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 50.1 p-80 -148.5 156.08 42.0 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 109.55 -0.537 . . . . 0.0 109.55 179.431 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 1.5 m-70 -150.41 172.44 15.42 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 110.661 -0.126 . . . . 0.0 110.661 -179.802 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 55.5 t-80 -156.08 143.94 19.62 Favored 'General case' 0 CA--C 1.536 0.404 0 CA-C-N 116.483 -0.326 . . . . 0.0 111.129 -179.436 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 43.7 t-80 -149.92 144.97 26.23 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.455 -0.339 . . . . 0.0 110.143 179.701 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 23.2 t -133.86 166.37 22.84 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.664 -0.243 . . . . 0.0 110.642 179.958 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 70.1 m -159.16 -172.08 3.62 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 122.522 0.329 . . . . 0.0 110.635 -179.776 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 168.86 135.29 1.86 Allowed Glycine 0 C--N 1.333 0.413 0 N-CA-C 111.331 -0.708 . . . . 0.0 111.331 179.832 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 19.2 mt -138.23 143.39 40.11 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 117.136 0.468 . . . . 0.0 110.754 -179.203 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 2.4 p -138.92 113.97 8.44 Favored Pre-proline 0 CA--C 1.538 0.503 0 CA-C-O 120.771 0.32 . . . . 0.0 111.312 -179.781 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 64.1 Cg_endo -97.19 176.25 0.58 Allowed 'Trans proline' 0 N--CA 1.457 -0.645 0 C-N-CA 123.476 2.784 . . . . 0.0 113.122 179.722 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 3.5 ptm180 -157.29 149.68 22.93 Favored 'General case' 0 N--CA 1.462 0.154 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.134 179.115 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -119.03 175.77 15.84 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.963 -0.636 . . . . 0.0 112.81 -179.543 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 2.7 m -106.01 -171.52 1.92 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.784 0.326 . . . . 0.0 111.047 -179.765 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 10.4 t-80 -153.93 142.28 20.58 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.269 179.788 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -116.14 170.13 8.75 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.369 179.46 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -173.25 132.67 2.39 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 121.101 -0.571 . . . . 0.0 111.813 179.939 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 3.3 t -89.75 136.79 32.83 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.714 0.257 . . . . 0.0 110.628 -179.29 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -80.8 116.46 20.8 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.879 -179.644 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -167.21 157.31 11.07 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.543 179.703 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -159.92 176.77 11.49 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.496 179.518 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 7.1 t70 -157.83 -145.29 0.14 Allowed 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 108.295 -1.002 . . . . 0.0 108.295 179.504 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -85.13 -179.74 7.08 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 109.19 -0.67 . . . . 0.0 109.19 178.48 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 81.9 mttt -117.44 124.67 49.39 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-O 120.793 0.33 . . . . 0.0 110.685 -179.586 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 84.8 tttt -166.09 91.85 0.48 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.729 -0.669 . . . . 0.0 110.367 -179.115 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . 0.535 ' HA ' ' CB ' ' A' ' 67' ' ' ALA . 8.9 ptm180 -61.83 99.33 0.12 Allowed 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.962 -0.563 . . . . 0.0 112.157 179.781 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -157.22 147.36 20.88 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.905 179.49 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 3.8 tptt 66.07 -166.99 0.22 Allowed 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 115.244 -0.889 . . . . 0.0 112.145 179.311 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -91.08 157.47 17.22 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.008 -179.178 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.463 ' HB ' ' CB ' ' A' ' 64' ' ' ALA . 1.5 pp -124.24 152.77 30.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.245 -179.986 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . 0.621 ' HB3' ' OG ' ' A' ' 61' ' ' SER . 9.4 tp10 -139.03 -84.3 0.26 Allowed 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 120.623 -0.431 . . . . 0.0 111.777 179.556 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . 0.42 ' CD ' HH12 ' A' ' 103' ' ' ARG . 2.5 mm-40 -168.38 -57.42 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.398 0 N-CA-C 112.478 0.547 . . . . 0.0 112.478 -178.33 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -61.89 158.63 15.65 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.826 -0.625 . . . . 0.0 112.496 -178.363 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -108.74 -163.07 0.85 Allowed 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.706 -179.81 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -155.49 -154.1 6.8 Favored Glycine 0 N--CA 1.446 -0.677 0 N-CA-C 111.283 -0.727 . . . . 0.0 111.283 179.994 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -140.89 175.24 9.78 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.855 0.327 . . . . 0.0 110.127 179.937 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 63.9 tp -72.81 91.42 1.5 Allowed 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 109.623 -0.51 . . . . 0.0 109.623 179.06 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . 0.431 ' HD2' ' SD ' ' A' ' 45' ' ' MET . 13.5 ttm-85 -119.28 -16.1 9.07 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.96 -0.564 . . . . 0.0 111.161 -179.292 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 60.07 29.45 19.01 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 121.375 0.607 . . . . 0.0 110.021 -179.317 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' MET . . . . . 0.431 ' SD ' ' HD2' ' A' ' 43' ' ' ARG . 19.9 ptt? -99.63 12.56 36.22 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.182 -0.917 . . . . 0.0 111.167 -179.69 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 9.9 mm100 -71.81 -20.89 61.78 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 120.853 0.359 . . . . 0.0 110.898 -179.361 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -71.77 -14.5 62.01 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.302 0.572 . . . . 0.0 109.866 178.381 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 34.1 ttpt -82.78 7.22 15.7 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.694 -0.684 . . . . 0.0 109.445 178.826 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 7.3 p -57.2 -20.62 13.26 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.202 0 CA-C-N 115.693 -0.685 . . . . 0.0 111.623 -179.923 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 12.7 mm-40 -64.06 -33.23 75.28 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.431 0.634 . . . . 0.0 109.573 178.705 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 23.1 mtmt -97.42 -31.1 12.54 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.247 -0.888 . . . . 0.0 110.827 179.316 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 20.1 mm-40 -88.04 18.48 4.22 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.592 -179.548 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 7.9 ptm -64.76 -30.37 71.38 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.894 0.378 . . . . 0.0 110.813 179.971 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -94.07 -4.86 62.8 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.771 -0.728 . . . . 0.0 111.445 178.883 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -118.97 26.57 9.43 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.218 0.532 . . . . 0.0 110.166 -179.61 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 19.0 m -65.08 -13.89 15.71 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.263 0 CA-C-N 115.732 -0.667 . . . . 0.0 111.175 -179.706 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 5.7 mp0 -77.25 -16.99 58.78 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.585 -179.915 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -120.41 -52.8 2.14 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.89 -179.298 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 7.3 m -71.52 -70.89 0.29 Allowed 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.536 -0.756 . . . . 0.0 111.687 -179.249 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -84.57 30.11 0.57 Allowed 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.028 0.442 . . . . 0.0 111.532 -179.227 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' SER . . . . . 0.621 ' OG ' ' HB3' ' A' ' 36' ' ' GLU . 3.8 t -75.28 -26.92 59.14 Favored 'General case' 0 N--CA 1.447 -0.578 0 N-CA-C 108.523 -0.917 . . . . 0.0 108.523 178.986 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -64.15 -19.78 65.53 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-N 115.083 -0.962 . . . . 0.0 110.904 179.216 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 69.1 m -61.23 -19.31 61.52 Favored 'General case' 0 N--CA 1.445 -0.684 0 CA-C-N 115.588 -0.733 . . . . 0.0 110.715 -179.828 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . 0.463 ' CB ' ' HB ' ' A' ' 35' ' ' ILE . . . -70.07 -37.65 75.54 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.874 0.369 . . . . 0.0 110.45 179.095 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -75.13 -1.37 22.76 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.967 -0.56 . . . . 0.0 111.684 -179.615 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -118.97 -40.17 2.87 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.873 179.988 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . 0.535 ' CB ' ' HA ' ' A' ' 31' ' ' ARG . . . -93.69 -58.97 2.11 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 112.203 0.445 . . . . 0.0 112.203 -179.408 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . 0.528 ' O ' HG23 ' A' ' 72' ' ' VAL . 2.4 tp10 -66.59 -29.34 69.37 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.611 -0.268 . . . . 0.0 110.997 -178.993 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 45.1 tptt -56.36 -27.88 57.39 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.027 179.715 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 24.1 mt-10 -59.23 -34.83 72.67 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-O 120.83 0.347 . . . . 0.0 110.504 179.274 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 6.8 tp10 -89.07 -41.32 12.38 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.173 179.214 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.528 HG23 ' O ' ' A' ' 68' ' ' GLU . 22.1 t -62.68 -42.02 94.5 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.444 0 N-CA-C 112.073 0.397 . . . . 0.0 112.073 -178.964 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 25.4 t0 -66.28 -20.11 66.01 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-O 121.6 0.714 . . . . 0.0 110.192 179.76 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 16.3 m -100.61 -12.95 18.79 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 114.972 -1.013 . . . . 0.0 110.871 179.998 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -109.21 47.39 0.92 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.485 -179.199 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -126.14 170.13 12.11 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.644 179.783 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -133.24 133.62 57.99 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 N-CA-C 109.832 -0.433 . . . . 0.0 109.832 178.851 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 22.4 t80 -88.5 124.67 34.22 Favored 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 109.497 -0.557 . . . . 0.0 109.497 179.952 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 5.2 t -105.89 111.11 33.66 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-N 116.519 -0.31 . . . . 0.0 110.297 179.861 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -117.04 170.57 13.47 Favored Glycine 0 N--CA 1.447 -0.621 0 N-CA-C 111.574 -0.61 . . . . 0.0 111.574 -179.982 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 3.9 m-20 55.91 43.29 27.68 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-O 121.238 0.542 . . . . 0.0 110.933 -179.099 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 2.5 t -85.49 166.38 2.05 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 CA-C-N 115.646 -0.706 . . . . 0.0 110.561 -179.505 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . 0.528 ' OD2' ' HD2' ' A' ' 142' ' ' ARG . 14.7 t70 -69.68 141.34 53.58 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.042 0.448 . . . . 0.0 110.392 179.978 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 14.5 p90 -64.0 -23.04 67.18 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.763 -0.653 . . . . 0.0 112.322 -178.575 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -107.13 16.01 24.57 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 120.874 0.368 . . . . 0.0 111.162 -179.27 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' CYS . . . . . 0.411 ' SG ' ' HB2' ' A' ' 140' ' ' HIS . 0.8 OUTLIER -79.84 145.43 32.76 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 121.207 0.527 . . . . 0.0 110.954 179.971 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 13.2 p -111.25 153.77 43.89 Favored Pre-proline 0 C--N 1.324 -0.524 0 CA-C-N 115.509 -0.769 . . . . 0.0 110.315 179.553 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 16.6 Cg_endo -56.43 -37.7 96.67 Favored 'Trans proline' 0 C--N 1.344 0.336 0 C-N-CA 122.855 2.37 . . . . 0.0 112.556 -179.311 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . 0.485 ' O ' ' HG2' ' A' ' 93' ' ' GLN . 0.0 OUTLIER -63.5 -52.26 62.03 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.9 -0.591 . . . . 0.0 111.886 -178.937 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . 0.409 ' O ' ' HB2' ' A' ' 94' ' ' HIS . 7.9 pt-20 -65.23 -15.3 62.33 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.763 0.316 . . . . 0.0 111.429 -178.475 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 61.7 t -89.65 -46.25 15.17 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 CA-C-N 116.63 -0.259 . . . . 0.0 110.873 -179.806 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 1.7 pt20 -72.35 -34.2 67.84 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 111.817 0.302 . . . . 0.0 111.817 -178.45 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . 0.485 ' HG2' ' O ' ' A' ' 89' ' ' GLU . 26.0 pt20 -80.59 -22.72 40.42 Favored 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 120.33 -0.548 . . . . 0.0 111.249 -179.157 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' HIS . . . . . 0.409 ' HB2' ' O ' ' A' ' 90' ' ' GLU . 0.3 OUTLIER -75.31 -32.42 60.96 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.952 0.405 . . . . 0.0 110.498 179.331 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 23.3 m-30 -89.68 -8.08 53.19 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.175 -179.266 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . 0.554 ' HA ' ' O ' ' A' ' 99' ' ' GLY . 1.3 tt0 -66.49 -22.54 66.19 Favored 'General case' 0 C--O 1.232 0.148 0 CA-C-O 121.163 0.506 . . . . 0.0 109.978 -179.694 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 1.2 m -63.36 -30.71 71.79 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.459 -0.791 . . . . 0.0 110.642 179.147 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 17.4 m -97.27 -46.03 6.27 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.397 179.63 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . 0.554 ' O ' ' HA ' ' A' ' 96' ' ' GLN . . . -144.92 143.35 11.81 Favored Glycine 0 N--CA 1.442 -0.95 0 C-N-CA 120.908 -0.663 . . . . 0.0 111.869 -179.892 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -66.06 145.65 55.6 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 120.574 0.226 . . . . 0.0 111.096 -179.872 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 2.5 p -111.09 129.51 66.23 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-O 120.957 0.408 . . . . 0.0 111.25 -179.335 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . 0.516 ' OD1' ' HD2' ' A' ' 103' ' ' ARG . 26.0 t-20 -100.88 -45.17 5.53 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 109.868 -0.419 . . . . 0.0 109.868 179.327 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . 0.516 ' HD2' ' OD1' ' A' ' 102' ' ' ASN . 0.0 OUTLIER -138.44 151.9 47.86 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.156 -0.475 . . . . 0.0 109.972 178.776 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 4.0 p -151.44 119.52 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-O 121.142 0.496 . . . . 0.0 110.299 179.144 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 105' ' ' THR . . . . . 0.424 ' HB ' ' CE1' ' A' ' 119' ' ' TYR . 1.2 m -112.27 120.12 40.66 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.116 179.655 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 106' ' ' ILE . . . . . 0.405 HD13 ' HA2' ' A' ' 116' ' ' GLY . 21.5 tt -108.06 146.38 14.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-O 121.025 0.44 . . . . 0.0 111.166 -179.903 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 26.0 tp -131.93 136.22 47.21 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.213 179.458 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -101.83 116.33 32.48 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 116.544 -0.298 . . . . 0.0 110.533 179.749 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . 0.436 ' O ' ' HG2' ' A' ' 115' ' ' LYS . 12.3 t70 -83.76 136.2 34.25 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.026 0.441 . . . . 0.0 111.155 -179.766 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -126.56 27.42 6.12 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 116.148 -0.478 . . . . 0.0 109.896 179.4 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 10.0 t80 -108.23 -2.01 19.7 Favored 'General case' 0 N--CA 1.45 -0.451 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.282 -179.36 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 114.45 3.2 22.63 Favored Glycine 0 N--CA 1.449 -0.434 0 C-N-CA 120.399 -0.905 . . . . 0.0 112.995 179.617 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 26.6 mt-30 -98.18 156.57 35.7 Favored Pre-proline 0 C--N 1.321 -0.645 0 N-CA-C 109.671 -0.492 . . . . 0.0 109.671 179.858 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 14.2 Cg_endo -57.37 126.71 22.85 Favored 'Trans proline' 0 C--N 1.349 0.566 0 C-N-CA 122.194 1.929 . . . . 0.0 110.894 178.798 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . 0.436 ' HG2' ' O ' ' A' ' 109' ' ' ASP . 10.7 mttp -82.67 177.55 8.64 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 110.008 -0.368 . . . . 0.0 110.008 -179.732 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . 0.405 ' HA2' HD13 ' A' ' 106' ' ' ILE . . . 94.78 2.91 62.66 Favored Glycine 0 N--CA 1.444 -0.774 0 C-N-CA 120.157 -1.02 . . . . 0.0 112.349 179.419 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 9.9 m-30 -55.84 117.73 3.94 Favored 'General case' 0 C--N 1.332 -0.194 0 N-CA-C 110.163 -0.31 . . . . 0.0 110.163 179.992 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -147.03 174.69 11.31 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-O 120.935 0.398 . . . . 0.0 111.145 -179.144 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 119' ' ' TYR . . . . . 0.424 ' CE1' ' HB ' ' A' ' 105' ' ' THR . 36.1 p90 -152.91 134.09 14.19 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.687 -0.688 . . . . 0.0 109.182 178.674 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 14.6 m -107.91 136.64 42.66 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 N-CA-C 109.42 -0.585 . . . . 0.0 109.42 178.906 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -122.61 152.25 40.64 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 120.619 0.247 . . . . 0.0 110.755 -179.728 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 11.9 t80 -148.4 170.07 18.79 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.028 -0.533 . . . . 0.0 109.961 179.421 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 21.4 t -87.49 -50.09 14.08 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-O 120.975 0.417 . . . . 0.0 111.568 -179.452 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 29.0 mt-10 -70.22 134.26 47.87 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.385 -179.128 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 2.6 mp -73.23 -30.97 32.58 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.59 -179.621 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 5.7 t70 -57.24 -40.45 77.59 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.892 -179.771 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -64.04 -54.95 26.13 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.708 -0.678 . . . . 0.0 111.402 -179.413 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 7.3 p -65.59 -30.58 50.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.447 -0.342 . . . . 0.0 111.193 -179.498 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 20.4 tt0 -59.98 -45.82 91.44 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-O 120.939 0.4 . . . . 0.0 110.361 179.539 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 82.8 m-20 -71.25 -32.61 68.94 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.183 179.701 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . 0.434 ' O ' ' HB2' ' A' ' 135' ' ' ASN . . . -66.32 -48.06 71.53 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.85 -0.614 . . . . 0.0 111.382 -179.927 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 4.2 pp -71.24 -16.87 62.51 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.784 0.326 . . . . 0.0 110.943 -179.734 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 5.5 tp -82.1 -48.96 10.74 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.068 -179.85 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 79.2 mt -136.98 104.06 5.34 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.398 -0.365 . . . . 0.0 110.503 -179.815 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 135' ' ' ASN . . . . . 0.434 ' HB2' ' O ' ' A' ' 131' ' ' ALA . 1.8 m-20 -152.33 -52.87 0.12 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.564 -0.289 . . . . 0.0 111.54 -179.743 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 5.2 pt-20 -73.83 89.27 1.83 Allowed 'General case' 0 C--N 1.33 -0.283 0 CA-C-O 121.528 0.68 . . . . 0.0 111.039 -179.658 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 6.7 m -130.78 -61.94 0.93 Allowed 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.548 -0.751 . . . . 0.0 110.51 179.672 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 8.0 tm-20 -162.16 127.21 3.36 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.22 -0.445 . . . . 0.0 109.813 -179.867 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -142.35 119.69 11.58 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.929 -0.578 . . . . 0.0 109.616 179.466 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 140' ' ' HIS . . . . . 0.411 ' HB2' ' SG ' ' A' ' 86' ' ' CYS . 3.7 t60 63.75 12.74 6.89 Favored 'General case' 0 N--CA 1.466 0.333 0 C-N-CA 122.717 0.407 . . . . 0.0 111.413 179.594 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 103.76 -8.42 50.79 Favored Glycine 0 N--CA 1.45 -0.398 0 C-N-CA 120.633 -0.794 . . . . 0.0 112.755 -179.59 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 142' ' ' ARG . . . . . 0.528 ' HD2' ' OD2' ' A' ' 83' ' ' ASP . 0.0 OUTLIER -116.2 169.77 9.03 Favored 'General case' 0 C--N 1.324 -0.543 0 O-C-N 122.602 -0.352 . . . . 0.0 110.843 -179.436 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 7.8 pt20 -110.93 125.72 53.97 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 109.544 -0.539 . . . . 0.0 109.544 179.046 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -104.92 177.35 4.87 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 120.734 0.302 . . . . 0.0 111.179 -179.277 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 145' ' ' LYS . . . . . 0.543 ' HE2' ' OG ' ' A' ' 147' ' ' SER . 0.1 OUTLIER -118.04 122.95 44.46 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 109.459 -0.571 . . . . 0.0 109.459 179.305 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 89.0 t -114.18 121.64 66.7 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-O 120.837 0.351 . . . . 0.0 111.226 -179.785 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 147' ' ' SER . . . . . 0.543 ' OG ' ' HE2' ' A' ' 145' ' ' LYS . 0.6 OUTLIER -118.63 141.77 48.28 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.007 179.68 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -67.6 123.51 20.66 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.722 0.296 . . . . 0.0 110.537 179.885 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 15.7 tttp -86.0 74.29 10.15 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.332 0.586 . . . . 0.0 110.312 -179.051 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 11.6 tpt85 -91.84 100.18 12.91 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 109.105 -0.702 . . . . 0.0 109.105 178.944 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 6.4 t -95.52 147.63 23.35 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.329 -179.61 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 152' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 177.94 178.39 0.35 Allowed 'General case' 0 CA--C 1.514 -0.424 0 CA-C-N 116.0 -0.545 . . . . 0.0 109.891 179.636 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 11.4 pt -82.57 135.46 46.4 Favored Pre-proline 0 C--N 1.321 -0.661 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.328 179.794 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 69.8 Cg_endo -78.46 67.95 8.16 Favored 'Trans proline' 0 N--CA 1.462 -0.329 0 C-N-CA 122.638 2.225 . . . . 0.0 112.171 -179.986 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.443 -0.852 0 CA-C-O 118.128 -1.373 . . . . 0.0 111.16 179.968 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 43.8 ttp . . . . . 0 N--CA 1.478 0.967 0 CA-C-O 120.879 0.371 . . . . 0.0 110.483 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 128.34 151.09 7.42 Favored Glycine 0 N--CA 1.448 -0.559 0 C-N-CA 120.647 -0.787 . . . . 0.0 112.273 -179.92 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 14.8 m -141.25 133.77 28.42 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 109.523 -0.547 . . . . 0.0 109.523 179.455 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -148.72 159.62 43.95 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.891 0.377 . . . . 0.0 111.633 -179.141 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 9.5 p-80 -169.78 138.04 1.77 Allowed 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 115.554 -0.748 . . . . 0.0 109.75 179.588 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -162.27 150.24 14.43 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 109.446 -0.575 . . . . 0.0 109.446 -179.749 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 36.5 t-80 -161.6 125.97 3.38 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.947 0.403 . . . . 0.0 111.73 -179.477 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 48.0 p-80 -163.15 113.1 1.36 Allowed 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.541 -0.754 . . . . 0.0 109.249 178.853 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 10.9 t-80 -172.42 146.85 1.84 Allowed 'General case' 0 C--N 1.327 -0.409 0 O-C-N 122.229 -0.294 . . . . 0.0 111.078 -179.379 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 7.7 p-80 -153.93 125.98 7.83 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 109.707 -0.479 . . . . 0.0 109.707 178.054 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 3.8 p -173.27 124.12 0.4 Allowed 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.132 -179.633 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 33.9 m -152.84 149.06 27.9 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.638 -0.255 . . . . 0.0 110.357 179.887 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -175.4 -151.46 8.62 Favored Glycine 0 N--CA 1.443 -0.886 0 C-N-CA 120.625 -0.798 . . . . 0.0 112.282 179.93 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 1.8 pt? -157.8 167.67 29.36 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 -179.86 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 3.6 p -140.22 125.02 11.1 Favored Pre-proline 0 C--N 1.323 -0.572 0 CA-C-O 121.026 0.441 . . . . 0.0 111.652 -179.093 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -77.01 153.67 32.65 Favored 'Trans proline' 0 C--O 1.234 0.323 0 C-N-CA 122.509 2.139 . . . . 0.0 112.571 179.43 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . 0.431 HH11 ' HD2' ' A' ' 17' ' ' ARG . 5.9 mtm105 -86.86 156.05 20.02 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.081 0.467 . . . . 0.0 111.279 -179.648 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . 0.409 ' HA3' ' O ' ' A' ' 57' ' ' GLN . . . -177.66 -112.32 0.32 Allowed Glycine 0 N--CA 1.447 -0.569 0 CA-C-N 115.508 -0.769 . . . . 0.0 111.548 -179.799 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' SER . . . . . 0.429 ' O ' ' HB3' ' A' ' 61' ' ' SER . 5.1 m -90.6 172.53 8.62 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 120.884 0.373 . . . . 0.0 111.269 -179.853 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 41.8 m170 -127.44 84.04 2.22 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.461 -0.336 . . . . 0.0 110.253 179.839 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 38.5 ttm -160.73 89.45 0.81 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.465 -179.489 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 143.76 -169.29 26.12 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.528 -0.844 . . . . 0.0 112.509 179.803 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 8.0 t -163.32 126.86 2.77 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 109.84 -0.43 . . . . 0.0 109.84 -179.863 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 17.4 t0 -143.08 171.29 14.26 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 110.176 -0.305 . . . . 0.0 110.176 -179.784 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 1.6 pt? -130.65 37.74 3.79 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 120.872 0.368 . . . . 0.0 110.353 -179.723 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 33.5 mt-10 67.61 74.17 0.31 Allowed 'General case' 0 C--O 1.236 0.388 0 CA-C-N 115.412 -0.813 . . . . 0.0 111.677 179.122 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -115.28 17.01 16.77 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.477 0.656 . . . . 0.0 110.21 178.482 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 26.7 ttt -70.97 101.85 2.28 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.663 -0.699 . . . . 0.0 109.994 179.395 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 4.9 mppt? -134.18 -70.83 0.51 Allowed 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.461 -0.336 . . . . 0.0 111.763 -179.255 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . 0.413 ' O ' ' HG2' ' A' ' 53' ' ' MET . 2.0 tmtp? -74.79 133.37 41.95 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.763 0.315 . . . . 0.0 110.927 -179.13 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -113.02 140.93 47.42 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.377 -179.98 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.467 ' H ' ' HE2' ' A' ' 53' ' ' MET . 48.0 tp -155.88 -71.16 0.11 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.772 0.32 . . . . 0.0 110.523 179.478 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.566 ' O ' ' HA ' ' A' ' 51' ' ' LYS . 17.8 tptt -150.47 169.25 21.92 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 109.338 -0.615 . . . . 0.0 109.338 -179.865 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 1.7 pm0 -138.83 73.69 1.44 Allowed 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.147 0.499 . . . . 0.0 110.934 179.97 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 1.2 mm -130.63 2.11 2.18 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.4 0 N-CA-C 112.094 0.405 . . . . 0.0 112.094 -179.331 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 66.8 tt0 -134.8 102.06 5.13 Favored 'General case' 0 C--N 1.33 -0.26 0 O-C-N 121.776 -0.577 . . . . 0.0 112.497 -177.867 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 1.9 pm0 -116.08 150.38 37.43 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.327 -0.397 . . . . 0.0 109.993 178.833 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . 0.56 ' OE1' ' HE2' ' A' ' 48' ' ' LYS . 34.1 mt-10 -148.87 -165.31 2.24 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-O 120.902 0.382 . . . . 0.0 110.926 -179.957 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . 0.431 ' H ' ' HB3' ' A' ' 38' ' ' GLU . . . -107.97 165.43 11.47 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.448 179.449 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -86.04 112.12 3.68 Favored Glycine 0 N--CA 1.45 -0.408 0 C-N-CA 120.719 -0.753 . . . . 0.0 113.021 -179.338 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -146.35 175.89 10.19 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 109.846 -0.427 . . . . 0.0 109.846 179.425 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 57.4 tp -73.87 91.39 1.97 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.314 0.578 . . . . 0.0 110.234 179.33 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . 0.667 ' HB3' ' SD ' ' A' ' 45' ' ' MET . 49.5 ttt85 -155.87 156.27 34.36 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.785 -0.643 . . . . 0.0 109.785 -179.31 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . 0.418 ' H ' ' HG2' ' A' ' 44' ' ' GLU . 2.0 pt-20 -79.56 39.55 0.41 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.803 0.811 . . . . 0.0 110.016 178.669 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' MET . . . . . 0.667 ' SD ' ' HB3' ' A' ' 43' ' ' ARG . 6.1 ptm -95.36 9.97 37.96 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 114.815 -1.084 . . . . 0.0 110.989 -179.26 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 22.0 mm-40 -69.87 -20.43 63.4 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.251 0.548 . . . . 0.0 110.459 -179.774 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -82.37 -3.26 55.17 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.664 179.173 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . 0.56 ' HE2' ' OE1' ' A' ' 38' ' ' GLU . 24.0 ttpp -81.87 -4.19 55.94 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.501 -179.794 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 9.9 p -61.85 -22.28 28.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 121.347 0.594 . . . . 0.0 110.238 179.549 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -67.83 -17.9 64.66 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.657 -0.701 . . . . 0.0 110.044 178.619 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . 0.566 ' HA ' ' O ' ' A' ' 33' ' ' LYS . 29.4 mtmt -103.86 -41.15 5.98 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.205 -0.907 . . . . 0.0 110.616 179.741 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . 0.425 ' CD ' ' HZ3' ' A' ' 48' ' ' LYS . 8.4 mt-10 -78.82 6.28 9.44 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.901 0.381 . . . . 0.0 111.24 179.752 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' MET . . . . . 0.467 ' HE2' ' H ' ' A' ' 32' ' ' LEU . 0.0 OUTLIER -72.74 -32.61 65.81 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 121.315 0.579 . . . . 0.0 109.526 178.142 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -89.37 -9.6 66.81 Favored Glycine 0 N--CA 1.445 -0.703 0 N-CA-C 110.429 -1.068 . . . . 0.0 110.429 179.034 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -106.98 20.62 18.79 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 114.654 -0.773 . . . . 0.0 109.838 179.868 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 17.2 m -66.55 -11.35 13.08 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.397 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.005 179.928 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . 0.409 ' O ' ' HA3' ' A' ' 18' ' ' GLY . 31.7 mt-30 -88.47 1.53 54.63 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.64 0.733 . . . . 0.0 110.352 178.809 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 7.7 t70 -130.17 -51.74 1.11 Allowed 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 115.24 -0.891 . . . . 0.0 109.81 178.776 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 8.6 m -79.1 -65.08 1.04 Allowed 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.377 -0.829 . . . . 0.0 112.377 -179.146 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 8.8 t -85.45 11.44 10.42 Favored 'General case' 0 CA--C 1.531 0.218 0 N-CA-C 112.119 0.415 . . . . 0.0 112.119 -178.125 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' SER . . . . . 0.429 ' HB3' ' O ' ' A' ' 19' ' ' SER . 0.5 OUTLIER -73.11 -20.96 60.83 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-O 121.085 0.469 . . . . 0.0 110.616 -179.967 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -69.62 -25.58 64.01 Favored 'General case' 0 N--CA 1.447 -0.581 0 CA-C-N 116.057 -0.519 . . . . 0.0 109.932 178.563 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 1.5 m -62.55 -28.09 69.62 Favored 'General case' 0 N--CA 1.448 -0.53 0 CA-C-N 115.483 -0.78 . . . . 0.0 110.722 179.774 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . 0.424 ' O ' ' HB3' ' A' ' 68' ' ' GLU . . . -68.4 -25.43 65.04 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 121.312 0.577 . . . . 0.0 110.1 178.789 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -81.56 1.76 32.26 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.733 179.814 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 24.3 tp60 -123.4 -50.88 1.87 Allowed 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.723 -0.671 . . . . 0.0 110.569 179.577 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -82.89 -57.85 3.12 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.545 -179.634 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . 0.424 ' HB3' ' O ' ' A' ' 64' ' ' ALA . 28.4 tt0 -64.06 -29.73 70.85 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 121.129 0.49 . . . . 0.0 110.587 -179.817 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 39.4 tptt -57.24 -30.14 64.37 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.785 -0.643 . . . . 0.0 111.265 179.955 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 7.2 mt-10 -61.42 -22.54 65.11 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-O 121.261 0.553 . . . . 0.0 111.25 179.998 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . 0.535 ' O ' ' HD3' ' A' ' 75' ' ' ARG . 42.7 tp10 -97.84 -43.35 7.16 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 115.881 -0.6 . . . . 0.0 109.536 178.481 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 45.3 t -61.84 -40.22 86.24 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-N 115.597 -0.729 . . . . 0.0 112.776 -178.815 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 16.1 p-10 -72.79 -14.21 61.48 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-O 120.742 0.306 . . . . 0.0 111.792 -178.709 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 48.0 t -106.37 -2.02 22.66 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.004 178.323 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . 0.535 ' HD3' ' O ' ' A' ' 71' ' ' GLU . 2.8 mpt_? -116.68 41.16 2.75 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.609 0.719 . . . . 0.0 109.331 -179.74 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -120.73 171.17 8.79 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.223 -0.899 . . . . 0.0 110.474 179.906 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -131.4 136.15 58.05 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 N-CA-C 109.74 -0.467 . . . . 0.0 109.74 178.603 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 79.2 t80 -93.05 124.06 36.75 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.286 -179.142 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 3.4 t -104.5 112.92 40.01 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.808 -179.708 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -119.24 167.69 13.3 Favored Glycine 0 N--CA 1.447 -0.599 0 N-CA-C 111.18 -0.768 . . . . 0.0 111.18 179.479 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 5.3 m-20 61.77 36.71 16.11 Favored 'General case' 0 N--CA 1.472 0.625 0 CA-C-O 121.218 0.532 . . . . 0.0 110.488 -179.702 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 2.5 t -78.55 164.03 3.48 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-N 115.624 -0.716 . . . . 0.0 111.116 -178.897 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . 0.543 ' OD2' ' HD3' ' A' ' 142' ' ' ARG . 10.8 t0 -68.06 136.58 54.01 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.996 -0.547 . . . . 0.0 109.61 179.313 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 25.7 p90 -64.98 -13.89 58.83 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.118 -0.492 . . . . 0.0 112.1 -179.253 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -113.28 14.21 19.26 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.773 0.321 . . . . 0.0 111.24 179.586 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' CYS . . . . . 0.449 ' SG ' ' HB2' ' A' ' 140' ' ' HIS . 0.8 OUTLIER -78.47 150.11 33.05 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.067 0.461 . . . . 0.0 111.521 -179.389 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 5.3 p -111.47 150.91 42.84 Favored Pre-proline 0 C--N 1.323 -0.55 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.259 179.099 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 16.9 Cg_endo -57.89 -35.03 99.01 Favored 'Trans proline' 0 C--N 1.342 0.235 0 C-N-CA 122.462 2.108 . . . . 0.0 111.566 -179.716 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 66.8 mm-40 -64.36 -53.45 48.46 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.549 -0.75 . . . . 0.0 111.89 -179.429 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 -64.16 -18.37 64.4 Favored 'General case' 0 C--N 1.333 -0.133 0 CA-C-O 120.901 0.381 . . . . 0.0 111.472 -178.225 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 55.0 t -83.71 -49.06 16.79 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.518 -179.884 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . 0.406 ' O ' ' HB2' ' A' ' 96' ' ' GLN . 2.8 pt20 -73.38 -32.47 64.5 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.472 -0.331 . . . . 0.0 111.611 -178.479 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 7.1 pt20 -77.25 -28.29 53.57 Favored 'General case' 0 C--N 1.33 -0.261 0 C-N-CA 120.618 -0.433 . . . . 0.0 111.048 -179.118 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 60.9 t-80 -74.95 -44.48 48.21 Favored 'General case' 0 CA--C 1.519 -0.248 0 CA-C-O 121.085 0.469 . . . . 0.0 110.165 179.536 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 20.5 m-30 -73.45 -17.78 61.2 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.866 -0.607 . . . . 0.0 110.517 -179.2 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . 0.482 ' HA ' ' O ' ' A' ' 99' ' ' GLY . 7.7 tt0 -64.61 -25.29 67.9 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.494 -0.775 . . . . 0.0 110.631 179.521 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 48.8 m -61.0 -32.18 71.77 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.514 179.682 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 18.2 m -92.35 -50.23 5.75 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.176 0.512 . . . . 0.0 110.078 179.42 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . 0.482 ' O ' ' HA ' ' A' ' 96' ' ' GLN . . . -137.77 133.7 6.53 Favored Glycine 0 N--CA 1.443 -0.854 0 C-N-CA 120.659 -0.782 . . . . 0.0 111.91 179.783 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -59.33 140.0 56.48 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.029 0.443 . . . . 0.0 110.686 179.975 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 2.8 p -105.51 140.18 24.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 115.876 -0.602 . . . . 0.0 112.171 -178.058 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 9.1 t30 -101.95 -50.56 3.63 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 109.431 -0.581 . . . . 0.0 109.431 178.125 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 9.0 mmm180 -141.8 158.32 43.94 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.386 179.698 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 6.6 p -151.54 127.57 1.83 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.104 179.566 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 105' ' ' THR . . . . . 0.408 ' HB ' ' CE1' ' A' ' 119' ' ' TYR . 1.8 m -117.9 119.17 34.04 Favored 'General case' 0 C--N 1.321 -0.669 0 O-C-N 122.263 -0.273 . . . . 0.0 110.441 -179.984 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 106' ' ' ILE . . . . . 0.405 HD13 ' HA2' ' A' ' 116' ' ' GLY . 18.6 tt -107.16 146.64 13.19 Favored 'Isoleucine or valine' 0 C--O 1.235 0.327 0 CA-C-O 120.959 0.409 . . . . 0.0 111.04 -179.592 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 60.4 tp -135.69 126.24 26.97 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.858 -0.61 . . . . 0.0 109.948 179.12 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -89.2 120.02 30.21 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 116.517 -0.311 . . . . 0.0 110.499 179.83 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . 0.531 ' O ' ' HG2' ' A' ' 115' ' ' LYS . 16.8 t70 -81.08 136.9 35.99 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.014 0.435 . . . . 0.0 110.829 -179.883 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -124.93 25.86 7.21 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.896 -0.593 . . . . 0.0 109.763 179.556 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 24.6 t80 -105.99 -3.87 21.19 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.059 -179.483 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 106.83 10.9 27.62 Favored Glycine 0 N--CA 1.449 -0.493 0 C-N-CA 120.678 -0.772 . . . . 0.0 112.536 -179.582 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 113' ' ' GLN . . . . . 0.404 ' HB3' ' HD2' ' A' ' 114' ' ' PRO . 20.9 mt-30 -99.8 159.36 30.14 Favored Pre-proline 0 C--N 1.325 -0.471 0 N-CA-C 109.509 -0.552 . . . . 0.0 109.509 179.388 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 114' ' ' PRO . . . . . 0.404 ' HD2' ' HB3' ' A' ' 113' ' ' GLN . 11.4 Cg_endo -55.77 115.67 2.62 Favored 'Trans proline' 0 C--N 1.344 0.327 0 C-N-CA 122.307 2.005 . . . . 0.0 110.835 178.584 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . 0.531 ' HG2' ' O ' ' A' ' 109' ' ' ASP . 54.9 mttt -75.52 172.27 12.83 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.044 -178.467 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . 0.405 ' HA2' HD13 ' A' ' 106' ' ' ILE . . . 98.55 7.81 55.32 Favored Glycine 0 N--CA 1.444 -0.767 0 C-N-CA 120.351 -0.928 . . . . 0.0 112.286 179.902 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 30.2 m-85 -53.27 115.48 1.92 Allowed 'General case' 0 C--N 1.334 -0.097 0 N-CA-C 110.146 -0.316 . . . . 0.0 110.146 179.749 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -146.23 175.53 10.44 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-O 121.034 0.445 . . . . 0.0 111.165 -179.168 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 119' ' ' TYR . . . . . 0.408 ' CE1' ' HB ' ' A' ' 105' ' ' THR . 51.7 p90 -160.08 135.64 8.29 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.581 -0.736 . . . . 0.0 109.234 178.799 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 17.4 m -105.55 142.0 19.62 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.727 0 N-CA-C 109.69 -0.485 . . . . 0.0 109.69 179.344 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 5.8 pt-20 -127.1 152.94 46.64 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.157 -179.417 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 15.4 t80 -156.46 166.99 31.82 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.476 179.163 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 3.8 t -84.37 -47.61 17.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 120.921 0.391 . . . . 0.0 111.627 -179.317 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 74.9 mm-40 -66.33 126.45 28.82 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.32 -179.394 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 2.5 mp -70.23 -32.92 52.41 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.02 -179.926 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 4.8 t70 -62.66 -36.64 83.5 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.505 179.884 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -61.3 -55.44 31.8 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.636 179.724 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 11.3 p -67.12 -28.86 44.12 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.756 179.729 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 7.0 tt0 -58.56 -46.53 86.68 Favored 'General case' 0 N--CA 1.462 0.165 0 CA-C-O 121.11 0.481 . . . . 0.0 110.399 179.223 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 46.2 m-80 -70.83 -31.16 67.78 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.878 -0.601 . . . . 0.0 109.985 179.913 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -68.03 -48.41 65.76 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.665 -0.698 . . . . 0.0 111.833 -179.537 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 3.8 pp -69.93 -18.97 63.4 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.943 0.401 . . . . 0.0 110.92 -179.666 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 5.4 tp -80.03 -49.91 11.12 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.765 179.858 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 79.1 mt -134.61 107.81 7.7 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.477 -0.329 . . . . 0.0 110.967 -179.609 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 2.8 m-20 -159.81 -52.53 0.06 Allowed 'General case' 0 N--CA 1.465 0.303 0 CA-C-O 121.181 0.515 . . . . 0.0 110.998 179.757 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 4.6 pt-20 -74.73 80.06 2.05 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.433 0.635 . . . . 0.0 111.205 -179.735 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 6.8 m -133.78 -60.58 0.82 Allowed 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.672 -0.695 . . . . 0.0 111.0 179.573 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 1.6 tp10 -150.97 121.25 7.28 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-O 120.532 0.206 . . . . 0.0 110.516 -179.325 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -141.93 111.43 6.55 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 109.867 -0.42 . . . . 0.0 109.867 179.237 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 140' ' ' HIS . . . . . 0.449 ' HB2' ' SG ' ' A' ' 86' ' ' CYS . 2.4 t60 67.34 18.27 10.2 Favored 'General case' 0 N--CA 1.468 0.425 0 CA-C-O 121.142 0.496 . . . . 0.0 110.402 179.582 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 88.9 4.14 75.72 Favored Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.869 -0.681 . . . . 0.0 111.54 -179.212 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 142' ' ' ARG . . . . . 0.543 ' HD3' ' OD2' ' A' ' 83' ' ' ASP . 4.3 mpt_? -121.28 166.49 13.95 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 109.825 -0.435 . . . . 0.0 109.825 179.499 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 18.7 pt20 -110.99 140.08 45.81 Favored 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 109.863 -0.421 . . . . 0.0 109.863 179.2 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -125.6 174.98 7.88 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.547 -179.549 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 15.6 ttpt -111.32 118.79 36.82 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.255 179.791 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 85.9 t -113.37 118.53 58.38 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-O 120.992 0.425 . . . . 0.0 110.005 179.276 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 66.3 m -127.49 143.36 51.2 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 116.116 -0.493 . . . . 0.0 109.921 -179.89 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -59.13 133.49 56.14 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.058 0.456 . . . . 0.0 111.888 -178.747 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 12.1 ttpp -96.0 78.29 3.18 Favored 'General case' 0 N--CA 1.449 -0.476 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.205 179.607 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 21.5 tpt180 -91.0 101.72 14.49 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 109.293 -0.632 . . . . 0.0 109.293 179.329 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 4.2 t -94.96 140.52 29.84 Favored 'General case' 0 N--CA 1.446 -0.666 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.777 -179.193 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 152' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 172.87 177.76 0.09 Allowed 'General case' 0 CA--C 1.516 -0.345 0 CA-C-N 115.494 -0.776 . . . . 0.0 109.484 179.632 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 16.6 pt -75.08 140.53 73.6 Favored Pre-proline 0 C--N 1.318 -0.791 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.895 179.839 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -75.95 59.98 5.98 Favored 'Trans proline' 0 CA--C 1.528 0.206 0 C-N-CA 122.949 2.432 . . . . 0.0 112.372 179.916 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.44 -1.068 0 CA-C-O 118.818 -0.99 . . . . 0.0 111.534 179.957 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.3 mpt? . . . . . 0 N--CA 1.482 1.172 0 N-CA-C 109.944 -0.391 . . . . 0.0 109.944 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 118.98 117.43 2.7 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.953 -0.641 . . . . 0.0 112.597 179.898 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -144.64 113.29 6.68 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 110.08 -0.341 . . . . 0.0 110.08 179.382 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 13.3 m -120.26 155.02 34.09 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.712 0.292 . . . . 0.0 111.364 -179.615 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 21.4 p-80 -159.39 141.54 13.57 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.586 179.971 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 35.7 t60 -155.96 139.84 16.24 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.803 0.335 . . . . 0.0 110.563 179.507 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 76.1 t60 -129.41 117.31 20.37 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.041 179.698 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 49.7 t-80 -90.0 129.06 36.37 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 120.782 0.325 . . . . 0.0 110.946 -179.734 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 8.6 p-80 -100.28 -177.7 3.6 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.821 179.926 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 4.6 p80 -136.79 174.51 10.54 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.555 0.217 . . . . 0.0 110.471 179.692 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 9.0 t -111.74 -160.82 0.73 Allowed 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.511 -0.313 . . . . 0.0 110.335 -179.483 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 14.3 m -155.7 119.34 4.43 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 109.593 -0.521 . . . . 0.0 109.593 179.363 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -169.74 156.37 27.17 Favored Glycine 0 N--CA 1.448 -0.537 0 N-CA-C 111.328 -0.709 . . . . 0.0 111.328 179.773 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 47.1 mt -135.93 98.9 4.01 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.141 0.496 . . . . 0.0 110.772 -179.78 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -135.47 79.83 47.02 Favored Pre-proline 0 C--N 1.323 -0.549 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.314 -179.789 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . 0.516 ' HA ' ' OE2' ' A' ' 68' ' ' GLU . 89.7 Cg_exo -45.63 115.82 1.15 Allowed 'Trans proline' 0 C--N 1.348 0.518 0 C-N-CA 123.611 2.874 . . . . 0.0 113.372 -178.844 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 11.8 ptm180 -156.71 177.89 10.97 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.518 -0.764 . . . . 0.0 110.653 -179.755 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -83.78 144.98 22.39 Favored Glycine 0 N--CA 1.445 -0.753 0 C-N-CA 120.685 -0.769 . . . . 0.0 111.484 178.97 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 1.6 m -98.0 139.07 34.37 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 120.714 0.292 . . . . 0.0 110.428 -179.887 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . 0.4 ' HB3' ' OG ' ' A' ' 61' ' ' SER . 36.9 t-80 -157.2 159.49 37.76 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 109.517 -0.549 . . . . 0.0 109.517 179.721 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 2.3 mpt? -66.27 156.97 32.79 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.581 -0.281 . . . . 0.0 110.923 179.64 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 177.26 -171.57 44.38 Favored Glycine 0 N--CA 1.447 -0.602 0 N-CA-C 111.097 -0.801 . . . . 0.0 111.097 -179.963 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' SER . . . . . 0.43 ' HG ' ' CD ' ' A' ' 38' ' ' GLU . 69.3 m -78.49 -97.85 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 116.782 0.291 . . . . 0.0 111.461 -179.888 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 13.8 p-10 -161.76 32.75 0.13 Allowed 'General case' 0 N--CA 1.464 0.245 0 CA-C-O 121.047 0.451 . . . . 0.0 111.686 -179.11 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 45.1 mt -93.85 155.4 17.21 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.82 0.343 . . . . 0.0 110.616 179.745 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 27.6 mt-10 -124.15 141.35 52.13 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.175 -179.354 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 3.3 t70 -153.3 169.72 22.39 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-N 116.482 -0.327 . . . . 0.0 110.229 179.495 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -139.15 2.05 2.07 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.49 -0.323 . . . . 0.0 111.659 -179.317 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 8.5 pttm -128.73 166.22 19.39 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 110.248 -0.279 . . . . 0.0 110.248 -179.943 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . 0.576 ' HA ' ' O ' ' A' ' 53' ' ' MET . 10.0 ptpt -157.32 145.27 19.07 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 109.866 -0.42 . . . . 0.0 109.866 179.359 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 2.8 mmp_? -143.2 -68.12 0.35 Allowed 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 120.876 0.369 . . . . 0.0 110.787 -179.861 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 1.9 mm? -87.83 -167.7 1.97 Allowed 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.067 -0.515 . . . . 0.0 109.996 -179.961 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.467 ' HA ' ' O ' ' A' ' 54' ' ' GLY . 3.5 mtpm? -143.27 81.1 1.7 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.189 0.519 . . . . 0.0 110.044 179.378 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 4.0 mm-40 -111.11 -171.49 1.84 Allowed 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.1 -179.178 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 1.3 pp -149.78 161.72 4.45 Favored 'Isoleucine or valine' 0 C--O 1.233 0.217 0 C-N-CA 122.536 0.335 . . . . 0.0 110.143 179.665 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 17.3 mm-40 61.37 -160.63 0.3 Allowed 'General case' 0 N--CA 1.465 0.318 0 O-C-N 123.437 0.461 . . . . 0.0 111.888 179.138 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 34.2 mm-40 67.46 30.57 6.76 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-N 115.817 -0.629 . . . . 0.0 111.353 179.232 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . 0.469 ' H ' ' HG3' ' A' ' 38' ' ' GLU . 0.0 OUTLIER -115.4 138.01 51.44 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 121.183 0.516 . . . . 0.0 111.754 -178.929 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -151.76 165.79 33.35 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.48 -0.782 . . . . 0.0 110.142 179.737 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -140.02 67.29 0.5 Allowed Glycine 0 N--CA 1.448 -0.529 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.427 -179.907 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -140.15 172.18 13.12 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 110.05 -0.352 . . . . 0.0 110.05 179.829 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 50.7 tp -72.45 94.32 1.64 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.095 0.474 . . . . 0.0 109.825 179.472 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 16.8 ttm180 -149.03 149.58 31.36 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.764 -0.653 . . . . 0.0 109.576 -179.71 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 10.4 tt0 -79.97 48.79 1.0 Allowed 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.272 0.558 . . . . 0.0 110.824 -179.508 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 6.4 ptm -107.35 12.31 28.19 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.441 179.674 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 19.7 mm-40 -69.63 -20.8 63.6 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.056 0.455 . . . . 0.0 111.212 -179.261 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -79.71 -5.44 55.23 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.25 178.913 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 37.1 ttpt -85.34 1.73 47.22 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.78 -0.645 . . . . 0.0 109.775 179.614 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 5.8 p -58.32 -19.44 13.59 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.432 0 CA-C-N 115.261 -0.882 . . . . 0.0 111.094 179.447 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 29.6 mt-10 -70.65 -19.9 62.76 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-O 121.207 0.527 . . . . 0.0 110.369 179.173 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 5.2 mtmt -101.63 -42.52 6.18 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.995 -0.548 . . . . 0.0 109.905 178.749 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 22.0 mt-10 -61.37 -26.6 67.94 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.854 179.391 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' MET . . . . . 0.576 ' O ' ' HA ' ' A' ' 30' ' ' LYS . 19.5 ptt? -66.55 -16.53 64.22 Favored 'General case' 0 C--O 1.227 -0.116 0 CA-C-O 121.372 0.606 . . . . 0.0 110.024 178.668 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . 0.467 ' O ' ' HA ' ' A' ' 33' ' ' LYS . . . -98.67 -7.93 55.04 Favored Glycine 0 N--CA 1.445 -0.725 0 N-CA-C 110.612 -0.995 . . . . 0.0 110.612 178.509 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -114.5 18.52 16.75 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-O 121.144 0.497 . . . . 0.0 110.055 -179.871 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 32.3 m -63.71 -6.87 2.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 115.913 -0.585 . . . . 0.0 112.229 -179.154 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 97.0 mt-30 -88.17 -8.63 55.08 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.234 0.54 . . . . 0.0 110.088 179.097 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -129.33 -58.4 1.12 Allowed 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.376 -0.829 . . . . 0.0 109.681 179.315 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 1.6 m -64.6 -69.69 0.27 Allowed 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.367 -0.833 . . . . 0.0 112.039 -179.674 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 2.1 m -91.38 35.83 0.94 Allowed 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.749 -0.66 . . . . 0.0 111.893 -178.91 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' SER . . . . . 0.4 ' OG ' ' HB3' ' A' ' 20' ' ' HIS . 0.1 OUTLIER -89.02 -21.73 23.33 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.76 0.314 . . . . 0.0 111.033 -179.535 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -69.7 -12.61 61.77 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.428 -179.672 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 33.9 p -61.32 -33.47 73.66 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.445 -179.87 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -70.49 -28.08 64.7 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.584 179.828 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -81.88 -1.64 48.42 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.993 179.867 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 22.9 tp60 -119.87 -44.75 2.51 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.565 -0.289 . . . . 0.0 111.337 179.811 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -90.86 -61.18 1.73 Allowed 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 120.844 0.354 . . . . 0.0 111.252 -179.415 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . 0.516 ' OE2' ' HA ' ' A' ' 16' ' ' PRO . 0.6 OUTLIER -61.94 -27.86 69.13 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.969 -0.56 . . . . 0.0 111.125 -179.313 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 19.4 tptp -58.4 -29.55 66.14 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.405 -179.727 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 17.7 mt-10 -66.27 -20.39 66.09 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-O 121.396 0.617 . . . . 0.0 110.605 179.722 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . 0.432 ' O ' ' HD2' ' A' ' 75' ' ' ARG . 5.5 tp10 -95.28 -39.88 9.83 Favored 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 109.091 -0.707 . . . . 0.0 109.091 177.176 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.458 HG23 ' O ' ' A' ' 68' ' ' GLU . 54.9 t -63.97 -42.64 96.39 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.374 0 CA-C-N 115.606 -0.724 . . . . 0.0 112.491 -179.464 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 14.5 p-10 -70.69 -18.18 62.82 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-O 120.949 0.404 . . . . 0.0 110.898 -179.076 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 33.6 t -97.41 -13.47 21.8 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.188 178.633 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . 0.432 ' HD2' ' O ' ' A' ' 71' ' ' GLU . 0.0 OUTLIER -106.04 44.95 1.0 Allowed 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.775 -0.648 . . . . 0.0 109.961 -179.498 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' SER . . . . . 0.449 ' CB ' ' HB3' ' A' ' 121' ' ' GLU . 0.3 OUTLIER -124.53 170.99 10.36 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.47 -0.786 . . . . 0.0 110.689 179.971 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 6.7 pt -132.15 135.15 58.73 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.772 0 CA-C-N 115.803 -0.635 . . . . 0.0 109.35 178.445 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 69.6 t80 -91.91 123.04 34.99 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 116.341 -0.39 . . . . 0.0 109.994 -179.883 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 4.6 t -102.78 111.48 32.71 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.493 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.223 -179.516 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -121.42 169.69 14.55 Favored Glycine 0 N--CA 1.447 -0.602 0 C-N-CA 120.828 -0.701 . . . . 0.0 111.57 179.858 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 4.2 m-20 61.01 37.66 17.89 Favored 'General case' 0 N--CA 1.469 0.514 0 CA-C-O 121.251 0.548 . . . . 0.0 110.431 -179.882 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 2.5 t -83.52 164.31 2.72 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-N 115.358 -0.837 . . . . 0.0 110.804 -179.01 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . 0.735 ' OD2' ' HB2' ' A' ' 142' ' ' ARG . 0.1 OUTLIER -66.17 137.3 56.91 Favored 'General case' 0 CA--C 1.517 -0.323 0 N-CA-C 109.707 -0.479 . . . . 0.0 109.707 179.288 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 24.6 p90 -65.64 -8.06 18.43 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 120.917 0.389 . . . . 0.0 111.379 -179.878 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -118.51 19.52 13.29 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.14 -179.743 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -87.01 143.88 27.14 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.707 179.971 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' THR . . . . . 0.427 ' O ' ' HG2' ' A' ' 90' ' ' GLU . 20.7 p -107.79 148.9 38.25 Favored Pre-proline 0 C--N 1.326 -0.429 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.425 179.572 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 11.7 Cg_endo -54.81 -39.65 88.83 Favored 'Trans proline' 0 C--N 1.344 0.339 0 C-N-CA 123.089 2.526 . . . . 0.0 112.977 -179.198 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 3.2 mp0 -65.1 -41.73 94.7 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 112.498 0.555 . . . . 0.0 112.498 -178.486 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . 0.473 ' O ' ' HB2' ' A' ' 94' ' ' HIS . 8.0 pt-20 -73.98 -14.8 61.09 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.97 0.414 . . . . 0.0 111.024 -178.977 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 74.5 t -88.52 -48.35 14.92 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.89 -179.561 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -69.0 -34.13 74.8 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.545 -178.333 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 7.6 pt20 -78.11 -28.97 48.7 Favored 'General case' 0 C--N 1.327 -0.384 0 C-N-CA 120.556 -0.457 . . . . 0.0 111.24 -178.854 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' HIS . . . . . 0.473 ' HB2' ' O ' ' A' ' 90' ' ' GLU . 1.8 t-80 -73.39 -32.19 64.33 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.97 0.414 . . . . 0.0 110.828 -179.664 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 21.4 m-30 -87.7 -11.69 47.54 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.144 179.543 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 26.4 tt0 -62.74 -27.64 69.41 Favored 'General case' 0 C--O 1.234 0.237 0 CA-C-N 115.538 -0.755 . . . . 0.0 110.343 -179.957 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 12.7 m -63.96 -35.5 80.89 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.233 179.085 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 3.8 m -85.29 -52.75 5.68 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.883 -0.599 . . . . 0.0 109.532 179.159 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -140.57 128.16 3.71 Favored Glycine 0 N--CA 1.441 -0.979 0 CA-C-N 115.684 -0.689 . . . . 0.0 111.689 179.752 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -57.33 136.25 56.55 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.853 0.359 . . . . 0.0 110.101 179.418 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 2.0 p -102.01 130.33 51.94 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-N 116.048 -0.524 . . . . 0.0 112.073 -177.913 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . 0.437 ' HB2' ' CD1' ' A' ' 122' ' ' PHE . 29.2 t-20 -99.85 -43.78 6.3 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 109.53 -0.544 . . . . 0.0 109.53 178.449 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . 0.412 ' HD3' ' OD1' ' A' ' 102' ' ' ASN . 1.5 mpt_? -135.7 151.24 49.98 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.328 179.657 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 6.1 p -155.46 129.82 1.39 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.552 -0.295 . . . . 0.0 110.211 179.28 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -127.49 124.8 39.19 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.492 -0.322 . . . . 0.0 110.248 179.472 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 20.8 tt -109.26 149.06 12.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 120.857 0.36 . . . . 0.0 111.014 -179.89 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 13.8 tp -130.14 136.22 49.05 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.002 -0.544 . . . . 0.0 109.991 179.516 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -100.8 111.35 23.55 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.488 179.9 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -76.73 146.91 37.68 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.188 0.518 . . . . 0.0 111.13 -179.618 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 3.3 mppt? -135.15 22.99 3.5 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.267 179.446 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 19.0 t80 -107.58 -3.89 18.88 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.222 0.534 . . . . 0.0 110.157 -179.544 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 114.78 0.62 22.96 Favored Glycine 0 N--CA 1.449 -0.474 0 C-N-CA 120.816 -0.707 . . . . 0.0 112.766 179.835 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 26.6 mt-30 -88.35 154.59 51.53 Favored Pre-proline 0 C--N 1.329 -0.315 0 N-CA-C 109.361 -0.607 . . . . 0.0 109.361 179.679 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 14.5 Cg_endo -58.45 115.92 2.88 Favored 'Trans proline' 0 N--CA 1.462 -0.378 0 C-N-CA 122.013 1.809 . . . . 0.0 111.444 178.917 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 60.0 mttt -70.86 167.06 19.77 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 109.558 -0.534 . . . . 0.0 109.558 -179.485 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 105.59 1.83 40.36 Favored Glycine 0 N--CA 1.447 -0.607 0 C-N-CA 120.073 -1.061 . . . . 0.0 112.197 179.914 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 32.4 m-85 -53.69 115.61 2.07 Favored 'General case' 0 C--N 1.333 -0.138 0 N-CA-C 110.269 -0.271 . . . . 0.0 110.269 179.46 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -143.41 173.01 12.0 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 120.915 0.388 . . . . 0.0 111.006 -179.162 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 51.9 p90 -155.21 130.09 9.35 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 115.847 -0.615 . . . . 0.0 109.765 178.681 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 18.6 m -107.21 141.27 22.85 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 N-CA-C 109.695 -0.483 . . . . 0.0 109.695 179.178 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . 0.449 ' HB3' ' CB ' ' A' ' 76' ' ' SER . 1.4 pt-20 -132.04 157.05 45.16 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.916 0.388 . . . . 0.0 111.17 179.723 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 122' ' ' PHE . . . . . 0.437 ' CD1' ' HB2' ' A' ' 102' ' ' ASN . 22.2 t80 -152.29 170.88 18.95 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.535 -0.757 . . . . 0.0 109.771 179.91 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 20.4 t -84.26 -51.6 13.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-O 120.969 0.414 . . . . 0.0 110.461 179.852 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 4.7 mm-40 -60.53 129.66 42.69 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.852 -0.613 . . . . 0.0 111.132 179.886 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 2.9 mp -73.9 -31.03 29.58 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 N-CA-C 109.327 -0.62 . . . . 0.0 109.327 179.516 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -60.53 -37.97 82.92 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.342 179.26 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -60.8 -56.33 22.52 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.537 -0.756 . . . . 0.0 111.107 -179.976 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 11.3 p -67.19 -30.13 48.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.442 -179.654 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 30.1 tt0 -61.31 -44.78 96.64 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 121.038 0.447 . . . . 0.0 110.436 179.653 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 37.9 m-80 -72.3 -29.11 63.55 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.055 -0.52 . . . . 0.0 109.994 179.601 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . 0.437 ' O ' ' HB2' ' A' ' 135' ' ' ASN . . . -69.53 -51.65 33.66 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.476 -0.784 . . . . 0.0 111.305 -179.939 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 4.2 pp -65.59 -23.34 66.81 Favored 'General case' 0 N--CA 1.462 0.142 0 CA-C-O 120.794 0.33 . . . . 0.0 110.681 -179.824 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 5.7 tp -73.37 -56.48 5.01 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.961 0.41 . . . . 0.0 110.228 179.595 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 69.1 mt -122.71 104.2 9.16 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.007 -0.542 . . . . 0.0 109.79 179.826 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 135' ' ' ASN . . . . . 0.437 ' HB2' ' O ' ' A' ' 131' ' ' ALA . 0.5 OUTLIER -148.4 -66.84 0.24 Allowed 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.15 0.5 . . . . 0.0 111.122 -179.186 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 5.6 pt-20 -73.68 106.29 5.37 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.563 -0.744 . . . . 0.0 111.414 -179.466 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 21.3 m -150.09 -59.13 0.19 Allowed 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.706 -0.679 . . . . 0.0 109.599 178.997 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 4.9 tt0 -161.55 120.96 2.5 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.813 -0.63 . . . . 0.0 109.572 178.946 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -139.35 123.18 17.63 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 -179.982 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 140' ' ' HIS . . . . . 0.618 ' HB3' ' OD2' ' A' ' 83' ' ' ASP . 6.9 t60 59.07 12.4 2.42 Favored 'General case' 0 CA--C 1.54 0.562 0 O-C-N 123.555 0.534 . . . . 0.0 111.553 179.28 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 101.36 -6.4 55.75 Favored Glycine 0 N--CA 1.449 -0.443 0 C-N-CA 120.904 -0.665 . . . . 0.0 112.754 -179.918 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 142' ' ' ARG . . . . . 0.735 ' HB2' ' OD2' ' A' ' 83' ' ' ASP . 8.0 mpt_? -113.43 173.42 6.42 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 117.023 0.412 . . . . 0.0 110.418 179.58 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 17.4 pt20 -116.87 114.16 23.49 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.093 0.473 . . . . 0.0 109.759 179.531 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -97.97 175.13 6.24 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.174 -179.15 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 6.4 ttpt -117.51 120.81 39.22 Favored 'General case' 0 N--CA 1.45 -0.457 0 CA-C-N 115.905 -0.589 . . . . 0.0 109.495 179.052 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 93.5 t -113.36 119.96 62.07 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.738 0 CA-C-O 120.898 0.38 . . . . 0.0 110.653 -179.635 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 58.2 m -123.25 141.68 51.72 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 116.195 -0.457 . . . . 0.0 109.801 -179.849 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -59.86 128.8 38.67 Favored 'General case' 0 C--O 1.236 0.378 0 CA-C-O 120.828 0.347 . . . . 0.0 111.277 -179.64 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 149' ' ' LYS . . . . . 0.426 ' HE2' ' OG ' ' A' ' 76' ' ' SER . 21.9 ttpt -91.94 67.8 5.25 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.384 0.611 . . . . 0.0 109.999 -179.601 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 24.7 tpt180 -88.12 94.56 9.84 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 121.236 0.541 . . . . 0.0 109.611 179.104 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 3.0 t -83.88 129.13 34.94 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 115.615 -0.721 . . . . 0.0 109.634 179.297 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 152' ' ' ASN . . . . . . . . . . . . . 62.5 t30 -163.68 158.9 20.96 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.001 -179.661 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 19.6 pt -78.36 148.81 74.67 Favored Pre-proline 0 C--N 1.32 -0.698 0 CA-C-N 116.577 -0.283 . . . . 0.0 110.322 179.733 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 30.5 Cg_endo -63.95 103.75 0.44 Allowed 'Trans proline' 0 C--N 1.344 0.31 0 C-N-CA 122.559 2.173 . . . . 0.0 111.987 179.848 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.161 0 CA-C-O 118.025 -1.431 . . . . 0.0 111.047 -179.577 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.454 -0.243 0 N-CA-C 109.772 -0.455 . . . . 0.0 109.772 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 56.8 tp -71.8 97.02 1.71 Allowed 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.177 0.513 . . . . 0.0 110.35 179.547 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 43' ' ' ARG . . . . . 0.422 ' C ' ' H ' ' A' ' 45' ' ' MET . 0.7 OUTLIER -150.13 147.92 28.34 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.655 -0.702 . . . . 0.0 109.582 -179.986 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -73.79 20.35 0.1 Allowed 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.623 -179.723 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 45' ' ' MET . . . . . 0.422 ' H ' ' C ' ' A' ' 43' ' ' ARG . 19.5 ptt? -83.86 8.1 15.98 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.026 0.441 . . . . 0.0 110.63 -179.854 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 87.7 mt-30 -66.1 -22.75 66.41 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.179 0.514 . . . . 0.0 110.477 179.361 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -80.37 -7.43 59.09 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.149 0.499 . . . . 0.0 110.681 179.648 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 18.7 ttmm -77.91 -6.28 53.81 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.539 -179.795 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 14.8 p -56.2 -28.57 25.83 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.32 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.596 -179.474 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 26.7 mt-10 -62.22 -31.36 71.89 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.91 0.386 . . . . 0.0 111.294 -179.359 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 37.6 mtmt -96.68 -41.18 8.63 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.609 -179.966 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 27.6 mm-40 -61.39 -29.6 70.02 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.71 -179.502 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 15.2 ptt? -62.62 -24.9 67.83 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-O 120.87 0.367 . . . . 0.0 110.629 179.797 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -94.3 -9.48 59.14 Favored Glycine 0 N--CA 1.447 -0.598 0 C-N-CA 120.699 -0.762 . . . . 0.0 111.483 179.463 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.326 -0.452 0 CA-C-O 120.909 0.385 . . . . 0.0 110.747 -179.753 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.225 -0.187 0 CA-C-O 120.901 0.382 . . . . 0.0 110.213 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -74.6 -0.08 16.63 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.048 0.452 . . . . 0.0 111.14 179.909 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 21.9 tp60 -119.47 -48.69 2.39 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.998 179.698 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -89.36 -52.94 4.78 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.864 0.364 . . . . 0.0 111.904 -179.236 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 68' ' ' GLU . . . . . 0.45 ' O ' HG23 ' A' ' 72' ' ' VAL . 6.4 tt0 -68.68 -26.1 65.13 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.143 0.497 . . . . 0.0 110.549 -179.094 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 51.2 tptt -58.91 -27.89 65.69 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.886 179.511 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 52.6 mt-10 -63.76 -21.94 66.66 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-O 121.443 0.64 . . . . 0.0 110.99 179.758 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 71' ' ' GLU . . . . . 0.522 ' O ' ' HD3' ' A' ' 75' ' ' ARG . 13.2 tp10 -94.8 -44.56 7.71 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 115.521 -0.763 . . . . 0.0 108.951 178.307 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.596 HG12 ' HB2' ' A' ' 121' ' ' GLU . 26.7 t -62.78 -40.45 88.69 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-N 115.351 -0.84 . . . . 0.0 112.883 -178.496 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 9.9 p-10 -70.86 -20.83 62.49 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-O 121.091 0.472 . . . . 0.0 111.64 -178.933 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 18.0 m -100.89 -5.05 26.61 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-O 121.335 0.588 . . . . 0.0 110.192 179.888 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 75' ' ' ARG . . . . . 0.522 ' HD3' ' O ' ' A' ' 71' ' ' GLU . 1.9 mpt_? -113.9 39.43 2.7 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.593 -0.73 . . . . 0.0 109.545 -179.92 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -119.26 173.83 6.71 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.381 -0.827 . . . . 0.0 110.886 -179.926 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.416 HD13 ' HB1' ' A' ' 131' ' ' ALA . 7.0 pt -133.31 140.41 47.03 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.067 178.585 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 71.0 t80 -96.53 126.52 41.77 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 109.624 -0.51 . . . . 0.0 109.624 179.815 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 5.1 t -108.09 114.33 46.23 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.983 -179.381 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -120.38 169.45 14.06 Favored Glycine 0 N--CA 1.448 -0.513 0 N-CA-C 111.192 -0.763 . . . . 0.0 111.192 179.36 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 93.8 m-20 60.06 38.66 20.47 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-O 121.073 0.463 . . . . 0.0 110.754 -179.712 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 2.4 t -81.82 164.44 2.91 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.753 -179.145 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 83' ' ' ASP . . . . . 0.414 ' O ' ' HB2' ' A' ' 86' ' ' CYS . 9.7 t70 -67.3 137.01 55.75 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 109.676 -0.491 . . . . 0.0 109.676 179.414 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 30.5 p90 -64.27 -18.46 64.59 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.897 -178.647 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -113.23 24.92 11.81 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 121.037 0.446 . . . . 0.0 110.747 179.851 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 86' ' ' CYS . . . . . 0.414 ' HB2' ' O ' ' A' ' 83' ' ' ASP . 0.1 OUTLIER -85.85 156.45 20.55 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.397 0.618 . . . . 0.0 111.549 -179.966 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 87' ' ' THR . . . . . 0.483 ' O ' ' HG2' ' A' ' 90' ' ' GLU . 0.0 OUTLIER -119.31 146.64 41.35 Favored Pre-proline 0 C--N 1.322 -0.601 0 CA-C-N 115.432 -0.804 . . . . 0.0 110.343 -179.941 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 88' ' ' PRO . . . . . 0.566 ' HD3' HD13 ' A' ' 106' ' ' ILE . 15.0 Cg_endo -56.7 -40.2 86.04 Favored 'Trans proline' 0 C--N 1.344 0.319 0 C-N-CA 122.83 2.353 . . . . 0.0 112.734 -178.867 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 60.1 mm-40 -60.42 -50.49 73.36 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.531 -179.097 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 90' ' ' GLU . . . . . 0.719 ' O ' ' HB2' ' A' ' 94' ' ' HIS . 6.6 pt-20 -63.91 -24.6 67.8 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.624 -0.262 . . . . 0.0 111.143 -178.706 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 70.0 t -80.76 -48.66 19.3 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.04 -179.343 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 2.3 pt20 -70.92 -34.03 71.12 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 112.1 0.407 . . . . 0.0 112.1 -178.167 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 18.5 pt20 -79.19 -23.8 43.61 Favored 'General case' 0 C--N 1.329 -0.285 0 C-N-CA 120.496 -0.481 . . . . 0.0 110.896 -179.502 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 94' ' ' HIS . . . . . 0.719 ' HB2' ' O ' ' A' ' 90' ' ' GLU . 0.4 OUTLIER -74.48 -43.66 55.0 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.048 0.452 . . . . 0.0 110.067 179.684 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 21.8 m-30 -78.17 -12.52 60.0 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.521 -179.873 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 96' ' ' GLN . . . . . 0.603 ' HA ' ' O ' ' A' ' 99' ' ' GLY . 15.8 tt0 -65.08 -19.72 66.13 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.378 -179.959 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 12.3 m -66.54 -26.82 67.32 Favored 'General case' 0 N--CA 1.451 -0.401 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.272 179.217 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 5.9 m -97.02 -42.97 7.64 Favored 'General case' 0 N--CA 1.453 -0.324 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.168 179.365 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 99' ' ' GLY . . . . . 0.603 ' O ' ' HA ' ' A' ' 96' ' ' GLN . . . -150.65 142.16 9.35 Favored Glycine 0 N--CA 1.445 -0.712 0 C-N-CA 120.875 -0.679 . . . . 0.0 111.768 179.855 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 100' ' ' THR . . . . . 0.417 ' HB ' ' CZ ' ' A' ' 122' ' ' PHE . 0.2 OUTLIER -62.68 150.03 42.09 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 120.937 0.398 . . . . 0.0 111.524 -179.924 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 2.2 p -119.54 129.26 75.55 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.754 -179.762 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 55.7 t30 -98.24 -39.51 8.81 Favored 'General case' 0 N--CA 1.463 0.175 0 CA-C-O 121.145 0.498 . . . . 0.0 110.274 179.385 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 2.2 tpt180 -145.93 153.29 40.66 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.223 -179.883 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 5.8 p -151.22 133.09 5.39 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.07 179.763 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 1.5 m -121.27 122.88 40.89 Favored 'General case' 0 C--N 1.32 -0.674 0 N-CA-C 110.129 -0.323 . . . . 0.0 110.129 179.612 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 106' ' ' ILE . . . . . 0.566 HD13 ' HD3' ' A' ' 88' ' ' PRO . 21.0 tt -113.49 144.36 21.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 120.935 0.398 . . . . 0.0 110.729 -179.514 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 27.0 tp -132.45 128.7 38.02 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.305 179.662 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -86.91 114.56 23.65 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.715 179.7 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 109' ' ' ASP . . . . . 0.423 ' O ' ' HG2' ' A' ' 115' ' ' LYS . 15.0 t70 -75.39 140.93 43.28 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.872 0.367 . . . . 0.0 110.796 -179.74 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -132.31 28.7 4.36 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 109.352 -0.61 . . . . 0.0 109.352 179.159 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 5.1 t80 -109.82 -2.37 17.32 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.589 -0.732 . . . . 0.0 109.707 179.919 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 106.89 6.29 34.81 Favored Glycine 0 N--CA 1.448 -0.51 0 CA-C-N 115.527 -0.76 . . . . 0.0 112.52 179.98 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 36.3 mt-30 -94.87 158.74 34.61 Favored Pre-proline 0 C--N 1.324 -0.511 0 N-CA-C 109.407 -0.59 . . . . 0.0 109.407 179.593 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 15.2 Cg_endo -58.11 119.3 6.47 Favored 'Trans proline' 0 C--N 1.345 0.388 0 C-N-CA 122.105 1.87 . . . . 0.0 110.88 178.886 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 115' ' ' LYS . . . . . 0.423 ' HG2' ' O ' ' A' ' 109' ' ' ASP . 58.3 mttt -74.4 173.37 10.38 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 109.976 -0.379 . . . . 0.0 109.976 -179.499 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 116' ' ' GLY . . . . . 0.529 ' HA2' HD11 ' A' ' 106' ' ' ILE . . . 98.32 3.27 57.68 Favored Glycine 0 N--CA 1.443 -0.844 0 C-N-CA 120.178 -1.01 . . . . 0.0 112.165 179.626 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 5.2 m-30 -54.82 117.56 3.51 Favored 'General case' 0 N--CA 1.463 0.206 0 N-CA-C 110.188 -0.301 . . . . 0.0 110.188 179.582 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -147.29 168.42 21.79 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.046 0.45 . . . . 0.0 111.451 -178.811 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 34.5 p90 -148.24 129.84 14.98 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.643 -0.708 . . . . 0.0 109.722 178.41 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 6.4 m -105.3 145.95 12.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 N-CA-C 109.742 -0.466 . . . . 0.0 109.742 179.781 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 121' ' ' GLU . . . . . 0.596 ' HB2' HG12 ' A' ' 72' ' ' VAL . 6.1 pt-20 -133.9 152.58 51.91 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 120.657 0.265 . . . . 0.0 111.005 -179.701 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 122' ' ' PHE . . . . . 0.417 ' CZ ' ' HB ' ' A' ' 100' ' ' THR . 13.0 t80 -148.64 167.01 26.6 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.124 179.525 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 10.1 t -83.44 -41.92 17.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.488 -0.324 . . . . 0.0 111.535 -179.286 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 43.6 mm-40 -74.02 132.12 42.06 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.121 0.486 . . . . 0.0 111.593 -179.087 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 2.4 mp -74.71 -35.51 37.44 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.444 -179.657 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -59.25 -33.49 71.1 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.151 0.5 . . . . 0.0 110.937 -179.692 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -65.56 -54.97 20.52 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.926 179.958 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 10.3 p -66.49 -29.6 47.06 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.804 -179.564 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 8.3 tt0 -60.39 -42.62 96.28 Favored 'General case' 0 C--N 1.333 -0.142 0 CA-C-O 120.909 0.385 . . . . 0.0 110.431 179.619 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 29.3 m-80 -73.59 -31.0 63.35 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.119 179.282 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 131' ' ' ALA . . . . . 0.416 ' HB1' HD13 ' A' ' 77' ' ' ILE . . . -67.93 -52.44 36.08 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.664 -0.698 . . . . 0.0 111.274 -179.885 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 4.0 pp -64.23 -22.22 66.87 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.85 0.357 . . . . 0.0 111.015 -179.802 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 5.5 tp -77.55 -55.72 5.13 Favored 'General case' 0 N--CA 1.451 -0.403 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.46 179.556 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 33.7 mt -123.74 103.04 8.14 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.078 -179.836 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -145.42 -71.25 0.26 Allowed 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 120.788 0.328 . . . . 0.0 111.56 -179.316 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 4.1 pt-20 -66.61 110.35 3.16 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.268 0.556 . . . . 0.0 111.268 -179.224 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 14.0 m -153.45 -58.14 0.13 Allowed 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.787 -0.642 . . . . 0.0 109.726 179.334 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -163.88 122.15 1.88 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.1 -0.5 . . . . 0.0 109.978 179.174 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -138.83 115.61 10.74 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 109.189 -0.671 . . . . 0.0 109.189 179.425 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 3.3 t60 64.83 16.45 10.47 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-O 120.896 0.379 . . . . 0.0 110.853 179.883 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 91.39 6.28 66.42 Favored Glycine 0 N--CA 1.448 -0.522 0 C-N-CA 120.893 -0.67 . . . . 0.0 111.761 -179.034 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -119.99 160.45 22.73 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 110.204 -0.295 . . . . 0.0 110.204 179.794 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 14.2 pt20 -108.22 126.5 52.87 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 109.443 -0.577 . . . . 0.0 109.443 178.573 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -112.47 175.43 5.44 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.688 -179.553 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 78.4 tttt -116.97 124.04 48.41 Favored 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 109.461 -0.57 . . . . 0.0 109.461 178.73 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 99.1 t -116.01 125.24 73.03 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.639 0 CA-C-O 120.941 0.4 . . . . 0.0 110.448 179.862 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 11.9 t -127.36 149.58 49.99 Favored 'General case' 0 N--CA 1.447 -0.624 0 N-CA-C 109.583 -0.525 . . . . 0.0 109.583 179.927 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -65.58 127.26 31.17 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.55 -0.295 . . . . 0.0 110.964 -179.829 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 19.9 ttpt -91.2 66.42 5.66 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.376 0.607 . . . . 0.0 109.683 179.88 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 150' ' ' ARG . . . . . 0.491 ' C ' ' HD2' ' A' ' 150' ' ' ARG . 0.0 OUTLIER . . . . . 0 C--N 1.322 -0.612 0 N-CA-C 109.439 -0.578 . . . . 0.0 109.439 179.819 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.177 0 CA-C-O 120.434 0.159 . . . . 0.0 110.623 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 64.7 tp -75.33 92.63 2.8 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-O 121.225 0.536 . . . . 0.0 110.569 179.696 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 43' ' ' ARG . . . . . 0.409 ' HB3' ' SD ' ' A' ' 45' ' ' MET . 4.3 ttp180 -155.84 159.73 39.62 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.836 -0.62 . . . . 0.0 109.675 -179.673 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 16.9 mt-10 -86.17 23.47 1.53 Allowed 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.371 0.605 . . . . 0.0 111.185 179.91 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 45' ' ' MET . . . . . 0.409 ' SD ' ' HB3' ' A' ' 43' ' ' ARG . 6.4 ptm -83.56 14.18 3.98 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.061 179.39 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 45.4 mt-30 -73.23 -27.53 61.65 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.837 -0.619 . . . . 0.0 109.713 179.408 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -75.8 -12.27 60.14 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.509 -0.769 . . . . 0.0 110.146 179.136 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 3.4 tmmt? -74.89 -2.62 27.69 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.214 -0.903 . . . . 0.0 110.21 179.681 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 8.1 p -60.5 -23.95 29.96 Favored 'Isoleucine or valine' 0 C--O 1.235 0.302 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.831 179.337 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 26.1 mm-40 -59.46 -27.28 65.95 Favored 'General case' 0 N--CA 1.457 -0.087 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.285 179.187 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 12.7 mtmm -97.85 -37.25 9.91 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.945 -0.571 . . . . 0.0 110.441 178.455 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -59.38 -22.32 61.19 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.687 -179.748 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 17.9 ptt? -58.47 -23.09 56.83 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.767 0.317 . . . . 0.0 110.859 179.814 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -105.86 4.37 39.18 Favored Glycine 0 N--CA 1.447 -0.592 0 C-N-CA 120.668 -0.777 . . . . 0.0 111.711 179.258 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.3 0 CA-C-O 121.139 0.495 . . . . 0.0 110.635 -179.829 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.453 -0.318 0 CA-C-O 120.867 0.365 . . . . 0.0 110.175 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -76.12 0.82 17.51 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.984 0.421 . . . . 0.0 111.243 179.826 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 57.1 tp60 -120.44 -50.52 2.22 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.972 179.679 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -85.04 -57.18 3.2 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 111.927 0.343 . . . . 0.0 111.927 -179.384 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 2.1 tp10 -63.09 -29.23 70.65 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-O 121.344 0.592 . . . . 0.0 110.211 -179.62 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 52.7 tptt -58.98 -28.59 66.49 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.459 -0.792 . . . . 0.0 111.251 179.453 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 63.4 mt-10 -62.43 -24.32 67.36 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-O 120.906 0.384 . . . . 0.0 111.174 -179.786 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 11.9 tp10 -96.83 -35.69 10.86 Favored 'General case' 0 C--N 1.318 -0.797 0 N-CA-C 109.841 -0.429 . . . . 0.0 109.841 178.423 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.526 HG12 ' HB2' ' A' ' 121' ' ' GLU . 57.5 t -65.98 -42.31 91.5 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.878 -179.337 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 24.9 p-10 -71.33 -14.71 62.28 Favored 'General case' 0 N--CA 1.466 0.325 0 CA-C-O 121.118 0.485 . . . . 0.0 110.864 -179.726 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 74' ' ' SER . . . . . 0.415 ' OG ' ' HD3' ' A' ' 75' ' ' ARG . 12.4 p -97.89 -14.61 20.59 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.093 178.894 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 75' ' ' ARG . . . . . 0.476 ' CZ ' HG12 ' A' ' 125' ' ' ILE . 0.1 OUTLIER -111.23 46.47 1.08 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.423 -0.808 . . . . 0.0 110.401 -178.85 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -122.25 172.42 8.31 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.456 179.921 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.544 HD13 ' HB1' ' A' ' 131' ' ' ALA . 10.4 pt -130.83 140.71 48.02 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.61 179.394 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 87.2 t80 -95.54 123.07 38.91 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.839 -0.619 . . . . 0.0 109.836 179.908 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 3.9 t -106.48 113.18 42.43 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.849 -179.426 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -120.45 165.68 13.79 Favored Glycine 0 N--CA 1.448 -0.516 0 C-N-CA 120.937 -0.649 . . . . 0.0 111.801 179.938 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 2.6 m-20 61.79 39.44 13.96 Favored 'General case' 0 N--CA 1.471 0.598 0 CA-C-O 121.112 0.482 . . . . 0.0 111.014 -179.602 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 2.3 t -81.4 162.99 3.39 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.693 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.331 -179.417 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 83' ' ' ASP . . . . . 0.729 ' OD2' ' HB2' ' A' ' 142' ' ' ARG . 0.3 OUTLIER -63.87 138.52 58.51 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 109.845 -0.428 . . . . 0.0 109.845 179.445 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 30.5 p90 -62.67 -12.44 23.55 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.107 -0.497 . . . . 0.0 112.057 -179.443 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -123.24 27.74 7.41 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.744 0.307 . . . . 0.0 110.948 -179.485 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -86.08 147.55 26.12 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 116.444 -0.344 . . . . 0.0 110.783 -179.975 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 87' ' ' THR . . . . . 0.487 ' HB ' ' OE1' ' A' ' 89' ' ' GLU . 15.5 p -108.88 146.82 34.59 Favored Pre-proline 0 C--N 1.325 -0.487 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.894 179.658 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 88' ' ' PRO . . . . . 0.428 ' HD3' HD13 ' A' ' 106' ' ' ILE . 16.1 Cg_endo -57.41 -37.43 97.45 Favored 'Trans proline' 0 C--N 1.344 0.29 0 C-N-CA 122.663 2.242 . . . . 0.0 113.2 -179.083 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 89' ' ' GLU . . . . . 0.487 ' OE1' ' HB ' ' A' ' 87' ' ' THR . 5.4 mp0 -64.75 -47.46 78.12 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.912 -178.347 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 90' ' ' GLU . . . . . 0.416 ' HG2' ' O ' ' A' ' 87' ' ' THR . 7.4 pt-20 -67.01 -24.19 66.0 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.843 0.354 . . . . 0.0 111.157 -178.958 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 75.0 t -79.97 -47.99 20.91 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.96 -179.535 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -69.43 -33.76 73.44 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.569 -0.287 . . . . 0.0 111.593 -178.356 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 11.1 pt20 -76.65 -30.17 56.72 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 120.516 -0.474 . . . . 0.0 111.143 -179.176 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 8.1 t60 -73.13 -40.04 65.23 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.053 0.454 . . . . 0.0 109.976 179.898 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 18.6 m-30 -78.35 -14.57 59.35 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.301 179.751 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 96' ' ' GLN . . . . . 0.595 ' HA ' ' O ' ' A' ' 99' ' ' GLY . 28.2 tt0 -67.57 -20.85 65.44 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.401 -0.818 . . . . 0.0 110.257 179.699 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 5.1 m -69.18 -23.09 63.88 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.648 -0.706 . . . . 0.0 110.173 179.241 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 26.5 m -99.91 -42.17 6.9 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.76 -0.655 . . . . 0.0 110.324 179.276 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 99' ' ' GLY . . . . . 0.595 ' O ' ' HA ' ' A' ' 96' ' ' GLN . . . -150.63 144.72 12.18 Favored Glycine 0 N--CA 1.442 -0.95 0 CA-C-N 115.906 -0.588 . . . . 0.0 111.84 179.897 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -63.25 146.5 53.29 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 120.993 0.425 . . . . 0.0 111.304 179.857 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 2.0 p -115.73 126.47 73.28 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.777 -179.533 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 5.5 t30 -94.57 -39.07 10.57 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 121.179 0.514 . . . . 0.0 110.047 179.309 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 3.0 tpt180 -150.01 151.98 34.17 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.121 -179.872 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 4.0 p -148.59 128.97 4.53 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-O 121.09 0.472 . . . . 0.0 110.122 179.483 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 105' ' ' THR . . . . . 0.596 ' HB ' ' CE1' ' A' ' 119' ' ' TYR . 4.9 m -121.47 122.38 39.63 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 116.473 -0.33 . . . . 0.0 110.573 179.845 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 106' ' ' ILE . . . . . 0.566 HD11 ' HA2' ' A' ' 116' ' ' GLY . 19.6 tt -108.87 148.54 12.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 O-C-N 123.206 0.316 . . . . 0.0 110.408 179.741 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 17.6 tp -136.75 124.89 22.99 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.386 -179.914 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -89.0 117.37 27.97 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 120.81 0.338 . . . . 0.0 110.651 179.434 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 4.7 t70 -77.94 139.64 39.21 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.698 0.285 . . . . 0.0 110.762 179.596 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -123.34 32.6 5.6 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 121.061 0.457 . . . . 0.0 110.261 179.274 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 1.7 t80 -113.73 -3.06 13.57 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.302 -179.889 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 106.65 6.7 35.06 Favored Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 120.828 -0.701 . . . . 0.0 112.738 -179.565 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 113' ' ' GLN . . . . . 0.415 ' HB3' ' HD2' ' A' ' 114' ' ' PRO . 27.5 mt-30 -92.02 158.81 38.96 Favored Pre-proline 0 C--N 1.323 -0.568 0 N-CA-C 109.564 -0.532 . . . . 0.0 109.564 -179.939 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 114' ' ' PRO . . . . . 0.415 ' HD2' ' HB3' ' A' ' 113' ' ' GLN . 18.0 Cg_endo -59.7 106.45 0.32 Allowed 'Trans proline' 0 C--N 1.347 0.466 0 C-N-CA 122.411 2.074 . . . . 0.0 111.528 179.148 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 5.2 mttp -68.3 175.46 3.29 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.07 -0.513 . . . . 0.0 110.588 -179.475 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 116' ' ' GLY . . . . . 0.566 ' HA2' HD11 ' A' ' 106' ' ' ILE . . . 98.51 4.02 57.28 Favored Glycine 0 N--CA 1.441 -0.993 0 C-N-CA 120.04 -1.076 . . . . 0.0 111.658 -179.628 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 30.0 m-85 -52.82 116.06 2.14 Favored 'General case' 0 CA--C 1.521 -0.152 0 O-C-N 123.776 0.339 . . . . 0.0 110.364 179.86 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -144.05 176.19 9.48 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 121.057 0.456 . . . . 0.0 111.236 -179.255 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 119' ' ' TYR . . . . . 0.596 ' CE1' ' HB ' ' A' ' 105' ' ' THR . 50.0 p90 -159.93 137.34 9.64 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.497 -0.774 . . . . 0.0 109.171 178.93 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 10.9 m -111.01 143.57 20.63 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 178.925 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 121' ' ' GLU . . . . . 0.526 ' HB2' HG12 ' A' ' 72' ' ' VAL . 4.4 pt-20 -128.8 157.05 42.56 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 116.562 -0.29 . . . . 0.0 111.054 -179.207 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 122' ' ' PHE . . . . . 0.415 ' O ' ' HA ' ' A' ' 72' ' ' VAL . 11.9 t80 -161.37 168.99 22.85 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 109.691 -0.485 . . . . 0.0 109.691 179.491 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 1.8 t -85.54 -48.38 16.21 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-O 120.921 0.391 . . . . 0.0 111.342 -179.182 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 11.0 mt-10 -62.44 130.31 44.6 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.956 -0.565 . . . . 0.0 111.795 -178.971 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 125' ' ' ILE . . . . . 0.476 HG12 ' CZ ' ' A' ' 75' ' ' ARG . 2.3 mp -76.06 -32.4 23.0 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.468 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.63 -179.795 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 13.2 t70 -60.43 -39.49 87.64 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.102 0.477 . . . . 0.0 110.232 179.333 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -61.36 -53.64 54.04 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.523 -0.762 . . . . 0.0 111.545 179.963 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 7.3 p -68.74 -28.11 38.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.127 -179.511 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 25.5 tt0 -58.86 -47.6 84.32 Favored 'General case' 0 C--N 1.334 -0.096 0 CA-C-O 121.023 0.439 . . . . 0.0 110.32 179.629 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 76.8 m-20 -70.9 -33.29 70.42 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.741 -0.663 . . . . 0.0 109.864 179.533 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 131' ' ' ALA . . . . . 0.544 ' HB1' HD13 ' A' ' 77' ' ' ILE . . . -66.06 -40.52 90.98 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.542 -0.754 . . . . 0.0 112.219 -179.408 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 3.9 pp -79.49 -16.84 55.35 Favored 'General case' 0 C--N 1.329 -0.325 0 O-C-N 122.128 -0.358 . . . . 0.0 110.959 179.905 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 5.2 tp -86.12 -50.15 7.23 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.283 -179.529 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 28.3 mt -132.47 112.68 12.33 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.501 -0.318 . . . . 0.0 110.944 -179.208 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 3.5 m-20 -168.95 -49.41 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.336 179.664 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 1.9 pt-20 -75.09 79.48 2.25 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.58 -0.737 . . . . 0.0 111.206 179.737 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 6.5 m -135.4 -59.93 0.76 Allowed 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.912 -0.586 . . . . 0.0 110.188 179.224 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 7.9 tm-20 -149.31 128.05 12.48 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 109.606 -0.516 . . . . 0.0 109.606 179.959 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -149.78 121.04 7.82 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 179.329 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 140' ' ' HIS . . . . . 0.662 ' HB3' ' OD2' ' A' ' 83' ' ' ASP . 5.4 t60 60.83 13.47 4.46 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-O 121.076 0.465 . . . . 0.0 111.614 178.742 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 98.58 -6.11 60.7 Favored Glycine 0 N--CA 1.447 -0.611 0 C-N-CA 120.803 -0.713 . . . . 0.0 112.216 -179.621 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 142' ' ' ARG . . . . . 0.729 ' HB2' ' OD2' ' A' ' 83' ' ' ASP . 2.1 mpt_? -114.01 -169.32 1.5 Allowed 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.008 0.432 . . . . 0.0 110.187 179.347 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 15.3 pt20 -131.65 138.74 48.88 Favored 'General case' 0 C--N 1.319 -0.754 0 N-CA-C 109.254 -0.647 . . . . 0.0 109.254 178.796 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -123.2 177.79 5.41 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-N 115.867 -0.606 . . . . 0.0 109.935 -179.528 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 1.7 tmtp? -117.27 121.8 42.17 Favored 'General case' 0 C--N 1.315 -0.907 0 N-CA-C 109.588 -0.523 . . . . 0.0 109.588 179.09 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 98.8 t -114.82 119.78 62.61 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-O 120.827 0.346 . . . . 0.0 110.911 -179.427 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 5.1 t -122.09 153.15 39.05 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.022 179.665 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -70.83 125.61 27.33 Favored 'General case' 0 N--CA 1.445 -0.713 0 CA-C-O 120.858 0.361 . . . . 0.0 111.187 179.956 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 18.9 ttpp -90.88 68.95 6.38 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.502 0.668 . . . . 0.0 109.29 179.909 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 13.0 tpt180 . . . . . 0 C--N 1.319 -0.724 0 CA-C-N 115.731 -0.668 . . . . 0.0 109.965 -179.999 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.233 0.228 0 N-CA-C 110.374 -0.232 . . . . 0.0 110.374 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 29.4 tp -73.81 84.43 1.67 Allowed 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.226 0.536 . . . . 0.0 110.387 179.741 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 17.0 tpt180 -130.8 151.83 50.8 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.161 -179.623 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 26.8 mm-40 -82.45 19.49 1.24 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.301 -179.825 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 11.9 ptm -83.7 4.37 29.0 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.735 -179.431 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 43.5 mt-30 -66.19 -22.03 66.33 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.945 -0.571 . . . . 0.0 110.578 179.911 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -78.89 -8.69 59.07 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.601 -0.727 . . . . 0.0 111.446 -179.763 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 48' ' ' LYS . . . . . 0.462 ' O ' ' HG2' ' A' ' 52' ' ' GLU . 10.3 ttpt -78.23 -6.31 54.54 Favored 'General case' 0 C--O 1.234 0.28 0 CA-C-O 120.991 0.424 . . . . 0.0 110.345 -179.869 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 8.4 p -59.32 -25.65 31.4 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.325 0 CA-C-N 115.936 -0.575 . . . . 0.0 111.581 -179.48 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 39.5 mt-10 -61.47 -30.61 70.71 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 121.008 0.432 . . . . 0.0 110.922 -179.876 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 15.3 mtmm -95.83 -36.27 11.19 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.244 -179.532 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 52' ' ' GLU . . . . . 0.462 ' HG2' ' O ' ' A' ' 48' ' ' LYS . 3.0 mm-40 -75.63 -16.99 60.14 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.936 -178.337 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 25.7 ptm -64.47 -24.11 67.51 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.178 0.513 . . . . 0.0 110.117 178.731 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -97.83 1.06 59.49 Favored Glycine 0 N--CA 1.446 -0.69 0 N-CA-C 110.885 -0.886 . . . . 0.0 110.885 178.595 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.327 -0.373 0 CA-C-O 121.235 0.54 . . . . 0.0 110.215 179.931 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.52 -0.195 0 CA-C-O 120.877 0.37 . . . . 0.0 110.53 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -80.59 5.75 14.54 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.012 0.434 . . . . 0.0 111.136 -179.762 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 49.7 tp60 -125.16 -40.38 2.15 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.448 -0.342 . . . . 0.0 111.006 179.616 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -94.1 -53.45 3.96 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.917 0.389 . . . . 0.0 111.341 179.826 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 3.2 tp10 -70.12 -30.36 67.53 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.032 -179.421 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.11 -25.76 64.11 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.542 -179.886 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 39.9 mt-10 -62.98 -23.77 67.59 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.186 0.517 . . . . 0.0 110.925 179.883 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 71' ' ' GLU . . . . . 0.608 ' O ' ' HD3' ' A' ' 75' ' ' ARG . 8.3 tp10 -96.66 -43.59 7.49 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.992 -0.549 . . . . 0.0 109.572 178.225 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.427 HG22 ' HA ' ' A' ' 123' ' ' VAL . 41.3 t -61.15 -44.13 97.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 115.467 -0.788 . . . . 0.0 112.459 -178.709 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 8.5 p-10 -63.29 -27.57 69.42 Favored 'General case' 0 N--CA 1.471 0.624 0 N-CA-C 111.921 0.341 . . . . 0.0 111.921 -179.31 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 40.0 t -95.54 -2.27 48.84 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-O 120.909 0.385 . . . . 0.0 110.741 179.772 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 75' ' ' ARG . . . . . 0.608 ' HD3' ' O ' ' A' ' 71' ' ' GLU . 2.2 mpt_? -115.26 46.95 1.37 Allowed 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.389 0.614 . . . . 0.0 109.582 -179.473 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -125.43 174.48 8.16 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.188 -0.914 . . . . 0.0 110.436 179.874 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.479 HG23 HG23 ' A' ' 128' ' ' VAL . 7.4 pt -131.02 140.48 48.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-O 120.742 0.306 . . . . 0.0 110.794 179.141 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 13.7 t80 -92.75 118.72 31.38 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.616 -0.72 . . . . 0.0 109.361 179.636 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.419 HG21 ' HE2' ' A' ' 95' ' ' PHE . 6.8 t -104.01 109.51 27.46 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-N 116.332 -0.395 . . . . 0.0 109.974 179.452 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -118.03 165.85 12.74 Favored Glycine 0 N--CA 1.447 -0.576 0 C-N-CA 120.773 -0.727 . . . . 0.0 111.995 -179.262 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 9.9 m120 59.21 41.12 20.69 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-O 121.043 0.449 . . . . 0.0 110.741 -179.621 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.422 HG12 ' H ' ' A' ' 83' ' ' ASP . 2.1 t -80.02 167.56 2.15 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-N 115.566 -0.743 . . . . 0.0 110.41 -179.172 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 83' ' ' ASP . . . . . 0.46 ' OD1' ' HD3' ' A' ' 142' ' ' ARG . 33.0 t70 -75.03 141.34 43.91 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.043 0.449 . . . . 0.0 110.627 179.901 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 29.2 p90 -63.09 -17.02 61.84 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.673 -0.694 . . . . 0.0 112.613 -178.743 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -110.42 8.27 23.13 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.828 0.346 . . . . 0.0 111.481 -179.592 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 86' ' ' CYS . . . . . 0.499 ' SG ' ' HB2' ' A' ' 140' ' ' HIS . 1.0 OUTLIER -73.27 142.42 47.22 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.154 0.502 . . . . 0.0 111.299 -179.893 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 87' ' ' THR . . . . . 0.506 ' O ' ' HG2' ' A' ' 90' ' ' GLU . 12.2 p -109.73 154.12 42.64 Favored Pre-proline 0 C--N 1.322 -0.602 0 CA-C-N 115.464 -0.789 . . . . 0.0 109.856 178.997 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 88' ' ' PRO . . . . . 0.559 ' O ' ' HG2' ' A' ' 92' ' ' GLN . 14.0 Cg_endo -57.25 -36.83 99.07 Favored 'Trans proline' 0 C--O 1.233 0.236 0 C-N-CA 122.391 2.061 . . . . 0.0 112.274 -179.726 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 89' ' ' GLU . . . . . 0.443 ' O ' ' HG2' ' A' ' 93' ' ' GLN . 28.2 mp0 -62.93 -51.51 66.64 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.781 -179.42 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 90' ' ' GLU . . . . . 0.506 ' HG2' ' O ' ' A' ' 87' ' ' THR . 8.3 pt-20 -63.96 -22.68 67.03 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.615 0.245 . . . . 0.0 111.344 -178.751 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 66.5 t -82.98 -48.05 17.97 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.521 -179.583 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 92' ' ' GLN . . . . . 0.559 ' HG2' ' O ' ' A' ' 88' ' ' PRO . 16.4 pt20 -71.86 -33.56 68.51 Favored 'General case' 0 N--CA 1.465 0.284 0 N-CA-C 111.881 0.326 . . . . 0.0 111.881 -178.397 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 93' ' ' GLN . . . . . 0.443 ' HG2' ' O ' ' A' ' 89' ' ' GLU . 0.8 OUTLIER -77.27 -27.87 53.29 Favored 'General case' 0 C--N 1.329 -0.32 0 C-N-CA 120.464 -0.494 . . . . 0.0 110.636 -179.515 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 94' ' ' HIS . . . . . 0.495 ' HB2' ' O ' ' A' ' 90' ' ' GLU . 0.1 OUTLIER -71.9 -43.33 65.52 Favored 'General case' 0 CA--C 1.517 -0.295 0 CA-C-O 121.11 0.481 . . . . 0.0 110.276 179.719 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 95' ' ' PHE . . . . . 0.419 ' HE2' HG21 ' A' ' 79' ' ' VAL . 21.0 m-30 -79.13 -15.36 58.25 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.93 -179.453 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 96' ' ' GLN . . . . . 0.507 ' HA ' ' O ' ' A' ' 99' ' ' GLY . 33.6 tt0 -64.64 -23.5 67.28 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.558 179.967 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 13.4 m -65.72 -33.41 75.8 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.409 179.454 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 11.1 m -94.95 -40.78 9.5 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.368 179.871 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 99' ' ' GLY . . . . . 0.507 ' O ' ' HA ' ' A' ' 96' ' ' GLN . . . -146.46 130.39 3.66 Favored Glycine 0 N--CA 1.444 -0.829 0 C-N-CA 120.688 -0.768 . . . . 0.0 111.742 -179.916 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 100' ' ' THR . . . . . 0.421 ' HB ' ' CZ ' ' A' ' 122' ' ' PHE . 0.2 OUTLIER -58.56 146.45 35.7 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 120.984 0.421 . . . . 0.0 111.539 179.894 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 2.4 p -111.99 131.43 63.43 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.112 -179.133 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 23.1 t-20 -99.19 -45.02 6.04 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 178.566 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 18.5 mmt180 -141.55 150.23 41.84 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-N 115.509 -0.769 . . . . 0.0 110.088 179.473 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 6.1 p -146.17 136.53 18.2 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-O 121.013 0.435 . . . . 0.0 110.191 179.385 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 105' ' ' THR . . . . . 0.516 ' HB ' ' CE1' ' A' ' 119' ' ' TYR . 1.4 m -128.15 129.4 46.47 Favored 'General case' 0 C--N 1.319 -0.722 0 N-CA-C 109.731 -0.47 . . . . 0.0 109.731 179.309 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 106' ' ' ILE . . . . . 0.537 HD13 ' HD3' ' A' ' 88' ' ' PRO . 20.1 tt -120.47 147.47 24.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-O 120.953 0.406 . . . . 0.0 111.294 -179.298 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 15.3 tp -133.11 143.52 49.34 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.25 179.361 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -104.5 119.34 38.76 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 120.588 0.232 . . . . 0.0 110.662 179.463 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 8.5 t70 -80.08 130.41 35.23 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.992 0.425 . . . . 0.0 111.245 -179.76 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 10.8 mmmm -114.66 20.51 15.23 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.272 -179.799 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 63.9 t80 -98.68 -11.26 22.18 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.491 0.662 . . . . 0.0 109.913 -179.446 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 111.15 8.56 23.49 Favored Glycine 0 N--CA 1.448 -0.534 0 CA-C-N 115.557 -0.747 . . . . 0.0 112.394 -179.269 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 113' ' ' GLN . . . . . 0.443 ' HB3' ' HD2' ' A' ' 114' ' ' PRO . 24.4 mt-30 -94.42 160.58 31.44 Favored Pre-proline 0 C--N 1.323 -0.553 0 N-CA-C 109.188 -0.671 . . . . 0.0 109.188 179.663 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 114' ' ' PRO . . . . . 0.443 ' HD2' ' HB3' ' A' ' 113' ' ' GLN . 14.4 Cg_endo -57.37 114.2 1.84 Allowed 'Trans proline' 0 C--N 1.346 0.415 0 C-N-CA 122.357 2.038 . . . . 0.0 111.686 179.119 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 6.3 mttp -76.98 179.3 6.3 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.403 -179.897 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 116' ' ' GLY . . . . . 0.498 ' HA2' HD11 ' A' ' 106' ' ' ILE . . . 94.99 1.45 63.1 Favored Glycine 0 N--CA 1.445 -0.718 0 C-N-CA 120.056 -1.068 . . . . 0.0 111.488 -179.884 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 6.8 t80 -53.74 117.31 3.06 Favored 'General case' 0 C--O 1.234 0.278 0 O-C-N 123.806 0.357 . . . . 0.0 110.125 179.744 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -145.32 175.34 10.37 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.781 -179.356 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 119' ' ' TYR . . . . . 0.516 ' CE1' ' HB ' ' A' ' 105' ' ' THR . 51.7 p90 -157.48 134.16 9.93 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.561 -0.745 . . . . 0.0 109.292 179.047 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 14.7 m -110.49 140.15 30.88 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 N-CA-C 109.766 -0.457 . . . . 0.0 109.766 179.705 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 121' ' ' GLU . . . . . 0.422 ' HB2' HG12 ' A' ' 72' ' ' VAL . 7.9 pt-20 -124.45 154.22 40.81 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 116.596 -0.275 . . . . 0.0 110.642 -179.993 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 122' ' ' PHE . . . . . 0.421 ' CZ ' ' HB ' ' A' ' 100' ' ' THR . 11.0 t80 -149.29 164.84 33.71 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.203 179.94 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 123' ' ' VAL . . . . . 0.427 ' HA ' HG22 ' A' ' 72' ' ' VAL . 11.8 t -81.56 -42.64 19.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.317 -179.579 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 81.9 mt-10 -76.38 138.73 40.6 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.043 0.449 . . . . 0.0 111.171 -179.541 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 2.5 mp -75.87 -30.55 21.2 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-N 115.745 -0.661 . . . . 0.0 110.029 179.572 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -54.15 -47.21 72.18 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 115.802 -0.636 . . . . 0.0 111.17 179.596 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -56.26 -58.0 9.84 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.396 -0.82 . . . . 0.0 111.488 -179.362 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 128' ' ' VAL . . . . . 0.479 HG23 HG23 ' A' ' 77' ' ' ILE . 8.9 p -66.04 -32.8 59.73 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-N 116.31 -0.404 . . . . 0.0 111.676 -179.049 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 44.9 tt0 -60.99 -41.11 95.85 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.817 0.341 . . . . 0.0 110.88 -179.579 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 94.4 m-20 -79.4 -28.9 41.83 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.148 0.499 . . . . 0.0 110.01 179.36 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -70.12 -39.13 75.63 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.651 -0.704 . . . . 0.0 112.045 -179.414 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 4.2 pp -75.89 -11.47 59.97 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.938 0.399 . . . . 0.0 110.809 -179.901 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -88.84 -58.94 2.37 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.841 -0.618 . . . . 0.0 111.063 -179.923 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 75.8 mt -125.53 108.27 11.44 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.681 -178.864 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 2.8 m-20 -162.99 -50.66 0.04 OUTLIER 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.771 -0.65 . . . . 0.0 110.801 179.876 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 5.0 pt-20 -73.35 85.11 1.45 Allowed 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.779 -0.646 . . . . 0.0 111.448 -179.917 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 6.3 m -137.97 -59.32 0.65 Allowed 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.58 -0.736 . . . . 0.0 110.154 179.091 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 22.7 tt0 -153.79 127.94 9.04 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.217 -179.816 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -145.57 115.61 7.42 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 108.764 -0.828 . . . . 0.0 108.764 179.101 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 140' ' ' HIS . . . . . 0.499 ' HB2' ' SG ' ' A' ' 86' ' ' CYS . 2.8 t60 65.83 21.09 11.47 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-O 121.058 0.456 . . . . 0.0 110.373 -179.596 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 87.53 4.4 80.13 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.213 -179.601 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 142' ' ' ARG . . . . . 0.46 ' HD3' ' OD1' ' A' ' 83' ' ' ASP . 0.8 OUTLIER -125.66 165.19 19.02 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 109.945 -0.391 . . . . 0.0 109.945 179.838 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 12.9 pt20 -107.85 139.61 42.18 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-O 120.982 0.42 . . . . 0.0 110.697 179.656 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -121.68 178.08 4.99 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.037 -179.97 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 28.5 ttpt -116.22 122.41 44.93 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 109.912 -0.403 . . . . 0.0 109.912 179.063 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 95.7 t -113.92 123.13 69.28 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-O 120.968 0.413 . . . . 0.0 110.525 179.713 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 30.5 t -125.05 149.37 47.86 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 109.507 -0.553 . . . . 0.0 109.507 179.892 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -68.83 127.55 33.48 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 110.56 -0.163 . . . . 0.0 110.56 179.687 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 64.8 tttp -90.94 83.15 5.62 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.294 0.569 . . . . 0.0 110.505 -179.74 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 23.8 tpt180 . . . . . 0 C--N 1.319 -0.751 0 CA-C-N 115.741 -0.663 . . . . 0.0 109.36 179.01 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.233 0.233 0 N-CA-C 110.085 -0.339 . . . . 0.0 110.085 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 18.6 tp -81.56 85.88 6.45 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.17 0.51 . . . . 0.0 110.067 179.622 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 13.4 tpp180 -145.95 132.36 19.65 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.899 -0.591 . . . . 0.0 109.652 179.96 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 3.3 tp10 -82.79 39.26 0.61 Allowed 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.559 0.695 . . . . 0.0 110.911 -179.742 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 17.6 ptt? -87.83 11.66 14.98 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.656 -0.702 . . . . 0.0 109.538 179.089 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 19.4 mm-40 -66.87 -22.5 65.98 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.277 -0.874 . . . . 0.0 111.101 -179.682 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -68.8 -14.4 63.0 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 121.348 0.594 . . . . 0.0 110.6 179.54 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 20.2 ttpp -83.24 1.05 42.73 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.589 -0.732 . . . . 0.0 110.33 179.814 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 8.3 p -59.48 -26.2 33.6 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.205 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.971 -179.912 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 26.6 mt-10 -67.14 -24.67 65.93 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 115.912 -0.586 . . . . 0.0 110.344 179.534 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 11.4 mtmm -97.22 -29.74 13.4 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.579 -0.737 . . . . 0.0 110.594 179.331 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 38.0 mm-40 -80.96 -5.32 57.36 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.677 -179.661 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 10.7 ptp -62.33 -30.83 71.44 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.891 0.377 . . . . 0.0 110.652 -179.932 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -91.55 3.89 79.17 Favored Glycine 0 N--CA 1.447 -0.594 0 C-N-CA 120.722 -0.751 . . . . 0.0 111.319 178.838 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.325 -0.461 0 CA-C-N 115.432 -0.384 . . . . 0.0 110.275 -179.802 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.453 -0.285 0 CA-C-O 120.939 0.399 . . . . 0.0 110.488 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -76.44 -2.12 30.45 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.25 0.548 . . . . 0.0 110.793 179.865 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 64.7 tt0 -114.39 -54.71 2.56 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.923 179.924 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -85.49 -56.09 3.69 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.793 -178.509 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 68' ' ' GLU . . . . . 0.458 ' O ' HG23 ' A' ' 72' ' ' VAL . 1.2 tt0 -62.65 -31.48 72.35 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.952 0.406 . . . . 0.0 110.896 -179.61 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 48.7 tptt -55.55 -30.01 59.99 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.587 -0.733 . . . . 0.0 111.299 179.937 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 99.3 mt-10 -58.63 -41.6 86.32 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.027 0.441 . . . . 0.0 110.455 179.469 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 71' ' ' GLU . . . . . 0.429 ' O ' ' HD2' ' A' ' 75' ' ' ARG . 7.4 tp10 -76.86 -43.37 36.38 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.057 -0.519 . . . . 0.0 109.871 179.308 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.583 HG12 ' HB2' ' A' ' 121' ' ' GLU . 43.8 t -60.75 -40.34 84.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 115.648 -0.705 . . . . 0.0 111.624 -179.241 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 7.5 t0 -68.23 -23.26 64.78 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-O 121.318 0.58 . . . . 0.0 110.723 -179.934 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 1.2 t -95.29 -9.9 31.77 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 121.686 0.755 . . . . 0.0 109.782 179.705 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 75' ' ' ARG . . . . . 0.429 ' HD2' ' O ' ' A' ' 71' ' ' GLU . 0.0 OUTLIER -111.75 44.77 1.32 Allowed 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.396 -0.82 . . . . 0.0 110.659 -179.259 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 76' ' ' SER . . . . . 0.464 ' OG ' ' HE2' ' A' ' 149' ' ' LYS . 0.0 OUTLIER -126.92 171.69 11.07 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.818 179.367 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 13.8 pt -131.01 136.95 56.97 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-N 116.465 -0.334 . . . . 0.0 110.198 178.64 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 78' ' ' TYR . . . . . 0.447 ' O ' ' HA ' ' A' ' 146' ' ' VAL . 43.0 t80 -91.12 123.29 34.47 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.142 -179.896 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 10.4 t -107.04 111.92 37.72 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.658 -179.749 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -121.48 170.8 14.84 Favored Glycine 0 N--CA 1.446 -0.682 0 N-CA-C 111.362 -0.695 . . . . 0.0 111.362 179.974 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 13.1 m120 58.39 44.24 18.6 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-O 121.294 0.569 . . . . 0.0 110.441 -179.627 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.498 HG12 ' H ' ' A' ' 83' ' ' ASP . 1.7 t -90.07 172.1 1.03 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 CA-C-N 115.338 -0.846 . . . . 0.0 110.615 -179.011 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 83' ' ' ASP . . . . . 0.498 ' H ' HG12 ' A' ' 82' ' ' VAL . 9.2 t0 -68.74 137.25 53.91 Favored 'General case' 0 N--CA 1.451 -0.395 0 N-CA-C 109.666 -0.494 . . . . 0.0 109.666 179.476 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 34.9 p90 -61.71 -18.14 58.51 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.459 -179.28 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -118.15 20.59 13.14 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.511 -0.313 . . . . 0.0 111.332 179.942 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 86' ' ' CYS . . . . . 0.459 ' SG ' ' HB3' ' A' ' 83' ' ' ASP . 0.5 OUTLIER -77.16 145.25 37.83 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.984 0.421 . . . . 0.0 110.869 179.603 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 87' ' ' THR . . . . . 0.474 ' O ' ' HG2' ' A' ' 90' ' ' GLU . 55.9 p -103.08 151.22 38.43 Favored Pre-proline 0 C--N 1.323 -0.57 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.261 179.637 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -61.77 -29.2 82.84 Favored 'Trans proline' 0 C--O 1.233 0.24 0 C-N-CA 122.3 2.0 . . . . 0.0 111.93 179.835 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 89' ' ' GLU . . . . . 0.517 ' O ' ' HG2' ' A' ' 93' ' ' GLN . 27.8 mt-10 -66.27 -53.26 38.94 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.343 -0.844 . . . . 0.0 111.933 -178.837 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 90' ' ' GLU . . . . . 0.474 ' HG2' ' O ' ' A' ' 87' ' ' THR . 9.2 pt-20 -61.71 -24.98 67.13 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.967 0.413 . . . . 0.0 111.24 -179.268 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 69.3 t -79.84 -48.57 20.41 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.275 -179.106 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 92' ' ' GLN . . . . . 0.411 ' O ' ' HB2' ' A' ' 96' ' ' GLN . 0.9 OUTLIER -70.29 -32.88 70.85 Favored 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 112.196 0.443 . . . . 0.0 112.196 -178.183 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 93' ' ' GLN . . . . . 0.517 ' HG2' ' O ' ' A' ' 89' ' ' GLU . 9.6 pt20 -79.79 -28.77 40.25 Favored 'General case' 0 C--N 1.325 -0.491 0 C-N-CA 120.061 -0.656 . . . . 0.0 111.19 -179.331 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 58.7 t-80 -68.92 -45.22 71.4 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.808 0.337 . . . . 0.0 110.57 179.989 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 23.9 m-85 -78.53 -11.8 59.98 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.68 -179.388 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 96' ' ' GLN . . . . . 0.563 ' HA ' ' O ' ' A' ' 99' ' ' GLY . 42.0 tt0 -68.9 -21.7 64.22 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 121.23 0.538 . . . . 0.0 109.958 179.802 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 4.5 m -66.52 -32.24 73.47 Favored 'General case' 0 N--CA 1.452 -0.347 0 CA-C-N 115.673 -0.694 . . . . 0.0 109.531 178.545 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 2.1 m -88.25 -47.83 8.14 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.546 -0.752 . . . . 0.0 110.075 179.575 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 99' ' ' GLY . . . . . 0.563 ' O ' ' HA ' ' A' ' 96' ' ' GLN . . . -147.07 142.35 10.23 Favored Glycine 0 N--CA 1.447 -0.603 0 C-N-CA 121.023 -0.608 . . . . 0.0 111.751 179.801 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -60.07 144.03 50.56 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 120.827 0.346 . . . . 0.0 111.503 -179.639 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 2.3 p -114.86 127.76 72.27 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.289 179.832 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 20.1 t-20 -95.1 -40.99 9.34 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.145 0.498 . . . . 0.0 110.098 179.649 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 3.2 tpp180 -144.87 155.91 43.72 Favored 'General case' 0 N--CA 1.45 -0.425 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.263 -179.487 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 5.7 p -154.32 133.95 3.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.109 179.804 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -126.13 127.74 46.23 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 109.736 -0.468 . . . . 0.0 109.736 179.006 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 106' ' ' ILE . . . . . 0.424 HD11 ' HA2' ' A' ' 116' ' ' GLY . 20.1 tt -111.04 146.07 16.54 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-O 121.017 0.437 . . . . 0.0 110.951 -179.368 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 43.3 tp -130.15 138.32 50.58 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.26 179.816 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -103.64 113.68 27.38 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 109.963 -0.384 . . . . 0.0 109.963 179.453 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 6.4 t70 -72.3 133.32 44.94 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.054 0.454 . . . . 0.0 111.367 -179.677 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 11.2 mmmt -111.31 19.22 18.5 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.722 -179.868 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 3.0 t80 -101.0 -9.93 21.0 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.973 0.416 . . . . 0.0 110.324 -179.372 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 110.83 -0.53 28.8 Favored Glycine 0 N--CA 1.449 -0.441 0 CA-C-N 115.788 -0.642 . . . . 0.0 112.227 -179.808 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 3.5 mt-30 -81.28 158.63 69.13 Favored Pre-proline 0 C--N 1.323 -0.581 0 N-CA-C 110.332 -0.247 . . . . 0.0 110.332 -179.911 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 13.5 Cg_endo -56.57 103.77 0.13 Allowed 'Trans proline' 0 C--N 1.347 0.486 0 C-N-CA 122.687 2.258 . . . . 0.0 111.319 178.419 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 7.8 mttp -68.84 176.67 2.94 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.606 -0.725 . . . . 0.0 110.776 -178.444 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 116' ' ' GLY . . . . . 0.424 ' HA2' HD11 ' A' ' 106' ' ' ILE . . . 99.92 4.52 55.53 Favored Glycine 0 N--CA 1.441 -0.998 0 C-N-CA 120.398 -0.906 . . . . 0.0 111.187 -179.54 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 59.2 m-85 -52.27 118.3 3.43 Favored 'General case' 0 CA--C 1.522 -0.098 0 C-N-CA 122.63 0.372 . . . . 0.0 110.121 179.401 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -146.23 176.33 9.84 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 121.052 0.453 . . . . 0.0 111.234 -178.916 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 43.5 p90 -156.56 133.95 10.7 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.418 -0.81 . . . . 0.0 109.706 179.155 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 15.7 m -108.42 142.5 20.89 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 N-CA-C 109.108 -0.701 . . . . 0.0 109.108 178.62 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 121' ' ' GLU . . . . . 0.583 ' HB2' HG12 ' A' ' 72' ' ' VAL . 5.9 pt-20 -131.39 156.18 46.0 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 120.927 0.394 . . . . 0.0 111.884 -178.901 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 13.8 t80 -152.08 166.64 30.99 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.796 -0.638 . . . . 0.0 109.755 179.134 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 13.0 t -83.96 -52.94 12.16 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-O 120.76 0.314 . . . . 0.0 111.242 -179.52 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 38.6 mt-10 -67.88 131.7 45.99 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.832 -179.66 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 2.2 mp -70.91 -31.07 44.25 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.88 -179.161 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -54.47 -40.48 68.47 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-O 121.15 0.5 . . . . 0.0 111.228 179.327 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -62.76 -57.05 12.29 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.837 -0.62 . . . . 0.0 111.273 -179.877 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 9.9 p -65.91 -27.97 42.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.192 -179.503 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 4.8 tp-100 -59.08 -44.58 91.92 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.902 0.382 . . . . 0.0 110.247 179.506 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 52.9 m-80 -77.31 -29.66 53.72 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.919 -0.582 . . . . 0.0 109.72 179.209 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -67.38 -41.6 84.75 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.799 -0.637 . . . . 0.0 111.342 179.821 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 4.2 pp -77.96 -10.31 59.53 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.915 0.388 . . . . 0.0 110.605 179.482 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -86.7 -52.51 5.48 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.928 -0.578 . . . . 0.0 109.648 179.257 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 27.7 mt -117.46 102.83 9.53 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.598 -0.728 . . . . 0.0 109.647 179.919 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 135' ' ' ASN . . . . . 0.536 ' OD1' ' HB ' ' A' ' 146' ' ' VAL . 1.3 p30 -142.96 -78.1 0.23 Allowed 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 112.422 0.527 . . . . 0.0 112.422 -178.46 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -68.76 109.99 4.11 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.432 0.634 . . . . 0.0 111.549 -178.67 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 56.2 m -152.43 -61.53 0.16 Allowed 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.709 -0.678 . . . . 0.0 109.666 179.0 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 -157.76 120.36 3.84 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 116.699 -0.228 . . . . 0.0 110.943 179.225 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -140.6 116.66 10.49 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 109.555 -0.535 . . . . 0.0 109.555 179.482 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 1.3 t60 61.69 17.21 8.48 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-O 120.992 0.425 . . . . 0.0 110.863 -179.866 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 96.34 -7.38 66.36 Favored Glycine 0 N--CA 1.448 -0.556 0 C-N-CA 120.992 -0.623 . . . . 0.0 112.173 -179.76 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 3.8 mpt_? -112.26 160.61 17.47 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.938 0.399 . . . . 0.0 111.443 -179.39 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 16.3 pt20 -104.79 116.9 32.8 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 109.387 -0.597 . . . . 0.0 109.387 178.641 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 144' ' ' LEU . . . . . 0.452 HD23 HG13 ' A' ' 82' ' ' VAL . 0.5 OUTLIER -95.32 176.73 6.09 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.081 -179.16 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 1.8 tmtp? -117.64 120.94 39.55 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 109.679 -0.489 . . . . 0.0 109.679 179.599 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 146' ' ' VAL . . . . . 0.536 ' HB ' ' OD1' ' A' ' 135' ' ' ASN . 99.3 t -119.34 133.02 67.5 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-O 120.879 0.371 . . . . 0.0 111.26 -179.336 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 5.3 m -135.24 142.86 46.06 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.114 -0.494 . . . . 0.0 109.954 178.92 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -58.87 124.98 21.65 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.846 0.355 . . . . 0.0 110.844 179.766 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 149' ' ' LYS . . . . . 0.464 ' HE2' ' OG ' ' A' ' 76' ' ' SER . 23.7 ttpt -91.17 63.33 5.01 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.562 0.696 . . . . 0.0 109.189 -179.877 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.32 -0.712 0 CA-C-N 115.405 -0.816 . . . . 0.0 109.81 -179.872 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.236 0.344 0 CA-C-O 120.742 0.306 . . . . 0.0 110.953 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 32.0 tp -79.82 79.55 6.32 Favored 'General case' 0 N--CA 1.45 -0.436 0 CA-C-O 121.796 0.808 . . . . 0.0 110.079 179.959 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 65.5 ttt180 -161.62 159.37 27.49 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 114.739 -1.119 . . . . 0.0 109.382 -179.787 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 4.5 tt0 -78.62 19.89 0.47 Allowed 'General case' 0 N--CA 1.465 0.316 0 CA-C-O 121.325 0.583 . . . . 0.0 110.922 179.988 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 13.6 ptm -88.16 6.0 38.68 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.717 -179.819 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 49.5 mt-30 -70.77 -23.03 62.32 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.581 179.999 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -75.51 -13.9 60.39 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.361 0.601 . . . . 0.0 110.623 179.33 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 6.1 ttmm -74.0 -2.28 23.48 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.683 -0.69 . . . . 0.0 111.09 -179.523 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 9.5 p -57.64 -24.4 22.33 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.275 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.155 -179.87 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 4.6 mm-40 -62.14 -27.99 69.33 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-O 121.107 0.48 . . . . 0.0 110.341 179.552 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 5.8 mtmm -106.76 -42.57 4.92 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.747 -0.66 . . . . 0.0 110.994 179.619 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 78.9 mm-40 -64.87 -6.09 7.5 Favored 'General case' 0 N--CA 1.467 0.397 0 N-CA-C 112.304 0.483 . . . . 0.0 112.304 -179.089 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 3.0 ptt? -65.76 -23.9 66.83 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.112 0.482 . . . . 0.0 109.937 178.777 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -96.78 5.42 64.06 Favored Glycine 0 N--CA 1.451 -0.332 0 N-CA-C 110.708 -0.957 . . . . 0.0 110.708 178.337 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.359 0 CA-C-N 115.284 -0.458 . . . . 0.0 110.134 -179.85 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.518 -0.265 0 CA-C-O 120.986 0.422 . . . . 0.0 110.215 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -82.36 7.21 14.67 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.439 0.638 . . . . 0.0 110.2 179.499 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 1.1 tp-100 -124.88 -55.34 1.6 Allowed 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.705 -0.68 . . . . 0.0 111.357 -179.795 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -85.16 -51.48 6.6 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.54 -179.275 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 4.8 tp10 -72.3 -24.27 61.3 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.102 0.477 . . . . 0.0 110.312 -179.549 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 2.2 tptm -64.23 -24.64 67.74 Favored 'General case' 0 N--CA 1.453 -0.317 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.611 178.902 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -63.55 -17.75 63.14 Favored 'General case' 0 C--O 1.232 0.141 0 CA-C-O 121.543 0.687 . . . . 0.0 109.927 178.882 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 71' ' ' GLU . . . . . 0.464 ' O ' ' HD2' ' A' ' 75' ' ' ARG . 6.6 tp10 -97.37 -47.17 5.8 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.147 -0.933 . . . . 0.0 109.208 177.744 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 94.7 t -60.36 -39.37 80.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 115.449 -0.796 . . . . 0.0 112.332 -178.943 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 17.5 p-10 -68.8 -21.31 64.33 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-O 120.754 0.311 . . . . 0.0 111.47 -178.596 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 39.1 t -101.32 -0.07 36.27 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 109.451 -0.574 . . . . 0.0 109.451 178.66 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 75' ' ' ARG . . . . . 0.464 ' HD2' ' O ' ' A' ' 71' ' ' GLU . 0.0 OUTLIER -117.91 44.15 2.25 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.551 -0.75 . . . . 0.0 110.309 -179.749 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -123.43 172.25 8.85 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.675 179.499 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 8.3 pt -132.99 137.46 53.7 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 N-CA-C 109.864 -0.421 . . . . 0.0 109.864 178.604 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 85.4 t80 -96.06 125.61 40.72 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 116.148 -0.478 . . . . 0.0 109.849 -179.775 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.436 HG12 HG22 ' A' ' 82' ' ' VAL . 4.6 t -105.24 114.32 44.49 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.057 -179.346 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -117.97 168.0 12.97 Favored Glycine 0 N--CA 1.448 -0.504 0 N-CA-C 111.123 -0.791 . . . . 0.0 111.123 179.502 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 4.3 m-20 58.61 41.4 22.27 Favored 'General case' 0 N--CA 1.472 0.662 0 CA-C-O 121.118 0.485 . . . . 0.0 110.844 -179.328 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.436 HG22 HG12 ' A' ' 79' ' ' VAL . 2.0 t -85.66 166.38 2.04 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.954 -179.245 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 83' ' ' ASP . . . . . 0.627 ' OD2' ' HD3' ' A' ' 142' ' ' ARG . 9.9 t70 -67.83 136.63 54.42 Favored 'General case' 0 CA--C 1.519 -0.243 0 N-CA-C 109.587 -0.523 . . . . 0.0 109.587 179.526 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 32.4 p90 -62.09 -19.71 63.26 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.944 -0.571 . . . . 0.0 112.493 -178.597 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -112.71 17.61 18.95 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 120.534 0.207 . . . . 0.0 111.508 -179.382 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 86' ' ' CYS . . . . . 0.442 ' SG ' ' HB3' ' A' ' 83' ' ' ASP . 0.7 OUTLIER -77.51 144.58 37.57 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.196 0.522 . . . . 0.0 111.41 -179.779 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 87' ' ' THR . . . . . 0.504 ' O ' ' HG2' ' A' ' 90' ' ' GLU . 20.5 p -105.44 152.92 40.04 Favored Pre-proline 0 C--N 1.323 -0.554 0 CA-C-N 115.496 -0.775 . . . . 0.0 110.008 179.222 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 88' ' ' PRO . . . . . 0.409 ' HD3' HD13 ' A' ' 106' ' ' ILE . 21.0 Cg_endo -61.32 -32.04 89.44 Favored 'Trans proline' 0 C--N 1.342 0.221 0 C-N-CA 122.342 2.028 . . . . 0.0 112.554 -179.071 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 12.3 mt-10 -64.54 -54.42 32.56 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.737 -0.665 . . . . 0.0 111.731 -178.862 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 90' ' ' GLU . . . . . 0.571 ' O ' ' HB2' ' A' ' 94' ' ' HIS . 11.3 pt-20 -60.72 -26.25 67.03 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.032 0.444 . . . . 0.0 111.299 -178.75 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 51.8 t -78.92 -48.97 20.96 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.319 -179.244 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -71.19 -32.47 68.9 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 111.794 0.294 . . . . 0.0 111.794 -178.585 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 16.7 pt20 -79.45 -25.99 41.85 Favored 'General case' 0 C--N 1.33 -0.243 0 C-N-CA 120.774 -0.37 . . . . 0.0 111.323 -179.117 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 94' ' ' HIS . . . . . 0.571 ' HB2' ' O ' ' A' ' 90' ' ' GLU . 2.3 t60 -76.34 -38.6 55.67 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.838 0.352 . . . . 0.0 110.414 -179.988 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 21.2 m-30 -81.23 -15.08 56.67 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.497 179.827 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 96' ' ' GLN . . . . . 0.538 ' HA ' ' O ' ' A' ' 99' ' ' GLY . 48.7 tt0 -65.72 -21.83 66.56 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.718 -0.674 . . . . 0.0 110.621 -179.977 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 17.3 m -68.58 -20.14 64.5 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.877 -0.602 . . . . 0.0 110.377 179.132 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 32.3 m -102.69 -46.42 4.73 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.005 179.188 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 99' ' ' GLY . . . . . 0.538 ' O ' ' HA ' ' A' ' 96' ' ' GLN . . . -145.2 142.29 10.66 Favored Glycine 0 N--CA 1.445 -0.76 0 N-CA-C 111.506 -0.637 . . . . 0.0 111.506 179.781 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 100' ' ' THR . . . . . 0.405 ' HB ' ' CZ ' ' A' ' 122' ' ' PHE . 0.2 OUTLIER -62.29 148.37 45.21 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-O 120.889 0.376 . . . . 0.0 111.305 -179.715 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 2.4 p -117.79 130.89 71.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.916 -179.652 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 16.6 t30 -98.46 -45.56 6.08 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.292 0.568 . . . . 0.0 109.868 179.123 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -142.54 150.78 40.86 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.756 -0.656 . . . . 0.0 109.668 179.844 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 3.5 p -146.04 129.54 10.22 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 N-CA-C 109.89 -0.411 . . . . 0.0 109.89 179.734 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 7.8 m -120.48 125.98 49.24 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 110.268 -0.271 . . . . 0.0 110.268 179.924 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 106' ' ' ILE . . . . . 0.409 HD13 ' HD3' ' A' ' 88' ' ' PRO . 19.8 tt -112.36 146.18 17.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.434 -179.944 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 16.4 tp -131.81 132.47 43.78 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.511 179.765 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -96.85 121.59 38.88 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 116.201 -0.454 . . . . 0.0 109.867 179.208 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -88.56 136.22 33.1 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.788 0.327 . . . . 0.0 110.592 179.968 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 110' ' ' LYS . . . . . 0.416 ' N ' ' HD3' ' A' ' 110' ' ' LYS . 0.0 OUTLIER -121.64 21.66 10.79 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 120.986 0.422 . . . . 0.0 110.474 179.819 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 17.3 t80 -101.68 -5.34 25.13 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.26 0.552 . . . . 0.0 110.277 -179.879 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 112.42 2.21 26.1 Favored Glycine 0 N--CA 1.447 -0.631 0 C-N-CA 120.879 -0.677 . . . . 0.0 112.392 179.733 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 19.4 mt-30 -89.52 154.89 48.67 Favored Pre-proline 0 C--N 1.326 -0.424 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 179.565 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -55.23 121.54 10.1 Favored 'Trans proline' 0 N--CA 1.46 -0.441 0 C-N-CA 121.737 1.625 . . . . 0.0 110.971 178.773 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 54.6 mttt -76.64 176.1 8.7 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 -179.352 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 94.95 6.9 60.14 Favored Glycine 0 N--CA 1.446 -0.634 0 C-N-CA 120.129 -1.034 . . . . 0.0 112.355 179.648 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 4.4 m-30 -58.75 103.94 0.19 Allowed 'General case' 0 C--N 1.332 -0.169 0 N-CA-C 109.815 -0.439 . . . . 0.0 109.815 179.607 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -132.18 177.25 7.71 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-O 121.085 0.469 . . . . 0.0 111.324 -179.059 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 2.0 p90 -158.56 139.58 13.03 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.372 -0.831 . . . . 0.0 109.379 179.179 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 13.8 m -112.49 142.87 23.5 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 N-CA-C 109.555 -0.535 . . . . 0.0 109.555 178.35 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 5.0 pt-20 -129.38 150.13 50.87 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.787 -179.671 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 122' ' ' PHE . . . . . 0.405 ' CZ ' ' HB ' ' A' ' 100' ' ' THR . 16.3 t80 -151.73 168.93 23.48 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.336 179.61 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 4.1 t -82.8 -54.21 9.9 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-O 120.836 0.35 . . . . 0.0 111.496 -179.359 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 56.7 mt-10 -60.61 126.52 27.73 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.958 -0.565 . . . . 0.0 111.586 -179.105 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 2.2 mp -71.69 -33.62 49.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 115.703 -0.681 . . . . 0.0 109.864 179.567 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -60.37 -38.05 82.65 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.466 -0.788 . . . . 0.0 110.707 179.585 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -63.95 -56.13 17.42 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.783 -0.644 . . . . 0.0 111.119 -179.986 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 9.9 p -64.12 -27.77 43.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-O 120.812 0.339 . . . . 0.0 110.561 179.774 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 17.8 tt0 -62.29 -47.25 85.16 Favored 'General case' 0 C--N 1.333 -0.121 0 CA-C-O 121.066 0.46 . . . . 0.0 109.876 178.853 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 88.4 m-20 -66.69 -31.95 72.95 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.337 0.589 . . . . 0.0 109.579 179.349 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 131' ' ' ALA . . . . . 0.438 ' O ' ' HB2' ' A' ' 135' ' ' ASN . . . -67.27 -51.93 46.97 Favored 'General case' 0 N--CA 1.452 -0.358 0 CA-C-N 115.267 -0.879 . . . . 0.0 110.986 179.684 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 4.3 pp -66.22 -21.49 66.3 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.142 0.496 . . . . 0.0 110.693 179.898 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 5.6 tp -76.78 -51.45 11.35 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.115 179.16 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 94.4 mt -125.83 99.86 6.14 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.286 179.953 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 135' ' ' ASN . . . . . 0.438 ' HB2' ' O ' ' A' ' 131' ' ' ALA . 0.4 OUTLIER -146.77 -70.1 0.25 Allowed 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.491 -179.112 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 136' ' ' GLU . . . . . 0.432 ' HB2' ' O ' ' A' ' 144' ' ' LEU . 9.3 pt-20 -69.86 103.21 2.14 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.601 0.715 . . . . 0.0 111.277 -179.234 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 13.1 m -152.33 -57.54 0.14 Allowed 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.831 -0.622 . . . . 0.0 109.667 179.246 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 28.8 tt0 -160.0 122.32 3.34 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.152 -179.854 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -143.64 115.28 8.15 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 109.368 -0.604 . . . . 0.0 109.368 179.62 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 2.4 t60 64.82 14.03 8.9 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-O 121.255 0.55 . . . . 0.0 110.586 -179.869 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 95.71 -0.49 63.02 Favored Glycine 0 N--CA 1.446 -0.675 0 C-N-CA 120.786 -0.721 . . . . 0.0 111.913 -179.207 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 142' ' ' ARG . . . . . 0.627 ' HD3' ' OD2' ' A' ' 83' ' ' ASP . 2.4 mpt_? -115.59 158.81 22.12 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 120.917 0.389 . . . . 0.0 110.595 179.614 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 15.3 pt20 -105.06 119.07 38.13 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 178.411 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 144' ' ' LEU . . . . . 0.432 ' O ' ' HB2' ' A' ' 136' ' ' GLU . 0.5 OUTLIER -103.29 176.74 5.05 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.04 -178.966 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 73.8 tttt -115.57 121.9 44.02 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 109.253 -0.647 . . . . 0.0 109.253 178.996 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 89.2 t -115.34 119.3 61.44 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-O 120.902 0.382 . . . . 0.0 111.039 -179.803 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 36.3 t -121.54 139.47 53.46 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 116.142 -0.481 . . . . 0.0 109.81 179.943 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -58.84 132.12 53.0 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 109.926 -0.398 . . . . 0.0 109.926 179.213 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 57.5 tttp -93.12 78.16 4.58 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-O 121.479 0.657 . . . . 0.0 109.942 -179.382 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 21.5 tpt180 . . . . . 0 C--N 1.317 -0.809 0 CA-C-N 115.371 -0.831 . . . . 0.0 109.281 179.435 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.235 0.337 0 CA-C-O 120.725 0.298 . . . . 0.0 110.853 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 25.4 tp -79.17 84.33 5.14 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.28 0.562 . . . . 0.0 110.52 179.562 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 31.3 ttm180 -147.12 146.92 30.09 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.843 -0.617 . . . . 0.0 109.601 179.824 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -77.97 40.49 0.33 Allowed 'General case' 0 N--CA 1.463 0.214 0 CA-C-O 121.407 0.622 . . . . 0.0 111.079 179.989 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 15.8 ptt? -92.51 6.12 48.31 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 115.771 -0.65 . . . . 0.0 110.342 -179.904 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 25.3 mt-30 -64.49 -25.27 67.92 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.942 -179.764 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -66.72 -16.43 64.22 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 121.125 0.488 . . . . 0.0 111.303 -179.875 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 24.4 ttpp -72.19 -10.01 59.21 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.564 179.976 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 5.6 p -59.99 -23.96 28.49 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.169 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.039 179.844 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 38.6 mt-10 -64.63 -21.68 66.78 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.253 0.549 . . . . 0.0 110.701 179.261 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 10.3 mtmm -102.77 -40.95 6.36 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.366 179.182 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -72.8 -3.85 27.96 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.0 -0.545 . . . . 0.0 111.723 -179.84 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -67.14 -27.65 67.48 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 109.304 -0.628 . . . . 0.0 109.304 178.392 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -89.87 2.56 82.2 Favored Glycine 0 N--CA 1.446 -0.675 0 N-CA-C 110.831 -0.908 . . . . 0.0 110.831 178.57 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.376 0 CA-C-O 121.034 0.445 . . . . 0.0 110.055 -179.974 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.456 -0.162 0 CA-C-O 120.783 0.325 . . . . 0.0 110.585 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -77.32 -1.73 31.32 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.637 -179.486 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 8.2 pt20 -121.36 -31.23 4.11 Favored 'General case' 0 C--N 1.328 -0.353 0 C-N-CA 120.613 -0.435 . . . . 0.0 111.181 179.396 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -99.65 -57.21 2.2 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.956 0.407 . . . . 0.0 111.39 -179.932 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 5.1 tp10 -71.74 -21.39 61.76 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 120.891 0.376 . . . . 0.0 110.866 -179.317 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -63.27 -24.51 67.9 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.659 -0.246 . . . . 0.0 110.736 179.318 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 51.4 mt-10 -63.52 -23.18 67.28 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.478 0.656 . . . . 0.0 109.412 178.754 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 6.6 tp10 -94.94 -45.57 7.22 Favored 'General case' 0 N--CA 1.45 -0.466 0 CA-C-N 115.217 -0.901 . . . . 0.0 109.937 178.647 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.47 HG12 ' HB2' ' A' ' 121' ' ' GLU . 84.2 t -61.17 -42.67 94.24 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.342 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.583 -179.234 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -68.18 -21.37 64.88 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-O 121.188 0.518 . . . . 0.0 110.892 -179.6 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 11.1 t -98.49 -4.66 33.9 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.625 -0.716 . . . . 0.0 109.737 179.811 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -116.56 40.65 2.86 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.485 -0.78 . . . . 0.0 110.321 -179.499 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -119.02 170.99 8.57 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.622 179.81 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 10.4 pt -127.78 137.91 56.24 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-O 120.763 0.316 . . . . 0.0 110.357 178.982 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 76.6 t80 -92.78 116.53 29.11 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 116.023 -0.535 . . . . 0.0 109.736 -179.753 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 10.9 t -105.2 113.97 43.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-O 120.914 0.387 . . . . 0.0 110.886 -179.102 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -122.52 170.56 15.25 Favored Glycine 0 N--CA 1.449 -0.49 0 N-CA-C 111.664 -0.574 . . . . 0.0 111.664 179.833 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 5.4 m-20 58.43 40.5 24.07 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-O 121.27 0.557 . . . . 0.0 110.775 -179.929 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.465 HG13 HD23 ' A' ' 144' ' ' LEU . 2.5 t -82.83 165.18 2.59 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 CA-C-N 115.364 -0.834 . . . . 0.0 110.41 -179.408 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 83' ' ' ASP . . . . . 0.606 ' HB3' ' SG ' ' A' ' 86' ' ' CYS . 13.6 t0 -67.23 140.88 57.42 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 109.96 -0.385 . . . . 0.0 109.96 179.316 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 34.6 p90 -68.49 -11.77 60.28 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.703 -179.13 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -113.46 14.38 19.06 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 120.739 0.304 . . . . 0.0 111.477 -179.803 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 86' ' ' CYS . . . . . 0.606 ' SG ' ' HB3' ' A' ' 83' ' ' ASP . 1.2 m -81.34 150.23 28.54 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.354 0.597 . . . . 0.0 111.747 -179.594 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 87' ' ' THR . . . . . 0.532 ' O ' ' HG2' ' A' ' 90' ' ' GLU . 1.2 p -116.02 155.75 47.58 Favored Pre-proline 0 C--N 1.323 -0.547 0 CA-C-N 115.513 -0.767 . . . . 0.0 109.933 179.235 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 88' ' ' PRO . . . . . 0.477 ' HD3' HD13 ' A' ' 106' ' ' ILE . 25.6 Cg_endo -60.51 -34.52 92.68 Favored 'Trans proline' 0 C--N 1.344 0.31 0 C-N-CA 122.464 2.109 . . . . 0.0 113.054 -178.599 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 8.4 mt-10 -63.4 -51.85 64.07 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.646 -178.94 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 90' ' ' GLU . . . . . 0.689 ' O ' ' HB2' ' A' ' 94' ' ' HIS . 8.8 pt-20 -61.73 -28.82 69.7 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.924 -179.201 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 79.6 t -76.96 -48.53 25.16 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.178 -179.003 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 92' ' ' GLN . . . . . 0.447 ' O ' ' HB2' ' A' ' 96' ' ' GLN . 0.0 OUTLIER -69.87 -32.64 71.1 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.57 -0.287 . . . . 0.0 111.474 -178.084 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 9.3 pt20 -80.97 -26.44 36.58 Favored 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 120.883 -0.327 . . . . 0.0 110.994 -179.239 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 94' ' ' HIS . . . . . 0.689 ' HB2' ' O ' ' A' ' 90' ' ' GLU . 0.9 OUTLIER -71.5 -39.15 71.02 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.961 0.41 . . . . 0.0 110.316 -179.777 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 15.4 m-85 -88.46 -13.98 39.02 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.974 -179.479 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 96' ' ' GLN . . . . . 0.476 ' HA ' ' O ' ' A' ' 99' ' ' GLY . 41.6 tt0 -63.22 -22.18 66.7 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.802 -179.904 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 35.7 m -72.74 -21.9 60.95 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.54 179.505 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 3.6 m -96.67 -44.15 7.24 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.202 0.525 . . . . 0.0 109.629 178.957 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 99' ' ' GLY . . . . . 0.476 ' O ' ' HA ' ' A' ' 96' ' ' GLN . . . -147.35 139.03 7.58 Favored Glycine 0 N--CA 1.442 -0.916 0 CA-C-N 115.516 -0.766 . . . . 0.0 111.229 179.529 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 2.3 m -62.73 143.14 57.75 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 120.819 0.342 . . . . 0.0 110.957 179.975 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 2.6 p -108.12 132.68 55.22 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.928 -179.365 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 10.7 t30 -93.68 -41.36 9.74 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 109.615 -0.513 . . . . 0.0 109.615 178.655 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -156.41 159.11 38.41 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.285 -0.87 . . . . 0.0 109.512 179.549 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 6.2 p -148.6 136.34 14.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-O 120.909 0.385 . . . . 0.0 110.581 -179.882 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 105' ' ' THR . . . . . 0.488 ' HB ' ' CE1' ' A' ' 119' ' ' TYR . 2.0 m -122.91 130.82 53.32 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.259 178.945 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 106' ' ' ILE . . . . . 0.477 HD13 ' HD3' ' A' ' 88' ' ' PRO . 21.1 tt -118.73 146.11 23.8 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-O 120.703 0.287 . . . . 0.0 110.535 -179.849 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 43.2 tp -135.46 127.29 29.32 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.36 179.855 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -87.59 124.32 33.38 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.6 179.759 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -86.98 137.44 32.35 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.033 0.444 . . . . 0.0 110.774 179.807 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 5.3 mmmm -121.24 17.38 11.52 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.669 -179.616 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 5.7 t80 -101.61 -0.64 34.45 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.075 0.464 . . . . 0.0 110.706 -179.172 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 105.38 5.41 39.95 Favored Glycine 0 N--CA 1.446 -0.679 0 C-N-CA 120.654 -0.784 . . . . 0.0 112.53 179.535 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 113' ' ' GLN . . . . . 0.449 ' HB3' ' HD2' ' A' ' 114' ' ' PRO . 36.8 mt-30 -91.25 160.03 38.14 Favored Pre-proline 0 C--N 1.322 -0.609 0 N-CA-C 109.018 -0.734 . . . . 0.0 109.018 179.677 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 114' ' ' PRO . . . . . 0.449 ' HD2' ' HB3' ' A' ' 113' ' ' GLN . 14.1 Cg_endo -57.42 117.45 4.15 Favored 'Trans proline' 0 C--N 1.345 0.379 0 C-N-CA 122.038 1.825 . . . . 0.0 111.577 179.333 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 63.9 mttt -76.55 179.49 5.91 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 109.071 -0.714 . . . . 0.0 109.071 179.975 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 116' ' ' GLY . . . . . 0.403 ' HA2' HD11 ' A' ' 106' ' ' ILE . . . 91.64 -0.79 74.41 Favored Glycine 0 N--CA 1.448 -0.515 0 C-N-CA 120.258 -0.973 . . . . 0.0 111.869 179.69 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 2.0 t80 -54.25 121.34 8.0 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.856 0.36 . . . . 0.0 110.153 179.809 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -149.95 175.45 11.66 Favored 'General case' 0 N--CA 1.448 -0.558 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.754 -179.216 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 119' ' ' TYR . . . . . 0.488 ' CE1' ' HB ' ' A' ' 105' ' ' THR . 35.2 p90 -157.49 134.46 10.13 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.985 -0.552 . . . . 0.0 109.615 179.068 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 11.8 m -106.41 149.33 9.93 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 N-CA-C 109.677 -0.49 . . . . 0.0 109.677 179.385 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 121' ' ' GLU . . . . . 0.47 ' HB2' HG12 ' A' ' 72' ' ' VAL . 0.7 OUTLIER -133.73 156.13 48.52 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.927 -178.789 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 122' ' ' PHE . . . . . 0.462 ' O ' ' HA ' ' A' ' 72' ' ' VAL . 13.2 t80 -155.1 165.63 36.11 Favored 'General case' 0 C--N 1.333 -0.116 0 CA-C-O 120.927 0.394 . . . . 0.0 111.126 179.275 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 123' ' ' VAL . . . . . 0.426 ' HA ' HG22 ' A' ' 72' ' ' VAL . 12.2 t -82.14 -45.26 19.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 115.694 -0.685 . . . . 0.0 112.226 -178.869 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 20.0 mm-40 -76.26 136.88 39.66 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.12 0.486 . . . . 0.0 111.306 -178.865 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 2.7 mp -74.82 -35.89 37.87 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.675 -179.493 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -55.79 -38.79 70.4 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.106 179.597 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -61.5 -57.05 13.68 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.018 179.971 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 10.0 p -66.36 -29.06 45.41 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.002 -179.544 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 19.6 tt0 -61.54 -39.46 91.17 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.666 179.804 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 46.4 m-80 -78.77 -31.12 45.99 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.142 0.496 . . . . 0.0 109.706 178.738 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -66.44 -51.07 60.79 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.657 -0.701 . . . . 0.0 111.221 179.996 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 4.2 pp -65.66 -16.08 63.4 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-O 121.036 0.446 . . . . 0.0 110.859 -179.868 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 3.8 tp -84.04 -52.89 5.95 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.014 179.237 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 69.5 mt -121.41 101.4 7.6 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.915 -0.584 . . . . 0.0 109.85 179.693 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -146.66 -70.53 0.24 Allowed 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.84 0.352 . . . . 0.0 111.706 -179.331 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -70.48 105.35 3.04 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.546 0.689 . . . . 0.0 111.598 -179.051 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 15.2 m -147.59 -58.49 0.26 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.573 -0.74 . . . . 0.0 109.41 178.769 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -161.32 127.75 3.89 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.976 -0.556 . . . . 0.0 109.839 179.433 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 139' ' ' LEU . . . . . 0.426 ' HG ' HD21 ' A' ' 144' ' ' LEU . 0.1 OUTLIER -142.82 111.93 6.56 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.16 -0.473 . . . . 0.0 109.861 179.794 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 140' ' ' HIS . . . . . 0.442 ' HB2' ' SG ' ' A' ' 86' ' ' CYS . 1.3 t60 62.81 25.41 15.08 Favored 'General case' 0 N--CA 1.466 0.33 0 O-C-N 123.41 0.444 . . . . 0.0 110.839 179.189 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 86.66 3.45 83.74 Favored Glycine 0 N--CA 1.45 -0.429 0 C-N-CA 120.871 -0.681 . . . . 0.0 112.029 -179.57 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -116.86 170.57 8.51 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 110.072 -0.344 . . . . 0.0 110.072 179.989 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 8.1 pt20 -120.53 117.03 26.56 Favored 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 109.486 -0.561 . . . . 0.0 109.486 178.957 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 144' ' ' LEU . . . . . 0.465 HD23 HG13 ' A' ' 82' ' ' VAL . 0.6 OUTLIER -99.62 175.22 5.9 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.934 0.397 . . . . 0.0 111.336 -178.934 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 145' ' ' LYS . . . . . 0.517 ' HE3' ' OG ' ' A' ' 147' ' ' SER . 1.2 tmtp? -116.37 123.19 46.99 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.645 -0.707 . . . . 0.0 109.413 179.34 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 90.8 t -120.55 137.28 54.85 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-O 120.771 0.32 . . . . 0.0 110.68 -179.303 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 147' ' ' SER . . . . . 0.517 ' OG ' ' HE3' ' A' ' 145' ' ' LYS . 66.9 m -144.62 149.23 35.41 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.284 -0.417 . . . . 0.0 109.911 178.902 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -61.74 123.55 18.27 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.757 0.313 . . . . 0.0 111.338 -179.794 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 12.5 ttpp -86.86 73.67 9.92 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.498 0.666 . . . . 0.0 109.755 -179.982 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 14.1 tpt180 . . . . . 0 C--N 1.32 -0.713 0 CA-C-N 115.69 -0.686 . . . . 0.0 110.716 -179.904 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.233 0.2 0 N-CA-C 109.837 -0.431 . . . . 0.0 109.837 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 29.0 tp -74.97 88.63 2.37 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.987 0.423 . . . . 0.0 110.079 179.734 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 20.0 ttp180 -138.74 158.42 44.26 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.249 -0.432 . . . . 0.0 109.852 -179.469 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 52.3 mt-10 -79.66 25.18 0.35 Allowed 'General case' 0 N--CA 1.464 0.267 0 CA-C-O 121.023 0.439 . . . . 0.0 111.311 -179.807 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 11.3 ptt? -79.89 4.05 17.92 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 120.811 0.338 . . . . 0.0 110.584 -178.961 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 59.5 mt-30 -71.83 -22.31 61.57 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.214 0.531 . . . . 0.0 110.011 179.424 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -78.44 -15.26 58.84 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.707 -0.679 . . . . 0.0 110.113 179.033 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 48' ' ' LYS . . . . . 0.531 ' O ' ' HG2' ' A' ' 52' ' ' GLU . 6.7 ttpp -76.93 2.85 13.53 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.458 -0.792 . . . . 0.0 110.309 -179.802 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 9.2 p -55.71 -24.21 16.15 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.142 0 CA-C-N 115.481 -0.781 . . . . 0.0 111.86 -179.541 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 50' ' ' GLU . . . . . 0.504 ' H ' ' HG3' ' A' ' 50' ' ' GLU . 0.1 OUTLIER -60.54 -32.25 71.31 Favored 'General case' 0 CA--C 1.52 -0.195 0 CA-C-O 121.43 0.633 . . . . 0.0 109.735 179.494 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 9.0 mtmm -103.22 -40.69 6.32 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.471 -0.786 . . . . 0.0 111.354 -179.645 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 52' ' ' GLU . . . . . 0.531 ' HG2' ' O ' ' A' ' 48' ' ' LYS . 44.1 mm-40 -64.63 -8.4 14.19 Favored 'General case' 0 N--CA 1.468 0.469 0 N-CA-C 112.421 0.526 . . . . 0.0 112.421 -179.356 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 9.2 ptp -57.98 -33.13 68.56 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.741 0.305 . . . . 0.0 111.257 179.604 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -91.04 -19.88 41.27 Favored Glycine 0 N--CA 1.449 -0.477 0 C-N-CA 120.573 -0.822 . . . . 0.0 111.214 179.082 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.323 -0.547 0 CA-C-N 115.125 -0.538 . . . . 0.0 110.899 -179.263 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.455 -0.184 0 CA-C-O 120.945 0.403 . . . . 0.0 110.047 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 1.2 m -76.15 5.35 6.94 Favored 'General case' 0 CA--C 1.533 0.299 0 CA-C-O 121.343 0.592 . . . . 0.0 110.98 179.731 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 7.3 tp-100 -124.81 -54.99 1.62 Allowed 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.916 -0.583 . . . . 0.0 110.398 179.21 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -78.89 -56.28 4.52 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.362 -179.427 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 1.7 tp10 -66.32 -28.72 68.9 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-O 121.325 0.583 . . . . 0.0 109.935 179.937 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 48.8 tptt -59.96 -29.17 68.24 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.437 -0.802 . . . . 0.0 111.268 179.487 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 48.8 mt-10 -61.69 -24.04 66.5 Favored 'General case' 0 N--CA 1.463 0.207 0 CA-C-O 120.977 0.418 . . . . 0.0 110.654 179.669 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 6.9 tp10 -95.19 -39.16 10.24 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.787 -0.642 . . . . 0.0 109.711 178.814 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.51 HG12 ' HB2' ' A' ' 121' ' ' GLU . 89.4 t -63.03 -44.65 99.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 115.795 -0.639 . . . . 0.0 112.127 -179.302 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -69.22 -23.11 63.85 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-O 121.17 0.51 . . . . 0.0 110.968 -179.129 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 49.9 m -90.6 -9.65 46.27 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.451 -0.795 . . . . 0.0 109.765 179.154 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -113.98 36.06 3.85 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 114.993 -1.003 . . . . 0.0 110.005 -179.839 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -111.89 169.27 8.95 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.04 179.425 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 7.6 pt -129.28 136.48 59.37 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 N-CA-C 110.029 -0.36 . . . . 0.0 110.029 178.748 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 78' ' ' TYR . . . . . 0.401 ' O ' ' HA ' ' A' ' 146' ' ' VAL . 68.8 t80 -90.42 120.83 31.86 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 116.042 -0.526 . . . . 0.0 109.808 -179.706 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.418 HG12 HG22 ' A' ' 82' ' ' VAL . 6.7 t -107.46 111.63 36.61 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-O 120.832 0.348 . . . . 0.0 110.593 -179.164 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -119.26 168.67 13.46 Favored Glycine 0 N--CA 1.449 -0.486 0 N-CA-C 111.683 -0.567 . . . . 0.0 111.683 179.708 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 96.8 m-20 60.93 34.38 19.51 Favored 'General case' 0 N--CA 1.47 0.535 0 CA-C-O 120.964 0.411 . . . . 0.0 111.262 -179.792 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.418 HG22 HG12 ' A' ' 79' ' ' VAL . 2.5 t -75.8 166.38 2.76 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.597 -179.768 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 22.0 t0 -73.08 145.36 46.57 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.854 0.359 . . . . 0.0 110.34 179.714 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 3.0 p90 -66.27 -19.97 65.97 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.732 -0.667 . . . . 0.0 111.712 -178.934 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -109.84 20.12 18.37 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 111.742 0.275 . . . . 0.0 111.742 -179.323 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 86' ' ' CYS . . . . . 0.471 ' SG ' ' HB2' ' A' ' 140' ' ' HIS . 0.8 OUTLIER -87.84 141.71 28.38 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.07 0.462 . . . . 0.0 111.286 -179.829 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 87' ' ' THR . . . . . 0.468 ' O ' ' HG2' ' A' ' 90' ' ' GLU . 41.7 p -107.1 155.61 38.97 Favored Pre-proline 0 C--N 1.328 -0.367 0 CA-C-N 115.593 -0.73 . . . . 0.0 110.343 179.562 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 88' ' ' PRO . . . . . 0.477 ' HD3' HD13 ' A' ' 106' ' ' ILE . 18.6 Cg_endo -59.12 -35.35 98.14 Favored 'Trans proline' 0 C--N 1.342 0.213 0 C-N-CA 122.457 2.104 . . . . 0.0 112.556 -179.576 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 28.8 mt-10 -65.02 -50.04 67.8 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.688 -0.687 . . . . 0.0 112.096 -178.861 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 90' ' ' GLU . . . . . 0.565 ' O ' ' HB2' ' A' ' 94' ' ' HIS . 10.9 pt-20 -67.24 -18.6 65.29 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.835 0.35 . . . . 0.0 111.193 -179.102 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 51.3 t -85.26 -49.66 15.37 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.115 -179.897 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 92' ' ' GLN . . . . . 0.4 ' HG2' ' O ' ' A' ' 88' ' ' PRO . 6.9 pt20 -68.81 -35.92 77.6 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.696 -0.229 . . . . 0.0 111.561 -178.098 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 16.0 pt20 -74.48 -28.71 61.13 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.939 0.4 . . . . 0.0 110.37 -179.5 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 94' ' ' HIS . . . . . 0.565 ' HB2' ' O ' ' A' ' 90' ' ' GLU . 0.1 OUTLIER -70.81 -42.5 70.18 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.652 -179.796 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 20.7 m-30 -80.04 -14.59 58.43 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.87 -0.604 . . . . 0.0 110.647 -179.511 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 96' ' ' GLN . . . . . 0.623 ' HA ' ' O ' ' A' ' 99' ' ' GLY . 10.9 tt0 -66.0 -19.15 65.76 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.131 179.513 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 13.9 m -66.84 -28.57 68.46 Favored 'General case' 0 N--CA 1.451 -0.384 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.257 178.871 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 4.9 m -100.33 -43.26 6.32 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.401 179.661 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 99' ' ' GLY . . . . . 0.623 ' O ' ' HA ' ' A' ' 96' ' ' GLN . . . -144.59 139.73 8.74 Favored Glycine 0 N--CA 1.447 -0.62 0 C-N-CA 120.88 -0.676 . . . . 0.0 111.904 -179.896 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -63.02 147.72 49.84 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 120.914 0.388 . . . . 0.0 111.601 -179.901 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 2.4 p -116.52 132.93 64.71 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.095 -179.458 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 27.4 t-20 -102.2 -43.64 5.66 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.068 0.461 . . . . 0.0 110.282 178.956 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 103' ' ' ARG . . . . . 0.401 HH11 ' HD2' ' A' ' 103' ' ' ARG . 0.2 OUTLIER -141.03 148.68 40.64 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.055 -0.521 . . . . 0.0 109.888 -179.872 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 4.5 p -146.94 134.99 15.12 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 N-CA-C 109.936 -0.394 . . . . 0.0 109.936 179.197 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 105' ' ' THR . . . . . 0.459 ' HB ' ' CE1' ' A' ' 119' ' ' TYR . 0.7 OUTLIER -128.16 126.13 40.45 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.236 179.376 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 106' ' ' ILE . . . . . 0.506 HD11 ' HA2' ' A' ' 116' ' ' GLY . 18.6 tt -112.55 148.3 15.69 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-O 120.862 0.363 . . . . 0.0 110.867 -179.941 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 18.0 tp -136.83 129.96 31.11 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.155 179.56 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -88.42 123.24 32.77 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 109.708 -0.479 . . . . 0.0 109.708 179.542 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 109' ' ' ASP . . . . . 0.417 ' O ' ' HB2' ' A' ' 110' ' ' LYS . 29.2 t70 -70.93 -80.17 0.06 Allowed 'General case' 0 CA--C 1.531 0.247 0 N-CA-C 112.628 0.603 . . . . 0.0 112.628 -178.239 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 110' ' ' LYS . . . . . 0.417 ' HB2' ' O ' ' A' ' 109' ' ' ASP . 1.7 mtpp 70.34 20.66 6.03 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 122.828 0.451 . . . . 0.0 111.621 -179.901 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 6.6 t80 -115.41 17.92 16.24 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-O 121.274 0.559 . . . . 0.0 109.955 -179.749 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 103.99 0.37 45.02 Favored Glycine 0 N--CA 1.449 -0.5 0 C-N-CA 120.768 -0.729 . . . . 0.0 112.158 179.952 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 20.9 mt-30 -111.34 157.72 38.24 Favored Pre-proline 0 C--N 1.322 -0.596 0 N-CA-C 109.588 -0.523 . . . . 0.0 109.588 179.599 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -59.77 129.7 31.84 Favored 'Trans proline' 0 N--CA 1.462 -0.335 0 C-N-CA 122.124 1.883 . . . . 0.0 111.366 178.827 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 15.6 mttp -82.8 -179.41 7.43 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 109.196 -0.668 . . . . 0.0 109.196 179.963 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 116' ' ' GLY . . . . . 0.506 ' HA2' HD11 ' A' ' 106' ' ' ILE . . . 92.36 2.53 68.02 Favored Glycine 0 N--CA 1.446 -0.645 0 C-N-CA 120.064 -1.065 . . . . 0.0 112.32 179.168 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 2.2 t80 -54.51 119.52 5.36 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-O 120.732 0.301 . . . . 0.0 110.278 179.793 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -146.56 177.89 8.71 Favored 'General case' 0 N--CA 1.45 -0.427 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.846 -179.316 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 119' ' ' TYR . . . . . 0.459 ' CE1' ' HB ' ' A' ' 105' ' ' THR . 43.6 p90 -161.1 134.84 6.75 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.521 -0.763 . . . . 0.0 109.225 179.045 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 15.1 m -108.74 147.07 13.69 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 N-CA-C 109.529 -0.545 . . . . 0.0 109.529 178.824 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 121' ' ' GLU . . . . . 0.51 ' HB2' HG12 ' A' ' 72' ' ' VAL . 7.2 pt-20 -131.7 155.91 46.82 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 116.389 -0.368 . . . . 0.0 111.022 -179.217 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 122' ' ' PHE . . . . . 0.446 ' O ' ' HA ' ' A' ' 72' ' ' VAL . 10.8 t80 -157.2 166.66 32.59 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.147 -179.943 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 5.1 t -84.82 -49.23 15.99 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-O 120.854 0.359 . . . . 0.0 111.708 -178.995 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 47.8 mm-40 -66.27 127.87 33.91 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.002 -0.545 . . . . 0.0 111.844 -178.608 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 2.3 mp -72.05 -29.4 32.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 115.6 -0.727 . . . . 0.0 109.643 179.516 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 16.7 t70 -58.1 -42.25 85.29 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.265 -0.88 . . . . 0.0 110.56 179.322 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -64.81 -52.98 53.9 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.731 -0.668 . . . . 0.0 111.532 -179.597 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 8.8 p -65.85 -27.05 40.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 116.636 -0.256 . . . . 0.0 111.43 -179.27 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 24.4 tt0 -60.31 -48.52 81.4 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.806 0.336 . . . . 0.0 110.404 179.898 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 86.6 m-20 -69.61 -32.41 71.11 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 121.021 0.439 . . . . 0.0 110.248 179.611 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 131' ' ' ALA . . . . . 0.421 ' O ' ' HB2' ' A' ' 135' ' ' ASN . . . -64.84 -53.16 51.13 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.604 -0.725 . . . . 0.0 111.254 -179.787 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 4.1 pp -65.23 -23.94 67.21 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.9 0.381 . . . . 0.0 110.888 -179.796 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 5.6 tp -76.42 -54.34 6.87 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.652 179.699 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 26.9 mt -122.38 103.04 8.47 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.091 -0.504 . . . . 0.0 109.878 -179.998 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 135' ' ' ASN . . . . . 0.421 ' HB2' ' O ' ' A' ' 131' ' ' ALA . 0.2 OUTLIER -150.23 -66.87 0.2 Allowed 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 120.977 0.418 . . . . 0.0 111.551 -179.22 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 3.3 pt-20 -69.73 101.18 1.63 Allowed 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.882 -0.599 . . . . 0.0 111.417 -179.188 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 23.7 m -151.31 -59.32 0.17 Allowed 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.909 -0.587 . . . . 0.0 109.966 178.93 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 6.0 tm-20 -154.78 127.68 8.17 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.457 179.755 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -147.72 111.27 4.98 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 178.774 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 140' ' ' HIS . . . . . 0.471 ' HB2' ' SG ' ' A' ' 86' ' ' CYS . 2.1 t60 64.6 28.22 13.25 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-O 121.241 0.543 . . . . 0.0 109.725 -179.585 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 79.23 1.27 85.5 Favored Glycine 0 CA--C 1.52 0.371 0 C-N-CA 121.012 -0.613 . . . . 0.0 112.485 -179.353 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 7.3 mpt_? -113.11 170.94 7.85 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 120.662 0.267 . . . . 0.0 110.437 -179.907 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 12.7 pt20 -115.11 137.55 51.89 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.114 -0.494 . . . . 0.0 109.83 179.162 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -125.58 174.48 8.22 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.135 179.951 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 76.7 tttt -116.91 122.33 44.0 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 109.775 -0.454 . . . . 0.0 109.775 179.371 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 146' ' ' VAL . . . . . 0.401 ' HA ' ' O ' ' A' ' 78' ' ' TYR . 77.6 t -115.88 125.21 72.93 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-O 120.843 0.354 . . . . 0.0 110.739 179.811 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 5.4 t -126.87 148.46 50.0 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 109.848 -0.427 . . . . 0.0 109.848 179.944 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -66.62 122.66 18.11 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.595 -0.275 . . . . 0.0 110.636 -179.737 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 14.0 ttpp -88.14 61.99 6.55 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.456 0.646 . . . . 0.0 109.63 -179.823 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.322 -0.618 0 CA-C-N 115.806 -0.634 . . . . 0.0 109.561 179.453 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.236 0.35 0 N-CA-C 110.467 -0.198 . . . . 0.0 110.467 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 37.9 tp -74.29 84.32 1.91 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.08 0.467 . . . . 0.0 109.897 179.346 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 43' ' ' ARG . . . . . 0.528 ' HA ' ' NE ' ' A' ' 43' ' ' ARG . 1.5 tpm_? -132.63 142.3 49.05 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.746 -179.376 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 21.5 mp0 -77.27 47.04 0.54 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.249 0.547 . . . . 0.0 110.278 179.252 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 9.1 ptt? -108.65 -0.41 20.18 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.498 -179.548 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 71.6 mt-30 -59.86 -22.68 62.62 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-O 120.889 0.376 . . . . 0.0 111.325 -179.048 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -68.03 -16.96 64.26 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.787 -179.914 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 3.4 ptmm? -73.82 3.59 6.39 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-O 120.635 0.255 . . . . 0.0 111.323 -179.383 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 11.0 p -54.73 -25.09 14.61 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.25 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.307 179.63 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -59.46 -37.03 77.1 Favored 'General case' 0 C--N 1.334 -0.095 0 CA-C-O 121.185 0.517 . . . . 0.0 110.152 179.134 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 10.7 mtmm -85.57 -41.14 15.53 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.804 -0.634 . . . . 0.0 110.328 -179.369 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 16.9 mm-40 -60.33 -38.05 82.53 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.519 -0.764 . . . . 0.0 111.991 -179.013 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 17.3 ptp -64.67 -25.94 68.17 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.679 0.276 . . . . 0.0 110.973 -179.607 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -95.61 -9.94 57.17 Favored Glycine 0 N--CA 1.448 -0.514 0 C-N-CA 120.812 -0.709 . . . . 0.0 111.539 179.433 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.325 -0.463 0 CA-C-O 121.029 0.442 . . . . 0.0 110.629 -179.458 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.456 -0.144 0 CA-C-O 120.717 0.294 . . . . 0.0 110.483 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -76.98 4.3 10.32 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.321 0.582 . . . . 0.0 110.605 179.772 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 46.3 tp60 -122.5 -54.9 1.86 Allowed 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.811 -0.632 . . . . 0.0 110.524 179.277 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -79.8 -54.42 5.86 Favored 'General case' 0 C--N 1.326 -0.413 0 N-CA-C 112.174 0.435 . . . . 0.0 112.174 -178.603 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 14.0 tp10 -69.58 -27.1 64.83 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.069 0.461 . . . . 0.0 110.963 -179.224 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 15.5 tptp -59.9 -27.2 66.52 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.995 179.303 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 94.8 mt-10 -62.74 -22.28 66.43 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-O 121.375 0.607 . . . . 0.0 111.009 179.583 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 71' ' ' GLU . . . . . 0.446 ' O ' ' HD2' ' A' ' 75' ' ' ARG . 7.0 tp10 -96.97 -40.01 9.09 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 115.727 -0.669 . . . . 0.0 109.596 178.007 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.436 HG12 ' HB2' ' A' ' 121' ' ' GLU . 59.0 t -65.27 -37.89 81.25 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-N 115.728 -0.669 . . . . 0.0 112.586 -179.034 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -72.98 -17.13 61.49 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-O 120.889 0.376 . . . . 0.0 111.148 -179.227 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -97.77 -18.56 18.72 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.964 -0.562 . . . . 0.0 109.952 177.831 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 75' ' ' ARG . . . . . 0.446 ' HD2' ' O ' ' A' ' 71' ' ' GLU . 0.0 OUTLIER -103.05 49.76 0.83 Allowed 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.353 -179.334 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 76' ' ' SER . . . . . 0.49 ' HB3' ' HB3' ' A' ' 121' ' ' GLU . 0.0 OUTLIER -128.04 170.57 12.76 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.542 -0.754 . . . . 0.0 110.313 179.703 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 4.8 pt -134.98 137.33 50.8 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.787 0 N-CA-C 109.795 -0.446 . . . . 0.0 109.795 178.88 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 67.0 t80 -95.81 128.18 42.48 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.151 -179.58 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 2.7 t -105.18 111.8 36.13 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.362 -179.861 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -116.93 162.98 12.57 Favored Glycine 0 N--CA 1.449 -0.498 0 C-N-CA 120.925 -0.655 . . . . 0.0 111.599 -179.859 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 9.9 m120 60.28 42.45 15.02 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-O 121.32 0.581 . . . . 0.0 110.542 -179.559 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.545 HG12 ' H ' ' A' ' 83' ' ' ASP . 2.0 t -83.26 172.9 1.0 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.656 0 CA-C-N 115.521 -0.763 . . . . 0.0 110.31 -179.375 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 83' ' ' ASP . . . . . 0.651 ' OD2' ' HD3' ' A' ' 142' ' ' ARG . 11.6 t0 -73.62 135.4 43.82 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 109.756 -0.461 . . . . 0.0 109.756 179.451 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 5.4 p90 -60.77 -21.4 63.01 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.88 -0.6 . . . . 0.0 111.924 -179.662 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -110.85 19.19 18.81 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.774 0.321 . . . . 0.0 111.237 -179.855 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 86' ' ' CYS . . . . . 0.442 ' SG ' ' HB3' ' A' ' 83' ' ' ASP . 0.5 OUTLIER -80.64 148.32 30.3 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.375 0.607 . . . . 0.0 110.993 -179.898 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 87' ' ' THR . . . . . 0.531 ' O ' ' HG2' ' A' ' 90' ' ' GLU . 40.1 p -109.97 152.38 43.0 Favored Pre-proline 0 C--N 1.321 -0.649 0 CA-C-N 115.338 -0.846 . . . . 0.0 110.194 179.409 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 88' ' ' PRO . . . . . 0.408 ' HD3' HD13 ' A' ' 106' ' ' ILE . 18.8 Cg_endo -60.14 -32.39 94.52 Favored 'Trans proline' 0 C--N 1.344 0.338 0 C-N-CA 122.414 2.076 . . . . 0.0 112.593 -179.543 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 7.8 mm-40 -64.6 -53.09 53.21 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.731 -0.668 . . . . 0.0 111.96 -179.165 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 90' ' ' GLU . . . . . 0.531 ' HG2' ' O ' ' A' ' 87' ' ' THR . 10.7 pt-20 -62.42 -23.93 67.13 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.966 0.412 . . . . 0.0 111.413 -178.904 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 76.6 t -79.86 -48.78 20.16 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.059 -179.86 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 92' ' ' GLN . . . . . 0.427 ' O ' ' HB2' ' A' ' 96' ' ' GLN . 1.6 pp0? -71.97 -33.63 68.32 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.708 -0.224 . . . . 0.0 111.372 -178.455 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 8.6 pt20 -74.21 -31.79 62.76 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.911 0.386 . . . . 0.0 111.068 -179.475 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 65.0 t-80 -73.79 -41.85 61.82 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.734 -179.431 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 18.1 m-30 -78.19 -12.97 60.03 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.124 -179.162 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 96' ' ' GLN . . . . . 0.545 ' HA ' ' O ' ' A' ' 99' ' ' GLY . 38.5 tt0 -70.06 -20.17 63.24 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.687 -0.688 . . . . 0.0 109.988 179.669 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 1.4 m -65.17 -36.41 84.14 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.496 -0.775 . . . . 0.0 110.692 179.555 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 0.2 OUTLIER -89.81 -46.43 8.59 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.304 -179.988 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 99' ' ' GLY . . . . . 0.545 ' O ' ' HA ' ' A' ' 96' ' ' GLN . . . -144.27 145.21 14.55 Favored Glycine 0 N--CA 1.445 -0.766 0 C-N-CA 120.672 -0.775 . . . . 0.0 111.801 179.792 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -64.12 145.91 55.12 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 121.033 0.444 . . . . 0.0 111.337 -179.781 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 1.2 p -118.65 121.79 67.86 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.259 -179.949 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 102' ' ' ASN . . . . . 0.482 ' OD1' ' HG2' ' A' ' 103' ' ' ARG . 26.6 t-20 -91.07 -44.83 9.04 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 109.859 -0.423 . . . . 0.0 109.859 179.733 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 103' ' ' ARG . . . . . 0.482 ' HG2' ' OD1' ' A' ' 102' ' ' ASN . 10.3 mmm180 -136.99 149.16 47.34 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.534 179.967 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 4.0 p -148.2 131.39 7.9 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.587 0 CA-C-N 115.919 -0.582 . . . . 0.0 109.473 179.711 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 105' ' ' THR . . . . . 0.419 ' HB ' ' CE1' ' A' ' 119' ' ' TYR . 0.7 OUTLIER -124.89 126.53 45.68 Favored 'General case' 0 C--N 1.32 -0.69 0 N-CA-C 110.08 -0.341 . . . . 0.0 110.08 179.237 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 106' ' ' ILE . . . . . 0.502 HD11 ' HA2' ' A' ' 116' ' ' GLY . 21.1 tt -113.26 143.62 22.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-O 120.895 0.379 . . . . 0.0 110.889 -179.598 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 51.4 tp -129.66 127.75 41.17 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.062 179.372 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -94.76 114.65 26.58 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.546 -0.297 . . . . 0.0 110.411 179.73 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 109' ' ' ASP . . . . . 0.468 ' C ' ' HD2' ' A' ' 110' ' ' LYS . 3.1 t70 -75.24 134.07 41.23 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.771 0.32 . . . . 0.0 110.899 -179.948 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 110' ' ' LYS . . . . . 0.468 ' HD2' ' C ' ' A' ' 109' ' ' ASP . 8.0 mmmm -116.66 30.17 7.5 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 120.94 0.4 . . . . 0.0 110.094 -179.906 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 8.5 t80 -112.72 -2.85 14.37 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.848 0.356 . . . . 0.0 110.81 -179.6 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 108.33 8.78 28.53 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.844 -0.693 . . . . 0.0 113.141 179.717 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 30.2 mt-30 -94.58 157.18 37.55 Favored Pre-proline 0 C--N 1.322 -0.596 0 N-CA-C 109.646 -0.502 . . . . 0.0 109.646 179.84 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -58.64 105.59 0.23 Allowed 'Trans proline' 0 C--N 1.348 0.502 0 C-N-CA 122.216 1.944 . . . . 0.0 110.819 178.998 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 115' ' ' LYS . . . . . 0.415 ' HG2' ' O ' ' A' ' 109' ' ' ASP . 3.3 mttp -68.22 177.34 2.32 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.68 -179.074 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 116' ' ' GLY . . . . . 0.502 ' HA2' HD11 ' A' ' 106' ' ' ILE . . . 99.54 2.93 56.46 Favored Glycine 0 N--CA 1.445 -0.729 0 C-N-CA 120.339 -0.934 . . . . 0.0 111.308 -179.73 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 39.9 m-85 -53.13 117.55 3.09 Favored 'General case' 0 C--N 1.331 -0.205 0 O-C-N 123.821 0.366 . . . . 0.0 110.097 179.505 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -147.15 173.49 12.46 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 121.154 0.502 . . . . 0.0 111.205 -179.099 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 119' ' ' TYR . . . . . 0.419 ' CE1' ' HB ' ' A' ' 105' ' ' THR . 39.2 p90 -156.14 134.6 11.58 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 115.436 -0.802 . . . . 0.0 109.0 178.642 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 14.4 m -109.43 139.24 33.18 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 N-CA-C 109.319 -0.623 . . . . 0.0 109.319 179.055 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 121' ' ' GLU . . . . . 0.49 ' HB3' ' HB3' ' A' ' 76' ' ' SER . 9.0 pt-20 -127.67 154.6 45.1 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 120.921 0.391 . . . . 0.0 111.334 -179.684 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 122' ' ' PHE . . . . . 0.412 ' O ' ' HA ' ' A' ' 72' ' ' VAL . 17.6 t80 -154.56 171.14 19.91 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.748 -0.66 . . . . 0.0 109.819 -179.821 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 3.8 t -84.65 -52.01 13.06 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-O 120.772 0.32 . . . . 0.0 111.551 -179.463 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -62.43 132.7 53.42 Favored 'General case' 0 C--O 1.236 0.346 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.674 -179.032 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 2.3 mp -76.04 -32.45 23.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 115.937 -0.574 . . . . 0.0 109.629 179.463 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 6.4 t70 -58.67 -39.16 79.88 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.358 -0.837 . . . . 0.0 110.632 179.324 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -62.59 -57.56 10.66 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.781 -0.645 . . . . 0.0 111.118 -179.829 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 7.6 p -65.2 -29.48 47.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.428 -0.351 . . . . 0.0 111.371 -179.449 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 40.6 tt0 -59.24 -47.17 86.36 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.284 0.564 . . . . 0.0 110.673 179.752 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 44.7 m-80 -70.68 -31.24 68.06 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.804 -0.635 . . . . 0.0 110.029 179.608 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -68.47 -47.91 65.87 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.58 -0.736 . . . . 0.0 111.672 -179.601 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 4.1 pp -68.02 -24.0 65.06 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.74 0.305 . . . . 0.0 110.9 -179.746 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 5.4 tp -74.24 -53.45 9.74 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.722 -179.354 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 61.9 mt -131.64 98.41 4.48 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 112.087 0.403 . . . . 0.0 112.087 -178.939 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 3.4 m-20 -149.9 -52.25 0.15 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.318 179.111 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 2.9 pt-20 -73.03 93.55 1.78 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.619 0.723 . . . . 0.0 110.708 179.614 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 4.6 m -142.38 -59.85 0.45 Allowed 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.544 -0.753 . . . . 0.0 110.354 179.376 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -156.47 127.41 6.86 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.216 179.894 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -146.95 122.99 10.77 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 109.481 -0.562 . . . . 0.0 109.481 179.691 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 2.0 t60 63.93 17.34 10.5 Favored 'General case' 0 N--CA 1.465 0.306 0 C-N-CA 122.71 0.404 . . . . 0.0 111.015 179.59 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 93.39 -1.59 69.73 Favored Glycine 0 N--CA 1.443 -0.843 0 C-N-CA 120.77 -0.728 . . . . 0.0 112.366 -179.465 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 142' ' ' ARG . . . . . 0.651 ' HD3' ' OD2' ' A' ' 83' ' ' ASP . 4.3 mpt_? -121.38 -173.7 2.68 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 110.127 -0.323 . . . . 0.0 110.127 179.861 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 20.7 pt20 -124.12 150.98 44.46 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 120.794 0.331 . . . . 0.0 110.402 179.735 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -133.54 177.89 7.35 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.472 -179.783 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 42.0 tttt -117.72 123.46 46.09 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 109.793 -0.447 . . . . 0.0 109.793 178.449 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 82.8 t -117.61 121.52 67.68 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-O 120.982 0.42 . . . . 0.0 110.451 179.875 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 56.8 m -127.44 147.63 50.29 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 116.33 -0.396 . . . . 0.0 110.185 179.51 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -65.23 126.79 29.25 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.903 0.382 . . . . 0.0 111.133 -179.479 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 19.8 ttpp -89.38 55.45 3.26 Favored 'General case' 0 N--CA 1.448 -0.533 0 CA-C-O 121.463 0.649 . . . . 0.0 109.302 -179.807 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.327 -0.383 0 CA-C-N 115.781 -0.645 . . . . 0.0 109.909 179.912 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.453 -0.302 0 N-CA-C 110.291 -0.263 . . . . 0.0 110.291 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 14.4 tp -75.21 77.23 2.34 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.395 0.617 . . . . 0.0 109.84 178.955 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 43' ' ' ARG . . . . . 0.406 ' C ' ' H ' ' A' ' 45' ' ' MET . 29.0 ttt180 -136.33 145.67 45.71 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.127 -179.333 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -75.45 37.32 0.13 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.23 0.538 . . . . 0.0 111.199 179.97 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 45' ' ' MET . . . . . 0.406 ' H ' ' C ' ' A' ' 43' ' ' ARG . 22.1 ptt? -100.29 8.38 43.76 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.05 -179.843 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 73.2 mm-40 -66.07 -26.5 67.52 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.368 179.753 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -72.86 -8.4 55.37 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.832 -0.622 . . . . 0.0 111.345 179.953 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 13.5 ttpt -75.14 -8.5 56.74 Favored 'General case' 0 C--O 1.236 0.363 0 CA-C-O 121.19 0.519 . . . . 0.0 110.04 179.947 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 9.9 p -58.86 -25.04 28.02 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.204 0 CA-C-N 115.747 -0.66 . . . . 0.0 111.122 179.646 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -61.1 -27.18 68.18 Favored 'General case' 0 C--N 1.333 -0.131 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.019 179.794 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 11.8 mtmt -101.55 -35.47 9.14 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.398 179.903 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 76.5 mm-40 -70.38 -21.32 62.88 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.591 -0.277 . . . . 0.0 111.188 179.986 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 13.7 ptp -62.8 -29.36 70.65 Favored 'General case' 0 N--CA 1.462 0.169 0 CA-C-O 120.829 0.347 . . . . 0.0 110.435 179.566 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -90.66 -10.97 62.69 Favored Glycine 0 N--CA 1.447 -0.602 0 N-CA-C 111.008 -0.837 . . . . 0.0 111.008 178.909 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.529 0 CA-C-O 120.805 0.336 . . . . 0.0 110.431 -179.838 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.328 0 N-CA-C 109.61 -0.515 . . . . 0.0 109.61 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -76.4 4.12 9.66 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.225 0.536 . . . . 0.0 110.521 179.312 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 46.4 tt0 -118.27 -52.55 2.38 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.607 179.674 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -85.98 -57.82 2.89 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.812 -179.488 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 3.7 tp10 -63.79 -27.51 69.24 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 120.838 0.352 . . . . 0.0 110.751 -179.717 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 2.3 tptm -61.0 -23.72 65.6 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.199 179.952 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 35.1 mt-10 -62.1 -23.97 66.84 Favored 'General case' 0 N--CA 1.461 0.12 0 CA-C-O 121.176 0.512 . . . . 0.0 110.496 179.02 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 7.2 tp10 -95.46 -38.71 10.34 Favored 'General case' 0 C--N 1.319 -0.751 0 N-CA-C 109.212 -0.662 . . . . 0.0 109.212 177.747 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.447 HG22 ' HA ' ' A' ' 123' ' ' VAL . 58.4 t -65.04 -42.18 93.93 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.331 0 CA-C-N 115.913 -0.585 . . . . 0.0 112.191 -179.209 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 51.3 p30 -69.4 -15.21 63.25 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-O 121.125 0.488 . . . . 0.0 111.057 -179.223 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 24.5 m -105.51 -3.88 21.93 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.54 179.826 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -116.19 47.77 1.35 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.652 -0.704 . . . . 0.0 110.255 -179.193 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -126.3 172.81 9.79 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.866 -179.839 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 8.7 pt -131.17 136.75 57.19 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 N-CA-C 109.92 -0.4 . . . . 0.0 109.92 178.392 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 78' ' ' TYR . . . . . 0.536 ' O ' ' HA ' ' A' ' 146' ' ' VAL . 36.8 t80 -91.63 124.3 35.68 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.62 -179.465 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.495 HG13 HG22 ' A' ' 146' ' ' VAL . 6.9 t -105.98 110.23 30.62 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 N-CA-C 110.103 -0.332 . . . . 0.0 110.103 179.759 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -118.4 167.24 12.95 Favored Glycine 0 N--CA 1.45 -0.37 0 N-CA-C 111.745 -0.542 . . . . 0.0 111.745 -179.857 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 4.6 m-20 59.25 40.77 21.03 Favored 'General case' 0 N--CA 1.468 0.471 0 CA-C-O 121.289 0.566 . . . . 0.0 110.794 -179.583 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.444 HG12 ' H ' ' A' ' 83' ' ' ASP . 2.1 t -83.46 169.1 1.61 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-N 115.354 -0.839 . . . . 0.0 109.851 -179.471 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 83' ' ' ASP . . . . . 0.477 ' HB3' ' SG ' ' A' ' 86' ' ' CYS . 29.8 t70 -73.2 143.14 47.28 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 120.901 0.381 . . . . 0.0 110.73 179.916 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 34.1 p90 -64.77 -13.53 55.61 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.799 -0.637 . . . . 0.0 112.549 -178.693 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -117.21 15.95 14.91 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.81 0.338 . . . . 0.0 111.019 179.923 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 86' ' ' CYS . . . . . 0.477 ' SG ' ' HB3' ' A' ' 83' ' ' ASP . 1.0 OUTLIER -78.68 142.55 37.05 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.113 0.483 . . . . 0.0 110.885 179.945 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 87' ' ' THR . . . . . 0.482 ' O ' ' HG2' ' A' ' 90' ' ' GLU . 70.2 p -106.12 155.41 38.55 Favored Pre-proline 0 C--N 1.321 -0.672 0 CA-C-N 115.444 -0.798 . . . . 0.0 110.272 -179.994 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 20.8 Cg_endo -61.46 -29.29 84.88 Favored 'Trans proline' 0 C--N 1.344 0.32 0 C-N-CA 122.219 1.946 . . . . 0.0 112.401 -179.788 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 14.0 mt-10 -65.31 -55.3 19.07 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.665 -179.073 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 90' ' ' GLU . . . . . 0.482 ' HG2' ' O ' ' A' ' 87' ' ' THR . 9.6 pt-20 -60.89 -25.53 66.78 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.921 0.391 . . . . 0.0 111.258 -178.634 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 69.2 t -78.24 -47.37 24.62 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.274 -179.286 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 92' ' ' GLN . . . . . 0.471 ' O ' ' HB2' ' A' ' 96' ' ' GLN . 13.9 pt20 -74.0 -31.75 63.1 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 112.172 0.434 . . . . 0.0 112.172 -178.212 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 1.5 pp0? -77.53 -27.85 51.8 Favored 'General case' 0 N--CA 1.467 0.419 0 C-N-CA 120.305 -0.558 . . . . 0.0 111.743 -179.155 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 1.5 m-70 -71.71 -44.46 64.14 Favored 'General case' 0 C--N 1.328 -0.349 0 C-N-CA 120.832 -0.347 . . . . 0.0 111.009 -179.571 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 23.0 m-85 -81.18 -11.72 59.36 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.682 0.277 . . . . 0.0 110.884 -179.707 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 96' ' ' GLN . . . . . 0.471 ' HB2' ' O ' ' A' ' 92' ' ' GLN . 43.3 tt0 -62.64 -28.56 70.0 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.002 -0.544 . . . . 0.0 110.59 -179.483 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 12.1 m -64.85 -38.95 92.7 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.305 179.263 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 6.1 m -81.01 -40.01 24.96 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.005 179.321 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 99' ' ' GLY . . . . . 0.456 ' O ' ' HA ' ' A' ' 96' ' ' GLN . . . -153.8 129.37 2.64 Favored Glycine 0 N--CA 1.442 -0.91 0 CA-C-N 115.76 -0.655 . . . . 0.0 111.516 179.487 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 100' ' ' THR . . . . . 0.424 HG22 ' H ' ' A' ' 100' ' ' THR . 0.6 OUTLIER -58.97 140.84 55.18 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.259 0.552 . . . . 0.0 110.748 179.868 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 101' ' ' VAL . . . . . 0.443 HG11 ' HB2' ' A' ' 92' ' ' GLN . 1.3 p -107.55 128.37 62.73 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 115.754 -0.657 . . . . 0.0 111.996 -178.057 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 102' ' ' ASN . . . . . 0.489 ' O ' ' HD2' ' A' ' 103' ' ' ARG . 6.3 t30 -86.39 -53.36 5.05 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 109.229 -0.656 . . . . 0.0 109.229 178.553 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 103' ' ' ARG . . . . . 0.489 ' HD2' ' O ' ' A' ' 102' ' ' ASN . 3.4 mpt_? -138.93 153.49 48.24 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 116.001 -0.545 . . . . 0.0 109.62 179.963 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 4.8 p -142.74 126.93 15.22 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 N-CA-C 109.787 -0.449 . . . . 0.0 109.787 179.669 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 105' ' ' THR . . . . . 0.409 ' O ' ' HA ' ' A' ' 118' ' ' ALA . 0.8 OUTLIER -114.75 127.19 55.6 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 110.308 -0.256 . . . . 0.0 110.308 179.847 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 20.0 tt -117.8 144.55 25.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-O 120.708 0.29 . . . . 0.0 110.597 -179.77 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 26.6 tp -133.45 121.97 23.01 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.557 179.84 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -84.09 114.53 21.82 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.543 -0.299 . . . . 0.0 110.318 179.258 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -78.54 134.21 37.29 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.182 0.515 . . . . 0.0 111.516 -179.698 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -119.94 22.85 11.33 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.167 179.33 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 4.0 t80 -101.07 1.39 39.35 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.113 -179.56 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 100.87 12.15 38.08 Favored Glycine 0 N--CA 1.449 -0.455 0 C-N-CA 120.796 -0.716 . . . . 0.0 112.361 179.898 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 36.4 mt-30 -100.11 157.61 33.53 Favored Pre-proline 0 C--N 1.325 -0.485 0 N-CA-C 109.37 -0.604 . . . . 0.0 109.37 179.372 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -58.53 112.76 1.29 Allowed 'Trans proline' 0 C--N 1.345 0.37 0 C-N-CA 122.433 2.089 . . . . 0.0 111.488 178.889 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 7.9 mttp -69.58 176.87 3.23 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.662 -179.745 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 99.06 2.96 56.93 Favored Glycine 0 N--CA 1.439 -1.139 0 C-N-CA 120.164 -1.017 . . . . 0.0 111.768 -179.801 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 29.1 m-85 -54.95 113.35 1.31 Allowed 'General case' 0 C--O 1.231 0.118 0 N-CA-C 110.12 -0.326 . . . . 0.0 110.12 179.53 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 118' ' ' ALA . . . . . 0.409 ' HA ' ' O ' ' A' ' 105' ' ' THR . . . -144.59 173.07 12.14 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 120.931 0.396 . . . . 0.0 110.87 -178.977 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 2.3 p90 -157.75 136.75 11.59 Favored 'General case' 0 N--CA 1.445 -0.676 0 CA-C-N 115.891 -0.595 . . . . 0.0 109.552 178.874 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 15.0 m -105.91 140.7 23.16 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 N-CA-C 109.489 -0.56 . . . . 0.0 109.489 178.985 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 121' ' ' GLU . . . . . 0.414 ' HB2' HG12 ' A' ' 72' ' ' VAL . 6.4 pt-20 -126.4 154.2 43.93 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.045 -179.287 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 122' ' ' PHE . . . . . 0.436 ' O ' ' HA ' ' A' ' 72' ' ' VAL . 14.3 t80 -154.65 167.87 28.7 Favored 'General case' 0 C--O 1.226 -0.15 0 CA-C-O 120.796 0.331 . . . . 0.0 110.637 179.306 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 123' ' ' VAL . . . . . 0.447 ' HA ' HG22 ' A' ' 72' ' ' VAL . 6.3 t -82.73 -50.32 15.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 115.715 -0.675 . . . . 0.0 111.626 -179.126 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 33.1 mt-10 -70.97 137.42 49.12 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.044 -0.526 . . . . 0.0 111.934 -178.748 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 2.9 mp -74.99 -32.46 27.17 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.313 179.707 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 37.8 t70 -58.0 -43.54 86.67 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-O 120.982 0.42 . . . . 0.0 111.003 -179.833 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -58.05 -57.37 13.15 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.872 -0.604 . . . . 0.0 111.471 -179.682 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 12.2 p -67.62 -29.52 45.6 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 116.477 -0.329 . . . . 0.0 111.608 -179.177 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 129' ' ' GLN . . . . . 0.455 ' O ' ' HG ' ' A' ' 132' ' ' LEU . 29.4 tt0 -63.16 -46.43 87.2 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.901 0.381 . . . . 0.0 110.308 179.889 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 48.6 m-80 -72.02 -27.15 62.53 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.216 0.532 . . . . 0.0 109.688 179.125 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -72.15 -40.73 67.8 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.561 -0.745 . . . . 0.0 111.317 179.892 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 132' ' ' LEU . . . . . 0.584 ' HA ' ' ND2' ' A' ' 135' ' ' ASN . 4.4 pp -74.7 -19.1 60.39 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.924 0.392 . . . . 0.0 110.789 179.861 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 5.3 tp -76.34 -47.48 23.31 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.383 -179.906 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 40.1 mt -126.19 95.28 4.34 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.973 -0.558 . . . . 0.0 109.818 179.959 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 135' ' ' ASN . . . . . 0.584 ' ND2' ' HA ' ' A' ' 132' ' ' LEU . 2.8 p30 -135.75 -74.74 0.45 Allowed 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 112.431 0.53 . . . . 0.0 112.431 -179.083 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 5.8 pt-20 -69.25 100.57 1.33 Allowed 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.505 0.669 . . . . 0.0 111.632 -178.708 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 26.5 m -142.68 -58.3 0.44 Allowed 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.577 -0.738 . . . . 0.0 109.929 178.815 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 3.0 tm-20 -162.17 124.51 2.85 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.151 -0.477 . . . . 0.0 109.961 179.491 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -144.51 119.11 9.75 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 109.374 -0.602 . . . . 0.0 109.374 179.448 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 2.5 t60 64.67 20.52 12.16 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-O 121.108 0.48 . . . . 0.0 110.386 179.541 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 85.15 5.61 85.48 Favored Glycine 0 N--CA 1.448 -0.543 0 C-N-CA 120.922 -0.656 . . . . 0.0 112.149 -179.303 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -120.34 173.33 7.2 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 109.98 -0.378 . . . . 0.0 109.98 179.994 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 10.3 pt20 -118.84 125.43 49.52 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 109.761 -0.459 . . . . 0.0 109.761 179.271 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -110.36 178.3 4.43 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.86 -178.9 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -118.67 118.64 32.2 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 109.394 -0.595 . . . . 0.0 109.394 179.22 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 146' ' ' VAL . . . . . 0.536 ' HA ' ' O ' ' A' ' 78' ' ' TYR . 42.0 t -122.03 119.56 58.91 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-O 120.753 0.311 . . . . 0.0 111.144 -179.065 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 60.0 m -124.16 152.49 42.77 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 109.901 -0.407 . . . . 0.0 109.901 179.499 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -61.49 130.31 45.4 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.939 0.399 . . . . 0.0 110.796 179.984 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 42.7 tttp -92.94 71.19 4.69 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 109.079 -0.711 . . . . 0.0 109.079 179.958 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 150' ' ' ARG . . . . . 0.407 HH11 ' HD2' ' A' ' 150' ' ' ARG . 3.6 tpt180 . . . . . 0 C--N 1.32 -0.706 0 CA-C-N 115.679 -0.692 . . . . 0.0 110.034 -179.563 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.165 0 N-CA-C 110.107 -0.331 . . . . 0.0 110.107 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 20.2 tp -83.75 79.39 9.48 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.147 0.499 . . . . 0.0 110.297 179.919 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 28.6 ttm180 -144.22 140.79 29.48 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.797 -0.638 . . . . 0.0 109.632 179.781 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 44' ' ' GLU . . . . . 0.409 ' H ' ' CD ' ' A' ' 44' ' ' GLU . 0.7 OUTLIER -71.97 84.08 0.96 Allowed 'General case' 0 C--O 1.235 0.305 0 CA-C-O 120.972 0.415 . . . . 0.0 110.112 179.398 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 14.9 ptt? -132.53 12.05 4.48 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.772 -179.244 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 1.7 mp0 -65.57 -11.64 45.91 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.834 -178.929 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -70.31 -17.43 63.08 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.963 0.411 . . . . 0.0 111.331 179.852 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 19.3 pttp -70.71 -13.22 61.99 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.49 -179.411 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 5.3 p -65.11 -20.53 27.72 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.317 0 CA-C-O 121.208 0.528 . . . . 0.0 110.952 -179.66 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 49.3 mt-10 -82.5 -12.0 58.09 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.284 179.673 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 28.7 ttmt -107.43 -32.71 7.62 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.18 0.514 . . . . 0.0 109.682 179.228 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 71.1 mt-10 -78.74 7.54 6.8 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.548 -0.751 . . . . 0.0 111.265 179.754 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -62.3 -29.21 70.27 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 109.944 -0.391 . . . . 0.0 109.944 178.988 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -96.78 3.27 62.69 Favored Glycine 0 N--CA 1.449 -0.449 0 N-CA-C 110.733 -0.947 . . . . 0.0 110.733 178.526 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.302 0 CA-C-O 121.113 0.482 . . . . 0.0 110.321 -179.388 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.153 0 CA-C-O 120.897 0.379 . . . . 0.0 110.799 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -78.24 6.19 8.71 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.374 -0.376 . . . . 0.0 111.179 179.754 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 4.2 tp-100 -119.43 -51.63 2.29 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.494 179.763 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -82.1 -62.1 1.72 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.364 -179.432 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 68' ' ' GLU . . . . . 0.501 ' O ' HG23 ' A' ' 72' ' ' VAL . 0.7 OUTLIER -58.52 -33.89 70.36 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.464 -179.101 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 32.6 tptt -53.25 -34.21 56.25 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 116.198 -0.455 . . . . 0.0 112.165 -179.577 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 2.5 mm-40 -61.0 -34.68 75.19 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.042 0.448 . . . . 0.0 110.764 -179.793 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 10.2 tp10 -88.42 -38.19 15.26 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.493 179.829 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.501 HG23 ' O ' ' A' ' 68' ' ' GLU . 61.4 t -64.7 -41.84 93.35 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.059 -179.589 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 4.6 t70 -68.04 -33.19 74.12 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.333 -179.357 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 74' ' ' SER . . . . . 0.45 ' HB2' ' HE ' ' A' ' 150' ' ' ARG . 11.5 p -82.47 -17.25 45.89 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 121.284 0.564 . . . . 0.0 109.964 179.908 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -101.79 48.19 0.89 Allowed 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.836 0.827 . . . . 0.0 108.849 178.717 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 76' ' ' SER . . . . . 0.426 ' HB3' ' HE3' ' A' ' 149' ' ' LYS . 28.0 t -125.0 158.8 32.78 Favored 'General case' 0 N--CA 1.446 -0.643 0 CA-C-N 114.726 -1.125 . . . . 0.0 110.22 -179.085 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 5.4 pt -126.94 134.8 65.37 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.138 178.895 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 61.2 t80 -92.19 130.27 37.94 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.323 -179.668 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.42 HG21 ' HE2' ' A' ' 95' ' ' PHE . 8.0 t -104.23 108.2 24.14 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.742 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.35 -179.947 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -112.88 170.24 13.32 Favored Glycine 0 N--CA 1.442 -0.961 0 N-CA-C 111.022 -0.831 . . . . 0.0 111.022 179.468 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 9.9 m-20 58.51 38.5 25.45 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-N 116.97 0.385 . . . . 0.0 110.557 -179.76 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.505 HG12 ' H ' ' A' ' 83' ' ' ASP . 1.4 t -79.35 171.81 1.23 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.971 -178.993 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 83' ' ' ASP . . . . . 0.562 ' OD1' ' HD2' ' A' ' 142' ' ' ARG . 30.2 t70 -81.24 141.71 33.87 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.287 -0.415 . . . . 0.0 109.906 179.476 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 55.2 p90 -65.01 -16.3 63.28 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 112.708 0.633 . . . . 0.0 112.708 -178.113 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -110.22 9.26 23.84 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.698 0.285 . . . . 0.0 111.327 -179.953 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 86' ' ' CYS . . . . . 0.432 ' SG ' ' HB2' ' A' ' 140' ' ' HIS . 0.9 OUTLIER -73.88 135.7 43.36 Favored 'General case' 0 C--O 1.235 0.294 0 CA-C-O 121.118 0.485 . . . . 0.0 111.336 179.888 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 87' ' ' THR . . . . . 0.582 ' O ' ' HG2' ' A' ' 90' ' ' GLU . 9.0 p -103.01 153.16 38.49 Favored Pre-proline 0 C--N 1.324 -0.514 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.19 179.337 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 15.2 Cg_endo -58.82 -37.86 91.64 Favored 'Trans proline' 0 CA--C 1.531 0.335 0 C-N-CA 122.48 2.12 . . . . 0.0 112.827 -179.426 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 7.5 mp0 -63.79 -46.3 85.83 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.756 -179.361 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 90' ' ' GLU . . . . . 0.582 ' HG2' ' O ' ' A' ' 87' ' ' THR . 7.7 pt-20 -65.65 -26.4 67.79 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.807 0.337 . . . . 0.0 111.069 -179.114 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 62.2 t -74.61 -55.51 11.74 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.874 -179.953 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 2.7 pt20 -62.51 -36.12 81.54 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 112.405 0.52 . . . . 0.0 112.405 -178.516 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 9.0 pt20 -76.35 -24.07 54.22 Favored 'General case' 0 N--CA 1.463 0.185 0 C-N-CA 120.792 -0.363 . . . . 0.0 111.605 -178.947 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -80.02 -39.25 30.3 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.856 0.36 . . . . 0.0 111.193 -179.494 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 95' ' ' PHE . . . . . 0.42 ' HE2' HG21 ' A' ' 79' ' ' VAL . 21.1 m-30 -81.3 -17.92 47.62 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.955 -179.22 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 96' ' ' GLN . . . . . 0.53 ' HA ' ' O ' ' A' ' 99' ' ' GLY . 1.9 tt0 -61.36 -23.78 66.01 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.801 179.702 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 2.7 m -63.11 -31.21 72.3 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.641 -0.708 . . . . 0.0 110.594 179.47 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 27.7 m -99.61 -44.96 5.95 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.213 179.547 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 99' ' ' GLY . . . . . 0.53 ' O ' ' HA ' ' A' ' 96' ' ' GLN . . . -141.52 132.24 5.2 Favored Glycine 0 N--CA 1.446 -0.646 0 C-N-CA 120.793 -0.718 . . . . 0.0 112.012 -179.815 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 2.5 m -68.0 147.23 52.69 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 120.728 0.299 . . . . 0.0 110.481 179.905 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 2.0 p -125.9 135.2 64.62 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-O 120.832 0.349 . . . . 0.0 111.325 -179.088 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 28.3 t-20 -104.78 -43.78 5.02 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.298 179.268 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 5.3 mpt_? -119.4 137.15 53.94 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.345 -0.388 . . . . 0.0 109.999 179.539 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 12.3 p -144.47 145.84 20.99 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.109 -179.948 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 105' ' ' THR . . . . . 0.581 ' HB ' ' CE2' ' A' ' 119' ' ' TYR . 4.2 m -146.13 137.83 24.9 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 110.036 -0.357 . . . . 0.0 110.036 179.358 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 14.9 tt -121.38 144.96 28.74 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-O 120.824 0.345 . . . . 0.0 110.631 -179.78 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 18.6 tp -123.22 127.64 48.89 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 116.438 -0.346 . . . . 0.0 110.469 -179.959 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -90.1 121.69 32.39 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.378 179.162 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 20.5 t70 -92.76 144.39 25.34 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 120.98 0.419 . . . . 0.0 111.174 -179.69 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -135.81 30.53 3.1 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 179.131 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 40.0 t80 -111.5 -12.24 13.99 Favored 'General case' 0 N--CA 1.452 -0.329 0 CA-C-N 115.19 -0.914 . . . . 0.0 110.029 -179.253 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 112.17 9.49 19.97 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.706 -179.466 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 32.6 mt-30 -91.81 157.59 41.29 Favored Pre-proline 0 C--N 1.325 -0.497 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 179.256 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 13.9 Cg_endo -58.1 99.09 0.09 OUTLIER 'Trans proline' 0 C--N 1.345 0.388 0 C-N-CA 122.095 1.863 . . . . 0.0 111.713 179.024 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 73.9 mttt -58.5 163.3 3.22 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.624 -0.717 . . . . 0.0 111.122 -179.196 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 102.55 6.12 47.57 Favored Glycine 0 N--CA 1.445 -0.75 0 C-N-CA 120.705 -0.76 . . . . 0.0 112.015 -179.811 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 46.5 m-85 -51.96 119.36 4.21 Favored 'General case' 0 CA--C 1.519 -0.236 0 CA-C-O 120.585 0.231 . . . . 0.0 110.473 179.56 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -146.79 172.94 12.87 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-O 121.034 0.445 . . . . 0.0 111.028 -179.136 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 119' ' ' TYR . . . . . 0.581 ' CE2' ' HB ' ' A' ' 105' ' ' THR . 50.5 p90 -154.2 148.75 26.28 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 115.791 -0.64 . . . . 0.0 109.471 179.02 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 30.6 m -124.64 136.31 61.07 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-N 116.476 -0.329 . . . . 0.0 110.314 179.566 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 121' ' ' GLU . . . . . 0.411 ' HB3' ' HB2' ' A' ' 76' ' ' SER . 10.2 pt-20 -128.38 149.09 50.69 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 120.898 0.38 . . . . 0.0 111.06 -179.844 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 7.7 t80 -148.87 167.96 24.3 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.535 -179.942 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 8.0 t -82.62 -42.27 18.19 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.177 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.446 -179.501 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -71.15 126.91 30.86 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.327 0.584 . . . . 0.0 111.292 -179.165 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 125' ' ' ILE . . . . . 0.408 HD12 ' H ' ' A' ' 125' ' ' ILE . 4.7 mp -67.87 -44.11 85.55 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-N 115.244 -0.889 . . . . 0.0 111.262 -178.845 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 126' ' ' ASP . . . . . 0.445 ' HA ' ' HB3' ' A' ' 129' ' ' GLN . 0.2 OUTLIER -62.34 -27.58 69.15 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.574 -0.284 . . . . 0.0 111.698 -179.132 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -63.66 -57.95 8.43 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.893 0.378 . . . . 0.0 110.23 179.423 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 11.5 p -69.26 -27.09 33.39 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 116.343 -0.389 . . . . 0.0 110.726 179.748 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 129' ' ' GLN . . . . . 0.445 ' HB3' ' HA ' ' A' ' 126' ' ' ASP . 16.1 tt0 -62.24 -45.4 93.48 Favored 'General case' 0 C--N 1.333 -0.121 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.493 179.504 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 37.6 m-80 -73.4 -26.84 61.15 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.246 0.546 . . . . 0.0 109.914 179.417 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 131' ' ' ALA . . . . . 0.451 ' O ' ' HB2' ' A' ' 135' ' ' ASN . . . -69.62 -49.72 51.2 Favored 'General case' 0 N--CA 1.45 -0.456 0 CA-C-N 115.661 -0.699 . . . . 0.0 110.792 179.623 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 3.9 pp -65.74 -16.08 63.44 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-O 120.884 0.373 . . . . 0.0 111.223 179.99 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 51.2 tp -82.39 -54.19 5.41 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.014 179.344 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 89.8 mt -120.43 93.64 4.11 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.298 179.827 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 135' ' ' ASN . . . . . 0.499 ' HB3' HG21 ' A' ' 146' ' ' VAL . 0.2 OUTLIER -145.98 -57.31 0.3 Allowed 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.978 -0.556 . . . . 0.0 111.054 -179.522 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 136' ' ' GLU . . . . . 0.418 ' HG2' ' H ' ' A' ' 136' ' ' GLU . 1.2 pt-20 -73.44 87.71 1.58 Allowed 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.854 -0.612 . . . . 0.0 111.19 -179.462 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 6.6 m -138.28 -65.87 0.5 Allowed 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.21 179.278 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 6.2 tm-20 -157.96 136.22 10.96 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.309 -179.576 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -152.23 119.23 5.83 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 109.071 -0.715 . . . . 0.0 109.071 179.181 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 140' ' ' HIS . . . . . 0.432 ' HB2' ' SG ' ' A' ' 86' ' ' CYS . 2.2 t60 65.45 19.07 11.51 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-O 121.147 0.499 . . . . 0.0 110.658 179.63 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 88.78 -5.84 84.21 Favored Glycine 0 N--CA 1.447 -0.589 0 C-N-CA 120.864 -0.684 . . . . 0.0 111.814 -179.189 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 142' ' ' ARG . . . . . 0.562 ' HD2' ' OD1' ' A' ' 83' ' ' ASP . 0.0 OUTLIER -108.1 175.56 5.43 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 120.798 0.332 . . . . 0.0 110.154 -179.676 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 10.8 pt20 -113.9 148.94 35.9 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 109.584 -0.525 . . . . 0.0 109.584 179.257 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -137.12 175.23 9.8 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 120.789 0.328 . . . . 0.0 110.897 -179.905 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 84.0 tttt -123.96 127.46 47.99 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.758 -0.655 . . . . 0.0 109.77 -179.873 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 146' ' ' VAL . . . . . 0.499 HG21 ' HB3' ' A' ' 135' ' ' ASN . 99.2 t -115.72 126.42 73.24 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 CA-C-O 120.801 0.334 . . . . 0.0 110.975 -179.073 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 3.8 m -121.81 153.27 38.56 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.673 -179.69 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -74.84 117.17 16.38 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.721 0.296 . . . . 0.0 110.489 179.386 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 149' ' ' LYS . . . . . 0.426 ' HE3' ' HB3' ' A' ' 76' ' ' SER . 11.6 ttpp -92.97 47.48 1.28 Allowed 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.728 -179.232 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 150' ' ' ARG . . . . . 0.45 ' HE ' ' HB2' ' A' ' 74' ' ' SER . 0.0 OUTLIER . . . . . 0 C--N 1.326 -0.438 0 N-CA-C 109.892 -0.41 . . . . 0.0 109.892 179.517 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.236 0.371 0 CA-C-O 120.59 0.233 . . . . 0.0 110.471 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 12.1 tp -77.5 86.07 3.86 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.247 0.546 . . . . 0.0 110.369 -179.811 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 22.0 ttm-85 -148.43 149.65 32.1 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.031 -179.636 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -79.76 56.11 2.2 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.582 0.706 . . . . 0.0 110.485 -179.86 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 27.4 ptm -106.54 12.62 29.3 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.42 -0.809 . . . . 0.0 109.968 179.752 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 28.9 mm-40 -73.91 -26.45 60.53 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.531 -179.307 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -70.29 -6.37 34.54 Favored 'General case' 0 C--O 1.236 0.347 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.679 179.501 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 13.9 ttpp -86.57 2.1 49.34 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.207 179.599 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 8.3 p -55.74 -30.32 27.16 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.331 0 CA-C-N 116.052 -0.522 . . . . 0.0 112.005 -179.233 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 17.1 pt-20 -67.19 -28.45 68.11 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.862 0.363 . . . . 0.0 110.9 -179.928 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 37.4 mttm -86.63 -32.55 20.52 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 109.342 -0.614 . . . . 0.0 109.342 179.515 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 15.8 mm-40 -77.23 -3.62 40.61 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.691 -0.686 . . . . 0.0 111.197 -179.427 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 21.3 ttt -59.11 -38.58 79.91 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.174 0.511 . . . . 0.0 110.064 179.059 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -88.57 1.75 84.15 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.678 -0.772 . . . . 0.0 112.125 179.72 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.324 -0.524 0 CA-C-O 121.252 0.548 . . . . 0.0 110.937 -179.693 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.457 -0.096 0 CA-C-O 120.787 0.327 . . . . 0.0 111.588 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 4.3 m -81.21 -4.95 57.1 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 120.894 0.378 . . . . 0.0 111.511 -179.18 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 20.1 tp60 -111.94 -65.52 1.17 Allowed 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 112.171 0.434 . . . . 0.0 112.171 -179.947 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -77.7 -54.58 6.2 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.774 0.321 . . . . 0.0 111.802 -178.276 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 68' ' ' GLU . . . . . 0.455 ' O ' HG23 ' A' ' 72' ' ' VAL . 1.0 OUTLIER -62.05 -25.86 67.92 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.323 -0.398 . . . . 0.0 110.756 -179.518 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 69' ' ' LYS . . . . . 0.432 ' HG3' ' OD2' ' A' ' 73' ' ' ASP . 0.1 OUTLIER -49.48 -42.91 44.67 Favored 'General case' 0 C--O 1.232 0.139 0 CA-C-N 115.998 -0.546 . . . . 0.0 112.036 -179.293 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 28.2 mt-10 -52.23 -35.84 50.66 Favored 'General case' 0 N--CA 1.465 0.301 0 O-C-N 123.696 0.622 . . . . 0.0 112.138 -179.243 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 5.7 tp10 -83.52 -32.96 25.62 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 116.564 -0.289 . . . . 0.0 111.56 -178.755 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.528 ' HA ' ' O ' ' A' ' 122' ' ' PHE . 0.6 OUTLIER -69.05 -40.95 81.4 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 116.583 -0.28 . . . . 0.0 111.518 -178.786 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 73' ' ' ASP . . . . . 0.432 ' OD2' ' HG3' ' A' ' 69' ' ' LYS . 0.8 OUTLIER -83.53 -11.44 57.41 Favored 'General case' 0 N--CA 1.463 0.204 0 C-N-CA 119.819 -0.753 . . . . 0.0 111.353 -179.961 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 46.4 m -87.28 -20.23 27.13 Favored 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 176.729 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -116.66 53.86 0.87 Allowed 'General case' 0 N--CA 1.454 -0.269 0 CA-C-N 115.108 -0.951 . . . . 0.0 110.468 -179.969 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -124.24 159.57 29.87 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 120.942 0.401 . . . . 0.0 110.606 179.368 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 4.5 pt -127.29 138.18 55.56 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.231 179.048 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 34.7 t80 -104.4 126.96 51.96 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 116.128 -0.487 . . . . 0.0 109.841 -179.697 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.427 HG12 HG22 ' A' ' 82' ' ' VAL . 4.6 t -98.89 112.65 31.54 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 CA-C-O 121.072 0.463 . . . . 0.0 110.464 -179.718 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -111.02 153.28 17.25 Favored Glycine 0 N--CA 1.444 -0.78 0 CA-C-N 115.74 -0.663 . . . . 0.0 111.793 179.864 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 11.2 m-80 61.01 53.08 3.8 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-O 121.083 0.468 . . . . 0.0 110.621 -179.643 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.427 HG22 HG12 ' A' ' 79' ' ' VAL . 1.1 t -89.46 169.08 1.43 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.221 -179.693 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 83' ' ' ASP . . . . . 0.511 ' OD1' ' HD2' ' A' ' 142' ' ' ARG . 28.4 t70 -73.99 140.35 45.43 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.877 0.37 . . . . 0.0 110.403 -179.958 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 1.1 p90 -63.97 -25.71 68.26 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.794 -0.639 . . . . 0.0 111.905 -178.907 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -96.72 10.43 38.74 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.728 0.299 . . . . 0.0 111.443 -179.595 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 86' ' ' CYS . . . . . 0.44 ' HB2' ' O ' ' A' ' 83' ' ' ASP . 0.8 OUTLIER -84.64 149.31 25.93 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.152 0.501 . . . . 0.0 111.15 179.823 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 87' ' ' THR . . . . . 0.472 ' O ' ' HG2' ' A' ' 90' ' ' GLU . 2.5 p -120.18 157.73 52.48 Favored Pre-proline 0 C--N 1.322 -0.622 0 CA-C-N 115.73 -0.668 . . . . 0.0 109.949 179.4 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -59.09 -36.56 95.9 Favored 'Trans proline' 0 C--N 1.345 0.392 0 C-N-CA 122.366 2.044 . . . . 0.0 112.647 -179.009 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 89' ' ' GLU . . . . . 0.424 ' O ' ' HG3' ' A' ' 92' ' ' GLN . 56.2 mp0 -63.83 -53.11 55.9 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.67 -179.176 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 90' ' ' GLU . . . . . 0.472 ' HG2' ' O ' ' A' ' 87' ' ' THR . 8.9 pt-20 -62.92 -24.71 67.98 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.79 0.328 . . . . 0.0 111.853 -178.743 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 52.5 t -78.3 -49.3 21.4 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.587 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.917 -179.932 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 92' ' ' GLN . . . . . 0.424 ' HG3' ' O ' ' A' ' 89' ' ' GLU . 0.0 OUTLIER -67.8 -37.59 82.2 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 112.382 0.512 . . . . 0.0 112.382 -178.582 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -71.86 -26.34 62.31 Favored 'General case' 0 N--CA 1.464 0.231 0 C-N-CA 120.836 -0.346 . . . . 0.0 111.325 -179.258 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 1.6 m80 -79.26 -37.34 38.18 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.064 0.459 . . . . 0.0 110.671 179.96 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 16.7 m-30 -81.26 -14.75 57.11 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.402 -179.631 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 96' ' ' GLN . . . . . 0.544 ' HA ' ' O ' ' A' ' 99' ' ' GLY . 52.4 tt0 -64.1 -23.22 67.24 Favored 'General case' 0 C--N 1.333 -0.113 0 CA-C-N 115.94 -0.573 . . . . 0.0 109.898 179.215 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 1.1 m -68.79 -26.25 65.11 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.229 178.942 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 5.6 m -91.6 -47.37 7.43 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 178.864 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 99' ' ' GLY . . . . . 0.544 ' O ' ' HA ' ' A' ' 96' ' ' GLN . . . -150.16 143.24 10.47 Favored Glycine 0 N--CA 1.443 -0.896 0 CA-C-N 115.485 -0.779 . . . . 0.0 111.155 179.344 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 100' ' ' THR . . . . . 0.518 ' HB ' ' CZ ' ' A' ' 122' ' ' PHE . 0.9 OUTLIER -62.09 139.22 58.46 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 116.881 0.34 . . . . 0.0 110.565 -179.832 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 101' ' ' VAL . . . . . 0.43 HG23 ' HB ' ' A' ' 120' ' ' VAL . 7.6 p -101.78 145.26 11.97 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 116.308 -0.406 . . . . 0.0 111.424 -179.275 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 102' ' ' ASN . . . . . 0.472 ' HB3' ' O ' ' A' ' 121' ' ' GLU . 17.9 t30 -113.74 -62.05 1.65 Allowed 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 109.687 -0.486 . . . . 0.0 109.687 178.789 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 1.2 mpp_? -120.62 145.62 47.21 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.107 179.236 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 5.4 p -137.12 128.92 42.67 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-O 121.238 0.542 . . . . 0.0 110.611 179.776 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 2.8 m -129.53 134.41 47.75 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.243 179.455 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 10.6 tt -125.02 148.9 29.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 120.697 0.284 . . . . 0.0 110.674 -179.718 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 30.2 tp -134.01 118.92 18.37 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.084 -0.507 . . . . 0.0 109.979 179.351 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -89.27 109.77 20.62 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 120.716 0.294 . . . . 0.0 110.31 179.502 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -74.03 146.89 43.38 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.15 -179.785 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 7.2 mptt -133.04 31.65 3.84 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.898 -0.592 . . . . 0.0 109.442 178.906 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -120.3 -3.69 9.98 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.628 -179.153 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 115.32 9.48 13.05 Favored Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.147 -1.025 . . . . 0.0 114.101 179.256 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 36.7 mt-30 -98.18 155.07 37.37 Favored Pre-proline 0 C--N 1.323 -0.562 0 CA-C-N 117.467 0.633 . . . . 0.0 109.382 179.206 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -53.65 98.84 0.05 OUTLIER 'Trans proline' 0 C--N 1.348 0.523 0 C-N-CA 122.887 2.392 . . . . 0.0 111.598 178.859 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 86.2 mttt -59.39 151.75 23.0 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.408 -0.815 . . . . 0.0 111.195 -179.302 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 110.36 6.22 27.58 Favored Glycine 0 N--CA 1.447 -0.625 0 C-N-CA 120.368 -0.92 . . . . 0.0 112.468 -179.698 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 51.8 m-85 -51.89 119.13 3.95 Favored 'General case' 0 CA--C 1.521 -0.169 0 CA-C-O 120.592 0.234 . . . . 0.0 110.425 179.185 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -143.49 161.65 37.87 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-O 120.806 0.336 . . . . 0.0 110.859 -179.263 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 15.1 p90 -151.19 145.26 25.29 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 109.517 -0.549 . . . . 0.0 109.517 178.878 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 120' ' ' VAL . . . . . 0.43 ' HB ' HG23 ' A' ' 101' ' ' VAL . 28.3 m -124.28 144.1 35.31 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.363 -179.794 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 121' ' ' GLU . . . . . 0.472 ' O ' ' HB3' ' A' ' 102' ' ' ASN . 7.4 pt-20 -124.56 144.57 50.06 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.703 -179.851 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 122' ' ' PHE . . . . . 0.528 ' O ' ' HA ' ' A' ' 72' ' ' VAL . 4.8 t80 -140.73 168.54 19.55 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.19 -0.459 . . . . 0.0 109.898 179.496 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -99.59 -24.77 4.07 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.241 0 N-CA-C 112.092 0.405 . . . . 0.0 112.092 -178.798 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 59.9 mm-40 -85.3 119.52 25.76 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.92 0.39 . . . . 0.0 110.496 -179.826 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 15.0 mt -64.48 -42.49 95.38 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 115.68 -0.691 . . . . 0.0 111.495 -179.132 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -57.48 -42.43 82.61 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.777 0.322 . . . . 0.0 111.599 -179.56 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -60.34 -51.86 67.71 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.634 -179.358 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 3.4 p -68.44 -24.26 29.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-O 120.856 0.36 . . . . 0.0 111.081 -179.328 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 45.3 tt0 -63.87 -41.44 97.76 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.747 179.921 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 19.7 t-20 -66.63 -33.89 76.65 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.046 179.972 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 131' ' ' ALA . . . . . 0.571 ' O ' ' HB2' ' A' ' 135' ' ' ASN . . . -73.05 -25.29 60.88 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.532 179.543 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 132' ' ' LEU . . . . . 0.443 ' HA ' HD13 ' A' ' 132' ' ' LEU . 0.2 OUTLIER -74.35 -25.78 59.73 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.233 0.539 . . . . 0.0 109.943 179.034 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 26.3 tp -81.26 -58.17 3.17 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.305 -0.862 . . . . 0.0 110.554 -179.643 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 134' ' ' LEU . . . . . 0.4 HD23 ' HA ' ' A' ' 134' ' ' LEU . 22.6 mt -127.78 121.14 29.44 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.314 -179.922 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 135' ' ' ASN . . . . . 0.571 ' HB2' ' O ' ' A' ' 131' ' ' ALA . 3.2 t30 -169.33 -53.72 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.163 0.506 . . . . 0.0 110.303 -179.915 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -80.04 71.27 6.76 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.814 -0.63 . . . . 0.0 111.06 179.997 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 2.3 p -112.65 -74.67 0.62 Allowed 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.362 179.012 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 24.3 tt0 -157.68 124.31 4.92 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.183 179.888 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -135.3 126.81 28.73 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 109.493 -0.558 . . . . 0.0 109.493 179.83 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 1.9 t60 64.79 22.16 12.5 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-O 121.331 0.586 . . . . 0.0 110.097 -179.697 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 84.04 -1.14 89.12 Favored Glycine 0 N--CA 1.448 -0.514 0 CA-C-N 115.758 -0.655 . . . . 0.0 112.415 -179.691 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 142' ' ' ARG . . . . . 0.511 ' HD2' ' OD1' ' A' ' 83' ' ' ASP . 0.0 OUTLIER -113.36 154.79 26.32 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.644 0.259 . . . . 0.0 110.323 -179.513 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 7.6 pt20 -95.86 146.64 24.4 Favored 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 109.499 -0.556 . . . . 0.0 109.499 178.75 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -141.05 -179.74 6.26 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.788 0.328 . . . . 0.0 110.608 -179.105 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -126.17 142.33 51.57 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.956 -0.566 . . . . 0.0 110.123 179.793 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 92.3 t -129.11 110.63 21.01 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 N-CA-C 109.789 -0.449 . . . . 0.0 109.789 -179.925 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -108.51 154.3 22.11 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.611 -179.614 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -76.02 116.43 16.71 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.02 0.438 . . . . 0.0 110.524 -179.91 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 3.6 ttpm? -86.51 68.89 10.32 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.974 -0.557 . . . . 0.0 109.684 179.927 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 150' ' ' ARG . . . . . 0.402 HH11 ' HD3' ' A' ' 150' ' ' ARG . 9.6 tpt180 . . . . . 0 C--N 1.325 -0.479 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.08 -179.392 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.453 -0.286 0 N-CA-C 110.035 -0.358 . . . . 0.0 110.035 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 11.2 tp -85.21 76.85 10.13 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 121.126 0.488 . . . . 0.0 110.399 -179.942 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 23.0 ttt180 -136.6 158.48 44.35 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.683 -179.942 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -82.83 56.34 3.38 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.709 179.957 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -119.49 17.97 12.86 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.343 0.592 . . . . 0.0 110.552 179.68 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 37.9 mm-40 -70.1 -22.83 62.99 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.758 -0.655 . . . . 0.0 110.835 -179.594 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -65.21 -14.59 61.02 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.966 -179.868 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 6.4 ttpp -77.05 -7.77 56.28 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.574 -0.284 . . . . 0.0 111.195 -179.718 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 10.6 p -59.37 -27.65 37.49 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.267 0 CA-C-O 120.98 0.419 . . . . 0.0 111.12 -179.895 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 26.8 mt-10 -66.88 -24.44 66.12 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.943 -0.572 . . . . 0.0 110.363 179.921 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 35.6 ttmt -99.24 -35.38 9.99 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.765 -0.652 . . . . 0.0 109.815 179.235 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 60.3 mm-40 -77.48 2.24 16.82 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.724 -0.671 . . . . 0.0 111.286 -179.965 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 20.0 ptt? -62.76 -28.87 70.27 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.158 0.504 . . . . 0.0 110.245 179.594 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -89.78 0.41 79.66 Favored Glycine 0 N--CA 1.445 -0.732 0 C-N-CA 120.737 -0.744 . . . . 0.0 111.448 179.321 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.325 -0.48 0 CA-C-O 121.269 0.557 . . . . 0.0 110.137 -179.763 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.52 -0.178 0 CA-C-O 120.979 0.419 . . . . 0.0 110.686 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 4.9 m -75.71 -4.52 40.81 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.696 -179.61 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 21.8 tp60 -114.72 -60.69 1.85 Allowed 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 111.962 0.356 . . . . 0.0 111.962 179.936 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -79.91 -56.29 4.36 Favored 'General case' 0 C--N 1.331 -0.215 0 N-CA-C 112.187 0.44 . . . . 0.0 112.187 -178.322 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 68' ' ' GLU . . . . . 0.62 ' O ' HG23 ' A' ' 72' ' ' VAL . 1.4 tp10 -59.17 -33.51 71.02 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.304 -179.575 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 69' ' ' LYS . . . . . 0.559 ' HG3' ' OD2' ' A' ' 73' ' ' ASP . 23.5 tptp -50.85 -33.83 25.41 Favored 'General case' 0 N--CA 1.462 0.155 0 CA-C-N 115.422 -0.808 . . . . 0.0 111.875 -179.364 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 34.5 mt-10 -49.38 -39.2 31.44 Favored 'General case' 0 N--CA 1.465 0.277 0 O-C-N 123.551 0.532 . . . . 0.0 111.583 179.911 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 7.7 tp10 -94.99 -31.46 13.62 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.251 -179.438 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.62 HG23 ' O ' ' A' ' 68' ' ' GLU . 22.9 t -58.17 -54.68 29.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 N-CA-C 112.453 0.538 . . . . 0.0 112.453 -178.084 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 73' ' ' ASP . . . . . 0.559 ' OD2' ' HG3' ' A' ' 69' ' ' LYS . 3.3 p30 -84.58 0.47 49.93 Favored 'General case' 0 N--CA 1.462 0.164 0 C-N-CA 119.676 -0.81 . . . . 0.0 111.588 -179.419 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 6.1 m -91.11 -27.25 18.68 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 108.318 -0.993 . . . . 0.0 108.318 175.562 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -106.54 59.61 0.64 Allowed 'General case' 0 N--CA 1.449 -0.5 0 CA-C-N 114.916 -1.038 . . . . 0.0 109.565 179.701 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -132.36 161.27 34.0 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.848 -179.908 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.421 HG22 HD23 ' A' ' 132' ' ' LEU . 15.1 pt -119.68 136.98 55.05 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.312 179.293 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 56.1 t80 -101.15 128.0 47.44 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 179.432 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 2.7 t -108.73 117.75 54.83 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.683 0 CA-C-O 121.074 0.464 . . . . 0.0 111.413 -178.711 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -113.44 164.41 12.05 Favored Glycine 0 N--CA 1.445 -0.719 0 N-CA-C 111.115 -0.794 . . . . 0.0 111.115 179.421 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 2.7 m-20 61.88 44.19 8.65 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-O 121.011 0.434 . . . . 0.0 110.941 179.943 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 10.7 t -85.43 154.27 3.5 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.5 -179.82 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 83' ' ' ASP . . . . . 0.576 ' HB3' ' SG ' ' A' ' 86' ' ' CYS . 0.8 OUTLIER -72.33 134.66 45.61 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.13 179.51 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 48.7 p90 -63.9 -16.34 61.19 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 113.057 0.762 . . . . 0.0 113.057 -178.015 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -96.46 4.37 52.16 Favored 'General case' 0 C--N 1.324 -0.52 0 C-N-CA 121.054 -0.258 . . . . 0.0 111.665 -179.151 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 86' ' ' CYS . . . . . 0.576 ' SG ' ' HB3' ' A' ' 83' ' ' ASP . 89.6 m -81.18 156.66 25.58 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 121.207 0.527 . . . . 0.0 111.285 179.974 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 48.7 p -124.12 152.74 67.63 Favored Pre-proline 0 C--N 1.325 -0.494 0 CA-C-N 115.616 -0.72 . . . . 0.0 109.637 178.996 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -58.77 -23.07 64.89 Favored 'Trans proline' 0 C--N 1.342 0.226 0 C-N-CA 122.469 2.113 . . . . 0.0 112.599 -179.258 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 34.1 mt-10 -69.96 -58.69 3.55 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.955 -179.811 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -65.12 -23.49 67.16 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.096 0.474 . . . . 0.0 111.008 -179.462 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 6.2 t -72.28 -52.56 23.46 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.667 0 CA-C-N 115.791 -0.64 . . . . 0.0 111.163 -179.967 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 8.7 pt20 -68.69 -36.26 78.25 Favored 'General case' 0 CA--C 1.532 0.258 0 N-CA-C 112.451 0.538 . . . . 0.0 112.451 -178.207 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -68.48 -31.11 70.16 Favored 'General case' 0 C--O 1.234 0.269 0 C-N-CA 120.733 -0.387 . . . . 0.0 111.329 -178.834 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 3.6 m80 -70.33 -38.64 74.93 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.104 0.478 . . . . 0.0 109.729 179.386 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 8.2 m-30 -74.14 -30.76 62.43 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.72 -0.673 . . . . 0.0 109.828 179.765 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 96' ' ' GLN . . . . . 0.582 ' HA ' ' O ' ' A' ' 99' ' ' GLY . 29.0 tt0 -62.99 -17.66 62.41 Favored 'General case' 0 C--O 1.231 0.131 0 CA-C-N 115.448 -0.796 . . . . 0.0 111.183 -179.79 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 5.2 m -76.09 -22.88 55.08 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.179 0.514 . . . . 0.0 109.878 179.165 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 24.8 m -98.24 -46.03 5.97 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.729 -0.668 . . . . 0.0 109.81 179.42 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 99' ' ' GLY . . . . . 0.582 ' O ' ' HA ' ' A' ' 96' ' ' GLN . . . -148.49 152.68 24.7 Favored Glycine 0 N--CA 1.449 -0.496 0 N-CA-C 111.546 -0.622 . . . . 0.0 111.546 179.538 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 100' ' ' THR . . . . . 0.554 ' HB ' ' CZ ' ' A' ' 122' ' ' PHE . 0.2 OUTLIER -66.96 146.82 53.98 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 116.799 0.3 . . . . 0.0 110.635 179.918 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 101' ' ' VAL . . . . . 0.482 HG23 ' HB ' ' A' ' 120' ' ' VAL . 2.7 p -117.21 137.72 50.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 121.015 0.436 . . . . 0.0 111.695 -178.659 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 24.1 t30 -99.13 -64.26 1.05 Allowed 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 109.487 -0.56 . . . . 0.0 109.487 179.331 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -122.88 149.18 44.55 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.486 179.44 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 7.9 p -136.28 139.94 44.57 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.018 179.677 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 105' ' ' THR . . . . . 0.588 ' HB ' ' CE1' ' A' ' 119' ' ' TYR . 4.0 m -138.19 140.69 39.89 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 109.59 -0.522 . . . . 0.0 109.59 179.304 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 20.6 tt -134.03 143.79 37.37 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 O-C-N 123.289 0.368 . . . . 0.0 110.446 -179.733 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 20.4 tp -127.09 134.55 50.23 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 120.998 0.428 . . . . 0.0 111.201 -179.804 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -101.62 114.77 29.1 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.595 179.256 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 109' ' ' ASP . . . . . 0.516 ' O ' ' HE2' ' A' ' 115' ' ' LYS . 17.3 t70 -85.44 148.54 25.94 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.397 -179.94 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 4.0 mppt? -128.6 23.31 5.86 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.861 179.956 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 3.8 t80 -110.52 -9.71 14.56 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.792 0.33 . . . . 0.0 110.904 -179.721 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 123.6 -3.54 9.4 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.251 -0.976 . . . . 0.0 113.465 179.327 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 34.1 mt-30 -79.22 154.82 77.18 Favored Pre-proline 0 C--N 1.326 -0.44 0 CA-C-N 117.215 0.507 . . . . 0.0 109.787 179.694 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 10.6 Cg_endo -55.72 101.64 0.09 OUTLIER 'Trans proline' 0 C--N 1.346 0.422 0 C-N-CA 122.533 2.155 . . . . 0.0 111.992 179.261 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 115' ' ' LYS . . . . . 0.516 ' HE2' ' O ' ' A' ' 109' ' ' ASP . 85.9 mttt -61.32 147.45 44.64 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.464 -0.789 . . . . 0.0 110.844 -179.778 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 109.76 11.45 21.0 Favored Glycine 0 N--CA 1.447 -0.627 0 C-N-CA 120.125 -1.035 . . . . 0.0 113.076 179.943 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 32.2 m-85 -54.47 116.69 2.79 Favored 'General case' 0 N--CA 1.465 0.278 0 N-CA-C 109.766 -0.457 . . . . 0.0 109.766 179.032 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -138.83 166.39 24.55 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 121.271 0.558 . . . . 0.0 111.826 -178.591 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 119' ' ' TYR . . . . . 0.588 ' CE1' ' HB ' ' A' ' 105' ' ' THR . 41.4 p90 -157.8 147.73 20.29 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.081 -0.963 . . . . 0.0 109.052 179.085 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 120' ' ' VAL . . . . . 0.482 ' HB ' HG23 ' A' ' 101' ' ' VAL . 29.8 m -125.59 136.58 60.4 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-N 116.643 -0.253 . . . . 0.0 110.702 -179.944 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 4.2 pt-20 -115.78 152.59 32.99 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.993 179.923 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 122' ' ' PHE . . . . . 0.554 ' CZ ' ' HB ' ' A' ' 100' ' ' THR . 8.7 t80 -152.2 167.14 29.54 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.253 -0.431 . . . . 0.0 109.935 179.498 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 123' ' ' VAL . . . . . 0.477 HG22 HG22 ' A' ' 72' ' ' VAL . 4.5 t -89.07 -38.63 11.6 Favored 'Isoleucine or valine' 0 C--O 1.236 0.354 0 CA-C-O 121.036 0.446 . . . . 0.0 111.392 -179.402 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 63.6 mm-40 -76.8 127.32 32.54 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.363 -179.368 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 32.4 mt -70.81 -38.37 72.45 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-N 115.593 -0.73 . . . . 0.0 111.426 -179.442 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -61.06 -38.52 86.48 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.383 -0.371 . . . . 0.0 111.697 -179.035 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -61.38 -55.8 27.43 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.213 -179.573 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 11.9 p -67.4 -27.77 39.9 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.173 -179.497 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 52.6 tt0 -61.3 -45.51 94.16 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.929 0.395 . . . . 0.0 110.788 179.937 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -64.54 -34.13 77.53 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.908 -179.726 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -77.55 -23.26 50.11 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.178 179.908 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 132' ' ' LEU . . . . . 0.421 HD23 HG22 ' A' ' 77' ' ' ILE . 0.4 OUTLIER -80.47 -15.78 55.92 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-O 121.358 0.599 . . . . 0.0 110.164 179.833 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 5.1 mp -96.62 -58.9 1.93 Allowed 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.771 179.661 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 78.9 mt -117.38 107.5 14.44 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.664 -179.435 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 65.8 t30 -166.51 -50.96 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.599 -179.799 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 136' ' ' GLU . . . . . 0.502 ' HB3' HG23 ' A' ' 146' ' ' VAL . 4.0 pt-20 -72.46 87.33 1.18 Allowed 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.299 0.571 . . . . 0.0 111.102 -179.618 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -131.21 -70.29 0.6 Allowed 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.393 179.845 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 2.9 tm-20 -150.11 132.93 15.99 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.228 -179.788 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -143.61 112.46 6.6 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.695 -0.684 . . . . 0.0 109.469 179.483 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 2.0 t60 62.37 27.72 16.51 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.208 179.49 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 90.0 -10.0 75.44 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.821 -0.704 . . . . 0.0 112.42 179.75 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 142' ' ' ARG . . . . . 0.427 HH11 ' HD3' ' A' ' 142' ' ' ARG . 0.4 OUTLIER -109.39 176.33 5.12 Favored 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 110.134 -0.321 . . . . 0.0 110.134 -179.886 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 5.0 pt20 -125.48 141.09 52.24 Favored 'General case' 0 C--N 1.319 -0.722 0 N-CA-C 109.891 -0.411 . . . . 0.0 109.891 179.195 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -125.3 173.83 8.55 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.467 -178.99 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -115.34 126.11 54.04 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.271 -0.422 . . . . 0.0 109.991 179.586 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 146' ' ' VAL . . . . . 0.502 HG23 ' HB3' ' A' ' 136' ' ' GLU . 94.1 t -104.47 117.18 49.63 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 CA-C-N 115.877 -0.601 . . . . 0.0 109.994 -179.743 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -117.2 156.17 28.15 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.39 -179.589 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -80.19 115.9 19.99 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 109.986 -0.376 . . . . 0.0 109.986 179.713 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 11.5 ttpp -88.52 52.9 2.55 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.219 0.533 . . . . 0.0 109.955 -179.73 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.325 -0.479 0 CA-C-N 115.804 -0.635 . . . . 0.0 110.48 -179.583 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.453 -0.293 0 N-CA-C 109.215 -0.661 . . . . 0.0 109.215 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 24.4 tp -74.86 82.76 2.16 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.405 0.622 . . . . 0.0 110.456 179.649 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 9.5 ttp180 -143.03 141.87 31.43 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.688 -0.687 . . . . 0.0 109.676 179.617 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -76.07 41.82 0.24 Allowed 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 121.139 0.495 . . . . 0.0 111.152 -179.749 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 10.9 ptt? -98.6 5.25 47.94 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.853 -0.612 . . . . 0.0 109.644 179.752 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 84.0 mt-30 -71.43 -20.95 62.04 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.351 -0.84 . . . . 0.0 111.383 -178.811 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -69.26 -17.51 63.76 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.214 0.531 . . . . 0.0 110.602 179.861 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 48' ' ' LYS . . . . . 0.556 ' O ' ' HG2' ' A' ' 52' ' ' GLU . 20.4 ttpp -72.99 1.48 8.78 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.572 -0.74 . . . . 0.0 110.885 179.72 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 8.1 p -55.38 -27.05 20.0 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.311 0 CA-C-N 116.463 -0.335 . . . . 0.0 111.601 -179.648 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 20.8 mt-10 -64.02 -19.9 65.53 Favored 'General case' 0 N--CA 1.463 0.19 0 CA-C-O 121.337 0.589 . . . . 0.0 110.248 179.377 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 13.1 mtmt -107.95 -37.66 6.03 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.598 -0.728 . . . . 0.0 110.904 178.749 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 52' ' ' GLU . . . . . 0.556 ' HG2' ' O ' ' A' ' 48' ' ' LYS . 9.2 mm-40 -62.77 -21.64 66.0 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 116.681 -0.236 . . . . 0.0 111.276 179.879 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 4.7 ppp? -59.36 -23.59 62.67 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-O 120.895 0.379 . . . . 0.0 110.994 179.573 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -94.53 -5.14 61.87 Favored Glycine 0 C--O 1.227 -0.324 0 C-N-CA 121.062 -0.59 . . . . 0.0 111.677 179.28 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.326 -0.42 0 CA-C-O 121.335 0.588 . . . . 0.0 110.079 -179.798 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.52 -0.211 0 CA-C-O 120.955 0.407 . . . . 0.0 110.28 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -77.57 0.87 21.38 Favored 'General case' 0 N--CA 1.453 -0.316 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.806 -179.868 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 38.8 tp60 -118.52 -50.49 2.43 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.441 179.502 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -82.58 -64.5 1.16 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.14 -0.482 . . . . 0.0 112.043 -179.15 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 68' ' ' GLU . . . . . 0.434 ' O ' HG23 ' A' ' 72' ' ' VAL . 26.0 tp10 -63.83 -26.67 68.72 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.707 0.289 . . . . 0.0 111.466 -178.775 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 36.2 tptt -58.02 -28.12 64.17 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.514 -0.312 . . . . 0.0 111.01 179.842 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 83.1 mt-10 -63.26 -21.35 66.18 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-O 121.388 0.613 . . . . 0.0 110.763 179.354 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 71' ' ' GLU . . . . . 0.521 ' O ' ' HD2' ' A' ' 75' ' ' ARG . 5.7 tp10 -97.49 -41.23 8.28 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.418 -0.81 . . . . 0.0 109.316 178.158 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.469 HG12 ' HB2' ' A' ' 121' ' ' GLU . 42.2 t -62.29 -40.13 86.68 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.379 0 CA-C-N 115.927 -0.578 . . . . 0.0 112.192 -179.25 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 12.9 p-10 -74.83 -14.19 60.66 Favored 'General case' 0 N--CA 1.466 0.375 0 CA-C-O 121.035 0.445 . . . . 0.0 110.867 -179.705 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 45.6 t -99.79 -12.98 19.45 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 121.504 0.669 . . . . 0.0 109.445 177.888 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 75' ' ' ARG . . . . . 0.521 ' HD2' ' O ' ' A' ' 71' ' ' GLU . 0.0 OUTLIER -107.66 41.05 1.58 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.054 -179.401 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -121.04 169.79 10.15 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 115.649 -0.705 . . . . 0.0 110.492 179.795 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -131.86 136.18 57.37 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 N-CA-C 109.616 -0.513 . . . . 0.0 109.616 178.433 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 71.3 t80 -91.79 123.27 35.05 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.409 -0.359 . . . . 0.0 110.278 -179.617 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 6.4 t -103.96 111.07 32.17 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.286 -179.615 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -119.95 169.66 13.96 Favored Glycine 0 N--CA 1.449 -0.48 0 C-N-CA 120.908 -0.663 . . . . 0.0 111.74 179.896 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 15.2 m120 61.48 35.62 17.5 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-O 121.102 0.477 . . . . 0.0 110.623 -179.742 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 2.1 t -79.79 165.85 2.71 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.674 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.65 -179.125 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -70.42 142.81 51.99 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 110.017 -0.364 . . . . 0.0 110.017 179.35 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 38.2 p90 -67.12 -13.47 61.98 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 112.03 0.381 . . . . 0.0 112.03 -178.723 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -114.06 16.78 18.1 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.787 0.327 . . . . 0.0 111.025 -179.968 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 86' ' ' CYS . . . . . 0.467 ' SG ' ' HB2' ' A' ' 140' ' ' HIS . 0.7 OUTLIER -82.16 142.1 32.5 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.132 0.491 . . . . 0.0 111.164 -179.927 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 87' ' ' THR . . . . . 0.549 ' O ' ' HG2' ' A' ' 90' ' ' GLU . 23.1 p -106.29 154.48 39.72 Favored Pre-proline 0 C--N 1.327 -0.406 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.548 179.705 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 88' ' ' PRO . . . . . 0.462 ' HD3' HD13 ' A' ' 106' ' ' ILE . 18.2 Cg_endo -59.19 -35.13 98.22 Favored 'Trans proline' 0 C--N 1.344 0.328 0 C-N-CA 122.769 2.313 . . . . 0.0 112.794 -179.355 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -65.51 -50.62 64.6 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.909 -0.587 . . . . 0.0 112.144 -178.705 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 90' ' ' GLU . . . . . 0.549 ' HG2' ' O ' ' A' ' 87' ' ' THR . 10.5 pt-20 -61.97 -24.78 67.22 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.888 0.375 . . . . 0.0 111.444 -178.806 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 76.1 t -81.2 -47.78 19.68 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.926 -178.761 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -71.5 -31.11 66.72 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.581 -178.627 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 3.7 pp0? -80.33 -27.91 38.26 Favored 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 120.383 -0.527 . . . . 0.0 111.252 -179.124 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 50.2 t-80 -77.44 -34.13 54.62 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.987 0.423 . . . . 0.0 110.479 -179.792 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 22.5 m-30 -84.38 -10.21 57.76 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.611 -179.987 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 96' ' ' GLN . . . . . 0.453 ' HA ' ' O ' ' A' ' 99' ' ' GLY . 9.3 tt0 -65.83 -25.4 67.2 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.488 -0.778 . . . . 0.0 109.979 179.804 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 3.6 m -62.95 -30.03 71.25 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.646 -0.706 . . . . 0.0 110.48 179.123 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 3.5 m -92.55 -49.67 6.0 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.346 179.951 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 99' ' ' GLY . . . . . 0.453 ' O ' ' HA ' ' A' ' 96' ' ' GLN . . . -145.41 144.24 12.8 Favored Glycine 0 N--CA 1.449 -0.473 0 C-N-CA 120.824 -0.703 . . . . 0.0 111.701 179.829 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 100' ' ' THR . . . . . 0.454 ' HB ' ' CZ ' ' A' ' 122' ' ' PHE . 0.2 OUTLIER -64.26 143.81 57.61 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-O 120.837 0.351 . . . . 0.0 110.69 179.945 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 1.7 p -110.72 126.45 68.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.077 -179.387 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 24.8 t-20 -90.91 -50.14 6.04 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 109.455 -0.572 . . . . 0.0 109.455 179.026 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -138.75 156.08 47.67 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.954 -0.567 . . . . 0.0 109.726 179.169 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 5.4 p -152.28 125.73 1.27 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.262 179.972 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 2.6 m -118.14 126.3 51.95 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 110.007 -0.368 . . . . 0.0 110.007 179.795 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 106' ' ' ILE . . . . . 0.503 HD11 ' HA2' ' A' ' 116' ' ' GLY . 20.9 tt -110.68 145.4 17.09 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-O 120.962 0.411 . . . . 0.0 110.794 179.816 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 32.6 tp -129.2 130.3 46.14 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.576 179.934 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -91.83 119.54 31.72 Favored 'General case' 0 N--CA 1.45 -0.47 0 CA-C-N 116.495 -0.32 . . . . 0.0 110.386 179.235 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 109' ' ' ASP . . . . . 0.437 ' O ' ' HG2' ' A' ' 115' ' ' LYS . 16.4 t70 -85.46 139.14 31.75 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.086 0.47 . . . . 0.0 110.633 179.917 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.3 23.49 5.98 Favored 'General case' 0 C--N 1.319 -0.749 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 179.113 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 1.1 t80 -103.82 1.79 31.97 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.542 -178.927 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 103.86 7.85 40.75 Favored Glycine 0 N--CA 1.448 -0.554 0 C-N-CA 121.066 -0.588 . . . . 0.0 112.701 179.527 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 18.3 mt-30 -98.56 158.19 32.97 Favored Pre-proline 0 C--N 1.324 -0.507 0 N-CA-C 109.489 -0.56 . . . . 0.0 109.489 179.581 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -59.26 118.91 5.87 Favored 'Trans proline' 0 C--N 1.346 0.403 0 C-N-CA 122.12 1.88 . . . . 0.0 111.169 178.665 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 115' ' ' LYS . . . . . 0.437 ' HG2' ' O ' ' A' ' 109' ' ' ASP . 60.1 mttt -72.93 173.74 8.82 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 109.892 -0.41 . . . . 0.0 109.892 -179.441 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 116' ' ' GLY . . . . . 0.503 ' HA2' HD11 ' A' ' 106' ' ' ILE . . . 100.28 2.53 55.72 Favored Glycine 0 N--CA 1.444 -0.788 0 C-N-CA 120.309 -0.948 . . . . 0.0 112.326 179.406 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 29.8 m-85 -52.48 115.2 1.65 Allowed 'General case' 0 C--N 1.333 -0.14 0 N-CA-C 110.117 -0.327 . . . . 0.0 110.117 179.445 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -144.6 175.36 10.2 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 121.087 0.47 . . . . 0.0 111.223 -178.913 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 50.8 p90 -159.26 137.75 10.73 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.58 -0.737 . . . . 0.0 109.506 179.002 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 11.3 m -110.31 140.66 28.39 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 N-CA-C 109.446 -0.576 . . . . 0.0 109.446 179.118 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 121' ' ' GLU . . . . . 0.469 ' HB2' HG12 ' A' ' 72' ' ' VAL . 4.9 pt-20 -126.02 151.57 46.92 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.487 -0.324 . . . . 0.0 110.812 179.887 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 122' ' ' PHE . . . . . 0.454 ' CZ ' ' HB ' ' A' ' 100' ' ' THR . 10.6 t80 -148.87 167.14 26.48 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.662 179.965 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 37.7 t -84.05 -45.37 18.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 115.765 -0.652 . . . . 0.0 111.741 -179.19 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 34.2 mm-40 -73.54 137.03 44.12 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.785 0.326 . . . . 0.0 110.669 -179.24 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 2.9 mp -77.42 -34.83 21.26 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.702 -179.59 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -59.28 -36.23 75.19 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.186 0.517 . . . . 0.0 111.203 -179.786 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -62.95 -57.71 9.81 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.354 -179.818 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 10.7 p -65.03 -28.7 45.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.532 -0.304 . . . . 0.0 111.271 -179.403 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 50.2 tt0 -61.49 -43.35 99.01 Favored 'General case' 0 C--N 1.334 -0.095 0 CA-C-O 120.973 0.416 . . . . 0.0 110.23 179.602 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 46.4 m-80 -72.17 -29.98 64.54 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 121.223 0.535 . . . . 0.0 109.951 179.477 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -67.97 -50.88 53.12 Favored 'General case' 0 N--CA 1.453 -0.285 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.989 179.827 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 4.1 pp -67.41 -17.31 64.67 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.986 0.422 . . . . 0.0 110.882 -179.965 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 1.4 tp -78.06 -50.49 11.96 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.506 -179.965 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 76.5 mt -135.2 104.25 5.83 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.15 179.916 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -148.64 -56.59 0.21 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.243 0.544 . . . . 0.0 111.344 -179.035 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 3.8 pt-20 -75.24 92.6 2.75 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.667 -0.697 . . . . 0.0 111.437 -179.39 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 2.5 m -140.04 -59.31 0.55 Allowed 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.005 179.276 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 11.4 tt0 -157.88 130.06 7.09 Favored 'General case' 0 N--CA 1.45 -0.438 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.482 179.413 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -148.3 120.59 8.4 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 108.82 -0.807 . . . . 0.0 108.82 179.823 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 140' ' ' HIS . . . . . 0.467 ' HB2' ' SG ' ' A' ' 86' ' ' CYS . 1.9 t60 60.48 28.08 17.73 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-O 120.87 0.367 . . . . 0.0 110.609 179.987 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 82.62 -6.0 71.54 Favored Glycine 0 CA--C 1.519 0.299 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.688 -179.845 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 1.4 mpt_? -110.94 -177.72 3.29 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.828 0.347 . . . . 0.0 110.246 -179.951 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 20.4 pt20 -123.15 141.65 51.74 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 179.077 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -125.1 175.87 7.09 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.253 179.953 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -118.06 121.27 40.17 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 109.348 -0.612 . . . . 0.0 109.348 179.61 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 96.8 t -118.73 122.64 69.93 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-O 120.71 0.29 . . . . 0.0 111.62 -178.834 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -125.77 148.26 49.15 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.041 179.196 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -63.65 130.58 44.87 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.768 0.318 . . . . 0.0 110.536 179.464 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 15.3 ttpp -91.46 67.41 5.61 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 121.351 0.596 . . . . 0.0 110.443 -179.642 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 24.3 tpt180 . . . . . 0 C--N 1.323 -0.548 0 N-CA-C 109.366 -0.605 . . . . 0.0 109.366 179.075 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.235 0.312 0 N-CA-C 110.127 -0.323 . . . . 0.0 110.127 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 41.4 tp -78.51 92.43 4.66 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.004 0.43 . . . . 0.0 110.172 179.866 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 43' ' ' ARG . . . . . 0.432 ' HD3' ' SD ' ' A' ' 45' ' ' MET . 57.7 ttt180 -150.86 143.06 24.15 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.455 -179.738 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 63.3 mt-10 -81.68 39.8 0.56 Allowed 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.956 -0.566 . . . . 0.0 110.757 -179.952 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 45' ' ' MET . . . . . 0.432 ' SD ' ' HD3' ' A' ' 43' ' ' ARG . 17.5 ptt? -97.35 14.85 24.76 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.262 0.554 . . . . 0.0 110.141 -179.611 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 51.5 mt-30 -69.09 -28.93 66.94 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.591 -0.731 . . . . 0.0 110.492 -179.826 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -70.79 -3.01 16.62 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.781 -0.645 . . . . 0.0 111.713 -179.519 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 33.6 ttpt -84.29 -3.25 58.11 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.557 179.871 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 8.9 p -57.97 -28.71 34.37 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.266 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.364 -179.874 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 50' ' ' GLU . . . . . 0.432 ' O ' ' HG2' ' A' ' 53' ' ' MET . 29.4 mt-10 -67.01 -20.13 65.82 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 121.245 0.545 . . . . 0.0 110.65 179.944 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 10.6 ttmt -98.5 -41.46 7.76 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.895 -0.593 . . . . 0.0 109.627 178.996 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -63.99 -21.63 66.58 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.651 -0.704 . . . . 0.0 111.0 179.629 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 53' ' ' MET . . . . . 0.432 ' HG2' ' O ' ' A' ' 50' ' ' GLU . 8.3 ptt? -61.63 -27.36 68.61 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 120.973 0.416 . . . . 0.0 110.577 179.502 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -98.97 10.72 62.19 Favored Glycine 0 N--CA 1.449 -0.453 0 N-CA-C 111.144 -0.782 . . . . 0.0 111.144 178.965 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.324 -0.519 0 CA-C-N 115.383 -0.408 . . . . 0.0 110.406 179.94 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.453 -0.321 0 CA-C-O 120.851 0.358 . . . . 0.0 110.341 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -76.21 -2.56 31.87 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.117 0.484 . . . . 0.0 111.085 179.515 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 35.3 tt0 -117.44 -50.66 2.53 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.208 -179.817 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -86.59 -58.31 2.66 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 112.105 0.409 . . . . 0.0 112.105 -178.675 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 68' ' ' GLU . . . . . 0.443 ' O ' HG23 ' A' ' 72' ' ' VAL . 2.9 tp10 -62.7 -31.0 71.82 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.587 -179.489 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 39.4 tptt -58.6 -28.67 65.81 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.976 -0.556 . . . . 0.0 111.169 179.87 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 49.1 mt-10 -61.98 -23.07 66.17 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-O 120.974 0.416 . . . . 0.0 111.151 -179.854 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 6.8 tp10 -97.77 -38.93 9.28 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 116.067 -0.515 . . . . 0.0 109.729 178.743 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.443 HG23 ' O ' ' A' ' 68' ' ' GLU . 46.6 t -65.01 -37.15 79.52 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-N 115.687 -0.688 . . . . 0.0 112.415 -178.907 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 52.1 p-10 -74.09 -16.11 61.03 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-O 120.951 0.405 . . . . 0.0 110.886 -179.526 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 42.3 t -101.8 -6.72 23.27 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.954 -0.566 . . . . 0.0 109.857 178.359 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -112.69 42.79 1.78 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.348 0.594 . . . . 0.0 109.96 -179.382 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -122.14 171.95 8.62 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.692 -0.686 . . . . 0.0 110.25 179.71 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.449 HD11 HG22 ' A' ' 120' ' ' VAL . 1.0 OUTLIER -132.02 139.05 51.23 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 N-CA-C 109.987 -0.375 . . . . 0.0 109.987 178.341 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 78' ' ' TYR . . . . . 0.428 ' O ' ' HA ' ' A' ' 146' ' ' VAL . 25.0 t80 -90.13 124.06 34.49 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.868 -0.606 . . . . 0.0 109.929 179.939 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 6.2 t -108.3 109.11 27.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.515 -0.311 . . . . 0.0 110.405 179.461 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -118.62 170.15 13.69 Favored Glycine 0 N--CA 1.447 -0.567 0 C-N-CA 120.996 -0.621 . . . . 0.0 111.7 -179.9 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 92.2 m-20 56.51 42.56 27.17 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-O 121.015 0.436 . . . . 0.0 110.829 -179.477 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.453 HG13 HD23 ' A' ' 144' ' ' LEU . 2.3 t -81.98 165.14 2.69 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-N 115.862 -0.608 . . . . 0.0 111.048 -178.998 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 83' ' ' ASP . . . . . 0.478 ' HB3' ' SG ' ' A' ' 86' ' ' CYS . 37.3 t70 -68.2 137.81 55.11 Favored 'General case' 0 CA--C 1.519 -0.212 0 N-CA-C 109.871 -0.418 . . . . 0.0 109.871 179.597 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 18.1 p90 -66.59 -10.07 41.8 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.901 -178.87 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -118.94 19.43 13.03 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.001 0.429 . . . . 0.0 110.719 179.521 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 86' ' ' CYS . . . . . 0.478 ' SG ' ' HB3' ' A' ' 83' ' ' ASP . 0.7 OUTLIER -79.45 149.28 31.61 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.966 180.0 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 87' ' ' THR . . . . . 0.483 ' O ' ' HG2' ' A' ' 90' ' ' GLU . 2.9 p -112.61 145.92 33.94 Favored Pre-proline 0 C--N 1.326 -0.441 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.659 179.226 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 88' ' ' PRO . . . . . 0.445 ' HD3' HD13 ' A' ' 106' ' ' ILE . 11.2 Cg_endo -54.29 -42.56 66.45 Favored 'Trans proline' 0 C--N 1.344 0.311 0 C-N-CA 122.942 2.428 . . . . 0.0 113.039 -178.996 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -62.05 -45.7 92.41 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.302 -0.408 . . . . 0.0 112.011 -179.429 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 90' ' ' GLU . . . . . 0.628 ' O ' ' HB2' ' A' ' 94' ' ' HIS . 4.8 pt-20 -67.68 -21.76 65.32 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.723 0.297 . . . . 0.0 111.24 -178.765 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.42 HG23 ' O ' ' A' ' 87' ' ' THR . 76.2 t -82.17 -48.31 18.42 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.734 -179.108 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 2.4 pt20 -71.54 -31.33 66.9 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.441 -0.345 . . . . 0.0 111.451 -178.258 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -80.13 -26.59 39.35 Favored 'General case' 0 C--N 1.327 -0.386 0 C-N-CA 120.53 -0.468 . . . . 0.0 110.586 -179.793 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 94' ' ' HIS . . . . . 0.628 ' HB2' ' O ' ' A' ' 90' ' ' GLU . 0.1 OUTLIER -72.17 -42.1 66.27 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.994 0.426 . . . . 0.0 110.483 -179.959 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 19.9 m-30 -80.63 -15.33 56.84 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.377 179.913 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 96' ' ' GLN . . . . . 0.544 ' HA ' ' O ' ' A' ' 99' ' ' GLY . 30.1 tt0 -62.77 -28.85 70.27 Favored 'General case' 0 CA--C 1.523 -0.065 0 CA-C-N 115.549 -0.75 . . . . 0.0 109.607 178.704 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 14.2 m -63.4 -23.05 67.24 Favored 'General case' 0 CA--C 1.533 0.291 0 CA-C-N 115.491 -0.777 . . . . 0.0 110.852 179.302 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 7.4 m -100.2 -43.97 6.12 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.169 -0.469 . . . . 0.0 109.807 179.044 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 99' ' ' GLY . . . . . 0.544 ' O ' ' HA ' ' A' ' 96' ' ' GLN . . . -150.19 139.31 7.25 Favored Glycine 0 N--CA 1.444 -0.81 0 N-CA-C 111.071 -0.811 . . . . 0.0 111.071 179.491 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -60.41 149.92 32.51 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 121.072 0.463 . . . . 0.0 111.564 -179.705 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 2.0 p -114.28 129.36 70.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.352 -178.897 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 8.0 t30 -94.05 -38.33 11.19 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.306 0.574 . . . . 0.0 109.817 179.078 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -155.15 149.32 25.91 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.573 -0.739 . . . . 0.0 110.289 -179.72 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 7.7 p -145.93 135.25 17.36 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 CA-C-N 116.015 -0.538 . . . . 0.0 110.15 179.858 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 105' ' ' THR . . . . . 0.497 ' HB ' ' CE1' ' A' ' 119' ' ' TYR . 2.3 m -126.37 119.74 28.08 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.468 -0.333 . . . . 0.0 110.232 179.62 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 106' ' ' ILE . . . . . 0.601 HD11 ' HA2' ' A' ' 116' ' ' GLY . 20.1 tt -108.24 143.42 18.67 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-O 120.808 0.337 . . . . 0.0 110.512 179.991 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 36.4 tp -129.39 135.39 48.63 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.713 -179.713 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -94.42 116.62 29.01 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 109.833 -0.432 . . . . 0.0 109.833 179.045 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 109' ' ' ASP . . . . . 0.401 ' O ' ' HG2' ' A' ' 115' ' ' LYS . 14.1 t70 -84.46 134.06 34.46 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.194 0.521 . . . . 0.0 110.87 -179.676 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 11.2 mmmm -117.77 24.22 11.2 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.742 -0.663 . . . . 0.0 109.703 179.915 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 11.6 t80 -106.87 10.77 30.55 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.208 0.528 . . . . 0.0 110.237 -179.02 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 93.79 6.83 61.88 Favored Glycine 0 N--CA 1.449 -0.461 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.697 179.396 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 27.8 mt-30 -95.47 157.61 35.93 Favored Pre-proline 0 C--N 1.323 -0.586 0 N-CA-C 109.752 -0.462 . . . . 0.0 109.752 179.89 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 11.0 Cg_endo -56.16 117.83 4.54 Favored 'Trans proline' 0 N--CA 1.462 -0.348 0 C-N-CA 122.237 1.958 . . . . 0.0 110.811 178.458 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 115' ' ' LYS . . . . . 0.401 ' HG2' ' O ' ' A' ' 109' ' ' ASP . 47.2 mttt -76.88 172.46 13.1 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 109.63 -0.507 . . . . 0.0 109.63 -179.289 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 116' ' ' GLY . . . . . 0.601 ' HA2' HD11 ' A' ' 106' ' ' ILE . . . 98.08 0.67 58.52 Favored Glycine 0 N--CA 1.446 -0.693 0 C-N-CA 120.115 -1.041 . . . . 0.0 112.599 179.596 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 1.8 t80 -52.99 119.28 4.48 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 121.018 0.437 . . . . 0.0 110.08 179.423 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -145.24 177.06 9.08 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.992 -178.845 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 119' ' ' TYR . . . . . 0.497 ' CE1' ' HB ' ' A' ' 105' ' ' THR . 49.9 p90 -158.34 133.91 8.86 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.606 -0.725 . . . . 0.0 109.059 178.905 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 120' ' ' VAL . . . . . 0.449 HG22 HD11 ' A' ' 77' ' ' ILE . 6.8 m -108.97 143.22 19.61 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.659 0 N-CA-C 109.666 -0.494 . . . . 0.0 109.666 178.895 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 121' ' ' GLU . . . . . 0.404 ' HB2' HG12 ' A' ' 72' ' ' VAL . 7.4 pt-20 -127.7 153.7 46.19 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.43 -0.35 . . . . 0.0 110.753 -179.903 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 8.4 t80 -151.97 169.57 21.99 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.297 179.318 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 3.0 t -89.52 -48.1 14.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 120.844 0.354 . . . . 0.0 111.376 -179.59 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -69.76 127.88 34.46 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.876 0.37 . . . . 0.0 110.86 -179.248 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 2.5 mp -68.03 -33.17 59.54 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.314 -179.075 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -58.09 -42.12 84.93 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.839 0.352 . . . . 0.0 111.465 -179.991 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -56.94 -56.47 21.33 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.171 -179.777 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 8.9 p -68.56 -28.32 39.79 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.363 -179.527 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 3.5 tt0 -63.01 -39.25 94.19 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.977 0.418 . . . . 0.0 110.453 -179.905 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 41.2 m-80 -77.7 -29.66 51.45 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.266 0.555 . . . . 0.0 109.797 179.096 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 131' ' ' ALA . . . . . 0.443 ' O ' ' HB2' ' A' ' 135' ' ' ASN . . . -67.65 -49.6 62.04 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.422 -0.808 . . . . 0.0 111.161 179.829 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 4.4 pp -66.38 -13.27 60.4 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.886 0.374 . . . . 0.0 111.555 -179.578 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 3.9 tp -89.06 -49.9 6.48 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.153 0.501 . . . . 0.0 109.986 179.036 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 25.3 mt -126.69 100.91 6.4 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.057 179.729 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 135' ' ' ASN . . . . . 0.443 ' HB2' ' O ' ' A' ' 131' ' ' ALA . 0.2 OUTLIER -150.62 -58.28 0.18 Allowed 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.239 0.542 . . . . 0.0 111.628 -179.293 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 4.6 pt-20 -77.5 85.98 3.86 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.8 -0.636 . . . . 0.0 111.67 -178.98 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 23.9 m -134.44 -58.88 0.83 Allowed 'General case' 0 N--CA 1.448 -0.526 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.117 179.248 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 6.8 tm-20 -155.02 128.37 8.4 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.906 0.384 . . . . 0.0 111.002 179.646 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -143.45 111.59 6.19 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 178.269 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 140' ' ' HIS . . . . . 0.482 ' HD1' ' CD ' ' A' ' 90' ' ' GLU . 1.7 t60 61.01 28.8 18.57 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.97 0.414 . . . . 0.0 110.7 -179.833 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 85.39 0.94 88.22 Favored Glycine 0 N--CA 1.449 -0.499 0 C-N-CA 120.978 -0.629 . . . . 0.0 113.043 179.779 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 142' ' ' ARG . . . . . 0.41 ' HD3' ' OD1' ' A' ' 83' ' ' ASP . 1.4 mpt_? -117.52 163.66 16.08 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 117.147 0.473 . . . . 0.0 110.868 179.928 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 7.7 pt20 -110.69 121.8 46.22 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 116.256 -0.429 . . . . 0.0 109.932 179.799 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 144' ' ' LEU . . . . . 0.453 HD23 HG13 ' A' ' 82' ' ' VAL . 0.5 OUTLIER -106.46 178.78 4.46 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.992 -179.025 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 6.1 tttt -115.44 121.78 43.77 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.088 -0.505 . . . . 0.0 109.859 178.893 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 146' ' ' VAL . . . . . 0.428 ' HA ' ' O ' ' A' ' 78' ' ' TYR . 96.9 t -120.98 126.9 75.77 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-O 121.094 0.473 . . . . 0.0 111.212 -179.712 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 39.7 m -134.61 151.73 51.27 Favored 'General case' 0 C--N 1.319 -0.743 0 N-CA-C 109.582 -0.525 . . . . 0.0 109.582 178.91 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -65.0 131.4 46.49 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.128 0.49 . . . . 0.0 111.46 -179.101 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 21.0 ttpt -93.48 80.29 4.35 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 121.363 0.601 . . . . 0.0 109.813 179.611 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 21.5 tpt180 . . . . . 0 C--N 1.321 -0.646 0 CA-C-N 115.346 -0.843 . . . . 0.0 109.483 179.236 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.453 -0.317 0 CA-C-O 120.732 0.301 . . . . 0.0 110.665 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 46.6 tp -72.75 90.1 1.39 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.346 179.699 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 51.2 ttt85 -154.43 147.13 24.25 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.064 -179.817 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 15.7 mt-10 -81.73 29.92 0.38 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.033 0.444 . . . . 0.0 111.111 -179.877 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 13.9 ptt? -83.64 1.83 40.44 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.277 0.56 . . . . 0.0 110.142 -179.924 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 38.6 mt-30 -71.4 -17.01 62.43 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.751 -179.793 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -78.31 -11.62 59.95 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.242 179.374 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 35.5 ttpt -77.8 -0.09 25.81 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.718 -0.674 . . . . 0.0 110.246 179.717 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 8.1 p -59.49 -26.03 33.12 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.237 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.901 179.883 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 25.7 mt-10 -67.37 -24.95 65.75 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.72 179.571 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 4.3 ttmt -98.81 -34.59 10.43 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.454 179.192 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 9.1 mm-40 -66.1 -16.04 63.6 Favored 'General case' 0 C--N 1.333 -0.112 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.22 179.781 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -64.53 -25.44 67.99 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.178 0.513 . . . . 0.0 109.785 178.694 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -97.41 12.04 65.02 Favored Glycine 0 N--CA 1.45 -0.378 0 N-CA-C 110.709 -0.956 . . . . 0.0 110.709 179.044 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.324 -0.533 0 CA-C-N 115.256 -0.472 . . . . 0.0 109.942 179.777 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.455 -0.177 0 CA-C-O 120.908 0.385 . . . . 0.0 110.575 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -74.47 -2.13 24.25 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.466 -179.922 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 22.5 tp60 -118.98 -49.37 2.42 Favored 'General case' 0 N--CA 1.451 -0.404 0 CA-C-O 120.593 0.235 . . . . 0.0 111.315 179.876 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -84.59 -52.68 5.93 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.881 0.372 . . . . 0.0 111.92 -178.549 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 68' ' ' GLU . . . . . 0.405 ' O ' HG23 ' A' ' 72' ' ' VAL . 1.3 tp10 -69.62 -30.67 68.45 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.989 0.423 . . . . 0.0 110.615 -179.387 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 50.9 tptt -55.81 -33.65 64.62 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.714 179.908 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 54.4 mt-10 -58.85 -25.7 63.51 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-O 121.02 0.438 . . . . 0.0 111.31 179.943 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 4.4 tp10 -93.82 -40.21 10.31 Favored 'General case' 0 N--CA 1.449 -0.517 0 N-CA-C 109.711 -0.477 . . . . 0.0 109.711 178.786 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.405 HG23 ' O ' ' A' ' 68' ' ' GLU . 61.8 t -63.01 -43.45 99.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 115.706 -0.679 . . . . 0.0 112.658 -178.804 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 9.0 p-10 -70.81 -18.89 62.73 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-O 121.154 0.502 . . . . 0.0 110.894 -179.365 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 49.1 m -97.79 -8.69 27.94 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.051 178.272 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -111.41 48.31 0.95 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.562 -0.744 . . . . 0.0 110.11 -179.368 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 76' ' ' SER . . . . . 0.466 ' OG ' ' HE2' ' A' ' 149' ' ' LYS . 0.1 OUTLIER -129.95 172.76 11.37 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.921 -0.581 . . . . 0.0 111.26 179.86 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -131.01 138.14 54.2 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-N 115.847 -0.615 . . . . 0.0 109.573 178.434 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 57.2 t80 -96.64 125.32 41.03 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.405 -179.485 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.419 HG21 ' HE2' ' A' ' 95' ' ' PHE . 2.9 t -104.8 118.41 52.09 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.391 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.843 -179.405 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -124.46 168.18 16.64 Favored Glycine 0 N--CA 1.449 -0.472 0 N-CA-C 110.936 -0.866 . . . . 0.0 110.936 179.521 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 2.4 m-20 59.42 34.75 22.81 Favored 'General case' 0 N--CA 1.474 0.746 0 CA-C-O 120.834 0.35 . . . . 0.0 111.279 -179.39 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.405 ' H ' HG23 ' A' ' 82' ' ' VAL . 2.2 t -76.4 163.51 3.91 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.724 0 CA-C-N 115.616 -0.72 . . . . 0.0 110.652 -178.975 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 83' ' ' ASP . . . . . 0.706 ' OD2' ' HB2' ' A' ' 142' ' ' ARG . 0.5 OUTLIER -63.48 137.66 58.22 Favored 'General case' 0 CA--C 1.515 -0.369 0 N-CA-C 109.67 -0.492 . . . . 0.0 109.67 179.015 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 37.2 p90 -66.17 -8.79 26.33 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.07 -179.768 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -120.41 20.54 11.87 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.038 -179.805 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -86.48 146.34 26.44 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.817 0.342 . . . . 0.0 111.052 -179.97 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 87' ' ' THR . . . . . 0.428 ' O ' ' HG2' ' A' ' 90' ' ' GLU . 17.7 p -109.73 155.0 42.2 Favored Pre-proline 0 C--N 1.323 -0.57 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.412 179.841 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 88' ' ' PRO . . . . . 0.479 ' HD3' HD13 ' A' ' 106' ' ' ILE . 18.3 Cg_endo -59.05 -38.88 84.9 Favored 'Trans proline' 0 C--N 1.345 0.372 0 C-N-CA 122.709 2.272 . . . . 0.0 112.929 -178.928 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 24.3 mt-10 -62.36 -50.57 71.04 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.766 -0.652 . . . . 0.0 112.348 -178.496 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 90' ' ' GLU . . . . . 0.428 ' HG2' ' O ' ' A' ' 87' ' ' THR . 11.1 pt-20 -66.31 -16.73 64.28 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.672 0.273 . . . . 0.0 111.535 -178.972 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 56.0 t -86.44 -47.23 16.39 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 CA-C-O 120.93 0.395 . . . . 0.0 110.495 -179.904 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -71.7 -33.39 68.73 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.791 -178.576 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 1.2 pp0? -77.09 -29.03 54.77 Favored 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 120.378 -0.529 . . . . 0.0 111.33 -178.759 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 2.9 m80 -76.7 -40.31 49.19 Favored 'General case' 0 C--N 1.327 -0.376 0 C-N-CA 120.725 -0.39 . . . . 0.0 110.809 -179.635 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 95' ' ' PHE . . . . . 0.419 ' HE2' HG21 ' A' ' 79' ' ' VAL . 22.0 m-30 -75.61 -16.53 60.21 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.58 179.899 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 96' ' ' GLN . . . . . 0.633 ' HA ' ' O ' ' A' ' 99' ' ' GLY . 2.7 tt0 -66.89 -21.77 65.99 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-N 115.982 -0.553 . . . . 0.0 110.391 179.22 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 46.7 m -66.14 -24.26 66.63 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-N 115.905 -0.588 . . . . 0.0 110.074 179.015 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 2.6 m -100.59 -48.84 4.39 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.635 -0.711 . . . . 0.0 109.497 179.042 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 99' ' ' GLY . . . . . 0.633 ' O ' ' HA ' ' A' ' 96' ' ' GLN . . . -142.18 138.4 8.5 Favored Glycine 0 N--CA 1.446 -0.666 0 N-CA-C 111.41 -0.676 . . . . 0.0 111.41 179.766 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 100' ' ' THR . . . . . 0.404 ' HB ' ' CZ ' ' A' ' 122' ' ' PHE . 0.2 OUTLIER -59.81 148.36 34.81 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.735 0.267 . . . . 0.0 111.413 -179.934 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 2.1 p -119.88 129.28 75.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.216 -179.237 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 58.2 t30 -100.42 -43.19 6.32 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.863 0.363 . . . . 0.0 110.182 178.986 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -139.77 148.6 42.45 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.392 179.996 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 5.9 p -148.07 134.33 12.45 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-N 115.856 -0.611 . . . . 0.0 109.854 179.286 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 2.8 m -126.01 122.89 37.17 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 116.479 -0.328 . . . . 0.0 110.341 179.554 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 106' ' ' ILE . . . . . 0.479 HD13 ' HD3' ' A' ' 88' ' ' PRO . 20.3 tt -112.02 148.0 15.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 120.895 0.379 . . . . 0.0 111.136 -179.61 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 27.5 tp -136.5 128.19 28.94 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.156 178.997 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -90.06 120.69 31.47 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 109.848 -0.427 . . . . 0.0 109.848 179.315 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 109' ' ' ASP . . . . . 0.455 ' O ' ' HG2' ' A' ' 115' ' ' LYS . 12.8 t70 -79.53 145.1 33.36 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.087 0.47 . . . . 0.0 111.088 -179.992 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 110' ' ' LYS . . . . . 0.406 ' HD3' ' C ' ' A' ' 109' ' ' ASP . 0.0 OUTLIER -131.59 23.83 4.72 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.8 -0.636 . . . . 0.0 109.286 179.161 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 4.8 t80 -106.62 -5.4 18.7 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.428 -179.126 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 108.39 12.56 21.25 Favored Glycine 0 CA--C 1.519 0.287 0 C-N-CA 120.979 -0.629 . . . . 0.0 112.86 -179.956 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 113' ' ' GLN . . . . . 0.412 ' HB3' ' HD2' ' A' ' 114' ' ' PRO . 22.6 mt-30 -99.84 159.19 30.56 Favored Pre-proline 0 C--N 1.323 -0.563 0 N-CA-C 109.662 -0.496 . . . . 0.0 109.662 179.701 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 114' ' ' PRO . . . . . 0.412 ' HD2' ' HB3' ' A' ' 113' ' ' GLN . 19.3 Cg_endo -58.85 110.04 0.61 Allowed 'Trans proline' 0 C--N 1.346 0.44 0 C-N-CA 122.233 1.955 . . . . 0.0 110.863 178.645 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 115' ' ' LYS . . . . . 0.455 ' HG2' ' O ' ' A' ' 109' ' ' ASP . 30.5 mttt -69.6 170.9 9.83 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.553 -178.616 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 116' ' ' GLY . . . . . 0.415 ' HA2' HD11 ' A' ' 106' ' ' ILE . . . 101.46 4.71 52.7 Favored Glycine 0 N--CA 1.446 -0.646 0 C-N-CA 120.514 -0.851 . . . . 0.0 111.877 -179.841 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 34.1 m-85 -53.01 117.89 3.32 Favored 'General case' 0 C--O 1.232 0.167 0 C-N-CA 122.338 0.255 . . . . 0.0 110.492 179.671 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -149.18 171.54 16.28 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 121.0 0.429 . . . . 0.0 111.13 -179.314 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 17.2 p90 -154.96 132.58 11.31 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 115.501 -0.772 . . . . 0.0 109.645 178.411 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 8.5 m -108.06 142.83 19.71 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 N-CA-C 109.726 -0.472 . . . . 0.0 109.726 179.735 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 121' ' ' GLU . . . . . 0.424 ' HB3' ' HB3' ' A' ' 76' ' ' SER . 4.5 pt-20 -130.92 153.42 49.18 Favored 'General case' 0 C--O 1.238 0.5 0 CA-C-O 120.944 0.402 . . . . 0.0 111.235 179.987 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 122' ' ' PHE . . . . . 0.404 ' CZ ' ' HB ' ' A' ' 100' ' ' THR . 11.5 t80 -148.26 172.67 13.99 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.644 -0.707 . . . . 0.0 110.095 179.834 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 6.3 t -89.37 -41.86 14.09 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-O 121.028 0.442 . . . . 0.0 111.192 -179.742 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 38.7 mm-40 -69.96 128.92 38.02 Favored 'General case' 0 C--O 1.236 0.392 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.937 -179.83 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 2.7 mp -74.57 -33.95 33.78 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.177 -179.869 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -59.85 -37.28 78.81 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.435 179.633 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -63.56 -56.49 15.56 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.641 -0.709 . . . . 0.0 111.256 -179.789 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 11.0 p -65.77 -28.06 43.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.367 -179.367 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 43.8 tt0 -60.38 -43.93 96.12 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-O 121.006 0.431 . . . . 0.0 110.371 179.447 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 92.5 m-20 -72.48 -31.57 65.5 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.053 -0.522 . . . . 0.0 110.05 179.699 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -67.53 -42.86 82.07 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.51 -0.768 . . . . 0.0 111.636 -179.857 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 4.1 pp -74.15 -17.67 60.89 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.915 0.388 . . . . 0.0 110.914 179.976 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 6.2 tp -83.8 -56.39 3.73 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.673 179.939 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 54.1 mt -125.38 103.18 7.77 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.642 -0.254 . . . . 0.0 111.44 -179.113 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 2.4 m-20 -154.49 -53.19 0.1 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.885 0.374 . . . . 0.0 111.15 178.764 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 3.9 pt-20 -75.82 98.22 4.11 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.464 0.65 . . . . 0.0 111.08 -179.888 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 43.3 m -145.92 -57.54 0.31 Allowed 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.669 -0.696 . . . . 0.0 109.821 178.865 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 24.4 tt0 -163.17 130.05 3.44 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 109.436 -0.579 . . . . 0.0 109.436 178.954 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -148.46 122.31 9.34 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 108.603 -0.888 . . . . 0.0 108.603 179.677 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 140' ' ' HIS . . . . . 0.651 ' HB3' ' OD2' ' A' ' 83' ' ' ASP . 5.0 t60 64.43 3.16 1.77 Allowed 'General case' 0 N--CA 1.471 0.623 0 O-C-N 123.544 0.528 . . . . 0.0 111.723 179.005 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 109.65 -9.93 32.56 Favored Glycine 0 N--CA 1.446 -0.637 0 C-N-CA 121.123 -0.56 . . . . 0.0 112.127 -179.704 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 142' ' ' ARG . . . . . 0.706 ' HB2' ' OD2' ' A' ' 83' ' ' ASP . 1.0 OUTLIER -111.7 170.98 7.76 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.154 0.502 . . . . 0.0 110.375 179.876 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 7.4 pt20 -113.0 129.67 56.41 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 179.303 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -113.91 173.27 6.51 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-O 120.907 0.384 . . . . 0.0 110.474 -179.645 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 8.8 ttpt -113.23 118.02 33.5 Favored 'General case' 0 C--N 1.318 -0.775 0 N-CA-C 109.428 -0.582 . . . . 0.0 109.428 179.278 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 96.7 t -114.42 116.95 54.1 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.659 0 CA-C-O 120.756 0.312 . . . . 0.0 110.431 -179.909 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 25.7 m -127.12 146.38 50.41 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 109.393 -0.595 . . . . 0.0 109.393 179.674 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -56.85 130.6 46.46 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 120.978 0.418 . . . . 0.0 111.501 -179.234 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 149' ' ' LYS . . . . . 0.466 ' HE2' ' OG ' ' A' ' 76' ' ' SER . 18.0 ttpt -93.2 63.11 3.59 Favored 'General case' 0 N--CA 1.451 -0.378 0 N-CA-C 108.622 -0.881 . . . . 0.0 108.622 179.508 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 16.4 tpt180 . . . . . 0 C--N 1.321 -0.657 0 CA-C-O 121.31 0.576 . . . . 0.0 110.25 -179.867 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.237 0.444 0 CA-C-O 120.891 0.377 . . . . 0.0 111.547 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 16.2 tp -72.11 80.42 0.96 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.422 -0.808 . . . . 0.0 111.015 179.862 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 43' ' ' ARG . . . . . 0.402 ' C ' ' H ' ' A' ' 45' ' ' MET . 0.8 OUTLIER -126.6 148.93 49.72 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 115.765 -0.652 . . . . 0.0 109.391 179.449 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -75.98 23.87 0.13 Allowed 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.088 0.471 . . . . 0.0 111.847 -179.58 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 45' ' ' MET . . . . . 0.402 ' H ' ' C ' ' A' ' 43' ' ' ARG . 16.6 ptt? -95.8 5.93 50.13 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.053 0.454 . . . . 0.0 110.127 179.754 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 40.5 mt-30 -67.22 -8.5 32.05 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.409 -179.264 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -82.7 -11.74 58.1 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.483 0.658 . . . . 0.0 109.994 178.722 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 48' ' ' LYS . . . . . 0.486 ' O ' ' HG2' ' A' ' 52' ' ' GLU . 13.5 ttpp -78.51 5.82 9.97 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.257 -0.883 . . . . 0.0 110.398 -179.806 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 12.6 p -58.04 -24.65 24.25 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.123 -179.866 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 32.0 mt-10 -65.13 -27.8 68.99 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 121.154 0.502 . . . . 0.0 110.247 179.042 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 12.8 mtmt -98.59 -33.7 10.87 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.238 178.711 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 52' ' ' GLU . . . . . 0.486 ' HG2' ' O ' ' A' ' 48' ' ' LYS . 38.1 mm-40 -83.31 12.14 5.76 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.807 -0.633 . . . . 0.0 111.651 -179.731 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 10.5 ptp -62.03 -30.64 71.1 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-O 120.717 0.294 . . . . 0.0 110.651 179.679 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -96.91 3.96 62.81 Favored Glycine 0 N--CA 1.449 -0.434 0 N-CA-C 111.05 -0.82 . . . . 0.0 111.05 178.474 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.326 -0.441 0 CA-C-O 121.406 0.622 . . . . 0.0 110.389 -179.722 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 64' ' ' ALA . . . . . 0.476 ' O ' ' HB3' ' A' ' 68' ' ' GLU . . . . . . . . 0 CA--C 1.522 -0.131 0 CA-C-O 121.101 0.477 . . . . 0.0 110.223 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -77.59 3.22 14.26 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-O 121.18 0.514 . . . . 0.0 111.21 -179.795 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 16.5 tp60 -121.81 -45.86 2.26 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.794 178.928 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -87.45 -48.9 7.58 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.513 -0.312 . . . . 0.0 111.343 -179.835 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 68' ' ' GLU . . . . . 0.476 ' HB3' ' O ' ' A' ' 64' ' ' ALA . 3.0 tp10 -72.54 -31.37 65.25 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 121.114 0.483 . . . . 0.0 109.92 179.795 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 69' ' ' LYS . . . . . 0.41 ' HE3' ' OE2' ' A' ' 121' ' ' GLU . 0.0 OUTLIER -55.11 -29.98 58.77 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.814 -0.63 . . . . 0.0 111.581 179.726 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 95.4 mt-10 -60.64 -21.48 62.81 Favored 'General case' 0 C--N 1.332 -0.182 0 O-C-N 123.525 0.516 . . . . 0.0 110.787 179.656 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 71' ' ' GLU . . . . . 0.553 ' O ' ' HD3' ' A' ' 75' ' ' ARG . 36.0 tp10 -98.68 -43.49 6.79 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 109.435 -0.58 . . . . 0.0 109.435 177.432 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.433 HG23 ' O ' ' A' ' 68' ' ' GLU . 21.8 t -60.24 -42.22 89.66 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.244 0 CA-C-N 115.699 -0.682 . . . . 0.0 112.655 -178.613 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 23.4 p-10 -66.93 -18.37 65.35 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-O 121.045 0.45 . . . . 0.0 111.041 -179.928 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 74' ' ' SER . . . . . 0.43 ' C ' ' HD2' ' A' ' 75' ' ' ARG . 28.8 t -101.64 -3.86 27.58 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 121.334 0.588 . . . . 0.0 110.125 179.018 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 75' ' ' ARG . . . . . 0.553 ' HD3' ' O ' ' A' ' 71' ' ' GLU . 2.6 mpt_? -115.93 49.06 1.14 Allowed 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.694 0.759 . . . . 0.0 109.631 -179.796 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 76' ' ' SER . . . . . 0.479 ' OG ' ' HE2' ' A' ' 149' ' ' LYS . 0.4 OUTLIER -130.38 175.15 9.19 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 115.057 -0.974 . . . . 0.0 110.153 179.958 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -133.96 137.1 52.85 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 N-CA-C 109.977 -0.379 . . . . 0.0 109.977 178.179 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 83.9 t80 -94.82 126.52 40.2 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 109.644 -0.502 . . . . 0.0 109.644 179.877 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.426 HG21 ' HE2' ' A' ' 95' ' ' PHE . 4.0 t -105.95 115.36 47.49 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.138 -179.013 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -118.08 169.32 13.3 Favored Glycine 0 N--CA 1.447 -0.606 0 N-CA-C 110.863 -0.895 . . . . 0.0 110.863 179.255 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 1.6 m-20 59.08 37.8 24.13 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-O 121.177 0.513 . . . . 0.0 110.936 -179.566 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.422 HG22 HG12 ' A' ' 79' ' ' VAL . 2.5 t -80.84 162.25 3.65 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.884 -179.319 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 83' ' ' ASP . . . . . 0.537 ' OD2' ' HD2' ' A' ' 142' ' ' ARG . 9.7 t0 -66.23 135.43 54.46 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 109.607 -0.516 . . . . 0.0 109.607 179.225 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 36.5 p90 -63.96 -14.25 52.44 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.075 -0.511 . . . . 0.0 112.005 -178.616 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -114.19 14.85 18.24 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.72 0.295 . . . . 0.0 111.456 179.753 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 86' ' ' CYS . . . . . 0.49 ' SG ' ' HB2' ' A' ' 140' ' ' HIS . 0.8 OUTLIER -78.1 148.91 33.99 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.103 0.478 . . . . 0.0 111.281 -179.795 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 87' ' ' THR . . . . . 0.501 ' O ' ' HG2' ' A' ' 90' ' ' GLU . 0.2 OUTLIER -110.67 149.71 40.7 Favored Pre-proline 0 C--N 1.325 -0.462 0 CA-C-N 115.743 -0.662 . . . . 0.0 109.921 179.114 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 88' ' ' PRO . . . . . 0.477 ' HD3' HD13 ' A' ' 106' ' ' ILE . 11.5 Cg_endo -55.32 -38.33 93.87 Favored 'Trans proline' 0 C--N 1.347 0.458 0 C-N-CA 122.83 2.353 . . . . 0.0 112.842 -179.039 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 89' ' ' GLU . . . . . 0.453 ' O ' ' HG3' ' A' ' 92' ' ' GLN . 3.2 mp0 -62.94 -52.14 64.2 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.485 -0.325 . . . . 0.0 111.802 -179.199 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 90' ' ' GLU . . . . . 0.501 ' HG2' ' O ' ' A' ' 87' ' ' THR . 6.0 pt-20 -61.04 -20.31 62.4 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-O 120.862 0.363 . . . . 0.0 111.519 -178.806 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 55.5 t -84.61 -47.21 17.45 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.674 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.739 -179.152 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 92' ' ' GLN . . . . . 0.453 ' HG3' ' O ' ' A' ' 89' ' ' GLU . 0.8 OUTLIER -72.17 -33.2 67.51 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.319 -0.401 . . . . 0.0 111.757 -178.423 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -78.04 -27.42 48.75 Favored 'General case' 0 N--CA 1.467 0.384 0 C-N-CA 120.237 -0.585 . . . . 0.0 111.53 -178.919 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 94' ' ' HIS . . . . . 0.492 ' HB2' ' O ' ' A' ' 90' ' ' GLU . 0.2 OUTLIER -75.12 -42.33 56.64 Favored 'General case' 0 C--N 1.325 -0.464 0 C-N-CA 120.819 -0.352 . . . . 0.0 110.721 -179.856 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 95' ' ' PHE . . . . . 0.426 ' HE2' HG21 ' A' ' 79' ' ' VAL . 20.3 m-30 -76.47 -18.9 58.53 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.464 179.931 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 96' ' ' GLN . . . . . 0.649 ' HA ' ' O ' ' A' ' 99' ' ' GLY . 0.9 OUTLIER -62.4 -22.09 65.88 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.397 179.342 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 21.5 t -62.91 -28.57 70.15 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.364 179.475 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 5.5 m -97.91 -40.7 8.36 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.23 179.837 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 99' ' ' GLY . . . . . 0.649 ' O ' ' HA ' ' A' ' 96' ' ' GLN . . . -151.28 141.86 8.99 Favored Glycine 0 N--CA 1.449 -0.484 0 N-CA-C 111.424 -0.671 . . . . 0.0 111.424 179.69 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 100' ' ' THR . . . . . 0.419 ' HB ' ' CE1' ' A' ' 122' ' ' PHE . 0.2 OUTLIER -62.22 154.5 27.32 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.104 0.478 . . . . 0.0 112.09 -179.471 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 2.1 p -118.03 131.19 71.51 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-N 115.747 -0.66 . . . . 0.0 110.91 -179.685 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 26.1 t30 -97.91 -45.0 6.46 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.152 0.501 . . . . 0.0 109.695 179.123 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -142.75 157.32 44.76 Favored 'General case' 0 C--O 1.235 0.318 0 CA-C-N 115.676 -0.693 . . . . 0.0 109.991 179.196 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 7.2 p -155.29 137.59 6.43 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 CA-C-N 115.82 -0.627 . . . . 0.0 109.974 179.59 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 105' ' ' THR . . . . . 0.479 ' HB ' ' CE1' ' A' ' 119' ' ' TYR . 3.5 m -131.59 128.29 38.89 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 109.732 -0.47 . . . . 0.0 109.732 179.317 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 106' ' ' ILE . . . . . 0.56 HD11 ' HA2' ' A' ' 116' ' ' GLY . 20.3 tt -113.27 137.15 47.31 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-O 121.3 0.571 . . . . 0.0 111.205 -179.804 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 35.0 tp -118.91 124.5 47.24 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.777 -0.647 . . . . 0.0 109.896 179.646 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -90.79 113.62 25.8 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 110.144 -0.317 . . . . 0.0 110.144 179.445 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 109' ' ' ASP . . . . . 0.419 ' O ' ' HG2' ' A' ' 115' ' ' LYS . 13.1 t70 -72.76 139.73 47.31 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.152 0.501 . . . . 0.0 111.253 -179.469 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -129.61 33.93 4.4 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 115.638 -0.71 . . . . 0.0 109.434 178.751 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 2.6 t80 -118.21 -4.31 10.97 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.618 -179.69 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 110.19 6.98 27.28 Favored Glycine 0 CA--C 1.52 0.353 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.833 179.936 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 113' ' ' GLN . . . . . 0.431 ' HB3' ' HD2' ' A' ' 114' ' ' PRO . 19.0 mt-30 -96.8 161.05 27.82 Favored Pre-proline 0 C--N 1.324 -0.513 0 N-CA-C 109.464 -0.569 . . . . 0.0 109.464 179.951 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 114' ' ' PRO . . . . . 0.431 ' HD2' ' HB3' ' A' ' 113' ' ' GLN . 19.5 Cg_endo -59.75 115.15 2.41 Favored 'Trans proline' 0 C--N 1.347 0.454 0 C-N-CA 122.039 1.826 . . . . 0.0 111.13 178.582 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 115' ' ' LYS . . . . . 0.419 ' HG2' ' O ' ' A' ' 109' ' ' ASP . 53.1 mttt -72.72 172.19 11.18 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 120.771 0.319 . . . . 0.0 110.246 -179.014 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 116' ' ' GLY . . . . . 0.56 ' HA2' HD11 ' A' ' 106' ' ' ILE . . . 101.4 3.89 53.29 Favored Glycine 0 N--CA 1.444 -0.781 0 C-N-CA 120.175 -1.012 . . . . 0.0 112.227 179.712 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 26.8 m-85 -52.73 112.66 0.88 Allowed 'General case' 0 N--CA 1.463 0.196 0 N-CA-C 110.094 -0.336 . . . . 0.0 110.094 179.49 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -141.37 174.25 10.72 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 121.191 0.52 . . . . 0.0 111.523 -178.61 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 119' ' ' TYR . . . . . 0.479 ' CE1' ' HB ' ' A' ' 105' ' ' THR . 48.5 p90 -156.48 129.59 7.98 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.34 -0.845 . . . . 0.0 109.81 179.202 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 13.9 m -105.92 142.94 17.78 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.686 0 N-CA-C 109.254 -0.646 . . . . 0.0 109.254 178.976 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 121' ' ' GLU . . . . . 0.41 ' OE2' ' HE3' ' A' ' 69' ' ' LYS . 7.1 pt-20 -129.92 150.23 51.3 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 120.765 0.317 . . . . 0.0 111.745 -179.68 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 122' ' ' PHE . . . . . 0.419 ' CE1' ' HB ' ' A' ' 100' ' ' THR . 11.5 t80 -145.89 172.44 13.34 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.706 -0.679 . . . . 0.0 109.308 178.796 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 2.9 t -92.64 -57.26 4.45 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 CA-C-O 120.782 0.325 . . . . 0.0 111.281 -178.979 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 93.0 mt-10 -62.65 118.07 7.14 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.451 -179.813 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 2.1 mp -57.29 -32.31 40.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 115.566 -0.743 . . . . 0.0 110.964 -179.435 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 17.6 t70 -53.35 -45.37 69.13 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.374 179.42 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -61.93 -54.82 36.61 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.758 -0.655 . . . . 0.0 111.691 -179.361 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 12.1 p -65.94 -29.65 47.52 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 C-N-CA 120.894 -0.322 . . . . 0.0 111.256 -179.249 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 129' ' ' GLN . . . . . 0.418 ' O ' ' HG ' ' A' ' 132' ' ' LEU . 9.6 tt0 -61.25 -48.59 80.75 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.178 0.513 . . . . 0.0 110.116 179.123 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 87.2 m-20 -69.29 -29.96 67.94 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.721 -0.672 . . . . 0.0 109.717 179.713 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 131' ' ' ALA . . . . . 0.451 ' O ' ' HB2' ' A' ' 135' ' ' ASN . . . -66.86 -52.18 46.63 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.618 -0.719 . . . . 0.0 111.089 179.66 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 132' ' ' LEU . . . . . 0.418 ' HG ' ' O ' ' A' ' 129' ' ' GLN . 4.0 pp -64.94 -23.92 67.37 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.79 0.328 . . . . 0.0 110.636 179.978 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 1.6 tp -72.0 -55.61 7.12 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.204 0.526 . . . . 0.0 110.058 179.597 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 49.4 mt -120.13 101.8 8.08 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.648 -0.705 . . . . 0.0 109.558 179.568 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 135' ' ' ASN . . . . . 0.451 ' HB2' ' O ' ' A' ' 131' ' ' ALA . 0.5 OUTLIER -146.68 -71.26 0.24 Allowed 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 120.87 0.367 . . . . 0.0 111.155 -178.976 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 7.5 pt-20 -69.91 95.12 0.9 Allowed 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.649 0.738 . . . . 0.0 111.849 -179.034 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 8.9 m -137.17 -59.53 0.69 Allowed 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.374 -0.83 . . . . 0.0 109.536 178.92 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 7.4 tt0 -165.4 130.84 2.56 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 109.525 -0.546 . . . . 0.0 109.525 179.222 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -146.0 118.04 8.28 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 109.672 -0.492 . . . . 0.0 109.672 -179.939 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 140' ' ' HIS . . . . . 0.49 ' HB2' ' SG ' ' A' ' 86' ' ' CYS . 3.2 t60 68.77 1.23 2.99 Favored 'General case' 0 N--CA 1.469 0.509 0 O-C-N 123.508 0.505 . . . . 0.0 111.393 178.971 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 113.52 -9.38 24.11 Favored Glycine 0 N--CA 1.447 -0.622 0 C-N-CA 121.038 -0.601 . . . . 0.0 111.743 -179.129 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 142' ' ' ARG . . . . . 0.537 ' HD2' ' OD2' ' A' ' 83' ' ' ASP . 0.0 OUTLIER -111.29 170.88 7.82 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 109.874 -0.417 . . . . 0.0 109.874 179.785 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 13.2 pt20 -115.75 121.45 42.5 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 109.217 -0.66 . . . . 0.0 109.217 178.705 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -99.08 175.65 5.83 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.066 -178.748 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 3.8 tttt -117.1 122.69 44.84 Favored 'General case' 0 C--N 1.317 -0.805 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 179.16 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 146' ' ' VAL . . . . . 0.415 HG21 ' OD1' ' A' ' 135' ' ' ASN . 96.2 t -117.49 137.51 51.17 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.652 0 CA-C-O 121.242 0.544 . . . . 0.0 111.409 -178.971 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 23.6 t -139.13 144.18 38.54 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.845 -0.616 . . . . 0.0 109.516 179.314 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -63.14 128.89 37.93 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 120.714 0.292 . . . . 0.0 110.277 179.47 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 149' ' ' LYS . . . . . 0.479 ' HE2' ' OG ' ' A' ' 76' ' ' SER . 28.3 ttpt -89.15 76.63 7.68 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 121.3 0.571 . . . . 0.0 109.76 -179.643 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 23.9 tpt180 . . . . . 0 C--N 1.324 -0.529 0 CA-C-N 115.654 -0.703 . . . . 0.0 109.802 179.539 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.423 0 N-CA-C 110.066 -0.346 . . . . 0.0 110.066 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 27.4 tp -69.26 90.93 0.51 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.101 0.477 . . . . 0.0 109.896 179.252 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 53.5 ttm-85 -153.69 -6.34 0.17 Allowed 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.861 -0.609 . . . . 0.0 111.177 -178.88 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 17.1 mt-10 65.2 19.71 11.78 Favored 'General case' 0 N--CA 1.468 0.471 0 CA-C-O 121.149 0.499 . . . . 0.0 110.662 -178.767 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 26.5 ptm -83.61 1.35 42.65 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.848 -0.615 . . . . 0.0 110.382 -179.88 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 30.6 mt-30 -72.39 -20.9 61.36 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.147 0.498 . . . . 0.0 110.116 179.72 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -76.5 -8.54 57.4 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 121.555 0.693 . . . . 0.0 109.965 178.788 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 21.6 ttmt -79.26 1.44 24.85 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.321 -0.854 . . . . 0.0 110.499 -179.91 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 7.4 p -58.28 -23.64 22.55 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.251 0 CA-C-N 115.781 -0.645 . . . . 0.0 111.102 179.632 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -63.42 -26.37 68.7 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.512 179.526 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 24.5 mtmt -101.97 -41.52 6.43 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.872 179.444 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 62.6 mm-40 -62.36 -16.65 55.75 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.969 -0.559 . . . . 0.0 111.522 -179.572 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 10.0 ptp -63.32 -25.41 68.29 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.978 0.418 . . . . 0.0 110.042 178.794 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -98.17 -5.08 57.35 Favored Glycine 0 N--CA 1.448 -0.542 0 N-CA-C 110.943 -0.863 . . . . 0.0 110.943 179.0 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.324 -0.519 0 CA-C-O 121.099 0.476 . . . . 0.0 110.154 -179.779 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.456 -0.154 0 CA-C-O 120.82 0.343 . . . . 0.0 110.832 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -76.47 -1.62 28.05 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.09 0.471 . . . . 0.0 110.931 179.802 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 7.0 tp60 -118.05 -51.27 2.45 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.64 179.507 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -83.08 -61.65 1.8 Allowed 'General case' 0 C--N 1.331 -0.201 0 N-CA-C 111.871 0.323 . . . . 0.0 111.871 -179.092 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -60.88 -29.7 69.7 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-O 120.976 0.417 . . . . 0.0 110.671 -179.384 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 51.5 tptt -56.11 -31.35 63.19 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.83 -0.623 . . . . 0.0 111.206 179.582 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 18.7 mt-10 -63.3 -21.15 66.07 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-O 121.18 0.514 . . . . 0.0 111.074 -179.797 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 71' ' ' GLU . . . . . 0.426 ' O ' ' HD2' ' A' ' 75' ' ' ARG . 13.5 tp10 -94.65 -42.96 8.51 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 115.675 -0.693 . . . . 0.0 109.172 177.98 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.539 HG12 ' HB2' ' A' ' 121' ' ' GLU . 47.9 t -62.34 -43.29 97.93 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-N 115.181 -0.918 . . . . 0.0 112.552 -178.924 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 17.2 p-10 -71.55 -19.68 62.13 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-O 121.025 0.441 . . . . 0.0 111.613 -178.958 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 74' ' ' SER . . . . . 0.582 ' OG ' ' HD3' ' A' ' 150' ' ' ARG . 44.4 t -96.65 -7.33 34.46 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 109.604 -0.517 . . . . 0.0 109.604 178.796 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 75' ' ' ARG . . . . . 0.426 ' HD2' ' O ' ' A' ' 71' ' ' GLU . 0.0 OUTLIER -114.47 40.94 2.42 Favored 'General case' 0 N--CA 1.452 -0.361 0 CA-C-N 115.505 -0.77 . . . . 0.0 110.185 -179.367 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 76' ' ' SER . . . . . 0.451 ' OG ' ' HE2' ' A' ' 149' ' ' LYS . 0.3 OUTLIER -120.11 174.6 6.39 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.708 179.509 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 6.5 pt -132.3 139.64 49.62 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.262 178.341 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 78' ' ' TYR . . . . . 0.405 ' O ' ' HA ' ' A' ' 146' ' ' VAL . 16.7 t80 -92.58 119.84 32.43 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.615 -0.72 . . . . 0.0 109.761 179.895 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 7.2 t -104.79 109.36 27.34 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-N 116.53 -0.304 . . . . 0.0 110.184 179.86 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -117.82 166.94 12.73 Favored Glycine 0 N--CA 1.448 -0.523 0 C-N-CA 120.815 -0.707 . . . . 0.0 112.278 -179.281 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 3.0 m120 57.01 44.13 23.32 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-O 121.314 0.578 . . . . 0.0 110.853 -179.818 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.429 HG12 ' H ' ' A' ' 83' ' ' ASP . 2.4 t -82.68 167.91 1.9 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 CA-C-N 115.236 -0.893 . . . . 0.0 110.368 -179.361 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 83' ' ' ASP . . . . . 0.509 ' HB3' ' SG ' ' A' ' 86' ' ' CYS . 24.7 t70 -68.71 140.97 55.41 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.855 0.36 . . . . 0.0 110.337 179.625 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 28.3 p90 -65.49 -12.66 54.69 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.831 -0.622 . . . . 0.0 112.521 -178.694 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -117.85 10.79 13.33 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.617 0.246 . . . . 0.0 111.492 -179.981 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 86' ' ' CYS . . . . . 0.509 ' SG ' ' HB3' ' A' ' 83' ' ' ASP . 0.9 OUTLIER -73.9 144.52 45.33 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.044 0.449 . . . . 0.0 111.001 -179.995 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 87' ' ' THR . . . . . 0.539 ' O ' ' HG2' ' A' ' 90' ' ' GLU . 5.6 p -108.24 157.54 36.07 Favored Pre-proline 0 C--N 1.327 -0.377 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.233 179.379 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 20.8 Cg_endo -60.53 -39.84 61.79 Favored 'Trans proline' 0 C--N 1.344 0.328 0 C-N-CA 122.399 2.066 . . . . 0.0 113.366 -178.979 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 89' ' ' GLU . . . . . 0.431 ' O ' ' HG2' ' A' ' 93' ' ' GLN . 7.9 mm-40 -64.16 -46.1 85.55 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 112.323 0.49 . . . . 0.0 112.323 -178.603 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 90' ' ' GLU . . . . . 0.539 ' HG2' ' O ' ' A' ' 87' ' ' THR . 9.8 pt-20 -65.79 -18.29 65.23 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-O 121.028 0.442 . . . . 0.0 111.432 -179.25 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 52.1 t -87.44 -47.36 15.85 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.83 -179.135 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 1.7 pp0? -68.79 -35.44 77.03 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.511 -0.313 . . . . 0.0 111.496 -178.581 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 93' ' ' GLN . . . . . 0.431 ' HG2' ' O ' ' A' ' 89' ' ' GLU . 10.4 pt20 -77.17 -29.89 54.66 Favored 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 120.372 -0.531 . . . . 0.0 111.337 -179.05 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -69.3 -41.68 76.46 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.853 0.358 . . . . 0.0 110.71 179.931 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 17.0 m-30 -82.47 -13.48 56.65 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 116.387 -0.37 . . . . 0.0 110.968 -179.557 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 96' ' ' GLN . . . . . 0.577 ' HA ' ' O ' ' A' ' 99' ' ' GLY . 37.3 tt0 -64.33 -23.94 67.47 Favored 'General case' 0 C--O 1.234 0.252 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.483 -179.86 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 15.2 m -67.12 -28.15 67.92 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.712 179.576 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 5.3 m -94.35 -41.62 9.32 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.144 -0.48 . . . . 0.0 109.978 179.542 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 99' ' ' GLY . . . . . 0.577 ' O ' ' HA ' ' A' ' 96' ' ' GLN . . . -150.55 144.26 11.63 Favored Glycine 0 N--CA 1.445 -0.745 0 CA-C-N 115.864 -0.607 . . . . 0.0 111.701 179.807 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -63.18 146.87 52.44 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 121.029 0.442 . . . . 0.0 111.48 -179.829 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 1.3 p -120.23 128.68 75.99 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.342 -179.878 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 27.2 t-20 -96.98 -46.97 5.99 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.687 0.28 . . . . 0.0 110.669 -179.999 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 2.6 tpt180 -137.44 148.33 46.04 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.571 -179.643 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 7.5 p -148.15 137.83 16.28 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-O 121.004 0.43 . . . . 0.0 110.638 179.265 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 2.3 m -130.24 129.44 43.34 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 116.008 -0.542 . . . . 0.0 109.983 178.961 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 106' ' ' ILE . . . . . 0.557 HD11 ' HA2' ' A' ' 116' ' ' GLY . 20.5 tt -114.63 148.04 17.66 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-O 120.995 0.426 . . . . 0.0 110.899 -179.494 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 9.1 tp -129.82 140.29 51.05 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.131 179.759 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -105.8 114.3 28.38 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.511 -0.313 . . . . 0.0 110.248 179.552 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 109' ' ' ASP . . . . . 0.415 ' O ' ' HG2' ' A' ' 115' ' ' LYS . 7.5 t70 -75.85 142.64 42.14 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.396 -0.365 . . . . 0.0 110.952 -179.818 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 2.6 mppt? -127.13 20.4 6.89 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.281 0.563 . . . . 0.0 109.906 179.015 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 36.0 t80 -100.92 -6.79 24.13 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.467 -0.788 . . . . 0.0 110.23 -179.608 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 106.36 11.61 26.99 Favored Glycine 0 N--CA 1.448 -0.534 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.443 -179.966 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 113' ' ' GLN . . . . . 0.443 ' HB3' ' HD2' ' A' ' 114' ' ' PRO . 24.5 mt-30 -97.1 160.86 28.04 Favored Pre-proline 0 C--O 1.239 0.535 0 N-CA-C 109.455 -0.572 . . . . 0.0 109.455 -179.972 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 114' ' ' PRO . . . . . 0.443 ' HD2' ' HB3' ' A' ' 113' ' ' GLN . 16.8 Cg_endo -58.7 113.77 1.71 Allowed 'Trans proline' 0 C--N 1.347 0.492 0 C-N-CA 122.207 1.938 . . . . 0.0 111.277 178.628 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 115' ' ' LYS . . . . . 0.415 ' HG2' ' O ' ' A' ' 109' ' ' ASP . 9.6 mttp -78.57 179.74 6.91 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.144 -179.226 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 116' ' ' GLY . . . . . 0.557 ' HA2' HD11 ' A' ' 106' ' ' ILE . . . 92.55 2.83 67.24 Favored Glycine 0 N--CA 1.444 -0.804 0 C-N-CA 120.081 -1.057 . . . . 0.0 111.462 179.978 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 5.1 t80 -55.67 124.59 17.91 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.725 0.298 . . . . 0.0 110.393 179.78 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -149.44 171.2 16.96 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.627 -179.374 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 44.9 p90 -152.4 130.41 11.82 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-N 115.656 -0.702 . . . . 0.0 109.204 178.782 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 13.7 m -108.56 142.49 21.04 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.139 179.905 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 121' ' ' GLU . . . . . 0.539 ' HB2' HG12 ' A' ' 72' ' ' VAL . 1.3 pt-20 -131.55 154.34 48.91 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 120.923 0.392 . . . . 0.0 111.192 179.637 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 12.1 t80 -146.88 167.61 23.5 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.587 -0.733 . . . . 0.0 110.363 179.689 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 11.0 t -84.45 -41.21 15.97 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-O 120.901 0.381 . . . . 0.0 111.565 -179.432 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 33.3 mm-40 -76.56 131.34 38.89 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.152 -179.429 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 2.1 mp -73.27 -34.53 44.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.018 -179.46 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 17.5 t70 -58.38 -36.1 73.0 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.204 0.526 . . . . 0.0 111.058 -179.763 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -64.13 -57.7 8.81 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.735 -0.666 . . . . 0.0 111.271 -179.893 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 10.9 p -65.27 -27.71 42.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.554 -0.293 . . . . 0.0 111.287 -179.52 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 7.1 tt0 -60.02 -46.77 88.39 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.887 0.375 . . . . 0.0 110.246 179.83 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 50.7 m-80 -74.96 -24.26 58.43 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.143 179.873 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -68.98 -51.78 35.81 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.608 179.344 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 3.8 pp -67.55 -16.89 64.43 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.988 0.423 . . . . 0.0 111.057 179.881 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 1.1 tp -77.41 -53.08 8.09 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.003 179.324 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 87.9 mt -126.36 102.83 7.33 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.742 -0.663 . . . . 0.0 109.687 179.568 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -147.52 -67.02 0.26 Allowed 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.166 0.508 . . . . 0.0 111.948 -178.931 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 4.5 pt-20 -74.12 95.04 2.5 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.629 0.728 . . . . 0.0 111.857 -178.819 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 5.9 m -141.21 -59.75 0.49 Allowed 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.692 -0.686 . . . . 0.0 110.134 178.801 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -154.21 121.36 5.68 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 109.935 -0.395 . . . . 0.0 109.935 179.841 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -141.97 117.04 9.99 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 109.459 -0.571 . . . . 0.0 109.459 179.744 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 140' ' ' HIS . . . . . 0.422 ' HB2' ' SG ' ' A' ' 86' ' ' CYS . 2.2 t60 64.52 21.09 12.36 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-O 120.99 0.424 . . . . 0.0 110.78 179.869 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 86.55 -1.84 87.27 Favored Glycine 0 N--CA 1.449 -0.469 0 C-N-CA 120.715 -0.755 . . . . 0.0 111.533 -179.084 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 1.4 mpt_? -116.17 178.88 4.16 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 109.663 -0.495 . . . . 0.0 109.663 -179.68 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -122.5 141.41 51.68 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-O 120.818 0.342 . . . . 0.0 110.268 179.41 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -123.98 178.72 5.15 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 115.968 -0.56 . . . . 0.0 109.971 -179.821 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -120.81 120.3 35.17 Favored 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 109.595 -0.52 . . . . 0.0 109.595 179.444 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 146' ' ' VAL . . . . . 0.405 ' HA ' ' O ' ' A' ' 78' ' ' TYR . 73.1 t -115.32 129.92 70.76 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-O 120.951 0.405 . . . . 0.0 111.063 -179.092 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 1.6 m -134.22 148.02 50.8 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 179.109 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -61.96 129.47 41.05 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 120.658 0.266 . . . . 0.0 111.246 -179.83 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 149' ' ' LYS . . . . . 0.451 ' HE2' ' OG ' ' A' ' 76' ' ' SER . 25.8 ttpt -90.39 62.19 5.25 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.919 0.866 . . . . 0.0 108.758 179.528 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 150' ' ' ARG . . . . . 0.582 ' HD3' ' OG ' ' A' ' 74' ' ' SER . 0.0 OUTLIER . . . . . 0 C--N 1.321 -0.631 0 CA-C-N 114.959 -1.019 . . . . 0.0 110.064 -179.729 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.454 -0.269 0 N-CA-C 110.127 -0.323 . . . . 0.0 110.127 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 63.9 tp -72.81 91.42 1.5 Allowed 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 109.623 -0.51 . . . . 0.0 109.623 179.06 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 43' ' ' ARG . . . . . 0.448 ' HD2' ' SD ' ' A' ' 45' ' ' MET . 13.5 ttm-85 -119.28 -16.1 9.07 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.96 -0.564 . . . . 0.0 111.161 -179.292 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 60.07 29.45 19.01 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 121.375 0.607 . . . . 0.0 110.021 -179.317 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 45' ' ' MET . . . . . 0.448 ' SD ' ' HD2' ' A' ' 43' ' ' ARG . 19.9 ptt? -99.63 12.56 36.22 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.182 -0.917 . . . . 0.0 111.167 -179.69 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 9.9 mm100 -71.81 -20.89 61.78 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 120.853 0.359 . . . . 0.0 110.898 -179.361 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -71.77 -14.5 62.01 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.302 0.572 . . . . 0.0 109.866 178.381 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 34.1 ttpt -82.78 7.22 15.7 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.694 -0.684 . . . . 0.0 109.445 178.826 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 7.3 p -57.2 -20.62 13.26 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.202 0 CA-C-N 115.693 -0.685 . . . . 0.0 111.623 -179.923 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 12.7 mm-40 -64.06 -33.23 75.28 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.431 0.634 . . . . 0.0 109.573 178.705 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 23.1 mtmt -97.42 -31.1 12.54 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.247 -0.888 . . . . 0.0 110.827 179.316 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 20.1 mm-40 -88.04 18.48 4.22 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.592 -179.548 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 7.9 ptm -64.76 -30.37 71.38 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.894 0.378 . . . . 0.0 110.813 179.971 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -94.07 -4.86 62.8 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.771 -0.728 . . . . 0.0 111.445 178.883 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.328 -0.343 0 CA-C-O 121.218 0.532 . . . . 0.0 110.166 -179.61 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.457 -0.092 0 CA-C-O 120.874 0.369 . . . . 0.0 110.45 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -75.13 -1.37 22.76 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.967 -0.56 . . . . 0.0 111.684 -179.615 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 1.9 tt0 -118.97 -40.17 2.87 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.873 179.988 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -93.69 -58.97 2.11 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 112.203 0.445 . . . . 0.0 112.203 -179.408 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 68' ' ' GLU . . . . . 0.53 ' O ' HG23 ' A' ' 72' ' ' VAL . 2.4 tp10 -66.59 -29.34 69.37 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.611 -0.268 . . . . 0.0 110.997 -178.993 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 45.1 tptt -56.36 -27.88 57.39 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.027 179.715 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 24.1 mt-10 -59.23 -34.83 72.67 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-O 120.83 0.347 . . . . 0.0 110.504 179.274 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 6.8 tp10 -89.07 -41.32 12.38 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.173 179.214 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.53 HG23 ' O ' ' A' ' 68' ' ' GLU . 22.1 t -62.68 -42.02 94.5 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.444 0 N-CA-C 112.073 0.397 . . . . 0.0 112.073 -178.964 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 25.4 t0 -66.28 -20.11 66.01 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-O 121.6 0.714 . . . . 0.0 110.192 179.76 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 16.3 m -100.61 -12.95 18.79 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 114.972 -1.013 . . . . 0.0 110.871 179.998 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -109.21 47.39 0.92 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.485 -179.199 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 76' ' ' SER . . . . . 0.409 ' HB3' ' HB3' ' A' ' 121' ' ' GLU . 0.0 OUTLIER -126.14 170.13 12.11 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.644 179.783 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -133.24 133.62 57.99 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 N-CA-C 109.832 -0.433 . . . . 0.0 109.832 178.851 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 22.4 t80 -88.5 124.67 34.22 Favored 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 109.497 -0.557 . . . . 0.0 109.497 179.952 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 5.2 t -105.89 111.11 33.66 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-N 116.519 -0.31 . . . . 0.0 110.297 179.861 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -117.04 170.57 13.47 Favored Glycine 0 N--CA 1.447 -0.621 0 N-CA-C 111.574 -0.61 . . . . 0.0 111.574 -179.982 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 3.9 m-20 55.91 43.29 27.68 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-O 121.238 0.542 . . . . 0.0 110.933 -179.099 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 2.5 t -85.49 166.38 2.05 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 CA-C-N 115.646 -0.706 . . . . 0.0 110.561 -179.505 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 83' ' ' ASP . . . . . 0.542 ' OD2' ' HD2' ' A' ' 142' ' ' ARG . 14.7 t70 -69.68 141.34 53.58 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.042 0.448 . . . . 0.0 110.392 179.978 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 14.5 p90 -64.0 -23.04 67.18 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.763 -0.653 . . . . 0.0 112.322 -178.575 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -107.13 16.01 24.57 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 120.874 0.368 . . . . 0.0 111.162 -179.27 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 86' ' ' CYS . . . . . 0.422 ' SG ' ' HB3' ' A' ' 83' ' ' ASP . 0.8 OUTLIER -79.84 145.43 32.76 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 121.207 0.527 . . . . 0.0 110.954 179.971 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 87' ' ' THR . . . . . 0.405 ' O ' ' HG2' ' A' ' 90' ' ' GLU . 13.2 p -111.25 153.77 43.89 Favored Pre-proline 0 C--N 1.324 -0.524 0 CA-C-N 115.509 -0.769 . . . . 0.0 110.315 179.553 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 88' ' ' PRO . . . . . 0.525 ' HD3' HD13 ' A' ' 106' ' ' ILE . 16.6 Cg_endo -56.43 -37.7 96.67 Favored 'Trans proline' 0 C--N 1.344 0.336 0 C-N-CA 122.855 2.37 . . . . 0.0 112.556 -179.311 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 89' ' ' GLU . . . . . 0.481 ' O ' ' HG2' ' A' ' 93' ' ' GLN . 0.0 OUTLIER -63.5 -52.26 62.03 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.9 -0.591 . . . . 0.0 111.886 -178.937 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 90' ' ' GLU . . . . . 0.406 ' O ' ' HB2' ' A' ' 94' ' ' HIS . 7.9 pt-20 -65.23 -15.3 62.33 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.763 0.316 . . . . 0.0 111.429 -178.475 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 61.7 t -89.65 -46.25 15.17 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 CA-C-N 116.63 -0.259 . . . . 0.0 110.873 -179.806 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 1.7 pt20 -72.35 -34.2 67.84 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 111.817 0.302 . . . . 0.0 111.817 -178.45 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 93' ' ' GLN . . . . . 0.481 ' HG2' ' O ' ' A' ' 89' ' ' GLU . 26.0 pt20 -80.59 -22.72 40.42 Favored 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 120.33 -0.548 . . . . 0.0 111.249 -179.157 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 94' ' ' HIS . . . . . 0.406 ' HB2' ' O ' ' A' ' 90' ' ' GLU . 0.3 OUTLIER -75.31 -32.42 60.96 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.952 0.405 . . . . 0.0 110.498 179.331 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 23.3 m-30 -89.68 -8.08 53.19 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.175 -179.266 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 96' ' ' GLN . . . . . 0.555 ' HA ' ' O ' ' A' ' 99' ' ' GLY . 1.3 tt0 -66.49 -22.54 66.19 Favored 'General case' 0 C--O 1.232 0.148 0 CA-C-O 121.163 0.506 . . . . 0.0 109.978 -179.694 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 1.2 m -63.36 -30.71 71.79 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.459 -0.791 . . . . 0.0 110.642 179.147 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 17.4 m -97.27 -46.03 6.27 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.397 179.63 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 99' ' ' GLY . . . . . 0.555 ' O ' ' HA ' ' A' ' 96' ' ' GLN . . . -144.92 143.35 11.81 Favored Glycine 0 N--CA 1.442 -0.95 0 C-N-CA 120.908 -0.663 . . . . 0.0 111.869 -179.892 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 100' ' ' THR . . . . . 0.406 ' HB ' ' CE1' ' A' ' 122' ' ' PHE . 0.2 OUTLIER -66.06 145.65 55.6 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 120.574 0.226 . . . . 0.0 111.096 -179.872 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 2.5 p -111.09 129.51 66.23 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-O 120.957 0.408 . . . . 0.0 111.25 -179.335 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 102' ' ' ASN . . . . . 0.535 ' OD1' ' HD2' ' A' ' 103' ' ' ARG . 26.0 t-20 -100.88 -45.17 5.53 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 109.868 -0.419 . . . . 0.0 109.868 179.327 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 103' ' ' ARG . . . . . 0.535 ' HD2' ' OD1' ' A' ' 102' ' ' ASN . 0.0 OUTLIER -138.44 151.9 47.86 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.156 -0.475 . . . . 0.0 109.972 178.776 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 4.0 p -151.44 119.52 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-O 121.142 0.496 . . . . 0.0 110.299 179.144 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 105' ' ' THR . . . . . 0.428 ' HB ' ' CE1' ' A' ' 119' ' ' TYR . 1.2 m -112.27 120.12 40.66 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.116 179.655 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 106' ' ' ILE . . . . . 0.525 HD13 ' HD3' ' A' ' 88' ' ' PRO . 21.5 tt -108.06 146.38 14.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-O 121.025 0.44 . . . . 0.0 111.166 -179.903 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 26.0 tp -131.93 136.22 47.21 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.213 179.458 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -101.83 116.33 32.48 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 116.544 -0.298 . . . . 0.0 110.533 179.749 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 109' ' ' ASP . . . . . 0.456 ' O ' ' HG2' ' A' ' 115' ' ' LYS . 12.3 t70 -83.76 136.2 34.25 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.026 0.441 . . . . 0.0 111.155 -179.766 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -126.56 27.42 6.12 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 116.148 -0.478 . . . . 0.0 109.896 179.4 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 10.0 t80 -108.23 -2.01 19.7 Favored 'General case' 0 N--CA 1.45 -0.451 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.282 -179.36 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 114.45 3.2 22.63 Favored Glycine 0 N--CA 1.449 -0.434 0 C-N-CA 120.399 -0.905 . . . . 0.0 112.995 179.617 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 26.6 mt-30 -98.18 156.57 35.7 Favored Pre-proline 0 C--N 1.321 -0.645 0 N-CA-C 109.671 -0.492 . . . . 0.0 109.671 179.858 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 14.2 Cg_endo -57.37 126.71 22.85 Favored 'Trans proline' 0 C--N 1.349 0.566 0 C-N-CA 122.194 1.929 . . . . 0.0 110.894 178.798 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 115' ' ' LYS . . . . . 0.456 ' HG2' ' O ' ' A' ' 109' ' ' ASP . 10.7 mttp -82.67 177.55 8.64 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 110.008 -0.368 . . . . 0.0 110.008 -179.732 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 116' ' ' GLY . . . . . 0.456 ' HA2' HD11 ' A' ' 106' ' ' ILE . . . 94.78 2.91 62.66 Favored Glycine 0 N--CA 1.444 -0.774 0 C-N-CA 120.157 -1.02 . . . . 0.0 112.349 179.419 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 9.9 m-30 -55.84 117.73 3.94 Favored 'General case' 0 C--N 1.332 -0.194 0 N-CA-C 110.163 -0.31 . . . . 0.0 110.163 179.992 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -147.03 174.69 11.31 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-O 120.935 0.398 . . . . 0.0 111.145 -179.144 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 119' ' ' TYR . . . . . 0.428 ' CE1' ' HB ' ' A' ' 105' ' ' THR . 36.1 p90 -152.91 134.09 14.19 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.687 -0.688 . . . . 0.0 109.182 178.674 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 14.6 m -107.91 136.64 42.66 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 N-CA-C 109.42 -0.585 . . . . 0.0 109.42 178.906 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 121' ' ' GLU . . . . . 0.491 ' HB2' HG12 ' A' ' 72' ' ' VAL . 10.7 pt-20 -122.61 152.25 40.64 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 120.619 0.247 . . . . 0.0 110.755 -179.728 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 122' ' ' PHE . . . . . 0.406 ' CE1' ' HB ' ' A' ' 100' ' ' THR . 11.9 t80 -148.4 170.07 18.79 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.028 -0.533 . . . . 0.0 109.961 179.421 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 21.4 t -87.49 -50.09 14.08 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-O 120.975 0.417 . . . . 0.0 111.568 -179.452 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 29.0 mt-10 -70.22 134.26 47.87 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.385 -179.128 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 2.6 mp -73.23 -30.97 32.58 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.59 -179.621 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 5.7 t70 -57.24 -40.45 77.59 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.892 -179.771 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -64.04 -54.95 26.13 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.708 -0.678 . . . . 0.0 111.402 -179.413 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 7.3 p -65.59 -30.58 50.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.447 -0.342 . . . . 0.0 111.193 -179.498 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 20.4 tt0 -59.98 -45.82 91.44 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-O 120.939 0.4 . . . . 0.0 110.361 179.539 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 82.8 m-20 -71.25 -32.61 68.94 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.183 179.701 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 131' ' ' ALA . . . . . 0.429 ' O ' ' HB2' ' A' ' 135' ' ' ASN . . . -66.32 -48.06 71.53 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.85 -0.614 . . . . 0.0 111.382 -179.927 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 4.2 pp -71.24 -16.87 62.51 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.784 0.326 . . . . 0.0 110.943 -179.734 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 5.5 tp -82.1 -48.96 10.74 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.068 -179.85 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 79.2 mt -136.98 104.06 5.34 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.398 -0.365 . . . . 0.0 110.503 -179.815 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 135' ' ' ASN . . . . . 0.429 ' HB2' ' O ' ' A' ' 131' ' ' ALA . 1.8 m-20 -152.33 -52.87 0.12 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.564 -0.289 . . . . 0.0 111.54 -179.743 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 5.2 pt-20 -73.83 89.27 1.83 Allowed 'General case' 0 C--N 1.33 -0.283 0 CA-C-O 121.528 0.68 . . . . 0.0 111.039 -179.658 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 6.7 m -130.78 -61.94 0.93 Allowed 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.548 -0.751 . . . . 0.0 110.51 179.672 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 8.0 tm-20 -162.16 127.21 3.36 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.22 -0.445 . . . . 0.0 109.813 -179.867 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -142.35 119.69 11.58 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.929 -0.578 . . . . 0.0 109.616 179.466 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 140' ' ' HIS . . . . . 0.42 ' HB2' ' SG ' ' A' ' 86' ' ' CYS . 3.7 t60 63.75 12.74 6.89 Favored 'General case' 0 N--CA 1.466 0.333 0 C-N-CA 122.717 0.407 . . . . 0.0 111.413 179.594 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 103.76 -8.42 50.79 Favored Glycine 0 N--CA 1.45 -0.398 0 C-N-CA 120.633 -0.794 . . . . 0.0 112.755 -179.59 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 142' ' ' ARG . . . . . 0.542 ' HD2' ' OD2' ' A' ' 83' ' ' ASP . 0.0 OUTLIER -116.2 169.77 9.03 Favored 'General case' 0 C--N 1.324 -0.543 0 O-C-N 122.602 -0.352 . . . . 0.0 110.843 -179.436 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 7.8 pt20 -110.93 125.72 53.97 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 109.544 -0.539 . . . . 0.0 109.544 179.046 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -104.92 177.35 4.87 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 120.734 0.302 . . . . 0.0 111.179 -179.277 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 145' ' ' LYS . . . . . 0.558 ' HE2' ' OG ' ' A' ' 147' ' ' SER . 0.1 OUTLIER -118.04 122.95 44.46 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 109.459 -0.571 . . . . 0.0 109.459 179.305 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 89.0 t -114.18 121.64 66.7 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-O 120.837 0.351 . . . . 0.0 111.226 -179.785 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 147' ' ' SER . . . . . 0.558 ' OG ' ' HE2' ' A' ' 145' ' ' LYS . 0.6 OUTLIER -118.63 141.77 48.28 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.007 179.68 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -67.6 123.51 20.66 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.722 0.296 . . . . 0.0 110.537 179.885 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 15.7 tttp -86.0 74.29 10.15 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.332 0.586 . . . . 0.0 110.312 -179.051 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 11.6 tpt85 . . . . . 0 C--N 1.323 -0.558 0 N-CA-C 109.105 -0.702 . . . . 0.0 109.105 178.944 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.234 0.268 0 N-CA-C 109.846 -0.427 . . . . 0.0 109.846 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 57.4 tp -73.87 91.39 1.97 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.314 0.578 . . . . 0.0 110.234 179.33 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 43' ' ' ARG . . . . . 0.677 ' HB3' ' SD ' ' A' ' 45' ' ' MET . 49.5 ttt85 -155.87 156.27 34.36 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.785 -0.643 . . . . 0.0 109.785 -179.31 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 2.0 pt-20 -79.56 39.55 0.41 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.803 0.811 . . . . 0.0 110.016 178.669 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 45' ' ' MET . . . . . 0.677 ' SD ' ' HB3' ' A' ' 43' ' ' ARG . 6.1 ptm -95.36 9.97 37.96 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 114.815 -1.084 . . . . 0.0 110.989 -179.26 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 22.0 mm-40 -69.87 -20.43 63.4 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.251 0.548 . . . . 0.0 110.459 -179.774 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -82.37 -3.26 55.17 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.664 179.173 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 24.0 ttpp -81.87 -4.19 55.94 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.501 -179.794 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 9.9 p -61.85 -22.28 28.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 121.347 0.594 . . . . 0.0 110.238 179.549 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -67.83 -17.9 64.66 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.657 -0.701 . . . . 0.0 110.044 178.619 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 29.4 mtmt -103.86 -41.15 5.98 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.205 -0.907 . . . . 0.0 110.616 179.741 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 8.4 mt-10 -78.82 6.28 9.44 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.901 0.381 . . . . 0.0 111.24 179.752 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -72.74 -32.61 65.81 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 121.315 0.579 . . . . 0.0 109.526 178.142 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -89.37 -9.6 66.81 Favored Glycine 0 N--CA 1.445 -0.703 0 N-CA-C 110.429 -1.068 . . . . 0.0 110.429 179.034 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.322 -0.612 0 CA-C-N 114.654 -0.773 . . . . 0.0 109.838 179.868 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 64' ' ' ALA . . . . . 0.434 ' O ' ' HB3' ' A' ' 68' ' ' GLU . . . . . . . . 0 C--O 1.227 -0.112 0 CA-C-O 121.312 0.577 . . . . 0.0 110.1 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -81.56 1.76 32.26 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.733 179.814 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 24.3 tp60 -123.4 -50.88 1.87 Allowed 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.723 -0.671 . . . . 0.0 110.569 179.577 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -82.89 -57.85 3.12 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.545 -179.634 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 68' ' ' GLU . . . . . 0.434 ' HB3' ' O ' ' A' ' 64' ' ' ALA . 28.4 tt0 -64.06 -29.73 70.85 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 121.129 0.49 . . . . 0.0 110.587 -179.817 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 39.4 tptt -57.24 -30.14 64.37 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.785 -0.643 . . . . 0.0 111.265 179.955 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 7.2 mt-10 -61.42 -22.54 65.11 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-O 121.261 0.553 . . . . 0.0 111.25 179.998 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 71' ' ' GLU . . . . . 0.546 ' O ' ' HD3' ' A' ' 75' ' ' ARG . 42.7 tp10 -97.84 -43.35 7.16 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 115.881 -0.6 . . . . 0.0 109.536 178.481 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.434 HG12 ' HB2' ' A' ' 121' ' ' GLU . 45.3 t -61.84 -40.22 86.24 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-N 115.597 -0.729 . . . . 0.0 112.776 -178.815 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 16.1 p-10 -72.79 -14.21 61.48 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-O 120.742 0.306 . . . . 0.0 111.792 -178.709 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 48.0 t -106.37 -2.02 22.66 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.004 178.323 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 75' ' ' ARG . . . . . 0.546 ' HD3' ' O ' ' A' ' 71' ' ' GLU . 2.8 mpt_? -116.68 41.16 2.75 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.609 0.719 . . . . 0.0 109.331 -179.74 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -120.73 171.17 8.79 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.223 -0.899 . . . . 0.0 110.474 179.906 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.414 HD11 HG22 ' A' ' 120' ' ' VAL . 0.8 OUTLIER -131.4 136.15 58.05 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 N-CA-C 109.74 -0.467 . . . . 0.0 109.74 178.603 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 79.2 t80 -93.05 124.06 36.75 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.286 -179.142 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.472 HG21 ' HE2' ' A' ' 95' ' ' PHE . 3.4 t -104.5 112.92 40.01 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.808 -179.708 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -119.24 167.69 13.3 Favored Glycine 0 N--CA 1.447 -0.599 0 N-CA-C 111.18 -0.768 . . . . 0.0 111.18 179.479 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 5.3 m-20 61.77 36.71 16.11 Favored 'General case' 0 N--CA 1.472 0.625 0 CA-C-O 121.218 0.532 . . . . 0.0 110.488 -179.702 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 2.5 t -78.55 164.03 3.48 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-N 115.624 -0.716 . . . . 0.0 111.116 -178.897 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 83' ' ' ASP . . . . . 0.545 ' OD2' ' HD3' ' A' ' 142' ' ' ARG . 10.8 t0 -68.06 136.58 54.01 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.996 -0.547 . . . . 0.0 109.61 179.313 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 25.7 p90 -64.98 -13.89 58.83 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.118 -0.492 . . . . 0.0 112.1 -179.253 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -113.28 14.21 19.26 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.773 0.321 . . . . 0.0 111.24 179.586 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 86' ' ' CYS . . . . . 0.458 ' SG ' ' HB2' ' A' ' 140' ' ' HIS . 0.8 OUTLIER -78.47 150.11 33.05 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.067 0.461 . . . . 0.0 111.521 -179.389 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 5.3 p -111.47 150.91 42.84 Favored Pre-proline 0 C--N 1.323 -0.55 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.259 179.099 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 88' ' ' PRO . . . . . 0.441 ' HD3' HD13 ' A' ' 106' ' ' ILE . 16.9 Cg_endo -57.89 -35.03 99.01 Favored 'Trans proline' 0 C--N 1.342 0.235 0 C-N-CA 122.462 2.108 . . . . 0.0 111.566 -179.716 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 66.8 mm-40 -64.36 -53.45 48.46 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.549 -0.75 . . . . 0.0 111.89 -179.429 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 -64.16 -18.37 64.4 Favored 'General case' 0 C--N 1.333 -0.133 0 CA-C-O 120.901 0.381 . . . . 0.0 111.472 -178.225 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 55.0 t -83.71 -49.06 16.79 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.518 -179.884 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 92' ' ' GLN . . . . . 0.417 ' O ' ' HB2' ' A' ' 96' ' ' GLN . 2.8 pt20 -73.38 -32.47 64.5 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.472 -0.331 . . . . 0.0 111.611 -178.479 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 7.1 pt20 -77.25 -28.29 53.57 Favored 'General case' 0 C--N 1.33 -0.261 0 C-N-CA 120.618 -0.433 . . . . 0.0 111.048 -179.118 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 60.9 t-80 -74.95 -44.48 48.21 Favored 'General case' 0 CA--C 1.519 -0.248 0 CA-C-O 121.085 0.469 . . . . 0.0 110.165 179.536 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 95' ' ' PHE . . . . . 0.472 ' HE2' HG21 ' A' ' 79' ' ' VAL . 20.5 m-30 -73.45 -17.78 61.2 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.866 -0.607 . . . . 0.0 110.517 -179.2 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 96' ' ' GLN . . . . . 0.492 ' HA ' ' O ' ' A' ' 99' ' ' GLY . 51.4 tt0 -64.61 -25.29 67.9 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.494 -0.775 . . . . 0.0 110.631 179.521 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 48.8 m -61.0 -32.18 71.77 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.514 179.682 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 18.2 m -92.35 -50.23 5.75 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.176 0.512 . . . . 0.0 110.078 179.42 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 99' ' ' GLY . . . . . 0.492 ' O ' ' HA ' ' A' ' 96' ' ' GLN . . . -137.77 133.7 6.53 Favored Glycine 0 N--CA 1.443 -0.854 0 C-N-CA 120.659 -0.782 . . . . 0.0 111.91 179.783 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -59.33 140.0 56.48 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.029 0.443 . . . . 0.0 110.686 179.975 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 2.8 p -105.51 140.18 24.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 115.876 -0.602 . . . . 0.0 112.171 -178.058 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 9.1 t30 -101.95 -50.56 3.63 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 109.431 -0.581 . . . . 0.0 109.431 178.125 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 9.0 mmm180 -141.8 158.32 43.94 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.386 179.698 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 6.6 p -151.54 127.57 1.83 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.104 179.566 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 105' ' ' THR . . . . . 0.416 ' HB ' ' CE1' ' A' ' 119' ' ' TYR . 1.8 m -117.9 119.17 34.04 Favored 'General case' 0 C--N 1.321 -0.669 0 O-C-N 122.263 -0.273 . . . . 0.0 110.441 -179.984 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 106' ' ' ILE . . . . . 0.441 HD13 ' HD3' ' A' ' 88' ' ' PRO . 18.6 tt -107.16 146.64 13.19 Favored 'Isoleucine or valine' 0 C--O 1.235 0.327 0 CA-C-O 120.959 0.409 . . . . 0.0 111.04 -179.592 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 60.4 tp -135.69 126.24 26.97 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.858 -0.61 . . . . 0.0 109.948 179.12 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -89.2 120.02 30.21 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 116.517 -0.311 . . . . 0.0 110.499 179.83 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 109' ' ' ASP . . . . . 0.543 ' O ' ' HG2' ' A' ' 115' ' ' LYS . 16.8 t70 -81.08 136.9 35.99 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.014 0.435 . . . . 0.0 110.829 -179.883 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -124.93 25.86 7.21 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.896 -0.593 . . . . 0.0 109.763 179.556 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 24.6 t80 -105.99 -3.87 21.19 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.059 -179.483 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 106.83 10.9 27.62 Favored Glycine 0 N--CA 1.449 -0.493 0 C-N-CA 120.678 -0.772 . . . . 0.0 112.536 -179.582 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 113' ' ' GLN . . . . . 0.417 ' HB3' ' HD2' ' A' ' 114' ' ' PRO . 20.9 mt-30 -99.8 159.36 30.14 Favored Pre-proline 0 C--N 1.325 -0.471 0 N-CA-C 109.509 -0.552 . . . . 0.0 109.509 179.388 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 114' ' ' PRO . . . . . 0.417 ' HD2' ' HB3' ' A' ' 113' ' ' GLN . 11.4 Cg_endo -55.77 115.67 2.62 Favored 'Trans proline' 0 C--N 1.344 0.327 0 C-N-CA 122.307 2.005 . . . . 0.0 110.835 178.584 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 115' ' ' LYS . . . . . 0.543 ' HG2' ' O ' ' A' ' 109' ' ' ASP . 54.9 mttt -75.52 172.27 12.83 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.044 -178.467 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 116' ' ' GLY . . . . . 0.42 ' HA2' HD11 ' A' ' 106' ' ' ILE . . . 98.55 7.81 55.32 Favored Glycine 0 N--CA 1.444 -0.767 0 C-N-CA 120.351 -0.928 . . . . 0.0 112.286 179.902 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 30.2 m-85 -53.27 115.48 1.92 Allowed 'General case' 0 C--N 1.334 -0.097 0 N-CA-C 110.146 -0.316 . . . . 0.0 110.146 179.749 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -146.23 175.53 10.44 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-O 121.034 0.445 . . . . 0.0 111.165 -179.168 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 119' ' ' TYR . . . . . 0.416 ' CE1' ' HB ' ' A' ' 105' ' ' THR . 51.7 p90 -160.08 135.64 8.29 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.581 -0.736 . . . . 0.0 109.234 178.799 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 120' ' ' VAL . . . . . 0.414 HG22 HD11 ' A' ' 77' ' ' ILE . 17.4 m -105.55 142.0 19.62 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.727 0 N-CA-C 109.69 -0.485 . . . . 0.0 109.69 179.344 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 121' ' ' GLU . . . . . 0.434 ' HB2' HG12 ' A' ' 72' ' ' VAL . 5.8 pt-20 -127.1 152.94 46.64 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.157 -179.417 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 15.4 t80 -156.46 166.99 31.82 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.476 179.163 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 3.8 t -84.37 -47.61 17.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 120.921 0.391 . . . . 0.0 111.627 -179.317 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 74.9 mm-40 -66.33 126.45 28.82 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.32 -179.394 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 2.5 mp -70.23 -32.92 52.41 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.02 -179.926 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 4.8 t70 -62.66 -36.64 83.5 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.505 179.884 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -61.3 -55.44 31.8 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.636 179.724 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 11.3 p -67.12 -28.86 44.12 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.756 179.729 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 50.7 tt0 -58.56 -46.53 86.68 Favored 'General case' 0 N--CA 1.462 0.165 0 CA-C-O 121.11 0.481 . . . . 0.0 110.399 179.223 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 46.2 m-80 -70.83 -31.16 67.78 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.878 -0.601 . . . . 0.0 109.985 179.913 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -68.03 -48.41 65.76 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.665 -0.698 . . . . 0.0 111.833 -179.537 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 3.8 pp -69.93 -18.97 63.4 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.943 0.401 . . . . 0.0 110.92 -179.666 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 5.4 tp -80.03 -49.91 11.12 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.765 179.858 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 79.1 mt -134.61 107.81 7.7 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.477 -0.329 . . . . 0.0 110.967 -179.609 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 2.8 m-20 -159.81 -52.53 0.06 Allowed 'General case' 0 N--CA 1.465 0.303 0 CA-C-O 121.181 0.515 . . . . 0.0 110.998 179.757 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 4.6 pt-20 -74.73 80.06 2.05 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.433 0.635 . . . . 0.0 111.205 -179.735 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 6.8 m -133.78 -60.58 0.82 Allowed 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.672 -0.695 . . . . 0.0 111.0 179.573 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 1.6 tp10 -150.97 121.25 7.28 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-O 120.532 0.206 . . . . 0.0 110.516 -179.325 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -141.93 111.43 6.55 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 109.867 -0.42 . . . . 0.0 109.867 179.237 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 140' ' ' HIS . . . . . 0.458 ' HB2' ' SG ' ' A' ' 86' ' ' CYS . 2.4 t60 67.34 18.27 10.2 Favored 'General case' 0 N--CA 1.468 0.425 0 CA-C-O 121.142 0.496 . . . . 0.0 110.402 179.582 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 88.9 4.14 75.72 Favored Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.869 -0.681 . . . . 0.0 111.54 -179.212 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 142' ' ' ARG . . . . . 0.545 ' HD3' ' OD2' ' A' ' 83' ' ' ASP . 4.3 mpt_? -121.28 166.49 13.95 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 109.825 -0.435 . . . . 0.0 109.825 179.499 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 18.7 pt20 -110.99 140.08 45.81 Favored 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 109.863 -0.421 . . . . 0.0 109.863 179.2 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -125.6 174.98 7.88 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.547 -179.549 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 15.6 ttpt -111.32 118.79 36.82 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.255 179.791 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 85.9 t -113.37 118.53 58.38 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-O 120.992 0.425 . . . . 0.0 110.005 179.276 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 66.3 m -127.49 143.36 51.2 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 116.116 -0.493 . . . . 0.0 109.921 -179.89 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -59.13 133.49 56.14 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.058 0.456 . . . . 0.0 111.888 -178.747 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 12.1 ttpp -96.0 78.29 3.18 Favored 'General case' 0 N--CA 1.449 -0.476 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.205 179.607 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 21.5 tpt180 . . . . . 0 C--N 1.322 -0.615 0 N-CA-C 109.293 -0.632 . . . . 0.0 109.293 179.329 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.235 0.319 0 N-CA-C 110.05 -0.352 . . . . 0.0 110.05 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 50.7 tp -72.45 94.32 1.64 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.095 0.474 . . . . 0.0 109.825 179.472 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 16.8 ttm180 -149.03 149.58 31.36 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.764 -0.653 . . . . 0.0 109.576 -179.71 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 10.4 tt0 -79.97 48.79 1.0 Allowed 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.272 0.558 . . . . 0.0 110.824 -179.508 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 6.4 ptm -107.35 12.31 28.19 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.441 179.674 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 19.7 mm-40 -69.63 -20.8 63.6 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.056 0.455 . . . . 0.0 111.212 -179.261 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -79.71 -5.44 55.23 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.25 178.913 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 37.1 ttpt -85.34 1.73 47.22 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.78 -0.645 . . . . 0.0 109.775 179.614 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 5.8 p -58.32 -19.44 13.59 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.432 0 CA-C-N 115.261 -0.882 . . . . 0.0 111.094 179.447 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 29.6 mt-10 -70.65 -19.9 62.76 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-O 121.207 0.527 . . . . 0.0 110.369 179.173 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 5.2 mtmt -101.63 -42.52 6.18 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.995 -0.548 . . . . 0.0 109.905 178.749 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 22.0 mt-10 -61.37 -26.6 67.94 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.854 179.391 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 19.5 ptt? -66.55 -16.53 64.22 Favored 'General case' 0 C--O 1.227 -0.116 0 CA-C-O 121.372 0.606 . . . . 0.0 110.024 178.668 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -98.67 -7.93 55.04 Favored Glycine 0 N--CA 1.445 -0.725 0 N-CA-C 110.612 -0.995 . . . . 0.0 110.612 178.509 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.318 -0.785 0 CA-C-O 121.144 0.497 . . . . 0.0 110.055 -179.871 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.453 -0.302 0 CA-C-O 120.879 0.371 . . . . 0.0 110.584 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -81.88 -1.64 48.42 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.993 179.867 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 22.9 tp60 -119.87 -44.75 2.51 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.565 -0.289 . . . . 0.0 111.337 179.811 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -90.86 -61.18 1.73 Allowed 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 120.844 0.354 . . . . 0.0 111.252 -179.415 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 68' ' ' GLU . . . . . 0.468 ' O ' HG23 ' A' ' 72' ' ' VAL . 0.6 OUTLIER -61.94 -27.86 69.13 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.969 -0.56 . . . . 0.0 111.125 -179.313 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 19.4 tptp -58.4 -29.55 66.14 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.405 -179.727 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 17.7 mt-10 -66.27 -20.39 66.09 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-O 121.396 0.617 . . . . 0.0 110.605 179.722 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 71' ' ' GLU . . . . . 0.445 ' O ' ' HD2' ' A' ' 75' ' ' ARG . 5.5 tp10 -95.28 -39.88 9.83 Favored 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 109.091 -0.707 . . . . 0.0 109.091 177.176 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.468 HG23 ' O ' ' A' ' 68' ' ' GLU . 54.9 t -63.97 -42.64 96.39 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.374 0 CA-C-N 115.606 -0.724 . . . . 0.0 112.491 -179.464 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 14.5 p-10 -70.69 -18.18 62.82 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-O 120.949 0.404 . . . . 0.0 110.898 -179.076 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 33.6 t -97.41 -13.47 21.8 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.188 178.633 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 75' ' ' ARG . . . . . 0.445 ' HD2' ' O ' ' A' ' 71' ' ' GLU . 0.0 OUTLIER -106.04 44.95 1.0 Allowed 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.775 -0.648 . . . . 0.0 109.961 -179.498 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 76' ' ' SER . . . . . 0.459 ' CB ' ' HB3' ' A' ' 121' ' ' GLU . 0.3 OUTLIER -124.53 170.99 10.36 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.47 -0.786 . . . . 0.0 110.689 179.971 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.436 HD13 ' HB1' ' A' ' 131' ' ' ALA . 6.7 pt -132.15 135.15 58.73 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.772 0 CA-C-N 115.803 -0.635 . . . . 0.0 109.35 178.445 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 69.6 t80 -91.91 123.04 34.99 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 116.341 -0.39 . . . . 0.0 109.994 -179.883 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 4.6 t -102.78 111.48 32.71 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.493 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.223 -179.516 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -121.42 169.69 14.55 Favored Glycine 0 N--CA 1.447 -0.602 0 C-N-CA 120.828 -0.701 . . . . 0.0 111.57 179.858 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 4.2 m-20 61.01 37.66 17.89 Favored 'General case' 0 N--CA 1.469 0.514 0 CA-C-O 121.251 0.548 . . . . 0.0 110.431 -179.882 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 2.5 t -83.52 164.31 2.72 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-N 115.358 -0.837 . . . . 0.0 110.804 -179.01 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 83' ' ' ASP . . . . . 0.732 ' OD2' ' HB2' ' A' ' 142' ' ' ARG . 0.1 OUTLIER -66.17 137.3 56.91 Favored 'General case' 0 CA--C 1.517 -0.323 0 N-CA-C 109.707 -0.479 . . . . 0.0 109.707 179.288 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 24.6 p90 -65.64 -8.06 18.43 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 120.917 0.389 . . . . 0.0 111.379 -179.878 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -118.51 19.52 13.29 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.14 -179.743 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -87.01 143.88 27.14 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.707 179.971 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 87' ' ' THR . . . . . 0.436 ' O ' ' HG2' ' A' ' 90' ' ' GLU . 20.7 p -107.79 148.9 38.25 Favored Pre-proline 0 C--N 1.326 -0.429 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.425 179.572 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 88' ' ' PRO . . . . . 0.545 ' HD3' HD13 ' A' ' 106' ' ' ILE . 11.7 Cg_endo -54.81 -39.65 88.83 Favored 'Trans proline' 0 C--N 1.344 0.339 0 C-N-CA 123.089 2.526 . . . . 0.0 112.977 -179.198 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 3.2 mp0 -65.1 -41.73 94.7 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 112.498 0.555 . . . . 0.0 112.498 -178.486 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 90' ' ' GLU . . . . . 0.485 ' O ' ' HB2' ' A' ' 94' ' ' HIS . 8.0 pt-20 -73.98 -14.8 61.09 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.97 0.414 . . . . 0.0 111.024 -178.977 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.424 HG23 ' O ' ' A' ' 87' ' ' THR . 74.5 t -88.52 -48.35 14.92 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.89 -179.561 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -69.0 -34.13 74.8 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.545 -178.333 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 7.6 pt20 -78.11 -28.97 48.7 Favored 'General case' 0 C--N 1.327 -0.384 0 C-N-CA 120.556 -0.457 . . . . 0.0 111.24 -178.854 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 94' ' ' HIS . . . . . 0.485 ' HB2' ' O ' ' A' ' 90' ' ' GLU . 1.8 t-80 -73.39 -32.19 64.33 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.97 0.414 . . . . 0.0 110.828 -179.664 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 21.4 m-30 -87.7 -11.69 47.54 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.144 179.543 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 26.4 tt0 -62.74 -27.64 69.41 Favored 'General case' 0 C--O 1.234 0.237 0 CA-C-N 115.538 -0.755 . . . . 0.0 110.343 -179.957 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 12.7 m -63.96 -35.5 80.89 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.233 179.085 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 3.8 m -85.29 -52.75 5.68 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.883 -0.599 . . . . 0.0 109.532 179.159 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -140.57 128.16 3.71 Favored Glycine 0 N--CA 1.441 -0.979 0 CA-C-N 115.684 -0.689 . . . . 0.0 111.689 179.752 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 100' ' ' THR . . . . . 0.444 ' H ' HG22 ' A' ' 100' ' ' THR . 0.1 OUTLIER -57.33 136.25 56.55 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.853 0.359 . . . . 0.0 110.101 179.418 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 2.0 p -102.01 130.33 51.94 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-N 116.048 -0.524 . . . . 0.0 112.073 -177.913 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 102' ' ' ASN . . . . . 0.457 ' HB2' ' CD1' ' A' ' 122' ' ' PHE . 29.2 t-20 -99.85 -43.78 6.3 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 109.53 -0.544 . . . . 0.0 109.53 178.449 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 103' ' ' ARG . . . . . 0.431 ' HD3' ' OD1' ' A' ' 102' ' ' ASN . 1.5 mpt_? -135.7 151.24 49.98 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.328 179.657 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 6.1 p -155.46 129.82 1.39 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.552 -0.295 . . . . 0.0 110.211 179.28 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -127.49 124.8 39.19 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.492 -0.322 . . . . 0.0 110.248 179.472 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 106' ' ' ILE . . . . . 0.548 HD11 ' HA2' ' A' ' 116' ' ' GLY . 20.8 tt -109.26 149.06 12.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 120.857 0.36 . . . . 0.0 111.014 -179.89 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 13.8 tp -130.14 136.22 49.05 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.002 -0.544 . . . . 0.0 109.991 179.516 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -100.8 111.35 23.55 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.488 179.9 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 109' ' ' ASP . . . . . 0.416 ' O ' ' HG2' ' A' ' 115' ' ' LYS . 23.1 t70 -76.73 146.91 37.68 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.188 0.518 . . . . 0.0 111.13 -179.618 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 3.3 mppt? -135.15 22.99 3.5 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.267 179.446 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 19.0 t80 -107.58 -3.89 18.88 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.222 0.534 . . . . 0.0 110.157 -179.544 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 114.78 0.62 22.96 Favored Glycine 0 N--CA 1.449 -0.474 0 C-N-CA 120.816 -0.707 . . . . 0.0 112.766 179.835 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 26.6 mt-30 -88.35 154.59 51.53 Favored Pre-proline 0 C--N 1.329 -0.315 0 N-CA-C 109.361 -0.607 . . . . 0.0 109.361 179.679 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 14.5 Cg_endo -58.45 115.92 2.88 Favored 'Trans proline' 0 N--CA 1.462 -0.378 0 C-N-CA 122.013 1.809 . . . . 0.0 111.444 178.917 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 115' ' ' LYS . . . . . 0.416 ' HG2' ' O ' ' A' ' 109' ' ' ASP . 60.0 mttt -70.86 167.06 19.77 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 109.558 -0.534 . . . . 0.0 109.558 -179.485 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 116' ' ' GLY . . . . . 0.548 ' HA2' HD11 ' A' ' 106' ' ' ILE . . . 105.59 1.83 40.36 Favored Glycine 0 N--CA 1.447 -0.607 0 C-N-CA 120.073 -1.061 . . . . 0.0 112.197 179.914 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 32.4 m-85 -53.69 115.61 2.07 Favored 'General case' 0 C--N 1.333 -0.138 0 N-CA-C 110.269 -0.271 . . . . 0.0 110.269 179.46 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -143.41 173.01 12.0 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 120.915 0.388 . . . . 0.0 111.006 -179.162 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 51.9 p90 -155.21 130.09 9.35 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 115.847 -0.615 . . . . 0.0 109.765 178.681 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 18.6 m -107.21 141.27 22.85 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 N-CA-C 109.695 -0.483 . . . . 0.0 109.695 179.178 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 121' ' ' GLU . . . . . 0.459 ' HB3' ' CB ' ' A' ' 76' ' ' SER . 1.4 pt-20 -132.04 157.05 45.16 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.916 0.388 . . . . 0.0 111.17 179.723 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 122' ' ' PHE . . . . . 0.457 ' CD1' ' HB2' ' A' ' 102' ' ' ASN . 22.2 t80 -152.29 170.88 18.95 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.535 -0.757 . . . . 0.0 109.771 179.91 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 20.4 t -84.26 -51.6 13.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-O 120.969 0.414 . . . . 0.0 110.461 179.852 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 4.7 mm-40 -60.53 129.66 42.69 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.852 -0.613 . . . . 0.0 111.132 179.886 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 2.9 mp -73.9 -31.03 29.58 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 N-CA-C 109.327 -0.62 . . . . 0.0 109.327 179.516 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -60.53 -37.97 82.92 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.342 179.26 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -60.8 -56.33 22.52 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.537 -0.756 . . . . 0.0 111.107 -179.976 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 11.3 p -67.19 -30.13 48.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.442 -179.654 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 30.1 tt0 -61.31 -44.78 96.64 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 121.038 0.447 . . . . 0.0 110.436 179.653 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 37.9 m-80 -72.3 -29.11 63.55 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.055 -0.52 . . . . 0.0 109.994 179.601 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 131' ' ' ALA . . . . . 0.436 ' HB1' HD13 ' A' ' 77' ' ' ILE . . . -69.53 -51.65 33.66 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.476 -0.784 . . . . 0.0 111.305 -179.939 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 4.2 pp -65.59 -23.34 66.81 Favored 'General case' 0 N--CA 1.462 0.142 0 CA-C-O 120.794 0.33 . . . . 0.0 110.681 -179.824 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 5.7 tp -73.37 -56.48 5.01 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.961 0.41 . . . . 0.0 110.228 179.595 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 69.1 mt -122.71 104.2 9.16 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.007 -0.542 . . . . 0.0 109.79 179.826 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 135' ' ' ASN . . . . . 0.43 ' HB2' ' O ' ' A' ' 131' ' ' ALA . 0.5 OUTLIER -148.4 -66.84 0.24 Allowed 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.15 0.5 . . . . 0.0 111.122 -179.186 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 5.6 pt-20 -73.68 106.29 5.37 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.563 -0.744 . . . . 0.0 111.414 -179.466 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 21.3 m -150.09 -59.13 0.19 Allowed 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.706 -0.679 . . . . 0.0 109.599 178.997 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 4.9 tt0 -161.55 120.96 2.5 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.813 -0.63 . . . . 0.0 109.572 178.946 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -139.35 123.18 17.63 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 -179.982 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 140' ' ' HIS . . . . . 0.621 ' HB3' ' OD2' ' A' ' 83' ' ' ASP . 6.9 t60 59.07 12.4 2.42 Favored 'General case' 0 CA--C 1.54 0.562 0 O-C-N 123.555 0.534 . . . . 0.0 111.553 179.28 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 101.36 -6.4 55.75 Favored Glycine 0 N--CA 1.449 -0.443 0 C-N-CA 120.904 -0.665 . . . . 0.0 112.754 -179.918 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 142' ' ' ARG . . . . . 0.732 ' HB2' ' OD2' ' A' ' 83' ' ' ASP . 8.0 mpt_? -113.43 173.42 6.42 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 117.023 0.412 . . . . 0.0 110.418 179.58 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 17.4 pt20 -116.87 114.16 23.49 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.093 0.473 . . . . 0.0 109.759 179.531 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -97.97 175.13 6.24 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.174 -179.15 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 6.4 ttpt -117.51 120.81 39.22 Favored 'General case' 0 N--CA 1.45 -0.457 0 CA-C-N 115.905 -0.589 . . . . 0.0 109.495 179.052 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 93.5 t -113.36 119.96 62.07 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.738 0 CA-C-O 120.898 0.38 . . . . 0.0 110.653 -179.635 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 58.2 m -123.25 141.68 51.72 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 116.195 -0.457 . . . . 0.0 109.801 -179.849 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -59.86 128.8 38.67 Favored 'General case' 0 C--O 1.236 0.378 0 CA-C-O 120.828 0.347 . . . . 0.0 111.277 -179.64 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 149' ' ' LYS . . . . . 0.429 ' HE2' ' OG ' ' A' ' 76' ' ' SER . 21.9 ttpt -91.94 67.8 5.25 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.384 0.611 . . . . 0.0 109.999 -179.601 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 24.7 tpt180 . . . . . 0 C--N 1.324 -0.537 0 CA-C-O 121.236 0.541 . . . . 0.0 109.611 179.104 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 18.6 mmt . . . . . 0 N--CA 1.48 1.069 0 N-CA-C 110.224 -0.287 . . . . 0.0 110.224 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 90.47 -61.64 3.18 Favored Glycine 0 N--CA 1.447 -0.598 0 C-N-CA 120.658 -0.782 . . . . 0.0 111.623 -179.711 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 2.2 m -67.35 148.02 52.18 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 120.667 0.27 . . . . 0.0 110.404 179.333 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -82.18 -59.68 2.47 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 120.723 0.297 . . . . 0.0 110.624 -179.896 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 11.4 t60 -160.11 118.1 2.62 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.306 179.88 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 19.1 p-80 -59.64 139.54 57.12 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.925 179.492 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 36.7 m80 -115.37 -155.1 0.56 Allowed 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.343 -0.389 . . . . 0.0 110.232 -179.926 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -134.34 133.1 40.29 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.968 0.413 . . . . 0.0 111.071 179.866 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 31.8 t-80 -121.89 103.25 8.71 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 109.606 -0.516 . . . . 0.0 109.606 179.291 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 3.1 t60 -65.2 122.99 18.37 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.495 -179.818 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -79.21 151.72 31.06 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.252 -179.317 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 35.6 m -92.68 132.48 36.88 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.005 -0.543 . . . . 0.0 109.919 178.824 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -78.79 109.12 2.78 Favored Glycine 0 N--CA 1.448 -0.506 0 C-N-CA 120.691 -0.766 . . . . 0.0 112.491 -179.657 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 42.5 mt -85.41 167.57 15.4 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 120.883 0.373 . . . . 0.0 110.555 179.53 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 12.9 m -95.37 144.44 27.82 Favored Pre-proline 0 C--N 1.325 -0.49 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.498 179.565 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_endo -68.88 145.71 63.17 Favored 'Trans proline' 0 C--O 1.234 0.304 0 C-N-CA 122.681 2.254 . . . . 0.0 112.292 -179.99 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' ARG . . . . . 0.426 ' HD3' HH11 ' A' ' 17' ' ' ARG . 6.1 ttt180 -92.09 87.81 6.29 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.287 179.95 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -76.85 86.76 0.96 Allowed Glycine 0 N--CA 1.449 -0.454 0 C-N-CA 120.801 -0.714 . . . . 0.0 111.695 179.68 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 6.0 m -148.13 144.92 28.13 Favored 'General case' 0 C--N 1.323 -0.557 0 O-C-N 122.813 -0.228 . . . . 0.0 110.58 -179.932 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 18.8 p-80 -130.67 111.19 11.96 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 109.729 -0.471 . . . . 0.0 109.729 178.842 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 45.8 mtt -148.98 174.63 12.07 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.174 -179.122 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 145.94 129.0 2.02 Favored Glycine 0 N--CA 1.445 -0.729 0 C-N-CA 120.901 -0.666 . . . . 0.0 112.338 179.564 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 2.8 m -92.32 138.78 31.23 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 120.717 0.294 . . . . 0.0 110.29 179.565 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -101.55 136.62 41.09 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.065 179.897 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 85.1 mt -105.11 120.84 42.5 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 120.983 0.42 . . . . 0.0 111.17 -179.404 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 23.3 mt-10 -93.8 129.46 40.16 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.781 -0.645 . . . . 0.0 109.932 179.372 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -83.56 120.91 26.53 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 110.183 -0.303 . . . . 0.0 110.183 179.694 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 25.8 ptm -163.85 -178.58 5.77 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.159 -179.482 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 37.5 tttm -66.79 136.55 55.63 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.085 179.524 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 16.3 pttm -72.27 144.56 48.35 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 109.719 -0.474 . . . . 0.0 109.719 179.256 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 65.0 mtt180 -114.5 171.36 7.67 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-O 120.962 0.41 . . . . 0.0 110.506 -179.71 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -75.06 97.23 3.38 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.699 -0.682 . . . . 0.0 109.58 179.411 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 20.5 pttp -66.13 118.85 10.45 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.363 0.602 . . . . 0.0 111.35 -179.452 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -96.79 -22.6 16.85 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.61 179.354 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.413 HG12 ' N ' ' A' ' 36' ' ' GLU . 11.5 tt -95.61 161.47 2.64 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 CA-C-N 115.813 -0.63 . . . . 0.0 110.725 -179.717 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 36' ' ' GLU . . . . . 0.413 ' N ' HG12 ' A' ' 35' ' ' ILE . 2.7 pt-20 -72.17 152.47 42.25 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.514 179.313 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -123.6 163.31 21.27 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 109.942 -0.392 . . . . 0.0 109.942 -179.94 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 22.2 mm-40 -79.57 79.6 6.03 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.28 0.562 . . . . 0.0 111.106 -179.424 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -123.42 110.19 14.81 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.781 -0.645 . . . . 0.0 109.777 179.296 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -78.45 106.44 2.32 Favored Glycine 0 N--CA 1.449 -0.498 0 C-N-CA 120.947 -0.644 . . . . 0.0 113.221 -179.187 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -112.54 -170.11 1.6 Allowed 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 109.772 -0.455 . . . . 0.0 109.772 179.128 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 56.8 tp -71.8 97.02 1.71 Allowed 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.177 0.513 . . . . 0.0 110.35 179.547 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' ARG . . . . . 0.422 ' C ' ' H ' ' A' ' 45' ' ' MET . 0.7 OUTLIER -150.13 147.92 28.34 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.655 -0.702 . . . . 0.0 109.582 -179.986 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -73.79 20.35 0.1 Allowed 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.623 -179.723 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' MET . . . . . 0.422 ' H ' ' C ' ' A' ' 43' ' ' ARG . 19.5 ptt? -83.86 8.1 15.98 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.026 0.441 . . . . 0.0 110.63 -179.854 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 87.7 mt-30 -66.1 -22.75 66.41 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.179 0.514 . . . . 0.0 110.477 179.361 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -80.37 -7.43 59.09 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.149 0.499 . . . . 0.0 110.681 179.648 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 18.7 ttmm -77.91 -6.28 53.81 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.539 -179.795 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 14.8 p -56.2 -28.57 25.83 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.32 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.596 -179.474 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 26.7 mt-10 -62.22 -31.36 71.89 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.91 0.386 . . . . 0.0 111.294 -179.359 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 37.6 mtmt -96.68 -41.18 8.63 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.609 -179.966 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 27.6 mm-40 -61.39 -29.6 70.02 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.71 -179.502 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 15.2 ptt? -62.62 -24.9 67.83 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-O 120.87 0.367 . . . . 0.0 110.629 179.797 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -94.3 -9.48 59.14 Favored Glycine 0 N--CA 1.447 -0.598 0 C-N-CA 120.699 -0.762 . . . . 0.0 111.483 179.463 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -110.79 17.05 20.98 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 120.909 0.385 . . . . 0.0 110.747 -179.753 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.417 HG12 ' HB2' ' A' ' 60' ' ' SER . 18.0 m -64.31 -13.71 14.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.376 179.797 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 92.6 mt-30 -78.83 -10.98 59.97 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.902 0.382 . . . . 0.0 110.39 179.232 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 26.8 t70 -127.38 -52.39 1.38 Allowed 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.474 179.92 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 7.6 m -71.71 -75.29 0.13 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.241 179.899 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' SER . . . . . 0.417 ' HB2' HG12 ' A' ' 56' ' ' VAL . 0.4 OUTLIER -79.61 39.91 0.43 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.172 0.51 . . . . 0.0 111.135 -179.827 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 45.5 p -80.78 -33.61 34.78 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.597 -179.44 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 1.3 m -67.51 -25.17 65.71 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.958 -0.565 . . . . 0.0 111.006 179.949 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -62.39 -27.61 69.2 Favored 'General case' 0 N--CA 1.449 -0.477 0 CA-C-N 115.771 -0.65 . . . . 0.0 110.492 179.794 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -69.63 -33.41 72.59 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.213 179.454 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -74.6 -0.08 16.63 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.048 0.452 . . . . 0.0 111.14 179.909 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 21.9 tp60 -119.47 -48.69 2.39 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.998 179.698 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -89.36 -52.94 4.78 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.864 0.364 . . . . 0.0 111.904 -179.236 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' GLU . . . . . 0.45 ' O ' HG23 ' A' ' 72' ' ' VAL . 6.4 tt0 -68.68 -26.1 65.13 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.143 0.497 . . . . 0.0 110.549 -179.094 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 51.2 tptt -58.91 -27.89 65.69 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.886 179.511 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 52.6 mt-10 -63.76 -21.94 66.66 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-O 121.443 0.64 . . . . 0.0 110.99 179.758 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 71' ' ' GLU . . . . . 0.522 ' O ' ' HD3' ' A' ' 75' ' ' ARG . 13.2 tp10 -94.8 -44.56 7.71 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 115.521 -0.763 . . . . 0.0 108.951 178.307 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.596 HG12 ' HB2' ' A' ' 121' ' ' GLU . 26.7 t -62.78 -40.45 88.69 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-N 115.351 -0.84 . . . . 0.0 112.883 -178.496 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 9.9 p-10 -70.86 -20.83 62.49 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-O 121.091 0.472 . . . . 0.0 111.64 -178.933 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 18.0 m -100.89 -5.05 26.61 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-O 121.335 0.588 . . . . 0.0 110.192 179.888 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' ARG . . . . . 0.522 ' HD3' ' O ' ' A' ' 71' ' ' GLU . 1.9 mpt_? -113.9 39.43 2.7 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.593 -0.73 . . . . 0.0 109.545 -179.92 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -119.26 173.83 6.71 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.381 -0.827 . . . . 0.0 110.886 -179.926 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.416 HD13 ' HB1' ' A' ' 131' ' ' ALA . 7.0 pt -133.31 140.41 47.03 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.067 178.585 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 71.0 t80 -96.53 126.52 41.77 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 109.624 -0.51 . . . . 0.0 109.624 179.815 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 5.1 t -108.09 114.33 46.23 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.983 -179.381 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -120.38 169.45 14.06 Favored Glycine 0 N--CA 1.448 -0.513 0 N-CA-C 111.192 -0.763 . . . . 0.0 111.192 179.36 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 93.8 m-20 60.06 38.66 20.47 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-O 121.073 0.463 . . . . 0.0 110.754 -179.712 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 2.4 t -81.82 164.44 2.91 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.753 -179.145 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 83' ' ' ASP . . . . . 0.414 ' O ' ' HB2' ' A' ' 86' ' ' CYS . 9.7 t70 -67.3 137.01 55.75 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 109.676 -0.491 . . . . 0.0 109.676 179.414 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 30.5 p90 -64.27 -18.46 64.59 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.897 -178.647 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -113.23 24.92 11.81 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 121.037 0.446 . . . . 0.0 110.747 179.851 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 86' ' ' CYS . . . . . 0.414 ' HB2' ' O ' ' A' ' 83' ' ' ASP . 0.1 OUTLIER -85.85 156.45 20.55 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.397 0.618 . . . . 0.0 111.549 -179.966 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 87' ' ' THR . . . . . 0.483 ' O ' ' HG2' ' A' ' 90' ' ' GLU . 0.0 OUTLIER -119.31 146.64 41.35 Favored Pre-proline 0 C--N 1.322 -0.601 0 CA-C-N 115.432 -0.804 . . . . 0.0 110.343 -179.941 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 88' ' ' PRO . . . . . 0.566 ' HD3' HD13 ' A' ' 106' ' ' ILE . 15.0 Cg_endo -56.7 -40.2 86.04 Favored 'Trans proline' 0 C--N 1.344 0.319 0 C-N-CA 122.83 2.353 . . . . 0.0 112.734 -178.867 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 60.1 mm-40 -60.42 -50.49 73.36 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.531 -179.097 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 90' ' ' GLU . . . . . 0.719 ' O ' ' HB2' ' A' ' 94' ' ' HIS . 6.6 pt-20 -63.91 -24.6 67.8 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.624 -0.262 . . . . 0.0 111.143 -178.706 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 70.0 t -80.76 -48.66 19.3 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.04 -179.343 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 2.3 pt20 -70.92 -34.03 71.12 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 112.1 0.407 . . . . 0.0 112.1 -178.167 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 18.5 pt20 -79.19 -23.8 43.61 Favored 'General case' 0 C--N 1.329 -0.285 0 C-N-CA 120.496 -0.481 . . . . 0.0 110.896 -179.502 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 94' ' ' HIS . . . . . 0.719 ' HB2' ' O ' ' A' ' 90' ' ' GLU . 0.4 OUTLIER -74.48 -43.66 55.0 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.048 0.452 . . . . 0.0 110.067 179.684 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 21.8 m-30 -78.17 -12.52 60.0 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.521 -179.873 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 96' ' ' GLN . . . . . 0.603 ' HA ' ' O ' ' A' ' 99' ' ' GLY . 15.8 tt0 -65.08 -19.72 66.13 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.378 -179.959 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 12.3 m -66.54 -26.82 67.32 Favored 'General case' 0 N--CA 1.451 -0.401 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.272 179.217 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 5.9 m -97.02 -42.97 7.64 Favored 'General case' 0 N--CA 1.453 -0.324 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.168 179.365 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 99' ' ' GLY . . . . . 0.603 ' O ' ' HA ' ' A' ' 96' ' ' GLN . . . -150.65 142.16 9.35 Favored Glycine 0 N--CA 1.445 -0.712 0 C-N-CA 120.875 -0.679 . . . . 0.0 111.768 179.855 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 100' ' ' THR . . . . . 0.417 ' HB ' ' CZ ' ' A' ' 122' ' ' PHE . 0.2 OUTLIER -62.68 150.03 42.09 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 120.937 0.398 . . . . 0.0 111.524 -179.924 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 2.2 p -119.54 129.26 75.55 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.754 -179.762 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 55.7 t30 -98.24 -39.51 8.81 Favored 'General case' 0 N--CA 1.463 0.175 0 CA-C-O 121.145 0.498 . . . . 0.0 110.274 179.385 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 2.2 tpt180 -145.93 153.29 40.66 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.223 -179.883 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 5.8 p -151.22 133.09 5.39 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.07 179.763 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 1.5 m -121.27 122.88 40.89 Favored 'General case' 0 C--N 1.32 -0.674 0 N-CA-C 110.129 -0.323 . . . . 0.0 110.129 179.612 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 106' ' ' ILE . . . . . 0.566 HD13 ' HD3' ' A' ' 88' ' ' PRO . 21.0 tt -113.49 144.36 21.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 120.935 0.398 . . . . 0.0 110.729 -179.514 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 27.0 tp -132.45 128.7 38.02 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.305 179.662 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -86.91 114.56 23.65 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.715 179.7 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 109' ' ' ASP . . . . . 0.423 ' O ' ' HG2' ' A' ' 115' ' ' LYS . 15.0 t70 -75.39 140.93 43.28 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.872 0.367 . . . . 0.0 110.796 -179.74 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -132.31 28.7 4.36 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 109.352 -0.61 . . . . 0.0 109.352 179.159 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 5.1 t80 -109.82 -2.37 17.32 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.589 -0.732 . . . . 0.0 109.707 179.919 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 106.89 6.29 34.81 Favored Glycine 0 N--CA 1.448 -0.51 0 CA-C-N 115.527 -0.76 . . . . 0.0 112.52 179.98 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 36.3 mt-30 -94.87 158.74 34.61 Favored Pre-proline 0 C--N 1.324 -0.511 0 N-CA-C 109.407 -0.59 . . . . 0.0 109.407 179.593 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 15.2 Cg_endo -58.11 119.3 6.47 Favored 'Trans proline' 0 C--N 1.345 0.388 0 C-N-CA 122.105 1.87 . . . . 0.0 110.88 178.886 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 115' ' ' LYS . . . . . 0.423 ' HG2' ' O ' ' A' ' 109' ' ' ASP . 58.3 mttt -74.4 173.37 10.38 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 109.976 -0.379 . . . . 0.0 109.976 -179.499 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 116' ' ' GLY . . . . . 0.529 ' HA2' HD11 ' A' ' 106' ' ' ILE . . . 98.32 3.27 57.68 Favored Glycine 0 N--CA 1.443 -0.844 0 C-N-CA 120.178 -1.01 . . . . 0.0 112.165 179.626 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 5.2 m-30 -54.82 117.56 3.51 Favored 'General case' 0 N--CA 1.463 0.206 0 N-CA-C 110.188 -0.301 . . . . 0.0 110.188 179.582 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -147.29 168.42 21.79 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.046 0.45 . . . . 0.0 111.451 -178.811 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 34.5 p90 -148.24 129.84 14.98 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.643 -0.708 . . . . 0.0 109.722 178.41 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 6.4 m -105.3 145.95 12.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 N-CA-C 109.742 -0.466 . . . . 0.0 109.742 179.781 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 121' ' ' GLU . . . . . 0.596 ' HB2' HG12 ' A' ' 72' ' ' VAL . 6.1 pt-20 -133.9 152.58 51.91 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 120.657 0.265 . . . . 0.0 111.005 -179.701 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 122' ' ' PHE . . . . . 0.417 ' CZ ' ' HB ' ' A' ' 100' ' ' THR . 13.0 t80 -148.64 167.01 26.6 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.124 179.525 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 10.1 t -83.44 -41.92 17.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.488 -0.324 . . . . 0.0 111.535 -179.286 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 43.6 mm-40 -74.02 132.12 42.06 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.121 0.486 . . . . 0.0 111.593 -179.087 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 2.4 mp -74.71 -35.51 37.44 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.444 -179.657 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -59.25 -33.49 71.1 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.151 0.5 . . . . 0.0 110.937 -179.692 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -65.56 -54.97 20.52 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.926 179.958 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 10.3 p -66.49 -29.6 47.06 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.804 -179.564 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 8.3 tt0 -60.39 -42.62 96.28 Favored 'General case' 0 C--N 1.333 -0.142 0 CA-C-O 120.909 0.385 . . . . 0.0 110.431 179.619 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 29.3 m-80 -73.59 -31.0 63.35 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.119 179.282 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 131' ' ' ALA . . . . . 0.416 ' HB1' HD13 ' A' ' 77' ' ' ILE . . . -67.93 -52.44 36.08 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.664 -0.698 . . . . 0.0 111.274 -179.885 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 4.0 pp -64.23 -22.22 66.87 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.85 0.357 . . . . 0.0 111.015 -179.802 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 5.5 tp -77.55 -55.72 5.13 Favored 'General case' 0 N--CA 1.451 -0.403 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.46 179.556 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 33.7 mt -123.74 103.04 8.14 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.078 -179.836 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -145.42 -71.25 0.26 Allowed 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 120.788 0.328 . . . . 0.0 111.56 -179.316 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 4.1 pt-20 -66.61 110.35 3.16 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.268 0.556 . . . . 0.0 111.268 -179.224 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 14.0 m -153.45 -58.14 0.13 Allowed 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.787 -0.642 . . . . 0.0 109.726 179.334 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -163.88 122.15 1.88 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.1 -0.5 . . . . 0.0 109.978 179.174 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -138.83 115.61 10.74 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 109.189 -0.671 . . . . 0.0 109.189 179.425 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 3.3 t60 64.83 16.45 10.47 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-O 120.896 0.379 . . . . 0.0 110.853 179.883 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 91.39 6.28 66.42 Favored Glycine 0 N--CA 1.448 -0.522 0 C-N-CA 120.893 -0.67 . . . . 0.0 111.761 -179.034 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -119.99 160.45 22.73 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 110.204 -0.295 . . . . 0.0 110.204 179.794 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 14.2 pt20 -108.22 126.5 52.87 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 109.443 -0.577 . . . . 0.0 109.443 178.573 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -112.47 175.43 5.44 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.688 -179.553 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 78.4 tttt -116.97 124.04 48.41 Favored 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 109.461 -0.57 . . . . 0.0 109.461 178.73 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 99.1 t -116.01 125.24 73.03 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.639 0 CA-C-O 120.941 0.4 . . . . 0.0 110.448 179.862 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 11.9 t -127.36 149.58 49.99 Favored 'General case' 0 N--CA 1.447 -0.624 0 N-CA-C 109.583 -0.525 . . . . 0.0 109.583 179.927 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -65.58 127.26 31.17 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.55 -0.295 . . . . 0.0 110.964 -179.829 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 19.9 ttpt -91.2 66.42 5.66 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.376 0.607 . . . . 0.0 109.683 179.88 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 150' ' ' ARG . . . . . 0.491 ' C ' ' HD2' ' A' ' 150' ' ' ARG . 0.0 OUTLIER -88.9 76.16 7.95 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 109.439 -0.578 . . . . 0.0 109.439 179.819 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 8.2 t -62.33 133.84 55.65 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.456 -0.793 . . . . 0.0 111.015 -179.799 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 152' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 -175.68 175.6 2.03 Favored 'General case' 0 C--O 1.235 0.326 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.039 179.995 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 7.7 pt -81.04 153.41 72.22 Favored Pre-proline 0 C--N 1.323 -0.564 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.951 -179.806 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 6.7 Cg_exo -74.08 73.24 3.81 Favored 'Trans proline' 0 C--N 1.346 0.443 0 C-N-CA 123.032 2.488 . . . . 0.0 111.832 179.436 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.443 -0.862 0 N-CA-C 110.803 -0.919 . . . . 0.0 110.803 -179.879 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.481 1.103 0 CA-C-O 120.669 0.271 . . . . 0.0 110.614 . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 133.24 158.8 8.88 Favored Glycine 0 N--CA 1.447 -0.624 0 C-N-CA 120.793 -0.718 . . . . 0.0 111.666 179.71 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 8.4 t -155.25 132.98 11.31 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 120.781 0.324 . . . . 0.0 110.214 -179.965 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -100.83 159.12 15.45 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.132 179.289 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 80.1 m-70 -133.8 155.27 50.12 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 110.417 -0.216 . . . . 0.0 110.417 -179.585 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 20.2 t-80 -162.27 131.5 4.37 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.478 179.765 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 34.7 m80 -93.4 -179.79 5.16 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.009 0.433 . . . . 0.0 111.271 -179.623 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 27.7 m80 -144.24 167.66 21.9 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.774 -0.648 . . . . 0.0 109.413 179.387 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 5.7 t60 -150.55 141.18 22.62 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.965 0.412 . . . . 0.0 111.034 -179.781 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 5.2 p80 -144.04 130.04 19.5 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.087 179.645 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 1.2 m -127.26 142.34 51.49 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.557 -179.627 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 15.1 m -126.74 127.2 44.72 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 110.068 -0.345 . . . . 0.0 110.068 179.825 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -81.89 172.46 53.07 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.989 -0.624 . . . . 0.0 113.242 -178.852 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 74.2 mt -103.64 -178.53 3.69 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 120.694 0.283 . . . . 0.0 110.765 -179.776 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 16.1 m -123.9 152.96 67.16 Favored Pre-proline 0 C--N 1.326 -0.417 0 CA-C-N 116.444 -0.344 . . . . 0.0 111.32 -179.719 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -75.31 -171.76 1.1 Allowed 'Trans proline' 0 C--N 1.345 0.378 0 C-N-CA 123.047 2.498 . . . . 0.0 112.499 179.802 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 4.7 mtp85 -130.07 146.97 51.76 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.509 -179.249 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -103.46 168.93 17.93 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 121.09 -0.576 . . . . 0.0 111.716 179.583 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -129.28 160.2 33.74 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.766 0.317 . . . . 0.0 110.824 -179.685 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 8.9 p-80 -131.79 161.33 33.15 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.54 179.616 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -131.78 -178.41 4.87 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.459 -0.337 . . . . 0.0 110.74 179.998 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -157.99 174.48 35.28 Favored Glycine 0 N--CA 1.452 -0.263 0 N-CA-C 111.601 -0.6 . . . . 0.0 111.601 -179.957 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 39.7 m -132.81 157.74 44.23 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 120.912 0.386 . . . . 0.0 111.259 -179.704 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 15.9 p-10 -106.27 -151.91 0.46 Allowed 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.839 -0.618 . . . . 0.0 110.551 179.865 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -148.04 167.69 24.3 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-O 120.651 0.263 . . . . 0.0 110.596 179.88 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 30.1 mt-10 -101.18 -172.81 2.23 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.076 -179.755 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 44.7 t0 -85.27 162.26 19.2 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.692 179.865 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 28.2 ptm -94.29 168.44 10.9 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.851 -179.491 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 21.8 pttm -86.43 -178.14 6.36 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.041 179.971 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -98.02 172.62 7.51 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.967 0.413 . . . . 0.0 111.105 -179.528 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 67.3 ttt180 -114.32 153.26 30.07 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.104 -179.552 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 48.1 tp -62.07 133.28 55.09 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-O 120.937 0.398 . . . . 0.0 110.59 179.342 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 49.0 tttm -130.72 119.31 22.17 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.003 179.839 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 4.6 tp10 -120.06 149.94 41.38 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.965 -0.562 . . . . 0.0 110.315 -179.662 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 19.0 tt -101.07 147.67 7.87 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 CA-C-N 115.877 -0.601 . . . . 0.0 109.943 179.778 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 3.7 mm-40 -125.73 -169.64 2.04 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-O 120.766 0.317 . . . . 0.0 110.868 -179.686 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 4.8 pt-20 -135.32 147.28 49.11 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.741 -0.663 . . . . 0.0 109.272 179.577 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -142.56 149.1 38.61 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.091 0.472 . . . . 0.0 111.361 -178.78 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -122.18 -28.46 4.36 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.516 -0.766 . . . . 0.0 110.271 179.333 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 77.57 98.59 0.2 Allowed Glycine 0 C--N 1.334 0.422 0 CA-C-N 116.011 -0.541 . . . . 0.0 112.634 179.407 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -160.0 -172.22 3.54 Favored 'General case' 0 C--N 1.328 -0.359 0 O-C-N 122.891 -0.182 . . . . 0.0 110.623 179.074 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 64.7 tp -75.33 92.63 2.8 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-O 121.225 0.536 . . . . 0.0 110.569 179.696 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' ARG . . . . . 0.409 ' HB3' ' SD ' ' A' ' 45' ' ' MET . 4.3 ttp180 -155.84 159.73 39.62 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.836 -0.62 . . . . 0.0 109.675 -179.673 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 16.9 mt-10 -86.17 23.47 1.53 Allowed 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.371 0.605 . . . . 0.0 111.185 179.91 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' MET . . . . . 0.409 ' SD ' ' HB3' ' A' ' 43' ' ' ARG . 6.4 ptm -83.56 14.18 3.98 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.061 179.39 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 45.4 mt-30 -73.23 -27.53 61.65 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.837 -0.619 . . . . 0.0 109.713 179.408 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -75.8 -12.27 60.14 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.509 -0.769 . . . . 0.0 110.146 179.136 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 3.4 tmmt? -74.89 -2.62 27.69 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.214 -0.903 . . . . 0.0 110.21 179.681 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 8.1 p -60.5 -23.95 29.96 Favored 'Isoleucine or valine' 0 C--O 1.235 0.302 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.831 179.337 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 26.1 mm-40 -59.46 -27.28 65.95 Favored 'General case' 0 N--CA 1.457 -0.087 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.285 179.187 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 12.7 mtmm -97.85 -37.25 9.91 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.945 -0.571 . . . . 0.0 110.441 178.455 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -59.38 -22.32 61.19 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.687 -179.748 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 17.9 ptt? -58.47 -23.09 56.83 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.767 0.317 . . . . 0.0 110.859 179.814 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -105.86 4.37 39.18 Favored Glycine 0 N--CA 1.447 -0.592 0 C-N-CA 120.668 -0.777 . . . . 0.0 111.711 179.258 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -129.11 21.76 5.74 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.139 0.495 . . . . 0.0 110.635 -179.829 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 15.2 m -63.46 -9.83 5.7 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.272 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.666 -179.845 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 84.5 mt-30 -81.81 -9.19 59.68 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.539 179.546 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 17.3 t70 -132.58 -51.89 0.93 Allowed 'General case' 0 CA--C 1.531 0.217 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.44 179.372 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 4.5 m -67.31 -56.57 9.21 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.069 0.462 . . . . 0.0 111.874 -179.591 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -102.29 25.99 8.27 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.602 -178.736 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 2.4 t -72.57 -29.9 63.93 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 120.993 0.425 . . . . 0.0 110.178 -179.738 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -66.4 -26.46 67.25 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.257 179.681 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 2.9 m -64.22 -26.74 68.64 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.106 0.479 . . . . 0.0 110.436 -179.979 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -72.31 -31.11 65.41 Favored 'General case' 0 N--CA 1.453 -0.318 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.175 179.242 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -76.12 0.82 17.51 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.984 0.421 . . . . 0.0 111.243 179.826 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 57.1 tp60 -120.44 -50.52 2.22 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.972 179.679 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -85.04 -57.18 3.2 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 111.927 0.343 . . . . 0.0 111.927 -179.384 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 2.1 tp10 -63.09 -29.23 70.65 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-O 121.344 0.592 . . . . 0.0 110.211 -179.62 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 52.7 tptt -58.98 -28.59 66.49 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.459 -0.792 . . . . 0.0 111.251 179.453 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 63.4 mt-10 -62.43 -24.32 67.36 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-O 120.906 0.384 . . . . 0.0 111.174 -179.786 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 11.9 tp10 -96.83 -35.69 10.86 Favored 'General case' 0 C--N 1.318 -0.797 0 N-CA-C 109.841 -0.429 . . . . 0.0 109.841 178.423 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.526 HG12 ' HB2' ' A' ' 121' ' ' GLU . 57.5 t -65.98 -42.31 91.5 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.878 -179.337 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 24.9 p-10 -71.33 -14.71 62.28 Favored 'General case' 0 N--CA 1.466 0.325 0 CA-C-O 121.118 0.485 . . . . 0.0 110.864 -179.726 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 74' ' ' SER . . . . . 0.415 ' OG ' ' HD3' ' A' ' 75' ' ' ARG . 12.4 p -97.89 -14.61 20.59 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.093 178.894 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 75' ' ' ARG . . . . . 0.476 ' CZ ' HG12 ' A' ' 125' ' ' ILE . 0.1 OUTLIER -111.23 46.47 1.08 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.423 -0.808 . . . . 0.0 110.401 -178.85 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -122.25 172.42 8.31 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.456 179.921 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.544 HD13 ' HB1' ' A' ' 131' ' ' ALA . 10.4 pt -130.83 140.71 48.02 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.61 179.394 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 87.2 t80 -95.54 123.07 38.91 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.839 -0.619 . . . . 0.0 109.836 179.908 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 3.9 t -106.48 113.18 42.43 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.849 -179.426 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -120.45 165.68 13.79 Favored Glycine 0 N--CA 1.448 -0.516 0 C-N-CA 120.937 -0.649 . . . . 0.0 111.801 179.938 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 2.6 m-20 61.79 39.44 13.96 Favored 'General case' 0 N--CA 1.471 0.598 0 CA-C-O 121.112 0.482 . . . . 0.0 111.014 -179.602 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 2.3 t -81.4 162.99 3.39 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.693 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.331 -179.417 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 83' ' ' ASP . . . . . 0.729 ' OD2' ' HB2' ' A' ' 142' ' ' ARG . 0.3 OUTLIER -63.87 138.52 58.51 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 109.845 -0.428 . . . . 0.0 109.845 179.445 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 30.5 p90 -62.67 -12.44 23.55 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.107 -0.497 . . . . 0.0 112.057 -179.443 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -123.24 27.74 7.41 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.744 0.307 . . . . 0.0 110.948 -179.485 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -86.08 147.55 26.12 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 116.444 -0.344 . . . . 0.0 110.783 -179.975 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 87' ' ' THR . . . . . 0.487 ' HB ' ' OE1' ' A' ' 89' ' ' GLU . 15.5 p -108.88 146.82 34.59 Favored Pre-proline 0 C--N 1.325 -0.487 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.894 179.658 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 88' ' ' PRO . . . . . 0.428 ' HD3' HD13 ' A' ' 106' ' ' ILE . 16.1 Cg_endo -57.41 -37.43 97.45 Favored 'Trans proline' 0 C--N 1.344 0.29 0 C-N-CA 122.663 2.242 . . . . 0.0 113.2 -179.083 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 89' ' ' GLU . . . . . 0.487 ' OE1' ' HB ' ' A' ' 87' ' ' THR . 5.4 mp0 -64.75 -47.46 78.12 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.912 -178.347 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 90' ' ' GLU . . . . . 0.416 ' HG2' ' O ' ' A' ' 87' ' ' THR . 7.4 pt-20 -67.01 -24.19 66.0 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.843 0.354 . . . . 0.0 111.157 -178.958 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 75.0 t -79.97 -47.99 20.91 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.96 -179.535 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -69.43 -33.76 73.44 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.569 -0.287 . . . . 0.0 111.593 -178.356 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 11.1 pt20 -76.65 -30.17 56.72 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 120.516 -0.474 . . . . 0.0 111.143 -179.176 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 8.1 t60 -73.13 -40.04 65.23 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.053 0.454 . . . . 0.0 109.976 179.898 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 18.6 m-30 -78.35 -14.57 59.35 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.301 179.751 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 96' ' ' GLN . . . . . 0.595 ' HA ' ' O ' ' A' ' 99' ' ' GLY . 28.2 tt0 -67.57 -20.85 65.44 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.401 -0.818 . . . . 0.0 110.257 179.699 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 5.1 m -69.18 -23.09 63.88 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.648 -0.706 . . . . 0.0 110.173 179.241 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 26.5 m -99.91 -42.17 6.9 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.76 -0.655 . . . . 0.0 110.324 179.276 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 99' ' ' GLY . . . . . 0.595 ' O ' ' HA ' ' A' ' 96' ' ' GLN . . . -150.63 144.72 12.18 Favored Glycine 0 N--CA 1.442 -0.95 0 CA-C-N 115.906 -0.588 . . . . 0.0 111.84 179.897 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -63.25 146.5 53.29 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 120.993 0.425 . . . . 0.0 111.304 179.857 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 2.0 p -115.73 126.47 73.28 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.777 -179.533 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 5.5 t30 -94.57 -39.07 10.57 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 121.179 0.514 . . . . 0.0 110.047 179.309 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 3.0 tpt180 -150.01 151.98 34.17 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.121 -179.872 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 4.0 p -148.59 128.97 4.53 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-O 121.09 0.472 . . . . 0.0 110.122 179.483 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 105' ' ' THR . . . . . 0.596 ' HB ' ' CE1' ' A' ' 119' ' ' TYR . 4.9 m -121.47 122.38 39.63 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 116.473 -0.33 . . . . 0.0 110.573 179.845 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 106' ' ' ILE . . . . . 0.566 HD11 ' HA2' ' A' ' 116' ' ' GLY . 19.6 tt -108.87 148.54 12.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 O-C-N 123.206 0.316 . . . . 0.0 110.408 179.741 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 17.6 tp -136.75 124.89 22.99 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.386 -179.914 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -89.0 117.37 27.97 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 120.81 0.338 . . . . 0.0 110.651 179.434 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 4.7 t70 -77.94 139.64 39.21 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.698 0.285 . . . . 0.0 110.762 179.596 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -123.34 32.6 5.6 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 121.061 0.457 . . . . 0.0 110.261 179.274 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 1.7 t80 -113.73 -3.06 13.57 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.302 -179.889 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 106.65 6.7 35.06 Favored Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 120.828 -0.701 . . . . 0.0 112.738 -179.565 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 113' ' ' GLN . . . . . 0.415 ' HB3' ' HD2' ' A' ' 114' ' ' PRO . 27.5 mt-30 -92.02 158.81 38.96 Favored Pre-proline 0 C--N 1.323 -0.568 0 N-CA-C 109.564 -0.532 . . . . 0.0 109.564 -179.939 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 114' ' ' PRO . . . . . 0.415 ' HD2' ' HB3' ' A' ' 113' ' ' GLN . 18.0 Cg_endo -59.7 106.45 0.32 Allowed 'Trans proline' 0 C--N 1.347 0.466 0 C-N-CA 122.411 2.074 . . . . 0.0 111.528 179.148 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 5.2 mttp -68.3 175.46 3.29 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.07 -0.513 . . . . 0.0 110.588 -179.475 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 116' ' ' GLY . . . . . 0.566 ' HA2' HD11 ' A' ' 106' ' ' ILE . . . 98.51 4.02 57.28 Favored Glycine 0 N--CA 1.441 -0.993 0 C-N-CA 120.04 -1.076 . . . . 0.0 111.658 -179.628 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 30.0 m-85 -52.82 116.06 2.14 Favored 'General case' 0 CA--C 1.521 -0.152 0 O-C-N 123.776 0.339 . . . . 0.0 110.364 179.86 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -144.05 176.19 9.48 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 121.057 0.456 . . . . 0.0 111.236 -179.255 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 119' ' ' TYR . . . . . 0.596 ' CE1' ' HB ' ' A' ' 105' ' ' THR . 50.0 p90 -159.93 137.34 9.64 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.497 -0.774 . . . . 0.0 109.171 178.93 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 10.9 m -111.01 143.57 20.63 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 178.925 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 121' ' ' GLU . . . . . 0.526 ' HB2' HG12 ' A' ' 72' ' ' VAL . 4.4 pt-20 -128.8 157.05 42.56 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 116.562 -0.29 . . . . 0.0 111.054 -179.207 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 122' ' ' PHE . . . . . 0.415 ' O ' ' HA ' ' A' ' 72' ' ' VAL . 11.9 t80 -161.37 168.99 22.85 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 109.691 -0.485 . . . . 0.0 109.691 179.491 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 1.8 t -85.54 -48.38 16.21 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-O 120.921 0.391 . . . . 0.0 111.342 -179.182 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 11.0 mt-10 -62.44 130.31 44.6 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.956 -0.565 . . . . 0.0 111.795 -178.971 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 125' ' ' ILE . . . . . 0.476 HG12 ' CZ ' ' A' ' 75' ' ' ARG . 2.3 mp -76.06 -32.4 23.0 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.468 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.63 -179.795 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 13.2 t70 -60.43 -39.49 87.64 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.102 0.477 . . . . 0.0 110.232 179.333 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -61.36 -53.64 54.04 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.523 -0.762 . . . . 0.0 111.545 179.963 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 7.3 p -68.74 -28.11 38.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.127 -179.511 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 25.5 tt0 -58.86 -47.6 84.32 Favored 'General case' 0 C--N 1.334 -0.096 0 CA-C-O 121.023 0.439 . . . . 0.0 110.32 179.629 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 76.8 m-20 -70.9 -33.29 70.42 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.741 -0.663 . . . . 0.0 109.864 179.533 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 131' ' ' ALA . . . . . 0.544 ' HB1' HD13 ' A' ' 77' ' ' ILE . . . -66.06 -40.52 90.98 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.542 -0.754 . . . . 0.0 112.219 -179.408 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 3.9 pp -79.49 -16.84 55.35 Favored 'General case' 0 C--N 1.329 -0.325 0 O-C-N 122.128 -0.358 . . . . 0.0 110.959 179.905 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 5.2 tp -86.12 -50.15 7.23 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.283 -179.529 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 28.3 mt -132.47 112.68 12.33 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.501 -0.318 . . . . 0.0 110.944 -179.208 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 3.5 m-20 -168.95 -49.41 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.336 179.664 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 1.9 pt-20 -75.09 79.48 2.25 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.58 -0.737 . . . . 0.0 111.206 179.737 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 6.5 m -135.4 -59.93 0.76 Allowed 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.912 -0.586 . . . . 0.0 110.188 179.224 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 7.9 tm-20 -149.31 128.05 12.48 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 109.606 -0.516 . . . . 0.0 109.606 179.959 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -149.78 121.04 7.82 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 179.329 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 140' ' ' HIS . . . . . 0.662 ' HB3' ' OD2' ' A' ' 83' ' ' ASP . 5.4 t60 60.83 13.47 4.46 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-O 121.076 0.465 . . . . 0.0 111.614 178.742 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 98.58 -6.11 60.7 Favored Glycine 0 N--CA 1.447 -0.611 0 C-N-CA 120.803 -0.713 . . . . 0.0 112.216 -179.621 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 142' ' ' ARG . . . . . 0.729 ' HB2' ' OD2' ' A' ' 83' ' ' ASP . 2.1 mpt_? -114.01 -169.32 1.5 Allowed 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.008 0.432 . . . . 0.0 110.187 179.347 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 15.3 pt20 -131.65 138.74 48.88 Favored 'General case' 0 C--N 1.319 -0.754 0 N-CA-C 109.254 -0.647 . . . . 0.0 109.254 178.796 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -123.2 177.79 5.41 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-N 115.867 -0.606 . . . . 0.0 109.935 -179.528 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 1.7 tmtp? -117.27 121.8 42.17 Favored 'General case' 0 C--N 1.315 -0.907 0 N-CA-C 109.588 -0.523 . . . . 0.0 109.588 179.09 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 98.8 t -114.82 119.78 62.61 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-O 120.827 0.346 . . . . 0.0 110.911 -179.427 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 5.1 t -122.09 153.15 39.05 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.022 179.665 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -70.83 125.61 27.33 Favored 'General case' 0 N--CA 1.445 -0.713 0 CA-C-O 120.858 0.361 . . . . 0.0 111.187 179.956 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 18.9 ttpp -90.88 68.95 6.38 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.502 0.668 . . . . 0.0 109.29 179.909 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 13.0 tpt180 -84.92 90.18 7.74 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.731 -0.668 . . . . 0.0 109.965 -179.999 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 6.8 t -74.29 129.8 38.49 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.581 -0.736 . . . . 0.0 109.658 179.69 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 152' ' ' ASN . . . . . . . . . . . . . 28.6 t-20 -174.89 148.23 1.04 Allowed 'General case' 0 C--O 1.235 0.309 0 CA-C-N 116.184 -0.462 . . . . 0.0 109.971 -179.029 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 11.5 pt -68.66 145.45 97.01 Favored Pre-proline 0 CA--C 1.533 0.303 0 O-C-N 123.186 0.304 . . . . 0.0 111.184 -179.806 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 25.9 Cg_exo -63.31 122.91 11.25 Favored 'Trans proline' 0 C--O 1.235 0.373 0 C-N-CA 122.5 2.133 . . . . 0.0 111.965 179.211 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.246 0.874 0 CA-C-O 118.686 -1.063 . . . . 0.0 111.84 179.996 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.7 ttp . . . . . 0 N--CA 1.48 1.072 0 N-CA-C 110.06 -0.348 . . . . 0.0 110.06 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 99.81 172.54 30.4 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.589 -0.815 . . . . 0.0 111.807 179.953 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 3.3 p -142.19 152.69 43.38 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.971 0.386 . . . . 0.0 111.15 -179.583 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -134.3 141.62 47.0 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 109.724 -0.473 . . . . 0.0 109.724 179.605 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -127.56 3.41 6.18 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.667 0.27 . . . . 0.0 111.167 -179.563 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 2.0 p80 -76.43 143.39 40.61 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 116.367 -0.378 . . . . 0.0 111.077 -179.732 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 15.3 p-80 -90.74 -176.5 4.72 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 109.966 -0.383 . . . . 0.0 109.966 179.287 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 49.9 m80 -126.13 173.33 9.31 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.648 0.261 . . . . 0.0 110.953 -179.406 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 52.3 p-80 -153.72 158.39 40.94 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.008 -0.542 . . . . 0.0 109.715 179.501 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -146.22 131.77 18.78 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 120.815 0.341 . . . . 0.0 111.003 -179.764 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 14.5 m -155.95 138.71 15.19 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.268 -0.424 . . . . 0.0 109.971 179.501 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 23.5 m -132.39 139.15 47.97 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.744 0.306 . . . . 0.0 110.816 179.336 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -116.55 118.48 4.19 Favored Glycine 0 N--CA 1.447 -0.6 0 C-N-CA 120.924 -0.655 . . . . 0.0 112.248 -179.502 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -141.64 179.22 6.95 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 109.669 -0.493 . . . . 0.0 109.669 179.678 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 4.7 p -104.94 126.75 30.29 Favored Pre-proline 0 C--N 1.323 -0.557 0 N-CA-C 110.35 -0.241 . . . . 0.0 110.35 179.727 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -70.75 90.2 0.62 Allowed 'Trans proline' 0 N--CA 1.462 -0.324 0 C-N-CA 122.475 2.116 . . . . 0.0 111.383 179.036 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 82.6 mtt-85 -74.9 143.96 43.54 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.617 -0.72 . . . . 0.0 110.403 -179.488 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 153.11 -171.58 32.08 Favored Glycine 0 N--CA 1.444 -0.81 0 C-N-CA 120.654 -0.784 . . . . 0.0 112.261 179.868 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -138.78 174.07 10.91 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 109.907 -0.405 . . . . 0.0 109.907 179.888 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 14.9 m170 -97.33 138.45 34.78 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 120.683 0.278 . . . . 0.0 110.384 179.447 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 28.6 ttt -142.77 132.29 23.7 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 120.984 0.421 . . . . 0.0 110.537 -179.864 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -153.3 -151.45 5.72 Favored Glycine 0 N--CA 1.448 -0.503 0 C-N-CA 120.852 -0.689 . . . . 0.0 111.927 179.847 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -73.96 86.26 1.79 Allowed 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.014 0.435 . . . . 0.0 110.793 -179.915 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 24.1 t0 -82.19 -42.18 19.34 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.928 179.916 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 32.3 mt -118.53 143.43 46.75 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.276 179.942 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -74.09 -171.65 1.18 Allowed 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.696 0.284 . . . . 0.0 110.971 -179.997 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -61.26 -54.97 37.3 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.41 -178.752 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 1.9 mmm 54.14 48.69 20.39 Favored 'General case' 0 N--CA 1.466 0.33 0 O-C-N 123.639 0.587 . . . . 0.0 110.964 -179.597 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 94.8 mttt -69.22 126.82 30.98 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.721 -0.672 . . . . 0.0 111.247 -179.383 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 68.1 tttt -93.76 127.67 39.61 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 121.002 0.43 . . . . 0.0 109.883 179.367 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 18.6 ptt180 -121.62 176.49 5.68 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.116 -179.941 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 35.7 mt -98.01 130.73 44.83 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 120.864 0.364 . . . . 0.0 111.04 -179.685 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 12.5 tmtt? -135.72 60.56 1.68 Allowed 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 179.071 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 35.3 mt-10 -81.94 78.48 8.64 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.933 -0.576 . . . . 0.0 109.865 179.878 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 40.5 mm -113.9 101.5 12.54 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.336 179.972 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 28.5 mt-10 -120.91 88.14 2.88 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.925 -0.579 . . . . 0.0 110.011 179.793 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -158.46 123.83 4.39 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.323 0.583 . . . . 0.0 111.667 -179.72 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -131.14 155.3 47.23 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.468 -0.787 . . . . 0.0 110.043 179.413 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.404 ' HB3' ' SD ' ' A' ' 45' ' ' MET . . . -150.43 169.42 21.5 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 109.817 -0.438 . . . . 0.0 109.817 -179.792 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -144.95 69.23 0.4 Allowed Glycine 0 N--CA 1.449 -0.438 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.564 -179.628 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -152.8 -177.23 6.13 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 110.374 -0.232 . . . . 0.0 110.374 179.713 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 29.4 tp -73.81 84.43 1.67 Allowed 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.226 0.536 . . . . 0.0 110.387 179.741 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 17.0 tpt180 -130.8 151.83 50.8 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.161 -179.623 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 26.8 mm-40 -82.45 19.49 1.24 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.301 -179.825 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' MET . . . . . 0.404 ' SD ' ' HB3' ' A' ' 39' ' ' ALA . 11.9 ptm -83.7 4.37 29.0 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.735 -179.431 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 43.5 mt-30 -66.19 -22.03 66.33 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.945 -0.571 . . . . 0.0 110.578 179.911 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -78.89 -8.69 59.07 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.601 -0.727 . . . . 0.0 111.446 -179.763 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' LYS . . . . . 0.462 ' O ' ' HG2' ' A' ' 52' ' ' GLU . 10.3 ttpt -78.23 -6.31 54.54 Favored 'General case' 0 C--O 1.234 0.28 0 CA-C-O 120.991 0.424 . . . . 0.0 110.345 -179.869 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 8.4 p -59.32 -25.65 31.4 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.325 0 CA-C-N 115.936 -0.575 . . . . 0.0 111.581 -179.48 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 39.5 mt-10 -61.47 -30.61 70.71 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 121.008 0.432 . . . . 0.0 110.922 -179.876 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 15.3 mtmm -95.83 -36.27 11.19 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.244 -179.532 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' GLU . . . . . 0.462 ' HG2' ' O ' ' A' ' 48' ' ' LYS . 3.0 mm-40 -75.63 -16.99 60.14 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.936 -178.337 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 25.7 ptm -64.47 -24.11 67.51 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.178 0.513 . . . . 0.0 110.117 178.731 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -97.83 1.06 59.49 Favored Glycine 0 N--CA 1.446 -0.69 0 N-CA-C 110.885 -0.886 . . . . 0.0 110.885 178.595 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -121.23 21.23 11.22 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.235 0.54 . . . . 0.0 110.215 179.931 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 13.6 m -65.88 -8.62 6.78 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 115.739 -0.664 . . . . 0.0 111.809 -179.664 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 23.1 mm-40 -83.67 -7.93 59.39 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 121.142 0.496 . . . . 0.0 109.937 179.756 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -129.73 -53.07 1.15 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.432 -0.804 . . . . 0.0 110.602 -179.804 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 8.0 m -68.75 -62.86 1.2 Allowed 'General case' 0 CA--C 1.531 0.243 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.241 179.954 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -91.23 30.45 1.25 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.213 0.53 . . . . 0.0 110.95 -179.822 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 22.8 t -77.32 -31.24 54.49 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.955 -178.938 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -63.62 -24.52 67.83 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.024 0.44 . . . . 0.0 111.37 -179.941 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 47.1 m -62.28 -25.73 68.01 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.927 -0.578 . . . . 0.0 110.836 179.931 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -70.05 -31.46 69.09 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.53 179.358 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -80.59 5.75 14.54 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.012 0.434 . . . . 0.0 111.136 -179.762 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 49.7 tp60 -125.16 -40.38 2.15 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.448 -0.342 . . . . 0.0 111.006 179.616 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -94.1 -53.45 3.96 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.917 0.389 . . . . 0.0 111.341 179.826 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 3.2 tp10 -70.12 -30.36 67.53 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.032 -179.421 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.11 -25.76 64.11 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.542 -179.886 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 39.9 mt-10 -62.98 -23.77 67.59 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.186 0.517 . . . . 0.0 110.925 179.883 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 71' ' ' GLU . . . . . 0.608 ' O ' ' HD3' ' A' ' 75' ' ' ARG . 8.3 tp10 -96.66 -43.59 7.49 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.992 -0.549 . . . . 0.0 109.572 178.225 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.427 HG22 ' HA ' ' A' ' 123' ' ' VAL . 41.3 t -61.15 -44.13 97.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 115.467 -0.788 . . . . 0.0 112.459 -178.709 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 8.5 p-10 -63.29 -27.57 69.42 Favored 'General case' 0 N--CA 1.471 0.624 0 N-CA-C 111.921 0.341 . . . . 0.0 111.921 -179.31 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 40.0 t -95.54 -2.27 48.84 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-O 120.909 0.385 . . . . 0.0 110.741 179.772 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 75' ' ' ARG . . . . . 0.608 ' HD3' ' O ' ' A' ' 71' ' ' GLU . 2.2 mpt_? -115.26 46.95 1.37 Allowed 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.389 0.614 . . . . 0.0 109.582 -179.473 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -125.43 174.48 8.16 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.188 -0.914 . . . . 0.0 110.436 179.874 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.479 HG23 HG23 ' A' ' 128' ' ' VAL . 7.4 pt -131.02 140.48 48.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-O 120.742 0.306 . . . . 0.0 110.794 179.141 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 13.7 t80 -92.75 118.72 31.38 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.616 -0.72 . . . . 0.0 109.361 179.636 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.419 HG21 ' HE2' ' A' ' 95' ' ' PHE . 6.8 t -104.01 109.51 27.46 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-N 116.332 -0.395 . . . . 0.0 109.974 179.452 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -118.03 165.85 12.74 Favored Glycine 0 N--CA 1.447 -0.576 0 C-N-CA 120.773 -0.727 . . . . 0.0 111.995 -179.262 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 9.9 m120 59.21 41.12 20.69 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-O 121.043 0.449 . . . . 0.0 110.741 -179.621 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.422 HG12 ' H ' ' A' ' 83' ' ' ASP . 2.1 t -80.02 167.56 2.15 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-N 115.566 -0.743 . . . . 0.0 110.41 -179.172 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 83' ' ' ASP . . . . . 0.46 ' OD1' ' HD3' ' A' ' 142' ' ' ARG . 33.0 t70 -75.03 141.34 43.91 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.043 0.449 . . . . 0.0 110.627 179.901 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 29.2 p90 -63.09 -17.02 61.84 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.673 -0.694 . . . . 0.0 112.613 -178.743 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -110.42 8.27 23.13 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.828 0.346 . . . . 0.0 111.481 -179.592 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 86' ' ' CYS . . . . . 0.499 ' SG ' ' HB2' ' A' ' 140' ' ' HIS . 1.0 OUTLIER -73.27 142.42 47.22 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.154 0.502 . . . . 0.0 111.299 -179.893 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 87' ' ' THR . . . . . 0.506 ' O ' ' HG2' ' A' ' 90' ' ' GLU . 12.2 p -109.73 154.12 42.64 Favored Pre-proline 0 C--N 1.322 -0.602 0 CA-C-N 115.464 -0.789 . . . . 0.0 109.856 178.997 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 88' ' ' PRO . . . . . 0.559 ' O ' ' HG2' ' A' ' 92' ' ' GLN . 14.0 Cg_endo -57.25 -36.83 99.07 Favored 'Trans proline' 0 C--O 1.233 0.236 0 C-N-CA 122.391 2.061 . . . . 0.0 112.274 -179.726 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 89' ' ' GLU . . . . . 0.443 ' O ' ' HG2' ' A' ' 93' ' ' GLN . 28.2 mp0 -62.93 -51.51 66.64 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.781 -179.42 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 90' ' ' GLU . . . . . 0.506 ' HG2' ' O ' ' A' ' 87' ' ' THR . 8.3 pt-20 -63.96 -22.68 67.03 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.615 0.245 . . . . 0.0 111.344 -178.751 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 66.5 t -82.98 -48.05 17.97 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.521 -179.583 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 92' ' ' GLN . . . . . 0.559 ' HG2' ' O ' ' A' ' 88' ' ' PRO . 16.4 pt20 -71.86 -33.56 68.51 Favored 'General case' 0 N--CA 1.465 0.284 0 N-CA-C 111.881 0.326 . . . . 0.0 111.881 -178.397 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 93' ' ' GLN . . . . . 0.443 ' HG2' ' O ' ' A' ' 89' ' ' GLU . 0.8 OUTLIER -77.27 -27.87 53.29 Favored 'General case' 0 C--N 1.329 -0.32 0 C-N-CA 120.464 -0.494 . . . . 0.0 110.636 -179.515 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 94' ' ' HIS . . . . . 0.495 ' HB2' ' O ' ' A' ' 90' ' ' GLU . 0.1 OUTLIER -71.9 -43.33 65.52 Favored 'General case' 0 CA--C 1.517 -0.295 0 CA-C-O 121.11 0.481 . . . . 0.0 110.276 179.719 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 95' ' ' PHE . . . . . 0.419 ' HE2' HG21 ' A' ' 79' ' ' VAL . 21.0 m-30 -79.13 -15.36 58.25 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.93 -179.453 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 96' ' ' GLN . . . . . 0.507 ' HA ' ' O ' ' A' ' 99' ' ' GLY . 33.6 tt0 -64.64 -23.5 67.28 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.558 179.967 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 13.4 m -65.72 -33.41 75.8 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.409 179.454 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 11.1 m -94.95 -40.78 9.5 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.368 179.871 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 99' ' ' GLY . . . . . 0.507 ' O ' ' HA ' ' A' ' 96' ' ' GLN . . . -146.46 130.39 3.66 Favored Glycine 0 N--CA 1.444 -0.829 0 C-N-CA 120.688 -0.768 . . . . 0.0 111.742 -179.916 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 100' ' ' THR . . . . . 0.421 ' HB ' ' CZ ' ' A' ' 122' ' ' PHE . 0.2 OUTLIER -58.56 146.45 35.7 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 120.984 0.421 . . . . 0.0 111.539 179.894 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 2.4 p -111.99 131.43 63.43 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.112 -179.133 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 23.1 t-20 -99.19 -45.02 6.04 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 178.566 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 18.5 mmt180 -141.55 150.23 41.84 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-N 115.509 -0.769 . . . . 0.0 110.088 179.473 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 6.1 p -146.17 136.53 18.2 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-O 121.013 0.435 . . . . 0.0 110.191 179.385 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 105' ' ' THR . . . . . 0.516 ' HB ' ' CE1' ' A' ' 119' ' ' TYR . 1.4 m -128.15 129.4 46.47 Favored 'General case' 0 C--N 1.319 -0.722 0 N-CA-C 109.731 -0.47 . . . . 0.0 109.731 179.309 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 106' ' ' ILE . . . . . 0.537 HD13 ' HD3' ' A' ' 88' ' ' PRO . 20.1 tt -120.47 147.47 24.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-O 120.953 0.406 . . . . 0.0 111.294 -179.298 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 15.3 tp -133.11 143.52 49.34 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.25 179.361 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -104.5 119.34 38.76 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 120.588 0.232 . . . . 0.0 110.662 179.463 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 8.5 t70 -80.08 130.41 35.23 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.992 0.425 . . . . 0.0 111.245 -179.76 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 10.8 mmmm -114.66 20.51 15.23 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.272 -179.799 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 63.9 t80 -98.68 -11.26 22.18 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.491 0.662 . . . . 0.0 109.913 -179.446 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 111.15 8.56 23.49 Favored Glycine 0 N--CA 1.448 -0.534 0 CA-C-N 115.557 -0.747 . . . . 0.0 112.394 -179.269 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 113' ' ' GLN . . . . . 0.443 ' HB3' ' HD2' ' A' ' 114' ' ' PRO . 24.4 mt-30 -94.42 160.58 31.44 Favored Pre-proline 0 C--N 1.323 -0.553 0 N-CA-C 109.188 -0.671 . . . . 0.0 109.188 179.663 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 114' ' ' PRO . . . . . 0.443 ' HD2' ' HB3' ' A' ' 113' ' ' GLN . 14.4 Cg_endo -57.37 114.2 1.84 Allowed 'Trans proline' 0 C--N 1.346 0.415 0 C-N-CA 122.357 2.038 . . . . 0.0 111.686 179.119 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 6.3 mttp -76.98 179.3 6.3 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.403 -179.897 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 116' ' ' GLY . . . . . 0.498 ' HA2' HD11 ' A' ' 106' ' ' ILE . . . 94.99 1.45 63.1 Favored Glycine 0 N--CA 1.445 -0.718 0 C-N-CA 120.056 -1.068 . . . . 0.0 111.488 -179.884 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 6.8 t80 -53.74 117.31 3.06 Favored 'General case' 0 C--O 1.234 0.278 0 O-C-N 123.806 0.357 . . . . 0.0 110.125 179.744 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -145.32 175.34 10.37 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.781 -179.356 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 119' ' ' TYR . . . . . 0.516 ' CE1' ' HB ' ' A' ' 105' ' ' THR . 51.7 p90 -157.48 134.16 9.93 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.561 -0.745 . . . . 0.0 109.292 179.047 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 14.7 m -110.49 140.15 30.88 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 N-CA-C 109.766 -0.457 . . . . 0.0 109.766 179.705 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 121' ' ' GLU . . . . . 0.422 ' HB2' HG12 ' A' ' 72' ' ' VAL . 7.9 pt-20 -124.45 154.22 40.81 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 116.596 -0.275 . . . . 0.0 110.642 -179.993 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 122' ' ' PHE . . . . . 0.421 ' CZ ' ' HB ' ' A' ' 100' ' ' THR . 11.0 t80 -149.29 164.84 33.71 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.203 179.94 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 123' ' ' VAL . . . . . 0.427 ' HA ' HG22 ' A' ' 72' ' ' VAL . 11.8 t -81.56 -42.64 19.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.317 -179.579 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 81.9 mt-10 -76.38 138.73 40.6 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.043 0.449 . . . . 0.0 111.171 -179.541 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 2.5 mp -75.87 -30.55 21.2 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-N 115.745 -0.661 . . . . 0.0 110.029 179.572 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -54.15 -47.21 72.18 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 115.802 -0.636 . . . . 0.0 111.17 179.596 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -56.26 -58.0 9.84 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.396 -0.82 . . . . 0.0 111.488 -179.362 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 128' ' ' VAL . . . . . 0.479 HG23 HG23 ' A' ' 77' ' ' ILE . 8.9 p -66.04 -32.8 59.73 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-N 116.31 -0.404 . . . . 0.0 111.676 -179.049 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 44.9 tt0 -60.99 -41.11 95.85 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.817 0.341 . . . . 0.0 110.88 -179.579 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 94.4 m-20 -79.4 -28.9 41.83 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.148 0.499 . . . . 0.0 110.01 179.36 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -70.12 -39.13 75.63 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.651 -0.704 . . . . 0.0 112.045 -179.414 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 4.2 pp -75.89 -11.47 59.97 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.938 0.399 . . . . 0.0 110.809 -179.901 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -88.84 -58.94 2.37 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.841 -0.618 . . . . 0.0 111.063 -179.923 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 75.8 mt -125.53 108.27 11.44 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.681 -178.864 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 2.8 m-20 -162.99 -50.66 0.04 OUTLIER 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.771 -0.65 . . . . 0.0 110.801 179.876 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 5.0 pt-20 -73.35 85.11 1.45 Allowed 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.779 -0.646 . . . . 0.0 111.448 -179.917 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 6.3 m -137.97 -59.32 0.65 Allowed 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.58 -0.736 . . . . 0.0 110.154 179.091 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 22.7 tt0 -153.79 127.94 9.04 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.217 -179.816 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -145.57 115.61 7.42 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 108.764 -0.828 . . . . 0.0 108.764 179.101 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 140' ' ' HIS . . . . . 0.499 ' HB2' ' SG ' ' A' ' 86' ' ' CYS . 2.8 t60 65.83 21.09 11.47 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-O 121.058 0.456 . . . . 0.0 110.373 -179.596 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 87.53 4.4 80.13 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.213 -179.601 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 142' ' ' ARG . . . . . 0.46 ' HD3' ' OD1' ' A' ' 83' ' ' ASP . 0.8 OUTLIER -125.66 165.19 19.02 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 109.945 -0.391 . . . . 0.0 109.945 179.838 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 12.9 pt20 -107.85 139.61 42.18 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-O 120.982 0.42 . . . . 0.0 110.697 179.656 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -121.68 178.08 4.99 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.037 -179.97 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 28.5 ttpt -116.22 122.41 44.93 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 109.912 -0.403 . . . . 0.0 109.912 179.063 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 95.7 t -113.92 123.13 69.28 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-O 120.968 0.413 . . . . 0.0 110.525 179.713 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 30.5 t -125.05 149.37 47.86 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 109.507 -0.553 . . . . 0.0 109.507 179.892 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -68.83 127.55 33.48 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 110.56 -0.163 . . . . 0.0 110.56 179.687 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 64.8 tttp -90.94 83.15 5.62 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.294 0.569 . . . . 0.0 110.505 -179.74 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 23.8 tpt180 -96.32 98.69 10.48 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 115.741 -0.663 . . . . 0.0 109.36 179.01 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 4.9 t -103.03 127.46 50.27 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.083 179.867 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 152' ' ' ASN . . . . . . . . . . . . . 5.2 t-20 -169.69 153.76 5.14 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.227 -179.857 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 153' ' ' ILE . . . . . 0.432 ' HA ' ' HD3' ' A' ' 154' ' ' PRO . 8.9 pt -62.24 127.98 90.42 Favored Pre-proline 0 C--N 1.327 -0.402 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.075 179.727 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 154' ' ' PRO . . . . . 0.432 ' HD3' ' HA ' ' A' ' 153' ' ' ILE . 4.3 Cg_exo -75.32 74.13 4.27 Favored 'Trans proline' 0 C--N 1.345 0.373 0 C-N-CA 122.559 2.173 . . . . 0.0 112.494 179.787 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 0.98 0 CA-C-O 118.924 -0.931 . . . . 0.0 111.331 179.874 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 15.3 tpt . . . . . 0 N--CA 1.482 1.163 0 CA-C-O 120.66 0.267 . . . . 0.0 110.669 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -131.5 -171.47 12.86 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.855 -0.688 . . . . 0.0 111.722 179.869 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 40.2 m 60.37 45.65 10.86 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-O 121.395 0.617 . . . . 0.0 111.062 179.936 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 1.1 m -89.33 170.76 10.29 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.381 -0.827 . . . . 0.0 110.532 179.953 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 37.4 m170 -73.77 143.47 46.03 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.74 0.305 . . . . 0.0 110.588 179.835 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 41.7 m-70 -101.03 -61.58 1.35 Allowed 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.398 -0.365 . . . . 0.0 111.262 -179.318 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 1.3 p-80 -162.06 157.06 22.9 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.746 0.307 . . . . 0.0 111.19 -178.735 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 33.0 p80 -167.38 142.62 3.98 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 109.193 -0.669 . . . . 0.0 109.193 178.865 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 19.2 p80 -165.12 150.82 9.69 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.024 0.44 . . . . 0.0 110.972 179.992 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 29.9 t-80 -138.99 145.16 39.36 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.661 -0.7 . . . . 0.0 109.375 179.407 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 1.2 p -126.77 148.58 49.9 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 120.853 0.358 . . . . 0.0 111.251 -179.879 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -102.2 172.39 6.92 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.619 179.667 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -88.91 -167.54 43.17 Favored Glycine 0 CA--C 1.518 0.234 0 C-N-CA 120.709 -0.757 . . . . 0.0 112.325 179.863 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 2.0 pt? -138.5 161.87 35.96 Favored 'General case' 0 C--N 1.326 -0.415 0 O-C-N 122.576 -0.367 . . . . 0.0 110.509 -179.904 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 1.6 p -134.04 102.37 12.16 Favored Pre-proline 0 C--N 1.325 -0.496 0 CA-C-O 121.391 0.615 . . . . 0.0 110.543 -179.825 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 94.5 Cg_endo -89.95 -176.85 1.24 Allowed 'Trans proline' 0 N--CA 1.456 -0.734 0 C-N-CA 122.818 2.345 . . . . 0.0 112.582 179.79 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 32.8 mtp180 -109.18 124.18 50.42 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.364 179.628 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -92.4 -167.79 39.78 Favored Glycine 0 N--CA 1.445 -0.749 0 C-N-CA 120.638 -0.792 . . . . 0.0 112.695 -179.621 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 51.3 m -151.21 146.87 26.39 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 110.273 -0.269 . . . . 0.0 110.273 179.661 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 9.3 p-80 -99.5 166.2 11.27 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.5 -179.857 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 31.9 mtt -83.46 152.03 25.17 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.607 -0.27 . . . . 0.0 110.389 -179.732 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -177.78 162.11 29.66 Favored Glycine 0 N--CA 1.447 -0.604 0 C-N-CA 120.773 -0.727 . . . . 0.0 111.883 -179.977 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -144.93 160.3 41.54 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.756 0.278 . . . . 0.0 110.634 -179.958 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 30.9 t0 -116.37 164.75 14.07 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.459 -0.337 . . . . 0.0 110.212 -179.863 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -105.83 -156.95 0.59 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.634 -0.257 . . . . 0.0 111.128 -179.385 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 15.9 pt-20 -129.96 -172.68 2.84 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.882 0.373 . . . . 0.0 111.102 -179.727 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 26.8 t70 -153.4 148.83 27.14 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.414 -179.681 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 21.3 ttt -120.69 136.97 54.7 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 109.734 -0.469 . . . . 0.0 109.734 179.505 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 20.5 tptt -129.53 154.92 46.56 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.757 0.313 . . . . 0.0 111.739 -179.033 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 96.9 mttt -130.77 169.2 16.02 Favored 'General case' 0 C--O 1.235 0.308 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.251 179.636 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 5.2 ptp180 -165.53 139.75 4.72 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 116.541 -0.3 . . . . 0.0 110.712 179.765 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -144.93 156.68 44.11 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 110.209 -0.293 . . . . 0.0 110.209 179.68 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 16.1 ttmt -151.21 114.7 4.86 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.907 0.384 . . . . 0.0 111.032 -179.97 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 6.4 mt-10 -128.66 84.13 2.21 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.059 179.381 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 39.2 pt -129.23 147.37 33.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 116.712 -0.222 . . . . 0.0 111.484 -179.055 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 22.1 mm-40 43.89 62.82 1.8 Allowed 'General case' 0 N--CA 1.468 0.473 0 O-C-N 124.249 0.968 . . . . 0.0 112.824 178.891 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 10.7 tt0 -82.75 -17.12 45.39 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.257 0.551 . . . . 0.0 109.936 179.732 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -130.06 110.26 11.49 Favored 'General case' 0 C--O 1.236 0.348 0 CA-C-N 115.619 -0.718 . . . . 0.0 110.995 -179.743 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -161.43 122.29 2.76 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.877 179.797 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 165.33 138.89 2.52 Favored Glycine 0 N--CA 1.449 -0.464 0 C-N-CA 120.876 -0.678 . . . . 0.0 112.234 179.693 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -164.1 -164.06 0.83 Allowed 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 110.085 -0.339 . . . . 0.0 110.085 -179.75 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 18.6 tp -81.56 85.88 6.45 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.17 0.51 . . . . 0.0 110.067 179.622 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 13.4 tpp180 -145.95 132.36 19.65 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.899 -0.591 . . . . 0.0 109.652 179.96 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 3.3 tp10 -82.79 39.26 0.61 Allowed 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.559 0.695 . . . . 0.0 110.911 -179.742 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 17.6 ptt? -87.83 11.66 14.98 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.656 -0.702 . . . . 0.0 109.538 179.089 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 19.4 mm-40 -66.87 -22.5 65.98 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.277 -0.874 . . . . 0.0 111.101 -179.682 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -68.8 -14.4 63.0 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 121.348 0.594 . . . . 0.0 110.6 179.54 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 20.2 ttpp -83.24 1.05 42.73 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.589 -0.732 . . . . 0.0 110.33 179.814 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 8.3 p -59.48 -26.2 33.6 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.205 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.971 -179.912 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 26.6 mt-10 -67.14 -24.67 65.93 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 115.912 -0.586 . . . . 0.0 110.344 179.534 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 11.4 mtmm -97.22 -29.74 13.4 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.579 -0.737 . . . . 0.0 110.594 179.331 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 38.0 mm-40 -80.96 -5.32 57.36 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.677 -179.661 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 10.7 ptp -62.33 -30.83 71.44 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.891 0.377 . . . . 0.0 110.652 -179.932 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -91.55 3.89 79.17 Favored Glycine 0 N--CA 1.447 -0.594 0 C-N-CA 120.722 -0.751 . . . . 0.0 111.319 178.838 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -130.41 26.66 5.08 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.432 -0.384 . . . . 0.0 110.275 -179.802 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 18.4 m -71.03 -4.33 4.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 120.773 0.32 . . . . 0.0 111.497 -179.489 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 28.7 mt-30 -94.25 -4.17 49.35 Favored 'General case' 0 CA--C 1.505 -0.785 0 N-CA-C 108.108 -1.071 . . . . 0.0 108.108 179.778 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -124.51 -60.64 1.38 Allowed 'General case' 0 C--N 1.31 -1.113 0 CA-C-N 113.399 -1.728 . . . . 0.0 110.023 -177.239 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 10.1 m -72.75 -70.1 0.37 Allowed 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.091 -0.959 . . . . 0.0 111.844 -179.36 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -85.08 33.7 0.54 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.816 0.341 . . . . 0.0 111.455 -178.931 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 3.6 t -75.74 -27.87 58.3 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 109.675 -0.491 . . . . 0.0 109.675 -179.812 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 1.3 m -65.61 -25.83 67.56 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-O 121.238 0.542 . . . . 0.0 110.681 178.857 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 18.1 m -60.88 -28.15 68.66 Favored 'General case' 0 N--CA 1.45 -0.46 0 CA-C-N 115.63 -0.714 . . . . 0.0 110.63 179.989 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -72.62 -33.45 66.66 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.488 179.15 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -76.44 -2.12 30.45 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.25 0.548 . . . . 0.0 110.793 179.865 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 64.7 tt0 -114.39 -54.71 2.56 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.923 179.924 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -85.49 -56.09 3.69 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.793 -178.509 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 68' ' ' GLU . . . . . 0.458 ' O ' HG23 ' A' ' 72' ' ' VAL . 1.2 tt0 -62.65 -31.48 72.35 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.952 0.406 . . . . 0.0 110.896 -179.61 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 48.7 tptt -55.55 -30.01 59.99 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.587 -0.733 . . . . 0.0 111.299 179.937 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 99.3 mt-10 -58.63 -41.6 86.32 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.027 0.441 . . . . 0.0 110.455 179.469 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 71' ' ' GLU . . . . . 0.429 ' O ' ' HD2' ' A' ' 75' ' ' ARG . 7.4 tp10 -76.86 -43.37 36.38 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.057 -0.519 . . . . 0.0 109.871 179.308 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.583 HG12 ' HB2' ' A' ' 121' ' ' GLU . 43.8 t -60.75 -40.34 84.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 115.648 -0.705 . . . . 0.0 111.624 -179.241 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 7.5 t0 -68.23 -23.26 64.78 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-O 121.318 0.58 . . . . 0.0 110.723 -179.934 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 1.2 t -95.29 -9.9 31.77 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 121.686 0.755 . . . . 0.0 109.782 179.705 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 75' ' ' ARG . . . . . 0.429 ' HD2' ' O ' ' A' ' 71' ' ' GLU . 0.0 OUTLIER -111.75 44.77 1.32 Allowed 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.396 -0.82 . . . . 0.0 110.659 -179.259 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 76' ' ' SER . . . . . 0.464 ' OG ' ' HE2' ' A' ' 149' ' ' LYS . 0.0 OUTLIER -126.92 171.69 11.07 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.818 179.367 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 13.8 pt -131.01 136.95 56.97 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-N 116.465 -0.334 . . . . 0.0 110.198 178.64 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 78' ' ' TYR . . . . . 0.447 ' O ' ' HA ' ' A' ' 146' ' ' VAL . 43.0 t80 -91.12 123.29 34.47 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.142 -179.896 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 10.4 t -107.04 111.92 37.72 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.658 -179.749 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -121.48 170.8 14.84 Favored Glycine 0 N--CA 1.446 -0.682 0 N-CA-C 111.362 -0.695 . . . . 0.0 111.362 179.974 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 13.1 m120 58.39 44.24 18.6 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-O 121.294 0.569 . . . . 0.0 110.441 -179.627 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.498 HG12 ' H ' ' A' ' 83' ' ' ASP . 1.7 t -90.07 172.1 1.03 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 CA-C-N 115.338 -0.846 . . . . 0.0 110.615 -179.011 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 83' ' ' ASP . . . . . 0.498 ' H ' HG12 ' A' ' 82' ' ' VAL . 9.2 t0 -68.74 137.25 53.91 Favored 'General case' 0 N--CA 1.451 -0.395 0 N-CA-C 109.666 -0.494 . . . . 0.0 109.666 179.476 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 34.9 p90 -61.71 -18.14 58.51 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.459 -179.28 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -118.15 20.59 13.14 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.511 -0.313 . . . . 0.0 111.332 179.942 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 86' ' ' CYS . . . . . 0.459 ' SG ' ' HB3' ' A' ' 83' ' ' ASP . 0.5 OUTLIER -77.16 145.25 37.83 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.984 0.421 . . . . 0.0 110.869 179.603 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 87' ' ' THR . . . . . 0.474 ' O ' ' HG2' ' A' ' 90' ' ' GLU . 55.9 p -103.08 151.22 38.43 Favored Pre-proline 0 C--N 1.323 -0.57 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.261 179.637 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -61.77 -29.2 82.84 Favored 'Trans proline' 0 C--O 1.233 0.24 0 C-N-CA 122.3 2.0 . . . . 0.0 111.93 179.835 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 89' ' ' GLU . . . . . 0.517 ' O ' ' HG2' ' A' ' 93' ' ' GLN . 27.8 mt-10 -66.27 -53.26 38.94 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.343 -0.844 . . . . 0.0 111.933 -178.837 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 90' ' ' GLU . . . . . 0.474 ' HG2' ' O ' ' A' ' 87' ' ' THR . 9.2 pt-20 -61.71 -24.98 67.13 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.967 0.413 . . . . 0.0 111.24 -179.268 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 69.3 t -79.84 -48.57 20.41 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.275 -179.106 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 92' ' ' GLN . . . . . 0.411 ' O ' ' HB2' ' A' ' 96' ' ' GLN . 0.9 OUTLIER -70.29 -32.88 70.85 Favored 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 112.196 0.443 . . . . 0.0 112.196 -178.183 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 93' ' ' GLN . . . . . 0.517 ' HG2' ' O ' ' A' ' 89' ' ' GLU . 9.6 pt20 -79.79 -28.77 40.25 Favored 'General case' 0 C--N 1.325 -0.491 0 C-N-CA 120.061 -0.656 . . . . 0.0 111.19 -179.331 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 58.7 t-80 -68.92 -45.22 71.4 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.808 0.337 . . . . 0.0 110.57 179.989 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 23.9 m-85 -78.53 -11.8 59.98 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.68 -179.388 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 96' ' ' GLN . . . . . 0.563 ' HA ' ' O ' ' A' ' 99' ' ' GLY . 42.0 tt0 -68.9 -21.7 64.22 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 121.23 0.538 . . . . 0.0 109.958 179.802 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 4.5 m -66.52 -32.24 73.47 Favored 'General case' 0 N--CA 1.452 -0.347 0 CA-C-N 115.673 -0.694 . . . . 0.0 109.531 178.545 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 2.1 m -88.25 -47.83 8.14 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.546 -0.752 . . . . 0.0 110.075 179.575 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 99' ' ' GLY . . . . . 0.563 ' O ' ' HA ' ' A' ' 96' ' ' GLN . . . -147.07 142.35 10.23 Favored Glycine 0 N--CA 1.447 -0.603 0 C-N-CA 121.023 -0.608 . . . . 0.0 111.751 179.801 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -60.07 144.03 50.56 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 120.827 0.346 . . . . 0.0 111.503 -179.639 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 2.3 p -114.86 127.76 72.27 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.289 179.832 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 20.1 t-20 -95.1 -40.99 9.34 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.145 0.498 . . . . 0.0 110.098 179.649 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 3.2 tpp180 -144.87 155.91 43.72 Favored 'General case' 0 N--CA 1.45 -0.425 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.263 -179.487 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 5.7 p -154.32 133.95 3.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.109 179.804 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -126.13 127.74 46.23 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 109.736 -0.468 . . . . 0.0 109.736 179.006 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 106' ' ' ILE . . . . . 0.424 HD11 ' HA2' ' A' ' 116' ' ' GLY . 20.1 tt -111.04 146.07 16.54 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-O 121.017 0.437 . . . . 0.0 110.951 -179.368 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 43.3 tp -130.15 138.32 50.58 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.26 179.816 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -103.64 113.68 27.38 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 109.963 -0.384 . . . . 0.0 109.963 179.453 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 6.4 t70 -72.3 133.32 44.94 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.054 0.454 . . . . 0.0 111.367 -179.677 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 11.2 mmmt -111.31 19.22 18.5 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.722 -179.868 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 3.0 t80 -101.0 -9.93 21.0 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.973 0.416 . . . . 0.0 110.324 -179.372 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 110.83 -0.53 28.8 Favored Glycine 0 N--CA 1.449 -0.441 0 CA-C-N 115.788 -0.642 . . . . 0.0 112.227 -179.808 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 3.5 mt-30 -81.28 158.63 69.13 Favored Pre-proline 0 C--N 1.323 -0.581 0 N-CA-C 110.332 -0.247 . . . . 0.0 110.332 -179.911 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 13.5 Cg_endo -56.57 103.77 0.13 Allowed 'Trans proline' 0 C--N 1.347 0.486 0 C-N-CA 122.687 2.258 . . . . 0.0 111.319 178.419 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 7.8 mttp -68.84 176.67 2.94 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.606 -0.725 . . . . 0.0 110.776 -178.444 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 116' ' ' GLY . . . . . 0.424 ' HA2' HD11 ' A' ' 106' ' ' ILE . . . 99.92 4.52 55.53 Favored Glycine 0 N--CA 1.441 -0.998 0 C-N-CA 120.398 -0.906 . . . . 0.0 111.187 -179.54 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 59.2 m-85 -52.27 118.3 3.43 Favored 'General case' 0 CA--C 1.522 -0.098 0 C-N-CA 122.63 0.372 . . . . 0.0 110.121 179.401 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -146.23 176.33 9.84 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 121.052 0.453 . . . . 0.0 111.234 -178.916 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 43.5 p90 -156.56 133.95 10.7 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.418 -0.81 . . . . 0.0 109.706 179.155 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 15.7 m -108.42 142.5 20.89 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 N-CA-C 109.108 -0.701 . . . . 0.0 109.108 178.62 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 121' ' ' GLU . . . . . 0.583 ' HB2' HG12 ' A' ' 72' ' ' VAL . 5.9 pt-20 -131.39 156.18 46.0 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 120.927 0.394 . . . . 0.0 111.884 -178.901 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 13.8 t80 -152.08 166.64 30.99 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.796 -0.638 . . . . 0.0 109.755 179.134 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 13.0 t -83.96 -52.94 12.16 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-O 120.76 0.314 . . . . 0.0 111.242 -179.52 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 38.6 mt-10 -67.88 131.7 45.99 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.832 -179.66 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 2.2 mp -70.91 -31.07 44.25 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.88 -179.161 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -54.47 -40.48 68.47 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-O 121.15 0.5 . . . . 0.0 111.228 179.327 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -62.76 -57.05 12.29 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.837 -0.62 . . . . 0.0 111.273 -179.877 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 9.9 p -65.91 -27.97 42.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.192 -179.503 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 4.8 tp-100 -59.08 -44.58 91.92 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.902 0.382 . . . . 0.0 110.247 179.506 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 52.9 m-80 -77.31 -29.66 53.72 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.919 -0.582 . . . . 0.0 109.72 179.209 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -67.38 -41.6 84.75 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.799 -0.637 . . . . 0.0 111.342 179.821 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 4.2 pp -77.96 -10.31 59.53 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.915 0.388 . . . . 0.0 110.605 179.482 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -86.7 -52.51 5.48 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.928 -0.578 . . . . 0.0 109.648 179.257 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 27.7 mt -117.46 102.83 9.53 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.598 -0.728 . . . . 0.0 109.647 179.919 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 135' ' ' ASN . . . . . 0.536 ' OD1' ' HB ' ' A' ' 146' ' ' VAL . 1.3 p30 -142.96 -78.1 0.23 Allowed 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 112.422 0.527 . . . . 0.0 112.422 -178.46 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -68.76 109.99 4.11 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.432 0.634 . . . . 0.0 111.549 -178.67 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 56.2 m -152.43 -61.53 0.16 Allowed 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.709 -0.678 . . . . 0.0 109.666 179.0 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 -157.76 120.36 3.84 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 116.699 -0.228 . . . . 0.0 110.943 179.225 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -140.6 116.66 10.49 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 109.555 -0.535 . . . . 0.0 109.555 179.482 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 1.3 t60 61.69 17.21 8.48 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-O 120.992 0.425 . . . . 0.0 110.863 -179.866 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 96.34 -7.38 66.36 Favored Glycine 0 N--CA 1.448 -0.556 0 C-N-CA 120.992 -0.623 . . . . 0.0 112.173 -179.76 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 3.8 mpt_? -112.26 160.61 17.47 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.938 0.399 . . . . 0.0 111.443 -179.39 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 16.3 pt20 -104.79 116.9 32.8 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 109.387 -0.597 . . . . 0.0 109.387 178.641 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 144' ' ' LEU . . . . . 0.452 HD23 HG13 ' A' ' 82' ' ' VAL . 0.5 OUTLIER -95.32 176.73 6.09 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.081 -179.16 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 1.8 tmtp? -117.64 120.94 39.55 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 109.679 -0.489 . . . . 0.0 109.679 179.599 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 146' ' ' VAL . . . . . 0.536 ' HB ' ' OD1' ' A' ' 135' ' ' ASN . 99.3 t -119.34 133.02 67.5 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-O 120.879 0.371 . . . . 0.0 111.26 -179.336 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 5.3 m -135.24 142.86 46.06 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.114 -0.494 . . . . 0.0 109.954 178.92 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -58.87 124.98 21.65 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.846 0.355 . . . . 0.0 110.844 179.766 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 149' ' ' LYS . . . . . 0.464 ' HE2' ' OG ' ' A' ' 76' ' ' SER . 23.7 ttpt -91.17 63.33 5.01 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.562 0.696 . . . . 0.0 109.189 -179.877 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -84.5 81.51 8.81 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.405 -0.816 . . . . 0.0 109.81 -179.872 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 13.0 t -61.24 129.03 39.28 Favored 'General case' 0 N--CA 1.45 -0.432 0 CA-C-N 115.926 -0.579 . . . . 0.0 109.614 179.204 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 152' ' ' ASN . . . . . . . . . . . . . 64.3 t30 -161.97 155.3 20.83 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 109.643 -0.503 . . . . 0.0 109.643 -179.295 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 153' ' ' ILE . . . . . 0.447 ' HA ' ' HD3' ' A' ' 154' ' ' PRO . 15.1 pt -74.68 137.25 73.86 Favored Pre-proline 0 C--N 1.322 -0.606 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.621 -179.956 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 154' ' ' PRO . . . . . 0.447 ' HD3' ' HA ' ' A' ' 153' ' ' ILE . 26.3 Cg_exo -62.65 140.48 81.21 Favored 'Trans proline' 0 C--N 1.343 0.289 0 C-N-CA 122.476 2.117 . . . . 0.0 112.111 179.729 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.244 0.746 0 CA-C-O 118.994 -0.892 . . . . 0.0 111.701 -179.647 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 37.7 mtt . . . . . 0 N--CA 1.479 0.977 0 N-CA-C 110.13 -0.322 . . . . 0.0 110.13 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 105.21 62.28 0.64 Allowed Glycine 0 N--CA 1.447 -0.568 0 C-N-CA 120.773 -0.727 . . . . 0.0 111.718 -179.311 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 2.0 m -96.94 89.48 4.86 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 120.958 0.408 . . . . 0.0 111.313 -179.261 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 1.1 m -130.66 93.34 3.41 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.119 -0.491 . . . . 0.0 109.965 179.38 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -154.03 138.48 16.77 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.681 0.277 . . . . 0.0 111.042 -179.437 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 27.3 t-80 -154.98 148.97 25.77 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 109.374 -0.602 . . . . 0.0 109.374 179.077 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 11.4 p80 -149.73 179.88 7.66 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.673 0.273 . . . . 0.0 110.539 -179.549 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 36.0 t60 -124.58 153.77 41.66 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 109.494 -0.558 . . . . 0.0 109.494 179.953 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 17.9 p-80 -83.13 156.13 23.43 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.724 0.297 . . . . 0.0 110.873 179.769 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 23.3 t-80 -105.97 142.1 36.25 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 109.836 -0.431 . . . . 0.0 109.836 179.197 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -130.02 150.63 51.21 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.327 179.644 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -134.21 152.45 51.83 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 120.899 0.38 . . . . 0.0 110.785 -179.83 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -97.48 -123.26 4.59 Favored Glycine 0 N--CA 1.448 -0.527 0 C-N-CA 120.614 -0.803 . . . . 0.0 112.541 -179.665 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -162.71 175.29 11.48 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 110.111 -0.329 . . . . 0.0 110.111 179.883 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.448 ' HA ' ' HD3' ' A' ' 16' ' ' PRO . 2.7 p -150.48 110.03 3.17 Favored Pre-proline 0 C--N 1.324 -0.518 0 CA-C-O 120.823 0.344 . . . . 0.0 110.66 179.69 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 16' ' ' PRO . . . . . 0.448 ' HD3' ' HA ' ' A' ' 15' ' ' VAL . 2.5 Cg_endo -84.3 -166.05 0.34 Allowed 'Trans proline' 0 N--CA 1.459 -0.547 0 C-N-CA 122.867 2.378 . . . . 0.0 111.936 179.474 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 31.1 mmm180 -113.42 -171.75 1.94 Allowed 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.407 -0.36 . . . . 0.0 110.141 179.734 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -148.31 169.4 28.96 Favored Glycine 0 N--CA 1.447 -0.605 0 C-N-CA 120.455 -0.878 . . . . 0.0 112.308 -179.798 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 2.3 t -144.98 170.69 15.66 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 109.956 -0.387 . . . . 0.0 109.956 -179.973 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 35.8 p-80 -160.63 144.76 13.88 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.549 -0.296 . . . . 0.0 110.379 -179.633 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' MET . . . . . 0.573 ' HB2' ' HG3' ' A' ' 36' ' ' GLU . 6.2 tpt -146.93 177.51 9.08 Favored 'General case' 0 C--N 1.326 -0.413 0 N-CA-C 109.607 -0.516 . . . . 0.0 109.607 179.838 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 22' ' ' GLY . . . . . 0.436 ' H ' ' HG3' ' A' ' 21' ' ' MET . . . -104.18 81.55 0.34 Allowed Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.699 -0.763 . . . . 0.0 112.561 -179.889 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 4.7 m -63.33 141.57 58.72 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.73 0.3 . . . . 0.0 111.571 179.808 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 15.5 p-10 -115.16 -154.25 0.54 Allowed 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.464 179.625 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 1.4 mm? -80.43 135.81 36.22 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.0 0.428 . . . . 0.0 111.753 -179.18 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -134.44 -147.14 0.27 Allowed 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 109.009 -0.737 . . . . 0.0 109.009 179.276 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 28.0 t0 -91.73 157.45 16.91 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.783 0.325 . . . . 0.0 110.126 179.362 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -99.2 91.67 5.09 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 120.976 0.417 . . . . 0.0 111.155 -179.291 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.506 ' HD3' ' OG ' ' A' ' 63' ' ' SER . 0.0 OUTLIER -139.43 159.79 41.34 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.474 179.608 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 36.9 mmtt -83.0 106.39 14.78 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.323 -0.398 . . . . 0.0 110.323 179.713 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 6.3 tpp180 -162.07 128.92 3.76 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.018 -0.537 . . . . 0.0 109.975 179.967 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 51.7 tp -113.08 112.71 24.31 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.899 -179.958 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -164.78 132.84 3.29 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.215 179.198 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -108.73 128.31 54.76 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.189 -179.636 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 9.2 tt 179.31 166.11 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 115.947 -0.569 . . . . 0.0 109.694 179.334 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' GLU . . . . . 0.573 ' HG3' ' HB2' ' A' ' 21' ' ' MET . 1.3 mp0 -77.5 144.05 38.0 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.765 0.317 . . . . 0.0 110.22 179.14 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -120.07 -174.69 2.83 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.378 -178.761 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 28.5 mt-10 -125.88 -100.71 0.38 Allowed 'General case' 0 C--O 1.236 0.354 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.352 179.499 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -168.68 164.85 12.2 Favored 'General case' 0 C--O 1.235 0.313 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.269 -179.851 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 139.89 71.8 0.04 OUTLIER Glycine 0 C--N 1.332 0.358 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.953 179.655 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -113.47 -63.5 1.44 Allowed 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.742 0.306 . . . . 0.0 110.953 179.88 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 32.0 tp -79.82 79.55 6.32 Favored 'General case' 0 N--CA 1.45 -0.436 0 CA-C-O 121.796 0.808 . . . . 0.0 110.079 179.959 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 65.5 ttt180 -161.62 159.37 27.49 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 114.739 -1.119 . . . . 0.0 109.382 -179.787 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 4.5 tt0 -78.62 19.89 0.47 Allowed 'General case' 0 N--CA 1.465 0.316 0 CA-C-O 121.325 0.583 . . . . 0.0 110.922 179.988 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 13.6 ptm -88.16 6.0 38.68 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.717 -179.819 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 49.5 mt-30 -70.77 -23.03 62.32 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.581 179.999 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -75.51 -13.9 60.39 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.361 0.601 . . . . 0.0 110.623 179.33 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 6.1 ttmm -74.0 -2.28 23.48 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.683 -0.69 . . . . 0.0 111.09 -179.523 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 9.5 p -57.64 -24.4 22.33 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.275 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.155 -179.87 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 4.6 mm-40 -62.14 -27.99 69.33 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-O 121.107 0.48 . . . . 0.0 110.341 179.552 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 5.8 mtmm -106.76 -42.57 4.92 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.747 -0.66 . . . . 0.0 110.994 179.619 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 78.9 mm-40 -64.87 -6.09 7.5 Favored 'General case' 0 N--CA 1.467 0.397 0 N-CA-C 112.304 0.483 . . . . 0.0 112.304 -179.089 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 3.0 ptt? -65.76 -23.9 66.83 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.112 0.482 . . . . 0.0 109.937 178.777 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -96.78 5.42 64.06 Favored Glycine 0 N--CA 1.451 -0.332 0 N-CA-C 110.708 -0.957 . . . . 0.0 110.708 178.337 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -128.31 19.28 6.37 Favored 'General case' 0 N--CA 1.452 -0.359 0 CA-C-N 115.284 -0.458 . . . . 0.0 110.134 -179.85 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 11.8 m -67.01 -12.19 14.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-O 121.234 0.54 . . . . 0.0 110.657 -179.735 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -83.08 -4.14 58.04 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.7 179.712 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -130.83 -53.09 1.06 Allowed 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.593 -0.731 . . . . 0.0 110.304 -179.946 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 3.5 m -73.28 -71.0 0.33 Allowed 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.394 -0.821 . . . . 0.0 111.646 -179.428 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -85.06 38.16 0.7 Allowed 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.178 0.514 . . . . 0.0 111.226 -179.254 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 7.0 t -85.69 -18.59 32.71 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 109.191 -0.67 . . . . 0.0 109.191 179.243 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 2.0 m -69.42 -24.59 63.85 Favored 'General case' 0 C--O 1.234 0.286 0 CA-C-N 115.364 -0.835 . . . . 0.0 109.599 179.125 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 63' ' ' SER . . . . . 0.506 ' OG ' ' HD3' ' A' ' 29' ' ' LYS . 71.9 m -58.25 -28.08 64.59 Favored 'General case' 0 N--CA 1.448 -0.559 0 CA-C-N 115.039 -0.982 . . . . 0.0 111.287 179.299 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -71.24 -31.57 67.7 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.986 0.422 . . . . 0.0 110.215 179.327 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -82.36 7.21 14.67 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.439 0.638 . . . . 0.0 110.2 179.499 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 1.1 tp-100 -124.88 -55.34 1.6 Allowed 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.705 -0.68 . . . . 0.0 111.357 -179.795 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -85.16 -51.48 6.6 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.54 -179.275 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 4.8 tp10 -72.3 -24.27 61.3 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.102 0.477 . . . . 0.0 110.312 -179.549 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 2.2 tptm -64.23 -24.64 67.74 Favored 'General case' 0 N--CA 1.453 -0.317 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.611 178.902 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -63.55 -17.75 63.14 Favored 'General case' 0 C--O 1.232 0.141 0 CA-C-O 121.543 0.687 . . . . 0.0 109.927 178.882 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 71' ' ' GLU . . . . . 0.464 ' O ' ' HD2' ' A' ' 75' ' ' ARG . 6.6 tp10 -97.37 -47.17 5.8 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.147 -0.933 . . . . 0.0 109.208 177.744 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 94.7 t -60.36 -39.37 80.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 115.449 -0.796 . . . . 0.0 112.332 -178.943 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 17.5 p-10 -68.8 -21.31 64.33 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-O 120.754 0.311 . . . . 0.0 111.47 -178.596 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 39.1 t -101.32 -0.07 36.27 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 109.451 -0.574 . . . . 0.0 109.451 178.66 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 75' ' ' ARG . . . . . 0.464 ' HD2' ' O ' ' A' ' 71' ' ' GLU . 0.0 OUTLIER -117.91 44.15 2.25 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.551 -0.75 . . . . 0.0 110.309 -179.749 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -123.43 172.25 8.85 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.675 179.499 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 8.3 pt -132.99 137.46 53.7 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 N-CA-C 109.864 -0.421 . . . . 0.0 109.864 178.604 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 85.4 t80 -96.06 125.61 40.72 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 116.148 -0.478 . . . . 0.0 109.849 -179.775 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.436 HG12 HG22 ' A' ' 82' ' ' VAL . 4.6 t -105.24 114.32 44.49 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.057 -179.346 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -117.97 168.0 12.97 Favored Glycine 0 N--CA 1.448 -0.504 0 N-CA-C 111.123 -0.791 . . . . 0.0 111.123 179.502 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 4.3 m-20 58.61 41.4 22.27 Favored 'General case' 0 N--CA 1.472 0.662 0 CA-C-O 121.118 0.485 . . . . 0.0 110.844 -179.328 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.436 HG22 HG12 ' A' ' 79' ' ' VAL . 2.0 t -85.66 166.38 2.04 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.954 -179.245 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 83' ' ' ASP . . . . . 0.627 ' OD2' ' HD3' ' A' ' 142' ' ' ARG . 9.9 t70 -67.83 136.63 54.42 Favored 'General case' 0 CA--C 1.519 -0.243 0 N-CA-C 109.587 -0.523 . . . . 0.0 109.587 179.526 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 32.4 p90 -62.09 -19.71 63.26 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.944 -0.571 . . . . 0.0 112.493 -178.597 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -112.71 17.61 18.95 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 120.534 0.207 . . . . 0.0 111.508 -179.382 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 86' ' ' CYS . . . . . 0.442 ' SG ' ' HB3' ' A' ' 83' ' ' ASP . 0.7 OUTLIER -77.51 144.58 37.57 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.196 0.522 . . . . 0.0 111.41 -179.779 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 87' ' ' THR . . . . . 0.504 ' O ' ' HG2' ' A' ' 90' ' ' GLU . 20.5 p -105.44 152.92 40.04 Favored Pre-proline 0 C--N 1.323 -0.554 0 CA-C-N 115.496 -0.775 . . . . 0.0 110.008 179.222 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 88' ' ' PRO . . . . . 0.409 ' HD3' HD13 ' A' ' 106' ' ' ILE . 21.0 Cg_endo -61.32 -32.04 89.44 Favored 'Trans proline' 0 C--N 1.342 0.221 0 C-N-CA 122.342 2.028 . . . . 0.0 112.554 -179.071 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 12.3 mt-10 -64.54 -54.42 32.56 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.737 -0.665 . . . . 0.0 111.731 -178.862 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 90' ' ' GLU . . . . . 0.571 ' O ' ' HB2' ' A' ' 94' ' ' HIS . 11.3 pt-20 -60.72 -26.25 67.03 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.032 0.444 . . . . 0.0 111.299 -178.75 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 51.8 t -78.92 -48.97 20.96 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.319 -179.244 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -71.19 -32.47 68.9 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 111.794 0.294 . . . . 0.0 111.794 -178.585 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 16.7 pt20 -79.45 -25.99 41.85 Favored 'General case' 0 C--N 1.33 -0.243 0 C-N-CA 120.774 -0.37 . . . . 0.0 111.323 -179.117 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 94' ' ' HIS . . . . . 0.571 ' HB2' ' O ' ' A' ' 90' ' ' GLU . 2.3 t60 -76.34 -38.6 55.67 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.838 0.352 . . . . 0.0 110.414 -179.988 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 21.2 m-30 -81.23 -15.08 56.67 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.497 179.827 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 96' ' ' GLN . . . . . 0.538 ' HA ' ' O ' ' A' ' 99' ' ' GLY . 48.7 tt0 -65.72 -21.83 66.56 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.718 -0.674 . . . . 0.0 110.621 -179.977 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 17.3 m -68.58 -20.14 64.5 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.877 -0.602 . . . . 0.0 110.377 179.132 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 32.3 m -102.69 -46.42 4.73 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.005 179.188 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 99' ' ' GLY . . . . . 0.538 ' O ' ' HA ' ' A' ' 96' ' ' GLN . . . -145.2 142.29 10.66 Favored Glycine 0 N--CA 1.445 -0.76 0 N-CA-C 111.506 -0.637 . . . . 0.0 111.506 179.781 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 100' ' ' THR . . . . . 0.405 ' HB ' ' CZ ' ' A' ' 122' ' ' PHE . 0.2 OUTLIER -62.29 148.37 45.21 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-O 120.889 0.376 . . . . 0.0 111.305 -179.715 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 2.4 p -117.79 130.89 71.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.916 -179.652 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 16.6 t30 -98.46 -45.56 6.08 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.292 0.568 . . . . 0.0 109.868 179.123 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -142.54 150.78 40.86 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.756 -0.656 . . . . 0.0 109.668 179.844 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 3.5 p -146.04 129.54 10.22 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 N-CA-C 109.89 -0.411 . . . . 0.0 109.89 179.734 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 7.8 m -120.48 125.98 49.24 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 110.268 -0.271 . . . . 0.0 110.268 179.924 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 106' ' ' ILE . . . . . 0.409 HD13 ' HD3' ' A' ' 88' ' ' PRO . 19.8 tt -112.36 146.18 17.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.434 -179.944 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 16.4 tp -131.81 132.47 43.78 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.511 179.765 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -96.85 121.59 38.88 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 116.201 -0.454 . . . . 0.0 109.867 179.208 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -88.56 136.22 33.1 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.788 0.327 . . . . 0.0 110.592 179.968 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 110' ' ' LYS . . . . . 0.416 ' N ' ' HD3' ' A' ' 110' ' ' LYS . 0.0 OUTLIER -121.64 21.66 10.79 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 120.986 0.422 . . . . 0.0 110.474 179.819 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 17.3 t80 -101.68 -5.34 25.13 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.26 0.552 . . . . 0.0 110.277 -179.879 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 112.42 2.21 26.1 Favored Glycine 0 N--CA 1.447 -0.631 0 C-N-CA 120.879 -0.677 . . . . 0.0 112.392 179.733 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 19.4 mt-30 -89.52 154.89 48.67 Favored Pre-proline 0 C--N 1.326 -0.424 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 179.565 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -55.23 121.54 10.1 Favored 'Trans proline' 0 N--CA 1.46 -0.441 0 C-N-CA 121.737 1.625 . . . . 0.0 110.971 178.773 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 54.6 mttt -76.64 176.1 8.7 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 -179.352 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 94.95 6.9 60.14 Favored Glycine 0 N--CA 1.446 -0.634 0 C-N-CA 120.129 -1.034 . . . . 0.0 112.355 179.648 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 4.4 m-30 -58.75 103.94 0.19 Allowed 'General case' 0 C--N 1.332 -0.169 0 N-CA-C 109.815 -0.439 . . . . 0.0 109.815 179.607 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -132.18 177.25 7.71 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-O 121.085 0.469 . . . . 0.0 111.324 -179.059 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 2.0 p90 -158.56 139.58 13.03 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.372 -0.831 . . . . 0.0 109.379 179.179 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 13.8 m -112.49 142.87 23.5 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 N-CA-C 109.555 -0.535 . . . . 0.0 109.555 178.35 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 5.0 pt-20 -129.38 150.13 50.87 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.787 -179.671 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 122' ' ' PHE . . . . . 0.405 ' CZ ' ' HB ' ' A' ' 100' ' ' THR . 16.3 t80 -151.73 168.93 23.48 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.336 179.61 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 4.1 t -82.8 -54.21 9.9 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-O 120.836 0.35 . . . . 0.0 111.496 -179.359 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 56.7 mt-10 -60.61 126.52 27.73 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.958 -0.565 . . . . 0.0 111.586 -179.105 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 2.2 mp -71.69 -33.62 49.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 115.703 -0.681 . . . . 0.0 109.864 179.567 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -60.37 -38.05 82.65 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.466 -0.788 . . . . 0.0 110.707 179.585 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -63.95 -56.13 17.42 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.783 -0.644 . . . . 0.0 111.119 -179.986 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 9.9 p -64.12 -27.77 43.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-O 120.812 0.339 . . . . 0.0 110.561 179.774 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 17.8 tt0 -62.29 -47.25 85.16 Favored 'General case' 0 C--N 1.333 -0.121 0 CA-C-O 121.066 0.46 . . . . 0.0 109.876 178.853 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 88.4 m-20 -66.69 -31.95 72.95 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.337 0.589 . . . . 0.0 109.579 179.349 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 131' ' ' ALA . . . . . 0.438 ' O ' ' HB2' ' A' ' 135' ' ' ASN . . . -67.27 -51.93 46.97 Favored 'General case' 0 N--CA 1.452 -0.358 0 CA-C-N 115.267 -0.879 . . . . 0.0 110.986 179.684 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 4.3 pp -66.22 -21.49 66.3 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.142 0.496 . . . . 0.0 110.693 179.898 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 5.6 tp -76.78 -51.45 11.35 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.115 179.16 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 94.4 mt -125.83 99.86 6.14 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.286 179.953 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 135' ' ' ASN . . . . . 0.438 ' HB2' ' O ' ' A' ' 131' ' ' ALA . 0.4 OUTLIER -146.77 -70.1 0.25 Allowed 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.491 -179.112 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 136' ' ' GLU . . . . . 0.432 ' HB2' ' O ' ' A' ' 144' ' ' LEU . 9.3 pt-20 -69.86 103.21 2.14 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.601 0.715 . . . . 0.0 111.277 -179.234 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 13.1 m -152.33 -57.54 0.14 Allowed 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.831 -0.622 . . . . 0.0 109.667 179.246 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 28.8 tt0 -160.0 122.32 3.34 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.152 -179.854 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -143.64 115.28 8.15 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 109.368 -0.604 . . . . 0.0 109.368 179.62 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 2.4 t60 64.82 14.03 8.9 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-O 121.255 0.55 . . . . 0.0 110.586 -179.869 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 95.71 -0.49 63.02 Favored Glycine 0 N--CA 1.446 -0.675 0 C-N-CA 120.786 -0.721 . . . . 0.0 111.913 -179.207 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 142' ' ' ARG . . . . . 0.627 ' HD3' ' OD2' ' A' ' 83' ' ' ASP . 2.4 mpt_? -115.59 158.81 22.12 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 120.917 0.389 . . . . 0.0 110.595 179.614 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 15.3 pt20 -105.06 119.07 38.13 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 178.411 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 144' ' ' LEU . . . . . 0.432 ' O ' ' HB2' ' A' ' 136' ' ' GLU . 0.5 OUTLIER -103.29 176.74 5.05 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.04 -178.966 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 73.8 tttt -115.57 121.9 44.02 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 109.253 -0.647 . . . . 0.0 109.253 178.996 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 89.2 t -115.34 119.3 61.44 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-O 120.902 0.382 . . . . 0.0 111.039 -179.803 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 36.3 t -121.54 139.47 53.46 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 116.142 -0.481 . . . . 0.0 109.81 179.943 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -58.84 132.12 53.0 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 109.926 -0.398 . . . . 0.0 109.926 179.213 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 57.5 tttp -93.12 78.16 4.58 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-O 121.479 0.657 . . . . 0.0 109.942 -179.382 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 21.5 tpt180 -92.31 93.46 8.65 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 115.371 -0.831 . . . . 0.0 109.281 179.435 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 8.8 t -72.79 133.08 44.34 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.288 -0.869 . . . . 0.0 109.656 179.562 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 152' ' ' ASN . . . . . . . . . . . . . 66.6 t30 -171.84 164.52 6.45 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 109.778 -0.452 . . . . 0.0 109.778 -179.449 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 7.2 pt -71.9 144.55 88.08 Favored Pre-proline 0 C--N 1.323 -0.583 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.285 179.301 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -75.65 59.44 5.61 Favored 'Trans proline' 0 CA--C 1.53 0.289 0 C-N-CA 122.828 2.352 . . . . 0.0 112.501 179.774 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.968 0 CA-C-O 119.007 -0.885 . . . . 0.0 111.483 179.938 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.2 mpt? . . . . . 0 N--CA 1.479 1.012 0 N-CA-C 110.137 -0.32 . . . . 0.0 110.137 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -123.04 122.59 5.04 Favored Glycine 0 N--CA 1.448 -0.566 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.422 -179.699 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 1.9 m -110.68 135.06 51.86 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 110.241 -0.281 . . . . 0.0 110.241 179.803 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 53.6 m -94.5 165.82 12.35 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 121.016 0.436 . . . . 0.0 111.026 -179.712 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 2.6 p-80 -148.45 150.35 33.31 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.207 -179.547 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 1.2 t-80 -139.33 141.35 37.68 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 109.538 -0.542 . . . . 0.0 109.538 179.892 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 89.8 m-70 -138.62 164.82 28.5 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 120.78 0.324 . . . . 0.0 110.753 -179.543 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 6.3 p80 -144.54 151.75 39.56 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.008 -0.542 . . . . 0.0 109.978 179.552 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 8.6 t-80 -149.2 154.58 39.34 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 109.532 -0.544 . . . . 0.0 109.532 -179.816 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 18.7 p80 -135.02 176.1 8.98 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 110.148 -0.316 . . . . 0.0 110.148 179.899 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 44.2 m -151.96 140.28 20.44 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.878 0.371 . . . . 0.0 110.807 -179.647 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 19.4 m -127.92 138.05 52.51 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.354 179.585 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -150.51 140.54 8.03 Favored Glycine 0 N--CA 1.447 -0.574 0 N-CA-C 111.119 -0.793 . . . . 0.0 111.119 -179.97 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -128.32 163.23 25.24 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 120.88 0.371 . . . . 0.0 111.095 -179.279 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -129.3 102.84 18.37 Favored Pre-proline 0 C--N 1.322 -0.592 0 CA-C-N 115.598 -0.728 . . . . 0.0 110.653 179.764 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 76.4 Cg_endo -82.22 158.71 17.6 Favored 'Trans proline' 0 N--CA 1.459 -0.543 0 C-N-CA 122.441 2.094 . . . . 0.0 112.346 179.737 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 11.2 ptt180 -138.33 131.85 30.68 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.191 179.918 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -163.46 107.39 0.3 Allowed Glycine 0 N--CA 1.447 -0.575 0 C-N-CA 120.673 -0.775 . . . . 0.0 112.568 -179.898 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 1.1 m -85.69 143.19 28.52 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 120.72 0.295 . . . . 0.0 110.46 179.758 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 47.7 t-80 -112.51 128.79 56.44 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 109.761 -0.459 . . . . 0.0 109.761 179.587 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 12.2 ptt? -153.17 154.46 34.79 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 120.84 0.352 . . . . 0.0 111.071 -179.644 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -119.73 163.51 13.68 Favored Glycine 0 N--CA 1.447 -0.632 0 N-CA-C 111.604 -0.598 . . . . 0.0 111.604 179.523 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -145.32 172.69 12.79 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 110.268 -0.271 . . . . 0.0 110.268 -179.887 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 1.5 t0 -110.79 176.39 5.05 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 110.088 -0.338 . . . . 0.0 110.088 179.466 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 27.8 mt -131.82 -176.58 4.1 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 116.439 -0.346 . . . . 0.0 110.563 -179.236 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 5.5 tp10 -72.93 153.0 41.16 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.66 -179.757 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 -112.76 167.32 10.59 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.346 179.77 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 23.9 mmt -107.25 129.59 54.86 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.069 -179.401 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 20.4 pttm -68.53 157.74 35.36 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.06 179.948 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 13.4 tptt -122.28 157.62 31.3 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.087 -179.294 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 53.4 ttm-85 -136.59 141.79 43.31 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 109.35 -0.611 . . . . 0.0 109.35 179.171 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -105.73 163.18 12.9 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 110.06 -0.348 . . . . 0.0 110.06 179.68 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -124.4 161.24 26.39 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.481 -0.327 . . . . 0.0 110.172 179.855 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 34.2 mt-10 -99.81 177.18 5.2 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.989 0.423 . . . . 0.0 111.703 -178.392 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 24.5 pt -74.67 157.11 6.17 Favored 'Isoleucine or valine' 0 C--O 1.234 0.281 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.601 -179.271 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 8.5 mm-40 -118.3 -162.29 0.88 Allowed 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.94 -179.52 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 15.3 pt-20 -74.06 159.29 32.87 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.869 -179.378 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -144.7 -119.88 0.08 Allowed 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.508 -0.769 . . . . 0.0 109.797 179.661 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . 55.57 81.95 0.11 Allowed 'General case' 0 C--O 1.234 0.259 0 C-N-CA 122.892 0.477 . . . . 0.0 112.206 179.293 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -80.66 134.03 12.9 Favored Glycine 0 N--CA 1.45 -0.406 0 C-N-CA 120.793 -0.717 . . . . 0.0 111.834 179.918 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -98.89 175.39 5.96 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 120.725 0.298 . . . . 0.0 110.853 -179.688 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 25.4 tp -79.17 84.33 5.14 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.28 0.562 . . . . 0.0 110.52 179.562 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 31.3 ttm180 -147.12 146.92 30.09 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.843 -0.617 . . . . 0.0 109.601 179.824 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -77.97 40.49 0.33 Allowed 'General case' 0 N--CA 1.463 0.214 0 CA-C-O 121.407 0.622 . . . . 0.0 111.079 179.989 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 15.8 ptt? -92.51 6.12 48.31 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 115.771 -0.65 . . . . 0.0 110.342 -179.904 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 25.3 mt-30 -64.49 -25.27 67.92 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.942 -179.764 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -66.72 -16.43 64.22 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 121.125 0.488 . . . . 0.0 111.303 -179.875 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 24.4 ttpp -72.19 -10.01 59.21 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.564 179.976 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 5.6 p -59.99 -23.96 28.49 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.169 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.039 179.844 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 38.6 mt-10 -64.63 -21.68 66.78 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.253 0.549 . . . . 0.0 110.701 179.261 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 10.3 mtmm -102.77 -40.95 6.36 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.366 179.182 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -72.8 -3.85 27.96 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.0 -0.545 . . . . 0.0 111.723 -179.84 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -67.14 -27.65 67.48 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 109.304 -0.628 . . . . 0.0 109.304 178.392 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -89.87 2.56 82.2 Favored Glycine 0 N--CA 1.446 -0.675 0 N-CA-C 110.831 -0.908 . . . . 0.0 110.831 178.57 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -131.08 27.68 4.83 Favored 'General case' 0 N--CA 1.451 -0.376 0 CA-C-O 121.034 0.445 . . . . 0.0 110.055 -179.974 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 16.0 m -63.47 -21.8 29.34 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.287 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.456 -179.762 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 20.1 mm-40 -72.75 -9.83 59.09 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.564 0.697 . . . . 0.0 109.731 179.036 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 6.8 t70 -120.15 -60.46 1.69 Allowed 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.491 -0.777 . . . . 0.0 110.91 -179.313 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 66.4 m -69.89 -75.81 0.11 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.776 -179.546 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -79.01 41.97 0.46 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.103 0.478 . . . . 0.0 111.207 -179.278 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 36.3 p -80.91 -31.68 35.01 Favored 'General case' 0 N--CA 1.448 -0.558 0 CA-C-O 121.282 0.563 . . . . 0.0 110.096 -179.356 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -69.81 -20.66 63.44 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.529 -0.76 . . . . 0.0 111.212 179.681 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 63' ' ' SER . . . . . 0.497 ' O ' ' HG2' ' A' ' 66' ' ' GLN . 3.8 m -62.07 -25.03 67.46 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.07 -179.604 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -69.92 -31.55 69.37 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.452 -0.34 . . . . 0.0 110.585 179.357 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -77.32 -1.73 31.32 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.637 -179.486 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 66' ' ' GLN . . . . . 0.497 ' HG2' ' O ' ' A' ' 63' ' ' SER . 18.3 pt20 -121.36 -31.23 4.11 Favored 'General case' 0 C--N 1.328 -0.353 0 C-N-CA 120.613 -0.435 . . . . 0.0 111.181 179.396 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -99.65 -57.21 2.2 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.956 0.407 . . . . 0.0 111.39 -179.932 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 5.1 tp10 -71.74 -21.39 61.76 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 120.891 0.376 . . . . 0.0 110.866 -179.317 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -63.27 -24.51 67.9 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.659 -0.246 . . . . 0.0 110.736 179.318 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 51.4 mt-10 -63.52 -23.18 67.28 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.478 0.656 . . . . 0.0 109.412 178.754 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 6.6 tp10 -94.94 -45.57 7.22 Favored 'General case' 0 N--CA 1.45 -0.466 0 CA-C-N 115.217 -0.901 . . . . 0.0 109.937 178.647 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.47 HG12 ' HB2' ' A' ' 121' ' ' GLU . 84.2 t -61.17 -42.67 94.24 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.342 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.583 -179.234 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -68.18 -21.37 64.88 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-O 121.188 0.518 . . . . 0.0 110.892 -179.6 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 11.1 t -98.49 -4.66 33.9 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.625 -0.716 . . . . 0.0 109.737 179.811 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -116.56 40.65 2.86 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.485 -0.78 . . . . 0.0 110.321 -179.499 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -119.02 170.99 8.57 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.622 179.81 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 10.4 pt -127.78 137.91 56.24 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-O 120.763 0.316 . . . . 0.0 110.357 178.982 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 76.6 t80 -92.78 116.53 29.11 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 116.023 -0.535 . . . . 0.0 109.736 -179.753 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 10.9 t -105.2 113.97 43.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-O 120.914 0.387 . . . . 0.0 110.886 -179.102 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -122.52 170.56 15.25 Favored Glycine 0 N--CA 1.449 -0.49 0 N-CA-C 111.664 -0.574 . . . . 0.0 111.664 179.833 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 5.4 m-20 58.43 40.5 24.07 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-O 121.27 0.557 . . . . 0.0 110.775 -179.929 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.465 HG13 HD23 ' A' ' 144' ' ' LEU . 2.5 t -82.83 165.18 2.59 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 CA-C-N 115.364 -0.834 . . . . 0.0 110.41 -179.408 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 83' ' ' ASP . . . . . 0.606 ' HB3' ' SG ' ' A' ' 86' ' ' CYS . 13.6 t0 -67.23 140.88 57.42 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 109.96 -0.385 . . . . 0.0 109.96 179.316 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 34.6 p90 -68.49 -11.77 60.28 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.703 -179.13 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -113.46 14.38 19.06 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 120.739 0.304 . . . . 0.0 111.477 -179.803 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 86' ' ' CYS . . . . . 0.606 ' SG ' ' HB3' ' A' ' 83' ' ' ASP . 1.2 m -81.34 150.23 28.54 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.354 0.597 . . . . 0.0 111.747 -179.594 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 87' ' ' THR . . . . . 0.532 ' O ' ' HG2' ' A' ' 90' ' ' GLU . 1.2 p -116.02 155.75 47.58 Favored Pre-proline 0 C--N 1.323 -0.547 0 CA-C-N 115.513 -0.767 . . . . 0.0 109.933 179.235 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 88' ' ' PRO . . . . . 0.477 ' HD3' HD13 ' A' ' 106' ' ' ILE . 25.6 Cg_endo -60.51 -34.52 92.68 Favored 'Trans proline' 0 C--N 1.344 0.31 0 C-N-CA 122.464 2.109 . . . . 0.0 113.054 -178.599 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 8.4 mt-10 -63.4 -51.85 64.07 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.646 -178.94 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 90' ' ' GLU . . . . . 0.689 ' O ' ' HB2' ' A' ' 94' ' ' HIS . 8.8 pt-20 -61.73 -28.82 69.7 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.924 -179.201 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 79.6 t -76.96 -48.53 25.16 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.178 -179.003 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 92' ' ' GLN . . . . . 0.447 ' O ' ' HB2' ' A' ' 96' ' ' GLN . 0.0 OUTLIER -69.87 -32.64 71.1 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.57 -0.287 . . . . 0.0 111.474 -178.084 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 9.3 pt20 -80.97 -26.44 36.58 Favored 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 120.883 -0.327 . . . . 0.0 110.994 -179.239 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 94' ' ' HIS . . . . . 0.689 ' HB2' ' O ' ' A' ' 90' ' ' GLU . 0.9 OUTLIER -71.5 -39.15 71.02 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.961 0.41 . . . . 0.0 110.316 -179.777 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 15.4 m-85 -88.46 -13.98 39.02 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.974 -179.479 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 96' ' ' GLN . . . . . 0.476 ' HA ' ' O ' ' A' ' 99' ' ' GLY . 41.6 tt0 -63.22 -22.18 66.7 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.802 -179.904 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 35.7 m -72.74 -21.9 60.95 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.54 179.505 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 3.6 m -96.67 -44.15 7.24 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.202 0.525 . . . . 0.0 109.629 178.957 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 99' ' ' GLY . . . . . 0.476 ' O ' ' HA ' ' A' ' 96' ' ' GLN . . . -147.35 139.03 7.58 Favored Glycine 0 N--CA 1.442 -0.916 0 CA-C-N 115.516 -0.766 . . . . 0.0 111.229 179.529 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 2.3 m -62.73 143.14 57.75 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 120.819 0.342 . . . . 0.0 110.957 179.975 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 2.6 p -108.12 132.68 55.22 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.928 -179.365 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 10.7 t30 -93.68 -41.36 9.74 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 109.615 -0.513 . . . . 0.0 109.615 178.655 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -156.41 159.11 38.41 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.285 -0.87 . . . . 0.0 109.512 179.549 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 6.2 p -148.6 136.34 14.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-O 120.909 0.385 . . . . 0.0 110.581 -179.882 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 105' ' ' THR . . . . . 0.488 ' HB ' ' CE1' ' A' ' 119' ' ' TYR . 2.0 m -122.91 130.82 53.32 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.259 178.945 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 106' ' ' ILE . . . . . 0.477 HD13 ' HD3' ' A' ' 88' ' ' PRO . 21.1 tt -118.73 146.11 23.8 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-O 120.703 0.287 . . . . 0.0 110.535 -179.849 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 43.2 tp -135.46 127.29 29.32 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.36 179.855 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -87.59 124.32 33.38 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.6 179.759 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -86.98 137.44 32.35 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.033 0.444 . . . . 0.0 110.774 179.807 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 5.3 mmmm -121.24 17.38 11.52 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.669 -179.616 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 5.7 t80 -101.61 -0.64 34.45 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.075 0.464 . . . . 0.0 110.706 -179.172 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 105.38 5.41 39.95 Favored Glycine 0 N--CA 1.446 -0.679 0 C-N-CA 120.654 -0.784 . . . . 0.0 112.53 179.535 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 113' ' ' GLN . . . . . 0.449 ' HB3' ' HD2' ' A' ' 114' ' ' PRO . 36.8 mt-30 -91.25 160.03 38.14 Favored Pre-proline 0 C--N 1.322 -0.609 0 N-CA-C 109.018 -0.734 . . . . 0.0 109.018 179.677 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 114' ' ' PRO . . . . . 0.449 ' HD2' ' HB3' ' A' ' 113' ' ' GLN . 14.1 Cg_endo -57.42 117.45 4.15 Favored 'Trans proline' 0 C--N 1.345 0.379 0 C-N-CA 122.038 1.825 . . . . 0.0 111.577 179.333 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 63.9 mttt -76.55 179.49 5.91 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 109.071 -0.714 . . . . 0.0 109.071 179.975 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 116' ' ' GLY . . . . . 0.403 ' HA2' HD11 ' A' ' 106' ' ' ILE . . . 91.64 -0.79 74.41 Favored Glycine 0 N--CA 1.448 -0.515 0 C-N-CA 120.258 -0.973 . . . . 0.0 111.869 179.69 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 2.0 t80 -54.25 121.34 8.0 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.856 0.36 . . . . 0.0 110.153 179.809 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -149.95 175.45 11.66 Favored 'General case' 0 N--CA 1.448 -0.558 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.754 -179.216 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 119' ' ' TYR . . . . . 0.488 ' CE1' ' HB ' ' A' ' 105' ' ' THR . 35.2 p90 -157.49 134.46 10.13 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.985 -0.552 . . . . 0.0 109.615 179.068 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 11.8 m -106.41 149.33 9.93 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 N-CA-C 109.677 -0.49 . . . . 0.0 109.677 179.385 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 121' ' ' GLU . . . . . 0.47 ' HB2' HG12 ' A' ' 72' ' ' VAL . 0.7 OUTLIER -133.73 156.13 48.52 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.927 -178.789 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 122' ' ' PHE . . . . . 0.462 ' O ' ' HA ' ' A' ' 72' ' ' VAL . 13.2 t80 -155.1 165.63 36.11 Favored 'General case' 0 C--N 1.333 -0.116 0 CA-C-O 120.927 0.394 . . . . 0.0 111.126 179.275 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 123' ' ' VAL . . . . . 0.426 ' HA ' HG22 ' A' ' 72' ' ' VAL . 12.2 t -82.14 -45.26 19.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 115.694 -0.685 . . . . 0.0 112.226 -178.869 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 20.0 mm-40 -76.26 136.88 39.66 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.12 0.486 . . . . 0.0 111.306 -178.865 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 2.7 mp -74.82 -35.89 37.87 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.675 -179.493 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -55.79 -38.79 70.4 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.106 179.597 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -61.5 -57.05 13.68 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.018 179.971 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 10.0 p -66.36 -29.06 45.41 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.002 -179.544 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 19.6 tt0 -61.54 -39.46 91.17 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.666 179.804 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 46.4 m-80 -78.77 -31.12 45.99 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.142 0.496 . . . . 0.0 109.706 178.738 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -66.44 -51.07 60.79 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.657 -0.701 . . . . 0.0 111.221 179.996 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 4.2 pp -65.66 -16.08 63.4 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-O 121.036 0.446 . . . . 0.0 110.859 -179.868 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 3.8 tp -84.04 -52.89 5.95 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.014 179.237 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 69.5 mt -121.41 101.4 7.6 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.915 -0.584 . . . . 0.0 109.85 179.693 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -146.66 -70.53 0.24 Allowed 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.84 0.352 . . . . 0.0 111.706 -179.331 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -70.48 105.35 3.04 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.546 0.689 . . . . 0.0 111.598 -179.051 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 15.2 m -147.59 -58.49 0.26 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.573 -0.74 . . . . 0.0 109.41 178.769 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -161.32 127.75 3.89 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.976 -0.556 . . . . 0.0 109.839 179.433 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 139' ' ' LEU . . . . . 0.426 ' HG ' HD21 ' A' ' 144' ' ' LEU . 0.1 OUTLIER -142.82 111.93 6.56 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.16 -0.473 . . . . 0.0 109.861 179.794 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 140' ' ' HIS . . . . . 0.442 ' HB2' ' SG ' ' A' ' 86' ' ' CYS . 1.3 t60 62.81 25.41 15.08 Favored 'General case' 0 N--CA 1.466 0.33 0 O-C-N 123.41 0.444 . . . . 0.0 110.839 179.189 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 86.66 3.45 83.74 Favored Glycine 0 N--CA 1.45 -0.429 0 C-N-CA 120.871 -0.681 . . . . 0.0 112.029 -179.57 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -116.86 170.57 8.51 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 110.072 -0.344 . . . . 0.0 110.072 179.989 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 8.1 pt20 -120.53 117.03 26.56 Favored 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 109.486 -0.561 . . . . 0.0 109.486 178.957 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 144' ' ' LEU . . . . . 0.465 HD23 HG13 ' A' ' 82' ' ' VAL . 0.6 OUTLIER -99.62 175.22 5.9 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.934 0.397 . . . . 0.0 111.336 -178.934 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 145' ' ' LYS . . . . . 0.517 ' HE3' ' OG ' ' A' ' 147' ' ' SER . 1.2 tmtp? -116.37 123.19 46.99 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.645 -0.707 . . . . 0.0 109.413 179.34 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 90.8 t -120.55 137.28 54.85 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-O 120.771 0.32 . . . . 0.0 110.68 -179.303 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 147' ' ' SER . . . . . 0.517 ' OG ' ' HE3' ' A' ' 145' ' ' LYS . 66.9 m -144.62 149.23 35.41 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.284 -0.417 . . . . 0.0 109.911 178.902 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -61.74 123.55 18.27 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.757 0.313 . . . . 0.0 111.338 -179.794 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 12.5 ttpp -86.86 73.67 9.92 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.498 0.666 . . . . 0.0 109.755 -179.982 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 14.1 tpt180 -83.5 96.62 8.65 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.69 -0.686 . . . . 0.0 110.716 -179.904 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 12.4 t -84.08 124.15 30.8 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 179.002 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 152' ' ' ASN . . . . . . . . . . . . . 57.0 t30 -169.29 152.55 4.98 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 110.207 -0.294 . . . . 0.0 110.207 -178.872 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 14.9 pt -76.93 150.95 81.77 Favored Pre-proline 0 C--N 1.323 -0.557 0 CA-C-N 116.155 -0.475 . . . . 0.0 109.897 179.12 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 28.1 Cg_endo -64.08 108.13 0.9 Allowed 'Trans proline' 0 C--O 1.234 0.309 0 C-N-CA 122.351 2.034 . . . . 0.0 112.198 179.859 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.914 0 CA-C-O 118.421 -1.21 . . . . 0.0 111.56 179.844 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.5 ptt? . . . . . 0 N--CA 1.479 1.009 0 CA-C-O 120.773 0.321 . . . . 0.0 110.443 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 160.26 156.23 8.08 Favored Glycine 0 N--CA 1.448 -0.522 0 N-CA-C 111.63 -0.588 . . . . 0.0 111.63 -179.687 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 18.4 m -139.25 137.67 36.13 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.852 0.326 . . . . 0.0 111.226 -179.859 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 1.2 m -129.87 145.63 51.6 Favored 'General case' 0 CA--C 1.532 0.27 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.429 179.94 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 10.8 p80 -168.29 133.05 1.7 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.451 -0.341 . . . . 0.0 110.366 179.883 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 8.8 p80 -160.84 102.29 1.31 Allowed 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.966 0.412 . . . . 0.0 111.271 -179.732 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 7.1 p80 -168.36 152.19 5.86 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.227 179.468 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 82.6 t60 -164.3 140.77 6.36 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.669 -0.242 . . . . 0.0 110.37 179.606 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 80.5 t60 -132.39 143.55 49.91 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.438 -0.346 . . . . 0.0 110.373 179.939 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 52.2 t60 -162.52 124.94 2.77 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.478 -0.328 . . . . 0.0 110.478 179.32 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 71.0 m -134.6 151.96 51.44 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.463 -0.335 . . . . 0.0 110.328 179.631 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 32.2 m -151.62 162.06 41.62 Favored 'General case' 0 C--O 1.236 0.392 0 CA-C-O 120.84 0.353 . . . . 0.0 110.873 -179.993 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -164.32 124.42 1.26 Allowed Glycine 0 N--CA 1.451 -0.31 0 N-CA-C 111.543 -0.623 . . . . 0.0 111.543 179.705 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 64.4 mt -136.21 164.36 28.25 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.91 0.386 . . . . 0.0 111.327 -179.268 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 4.2 p -150.07 124.5 4.64 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-N 115.663 -0.699 . . . . 0.0 109.752 179.365 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -75.78 -173.72 1.76 Allowed 'Trans proline' 0 C--N 1.343 0.287 0 C-N-CA 122.814 2.343 . . . . 0.0 112.917 -179.247 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 7.9 tpp85 -162.12 145.96 12.12 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.7 179.667 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -108.46 -163.45 20.81 Favored Glycine 0 N--CA 1.449 -0.436 0 C-N-CA 120.948 -0.644 . . . . 0.0 111.69 179.337 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 41.4 m -152.02 158.26 42.82 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.757 0.278 . . . . 0.0 110.288 179.59 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 13.3 p80 -146.31 131.06 17.97 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.813 0.34 . . . . 0.0 110.963 -179.989 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 1.7 tmm? -163.49 147.77 10.71 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 179.279 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -167.31 122.04 1.02 Allowed Glycine 0 N--CA 1.447 -0.614 0 C-N-CA 120.467 -0.873 . . . . 0.0 112.782 -179.873 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 3.7 p -139.76 93.6 2.68 Favored 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 108.932 -0.766 . . . . 0.0 108.932 178.907 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -91.23 178.23 6.03 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.672 -0.694 . . . . 0.0 111.999 -178.249 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 54.5 mt -136.27 159.06 42.88 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.062 -0.972 . . . . 0.0 108.395 179.41 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -113.08 116.88 30.58 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 121.091 0.472 . . . . 0.0 111.22 -179.273 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -152.24 152.47 32.24 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.496 -0.774 . . . . 0.0 109.669 -179.844 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 74.8 mtp -118.55 156.5 29.04 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 110.272 -0.27 . . . . 0.0 110.272 -179.73 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.815 ' HE2' HG11 ' A' ' 56' ' ' VAL . 0.0 OUTLIER -133.74 171.09 14.61 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.824 0.345 . . . . 0.0 111.417 -178.276 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 20.3 ptmt -105.19 9.32 34.15 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.123 0.487 . . . . 0.0 110.703 -179.921 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' ARG . . . . . 0.442 HH11 ' HD3' ' A' ' 31' ' ' ARG . 27.9 mtm180 -100.85 112.14 24.51 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.672 -179.488 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 13.2 tp -169.47 33.06 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.377 -179.899 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.448 ' HE3' ' OE2' ' A' ' 68' ' ' GLU . 0.7 OUTLIER -164.93 37.6 0.07 Allowed 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.48 0.657 . . . . 0.0 109.816 -179.262 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 5.2 mp0 -86.97 -75.47 0.4 Allowed 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.55 -0.75 . . . . 0.0 111.842 -178.315 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 11.4 pt -141.02 175.92 5.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-O 120.613 0.244 . . . . 0.0 110.875 -179.282 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 67.1 mt-10 -125.23 113.64 17.91 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 109.513 -0.551 . . . . 0.0 109.513 178.682 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 2.9 mm-40 -124.04 -77.05 0.59 Allowed 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.004 0.431 . . . . 0.0 111.772 -178.508 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 4.7 tp10 -72.32 150.85 43.16 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.998 -0.546 . . . . 0.0 111.022 -178.97 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.442 ' O ' HG21 ' A' ' 62' ' ' THR . . . -101.99 -34.61 9.28 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.186 0.517 . . . . 0.0 110.267 179.233 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 84.66 167.7 43.3 Favored Glycine 0 N--CA 1.448 -0.515 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.489 179.467 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -161.5 178.01 9.51 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 109.837 -0.431 . . . . 0.0 109.837 -179.57 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 29.0 tp -74.97 88.63 2.37 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.987 0.423 . . . . 0.0 110.079 179.734 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 20.0 ttp180 -138.74 158.42 44.26 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.249 -0.432 . . . . 0.0 109.852 -179.469 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 52.3 mt-10 -79.66 25.18 0.35 Allowed 'General case' 0 N--CA 1.464 0.267 0 CA-C-O 121.023 0.439 . . . . 0.0 111.311 -179.807 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 11.3 ptt? -79.89 4.05 17.92 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 120.811 0.338 . . . . 0.0 110.584 -178.961 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 59.5 mt-30 -71.83 -22.31 61.57 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.214 0.531 . . . . 0.0 110.011 179.424 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -78.44 -15.26 58.84 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.707 -0.679 . . . . 0.0 110.113 179.033 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' LYS . . . . . 0.531 ' O ' ' HG2' ' A' ' 52' ' ' GLU . 6.7 ttpp -76.93 2.85 13.53 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.458 -0.792 . . . . 0.0 110.309 -179.802 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 9.2 p -55.71 -24.21 16.15 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.142 0 CA-C-N 115.481 -0.781 . . . . 0.0 111.86 -179.541 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.504 ' H ' ' HG3' ' A' ' 50' ' ' GLU . 0.1 OUTLIER -60.54 -32.25 71.31 Favored 'General case' 0 CA--C 1.52 -0.195 0 CA-C-O 121.43 0.633 . . . . 0.0 109.735 179.494 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 9.0 mtmm -103.22 -40.69 6.32 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.471 -0.786 . . . . 0.0 111.354 -179.645 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 52' ' ' GLU . . . . . 0.531 ' HG2' ' O ' ' A' ' 48' ' ' LYS . 44.1 mm-40 -64.63 -8.4 14.19 Favored 'General case' 0 N--CA 1.468 0.469 0 N-CA-C 112.421 0.526 . . . . 0.0 112.421 -179.356 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 9.2 ptp -57.98 -33.13 68.56 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.741 0.305 . . . . 0.0 111.257 179.604 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -91.04 -19.88 41.27 Favored Glycine 0 N--CA 1.449 -0.477 0 C-N-CA 120.573 -0.822 . . . . 0.0 111.214 179.082 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -98.57 23.21 8.87 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.125 -0.538 . . . . 0.0 110.899 -179.263 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.815 HG11 ' HE2' ' A' ' 29' ' ' LYS . 15.7 m -64.95 -9.24 6.69 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.38 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.48 179.557 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 37.2 mt-30 -86.4 -2.74 58.7 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.338 0.589 . . . . 0.0 110.14 179.531 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 11.2 t70 -133.0 -52.29 0.9 Allowed 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.41 -0.813 . . . . 0.0 110.234 179.625 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 3.3 m -74.24 -63.49 1.22 Allowed 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.374 -0.83 . . . . 0.0 112.657 -179.008 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -87.88 15.21 7.42 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.522 -0.308 . . . . 0.0 111.363 -178.489 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -73.87 -26.42 60.56 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.019 0.438 . . . . 0.0 110.089 -179.905 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 62' ' ' THR . . . . . 0.442 HG21 ' O ' ' A' ' 39' ' ' ALA . 0.2 OUTLIER -69.86 -23.68 63.31 Favored 'General case' 0 N--CA 1.447 -0.602 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.409 179.325 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 2.9 m -62.26 -23.07 66.48 Favored 'General case' 0 N--CA 1.448 -0.555 0 CA-C-N 115.601 -0.727 . . . . 0.0 109.939 179.814 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -71.52 -33.25 69.04 Favored 'General case' 0 N--CA 1.455 -0.184 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.047 178.812 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 1.2 m -76.15 5.35 6.94 Favored 'General case' 0 CA--C 1.533 0.299 0 CA-C-O 121.343 0.592 . . . . 0.0 110.98 179.731 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 7.3 tp-100 -124.81 -54.99 1.62 Allowed 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.916 -0.583 . . . . 0.0 110.398 179.21 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -78.89 -56.28 4.52 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.362 -179.427 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 68' ' ' GLU . . . . . 0.448 ' OE2' ' HE3' ' A' ' 33' ' ' LYS . 1.7 tp10 -66.32 -28.72 68.9 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-O 121.325 0.583 . . . . 0.0 109.935 179.937 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 48.8 tptt -59.96 -29.17 68.24 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.437 -0.802 . . . . 0.0 111.268 179.487 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 48.8 mt-10 -61.69 -24.04 66.5 Favored 'General case' 0 N--CA 1.463 0.207 0 CA-C-O 120.977 0.418 . . . . 0.0 110.654 179.669 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 6.9 tp10 -95.19 -39.16 10.24 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.787 -0.642 . . . . 0.0 109.711 178.814 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.51 HG12 ' HB2' ' A' ' 121' ' ' GLU . 89.4 t -63.03 -44.65 99.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 115.795 -0.639 . . . . 0.0 112.127 -179.302 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -69.22 -23.11 63.85 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-O 121.17 0.51 . . . . 0.0 110.968 -179.129 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 49.9 m -90.6 -9.65 46.27 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.451 -0.795 . . . . 0.0 109.765 179.154 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -113.98 36.06 3.85 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 114.993 -1.003 . . . . 0.0 110.005 -179.839 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -111.89 169.27 8.95 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.04 179.425 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 7.6 pt -129.28 136.48 59.37 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 N-CA-C 110.029 -0.36 . . . . 0.0 110.029 178.748 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 78' ' ' TYR . . . . . 0.401 ' O ' ' HA ' ' A' ' 146' ' ' VAL . 68.8 t80 -90.42 120.83 31.86 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 116.042 -0.526 . . . . 0.0 109.808 -179.706 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.418 HG12 HG22 ' A' ' 82' ' ' VAL . 6.7 t -107.46 111.63 36.61 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-O 120.832 0.348 . . . . 0.0 110.593 -179.164 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -119.26 168.67 13.46 Favored Glycine 0 N--CA 1.449 -0.486 0 N-CA-C 111.683 -0.567 . . . . 0.0 111.683 179.708 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 96.8 m-20 60.93 34.38 19.51 Favored 'General case' 0 N--CA 1.47 0.535 0 CA-C-O 120.964 0.411 . . . . 0.0 111.262 -179.792 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.418 HG22 HG12 ' A' ' 79' ' ' VAL . 2.5 t -75.8 166.38 2.76 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.597 -179.768 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 22.0 t0 -73.08 145.36 46.57 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.854 0.359 . . . . 0.0 110.34 179.714 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 3.0 p90 -66.27 -19.97 65.97 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.732 -0.667 . . . . 0.0 111.712 -178.934 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -109.84 20.12 18.37 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 111.742 0.275 . . . . 0.0 111.742 -179.323 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 86' ' ' CYS . . . . . 0.471 ' SG ' ' HB2' ' A' ' 140' ' ' HIS . 0.8 OUTLIER -87.84 141.71 28.38 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.07 0.462 . . . . 0.0 111.286 -179.829 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 87' ' ' THR . . . . . 0.468 ' O ' ' HG2' ' A' ' 90' ' ' GLU . 41.7 p -107.1 155.61 38.97 Favored Pre-proline 0 C--N 1.328 -0.367 0 CA-C-N 115.593 -0.73 . . . . 0.0 110.343 179.562 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 88' ' ' PRO . . . . . 0.477 ' HD3' HD13 ' A' ' 106' ' ' ILE . 18.6 Cg_endo -59.12 -35.35 98.14 Favored 'Trans proline' 0 C--N 1.342 0.213 0 C-N-CA 122.457 2.104 . . . . 0.0 112.556 -179.576 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 28.8 mt-10 -65.02 -50.04 67.8 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.688 -0.687 . . . . 0.0 112.096 -178.861 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 90' ' ' GLU . . . . . 0.565 ' O ' ' HB2' ' A' ' 94' ' ' HIS . 10.9 pt-20 -67.24 -18.6 65.29 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.835 0.35 . . . . 0.0 111.193 -179.102 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 51.3 t -85.26 -49.66 15.37 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.115 -179.897 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 92' ' ' GLN . . . . . 0.4 ' HG2' ' O ' ' A' ' 88' ' ' PRO . 6.9 pt20 -68.81 -35.92 77.6 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.696 -0.229 . . . . 0.0 111.561 -178.098 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 16.0 pt20 -74.48 -28.71 61.13 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.939 0.4 . . . . 0.0 110.37 -179.5 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 94' ' ' HIS . . . . . 0.565 ' HB2' ' O ' ' A' ' 90' ' ' GLU . 0.1 OUTLIER -70.81 -42.5 70.18 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.652 -179.796 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 20.7 m-30 -80.04 -14.59 58.43 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.87 -0.604 . . . . 0.0 110.647 -179.511 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 96' ' ' GLN . . . . . 0.623 ' HA ' ' O ' ' A' ' 99' ' ' GLY . 10.9 tt0 -66.0 -19.15 65.76 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.131 179.513 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 13.9 m -66.84 -28.57 68.46 Favored 'General case' 0 N--CA 1.451 -0.384 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.257 178.871 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 4.9 m -100.33 -43.26 6.32 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.401 179.661 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 99' ' ' GLY . . . . . 0.623 ' O ' ' HA ' ' A' ' 96' ' ' GLN . . . -144.59 139.73 8.74 Favored Glycine 0 N--CA 1.447 -0.62 0 C-N-CA 120.88 -0.676 . . . . 0.0 111.904 -179.896 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -63.02 147.72 49.84 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 120.914 0.388 . . . . 0.0 111.601 -179.901 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 2.4 p -116.52 132.93 64.71 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.095 -179.458 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 27.4 t-20 -102.2 -43.64 5.66 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.068 0.461 . . . . 0.0 110.282 178.956 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 103' ' ' ARG . . . . . 0.401 HH11 ' HD2' ' A' ' 103' ' ' ARG . 0.2 OUTLIER -141.03 148.68 40.64 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.055 -0.521 . . . . 0.0 109.888 -179.872 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 4.5 p -146.94 134.99 15.12 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 N-CA-C 109.936 -0.394 . . . . 0.0 109.936 179.197 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 105' ' ' THR . . . . . 0.459 ' HB ' ' CE1' ' A' ' 119' ' ' TYR . 0.7 OUTLIER -128.16 126.13 40.45 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.236 179.376 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 106' ' ' ILE . . . . . 0.506 HD11 ' HA2' ' A' ' 116' ' ' GLY . 18.6 tt -112.55 148.3 15.69 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-O 120.862 0.363 . . . . 0.0 110.867 -179.941 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 18.0 tp -136.83 129.96 31.11 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.155 179.56 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -88.42 123.24 32.77 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 109.708 -0.479 . . . . 0.0 109.708 179.542 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 109' ' ' ASP . . . . . 0.417 ' O ' ' HB2' ' A' ' 110' ' ' LYS . 29.2 t70 -70.93 -80.17 0.06 Allowed 'General case' 0 CA--C 1.531 0.247 0 N-CA-C 112.628 0.603 . . . . 0.0 112.628 -178.239 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 110' ' ' LYS . . . . . 0.417 ' HB2' ' O ' ' A' ' 109' ' ' ASP . 1.7 mtpp 70.34 20.66 6.03 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 122.828 0.451 . . . . 0.0 111.621 -179.901 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 6.6 t80 -115.41 17.92 16.24 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-O 121.274 0.559 . . . . 0.0 109.955 -179.749 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 103.99 0.37 45.02 Favored Glycine 0 N--CA 1.449 -0.5 0 C-N-CA 120.768 -0.729 . . . . 0.0 112.158 179.952 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 20.9 mt-30 -111.34 157.72 38.24 Favored Pre-proline 0 C--N 1.322 -0.596 0 N-CA-C 109.588 -0.523 . . . . 0.0 109.588 179.599 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -59.77 129.7 31.84 Favored 'Trans proline' 0 N--CA 1.462 -0.335 0 C-N-CA 122.124 1.883 . . . . 0.0 111.366 178.827 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 15.6 mttp -82.8 -179.41 7.43 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 109.196 -0.668 . . . . 0.0 109.196 179.963 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 116' ' ' GLY . . . . . 0.506 ' HA2' HD11 ' A' ' 106' ' ' ILE . . . 92.36 2.53 68.02 Favored Glycine 0 N--CA 1.446 -0.645 0 C-N-CA 120.064 -1.065 . . . . 0.0 112.32 179.168 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 2.2 t80 -54.51 119.52 5.36 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-O 120.732 0.301 . . . . 0.0 110.278 179.793 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -146.56 177.89 8.71 Favored 'General case' 0 N--CA 1.45 -0.427 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.846 -179.316 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 119' ' ' TYR . . . . . 0.459 ' CE1' ' HB ' ' A' ' 105' ' ' THR . 43.6 p90 -161.1 134.84 6.75 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.521 -0.763 . . . . 0.0 109.225 179.045 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 15.1 m -108.74 147.07 13.69 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 N-CA-C 109.529 -0.545 . . . . 0.0 109.529 178.824 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 121' ' ' GLU . . . . . 0.51 ' HB2' HG12 ' A' ' 72' ' ' VAL . 7.2 pt-20 -131.7 155.91 46.82 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 116.389 -0.368 . . . . 0.0 111.022 -179.217 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 122' ' ' PHE . . . . . 0.446 ' O ' ' HA ' ' A' ' 72' ' ' VAL . 10.8 t80 -157.2 166.66 32.59 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.147 -179.943 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 5.1 t -84.82 -49.23 15.99 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-O 120.854 0.359 . . . . 0.0 111.708 -178.995 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 47.8 mm-40 -66.27 127.87 33.91 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.002 -0.545 . . . . 0.0 111.844 -178.608 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 2.3 mp -72.05 -29.4 32.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 115.6 -0.727 . . . . 0.0 109.643 179.516 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 16.7 t70 -58.1 -42.25 85.29 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.265 -0.88 . . . . 0.0 110.56 179.322 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -64.81 -52.98 53.9 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.731 -0.668 . . . . 0.0 111.532 -179.597 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 8.8 p -65.85 -27.05 40.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 116.636 -0.256 . . . . 0.0 111.43 -179.27 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 24.4 tt0 -60.31 -48.52 81.4 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.806 0.336 . . . . 0.0 110.404 179.898 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 86.6 m-20 -69.61 -32.41 71.11 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 121.021 0.439 . . . . 0.0 110.248 179.611 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 131' ' ' ALA . . . . . 0.421 ' O ' ' HB2' ' A' ' 135' ' ' ASN . . . -64.84 -53.16 51.13 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.604 -0.725 . . . . 0.0 111.254 -179.787 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 4.1 pp -65.23 -23.94 67.21 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.9 0.381 . . . . 0.0 110.888 -179.796 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 5.6 tp -76.42 -54.34 6.87 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.652 179.699 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 26.9 mt -122.38 103.04 8.47 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.091 -0.504 . . . . 0.0 109.878 -179.998 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 135' ' ' ASN . . . . . 0.421 ' HB2' ' O ' ' A' ' 131' ' ' ALA . 0.2 OUTLIER -150.23 -66.87 0.2 Allowed 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 120.977 0.418 . . . . 0.0 111.551 -179.22 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 3.3 pt-20 -69.73 101.18 1.63 Allowed 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.882 -0.599 . . . . 0.0 111.417 -179.188 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 23.7 m -151.31 -59.32 0.17 Allowed 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.909 -0.587 . . . . 0.0 109.966 178.93 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 6.0 tm-20 -154.78 127.68 8.17 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.457 179.755 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -147.72 111.27 4.98 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 178.774 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 140' ' ' HIS . . . . . 0.471 ' HB2' ' SG ' ' A' ' 86' ' ' CYS . 2.1 t60 64.6 28.22 13.25 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-O 121.241 0.543 . . . . 0.0 109.725 -179.585 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 79.23 1.27 85.5 Favored Glycine 0 CA--C 1.52 0.371 0 C-N-CA 121.012 -0.613 . . . . 0.0 112.485 -179.353 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 7.3 mpt_? -113.11 170.94 7.85 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 120.662 0.267 . . . . 0.0 110.437 -179.907 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 12.7 pt20 -115.11 137.55 51.89 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.114 -0.494 . . . . 0.0 109.83 179.162 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -125.58 174.48 8.22 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.135 179.951 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 76.7 tttt -116.91 122.33 44.0 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 109.775 -0.454 . . . . 0.0 109.775 179.371 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 146' ' ' VAL . . . . . 0.401 ' HA ' ' O ' ' A' ' 78' ' ' TYR . 77.6 t -115.88 125.21 72.93 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-O 120.843 0.354 . . . . 0.0 110.739 179.811 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 5.4 t -126.87 148.46 50.0 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 109.848 -0.427 . . . . 0.0 109.848 179.944 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -66.62 122.66 18.11 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.595 -0.275 . . . . 0.0 110.636 -179.737 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 14.0 ttpp -88.14 61.99 6.55 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.456 0.646 . . . . 0.0 109.63 -179.823 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -82.42 77.94 9.13 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.806 -0.634 . . . . 0.0 109.561 179.453 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 2.9 t -70.84 129.21 38.49 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-N 115.116 -0.947 . . . . 0.0 110.95 179.972 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 152' ' ' ASN . . . . . . . . . . . . . 6.8 t-20 -171.45 156.97 4.69 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.198 -0.455 . . . . 0.0 109.984 179.748 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 8.3 pt -60.72 151.04 73.76 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-O 120.841 0.353 . . . . 0.0 111.421 179.966 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 96.1 Cg_endo -78.78 48.5 2.8 Favored 'Trans proline' 0 CA--C 1.53 0.278 0 C-N-CA 123.201 2.601 . . . . 0.0 112.695 179.929 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.934 0 CA-C-O 118.842 -0.976 . . . . 0.0 111.973 -179.95 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.5 mpt? . . . . . 0 N--CA 1.478 0.925 0 N-CA-C 109.791 -0.448 . . . . 0.0 109.791 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -159.61 152.46 23.39 Favored Glycine 0 N--CA 1.447 -0.614 0 C-N-CA 120.654 -0.784 . . . . 0.0 112.219 -179.465 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -114.62 150.66 34.75 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 110.172 -0.307 . . . . 0.0 110.172 179.929 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 2.1 p -143.64 137.9 28.61 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.559 -0.291 . . . . 0.0 110.715 -179.946 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -149.06 138.48 21.67 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.597 -0.274 . . . . 0.0 110.599 179.417 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 39.9 m80 -94.47 163.71 13.29 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.914 -179.701 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 7.1 p80 -173.55 153.19 2.26 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.758 -0.656 . . . . 0.0 109.673 179.713 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 38.0 t-80 -143.53 134.43 25.39 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 120.789 0.328 . . . . 0.0 110.341 179.808 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 4.9 t-80 -144.43 119.43 10.01 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 109.421 -0.585 . . . . 0.0 109.421 179.596 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 17.1 t-80 -112.7 111.16 21.76 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 120.869 0.366 . . . . 0.0 111.228 -179.286 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 4.0 m -67.83 152.78 45.03 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.933 -0.576 . . . . 0.0 109.648 178.728 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 15.6 m -134.04 114.44 13.2 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-O 120.99 0.424 . . . . 0.0 110.906 -179.123 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -100.15 -162.59 28.56 Favored Glycine 0 N--CA 1.444 -0.828 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.245 179.95 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -131.67 159.29 38.77 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 110.402 -0.222 . . . . 0.0 110.402 -179.828 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 2.4 p -130.94 119.11 17.82 Favored Pre-proline 0 C--N 1.325 -0.477 0 CA-C-O 121.028 0.442 . . . . 0.0 110.892 179.821 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 70.0 Cg_endo -77.87 120.37 5.05 Favored 'Trans proline' 0 N--CA 1.458 -0.571 0 C-N-CA 122.65 2.234 . . . . 0.0 111.491 178.948 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 1.1 tpm_? -119.0 145.72 45.61 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.25 -179.357 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -138.65 121.5 2.16 Favored Glycine 0 N--CA 1.45 -0.425 0 C-N-CA 121.12 -0.562 . . . . 0.0 111.892 179.841 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 4.7 m -82.32 140.57 33.49 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 120.847 0.356 . . . . 0.0 111.051 -179.445 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 54.2 t-80 -90.48 140.99 29.21 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.188 -179.972 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 19.2 ptt? -137.16 -179.19 5.57 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.776 -179.624 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 148.59 119.99 1.07 Allowed Glycine 0 N--CA 1.45 -0.373 0 N-CA-C 111.723 -0.551 . . . . 0.0 111.723 -179.93 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 1.2 m -109.16 123.4 49.14 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 120.783 0.325 . . . . 0.0 111.383 -179.516 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 36.9 t0 -87.97 153.47 21.26 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.021 179.738 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 3.0 tp -114.63 139.9 49.25 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 116.683 -0.235 . . . . 0.0 110.866 -179.018 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 23.5 mm-40 -68.37 131.92 46.15 Favored 'General case' 0 C--N 1.332 -0.177 0 N-CA-C 110.347 -0.242 . . . . 0.0 110.347 179.593 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -109.0 141.07 41.64 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.982 -179.531 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 32.6 tpp -144.06 127.77 17.18 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.546 179.679 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 19.5 mmtp -131.3 166.13 21.88 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.606 -0.27 . . . . 0.0 110.721 -179.615 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 1.3 ptmm? -157.8 -175.08 5.17 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.27 179.52 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 12.4 ptt180 -150.82 174.17 13.38 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 109.654 -0.498 . . . . 0.0 109.654 179.504 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.497 HD22 ' HA ' ' A' ' 32' ' ' LEU . 0.4 OUTLIER -150.67 144.74 25.39 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.682 0.277 . . . . 0.0 110.377 -179.534 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 17.7 ttmm -100.81 125.0 47.28 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.71 -179.957 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 32.3 tt0 -84.61 126.0 32.96 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.136 179.453 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 10.6 pt -135.67 130.3 49.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-O 120.816 0.341 . . . . 0.0 110.982 -179.904 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 6.4 tp10 -147.37 153.54 39.78 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.521 -0.309 . . . . 0.0 110.414 179.549 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 1.5 mm-40 -114.4 176.08 5.2 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.004 0.43 . . . . 0.0 111.506 -179.443 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 7.9 mt-10 -115.49 145.98 42.1 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.643 -0.708 . . . . 0.0 109.948 179.551 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -145.18 124.68 13.15 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 120.901 0.382 . . . . 0.0 111.347 -179.667 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -96.93 77.87 0.69 Allowed Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.726 -0.749 . . . . 0.0 111.895 179.687 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -141.77 177.43 8.18 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 110.467 -0.198 . . . . 0.0 110.467 -179.245 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 37.9 tp -74.29 84.32 1.91 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.08 0.467 . . . . 0.0 109.897 179.346 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' ARG . . . . . 0.528 ' HA ' ' NE ' ' A' ' 43' ' ' ARG . 1.5 tpm_? -132.63 142.3 49.05 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.746 -179.376 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 21.5 mp0 -77.27 47.04 0.54 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.249 0.547 . . . . 0.0 110.278 179.252 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 9.1 ptt? -108.65 -0.41 20.18 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.498 -179.548 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 71.6 mt-30 -59.86 -22.68 62.62 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-O 120.889 0.376 . . . . 0.0 111.325 -179.048 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -68.03 -16.96 64.26 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.787 -179.914 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 3.4 ptmm? -73.82 3.59 6.39 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-O 120.635 0.255 . . . . 0.0 111.323 -179.383 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 11.0 p -54.73 -25.09 14.61 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.25 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.307 179.63 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -59.46 -37.03 77.1 Favored 'General case' 0 C--N 1.334 -0.095 0 CA-C-O 121.185 0.517 . . . . 0.0 110.152 179.134 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 10.7 mtmm -85.57 -41.14 15.53 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.804 -0.634 . . . . 0.0 110.328 -179.369 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 16.9 mm-40 -60.33 -38.05 82.53 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.519 -0.764 . . . . 0.0 111.991 -179.013 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 17.3 ptp -64.67 -25.94 68.17 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.679 0.276 . . . . 0.0 110.973 -179.607 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -95.61 -9.94 57.17 Favored Glycine 0 N--CA 1.448 -0.514 0 C-N-CA 120.812 -0.709 . . . . 0.0 111.539 179.433 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -112.86 23.79 13.08 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.029 0.442 . . . . 0.0 110.629 -179.458 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 7.7 m -64.18 -14.36 15.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.835 -179.863 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 17.7 mm-40 -81.09 -11.59 59.46 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.838 0.352 . . . . 0.0 110.544 179.561 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -121.61 -51.97 2.04 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.105 -179.785 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 13.6 m -72.76 -71.8 0.28 Allowed 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.011 -0.541 . . . . 0.0 111.295 -179.959 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -83.56 32.33 0.46 Allowed 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.798 -178.861 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 1.4 t -80.23 -31.38 38.58 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 121.042 0.449 . . . . 0.0 109.948 -179.57 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -66.47 -25.68 66.83 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.914 -0.585 . . . . 0.0 111.212 179.777 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 1.4 m -61.15 -24.53 66.36 Favored 'General case' 0 N--CA 1.449 -0.495 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.079 -179.653 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -71.7 -31.24 66.55 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.527 -0.306 . . . . 0.0 110.483 179.026 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -76.98 4.3 10.32 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.321 0.582 . . . . 0.0 110.605 179.772 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 46.3 tp60 -122.5 -54.9 1.86 Allowed 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.811 -0.632 . . . . 0.0 110.524 179.277 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -79.8 -54.42 5.86 Favored 'General case' 0 C--N 1.326 -0.413 0 N-CA-C 112.174 0.435 . . . . 0.0 112.174 -178.603 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 14.0 tp10 -69.58 -27.1 64.83 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.069 0.461 . . . . 0.0 110.963 -179.224 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 15.5 tptp -59.9 -27.2 66.52 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.995 179.303 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 94.8 mt-10 -62.74 -22.28 66.43 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-O 121.375 0.607 . . . . 0.0 111.009 179.583 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 71' ' ' GLU . . . . . 0.446 ' O ' ' HD2' ' A' ' 75' ' ' ARG . 7.0 tp10 -96.97 -40.01 9.09 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 115.727 -0.669 . . . . 0.0 109.596 178.007 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.436 HG12 ' HB2' ' A' ' 121' ' ' GLU . 59.0 t -65.27 -37.89 81.25 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-N 115.728 -0.669 . . . . 0.0 112.586 -179.034 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 73' ' ' ASP . . . . . 0.469 ' OD2' HG21 ' A' ' 151' ' ' THR . 6.5 p-10 -72.98 -17.13 61.49 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-O 120.889 0.376 . . . . 0.0 111.148 -179.227 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -97.77 -18.56 18.72 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.964 -0.562 . . . . 0.0 109.952 177.831 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 75' ' ' ARG . . . . . 0.446 ' HD2' ' O ' ' A' ' 71' ' ' GLU . 0.0 OUTLIER -103.05 49.76 0.83 Allowed 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.353 -179.334 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 76' ' ' SER . . . . . 0.49 ' HB3' ' HB3' ' A' ' 121' ' ' GLU . 0.0 OUTLIER -128.04 170.57 12.76 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.542 -0.754 . . . . 0.0 110.313 179.703 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 4.8 pt -134.98 137.33 50.8 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.787 0 N-CA-C 109.795 -0.446 . . . . 0.0 109.795 178.88 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 67.0 t80 -95.81 128.18 42.48 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.151 -179.58 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 2.7 t -105.18 111.8 36.13 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.362 -179.861 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -116.93 162.98 12.57 Favored Glycine 0 N--CA 1.449 -0.498 0 C-N-CA 120.925 -0.655 . . . . 0.0 111.599 -179.859 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 9.9 m120 60.28 42.45 15.02 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-O 121.32 0.581 . . . . 0.0 110.542 -179.559 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.545 HG12 ' H ' ' A' ' 83' ' ' ASP . 2.0 t -83.26 172.9 1.0 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.656 0 CA-C-N 115.521 -0.763 . . . . 0.0 110.31 -179.375 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 83' ' ' ASP . . . . . 0.651 ' OD2' ' HD3' ' A' ' 142' ' ' ARG . 11.6 t0 -73.62 135.4 43.82 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 109.756 -0.461 . . . . 0.0 109.756 179.451 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 5.4 p90 -60.77 -21.4 63.01 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.88 -0.6 . . . . 0.0 111.924 -179.662 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -110.85 19.19 18.81 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.774 0.321 . . . . 0.0 111.237 -179.855 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 86' ' ' CYS . . . . . 0.442 ' SG ' ' HB3' ' A' ' 83' ' ' ASP . 0.5 OUTLIER -80.64 148.32 30.3 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.375 0.607 . . . . 0.0 110.993 -179.898 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 87' ' ' THR . . . . . 0.531 ' O ' ' HG2' ' A' ' 90' ' ' GLU . 40.1 p -109.97 152.38 43.0 Favored Pre-proline 0 C--N 1.321 -0.649 0 CA-C-N 115.338 -0.846 . . . . 0.0 110.194 179.409 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 88' ' ' PRO . . . . . 0.408 ' HD3' HD13 ' A' ' 106' ' ' ILE . 18.8 Cg_endo -60.14 -32.39 94.52 Favored 'Trans proline' 0 C--N 1.344 0.338 0 C-N-CA 122.414 2.076 . . . . 0.0 112.593 -179.543 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 7.8 mm-40 -64.6 -53.09 53.21 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.731 -0.668 . . . . 0.0 111.96 -179.165 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 90' ' ' GLU . . . . . 0.531 ' HG2' ' O ' ' A' ' 87' ' ' THR . 10.7 pt-20 -62.42 -23.93 67.13 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.966 0.412 . . . . 0.0 111.413 -178.904 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 76.6 t -79.86 -48.78 20.16 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.059 -179.86 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 92' ' ' GLN . . . . . 0.427 ' O ' ' HB2' ' A' ' 96' ' ' GLN . 1.6 pp0? -71.97 -33.63 68.32 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.708 -0.224 . . . . 0.0 111.372 -178.455 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 8.6 pt20 -74.21 -31.79 62.76 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.911 0.386 . . . . 0.0 111.068 -179.475 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 65.0 t-80 -73.79 -41.85 61.82 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.734 -179.431 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 18.1 m-30 -78.19 -12.97 60.03 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.124 -179.162 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 96' ' ' GLN . . . . . 0.545 ' HA ' ' O ' ' A' ' 99' ' ' GLY . 38.5 tt0 -70.06 -20.17 63.24 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.687 -0.688 . . . . 0.0 109.988 179.669 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 1.4 m -65.17 -36.41 84.14 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.496 -0.775 . . . . 0.0 110.692 179.555 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 0.2 OUTLIER -89.81 -46.43 8.59 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.304 -179.988 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 99' ' ' GLY . . . . . 0.545 ' O ' ' HA ' ' A' ' 96' ' ' GLN . . . -144.27 145.21 14.55 Favored Glycine 0 N--CA 1.445 -0.766 0 C-N-CA 120.672 -0.775 . . . . 0.0 111.801 179.792 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -64.12 145.91 55.12 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 121.033 0.444 . . . . 0.0 111.337 -179.781 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 1.2 p -118.65 121.79 67.86 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.259 -179.949 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 102' ' ' ASN . . . . . 0.482 ' OD1' ' HG2' ' A' ' 103' ' ' ARG . 26.6 t-20 -91.07 -44.83 9.04 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 109.859 -0.423 . . . . 0.0 109.859 179.733 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 103' ' ' ARG . . . . . 0.482 ' HG2' ' OD1' ' A' ' 102' ' ' ASN . 10.3 mmm180 -136.99 149.16 47.34 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.534 179.967 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 4.0 p -148.2 131.39 7.9 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.587 0 CA-C-N 115.919 -0.582 . . . . 0.0 109.473 179.711 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 105' ' ' THR . . . . . 0.419 ' HB ' ' CE1' ' A' ' 119' ' ' TYR . 0.7 OUTLIER -124.89 126.53 45.68 Favored 'General case' 0 C--N 1.32 -0.69 0 N-CA-C 110.08 -0.341 . . . . 0.0 110.08 179.237 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 106' ' ' ILE . . . . . 0.502 HD11 ' HA2' ' A' ' 116' ' ' GLY . 21.1 tt -113.26 143.62 22.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-O 120.895 0.379 . . . . 0.0 110.889 -179.598 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 51.4 tp -129.66 127.75 41.17 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.062 179.372 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -94.76 114.65 26.58 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.546 -0.297 . . . . 0.0 110.411 179.73 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 109' ' ' ASP . . . . . 0.468 ' C ' ' HD2' ' A' ' 110' ' ' LYS . 3.1 t70 -75.24 134.07 41.23 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.771 0.32 . . . . 0.0 110.899 -179.948 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 110' ' ' LYS . . . . . 0.468 ' HD2' ' C ' ' A' ' 109' ' ' ASP . 8.0 mmmm -116.66 30.17 7.5 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 120.94 0.4 . . . . 0.0 110.094 -179.906 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 8.5 t80 -112.72 -2.85 14.37 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.848 0.356 . . . . 0.0 110.81 -179.6 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 108.33 8.78 28.53 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.844 -0.693 . . . . 0.0 113.141 179.717 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 30.2 mt-30 -94.58 157.18 37.55 Favored Pre-proline 0 C--N 1.322 -0.596 0 N-CA-C 109.646 -0.502 . . . . 0.0 109.646 179.84 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -58.64 105.59 0.23 Allowed 'Trans proline' 0 C--N 1.348 0.502 0 C-N-CA 122.216 1.944 . . . . 0.0 110.819 178.998 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 115' ' ' LYS . . . . . 0.415 ' HG2' ' O ' ' A' ' 109' ' ' ASP . 3.3 mttp -68.22 177.34 2.32 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.68 -179.074 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 116' ' ' GLY . . . . . 0.502 ' HA2' HD11 ' A' ' 106' ' ' ILE . . . 99.54 2.93 56.46 Favored Glycine 0 N--CA 1.445 -0.729 0 C-N-CA 120.339 -0.934 . . . . 0.0 111.308 -179.73 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 39.9 m-85 -53.13 117.55 3.09 Favored 'General case' 0 C--N 1.331 -0.205 0 O-C-N 123.821 0.366 . . . . 0.0 110.097 179.505 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -147.15 173.49 12.46 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 121.154 0.502 . . . . 0.0 111.205 -179.099 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 119' ' ' TYR . . . . . 0.419 ' CE1' ' HB ' ' A' ' 105' ' ' THR . 39.2 p90 -156.14 134.6 11.58 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 115.436 -0.802 . . . . 0.0 109.0 178.642 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 14.4 m -109.43 139.24 33.18 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 N-CA-C 109.319 -0.623 . . . . 0.0 109.319 179.055 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 121' ' ' GLU . . . . . 0.49 ' HB3' ' HB3' ' A' ' 76' ' ' SER . 9.0 pt-20 -127.67 154.6 45.1 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 120.921 0.391 . . . . 0.0 111.334 -179.684 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 122' ' ' PHE . . . . . 0.412 ' O ' ' HA ' ' A' ' 72' ' ' VAL . 17.6 t80 -154.56 171.14 19.91 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.748 -0.66 . . . . 0.0 109.819 -179.821 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 3.8 t -84.65 -52.01 13.06 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-O 120.772 0.32 . . . . 0.0 111.551 -179.463 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -62.43 132.7 53.42 Favored 'General case' 0 C--O 1.236 0.346 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.674 -179.032 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 2.3 mp -76.04 -32.45 23.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 115.937 -0.574 . . . . 0.0 109.629 179.463 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 6.4 t70 -58.67 -39.16 79.88 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.358 -0.837 . . . . 0.0 110.632 179.324 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -62.59 -57.56 10.66 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.781 -0.645 . . . . 0.0 111.118 -179.829 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 7.6 p -65.2 -29.48 47.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.428 -0.351 . . . . 0.0 111.371 -179.449 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 40.6 tt0 -59.24 -47.17 86.36 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.284 0.564 . . . . 0.0 110.673 179.752 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 44.7 m-80 -70.68 -31.24 68.06 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.804 -0.635 . . . . 0.0 110.029 179.608 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -68.47 -47.91 65.87 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.58 -0.736 . . . . 0.0 111.672 -179.601 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 4.1 pp -68.02 -24.0 65.06 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.74 0.305 . . . . 0.0 110.9 -179.746 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 5.4 tp -74.24 -53.45 9.74 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.722 -179.354 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 61.9 mt -131.64 98.41 4.48 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 112.087 0.403 . . . . 0.0 112.087 -178.939 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 3.4 m-20 -149.9 -52.25 0.15 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.318 179.111 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 2.9 pt-20 -73.03 93.55 1.78 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.619 0.723 . . . . 0.0 110.708 179.614 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 4.6 m -142.38 -59.85 0.45 Allowed 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.544 -0.753 . . . . 0.0 110.354 179.376 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -156.47 127.41 6.86 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.216 179.894 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -146.95 122.99 10.77 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 109.481 -0.562 . . . . 0.0 109.481 179.691 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 2.0 t60 63.93 17.34 10.5 Favored 'General case' 0 N--CA 1.465 0.306 0 C-N-CA 122.71 0.404 . . . . 0.0 111.015 179.59 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 93.39 -1.59 69.73 Favored Glycine 0 N--CA 1.443 -0.843 0 C-N-CA 120.77 -0.728 . . . . 0.0 112.366 -179.465 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 142' ' ' ARG . . . . . 0.651 ' HD3' ' OD2' ' A' ' 83' ' ' ASP . 4.3 mpt_? -121.38 -173.7 2.68 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 110.127 -0.323 . . . . 0.0 110.127 179.861 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 20.7 pt20 -124.12 150.98 44.46 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 120.794 0.331 . . . . 0.0 110.402 179.735 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -133.54 177.89 7.35 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.472 -179.783 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 42.0 tttt -117.72 123.46 46.09 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 109.793 -0.447 . . . . 0.0 109.793 178.449 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 82.8 t -117.61 121.52 67.68 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-O 120.982 0.42 . . . . 0.0 110.451 179.875 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 56.8 m -127.44 147.63 50.29 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 116.33 -0.396 . . . . 0.0 110.185 179.51 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -65.23 126.79 29.25 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.903 0.382 . . . . 0.0 111.133 -179.479 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 19.8 ttpp -89.38 55.45 3.26 Favored 'General case' 0 N--CA 1.448 -0.533 0 CA-C-O 121.463 0.649 . . . . 0.0 109.302 -179.807 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.99 84.74 2.26 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.781 -0.645 . . . . 0.0 109.909 179.912 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 151' ' ' THR . . . . . 0.469 HG21 ' OD2' ' A' ' 73' ' ' ASP . 11.1 t -67.04 139.75 57.63 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.564 -0.744 . . . . 0.0 110.248 179.58 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 152' ' ' ASN . . . . . . . . . . . . . 7.5 t-20 -177.22 167.07 2.38 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 109.166 -0.679 . . . . 0.0 109.166 -179.915 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 14.1 pt -74.87 119.85 78.78 Favored Pre-proline 0 C--N 1.323 -0.562 0 CA-C-O 120.919 0.39 . . . . 0.0 110.09 179.588 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -60.36 124.17 14.6 Favored 'Trans proline' 0 C--O 1.236 0.421 0 C-N-CA 122.758 2.305 . . . . 0.0 112.929 -178.71 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.246 0.9 0 CA-C-O 118.869 -0.962 . . . . 0.0 111.63 179.554 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 59.1 tpp . . . . . 0 N--CA 1.481 1.094 0 CA-C-O 120.662 0.268 . . . . 0.0 110.324 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 124.78 122.26 2.63 Favored Glycine 0 N--CA 1.448 -0.562 0 C-N-CA 120.915 -0.659 . . . . 0.0 111.871 -179.725 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 1.1 m -65.72 -59.32 4.03 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 120.951 0.405 . . . . 0.0 110.78 -179.89 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -78.02 100.98 6.71 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.104 0.478 . . . . 0.0 110.287 179.826 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 46.8 p-80 -124.48 114.94 20.11 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.48 -179.519 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -137.38 109.52 7.26 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.113 179.867 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 2.2 t60 60.91 37.52 18.32 Favored 'General case' 0 N--CA 1.464 0.262 0 O-C-N 123.497 0.498 . . . . 0.0 110.703 179.516 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 28.0 t-80 -107.79 75.2 0.99 Allowed 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.146 0.498 . . . . 0.0 111.018 -178.997 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 15.2 p80 -78.04 167.25 21.74 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.882 179.674 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 8.7 m170 -98.14 165.22 11.99 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.648 -179.965 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 5.0 m -87.6 87.82 7.5 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 120.795 0.331 . . . . 0.0 110.466 179.459 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 3.4 t -167.64 152.93 7.11 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.176 -0.466 . . . . 0.0 109.839 179.455 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -174.61 -179.69 45.37 Favored Glycine 0 N--CA 1.444 -0.827 0 C-N-CA 120.936 -0.649 . . . . 0.0 111.75 -179.976 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 19.6 tp -131.24 121.49 24.87 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 110.08 -0.341 . . . . 0.0 110.08 179.922 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 6.6 p -91.82 127.27 50.62 Favored Pre-proline 0 C--N 1.321 -0.642 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.745 -179.957 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -71.23 155.31 60.98 Favored 'Trans proline' 0 C--N 1.346 0.418 0 C-N-CA 122.383 2.056 . . . . 0.0 111.833 179.207 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 25.3 ptt180 -72.54 137.71 46.43 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.099 0.476 . . . . 0.0 110.62 -179.883 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -177.1 72.92 0.08 OUTLIER Glycine 0 N--CA 1.445 -0.71 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.094 -179.46 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 16.1 m -123.65 139.67 53.77 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 110.348 -0.242 . . . . 0.0 110.348 179.872 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 48.9 p-80 -159.57 132.97 7.08 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 109.835 -0.432 . . . . 0.0 109.835 -179.757 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 51.2 ttp -166.53 104.65 0.61 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.845 0.355 . . . . 0.0 110.686 -179.848 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -147.87 51.53 0.56 Allowed Glycine 0 N--CA 1.448 -0.503 0 C-N-CA 120.813 -0.708 . . . . 0.0 112.001 179.737 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 24.5 m -133.89 129.83 36.95 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 110.535 -0.172 . . . . 0.0 110.535 -179.775 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -116.61 142.25 47.14 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 109.873 -0.418 . . . . 0.0 109.873 179.565 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 39.3 mt -113.83 168.56 9.68 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.581 -179.204 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 17.7 mm-40 -76.9 -178.04 4.69 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.515 179.458 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -148.53 -172.67 4.14 Favored 'General case' 0 C--N 1.325 -0.465 0 C-N-CA 121.125 -0.23 . . . . 0.0 110.901 -179.868 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 22.2 ptp -79.48 154.68 28.71 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.503 179.717 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 2.3 mtmm -95.18 148.09 22.76 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.5 -0.318 . . . . 0.0 110.274 179.6 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -68.84 174.01 4.78 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.923 -0.58 . . . . 0.0 111.618 -179.782 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 2.6 tmt_? -62.26 142.47 57.7 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.123 179.596 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 1.3 mm? -59.78 102.32 0.15 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.103 0.478 . . . . 0.0 110.867 179.811 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 23.7 tptm -170.94 91.26 0.15 Allowed 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.349 -0.841 . . . . 0.0 108.79 -179.852 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 24.9 mm-40 -100.57 -77.19 0.54 Allowed 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.34 -179.028 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 16.8 mm 58.8 53.16 0.3 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.185 0 CA-C-O 121.745 0.784 . . . . 0.0 109.544 -179.101 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 61.1 mm-40 -111.96 143.96 42.08 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.375 -0.829 . . . . 0.0 109.883 -179.672 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 77.9 mt-10 -79.4 76.12 5.98 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.204 0.526 . . . . 0.0 110.657 179.99 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 32.7 mt-10 -76.23 152.91 36.42 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.604 -0.725 . . . . 0.0 110.507 -179.817 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -107.72 168.08 9.51 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.076 -179.127 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -72.36 128.7 13.68 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.865 -0.683 . . . . 0.0 112.348 179.999 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -156.97 168.94 25.99 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 110.291 -0.263 . . . . 0.0 110.291 -179.697 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 14.4 tp -75.21 77.23 2.34 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.395 0.617 . . . . 0.0 109.84 178.955 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' ARG . . . . . 0.406 ' C ' ' H ' ' A' ' 45' ' ' MET . 29.0 ttt180 -136.33 145.67 45.71 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.127 -179.333 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -75.45 37.32 0.13 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.23 0.538 . . . . 0.0 111.199 179.97 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' MET . . . . . 0.406 ' H ' ' C ' ' A' ' 43' ' ' ARG . 22.1 ptt? -100.29 8.38 43.76 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.05 -179.843 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 73.2 mm-40 -66.07 -26.5 67.52 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.368 179.753 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -72.86 -8.4 55.37 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.832 -0.622 . . . . 0.0 111.345 179.953 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 13.5 ttpt -75.14 -8.5 56.74 Favored 'General case' 0 C--O 1.236 0.363 0 CA-C-O 121.19 0.519 . . . . 0.0 110.04 179.947 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 9.9 p -58.86 -25.04 28.02 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.204 0 CA-C-N 115.747 -0.66 . . . . 0.0 111.122 179.646 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -61.1 -27.18 68.18 Favored 'General case' 0 C--N 1.333 -0.131 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.019 179.794 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 11.8 mtmt -101.55 -35.47 9.14 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.398 179.903 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 76.5 mm-40 -70.38 -21.32 62.88 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.591 -0.277 . . . . 0.0 111.188 179.986 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 13.7 ptp -62.8 -29.36 70.65 Favored 'General case' 0 N--CA 1.462 0.169 0 CA-C-O 120.829 0.347 . . . . 0.0 110.435 179.566 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -90.66 -10.97 62.69 Favored Glycine 0 N--CA 1.447 -0.602 0 N-CA-C 111.008 -0.837 . . . . 0.0 111.008 178.909 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -105.22 14.2 29.39 Favored 'General case' 0 N--CA 1.448 -0.529 0 CA-C-O 120.805 0.336 . . . . 0.0 110.431 -179.838 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 26.8 m -62.46 -16.17 16.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.904 179.473 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 77.4 mt-30 -79.24 -3.77 47.44 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 121.42 0.628 . . . . 0.0 109.887 179.223 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 7.1 t0 -132.02 -63.16 0.82 Allowed 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.43 -0.804 . . . . 0.0 110.333 179.836 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 5.0 m -59.49 -61.61 2.49 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.728 -0.669 . . . . 0.0 111.655 -179.604 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -94.8 25.16 4.22 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.819 -0.628 . . . . 0.0 111.589 -178.934 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 5.7 t -76.9 -26.14 53.79 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 120.966 0.412 . . . . 0.0 110.664 -179.583 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 1.3 m -67.9 -23.75 65.14 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-O 121.105 0.479 . . . . 0.0 110.276 179.49 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 18.8 m -63.42 -27.36 69.24 Favored 'General case' 0 N--CA 1.449 -0.495 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.446 179.676 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -68.53 -33.48 74.19 Favored 'General case' 0 N--CA 1.452 -0.328 0 N-CA-C 109.61 -0.515 . . . . 0.0 109.61 179.08 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -76.4 4.12 9.66 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.225 0.536 . . . . 0.0 110.521 179.312 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 46.4 tt0 -118.27 -52.55 2.38 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.607 179.674 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -85.98 -57.82 2.89 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.812 -179.488 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 3.7 tp10 -63.79 -27.51 69.24 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 120.838 0.352 . . . . 0.0 110.751 -179.717 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 2.3 tptm -61.0 -23.72 65.6 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.199 179.952 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 35.1 mt-10 -62.1 -23.97 66.84 Favored 'General case' 0 N--CA 1.461 0.12 0 CA-C-O 121.176 0.512 . . . . 0.0 110.496 179.02 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 7.2 tp10 -95.46 -38.71 10.34 Favored 'General case' 0 C--N 1.319 -0.751 0 N-CA-C 109.212 -0.662 . . . . 0.0 109.212 177.747 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.447 HG22 ' HA ' ' A' ' 123' ' ' VAL . 58.4 t -65.04 -42.18 93.93 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.331 0 CA-C-N 115.913 -0.585 . . . . 0.0 112.191 -179.209 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 51.3 p30 -69.4 -15.21 63.25 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-O 121.125 0.488 . . . . 0.0 111.057 -179.223 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 24.5 m -105.51 -3.88 21.93 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.54 179.826 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -116.19 47.77 1.35 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.652 -0.704 . . . . 0.0 110.255 -179.193 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -126.3 172.81 9.79 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.866 -179.839 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 8.7 pt -131.17 136.75 57.19 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 N-CA-C 109.92 -0.4 . . . . 0.0 109.92 178.392 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 78' ' ' TYR . . . . . 0.536 ' O ' ' HA ' ' A' ' 146' ' ' VAL . 36.8 t80 -91.63 124.3 35.68 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.62 -179.465 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.495 HG13 HG22 ' A' ' 146' ' ' VAL . 6.9 t -105.98 110.23 30.62 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 N-CA-C 110.103 -0.332 . . . . 0.0 110.103 179.759 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -118.4 167.24 12.95 Favored Glycine 0 N--CA 1.45 -0.37 0 N-CA-C 111.745 -0.542 . . . . 0.0 111.745 -179.857 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 4.6 m-20 59.25 40.77 21.03 Favored 'General case' 0 N--CA 1.468 0.471 0 CA-C-O 121.289 0.566 . . . . 0.0 110.794 -179.583 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.444 HG12 ' H ' ' A' ' 83' ' ' ASP . 2.1 t -83.46 169.1 1.61 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-N 115.354 -0.839 . . . . 0.0 109.851 -179.471 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 83' ' ' ASP . . . . . 0.477 ' HB3' ' SG ' ' A' ' 86' ' ' CYS . 29.8 t70 -73.2 143.14 47.28 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 120.901 0.381 . . . . 0.0 110.73 179.916 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 34.1 p90 -64.77 -13.53 55.61 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.799 -0.637 . . . . 0.0 112.549 -178.693 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -117.21 15.95 14.91 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.81 0.338 . . . . 0.0 111.019 179.923 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 86' ' ' CYS . . . . . 0.477 ' SG ' ' HB3' ' A' ' 83' ' ' ASP . 1.0 OUTLIER -78.68 142.55 37.05 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.113 0.483 . . . . 0.0 110.885 179.945 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 87' ' ' THR . . . . . 0.482 ' O ' ' HG2' ' A' ' 90' ' ' GLU . 70.2 p -106.12 155.41 38.55 Favored Pre-proline 0 C--N 1.321 -0.672 0 CA-C-N 115.444 -0.798 . . . . 0.0 110.272 -179.994 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 20.8 Cg_endo -61.46 -29.29 84.88 Favored 'Trans proline' 0 C--N 1.344 0.32 0 C-N-CA 122.219 1.946 . . . . 0.0 112.401 -179.788 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 14.0 mt-10 -65.31 -55.3 19.07 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.665 -179.073 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 90' ' ' GLU . . . . . 0.482 ' HG2' ' O ' ' A' ' 87' ' ' THR . 9.6 pt-20 -60.89 -25.53 66.78 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.921 0.391 . . . . 0.0 111.258 -178.634 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 69.2 t -78.24 -47.37 24.62 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.274 -179.286 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 92' ' ' GLN . . . . . 0.471 ' O ' ' HB2' ' A' ' 96' ' ' GLN . 13.9 pt20 -74.0 -31.75 63.1 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 112.172 0.434 . . . . 0.0 112.172 -178.212 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 1.5 pp0? -77.53 -27.85 51.8 Favored 'General case' 0 N--CA 1.467 0.419 0 C-N-CA 120.305 -0.558 . . . . 0.0 111.743 -179.155 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 1.5 m-70 -71.71 -44.46 64.14 Favored 'General case' 0 C--N 1.328 -0.349 0 C-N-CA 120.832 -0.347 . . . . 0.0 111.009 -179.571 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 23.0 m-85 -81.18 -11.72 59.36 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.682 0.277 . . . . 0.0 110.884 -179.707 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 96' ' ' GLN . . . . . 0.471 ' HB2' ' O ' ' A' ' 92' ' ' GLN . 43.3 tt0 -62.64 -28.56 70.0 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.002 -0.544 . . . . 0.0 110.59 -179.483 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 12.1 m -64.85 -38.95 92.7 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.305 179.263 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 6.1 m -81.01 -40.01 24.96 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.005 179.321 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 99' ' ' GLY . . . . . 0.456 ' O ' ' HA ' ' A' ' 96' ' ' GLN . . . -153.8 129.37 2.64 Favored Glycine 0 N--CA 1.442 -0.91 0 CA-C-N 115.76 -0.655 . . . . 0.0 111.516 179.487 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 100' ' ' THR . . . . . 0.424 HG22 ' H ' ' A' ' 100' ' ' THR . 0.6 OUTLIER -58.97 140.84 55.18 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.259 0.552 . . . . 0.0 110.748 179.868 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.443 HG11 ' HB2' ' A' ' 92' ' ' GLN . 1.3 p -107.55 128.37 62.73 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 115.754 -0.657 . . . . 0.0 111.996 -178.057 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 102' ' ' ASN . . . . . 0.489 ' O ' ' HD2' ' A' ' 103' ' ' ARG . 6.3 t30 -86.39 -53.36 5.05 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 109.229 -0.656 . . . . 0.0 109.229 178.553 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 103' ' ' ARG . . . . . 0.489 ' HD2' ' O ' ' A' ' 102' ' ' ASN . 3.4 mpt_? -138.93 153.49 48.24 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 116.001 -0.545 . . . . 0.0 109.62 179.963 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 4.8 p -142.74 126.93 15.22 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 N-CA-C 109.787 -0.449 . . . . 0.0 109.787 179.669 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 105' ' ' THR . . . . . 0.409 ' O ' ' HA ' ' A' ' 118' ' ' ALA . 0.8 OUTLIER -114.75 127.19 55.6 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 110.308 -0.256 . . . . 0.0 110.308 179.847 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 20.0 tt -117.8 144.55 25.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-O 120.708 0.29 . . . . 0.0 110.597 -179.77 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 26.6 tp -133.45 121.97 23.01 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.557 179.84 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -84.09 114.53 21.82 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.543 -0.299 . . . . 0.0 110.318 179.258 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -78.54 134.21 37.29 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.182 0.515 . . . . 0.0 111.516 -179.698 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -119.94 22.85 11.33 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.167 179.33 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 4.0 t80 -101.07 1.39 39.35 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.113 -179.56 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 100.87 12.15 38.08 Favored Glycine 0 N--CA 1.449 -0.455 0 C-N-CA 120.796 -0.716 . . . . 0.0 112.361 179.898 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 36.4 mt-30 -100.11 157.61 33.53 Favored Pre-proline 0 C--N 1.325 -0.485 0 N-CA-C 109.37 -0.604 . . . . 0.0 109.37 179.372 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -58.53 112.76 1.29 Allowed 'Trans proline' 0 C--N 1.345 0.37 0 C-N-CA 122.433 2.089 . . . . 0.0 111.488 178.889 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 7.9 mttp -69.58 176.87 3.23 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.662 -179.745 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 99.06 2.96 56.93 Favored Glycine 0 N--CA 1.439 -1.139 0 C-N-CA 120.164 -1.017 . . . . 0.0 111.768 -179.801 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 29.1 m-85 -54.95 113.35 1.31 Allowed 'General case' 0 C--O 1.231 0.118 0 N-CA-C 110.12 -0.326 . . . . 0.0 110.12 179.53 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 118' ' ' ALA . . . . . 0.409 ' HA ' ' O ' ' A' ' 105' ' ' THR . . . -144.59 173.07 12.14 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 120.931 0.396 . . . . 0.0 110.87 -178.977 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 2.3 p90 -157.75 136.75 11.59 Favored 'General case' 0 N--CA 1.445 -0.676 0 CA-C-N 115.891 -0.595 . . . . 0.0 109.552 178.874 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 15.0 m -105.91 140.7 23.16 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 N-CA-C 109.489 -0.56 . . . . 0.0 109.489 178.985 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 121' ' ' GLU . . . . . 0.414 ' HB2' HG12 ' A' ' 72' ' ' VAL . 6.4 pt-20 -126.4 154.2 43.93 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.045 -179.287 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 122' ' ' PHE . . . . . 0.436 ' O ' ' HA ' ' A' ' 72' ' ' VAL . 14.3 t80 -154.65 167.87 28.7 Favored 'General case' 0 C--O 1.226 -0.15 0 CA-C-O 120.796 0.331 . . . . 0.0 110.637 179.306 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 123' ' ' VAL . . . . . 0.447 ' HA ' HG22 ' A' ' 72' ' ' VAL . 6.3 t -82.73 -50.32 15.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 115.715 -0.675 . . . . 0.0 111.626 -179.126 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 33.1 mt-10 -70.97 137.42 49.12 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.044 -0.526 . . . . 0.0 111.934 -178.748 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 2.9 mp -74.99 -32.46 27.17 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.313 179.707 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 37.8 t70 -58.0 -43.54 86.67 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-O 120.982 0.42 . . . . 0.0 111.003 -179.833 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -58.05 -57.37 13.15 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.872 -0.604 . . . . 0.0 111.471 -179.682 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 12.2 p -67.62 -29.52 45.6 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 116.477 -0.329 . . . . 0.0 111.608 -179.177 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 129' ' ' GLN . . . . . 0.455 ' O ' ' HG ' ' A' ' 132' ' ' LEU . 29.4 tt0 -63.16 -46.43 87.2 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.901 0.381 . . . . 0.0 110.308 179.889 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 48.6 m-80 -72.02 -27.15 62.53 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.216 0.532 . . . . 0.0 109.688 179.125 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -72.15 -40.73 67.8 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.561 -0.745 . . . . 0.0 111.317 179.892 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 132' ' ' LEU . . . . . 0.584 ' HA ' ' ND2' ' A' ' 135' ' ' ASN . 4.4 pp -74.7 -19.1 60.39 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.924 0.392 . . . . 0.0 110.789 179.861 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 5.3 tp -76.34 -47.48 23.31 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.383 -179.906 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 40.1 mt -126.19 95.28 4.34 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.973 -0.558 . . . . 0.0 109.818 179.959 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 135' ' ' ASN . . . . . 0.584 ' ND2' ' HA ' ' A' ' 132' ' ' LEU . 2.8 p30 -135.75 -74.74 0.45 Allowed 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 112.431 0.53 . . . . 0.0 112.431 -179.083 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 5.8 pt-20 -69.25 100.57 1.33 Allowed 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.505 0.669 . . . . 0.0 111.632 -178.708 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 26.5 m -142.68 -58.3 0.44 Allowed 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.577 -0.738 . . . . 0.0 109.929 178.815 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 3.0 tm-20 -162.17 124.51 2.85 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.151 -0.477 . . . . 0.0 109.961 179.491 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -144.51 119.11 9.75 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 109.374 -0.602 . . . . 0.0 109.374 179.448 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 2.5 t60 64.67 20.52 12.16 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-O 121.108 0.48 . . . . 0.0 110.386 179.541 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 85.15 5.61 85.48 Favored Glycine 0 N--CA 1.448 -0.543 0 C-N-CA 120.922 -0.656 . . . . 0.0 112.149 -179.303 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -120.34 173.33 7.2 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 109.98 -0.378 . . . . 0.0 109.98 179.994 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 10.3 pt20 -118.84 125.43 49.52 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 109.761 -0.459 . . . . 0.0 109.761 179.271 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -110.36 178.3 4.43 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.86 -178.9 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -118.67 118.64 32.2 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 109.394 -0.595 . . . . 0.0 109.394 179.22 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 146' ' ' VAL . . . . . 0.536 ' HA ' ' O ' ' A' ' 78' ' ' TYR . 42.0 t -122.03 119.56 58.91 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-O 120.753 0.311 . . . . 0.0 111.144 -179.065 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 60.0 m -124.16 152.49 42.77 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 109.901 -0.407 . . . . 0.0 109.901 179.499 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -61.49 130.31 45.4 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.939 0.399 . . . . 0.0 110.796 179.984 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 42.7 tttp -92.94 71.19 4.69 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 109.079 -0.711 . . . . 0.0 109.079 179.958 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 150' ' ' ARG . . . . . 0.407 HH11 ' HD2' ' A' ' 150' ' ' ARG . 3.6 tpt180 -90.79 86.74 6.42 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.679 -0.692 . . . . 0.0 110.034 -179.563 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 9.0 t -68.01 138.14 55.63 Favored 'General case' 0 N--CA 1.447 -0.591 0 CA-C-N 115.66 -0.7 . . . . 0.0 109.927 179.659 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 152' ' ' ASN . . . . . . . . . . . . . 64.3 t30 -168.55 152.5 5.76 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 109.066 -0.716 . . . . 0.0 109.066 -179.779 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 18.8 pt -63.73 139.01 97.55 Favored Pre-proline 0 C--N 1.327 -0.381 0 O-C-N 123.153 0.283 . . . . 0.0 110.869 179.951 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 28.5 Cg_endo -63.82 115.89 3.35 Favored 'Trans proline' 0 CA--C 1.528 0.22 0 C-N-CA 122.891 2.394 . . . . 0.0 112.676 -179.824 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.255 1.427 0 CA-C-O 118.241 -1.31 . . . . 0.0 111.365 179.822 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 68.3 mtt . . . . . 0 N--CA 1.482 1.172 0 CA-C-O 120.77 0.319 . . . . 0.0 110.732 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 100.52 117.58 4.13 Favored Glycine 0 N--CA 1.449 -0.452 0 C-N-CA 120.915 -0.66 . . . . 0.0 111.933 179.872 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 36.5 m -129.9 128.04 41.39 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 122.665 -0.314 . . . . 0.0 111.146 -179.604 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -122.49 137.23 54.94 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.328 -0.396 . . . . 0.0 109.971 179.682 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 12.7 p-80 -155.35 125.09 6.48 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.582 -0.281 . . . . 0.0 110.735 -179.39 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -164.27 112.88 1.15 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.444 -0.344 . . . . 0.0 111.074 179.559 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 2.7 p80 -164.24 138.95 5.7 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.96 -0.564 . . . . 0.0 109.906 179.763 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 51.7 p-80 -169.12 136.96 1.9 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.818 0.342 . . . . 0.0 110.612 179.418 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 20.6 p80 -146.9 151.5 37.14 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.684 -179.505 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 72.4 t60 -161.26 115.51 2.02 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.221 -0.445 . . . . 0.0 109.851 179.235 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 2.7 p -134.12 131.72 39.05 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 120.568 0.223 . . . . 0.0 111.124 -179.391 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 19.0 m -157.97 -178.24 7.16 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 110.03 -0.359 . . . . 0.0 110.03 179.772 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 131.3 78.56 0.17 Allowed Glycine 0 N--CA 1.45 -0.432 0 C-N-CA 120.308 -0.949 . . . . 0.0 113.334 179.324 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 33.4 tp -157.15 132.55 9.15 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 120.657 0.265 . . . . 0.0 110.517 179.153 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 2.8 m -137.24 149.95 67.51 Favored Pre-proline 0 C--N 1.327 -0.375 0 CA-C-N 116.485 -0.325 . . . . 0.0 110.256 179.692 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 89.7 Cg_endo -83.19 178.7 5.64 Favored 'Trans proline' 0 C--O 1.238 0.499 0 C-N-CA 122.781 2.321 . . . . 0.0 112.688 179.545 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 37.4 ttm180 -164.94 158.09 16.75 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.196 -179.797 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 143.12 123.26 1.77 Allowed Glycine 0 C--N 1.331 0.284 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.743 179.205 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 62.4 m -155.63 143.23 19.59 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 110.207 -0.294 . . . . 0.0 110.207 179.202 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -158.72 128.12 5.63 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.576 -0.283 . . . . 0.0 110.463 -179.563 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -170.04 170.93 7.28 Favored 'General case' 0 C--O 1.236 0.344 0 O-C-N 123.103 0.252 . . . . 0.0 110.935 179.817 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 162.88 162.05 13.17 Favored Glycine 0 C--N 1.33 0.228 0 C-N-CA 120.843 -0.694 . . . . 0.0 112.422 179.656 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 19.3 m -157.7 154.9 29.03 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 116.778 0.289 . . . . 0.0 110.517 179.874 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -143.93 169.68 17.34 Favored 'General case' 0 C--O 1.235 0.331 0 CA-C-N 116.576 -0.284 . . . . 0.0 110.388 179.855 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 29.3 tp -153.76 147.73 25.55 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-O 120.7 0.285 . . . . 0.0 110.896 -179.898 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 14.7 tt0 -108.27 154.38 21.88 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.383 -0.372 . . . . 0.0 110.615 179.686 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 14.5 p-10 -114.99 -168.0 1.32 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.516 -0.311 . . . . 0.0 110.878 -179.83 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 46.2 ttm -156.53 142.89 18.32 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-N 116.506 -0.316 . . . . 0.0 110.559 -179.584 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -118.71 168.87 10.32 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.621 0.248 . . . . 0.0 110.671 179.329 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 51.0 mttt -132.34 172.76 12.04 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.465 -0.334 . . . . 0.0 110.88 -179.654 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 86.3 mtt180 -132.56 172.98 11.8 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.992 -179.613 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 16.5 mt -102.77 -160.47 0.78 Allowed 'General case' 0 C--O 1.236 0.344 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.046 179.858 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.524 ' NZ ' ' HG3' ' A' ' 36' ' ' GLU . 35.2 mtpt -124.58 -178.01 4.0 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.633 -0.258 . . . . 0.0 110.733 179.92 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 15.7 mm-40 -101.38 56.1 0.84 Allowed 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.504 -0.316 . . . . 0.0 111.144 -179.215 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 4.3 pt 30.78 85.38 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.48 1.05 0 C-N-CA 124.406 1.082 . . . . 0.0 113.134 179.764 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' GLU . . . . . 0.524 ' HG3' ' NZ ' ' A' ' 33' ' ' LYS . 9.1 mm-40 -78.96 -76.28 0.21 Allowed 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.48 -0.782 . . . . 0.0 112.042 -178.828 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 24.2 mt-10 59.9 73.04 0.5 Allowed 'General case' 0 N--CA 1.466 0.327 0 O-C-N 123.473 0.483 . . . . 0.0 111.167 -179.158 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' GLU . . . . . 0.414 ' H ' ' HG3' ' A' ' 38' ' ' GLU . 1.1 pp20? -81.96 173.49 12.16 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.939 179.975 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -94.53 -66.8 0.89 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.784 0.326 . . . . 0.0 111.188 -179.138 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 116.75 96.79 1.96 Allowed Glycine 0 N--CA 1.449 -0.488 0 C-N-CA 120.629 -0.796 . . . . 0.0 113.042 179.763 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -104.09 -172.34 2.09 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 110.107 -0.331 . . . . 0.0 110.107 179.229 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 20.2 tp -83.75 79.39 9.48 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.147 0.499 . . . . 0.0 110.297 179.919 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 28.6 ttm180 -144.22 140.79 29.48 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.797 -0.638 . . . . 0.0 109.632 179.781 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 44' ' ' GLU . . . . . 0.409 ' H ' ' CD ' ' A' ' 44' ' ' GLU . 0.7 OUTLIER -71.97 84.08 0.96 Allowed 'General case' 0 C--O 1.235 0.305 0 CA-C-O 120.972 0.415 . . . . 0.0 110.112 179.398 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 14.9 ptt? -132.53 12.05 4.48 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.772 -179.244 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 1.7 mp0 -65.57 -11.64 45.91 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.834 -178.929 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -70.31 -17.43 63.08 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.963 0.411 . . . . 0.0 111.331 179.852 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 19.3 pttp -70.71 -13.22 61.99 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.49 -179.411 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 5.3 p -65.11 -20.53 27.72 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.317 0 CA-C-O 121.208 0.528 . . . . 0.0 110.952 -179.66 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 49.3 mt-10 -82.5 -12.0 58.09 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.284 179.673 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 28.7 ttmt -107.43 -32.71 7.62 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.18 0.514 . . . . 0.0 109.682 179.228 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 71.1 mt-10 -78.74 7.54 6.8 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.548 -0.751 . . . . 0.0 111.265 179.754 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -62.3 -29.21 70.27 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 109.944 -0.391 . . . . 0.0 109.944 178.988 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -96.78 3.27 62.69 Favored Glycine 0 N--CA 1.449 -0.449 0 N-CA-C 110.733 -0.947 . . . . 0.0 110.733 178.526 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -101.47 23.3 11.28 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.113 0.482 . . . . 0.0 110.321 -179.388 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 10.8 m -65.72 -17.63 22.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.762 179.58 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 10.1 mm-40 -105.28 14.24 29.25 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.066 179.057 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -125.82 -59.39 1.35 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.968 -179.729 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 64.7 m -109.86 -45.08 3.69 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 111.978 0.362 . . . . 0.0 111.978 -179.062 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -79.85 29.77 0.26 Allowed 'General case' 0 CA--C 1.533 0.323 0 N-CA-C 112.243 0.46 . . . . 0.0 112.243 -178.884 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 7.7 m -92.46 -29.17 16.39 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.935 0.398 . . . . 0.0 110.454 179.932 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -65.19 -22.8 66.95 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.883 -0.599 . . . . 0.0 111.46 -179.562 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -66.89 -31.08 71.44 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.111 0.481 . . . . 0.0 110.431 179.324 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -70.22 -36.23 74.4 Favored 'General case' 0 C--O 1.232 0.153 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.799 -179.932 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -78.24 6.19 8.71 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.374 -0.376 . . . . 0.0 111.179 179.754 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 4.2 tp-100 -119.43 -51.63 2.29 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.494 179.763 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -82.1 -62.1 1.72 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.364 -179.432 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 68' ' ' GLU . . . . . 0.501 ' O ' HG23 ' A' ' 72' ' ' VAL . 0.7 OUTLIER -58.52 -33.89 70.36 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.464 -179.101 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 32.6 tptt -53.25 -34.21 56.25 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 116.198 -0.455 . . . . 0.0 112.165 -179.577 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 2.5 mm-40 -61.0 -34.68 75.19 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.042 0.448 . . . . 0.0 110.764 -179.793 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 10.2 tp10 -88.42 -38.19 15.26 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.493 179.829 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.501 HG23 ' O ' ' A' ' 68' ' ' GLU . 61.4 t -64.7 -41.84 93.35 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.059 -179.589 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 4.6 t70 -68.04 -33.19 74.12 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.333 -179.357 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 74' ' ' SER . . . . . 0.45 ' HB2' ' HE ' ' A' ' 150' ' ' ARG . 11.5 p -82.47 -17.25 45.89 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 121.284 0.564 . . . . 0.0 109.964 179.908 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -101.79 48.19 0.89 Allowed 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.836 0.827 . . . . 0.0 108.849 178.717 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 76' ' ' SER . . . . . 0.426 ' HB3' ' HE3' ' A' ' 149' ' ' LYS . 28.0 t -125.0 158.8 32.78 Favored 'General case' 0 N--CA 1.446 -0.643 0 CA-C-N 114.726 -1.125 . . . . 0.0 110.22 -179.085 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 5.4 pt -126.94 134.8 65.37 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.138 178.895 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 61.2 t80 -92.19 130.27 37.94 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.323 -179.668 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.42 HG21 ' HE2' ' A' ' 95' ' ' PHE . 8.0 t -104.23 108.2 24.14 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.742 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.35 -179.947 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -112.88 170.24 13.32 Favored Glycine 0 N--CA 1.442 -0.961 0 N-CA-C 111.022 -0.831 . . . . 0.0 111.022 179.468 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 9.9 m-20 58.51 38.5 25.45 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-N 116.97 0.385 . . . . 0.0 110.557 -179.76 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.505 HG12 ' H ' ' A' ' 83' ' ' ASP . 1.4 t -79.35 171.81 1.23 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.971 -178.993 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 83' ' ' ASP . . . . . 0.562 ' OD1' ' HD2' ' A' ' 142' ' ' ARG . 30.2 t70 -81.24 141.71 33.87 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.287 -0.415 . . . . 0.0 109.906 179.476 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 55.2 p90 -65.01 -16.3 63.28 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 112.708 0.633 . . . . 0.0 112.708 -178.113 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -110.22 9.26 23.84 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.698 0.285 . . . . 0.0 111.327 -179.953 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 86' ' ' CYS . . . . . 0.432 ' SG ' ' HB2' ' A' ' 140' ' ' HIS . 0.9 OUTLIER -73.88 135.7 43.36 Favored 'General case' 0 C--O 1.235 0.294 0 CA-C-O 121.118 0.485 . . . . 0.0 111.336 179.888 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 87' ' ' THR . . . . . 0.582 ' O ' ' HG2' ' A' ' 90' ' ' GLU . 9.0 p -103.01 153.16 38.49 Favored Pre-proline 0 C--N 1.324 -0.514 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.19 179.337 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 15.2 Cg_endo -58.82 -37.86 91.64 Favored 'Trans proline' 0 CA--C 1.531 0.335 0 C-N-CA 122.48 2.12 . . . . 0.0 112.827 -179.426 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 7.5 mp0 -63.79 -46.3 85.83 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.756 -179.361 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 90' ' ' GLU . . . . . 0.582 ' HG2' ' O ' ' A' ' 87' ' ' THR . 7.7 pt-20 -65.65 -26.4 67.79 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.807 0.337 . . . . 0.0 111.069 -179.114 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 62.2 t -74.61 -55.51 11.74 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.874 -179.953 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 2.7 pt20 -62.51 -36.12 81.54 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 112.405 0.52 . . . . 0.0 112.405 -178.516 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 9.0 pt20 -76.35 -24.07 54.22 Favored 'General case' 0 N--CA 1.463 0.185 0 C-N-CA 120.792 -0.363 . . . . 0.0 111.605 -178.947 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -80.02 -39.25 30.3 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.856 0.36 . . . . 0.0 111.193 -179.494 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 95' ' ' PHE . . . . . 0.42 ' HE2' HG21 ' A' ' 79' ' ' VAL . 21.1 m-30 -81.3 -17.92 47.62 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.955 -179.22 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 96' ' ' GLN . . . . . 0.53 ' HA ' ' O ' ' A' ' 99' ' ' GLY . 1.9 tt0 -61.36 -23.78 66.01 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.801 179.702 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 2.7 m -63.11 -31.21 72.3 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.641 -0.708 . . . . 0.0 110.594 179.47 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 27.7 m -99.61 -44.96 5.95 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.213 179.547 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 99' ' ' GLY . . . . . 0.53 ' O ' ' HA ' ' A' ' 96' ' ' GLN . . . -141.52 132.24 5.2 Favored Glycine 0 N--CA 1.446 -0.646 0 C-N-CA 120.793 -0.718 . . . . 0.0 112.012 -179.815 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 2.5 m -68.0 147.23 52.69 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 120.728 0.299 . . . . 0.0 110.481 179.905 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 2.0 p -125.9 135.2 64.62 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-O 120.832 0.349 . . . . 0.0 111.325 -179.088 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 28.3 t-20 -104.78 -43.78 5.02 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.298 179.268 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 5.3 mpt_? -119.4 137.15 53.94 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.345 -0.388 . . . . 0.0 109.999 179.539 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 12.3 p -144.47 145.84 20.99 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.109 -179.948 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 105' ' ' THR . . . . . 0.581 ' HB ' ' CE2' ' A' ' 119' ' ' TYR . 4.2 m -146.13 137.83 24.9 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 110.036 -0.357 . . . . 0.0 110.036 179.358 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 14.9 tt -121.38 144.96 28.74 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-O 120.824 0.345 . . . . 0.0 110.631 -179.78 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 18.6 tp -123.22 127.64 48.89 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 116.438 -0.346 . . . . 0.0 110.469 -179.959 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -90.1 121.69 32.39 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.378 179.162 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 20.5 t70 -92.76 144.39 25.34 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 120.98 0.419 . . . . 0.0 111.174 -179.69 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -135.81 30.53 3.1 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 179.131 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 40.0 t80 -111.5 -12.24 13.99 Favored 'General case' 0 N--CA 1.452 -0.329 0 CA-C-N 115.19 -0.914 . . . . 0.0 110.029 -179.253 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 112.17 9.49 19.97 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.706 -179.466 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 32.6 mt-30 -91.81 157.59 41.29 Favored Pre-proline 0 C--N 1.325 -0.497 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 179.256 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 13.9 Cg_endo -58.1 99.09 0.09 OUTLIER 'Trans proline' 0 C--N 1.345 0.388 0 C-N-CA 122.095 1.863 . . . . 0.0 111.713 179.024 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 73.9 mttt -58.5 163.3 3.22 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.624 -0.717 . . . . 0.0 111.122 -179.196 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 102.55 6.12 47.57 Favored Glycine 0 N--CA 1.445 -0.75 0 C-N-CA 120.705 -0.76 . . . . 0.0 112.015 -179.811 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 46.5 m-85 -51.96 119.36 4.21 Favored 'General case' 0 CA--C 1.519 -0.236 0 CA-C-O 120.585 0.231 . . . . 0.0 110.473 179.56 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -146.79 172.94 12.87 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-O 121.034 0.445 . . . . 0.0 111.028 -179.136 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 119' ' ' TYR . . . . . 0.581 ' CE2' ' HB ' ' A' ' 105' ' ' THR . 50.5 p90 -154.2 148.75 26.28 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 115.791 -0.64 . . . . 0.0 109.471 179.02 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 30.6 m -124.64 136.31 61.07 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-N 116.476 -0.329 . . . . 0.0 110.314 179.566 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 121' ' ' GLU . . . . . 0.411 ' HB3' ' HB2' ' A' ' 76' ' ' SER . 10.2 pt-20 -128.38 149.09 50.69 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 120.898 0.38 . . . . 0.0 111.06 -179.844 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 7.7 t80 -148.87 167.96 24.3 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.535 -179.942 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 8.0 t -82.62 -42.27 18.19 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.177 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.446 -179.501 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -71.15 126.91 30.86 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.327 0.584 . . . . 0.0 111.292 -179.165 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 125' ' ' ILE . . . . . 0.408 HD12 ' H ' ' A' ' 125' ' ' ILE . 4.7 mp -67.87 -44.11 85.55 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-N 115.244 -0.889 . . . . 0.0 111.262 -178.845 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 126' ' ' ASP . . . . . 0.445 ' HA ' ' HB3' ' A' ' 129' ' ' GLN . 0.2 OUTLIER -62.34 -27.58 69.15 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.574 -0.284 . . . . 0.0 111.698 -179.132 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -63.66 -57.95 8.43 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.893 0.378 . . . . 0.0 110.23 179.423 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 11.5 p -69.26 -27.09 33.39 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 116.343 -0.389 . . . . 0.0 110.726 179.748 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 129' ' ' GLN . . . . . 0.445 ' HB3' ' HA ' ' A' ' 126' ' ' ASP . 16.1 tt0 -62.24 -45.4 93.48 Favored 'General case' 0 C--N 1.333 -0.121 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.493 179.504 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 37.6 m-80 -73.4 -26.84 61.15 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.246 0.546 . . . . 0.0 109.914 179.417 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 131' ' ' ALA . . . . . 0.451 ' O ' ' HB2' ' A' ' 135' ' ' ASN . . . -69.62 -49.72 51.2 Favored 'General case' 0 N--CA 1.45 -0.456 0 CA-C-N 115.661 -0.699 . . . . 0.0 110.792 179.623 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 3.9 pp -65.74 -16.08 63.44 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-O 120.884 0.373 . . . . 0.0 111.223 179.99 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 51.2 tp -82.39 -54.19 5.41 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.014 179.344 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 89.8 mt -120.43 93.64 4.11 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.298 179.827 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 135' ' ' ASN . . . . . 0.499 ' HB3' HG21 ' A' ' 146' ' ' VAL . 0.2 OUTLIER -145.98 -57.31 0.3 Allowed 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.978 -0.556 . . . . 0.0 111.054 -179.522 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 136' ' ' GLU . . . . . 0.418 ' HG2' ' H ' ' A' ' 136' ' ' GLU . 1.2 pt-20 -73.44 87.71 1.58 Allowed 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.854 -0.612 . . . . 0.0 111.19 -179.462 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 6.6 m -138.28 -65.87 0.5 Allowed 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.21 179.278 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 6.2 tm-20 -157.96 136.22 10.96 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.309 -179.576 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -152.23 119.23 5.83 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 109.071 -0.715 . . . . 0.0 109.071 179.181 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 140' ' ' HIS . . . . . 0.432 ' HB2' ' SG ' ' A' ' 86' ' ' CYS . 2.2 t60 65.45 19.07 11.51 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-O 121.147 0.499 . . . . 0.0 110.658 179.63 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 88.78 -5.84 84.21 Favored Glycine 0 N--CA 1.447 -0.589 0 C-N-CA 120.864 -0.684 . . . . 0.0 111.814 -179.189 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 142' ' ' ARG . . . . . 0.562 ' HD2' ' OD1' ' A' ' 83' ' ' ASP . 0.0 OUTLIER -108.1 175.56 5.43 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 120.798 0.332 . . . . 0.0 110.154 -179.676 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 10.8 pt20 -113.9 148.94 35.9 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 109.584 -0.525 . . . . 0.0 109.584 179.257 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -137.12 175.23 9.8 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 120.789 0.328 . . . . 0.0 110.897 -179.905 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 84.0 tttt -123.96 127.46 47.99 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.758 -0.655 . . . . 0.0 109.77 -179.873 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 146' ' ' VAL . . . . . 0.499 HG21 ' HB3' ' A' ' 135' ' ' ASN . 99.2 t -115.72 126.42 73.24 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 CA-C-O 120.801 0.334 . . . . 0.0 110.975 -179.073 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 3.8 m -121.81 153.27 38.56 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.673 -179.69 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -74.84 117.17 16.38 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.721 0.296 . . . . 0.0 110.489 179.386 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 149' ' ' LYS . . . . . 0.426 ' HE3' ' HB3' ' A' ' 76' ' ' SER . 11.6 ttpp -92.97 47.48 1.28 Allowed 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.728 -179.232 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 150' ' ' ARG . . . . . 0.45 ' HE ' ' HB2' ' A' ' 74' ' ' SER . 0.0 OUTLIER -74.46 95.66 2.77 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 109.892 -0.41 . . . . 0.0 109.892 179.517 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 13.5 t -62.31 144.4 55.72 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.836 -179.815 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 152' ' ' ASN . . . . . . . . . . . . . 1.9 t-20 -163.85 -165.65 1.05 Allowed 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.769 -0.65 . . . . 0.0 109.459 -179.762 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 19.0 pt -112.4 150.94 43.36 Favored Pre-proline 0 C--N 1.325 -0.496 0 N-CA-C 110.284 -0.265 . . . . 0.0 110.284 179.787 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -60.14 101.64 0.16 Allowed 'Trans proline' 0 C--N 1.346 0.422 0 C-N-CA 122.776 2.317 . . . . 0.0 112.171 179.733 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.244 0 CA-C-O 118.309 -1.273 . . . . 0.0 111.046 -179.661 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 19.7 mmt . . . . . 0 N--CA 1.48 1.047 0 N-CA-C 110.071 -0.344 . . . . 0.0 110.071 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 122.56 120.19 2.61 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 121.003 -0.618 . . . . 0.0 112.112 179.914 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 66.7 m -115.09 152.98 31.57 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 120.68 0.276 . . . . 0.0 110.708 -179.932 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -126.14 158.48 35.41 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.612 -179.575 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 2.5 t60 -146.78 139.51 25.14 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.646 0.26 . . . . 0.0 110.507 -179.944 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 19.3 p80 -150.83 168.57 24.04 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.782 0.325 . . . . 0.0 111.014 -179.444 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 6.8 p80 -155.41 173.53 16.53 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.144 -0.48 . . . . 0.0 109.979 179.93 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 28.4 p80 -144.93 174.23 11.2 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 110.167 -0.309 . . . . 0.0 110.167 179.558 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 30.4 p-80 -101.16 178.61 4.61 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.896 0.379 . . . . 0.0 111.374 -179.143 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 10.5 p-80 -146.54 141.18 26.74 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.316 -179.957 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 2.4 m -138.13 154.07 49.21 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.661 0.267 . . . . 0.0 111.056 -179.981 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 42.2 m -149.59 -178.83 6.66 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.511 -0.313 . . . . 0.0 110.613 -179.738 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -168.51 156.39 27.8 Favored Glycine 0 C--N 1.331 0.269 0 C-N-CA 121.02 -0.609 . . . . 0.0 112.281 179.809 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 69.1 mt -103.09 173.47 6.29 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.689 0.281 . . . . 0.0 110.856 -179.987 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 24.4 m -123.42 161.03 47.85 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-N 116.663 -0.244 . . . . 0.0 111.021 179.963 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_exo -78.65 -177.35 3.83 Favored 'Trans proline' 0 C--N 1.35 0.625 0 C-N-CA 123.167 2.578 . . . . 0.0 112.561 179.885 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 53.9 mtm180 -126.14 -172.49 2.63 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.657 -179.624 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -147.42 168.5 28.45 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.89 -0.672 . . . . 0.0 111.755 179.767 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 1.4 m -125.27 178.56 5.52 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.742 0.271 . . . . 0.0 110.894 -179.877 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -155.24 144.06 20.67 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 109.977 -0.379 . . . . 0.0 109.977 179.804 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -138.47 164.51 29.19 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 110.355 -0.239 . . . . 0.0 110.355 -179.928 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -116.14 -158.49 11.5 Favored Glycine 0 N--CA 1.449 -0.45 0 C-N-CA 120.682 -0.77 . . . . 0.0 113.067 -179.702 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 6.6 m -131.2 179.94 5.72 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 120.812 0.339 . . . . 0.0 110.846 -179.644 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 8.6 p-10 -106.77 164.99 11.65 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.824 -179.812 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 3.1 tt -148.41 123.09 9.86 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 109.576 -0.527 . . . . 0.0 109.576 -179.947 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.424 ' HG2' ' H ' ' A' ' 26' ' ' GLU . 1.7 pt-20 -76.39 121.37 22.94 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.1 0.476 . . . . 0.0 112.049 -178.969 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 5.2 t70 -133.22 -159.52 0.97 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.601 -0.727 . . . . 0.0 109.463 179.319 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 23.6 ttp -155.47 3.02 0.18 Allowed 'General case' 0 CA--C 1.536 0.418 0 N-CA-C 112.251 0.463 . . . . 0.0 112.251 -179.525 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 27.6 mmtp -94.83 127.54 40.91 Favored 'General case' 0 C--N 1.327 -0.371 0 O-C-N 122.015 -0.428 . . . . 0.0 111.484 -179.812 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 49.0 mtmt -143.02 124.44 14.72 Favored 'General case' 0 C--O 1.238 0.462 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.195 179.637 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -177.07 14.25 0.0 OUTLIER 'General case' 0 CA--C 1.536 0.415 0 N-CA-C 111.887 0.328 . . . . 0.0 111.887 -179.733 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 34.1 mt -129.65 -179.38 5.15 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.789 0.328 . . . . 0.0 110.909 -179.235 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -162.99 31.77 0.1 Allowed 'General case' 0 CA--C 1.532 0.28 0 O-C-N 122.203 -0.311 . . . . 0.0 111.433 -179.992 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 1.5 pm0 -117.33 -175.3 2.78 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.895 0.379 . . . . 0.0 111.27 -179.331 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -133.37 130.41 57.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 115.618 -0.719 . . . . 0.0 109.564 178.979 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 36' ' ' GLU . . . . . 0.656 ' CD ' ' HA ' ' A' ' 62' ' ' THR . 0.0 OUTLIER -139.61 -159.74 0.99 Allowed 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 116.613 -0.267 . . . . 0.0 110.85 -178.987 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 -135.66 168.23 19.66 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.914 0.388 . . . . 0.0 110.91 179.523 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -68.44 127.27 32.37 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.505 -0.771 . . . . 0.0 111.272 -179.229 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -145.83 38.67 1.11 Allowed 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.971 0.415 . . . . 0.0 110.799 179.741 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -107.49 151.25 16.92 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.821 -0.704 . . . . 0.0 112.133 -179.705 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -145.98 162.38 37.96 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.59 0.233 . . . . 0.0 110.471 -179.778 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 12.1 tp -77.5 86.07 3.86 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.247 0.546 . . . . 0.0 110.369 -179.811 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 22.0 ttm-85 -148.43 149.65 32.1 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.031 -179.636 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -79.76 56.11 2.2 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.582 0.706 . . . . 0.0 110.485 -179.86 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 27.4 ptm -106.54 12.62 29.3 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.42 -0.809 . . . . 0.0 109.968 179.752 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 28.9 mm-40 -73.91 -26.45 60.53 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.531 -179.307 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -70.29 -6.37 34.54 Favored 'General case' 0 C--O 1.236 0.347 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.679 179.501 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 13.9 ttpp -86.57 2.1 49.34 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.207 179.599 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 8.3 p -55.74 -30.32 27.16 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.331 0 CA-C-N 116.052 -0.522 . . . . 0.0 112.005 -179.233 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 17.1 pt-20 -67.19 -28.45 68.11 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.862 0.363 . . . . 0.0 110.9 -179.928 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 37.4 mttm -86.63 -32.55 20.52 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 109.342 -0.614 . . . . 0.0 109.342 179.515 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 15.8 mm-40 -77.23 -3.62 40.61 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.691 -0.686 . . . . 0.0 111.197 -179.427 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 21.3 ttt -59.11 -38.58 79.91 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.174 0.511 . . . . 0.0 110.064 179.059 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -88.57 1.75 84.15 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.678 -0.772 . . . . 0.0 112.125 179.72 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -127.39 29.75 5.49 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 121.252 0.548 . . . . 0.0 110.937 -179.693 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 6.8 m -64.33 -17.44 21.05 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.206 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.937 179.704 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 5.5 mp0 -101.67 12.76 36.61 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.634 179.557 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 21.2 t70 -130.61 -54.06 1.08 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.588 -0.278 . . . . 0.0 111.43 179.724 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -99.36 -37.46 9.23 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 112.259 0.466 . . . . 0.0 112.259 -179.314 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -98.06 20.07 12.94 Favored 'General case' 0 C--O 1.237 0.399 0 N-CA-C 111.768 0.285 . . . . 0.0 111.768 -178.609 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -71.95 -17.25 62.09 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 111.818 0.303 . . . . 0.0 111.818 -179.594 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 62' ' ' THR . . . . . 0.656 ' HA ' ' CD ' ' A' ' 36' ' ' GLU . 0.7 OUTLIER -56.64 -19.2 15.1 Favored 'General case' 0 CA--C 1.533 0.301 0 N-CA-C 112.693 0.627 . . . . 0.0 112.693 -179.095 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -69.52 -16.01 63.36 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.354 -0.384 . . . . 0.0 110.884 179.499 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -75.54 -48.9 20.44 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.588 -179.42 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 4.3 m -81.21 -4.95 57.1 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 120.894 0.378 . . . . 0.0 111.511 -179.18 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 20.1 tp60 -111.94 -65.52 1.17 Allowed 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 112.171 0.434 . . . . 0.0 112.171 -179.947 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -77.7 -54.58 6.2 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.774 0.321 . . . . 0.0 111.802 -178.276 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 68' ' ' GLU . . . . . 0.455 ' O ' HG23 ' A' ' 72' ' ' VAL . 1.0 OUTLIER -62.05 -25.86 67.92 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.323 -0.398 . . . . 0.0 110.756 -179.518 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 69' ' ' LYS . . . . . 0.432 ' HG3' ' OD2' ' A' ' 73' ' ' ASP . 0.1 OUTLIER -49.48 -42.91 44.67 Favored 'General case' 0 C--O 1.232 0.139 0 CA-C-N 115.998 -0.546 . . . . 0.0 112.036 -179.293 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 28.2 mt-10 -52.23 -35.84 50.66 Favored 'General case' 0 N--CA 1.465 0.301 0 O-C-N 123.696 0.622 . . . . 0.0 112.138 -179.243 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 5.7 tp10 -83.52 -32.96 25.62 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 116.564 -0.289 . . . . 0.0 111.56 -178.755 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.528 ' HA ' ' O ' ' A' ' 122' ' ' PHE . 0.6 OUTLIER -69.05 -40.95 81.4 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 116.583 -0.28 . . . . 0.0 111.518 -178.786 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 73' ' ' ASP . . . . . 0.432 ' OD2' ' HG3' ' A' ' 69' ' ' LYS . 0.8 OUTLIER -83.53 -11.44 57.41 Favored 'General case' 0 N--CA 1.463 0.204 0 C-N-CA 119.819 -0.753 . . . . 0.0 111.353 -179.961 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 46.4 m -87.28 -20.23 27.13 Favored 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 176.729 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -116.66 53.86 0.87 Allowed 'General case' 0 N--CA 1.454 -0.269 0 CA-C-N 115.108 -0.951 . . . . 0.0 110.468 -179.969 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -124.24 159.57 29.87 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 120.942 0.401 . . . . 0.0 110.606 179.368 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 4.5 pt -127.29 138.18 55.56 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.231 179.048 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 34.7 t80 -104.4 126.96 51.96 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 116.128 -0.487 . . . . 0.0 109.841 -179.697 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.427 HG12 HG22 ' A' ' 82' ' ' VAL . 4.6 t -98.89 112.65 31.54 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 CA-C-O 121.072 0.463 . . . . 0.0 110.464 -179.718 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -111.02 153.28 17.25 Favored Glycine 0 N--CA 1.444 -0.78 0 CA-C-N 115.74 -0.663 . . . . 0.0 111.793 179.864 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 11.2 m-80 61.01 53.08 3.8 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-O 121.083 0.468 . . . . 0.0 110.621 -179.643 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.427 HG22 HG12 ' A' ' 79' ' ' VAL . 1.1 t -89.46 169.08 1.43 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.221 -179.693 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 83' ' ' ASP . . . . . 0.511 ' OD1' ' HD2' ' A' ' 142' ' ' ARG . 28.4 t70 -73.99 140.35 45.43 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.877 0.37 . . . . 0.0 110.403 -179.958 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 1.1 p90 -63.97 -25.71 68.26 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.794 -0.639 . . . . 0.0 111.905 -178.907 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -96.72 10.43 38.74 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.728 0.299 . . . . 0.0 111.443 -179.595 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 86' ' ' CYS . . . . . 0.44 ' HB2' ' O ' ' A' ' 83' ' ' ASP . 0.8 OUTLIER -84.64 149.31 25.93 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.152 0.501 . . . . 0.0 111.15 179.823 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 87' ' ' THR . . . . . 0.472 ' O ' ' HG2' ' A' ' 90' ' ' GLU . 2.5 p -120.18 157.73 52.48 Favored Pre-proline 0 C--N 1.322 -0.622 0 CA-C-N 115.73 -0.668 . . . . 0.0 109.949 179.4 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -59.09 -36.56 95.9 Favored 'Trans proline' 0 C--N 1.345 0.392 0 C-N-CA 122.366 2.044 . . . . 0.0 112.647 -179.009 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 89' ' ' GLU . . . . . 0.424 ' O ' ' HG3' ' A' ' 92' ' ' GLN . 56.2 mp0 -63.83 -53.11 55.9 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.67 -179.176 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 90' ' ' GLU . . . . . 0.472 ' HG2' ' O ' ' A' ' 87' ' ' THR . 8.9 pt-20 -62.92 -24.71 67.98 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.79 0.328 . . . . 0.0 111.853 -178.743 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 52.5 t -78.3 -49.3 21.4 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.587 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.917 -179.932 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 92' ' ' GLN . . . . . 0.424 ' HG3' ' O ' ' A' ' 89' ' ' GLU . 0.0 OUTLIER -67.8 -37.59 82.2 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 112.382 0.512 . . . . 0.0 112.382 -178.582 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -71.86 -26.34 62.31 Favored 'General case' 0 N--CA 1.464 0.231 0 C-N-CA 120.836 -0.346 . . . . 0.0 111.325 -179.258 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 1.6 m80 -79.26 -37.34 38.18 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.064 0.459 . . . . 0.0 110.671 179.96 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 16.7 m-30 -81.26 -14.75 57.11 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.402 -179.631 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 96' ' ' GLN . . . . . 0.544 ' HA ' ' O ' ' A' ' 99' ' ' GLY . 52.4 tt0 -64.1 -23.22 67.24 Favored 'General case' 0 C--N 1.333 -0.113 0 CA-C-N 115.94 -0.573 . . . . 0.0 109.898 179.215 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 1.1 m -68.79 -26.25 65.11 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.229 178.942 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 5.6 m -91.6 -47.37 7.43 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 178.864 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 99' ' ' GLY . . . . . 0.544 ' O ' ' HA ' ' A' ' 96' ' ' GLN . . . -150.16 143.24 10.47 Favored Glycine 0 N--CA 1.443 -0.896 0 CA-C-N 115.485 -0.779 . . . . 0.0 111.155 179.344 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 100' ' ' THR . . . . . 0.518 ' HB ' ' CZ ' ' A' ' 122' ' ' PHE . 0.9 OUTLIER -62.09 139.22 58.46 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 116.881 0.34 . . . . 0.0 110.565 -179.832 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.43 HG23 ' HB ' ' A' ' 120' ' ' VAL . 7.6 p -101.78 145.26 11.97 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 116.308 -0.406 . . . . 0.0 111.424 -179.275 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 102' ' ' ASN . . . . . 0.472 ' HB3' ' O ' ' A' ' 121' ' ' GLU . 17.9 t30 -113.74 -62.05 1.65 Allowed 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 109.687 -0.486 . . . . 0.0 109.687 178.789 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 1.2 mpp_? -120.62 145.62 47.21 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.107 179.236 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 5.4 p -137.12 128.92 42.67 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-O 121.238 0.542 . . . . 0.0 110.611 179.776 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 2.8 m -129.53 134.41 47.75 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.243 179.455 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 10.6 tt -125.02 148.9 29.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 120.697 0.284 . . . . 0.0 110.674 -179.718 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 30.2 tp -134.01 118.92 18.37 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.084 -0.507 . . . . 0.0 109.979 179.351 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -89.27 109.77 20.62 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 120.716 0.294 . . . . 0.0 110.31 179.502 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -74.03 146.89 43.38 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.15 -179.785 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 7.2 mptt -133.04 31.65 3.84 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.898 -0.592 . . . . 0.0 109.442 178.906 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -120.3 -3.69 9.98 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.628 -179.153 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 115.32 9.48 13.05 Favored Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.147 -1.025 . . . . 0.0 114.101 179.256 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 36.7 mt-30 -98.18 155.07 37.37 Favored Pre-proline 0 C--N 1.323 -0.562 0 CA-C-N 117.467 0.633 . . . . 0.0 109.382 179.206 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -53.65 98.84 0.05 OUTLIER 'Trans proline' 0 C--N 1.348 0.523 0 C-N-CA 122.887 2.392 . . . . 0.0 111.598 178.859 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 86.2 mttt -59.39 151.75 23.0 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.408 -0.815 . . . . 0.0 111.195 -179.302 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 110.36 6.22 27.58 Favored Glycine 0 N--CA 1.447 -0.625 0 C-N-CA 120.368 -0.92 . . . . 0.0 112.468 -179.698 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 51.8 m-85 -51.89 119.13 3.95 Favored 'General case' 0 CA--C 1.521 -0.169 0 CA-C-O 120.592 0.234 . . . . 0.0 110.425 179.185 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -143.49 161.65 37.87 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-O 120.806 0.336 . . . . 0.0 110.859 -179.263 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 15.1 p90 -151.19 145.26 25.29 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 109.517 -0.549 . . . . 0.0 109.517 178.878 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 120' ' ' VAL . . . . . 0.43 ' HB ' HG23 ' A' ' 101' ' ' VAL . 28.3 m -124.28 144.1 35.31 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.363 -179.794 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 121' ' ' GLU . . . . . 0.472 ' O ' ' HB3' ' A' ' 102' ' ' ASN . 7.4 pt-20 -124.56 144.57 50.06 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.703 -179.851 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 122' ' ' PHE . . . . . 0.528 ' O ' ' HA ' ' A' ' 72' ' ' VAL . 4.8 t80 -140.73 168.54 19.55 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.19 -0.459 . . . . 0.0 109.898 179.496 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -99.59 -24.77 4.07 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.241 0 N-CA-C 112.092 0.405 . . . . 0.0 112.092 -178.798 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 59.9 mm-40 -85.3 119.52 25.76 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.92 0.39 . . . . 0.0 110.496 -179.826 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 15.0 mt -64.48 -42.49 95.38 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 115.68 -0.691 . . . . 0.0 111.495 -179.132 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -57.48 -42.43 82.61 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.777 0.322 . . . . 0.0 111.599 -179.56 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -60.34 -51.86 67.71 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.634 -179.358 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 3.4 p -68.44 -24.26 29.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-O 120.856 0.36 . . . . 0.0 111.081 -179.328 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 45.3 tt0 -63.87 -41.44 97.76 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.747 179.921 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 19.7 t-20 -66.63 -33.89 76.65 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.046 179.972 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 131' ' ' ALA . . . . . 0.571 ' O ' ' HB2' ' A' ' 135' ' ' ASN . . . -73.05 -25.29 60.88 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.532 179.543 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 132' ' ' LEU . . . . . 0.443 ' HA ' HD13 ' A' ' 132' ' ' LEU . 0.2 OUTLIER -74.35 -25.78 59.73 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.233 0.539 . . . . 0.0 109.943 179.034 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 26.3 tp -81.26 -58.17 3.17 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.305 -0.862 . . . . 0.0 110.554 -179.643 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 134' ' ' LEU . . . . . 0.4 HD23 ' HA ' ' A' ' 134' ' ' LEU . 22.6 mt -127.78 121.14 29.44 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.314 -179.922 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 135' ' ' ASN . . . . . 0.571 ' HB2' ' O ' ' A' ' 131' ' ' ALA . 3.2 t30 -169.33 -53.72 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.163 0.506 . . . . 0.0 110.303 -179.915 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -80.04 71.27 6.76 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.814 -0.63 . . . . 0.0 111.06 179.997 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 2.3 p -112.65 -74.67 0.62 Allowed 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.362 179.012 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 24.3 tt0 -157.68 124.31 4.92 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.183 179.888 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -135.3 126.81 28.73 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 109.493 -0.558 . . . . 0.0 109.493 179.83 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 1.9 t60 64.79 22.16 12.5 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-O 121.331 0.586 . . . . 0.0 110.097 -179.697 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 84.04 -1.14 89.12 Favored Glycine 0 N--CA 1.448 -0.514 0 CA-C-N 115.758 -0.655 . . . . 0.0 112.415 -179.691 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 142' ' ' ARG . . . . . 0.511 ' HD2' ' OD1' ' A' ' 83' ' ' ASP . 0.0 OUTLIER -113.36 154.79 26.32 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.644 0.259 . . . . 0.0 110.323 -179.513 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 7.6 pt20 -95.86 146.64 24.4 Favored 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 109.499 -0.556 . . . . 0.0 109.499 178.75 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -141.05 -179.74 6.26 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.788 0.328 . . . . 0.0 110.608 -179.105 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -126.17 142.33 51.57 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.956 -0.566 . . . . 0.0 110.123 179.793 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 92.3 t -129.11 110.63 21.01 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 N-CA-C 109.789 -0.449 . . . . 0.0 109.789 -179.925 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -108.51 154.3 22.11 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.611 -179.614 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -76.02 116.43 16.71 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.02 0.438 . . . . 0.0 110.524 -179.91 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 3.6 ttpm? -86.51 68.89 10.32 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.974 -0.557 . . . . 0.0 109.684 179.927 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 150' ' ' ARG . . . . . 0.402 HH11 ' HD3' ' A' ' 150' ' ' ARG . 9.6 tpt180 -77.24 96.84 4.65 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.08 -179.392 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 95.4 m -71.1 103.99 2.9 Favored 'General case' 0 N--CA 1.453 -0.315 0 N-CA-C 109.671 -0.492 . . . . 0.0 109.671 178.738 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 152' ' ' ASN . . . . . . . . . . . . . 12.3 t-20 -148.83 151.51 34.88 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.773 -179.03 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 48.2 pt -77.04 151.46 81.79 Favored Pre-proline 0 C--N 1.324 -0.519 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.356 179.579 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 16.6 Cg_exo -66.96 99.96 0.49 Allowed 'Trans proline' 0 N--CA 1.462 -0.359 0 C-N-CA 122.438 2.092 . . . . 0.0 111.422 179.633 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.242 0 CA-C-O 118.312 -1.271 . . . . 0.0 111.456 -179.948 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 20.7 mmt . . . . . 0 N--CA 1.479 1.009 0 N-CA-C 109.882 -0.414 . . . . 0.0 109.882 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 119.0 168.82 14.2 Favored Glycine 0 N--CA 1.45 -0.427 0 C-N-CA 120.818 -0.706 . . . . 0.0 112.044 179.877 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 75.6 m -148.51 156.65 42.73 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 120.881 0.372 . . . . 0.0 110.858 -179.977 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -119.33 169.88 9.6 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.352 179.808 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 22.2 t60 -148.98 136.7 20.49 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 109.719 -0.474 . . . . 0.0 109.719 179.832 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -131.97 174.46 10.15 Favored 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 121.275 -0.17 . . . . 0.0 110.635 179.745 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 48.5 p-80 -149.23 169.12 21.48 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.392 0.139 . . . . 0.0 110.926 -179.714 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 1.8 p80 -160.66 173.52 15.34 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.585 -179.628 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 17.0 p-80 -150.26 163.69 37.63 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.549 -0.296 . . . . 0.0 110.473 -179.926 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 24.0 p-80 -145.56 152.36 39.59 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.844 -0.162 . . . . 0.0 110.606 179.623 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 2.4 m -109.05 -179.2 3.78 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.477 -0.329 . . . . 0.0 110.752 -179.742 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 8.5 t -146.92 166.02 28.01 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 109.879 -0.415 . . . . 0.0 109.879 179.824 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -158.86 167.03 34.68 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.916 -0.659 . . . . 0.0 112.414 -179.649 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 90.8 mt -132.81 175.31 9.46 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.712 0.291 . . . . 0.0 110.733 -179.809 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 17.3 m -127.23 155.76 75.77 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.667 -179.682 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 69.3 Cg_endo -74.59 -177.79 3.6 Favored 'Trans proline' 0 C--N 1.346 0.435 0 C-N-CA 122.762 2.308 . . . . 0.0 112.731 179.82 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 79.8 mtm180 -124.71 176.34 6.64 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.051 -179.744 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -136.81 150.65 20.65 Favored Glycine 0 N--CA 1.448 -0.535 0 C-N-CA 120.902 -0.666 . . . . 0.0 112.149 -179.776 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 1.4 m -106.74 155.08 20.07 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 110.4 -0.222 . . . . 0.0 110.4 -179.67 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 6.6 m170 -112.8 169.24 9.05 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.724 0.297 . . . . 0.0 110.891 -179.8 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 1.3 pmm? -147.53 172.94 13.19 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.183 -0.462 . . . . 0.0 109.994 -179.985 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -141.71 -176.75 16.23 Favored Glycine 0 N--CA 1.453 -0.226 0 C-N-CA 120.94 -0.648 . . . . 0.0 111.946 179.903 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 19.3 m -121.32 161.17 22.52 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.802 0.334 . . . . 0.0 111.019 -179.832 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -94.2 177.9 5.81 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.994 179.928 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 22.9 tp -157.57 147.5 20.47 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 109.358 -0.608 . . . . 0.0 109.358 179.763 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 13.5 mt-10 -101.34 126.59 48.11 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.038 0.447 . . . . 0.0 111.535 -179.558 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 27' ' ' ASP . . . . . 0.44 ' OD1' ' HG2' ' A' ' 29' ' ' LYS . 4.8 t70 -140.86 -167.77 2.44 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.78 -0.645 . . . . 0.0 109.488 178.992 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 85.9 mtp -130.31 -9.29 4.21 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 111.619 0.229 . . . . 0.0 111.619 -179.417 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.44 ' HG2' ' OD1' ' A' ' 27' ' ' ASP . 0.3 OUTLIER -63.04 133.5 54.63 Favored 'General case' 0 N--CA 1.466 0.356 0 CA-C-N 116.52 -0.309 . . . . 0.0 111.451 -179.473 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 30' ' ' LYS . . . . . 0.457 ' O ' ' HB2' ' A' ' 31' ' ' ARG . 25.6 mttt -159.23 104.48 1.67 Allowed 'General case' 0 C--O 1.236 0.361 0 CA-C-N 116.385 -0.37 . . . . 0.0 111.03 -179.975 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 31' ' ' ARG . . . . . 0.623 ' HA ' ' NE ' ' A' ' 31' ' ' ARG . 0.0 OUTLIER 172.17 23.6 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.506 0 O-C-N 123.584 0.552 . . . . 0.0 111.696 179.111 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.499 ' HB2' ' HB2' ' A' ' 64' ' ' ALA . 32.8 mt -134.37 168.16 19.41 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.747 0.308 . . . . 0.0 111.134 -179.464 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 2.3 ttmt -157.13 41.78 0.33 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.094 0.474 . . . . 0.0 110.085 -179.759 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -102.46 174.13 6.04 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.155 -178.718 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.447 HG12 HH11 ' A' ' 103' ' ' ARG . 0.0 OUTLIER -136.41 106.12 5.11 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.206 0 N-CA-C 108.919 -0.771 . . . . 0.0 108.919 179.144 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 36' ' ' GLU . . . . . 0.539 ' OE1' ' HB2' ' A' ' 61' ' ' SER . 0.2 OUTLIER -142.61 -171.58 3.45 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 121.036 0.445 . . . . 0.0 111.421 -178.381 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 64.0 mt-10 -120.87 -173.57 2.63 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.881 -179.822 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 3.2 mp0 -70.62 144.92 51.0 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.544 -179.833 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -155.96 24.78 0.38 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.902 -179.965 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -111.92 154.71 16.63 Favored Glycine 0 N--CA 1.449 -0.463 0 C-N-CA 120.814 -0.708 . . . . 0.0 112.674 -179.303 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -140.75 168.06 20.69 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 110.035 -0.358 . . . . 0.0 110.035 -179.683 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 11.2 tp -85.21 76.85 10.13 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 121.126 0.488 . . . . 0.0 110.399 -179.942 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 23.0 ttt180 -136.6 158.48 44.35 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.683 -179.942 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -82.83 56.34 3.38 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.709 179.957 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -119.49 17.97 12.86 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.343 0.592 . . . . 0.0 110.552 179.68 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 37.9 mm-40 -70.1 -22.83 62.99 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.758 -0.655 . . . . 0.0 110.835 -179.594 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -65.21 -14.59 61.02 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.966 -179.868 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 6.4 ttpp -77.05 -7.77 56.28 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.574 -0.284 . . . . 0.0 111.195 -179.718 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 10.6 p -59.37 -27.65 37.49 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.267 0 CA-C-O 120.98 0.419 . . . . 0.0 111.12 -179.895 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 26.8 mt-10 -66.88 -24.44 66.12 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.943 -0.572 . . . . 0.0 110.363 179.921 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 35.6 ttmt -99.24 -35.38 9.99 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.765 -0.652 . . . . 0.0 109.815 179.235 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 60.3 mm-40 -77.48 2.24 16.82 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.724 -0.671 . . . . 0.0 111.286 -179.965 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 20.0 ptt? -62.76 -28.87 70.27 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.158 0.504 . . . . 0.0 110.245 179.594 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -89.78 0.41 79.66 Favored Glycine 0 N--CA 1.445 -0.732 0 C-N-CA 120.737 -0.744 . . . . 0.0 111.448 179.321 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -125.48 32.96 5.22 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.269 0.557 . . . . 0.0 110.137 -179.763 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 5.8 m -64.52 -11.44 10.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 115.593 -0.731 . . . . 0.0 111.588 -179.668 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 14.1 mp0 -89.67 3.34 52.97 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.717 179.594 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 38.3 t70 -142.82 -44.17 0.31 Allowed 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 112.141 0.422 . . . . 0.0 112.141 -179.903 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 2.6 m -86.77 -26.76 23.98 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 120.788 0.328 . . . . 0.0 111.769 -179.303 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 11.4 t -127.23 22.03 6.64 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 120.942 0.401 . . . . 0.0 110.444 -179.526 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 61' ' ' SER . . . . . 0.539 ' HB2' ' OE1' ' A' ' 36' ' ' GLU . 0.3 OUTLIER -67.88 -29.86 69.07 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.091 -179.332 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 62' ' ' THR . . . . . 0.508 ' HA ' ' OE2' ' A' ' 36' ' ' GLU . 1.3 m -54.59 -23.04 15.17 Favored 'General case' 0 CA--C 1.532 0.275 0 CA-C-N 116.037 -0.529 . . . . 0.0 112.028 -179.39 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 4.2 m -66.79 -17.29 64.8 Favored 'General case' 0 N--CA 1.452 -0.352 0 CA-C-O 120.735 0.302 . . . . 0.0 110.708 179.568 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 64' ' ' ALA . . . . . 0.499 ' HB2' ' HB2' ' A' ' 32' ' ' LEU . . . -78.03 -47.94 17.26 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.979 0.419 . . . . 0.0 110.686 179.728 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 4.9 m -75.71 -4.52 40.81 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.696 -179.61 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 21.8 tp60 -114.72 -60.69 1.85 Allowed 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 111.962 0.356 . . . . 0.0 111.962 179.936 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -79.91 -56.29 4.36 Favored 'General case' 0 C--N 1.331 -0.215 0 N-CA-C 112.187 0.44 . . . . 0.0 112.187 -178.322 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 68' ' ' GLU . . . . . 0.62 ' O ' HG23 ' A' ' 72' ' ' VAL . 1.4 tp10 -59.17 -33.51 71.02 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.304 -179.575 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 69' ' ' LYS . . . . . 0.559 ' HG3' ' OD2' ' A' ' 73' ' ' ASP . 23.5 tptp -50.85 -33.83 25.41 Favored 'General case' 0 N--CA 1.462 0.155 0 CA-C-N 115.422 -0.808 . . . . 0.0 111.875 -179.364 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 34.5 mt-10 -49.38 -39.2 31.44 Favored 'General case' 0 N--CA 1.465 0.277 0 O-C-N 123.551 0.532 . . . . 0.0 111.583 179.911 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 7.7 tp10 -94.99 -31.46 13.62 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.251 -179.438 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.62 HG23 ' O ' ' A' ' 68' ' ' GLU . 22.9 t -58.17 -54.68 29.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 N-CA-C 112.453 0.538 . . . . 0.0 112.453 -178.084 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 73' ' ' ASP . . . . . 0.559 ' OD2' ' HG3' ' A' ' 69' ' ' LYS . 3.3 p30 -84.58 0.47 49.93 Favored 'General case' 0 N--CA 1.462 0.164 0 C-N-CA 119.676 -0.81 . . . . 0.0 111.588 -179.419 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 6.1 m -91.11 -27.25 18.68 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 108.318 -0.993 . . . . 0.0 108.318 175.562 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -106.54 59.61 0.64 Allowed 'General case' 0 N--CA 1.449 -0.5 0 CA-C-N 114.916 -1.038 . . . . 0.0 109.565 179.701 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -132.36 161.27 34.0 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.848 -179.908 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.421 HG22 HD23 ' A' ' 132' ' ' LEU . 15.1 pt -119.68 136.98 55.05 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.312 179.293 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 56.1 t80 -101.15 128.0 47.44 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 179.432 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 2.7 t -108.73 117.75 54.83 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.683 0 CA-C-O 121.074 0.464 . . . . 0.0 111.413 -178.711 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -113.44 164.41 12.05 Favored Glycine 0 N--CA 1.445 -0.719 0 N-CA-C 111.115 -0.794 . . . . 0.0 111.115 179.421 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 2.7 m-20 61.88 44.19 8.65 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-O 121.011 0.434 . . . . 0.0 110.941 179.943 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 10.7 t -85.43 154.27 3.5 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.5 -179.82 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 83' ' ' ASP . . . . . 0.576 ' HB3' ' SG ' ' A' ' 86' ' ' CYS . 0.8 OUTLIER -72.33 134.66 45.61 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.13 179.51 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 48.7 p90 -63.9 -16.34 61.19 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 113.057 0.762 . . . . 0.0 113.057 -178.015 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -96.46 4.37 52.16 Favored 'General case' 0 C--N 1.324 -0.52 0 C-N-CA 121.054 -0.258 . . . . 0.0 111.665 -179.151 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 86' ' ' CYS . . . . . 0.576 ' SG ' ' HB3' ' A' ' 83' ' ' ASP . 89.6 m -81.18 156.66 25.58 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 121.207 0.527 . . . . 0.0 111.285 179.974 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 48.7 p -124.12 152.74 67.63 Favored Pre-proline 0 C--N 1.325 -0.494 0 CA-C-N 115.616 -0.72 . . . . 0.0 109.637 178.996 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -58.77 -23.07 64.89 Favored 'Trans proline' 0 C--N 1.342 0.226 0 C-N-CA 122.469 2.113 . . . . 0.0 112.599 -179.258 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 34.1 mt-10 -69.96 -58.69 3.55 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.955 -179.811 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -65.12 -23.49 67.16 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.096 0.474 . . . . 0.0 111.008 -179.462 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 6.2 t -72.28 -52.56 23.46 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.667 0 CA-C-N 115.791 -0.64 . . . . 0.0 111.163 -179.967 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 8.7 pt20 -68.69 -36.26 78.25 Favored 'General case' 0 CA--C 1.532 0.258 0 N-CA-C 112.451 0.538 . . . . 0.0 112.451 -178.207 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -68.48 -31.11 70.16 Favored 'General case' 0 C--O 1.234 0.269 0 C-N-CA 120.733 -0.387 . . . . 0.0 111.329 -178.834 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 3.6 m80 -70.33 -38.64 74.93 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.104 0.478 . . . . 0.0 109.729 179.386 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 8.2 m-30 -74.14 -30.76 62.43 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.72 -0.673 . . . . 0.0 109.828 179.765 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 96' ' ' GLN . . . . . 0.582 ' HA ' ' O ' ' A' ' 99' ' ' GLY . 29.0 tt0 -62.99 -17.66 62.41 Favored 'General case' 0 C--O 1.231 0.131 0 CA-C-N 115.448 -0.796 . . . . 0.0 111.183 -179.79 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 5.2 m -76.09 -22.88 55.08 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.179 0.514 . . . . 0.0 109.878 179.165 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 24.8 m -98.24 -46.03 5.97 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.729 -0.668 . . . . 0.0 109.81 179.42 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 99' ' ' GLY . . . . . 0.582 ' O ' ' HA ' ' A' ' 96' ' ' GLN . . . -148.49 152.68 24.7 Favored Glycine 0 N--CA 1.449 -0.496 0 N-CA-C 111.546 -0.622 . . . . 0.0 111.546 179.538 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 100' ' ' THR . . . . . 0.554 ' HB ' ' CZ ' ' A' ' 122' ' ' PHE . 0.2 OUTLIER -66.96 146.82 53.98 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 116.799 0.3 . . . . 0.0 110.635 179.918 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.482 HG23 ' HB ' ' A' ' 120' ' ' VAL . 2.7 p -117.21 137.72 50.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 121.015 0.436 . . . . 0.0 111.695 -178.659 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 24.1 t30 -99.13 -64.26 1.05 Allowed 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 109.487 -0.56 . . . . 0.0 109.487 179.331 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 103' ' ' ARG . . . . . 0.447 HH11 HG12 ' A' ' 35' ' ' ILE . 0.9 OUTLIER -122.88 149.18 44.55 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.486 179.44 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 7.9 p -136.28 139.94 44.57 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.018 179.677 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 105' ' ' THR . . . . . 0.588 ' HB ' ' CE1' ' A' ' 119' ' ' TYR . 4.0 m -138.19 140.69 39.89 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 109.59 -0.522 . . . . 0.0 109.59 179.304 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 20.6 tt -134.03 143.79 37.37 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 O-C-N 123.289 0.368 . . . . 0.0 110.446 -179.733 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 20.4 tp -127.09 134.55 50.23 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 120.998 0.428 . . . . 0.0 111.201 -179.804 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -101.62 114.77 29.1 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.595 179.256 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 109' ' ' ASP . . . . . 0.516 ' O ' ' HE2' ' A' ' 115' ' ' LYS . 17.3 t70 -85.44 148.54 25.94 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.397 -179.94 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 4.0 mppt? -128.6 23.31 5.86 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.861 179.956 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 3.8 t80 -110.52 -9.71 14.56 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.792 0.33 . . . . 0.0 110.904 -179.721 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 123.6 -3.54 9.4 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.251 -0.976 . . . . 0.0 113.465 179.327 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 34.1 mt-30 -79.22 154.82 77.18 Favored Pre-proline 0 C--N 1.326 -0.44 0 CA-C-N 117.215 0.507 . . . . 0.0 109.787 179.694 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 10.6 Cg_endo -55.72 101.64 0.09 OUTLIER 'Trans proline' 0 C--N 1.346 0.422 0 C-N-CA 122.533 2.155 . . . . 0.0 111.992 179.261 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 115' ' ' LYS . . . . . 0.516 ' HE2' ' O ' ' A' ' 109' ' ' ASP . 85.9 mttt -61.32 147.45 44.64 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.464 -0.789 . . . . 0.0 110.844 -179.778 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 109.76 11.45 21.0 Favored Glycine 0 N--CA 1.447 -0.627 0 C-N-CA 120.125 -1.035 . . . . 0.0 113.076 179.943 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 32.2 m-85 -54.47 116.69 2.79 Favored 'General case' 0 N--CA 1.465 0.278 0 N-CA-C 109.766 -0.457 . . . . 0.0 109.766 179.032 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -138.83 166.39 24.55 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 121.271 0.558 . . . . 0.0 111.826 -178.591 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 119' ' ' TYR . . . . . 0.588 ' CE1' ' HB ' ' A' ' 105' ' ' THR . 41.4 p90 -157.8 147.73 20.29 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.081 -0.963 . . . . 0.0 109.052 179.085 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 120' ' ' VAL . . . . . 0.482 ' HB ' HG23 ' A' ' 101' ' ' VAL . 29.8 m -125.59 136.58 60.4 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-N 116.643 -0.253 . . . . 0.0 110.702 -179.944 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 4.2 pt-20 -115.78 152.59 32.99 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.993 179.923 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 122' ' ' PHE . . . . . 0.554 ' CZ ' ' HB ' ' A' ' 100' ' ' THR . 8.7 t80 -152.2 167.14 29.54 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.253 -0.431 . . . . 0.0 109.935 179.498 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 123' ' ' VAL . . . . . 0.477 HG22 HG22 ' A' ' 72' ' ' VAL . 4.5 t -89.07 -38.63 11.6 Favored 'Isoleucine or valine' 0 C--O 1.236 0.354 0 CA-C-O 121.036 0.446 . . . . 0.0 111.392 -179.402 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 63.6 mm-40 -76.8 127.32 32.54 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.363 -179.368 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 32.4 mt -70.81 -38.37 72.45 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-N 115.593 -0.73 . . . . 0.0 111.426 -179.442 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -61.06 -38.52 86.48 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.383 -0.371 . . . . 0.0 111.697 -179.035 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -61.38 -55.8 27.43 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.213 -179.573 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 11.9 p -67.4 -27.77 39.9 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.173 -179.497 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 52.6 tt0 -61.3 -45.51 94.16 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.929 0.395 . . . . 0.0 110.788 179.937 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -64.54 -34.13 77.53 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.908 -179.726 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -77.55 -23.26 50.11 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.178 179.908 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 132' ' ' LEU . . . . . 0.421 HD23 HG22 ' A' ' 77' ' ' ILE . 0.4 OUTLIER -80.47 -15.78 55.92 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-O 121.358 0.599 . . . . 0.0 110.164 179.833 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 5.1 mp -96.62 -58.9 1.93 Allowed 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.771 179.661 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 78.9 mt -117.38 107.5 14.44 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.664 -179.435 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 65.8 t30 -166.51 -50.96 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.599 -179.799 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 136' ' ' GLU . . . . . 0.502 ' HB3' HG23 ' A' ' 146' ' ' VAL . 4.0 pt-20 -72.46 87.33 1.18 Allowed 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.299 0.571 . . . . 0.0 111.102 -179.618 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -131.21 -70.29 0.6 Allowed 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.393 179.845 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 2.9 tm-20 -150.11 132.93 15.99 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.228 -179.788 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -143.61 112.46 6.6 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.695 -0.684 . . . . 0.0 109.469 179.483 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 2.0 t60 62.37 27.72 16.51 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.208 179.49 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 90.0 -10.0 75.44 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.821 -0.704 . . . . 0.0 112.42 179.75 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 142' ' ' ARG . . . . . 0.427 HH11 ' HD3' ' A' ' 142' ' ' ARG . 0.4 OUTLIER -109.39 176.33 5.12 Favored 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 110.134 -0.321 . . . . 0.0 110.134 -179.886 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 5.0 pt20 -125.48 141.09 52.24 Favored 'General case' 0 C--N 1.319 -0.722 0 N-CA-C 109.891 -0.411 . . . . 0.0 109.891 179.195 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -125.3 173.83 8.55 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.467 -178.99 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -115.34 126.11 54.04 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.271 -0.422 . . . . 0.0 109.991 179.586 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 146' ' ' VAL . . . . . 0.502 HG23 ' HB3' ' A' ' 136' ' ' GLU . 94.1 t -104.47 117.18 49.63 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 CA-C-N 115.877 -0.601 . . . . 0.0 109.994 -179.743 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -117.2 156.17 28.15 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.39 -179.589 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -80.19 115.9 19.99 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 109.986 -0.376 . . . . 0.0 109.986 179.713 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 11.5 ttpp -88.52 52.9 2.55 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.219 0.533 . . . . 0.0 109.955 -179.73 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -76.13 96.13 3.8 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.804 -0.635 . . . . 0.0 110.48 -179.583 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 6.8 t -65.53 145.0 56.63 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.992 -0.549 . . . . 0.0 109.935 179.135 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 152' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 -168.7 179.42 4.25 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 109.001 -0.74 . . . . 0.0 109.001 -179.346 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 20.8 pt -96.56 154.8 38.41 Favored Pre-proline 0 C--N 1.317 -0.836 0 N-CA-C 109.451 -0.574 . . . . 0.0 109.451 179.228 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -74.88 58.7 4.89 Favored 'Trans proline' 0 C--O 1.235 0.372 0 C-N-CA 122.621 2.214 . . . . 0.0 112.141 179.62 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.048 0 CA-C-O 118.34 -1.256 . . . . 0.0 111.242 -179.769 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 63.4 mtt . . . . . 0 N--CA 1.481 1.104 0 N-CA-C 110.046 -0.353 . . . . 0.0 110.046 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 136.4 165.16 10.46 Favored Glycine 0 N--CA 1.445 -0.711 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.362 179.773 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -145.19 96.38 2.83 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-O 121.089 0.471 . . . . 0.0 110.126 179.339 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -84.49 140.72 31.28 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.969 -179.44 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 25.1 m-70 -117.17 147.07 42.78 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.554 179.779 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 2.4 t60 -123.68 118.03 26.33 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.158 -179.494 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -166.8 144.28 4.92 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.465 0.174 . . . . 0.0 111.025 -179.611 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 8.5 p80 -155.85 159.2 39.15 Favored 'General case' 0 N--CA 1.464 0.231 0 N-CA-C 109.653 -0.499 . . . . 0.0 109.653 179.637 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 30.1 t60 -158.21 145.57 18.06 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.534 0.207 . . . . 0.0 111.074 -179.267 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 25.7 p80 -148.76 136.46 20.57 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 116.438 -0.346 . . . . 0.0 110.494 179.232 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -159.08 137.32 10.6 Favored 'General case' 0 C--O 1.235 0.335 0 CA-C-N 116.511 -0.313 . . . . 0.0 110.709 -179.791 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 2.7 t -160.06 177.39 10.77 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.094 179.745 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 135.6 145.08 5.05 Favored Glycine 0 N--CA 1.449 -0.456 0 C-N-CA 120.802 -0.713 . . . . 0.0 112.814 179.516 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 1.8 pt? -151.24 148.38 28.14 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 109.744 -0.465 . . . . 0.0 109.744 179.593 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 22.0 t -126.41 107.95 23.76 Favored Pre-proline 0 C--N 1.328 -0.351 0 CA-C-N 116.711 -0.222 . . . . 0.0 110.991 -179.431 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 6.4 Cg_exo -74.18 171.66 17.56 Favored 'Trans proline' 0 C--N 1.345 0.365 0 C-N-CA 122.732 2.288 . . . . 0.0 112.211 179.527 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -132.48 125.24 30.2 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.463 -0.335 . . . . 0.0 110.217 179.76 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -160.88 98.45 0.17 Allowed Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.428 -0.891 . . . . 0.0 112.888 179.976 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 19.6 m -143.69 126.94 16.63 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 120.938 0.399 . . . . 0.0 110.02 179.152 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 1.8 t-80 -122.75 120.07 32.53 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.084 -179.756 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 26.7 ptm -136.74 164.11 29.02 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.226 -0.443 . . . . 0.0 109.996 -179.898 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 146.86 155.44 6.54 Favored Glycine 0 N--CA 1.447 -0.606 0 C-N-CA 120.316 -0.945 . . . . 0.0 112.79 179.602 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -153.04 81.62 1.2 Allowed 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.264 0.554 . . . . 0.0 109.731 179.599 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -101.51 115.88 31.51 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.147 -179.974 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.449 ' HA ' ' OE1' ' A' ' 66' ' ' GLN . 33.1 tp -129.02 91.96 3.3 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.751 -179.46 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 24.9 tt0 -175.86 128.34 0.24 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.882 -0.599 . . . . 0.0 109.82 179.4 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 18.5 t0 -85.99 152.63 22.77 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 120.782 0.325 . . . . 0.0 110.367 179.805 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 35.6 mtm -130.79 -13.7 3.65 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.612 -179.344 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 9.4 tppt? -170.12 133.95 1.2 Allowed 'General case' 0 C--N 1.332 -0.16 0 CA-C-O 120.968 0.413 . . . . 0.0 111.199 -179.293 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 62.0 tttt -78.53 70.11 4.82 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.169 179.348 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 2.4 tpt180 -132.05 131.27 42.29 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.433 -179.659 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.537 ' HA ' ' HB2' ' A' ' 64' ' ' ALA . 0.4 OUTLIER -126.64 115.29 19.24 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.052 179.783 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.447 ' HB3' ' H ' ' A' ' 34' ' ' GLU . 23.0 tptt -149.85 -87.34 0.08 Allowed 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.606 -0.27 . . . . 0.0 110.886 -179.637 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.447 ' H ' ' HB3' ' A' ' 33' ' ' LYS . 48.8 mm-40 -123.88 -155.15 0.65 Allowed 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 109.742 -0.466 . . . . 0.0 109.742 -179.405 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 13.1 pt -140.83 135.78 34.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.744 -0.207 . . . . 0.0 110.767 179.632 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 6.0 tp10 -140.29 -115.28 0.13 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.809 -0.178 . . . . 0.0 111.0 179.859 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 33.6 mt-10 -122.43 157.29 32.24 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-O 121.223 0.535 . . . . 0.0 111.867 -178.552 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 38' ' ' GLU . . . . . 0.473 ' H ' ' CD ' ' A' ' 38' ' ' GLU . 0.4 OUTLIER -87.75 121.76 30.56 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.846 -0.615 . . . . 0.0 110.53 179.618 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -132.51 82.18 1.99 Allowed 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.414 179.494 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -142.9 138.17 8.16 Favored Glycine 0 N--CA 1.444 -0.775 0 C-N-CA 120.669 -0.777 . . . . 0.0 112.255 -179.604 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -164.85 168.56 17.6 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 109.215 -0.661 . . . . 0.0 109.215 179.678 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 24.4 tp -74.86 82.76 2.16 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.405 0.622 . . . . 0.0 110.456 179.649 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 9.5 ttp180 -143.03 141.87 31.43 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.688 -0.687 . . . . 0.0 109.676 179.617 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -76.07 41.82 0.24 Allowed 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 121.139 0.495 . . . . 0.0 111.152 -179.749 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 10.9 ptt? -98.6 5.25 47.94 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.853 -0.612 . . . . 0.0 109.644 179.752 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 84.0 mt-30 -71.43 -20.95 62.04 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.351 -0.84 . . . . 0.0 111.383 -178.811 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -69.26 -17.51 63.76 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.214 0.531 . . . . 0.0 110.602 179.861 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 48' ' ' LYS . . . . . 0.556 ' O ' ' HG2' ' A' ' 52' ' ' GLU . 20.4 ttpp -72.99 1.48 8.78 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.572 -0.74 . . . . 0.0 110.885 179.72 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 8.1 p -55.38 -27.05 20.0 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.311 0 CA-C-N 116.463 -0.335 . . . . 0.0 111.601 -179.648 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 20.8 mt-10 -64.02 -19.9 65.53 Favored 'General case' 0 N--CA 1.463 0.19 0 CA-C-O 121.337 0.589 . . . . 0.0 110.248 179.377 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 13.1 mtmt -107.95 -37.66 6.03 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.598 -0.728 . . . . 0.0 110.904 178.749 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 52' ' ' GLU . . . . . 0.556 ' HG2' ' O ' ' A' ' 48' ' ' LYS . 9.2 mm-40 -62.77 -21.64 66.0 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 116.681 -0.236 . . . . 0.0 111.276 179.879 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 4.7 ppp? -59.36 -23.59 62.67 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-O 120.895 0.379 . . . . 0.0 110.994 179.573 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -94.53 -5.14 61.87 Favored Glycine 0 C--O 1.227 -0.324 0 C-N-CA 121.062 -0.59 . . . . 0.0 111.677 179.28 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -121.96 24.08 9.74 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.335 0.588 . . . . 0.0 110.079 -179.798 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 20.8 m -66.4 -11.42 13.03 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 115.799 -0.637 . . . . 0.0 111.817 -179.458 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 72.6 mt-30 -84.29 -9.61 58.34 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.258 0.552 . . . . 0.0 109.955 179.15 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 6.6 t70 -119.94 -55.01 2.11 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.362 -0.835 . . . . 0.0 110.246 -179.778 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 17.9 m -77.86 -72.35 0.37 Allowed 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.297 -0.865 . . . . 0.0 111.915 -178.834 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -79.36 29.33 0.23 Allowed 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 112.617 0.599 . . . . 0.0 112.617 -178.315 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -88.85 -39.99 13.45 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 109.327 -0.62 . . . . 0.0 109.327 179.066 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -59.9 -18.9 48.37 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.287 -0.87 . . . . 0.0 112.262 -179.559 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -63.6 -26.95 68.92 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 121.197 0.522 . . . . 0.0 110.343 179.221 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 64' ' ' ALA . . . . . 0.537 ' HB2' ' HA ' ' A' ' 32' ' ' LEU . . . -65.16 -29.99 70.87 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.28 179.102 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -77.57 0.87 21.38 Favored 'General case' 0 N--CA 1.453 -0.316 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.806 -179.868 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 66' ' ' GLN . . . . . 0.449 ' OE1' ' HA ' ' A' ' 25' ' ' LEU . 6.3 tp-100 -118.52 -50.49 2.43 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.441 179.502 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -82.58 -64.5 1.16 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.14 -0.482 . . . . 0.0 112.043 -179.15 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 68' ' ' GLU . . . . . 0.434 ' O ' HG23 ' A' ' 72' ' ' VAL . 26.0 tp10 -63.83 -26.67 68.72 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.707 0.289 . . . . 0.0 111.466 -178.775 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 36.2 tptt -58.02 -28.12 64.17 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.514 -0.312 . . . . 0.0 111.01 179.842 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 83.1 mt-10 -63.26 -21.35 66.18 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-O 121.388 0.613 . . . . 0.0 110.763 179.354 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 71' ' ' GLU . . . . . 0.521 ' O ' ' HD2' ' A' ' 75' ' ' ARG . 5.7 tp10 -97.49 -41.23 8.28 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.418 -0.81 . . . . 0.0 109.316 178.158 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.469 HG12 ' HB2' ' A' ' 121' ' ' GLU . 42.2 t -62.29 -40.13 86.68 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.379 0 CA-C-N 115.927 -0.578 . . . . 0.0 112.192 -179.25 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 73' ' ' ASP . . . . . 0.425 ' OD2' HG21 ' A' ' 151' ' ' THR . 12.9 p-10 -74.83 -14.19 60.66 Favored 'General case' 0 N--CA 1.466 0.375 0 CA-C-O 121.035 0.445 . . . . 0.0 110.867 -179.705 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 45.6 t -99.79 -12.98 19.45 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 121.504 0.669 . . . . 0.0 109.445 177.888 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 75' ' ' ARG . . . . . 0.521 ' HD2' ' O ' ' A' ' 71' ' ' GLU . 0.0 OUTLIER -107.66 41.05 1.58 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.054 -179.401 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -121.04 169.79 10.15 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 115.649 -0.705 . . . . 0.0 110.492 179.795 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -131.86 136.18 57.37 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 N-CA-C 109.616 -0.513 . . . . 0.0 109.616 178.433 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 71.3 t80 -91.79 123.27 35.05 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.409 -0.359 . . . . 0.0 110.278 -179.617 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 6.4 t -103.96 111.07 32.17 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.286 -179.615 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -119.95 169.66 13.96 Favored Glycine 0 N--CA 1.449 -0.48 0 C-N-CA 120.908 -0.663 . . . . 0.0 111.74 179.896 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 15.2 m120 61.48 35.62 17.5 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-O 121.102 0.477 . . . . 0.0 110.623 -179.742 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 2.1 t -79.79 165.85 2.71 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.674 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.65 -179.125 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -70.42 142.81 51.99 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 110.017 -0.364 . . . . 0.0 110.017 179.35 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 38.2 p90 -67.12 -13.47 61.98 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 112.03 0.381 . . . . 0.0 112.03 -178.723 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -114.06 16.78 18.1 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.787 0.327 . . . . 0.0 111.025 -179.968 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 86' ' ' CYS . . . . . 0.467 ' SG ' ' HB2' ' A' ' 140' ' ' HIS . 0.7 OUTLIER -82.16 142.1 32.5 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.132 0.491 . . . . 0.0 111.164 -179.927 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 87' ' ' THR . . . . . 0.549 ' O ' ' HG2' ' A' ' 90' ' ' GLU . 23.1 p -106.29 154.48 39.72 Favored Pre-proline 0 C--N 1.327 -0.406 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.548 179.705 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 88' ' ' PRO . . . . . 0.462 ' HD3' HD13 ' A' ' 106' ' ' ILE . 18.2 Cg_endo -59.19 -35.13 98.22 Favored 'Trans proline' 0 C--N 1.344 0.328 0 C-N-CA 122.769 2.313 . . . . 0.0 112.794 -179.355 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -65.51 -50.62 64.6 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.909 -0.587 . . . . 0.0 112.144 -178.705 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 90' ' ' GLU . . . . . 0.549 ' HG2' ' O ' ' A' ' 87' ' ' THR . 10.5 pt-20 -61.97 -24.78 67.22 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.888 0.375 . . . . 0.0 111.444 -178.806 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 76.1 t -81.2 -47.78 19.68 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.926 -178.761 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -71.5 -31.11 66.72 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.581 -178.627 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 3.7 pp0? -80.33 -27.91 38.26 Favored 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 120.383 -0.527 . . . . 0.0 111.252 -179.124 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 50.2 t-80 -77.44 -34.13 54.62 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.987 0.423 . . . . 0.0 110.479 -179.792 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 22.5 m-30 -84.38 -10.21 57.76 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.611 -179.987 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 96' ' ' GLN . . . . . 0.453 ' HA ' ' O ' ' A' ' 99' ' ' GLY . 9.3 tt0 -65.83 -25.4 67.2 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.488 -0.778 . . . . 0.0 109.979 179.804 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 3.6 m -62.95 -30.03 71.25 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.646 -0.706 . . . . 0.0 110.48 179.123 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 3.5 m -92.55 -49.67 6.0 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.346 179.951 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 99' ' ' GLY . . . . . 0.453 ' O ' ' HA ' ' A' ' 96' ' ' GLN . . . -145.41 144.24 12.8 Favored Glycine 0 N--CA 1.449 -0.473 0 C-N-CA 120.824 -0.703 . . . . 0.0 111.701 179.829 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 100' ' ' THR . . . . . 0.454 ' HB ' ' CZ ' ' A' ' 122' ' ' PHE . 0.2 OUTLIER -64.26 143.81 57.61 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-O 120.837 0.351 . . . . 0.0 110.69 179.945 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 1.7 p -110.72 126.45 68.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.077 -179.387 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 24.8 t-20 -90.91 -50.14 6.04 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 109.455 -0.572 . . . . 0.0 109.455 179.026 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -138.75 156.08 47.67 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.954 -0.567 . . . . 0.0 109.726 179.169 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 5.4 p -152.28 125.73 1.27 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.262 179.972 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 2.6 m -118.14 126.3 51.95 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 110.007 -0.368 . . . . 0.0 110.007 179.795 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 106' ' ' ILE . . . . . 0.503 HD11 ' HA2' ' A' ' 116' ' ' GLY . 20.9 tt -110.68 145.4 17.09 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-O 120.962 0.411 . . . . 0.0 110.794 179.816 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 32.6 tp -129.2 130.3 46.14 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.576 179.934 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -91.83 119.54 31.72 Favored 'General case' 0 N--CA 1.45 -0.47 0 CA-C-N 116.495 -0.32 . . . . 0.0 110.386 179.235 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 109' ' ' ASP . . . . . 0.437 ' O ' ' HG2' ' A' ' 115' ' ' LYS . 16.4 t70 -85.46 139.14 31.75 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.086 0.47 . . . . 0.0 110.633 179.917 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.3 23.49 5.98 Favored 'General case' 0 C--N 1.319 -0.749 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 179.113 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 1.1 t80 -103.82 1.79 31.97 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.542 -178.927 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 103.86 7.85 40.75 Favored Glycine 0 N--CA 1.448 -0.554 0 C-N-CA 121.066 -0.588 . . . . 0.0 112.701 179.527 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 18.3 mt-30 -98.56 158.19 32.97 Favored Pre-proline 0 C--N 1.324 -0.507 0 N-CA-C 109.489 -0.56 . . . . 0.0 109.489 179.581 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -59.26 118.91 5.87 Favored 'Trans proline' 0 C--N 1.346 0.403 0 C-N-CA 122.12 1.88 . . . . 0.0 111.169 178.665 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 115' ' ' LYS . . . . . 0.437 ' HG2' ' O ' ' A' ' 109' ' ' ASP . 60.1 mttt -72.93 173.74 8.82 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 109.892 -0.41 . . . . 0.0 109.892 -179.441 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 116' ' ' GLY . . . . . 0.503 ' HA2' HD11 ' A' ' 106' ' ' ILE . . . 100.28 2.53 55.72 Favored Glycine 0 N--CA 1.444 -0.788 0 C-N-CA 120.309 -0.948 . . . . 0.0 112.326 179.406 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 29.8 m-85 -52.48 115.2 1.65 Allowed 'General case' 0 C--N 1.333 -0.14 0 N-CA-C 110.117 -0.327 . . . . 0.0 110.117 179.445 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -144.6 175.36 10.2 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 121.087 0.47 . . . . 0.0 111.223 -178.913 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 50.8 p90 -159.26 137.75 10.73 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.58 -0.737 . . . . 0.0 109.506 179.002 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 11.3 m -110.31 140.66 28.39 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 N-CA-C 109.446 -0.576 . . . . 0.0 109.446 179.118 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 121' ' ' GLU . . . . . 0.469 ' HB2' HG12 ' A' ' 72' ' ' VAL . 4.9 pt-20 -126.02 151.57 46.92 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.487 -0.324 . . . . 0.0 110.812 179.887 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 122' ' ' PHE . . . . . 0.454 ' CZ ' ' HB ' ' A' ' 100' ' ' THR . 10.6 t80 -148.87 167.14 26.48 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.662 179.965 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 37.7 t -84.05 -45.37 18.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 115.765 -0.652 . . . . 0.0 111.741 -179.19 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 34.2 mm-40 -73.54 137.03 44.12 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.785 0.326 . . . . 0.0 110.669 -179.24 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 2.9 mp -77.42 -34.83 21.26 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.702 -179.59 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -59.28 -36.23 75.19 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.186 0.517 . . . . 0.0 111.203 -179.786 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -62.95 -57.71 9.81 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.354 -179.818 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 10.7 p -65.03 -28.7 45.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.532 -0.304 . . . . 0.0 111.271 -179.403 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 50.2 tt0 -61.49 -43.35 99.01 Favored 'General case' 0 C--N 1.334 -0.095 0 CA-C-O 120.973 0.416 . . . . 0.0 110.23 179.602 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 46.4 m-80 -72.17 -29.98 64.54 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 121.223 0.535 . . . . 0.0 109.951 179.477 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -67.97 -50.88 53.12 Favored 'General case' 0 N--CA 1.453 -0.285 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.989 179.827 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 4.1 pp -67.41 -17.31 64.67 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.986 0.422 . . . . 0.0 110.882 -179.965 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 1.4 tp -78.06 -50.49 11.96 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.506 -179.965 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 76.5 mt -135.2 104.25 5.83 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.15 179.916 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -148.64 -56.59 0.21 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.243 0.544 . . . . 0.0 111.344 -179.035 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 3.8 pt-20 -75.24 92.6 2.75 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.667 -0.697 . . . . 0.0 111.437 -179.39 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 2.5 m -140.04 -59.31 0.55 Allowed 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.005 179.276 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 11.4 tt0 -157.88 130.06 7.09 Favored 'General case' 0 N--CA 1.45 -0.438 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.482 179.413 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -148.3 120.59 8.4 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 108.82 -0.807 . . . . 0.0 108.82 179.823 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 140' ' ' HIS . . . . . 0.467 ' HB2' ' SG ' ' A' ' 86' ' ' CYS . 1.9 t60 60.48 28.08 17.73 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-O 120.87 0.367 . . . . 0.0 110.609 179.987 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 82.62 -6.0 71.54 Favored Glycine 0 CA--C 1.519 0.299 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.688 -179.845 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 1.4 mpt_? -110.94 -177.72 3.29 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.828 0.347 . . . . 0.0 110.246 -179.951 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 20.4 pt20 -123.15 141.65 51.74 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 179.077 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -125.1 175.87 7.09 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.253 179.953 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -118.06 121.27 40.17 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 109.348 -0.612 . . . . 0.0 109.348 179.61 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 96.8 t -118.73 122.64 69.93 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-O 120.71 0.29 . . . . 0.0 111.62 -178.834 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -125.77 148.26 49.15 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.041 179.196 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -63.65 130.58 44.87 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.768 0.318 . . . . 0.0 110.536 179.464 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 15.3 ttpp -91.46 67.41 5.61 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 121.351 0.596 . . . . 0.0 110.443 -179.642 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 24.3 tpt180 -81.95 100.66 9.79 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 109.366 -0.605 . . . . 0.0 109.366 179.075 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 151' ' ' THR . . . . . 0.425 HG21 ' OD2' ' A' ' 73' ' ' ASP . 6.5 t -87.88 121.32 30.16 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 116.028 -0.533 . . . . 0.0 109.985 179.96 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 152' ' ' ASN . . . . . . . . . . . . . 60.6 t30 -161.15 155.22 22.6 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 109.621 -0.511 . . . . 0.0 109.621 -179.434 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 26.1 pt -81.15 146.77 59.31 Favored Pre-proline 0 C--N 1.321 -0.653 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.105 179.613 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -60.78 -33.26 93.17 Favored 'Trans proline' 0 CA--C 1.531 0.366 0 C-N-CA 122.493 2.128 . . . . 0.0 111.984 179.767 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.246 0.859 0 CA-C-O 118.598 -1.112 . . . . 0.0 111.921 179.791 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.478 0.969 0 CA-C-O 120.81 0.338 . . . . 0.0 110.289 . . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 104.38 179.93 24.81 Favored Glycine 0 N--CA 1.449 -0.464 0 C-N-CA 120.614 -0.803 . . . . 0.0 112.146 179.905 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 2.0 t -164.34 179.03 7.05 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 109.709 -0.478 . . . . 0.0 109.709 -179.85 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 8.6 t -87.25 -173.27 4.32 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 120.885 0.374 . . . . 0.0 110.436 179.857 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 22.6 p-80 -146.09 137.17 24.54 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.012 -179.836 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 4.4 m-70 -143.46 136.23 27.5 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.378 -0.373 . . . . 0.0 110.527 -179.64 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 36.3 p-80 -135.65 150.21 49.54 Favored 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 109.89 -0.411 . . . . 0.0 109.89 179.113 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 57.5 t60 -123.59 145.61 48.78 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-O 120.876 0.369 . . . . 0.0 110.836 -179.2 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -113.22 136.25 52.94 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.561 -179.944 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 5.6 p80 -161.56 139.21 8.98 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.296 179.761 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 3.8 m -130.78 155.66 46.29 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.482 -0.326 . . . . 0.0 110.174 179.856 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 47.5 m -149.47 163.96 36.36 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.59 -0.277 . . . . 0.0 110.776 -179.56 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -149.44 172.23 29.48 Favored Glycine 0 N--CA 1.449 -0.469 0 C-N-CA 121.101 -0.571 . . . . 0.0 111.694 -179.897 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -142.88 125.49 15.84 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.888 0.375 . . . . 0.0 111.035 -179.964 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 39.6 t -124.78 105.92 29.56 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.567 179.776 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 91.2 Cg_endo -88.11 165.46 7.04 Favored 'Trans proline' 0 N--CA 1.458 -0.586 0 C-N-CA 122.854 2.369 . . . . 0.0 112.116 179.143 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' ARG . . . . . 0.411 HH11 ' HD3' ' A' ' 17' ' ' ARG . 0.6 OUTLIER -146.85 156.1 42.85 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 120.678 0.275 . . . . 0.0 110.453 179.431 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -92.22 -164.74 38.57 Favored Glycine 0 N--CA 1.445 -0.705 0 C-N-CA 121.092 -0.575 . . . . 0.0 112.707 -179.626 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 4.4 t -129.42 -172.45 2.75 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 110.365 -0.235 . . . . 0.0 110.365 -179.849 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 18.3 p80 -126.86 127.74 45.42 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.719 -179.884 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 26.2 ptt? -88.78 179.72 6.16 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.555 179.97 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -129.37 -160.08 10.09 Favored Glycine 0 N--CA 1.446 -0.634 0 C-N-CA 121.061 -0.59 . . . . 0.0 112.2 179.583 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 3.4 m -120.08 168.61 11.01 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 120.828 0.347 . . . . 0.0 110.894 -179.803 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 44.4 t0 -104.39 167.79 9.51 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.131 -0.486 . . . . 0.0 109.755 179.82 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 3.5 mp -122.66 150.97 41.97 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 120.743 0.306 . . . . 0.0 111.464 -178.949 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -92.43 -172.15 3.0 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.111 179.009 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 2.4 p-10 -123.81 173.44 8.16 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.656 -0.247 . . . . 0.0 110.62 -179.853 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 21.9 ttt -156.26 144.43 19.76 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.776 -179.713 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 73.9 mttt -82.77 146.46 28.97 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 110.115 -0.328 . . . . 0.0 110.115 179.368 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 43.1 mttt -117.49 176.63 5.08 Favored 'General case' 0 C--O 1.236 0.362 0 CA-C-O 121.257 0.551 . . . . 0.0 111.779 -179.084 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 22.7 mmt180 -121.37 121.32 37.36 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.394 -0.821 . . . . 0.0 110.077 179.603 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 49.5 tp -85.45 139.9 31.14 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.42 -179.119 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.454 ' HG2' ' H ' ' A' ' 34' ' ' GLU . 26.8 tttm -157.54 -157.09 0.64 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.115 178.969 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.454 ' H ' ' HG2' ' A' ' 33' ' ' LYS . 6.9 mm-40 -65.32 144.54 57.05 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.972 0.415 . . . . 0.0 111.847 -179.267 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 34.5 mm -88.64 131.54 35.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.817 -179.374 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 5.5 tp10 -126.15 175.88 7.45 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.022 179.88 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -98.64 151.72 20.39 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.952 -179.828 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 7.8 tp10 -155.61 158.71 38.8 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.911 -0.586 . . . . 0.0 109.786 179.907 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -138.94 163.51 32.14 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.836 0.351 . . . . 0.0 111.137 -179.793 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -140.57 141.81 11.75 Favored Glycine 0 N--CA 1.449 -0.47 0 C-N-CA 120.888 -0.672 . . . . 0.0 112.308 179.617 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -157.15 -170.24 3.2 Favored 'General case' 0 C--O 1.235 0.312 0 N-CA-C 110.127 -0.323 . . . . 0.0 110.127 179.944 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 41.4 tp -78.51 92.43 4.66 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.004 0.43 . . . . 0.0 110.172 179.866 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 43' ' ' ARG . . . . . 0.432 ' HD3' ' SD ' ' A' ' 45' ' ' MET . 57.7 ttt180 -150.86 143.06 24.15 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.455 -179.738 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 63.3 mt-10 -81.68 39.8 0.56 Allowed 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.956 -0.566 . . . . 0.0 110.757 -179.952 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 45' ' ' MET . . . . . 0.432 ' SD ' ' HD3' ' A' ' 43' ' ' ARG . 17.5 ptt? -97.35 14.85 24.76 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.262 0.554 . . . . 0.0 110.141 -179.611 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 51.5 mt-30 -69.09 -28.93 66.94 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.591 -0.731 . . . . 0.0 110.492 -179.826 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -70.79 -3.01 16.62 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.781 -0.645 . . . . 0.0 111.713 -179.519 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 33.6 ttpt -84.29 -3.25 58.11 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.557 179.871 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 8.9 p -57.97 -28.71 34.37 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.266 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.364 -179.874 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.432 ' O ' ' HG2' ' A' ' 53' ' ' MET . 29.4 mt-10 -67.01 -20.13 65.82 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 121.245 0.545 . . . . 0.0 110.65 179.944 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 10.6 ttmt -98.5 -41.46 7.76 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.895 -0.593 . . . . 0.0 109.627 178.996 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -63.99 -21.63 66.58 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.651 -0.704 . . . . 0.0 111.0 179.629 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 53' ' ' MET . . . . . 0.432 ' HG2' ' O ' ' A' ' 50' ' ' GLU . 8.3 ptt? -61.63 -27.36 68.61 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 120.973 0.416 . . . . 0.0 110.577 179.502 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -98.97 10.72 62.19 Favored Glycine 0 N--CA 1.449 -0.453 0 N-CA-C 111.144 -0.782 . . . . 0.0 111.144 178.965 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -134.7 19.68 3.56 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.383 -0.408 . . . . 0.0 110.406 179.94 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 18.1 m -65.64 -15.4 18.62 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.411 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.796 -179.888 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 14.5 mp0 -80.22 -2.58 45.55 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.489 0.661 . . . . 0.0 110.442 179.343 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -134.24 -59.47 0.83 Allowed 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.424 -0.807 . . . . 0.0 110.22 179.62 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 4.6 m -65.09 -67.85 0.41 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.589 -179.433 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -86.76 21.83 2.12 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.972 -178.705 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 3.2 t -71.56 -28.14 63.65 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 120.874 0.368 . . . . 0.0 110.926 -179.243 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -65.84 -15.52 62.98 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 112.005 0.372 . . . . 0.0 112.005 -179.502 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 93.6 p -68.31 -25.85 65.33 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.018 0.437 . . . . 0.0 110.112 179.51 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -69.21 -32.57 71.92 Favored 'General case' 0 N--CA 1.453 -0.321 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.341 179.886 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -76.21 -2.56 31.87 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.117 0.484 . . . . 0.0 111.085 179.515 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 35.3 tt0 -117.44 -50.66 2.53 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.208 -179.817 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -86.59 -58.31 2.66 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 112.105 0.409 . . . . 0.0 112.105 -178.675 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 68' ' ' GLU . . . . . 0.443 ' O ' HG23 ' A' ' 72' ' ' VAL . 2.9 tp10 -62.7 -31.0 71.82 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.587 -179.489 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 39.4 tptt -58.6 -28.67 65.81 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.976 -0.556 . . . . 0.0 111.169 179.87 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 49.1 mt-10 -61.98 -23.07 66.17 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-O 120.974 0.416 . . . . 0.0 111.151 -179.854 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 6.8 tp10 -97.77 -38.93 9.28 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 116.067 -0.515 . . . . 0.0 109.729 178.743 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.443 HG23 ' O ' ' A' ' 68' ' ' GLU . 46.6 t -65.01 -37.15 79.52 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-N 115.687 -0.688 . . . . 0.0 112.415 -178.907 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 52.1 p-10 -74.09 -16.11 61.03 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-O 120.951 0.405 . . . . 0.0 110.886 -179.526 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 42.3 t -101.8 -6.72 23.27 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.954 -0.566 . . . . 0.0 109.857 178.359 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -112.69 42.79 1.78 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.348 0.594 . . . . 0.0 109.96 -179.382 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -122.14 171.95 8.62 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.692 -0.686 . . . . 0.0 110.25 179.71 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.449 HD11 HG22 ' A' ' 120' ' ' VAL . 1.0 OUTLIER -132.02 139.05 51.23 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 N-CA-C 109.987 -0.375 . . . . 0.0 109.987 178.341 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 78' ' ' TYR . . . . . 0.428 ' O ' ' HA ' ' A' ' 146' ' ' VAL . 25.0 t80 -90.13 124.06 34.49 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.868 -0.606 . . . . 0.0 109.929 179.939 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 6.2 t -108.3 109.11 27.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.515 -0.311 . . . . 0.0 110.405 179.461 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -118.62 170.15 13.69 Favored Glycine 0 N--CA 1.447 -0.567 0 C-N-CA 120.996 -0.621 . . . . 0.0 111.7 -179.9 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 92.2 m-20 56.51 42.56 27.17 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-O 121.015 0.436 . . . . 0.0 110.829 -179.477 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.453 HG13 HD23 ' A' ' 144' ' ' LEU . 2.3 t -81.98 165.14 2.69 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-N 115.862 -0.608 . . . . 0.0 111.048 -178.998 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 83' ' ' ASP . . . . . 0.478 ' HB3' ' SG ' ' A' ' 86' ' ' CYS . 37.3 t70 -68.2 137.81 55.11 Favored 'General case' 0 CA--C 1.519 -0.212 0 N-CA-C 109.871 -0.418 . . . . 0.0 109.871 179.597 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 18.1 p90 -66.59 -10.07 41.8 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.901 -178.87 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -118.94 19.43 13.03 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.001 0.429 . . . . 0.0 110.719 179.521 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 86' ' ' CYS . . . . . 0.478 ' SG ' ' HB3' ' A' ' 83' ' ' ASP . 0.7 OUTLIER -79.45 149.28 31.61 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.966 180.0 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 87' ' ' THR . . . . . 0.483 ' O ' ' HG2' ' A' ' 90' ' ' GLU . 2.9 p -112.61 145.92 33.94 Favored Pre-proline 0 C--N 1.326 -0.441 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.659 179.226 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 88' ' ' PRO . . . . . 0.445 ' HD3' HD13 ' A' ' 106' ' ' ILE . 11.2 Cg_endo -54.29 -42.56 66.45 Favored 'Trans proline' 0 C--N 1.344 0.311 0 C-N-CA 122.942 2.428 . . . . 0.0 113.039 -178.996 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -62.05 -45.7 92.41 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.302 -0.408 . . . . 0.0 112.011 -179.429 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 90' ' ' GLU . . . . . 0.628 ' O ' ' HB2' ' A' ' 94' ' ' HIS . 4.8 pt-20 -67.68 -21.76 65.32 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.723 0.297 . . . . 0.0 111.24 -178.765 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.42 HG23 ' O ' ' A' ' 87' ' ' THR . 76.2 t -82.17 -48.31 18.42 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.734 -179.108 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 2.4 pt20 -71.54 -31.33 66.9 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.441 -0.345 . . . . 0.0 111.451 -178.258 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -80.13 -26.59 39.35 Favored 'General case' 0 C--N 1.327 -0.386 0 C-N-CA 120.53 -0.468 . . . . 0.0 110.586 -179.793 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 94' ' ' HIS . . . . . 0.628 ' HB2' ' O ' ' A' ' 90' ' ' GLU . 0.1 OUTLIER -72.17 -42.1 66.27 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.994 0.426 . . . . 0.0 110.483 -179.959 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 19.9 m-30 -80.63 -15.33 56.84 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.377 179.913 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 96' ' ' GLN . . . . . 0.544 ' HA ' ' O ' ' A' ' 99' ' ' GLY . 30.1 tt0 -62.77 -28.85 70.27 Favored 'General case' 0 CA--C 1.523 -0.065 0 CA-C-N 115.549 -0.75 . . . . 0.0 109.607 178.704 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 14.2 m -63.4 -23.05 67.24 Favored 'General case' 0 CA--C 1.533 0.291 0 CA-C-N 115.491 -0.777 . . . . 0.0 110.852 179.302 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 7.4 m -100.2 -43.97 6.12 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.169 -0.469 . . . . 0.0 109.807 179.044 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 99' ' ' GLY . . . . . 0.544 ' O ' ' HA ' ' A' ' 96' ' ' GLN . . . -150.19 139.31 7.25 Favored Glycine 0 N--CA 1.444 -0.81 0 N-CA-C 111.071 -0.811 . . . . 0.0 111.071 179.491 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -60.41 149.92 32.51 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 121.072 0.463 . . . . 0.0 111.564 -179.705 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 2.0 p -114.28 129.36 70.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.352 -178.897 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 8.0 t30 -94.05 -38.33 11.19 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.306 0.574 . . . . 0.0 109.817 179.078 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -155.15 149.32 25.91 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.573 -0.739 . . . . 0.0 110.289 -179.72 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 7.7 p -145.93 135.25 17.36 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 CA-C-N 116.015 -0.538 . . . . 0.0 110.15 179.858 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 105' ' ' THR . . . . . 0.497 ' HB ' ' CE1' ' A' ' 119' ' ' TYR . 2.3 m -126.37 119.74 28.08 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.468 -0.333 . . . . 0.0 110.232 179.62 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 106' ' ' ILE . . . . . 0.601 HD11 ' HA2' ' A' ' 116' ' ' GLY . 20.1 tt -108.24 143.42 18.67 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-O 120.808 0.337 . . . . 0.0 110.512 179.991 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 36.4 tp -129.39 135.39 48.63 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.713 -179.713 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -94.42 116.62 29.01 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 109.833 -0.432 . . . . 0.0 109.833 179.045 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 109' ' ' ASP . . . . . 0.401 ' O ' ' HG2' ' A' ' 115' ' ' LYS . 14.1 t70 -84.46 134.06 34.46 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.194 0.521 . . . . 0.0 110.87 -179.676 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 11.2 mmmm -117.77 24.22 11.2 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.742 -0.663 . . . . 0.0 109.703 179.915 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 11.6 t80 -106.87 10.77 30.55 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.208 0.528 . . . . 0.0 110.237 -179.02 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 93.79 6.83 61.88 Favored Glycine 0 N--CA 1.449 -0.461 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.697 179.396 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 27.8 mt-30 -95.47 157.61 35.93 Favored Pre-proline 0 C--N 1.323 -0.586 0 N-CA-C 109.752 -0.462 . . . . 0.0 109.752 179.89 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 11.0 Cg_endo -56.16 117.83 4.54 Favored 'Trans proline' 0 N--CA 1.462 -0.348 0 C-N-CA 122.237 1.958 . . . . 0.0 110.811 178.458 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 115' ' ' LYS . . . . . 0.401 ' HG2' ' O ' ' A' ' 109' ' ' ASP . 47.2 mttt -76.88 172.46 13.1 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 109.63 -0.507 . . . . 0.0 109.63 -179.289 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 116' ' ' GLY . . . . . 0.601 ' HA2' HD11 ' A' ' 106' ' ' ILE . . . 98.08 0.67 58.52 Favored Glycine 0 N--CA 1.446 -0.693 0 C-N-CA 120.115 -1.041 . . . . 0.0 112.599 179.596 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 1.8 t80 -52.99 119.28 4.48 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 121.018 0.437 . . . . 0.0 110.08 179.423 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -145.24 177.06 9.08 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.992 -178.845 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 119' ' ' TYR . . . . . 0.497 ' CE1' ' HB ' ' A' ' 105' ' ' THR . 49.9 p90 -158.34 133.91 8.86 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.606 -0.725 . . . . 0.0 109.059 178.905 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 120' ' ' VAL . . . . . 0.449 HG22 HD11 ' A' ' 77' ' ' ILE . 6.8 m -108.97 143.22 19.61 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.659 0 N-CA-C 109.666 -0.494 . . . . 0.0 109.666 178.895 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 121' ' ' GLU . . . . . 0.404 ' HB2' HG12 ' A' ' 72' ' ' VAL . 7.4 pt-20 -127.7 153.7 46.19 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.43 -0.35 . . . . 0.0 110.753 -179.903 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 8.4 t80 -151.97 169.57 21.99 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.297 179.318 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 3.0 t -89.52 -48.1 14.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 120.844 0.354 . . . . 0.0 111.376 -179.59 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -69.76 127.88 34.46 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.876 0.37 . . . . 0.0 110.86 -179.248 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 2.5 mp -68.03 -33.17 59.54 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.314 -179.075 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -58.09 -42.12 84.93 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.839 0.352 . . . . 0.0 111.465 -179.991 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -56.94 -56.47 21.33 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.171 -179.777 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 8.9 p -68.56 -28.32 39.79 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.363 -179.527 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 3.5 tt0 -63.01 -39.25 94.19 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.977 0.418 . . . . 0.0 110.453 -179.905 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 41.2 m-80 -77.7 -29.66 51.45 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.266 0.555 . . . . 0.0 109.797 179.096 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 131' ' ' ALA . . . . . 0.443 ' O ' ' HB2' ' A' ' 135' ' ' ASN . . . -67.65 -49.6 62.04 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.422 -0.808 . . . . 0.0 111.161 179.829 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 4.4 pp -66.38 -13.27 60.4 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.886 0.374 . . . . 0.0 111.555 -179.578 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 3.9 tp -89.06 -49.9 6.48 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.153 0.501 . . . . 0.0 109.986 179.036 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 25.3 mt -126.69 100.91 6.4 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.057 179.729 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 135' ' ' ASN . . . . . 0.443 ' HB2' ' O ' ' A' ' 131' ' ' ALA . 0.2 OUTLIER -150.62 -58.28 0.18 Allowed 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.239 0.542 . . . . 0.0 111.628 -179.293 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 4.6 pt-20 -77.5 85.98 3.86 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.8 -0.636 . . . . 0.0 111.67 -178.98 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 23.9 m -134.44 -58.88 0.83 Allowed 'General case' 0 N--CA 1.448 -0.526 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.117 179.248 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 6.8 tm-20 -155.02 128.37 8.4 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.906 0.384 . . . . 0.0 111.002 179.646 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -143.45 111.59 6.19 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 178.269 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 140' ' ' HIS . . . . . 0.482 ' HD1' ' CD ' ' A' ' 90' ' ' GLU . 1.7 t60 61.01 28.8 18.57 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.97 0.414 . . . . 0.0 110.7 -179.833 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 85.39 0.94 88.22 Favored Glycine 0 N--CA 1.449 -0.499 0 C-N-CA 120.978 -0.629 . . . . 0.0 113.043 179.779 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 142' ' ' ARG . . . . . 0.41 ' HD3' ' OD1' ' A' ' 83' ' ' ASP . 1.4 mpt_? -117.52 163.66 16.08 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 117.147 0.473 . . . . 0.0 110.868 179.928 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 7.7 pt20 -110.69 121.8 46.22 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 116.256 -0.429 . . . . 0.0 109.932 179.799 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 144' ' ' LEU . . . . . 0.453 HD23 HG13 ' A' ' 82' ' ' VAL . 0.5 OUTLIER -106.46 178.78 4.46 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.992 -179.025 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 6.1 tttt -115.44 121.78 43.77 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.088 -0.505 . . . . 0.0 109.859 178.893 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 146' ' ' VAL . . . . . 0.428 ' HA ' ' O ' ' A' ' 78' ' ' TYR . 96.9 t -120.98 126.9 75.77 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-O 121.094 0.473 . . . . 0.0 111.212 -179.712 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 39.7 m -134.61 151.73 51.27 Favored 'General case' 0 C--N 1.319 -0.743 0 N-CA-C 109.582 -0.525 . . . . 0.0 109.582 178.91 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -65.0 131.4 46.49 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.128 0.49 . . . . 0.0 111.46 -179.101 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 21.0 ttpt -93.48 80.29 4.35 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 121.363 0.601 . . . . 0.0 109.813 179.611 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 21.5 tpt180 -93.64 104.65 16.74 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.346 -0.843 . . . . 0.0 109.483 179.236 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 9.6 t -89.07 136.97 32.73 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 116.083 -0.508 . . . . 0.0 109.803 179.262 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 152' ' ' ASN . . . . . . . . . . . . . 59.8 t30 -172.51 154.87 3.24 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 108.89 -0.782 . . . . 0.0 108.89 -179.864 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 24.1 pt -71.39 139.23 84.1 Favored Pre-proline 0 C--N 1.32 -0.705 0 CA-C-O 120.635 0.255 . . . . 0.0 110.375 179.763 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 20.7 Cg_endo -61.9 119.16 6.14 Favored 'Trans proline' 0 N--CA 1.462 -0.328 0 C-N-CA 122.549 2.166 . . . . 0.0 112.169 179.954 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.063 0 CA-C-O 118.822 -0.988 . . . . 0.0 111.397 179.994 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.2 mpp? . . . . . 0 N--CA 1.481 1.122 0 N-CA-C 110.206 -0.294 . . . . 0.0 110.206 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -139.76 138.78 9.43 Favored Glycine 0 N--CA 1.445 -0.765 0 C-N-CA 120.858 -0.687 . . . . 0.0 111.763 179.557 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 16.7 m -145.24 126.36 14.67 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 120.761 0.315 . . . . 0.0 110.2 179.985 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 46.9 m -154.45 120.42 5.26 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.709 -179.439 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -160.07 124.41 3.77 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.25 179.802 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -152.62 126.82 9.17 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.43 -0.35 . . . . 0.0 110.23 -179.948 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 6.5 p80 -141.37 147.02 37.38 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 109.964 -0.384 . . . . 0.0 109.964 179.947 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 57.4 t60 -171.8 112.93 0.33 Allowed 'General case' 0 C--N 1.328 -0.333 0 O-C-N 123.182 0.301 . . . . 0.0 111.061 -179.5 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 7.9 t-80 -167.19 114.52 0.79 Allowed 'General case' 0 N--CA 1.464 0.241 0 CA-C-O 120.723 0.297 . . . . 0.0 111.021 178.998 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 1.5 m-70 -156.76 122.04 4.67 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.671 179.954 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -129.62 147.72 51.45 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.48 -0.327 . . . . 0.0 110.595 179.159 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -147.33 164.88 31.85 Favored 'General case' 0 C--O 1.237 0.436 0 CA-C-N 116.58 -0.282 . . . . 0.0 111.051 179.852 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -174.62 161.17 30.8 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.819 -0.705 . . . . 0.0 112.561 -179.976 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 15.2 tp -118.84 140.96 49.11 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.64 0.257 . . . . 0.0 110.606 179.851 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -117.51 109.56 41.77 Favored Pre-proline 0 C--N 1.325 -0.478 0 CA-C-O 120.91 0.386 . . . . 0.0 110.586 179.421 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 87.2 Cg_endo -84.44 -175.49 2.17 Favored 'Trans proline' 0 N--CA 1.461 -0.388 0 C-N-CA 122.829 2.353 . . . . 0.0 112.913 -179.743 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -143.06 121.26 12.2 Favored 'General case' 0 N--CA 1.452 -0.343 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.114 -179.807 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 173.35 87.37 0.07 OUTLIER Glycine 0 N--CA 1.448 -0.538 0 C-N-CA 120.842 -0.695 . . . . 0.0 111.905 -179.923 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 6.0 m -138.42 157.77 45.57 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 110.305 -0.257 . . . . 0.0 110.305 179.615 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 14.4 p80 -145.24 163.12 35.41 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 116.498 -0.319 . . . . 0.0 110.207 179.475 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 3.5 mpp? -108.06 -179.04 3.78 Favored 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 109.482 -0.562 . . . . 0.0 109.482 179.336 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 132.03 93.52 0.58 Allowed Glycine 0 N--CA 1.446 -0.653 0 C-N-CA 120.228 -0.986 . . . . 0.0 112.719 179.645 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 3.4 p -131.05 99.13 4.78 Favored 'General case' 0 C--N 1.32 -0.704 0 N-CA-C 110.079 -0.341 . . . . 0.0 110.079 179.815 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -146.61 97.4 2.91 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.546 -0.297 . . . . 0.0 110.367 179.782 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 4.0 mt -165.72 -167.39 1.1 Allowed 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.925 -0.579 . . . . 0.0 109.83 179.925 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 8.7 mm-40 -80.18 179.82 7.45 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.864 0.364 . . . . 0.0 111.071 179.771 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -134.16 171.86 13.66 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.656 -178.653 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 8.8 ttm -113.18 150.55 32.12 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 178.387 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 31.8 mmmt -61.52 -79.41 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.199 0 N-CA-C 110.434 -0.21 . . . . 0.0 110.434 -179.897 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 47.5 pttt -167.93 128.47 1.37 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.97 0.414 . . . . 0.0 110.789 178.956 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -109.26 1.92 20.51 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.641 -0.709 . . . . 0.0 109.969 179.375 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 16.6 tp 60.35 70.38 0.63 Allowed 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.247 -0.888 . . . . 0.0 110.952 179.787 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 15.6 ptpt -159.49 159.25 33.26 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.797 -0.638 . . . . 0.0 109.857 179.574 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 26.7 tt0 -161.58 87.65 0.69 Allowed 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 120.839 0.352 . . . . 0.0 110.157 -179.68 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 19.3 tt -147.36 149.5 15.5 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-O 120.766 0.317 . . . . 0.0 110.566 -179.307 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -119.44 175.4 5.85 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.173 179.317 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 5.2 tt0 -144.39 -160.62 1.15 Allowed 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.396 179.869 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 4.4 mm-40 -94.15 152.44 18.74 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 116.62 -0.264 . . . . 0.0 110.395 179.916 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -70.32 158.6 35.63 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.361 -179.226 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -82.3 -158.99 24.66 Favored Glycine 0 N--CA 1.448 -0.535 0 C-N-CA 121.027 -0.606 . . . . 0.0 112.438 179.783 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -152.73 -150.8 0.35 Allowed 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 120.732 0.301 . . . . 0.0 110.665 -179.875 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 46.6 tp -72.75 90.1 1.39 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.346 179.699 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 51.2 ttt85 -154.43 147.13 24.25 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.064 -179.817 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 15.7 mt-10 -81.73 29.92 0.38 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.033 0.444 . . . . 0.0 111.111 -179.877 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 13.9 ptt? -83.64 1.83 40.44 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.277 0.56 . . . . 0.0 110.142 -179.924 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 38.6 mt-30 -71.4 -17.01 62.43 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.751 -179.793 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -78.31 -11.62 59.95 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.242 179.374 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 35.5 ttpt -77.8 -0.09 25.81 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.718 -0.674 . . . . 0.0 110.246 179.717 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 8.1 p -59.49 -26.03 33.12 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.237 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.901 179.883 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 25.7 mt-10 -67.37 -24.95 65.75 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.72 179.571 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 4.3 ttmt -98.81 -34.59 10.43 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.454 179.192 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 9.1 mm-40 -66.1 -16.04 63.6 Favored 'General case' 0 C--N 1.333 -0.112 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.22 179.781 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -64.53 -25.44 67.99 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.178 0.513 . . . . 0.0 109.785 178.694 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -97.41 12.04 65.02 Favored Glycine 0 N--CA 1.45 -0.378 0 N-CA-C 110.709 -0.956 . . . . 0.0 110.709 179.044 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -138.92 26.34 2.47 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.256 -0.472 . . . . 0.0 109.942 179.777 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 16.0 m -63.32 -20.17 25.46 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.419 0 CA-C-N 116.094 -0.503 . . . . 0.0 112.073 -179.65 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 16.4 mt-30 -80.22 -5.1 55.59 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.233 0.54 . . . . 0.0 110.437 179.534 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -123.88 -48.35 1.89 Allowed 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.534 -0.757 . . . . 0.0 110.974 -179.799 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 16.5 m -81.86 -56.98 3.63 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.735 -0.666 . . . . 0.0 112.595 -178.675 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -98.81 27.18 5.09 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.068 0.461 . . . . 0.0 111.344 -178.576 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 7.6 t -70.22 -31.54 69.01 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-O 121.157 0.503 . . . . 0.0 110.316 -179.742 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -68.52 -22.77 64.5 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.854 -0.612 . . . . 0.0 111.474 179.968 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 3.5 m -63.13 -26.91 69.04 Favored 'General case' 0 N--CA 1.449 -0.499 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.823 -179.275 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -71.72 -32.77 68.12 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.908 0.385 . . . . 0.0 110.575 179.559 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -74.47 -2.13 24.25 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.466 -179.922 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 22.5 tp60 -118.98 -49.37 2.42 Favored 'General case' 0 N--CA 1.451 -0.404 0 CA-C-O 120.593 0.235 . . . . 0.0 111.315 179.876 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -84.59 -52.68 5.93 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.881 0.372 . . . . 0.0 111.92 -178.549 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 68' ' ' GLU . . . . . 0.405 ' O ' HG23 ' A' ' 72' ' ' VAL . 1.3 tp10 -69.62 -30.67 68.45 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.989 0.423 . . . . 0.0 110.615 -179.387 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 50.9 tptt -55.81 -33.65 64.62 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.714 179.908 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 54.4 mt-10 -58.85 -25.7 63.51 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-O 121.02 0.438 . . . . 0.0 111.31 179.943 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 4.4 tp10 -93.82 -40.21 10.31 Favored 'General case' 0 N--CA 1.449 -0.517 0 N-CA-C 109.711 -0.477 . . . . 0.0 109.711 178.786 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.405 HG23 ' O ' ' A' ' 68' ' ' GLU . 61.8 t -63.01 -43.45 99.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 115.706 -0.679 . . . . 0.0 112.658 -178.804 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 73' ' ' ASP . . . . . 0.41 ' OD2' HG21 ' A' ' 151' ' ' THR . 9.0 p-10 -70.81 -18.89 62.73 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-O 121.154 0.502 . . . . 0.0 110.894 -179.365 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 49.1 m -97.79 -8.69 27.94 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.051 178.272 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -111.41 48.31 0.95 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.562 -0.744 . . . . 0.0 110.11 -179.368 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 76' ' ' SER . . . . . 0.466 ' OG ' ' HE2' ' A' ' 149' ' ' LYS . 0.1 OUTLIER -129.95 172.76 11.37 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.921 -0.581 . . . . 0.0 111.26 179.86 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -131.01 138.14 54.2 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-N 115.847 -0.615 . . . . 0.0 109.573 178.434 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 57.2 t80 -96.64 125.32 41.03 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.405 -179.485 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.419 HG21 ' HE2' ' A' ' 95' ' ' PHE . 2.9 t -104.8 118.41 52.09 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.391 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.843 -179.405 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -124.46 168.18 16.64 Favored Glycine 0 N--CA 1.449 -0.472 0 N-CA-C 110.936 -0.866 . . . . 0.0 110.936 179.521 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 2.4 m-20 59.42 34.75 22.81 Favored 'General case' 0 N--CA 1.474 0.746 0 CA-C-O 120.834 0.35 . . . . 0.0 111.279 -179.39 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.405 ' H ' HG23 ' A' ' 82' ' ' VAL . 2.2 t -76.4 163.51 3.91 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.724 0 CA-C-N 115.616 -0.72 . . . . 0.0 110.652 -178.975 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 83' ' ' ASP . . . . . 0.706 ' OD2' ' HB2' ' A' ' 142' ' ' ARG . 0.5 OUTLIER -63.48 137.66 58.22 Favored 'General case' 0 CA--C 1.515 -0.369 0 N-CA-C 109.67 -0.492 . . . . 0.0 109.67 179.015 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 37.2 p90 -66.17 -8.79 26.33 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.07 -179.768 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -120.41 20.54 11.87 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.038 -179.805 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -86.48 146.34 26.44 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.817 0.342 . . . . 0.0 111.052 -179.97 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 87' ' ' THR . . . . . 0.428 ' O ' ' HG2' ' A' ' 90' ' ' GLU . 17.7 p -109.73 155.0 42.2 Favored Pre-proline 0 C--N 1.323 -0.57 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.412 179.841 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 88' ' ' PRO . . . . . 0.479 ' HD3' HD13 ' A' ' 106' ' ' ILE . 18.3 Cg_endo -59.05 -38.88 84.9 Favored 'Trans proline' 0 C--N 1.345 0.372 0 C-N-CA 122.709 2.272 . . . . 0.0 112.929 -178.928 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 24.3 mt-10 -62.36 -50.57 71.04 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.766 -0.652 . . . . 0.0 112.348 -178.496 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 90' ' ' GLU . . . . . 0.428 ' HG2' ' O ' ' A' ' 87' ' ' THR . 11.1 pt-20 -66.31 -16.73 64.28 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.672 0.273 . . . . 0.0 111.535 -178.972 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 56.0 t -86.44 -47.23 16.39 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 CA-C-O 120.93 0.395 . . . . 0.0 110.495 -179.904 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -71.7 -33.39 68.73 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.791 -178.576 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 1.2 pp0? -77.09 -29.03 54.77 Favored 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 120.378 -0.529 . . . . 0.0 111.33 -178.759 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 2.9 m80 -76.7 -40.31 49.19 Favored 'General case' 0 C--N 1.327 -0.376 0 C-N-CA 120.725 -0.39 . . . . 0.0 110.809 -179.635 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 95' ' ' PHE . . . . . 0.419 ' HE2' HG21 ' A' ' 79' ' ' VAL . 22.0 m-30 -75.61 -16.53 60.21 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.58 179.899 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 96' ' ' GLN . . . . . 0.633 ' HA ' ' O ' ' A' ' 99' ' ' GLY . 2.7 tt0 -66.89 -21.77 65.99 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-N 115.982 -0.553 . . . . 0.0 110.391 179.22 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 46.7 m -66.14 -24.26 66.63 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-N 115.905 -0.588 . . . . 0.0 110.074 179.015 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 2.6 m -100.59 -48.84 4.39 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.635 -0.711 . . . . 0.0 109.497 179.042 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 99' ' ' GLY . . . . . 0.633 ' O ' ' HA ' ' A' ' 96' ' ' GLN . . . -142.18 138.4 8.5 Favored Glycine 0 N--CA 1.446 -0.666 0 N-CA-C 111.41 -0.676 . . . . 0.0 111.41 179.766 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 100' ' ' THR . . . . . 0.404 ' HB ' ' CZ ' ' A' ' 122' ' ' PHE . 0.2 OUTLIER -59.81 148.36 34.81 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.735 0.267 . . . . 0.0 111.413 -179.934 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 2.1 p -119.88 129.28 75.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.216 -179.237 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 58.2 t30 -100.42 -43.19 6.32 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.863 0.363 . . . . 0.0 110.182 178.986 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -139.77 148.6 42.45 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.392 179.996 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 5.9 p -148.07 134.33 12.45 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-N 115.856 -0.611 . . . . 0.0 109.854 179.286 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 2.8 m -126.01 122.89 37.17 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 116.479 -0.328 . . . . 0.0 110.341 179.554 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 106' ' ' ILE . . . . . 0.479 HD13 ' HD3' ' A' ' 88' ' ' PRO . 20.3 tt -112.02 148.0 15.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 120.895 0.379 . . . . 0.0 111.136 -179.61 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 27.5 tp -136.5 128.19 28.94 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.156 178.997 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -90.06 120.69 31.47 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 109.848 -0.427 . . . . 0.0 109.848 179.315 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 109' ' ' ASP . . . . . 0.455 ' O ' ' HG2' ' A' ' 115' ' ' LYS . 12.8 t70 -79.53 145.1 33.36 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.087 0.47 . . . . 0.0 111.088 -179.992 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 110' ' ' LYS . . . . . 0.406 ' HD3' ' C ' ' A' ' 109' ' ' ASP . 0.0 OUTLIER -131.59 23.83 4.72 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.8 -0.636 . . . . 0.0 109.286 179.161 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 4.8 t80 -106.62 -5.4 18.7 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.428 -179.126 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 108.39 12.56 21.25 Favored Glycine 0 CA--C 1.519 0.287 0 C-N-CA 120.979 -0.629 . . . . 0.0 112.86 -179.956 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 113' ' ' GLN . . . . . 0.412 ' HB3' ' HD2' ' A' ' 114' ' ' PRO . 22.6 mt-30 -99.84 159.19 30.56 Favored Pre-proline 0 C--N 1.323 -0.563 0 N-CA-C 109.662 -0.496 . . . . 0.0 109.662 179.701 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 114' ' ' PRO . . . . . 0.412 ' HD2' ' HB3' ' A' ' 113' ' ' GLN . 19.3 Cg_endo -58.85 110.04 0.61 Allowed 'Trans proline' 0 C--N 1.346 0.44 0 C-N-CA 122.233 1.955 . . . . 0.0 110.863 178.645 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 115' ' ' LYS . . . . . 0.455 ' HG2' ' O ' ' A' ' 109' ' ' ASP . 30.5 mttt -69.6 170.9 9.83 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.553 -178.616 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 116' ' ' GLY . . . . . 0.415 ' HA2' HD11 ' A' ' 106' ' ' ILE . . . 101.46 4.71 52.7 Favored Glycine 0 N--CA 1.446 -0.646 0 C-N-CA 120.514 -0.851 . . . . 0.0 111.877 -179.841 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 34.1 m-85 -53.01 117.89 3.32 Favored 'General case' 0 C--O 1.232 0.167 0 C-N-CA 122.338 0.255 . . . . 0.0 110.492 179.671 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -149.18 171.54 16.28 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 121.0 0.429 . . . . 0.0 111.13 -179.314 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 17.2 p90 -154.96 132.58 11.31 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 115.501 -0.772 . . . . 0.0 109.645 178.411 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 8.5 m -108.06 142.83 19.71 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 N-CA-C 109.726 -0.472 . . . . 0.0 109.726 179.735 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 121' ' ' GLU . . . . . 0.424 ' HB3' ' HB3' ' A' ' 76' ' ' SER . 4.5 pt-20 -130.92 153.42 49.18 Favored 'General case' 0 C--O 1.238 0.5 0 CA-C-O 120.944 0.402 . . . . 0.0 111.235 179.987 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 122' ' ' PHE . . . . . 0.404 ' CZ ' ' HB ' ' A' ' 100' ' ' THR . 11.5 t80 -148.26 172.67 13.99 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.644 -0.707 . . . . 0.0 110.095 179.834 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 6.3 t -89.37 -41.86 14.09 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-O 121.028 0.442 . . . . 0.0 111.192 -179.742 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 38.7 mm-40 -69.96 128.92 38.02 Favored 'General case' 0 C--O 1.236 0.392 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.937 -179.83 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 2.7 mp -74.57 -33.95 33.78 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.177 -179.869 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -59.85 -37.28 78.81 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.435 179.633 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -63.56 -56.49 15.56 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.641 -0.709 . . . . 0.0 111.256 -179.789 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 11.0 p -65.77 -28.06 43.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.367 -179.367 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 43.8 tt0 -60.38 -43.93 96.12 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-O 121.006 0.431 . . . . 0.0 110.371 179.447 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 92.5 m-20 -72.48 -31.57 65.5 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.053 -0.522 . . . . 0.0 110.05 179.699 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -67.53 -42.86 82.07 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.51 -0.768 . . . . 0.0 111.636 -179.857 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 4.1 pp -74.15 -17.67 60.89 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.915 0.388 . . . . 0.0 110.914 179.976 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 6.2 tp -83.8 -56.39 3.73 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.673 179.939 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 54.1 mt -125.38 103.18 7.77 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.642 -0.254 . . . . 0.0 111.44 -179.113 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 2.4 m-20 -154.49 -53.19 0.1 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.885 0.374 . . . . 0.0 111.15 178.764 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 3.9 pt-20 -75.82 98.22 4.11 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.464 0.65 . . . . 0.0 111.08 -179.888 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 43.3 m -145.92 -57.54 0.31 Allowed 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.669 -0.696 . . . . 0.0 109.821 178.865 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 24.4 tt0 -163.17 130.05 3.44 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 109.436 -0.579 . . . . 0.0 109.436 178.954 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -148.46 122.31 9.34 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 108.603 -0.888 . . . . 0.0 108.603 179.677 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 140' ' ' HIS . . . . . 0.651 ' HB3' ' OD2' ' A' ' 83' ' ' ASP . 5.0 t60 64.43 3.16 1.77 Allowed 'General case' 0 N--CA 1.471 0.623 0 O-C-N 123.544 0.528 . . . . 0.0 111.723 179.005 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 109.65 -9.93 32.56 Favored Glycine 0 N--CA 1.446 -0.637 0 C-N-CA 121.123 -0.56 . . . . 0.0 112.127 -179.704 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 142' ' ' ARG . . . . . 0.706 ' HB2' ' OD2' ' A' ' 83' ' ' ASP . 1.0 OUTLIER -111.7 170.98 7.76 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.154 0.502 . . . . 0.0 110.375 179.876 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 7.4 pt20 -113.0 129.67 56.41 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 179.303 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -113.91 173.27 6.51 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-O 120.907 0.384 . . . . 0.0 110.474 -179.645 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 8.8 ttpt -113.23 118.02 33.5 Favored 'General case' 0 C--N 1.318 -0.775 0 N-CA-C 109.428 -0.582 . . . . 0.0 109.428 179.278 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 96.7 t -114.42 116.95 54.1 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.659 0 CA-C-O 120.756 0.312 . . . . 0.0 110.431 -179.909 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 25.7 m -127.12 146.38 50.41 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 109.393 -0.595 . . . . 0.0 109.393 179.674 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -56.85 130.6 46.46 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 120.978 0.418 . . . . 0.0 111.501 -179.234 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 149' ' ' LYS . . . . . 0.466 ' HE2' ' OG ' ' A' ' 76' ' ' SER . 18.0 ttpt -93.2 63.11 3.59 Favored 'General case' 0 N--CA 1.451 -0.378 0 N-CA-C 108.622 -0.881 . . . . 0.0 108.622 179.508 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 16.4 tpt180 -84.99 90.76 7.91 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 121.31 0.576 . . . . 0.0 110.25 -179.867 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 151' ' ' THR . . . . . 0.41 HG21 ' OD2' ' A' ' 73' ' ' ASP . 13.7 t -74.75 141.19 44.44 Favored 'General case' 0 N--CA 1.44 -0.927 0 N-CA-C 108.622 -0.881 . . . . 0.0 108.622 178.442 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 152' ' ' ASN . . . . . . . . . . . . . 64.3 t30 -172.04 166.34 6.19 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 120.64 0.257 . . . . 0.0 110.551 -178.953 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 23.5 pt -79.58 152.29 75.22 Favored Pre-proline 0 C--N 1.325 -0.469 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.041 179.087 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -76.02 55.95 4.67 Favored 'Trans proline' 0 C--N 1.345 0.359 0 C-N-CA 122.55 2.167 . . . . 0.0 112.478 179.917 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.166 0 CA-C-O 118.491 -1.172 . . . . 0.0 111.927 -179.71 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 5.2 mpp? . . . . . 0 N--CA 1.481 1.085 0 CA-C-O 120.792 0.33 . . . . 0.0 110.141 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 155.67 128.52 1.13 Allowed Glycine 0 N--CA 1.448 -0.552 0 C-N-CA 120.933 -0.651 . . . . 0.0 112.292 -179.608 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 31.4 m -134.95 140.29 45.59 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 110.291 -0.263 . . . . 0.0 110.291 -179.971 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 8.1 m -107.15 154.4 21.24 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 120.514 0.197 . . . . 0.0 110.532 -179.804 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 7.7 p80 -165.09 138.81 4.78 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.705 -0.225 . . . . 0.0 110.657 -179.629 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 41.9 t-80 -161.58 138.12 8.28 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.444 179.619 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 1.9 m-70 -129.4 164.66 23.16 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.172 179.374 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -145.56 142.08 28.81 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.473 -0.33 . . . . 0.0 110.684 179.81 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 12.3 p-80 -143.19 162.22 36.19 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.724 0.297 . . . . 0.0 110.929 179.721 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 46.2 t-80 -155.33 148.73 25.0 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 109.73 -0.471 . . . . 0.0 109.73 179.826 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 3.1 m -88.1 174.59 8.17 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 120.687 0.279 . . . . 0.0 111.01 179.863 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 45.3 m -120.85 -162.31 0.95 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.951 179.801 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -146.62 173.87 26.69 Favored Glycine 0 N--CA 1.449 -0.45 0 N-CA-C 111.537 -0.625 . . . . 0.0 111.537 -179.771 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 23.3 tp -60.17 137.29 58.14 Favored 'General case' 0 C--O 1.238 0.45 0 CA-C-O 120.953 0.406 . . . . 0.0 111.376 -179.591 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.447 ' HB ' ' CE ' ' A' ' 33' ' ' LYS . 10.2 m -138.86 148.48 58.25 Favored Pre-proline 0 C--N 1.324 -0.505 0 CA-C-N 115.806 -0.634 . . . . 0.0 111.038 -179.744 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 70.6 Cg_endo -76.94 131.31 12.0 Favored 'Trans proline' 0 C--N 1.346 0.438 0 C-N-CA 122.61 2.206 . . . . 0.0 110.954 178.183 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 17' ' ' ARG . . . . . 0.514 ' HA ' ' OE2' ' A' ' 68' ' ' GLU . 2.0 mpt_? -86.11 150.76 24.2 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.094 0.473 . . . . 0.0 111.933 -178.411 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 18' ' ' GLY . . . . . 0.402 ' O ' ' HB ' ' A' ' 123' ' ' VAL . . . -139.99 -149.88 5.4 Favored Glycine 0 CA--C 1.522 0.503 0 CA-C-N 115.549 -0.75 . . . . 0.0 112.129 179.198 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 19' ' ' SER . . . . . 0.428 ' N ' HG12 ' A' ' 35' ' ' ILE . 0.0 OUTLIER -150.28 133.7 16.47 Favored 'General case' 0 CA--C 1.532 0.285 0 CA-C-N 116.847 0.324 . . . . 0.0 111.299 179.899 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 20' ' ' HIS . . . . . 0.456 ' CE1' ' HA ' ' A' ' 37' ' ' GLU . 0.2 OUTLIER -174.17 167.49 4.13 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 122.353 0.261 . . . . 0.0 110.326 179.311 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 92.8 mtp -120.7 145.78 47.12 Favored 'General case' 0 C--O 1.235 0.321 0 N-CA-C 108.751 -0.833 . . . . 0.0 108.751 178.217 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -169.73 -139.94 2.85 Favored Glycine 0 C--N 1.331 0.302 0 C-N-CA 119.939 -1.124 . . . . 0.0 113.893 -179.287 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 46.5 m -127.98 -155.8 0.72 Allowed 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 122.297 0.239 . . . . 0.0 110.749 -178.925 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 12.0 t70 -124.5 142.31 51.43 Favored 'General case' 0 C--N 1.328 -0.345 0 O-C-N 122.068 -0.395 . . . . 0.0 110.872 -179.9 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 42.9 tp -171.42 107.63 0.25 Allowed 'General case' 0 CA--C 1.532 0.259 0 CA-C-O 120.952 0.406 . . . . 0.0 110.894 -179.621 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 4.3 tt0 -94.25 131.42 39.86 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.352 179.5 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 4.1 t70 -146.12 -145.05 0.16 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.625 -0.261 . . . . 0.0 110.443 -179.944 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -70.79 161.98 29.95 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.992 0.425 . . . . 0.0 111.202 -179.874 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 44.5 mttm -99.21 108.58 21.19 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.09 -178.917 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 10.4 mptt -128.15 151.96 48.6 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.539 179.517 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -102.72 -170.19 1.77 Allowed 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.879 -0.601 . . . . 0.0 109.755 179.096 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER 63.56 68.62 0.59 Allowed 'General case' 0 N--CA 1.465 0.302 0 CA-C-O 121.255 0.55 . . . . 0.0 111.081 -179.677 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.454 ' HZ3' ' CD ' ' A' ' 68' ' ' GLU . 0.5 OUTLIER -141.74 163.66 32.3 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.734 -0.666 . . . . 0.0 109.554 179.84 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -110.88 -81.22 0.58 Allowed 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 109.879 -0.415 . . . . 0.0 109.879 179.502 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.614 HD11 HG21 ' A' ' 123' ' ' VAL . 8.6 tp -174.59 47.3 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-O 122.398 1.094 . . . . 0.0 110.643 -179.591 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 1.3 pm0 -87.14 -173.01 4.22 Favored 'General case' 0 C--N 1.314 -0.944 0 CA-C-N 115.472 -0.785 . . . . 0.0 110.607 179.964 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 37' ' ' GLU . . . . . 0.456 ' HA ' ' CE1' ' A' ' 20' ' ' HIS . 26.9 mt-10 -77.62 -150.89 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.662 -0.244 . . . . 0.0 111.184 -179.508 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 38' ' ' GLU . . . . . 0.69 ' HB3' ' OG1' ' A' ' 65' ' ' THR . 1.6 pm0 -139.82 126.7 20.77 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.72 0.295 . . . . 0.0 111.096 -179.728 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -168.21 100.76 0.44 Allowed 'General case' 0 C--O 1.232 0.155 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.82 -179.844 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 177.29 -179.72 47.95 Favored Glycine 0 N--CA 1.448 -0.519 0 N-CA-C 111.559 -0.616 . . . . 0.0 111.559 -179.787 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -149.15 170.91 17.35 Favored 'General case' 0 C--O 1.237 0.444 0 CA-C-O 120.891 0.377 . . . . 0.0 111.547 -179.596 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 16.2 tp -72.11 80.42 0.96 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.422 -0.808 . . . . 0.0 111.015 179.862 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 43' ' ' ARG . . . . . 0.402 ' C ' ' H ' ' A' ' 45' ' ' MET . 0.8 OUTLIER -126.6 148.93 49.72 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 115.765 -0.652 . . . . 0.0 109.391 179.449 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -75.98 23.87 0.13 Allowed 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.088 0.471 . . . . 0.0 111.847 -179.58 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 45' ' ' MET . . . . . 0.402 ' H ' ' C ' ' A' ' 43' ' ' ARG . 16.6 ptt? -95.8 5.93 50.13 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.053 0.454 . . . . 0.0 110.127 179.754 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 40.5 mt-30 -67.22 -8.5 32.05 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.409 -179.264 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -82.7 -11.74 58.1 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.483 0.658 . . . . 0.0 109.994 178.722 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 48' ' ' LYS . . . . . 0.486 ' O ' ' HG2' ' A' ' 52' ' ' GLU . 13.5 ttpp -78.51 5.82 9.97 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.257 -0.883 . . . . 0.0 110.398 -179.806 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 12.6 p -58.04 -24.65 24.25 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.123 -179.866 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 32.0 mt-10 -65.13 -27.8 68.99 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 121.154 0.502 . . . . 0.0 110.247 179.042 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 12.8 mtmt -98.59 -33.7 10.87 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.238 178.711 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 52' ' ' GLU . . . . . 0.486 ' HG2' ' O ' ' A' ' 48' ' ' LYS . 38.1 mm-40 -83.31 12.14 5.76 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.807 -0.633 . . . . 0.0 111.651 -179.731 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 10.5 ptp -62.03 -30.64 71.1 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-O 120.717 0.294 . . . . 0.0 110.651 179.679 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -96.91 3.96 62.81 Favored Glycine 0 N--CA 1.449 -0.434 0 N-CA-C 111.05 -0.82 . . . . 0.0 111.05 178.474 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -129.66 29.49 5.02 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.406 0.622 . . . . 0.0 110.389 -179.722 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 17.3 m -65.88 -19.73 26.15 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.483 0 CA-C-N 115.817 -0.629 . . . . 0.0 111.355 -179.548 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 45.6 mt-30 -79.55 -2.18 41.18 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.15 0.5 . . . . 0.0 111.034 179.765 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 15.8 t70 -129.84 -41.9 1.29 Allowed 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.991 179.741 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 24.0 m -90.23 -70.18 0.68 Allowed 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.91 -179.307 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -81.43 30.69 0.35 Allowed 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.3 0.571 . . . . 0.0 110.988 -179.609 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 1.8 t -77.02 -43.54 34.28 Favored 'General case' 0 N--CA 1.449 -0.516 0 CA-C-N 115.512 -0.767 . . . . 0.0 110.834 -178.898 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -56.03 -22.57 27.96 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 112.604 0.594 . . . . 0.0 112.604 -178.794 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 19.5 m -61.73 -22.56 65.49 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.381 -179.708 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 64' ' ' ALA . . . . . 0.476 ' O ' ' HB3' ' A' ' 68' ' ' GLU . . . -73.73 -34.69 64.88 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.101 0.477 . . . . 0.0 110.223 178.958 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 65' ' ' THR . . . . . 0.69 ' OG1' ' HB3' ' A' ' 38' ' ' GLU . 0.2 OUTLIER -77.59 3.22 14.26 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-O 121.18 0.514 . . . . 0.0 111.21 -179.795 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 16.5 tp60 -121.81 -45.86 2.26 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.794 178.928 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -87.45 -48.9 7.58 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.513 -0.312 . . . . 0.0 111.343 -179.835 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 68' ' ' GLU . . . . . 0.514 ' OE2' ' HA ' ' A' ' 17' ' ' ARG . 3.0 tp10 -72.54 -31.37 65.25 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 121.114 0.483 . . . . 0.0 109.92 179.795 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 69' ' ' LYS . . . . . 0.41 ' HE3' ' OE2' ' A' ' 121' ' ' GLU . 0.0 OUTLIER -55.11 -29.98 58.77 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.814 -0.63 . . . . 0.0 111.581 179.726 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 95.4 mt-10 -60.64 -21.48 62.81 Favored 'General case' 0 C--N 1.332 -0.182 0 O-C-N 123.525 0.516 . . . . 0.0 110.787 179.656 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 71' ' ' GLU . . . . . 0.553 ' O ' ' HD3' ' A' ' 75' ' ' ARG . 36.0 tp10 -98.68 -43.49 6.79 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 109.435 -0.58 . . . . 0.0 109.435 177.432 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.433 HG23 ' O ' ' A' ' 68' ' ' GLU . 21.8 t -60.24 -42.22 89.66 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.244 0 CA-C-N 115.699 -0.682 . . . . 0.0 112.655 -178.613 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 23.4 p-10 -66.93 -18.37 65.35 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-O 121.045 0.45 . . . . 0.0 111.041 -179.928 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 74' ' ' SER . . . . . 0.43 ' C ' ' HD2' ' A' ' 75' ' ' ARG . 28.8 t -101.64 -3.86 27.58 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 121.334 0.588 . . . . 0.0 110.125 179.018 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 75' ' ' ARG . . . . . 0.553 ' HD3' ' O ' ' A' ' 71' ' ' GLU . 2.6 mpt_? -115.93 49.06 1.14 Allowed 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.694 0.759 . . . . 0.0 109.631 -179.796 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 76' ' ' SER . . . . . 0.479 ' OG ' ' HE2' ' A' ' 149' ' ' LYS . 0.4 OUTLIER -130.38 175.15 9.19 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 115.057 -0.974 . . . . 0.0 110.153 179.958 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -133.96 137.1 52.85 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 N-CA-C 109.977 -0.379 . . . . 0.0 109.977 178.179 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 83.9 t80 -94.82 126.52 40.2 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 109.644 -0.502 . . . . 0.0 109.644 179.877 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.426 HG21 ' HE2' ' A' ' 95' ' ' PHE . 4.0 t -105.95 115.36 47.49 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.138 -179.013 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -118.08 169.32 13.3 Favored Glycine 0 N--CA 1.447 -0.606 0 N-CA-C 110.863 -0.895 . . . . 0.0 110.863 179.255 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 1.6 m-20 59.08 37.8 24.13 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-O 121.177 0.513 . . . . 0.0 110.936 -179.566 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.422 HG22 HG12 ' A' ' 79' ' ' VAL . 2.5 t -80.84 162.25 3.65 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.884 -179.319 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 83' ' ' ASP . . . . . 0.537 ' OD2' ' HD2' ' A' ' 142' ' ' ARG . 9.7 t0 -66.23 135.43 54.46 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 109.607 -0.516 . . . . 0.0 109.607 179.225 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 36.5 p90 -63.96 -14.25 52.44 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.075 -0.511 . . . . 0.0 112.005 -178.616 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -114.19 14.85 18.24 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.72 0.295 . . . . 0.0 111.456 179.753 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 86' ' ' CYS . . . . . 0.49 ' SG ' ' HB2' ' A' ' 140' ' ' HIS . 0.8 OUTLIER -78.1 148.91 33.99 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.103 0.478 . . . . 0.0 111.281 -179.795 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 87' ' ' THR . . . . . 0.501 ' O ' ' HG2' ' A' ' 90' ' ' GLU . 0.2 OUTLIER -110.67 149.71 40.7 Favored Pre-proline 0 C--N 1.325 -0.462 0 CA-C-N 115.743 -0.662 . . . . 0.0 109.921 179.114 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 88' ' ' PRO . . . . . 0.477 ' HD3' HD13 ' A' ' 106' ' ' ILE . 11.5 Cg_endo -55.32 -38.33 93.87 Favored 'Trans proline' 0 C--N 1.347 0.458 0 C-N-CA 122.83 2.353 . . . . 0.0 112.842 -179.039 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 89' ' ' GLU . . . . . 0.453 ' O ' ' HG3' ' A' ' 92' ' ' GLN . 3.2 mp0 -62.94 -52.14 64.2 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.485 -0.325 . . . . 0.0 111.802 -179.199 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 90' ' ' GLU . . . . . 0.501 ' HG2' ' O ' ' A' ' 87' ' ' THR . 6.0 pt-20 -61.04 -20.31 62.4 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-O 120.862 0.363 . . . . 0.0 111.519 -178.806 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 55.5 t -84.61 -47.21 17.45 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.674 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.739 -179.152 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 92' ' ' GLN . . . . . 0.453 ' HG3' ' O ' ' A' ' 89' ' ' GLU . 0.8 OUTLIER -72.17 -33.2 67.51 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.319 -0.401 . . . . 0.0 111.757 -178.423 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -78.04 -27.42 48.75 Favored 'General case' 0 N--CA 1.467 0.384 0 C-N-CA 120.237 -0.585 . . . . 0.0 111.53 -178.919 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 94' ' ' HIS . . . . . 0.492 ' HB2' ' O ' ' A' ' 90' ' ' GLU . 0.2 OUTLIER -75.12 -42.33 56.64 Favored 'General case' 0 C--N 1.325 -0.464 0 C-N-CA 120.819 -0.352 . . . . 0.0 110.721 -179.856 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 95' ' ' PHE . . . . . 0.426 ' HE2' HG21 ' A' ' 79' ' ' VAL . 20.3 m-30 -76.47 -18.9 58.53 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.464 179.931 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 96' ' ' GLN . . . . . 0.649 ' HA ' ' O ' ' A' ' 99' ' ' GLY . 0.9 OUTLIER -62.4 -22.09 65.88 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.397 179.342 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 21.5 t -62.91 -28.57 70.15 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.364 179.475 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 5.5 m -97.91 -40.7 8.36 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.23 179.837 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 99' ' ' GLY . . . . . 0.649 ' O ' ' HA ' ' A' ' 96' ' ' GLN . . . -151.28 141.86 8.99 Favored Glycine 0 N--CA 1.449 -0.484 0 N-CA-C 111.424 -0.671 . . . . 0.0 111.424 179.69 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 100' ' ' THR . . . . . 0.419 ' HB ' ' CE1' ' A' ' 122' ' ' PHE . 0.2 OUTLIER -62.22 154.5 27.32 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.104 0.478 . . . . 0.0 112.09 -179.471 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 2.1 p -118.03 131.19 71.51 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-N 115.747 -0.66 . . . . 0.0 110.91 -179.685 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 26.1 t30 -97.91 -45.0 6.46 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.152 0.501 . . . . 0.0 109.695 179.123 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -142.75 157.32 44.76 Favored 'General case' 0 C--O 1.235 0.318 0 CA-C-N 115.676 -0.693 . . . . 0.0 109.991 179.196 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 7.2 p -155.29 137.59 6.43 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 CA-C-N 115.82 -0.627 . . . . 0.0 109.974 179.59 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 105' ' ' THR . . . . . 0.479 ' HB ' ' CE1' ' A' ' 119' ' ' TYR . 3.5 m -131.59 128.29 38.89 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 109.732 -0.47 . . . . 0.0 109.732 179.317 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 106' ' ' ILE . . . . . 0.56 HD11 ' HA2' ' A' ' 116' ' ' GLY . 20.3 tt -113.27 137.15 47.31 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-O 121.3 0.571 . . . . 0.0 111.205 -179.804 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 35.0 tp -118.91 124.5 47.24 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.777 -0.647 . . . . 0.0 109.896 179.646 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -90.79 113.62 25.8 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 110.144 -0.317 . . . . 0.0 110.144 179.445 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 109' ' ' ASP . . . . . 0.419 ' O ' ' HG2' ' A' ' 115' ' ' LYS . 13.1 t70 -72.76 139.73 47.31 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.152 0.501 . . . . 0.0 111.253 -179.469 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -129.61 33.93 4.4 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 115.638 -0.71 . . . . 0.0 109.434 178.751 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 2.6 t80 -118.21 -4.31 10.97 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.618 -179.69 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 110.19 6.98 27.28 Favored Glycine 0 CA--C 1.52 0.353 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.833 179.936 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 113' ' ' GLN . . . . . 0.431 ' HB3' ' HD2' ' A' ' 114' ' ' PRO . 19.0 mt-30 -96.8 161.05 27.82 Favored Pre-proline 0 C--N 1.324 -0.513 0 N-CA-C 109.464 -0.569 . . . . 0.0 109.464 179.951 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 114' ' ' PRO . . . . . 0.431 ' HD2' ' HB3' ' A' ' 113' ' ' GLN . 19.5 Cg_endo -59.75 115.15 2.41 Favored 'Trans proline' 0 C--N 1.347 0.454 0 C-N-CA 122.039 1.826 . . . . 0.0 111.13 178.582 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 115' ' ' LYS . . . . . 0.419 ' HG2' ' O ' ' A' ' 109' ' ' ASP . 53.1 mttt -72.72 172.19 11.18 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 120.771 0.319 . . . . 0.0 110.246 -179.014 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 116' ' ' GLY . . . . . 0.56 ' HA2' HD11 ' A' ' 106' ' ' ILE . . . 101.4 3.89 53.29 Favored Glycine 0 N--CA 1.444 -0.781 0 C-N-CA 120.175 -1.012 . . . . 0.0 112.227 179.712 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 26.8 m-85 -52.73 112.66 0.88 Allowed 'General case' 0 N--CA 1.463 0.196 0 N-CA-C 110.094 -0.336 . . . . 0.0 110.094 179.49 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -141.37 174.25 10.72 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 121.191 0.52 . . . . 0.0 111.523 -178.61 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 119' ' ' TYR . . . . . 0.479 ' CE1' ' HB ' ' A' ' 105' ' ' THR . 48.5 p90 -156.48 129.59 7.98 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.34 -0.845 . . . . 0.0 109.81 179.202 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 13.9 m -105.92 142.94 17.78 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.686 0 N-CA-C 109.254 -0.646 . . . . 0.0 109.254 178.976 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 121' ' ' GLU . . . . . 0.41 ' OE2' ' HE3' ' A' ' 69' ' ' LYS . 7.1 pt-20 -129.92 150.23 51.3 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 120.765 0.317 . . . . 0.0 111.745 -179.68 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 122' ' ' PHE . . . . . 0.419 ' CE1' ' HB ' ' A' ' 100' ' ' THR . 11.5 t80 -145.89 172.44 13.34 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.706 -0.679 . . . . 0.0 109.308 178.796 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 123' ' ' VAL . . . . . 0.614 HG21 HD11 ' A' ' 35' ' ' ILE . 2.9 t -92.64 -57.26 4.45 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 CA-C-O 120.782 0.325 . . . . 0.0 111.281 -178.979 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 93.0 mt-10 -62.65 118.07 7.14 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.451 -179.813 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 2.1 mp -57.29 -32.31 40.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 115.566 -0.743 . . . . 0.0 110.964 -179.435 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 17.6 t70 -53.35 -45.37 69.13 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.374 179.42 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -61.93 -54.82 36.61 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.758 -0.655 . . . . 0.0 111.691 -179.361 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 12.1 p -65.94 -29.65 47.52 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 C-N-CA 120.894 -0.322 . . . . 0.0 111.256 -179.249 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 129' ' ' GLN . . . . . 0.418 ' O ' ' HG ' ' A' ' 132' ' ' LEU . 9.6 tt0 -61.25 -48.59 80.75 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.178 0.513 . . . . 0.0 110.116 179.123 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 87.2 m-20 -69.29 -29.96 67.94 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.721 -0.672 . . . . 0.0 109.717 179.713 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 131' ' ' ALA . . . . . 0.451 ' O ' ' HB2' ' A' ' 135' ' ' ASN . . . -66.86 -52.18 46.63 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.618 -0.719 . . . . 0.0 111.089 179.66 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 132' ' ' LEU . . . . . 0.418 ' HG ' ' O ' ' A' ' 129' ' ' GLN . 4.0 pp -64.94 -23.92 67.37 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.79 0.328 . . . . 0.0 110.636 179.978 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 1.6 tp -72.0 -55.61 7.12 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.204 0.526 . . . . 0.0 110.058 179.597 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 49.4 mt -120.13 101.8 8.08 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.648 -0.705 . . . . 0.0 109.558 179.568 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 135' ' ' ASN . . . . . 0.451 ' HB2' ' O ' ' A' ' 131' ' ' ALA . 0.5 OUTLIER -146.68 -71.26 0.24 Allowed 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 120.87 0.367 . . . . 0.0 111.155 -178.976 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 7.5 pt-20 -69.91 95.12 0.9 Allowed 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.649 0.738 . . . . 0.0 111.849 -179.034 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 8.9 m -137.17 -59.53 0.69 Allowed 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.374 -0.83 . . . . 0.0 109.536 178.92 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 7.4 tt0 -165.4 130.84 2.56 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 109.525 -0.546 . . . . 0.0 109.525 179.222 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -146.0 118.04 8.28 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 109.672 -0.492 . . . . 0.0 109.672 -179.939 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 140' ' ' HIS . . . . . 0.49 ' HB2' ' SG ' ' A' ' 86' ' ' CYS . 3.2 t60 68.77 1.23 2.99 Favored 'General case' 0 N--CA 1.469 0.509 0 O-C-N 123.508 0.505 . . . . 0.0 111.393 178.971 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 113.52 -9.38 24.11 Favored Glycine 0 N--CA 1.447 -0.622 0 C-N-CA 121.038 -0.601 . . . . 0.0 111.743 -179.129 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 142' ' ' ARG . . . . . 0.537 ' HD2' ' OD2' ' A' ' 83' ' ' ASP . 0.0 OUTLIER -111.29 170.88 7.82 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 109.874 -0.417 . . . . 0.0 109.874 179.785 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 13.2 pt20 -115.75 121.45 42.5 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 109.217 -0.66 . . . . 0.0 109.217 178.705 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -99.08 175.65 5.83 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.066 -178.748 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 3.8 tttt -117.1 122.69 44.84 Favored 'General case' 0 C--N 1.317 -0.805 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 179.16 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 146' ' ' VAL . . . . . 0.415 HG21 ' OD1' ' A' ' 135' ' ' ASN . 96.2 t -117.49 137.51 51.17 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.652 0 CA-C-O 121.242 0.544 . . . . 0.0 111.409 -178.971 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 23.6 t -139.13 144.18 38.54 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.845 -0.616 . . . . 0.0 109.516 179.314 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -63.14 128.89 37.93 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 120.714 0.292 . . . . 0.0 110.277 179.47 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 149' ' ' LYS . . . . . 0.479 ' HE2' ' OG ' ' A' ' 76' ' ' SER . 28.3 ttpt -89.15 76.63 7.68 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 121.3 0.571 . . . . 0.0 109.76 -179.643 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 23.9 tpt180 -95.01 95.42 8.59 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.654 -0.703 . . . . 0.0 109.802 179.539 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 7.0 t -84.24 137.69 33.34 Favored 'General case' 0 N--CA 1.445 -0.723 0 CA-C-N 115.375 -0.83 . . . . 0.0 109.992 179.467 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 152' ' ' ASN . . . . . . . . . . . . . 58.6 t30 -171.2 157.78 5.21 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 109.449 -0.575 . . . . 0.0 109.449 -179.721 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 25.1 pt -68.94 150.65 97.55 Favored Pre-proline 0 C--N 1.325 -0.493 0 N-CA-C 109.955 -0.387 . . . . 0.0 109.955 179.266 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_endo -66.0 83.97 0.25 Allowed 'Trans proline' 0 C--O 1.233 0.268 0 C-N-CA 122.479 2.12 . . . . 0.0 112.182 179.786 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.084 0 CA-C-O 118.181 -1.344 . . . . 0.0 111.082 179.696 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.6 ptm . . . . . 0 N--CA 1.482 1.132 0 N-CA-C 110.158 -0.312 . . . . 0.0 110.158 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 91.52 66.88 1.15 Allowed Glycine 0 N--CA 1.448 -0.534 0 C-N-CA 120.987 -0.625 . . . . 0.0 112.018 -179.887 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 25.0 m -112.88 88.38 2.81 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 121.013 0.435 . . . . 0.0 111.875 -179.39 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 10.6 t -91.9 156.1 17.71 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 109.941 -0.392 . . . . 0.0 109.941 179.09 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 14.1 p-80 -169.77 142.82 2.53 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.493 -0.321 . . . . 0.0 110.804 -179.46 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 26.3 p80 -167.96 145.26 4.25 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.197 -0.456 . . . . 0.0 109.954 179.217 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 16.3 p-80 -146.4 150.68 36.12 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.557 -0.292 . . . . 0.0 110.669 -179.859 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -142.35 -175.5 4.47 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.222 -179.943 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 8.6 p80 -163.4 151.19 13.15 Favored 'General case' 0 C--N 1.332 -0.196 0 N-CA-C 109.886 -0.413 . . . . 0.0 109.886 -179.498 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 77.4 t60 -160.57 111.51 1.85 Allowed 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 120.727 0.299 . . . . 0.0 110.812 179.35 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -80.19 168.51 19.0 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.411 179.561 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 14.4 m -154.58 119.89 5.05 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.757 0.313 . . . . 0.0 110.879 -179.782 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -86.26 123.54 6.5 Favored Glycine 0 N--CA 1.448 -0.511 0 C-N-CA 121.011 -0.614 . . . . 0.0 111.736 179.352 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 8.9 mt -92.87 131.15 38.15 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.15 0.5 . . . . 0.0 111.815 -179.433 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 2.5 p -149.14 92.78 4.25 Favored Pre-proline 0 C--N 1.322 -0.616 0 CA-C-N 115.543 -0.753 . . . . 0.0 109.919 179.031 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 16.2 Cg_exo -67.93 133.34 28.88 Favored 'Trans proline' 0 N--CA 1.464 -0.214 0 C-N-CA 122.81 2.34 . . . . 0.0 112.033 -179.6 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -118.26 120.13 36.74 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 116.322 -0.399 . . . . 0.0 109.975 179.298 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -134.61 -177.14 14.74 Favored Glycine 0 N--CA 1.447 -0.608 0 C-N-CA 120.839 -0.696 . . . . 0.0 111.766 -179.993 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 61.2 m -154.93 129.08 8.89 Favored 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 110.403 -0.221 . . . . 0.0 110.403 179.94 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 28.6 p-80 -74.0 148.68 41.82 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 109.819 -0.437 . . . . 0.0 109.819 179.461 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -87.77 148.27 24.79 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 120.813 0.339 . . . . 0.0 110.144 -179.869 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -97.94 -171.74 32.76 Favored Glycine 0 N--CA 1.446 -0.68 0 CA-C-N 115.828 -0.624 . . . . 0.0 111.911 179.817 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -139.24 150.03 45.02 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 120.615 0.245 . . . . 0.0 110.396 -179.988 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 2.4 p-10 -76.37 137.67 39.93 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.307 -0.406 . . . . 0.0 109.919 179.174 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 12.8 tp -163.41 165.34 24.03 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.191 -179.634 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 15.4 mp0 -69.23 137.82 53.47 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.901 -0.59 . . . . 0.0 109.971 179.915 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 21.6 t0 -116.34 129.05 56.06 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.576 -179.876 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 15.9 tpt -100.97 127.62 47.37 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.205 -179.703 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 1.3 ptpt -147.65 148.21 30.82 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 120.636 0.255 . . . . 0.0 110.496 179.926 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 57.1 mttp -92.24 87.92 6.27 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.272 179.875 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -138.12 -167.77 2.23 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.114 -179.987 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 83.4 mt 69.69 -170.95 0.17 Allowed 'General case' 0 C--O 1.233 0.237 0 O-C-N 123.794 0.684 . . . . 0.0 111.162 179.5 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 48.6 mtpt -122.61 146.99 46.94 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.692 -179.313 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 29.2 mt-10 -79.88 135.89 36.55 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.825 -179.365 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.457 HG23 ' OD1' ' A' ' 58' ' ' ASP . 80.1 mt -123.71 117.47 51.26 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.386 -179.698 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 16.6 tt0 -178.82 126.0 0.1 Allowed 'General case' 0 C--N 1.331 -0.211 0 O-C-N 123.442 0.464 . . . . 0.0 110.469 -179.602 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -114.59 130.66 56.8 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.038 0.447 . . . . 0.0 110.467 179.613 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 49.9 mt-10 -116.01 152.64 33.15 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.006 179.368 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -93.81 160.37 14.78 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 120.921 0.391 . . . . 0.0 111.198 -179.455 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -68.66 120.98 11.8 Favored Glycine 0 N--CA 1.446 -0.693 0 CA-C-N 115.745 -0.661 . . . . 0.0 112.343 179.982 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -144.47 172.85 12.38 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 110.066 -0.346 . . . . 0.0 110.066 179.754 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 27.4 tp -69.26 90.93 0.51 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.101 0.477 . . . . 0.0 109.896 179.252 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 53.5 ttm-85 -153.69 -6.34 0.17 Allowed 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.861 -0.609 . . . . 0.0 111.177 -178.88 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 17.1 mt-10 65.2 19.71 11.78 Favored 'General case' 0 N--CA 1.468 0.471 0 CA-C-O 121.149 0.499 . . . . 0.0 110.662 -178.767 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 26.5 ptm -83.61 1.35 42.65 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.848 -0.615 . . . . 0.0 110.382 -179.88 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 30.6 mt-30 -72.39 -20.9 61.36 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.147 0.498 . . . . 0.0 110.116 179.72 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -76.5 -8.54 57.4 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 121.555 0.693 . . . . 0.0 109.965 178.788 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 21.6 ttmt -79.26 1.44 24.85 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.321 -0.854 . . . . 0.0 110.499 -179.91 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 7.4 p -58.28 -23.64 22.55 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.251 0 CA-C-N 115.781 -0.645 . . . . 0.0 111.102 179.632 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -63.42 -26.37 68.7 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.512 179.526 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 24.5 mtmt -101.97 -41.52 6.43 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.872 179.444 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 62.6 mm-40 -62.36 -16.65 55.75 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.969 -0.559 . . . . 0.0 111.522 -179.572 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 10.0 ptp -63.32 -25.41 68.29 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.978 0.418 . . . . 0.0 110.042 178.794 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -98.17 -5.08 57.35 Favored Glycine 0 N--CA 1.448 -0.542 0 N-CA-C 110.943 -0.863 . . . . 0.0 110.943 179.0 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -109.6 13.35 23.92 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.099 0.476 . . . . 0.0 110.154 -179.779 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 28.2 m -61.64 -16.81 15.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.769 179.767 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 20.5 mm-40 -77.8 -9.03 58.82 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.997 0.427 . . . . 0.0 110.588 179.884 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.457 ' OD1' HG23 ' A' ' 35' ' ' ILE . 38.4 t70 -127.5 -58.87 1.24 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.176 179.22 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 4.8 m -65.69 -62.98 1.2 Allowed 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.8 0.809 . . . . 0.0 111.574 -179.606 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -85.15 19.42 2.22 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-N 114.95 -1.023 . . . . 0.0 111.774 -178.344 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -79.79 -33.43 40.51 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 121.028 0.442 . . . . 0.0 110.824 -179.136 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -65.33 -22.62 66.84 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 121.008 0.432 . . . . 0.0 111.663 -179.957 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -64.3 -26.82 68.66 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.113 0.482 . . . . 0.0 110.556 179.655 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -70.58 -30.13 66.75 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.832 179.582 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -76.47 -1.62 28.05 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.09 0.471 . . . . 0.0 110.931 179.802 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 7.0 tp60 -118.05 -51.27 2.45 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.64 179.507 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -83.08 -61.65 1.8 Allowed 'General case' 0 C--N 1.331 -0.201 0 N-CA-C 111.871 0.323 . . . . 0.0 111.871 -179.092 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -60.88 -29.7 69.7 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-O 120.976 0.417 . . . . 0.0 110.671 -179.384 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 51.5 tptt -56.11 -31.35 63.19 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.83 -0.623 . . . . 0.0 111.206 179.582 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 18.7 mt-10 -63.3 -21.15 66.07 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-O 121.18 0.514 . . . . 0.0 111.074 -179.797 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 71' ' ' GLU . . . . . 0.426 ' O ' ' HD2' ' A' ' 75' ' ' ARG . 13.5 tp10 -94.65 -42.96 8.51 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 115.675 -0.693 . . . . 0.0 109.172 177.98 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.539 HG12 ' HB2' ' A' ' 121' ' ' GLU . 47.9 t -62.34 -43.29 97.93 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-N 115.181 -0.918 . . . . 0.0 112.552 -178.924 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 17.2 p-10 -71.55 -19.68 62.13 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-O 121.025 0.441 . . . . 0.0 111.613 -178.958 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 74' ' ' SER . . . . . 0.582 ' OG ' ' HD3' ' A' ' 150' ' ' ARG . 44.4 t -96.65 -7.33 34.46 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 109.604 -0.517 . . . . 0.0 109.604 178.796 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 75' ' ' ARG . . . . . 0.426 ' HD2' ' O ' ' A' ' 71' ' ' GLU . 0.0 OUTLIER -114.47 40.94 2.42 Favored 'General case' 0 N--CA 1.452 -0.361 0 CA-C-N 115.505 -0.77 . . . . 0.0 110.185 -179.367 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 76' ' ' SER . . . . . 0.451 ' OG ' ' HE2' ' A' ' 149' ' ' LYS . 0.3 OUTLIER -120.11 174.6 6.39 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.708 179.509 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 6.5 pt -132.3 139.64 49.62 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.262 178.341 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 78' ' ' TYR . . . . . 0.405 ' O ' ' HA ' ' A' ' 146' ' ' VAL . 16.7 t80 -92.58 119.84 32.43 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.615 -0.72 . . . . 0.0 109.761 179.895 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 7.2 t -104.79 109.36 27.34 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-N 116.53 -0.304 . . . . 0.0 110.184 179.86 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -117.82 166.94 12.73 Favored Glycine 0 N--CA 1.448 -0.523 0 C-N-CA 120.815 -0.707 . . . . 0.0 112.278 -179.281 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 3.0 m120 57.01 44.13 23.32 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-O 121.314 0.578 . . . . 0.0 110.853 -179.818 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.429 HG12 ' H ' ' A' ' 83' ' ' ASP . 2.4 t -82.68 167.91 1.9 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 CA-C-N 115.236 -0.893 . . . . 0.0 110.368 -179.361 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 83' ' ' ASP . . . . . 0.509 ' HB3' ' SG ' ' A' ' 86' ' ' CYS . 24.7 t70 -68.71 140.97 55.41 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.855 0.36 . . . . 0.0 110.337 179.625 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 28.3 p90 -65.49 -12.66 54.69 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.831 -0.622 . . . . 0.0 112.521 -178.694 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -117.85 10.79 13.33 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.617 0.246 . . . . 0.0 111.492 -179.981 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 86' ' ' CYS . . . . . 0.509 ' SG ' ' HB3' ' A' ' 83' ' ' ASP . 0.9 OUTLIER -73.9 144.52 45.33 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.044 0.449 . . . . 0.0 111.001 -179.995 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 87' ' ' THR . . . . . 0.539 ' O ' ' HG2' ' A' ' 90' ' ' GLU . 5.6 p -108.24 157.54 36.07 Favored Pre-proline 0 C--N 1.327 -0.377 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.233 179.379 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 20.8 Cg_endo -60.53 -39.84 61.79 Favored 'Trans proline' 0 C--N 1.344 0.328 0 C-N-CA 122.399 2.066 . . . . 0.0 113.366 -178.979 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 89' ' ' GLU . . . . . 0.431 ' O ' ' HG2' ' A' ' 93' ' ' GLN . 7.9 mm-40 -64.16 -46.1 85.55 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 112.323 0.49 . . . . 0.0 112.323 -178.603 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 90' ' ' GLU . . . . . 0.539 ' HG2' ' O ' ' A' ' 87' ' ' THR . 9.8 pt-20 -65.79 -18.29 65.23 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-O 121.028 0.442 . . . . 0.0 111.432 -179.25 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 52.1 t -87.44 -47.36 15.85 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.83 -179.135 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 1.7 pp0? -68.79 -35.44 77.03 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.511 -0.313 . . . . 0.0 111.496 -178.581 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 93' ' ' GLN . . . . . 0.431 ' HG2' ' O ' ' A' ' 89' ' ' GLU . 10.4 pt20 -77.17 -29.89 54.66 Favored 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 120.372 -0.531 . . . . 0.0 111.337 -179.05 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -69.3 -41.68 76.46 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.853 0.358 . . . . 0.0 110.71 179.931 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 17.0 m-30 -82.47 -13.48 56.65 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 116.387 -0.37 . . . . 0.0 110.968 -179.557 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 96' ' ' GLN . . . . . 0.577 ' HA ' ' O ' ' A' ' 99' ' ' GLY . 37.3 tt0 -64.33 -23.94 67.47 Favored 'General case' 0 C--O 1.234 0.252 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.483 -179.86 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 15.2 m -67.12 -28.15 67.92 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.712 179.576 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 5.3 m -94.35 -41.62 9.32 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.144 -0.48 . . . . 0.0 109.978 179.542 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 99' ' ' GLY . . . . . 0.577 ' O ' ' HA ' ' A' ' 96' ' ' GLN . . . -150.55 144.26 11.63 Favored Glycine 0 N--CA 1.445 -0.745 0 CA-C-N 115.864 -0.607 . . . . 0.0 111.701 179.807 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -63.18 146.87 52.44 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 121.029 0.442 . . . . 0.0 111.48 -179.829 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 1.3 p -120.23 128.68 75.99 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.342 -179.878 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 27.2 t-20 -96.98 -46.97 5.99 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.687 0.28 . . . . 0.0 110.669 -179.999 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 2.6 tpt180 -137.44 148.33 46.04 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.571 -179.643 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 7.5 p -148.15 137.83 16.28 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-O 121.004 0.43 . . . . 0.0 110.638 179.265 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 2.3 m -130.24 129.44 43.34 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 116.008 -0.542 . . . . 0.0 109.983 178.961 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 106' ' ' ILE . . . . . 0.557 HD11 ' HA2' ' A' ' 116' ' ' GLY . 20.5 tt -114.63 148.04 17.66 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-O 120.995 0.426 . . . . 0.0 110.899 -179.494 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 9.1 tp -129.82 140.29 51.05 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.131 179.759 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -105.8 114.3 28.38 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.511 -0.313 . . . . 0.0 110.248 179.552 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 109' ' ' ASP . . . . . 0.415 ' O ' ' HG2' ' A' ' 115' ' ' LYS . 7.5 t70 -75.85 142.64 42.14 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.396 -0.365 . . . . 0.0 110.952 -179.818 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 2.6 mppt? -127.13 20.4 6.89 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.281 0.563 . . . . 0.0 109.906 179.015 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 36.0 t80 -100.92 -6.79 24.13 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.467 -0.788 . . . . 0.0 110.23 -179.608 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 106.36 11.61 26.99 Favored Glycine 0 N--CA 1.448 -0.534 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.443 -179.966 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 113' ' ' GLN . . . . . 0.443 ' HB3' ' HD2' ' A' ' 114' ' ' PRO . 24.5 mt-30 -97.1 160.86 28.04 Favored Pre-proline 0 C--O 1.239 0.535 0 N-CA-C 109.455 -0.572 . . . . 0.0 109.455 -179.972 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 114' ' ' PRO . . . . . 0.443 ' HD2' ' HB3' ' A' ' 113' ' ' GLN . 16.8 Cg_endo -58.7 113.77 1.71 Allowed 'Trans proline' 0 C--N 1.347 0.492 0 C-N-CA 122.207 1.938 . . . . 0.0 111.277 178.628 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 115' ' ' LYS . . . . . 0.415 ' HG2' ' O ' ' A' ' 109' ' ' ASP . 9.6 mttp -78.57 179.74 6.91 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.144 -179.226 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 116' ' ' GLY . . . . . 0.557 ' HA2' HD11 ' A' ' 106' ' ' ILE . . . 92.55 2.83 67.24 Favored Glycine 0 N--CA 1.444 -0.804 0 C-N-CA 120.081 -1.057 . . . . 0.0 111.462 179.978 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 5.1 t80 -55.67 124.59 17.91 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.725 0.298 . . . . 0.0 110.393 179.78 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -149.44 171.2 16.96 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.627 -179.374 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 44.9 p90 -152.4 130.41 11.82 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-N 115.656 -0.702 . . . . 0.0 109.204 178.782 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 13.7 m -108.56 142.49 21.04 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.139 179.905 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 121' ' ' GLU . . . . . 0.539 ' HB2' HG12 ' A' ' 72' ' ' VAL . 1.3 pt-20 -131.55 154.34 48.91 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 120.923 0.392 . . . . 0.0 111.192 179.637 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 12.1 t80 -146.88 167.61 23.5 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.587 -0.733 . . . . 0.0 110.363 179.689 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 11.0 t -84.45 -41.21 15.97 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-O 120.901 0.381 . . . . 0.0 111.565 -179.432 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 33.3 mm-40 -76.56 131.34 38.89 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.152 -179.429 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 2.1 mp -73.27 -34.53 44.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.018 -179.46 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 17.5 t70 -58.38 -36.1 73.0 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.204 0.526 . . . . 0.0 111.058 -179.763 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -64.13 -57.7 8.81 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.735 -0.666 . . . . 0.0 111.271 -179.893 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 10.9 p -65.27 -27.71 42.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.554 -0.293 . . . . 0.0 111.287 -179.52 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 7.1 tt0 -60.02 -46.77 88.39 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.887 0.375 . . . . 0.0 110.246 179.83 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 50.7 m-80 -74.96 -24.26 58.43 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.143 179.873 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -68.98 -51.78 35.81 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.608 179.344 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 3.8 pp -67.55 -16.89 64.43 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.988 0.423 . . . . 0.0 111.057 179.881 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 1.1 tp -77.41 -53.08 8.09 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.003 179.324 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 87.9 mt -126.36 102.83 7.33 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.742 -0.663 . . . . 0.0 109.687 179.568 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -147.52 -67.02 0.26 Allowed 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.166 0.508 . . . . 0.0 111.948 -178.931 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 4.5 pt-20 -74.12 95.04 2.5 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.629 0.728 . . . . 0.0 111.857 -178.819 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 5.9 m -141.21 -59.75 0.49 Allowed 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.692 -0.686 . . . . 0.0 110.134 178.801 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -154.21 121.36 5.68 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 109.935 -0.395 . . . . 0.0 109.935 179.841 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -141.97 117.04 9.99 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 109.459 -0.571 . . . . 0.0 109.459 179.744 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 140' ' ' HIS . . . . . 0.422 ' HB2' ' SG ' ' A' ' 86' ' ' CYS . 2.2 t60 64.52 21.09 12.36 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-O 120.99 0.424 . . . . 0.0 110.78 179.869 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 86.55 -1.84 87.27 Favored Glycine 0 N--CA 1.449 -0.469 0 C-N-CA 120.715 -0.755 . . . . 0.0 111.533 -179.084 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 1.4 mpt_? -116.17 178.88 4.16 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 109.663 -0.495 . . . . 0.0 109.663 -179.68 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -122.5 141.41 51.68 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-O 120.818 0.342 . . . . 0.0 110.268 179.41 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -123.98 178.72 5.15 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 115.968 -0.56 . . . . 0.0 109.971 -179.821 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -120.81 120.3 35.17 Favored 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 109.595 -0.52 . . . . 0.0 109.595 179.444 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 146' ' ' VAL . . . . . 0.405 ' HA ' ' O ' ' A' ' 78' ' ' TYR . 73.1 t -115.32 129.92 70.76 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-O 120.951 0.405 . . . . 0.0 111.063 -179.092 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 1.6 m -134.22 148.02 50.8 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 179.109 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -61.96 129.47 41.05 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 120.658 0.266 . . . . 0.0 111.246 -179.83 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 149' ' ' LYS . . . . . 0.451 ' HE2' ' OG ' ' A' ' 76' ' ' SER . 25.8 ttpt -90.39 62.19 5.25 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.919 0.866 . . . . 0.0 108.758 179.528 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 150' ' ' ARG . . . . . 0.582 ' HD3' ' OG ' ' A' ' 74' ' ' SER . 0.0 OUTLIER -81.93 81.85 7.77 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 114.959 -1.019 . . . . 0.0 110.064 -179.729 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 8.7 t -69.28 122.76 19.52 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.359 179.937 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 152' ' ' ASN . . . . . . . . . . . . . 4.8 t30 -163.15 151.39 13.83 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.086 -179.88 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 13.1 pt -69.97 148.3 96.18 Favored Pre-proline 0 C--N 1.321 -0.657 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.847 179.752 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -73.0 103.76 1.65 Allowed 'Trans proline' 0 N--CA 1.464 -0.262 0 C-N-CA 122.34 2.027 . . . . 0.0 111.884 179.328 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.914 0 CA-C-O 118.757 -1.024 . . . . 0.0 111.937 -179.784 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.1 mpt? . . . . . 0 N--CA 1.48 1.038 0 N-CA-C 110.351 -0.24 . . . . 0.0 110.351 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 144.12 148.28 4.85 Favored Glycine 0 N--CA 1.449 -0.472 0 C-N-CA 120.538 -0.839 . . . . 0.0 112.459 179.886 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 8.1 m -136.13 152.0 50.37 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.615 0.245 . . . . 0.0 110.387 179.768 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 2.1 m -131.91 161.72 32.37 Favored 'General case' 0 C--O 1.237 0.398 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.601 179.85 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -157.88 121.91 4.15 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.583 179.377 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 1.3 t60 -159.99 124.87 3.92 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.506 -0.315 . . . . 0.0 110.853 -179.987 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 50.1 p-80 -148.5 156.08 42.0 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 109.55 -0.537 . . . . 0.0 109.55 179.431 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 1.5 m-70 -150.41 172.44 15.42 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 110.661 -0.126 . . . . 0.0 110.661 -179.802 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 55.5 t-80 -156.08 143.94 19.62 Favored 'General case' 0 CA--C 1.536 0.404 0 CA-C-N 116.483 -0.326 . . . . 0.0 111.129 -179.436 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 43.7 t-80 -149.92 144.97 26.23 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.455 -0.339 . . . . 0.0 110.143 179.701 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 23.2 t -133.86 166.37 22.84 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.664 -0.243 . . . . 0.0 110.642 179.958 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 70.1 m -159.16 -172.08 3.62 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 122.522 0.329 . . . . 0.0 110.635 -179.776 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 168.86 135.29 1.86 Allowed Glycine 0 C--N 1.333 0.413 0 N-CA-C 111.331 -0.708 . . . . 0.0 111.331 179.832 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 19.2 mt -138.23 143.39 40.11 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 117.136 0.468 . . . . 0.0 110.754 -179.203 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 2.4 p -138.92 113.97 8.44 Favored Pre-proline 0 CA--C 1.538 0.503 0 CA-C-O 120.771 0.32 . . . . 0.0 111.312 -179.781 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 64.1 Cg_endo -97.19 176.25 0.58 Allowed 'Trans proline' 0 N--CA 1.457 -0.645 0 C-N-CA 123.476 2.784 . . . . 0.0 113.122 179.722 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 3.5 ptm180 -157.29 149.68 22.93 Favored 'General case' 0 N--CA 1.462 0.154 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.134 179.115 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -119.03 175.77 15.84 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.963 -0.636 . . . . 0.0 112.81 -179.543 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 2.7 m -106.01 -171.52 1.92 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.784 0.326 . . . . 0.0 111.047 -179.765 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 10.4 t-80 -153.93 142.28 20.58 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.269 179.788 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -116.14 170.13 8.75 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.369 179.46 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -173.25 132.67 2.39 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 121.101 -0.571 . . . . 0.0 111.813 179.939 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 3.3 t -89.75 136.79 32.83 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.714 0.257 . . . . 0.0 110.628 -179.29 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -80.8 116.46 20.8 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.879 -179.644 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -167.21 157.31 11.07 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.543 179.703 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.5 ' HA ' HG22 ' A' ' 65' ' ' THR . 0.0 OUTLIER -159.92 176.77 11.49 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.496 179.518 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 7.1 t70 -157.83 -145.29 0.14 Allowed 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 108.295 -1.002 . . . . 0.0 108.295 179.504 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -85.13 -179.74 7.08 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 109.19 -0.67 . . . . 0.0 109.19 178.48 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 81.9 mttt -117.44 124.67 49.39 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-O 120.793 0.33 . . . . 0.0 110.685 -179.586 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 84.8 tttt -166.09 91.85 0.48 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.729 -0.669 . . . . 0.0 110.367 -179.115 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 31' ' ' ARG . . . . . 0.552 ' HA ' ' CB ' ' A' ' 67' ' ' ALA . 8.9 ptm180 -61.83 99.33 0.12 Allowed 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.962 -0.563 . . . . 0.0 112.157 179.781 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -157.22 147.36 20.88 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.905 179.49 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 3.8 tptt 66.07 -166.99 0.22 Allowed 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 115.244 -0.889 . . . . 0.0 112.145 179.311 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -91.08 157.47 17.22 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.008 -179.178 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.516 ' HB ' ' HB2' ' A' ' 64' ' ' ALA . 1.5 pp -124.24 152.77 30.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.245 -179.986 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 36' ' ' GLU . . . . . 0.632 ' HB3' ' OG ' ' A' ' 61' ' ' SER . 9.4 tp10 -139.03 -84.3 0.26 Allowed 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 120.623 -0.431 . . . . 0.0 111.777 179.556 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 37' ' ' GLU . . . . . 0.426 ' CD ' HH12 ' A' ' 103' ' ' ARG . 2.5 mm-40 -168.38 -57.42 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.398 0 N-CA-C 112.478 0.547 . . . . 0.0 112.478 -178.33 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -61.89 158.63 15.65 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.826 -0.625 . . . . 0.0 112.496 -178.363 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -108.74 -163.07 0.85 Allowed 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.706 -179.81 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -155.49 -154.1 6.8 Favored Glycine 0 N--CA 1.446 -0.677 0 N-CA-C 111.283 -0.727 . . . . 0.0 111.283 179.994 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -140.89 175.24 9.78 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.855 0.327 . . . . 0.0 110.127 179.937 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 63.9 tp -72.81 91.42 1.5 Allowed 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 109.623 -0.51 . . . . 0.0 109.623 179.06 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 43' ' ' ARG . . . . . 0.448 ' HD2' ' SD ' ' A' ' 45' ' ' MET . 13.5 ttm-85 -119.28 -16.1 9.07 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.96 -0.564 . . . . 0.0 111.161 -179.292 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 60.07 29.45 19.01 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 121.375 0.607 . . . . 0.0 110.021 -179.317 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 45' ' ' MET . . . . . 0.448 ' SD ' ' HD2' ' A' ' 43' ' ' ARG . 19.9 ptt? -99.63 12.56 36.22 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.182 -0.917 . . . . 0.0 111.167 -179.69 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 9.9 mm100 -71.81 -20.89 61.78 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 120.853 0.359 . . . . 0.0 110.898 -179.361 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -71.77 -14.5 62.01 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.302 0.572 . . . . 0.0 109.866 178.381 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 34.1 ttpt -82.78 7.22 15.7 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.694 -0.684 . . . . 0.0 109.445 178.826 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 7.3 p -57.2 -20.62 13.26 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.202 0 CA-C-N 115.693 -0.685 . . . . 0.0 111.623 -179.923 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 12.7 mm-40 -64.06 -33.23 75.28 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.431 0.634 . . . . 0.0 109.573 178.705 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 23.1 mtmt -97.42 -31.1 12.54 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.247 -0.888 . . . . 0.0 110.827 179.316 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 20.1 mm-40 -88.04 18.48 4.22 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.592 -179.548 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 7.9 ptm -64.76 -30.37 71.38 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.894 0.378 . . . . 0.0 110.813 179.971 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -94.07 -4.86 62.8 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.771 -0.728 . . . . 0.0 111.445 178.883 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -118.97 26.57 9.43 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.218 0.532 . . . . 0.0 110.166 -179.61 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 19.0 m -65.08 -13.89 15.71 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.263 0 CA-C-N 115.732 -0.667 . . . . 0.0 111.175 -179.706 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 5.7 mp0 -77.25 -16.99 58.78 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.585 -179.915 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -120.41 -52.8 2.14 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.89 -179.298 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 7.3 m -71.52 -70.89 0.29 Allowed 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.536 -0.756 . . . . 0.0 111.687 -179.249 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -84.57 30.11 0.57 Allowed 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.028 0.442 . . . . 0.0 111.532 -179.227 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 61' ' ' SER . . . . . 0.632 ' OG ' ' HB3' ' A' ' 36' ' ' GLU . 3.8 t -75.28 -26.92 59.14 Favored 'General case' 0 N--CA 1.447 -0.578 0 N-CA-C 108.523 -0.917 . . . . 0.0 108.523 178.986 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -64.15 -19.78 65.53 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-N 115.083 -0.962 . . . . 0.0 110.904 179.216 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 69.1 m -61.23 -19.31 61.52 Favored 'General case' 0 N--CA 1.445 -0.684 0 CA-C-N 115.588 -0.733 . . . . 0.0 110.715 -179.828 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 64' ' ' ALA . . . . . 0.516 ' HB2' ' HB ' ' A' ' 35' ' ' ILE . . . -70.07 -37.65 75.54 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.874 0.369 . . . . 0.0 110.45 179.095 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 65' ' ' THR . . . . . 0.5 HG22 ' HA ' ' A' ' 26' ' ' GLU . 0.2 OUTLIER -75.13 -1.37 22.76 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.967 -0.56 . . . . 0.0 111.684 -179.615 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 1.9 tt0 -118.97 -40.17 2.87 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.873 179.988 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 67' ' ' ALA . . . . . 0.552 ' CB ' ' HA ' ' A' ' 31' ' ' ARG . . . -93.69 -58.97 2.11 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 112.203 0.445 . . . . 0.0 112.203 -179.408 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 68' ' ' GLU . . . . . 0.53 ' O ' HG23 ' A' ' 72' ' ' VAL . 2.4 tp10 -66.59 -29.34 69.37 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.611 -0.268 . . . . 0.0 110.997 -178.993 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 45.1 tptt -56.36 -27.88 57.39 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.027 179.715 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 24.1 mt-10 -59.23 -34.83 72.67 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-O 120.83 0.347 . . . . 0.0 110.504 179.274 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 6.8 tp10 -89.07 -41.32 12.38 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.173 179.214 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.53 HG23 ' O ' ' A' ' 68' ' ' GLU . 22.1 t -62.68 -42.02 94.5 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.444 0 N-CA-C 112.073 0.397 . . . . 0.0 112.073 -178.964 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 73' ' ' ASP . . . . . 0.532 ' OD2' HG21 ' A' ' 151' ' ' THR . 25.4 t0 -66.28 -20.11 66.01 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-O 121.6 0.714 . . . . 0.0 110.192 179.76 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 16.3 m -100.61 -12.95 18.79 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 114.972 -1.013 . . . . 0.0 110.871 179.998 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -109.21 47.39 0.92 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.485 -179.199 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 76' ' ' SER . . . . . 0.409 ' HB3' ' HB3' ' A' ' 121' ' ' GLU . 0.0 OUTLIER -126.14 170.13 12.11 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.644 179.783 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -133.24 133.62 57.99 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 N-CA-C 109.832 -0.433 . . . . 0.0 109.832 178.851 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 22.4 t80 -88.5 124.67 34.22 Favored 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 109.497 -0.557 . . . . 0.0 109.497 179.952 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 5.2 t -105.89 111.11 33.66 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-N 116.519 -0.31 . . . . 0.0 110.297 179.861 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -117.04 170.57 13.47 Favored Glycine 0 N--CA 1.447 -0.621 0 N-CA-C 111.574 -0.61 . . . . 0.0 111.574 -179.982 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 3.9 m-20 55.91 43.29 27.68 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-O 121.238 0.542 . . . . 0.0 110.933 -179.099 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 2.5 t -85.49 166.38 2.05 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 CA-C-N 115.646 -0.706 . . . . 0.0 110.561 -179.505 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 83' ' ' ASP . . . . . 0.542 ' OD2' ' HD2' ' A' ' 142' ' ' ARG . 14.7 t70 -69.68 141.34 53.58 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.042 0.448 . . . . 0.0 110.392 179.978 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 14.5 p90 -64.0 -23.04 67.18 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.763 -0.653 . . . . 0.0 112.322 -178.575 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -107.13 16.01 24.57 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 120.874 0.368 . . . . 0.0 111.162 -179.27 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 86' ' ' CYS . . . . . 0.422 ' SG ' ' HB3' ' A' ' 83' ' ' ASP . 0.8 OUTLIER -79.84 145.43 32.76 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 121.207 0.527 . . . . 0.0 110.954 179.971 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 87' ' ' THR . . . . . 0.405 ' O ' ' HG2' ' A' ' 90' ' ' GLU . 13.2 p -111.25 153.77 43.89 Favored Pre-proline 0 C--N 1.324 -0.524 0 CA-C-N 115.509 -0.769 . . . . 0.0 110.315 179.553 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 88' ' ' PRO . . . . . 0.525 ' HD3' HD13 ' A' ' 106' ' ' ILE . 16.6 Cg_endo -56.43 -37.7 96.67 Favored 'Trans proline' 0 C--N 1.344 0.336 0 C-N-CA 122.855 2.37 . . . . 0.0 112.556 -179.311 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 89' ' ' GLU . . . . . 0.481 ' O ' ' HG2' ' A' ' 93' ' ' GLN . 0.0 OUTLIER -63.5 -52.26 62.03 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.9 -0.591 . . . . 0.0 111.886 -178.937 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 90' ' ' GLU . . . . . 0.406 ' O ' ' HB2' ' A' ' 94' ' ' HIS . 7.9 pt-20 -65.23 -15.3 62.33 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.763 0.316 . . . . 0.0 111.429 -178.475 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 61.7 t -89.65 -46.25 15.17 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 CA-C-N 116.63 -0.259 . . . . 0.0 110.873 -179.806 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 1.7 pt20 -72.35 -34.2 67.84 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 111.817 0.302 . . . . 0.0 111.817 -178.45 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 93' ' ' GLN . . . . . 0.481 ' HG2' ' O ' ' A' ' 89' ' ' GLU . 26.0 pt20 -80.59 -22.72 40.42 Favored 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 120.33 -0.548 . . . . 0.0 111.249 -179.157 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 94' ' ' HIS . . . . . 0.406 ' HB2' ' O ' ' A' ' 90' ' ' GLU . 0.3 OUTLIER -75.31 -32.42 60.96 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.952 0.405 . . . . 0.0 110.498 179.331 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 23.3 m-30 -89.68 -8.08 53.19 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.175 -179.266 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 96' ' ' GLN . . . . . 0.555 ' HA ' ' O ' ' A' ' 99' ' ' GLY . 1.3 tt0 -66.49 -22.54 66.19 Favored 'General case' 0 C--O 1.232 0.148 0 CA-C-O 121.163 0.506 . . . . 0.0 109.978 -179.694 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 1.2 m -63.36 -30.71 71.79 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.459 -0.791 . . . . 0.0 110.642 179.147 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 17.4 m -97.27 -46.03 6.27 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.397 179.63 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 99' ' ' GLY . . . . . 0.555 ' O ' ' HA ' ' A' ' 96' ' ' GLN . . . -144.92 143.35 11.81 Favored Glycine 0 N--CA 1.442 -0.95 0 C-N-CA 120.908 -0.663 . . . . 0.0 111.869 -179.892 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 100' ' ' THR . . . . . 0.406 ' HB ' ' CE1' ' A' ' 122' ' ' PHE . 0.2 OUTLIER -66.06 145.65 55.6 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 120.574 0.226 . . . . 0.0 111.096 -179.872 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 2.5 p -111.09 129.51 66.23 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-O 120.957 0.408 . . . . 0.0 111.25 -179.335 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 102' ' ' ASN . . . . . 0.535 ' OD1' ' HD2' ' A' ' 103' ' ' ARG . 26.0 t-20 -100.88 -45.17 5.53 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 109.868 -0.419 . . . . 0.0 109.868 179.327 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 103' ' ' ARG . . . . . 0.535 ' HD2' ' OD1' ' A' ' 102' ' ' ASN . 0.0 OUTLIER -138.44 151.9 47.86 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.156 -0.475 . . . . 0.0 109.972 178.776 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 4.0 p -151.44 119.52 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-O 121.142 0.496 . . . . 0.0 110.299 179.144 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 105' ' ' THR . . . . . 0.428 ' HB ' ' CE1' ' A' ' 119' ' ' TYR . 1.2 m -112.27 120.12 40.66 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.116 179.655 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 106' ' ' ILE . . . . . 0.525 HD13 ' HD3' ' A' ' 88' ' ' PRO . 21.5 tt -108.06 146.38 14.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-O 121.025 0.44 . . . . 0.0 111.166 -179.903 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 26.0 tp -131.93 136.22 47.21 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.213 179.458 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -101.83 116.33 32.48 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 116.544 -0.298 . . . . 0.0 110.533 179.749 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 109' ' ' ASP . . . . . 0.456 ' O ' ' HG2' ' A' ' 115' ' ' LYS . 12.3 t70 -83.76 136.2 34.25 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.026 0.441 . . . . 0.0 111.155 -179.766 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -126.56 27.42 6.12 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 116.148 -0.478 . . . . 0.0 109.896 179.4 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 10.0 t80 -108.23 -2.01 19.7 Favored 'General case' 0 N--CA 1.45 -0.451 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.282 -179.36 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 114.45 3.2 22.63 Favored Glycine 0 N--CA 1.449 -0.434 0 C-N-CA 120.399 -0.905 . . . . 0.0 112.995 179.617 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 26.6 mt-30 -98.18 156.57 35.7 Favored Pre-proline 0 C--N 1.321 -0.645 0 N-CA-C 109.671 -0.492 . . . . 0.0 109.671 179.858 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 14.2 Cg_endo -57.37 126.71 22.85 Favored 'Trans proline' 0 C--N 1.349 0.566 0 C-N-CA 122.194 1.929 . . . . 0.0 110.894 178.798 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 115' ' ' LYS . . . . . 0.456 ' HG2' ' O ' ' A' ' 109' ' ' ASP . 10.7 mttp -82.67 177.55 8.64 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 110.008 -0.368 . . . . 0.0 110.008 -179.732 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 116' ' ' GLY . . . . . 0.456 ' HA2' HD11 ' A' ' 106' ' ' ILE . . . 94.78 2.91 62.66 Favored Glycine 0 N--CA 1.444 -0.774 0 C-N-CA 120.157 -1.02 . . . . 0.0 112.349 179.419 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 9.9 m-30 -55.84 117.73 3.94 Favored 'General case' 0 C--N 1.332 -0.194 0 N-CA-C 110.163 -0.31 . . . . 0.0 110.163 179.992 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -147.03 174.69 11.31 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-O 120.935 0.398 . . . . 0.0 111.145 -179.144 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 119' ' ' TYR . . . . . 0.428 ' CE1' ' HB ' ' A' ' 105' ' ' THR . 36.1 p90 -152.91 134.09 14.19 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.687 -0.688 . . . . 0.0 109.182 178.674 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 14.6 m -107.91 136.64 42.66 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 N-CA-C 109.42 -0.585 . . . . 0.0 109.42 178.906 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 121' ' ' GLU . . . . . 0.491 ' HB2' HG12 ' A' ' 72' ' ' VAL . 10.7 pt-20 -122.61 152.25 40.64 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 120.619 0.247 . . . . 0.0 110.755 -179.728 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 122' ' ' PHE . . . . . 0.406 ' CE1' ' HB ' ' A' ' 100' ' ' THR . 11.9 t80 -148.4 170.07 18.79 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.028 -0.533 . . . . 0.0 109.961 179.421 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 21.4 t -87.49 -50.09 14.08 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-O 120.975 0.417 . . . . 0.0 111.568 -179.452 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 29.0 mt-10 -70.22 134.26 47.87 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.385 -179.128 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 2.6 mp -73.23 -30.97 32.58 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.59 -179.621 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 5.7 t70 -57.24 -40.45 77.59 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.892 -179.771 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -64.04 -54.95 26.13 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.708 -0.678 . . . . 0.0 111.402 -179.413 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 7.3 p -65.59 -30.58 50.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.447 -0.342 . . . . 0.0 111.193 -179.498 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 20.4 tt0 -59.98 -45.82 91.44 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-O 120.939 0.4 . . . . 0.0 110.361 179.539 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 82.8 m-20 -71.25 -32.61 68.94 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.183 179.701 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 131' ' ' ALA . . . . . 0.429 ' O ' ' HB2' ' A' ' 135' ' ' ASN . . . -66.32 -48.06 71.53 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.85 -0.614 . . . . 0.0 111.382 -179.927 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 4.2 pp -71.24 -16.87 62.51 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.784 0.326 . . . . 0.0 110.943 -179.734 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 5.5 tp -82.1 -48.96 10.74 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.068 -179.85 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 79.2 mt -136.98 104.06 5.34 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.398 -0.365 . . . . 0.0 110.503 -179.815 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 135' ' ' ASN . . . . . 0.429 ' HB2' ' O ' ' A' ' 131' ' ' ALA . 1.8 m-20 -152.33 -52.87 0.12 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.564 -0.289 . . . . 0.0 111.54 -179.743 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 5.2 pt-20 -73.83 89.27 1.83 Allowed 'General case' 0 C--N 1.33 -0.283 0 CA-C-O 121.528 0.68 . . . . 0.0 111.039 -179.658 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 6.7 m -130.78 -61.94 0.93 Allowed 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.548 -0.751 . . . . 0.0 110.51 179.672 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 8.0 tm-20 -162.16 127.21 3.36 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.22 -0.445 . . . . 0.0 109.813 -179.867 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -142.35 119.69 11.58 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.929 -0.578 . . . . 0.0 109.616 179.466 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 140' ' ' HIS . . . . . 0.42 ' HB2' ' SG ' ' A' ' 86' ' ' CYS . 3.7 t60 63.75 12.74 6.89 Favored 'General case' 0 N--CA 1.466 0.333 0 C-N-CA 122.717 0.407 . . . . 0.0 111.413 179.594 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 103.76 -8.42 50.79 Favored Glycine 0 N--CA 1.45 -0.398 0 C-N-CA 120.633 -0.794 . . . . 0.0 112.755 -179.59 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 142' ' ' ARG . . . . . 0.542 ' HD2' ' OD2' ' A' ' 83' ' ' ASP . 0.0 OUTLIER -116.2 169.77 9.03 Favored 'General case' 0 C--N 1.324 -0.543 0 O-C-N 122.602 -0.352 . . . . 0.0 110.843 -179.436 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 7.8 pt20 -110.93 125.72 53.97 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 109.544 -0.539 . . . . 0.0 109.544 179.046 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -104.92 177.35 4.87 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 120.734 0.302 . . . . 0.0 111.179 -179.277 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 145' ' ' LYS . . . . . 0.558 ' HE2' ' OG ' ' A' ' 147' ' ' SER . 0.1 OUTLIER -118.04 122.95 44.46 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 109.459 -0.571 . . . . 0.0 109.459 179.305 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 89.0 t -114.18 121.64 66.7 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-O 120.837 0.351 . . . . 0.0 111.226 -179.785 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 147' ' ' SER . . . . . 0.558 ' OG ' ' HE2' ' A' ' 145' ' ' LYS . 0.6 OUTLIER -118.63 141.77 48.28 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.007 179.68 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -67.6 123.51 20.66 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.722 0.296 . . . . 0.0 110.537 179.885 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 15.7 tttp -86.0 74.29 10.15 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.332 0.586 . . . . 0.0 110.312 -179.051 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 11.6 tpt85 -91.84 100.18 12.91 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 109.105 -0.702 . . . . 0.0 109.105 178.944 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 151' ' ' THR . . . . . 0.532 HG21 ' OD2' ' A' ' 73' ' ' ASP . 6.4 t -95.52 147.63 23.35 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.329 -179.61 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 152' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 177.94 178.39 0.35 Allowed 'General case' 0 CA--C 1.514 -0.424 0 CA-C-N 116.0 -0.545 . . . . 0.0 109.891 179.636 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 11.4 pt -82.57 135.46 46.4 Favored Pre-proline 0 C--N 1.321 -0.661 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.328 179.794 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 69.8 Cg_endo -78.46 67.95 8.16 Favored 'Trans proline' 0 N--CA 1.462 -0.329 0 C-N-CA 122.638 2.225 . . . . 0.0 112.171 -179.986 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.443 -0.852 0 CA-C-O 118.128 -1.373 . . . . 0.0 111.16 179.968 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 43.8 ttp . . . . . 0 N--CA 1.478 0.967 0 CA-C-O 120.879 0.371 . . . . 0.0 110.483 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 128.34 151.09 7.42 Favored Glycine 0 N--CA 1.448 -0.559 0 C-N-CA 120.647 -0.787 . . . . 0.0 112.273 -179.92 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 14.8 m -141.25 133.77 28.42 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 109.523 -0.547 . . . . 0.0 109.523 179.455 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -148.72 159.62 43.95 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.891 0.377 . . . . 0.0 111.633 -179.141 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 9.5 p-80 -169.78 138.04 1.77 Allowed 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 115.554 -0.748 . . . . 0.0 109.75 179.588 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -162.27 150.24 14.43 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 109.446 -0.575 . . . . 0.0 109.446 -179.749 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 36.5 t-80 -161.6 125.97 3.38 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.947 0.403 . . . . 0.0 111.73 -179.477 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 48.0 p-80 -163.15 113.1 1.36 Allowed 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.541 -0.754 . . . . 0.0 109.249 178.853 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 10.9 t-80 -172.42 146.85 1.84 Allowed 'General case' 0 C--N 1.327 -0.409 0 O-C-N 122.229 -0.294 . . . . 0.0 111.078 -179.379 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 7.7 p-80 -153.93 125.98 7.83 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 109.707 -0.479 . . . . 0.0 109.707 178.054 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 3.8 p -173.27 124.12 0.4 Allowed 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.132 -179.633 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 33.9 m -152.84 149.06 27.9 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.638 -0.255 . . . . 0.0 110.357 179.887 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -175.4 -151.46 8.62 Favored Glycine 0 N--CA 1.443 -0.886 0 C-N-CA 120.625 -0.798 . . . . 0.0 112.282 179.93 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 1.8 pt? -157.8 167.67 29.36 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 -179.86 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 3.6 p -140.22 125.02 11.1 Favored Pre-proline 0 C--N 1.323 -0.572 0 CA-C-O 121.026 0.441 . . . . 0.0 111.652 -179.093 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -77.01 153.67 32.65 Favored 'Trans proline' 0 C--O 1.234 0.323 0 C-N-CA 122.509 2.139 . . . . 0.0 112.571 179.43 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 17' ' ' ARG . . . . . 0.443 HH11 ' HD2' ' A' ' 17' ' ' ARG . 5.9 mtm105 -86.86 156.05 20.02 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.081 0.467 . . . . 0.0 111.279 -179.648 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 18' ' ' GLY . . . . . 0.416 ' HA3' ' O ' ' A' ' 57' ' ' GLN . . . -177.66 -112.32 0.32 Allowed Glycine 0 N--CA 1.447 -0.569 0 CA-C-N 115.508 -0.769 . . . . 0.0 111.548 -179.799 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 19' ' ' SER . . . . . 0.45 ' O ' ' HB3' ' A' ' 61' ' ' SER . 5.1 m -90.6 172.53 8.62 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 120.884 0.373 . . . . 0.0 111.269 -179.853 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 41.8 m170 -127.44 84.04 2.22 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.461 -0.336 . . . . 0.0 110.253 179.839 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 38.5 ttm -160.73 89.45 0.81 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.465 -179.489 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 143.76 -169.29 26.12 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.528 -0.844 . . . . 0.0 112.509 179.803 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 8.0 t -163.32 126.86 2.77 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 109.84 -0.43 . . . . 0.0 109.84 -179.863 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 17.4 t0 -143.08 171.29 14.26 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 110.176 -0.305 . . . . 0.0 110.176 -179.784 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 1.6 pt? -130.65 37.74 3.79 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 120.872 0.368 . . . . 0.0 110.353 -179.723 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 33.5 mt-10 67.61 74.17 0.31 Allowed 'General case' 0 C--O 1.236 0.388 0 CA-C-N 115.412 -0.813 . . . . 0.0 111.677 179.122 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 27' ' ' ASP . . . . . 0.595 ' HB3' HG21 ' A' ' 49' ' ' VAL . 6.1 t70 -115.28 17.01 16.77 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.477 0.656 . . . . 0.0 110.21 178.482 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 26.7 ttt -70.97 101.85 2.28 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.663 -0.699 . . . . 0.0 109.994 179.395 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 4.9 mppt? -134.18 -70.83 0.51 Allowed 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.461 -0.336 . . . . 0.0 111.763 -179.255 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 30' ' ' LYS . . . . . 0.412 ' O ' ' HG2' ' A' ' 53' ' ' MET . 2.0 tmtp? -74.79 133.37 41.95 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.763 0.315 . . . . 0.0 110.927 -179.13 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -113.02 140.93 47.42 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.377 -179.98 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 48.0 tp -155.88 -71.16 0.11 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.772 0.32 . . . . 0.0 110.523 179.478 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.588 ' O ' ' HA ' ' A' ' 51' ' ' LYS . 17.8 tptt -150.47 169.25 21.92 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 109.338 -0.615 . . . . 0.0 109.338 -179.865 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 1.7 pm0 -138.83 73.69 1.44 Allowed 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.147 0.499 . . . . 0.0 110.934 179.97 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 1.2 mm -130.63 2.11 2.18 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.4 0 N-CA-C 112.094 0.405 . . . . 0.0 112.094 -179.331 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 66.8 tt0 -134.8 102.06 5.13 Favored 'General case' 0 C--N 1.33 -0.26 0 O-C-N 121.776 -0.577 . . . . 0.0 112.497 -177.867 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 1.9 pm0 -116.08 150.38 37.43 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.327 -0.397 . . . . 0.0 109.993 178.833 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 38' ' ' GLU . . . . . 0.573 ' OE1' ' HE2' ' A' ' 48' ' ' LYS . 34.1 mt-10 -148.87 -165.31 2.24 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-O 120.902 0.382 . . . . 0.0 110.926 -179.957 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -107.97 165.43 11.47 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.448 179.449 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -86.04 112.12 3.68 Favored Glycine 0 N--CA 1.45 -0.408 0 C-N-CA 120.719 -0.753 . . . . 0.0 113.021 -179.338 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -146.35 175.89 10.19 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 109.846 -0.427 . . . . 0.0 109.846 179.425 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 57.4 tp -73.87 91.39 1.97 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.314 0.578 . . . . 0.0 110.234 179.33 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 43' ' ' ARG . . . . . 0.677 ' HB3' ' SD ' ' A' ' 45' ' ' MET . 49.5 ttt85 -155.87 156.27 34.36 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.785 -0.643 . . . . 0.0 109.785 -179.31 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 2.0 pt-20 -79.56 39.55 0.41 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.803 0.811 . . . . 0.0 110.016 178.669 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 45' ' ' MET . . . . . 0.677 ' SD ' ' HB3' ' A' ' 43' ' ' ARG . 6.1 ptm -95.36 9.97 37.96 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 114.815 -1.084 . . . . 0.0 110.989 -179.26 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 22.0 mm-40 -69.87 -20.43 63.4 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.251 0.548 . . . . 0.0 110.459 -179.774 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -82.37 -3.26 55.17 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.664 179.173 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 48' ' ' LYS . . . . . 0.573 ' HE2' ' OE1' ' A' ' 38' ' ' GLU . 24.0 ttpp -81.87 -4.19 55.94 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.501 -179.794 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.595 HG21 ' HB3' ' A' ' 27' ' ' ASP . 9.9 p -61.85 -22.28 28.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 121.347 0.594 . . . . 0.0 110.238 179.549 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -67.83 -17.9 64.66 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.657 -0.701 . . . . 0.0 110.044 178.619 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 51' ' ' LYS . . . . . 0.588 ' HA ' ' O ' ' A' ' 33' ' ' LYS . 29.4 mtmt -103.86 -41.15 5.98 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.205 -0.907 . . . . 0.0 110.616 179.741 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 8.4 mt-10 -78.82 6.28 9.44 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.901 0.381 . . . . 0.0 111.24 179.752 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 53' ' ' MET . . . . . 0.412 ' HG2' ' O ' ' A' ' 30' ' ' LYS . 0.0 OUTLIER -72.74 -32.61 65.81 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 121.315 0.579 . . . . 0.0 109.526 178.142 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -89.37 -9.6 66.81 Favored Glycine 0 N--CA 1.445 -0.703 0 N-CA-C 110.429 -1.068 . . . . 0.0 110.429 179.034 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -106.98 20.62 18.79 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 114.654 -0.773 . . . . 0.0 109.838 179.868 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 17.2 m -66.55 -11.35 13.08 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.397 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.005 179.928 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 57' ' ' GLN . . . . . 0.416 ' O ' ' HA3' ' A' ' 18' ' ' GLY . 31.7 mt-30 -88.47 1.53 54.63 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.64 0.733 . . . . 0.0 110.352 178.809 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 7.7 t70 -130.17 -51.74 1.11 Allowed 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 115.24 -0.891 . . . . 0.0 109.81 178.776 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 8.6 m -79.1 -65.08 1.04 Allowed 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.377 -0.829 . . . . 0.0 112.377 -179.146 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 8.8 t -85.45 11.44 10.42 Favored 'General case' 0 CA--C 1.531 0.218 0 N-CA-C 112.119 0.415 . . . . 0.0 112.119 -178.125 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 61' ' ' SER . . . . . 0.45 ' HB3' ' O ' ' A' ' 19' ' ' SER . 0.5 OUTLIER -73.11 -20.96 60.83 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-O 121.085 0.469 . . . . 0.0 110.616 -179.967 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -69.62 -25.58 64.01 Favored 'General case' 0 N--CA 1.447 -0.581 0 CA-C-N 116.057 -0.519 . . . . 0.0 109.932 178.563 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 1.5 m -62.55 -28.09 69.62 Favored 'General case' 0 N--CA 1.448 -0.53 0 CA-C-N 115.483 -0.78 . . . . 0.0 110.722 179.774 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 64' ' ' ALA . . . . . 0.434 ' O ' ' HB3' ' A' ' 68' ' ' GLU . . . -68.4 -25.43 65.04 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 121.312 0.577 . . . . 0.0 110.1 178.789 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -81.56 1.76 32.26 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.733 179.814 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 24.3 tp60 -123.4 -50.88 1.87 Allowed 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.723 -0.671 . . . . 0.0 110.569 179.577 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -82.89 -57.85 3.12 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.545 -179.634 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 68' ' ' GLU . . . . . 0.434 ' HB3' ' O ' ' A' ' 64' ' ' ALA . 28.4 tt0 -64.06 -29.73 70.85 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 121.129 0.49 . . . . 0.0 110.587 -179.817 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 39.4 tptt -57.24 -30.14 64.37 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.785 -0.643 . . . . 0.0 111.265 179.955 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 7.2 mt-10 -61.42 -22.54 65.11 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-O 121.261 0.553 . . . . 0.0 111.25 179.998 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 71' ' ' GLU . . . . . 0.546 ' O ' ' HD3' ' A' ' 75' ' ' ARG . 42.7 tp10 -97.84 -43.35 7.16 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 115.881 -0.6 . . . . 0.0 109.536 178.481 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.434 HG12 ' HB2' ' A' ' 121' ' ' GLU . 45.3 t -61.84 -40.22 86.24 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-N 115.597 -0.729 . . . . 0.0 112.776 -178.815 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 16.1 p-10 -72.79 -14.21 61.48 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-O 120.742 0.306 . . . . 0.0 111.792 -178.709 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 48.0 t -106.37 -2.02 22.66 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.004 178.323 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 75' ' ' ARG . . . . . 0.546 ' HD3' ' O ' ' A' ' 71' ' ' GLU . 2.8 mpt_? -116.68 41.16 2.75 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.609 0.719 . . . . 0.0 109.331 -179.74 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -120.73 171.17 8.79 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.223 -0.899 . . . . 0.0 110.474 179.906 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.414 HD11 HG22 ' A' ' 120' ' ' VAL . 0.8 OUTLIER -131.4 136.15 58.05 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 N-CA-C 109.74 -0.467 . . . . 0.0 109.74 178.603 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 79.2 t80 -93.05 124.06 36.75 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.286 -179.142 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.472 HG21 ' HE2' ' A' ' 95' ' ' PHE . 3.4 t -104.5 112.92 40.01 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.808 -179.708 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -119.24 167.69 13.3 Favored Glycine 0 N--CA 1.447 -0.599 0 N-CA-C 111.18 -0.768 . . . . 0.0 111.18 179.479 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 5.3 m-20 61.77 36.71 16.11 Favored 'General case' 0 N--CA 1.472 0.625 0 CA-C-O 121.218 0.532 . . . . 0.0 110.488 -179.702 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 2.5 t -78.55 164.03 3.48 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-N 115.624 -0.716 . . . . 0.0 111.116 -178.897 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 83' ' ' ASP . . . . . 0.545 ' OD2' ' HD3' ' A' ' 142' ' ' ARG . 10.8 t0 -68.06 136.58 54.01 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.996 -0.547 . . . . 0.0 109.61 179.313 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 25.7 p90 -64.98 -13.89 58.83 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.118 -0.492 . . . . 0.0 112.1 -179.253 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -113.28 14.21 19.26 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.773 0.321 . . . . 0.0 111.24 179.586 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 86' ' ' CYS . . . . . 0.458 ' SG ' ' HB2' ' A' ' 140' ' ' HIS . 0.8 OUTLIER -78.47 150.11 33.05 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.067 0.461 . . . . 0.0 111.521 -179.389 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 5.3 p -111.47 150.91 42.84 Favored Pre-proline 0 C--N 1.323 -0.55 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.259 179.099 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 88' ' ' PRO . . . . . 0.441 ' HD3' HD13 ' A' ' 106' ' ' ILE . 16.9 Cg_endo -57.89 -35.03 99.01 Favored 'Trans proline' 0 C--N 1.342 0.235 0 C-N-CA 122.462 2.108 . . . . 0.0 111.566 -179.716 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 66.8 mm-40 -64.36 -53.45 48.46 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.549 -0.75 . . . . 0.0 111.89 -179.429 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 -64.16 -18.37 64.4 Favored 'General case' 0 C--N 1.333 -0.133 0 CA-C-O 120.901 0.381 . . . . 0.0 111.472 -178.225 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 55.0 t -83.71 -49.06 16.79 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.518 -179.884 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 92' ' ' GLN . . . . . 0.417 ' O ' ' HB2' ' A' ' 96' ' ' GLN . 2.8 pt20 -73.38 -32.47 64.5 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.472 -0.331 . . . . 0.0 111.611 -178.479 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 7.1 pt20 -77.25 -28.29 53.57 Favored 'General case' 0 C--N 1.33 -0.261 0 C-N-CA 120.618 -0.433 . . . . 0.0 111.048 -179.118 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 60.9 t-80 -74.95 -44.48 48.21 Favored 'General case' 0 CA--C 1.519 -0.248 0 CA-C-O 121.085 0.469 . . . . 0.0 110.165 179.536 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 95' ' ' PHE . . . . . 0.472 ' HE2' HG21 ' A' ' 79' ' ' VAL . 20.5 m-30 -73.45 -17.78 61.2 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.866 -0.607 . . . . 0.0 110.517 -179.2 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 96' ' ' GLN . . . . . 0.492 ' HA ' ' O ' ' A' ' 99' ' ' GLY . 51.4 tt0 -64.61 -25.29 67.9 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.494 -0.775 . . . . 0.0 110.631 179.521 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 48.8 m -61.0 -32.18 71.77 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.514 179.682 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 18.2 m -92.35 -50.23 5.75 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.176 0.512 . . . . 0.0 110.078 179.42 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 99' ' ' GLY . . . . . 0.492 ' O ' ' HA ' ' A' ' 96' ' ' GLN . . . -137.77 133.7 6.53 Favored Glycine 0 N--CA 1.443 -0.854 0 C-N-CA 120.659 -0.782 . . . . 0.0 111.91 179.783 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -59.33 140.0 56.48 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.029 0.443 . . . . 0.0 110.686 179.975 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 2.8 p -105.51 140.18 24.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 115.876 -0.602 . . . . 0.0 112.171 -178.058 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 9.1 t30 -101.95 -50.56 3.63 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 109.431 -0.581 . . . . 0.0 109.431 178.125 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 9.0 mmm180 -141.8 158.32 43.94 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.386 179.698 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 6.6 p -151.54 127.57 1.83 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.104 179.566 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 105' ' ' THR . . . . . 0.416 ' HB ' ' CE1' ' A' ' 119' ' ' TYR . 1.8 m -117.9 119.17 34.04 Favored 'General case' 0 C--N 1.321 -0.669 0 O-C-N 122.263 -0.273 . . . . 0.0 110.441 -179.984 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 106' ' ' ILE . . . . . 0.441 HD13 ' HD3' ' A' ' 88' ' ' PRO . 18.6 tt -107.16 146.64 13.19 Favored 'Isoleucine or valine' 0 C--O 1.235 0.327 0 CA-C-O 120.959 0.409 . . . . 0.0 111.04 -179.592 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 60.4 tp -135.69 126.24 26.97 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.858 -0.61 . . . . 0.0 109.948 179.12 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -89.2 120.02 30.21 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 116.517 -0.311 . . . . 0.0 110.499 179.83 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 109' ' ' ASP . . . . . 0.543 ' O ' ' HG2' ' A' ' 115' ' ' LYS . 16.8 t70 -81.08 136.9 35.99 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.014 0.435 . . . . 0.0 110.829 -179.883 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -124.93 25.86 7.21 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.896 -0.593 . . . . 0.0 109.763 179.556 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 24.6 t80 -105.99 -3.87 21.19 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.059 -179.483 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 106.83 10.9 27.62 Favored Glycine 0 N--CA 1.449 -0.493 0 C-N-CA 120.678 -0.772 . . . . 0.0 112.536 -179.582 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 113' ' ' GLN . . . . . 0.417 ' HB3' ' HD2' ' A' ' 114' ' ' PRO . 20.9 mt-30 -99.8 159.36 30.14 Favored Pre-proline 0 C--N 1.325 -0.471 0 N-CA-C 109.509 -0.552 . . . . 0.0 109.509 179.388 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 114' ' ' PRO . . . . . 0.417 ' HD2' ' HB3' ' A' ' 113' ' ' GLN . 11.4 Cg_endo -55.77 115.67 2.62 Favored 'Trans proline' 0 C--N 1.344 0.327 0 C-N-CA 122.307 2.005 . . . . 0.0 110.835 178.584 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 115' ' ' LYS . . . . . 0.543 ' HG2' ' O ' ' A' ' 109' ' ' ASP . 54.9 mttt -75.52 172.27 12.83 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.044 -178.467 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 116' ' ' GLY . . . . . 0.42 ' HA2' HD11 ' A' ' 106' ' ' ILE . . . 98.55 7.81 55.32 Favored Glycine 0 N--CA 1.444 -0.767 0 C-N-CA 120.351 -0.928 . . . . 0.0 112.286 179.902 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 30.2 m-85 -53.27 115.48 1.92 Allowed 'General case' 0 C--N 1.334 -0.097 0 N-CA-C 110.146 -0.316 . . . . 0.0 110.146 179.749 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -146.23 175.53 10.44 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-O 121.034 0.445 . . . . 0.0 111.165 -179.168 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 119' ' ' TYR . . . . . 0.416 ' CE1' ' HB ' ' A' ' 105' ' ' THR . 51.7 p90 -160.08 135.64 8.29 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.581 -0.736 . . . . 0.0 109.234 178.799 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 120' ' ' VAL . . . . . 0.414 HG22 HD11 ' A' ' 77' ' ' ILE . 17.4 m -105.55 142.0 19.62 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.727 0 N-CA-C 109.69 -0.485 . . . . 0.0 109.69 179.344 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 121' ' ' GLU . . . . . 0.434 ' HB2' HG12 ' A' ' 72' ' ' VAL . 5.8 pt-20 -127.1 152.94 46.64 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.157 -179.417 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 15.4 t80 -156.46 166.99 31.82 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.476 179.163 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 3.8 t -84.37 -47.61 17.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 120.921 0.391 . . . . 0.0 111.627 -179.317 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 74.9 mm-40 -66.33 126.45 28.82 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.32 -179.394 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 2.5 mp -70.23 -32.92 52.41 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.02 -179.926 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 4.8 t70 -62.66 -36.64 83.5 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.505 179.884 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -61.3 -55.44 31.8 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.636 179.724 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 11.3 p -67.12 -28.86 44.12 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.756 179.729 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 50.7 tt0 -58.56 -46.53 86.68 Favored 'General case' 0 N--CA 1.462 0.165 0 CA-C-O 121.11 0.481 . . . . 0.0 110.399 179.223 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 46.2 m-80 -70.83 -31.16 67.78 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.878 -0.601 . . . . 0.0 109.985 179.913 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -68.03 -48.41 65.76 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.665 -0.698 . . . . 0.0 111.833 -179.537 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 3.8 pp -69.93 -18.97 63.4 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.943 0.401 . . . . 0.0 110.92 -179.666 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 5.4 tp -80.03 -49.91 11.12 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.765 179.858 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 79.1 mt -134.61 107.81 7.7 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.477 -0.329 . . . . 0.0 110.967 -179.609 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 2.8 m-20 -159.81 -52.53 0.06 Allowed 'General case' 0 N--CA 1.465 0.303 0 CA-C-O 121.181 0.515 . . . . 0.0 110.998 179.757 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 4.6 pt-20 -74.73 80.06 2.05 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.433 0.635 . . . . 0.0 111.205 -179.735 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 6.8 m -133.78 -60.58 0.82 Allowed 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.672 -0.695 . . . . 0.0 111.0 179.573 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 1.6 tp10 -150.97 121.25 7.28 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-O 120.532 0.206 . . . . 0.0 110.516 -179.325 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -141.93 111.43 6.55 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 109.867 -0.42 . . . . 0.0 109.867 179.237 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 140' ' ' HIS . . . . . 0.458 ' HB2' ' SG ' ' A' ' 86' ' ' CYS . 2.4 t60 67.34 18.27 10.2 Favored 'General case' 0 N--CA 1.468 0.425 0 CA-C-O 121.142 0.496 . . . . 0.0 110.402 179.582 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 88.9 4.14 75.72 Favored Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.869 -0.681 . . . . 0.0 111.54 -179.212 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 142' ' ' ARG . . . . . 0.545 ' HD3' ' OD2' ' A' ' 83' ' ' ASP . 4.3 mpt_? -121.28 166.49 13.95 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 109.825 -0.435 . . . . 0.0 109.825 179.499 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 18.7 pt20 -110.99 140.08 45.81 Favored 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 109.863 -0.421 . . . . 0.0 109.863 179.2 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -125.6 174.98 7.88 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.547 -179.549 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 15.6 ttpt -111.32 118.79 36.82 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.255 179.791 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 85.9 t -113.37 118.53 58.38 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-O 120.992 0.425 . . . . 0.0 110.005 179.276 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 66.3 m -127.49 143.36 51.2 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 116.116 -0.493 . . . . 0.0 109.921 -179.89 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -59.13 133.49 56.14 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.058 0.456 . . . . 0.0 111.888 -178.747 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 12.1 ttpp -96.0 78.29 3.18 Favored 'General case' 0 N--CA 1.449 -0.476 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.205 179.607 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 21.5 tpt180 -91.0 101.72 14.49 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 109.293 -0.632 . . . . 0.0 109.293 179.329 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 4.2 t -94.96 140.52 29.84 Favored 'General case' 0 N--CA 1.446 -0.666 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.777 -179.193 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 152' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 172.87 177.76 0.09 Allowed 'General case' 0 CA--C 1.516 -0.345 0 CA-C-N 115.494 -0.776 . . . . 0.0 109.484 179.632 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 16.6 pt -75.08 140.53 73.6 Favored Pre-proline 0 C--N 1.318 -0.791 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.895 179.839 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -75.95 59.98 5.98 Favored 'Trans proline' 0 CA--C 1.528 0.206 0 C-N-CA 122.949 2.432 . . . . 0.0 112.372 179.916 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.44 -1.068 0 CA-C-O 118.818 -0.99 . . . . 0.0 111.534 179.957 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.3 mpt? . . . . . 0 N--CA 1.482 1.172 0 N-CA-C 109.944 -0.391 . . . . 0.0 109.944 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 118.98 117.43 2.7 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.953 -0.641 . . . . 0.0 112.597 179.898 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -144.64 113.29 6.68 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 110.08 -0.341 . . . . 0.0 110.08 179.382 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 13.3 m -120.26 155.02 34.09 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.712 0.292 . . . . 0.0 111.364 -179.615 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 21.4 p-80 -159.39 141.54 13.57 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.586 179.971 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 35.7 t60 -155.96 139.84 16.24 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.803 0.335 . . . . 0.0 110.563 179.507 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 76.1 t60 -129.41 117.31 20.37 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.041 179.698 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 49.7 t-80 -90.0 129.06 36.37 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 120.782 0.325 . . . . 0.0 110.946 -179.734 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 8.6 p-80 -100.28 -177.7 3.6 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.821 179.926 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 4.6 p80 -136.79 174.51 10.54 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.555 0.217 . . . . 0.0 110.471 179.692 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 9.0 t -111.74 -160.82 0.73 Allowed 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.511 -0.313 . . . . 0.0 110.335 -179.483 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 14.3 m -155.7 119.34 4.43 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 109.593 -0.521 . . . . 0.0 109.593 179.363 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -169.74 156.37 27.17 Favored Glycine 0 N--CA 1.448 -0.537 0 N-CA-C 111.328 -0.709 . . . . 0.0 111.328 179.773 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 47.1 mt -135.93 98.9 4.01 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.141 0.496 . . . . 0.0 110.772 -179.78 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.401 ' O ' ' HG2' ' A' ' 17' ' ' ARG . 0.2 OUTLIER -135.47 79.83 47.02 Favored Pre-proline 0 C--N 1.323 -0.549 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.314 -179.789 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 16' ' ' PRO . . . . . 0.58 ' HA ' ' OE2' ' A' ' 68' ' ' GLU . 89.7 Cg_exo -45.63 115.82 1.15 Allowed 'Trans proline' 0 C--N 1.348 0.518 0 C-N-CA 123.611 2.874 . . . . 0.0 113.372 -178.844 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 17' ' ' ARG . . . . . 0.401 ' HG2' ' O ' ' A' ' 15' ' ' VAL . 11.8 ptm180 -156.71 177.89 10.97 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.518 -0.764 . . . . 0.0 110.653 -179.755 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -83.78 144.98 22.39 Favored Glycine 0 N--CA 1.445 -0.753 0 C-N-CA 120.685 -0.769 . . . . 0.0 111.484 178.97 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 1.6 m -98.0 139.07 34.37 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 120.714 0.292 . . . . 0.0 110.428 -179.887 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 20' ' ' HIS . . . . . 0.419 ' HB3' ' OG ' ' A' ' 61' ' ' SER . 36.9 t-80 -157.2 159.49 37.76 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 109.517 -0.549 . . . . 0.0 109.517 179.721 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 2.3 mpt? -66.27 156.97 32.79 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.581 -0.281 . . . . 0.0 110.923 179.64 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 177.26 -171.57 44.38 Favored Glycine 0 N--CA 1.447 -0.602 0 N-CA-C 111.097 -0.801 . . . . 0.0 111.097 -179.963 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 69.3 m -78.49 -97.85 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 116.782 0.291 . . . . 0.0 111.461 -179.888 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 13.8 p-10 -161.76 32.75 0.13 Allowed 'General case' 0 N--CA 1.464 0.245 0 CA-C-O 121.047 0.451 . . . . 0.0 111.686 -179.11 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 45.1 mt -93.85 155.4 17.21 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.82 0.343 . . . . 0.0 110.616 179.745 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.405 ' HA ' ' HB3' ' A' ' 63' ' ' SER . 27.6 mt-10 -124.15 141.35 52.13 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.175 -179.354 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 3.3 t70 -153.3 169.72 22.39 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-N 116.482 -0.327 . . . . 0.0 110.229 179.495 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -139.15 2.05 2.07 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.49 -0.323 . . . . 0.0 111.659 -179.317 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 8.5 pttm -128.73 166.22 19.39 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 110.248 -0.279 . . . . 0.0 110.248 -179.943 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 30' ' ' LYS . . . . . 0.593 ' HA ' ' O ' ' A' ' 53' ' ' MET . 10.0 ptpt -157.32 145.27 19.07 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 109.866 -0.42 . . . . 0.0 109.866 179.359 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 2.8 mmp_? -143.2 -68.12 0.35 Allowed 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 120.876 0.369 . . . . 0.0 110.787 -179.861 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 1.9 mm? -87.83 -167.7 1.97 Allowed 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.067 -0.515 . . . . 0.0 109.996 -179.961 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.461 ' HA ' ' O ' ' A' ' 54' ' ' GLY . 3.5 mtpm? -143.27 81.1 1.7 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.189 0.519 . . . . 0.0 110.044 179.378 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 4.0 mm-40 -111.11 -171.49 1.84 Allowed 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.1 -179.178 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 1.3 pp -149.78 161.72 4.45 Favored 'Isoleucine or valine' 0 C--O 1.233 0.217 0 C-N-CA 122.536 0.335 . . . . 0.0 110.143 179.665 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 36' ' ' GLU . . . . . 0.407 ' HB3' ' H ' ' A' ' 37' ' ' GLU . 17.3 mm-40 61.37 -160.63 0.3 Allowed 'General case' 0 N--CA 1.465 0.318 0 O-C-N 123.437 0.461 . . . . 0.0 111.888 179.138 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 37' ' ' GLU . . . . . 0.407 ' H ' ' HB3' ' A' ' 36' ' ' GLU . 34.2 mm-40 67.46 30.57 6.76 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-N 115.817 -0.629 . . . . 0.0 111.353 179.232 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 38' ' ' GLU . . . . . 0.407 ' H ' ' HG3' ' A' ' 38' ' ' GLU . 0.0 OUTLIER -115.4 138.01 51.44 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 121.183 0.516 . . . . 0.0 111.754 -178.929 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -151.76 165.79 33.35 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.48 -0.782 . . . . 0.0 110.142 179.737 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -140.02 67.29 0.5 Allowed Glycine 0 N--CA 1.448 -0.529 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.427 -179.907 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -140.15 172.18 13.12 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 110.05 -0.352 . . . . 0.0 110.05 179.829 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 50.7 tp -72.45 94.32 1.64 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.095 0.474 . . . . 0.0 109.825 179.472 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 16.8 ttm180 -149.03 149.58 31.36 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.764 -0.653 . . . . 0.0 109.576 -179.71 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 10.4 tt0 -79.97 48.79 1.0 Allowed 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.272 0.558 . . . . 0.0 110.824 -179.508 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 6.4 ptm -107.35 12.31 28.19 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.441 179.674 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 19.7 mm-40 -69.63 -20.8 63.6 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.056 0.455 . . . . 0.0 111.212 -179.261 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -79.71 -5.44 55.23 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.25 178.913 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 37.1 ttpt -85.34 1.73 47.22 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.78 -0.645 . . . . 0.0 109.775 179.614 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 5.8 p -58.32 -19.44 13.59 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.432 0 CA-C-N 115.261 -0.882 . . . . 0.0 111.094 179.447 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 29.6 mt-10 -70.65 -19.9 62.76 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-O 121.207 0.527 . . . . 0.0 110.369 179.173 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 5.2 mtmt -101.63 -42.52 6.18 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.995 -0.548 . . . . 0.0 109.905 178.749 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 22.0 mt-10 -61.37 -26.6 67.94 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.854 179.391 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 53' ' ' MET . . . . . 0.593 ' O ' ' HA ' ' A' ' 30' ' ' LYS . 19.5 ptt? -66.55 -16.53 64.22 Favored 'General case' 0 C--O 1.227 -0.116 0 CA-C-O 121.372 0.606 . . . . 0.0 110.024 178.668 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 54' ' ' GLY . . . . . 0.461 ' O ' ' HA ' ' A' ' 33' ' ' LYS . . . -98.67 -7.93 55.04 Favored Glycine 0 N--CA 1.445 -0.725 0 N-CA-C 110.612 -0.995 . . . . 0.0 110.612 178.509 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -114.5 18.52 16.75 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-O 121.144 0.497 . . . . 0.0 110.055 -179.871 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 32.3 m -63.71 -6.87 2.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 115.913 -0.585 . . . . 0.0 112.229 -179.154 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 97.0 mt-30 -88.17 -8.63 55.08 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.234 0.54 . . . . 0.0 110.088 179.097 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -129.33 -58.4 1.12 Allowed 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.376 -0.829 . . . . 0.0 109.681 179.315 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 1.6 m -64.6 -69.69 0.27 Allowed 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.367 -0.833 . . . . 0.0 112.039 -179.674 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 2.1 m -91.38 35.83 0.94 Allowed 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.749 -0.66 . . . . 0.0 111.893 -178.91 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 61' ' ' SER . . . . . 0.419 ' OG ' ' HB3' ' A' ' 20' ' ' HIS . 0.1 OUTLIER -89.02 -21.73 23.33 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.76 0.314 . . . . 0.0 111.033 -179.535 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -69.7 -12.61 61.77 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.428 -179.672 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 63' ' ' SER . . . . . 0.405 ' HB3' ' HA ' ' A' ' 26' ' ' GLU . 33.9 p -61.32 -33.47 73.66 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.445 -179.87 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -70.49 -28.08 64.7 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.584 179.828 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -81.88 -1.64 48.42 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.993 179.867 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 22.9 tp60 -119.87 -44.75 2.51 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.565 -0.289 . . . . 0.0 111.337 179.811 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -90.86 -61.18 1.73 Allowed 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 120.844 0.354 . . . . 0.0 111.252 -179.415 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 68' ' ' GLU . . . . . 0.58 ' OE2' ' HA ' ' A' ' 16' ' ' PRO . 0.6 OUTLIER -61.94 -27.86 69.13 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.969 -0.56 . . . . 0.0 111.125 -179.313 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 19.4 tptp -58.4 -29.55 66.14 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.405 -179.727 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 17.7 mt-10 -66.27 -20.39 66.09 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-O 121.396 0.617 . . . . 0.0 110.605 179.722 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 71' ' ' GLU . . . . . 0.445 ' O ' ' HD2' ' A' ' 75' ' ' ARG . 5.5 tp10 -95.28 -39.88 9.83 Favored 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 109.091 -0.707 . . . . 0.0 109.091 177.176 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.468 HG23 ' O ' ' A' ' 68' ' ' GLU . 54.9 t -63.97 -42.64 96.39 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.374 0 CA-C-N 115.606 -0.724 . . . . 0.0 112.491 -179.464 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 14.5 p-10 -70.69 -18.18 62.82 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-O 120.949 0.404 . . . . 0.0 110.898 -179.076 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 33.6 t -97.41 -13.47 21.8 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.188 178.633 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 75' ' ' ARG . . . . . 0.445 ' HD2' ' O ' ' A' ' 71' ' ' GLU . 0.0 OUTLIER -106.04 44.95 1.0 Allowed 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.775 -0.648 . . . . 0.0 109.961 -179.498 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 76' ' ' SER . . . . . 0.459 ' CB ' ' HB3' ' A' ' 121' ' ' GLU . 0.3 OUTLIER -124.53 170.99 10.36 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.47 -0.786 . . . . 0.0 110.689 179.971 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.436 HD13 ' HB1' ' A' ' 131' ' ' ALA . 6.7 pt -132.15 135.15 58.73 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.772 0 CA-C-N 115.803 -0.635 . . . . 0.0 109.35 178.445 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 69.6 t80 -91.91 123.04 34.99 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 116.341 -0.39 . . . . 0.0 109.994 -179.883 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 4.6 t -102.78 111.48 32.71 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.493 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.223 -179.516 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -121.42 169.69 14.55 Favored Glycine 0 N--CA 1.447 -0.602 0 C-N-CA 120.828 -0.701 . . . . 0.0 111.57 179.858 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 4.2 m-20 61.01 37.66 17.89 Favored 'General case' 0 N--CA 1.469 0.514 0 CA-C-O 121.251 0.548 . . . . 0.0 110.431 -179.882 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 2.5 t -83.52 164.31 2.72 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-N 115.358 -0.837 . . . . 0.0 110.804 -179.01 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 83' ' ' ASP . . . . . 0.732 ' OD2' ' HB2' ' A' ' 142' ' ' ARG . 0.1 OUTLIER -66.17 137.3 56.91 Favored 'General case' 0 CA--C 1.517 -0.323 0 N-CA-C 109.707 -0.479 . . . . 0.0 109.707 179.288 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 24.6 p90 -65.64 -8.06 18.43 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 120.917 0.389 . . . . 0.0 111.379 -179.878 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -118.51 19.52 13.29 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.14 -179.743 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -87.01 143.88 27.14 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.707 179.971 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 87' ' ' THR . . . . . 0.436 ' O ' ' HG2' ' A' ' 90' ' ' GLU . 20.7 p -107.79 148.9 38.25 Favored Pre-proline 0 C--N 1.326 -0.429 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.425 179.572 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 88' ' ' PRO . . . . . 0.545 ' HD3' HD13 ' A' ' 106' ' ' ILE . 11.7 Cg_endo -54.81 -39.65 88.83 Favored 'Trans proline' 0 C--N 1.344 0.339 0 C-N-CA 123.089 2.526 . . . . 0.0 112.977 -179.198 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 3.2 mp0 -65.1 -41.73 94.7 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 112.498 0.555 . . . . 0.0 112.498 -178.486 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 90' ' ' GLU . . . . . 0.485 ' O ' ' HB2' ' A' ' 94' ' ' HIS . 8.0 pt-20 -73.98 -14.8 61.09 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.97 0.414 . . . . 0.0 111.024 -178.977 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.424 HG23 ' O ' ' A' ' 87' ' ' THR . 74.5 t -88.52 -48.35 14.92 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.89 -179.561 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -69.0 -34.13 74.8 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.545 -178.333 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 7.6 pt20 -78.11 -28.97 48.7 Favored 'General case' 0 C--N 1.327 -0.384 0 C-N-CA 120.556 -0.457 . . . . 0.0 111.24 -178.854 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 94' ' ' HIS . . . . . 0.485 ' HB2' ' O ' ' A' ' 90' ' ' GLU . 1.8 t-80 -73.39 -32.19 64.33 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.97 0.414 . . . . 0.0 110.828 -179.664 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 21.4 m-30 -87.7 -11.69 47.54 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.144 179.543 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 26.4 tt0 -62.74 -27.64 69.41 Favored 'General case' 0 C--O 1.234 0.237 0 CA-C-N 115.538 -0.755 . . . . 0.0 110.343 -179.957 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 12.7 m -63.96 -35.5 80.89 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.233 179.085 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 3.8 m -85.29 -52.75 5.68 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.883 -0.599 . . . . 0.0 109.532 179.159 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -140.57 128.16 3.71 Favored Glycine 0 N--CA 1.441 -0.979 0 CA-C-N 115.684 -0.689 . . . . 0.0 111.689 179.752 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 100' ' ' THR . . . . . 0.444 ' H ' HG22 ' A' ' 100' ' ' THR . 0.1 OUTLIER -57.33 136.25 56.55 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.853 0.359 . . . . 0.0 110.101 179.418 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 2.0 p -102.01 130.33 51.94 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-N 116.048 -0.524 . . . . 0.0 112.073 -177.913 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 102' ' ' ASN . . . . . 0.457 ' HB2' ' CD1' ' A' ' 122' ' ' PHE . 29.2 t-20 -99.85 -43.78 6.3 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 109.53 -0.544 . . . . 0.0 109.53 178.449 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 103' ' ' ARG . . . . . 0.431 ' HD3' ' OD1' ' A' ' 102' ' ' ASN . 1.5 mpt_? -135.7 151.24 49.98 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.328 179.657 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 6.1 p -155.46 129.82 1.39 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.552 -0.295 . . . . 0.0 110.211 179.28 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -127.49 124.8 39.19 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.492 -0.322 . . . . 0.0 110.248 179.472 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 106' ' ' ILE . . . . . 0.548 HD11 ' HA2' ' A' ' 116' ' ' GLY . 20.8 tt -109.26 149.06 12.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 120.857 0.36 . . . . 0.0 111.014 -179.89 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 13.8 tp -130.14 136.22 49.05 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.002 -0.544 . . . . 0.0 109.991 179.516 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -100.8 111.35 23.55 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.488 179.9 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 109' ' ' ASP . . . . . 0.416 ' O ' ' HG2' ' A' ' 115' ' ' LYS . 23.1 t70 -76.73 146.91 37.68 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.188 0.518 . . . . 0.0 111.13 -179.618 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 3.3 mppt? -135.15 22.99 3.5 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.267 179.446 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 19.0 t80 -107.58 -3.89 18.88 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.222 0.534 . . . . 0.0 110.157 -179.544 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 114.78 0.62 22.96 Favored Glycine 0 N--CA 1.449 -0.474 0 C-N-CA 120.816 -0.707 . . . . 0.0 112.766 179.835 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 26.6 mt-30 -88.35 154.59 51.53 Favored Pre-proline 0 C--N 1.329 -0.315 0 N-CA-C 109.361 -0.607 . . . . 0.0 109.361 179.679 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 14.5 Cg_endo -58.45 115.92 2.88 Favored 'Trans proline' 0 N--CA 1.462 -0.378 0 C-N-CA 122.013 1.809 . . . . 0.0 111.444 178.917 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 115' ' ' LYS . . . . . 0.416 ' HG2' ' O ' ' A' ' 109' ' ' ASP . 60.0 mttt -70.86 167.06 19.77 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 109.558 -0.534 . . . . 0.0 109.558 -179.485 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 116' ' ' GLY . . . . . 0.548 ' HA2' HD11 ' A' ' 106' ' ' ILE . . . 105.59 1.83 40.36 Favored Glycine 0 N--CA 1.447 -0.607 0 C-N-CA 120.073 -1.061 . . . . 0.0 112.197 179.914 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 32.4 m-85 -53.69 115.61 2.07 Favored 'General case' 0 C--N 1.333 -0.138 0 N-CA-C 110.269 -0.271 . . . . 0.0 110.269 179.46 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -143.41 173.01 12.0 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 120.915 0.388 . . . . 0.0 111.006 -179.162 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 51.9 p90 -155.21 130.09 9.35 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 115.847 -0.615 . . . . 0.0 109.765 178.681 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 18.6 m -107.21 141.27 22.85 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 N-CA-C 109.695 -0.483 . . . . 0.0 109.695 179.178 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 121' ' ' GLU . . . . . 0.459 ' HB3' ' CB ' ' A' ' 76' ' ' SER . 1.4 pt-20 -132.04 157.05 45.16 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.916 0.388 . . . . 0.0 111.17 179.723 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 122' ' ' PHE . . . . . 0.457 ' CD1' ' HB2' ' A' ' 102' ' ' ASN . 22.2 t80 -152.29 170.88 18.95 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.535 -0.757 . . . . 0.0 109.771 179.91 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 20.4 t -84.26 -51.6 13.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-O 120.969 0.414 . . . . 0.0 110.461 179.852 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 4.7 mm-40 -60.53 129.66 42.69 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.852 -0.613 . . . . 0.0 111.132 179.886 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 2.9 mp -73.9 -31.03 29.58 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 N-CA-C 109.327 -0.62 . . . . 0.0 109.327 179.516 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -60.53 -37.97 82.92 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.342 179.26 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -60.8 -56.33 22.52 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.537 -0.756 . . . . 0.0 111.107 -179.976 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 11.3 p -67.19 -30.13 48.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.442 -179.654 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 30.1 tt0 -61.31 -44.78 96.64 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 121.038 0.447 . . . . 0.0 110.436 179.653 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 37.9 m-80 -72.3 -29.11 63.55 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.055 -0.52 . . . . 0.0 109.994 179.601 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 131' ' ' ALA . . . . . 0.436 ' HB1' HD13 ' A' ' 77' ' ' ILE . . . -69.53 -51.65 33.66 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.476 -0.784 . . . . 0.0 111.305 -179.939 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 4.2 pp -65.59 -23.34 66.81 Favored 'General case' 0 N--CA 1.462 0.142 0 CA-C-O 120.794 0.33 . . . . 0.0 110.681 -179.824 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 5.7 tp -73.37 -56.48 5.01 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.961 0.41 . . . . 0.0 110.228 179.595 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 69.1 mt -122.71 104.2 9.16 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.007 -0.542 . . . . 0.0 109.79 179.826 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 135' ' ' ASN . . . . . 0.43 ' HB2' ' O ' ' A' ' 131' ' ' ALA . 0.5 OUTLIER -148.4 -66.84 0.24 Allowed 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.15 0.5 . . . . 0.0 111.122 -179.186 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 5.6 pt-20 -73.68 106.29 5.37 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.563 -0.744 . . . . 0.0 111.414 -179.466 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 21.3 m -150.09 -59.13 0.19 Allowed 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.706 -0.679 . . . . 0.0 109.599 178.997 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 4.9 tt0 -161.55 120.96 2.5 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.813 -0.63 . . . . 0.0 109.572 178.946 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -139.35 123.18 17.63 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 -179.982 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 140' ' ' HIS . . . . . 0.621 ' HB3' ' OD2' ' A' ' 83' ' ' ASP . 6.9 t60 59.07 12.4 2.42 Favored 'General case' 0 CA--C 1.54 0.562 0 O-C-N 123.555 0.534 . . . . 0.0 111.553 179.28 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 101.36 -6.4 55.75 Favored Glycine 0 N--CA 1.449 -0.443 0 C-N-CA 120.904 -0.665 . . . . 0.0 112.754 -179.918 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 142' ' ' ARG . . . . . 0.732 ' HB2' ' OD2' ' A' ' 83' ' ' ASP . 8.0 mpt_? -113.43 173.42 6.42 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 117.023 0.412 . . . . 0.0 110.418 179.58 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 17.4 pt20 -116.87 114.16 23.49 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.093 0.473 . . . . 0.0 109.759 179.531 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -97.97 175.13 6.24 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.174 -179.15 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 6.4 ttpt -117.51 120.81 39.22 Favored 'General case' 0 N--CA 1.45 -0.457 0 CA-C-N 115.905 -0.589 . . . . 0.0 109.495 179.052 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 93.5 t -113.36 119.96 62.07 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.738 0 CA-C-O 120.898 0.38 . . . . 0.0 110.653 -179.635 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 58.2 m -123.25 141.68 51.72 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 116.195 -0.457 . . . . 0.0 109.801 -179.849 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -59.86 128.8 38.67 Favored 'General case' 0 C--O 1.236 0.378 0 CA-C-O 120.828 0.347 . . . . 0.0 111.277 -179.64 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 149' ' ' LYS . . . . . 0.429 ' HE2' ' OG ' ' A' ' 76' ' ' SER . 21.9 ttpt -91.94 67.8 5.25 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.384 0.611 . . . . 0.0 109.999 -179.601 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 24.7 tpt180 -88.12 94.56 9.84 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 121.236 0.541 . . . . 0.0 109.611 179.104 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 3.0 t -83.88 129.13 34.94 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 115.615 -0.721 . . . . 0.0 109.634 179.297 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 152' ' ' ASN . . . . . . . . . . . . . 62.5 t30 -163.68 158.9 20.96 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.001 -179.661 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 19.6 pt -78.36 148.81 74.67 Favored Pre-proline 0 C--N 1.32 -0.698 0 CA-C-N 116.577 -0.283 . . . . 0.0 110.322 179.733 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 30.5 Cg_endo -63.95 103.75 0.44 Allowed 'Trans proline' 0 C--N 1.344 0.31 0 C-N-CA 122.559 2.173 . . . . 0.0 111.987 179.848 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.161 0 CA-C-O 118.025 -1.431 . . . . 0.0 111.047 -179.577 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.454 -0.243 0 N-CA-C 109.772 -0.455 . . . . 0.0 109.772 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 56.8 tp -71.8 97.02 1.71 Allowed 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.177 0.513 . . . . 0.0 110.35 179.547 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . 0.422 ' C ' ' H ' ' A' ' 45' ' ' MET . 0.7 OUTLIER -150.13 147.92 28.34 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.655 -0.702 . . . . 0.0 109.582 -179.986 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -73.79 20.35 0.1 Allowed 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.623 -179.723 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' MET . . . . . 0.422 ' H ' ' C ' ' A' ' 43' ' ' ARG . 19.5 ptt? -83.86 8.1 15.98 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.026 0.441 . . . . 0.0 110.63 -179.854 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 87.7 mt-30 -66.1 -22.75 66.41 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.179 0.514 . . . . 0.0 110.477 179.361 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -80.37 -7.43 59.09 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.149 0.499 . . . . 0.0 110.681 179.648 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 18.7 ttmm -77.91 -6.28 53.81 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.539 -179.795 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 14.8 p -56.2 -28.57 25.83 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.32 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.596 -179.474 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 26.7 mt-10 -62.22 -31.36 71.89 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.91 0.386 . . . . 0.0 111.294 -179.359 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 37.6 mtmt -96.68 -41.18 8.63 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.609 -179.966 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 27.6 mm-40 -61.39 -29.6 70.02 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.71 -179.502 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 15.2 ptt? -62.62 -24.9 67.83 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-O 120.87 0.367 . . . . 0.0 110.629 179.797 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -94.3 -9.48 59.14 Favored Glycine 0 N--CA 1.447 -0.598 0 C-N-CA 120.699 -0.762 . . . . 0.0 111.483 179.463 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.326 -0.452 0 CA-C-O 120.909 0.385 . . . . 0.0 110.747 -179.753 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.225 -0.187 0 CA-C-O 120.901 0.382 . . . . 0.0 110.213 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -74.6 -0.08 16.63 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.048 0.452 . . . . 0.0 111.14 179.909 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 21.9 tp60 -119.47 -48.69 2.39 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.998 179.698 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -89.36 -52.94 4.78 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.864 0.364 . . . . 0.0 111.904 -179.236 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . 0.45 ' O ' HG23 ' A' ' 72' ' ' VAL . 6.4 tt0 -68.68 -26.1 65.13 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.143 0.497 . . . . 0.0 110.549 -179.094 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 51.2 tptt -58.91 -27.89 65.69 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.886 179.511 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 52.6 mt-10 -63.76 -21.94 66.66 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-O 121.443 0.64 . . . . 0.0 110.99 179.758 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . 0.522 ' O ' ' HD3' ' A' ' 75' ' ' ARG . 13.2 tp10 -94.8 -44.56 7.71 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 115.521 -0.763 . . . . 0.0 108.951 178.307 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.596 HG12 ' HB2' ' A' ' 121' ' ' GLU . 26.7 t -62.78 -40.45 88.69 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-N 115.351 -0.84 . . . . 0.0 112.883 -178.496 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 9.9 p-10 -70.86 -20.83 62.49 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-O 121.091 0.472 . . . . 0.0 111.64 -178.933 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 18.0 m -100.89 -5.05 26.61 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-O 121.335 0.588 . . . . 0.0 110.192 179.888 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . 0.522 ' HD3' ' O ' ' A' ' 71' ' ' GLU . 1.9 mpt_? -113.9 39.43 2.7 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.593 -0.73 . . . . 0.0 109.545 -179.92 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -119.26 173.83 6.71 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.381 -0.827 . . . . 0.0 110.886 -179.926 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.416 HD13 ' HB1' ' A' ' 131' ' ' ALA . 7.0 pt -133.31 140.41 47.03 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.067 178.585 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 71.0 t80 -96.53 126.52 41.77 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 109.624 -0.51 . . . . 0.0 109.624 179.815 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 5.1 t -108.09 114.33 46.23 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.983 -179.381 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -120.38 169.45 14.06 Favored Glycine 0 N--CA 1.448 -0.513 0 N-CA-C 111.192 -0.763 . . . . 0.0 111.192 179.36 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 93.8 m-20 60.06 38.66 20.47 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-O 121.073 0.463 . . . . 0.0 110.754 -179.712 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 2.4 t -81.82 164.44 2.91 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.753 -179.145 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . 0.414 ' O ' ' HB2' ' A' ' 86' ' ' CYS . 9.7 t70 -67.3 137.01 55.75 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 109.676 -0.491 . . . . 0.0 109.676 179.414 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 30.5 p90 -64.27 -18.46 64.59 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.897 -178.647 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -113.23 24.92 11.81 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 121.037 0.446 . . . . 0.0 110.747 179.851 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' CYS . . . . . 0.414 ' HB2' ' O ' ' A' ' 83' ' ' ASP . 0.1 OUTLIER -85.85 156.45 20.55 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.397 0.618 . . . . 0.0 111.549 -179.966 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . 0.483 ' O ' ' HG2' ' A' ' 90' ' ' GLU . 0.0 OUTLIER -119.31 146.64 41.35 Favored Pre-proline 0 C--N 1.322 -0.601 0 CA-C-N 115.432 -0.804 . . . . 0.0 110.343 -179.941 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . 0.566 ' HD3' HD13 ' A' ' 106' ' ' ILE . 15.0 Cg_endo -56.7 -40.2 86.04 Favored 'Trans proline' 0 C--N 1.344 0.319 0 C-N-CA 122.83 2.353 . . . . 0.0 112.734 -178.867 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 60.1 mm-40 -60.42 -50.49 73.36 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.531 -179.097 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . 0.719 ' O ' ' HB2' ' A' ' 94' ' ' HIS . 6.6 pt-20 -63.91 -24.6 67.8 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.624 -0.262 . . . . 0.0 111.143 -178.706 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 70.0 t -80.76 -48.66 19.3 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.04 -179.343 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 2.3 pt20 -70.92 -34.03 71.12 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 112.1 0.407 . . . . 0.0 112.1 -178.167 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 18.5 pt20 -79.19 -23.8 43.61 Favored 'General case' 0 C--N 1.329 -0.285 0 C-N-CA 120.496 -0.481 . . . . 0.0 110.896 -179.502 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' HIS . . . . . 0.719 ' HB2' ' O ' ' A' ' 90' ' ' GLU . 0.4 OUTLIER -74.48 -43.66 55.0 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.048 0.452 . . . . 0.0 110.067 179.684 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 21.8 m-30 -78.17 -12.52 60.0 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.521 -179.873 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . 0.603 ' HA ' ' O ' ' A' ' 99' ' ' GLY . 15.8 tt0 -65.08 -19.72 66.13 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.378 -179.959 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 12.3 m -66.54 -26.82 67.32 Favored 'General case' 0 N--CA 1.451 -0.401 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.272 179.217 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 5.9 m -97.02 -42.97 7.64 Favored 'General case' 0 N--CA 1.453 -0.324 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.168 179.365 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . 0.603 ' O ' ' HA ' ' A' ' 96' ' ' GLN . . . -150.65 142.16 9.35 Favored Glycine 0 N--CA 1.445 -0.712 0 C-N-CA 120.875 -0.679 . . . . 0.0 111.768 179.855 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . 0.417 ' HB ' ' CZ ' ' A' ' 122' ' ' PHE . 0.2 OUTLIER -62.68 150.03 42.09 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 120.937 0.398 . . . . 0.0 111.524 -179.924 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 2.2 p -119.54 129.26 75.55 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.754 -179.762 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 55.7 t30 -98.24 -39.51 8.81 Favored 'General case' 0 N--CA 1.463 0.175 0 CA-C-O 121.145 0.498 . . . . 0.0 110.274 179.385 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 2.2 tpt180 -145.93 153.29 40.66 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.223 -179.883 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 5.8 p -151.22 133.09 5.39 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.07 179.763 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 1.5 m -121.27 122.88 40.89 Favored 'General case' 0 C--N 1.32 -0.674 0 N-CA-C 110.129 -0.323 . . . . 0.0 110.129 179.612 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' ILE . . . . . 0.566 HD13 ' HD3' ' A' ' 88' ' ' PRO . 21.0 tt -113.49 144.36 21.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 120.935 0.398 . . . . 0.0 110.729 -179.514 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 27.0 tp -132.45 128.7 38.02 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.305 179.662 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -86.91 114.56 23.65 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.715 179.7 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . 0.423 ' O ' ' HG2' ' A' ' 115' ' ' LYS . 15.0 t70 -75.39 140.93 43.28 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.872 0.367 . . . . 0.0 110.796 -179.74 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -132.31 28.7 4.36 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 109.352 -0.61 . . . . 0.0 109.352 179.159 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 5.1 t80 -109.82 -2.37 17.32 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.589 -0.732 . . . . 0.0 109.707 179.919 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 106.89 6.29 34.81 Favored Glycine 0 N--CA 1.448 -0.51 0 CA-C-N 115.527 -0.76 . . . . 0.0 112.52 179.98 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 36.3 mt-30 -94.87 158.74 34.61 Favored Pre-proline 0 C--N 1.324 -0.511 0 N-CA-C 109.407 -0.59 . . . . 0.0 109.407 179.593 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 15.2 Cg_endo -58.11 119.3 6.47 Favored 'Trans proline' 0 C--N 1.345 0.388 0 C-N-CA 122.105 1.87 . . . . 0.0 110.88 178.886 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . 0.423 ' HG2' ' O ' ' A' ' 109' ' ' ASP . 58.3 mttt -74.4 173.37 10.38 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 109.976 -0.379 . . . . 0.0 109.976 -179.499 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . 0.529 ' HA2' HD11 ' A' ' 106' ' ' ILE . . . 98.32 3.27 57.68 Favored Glycine 0 N--CA 1.443 -0.844 0 C-N-CA 120.178 -1.01 . . . . 0.0 112.165 179.626 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 5.2 m-30 -54.82 117.56 3.51 Favored 'General case' 0 N--CA 1.463 0.206 0 N-CA-C 110.188 -0.301 . . . . 0.0 110.188 179.582 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -147.29 168.42 21.79 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.046 0.45 . . . . 0.0 111.451 -178.811 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 34.5 p90 -148.24 129.84 14.98 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.643 -0.708 . . . . 0.0 109.722 178.41 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 6.4 m -105.3 145.95 12.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 N-CA-C 109.742 -0.466 . . . . 0.0 109.742 179.781 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . 0.596 ' HB2' HG12 ' A' ' 72' ' ' VAL . 6.1 pt-20 -133.9 152.58 51.91 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 120.657 0.265 . . . . 0.0 111.005 -179.701 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 122' ' ' PHE . . . . . 0.417 ' CZ ' ' HB ' ' A' ' 100' ' ' THR . 13.0 t80 -148.64 167.01 26.6 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.124 179.525 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 10.1 t -83.44 -41.92 17.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.488 -0.324 . . . . 0.0 111.535 -179.286 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 43.6 mm-40 -74.02 132.12 42.06 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.121 0.486 . . . . 0.0 111.593 -179.087 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 2.4 mp -74.71 -35.51 37.44 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.444 -179.657 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -59.25 -33.49 71.1 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.151 0.5 . . . . 0.0 110.937 -179.692 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -65.56 -54.97 20.52 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.926 179.958 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 10.3 p -66.49 -29.6 47.06 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.804 -179.564 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 8.3 tt0 -60.39 -42.62 96.28 Favored 'General case' 0 C--N 1.333 -0.142 0 CA-C-O 120.909 0.385 . . . . 0.0 110.431 179.619 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 29.3 m-80 -73.59 -31.0 63.35 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.119 179.282 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 131' ' ' ALA . . . . . 0.416 ' HB1' HD13 ' A' ' 77' ' ' ILE . . . -67.93 -52.44 36.08 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.664 -0.698 . . . . 0.0 111.274 -179.885 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 4.0 pp -64.23 -22.22 66.87 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.85 0.357 . . . . 0.0 111.015 -179.802 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 5.5 tp -77.55 -55.72 5.13 Favored 'General case' 0 N--CA 1.451 -0.403 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.46 179.556 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 33.7 mt -123.74 103.04 8.14 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.078 -179.836 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -145.42 -71.25 0.26 Allowed 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 120.788 0.328 . . . . 0.0 111.56 -179.316 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 4.1 pt-20 -66.61 110.35 3.16 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.268 0.556 . . . . 0.0 111.268 -179.224 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 14.0 m -153.45 -58.14 0.13 Allowed 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.787 -0.642 . . . . 0.0 109.726 179.334 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -163.88 122.15 1.88 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.1 -0.5 . . . . 0.0 109.978 179.174 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -138.83 115.61 10.74 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 109.189 -0.671 . . . . 0.0 109.189 179.425 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 3.3 t60 64.83 16.45 10.47 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-O 120.896 0.379 . . . . 0.0 110.853 179.883 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 91.39 6.28 66.42 Favored Glycine 0 N--CA 1.448 -0.522 0 C-N-CA 120.893 -0.67 . . . . 0.0 111.761 -179.034 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -119.99 160.45 22.73 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 110.204 -0.295 . . . . 0.0 110.204 179.794 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 14.2 pt20 -108.22 126.5 52.87 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 109.443 -0.577 . . . . 0.0 109.443 178.573 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -112.47 175.43 5.44 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.688 -179.553 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 78.4 tttt -116.97 124.04 48.41 Favored 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 109.461 -0.57 . . . . 0.0 109.461 178.73 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 99.1 t -116.01 125.24 73.03 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.639 0 CA-C-O 120.941 0.4 . . . . 0.0 110.448 179.862 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 11.9 t -127.36 149.58 49.99 Favored 'General case' 0 N--CA 1.447 -0.624 0 N-CA-C 109.583 -0.525 . . . . 0.0 109.583 179.927 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -65.58 127.26 31.17 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.55 -0.295 . . . . 0.0 110.964 -179.829 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 19.9 ttpt -91.2 66.42 5.66 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.376 0.607 . . . . 0.0 109.683 179.88 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 150' ' ' ARG . . . . . 0.491 ' C ' ' HD2' ' A' ' 150' ' ' ARG . 0.0 OUTLIER . . . . . 0 C--N 1.322 -0.612 0 N-CA-C 109.439 -0.578 . . . . 0.0 109.439 179.819 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.177 0 CA-C-O 120.434 0.159 . . . . 0.0 110.623 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 64.7 tp -75.33 92.63 2.8 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-O 121.225 0.536 . . . . 0.0 110.569 179.696 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . 0.409 ' HB3' ' SD ' ' A' ' 45' ' ' MET . 4.3 ttp180 -155.84 159.73 39.62 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.836 -0.62 . . . . 0.0 109.675 -179.673 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 16.9 mt-10 -86.17 23.47 1.53 Allowed 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.371 0.605 . . . . 0.0 111.185 179.91 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' MET . . . . . 0.409 ' SD ' ' HB3' ' A' ' 43' ' ' ARG . 6.4 ptm -83.56 14.18 3.98 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.061 179.39 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 45.4 mt-30 -73.23 -27.53 61.65 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.837 -0.619 . . . . 0.0 109.713 179.408 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -75.8 -12.27 60.14 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.509 -0.769 . . . . 0.0 110.146 179.136 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 3.4 tmmt? -74.89 -2.62 27.69 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.214 -0.903 . . . . 0.0 110.21 179.681 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 8.1 p -60.5 -23.95 29.96 Favored 'Isoleucine or valine' 0 C--O 1.235 0.302 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.831 179.337 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 26.1 mm-40 -59.46 -27.28 65.95 Favored 'General case' 0 N--CA 1.457 -0.087 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.285 179.187 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 12.7 mtmm -97.85 -37.25 9.91 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.945 -0.571 . . . . 0.0 110.441 178.455 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -59.38 -22.32 61.19 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.687 -179.748 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 17.9 ptt? -58.47 -23.09 56.83 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.767 0.317 . . . . 0.0 110.859 179.814 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -105.86 4.37 39.18 Favored Glycine 0 N--CA 1.447 -0.592 0 C-N-CA 120.668 -0.777 . . . . 0.0 111.711 179.258 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.3 0 CA-C-O 121.139 0.495 . . . . 0.0 110.635 -179.829 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.453 -0.318 0 CA-C-O 120.867 0.365 . . . . 0.0 110.175 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -76.12 0.82 17.51 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.984 0.421 . . . . 0.0 111.243 179.826 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 57.1 tp60 -120.44 -50.52 2.22 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.972 179.679 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -85.04 -57.18 3.2 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 111.927 0.343 . . . . 0.0 111.927 -179.384 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 2.1 tp10 -63.09 -29.23 70.65 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-O 121.344 0.592 . . . . 0.0 110.211 -179.62 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 52.7 tptt -58.98 -28.59 66.49 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.459 -0.792 . . . . 0.0 111.251 179.453 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 63.4 mt-10 -62.43 -24.32 67.36 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-O 120.906 0.384 . . . . 0.0 111.174 -179.786 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 11.9 tp10 -96.83 -35.69 10.86 Favored 'General case' 0 C--N 1.318 -0.797 0 N-CA-C 109.841 -0.429 . . . . 0.0 109.841 178.423 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.526 HG12 ' HB2' ' A' ' 121' ' ' GLU . 57.5 t -65.98 -42.31 91.5 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.878 -179.337 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 24.9 p-10 -71.33 -14.71 62.28 Favored 'General case' 0 N--CA 1.466 0.325 0 CA-C-O 121.118 0.485 . . . . 0.0 110.864 -179.726 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . 0.415 ' OG ' ' HD3' ' A' ' 75' ' ' ARG . 12.4 p -97.89 -14.61 20.59 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.093 178.894 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . 0.476 ' CZ ' HG12 ' A' ' 125' ' ' ILE . 0.1 OUTLIER -111.23 46.47 1.08 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.423 -0.808 . . . . 0.0 110.401 -178.85 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -122.25 172.42 8.31 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.456 179.921 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.544 HD13 ' HB1' ' A' ' 131' ' ' ALA . 10.4 pt -130.83 140.71 48.02 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.61 179.394 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 87.2 t80 -95.54 123.07 38.91 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.839 -0.619 . . . . 0.0 109.836 179.908 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 3.9 t -106.48 113.18 42.43 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.849 -179.426 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -120.45 165.68 13.79 Favored Glycine 0 N--CA 1.448 -0.516 0 C-N-CA 120.937 -0.649 . . . . 0.0 111.801 179.938 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 2.6 m-20 61.79 39.44 13.96 Favored 'General case' 0 N--CA 1.471 0.598 0 CA-C-O 121.112 0.482 . . . . 0.0 111.014 -179.602 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 2.3 t -81.4 162.99 3.39 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.693 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.331 -179.417 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . 0.729 ' OD2' ' HB2' ' A' ' 142' ' ' ARG . 0.3 OUTLIER -63.87 138.52 58.51 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 109.845 -0.428 . . . . 0.0 109.845 179.445 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 30.5 p90 -62.67 -12.44 23.55 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.107 -0.497 . . . . 0.0 112.057 -179.443 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -123.24 27.74 7.41 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.744 0.307 . . . . 0.0 110.948 -179.485 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -86.08 147.55 26.12 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 116.444 -0.344 . . . . 0.0 110.783 -179.975 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . 0.487 ' HB ' ' OE1' ' A' ' 89' ' ' GLU . 15.5 p -108.88 146.82 34.59 Favored Pre-proline 0 C--N 1.325 -0.487 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.894 179.658 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . 0.428 ' HD3' HD13 ' A' ' 106' ' ' ILE . 16.1 Cg_endo -57.41 -37.43 97.45 Favored 'Trans proline' 0 C--N 1.344 0.29 0 C-N-CA 122.663 2.242 . . . . 0.0 113.2 -179.083 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . 0.487 ' OE1' ' HB ' ' A' ' 87' ' ' THR . 5.4 mp0 -64.75 -47.46 78.12 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.912 -178.347 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . 0.416 ' HG2' ' O ' ' A' ' 87' ' ' THR . 7.4 pt-20 -67.01 -24.19 66.0 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.843 0.354 . . . . 0.0 111.157 -178.958 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 75.0 t -79.97 -47.99 20.91 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.96 -179.535 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -69.43 -33.76 73.44 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.569 -0.287 . . . . 0.0 111.593 -178.356 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 11.1 pt20 -76.65 -30.17 56.72 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 120.516 -0.474 . . . . 0.0 111.143 -179.176 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 8.1 t60 -73.13 -40.04 65.23 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.053 0.454 . . . . 0.0 109.976 179.898 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 18.6 m-30 -78.35 -14.57 59.35 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.301 179.751 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . 0.595 ' HA ' ' O ' ' A' ' 99' ' ' GLY . 28.2 tt0 -67.57 -20.85 65.44 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.401 -0.818 . . . . 0.0 110.257 179.699 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 5.1 m -69.18 -23.09 63.88 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.648 -0.706 . . . . 0.0 110.173 179.241 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 26.5 m -99.91 -42.17 6.9 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.76 -0.655 . . . . 0.0 110.324 179.276 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . 0.595 ' O ' ' HA ' ' A' ' 96' ' ' GLN . . . -150.63 144.72 12.18 Favored Glycine 0 N--CA 1.442 -0.95 0 CA-C-N 115.906 -0.588 . . . . 0.0 111.84 179.897 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -63.25 146.5 53.29 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 120.993 0.425 . . . . 0.0 111.304 179.857 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 2.0 p -115.73 126.47 73.28 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.777 -179.533 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 5.5 t30 -94.57 -39.07 10.57 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 121.179 0.514 . . . . 0.0 110.047 179.309 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 3.0 tpt180 -150.01 151.98 34.17 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.121 -179.872 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 4.0 p -148.59 128.97 4.53 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-O 121.09 0.472 . . . . 0.0 110.122 179.483 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . 0.596 ' HB ' ' CE1' ' A' ' 119' ' ' TYR . 4.9 m -121.47 122.38 39.63 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 116.473 -0.33 . . . . 0.0 110.573 179.845 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' ILE . . . . . 0.566 HD11 ' HA2' ' A' ' 116' ' ' GLY . 19.6 tt -108.87 148.54 12.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 O-C-N 123.206 0.316 . . . . 0.0 110.408 179.741 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 17.6 tp -136.75 124.89 22.99 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.386 -179.914 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -89.0 117.37 27.97 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 120.81 0.338 . . . . 0.0 110.651 179.434 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 4.7 t70 -77.94 139.64 39.21 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.698 0.285 . . . . 0.0 110.762 179.596 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -123.34 32.6 5.6 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 121.061 0.457 . . . . 0.0 110.261 179.274 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 1.7 t80 -113.73 -3.06 13.57 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.302 -179.889 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 106.65 6.7 35.06 Favored Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 120.828 -0.701 . . . . 0.0 112.738 -179.565 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 113' ' ' GLN . . . . . 0.415 ' HB3' ' HD2' ' A' ' 114' ' ' PRO . 27.5 mt-30 -92.02 158.81 38.96 Favored Pre-proline 0 C--N 1.323 -0.568 0 N-CA-C 109.564 -0.532 . . . . 0.0 109.564 -179.939 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 114' ' ' PRO . . . . . 0.415 ' HD2' ' HB3' ' A' ' 113' ' ' GLN . 18.0 Cg_endo -59.7 106.45 0.32 Allowed 'Trans proline' 0 C--N 1.347 0.466 0 C-N-CA 122.411 2.074 . . . . 0.0 111.528 179.148 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 5.2 mttp -68.3 175.46 3.29 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.07 -0.513 . . . . 0.0 110.588 -179.475 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . 0.566 ' HA2' HD11 ' A' ' 106' ' ' ILE . . . 98.51 4.02 57.28 Favored Glycine 0 N--CA 1.441 -0.993 0 C-N-CA 120.04 -1.076 . . . . 0.0 111.658 -179.628 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 30.0 m-85 -52.82 116.06 2.14 Favored 'General case' 0 CA--C 1.521 -0.152 0 O-C-N 123.776 0.339 . . . . 0.0 110.364 179.86 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -144.05 176.19 9.48 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 121.057 0.456 . . . . 0.0 111.236 -179.255 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 119' ' ' TYR . . . . . 0.596 ' CE1' ' HB ' ' A' ' 105' ' ' THR . 50.0 p90 -159.93 137.34 9.64 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.497 -0.774 . . . . 0.0 109.171 178.93 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 10.9 m -111.01 143.57 20.63 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 178.925 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . 0.526 ' HB2' HG12 ' A' ' 72' ' ' VAL . 4.4 pt-20 -128.8 157.05 42.56 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 116.562 -0.29 . . . . 0.0 111.054 -179.207 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 122' ' ' PHE . . . . . 0.415 ' O ' ' HA ' ' A' ' 72' ' ' VAL . 11.9 t80 -161.37 168.99 22.85 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 109.691 -0.485 . . . . 0.0 109.691 179.491 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 1.8 t -85.54 -48.38 16.21 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-O 120.921 0.391 . . . . 0.0 111.342 -179.182 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 11.0 mt-10 -62.44 130.31 44.6 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.956 -0.565 . . . . 0.0 111.795 -178.971 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . 0.476 HG12 ' CZ ' ' A' ' 75' ' ' ARG . 2.3 mp -76.06 -32.4 23.0 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.468 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.63 -179.795 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 13.2 t70 -60.43 -39.49 87.64 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.102 0.477 . . . . 0.0 110.232 179.333 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -61.36 -53.64 54.04 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.523 -0.762 . . . . 0.0 111.545 179.963 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 7.3 p -68.74 -28.11 38.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.127 -179.511 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 25.5 tt0 -58.86 -47.6 84.32 Favored 'General case' 0 C--N 1.334 -0.096 0 CA-C-O 121.023 0.439 . . . . 0.0 110.32 179.629 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 76.8 m-20 -70.9 -33.29 70.42 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.741 -0.663 . . . . 0.0 109.864 179.533 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 131' ' ' ALA . . . . . 0.544 ' HB1' HD13 ' A' ' 77' ' ' ILE . . . -66.06 -40.52 90.98 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.542 -0.754 . . . . 0.0 112.219 -179.408 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 3.9 pp -79.49 -16.84 55.35 Favored 'General case' 0 C--N 1.329 -0.325 0 O-C-N 122.128 -0.358 . . . . 0.0 110.959 179.905 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 5.2 tp -86.12 -50.15 7.23 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.283 -179.529 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 28.3 mt -132.47 112.68 12.33 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.501 -0.318 . . . . 0.0 110.944 -179.208 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 3.5 m-20 -168.95 -49.41 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.336 179.664 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 1.9 pt-20 -75.09 79.48 2.25 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.58 -0.737 . . . . 0.0 111.206 179.737 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 6.5 m -135.4 -59.93 0.76 Allowed 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.912 -0.586 . . . . 0.0 110.188 179.224 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 7.9 tm-20 -149.31 128.05 12.48 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 109.606 -0.516 . . . . 0.0 109.606 179.959 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -149.78 121.04 7.82 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 179.329 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 140' ' ' HIS . . . . . 0.662 ' HB3' ' OD2' ' A' ' 83' ' ' ASP . 5.4 t60 60.83 13.47 4.46 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-O 121.076 0.465 . . . . 0.0 111.614 178.742 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 98.58 -6.11 60.7 Favored Glycine 0 N--CA 1.447 -0.611 0 C-N-CA 120.803 -0.713 . . . . 0.0 112.216 -179.621 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 142' ' ' ARG . . . . . 0.729 ' HB2' ' OD2' ' A' ' 83' ' ' ASP . 2.1 mpt_? -114.01 -169.32 1.5 Allowed 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.008 0.432 . . . . 0.0 110.187 179.347 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 15.3 pt20 -131.65 138.74 48.88 Favored 'General case' 0 C--N 1.319 -0.754 0 N-CA-C 109.254 -0.647 . . . . 0.0 109.254 178.796 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -123.2 177.79 5.41 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-N 115.867 -0.606 . . . . 0.0 109.935 -179.528 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 1.7 tmtp? -117.27 121.8 42.17 Favored 'General case' 0 C--N 1.315 -0.907 0 N-CA-C 109.588 -0.523 . . . . 0.0 109.588 179.09 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 98.8 t -114.82 119.78 62.61 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-O 120.827 0.346 . . . . 0.0 110.911 -179.427 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 5.1 t -122.09 153.15 39.05 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.022 179.665 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -70.83 125.61 27.33 Favored 'General case' 0 N--CA 1.445 -0.713 0 CA-C-O 120.858 0.361 . . . . 0.0 111.187 179.956 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 18.9 ttpp -90.88 68.95 6.38 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.502 0.668 . . . . 0.0 109.29 179.909 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 13.0 tpt180 . . . . . 0 C--N 1.319 -0.724 0 CA-C-N 115.731 -0.668 . . . . 0.0 109.965 -179.999 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.233 0.228 0 N-CA-C 110.374 -0.232 . . . . 0.0 110.374 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 29.4 tp -73.81 84.43 1.67 Allowed 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.226 0.536 . . . . 0.0 110.387 179.741 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 17.0 tpt180 -130.8 151.83 50.8 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.161 -179.623 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 26.8 mm-40 -82.45 19.49 1.24 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.301 -179.825 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 11.9 ptm -83.7 4.37 29.0 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.735 -179.431 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 43.5 mt-30 -66.19 -22.03 66.33 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.945 -0.571 . . . . 0.0 110.578 179.911 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -78.89 -8.69 59.07 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.601 -0.727 . . . . 0.0 111.446 -179.763 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . 0.462 ' O ' ' HG2' ' A' ' 52' ' ' GLU . 10.3 ttpt -78.23 -6.31 54.54 Favored 'General case' 0 C--O 1.234 0.28 0 CA-C-O 120.991 0.424 . . . . 0.0 110.345 -179.869 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 8.4 p -59.32 -25.65 31.4 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.325 0 CA-C-N 115.936 -0.575 . . . . 0.0 111.581 -179.48 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 39.5 mt-10 -61.47 -30.61 70.71 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 121.008 0.432 . . . . 0.0 110.922 -179.876 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 15.3 mtmm -95.83 -36.27 11.19 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.244 -179.532 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . 0.462 ' HG2' ' O ' ' A' ' 48' ' ' LYS . 3.0 mm-40 -75.63 -16.99 60.14 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.936 -178.337 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 25.7 ptm -64.47 -24.11 67.51 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.178 0.513 . . . . 0.0 110.117 178.731 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -97.83 1.06 59.49 Favored Glycine 0 N--CA 1.446 -0.69 0 N-CA-C 110.885 -0.886 . . . . 0.0 110.885 178.595 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.327 -0.373 0 CA-C-O 121.235 0.54 . . . . 0.0 110.215 179.931 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.52 -0.195 0 CA-C-O 120.877 0.37 . . . . 0.0 110.53 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -80.59 5.75 14.54 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.012 0.434 . . . . 0.0 111.136 -179.762 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 49.7 tp60 -125.16 -40.38 2.15 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.448 -0.342 . . . . 0.0 111.006 179.616 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -94.1 -53.45 3.96 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.917 0.389 . . . . 0.0 111.341 179.826 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 3.2 tp10 -70.12 -30.36 67.53 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.032 -179.421 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.11 -25.76 64.11 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.542 -179.886 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 39.9 mt-10 -62.98 -23.77 67.59 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.186 0.517 . . . . 0.0 110.925 179.883 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . 0.608 ' O ' ' HD3' ' A' ' 75' ' ' ARG . 8.3 tp10 -96.66 -43.59 7.49 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.992 -0.549 . . . . 0.0 109.572 178.225 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.427 HG22 ' HA ' ' A' ' 123' ' ' VAL . 41.3 t -61.15 -44.13 97.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 115.467 -0.788 . . . . 0.0 112.459 -178.709 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 8.5 p-10 -63.29 -27.57 69.42 Favored 'General case' 0 N--CA 1.471 0.624 0 N-CA-C 111.921 0.341 . . . . 0.0 111.921 -179.31 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 40.0 t -95.54 -2.27 48.84 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-O 120.909 0.385 . . . . 0.0 110.741 179.772 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . 0.608 ' HD3' ' O ' ' A' ' 71' ' ' GLU . 2.2 mpt_? -115.26 46.95 1.37 Allowed 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.389 0.614 . . . . 0.0 109.582 -179.473 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -125.43 174.48 8.16 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.188 -0.914 . . . . 0.0 110.436 179.874 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.479 HG23 HG23 ' A' ' 128' ' ' VAL . 7.4 pt -131.02 140.48 48.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-O 120.742 0.306 . . . . 0.0 110.794 179.141 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 13.7 t80 -92.75 118.72 31.38 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.616 -0.72 . . . . 0.0 109.361 179.636 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.419 HG21 ' HE2' ' A' ' 95' ' ' PHE . 6.8 t -104.01 109.51 27.46 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-N 116.332 -0.395 . . . . 0.0 109.974 179.452 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -118.03 165.85 12.74 Favored Glycine 0 N--CA 1.447 -0.576 0 C-N-CA 120.773 -0.727 . . . . 0.0 111.995 -179.262 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 9.9 m120 59.21 41.12 20.69 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-O 121.043 0.449 . . . . 0.0 110.741 -179.621 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.422 HG12 ' H ' ' A' ' 83' ' ' ASP . 2.1 t -80.02 167.56 2.15 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-N 115.566 -0.743 . . . . 0.0 110.41 -179.172 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . 0.46 ' OD1' ' HD3' ' A' ' 142' ' ' ARG . 33.0 t70 -75.03 141.34 43.91 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.043 0.449 . . . . 0.0 110.627 179.901 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 29.2 p90 -63.09 -17.02 61.84 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.673 -0.694 . . . . 0.0 112.613 -178.743 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -110.42 8.27 23.13 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.828 0.346 . . . . 0.0 111.481 -179.592 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' CYS . . . . . 0.499 ' SG ' ' HB2' ' A' ' 140' ' ' HIS . 1.0 OUTLIER -73.27 142.42 47.22 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.154 0.502 . . . . 0.0 111.299 -179.893 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . 0.506 ' O ' ' HG2' ' A' ' 90' ' ' GLU . 12.2 p -109.73 154.12 42.64 Favored Pre-proline 0 C--N 1.322 -0.602 0 CA-C-N 115.464 -0.789 . . . . 0.0 109.856 178.997 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . 0.559 ' O ' ' HG2' ' A' ' 92' ' ' GLN . 14.0 Cg_endo -57.25 -36.83 99.07 Favored 'Trans proline' 0 C--O 1.233 0.236 0 C-N-CA 122.391 2.061 . . . . 0.0 112.274 -179.726 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . 0.443 ' O ' ' HG2' ' A' ' 93' ' ' GLN . 28.2 mp0 -62.93 -51.51 66.64 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.781 -179.42 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . 0.506 ' HG2' ' O ' ' A' ' 87' ' ' THR . 8.3 pt-20 -63.96 -22.68 67.03 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.615 0.245 . . . . 0.0 111.344 -178.751 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 66.5 t -82.98 -48.05 17.97 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.521 -179.583 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' GLN . . . . . 0.559 ' HG2' ' O ' ' A' ' 88' ' ' PRO . 16.4 pt20 -71.86 -33.56 68.51 Favored 'General case' 0 N--CA 1.465 0.284 0 N-CA-C 111.881 0.326 . . . . 0.0 111.881 -178.397 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . 0.443 ' HG2' ' O ' ' A' ' 89' ' ' GLU . 0.8 OUTLIER -77.27 -27.87 53.29 Favored 'General case' 0 C--N 1.329 -0.32 0 C-N-CA 120.464 -0.494 . . . . 0.0 110.636 -179.515 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' HIS . . . . . 0.495 ' HB2' ' O ' ' A' ' 90' ' ' GLU . 0.1 OUTLIER -71.9 -43.33 65.52 Favored 'General case' 0 CA--C 1.517 -0.295 0 CA-C-O 121.11 0.481 . . . . 0.0 110.276 179.719 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . 0.419 ' HE2' HG21 ' A' ' 79' ' ' VAL . 21.0 m-30 -79.13 -15.36 58.25 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.93 -179.453 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . 0.507 ' HA ' ' O ' ' A' ' 99' ' ' GLY . 33.6 tt0 -64.64 -23.5 67.28 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.558 179.967 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 13.4 m -65.72 -33.41 75.8 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.409 179.454 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 11.1 m -94.95 -40.78 9.5 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.368 179.871 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . 0.507 ' O ' ' HA ' ' A' ' 96' ' ' GLN . . . -146.46 130.39 3.66 Favored Glycine 0 N--CA 1.444 -0.829 0 C-N-CA 120.688 -0.768 . . . . 0.0 111.742 -179.916 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . 0.421 ' HB ' ' CZ ' ' A' ' 122' ' ' PHE . 0.2 OUTLIER -58.56 146.45 35.7 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 120.984 0.421 . . . . 0.0 111.539 179.894 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 2.4 p -111.99 131.43 63.43 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.112 -179.133 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 23.1 t-20 -99.19 -45.02 6.04 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 178.566 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 18.5 mmt180 -141.55 150.23 41.84 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-N 115.509 -0.769 . . . . 0.0 110.088 179.473 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 6.1 p -146.17 136.53 18.2 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-O 121.013 0.435 . . . . 0.0 110.191 179.385 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . 0.516 ' HB ' ' CE1' ' A' ' 119' ' ' TYR . 1.4 m -128.15 129.4 46.47 Favored 'General case' 0 C--N 1.319 -0.722 0 N-CA-C 109.731 -0.47 . . . . 0.0 109.731 179.309 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' ILE . . . . . 0.537 HD13 ' HD3' ' A' ' 88' ' ' PRO . 20.1 tt -120.47 147.47 24.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-O 120.953 0.406 . . . . 0.0 111.294 -179.298 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 15.3 tp -133.11 143.52 49.34 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.25 179.361 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -104.5 119.34 38.76 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 120.588 0.232 . . . . 0.0 110.662 179.463 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 8.5 t70 -80.08 130.41 35.23 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.992 0.425 . . . . 0.0 111.245 -179.76 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 10.8 mmmm -114.66 20.51 15.23 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.272 -179.799 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 63.9 t80 -98.68 -11.26 22.18 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.491 0.662 . . . . 0.0 109.913 -179.446 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 111.15 8.56 23.49 Favored Glycine 0 N--CA 1.448 -0.534 0 CA-C-N 115.557 -0.747 . . . . 0.0 112.394 -179.269 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 113' ' ' GLN . . . . . 0.443 ' HB3' ' HD2' ' A' ' 114' ' ' PRO . 24.4 mt-30 -94.42 160.58 31.44 Favored Pre-proline 0 C--N 1.323 -0.553 0 N-CA-C 109.188 -0.671 . . . . 0.0 109.188 179.663 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 114' ' ' PRO . . . . . 0.443 ' HD2' ' HB3' ' A' ' 113' ' ' GLN . 14.4 Cg_endo -57.37 114.2 1.84 Allowed 'Trans proline' 0 C--N 1.346 0.415 0 C-N-CA 122.357 2.038 . . . . 0.0 111.686 179.119 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 6.3 mttp -76.98 179.3 6.3 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.403 -179.897 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . 0.498 ' HA2' HD11 ' A' ' 106' ' ' ILE . . . 94.99 1.45 63.1 Favored Glycine 0 N--CA 1.445 -0.718 0 C-N-CA 120.056 -1.068 . . . . 0.0 111.488 -179.884 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 6.8 t80 -53.74 117.31 3.06 Favored 'General case' 0 C--O 1.234 0.278 0 O-C-N 123.806 0.357 . . . . 0.0 110.125 179.744 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -145.32 175.34 10.37 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.781 -179.356 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 119' ' ' TYR . . . . . 0.516 ' CE1' ' HB ' ' A' ' 105' ' ' THR . 51.7 p90 -157.48 134.16 9.93 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.561 -0.745 . . . . 0.0 109.292 179.047 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 14.7 m -110.49 140.15 30.88 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 N-CA-C 109.766 -0.457 . . . . 0.0 109.766 179.705 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . 0.422 ' HB2' HG12 ' A' ' 72' ' ' VAL . 7.9 pt-20 -124.45 154.22 40.81 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 116.596 -0.275 . . . . 0.0 110.642 -179.993 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 122' ' ' PHE . . . . . 0.421 ' CZ ' ' HB ' ' A' ' 100' ' ' THR . 11.0 t80 -149.29 164.84 33.71 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.203 179.94 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . 0.427 ' HA ' HG22 ' A' ' 72' ' ' VAL . 11.8 t -81.56 -42.64 19.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.317 -179.579 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 81.9 mt-10 -76.38 138.73 40.6 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.043 0.449 . . . . 0.0 111.171 -179.541 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 2.5 mp -75.87 -30.55 21.2 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-N 115.745 -0.661 . . . . 0.0 110.029 179.572 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -54.15 -47.21 72.18 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 115.802 -0.636 . . . . 0.0 111.17 179.596 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -56.26 -58.0 9.84 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.396 -0.82 . . . . 0.0 111.488 -179.362 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . 0.479 HG23 HG23 ' A' ' 77' ' ' ILE . 8.9 p -66.04 -32.8 59.73 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-N 116.31 -0.404 . . . . 0.0 111.676 -179.049 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 44.9 tt0 -60.99 -41.11 95.85 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.817 0.341 . . . . 0.0 110.88 -179.579 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 94.4 m-20 -79.4 -28.9 41.83 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.148 0.499 . . . . 0.0 110.01 179.36 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -70.12 -39.13 75.63 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.651 -0.704 . . . . 0.0 112.045 -179.414 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 4.2 pp -75.89 -11.47 59.97 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.938 0.399 . . . . 0.0 110.809 -179.901 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -88.84 -58.94 2.37 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.841 -0.618 . . . . 0.0 111.063 -179.923 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 75.8 mt -125.53 108.27 11.44 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.681 -178.864 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 2.8 m-20 -162.99 -50.66 0.04 OUTLIER 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.771 -0.65 . . . . 0.0 110.801 179.876 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 5.0 pt-20 -73.35 85.11 1.45 Allowed 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.779 -0.646 . . . . 0.0 111.448 -179.917 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 6.3 m -137.97 -59.32 0.65 Allowed 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.58 -0.736 . . . . 0.0 110.154 179.091 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 22.7 tt0 -153.79 127.94 9.04 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.217 -179.816 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -145.57 115.61 7.42 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 108.764 -0.828 . . . . 0.0 108.764 179.101 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 140' ' ' HIS . . . . . 0.499 ' HB2' ' SG ' ' A' ' 86' ' ' CYS . 2.8 t60 65.83 21.09 11.47 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-O 121.058 0.456 . . . . 0.0 110.373 -179.596 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 87.53 4.4 80.13 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.213 -179.601 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 142' ' ' ARG . . . . . 0.46 ' HD3' ' OD1' ' A' ' 83' ' ' ASP . 0.8 OUTLIER -125.66 165.19 19.02 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 109.945 -0.391 . . . . 0.0 109.945 179.838 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 12.9 pt20 -107.85 139.61 42.18 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-O 120.982 0.42 . . . . 0.0 110.697 179.656 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -121.68 178.08 4.99 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.037 -179.97 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 28.5 ttpt -116.22 122.41 44.93 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 109.912 -0.403 . . . . 0.0 109.912 179.063 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 95.7 t -113.92 123.13 69.28 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-O 120.968 0.413 . . . . 0.0 110.525 179.713 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 30.5 t -125.05 149.37 47.86 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 109.507 -0.553 . . . . 0.0 109.507 179.892 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -68.83 127.55 33.48 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 110.56 -0.163 . . . . 0.0 110.56 179.687 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 64.8 tttp -90.94 83.15 5.62 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.294 0.569 . . . . 0.0 110.505 -179.74 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 23.8 tpt180 . . . . . 0 C--N 1.319 -0.751 0 CA-C-N 115.741 -0.663 . . . . 0.0 109.36 179.01 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.233 0.233 0 N-CA-C 110.085 -0.339 . . . . 0.0 110.085 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 18.6 tp -81.56 85.88 6.45 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.17 0.51 . . . . 0.0 110.067 179.622 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 13.4 tpp180 -145.95 132.36 19.65 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.899 -0.591 . . . . 0.0 109.652 179.96 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 3.3 tp10 -82.79 39.26 0.61 Allowed 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.559 0.695 . . . . 0.0 110.911 -179.742 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 17.6 ptt? -87.83 11.66 14.98 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.656 -0.702 . . . . 0.0 109.538 179.089 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 19.4 mm-40 -66.87 -22.5 65.98 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.277 -0.874 . . . . 0.0 111.101 -179.682 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -68.8 -14.4 63.0 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 121.348 0.594 . . . . 0.0 110.6 179.54 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 20.2 ttpp -83.24 1.05 42.73 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.589 -0.732 . . . . 0.0 110.33 179.814 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 8.3 p -59.48 -26.2 33.6 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.205 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.971 -179.912 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 26.6 mt-10 -67.14 -24.67 65.93 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 115.912 -0.586 . . . . 0.0 110.344 179.534 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 11.4 mtmm -97.22 -29.74 13.4 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.579 -0.737 . . . . 0.0 110.594 179.331 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 38.0 mm-40 -80.96 -5.32 57.36 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.677 -179.661 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 10.7 ptp -62.33 -30.83 71.44 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.891 0.377 . . . . 0.0 110.652 -179.932 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -91.55 3.89 79.17 Favored Glycine 0 N--CA 1.447 -0.594 0 C-N-CA 120.722 -0.751 . . . . 0.0 111.319 178.838 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.325 -0.461 0 CA-C-N 115.432 -0.384 . . . . 0.0 110.275 -179.802 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.453 -0.285 0 CA-C-O 120.939 0.399 . . . . 0.0 110.488 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -76.44 -2.12 30.45 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.25 0.548 . . . . 0.0 110.793 179.865 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 64.7 tt0 -114.39 -54.71 2.56 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.923 179.924 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -85.49 -56.09 3.69 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.793 -178.509 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . 0.458 ' O ' HG23 ' A' ' 72' ' ' VAL . 1.2 tt0 -62.65 -31.48 72.35 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.952 0.406 . . . . 0.0 110.896 -179.61 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 48.7 tptt -55.55 -30.01 59.99 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.587 -0.733 . . . . 0.0 111.299 179.937 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 99.3 mt-10 -58.63 -41.6 86.32 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.027 0.441 . . . . 0.0 110.455 179.469 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . 0.429 ' O ' ' HD2' ' A' ' 75' ' ' ARG . 7.4 tp10 -76.86 -43.37 36.38 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.057 -0.519 . . . . 0.0 109.871 179.308 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.583 HG12 ' HB2' ' A' ' 121' ' ' GLU . 43.8 t -60.75 -40.34 84.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 115.648 -0.705 . . . . 0.0 111.624 -179.241 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 7.5 t0 -68.23 -23.26 64.78 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-O 121.318 0.58 . . . . 0.0 110.723 -179.934 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 1.2 t -95.29 -9.9 31.77 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 121.686 0.755 . . . . 0.0 109.782 179.705 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . 0.429 ' HD2' ' O ' ' A' ' 71' ' ' GLU . 0.0 OUTLIER -111.75 44.77 1.32 Allowed 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.396 -0.82 . . . . 0.0 110.659 -179.259 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . 0.464 ' OG ' ' HE2' ' A' ' 149' ' ' LYS . 0.0 OUTLIER -126.92 171.69 11.07 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.818 179.367 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 13.8 pt -131.01 136.95 56.97 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-N 116.465 -0.334 . . . . 0.0 110.198 178.64 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' TYR . . . . . 0.447 ' O ' ' HA ' ' A' ' 146' ' ' VAL . 43.0 t80 -91.12 123.29 34.47 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.142 -179.896 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 10.4 t -107.04 111.92 37.72 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.658 -179.749 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -121.48 170.8 14.84 Favored Glycine 0 N--CA 1.446 -0.682 0 N-CA-C 111.362 -0.695 . . . . 0.0 111.362 179.974 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 13.1 m120 58.39 44.24 18.6 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-O 121.294 0.569 . . . . 0.0 110.441 -179.627 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.498 HG12 ' H ' ' A' ' 83' ' ' ASP . 1.7 t -90.07 172.1 1.03 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 CA-C-N 115.338 -0.846 . . . . 0.0 110.615 -179.011 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . 0.498 ' H ' HG12 ' A' ' 82' ' ' VAL . 9.2 t0 -68.74 137.25 53.91 Favored 'General case' 0 N--CA 1.451 -0.395 0 N-CA-C 109.666 -0.494 . . . . 0.0 109.666 179.476 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 34.9 p90 -61.71 -18.14 58.51 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.459 -179.28 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -118.15 20.59 13.14 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.511 -0.313 . . . . 0.0 111.332 179.942 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' CYS . . . . . 0.459 ' SG ' ' HB3' ' A' ' 83' ' ' ASP . 0.5 OUTLIER -77.16 145.25 37.83 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.984 0.421 . . . . 0.0 110.869 179.603 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . 0.474 ' O ' ' HG2' ' A' ' 90' ' ' GLU . 55.9 p -103.08 151.22 38.43 Favored Pre-proline 0 C--N 1.323 -0.57 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.261 179.637 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -61.77 -29.2 82.84 Favored 'Trans proline' 0 C--O 1.233 0.24 0 C-N-CA 122.3 2.0 . . . . 0.0 111.93 179.835 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . 0.517 ' O ' ' HG2' ' A' ' 93' ' ' GLN . 27.8 mt-10 -66.27 -53.26 38.94 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.343 -0.844 . . . . 0.0 111.933 -178.837 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . 0.474 ' HG2' ' O ' ' A' ' 87' ' ' THR . 9.2 pt-20 -61.71 -24.98 67.13 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.967 0.413 . . . . 0.0 111.24 -179.268 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 69.3 t -79.84 -48.57 20.41 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.275 -179.106 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' GLN . . . . . 0.411 ' O ' ' HB2' ' A' ' 96' ' ' GLN . 0.0 OUTLIER -70.29 -32.88 70.85 Favored 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 112.196 0.443 . . . . 0.0 112.196 -178.183 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . 0.517 ' HG2' ' O ' ' A' ' 89' ' ' GLU . 9.6 pt20 -79.79 -28.77 40.25 Favored 'General case' 0 C--N 1.325 -0.491 0 C-N-CA 120.061 -0.656 . . . . 0.0 111.19 -179.331 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 58.7 t-80 -68.92 -45.22 71.4 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.808 0.337 . . . . 0.0 110.57 179.989 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 23.9 m-85 -78.53 -11.8 59.98 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.68 -179.388 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . 0.563 ' HA ' ' O ' ' A' ' 99' ' ' GLY . 8.2 tt0 -68.9 -21.7 64.22 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 121.23 0.538 . . . . 0.0 109.958 179.802 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 4.5 m -66.52 -32.24 73.47 Favored 'General case' 0 N--CA 1.452 -0.347 0 CA-C-N 115.673 -0.694 . . . . 0.0 109.531 178.545 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 2.1 m -88.25 -47.83 8.14 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.546 -0.752 . . . . 0.0 110.075 179.575 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . 0.563 ' O ' ' HA ' ' A' ' 96' ' ' GLN . . . -147.07 142.35 10.23 Favored Glycine 0 N--CA 1.447 -0.603 0 C-N-CA 121.023 -0.608 . . . . 0.0 111.751 179.801 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -60.07 144.03 50.56 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 120.827 0.346 . . . . 0.0 111.503 -179.639 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 2.3 p -114.86 127.76 72.27 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.289 179.832 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 20.1 t-20 -95.1 -40.99 9.34 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.145 0.498 . . . . 0.0 110.098 179.649 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 3.2 tpp180 -144.87 155.91 43.72 Favored 'General case' 0 N--CA 1.45 -0.425 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.263 -179.487 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 5.7 p -154.32 133.95 3.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.109 179.804 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -126.13 127.74 46.23 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 109.736 -0.468 . . . . 0.0 109.736 179.006 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' ILE . . . . . 0.424 HD11 ' HA2' ' A' ' 116' ' ' GLY . 20.1 tt -111.04 146.07 16.54 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-O 121.017 0.437 . . . . 0.0 110.951 -179.368 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 43.3 tp -130.15 138.32 50.58 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.26 179.816 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -103.64 113.68 27.38 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 109.963 -0.384 . . . . 0.0 109.963 179.453 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 6.4 t70 -72.3 133.32 44.94 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.054 0.454 . . . . 0.0 111.367 -179.677 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 11.2 mmmt -111.31 19.22 18.5 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.722 -179.868 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 3.0 t80 -101.0 -9.93 21.0 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.973 0.416 . . . . 0.0 110.324 -179.372 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 110.83 -0.53 28.8 Favored Glycine 0 N--CA 1.449 -0.441 0 CA-C-N 115.788 -0.642 . . . . 0.0 112.227 -179.808 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 3.5 mt-30 -81.28 158.63 69.13 Favored Pre-proline 0 C--N 1.323 -0.581 0 N-CA-C 110.332 -0.247 . . . . 0.0 110.332 -179.911 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 13.5 Cg_endo -56.57 103.77 0.13 Allowed 'Trans proline' 0 C--N 1.347 0.486 0 C-N-CA 122.687 2.258 . . . . 0.0 111.319 178.419 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 7.8 mttp -68.84 176.67 2.94 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.606 -0.725 . . . . 0.0 110.776 -178.444 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . 0.424 ' HA2' HD11 ' A' ' 106' ' ' ILE . . . 99.92 4.52 55.53 Favored Glycine 0 N--CA 1.441 -0.998 0 C-N-CA 120.398 -0.906 . . . . 0.0 111.187 -179.54 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 59.2 m-85 -52.27 118.3 3.43 Favored 'General case' 0 CA--C 1.522 -0.098 0 C-N-CA 122.63 0.372 . . . . 0.0 110.121 179.401 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -146.23 176.33 9.84 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 121.052 0.453 . . . . 0.0 111.234 -178.916 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 43.5 p90 -156.56 133.95 10.7 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.418 -0.81 . . . . 0.0 109.706 179.155 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 15.7 m -108.42 142.5 20.89 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 N-CA-C 109.108 -0.701 . . . . 0.0 109.108 178.62 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . 0.583 ' HB2' HG12 ' A' ' 72' ' ' VAL . 5.9 pt-20 -131.39 156.18 46.0 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 120.927 0.394 . . . . 0.0 111.884 -178.901 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 13.8 t80 -152.08 166.64 30.99 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.796 -0.638 . . . . 0.0 109.755 179.134 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 13.0 t -83.96 -52.94 12.16 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-O 120.76 0.314 . . . . 0.0 111.242 -179.52 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 38.6 mt-10 -67.88 131.7 45.99 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.832 -179.66 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 2.2 mp -70.91 -31.07 44.25 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.88 -179.161 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -54.47 -40.48 68.47 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-O 121.15 0.5 . . . . 0.0 111.228 179.327 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -62.76 -57.05 12.29 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.837 -0.62 . . . . 0.0 111.273 -179.877 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 9.9 p -65.91 -27.97 42.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.192 -179.503 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 129' ' ' GLN . . . . . 0.432 HE21 HD11 ' A' ' 132' ' ' LEU . 18.6 tp60 -59.08 -44.58 91.92 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.902 0.382 . . . . 0.0 110.247 179.506 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 52.9 m-80 -77.31 -29.66 53.72 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.919 -0.582 . . . . 0.0 109.72 179.209 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -67.38 -41.6 84.75 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.799 -0.637 . . . . 0.0 111.342 179.821 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 132' ' ' LEU . . . . . 0.432 HD11 HE21 ' A' ' 129' ' ' GLN . 4.2 pp -77.96 -10.31 59.53 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.915 0.388 . . . . 0.0 110.605 179.482 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -86.7 -52.51 5.48 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.928 -0.578 . . . . 0.0 109.648 179.257 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 27.7 mt -117.46 102.83 9.53 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.598 -0.728 . . . . 0.0 109.647 179.919 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 135' ' ' ASN . . . . . 0.536 ' OD1' ' HB ' ' A' ' 146' ' ' VAL . 1.3 p30 -142.96 -78.1 0.23 Allowed 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 112.422 0.527 . . . . 0.0 112.422 -178.46 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -68.76 109.99 4.11 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.432 0.634 . . . . 0.0 111.549 -178.67 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 56.2 m -152.43 -61.53 0.16 Allowed 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.709 -0.678 . . . . 0.0 109.666 179.0 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 -157.76 120.36 3.84 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 116.699 -0.228 . . . . 0.0 110.943 179.225 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -140.6 116.66 10.49 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 109.555 -0.535 . . . . 0.0 109.555 179.482 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 1.3 t60 61.69 17.21 8.48 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-O 120.992 0.425 . . . . 0.0 110.863 -179.866 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 96.34 -7.38 66.36 Favored Glycine 0 N--CA 1.448 -0.556 0 C-N-CA 120.992 -0.623 . . . . 0.0 112.173 -179.76 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 3.8 mpt_? -112.26 160.61 17.47 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.938 0.399 . . . . 0.0 111.443 -179.39 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 16.3 pt20 -104.79 116.9 32.8 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 109.387 -0.597 . . . . 0.0 109.387 178.641 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . 0.452 HD23 HG13 ' A' ' 82' ' ' VAL . 0.5 OUTLIER -95.32 176.73 6.09 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.081 -179.16 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 1.8 tmtp? -117.64 120.94 39.55 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 109.679 -0.489 . . . . 0.0 109.679 179.599 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 146' ' ' VAL . . . . . 0.536 ' HB ' ' OD1' ' A' ' 135' ' ' ASN . 99.3 t -119.34 133.02 67.5 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-O 120.879 0.371 . . . . 0.0 111.26 -179.336 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 5.3 m -135.24 142.86 46.06 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.114 -0.494 . . . . 0.0 109.954 178.92 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -58.87 124.98 21.65 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.846 0.355 . . . . 0.0 110.844 179.766 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 149' ' ' LYS . . . . . 0.464 ' HE2' ' OG ' ' A' ' 76' ' ' SER . 23.7 ttpt -91.17 63.33 5.01 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.562 0.696 . . . . 0.0 109.189 -179.877 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.32 -0.712 0 CA-C-N 115.405 -0.816 . . . . 0.0 109.81 -179.872 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.236 0.344 0 CA-C-O 120.742 0.306 . . . . 0.0 110.953 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 32.0 tp -79.82 79.55 6.32 Favored 'General case' 0 N--CA 1.45 -0.436 0 CA-C-O 121.796 0.808 . . . . 0.0 110.079 179.959 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 65.5 ttt180 -161.62 159.37 27.49 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 114.739 -1.119 . . . . 0.0 109.382 -179.787 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 4.5 tt0 -78.62 19.89 0.47 Allowed 'General case' 0 N--CA 1.465 0.316 0 CA-C-O 121.325 0.583 . . . . 0.0 110.922 179.988 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 13.6 ptm -88.16 6.0 38.68 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.717 -179.819 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 49.5 mt-30 -70.77 -23.03 62.32 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.581 179.999 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -75.51 -13.9 60.39 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.361 0.601 . . . . 0.0 110.623 179.33 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 6.1 ttmm -74.0 -2.28 23.48 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.683 -0.69 . . . . 0.0 111.09 -179.523 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 9.5 p -57.64 -24.4 22.33 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.275 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.155 -179.87 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 4.6 mm-40 -62.14 -27.99 69.33 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-O 121.107 0.48 . . . . 0.0 110.341 179.552 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 5.8 mtmm -106.76 -42.57 4.92 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.747 -0.66 . . . . 0.0 110.994 179.619 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 78.9 mm-40 -64.87 -6.09 7.5 Favored 'General case' 0 N--CA 1.467 0.397 0 N-CA-C 112.304 0.483 . . . . 0.0 112.304 -179.089 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 3.0 ptt? -65.76 -23.9 66.83 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.112 0.482 . . . . 0.0 109.937 178.777 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -96.78 5.42 64.06 Favored Glycine 0 N--CA 1.451 -0.332 0 N-CA-C 110.708 -0.957 . . . . 0.0 110.708 178.337 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.359 0 CA-C-N 115.284 -0.458 . . . . 0.0 110.134 -179.85 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.518 -0.265 0 CA-C-O 120.986 0.422 . . . . 0.0 110.215 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -82.36 7.21 14.67 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.439 0.638 . . . . 0.0 110.2 179.499 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 1.1 tp-100 -124.88 -55.34 1.6 Allowed 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.705 -0.68 . . . . 0.0 111.357 -179.795 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -85.16 -51.48 6.6 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.54 -179.275 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 4.8 tp10 -72.3 -24.27 61.3 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.102 0.477 . . . . 0.0 110.312 -179.549 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 2.2 tptm -64.23 -24.64 67.74 Favored 'General case' 0 N--CA 1.453 -0.317 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.611 178.902 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -63.55 -17.75 63.14 Favored 'General case' 0 C--O 1.232 0.141 0 CA-C-O 121.543 0.687 . . . . 0.0 109.927 178.882 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . 0.464 ' O ' ' HD2' ' A' ' 75' ' ' ARG . 6.6 tp10 -97.37 -47.17 5.8 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.147 -0.933 . . . . 0.0 109.208 177.744 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 94.7 t -60.36 -39.37 80.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 115.449 -0.796 . . . . 0.0 112.332 -178.943 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 17.5 p-10 -68.8 -21.31 64.33 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-O 120.754 0.311 . . . . 0.0 111.47 -178.596 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 39.1 t -101.32 -0.07 36.27 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 109.451 -0.574 . . . . 0.0 109.451 178.66 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . 0.464 ' HD2' ' O ' ' A' ' 71' ' ' GLU . 0.0 OUTLIER -117.91 44.15 2.25 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.551 -0.75 . . . . 0.0 110.309 -179.749 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -123.43 172.25 8.85 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.675 179.499 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 8.3 pt -132.99 137.46 53.7 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 N-CA-C 109.864 -0.421 . . . . 0.0 109.864 178.604 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 85.4 t80 -96.06 125.61 40.72 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 116.148 -0.478 . . . . 0.0 109.849 -179.775 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.436 HG12 HG22 ' A' ' 82' ' ' VAL . 4.6 t -105.24 114.32 44.49 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.057 -179.346 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -117.97 168.0 12.97 Favored Glycine 0 N--CA 1.448 -0.504 0 N-CA-C 111.123 -0.791 . . . . 0.0 111.123 179.502 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 4.3 m-20 58.61 41.4 22.27 Favored 'General case' 0 N--CA 1.472 0.662 0 CA-C-O 121.118 0.485 . . . . 0.0 110.844 -179.328 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.436 HG22 HG12 ' A' ' 79' ' ' VAL . 2.0 t -85.66 166.38 2.04 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.954 -179.245 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . 0.627 ' OD2' ' HD3' ' A' ' 142' ' ' ARG . 9.9 t70 -67.83 136.63 54.42 Favored 'General case' 0 CA--C 1.519 -0.243 0 N-CA-C 109.587 -0.523 . . . . 0.0 109.587 179.526 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 32.4 p90 -62.09 -19.71 63.26 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.944 -0.571 . . . . 0.0 112.493 -178.597 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -112.71 17.61 18.95 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 120.534 0.207 . . . . 0.0 111.508 -179.382 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' CYS . . . . . 0.442 ' SG ' ' HB3' ' A' ' 83' ' ' ASP . 0.7 OUTLIER -77.51 144.58 37.57 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.196 0.522 . . . . 0.0 111.41 -179.779 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . 0.504 ' O ' ' HG2' ' A' ' 90' ' ' GLU . 20.5 p -105.44 152.92 40.04 Favored Pre-proline 0 C--N 1.323 -0.554 0 CA-C-N 115.496 -0.775 . . . . 0.0 110.008 179.222 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . 0.409 ' HD3' HD13 ' A' ' 106' ' ' ILE . 21.0 Cg_endo -61.32 -32.04 89.44 Favored 'Trans proline' 0 C--N 1.342 0.221 0 C-N-CA 122.342 2.028 . . . . 0.0 112.554 -179.071 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 12.3 mt-10 -64.54 -54.42 32.56 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.737 -0.665 . . . . 0.0 111.731 -178.862 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . 0.571 ' O ' ' HB2' ' A' ' 94' ' ' HIS . 11.3 pt-20 -60.72 -26.25 67.03 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.032 0.444 . . . . 0.0 111.299 -178.75 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 51.8 t -78.92 -48.97 20.96 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.319 -179.244 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -71.19 -32.47 68.9 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 111.794 0.294 . . . . 0.0 111.794 -178.585 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 16.7 pt20 -79.45 -25.99 41.85 Favored 'General case' 0 C--N 1.33 -0.243 0 C-N-CA 120.774 -0.37 . . . . 0.0 111.323 -179.117 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' HIS . . . . . 0.571 ' HB2' ' O ' ' A' ' 90' ' ' GLU . 2.3 t60 -76.34 -38.6 55.67 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.838 0.352 . . . . 0.0 110.414 -179.988 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 21.2 m-30 -81.23 -15.08 56.67 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.497 179.827 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . 0.538 ' HA ' ' O ' ' A' ' 99' ' ' GLY . 48.7 tt0 -65.72 -21.83 66.56 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.718 -0.674 . . . . 0.0 110.621 -179.977 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 17.3 m -68.58 -20.14 64.5 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.877 -0.602 . . . . 0.0 110.377 179.132 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 32.3 m -102.69 -46.42 4.73 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.005 179.188 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . 0.538 ' O ' ' HA ' ' A' ' 96' ' ' GLN . . . -145.2 142.29 10.66 Favored Glycine 0 N--CA 1.445 -0.76 0 N-CA-C 111.506 -0.637 . . . . 0.0 111.506 179.781 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . 0.405 ' HB ' ' CZ ' ' A' ' 122' ' ' PHE . 0.2 OUTLIER -62.29 148.37 45.21 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-O 120.889 0.376 . . . . 0.0 111.305 -179.715 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 2.4 p -117.79 130.89 71.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.916 -179.652 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 16.6 t30 -98.46 -45.56 6.08 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.292 0.568 . . . . 0.0 109.868 179.123 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -142.54 150.78 40.86 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.756 -0.656 . . . . 0.0 109.668 179.844 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 3.5 p -146.04 129.54 10.22 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 N-CA-C 109.89 -0.411 . . . . 0.0 109.89 179.734 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 7.8 m -120.48 125.98 49.24 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 110.268 -0.271 . . . . 0.0 110.268 179.924 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' ILE . . . . . 0.409 HD13 ' HD3' ' A' ' 88' ' ' PRO . 19.8 tt -112.36 146.18 17.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.434 -179.944 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 16.4 tp -131.81 132.47 43.78 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.511 179.765 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -96.85 121.59 38.88 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 116.201 -0.454 . . . . 0.0 109.867 179.208 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -88.56 136.22 33.1 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.788 0.327 . . . . 0.0 110.592 179.968 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . 0.416 ' N ' ' HD3' ' A' ' 110' ' ' LYS . 0.0 OUTLIER -121.64 21.66 10.79 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 120.986 0.422 . . . . 0.0 110.474 179.819 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 17.3 t80 -101.68 -5.34 25.13 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.26 0.552 . . . . 0.0 110.277 -179.879 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 112.42 2.21 26.1 Favored Glycine 0 N--CA 1.447 -0.631 0 C-N-CA 120.879 -0.677 . . . . 0.0 112.392 179.733 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 19.4 mt-30 -89.52 154.89 48.67 Favored Pre-proline 0 C--N 1.326 -0.424 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 179.565 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -55.23 121.54 10.1 Favored 'Trans proline' 0 N--CA 1.46 -0.441 0 C-N-CA 121.737 1.625 . . . . 0.0 110.971 178.773 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 54.6 mttt -76.64 176.1 8.7 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 -179.352 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 94.95 6.9 60.14 Favored Glycine 0 N--CA 1.446 -0.634 0 C-N-CA 120.129 -1.034 . . . . 0.0 112.355 179.648 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 4.4 m-30 -58.75 103.94 0.19 Allowed 'General case' 0 C--N 1.332 -0.169 0 N-CA-C 109.815 -0.439 . . . . 0.0 109.815 179.607 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -132.18 177.25 7.71 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-O 121.085 0.469 . . . . 0.0 111.324 -179.059 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 2.0 p90 -158.56 139.58 13.03 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.372 -0.831 . . . . 0.0 109.379 179.179 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 13.8 m -112.49 142.87 23.5 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 N-CA-C 109.555 -0.535 . . . . 0.0 109.555 178.35 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 5.0 pt-20 -129.38 150.13 50.87 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.787 -179.671 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 122' ' ' PHE . . . . . 0.405 ' CZ ' ' HB ' ' A' ' 100' ' ' THR . 16.3 t80 -151.73 168.93 23.48 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.336 179.61 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 4.1 t -82.8 -54.21 9.9 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-O 120.836 0.35 . . . . 0.0 111.496 -179.359 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 56.7 mt-10 -60.61 126.52 27.73 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.958 -0.565 . . . . 0.0 111.586 -179.105 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 2.2 mp -71.69 -33.62 49.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 115.703 -0.681 . . . . 0.0 109.864 179.567 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -60.37 -38.05 82.65 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.466 -0.788 . . . . 0.0 110.707 179.585 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -63.95 -56.13 17.42 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.783 -0.644 . . . . 0.0 111.119 -179.986 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 9.9 p -64.12 -27.77 43.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-O 120.812 0.339 . . . . 0.0 110.561 179.774 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 129' ' ' GLN . . . . . 0.421 HE21 ' HB3' ' A' ' 129' ' ' GLN . 1.7 tt0 -62.29 -47.25 85.16 Favored 'General case' 0 C--N 1.333 -0.121 0 CA-C-O 121.066 0.46 . . . . 0.0 109.876 178.853 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 88.4 m-20 -66.69 -31.95 72.95 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.337 0.589 . . . . 0.0 109.579 179.349 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 131' ' ' ALA . . . . . 0.438 ' O ' ' HB2' ' A' ' 135' ' ' ASN . . . -67.27 -51.93 46.97 Favored 'General case' 0 N--CA 1.452 -0.358 0 CA-C-N 115.267 -0.879 . . . . 0.0 110.986 179.684 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 4.3 pp -66.22 -21.49 66.3 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.142 0.496 . . . . 0.0 110.693 179.898 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 5.6 tp -76.78 -51.45 11.35 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.115 179.16 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 94.4 mt -125.83 99.86 6.14 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.286 179.953 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 135' ' ' ASN . . . . . 0.438 ' HB2' ' O ' ' A' ' 131' ' ' ALA . 0.4 OUTLIER -146.77 -70.1 0.25 Allowed 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.491 -179.112 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 136' ' ' GLU . . . . . 0.432 ' HB2' ' O ' ' A' ' 144' ' ' LEU . 9.3 pt-20 -69.86 103.21 2.14 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.601 0.715 . . . . 0.0 111.277 -179.234 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 13.1 m -152.33 -57.54 0.14 Allowed 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.831 -0.622 . . . . 0.0 109.667 179.246 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 28.8 tt0 -160.0 122.32 3.34 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.152 -179.854 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -143.64 115.28 8.15 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 109.368 -0.604 . . . . 0.0 109.368 179.62 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 2.4 t60 64.82 14.03 8.9 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-O 121.255 0.55 . . . . 0.0 110.586 -179.869 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 95.71 -0.49 63.02 Favored Glycine 0 N--CA 1.446 -0.675 0 C-N-CA 120.786 -0.721 . . . . 0.0 111.913 -179.207 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 142' ' ' ARG . . . . . 0.627 ' HD3' ' OD2' ' A' ' 83' ' ' ASP . 2.4 mpt_? -115.59 158.81 22.12 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 120.917 0.389 . . . . 0.0 110.595 179.614 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 15.3 pt20 -105.06 119.07 38.13 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 178.411 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . 0.432 ' O ' ' HB2' ' A' ' 136' ' ' GLU . 0.5 OUTLIER -103.29 176.74 5.05 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.04 -178.966 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 73.8 tttt -115.57 121.9 44.02 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 109.253 -0.647 . . . . 0.0 109.253 178.996 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 89.2 t -115.34 119.3 61.44 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-O 120.902 0.382 . . . . 0.0 111.039 -179.803 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 36.3 t -121.54 139.47 53.46 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 116.142 -0.481 . . . . 0.0 109.81 179.943 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -58.84 132.12 53.0 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 109.926 -0.398 . . . . 0.0 109.926 179.213 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 57.5 tttp -93.12 78.16 4.58 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-O 121.479 0.657 . . . . 0.0 109.942 -179.382 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 21.5 tpt180 . . . . . 0 C--N 1.317 -0.809 0 CA-C-N 115.371 -0.831 . . . . 0.0 109.281 179.435 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.235 0.337 0 CA-C-O 120.725 0.298 . . . . 0.0 110.853 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 25.4 tp -79.17 84.33 5.14 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.28 0.562 . . . . 0.0 110.52 179.562 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 31.3 ttm180 -147.12 146.92 30.09 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.843 -0.617 . . . . 0.0 109.601 179.824 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -77.97 40.49 0.33 Allowed 'General case' 0 N--CA 1.463 0.214 0 CA-C-O 121.407 0.622 . . . . 0.0 111.079 179.989 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 15.8 ptt? -92.51 6.12 48.31 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 115.771 -0.65 . . . . 0.0 110.342 -179.904 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 25.3 mt-30 -64.49 -25.27 67.92 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.942 -179.764 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -66.72 -16.43 64.22 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 121.125 0.488 . . . . 0.0 111.303 -179.875 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 24.4 ttpp -72.19 -10.01 59.21 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.564 179.976 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 5.6 p -59.99 -23.96 28.49 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.169 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.039 179.844 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 38.6 mt-10 -64.63 -21.68 66.78 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.253 0.549 . . . . 0.0 110.701 179.261 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 10.3 mtmm -102.77 -40.95 6.36 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.366 179.182 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -72.8 -3.85 27.96 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.0 -0.545 . . . . 0.0 111.723 -179.84 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -67.14 -27.65 67.48 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 109.304 -0.628 . . . . 0.0 109.304 178.392 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -89.87 2.56 82.2 Favored Glycine 0 N--CA 1.446 -0.675 0 N-CA-C 110.831 -0.908 . . . . 0.0 110.831 178.57 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.376 0 CA-C-O 121.034 0.445 . . . . 0.0 110.055 -179.974 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.456 -0.162 0 CA-C-O 120.783 0.325 . . . . 0.0 110.585 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -77.32 -1.73 31.32 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.637 -179.486 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 8.2 pt20 -121.36 -31.23 4.11 Favored 'General case' 0 C--N 1.328 -0.353 0 C-N-CA 120.613 -0.435 . . . . 0.0 111.181 179.396 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -99.65 -57.21 2.2 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.956 0.407 . . . . 0.0 111.39 -179.932 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 5.1 tp10 -71.74 -21.39 61.76 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 120.891 0.376 . . . . 0.0 110.866 -179.317 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -63.27 -24.51 67.9 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.659 -0.246 . . . . 0.0 110.736 179.318 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 51.4 mt-10 -63.52 -23.18 67.28 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.478 0.656 . . . . 0.0 109.412 178.754 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 6.6 tp10 -94.94 -45.57 7.22 Favored 'General case' 0 N--CA 1.45 -0.466 0 CA-C-N 115.217 -0.901 . . . . 0.0 109.937 178.647 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.47 HG12 ' HB2' ' A' ' 121' ' ' GLU . 84.2 t -61.17 -42.67 94.24 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.342 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.583 -179.234 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -68.18 -21.37 64.88 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-O 121.188 0.518 . . . . 0.0 110.892 -179.6 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 11.1 t -98.49 -4.66 33.9 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.625 -0.716 . . . . 0.0 109.737 179.811 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -116.56 40.65 2.86 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.485 -0.78 . . . . 0.0 110.321 -179.499 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -119.02 170.99 8.57 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.622 179.81 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 10.4 pt -127.78 137.91 56.24 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-O 120.763 0.316 . . . . 0.0 110.357 178.982 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 76.6 t80 -92.78 116.53 29.11 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 116.023 -0.535 . . . . 0.0 109.736 -179.753 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 10.9 t -105.2 113.97 43.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-O 120.914 0.387 . . . . 0.0 110.886 -179.102 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -122.52 170.56 15.25 Favored Glycine 0 N--CA 1.449 -0.49 0 N-CA-C 111.664 -0.574 . . . . 0.0 111.664 179.833 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 5.4 m-20 58.43 40.5 24.07 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-O 121.27 0.557 . . . . 0.0 110.775 -179.929 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.465 HG13 HD23 ' A' ' 144' ' ' LEU . 2.5 t -82.83 165.18 2.59 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 CA-C-N 115.364 -0.834 . . . . 0.0 110.41 -179.408 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . 0.606 ' HB3' ' SG ' ' A' ' 86' ' ' CYS . 13.6 t0 -67.23 140.88 57.42 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 109.96 -0.385 . . . . 0.0 109.96 179.316 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 34.6 p90 -68.49 -11.77 60.28 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.703 -179.13 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -113.46 14.38 19.06 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 120.739 0.304 . . . . 0.0 111.477 -179.803 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' CYS . . . . . 0.606 ' SG ' ' HB3' ' A' ' 83' ' ' ASP . 1.2 m -81.34 150.23 28.54 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.354 0.597 . . . . 0.0 111.747 -179.594 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . 0.532 ' O ' ' HG2' ' A' ' 90' ' ' GLU . 1.2 p -116.02 155.75 47.58 Favored Pre-proline 0 C--N 1.323 -0.547 0 CA-C-N 115.513 -0.767 . . . . 0.0 109.933 179.235 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . 0.477 ' HD3' HD13 ' A' ' 106' ' ' ILE . 25.6 Cg_endo -60.51 -34.52 92.68 Favored 'Trans proline' 0 C--N 1.344 0.31 0 C-N-CA 122.464 2.109 . . . . 0.0 113.054 -178.599 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 8.4 mt-10 -63.4 -51.85 64.07 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.646 -178.94 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . 0.689 ' O ' ' HB2' ' A' ' 94' ' ' HIS . 8.8 pt-20 -61.73 -28.82 69.7 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.924 -179.201 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 79.6 t -76.96 -48.53 25.16 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.178 -179.003 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' GLN . . . . . 0.447 ' O ' ' HB2' ' A' ' 96' ' ' GLN . 0.0 OUTLIER -69.87 -32.64 71.1 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.57 -0.287 . . . . 0.0 111.474 -178.084 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 1.7 pt20 -80.97 -26.44 36.58 Favored 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 120.883 -0.327 . . . . 0.0 110.994 -179.239 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' HIS . . . . . 0.689 ' HB2' ' O ' ' A' ' 90' ' ' GLU . 0.9 OUTLIER -71.5 -39.15 71.02 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.961 0.41 . . . . 0.0 110.316 -179.777 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 15.4 m-85 -88.46 -13.98 39.02 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.974 -179.479 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . 0.476 ' HA ' ' O ' ' A' ' 99' ' ' GLY . 41.6 tt0 -63.22 -22.18 66.7 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.802 -179.904 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 35.7 m -72.74 -21.9 60.95 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.54 179.505 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 3.6 m -96.67 -44.15 7.24 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.202 0.525 . . . . 0.0 109.629 178.957 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . 0.476 ' O ' ' HA ' ' A' ' 96' ' ' GLN . . . -147.35 139.03 7.58 Favored Glycine 0 N--CA 1.442 -0.916 0 CA-C-N 115.516 -0.766 . . . . 0.0 111.229 179.529 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 2.3 m -62.73 143.14 57.75 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 120.819 0.342 . . . . 0.0 110.957 179.975 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 2.6 p -108.12 132.68 55.22 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.928 -179.365 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 10.7 t30 -93.68 -41.36 9.74 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 109.615 -0.513 . . . . 0.0 109.615 178.655 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -156.41 159.11 38.41 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.285 -0.87 . . . . 0.0 109.512 179.549 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 6.2 p -148.6 136.34 14.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-O 120.909 0.385 . . . . 0.0 110.581 -179.882 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . 0.488 ' HB ' ' CE1' ' A' ' 119' ' ' TYR . 2.0 m -122.91 130.82 53.32 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.259 178.945 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' ILE . . . . . 0.477 HD13 ' HD3' ' A' ' 88' ' ' PRO . 21.1 tt -118.73 146.11 23.8 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-O 120.703 0.287 . . . . 0.0 110.535 -179.849 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 43.2 tp -135.46 127.29 29.32 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.36 179.855 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -87.59 124.32 33.38 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.6 179.759 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -86.98 137.44 32.35 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.033 0.444 . . . . 0.0 110.774 179.807 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 5.3 mmmm -121.24 17.38 11.52 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.669 -179.616 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 5.7 t80 -101.61 -0.64 34.45 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.075 0.464 . . . . 0.0 110.706 -179.172 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 105.38 5.41 39.95 Favored Glycine 0 N--CA 1.446 -0.679 0 C-N-CA 120.654 -0.784 . . . . 0.0 112.53 179.535 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 113' ' ' GLN . . . . . 0.449 ' HB3' ' HD2' ' A' ' 114' ' ' PRO . 7.7 mt-30 -91.25 160.03 38.14 Favored Pre-proline 0 C--N 1.322 -0.609 0 N-CA-C 109.018 -0.734 . . . . 0.0 109.018 179.677 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 114' ' ' PRO . . . . . 0.449 ' HD2' ' HB3' ' A' ' 113' ' ' GLN . 14.1 Cg_endo -57.42 117.45 4.15 Favored 'Trans proline' 0 C--N 1.345 0.379 0 C-N-CA 122.038 1.825 . . . . 0.0 111.577 179.333 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 63.9 mttt -76.55 179.49 5.91 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 109.071 -0.714 . . . . 0.0 109.071 179.975 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . 0.403 ' HA2' HD11 ' A' ' 106' ' ' ILE . . . 91.64 -0.79 74.41 Favored Glycine 0 N--CA 1.448 -0.515 0 C-N-CA 120.258 -0.973 . . . . 0.0 111.869 179.69 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 2.0 t80 -54.25 121.34 8.0 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.856 0.36 . . . . 0.0 110.153 179.809 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -149.95 175.45 11.66 Favored 'General case' 0 N--CA 1.448 -0.558 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.754 -179.216 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 119' ' ' TYR . . . . . 0.488 ' CE1' ' HB ' ' A' ' 105' ' ' THR . 35.2 p90 -157.49 134.46 10.13 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.985 -0.552 . . . . 0.0 109.615 179.068 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 11.8 m -106.41 149.33 9.93 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 N-CA-C 109.677 -0.49 . . . . 0.0 109.677 179.385 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . 0.47 ' HB2' HG12 ' A' ' 72' ' ' VAL . 0.7 OUTLIER -133.73 156.13 48.52 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.927 -178.789 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 122' ' ' PHE . . . . . 0.462 ' O ' ' HA ' ' A' ' 72' ' ' VAL . 13.2 t80 -155.1 165.63 36.11 Favored 'General case' 0 C--N 1.333 -0.116 0 CA-C-O 120.927 0.394 . . . . 0.0 111.126 179.275 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . 0.426 ' HA ' HG22 ' A' ' 72' ' ' VAL . 12.2 t -82.14 -45.26 19.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 115.694 -0.685 . . . . 0.0 112.226 -178.869 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 20.0 mm-40 -76.26 136.88 39.66 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.12 0.486 . . . . 0.0 111.306 -178.865 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 2.7 mp -74.82 -35.89 37.87 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.675 -179.493 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -55.79 -38.79 70.4 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.106 179.597 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -61.5 -57.05 13.68 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.018 179.971 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 10.0 p -66.36 -29.06 45.41 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.002 -179.544 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 19.6 tt0 -61.54 -39.46 91.17 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.666 179.804 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 46.4 m-80 -78.77 -31.12 45.99 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.142 0.496 . . . . 0.0 109.706 178.738 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -66.44 -51.07 60.79 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.657 -0.701 . . . . 0.0 111.221 179.996 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 4.2 pp -65.66 -16.08 63.4 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-O 121.036 0.446 . . . . 0.0 110.859 -179.868 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 3.8 tp -84.04 -52.89 5.95 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.014 179.237 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 69.5 mt -121.41 101.4 7.6 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.915 -0.584 . . . . 0.0 109.85 179.693 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -146.66 -70.53 0.24 Allowed 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.84 0.352 . . . . 0.0 111.706 -179.331 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -70.48 105.35 3.04 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.546 0.689 . . . . 0.0 111.598 -179.051 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 15.2 m -147.59 -58.49 0.26 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.573 -0.74 . . . . 0.0 109.41 178.769 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -161.32 127.75 3.89 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.976 -0.556 . . . . 0.0 109.839 179.433 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 139' ' ' LEU . . . . . 0.426 ' HG ' HD21 ' A' ' 144' ' ' LEU . 0.1 OUTLIER -142.82 111.93 6.56 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.16 -0.473 . . . . 0.0 109.861 179.794 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 140' ' ' HIS . . . . . 0.442 ' HB2' ' SG ' ' A' ' 86' ' ' CYS . 1.3 t60 62.81 25.41 15.08 Favored 'General case' 0 N--CA 1.466 0.33 0 O-C-N 123.41 0.444 . . . . 0.0 110.839 179.189 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 86.66 3.45 83.74 Favored Glycine 0 N--CA 1.45 -0.429 0 C-N-CA 120.871 -0.681 . . . . 0.0 112.029 -179.57 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -116.86 170.57 8.51 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 110.072 -0.344 . . . . 0.0 110.072 179.989 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 8.1 pt20 -120.53 117.03 26.56 Favored 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 109.486 -0.561 . . . . 0.0 109.486 178.957 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . 0.465 HD23 HG13 ' A' ' 82' ' ' VAL . 0.6 OUTLIER -99.62 175.22 5.9 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.934 0.397 . . . . 0.0 111.336 -178.934 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 145' ' ' LYS . . . . . 0.517 ' HE3' ' OG ' ' A' ' 147' ' ' SER . 1.2 tmtp? -116.37 123.19 46.99 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.645 -0.707 . . . . 0.0 109.413 179.34 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 90.8 t -120.55 137.28 54.85 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-O 120.771 0.32 . . . . 0.0 110.68 -179.303 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 147' ' ' SER . . . . . 0.517 ' OG ' ' HE3' ' A' ' 145' ' ' LYS . 66.9 m -144.62 149.23 35.41 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.284 -0.417 . . . . 0.0 109.911 178.902 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -61.74 123.55 18.27 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.757 0.313 . . . . 0.0 111.338 -179.794 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 12.5 ttpp -86.86 73.67 9.92 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.498 0.666 . . . . 0.0 109.755 -179.982 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 14.1 tpt180 . . . . . 0 C--N 1.32 -0.713 0 CA-C-N 115.69 -0.686 . . . . 0.0 110.716 -179.904 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.233 0.2 0 N-CA-C 109.837 -0.431 . . . . 0.0 109.837 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 29.0 tp -74.97 88.63 2.37 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.987 0.423 . . . . 0.0 110.079 179.734 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 20.0 ttp180 -138.74 158.42 44.26 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.249 -0.432 . . . . 0.0 109.852 -179.469 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 52.3 mt-10 -79.66 25.18 0.35 Allowed 'General case' 0 N--CA 1.464 0.267 0 CA-C-O 121.023 0.439 . . . . 0.0 111.311 -179.807 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 11.3 ptt? -79.89 4.05 17.92 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 120.811 0.338 . . . . 0.0 110.584 -178.961 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 14.2 mt-30 -71.83 -22.31 61.57 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.214 0.531 . . . . 0.0 110.011 179.424 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -78.44 -15.26 58.84 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.707 -0.679 . . . . 0.0 110.113 179.033 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . 0.531 ' O ' ' HG2' ' A' ' 52' ' ' GLU . 6.7 ttpp -76.93 2.85 13.53 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.458 -0.792 . . . . 0.0 110.309 -179.802 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 9.2 p -55.71 -24.21 16.15 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.142 0 CA-C-N 115.481 -0.781 . . . . 0.0 111.86 -179.541 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . 0.504 ' H ' ' HG3' ' A' ' 50' ' ' GLU . 0.1 OUTLIER -60.54 -32.25 71.31 Favored 'General case' 0 CA--C 1.52 -0.195 0 CA-C-O 121.43 0.633 . . . . 0.0 109.735 179.494 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 9.0 mtmm -103.22 -40.69 6.32 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.471 -0.786 . . . . 0.0 111.354 -179.645 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . 0.531 ' HG2' ' O ' ' A' ' 48' ' ' LYS . 44.1 mm-40 -64.63 -8.4 14.19 Favored 'General case' 0 N--CA 1.468 0.469 0 N-CA-C 112.421 0.526 . . . . 0.0 112.421 -179.356 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 9.2 ptp -57.98 -33.13 68.56 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.741 0.305 . . . . 0.0 111.257 179.604 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -91.04 -19.88 41.27 Favored Glycine 0 N--CA 1.449 -0.477 0 C-N-CA 120.573 -0.822 . . . . 0.0 111.214 179.082 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.323 -0.547 0 CA-C-N 115.125 -0.538 . . . . 0.0 110.899 -179.263 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.455 -0.184 0 CA-C-O 120.945 0.403 . . . . 0.0 110.047 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 1.2 m -76.15 5.35 6.94 Favored 'General case' 0 CA--C 1.533 0.299 0 CA-C-O 121.343 0.592 . . . . 0.0 110.98 179.731 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 7.3 tp-100 -124.81 -54.99 1.62 Allowed 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.916 -0.583 . . . . 0.0 110.398 179.21 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -78.89 -56.28 4.52 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.362 -179.427 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 1.7 tp10 -66.32 -28.72 68.9 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-O 121.325 0.583 . . . . 0.0 109.935 179.937 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 48.8 tptt -59.96 -29.17 68.24 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.437 -0.802 . . . . 0.0 111.268 179.487 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 48.8 mt-10 -61.69 -24.04 66.5 Favored 'General case' 0 N--CA 1.463 0.207 0 CA-C-O 120.977 0.418 . . . . 0.0 110.654 179.669 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 6.9 tp10 -95.19 -39.16 10.24 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.787 -0.642 . . . . 0.0 109.711 178.814 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.51 HG12 ' HB2' ' A' ' 121' ' ' GLU . 89.4 t -63.03 -44.65 99.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 115.795 -0.639 . . . . 0.0 112.127 -179.302 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -69.22 -23.11 63.85 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-O 121.17 0.51 . . . . 0.0 110.968 -179.129 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 49.9 m -90.6 -9.65 46.27 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.451 -0.795 . . . . 0.0 109.765 179.154 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -113.98 36.06 3.85 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 114.993 -1.003 . . . . 0.0 110.005 -179.839 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -111.89 169.27 8.95 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.04 179.425 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 7.6 pt -129.28 136.48 59.37 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 N-CA-C 110.029 -0.36 . . . . 0.0 110.029 178.748 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' TYR . . . . . 0.401 ' O ' ' HA ' ' A' ' 146' ' ' VAL . 68.8 t80 -90.42 120.83 31.86 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 116.042 -0.526 . . . . 0.0 109.808 -179.706 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.418 HG12 HG22 ' A' ' 82' ' ' VAL . 6.7 t -107.46 111.63 36.61 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-O 120.832 0.348 . . . . 0.0 110.593 -179.164 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -119.26 168.67 13.46 Favored Glycine 0 N--CA 1.449 -0.486 0 N-CA-C 111.683 -0.567 . . . . 0.0 111.683 179.708 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 96.8 m-20 60.93 34.38 19.51 Favored 'General case' 0 N--CA 1.47 0.535 0 CA-C-O 120.964 0.411 . . . . 0.0 111.262 -179.792 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.418 HG22 HG12 ' A' ' 79' ' ' VAL . 2.5 t -75.8 166.38 2.76 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.597 -179.768 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 22.0 t0 -73.08 145.36 46.57 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.854 0.359 . . . . 0.0 110.34 179.714 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 3.0 p90 -66.27 -19.97 65.97 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.732 -0.667 . . . . 0.0 111.712 -178.934 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -109.84 20.12 18.37 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 111.742 0.275 . . . . 0.0 111.742 -179.323 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' CYS . . . . . 0.471 ' SG ' ' HB2' ' A' ' 140' ' ' HIS . 0.8 OUTLIER -87.84 141.71 28.38 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.07 0.462 . . . . 0.0 111.286 -179.829 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . 0.468 ' O ' ' HG2' ' A' ' 90' ' ' GLU . 41.7 p -107.1 155.61 38.97 Favored Pre-proline 0 C--N 1.328 -0.367 0 CA-C-N 115.593 -0.73 . . . . 0.0 110.343 179.562 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . 0.477 ' HD3' HD13 ' A' ' 106' ' ' ILE . 18.6 Cg_endo -59.12 -35.35 98.14 Favored 'Trans proline' 0 C--N 1.342 0.213 0 C-N-CA 122.457 2.104 . . . . 0.0 112.556 -179.576 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 28.8 mt-10 -65.02 -50.04 67.8 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.688 -0.687 . . . . 0.0 112.096 -178.861 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . 0.565 ' O ' ' HB2' ' A' ' 94' ' ' HIS . 10.9 pt-20 -67.24 -18.6 65.29 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.835 0.35 . . . . 0.0 111.193 -179.102 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 51.3 t -85.26 -49.66 15.37 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.115 -179.897 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' GLN . . . . . 0.4 ' HG2' ' O ' ' A' ' 88' ' ' PRO . 6.9 pt20 -68.81 -35.92 77.6 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.696 -0.229 . . . . 0.0 111.561 -178.098 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 16.0 pt20 -74.48 -28.71 61.13 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.939 0.4 . . . . 0.0 110.37 -179.5 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' HIS . . . . . 0.565 ' HB2' ' O ' ' A' ' 90' ' ' GLU . 0.1 OUTLIER -70.81 -42.5 70.18 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.652 -179.796 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 20.7 m-30 -80.04 -14.59 58.43 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.87 -0.604 . . . . 0.0 110.647 -179.511 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . 0.623 ' HA ' ' O ' ' A' ' 99' ' ' GLY . 10.9 tt0 -66.0 -19.15 65.76 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.131 179.513 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 13.9 m -66.84 -28.57 68.46 Favored 'General case' 0 N--CA 1.451 -0.384 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.257 178.871 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 4.9 m -100.33 -43.26 6.32 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.401 179.661 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . 0.623 ' O ' ' HA ' ' A' ' 96' ' ' GLN . . . -144.59 139.73 8.74 Favored Glycine 0 N--CA 1.447 -0.62 0 C-N-CA 120.88 -0.676 . . . . 0.0 111.904 -179.896 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -63.02 147.72 49.84 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 120.914 0.388 . . . . 0.0 111.601 -179.901 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 2.4 p -116.52 132.93 64.71 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.095 -179.458 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 27.4 t-20 -102.2 -43.64 5.66 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.068 0.461 . . . . 0.0 110.282 178.956 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' ARG . . . . . 0.401 HH11 ' HD2' ' A' ' 103' ' ' ARG . 0.2 OUTLIER -141.03 148.68 40.64 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.055 -0.521 . . . . 0.0 109.888 -179.872 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 4.5 p -146.94 134.99 15.12 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 N-CA-C 109.936 -0.394 . . . . 0.0 109.936 179.197 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . 0.459 ' HB ' ' CE1' ' A' ' 119' ' ' TYR . 0.7 OUTLIER -128.16 126.13 40.45 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.236 179.376 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' ILE . . . . . 0.506 HD11 ' HA2' ' A' ' 116' ' ' GLY . 18.6 tt -112.55 148.3 15.69 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-O 120.862 0.363 . . . . 0.0 110.867 -179.941 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 18.0 tp -136.83 129.96 31.11 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.155 179.56 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -88.42 123.24 32.77 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 109.708 -0.479 . . . . 0.0 109.708 179.542 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . 0.417 ' O ' ' HB2' ' A' ' 110' ' ' LYS . 29.2 t70 -70.93 -80.17 0.06 Allowed 'General case' 0 CA--C 1.531 0.247 0 N-CA-C 112.628 0.603 . . . . 0.0 112.628 -178.239 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . 0.417 ' HB2' ' O ' ' A' ' 109' ' ' ASP . 1.7 mtpp 70.34 20.66 6.03 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 122.828 0.451 . . . . 0.0 111.621 -179.901 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 6.6 t80 -115.41 17.92 16.24 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-O 121.274 0.559 . . . . 0.0 109.955 -179.749 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 103.99 0.37 45.02 Favored Glycine 0 N--CA 1.449 -0.5 0 C-N-CA 120.768 -0.729 . . . . 0.0 112.158 179.952 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 4.3 mt-30 -111.34 157.72 38.24 Favored Pre-proline 0 C--N 1.322 -0.596 0 N-CA-C 109.588 -0.523 . . . . 0.0 109.588 179.599 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -59.77 129.7 31.84 Favored 'Trans proline' 0 N--CA 1.462 -0.335 0 C-N-CA 122.124 1.883 . . . . 0.0 111.366 178.827 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 15.6 mttp -82.8 -179.41 7.43 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 109.196 -0.668 . . . . 0.0 109.196 179.963 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . 0.506 ' HA2' HD11 ' A' ' 106' ' ' ILE . . . 92.36 2.53 68.02 Favored Glycine 0 N--CA 1.446 -0.645 0 C-N-CA 120.064 -1.065 . . . . 0.0 112.32 179.168 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 2.2 t80 -54.51 119.52 5.36 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-O 120.732 0.301 . . . . 0.0 110.278 179.793 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -146.56 177.89 8.71 Favored 'General case' 0 N--CA 1.45 -0.427 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.846 -179.316 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 119' ' ' TYR . . . . . 0.459 ' CE1' ' HB ' ' A' ' 105' ' ' THR . 43.6 p90 -161.1 134.84 6.75 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.521 -0.763 . . . . 0.0 109.225 179.045 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 15.1 m -108.74 147.07 13.69 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 N-CA-C 109.529 -0.545 . . . . 0.0 109.529 178.824 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . 0.51 ' HB2' HG12 ' A' ' 72' ' ' VAL . 7.2 pt-20 -131.7 155.91 46.82 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 116.389 -0.368 . . . . 0.0 111.022 -179.217 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 122' ' ' PHE . . . . . 0.446 ' O ' ' HA ' ' A' ' 72' ' ' VAL . 10.8 t80 -157.2 166.66 32.59 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.147 -179.943 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 5.1 t -84.82 -49.23 15.99 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-O 120.854 0.359 . . . . 0.0 111.708 -178.995 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 47.8 mm-40 -66.27 127.87 33.91 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.002 -0.545 . . . . 0.0 111.844 -178.608 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 2.3 mp -72.05 -29.4 32.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 115.6 -0.727 . . . . 0.0 109.643 179.516 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 16.7 t70 -58.1 -42.25 85.29 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.265 -0.88 . . . . 0.0 110.56 179.322 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -64.81 -52.98 53.9 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.731 -0.668 . . . . 0.0 111.532 -179.597 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 8.8 p -65.85 -27.05 40.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 116.636 -0.256 . . . . 0.0 111.43 -179.27 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 24.4 tt0 -60.31 -48.52 81.4 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.806 0.336 . . . . 0.0 110.404 179.898 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 86.6 m-20 -69.61 -32.41 71.11 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 121.021 0.439 . . . . 0.0 110.248 179.611 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 131' ' ' ALA . . . . . 0.421 ' O ' ' HB2' ' A' ' 135' ' ' ASN . . . -64.84 -53.16 51.13 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.604 -0.725 . . . . 0.0 111.254 -179.787 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 4.1 pp -65.23 -23.94 67.21 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.9 0.381 . . . . 0.0 110.888 -179.796 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 5.6 tp -76.42 -54.34 6.87 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.652 179.699 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 26.9 mt -122.38 103.04 8.47 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.091 -0.504 . . . . 0.0 109.878 -179.998 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 135' ' ' ASN . . . . . 0.421 ' HB2' ' O ' ' A' ' 131' ' ' ALA . 0.2 OUTLIER -150.23 -66.87 0.2 Allowed 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 120.977 0.418 . . . . 0.0 111.551 -179.22 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 3.3 pt-20 -69.73 101.18 1.63 Allowed 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.882 -0.599 . . . . 0.0 111.417 -179.188 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 23.7 m -151.31 -59.32 0.17 Allowed 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.909 -0.587 . . . . 0.0 109.966 178.93 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 6.0 tm-20 -154.78 127.68 8.17 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.457 179.755 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -147.72 111.27 4.98 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 178.774 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 140' ' ' HIS . . . . . 0.471 ' HB2' ' SG ' ' A' ' 86' ' ' CYS . 2.1 t60 64.6 28.22 13.25 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-O 121.241 0.543 . . . . 0.0 109.725 -179.585 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 79.23 1.27 85.5 Favored Glycine 0 CA--C 1.52 0.371 0 C-N-CA 121.012 -0.613 . . . . 0.0 112.485 -179.353 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 7.3 mpt_? -113.11 170.94 7.85 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 120.662 0.267 . . . . 0.0 110.437 -179.907 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 12.7 pt20 -115.11 137.55 51.89 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.114 -0.494 . . . . 0.0 109.83 179.162 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -125.58 174.48 8.22 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.135 179.951 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 76.7 tttt -116.91 122.33 44.0 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 109.775 -0.454 . . . . 0.0 109.775 179.371 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 146' ' ' VAL . . . . . 0.401 ' HA ' ' O ' ' A' ' 78' ' ' TYR . 77.6 t -115.88 125.21 72.93 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-O 120.843 0.354 . . . . 0.0 110.739 179.811 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 5.4 t -126.87 148.46 50.0 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 109.848 -0.427 . . . . 0.0 109.848 179.944 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -66.62 122.66 18.11 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.595 -0.275 . . . . 0.0 110.636 -179.737 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 14.0 ttpp -88.14 61.99 6.55 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.456 0.646 . . . . 0.0 109.63 -179.823 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.322 -0.618 0 CA-C-N 115.806 -0.634 . . . . 0.0 109.561 179.453 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.236 0.35 0 N-CA-C 110.467 -0.198 . . . . 0.0 110.467 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 37.9 tp -74.29 84.32 1.91 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.08 0.467 . . . . 0.0 109.897 179.346 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . 0.528 ' HA ' ' NE ' ' A' ' 43' ' ' ARG . 1.5 tpm_? -132.63 142.3 49.05 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.746 -179.376 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 21.5 mp0 -77.27 47.04 0.54 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.249 0.547 . . . . 0.0 110.278 179.252 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 9.1 ptt? -108.65 -0.41 20.18 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.498 -179.548 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 24.6 mt-30 -59.86 -22.68 62.62 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-O 120.889 0.376 . . . . 0.0 111.325 -179.048 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -68.03 -16.96 64.26 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.787 -179.914 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 3.4 ptmm? -73.82 3.59 6.39 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-O 120.635 0.255 . . . . 0.0 111.323 -179.383 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 11.0 p -54.73 -25.09 14.61 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.25 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.307 179.63 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -59.46 -37.03 77.1 Favored 'General case' 0 C--N 1.334 -0.095 0 CA-C-O 121.185 0.517 . . . . 0.0 110.152 179.134 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 10.7 mtmm -85.57 -41.14 15.53 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.804 -0.634 . . . . 0.0 110.328 -179.369 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 16.9 mm-40 -60.33 -38.05 82.53 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.519 -0.764 . . . . 0.0 111.991 -179.013 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 17.3 ptp -64.67 -25.94 68.17 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.679 0.276 . . . . 0.0 110.973 -179.607 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -95.61 -9.94 57.17 Favored Glycine 0 N--CA 1.448 -0.514 0 C-N-CA 120.812 -0.709 . . . . 0.0 111.539 179.433 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.325 -0.463 0 CA-C-O 121.029 0.442 . . . . 0.0 110.629 -179.458 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.456 -0.144 0 CA-C-O 120.717 0.294 . . . . 0.0 110.483 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -76.98 4.3 10.32 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.321 0.582 . . . . 0.0 110.605 179.772 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 46.3 tp60 -122.5 -54.9 1.86 Allowed 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.811 -0.632 . . . . 0.0 110.524 179.277 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -79.8 -54.42 5.86 Favored 'General case' 0 C--N 1.326 -0.413 0 N-CA-C 112.174 0.435 . . . . 0.0 112.174 -178.603 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 14.0 tp10 -69.58 -27.1 64.83 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.069 0.461 . . . . 0.0 110.963 -179.224 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 15.5 tptp -59.9 -27.2 66.52 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.995 179.303 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 94.8 mt-10 -62.74 -22.28 66.43 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-O 121.375 0.607 . . . . 0.0 111.009 179.583 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . 0.446 ' O ' ' HD2' ' A' ' 75' ' ' ARG . 7.0 tp10 -96.97 -40.01 9.09 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 115.727 -0.669 . . . . 0.0 109.596 178.007 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.436 HG12 ' HB2' ' A' ' 121' ' ' GLU . 59.0 t -65.27 -37.89 81.25 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-N 115.728 -0.669 . . . . 0.0 112.586 -179.034 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -72.98 -17.13 61.49 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-O 120.889 0.376 . . . . 0.0 111.148 -179.227 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -97.77 -18.56 18.72 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.964 -0.562 . . . . 0.0 109.952 177.831 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . 0.446 ' HD2' ' O ' ' A' ' 71' ' ' GLU . 0.0 OUTLIER -103.05 49.76 0.83 Allowed 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.353 -179.334 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . 0.49 ' HB3' ' HB3' ' A' ' 121' ' ' GLU . 0.0 OUTLIER -128.04 170.57 12.76 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.542 -0.754 . . . . 0.0 110.313 179.703 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 4.8 pt -134.98 137.33 50.8 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.787 0 N-CA-C 109.795 -0.446 . . . . 0.0 109.795 178.88 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 67.0 t80 -95.81 128.18 42.48 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.151 -179.58 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 2.7 t -105.18 111.8 36.13 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.362 -179.861 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -116.93 162.98 12.57 Favored Glycine 0 N--CA 1.449 -0.498 0 C-N-CA 120.925 -0.655 . . . . 0.0 111.599 -179.859 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 9.9 m120 60.28 42.45 15.02 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-O 121.32 0.581 . . . . 0.0 110.542 -179.559 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.545 HG12 ' H ' ' A' ' 83' ' ' ASP . 2.0 t -83.26 172.9 1.0 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.656 0 CA-C-N 115.521 -0.763 . . . . 0.0 110.31 -179.375 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . 0.651 ' OD2' ' HD3' ' A' ' 142' ' ' ARG . 11.6 t0 -73.62 135.4 43.82 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 109.756 -0.461 . . . . 0.0 109.756 179.451 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 5.4 p90 -60.77 -21.4 63.01 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.88 -0.6 . . . . 0.0 111.924 -179.662 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -110.85 19.19 18.81 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.774 0.321 . . . . 0.0 111.237 -179.855 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' CYS . . . . . 0.442 ' SG ' ' HB3' ' A' ' 83' ' ' ASP . 0.5 OUTLIER -80.64 148.32 30.3 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.375 0.607 . . . . 0.0 110.993 -179.898 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . 0.531 ' O ' ' HG2' ' A' ' 90' ' ' GLU . 40.1 p -109.97 152.38 43.0 Favored Pre-proline 0 C--N 1.321 -0.649 0 CA-C-N 115.338 -0.846 . . . . 0.0 110.194 179.409 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . 0.408 ' HD3' HD13 ' A' ' 106' ' ' ILE . 18.8 Cg_endo -60.14 -32.39 94.52 Favored 'Trans proline' 0 C--N 1.344 0.338 0 C-N-CA 122.414 2.076 . . . . 0.0 112.593 -179.543 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 7.8 mm-40 -64.6 -53.09 53.21 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.731 -0.668 . . . . 0.0 111.96 -179.165 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . 0.531 ' HG2' ' O ' ' A' ' 87' ' ' THR . 10.7 pt-20 -62.42 -23.93 67.13 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.966 0.412 . . . . 0.0 111.413 -178.904 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 76.6 t -79.86 -48.78 20.16 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.059 -179.86 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' GLN . . . . . 0.427 ' O ' ' HB2' ' A' ' 96' ' ' GLN . 1.6 pp0? -71.97 -33.63 68.32 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.708 -0.224 . . . . 0.0 111.372 -178.455 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 8.6 pt20 -74.21 -31.79 62.76 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.911 0.386 . . . . 0.0 111.068 -179.475 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 65.0 t-80 -73.79 -41.85 61.82 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.734 -179.431 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 18.1 m-30 -78.19 -12.97 60.03 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.124 -179.162 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . 0.545 ' HA ' ' O ' ' A' ' 99' ' ' GLY . 7.5 tt0 -70.06 -20.17 63.24 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.687 -0.688 . . . . 0.0 109.988 179.669 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 1.4 m -65.17 -36.41 84.14 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.496 -0.775 . . . . 0.0 110.692 179.555 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 0.2 OUTLIER -89.81 -46.43 8.59 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.304 -179.988 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . 0.545 ' O ' ' HA ' ' A' ' 96' ' ' GLN . . . -144.27 145.21 14.55 Favored Glycine 0 N--CA 1.445 -0.766 0 C-N-CA 120.672 -0.775 . . . . 0.0 111.801 179.792 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -64.12 145.91 55.12 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 121.033 0.444 . . . . 0.0 111.337 -179.781 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 1.2 p -118.65 121.79 67.86 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.259 -179.949 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . 0.482 ' OD1' ' HG2' ' A' ' 103' ' ' ARG . 26.6 t-20 -91.07 -44.83 9.04 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 109.859 -0.423 . . . . 0.0 109.859 179.733 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' ARG . . . . . 0.482 ' HG2' ' OD1' ' A' ' 102' ' ' ASN . 10.3 mmm180 -136.99 149.16 47.34 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.534 179.967 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 4.0 p -148.2 131.39 7.9 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.587 0 CA-C-N 115.919 -0.582 . . . . 0.0 109.473 179.711 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . 0.419 ' HB ' ' CE1' ' A' ' 119' ' ' TYR . 0.7 OUTLIER -124.89 126.53 45.68 Favored 'General case' 0 C--N 1.32 -0.69 0 N-CA-C 110.08 -0.341 . . . . 0.0 110.08 179.237 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' ILE . . . . . 0.502 HD11 ' HA2' ' A' ' 116' ' ' GLY . 21.1 tt -113.26 143.62 22.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-O 120.895 0.379 . . . . 0.0 110.889 -179.598 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 51.4 tp -129.66 127.75 41.17 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.062 179.372 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -94.76 114.65 26.58 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.546 -0.297 . . . . 0.0 110.411 179.73 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . 0.468 ' C ' ' HD2' ' A' ' 110' ' ' LYS . 3.1 t70 -75.24 134.07 41.23 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.771 0.32 . . . . 0.0 110.899 -179.948 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . 0.468 ' HD2' ' C ' ' A' ' 109' ' ' ASP . 8.0 mmmm -116.66 30.17 7.5 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 120.94 0.4 . . . . 0.0 110.094 -179.906 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 8.5 t80 -112.72 -2.85 14.37 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.848 0.356 . . . . 0.0 110.81 -179.6 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 108.33 8.78 28.53 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.844 -0.693 . . . . 0.0 113.141 179.717 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 30.2 mt-30 -94.58 157.18 37.55 Favored Pre-proline 0 C--N 1.322 -0.596 0 N-CA-C 109.646 -0.502 . . . . 0.0 109.646 179.84 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -58.64 105.59 0.23 Allowed 'Trans proline' 0 C--N 1.348 0.502 0 C-N-CA 122.216 1.944 . . . . 0.0 110.819 178.998 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . 0.415 ' HG2' ' O ' ' A' ' 109' ' ' ASP . 3.3 mttp -68.22 177.34 2.32 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.68 -179.074 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . 0.502 ' HA2' HD11 ' A' ' 106' ' ' ILE . . . 99.54 2.93 56.46 Favored Glycine 0 N--CA 1.445 -0.729 0 C-N-CA 120.339 -0.934 . . . . 0.0 111.308 -179.73 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 39.9 m-85 -53.13 117.55 3.09 Favored 'General case' 0 C--N 1.331 -0.205 0 O-C-N 123.821 0.366 . . . . 0.0 110.097 179.505 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -147.15 173.49 12.46 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 121.154 0.502 . . . . 0.0 111.205 -179.099 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 119' ' ' TYR . . . . . 0.419 ' CE1' ' HB ' ' A' ' 105' ' ' THR . 39.2 p90 -156.14 134.6 11.58 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 115.436 -0.802 . . . . 0.0 109.0 178.642 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 14.4 m -109.43 139.24 33.18 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 N-CA-C 109.319 -0.623 . . . . 0.0 109.319 179.055 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . 0.49 ' HB3' ' HB3' ' A' ' 76' ' ' SER . 9.0 pt-20 -127.67 154.6 45.1 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 120.921 0.391 . . . . 0.0 111.334 -179.684 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 122' ' ' PHE . . . . . 0.412 ' O ' ' HA ' ' A' ' 72' ' ' VAL . 17.6 t80 -154.56 171.14 19.91 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.748 -0.66 . . . . 0.0 109.819 -179.821 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 3.8 t -84.65 -52.01 13.06 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-O 120.772 0.32 . . . . 0.0 111.551 -179.463 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -62.43 132.7 53.42 Favored 'General case' 0 C--O 1.236 0.346 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.674 -179.032 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 2.3 mp -76.04 -32.45 23.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 115.937 -0.574 . . . . 0.0 109.629 179.463 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 6.4 t70 -58.67 -39.16 79.88 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.358 -0.837 . . . . 0.0 110.632 179.324 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -62.59 -57.56 10.66 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.781 -0.645 . . . . 0.0 111.118 -179.829 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 7.6 p -65.2 -29.48 47.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.428 -0.351 . . . . 0.0 111.371 -179.449 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 40.6 tt0 -59.24 -47.17 86.36 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.284 0.564 . . . . 0.0 110.673 179.752 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 44.7 m-80 -70.68 -31.24 68.06 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.804 -0.635 . . . . 0.0 110.029 179.608 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -68.47 -47.91 65.87 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.58 -0.736 . . . . 0.0 111.672 -179.601 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 4.1 pp -68.02 -24.0 65.06 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.74 0.305 . . . . 0.0 110.9 -179.746 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 5.4 tp -74.24 -53.45 9.74 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.722 -179.354 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 61.9 mt -131.64 98.41 4.48 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 112.087 0.403 . . . . 0.0 112.087 -178.939 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 3.4 m-20 -149.9 -52.25 0.15 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.318 179.111 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 2.9 pt-20 -73.03 93.55 1.78 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.619 0.723 . . . . 0.0 110.708 179.614 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 4.6 m -142.38 -59.85 0.45 Allowed 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.544 -0.753 . . . . 0.0 110.354 179.376 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -156.47 127.41 6.86 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.216 179.894 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -146.95 122.99 10.77 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 109.481 -0.562 . . . . 0.0 109.481 179.691 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 2.0 t60 63.93 17.34 10.5 Favored 'General case' 0 N--CA 1.465 0.306 0 C-N-CA 122.71 0.404 . . . . 0.0 111.015 179.59 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 93.39 -1.59 69.73 Favored Glycine 0 N--CA 1.443 -0.843 0 C-N-CA 120.77 -0.728 . . . . 0.0 112.366 -179.465 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 142' ' ' ARG . . . . . 0.651 ' HD3' ' OD2' ' A' ' 83' ' ' ASP . 4.3 mpt_? -121.38 -173.7 2.68 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 110.127 -0.323 . . . . 0.0 110.127 179.861 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 20.7 pt20 -124.12 150.98 44.46 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 120.794 0.331 . . . . 0.0 110.402 179.735 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -133.54 177.89 7.35 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.472 -179.783 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 42.0 tttt -117.72 123.46 46.09 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 109.793 -0.447 . . . . 0.0 109.793 178.449 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 82.8 t -117.61 121.52 67.68 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-O 120.982 0.42 . . . . 0.0 110.451 179.875 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 56.8 m -127.44 147.63 50.29 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 116.33 -0.396 . . . . 0.0 110.185 179.51 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -65.23 126.79 29.25 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.903 0.382 . . . . 0.0 111.133 -179.479 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 19.8 ttpp -89.38 55.45 3.26 Favored 'General case' 0 N--CA 1.448 -0.533 0 CA-C-O 121.463 0.649 . . . . 0.0 109.302 -179.807 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.327 -0.383 0 CA-C-N 115.781 -0.645 . . . . 0.0 109.909 179.912 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.453 -0.302 0 N-CA-C 110.291 -0.263 . . . . 0.0 110.291 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 14.4 tp -75.21 77.23 2.34 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.395 0.617 . . . . 0.0 109.84 178.955 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . 0.406 ' C ' ' H ' ' A' ' 45' ' ' MET . 29.0 ttt180 -136.33 145.67 45.71 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.127 -179.333 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -75.45 37.32 0.13 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.23 0.538 . . . . 0.0 111.199 179.97 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' MET . . . . . 0.406 ' H ' ' C ' ' A' ' 43' ' ' ARG . 22.1 ptt? -100.29 8.38 43.76 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.05 -179.843 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 73.2 mm-40 -66.07 -26.5 67.52 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.368 179.753 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -72.86 -8.4 55.37 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.832 -0.622 . . . . 0.0 111.345 179.953 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 13.5 ttpt -75.14 -8.5 56.74 Favored 'General case' 0 C--O 1.236 0.363 0 CA-C-O 121.19 0.519 . . . . 0.0 110.04 179.947 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 9.9 p -58.86 -25.04 28.02 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.204 0 CA-C-N 115.747 -0.66 . . . . 0.0 111.122 179.646 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -61.1 -27.18 68.18 Favored 'General case' 0 C--N 1.333 -0.131 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.019 179.794 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 11.8 mtmt -101.55 -35.47 9.14 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.398 179.903 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 76.5 mm-40 -70.38 -21.32 62.88 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.591 -0.277 . . . . 0.0 111.188 179.986 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 13.7 ptp -62.8 -29.36 70.65 Favored 'General case' 0 N--CA 1.462 0.169 0 CA-C-O 120.829 0.347 . . . . 0.0 110.435 179.566 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -90.66 -10.97 62.69 Favored Glycine 0 N--CA 1.447 -0.602 0 N-CA-C 111.008 -0.837 . . . . 0.0 111.008 178.909 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.529 0 CA-C-O 120.805 0.336 . . . . 0.0 110.431 -179.838 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.328 0 N-CA-C 109.61 -0.515 . . . . 0.0 109.61 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -76.4 4.12 9.66 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.225 0.536 . . . . 0.0 110.521 179.312 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 46.4 tt0 -118.27 -52.55 2.38 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.607 179.674 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -85.98 -57.82 2.89 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.812 -179.488 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 3.7 tp10 -63.79 -27.51 69.24 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 120.838 0.352 . . . . 0.0 110.751 -179.717 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 2.3 tptm -61.0 -23.72 65.6 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.199 179.952 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 35.1 mt-10 -62.1 -23.97 66.84 Favored 'General case' 0 N--CA 1.461 0.12 0 CA-C-O 121.176 0.512 . . . . 0.0 110.496 179.02 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 7.2 tp10 -95.46 -38.71 10.34 Favored 'General case' 0 C--N 1.319 -0.751 0 N-CA-C 109.212 -0.662 . . . . 0.0 109.212 177.747 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.447 HG22 ' HA ' ' A' ' 123' ' ' VAL . 58.4 t -65.04 -42.18 93.93 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.331 0 CA-C-N 115.913 -0.585 . . . . 0.0 112.191 -179.209 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 51.3 p30 -69.4 -15.21 63.25 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-O 121.125 0.488 . . . . 0.0 111.057 -179.223 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 24.5 m -105.51 -3.88 21.93 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.54 179.826 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -116.19 47.77 1.35 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.652 -0.704 . . . . 0.0 110.255 -179.193 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -126.3 172.81 9.79 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.866 -179.839 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 8.7 pt -131.17 136.75 57.19 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 N-CA-C 109.92 -0.4 . . . . 0.0 109.92 178.392 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' TYR . . . . . 0.536 ' O ' ' HA ' ' A' ' 146' ' ' VAL . 36.8 t80 -91.63 124.3 35.68 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.62 -179.465 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.495 HG13 HG22 ' A' ' 146' ' ' VAL . 6.9 t -105.98 110.23 30.62 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 N-CA-C 110.103 -0.332 . . . . 0.0 110.103 179.759 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -118.4 167.24 12.95 Favored Glycine 0 N--CA 1.45 -0.37 0 N-CA-C 111.745 -0.542 . . . . 0.0 111.745 -179.857 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 4.6 m-20 59.25 40.77 21.03 Favored 'General case' 0 N--CA 1.468 0.471 0 CA-C-O 121.289 0.566 . . . . 0.0 110.794 -179.583 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.444 HG12 ' H ' ' A' ' 83' ' ' ASP . 2.1 t -83.46 169.1 1.61 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-N 115.354 -0.839 . . . . 0.0 109.851 -179.471 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . 0.477 ' HB3' ' SG ' ' A' ' 86' ' ' CYS . 29.8 t70 -73.2 143.14 47.28 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 120.901 0.381 . . . . 0.0 110.73 179.916 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 34.1 p90 -64.77 -13.53 55.61 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.799 -0.637 . . . . 0.0 112.549 -178.693 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -117.21 15.95 14.91 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.81 0.338 . . . . 0.0 111.019 179.923 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' CYS . . . . . 0.477 ' SG ' ' HB3' ' A' ' 83' ' ' ASP . 1.0 OUTLIER -78.68 142.55 37.05 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.113 0.483 . . . . 0.0 110.885 179.945 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . 0.482 ' O ' ' HG2' ' A' ' 90' ' ' GLU . 70.2 p -106.12 155.41 38.55 Favored Pre-proline 0 C--N 1.321 -0.672 0 CA-C-N 115.444 -0.798 . . . . 0.0 110.272 -179.994 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 20.8 Cg_endo -61.46 -29.29 84.88 Favored 'Trans proline' 0 C--N 1.344 0.32 0 C-N-CA 122.219 1.946 . . . . 0.0 112.401 -179.788 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 14.0 mt-10 -65.31 -55.3 19.07 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.665 -179.073 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . 0.482 ' HG2' ' O ' ' A' ' 87' ' ' THR . 9.6 pt-20 -60.89 -25.53 66.78 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.921 0.391 . . . . 0.0 111.258 -178.634 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 69.2 t -78.24 -47.37 24.62 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.274 -179.286 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' GLN . . . . . 0.471 ' O ' ' HB2' ' A' ' 96' ' ' GLN . 13.9 pt20 -74.0 -31.75 63.1 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 112.172 0.434 . . . . 0.0 112.172 -178.212 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 1.5 pp0? -77.53 -27.85 51.8 Favored 'General case' 0 N--CA 1.467 0.419 0 C-N-CA 120.305 -0.558 . . . . 0.0 111.743 -179.155 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 1.5 m-70 -71.71 -44.46 64.14 Favored 'General case' 0 C--N 1.328 -0.349 0 C-N-CA 120.832 -0.347 . . . . 0.0 111.009 -179.571 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 23.0 m-85 -81.18 -11.72 59.36 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.682 0.277 . . . . 0.0 110.884 -179.707 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . 0.471 ' HB2' ' O ' ' A' ' 92' ' ' GLN . 43.3 tt0 -62.64 -28.56 70.0 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.002 -0.544 . . . . 0.0 110.59 -179.483 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 12.1 m -64.85 -38.95 92.7 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.305 179.263 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 6.1 m -81.01 -40.01 24.96 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.005 179.321 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . 0.456 ' O ' ' HA ' ' A' ' 96' ' ' GLN . . . -153.8 129.37 2.64 Favored Glycine 0 N--CA 1.442 -0.91 0 CA-C-N 115.76 -0.655 . . . . 0.0 111.516 179.487 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . 0.424 HG22 ' H ' ' A' ' 100' ' ' THR . 0.6 OUTLIER -58.97 140.84 55.18 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.259 0.552 . . . . 0.0 110.748 179.868 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . 0.443 HG11 ' HB2' ' A' ' 92' ' ' GLN . 1.3 p -107.55 128.37 62.73 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 115.754 -0.657 . . . . 0.0 111.996 -178.057 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . 0.489 ' O ' ' HD2' ' A' ' 103' ' ' ARG . 6.3 t30 -86.39 -53.36 5.05 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 109.229 -0.656 . . . . 0.0 109.229 178.553 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' ARG . . . . . 0.489 ' HD2' ' O ' ' A' ' 102' ' ' ASN . 3.4 mpt_? -138.93 153.49 48.24 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 116.001 -0.545 . . . . 0.0 109.62 179.963 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 4.8 p -142.74 126.93 15.22 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 N-CA-C 109.787 -0.449 . . . . 0.0 109.787 179.669 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . 0.409 ' O ' ' HA ' ' A' ' 118' ' ' ALA . 0.8 OUTLIER -114.75 127.19 55.6 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 110.308 -0.256 . . . . 0.0 110.308 179.847 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 20.0 tt -117.8 144.55 25.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-O 120.708 0.29 . . . . 0.0 110.597 -179.77 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 26.6 tp -133.45 121.97 23.01 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.557 179.84 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -84.09 114.53 21.82 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.543 -0.299 . . . . 0.0 110.318 179.258 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -78.54 134.21 37.29 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.182 0.515 . . . . 0.0 111.516 -179.698 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -119.94 22.85 11.33 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.167 179.33 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 4.0 t80 -101.07 1.39 39.35 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.113 -179.56 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 100.87 12.15 38.08 Favored Glycine 0 N--CA 1.449 -0.455 0 C-N-CA 120.796 -0.716 . . . . 0.0 112.361 179.898 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 7.2 mt-30 -100.11 157.61 33.53 Favored Pre-proline 0 C--N 1.325 -0.485 0 N-CA-C 109.37 -0.604 . . . . 0.0 109.37 179.372 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -58.53 112.76 1.29 Allowed 'Trans proline' 0 C--N 1.345 0.37 0 C-N-CA 122.433 2.089 . . . . 0.0 111.488 178.889 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 7.9 mttp -69.58 176.87 3.23 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.662 -179.745 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 99.06 2.96 56.93 Favored Glycine 0 N--CA 1.439 -1.139 0 C-N-CA 120.164 -1.017 . . . . 0.0 111.768 -179.801 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 29.1 m-85 -54.95 113.35 1.31 Allowed 'General case' 0 C--O 1.231 0.118 0 N-CA-C 110.12 -0.326 . . . . 0.0 110.12 179.53 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . 0.409 ' HA ' ' O ' ' A' ' 105' ' ' THR . . . -144.59 173.07 12.14 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 120.931 0.396 . . . . 0.0 110.87 -178.977 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 2.3 p90 -157.75 136.75 11.59 Favored 'General case' 0 N--CA 1.445 -0.676 0 CA-C-N 115.891 -0.595 . . . . 0.0 109.552 178.874 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 15.0 m -105.91 140.7 23.16 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 N-CA-C 109.489 -0.56 . . . . 0.0 109.489 178.985 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . 0.414 ' HB2' HG12 ' A' ' 72' ' ' VAL . 6.4 pt-20 -126.4 154.2 43.93 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.045 -179.287 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 122' ' ' PHE . . . . . 0.436 ' O ' ' HA ' ' A' ' 72' ' ' VAL . 14.3 t80 -154.65 167.87 28.7 Favored 'General case' 0 C--O 1.226 -0.15 0 CA-C-O 120.796 0.331 . . . . 0.0 110.637 179.306 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . 0.447 ' HA ' HG22 ' A' ' 72' ' ' VAL . 6.3 t -82.73 -50.32 15.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 115.715 -0.675 . . . . 0.0 111.626 -179.126 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 33.1 mt-10 -70.97 137.42 49.12 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.044 -0.526 . . . . 0.0 111.934 -178.748 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 2.9 mp -74.99 -32.46 27.17 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.313 179.707 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 37.8 t70 -58.0 -43.54 86.67 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-O 120.982 0.42 . . . . 0.0 111.003 -179.833 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -58.05 -57.37 13.15 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.872 -0.604 . . . . 0.0 111.471 -179.682 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 12.2 p -67.62 -29.52 45.6 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 116.477 -0.329 . . . . 0.0 111.608 -179.177 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 129' ' ' GLN . . . . . 0.455 ' O ' ' HG ' ' A' ' 132' ' ' LEU . 29.4 tt0 -63.16 -46.43 87.2 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.901 0.381 . . . . 0.0 110.308 179.889 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 48.6 m-80 -72.02 -27.15 62.53 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.216 0.532 . . . . 0.0 109.688 179.125 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -72.15 -40.73 67.8 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.561 -0.745 . . . . 0.0 111.317 179.892 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 132' ' ' LEU . . . . . 0.584 ' HA ' ' ND2' ' A' ' 135' ' ' ASN . 4.4 pp -74.7 -19.1 60.39 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.924 0.392 . . . . 0.0 110.789 179.861 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 5.3 tp -76.34 -47.48 23.31 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.383 -179.906 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 40.1 mt -126.19 95.28 4.34 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.973 -0.558 . . . . 0.0 109.818 179.959 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 135' ' ' ASN . . . . . 0.584 ' ND2' ' HA ' ' A' ' 132' ' ' LEU . 2.8 p30 -135.75 -74.74 0.45 Allowed 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 112.431 0.53 . . . . 0.0 112.431 -179.083 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 5.8 pt-20 -69.25 100.57 1.33 Allowed 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.505 0.669 . . . . 0.0 111.632 -178.708 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 26.5 m -142.68 -58.3 0.44 Allowed 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.577 -0.738 . . . . 0.0 109.929 178.815 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 3.0 tm-20 -162.17 124.51 2.85 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.151 -0.477 . . . . 0.0 109.961 179.491 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -144.51 119.11 9.75 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 109.374 -0.602 . . . . 0.0 109.374 179.448 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 2.5 t60 64.67 20.52 12.16 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-O 121.108 0.48 . . . . 0.0 110.386 179.541 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 85.15 5.61 85.48 Favored Glycine 0 N--CA 1.448 -0.543 0 C-N-CA 120.922 -0.656 . . . . 0.0 112.149 -179.303 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -120.34 173.33 7.2 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 109.98 -0.378 . . . . 0.0 109.98 179.994 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 10.3 pt20 -118.84 125.43 49.52 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 109.761 -0.459 . . . . 0.0 109.761 179.271 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -110.36 178.3 4.43 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.86 -178.9 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -118.67 118.64 32.2 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 109.394 -0.595 . . . . 0.0 109.394 179.22 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 146' ' ' VAL . . . . . 0.536 ' HA ' ' O ' ' A' ' 78' ' ' TYR . 42.0 t -122.03 119.56 58.91 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-O 120.753 0.311 . . . . 0.0 111.144 -179.065 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 60.0 m -124.16 152.49 42.77 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 109.901 -0.407 . . . . 0.0 109.901 179.499 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -61.49 130.31 45.4 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.939 0.399 . . . . 0.0 110.796 179.984 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 42.7 tttp -92.94 71.19 4.69 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 109.079 -0.711 . . . . 0.0 109.079 179.958 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 150' ' ' ARG . . . . . 0.407 HH11 ' HD2' ' A' ' 150' ' ' ARG . 3.6 tpt180 . . . . . 0 C--N 1.32 -0.706 0 CA-C-N 115.679 -0.692 . . . . 0.0 110.034 -179.563 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.165 0 N-CA-C 110.107 -0.331 . . . . 0.0 110.107 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 20.2 tp -83.75 79.39 9.48 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.147 0.499 . . . . 0.0 110.297 179.919 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 28.6 ttm180 -144.22 140.79 29.48 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.797 -0.638 . . . . 0.0 109.632 179.781 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . 0.409 ' H ' ' CD ' ' A' ' 44' ' ' GLU . 0.7 OUTLIER -71.97 84.08 0.96 Allowed 'General case' 0 C--O 1.235 0.305 0 CA-C-O 120.972 0.415 . . . . 0.0 110.112 179.398 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 14.9 ptt? -132.53 12.05 4.48 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.772 -179.244 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 1.7 mp0 -65.57 -11.64 45.91 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.834 -178.929 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -70.31 -17.43 63.08 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.963 0.411 . . . . 0.0 111.331 179.852 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 19.3 pttp -70.71 -13.22 61.99 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.49 -179.411 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 5.3 p -65.11 -20.53 27.72 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.317 0 CA-C-O 121.208 0.528 . . . . 0.0 110.952 -179.66 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 49.3 mt-10 -82.5 -12.0 58.09 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.284 179.673 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 28.7 ttmt -107.43 -32.71 7.62 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.18 0.514 . . . . 0.0 109.682 179.228 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 71.1 mt-10 -78.74 7.54 6.8 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.548 -0.751 . . . . 0.0 111.265 179.754 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -62.3 -29.21 70.27 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 109.944 -0.391 . . . . 0.0 109.944 178.988 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -96.78 3.27 62.69 Favored Glycine 0 N--CA 1.449 -0.449 0 N-CA-C 110.733 -0.947 . . . . 0.0 110.733 178.526 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.302 0 CA-C-O 121.113 0.482 . . . . 0.0 110.321 -179.388 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.153 0 CA-C-O 120.897 0.379 . . . . 0.0 110.799 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -78.24 6.19 8.71 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.374 -0.376 . . . . 0.0 111.179 179.754 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 4.2 tp-100 -119.43 -51.63 2.29 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.494 179.763 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -82.1 -62.1 1.72 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.364 -179.432 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . 0.501 ' O ' HG23 ' A' ' 72' ' ' VAL . 0.7 OUTLIER -58.52 -33.89 70.36 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.464 -179.101 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 32.6 tptt -53.25 -34.21 56.25 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 116.198 -0.455 . . . . 0.0 112.165 -179.577 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 2.5 mm-40 -61.0 -34.68 75.19 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.042 0.448 . . . . 0.0 110.764 -179.793 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 10.2 tp10 -88.42 -38.19 15.26 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.493 179.829 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.501 HG23 ' O ' ' A' ' 68' ' ' GLU . 61.4 t -64.7 -41.84 93.35 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.059 -179.589 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 4.6 t70 -68.04 -33.19 74.12 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.333 -179.357 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . 0.45 ' HB2' ' HE ' ' A' ' 150' ' ' ARG . 11.5 p -82.47 -17.25 45.89 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 121.284 0.564 . . . . 0.0 109.964 179.908 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -101.79 48.19 0.89 Allowed 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.836 0.827 . . . . 0.0 108.849 178.717 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . 0.426 ' HB3' ' HE3' ' A' ' 149' ' ' LYS . 28.0 t -125.0 158.8 32.78 Favored 'General case' 0 N--CA 1.446 -0.643 0 CA-C-N 114.726 -1.125 . . . . 0.0 110.22 -179.085 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 5.4 pt -126.94 134.8 65.37 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.138 178.895 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 61.2 t80 -92.19 130.27 37.94 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.323 -179.668 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.42 HG21 ' HE2' ' A' ' 95' ' ' PHE . 8.0 t -104.23 108.2 24.14 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.742 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.35 -179.947 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -112.88 170.24 13.32 Favored Glycine 0 N--CA 1.442 -0.961 0 N-CA-C 111.022 -0.831 . . . . 0.0 111.022 179.468 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 9.9 m-20 58.51 38.5 25.45 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-N 116.97 0.385 . . . . 0.0 110.557 -179.76 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.505 HG12 ' H ' ' A' ' 83' ' ' ASP . 1.4 t -79.35 171.81 1.23 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.971 -178.993 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . 0.562 ' OD1' ' HD2' ' A' ' 142' ' ' ARG . 30.2 t70 -81.24 141.71 33.87 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.287 -0.415 . . . . 0.0 109.906 179.476 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 55.2 p90 -65.01 -16.3 63.28 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 112.708 0.633 . . . . 0.0 112.708 -178.113 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -110.22 9.26 23.84 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.698 0.285 . . . . 0.0 111.327 -179.953 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' CYS . . . . . 0.432 ' SG ' ' HB2' ' A' ' 140' ' ' HIS . 0.9 OUTLIER -73.88 135.7 43.36 Favored 'General case' 0 C--O 1.235 0.294 0 CA-C-O 121.118 0.485 . . . . 0.0 111.336 179.888 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . 0.582 ' O ' ' HG2' ' A' ' 90' ' ' GLU . 9.0 p -103.01 153.16 38.49 Favored Pre-proline 0 C--N 1.324 -0.514 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.19 179.337 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 15.2 Cg_endo -58.82 -37.86 91.64 Favored 'Trans proline' 0 CA--C 1.531 0.335 0 C-N-CA 122.48 2.12 . . . . 0.0 112.827 -179.426 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 7.5 mp0 -63.79 -46.3 85.83 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.756 -179.361 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . 0.582 ' HG2' ' O ' ' A' ' 87' ' ' THR . 7.7 pt-20 -65.65 -26.4 67.79 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.807 0.337 . . . . 0.0 111.069 -179.114 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 62.2 t -74.61 -55.51 11.74 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.874 -179.953 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 2.7 pt20 -62.51 -36.12 81.54 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 112.405 0.52 . . . . 0.0 112.405 -178.516 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 2.9 pt20 -76.35 -24.07 54.22 Favored 'General case' 0 N--CA 1.463 0.185 0 C-N-CA 120.792 -0.363 . . . . 0.0 111.605 -178.947 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -80.02 -39.25 30.3 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.856 0.36 . . . . 0.0 111.193 -179.494 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . 0.42 ' HE2' HG21 ' A' ' 79' ' ' VAL . 21.1 m-30 -81.3 -17.92 47.62 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.955 -179.22 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . 0.53 ' HA ' ' O ' ' A' ' 99' ' ' GLY . 1.9 tt0 -61.36 -23.78 66.01 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.801 179.702 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 2.7 m -63.11 -31.21 72.3 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.641 -0.708 . . . . 0.0 110.594 179.47 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 27.7 m -99.61 -44.96 5.95 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.213 179.547 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . 0.53 ' O ' ' HA ' ' A' ' 96' ' ' GLN . . . -141.52 132.24 5.2 Favored Glycine 0 N--CA 1.446 -0.646 0 C-N-CA 120.793 -0.718 . . . . 0.0 112.012 -179.815 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 2.5 m -68.0 147.23 52.69 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 120.728 0.299 . . . . 0.0 110.481 179.905 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 2.0 p -125.9 135.2 64.62 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-O 120.832 0.349 . . . . 0.0 111.325 -179.088 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 28.3 t-20 -104.78 -43.78 5.02 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.298 179.268 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 5.3 mpt_? -119.4 137.15 53.94 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.345 -0.388 . . . . 0.0 109.999 179.539 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 12.3 p -144.47 145.84 20.99 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.109 -179.948 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . 0.581 ' HB ' ' CE2' ' A' ' 119' ' ' TYR . 4.2 m -146.13 137.83 24.9 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 110.036 -0.357 . . . . 0.0 110.036 179.358 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 14.9 tt -121.38 144.96 28.74 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-O 120.824 0.345 . . . . 0.0 110.631 -179.78 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 18.6 tp -123.22 127.64 48.89 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 116.438 -0.346 . . . . 0.0 110.469 -179.959 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -90.1 121.69 32.39 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.378 179.162 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 20.5 t70 -92.76 144.39 25.34 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 120.98 0.419 . . . . 0.0 111.174 -179.69 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -135.81 30.53 3.1 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 179.131 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 40.0 t80 -111.5 -12.24 13.99 Favored 'General case' 0 N--CA 1.452 -0.329 0 CA-C-N 115.19 -0.914 . . . . 0.0 110.029 -179.253 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 112.17 9.49 19.97 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.706 -179.466 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 32.6 mt-30 -91.81 157.59 41.29 Favored Pre-proline 0 C--N 1.325 -0.497 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 179.256 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 13.9 Cg_endo -58.1 99.09 0.09 OUTLIER 'Trans proline' 0 C--N 1.345 0.388 0 C-N-CA 122.095 1.863 . . . . 0.0 111.713 179.024 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 73.9 mttt -58.5 163.3 3.22 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.624 -0.717 . . . . 0.0 111.122 -179.196 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 102.55 6.12 47.57 Favored Glycine 0 N--CA 1.445 -0.75 0 C-N-CA 120.705 -0.76 . . . . 0.0 112.015 -179.811 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 46.5 m-85 -51.96 119.36 4.21 Favored 'General case' 0 CA--C 1.519 -0.236 0 CA-C-O 120.585 0.231 . . . . 0.0 110.473 179.56 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -146.79 172.94 12.87 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-O 121.034 0.445 . . . . 0.0 111.028 -179.136 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 119' ' ' TYR . . . . . 0.581 ' CE2' ' HB ' ' A' ' 105' ' ' THR . 50.5 p90 -154.2 148.75 26.28 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 115.791 -0.64 . . . . 0.0 109.471 179.02 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 30.6 m -124.64 136.31 61.07 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-N 116.476 -0.329 . . . . 0.0 110.314 179.566 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . 0.411 ' HB3' ' HB2' ' A' ' 76' ' ' SER . 10.2 pt-20 -128.38 149.09 50.69 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 120.898 0.38 . . . . 0.0 111.06 -179.844 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 7.7 t80 -148.87 167.96 24.3 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.535 -179.942 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 8.0 t -82.62 -42.27 18.19 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.177 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.446 -179.501 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -71.15 126.91 30.86 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.327 0.584 . . . . 0.0 111.292 -179.165 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . 0.408 HD12 ' H ' ' A' ' 125' ' ' ILE . 4.7 mp -67.87 -44.11 85.55 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-N 115.244 -0.889 . . . . 0.0 111.262 -178.845 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . 0.445 ' HA ' ' HB3' ' A' ' 129' ' ' GLN . 0.2 OUTLIER -62.34 -27.58 69.15 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.574 -0.284 . . . . 0.0 111.698 -179.132 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -63.66 -57.95 8.43 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.893 0.378 . . . . 0.0 110.23 179.423 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 11.5 p -69.26 -27.09 33.39 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 116.343 -0.389 . . . . 0.0 110.726 179.748 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 129' ' ' GLN . . . . . 0.445 ' HB3' ' HA ' ' A' ' 126' ' ' ASP . 16.1 tt0 -62.24 -45.4 93.48 Favored 'General case' 0 C--N 1.333 -0.121 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.493 179.504 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 37.6 m-80 -73.4 -26.84 61.15 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.246 0.546 . . . . 0.0 109.914 179.417 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 131' ' ' ALA . . . . . 0.451 ' O ' ' HB2' ' A' ' 135' ' ' ASN . . . -69.62 -49.72 51.2 Favored 'General case' 0 N--CA 1.45 -0.456 0 CA-C-N 115.661 -0.699 . . . . 0.0 110.792 179.623 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 3.9 pp -65.74 -16.08 63.44 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-O 120.884 0.373 . . . . 0.0 111.223 179.99 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 51.2 tp -82.39 -54.19 5.41 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.014 179.344 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 89.8 mt -120.43 93.64 4.11 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.298 179.827 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 135' ' ' ASN . . . . . 0.499 ' HB3' HG21 ' A' ' 146' ' ' VAL . 0.2 OUTLIER -145.98 -57.31 0.3 Allowed 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.978 -0.556 . . . . 0.0 111.054 -179.522 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 136' ' ' GLU . . . . . 0.418 ' HG2' ' H ' ' A' ' 136' ' ' GLU . 1.2 pt-20 -73.44 87.71 1.58 Allowed 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.854 -0.612 . . . . 0.0 111.19 -179.462 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 6.6 m -138.28 -65.87 0.5 Allowed 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.21 179.278 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 6.2 tm-20 -157.96 136.22 10.96 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.309 -179.576 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -152.23 119.23 5.83 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 109.071 -0.715 . . . . 0.0 109.071 179.181 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 140' ' ' HIS . . . . . 0.432 ' HB2' ' SG ' ' A' ' 86' ' ' CYS . 2.2 t60 65.45 19.07 11.51 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-O 121.147 0.499 . . . . 0.0 110.658 179.63 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 88.78 -5.84 84.21 Favored Glycine 0 N--CA 1.447 -0.589 0 C-N-CA 120.864 -0.684 . . . . 0.0 111.814 -179.189 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 142' ' ' ARG . . . . . 0.562 ' HD2' ' OD1' ' A' ' 83' ' ' ASP . 0.0 OUTLIER -108.1 175.56 5.43 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 120.798 0.332 . . . . 0.0 110.154 -179.676 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 10.8 pt20 -113.9 148.94 35.9 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 109.584 -0.525 . . . . 0.0 109.584 179.257 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -137.12 175.23 9.8 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 120.789 0.328 . . . . 0.0 110.897 -179.905 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 84.0 tttt -123.96 127.46 47.99 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.758 -0.655 . . . . 0.0 109.77 -179.873 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 146' ' ' VAL . . . . . 0.499 HG21 ' HB3' ' A' ' 135' ' ' ASN . 99.2 t -115.72 126.42 73.24 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 CA-C-O 120.801 0.334 . . . . 0.0 110.975 -179.073 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 3.8 m -121.81 153.27 38.56 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.673 -179.69 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -74.84 117.17 16.38 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.721 0.296 . . . . 0.0 110.489 179.386 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 149' ' ' LYS . . . . . 0.426 ' HE3' ' HB3' ' A' ' 76' ' ' SER . 11.6 ttpp -92.97 47.48 1.28 Allowed 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.728 -179.232 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 150' ' ' ARG . . . . . 0.45 ' HE ' ' HB2' ' A' ' 74' ' ' SER . 0.0 OUTLIER . . . . . 0 C--N 1.326 -0.438 0 N-CA-C 109.892 -0.41 . . . . 0.0 109.892 179.517 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.236 0.371 0 CA-C-O 120.59 0.233 . . . . 0.0 110.471 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 12.1 tp -77.5 86.07 3.86 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.247 0.546 . . . . 0.0 110.369 -179.811 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 22.0 ttm-85 -148.43 149.65 32.1 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.031 -179.636 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -79.76 56.11 2.2 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.582 0.706 . . . . 0.0 110.485 -179.86 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 27.4 ptm -106.54 12.62 29.3 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.42 -0.809 . . . . 0.0 109.968 179.752 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 28.9 mm-40 -73.91 -26.45 60.53 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.531 -179.307 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -70.29 -6.37 34.54 Favored 'General case' 0 C--O 1.236 0.347 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.679 179.501 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 13.9 ttpp -86.57 2.1 49.34 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.207 179.599 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 8.3 p -55.74 -30.32 27.16 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.331 0 CA-C-N 116.052 -0.522 . . . . 0.0 112.005 -179.233 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 17.1 pt-20 -67.19 -28.45 68.11 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.862 0.363 . . . . 0.0 110.9 -179.928 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 37.4 mttm -86.63 -32.55 20.52 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 109.342 -0.614 . . . . 0.0 109.342 179.515 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 15.8 mm-40 -77.23 -3.62 40.61 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.691 -0.686 . . . . 0.0 111.197 -179.427 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 21.3 ttt -59.11 -38.58 79.91 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.174 0.511 . . . . 0.0 110.064 179.059 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -88.57 1.75 84.15 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.678 -0.772 . . . . 0.0 112.125 179.72 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.324 -0.524 0 CA-C-O 121.252 0.548 . . . . 0.0 110.937 -179.693 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.457 -0.096 0 CA-C-O 120.787 0.327 . . . . 0.0 111.588 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 4.3 m -81.21 -4.95 57.1 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 120.894 0.378 . . . . 0.0 111.511 -179.18 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 20.1 tp60 -111.94 -65.52 1.17 Allowed 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 112.171 0.434 . . . . 0.0 112.171 -179.947 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -77.7 -54.58 6.2 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.774 0.321 . . . . 0.0 111.802 -178.276 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . 0.455 ' O ' HG23 ' A' ' 72' ' ' VAL . 1.0 OUTLIER -62.05 -25.86 67.92 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.323 -0.398 . . . . 0.0 110.756 -179.518 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . 0.432 ' HG3' ' OD2' ' A' ' 73' ' ' ASP . 0.1 OUTLIER -49.48 -42.91 44.67 Favored 'General case' 0 C--O 1.232 0.139 0 CA-C-N 115.998 -0.546 . . . . 0.0 112.036 -179.293 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 28.2 mt-10 -52.23 -35.84 50.66 Favored 'General case' 0 N--CA 1.465 0.301 0 O-C-N 123.696 0.622 . . . . 0.0 112.138 -179.243 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 5.7 tp10 -83.52 -32.96 25.62 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 116.564 -0.289 . . . . 0.0 111.56 -178.755 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.528 ' HA ' ' O ' ' A' ' 122' ' ' PHE . 0.6 OUTLIER -69.05 -40.95 81.4 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 116.583 -0.28 . . . . 0.0 111.518 -178.786 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . 0.432 ' OD2' ' HG3' ' A' ' 69' ' ' LYS . 0.8 OUTLIER -83.53 -11.44 57.41 Favored 'General case' 0 N--CA 1.463 0.204 0 C-N-CA 119.819 -0.753 . . . . 0.0 111.353 -179.961 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 46.4 m -87.28 -20.23 27.13 Favored 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 176.729 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -116.66 53.86 0.87 Allowed 'General case' 0 N--CA 1.454 -0.269 0 CA-C-N 115.108 -0.951 . . . . 0.0 110.468 -179.969 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -124.24 159.57 29.87 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 120.942 0.401 . . . . 0.0 110.606 179.368 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 4.5 pt -127.29 138.18 55.56 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.231 179.048 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 34.7 t80 -104.4 126.96 51.96 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 116.128 -0.487 . . . . 0.0 109.841 -179.697 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.427 HG12 HG22 ' A' ' 82' ' ' VAL . 4.6 t -98.89 112.65 31.54 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 CA-C-O 121.072 0.463 . . . . 0.0 110.464 -179.718 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -111.02 153.28 17.25 Favored Glycine 0 N--CA 1.444 -0.78 0 CA-C-N 115.74 -0.663 . . . . 0.0 111.793 179.864 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 11.2 m-80 61.01 53.08 3.8 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-O 121.083 0.468 . . . . 0.0 110.621 -179.643 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.427 HG22 HG12 ' A' ' 79' ' ' VAL . 1.1 t -89.46 169.08 1.43 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.221 -179.693 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . 0.511 ' OD1' ' HD2' ' A' ' 142' ' ' ARG . 28.4 t70 -73.99 140.35 45.43 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.877 0.37 . . . . 0.0 110.403 -179.958 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 1.1 p90 -63.97 -25.71 68.26 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.794 -0.639 . . . . 0.0 111.905 -178.907 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -96.72 10.43 38.74 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.728 0.299 . . . . 0.0 111.443 -179.595 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' CYS . . . . . 0.44 ' HB2' ' O ' ' A' ' 83' ' ' ASP . 0.8 OUTLIER -84.64 149.31 25.93 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.152 0.501 . . . . 0.0 111.15 179.823 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . 0.472 ' O ' ' HG2' ' A' ' 90' ' ' GLU . 2.5 p -120.18 157.73 52.48 Favored Pre-proline 0 C--N 1.322 -0.622 0 CA-C-N 115.73 -0.668 . . . . 0.0 109.949 179.4 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -59.09 -36.56 95.9 Favored 'Trans proline' 0 C--N 1.345 0.392 0 C-N-CA 122.366 2.044 . . . . 0.0 112.647 -179.009 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . 0.424 ' O ' ' HG3' ' A' ' 92' ' ' GLN . 56.2 mp0 -63.83 -53.11 55.9 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.67 -179.176 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . 0.472 ' HG2' ' O ' ' A' ' 87' ' ' THR . 8.9 pt-20 -62.92 -24.71 67.98 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.79 0.328 . . . . 0.0 111.853 -178.743 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 52.5 t -78.3 -49.3 21.4 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.587 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.917 -179.932 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' GLN . . . . . 0.424 ' HG3' ' O ' ' A' ' 89' ' ' GLU . 0.0 OUTLIER -67.8 -37.59 82.2 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 112.382 0.512 . . . . 0.0 112.382 -178.582 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -71.86 -26.34 62.31 Favored 'General case' 0 N--CA 1.464 0.231 0 C-N-CA 120.836 -0.346 . . . . 0.0 111.325 -179.258 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 1.6 m80 -79.26 -37.34 38.18 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.064 0.459 . . . . 0.0 110.671 179.96 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 16.7 m-30 -81.26 -14.75 57.11 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.402 -179.631 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . 0.544 ' HA ' ' O ' ' A' ' 99' ' ' GLY . 52.4 tt0 -64.1 -23.22 67.24 Favored 'General case' 0 C--N 1.333 -0.113 0 CA-C-N 115.94 -0.573 . . . . 0.0 109.898 179.215 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 1.1 m -68.79 -26.25 65.11 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.229 178.942 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 5.6 m -91.6 -47.37 7.43 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 178.864 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . 0.544 ' O ' ' HA ' ' A' ' 96' ' ' GLN . . . -150.16 143.24 10.47 Favored Glycine 0 N--CA 1.443 -0.896 0 CA-C-N 115.485 -0.779 . . . . 0.0 111.155 179.344 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . 0.518 ' HB ' ' CZ ' ' A' ' 122' ' ' PHE . 0.9 OUTLIER -62.09 139.22 58.46 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 116.881 0.34 . . . . 0.0 110.565 -179.832 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . 0.43 HG23 ' HB ' ' A' ' 120' ' ' VAL . 7.6 p -101.78 145.26 11.97 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 116.308 -0.406 . . . . 0.0 111.424 -179.275 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . 0.472 ' HB3' ' O ' ' A' ' 121' ' ' GLU . 17.9 t30 -113.74 -62.05 1.65 Allowed 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 109.687 -0.486 . . . . 0.0 109.687 178.789 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 1.2 mpp_? -120.62 145.62 47.21 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.107 179.236 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 5.4 p -137.12 128.92 42.67 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-O 121.238 0.542 . . . . 0.0 110.611 179.776 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 2.8 m -129.53 134.41 47.75 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.243 179.455 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 10.6 tt -125.02 148.9 29.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 120.697 0.284 . . . . 0.0 110.674 -179.718 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 30.2 tp -134.01 118.92 18.37 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.084 -0.507 . . . . 0.0 109.979 179.351 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -89.27 109.77 20.62 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 120.716 0.294 . . . . 0.0 110.31 179.502 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -74.03 146.89 43.38 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.15 -179.785 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 7.2 mptt -133.04 31.65 3.84 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.898 -0.592 . . . . 0.0 109.442 178.906 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -120.3 -3.69 9.98 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.628 -179.153 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 115.32 9.48 13.05 Favored Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.147 -1.025 . . . . 0.0 114.101 179.256 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 36.7 mt-30 -98.18 155.07 37.37 Favored Pre-proline 0 C--N 1.323 -0.562 0 CA-C-N 117.467 0.633 . . . . 0.0 109.382 179.206 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -53.65 98.84 0.05 OUTLIER 'Trans proline' 0 C--N 1.348 0.523 0 C-N-CA 122.887 2.392 . . . . 0.0 111.598 178.859 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 86.2 mttt -59.39 151.75 23.0 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.408 -0.815 . . . . 0.0 111.195 -179.302 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 110.36 6.22 27.58 Favored Glycine 0 N--CA 1.447 -0.625 0 C-N-CA 120.368 -0.92 . . . . 0.0 112.468 -179.698 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 51.8 m-85 -51.89 119.13 3.95 Favored 'General case' 0 CA--C 1.521 -0.169 0 CA-C-O 120.592 0.234 . . . . 0.0 110.425 179.185 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -143.49 161.65 37.87 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-O 120.806 0.336 . . . . 0.0 110.859 -179.263 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 15.1 p90 -151.19 145.26 25.29 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 109.517 -0.549 . . . . 0.0 109.517 178.878 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . 0.43 ' HB ' HG23 ' A' ' 101' ' ' VAL . 28.3 m -124.28 144.1 35.31 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.363 -179.794 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . 0.472 ' O ' ' HB3' ' A' ' 102' ' ' ASN . 7.4 pt-20 -124.56 144.57 50.06 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.703 -179.851 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 122' ' ' PHE . . . . . 0.528 ' O ' ' HA ' ' A' ' 72' ' ' VAL . 4.8 t80 -140.73 168.54 19.55 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.19 -0.459 . . . . 0.0 109.898 179.496 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -99.59 -24.77 4.07 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.241 0 N-CA-C 112.092 0.405 . . . . 0.0 112.092 -178.798 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 59.9 mm-40 -85.3 119.52 25.76 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.92 0.39 . . . . 0.0 110.496 -179.826 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 15.0 mt -64.48 -42.49 95.38 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 115.68 -0.691 . . . . 0.0 111.495 -179.132 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -57.48 -42.43 82.61 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.777 0.322 . . . . 0.0 111.599 -179.56 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -60.34 -51.86 67.71 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.634 -179.358 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 3.4 p -68.44 -24.26 29.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-O 120.856 0.36 . . . . 0.0 111.081 -179.328 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 45.3 tt0 -63.87 -41.44 97.76 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.747 179.921 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 19.7 t-20 -66.63 -33.89 76.65 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.046 179.972 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 131' ' ' ALA . . . . . 0.571 ' O ' ' HB2' ' A' ' 135' ' ' ASN . . . -73.05 -25.29 60.88 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.532 179.543 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 132' ' ' LEU . . . . . 0.443 HD13 ' HA ' ' A' ' 132' ' ' LEU . 0.2 OUTLIER -74.35 -25.78 59.73 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.233 0.539 . . . . 0.0 109.943 179.034 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 26.3 tp -81.26 -58.17 3.17 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.305 -0.862 . . . . 0.0 110.554 -179.643 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . 0.4 HD23 ' HA ' ' A' ' 134' ' ' LEU . 22.6 mt -127.78 121.14 29.44 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.314 -179.922 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 135' ' ' ASN . . . . . 0.571 ' HB2' ' O ' ' A' ' 131' ' ' ALA . 3.2 t30 -169.33 -53.72 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.163 0.506 . . . . 0.0 110.303 -179.915 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -80.04 71.27 6.76 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.814 -0.63 . . . . 0.0 111.06 179.997 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 2.3 p -112.65 -74.67 0.62 Allowed 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.362 179.012 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 24.3 tt0 -157.68 124.31 4.92 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.183 179.888 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -135.3 126.81 28.73 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 109.493 -0.558 . . . . 0.0 109.493 179.83 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 1.9 t60 64.79 22.16 12.5 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-O 121.331 0.586 . . . . 0.0 110.097 -179.697 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 84.04 -1.14 89.12 Favored Glycine 0 N--CA 1.448 -0.514 0 CA-C-N 115.758 -0.655 . . . . 0.0 112.415 -179.691 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 142' ' ' ARG . . . . . 0.511 ' HD2' ' OD1' ' A' ' 83' ' ' ASP . 0.0 OUTLIER -113.36 154.79 26.32 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.644 0.259 . . . . 0.0 110.323 -179.513 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 7.6 pt20 -95.86 146.64 24.4 Favored 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 109.499 -0.556 . . . . 0.0 109.499 178.75 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -141.05 -179.74 6.26 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.788 0.328 . . . . 0.0 110.608 -179.105 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -126.17 142.33 51.57 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.956 -0.566 . . . . 0.0 110.123 179.793 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 92.3 t -129.11 110.63 21.01 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 N-CA-C 109.789 -0.449 . . . . 0.0 109.789 -179.925 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -108.51 154.3 22.11 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.611 -179.614 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -76.02 116.43 16.71 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.02 0.438 . . . . 0.0 110.524 -179.91 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 3.6 ttpm? -86.51 68.89 10.32 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.974 -0.557 . . . . 0.0 109.684 179.927 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 150' ' ' ARG . . . . . 0.402 HH11 ' HD3' ' A' ' 150' ' ' ARG . 9.6 tpt180 . . . . . 0 C--N 1.325 -0.479 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.08 -179.392 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.453 -0.286 0 N-CA-C 110.035 -0.358 . . . . 0.0 110.035 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 11.2 tp -85.21 76.85 10.13 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 121.126 0.488 . . . . 0.0 110.399 -179.942 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 23.0 ttt180 -136.6 158.48 44.35 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.683 -179.942 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -82.83 56.34 3.38 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.709 179.957 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -119.49 17.97 12.86 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.343 0.592 . . . . 0.0 110.552 179.68 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 37.9 mm-40 -70.1 -22.83 62.99 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.758 -0.655 . . . . 0.0 110.835 -179.594 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -65.21 -14.59 61.02 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.966 -179.868 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 6.4 ttpp -77.05 -7.77 56.28 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.574 -0.284 . . . . 0.0 111.195 -179.718 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 10.6 p -59.37 -27.65 37.49 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.267 0 CA-C-O 120.98 0.419 . . . . 0.0 111.12 -179.895 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 26.8 mt-10 -66.88 -24.44 66.12 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.943 -0.572 . . . . 0.0 110.363 179.921 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 35.6 ttmt -99.24 -35.38 9.99 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.765 -0.652 . . . . 0.0 109.815 179.235 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 60.3 mm-40 -77.48 2.24 16.82 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.724 -0.671 . . . . 0.0 111.286 -179.965 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 20.0 ptt? -62.76 -28.87 70.27 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.158 0.504 . . . . 0.0 110.245 179.594 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -89.78 0.41 79.66 Favored Glycine 0 N--CA 1.445 -0.732 0 C-N-CA 120.737 -0.744 . . . . 0.0 111.448 179.321 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.325 -0.48 0 CA-C-O 121.269 0.557 . . . . 0.0 110.137 -179.763 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.52 -0.178 0 CA-C-O 120.979 0.419 . . . . 0.0 110.686 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 4.9 m -75.71 -4.52 40.81 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.696 -179.61 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 21.8 tp60 -114.72 -60.69 1.85 Allowed 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 111.962 0.356 . . . . 0.0 111.962 179.936 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -79.91 -56.29 4.36 Favored 'General case' 0 C--N 1.331 -0.215 0 N-CA-C 112.187 0.44 . . . . 0.0 112.187 -178.322 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . 0.62 ' O ' HG23 ' A' ' 72' ' ' VAL . 1.4 tp10 -59.17 -33.51 71.02 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.304 -179.575 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . 0.559 ' HG3' ' OD2' ' A' ' 73' ' ' ASP . 23.5 tptp -50.85 -33.83 25.41 Favored 'General case' 0 N--CA 1.462 0.155 0 CA-C-N 115.422 -0.808 . . . . 0.0 111.875 -179.364 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 34.5 mt-10 -49.38 -39.2 31.44 Favored 'General case' 0 N--CA 1.465 0.277 0 O-C-N 123.551 0.532 . . . . 0.0 111.583 179.911 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 7.7 tp10 -94.99 -31.46 13.62 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.251 -179.438 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.62 HG23 ' O ' ' A' ' 68' ' ' GLU . 22.9 t -58.17 -54.68 29.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 N-CA-C 112.453 0.538 . . . . 0.0 112.453 -178.084 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . 0.559 ' OD2' ' HG3' ' A' ' 69' ' ' LYS . 3.3 p30 -84.58 0.47 49.93 Favored 'General case' 0 N--CA 1.462 0.164 0 C-N-CA 119.676 -0.81 . . . . 0.0 111.588 -179.419 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 6.1 m -91.11 -27.25 18.68 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 108.318 -0.993 . . . . 0.0 108.318 175.562 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -106.54 59.61 0.64 Allowed 'General case' 0 N--CA 1.449 -0.5 0 CA-C-N 114.916 -1.038 . . . . 0.0 109.565 179.701 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -132.36 161.27 34.0 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.848 -179.908 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.421 HG22 HD23 ' A' ' 132' ' ' LEU . 15.1 pt -119.68 136.98 55.05 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.312 179.293 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 56.1 t80 -101.15 128.0 47.44 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 179.432 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 2.7 t -108.73 117.75 54.83 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.683 0 CA-C-O 121.074 0.464 . . . . 0.0 111.413 -178.711 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -113.44 164.41 12.05 Favored Glycine 0 N--CA 1.445 -0.719 0 N-CA-C 111.115 -0.794 . . . . 0.0 111.115 179.421 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 2.7 m-20 61.88 44.19 8.65 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-O 121.011 0.434 . . . . 0.0 110.941 179.943 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 10.7 t -85.43 154.27 3.5 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.5 -179.82 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . 0.576 ' HB3' ' SG ' ' A' ' 86' ' ' CYS . 0.8 OUTLIER -72.33 134.66 45.61 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.13 179.51 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 48.7 p90 -63.9 -16.34 61.19 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 113.057 0.762 . . . . 0.0 113.057 -178.015 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -96.46 4.37 52.16 Favored 'General case' 0 C--N 1.324 -0.52 0 C-N-CA 121.054 -0.258 . . . . 0.0 111.665 -179.151 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' CYS . . . . . 0.576 ' SG ' ' HB3' ' A' ' 83' ' ' ASP . 89.6 m -81.18 156.66 25.58 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 121.207 0.527 . . . . 0.0 111.285 179.974 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 48.7 p -124.12 152.74 67.63 Favored Pre-proline 0 C--N 1.325 -0.494 0 CA-C-N 115.616 -0.72 . . . . 0.0 109.637 178.996 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -58.77 -23.07 64.89 Favored 'Trans proline' 0 C--N 1.342 0.226 0 C-N-CA 122.469 2.113 . . . . 0.0 112.599 -179.258 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 34.1 mt-10 -69.96 -58.69 3.55 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.955 -179.811 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -65.12 -23.49 67.16 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.096 0.474 . . . . 0.0 111.008 -179.462 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 6.2 t -72.28 -52.56 23.46 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.667 0 CA-C-N 115.791 -0.64 . . . . 0.0 111.163 -179.967 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 8.7 pt20 -68.69 -36.26 78.25 Favored 'General case' 0 CA--C 1.532 0.258 0 N-CA-C 112.451 0.538 . . . . 0.0 112.451 -178.207 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -68.48 -31.11 70.16 Favored 'General case' 0 C--O 1.234 0.269 0 C-N-CA 120.733 -0.387 . . . . 0.0 111.329 -178.834 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 3.6 m80 -70.33 -38.64 74.93 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.104 0.478 . . . . 0.0 109.729 179.386 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 8.2 m-30 -74.14 -30.76 62.43 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.72 -0.673 . . . . 0.0 109.828 179.765 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . 0.582 ' HA ' ' O ' ' A' ' 99' ' ' GLY . 29.0 tt0 -62.99 -17.66 62.41 Favored 'General case' 0 C--O 1.231 0.131 0 CA-C-N 115.448 -0.796 . . . . 0.0 111.183 -179.79 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 5.2 m -76.09 -22.88 55.08 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.179 0.514 . . . . 0.0 109.878 179.165 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 24.8 m -98.24 -46.03 5.97 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.729 -0.668 . . . . 0.0 109.81 179.42 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . 0.582 ' O ' ' HA ' ' A' ' 96' ' ' GLN . . . -148.49 152.68 24.7 Favored Glycine 0 N--CA 1.449 -0.496 0 N-CA-C 111.546 -0.622 . . . . 0.0 111.546 179.538 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . 0.554 ' HB ' ' CZ ' ' A' ' 122' ' ' PHE . 0.2 OUTLIER -66.96 146.82 53.98 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 116.799 0.3 . . . . 0.0 110.635 179.918 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . 0.482 HG23 ' HB ' ' A' ' 120' ' ' VAL . 2.7 p -117.21 137.72 50.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 121.015 0.436 . . . . 0.0 111.695 -178.659 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 24.1 t30 -99.13 -64.26 1.05 Allowed 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 109.487 -0.56 . . . . 0.0 109.487 179.331 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -122.88 149.18 44.55 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.486 179.44 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 7.9 p -136.28 139.94 44.57 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.018 179.677 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . 0.588 ' HB ' ' CE1' ' A' ' 119' ' ' TYR . 4.0 m -138.19 140.69 39.89 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 109.59 -0.522 . . . . 0.0 109.59 179.304 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 20.6 tt -134.03 143.79 37.37 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 O-C-N 123.289 0.368 . . . . 0.0 110.446 -179.733 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 20.4 tp -127.09 134.55 50.23 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 120.998 0.428 . . . . 0.0 111.201 -179.804 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -101.62 114.77 29.1 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.595 179.256 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . 0.516 ' O ' ' HE2' ' A' ' 115' ' ' LYS . 17.3 t70 -85.44 148.54 25.94 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.397 -179.94 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 4.0 mppt? -128.6 23.31 5.86 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.861 179.956 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 3.8 t80 -110.52 -9.71 14.56 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.792 0.33 . . . . 0.0 110.904 -179.721 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 123.6 -3.54 9.4 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.251 -0.976 . . . . 0.0 113.465 179.327 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 34.1 mt-30 -79.22 154.82 77.18 Favored Pre-proline 0 C--N 1.326 -0.44 0 CA-C-N 117.215 0.507 . . . . 0.0 109.787 179.694 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 10.6 Cg_endo -55.72 101.64 0.09 OUTLIER 'Trans proline' 0 C--N 1.346 0.422 0 C-N-CA 122.533 2.155 . . . . 0.0 111.992 179.261 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . 0.516 ' HE2' ' O ' ' A' ' 109' ' ' ASP . 85.9 mttt -61.32 147.45 44.64 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.464 -0.789 . . . . 0.0 110.844 -179.778 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 109.76 11.45 21.0 Favored Glycine 0 N--CA 1.447 -0.627 0 C-N-CA 120.125 -1.035 . . . . 0.0 113.076 179.943 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 32.2 m-85 -54.47 116.69 2.79 Favored 'General case' 0 N--CA 1.465 0.278 0 N-CA-C 109.766 -0.457 . . . . 0.0 109.766 179.032 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -138.83 166.39 24.55 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 121.271 0.558 . . . . 0.0 111.826 -178.591 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 119' ' ' TYR . . . . . 0.588 ' CE1' ' HB ' ' A' ' 105' ' ' THR . 41.4 p90 -157.8 147.73 20.29 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.081 -0.963 . . . . 0.0 109.052 179.085 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . 0.482 ' HB ' HG23 ' A' ' 101' ' ' VAL . 29.8 m -125.59 136.58 60.4 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-N 116.643 -0.253 . . . . 0.0 110.702 -179.944 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 4.2 pt-20 -115.78 152.59 32.99 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.993 179.923 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 122' ' ' PHE . . . . . 0.554 ' CZ ' ' HB ' ' A' ' 100' ' ' THR . 8.7 t80 -152.2 167.14 29.54 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.253 -0.431 . . . . 0.0 109.935 179.498 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . 0.477 HG22 HG22 ' A' ' 72' ' ' VAL . 4.5 t -89.07 -38.63 11.6 Favored 'Isoleucine or valine' 0 C--O 1.236 0.354 0 CA-C-O 121.036 0.446 . . . . 0.0 111.392 -179.402 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 63.6 mm-40 -76.8 127.32 32.54 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.363 -179.368 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 32.4 mt -70.81 -38.37 72.45 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-N 115.593 -0.73 . . . . 0.0 111.426 -179.442 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -61.06 -38.52 86.48 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.383 -0.371 . . . . 0.0 111.697 -179.035 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -61.38 -55.8 27.43 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.213 -179.573 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 11.9 p -67.4 -27.77 39.9 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.173 -179.497 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 52.6 tt0 -61.3 -45.51 94.16 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.929 0.395 . . . . 0.0 110.788 179.937 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -64.54 -34.13 77.53 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.908 -179.726 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -77.55 -23.26 50.11 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.178 179.908 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 132' ' ' LEU . . . . . 0.421 HD23 HG22 ' A' ' 77' ' ' ILE . 0.4 OUTLIER -80.47 -15.78 55.92 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-O 121.358 0.599 . . . . 0.0 110.164 179.833 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 5.1 mp -96.62 -58.9 1.93 Allowed 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.771 179.661 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 78.9 mt -117.38 107.5 14.44 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.664 -179.435 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 65.8 t30 -166.51 -50.96 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.599 -179.799 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 136' ' ' GLU . . . . . 0.502 ' HB3' HG23 ' A' ' 146' ' ' VAL . 4.0 pt-20 -72.46 87.33 1.18 Allowed 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.299 0.571 . . . . 0.0 111.102 -179.618 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -131.21 -70.29 0.6 Allowed 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.393 179.845 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 2.9 tm-20 -150.11 132.93 15.99 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.228 -179.788 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -143.61 112.46 6.6 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.695 -0.684 . . . . 0.0 109.469 179.483 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 2.0 t60 62.37 27.72 16.51 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.208 179.49 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 90.0 -10.0 75.44 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.821 -0.704 . . . . 0.0 112.42 179.75 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 142' ' ' ARG . . . . . 0.427 HH11 ' HD3' ' A' ' 142' ' ' ARG . 0.4 OUTLIER -109.39 176.33 5.12 Favored 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 110.134 -0.321 . . . . 0.0 110.134 -179.886 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 5.0 pt20 -125.48 141.09 52.24 Favored 'General case' 0 C--N 1.319 -0.722 0 N-CA-C 109.891 -0.411 . . . . 0.0 109.891 179.195 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -125.3 173.83 8.55 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.467 -178.99 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -115.34 126.11 54.04 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.271 -0.422 . . . . 0.0 109.991 179.586 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 146' ' ' VAL . . . . . 0.502 HG23 ' HB3' ' A' ' 136' ' ' GLU . 94.1 t -104.47 117.18 49.63 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 CA-C-N 115.877 -0.601 . . . . 0.0 109.994 -179.743 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -117.2 156.17 28.15 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.39 -179.589 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -80.19 115.9 19.99 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 109.986 -0.376 . . . . 0.0 109.986 179.713 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 11.5 ttpp -88.52 52.9 2.55 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.219 0.533 . . . . 0.0 109.955 -179.73 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.325 -0.479 0 CA-C-N 115.804 -0.635 . . . . 0.0 110.48 -179.583 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.453 -0.293 0 N-CA-C 109.215 -0.661 . . . . 0.0 109.215 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 24.4 tp -74.86 82.76 2.16 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.405 0.622 . . . . 0.0 110.456 179.649 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 9.5 ttp180 -143.03 141.87 31.43 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.688 -0.687 . . . . 0.0 109.676 179.617 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -76.07 41.82 0.24 Allowed 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 121.139 0.495 . . . . 0.0 111.152 -179.749 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 10.9 ptt? -98.6 5.25 47.94 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.853 -0.612 . . . . 0.0 109.644 179.752 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 84.0 mt-30 -71.43 -20.95 62.04 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.351 -0.84 . . . . 0.0 111.383 -178.811 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -69.26 -17.51 63.76 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.214 0.531 . . . . 0.0 110.602 179.861 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . 0.556 ' O ' ' HG2' ' A' ' 52' ' ' GLU . 20.4 ttpp -72.99 1.48 8.78 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.572 -0.74 . . . . 0.0 110.885 179.72 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 8.1 p -55.38 -27.05 20.0 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.311 0 CA-C-N 116.463 -0.335 . . . . 0.0 111.601 -179.648 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 20.8 mt-10 -64.02 -19.9 65.53 Favored 'General case' 0 N--CA 1.463 0.19 0 CA-C-O 121.337 0.589 . . . . 0.0 110.248 179.377 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 13.1 mtmt -107.95 -37.66 6.03 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.598 -0.728 . . . . 0.0 110.904 178.749 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . 0.556 ' HG2' ' O ' ' A' ' 48' ' ' LYS . 9.2 mm-40 -62.77 -21.64 66.0 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 116.681 -0.236 . . . . 0.0 111.276 179.879 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 4.7 ppp? -59.36 -23.59 62.67 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-O 120.895 0.379 . . . . 0.0 110.994 179.573 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -94.53 -5.14 61.87 Favored Glycine 0 C--O 1.227 -0.324 0 C-N-CA 121.062 -0.59 . . . . 0.0 111.677 179.28 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.326 -0.42 0 CA-C-O 121.335 0.588 . . . . 0.0 110.079 -179.798 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.52 -0.211 0 CA-C-O 120.955 0.407 . . . . 0.0 110.28 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -77.57 0.87 21.38 Favored 'General case' 0 N--CA 1.453 -0.316 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.806 -179.868 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 6.3 tp-100 -118.52 -50.49 2.43 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.441 179.502 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -82.58 -64.5 1.16 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.14 -0.482 . . . . 0.0 112.043 -179.15 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . 0.434 ' O ' HG23 ' A' ' 72' ' ' VAL . 26.0 tp10 -63.83 -26.67 68.72 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.707 0.289 . . . . 0.0 111.466 -178.775 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 36.2 tptt -58.02 -28.12 64.17 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.514 -0.312 . . . . 0.0 111.01 179.842 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 83.1 mt-10 -63.26 -21.35 66.18 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-O 121.388 0.613 . . . . 0.0 110.763 179.354 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . 0.521 ' O ' ' HD2' ' A' ' 75' ' ' ARG . 5.7 tp10 -97.49 -41.23 8.28 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.418 -0.81 . . . . 0.0 109.316 178.158 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.469 HG12 ' HB2' ' A' ' 121' ' ' GLU . 42.2 t -62.29 -40.13 86.68 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.379 0 CA-C-N 115.927 -0.578 . . . . 0.0 112.192 -179.25 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 12.9 p-10 -74.83 -14.19 60.66 Favored 'General case' 0 N--CA 1.466 0.375 0 CA-C-O 121.035 0.445 . . . . 0.0 110.867 -179.705 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 45.6 t -99.79 -12.98 19.45 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 121.504 0.669 . . . . 0.0 109.445 177.888 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . 0.521 ' HD2' ' O ' ' A' ' 71' ' ' GLU . 0.0 OUTLIER -107.66 41.05 1.58 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.054 -179.401 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -121.04 169.79 10.15 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 115.649 -0.705 . . . . 0.0 110.492 179.795 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -131.86 136.18 57.37 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 N-CA-C 109.616 -0.513 . . . . 0.0 109.616 178.433 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 71.3 t80 -91.79 123.27 35.05 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.409 -0.359 . . . . 0.0 110.278 -179.617 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 6.4 t -103.96 111.07 32.17 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.286 -179.615 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -119.95 169.66 13.96 Favored Glycine 0 N--CA 1.449 -0.48 0 C-N-CA 120.908 -0.663 . . . . 0.0 111.74 179.896 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 15.2 m120 61.48 35.62 17.5 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-O 121.102 0.477 . . . . 0.0 110.623 -179.742 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 2.1 t -79.79 165.85 2.71 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.674 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.65 -179.125 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -70.42 142.81 51.99 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 110.017 -0.364 . . . . 0.0 110.017 179.35 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 38.2 p90 -67.12 -13.47 61.98 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 112.03 0.381 . . . . 0.0 112.03 -178.723 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -114.06 16.78 18.1 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.787 0.327 . . . . 0.0 111.025 -179.968 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' CYS . . . . . 0.467 ' SG ' ' HB2' ' A' ' 140' ' ' HIS . 0.7 OUTLIER -82.16 142.1 32.5 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.132 0.491 . . . . 0.0 111.164 -179.927 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . 0.549 ' O ' ' HG2' ' A' ' 90' ' ' GLU . 23.1 p -106.29 154.48 39.72 Favored Pre-proline 0 C--N 1.327 -0.406 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.548 179.705 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . 0.462 ' HD3' HD13 ' A' ' 106' ' ' ILE . 18.2 Cg_endo -59.19 -35.13 98.22 Favored 'Trans proline' 0 C--N 1.344 0.328 0 C-N-CA 122.769 2.313 . . . . 0.0 112.794 -179.355 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -65.51 -50.62 64.6 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.909 -0.587 . . . . 0.0 112.144 -178.705 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . 0.549 ' HG2' ' O ' ' A' ' 87' ' ' THR . 10.5 pt-20 -61.97 -24.78 67.22 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.888 0.375 . . . . 0.0 111.444 -178.806 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 76.1 t -81.2 -47.78 19.68 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.926 -178.761 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -71.5 -31.11 66.72 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.581 -178.627 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 3.7 pp0? -80.33 -27.91 38.26 Favored 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 120.383 -0.527 . . . . 0.0 111.252 -179.124 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 50.2 t-80 -77.44 -34.13 54.62 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.987 0.423 . . . . 0.0 110.479 -179.792 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 22.5 m-30 -84.38 -10.21 57.76 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.611 -179.987 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . 0.453 ' HA ' ' O ' ' A' ' 99' ' ' GLY . 14.8 tt0 -65.83 -25.4 67.2 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.488 -0.778 . . . . 0.0 109.979 179.804 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 3.6 m -62.95 -30.03 71.25 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.646 -0.706 . . . . 0.0 110.48 179.123 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 3.5 m -92.55 -49.67 6.0 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.346 179.951 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . 0.453 ' O ' ' HA ' ' A' ' 96' ' ' GLN . . . -145.41 144.24 12.8 Favored Glycine 0 N--CA 1.449 -0.473 0 C-N-CA 120.824 -0.703 . . . . 0.0 111.701 179.829 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . 0.454 ' HB ' ' CZ ' ' A' ' 122' ' ' PHE . 0.2 OUTLIER -64.26 143.81 57.61 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-O 120.837 0.351 . . . . 0.0 110.69 179.945 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 1.7 p -110.72 126.45 68.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.077 -179.387 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 24.8 t-20 -90.91 -50.14 6.04 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 109.455 -0.572 . . . . 0.0 109.455 179.026 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -138.75 156.08 47.67 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.954 -0.567 . . . . 0.0 109.726 179.169 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 5.4 p -152.28 125.73 1.27 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.262 179.972 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 2.6 m -118.14 126.3 51.95 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 110.007 -0.368 . . . . 0.0 110.007 179.795 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 106' ' ' ILE . . . . . 0.503 HD11 ' HA2' ' A' ' 116' ' ' GLY . 20.9 tt -110.68 145.4 17.09 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-O 120.962 0.411 . . . . 0.0 110.794 179.816 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 32.6 tp -129.2 130.3 46.14 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.576 179.934 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -91.83 119.54 31.72 Favored 'General case' 0 N--CA 1.45 -0.47 0 CA-C-N 116.495 -0.32 . . . . 0.0 110.386 179.235 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . 0.437 ' O ' ' HG2' ' A' ' 115' ' ' LYS . 16.4 t70 -85.46 139.14 31.75 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.086 0.47 . . . . 0.0 110.633 179.917 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.3 23.49 5.98 Favored 'General case' 0 C--N 1.319 -0.749 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 179.113 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 1.1 t80 -103.82 1.79 31.97 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.542 -178.927 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 103.86 7.85 40.75 Favored Glycine 0 N--CA 1.448 -0.554 0 C-N-CA 121.066 -0.588 . . . . 0.0 112.701 179.527 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 18.3 mt-30 -98.56 158.19 32.97 Favored Pre-proline 0 C--N 1.324 -0.507 0 N-CA-C 109.489 -0.56 . . . . 0.0 109.489 179.581 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -59.26 118.91 5.87 Favored 'Trans proline' 0 C--N 1.346 0.403 0 C-N-CA 122.12 1.88 . . . . 0.0 111.169 178.665 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . 0.437 ' HG2' ' O ' ' A' ' 109' ' ' ASP . 60.1 mttt -72.93 173.74 8.82 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 109.892 -0.41 . . . . 0.0 109.892 -179.441 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . 0.503 ' HA2' HD11 ' A' ' 106' ' ' ILE . . . 100.28 2.53 55.72 Favored Glycine 0 N--CA 1.444 -0.788 0 C-N-CA 120.309 -0.948 . . . . 0.0 112.326 179.406 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 29.8 m-85 -52.48 115.2 1.65 Allowed 'General case' 0 C--N 1.333 -0.14 0 N-CA-C 110.117 -0.327 . . . . 0.0 110.117 179.445 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -144.6 175.36 10.2 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 121.087 0.47 . . . . 0.0 111.223 -178.913 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 50.8 p90 -159.26 137.75 10.73 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.58 -0.737 . . . . 0.0 109.506 179.002 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 11.3 m -110.31 140.66 28.39 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 N-CA-C 109.446 -0.576 . . . . 0.0 109.446 179.118 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . 0.469 ' HB2' HG12 ' A' ' 72' ' ' VAL . 4.9 pt-20 -126.02 151.57 46.92 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.487 -0.324 . . . . 0.0 110.812 179.887 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 122' ' ' PHE . . . . . 0.454 ' CZ ' ' HB ' ' A' ' 100' ' ' THR . 10.6 t80 -148.87 167.14 26.48 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.662 179.965 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 37.7 t -84.05 -45.37 18.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 115.765 -0.652 . . . . 0.0 111.741 -179.19 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 34.2 mm-40 -73.54 137.03 44.12 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.785 0.326 . . . . 0.0 110.669 -179.24 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 2.9 mp -77.42 -34.83 21.26 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.702 -179.59 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -59.28 -36.23 75.19 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.186 0.517 . . . . 0.0 111.203 -179.786 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -62.95 -57.71 9.81 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.354 -179.818 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 10.7 p -65.03 -28.7 45.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.532 -0.304 . . . . 0.0 111.271 -179.403 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 50.2 tt0 -61.49 -43.35 99.01 Favored 'General case' 0 C--N 1.334 -0.095 0 CA-C-O 120.973 0.416 . . . . 0.0 110.23 179.602 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 46.4 m-80 -72.17 -29.98 64.54 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 121.223 0.535 . . . . 0.0 109.951 179.477 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -67.97 -50.88 53.12 Favored 'General case' 0 N--CA 1.453 -0.285 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.989 179.827 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 4.1 pp -67.41 -17.31 64.67 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.986 0.422 . . . . 0.0 110.882 -179.965 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 1.4 tp -78.06 -50.49 11.96 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.506 -179.965 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 76.5 mt -135.2 104.25 5.83 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.15 179.916 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -148.64 -56.59 0.21 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.243 0.544 . . . . 0.0 111.344 -179.035 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 3.8 pt-20 -75.24 92.6 2.75 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.667 -0.697 . . . . 0.0 111.437 -179.39 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 2.5 m -140.04 -59.31 0.55 Allowed 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.005 179.276 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 11.4 tt0 -157.88 130.06 7.09 Favored 'General case' 0 N--CA 1.45 -0.438 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.482 179.413 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -148.3 120.59 8.4 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 108.82 -0.807 . . . . 0.0 108.82 179.823 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 140' ' ' HIS . . . . . 0.467 ' HB2' ' SG ' ' A' ' 86' ' ' CYS . 1.9 t60 60.48 28.08 17.73 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-O 120.87 0.367 . . . . 0.0 110.609 179.987 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 82.62 -6.0 71.54 Favored Glycine 0 CA--C 1.519 0.299 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.688 -179.845 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 1.4 mpt_? -110.94 -177.72 3.29 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.828 0.347 . . . . 0.0 110.246 -179.951 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 20.4 pt20 -123.15 141.65 51.74 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 179.077 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -125.1 175.87 7.09 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.253 179.953 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -118.06 121.27 40.17 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 109.348 -0.612 . . . . 0.0 109.348 179.61 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 96.8 t -118.73 122.64 69.93 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-O 120.71 0.29 . . . . 0.0 111.62 -178.834 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -125.77 148.26 49.15 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.041 179.196 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -63.65 130.58 44.87 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.768 0.318 . . . . 0.0 110.536 179.464 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 15.3 ttpp -91.46 67.41 5.61 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 121.351 0.596 . . . . 0.0 110.443 -179.642 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 24.3 tpt180 . . . . . 0 C--N 1.323 -0.548 0 N-CA-C 109.366 -0.605 . . . . 0.0 109.366 179.075 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.235 0.312 0 N-CA-C 110.127 -0.323 . . . . 0.0 110.127 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 41.4 tp -78.51 92.43 4.66 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.004 0.43 . . . . 0.0 110.172 179.866 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . 0.432 ' HD3' ' SD ' ' A' ' 45' ' ' MET . 57.7 ttt180 -150.86 143.06 24.15 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.455 -179.738 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 63.3 mt-10 -81.68 39.8 0.56 Allowed 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.956 -0.566 . . . . 0.0 110.757 -179.952 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' MET . . . . . 0.432 ' SD ' ' HD3' ' A' ' 43' ' ' ARG . 17.5 ptt? -97.35 14.85 24.76 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.262 0.554 . . . . 0.0 110.141 -179.611 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 51.5 mt-30 -69.09 -28.93 66.94 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.591 -0.731 . . . . 0.0 110.492 -179.826 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -70.79 -3.01 16.62 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.781 -0.645 . . . . 0.0 111.713 -179.519 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 33.6 ttpt -84.29 -3.25 58.11 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.557 179.871 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 8.9 p -57.97 -28.71 34.37 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.266 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.364 -179.874 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . 0.432 ' O ' ' HG2' ' A' ' 53' ' ' MET . 29.4 mt-10 -67.01 -20.13 65.82 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 121.245 0.545 . . . . 0.0 110.65 179.944 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 10.6 ttmt -98.5 -41.46 7.76 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.895 -0.593 . . . . 0.0 109.627 178.996 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -63.99 -21.63 66.58 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.651 -0.704 . . . . 0.0 111.0 179.629 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' MET . . . . . 0.432 ' HG2' ' O ' ' A' ' 50' ' ' GLU . 8.3 ptt? -61.63 -27.36 68.61 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 120.973 0.416 . . . . 0.0 110.577 179.502 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -98.97 10.72 62.19 Favored Glycine 0 N--CA 1.449 -0.453 0 N-CA-C 111.144 -0.782 . . . . 0.0 111.144 178.965 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.324 -0.519 0 CA-C-N 115.383 -0.408 . . . . 0.0 110.406 179.94 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.453 -0.321 0 CA-C-O 120.851 0.358 . . . . 0.0 110.341 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -76.21 -2.56 31.87 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.117 0.484 . . . . 0.0 111.085 179.515 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 35.3 tt0 -117.44 -50.66 2.53 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.208 -179.817 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -86.59 -58.31 2.66 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 112.105 0.409 . . . . 0.0 112.105 -178.675 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . 0.443 ' O ' HG23 ' A' ' 72' ' ' VAL . 2.9 tp10 -62.7 -31.0 71.82 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.587 -179.489 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 39.4 tptt -58.6 -28.67 65.81 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.976 -0.556 . . . . 0.0 111.169 179.87 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 49.1 mt-10 -61.98 -23.07 66.17 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-O 120.974 0.416 . . . . 0.0 111.151 -179.854 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 6.8 tp10 -97.77 -38.93 9.28 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 116.067 -0.515 . . . . 0.0 109.729 178.743 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.443 HG23 ' O ' ' A' ' 68' ' ' GLU . 46.6 t -65.01 -37.15 79.52 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-N 115.687 -0.688 . . . . 0.0 112.415 -178.907 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 52.1 p-10 -74.09 -16.11 61.03 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-O 120.951 0.405 . . . . 0.0 110.886 -179.526 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 42.3 t -101.8 -6.72 23.27 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.954 -0.566 . . . . 0.0 109.857 178.359 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -112.69 42.79 1.78 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.348 0.594 . . . . 0.0 109.96 -179.382 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -122.14 171.95 8.62 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.692 -0.686 . . . . 0.0 110.25 179.71 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.449 HD11 HG22 ' A' ' 120' ' ' VAL . 1.0 OUTLIER -132.02 139.05 51.23 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 N-CA-C 109.987 -0.375 . . . . 0.0 109.987 178.341 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' TYR . . . . . 0.428 ' O ' ' HA ' ' A' ' 146' ' ' VAL . 25.0 t80 -90.13 124.06 34.49 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.868 -0.606 . . . . 0.0 109.929 179.939 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 6.2 t -108.3 109.11 27.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.515 -0.311 . . . . 0.0 110.405 179.461 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -118.62 170.15 13.69 Favored Glycine 0 N--CA 1.447 -0.567 0 C-N-CA 120.996 -0.621 . . . . 0.0 111.7 -179.9 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 92.2 m-20 56.51 42.56 27.17 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-O 121.015 0.436 . . . . 0.0 110.829 -179.477 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.453 HG13 HD23 ' A' ' 144' ' ' LEU . 2.3 t -81.98 165.14 2.69 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-N 115.862 -0.608 . . . . 0.0 111.048 -178.998 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . 0.478 ' HB3' ' SG ' ' A' ' 86' ' ' CYS . 37.3 t70 -68.2 137.81 55.11 Favored 'General case' 0 CA--C 1.519 -0.212 0 N-CA-C 109.871 -0.418 . . . . 0.0 109.871 179.597 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 18.1 p90 -66.59 -10.07 41.8 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.901 -178.87 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -118.94 19.43 13.03 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.001 0.429 . . . . 0.0 110.719 179.521 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' CYS . . . . . 0.478 ' SG ' ' HB3' ' A' ' 83' ' ' ASP . 0.7 OUTLIER -79.45 149.28 31.61 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.966 180.0 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . 0.483 ' O ' ' HG2' ' A' ' 90' ' ' GLU . 2.9 p -112.61 145.92 33.94 Favored Pre-proline 0 C--N 1.326 -0.441 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.659 179.226 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . 0.445 ' HD3' HD13 ' A' ' 106' ' ' ILE . 11.2 Cg_endo -54.29 -42.56 66.45 Favored 'Trans proline' 0 C--N 1.344 0.311 0 C-N-CA 122.942 2.428 . . . . 0.0 113.039 -178.996 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -62.05 -45.7 92.41 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.302 -0.408 . . . . 0.0 112.011 -179.429 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . 0.628 ' O ' ' HB2' ' A' ' 94' ' ' HIS . 4.8 pt-20 -67.68 -21.76 65.32 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.723 0.297 . . . . 0.0 111.24 -178.765 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.42 HG23 ' O ' ' A' ' 87' ' ' THR . 76.2 t -82.17 -48.31 18.42 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.734 -179.108 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 2.4 pt20 -71.54 -31.33 66.9 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.441 -0.345 . . . . 0.0 111.451 -178.258 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -80.13 -26.59 39.35 Favored 'General case' 0 C--N 1.327 -0.386 0 C-N-CA 120.53 -0.468 . . . . 0.0 110.586 -179.793 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' HIS . . . . . 0.628 ' HB2' ' O ' ' A' ' 90' ' ' GLU . 0.1 OUTLIER -72.17 -42.1 66.27 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.994 0.426 . . . . 0.0 110.483 -179.959 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 19.9 m-30 -80.63 -15.33 56.84 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.377 179.913 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . 0.544 ' HA ' ' O ' ' A' ' 99' ' ' GLY . 30.1 tt0 -62.77 -28.85 70.27 Favored 'General case' 0 CA--C 1.523 -0.065 0 CA-C-N 115.549 -0.75 . . . . 0.0 109.607 178.704 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 14.2 m -63.4 -23.05 67.24 Favored 'General case' 0 CA--C 1.533 0.291 0 CA-C-N 115.491 -0.777 . . . . 0.0 110.852 179.302 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 7.4 m -100.2 -43.97 6.12 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.169 -0.469 . . . . 0.0 109.807 179.044 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . 0.544 ' O ' ' HA ' ' A' ' 96' ' ' GLN . . . -150.19 139.31 7.25 Favored Glycine 0 N--CA 1.444 -0.81 0 N-CA-C 111.071 -0.811 . . . . 0.0 111.071 179.491 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -60.41 149.92 32.51 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 121.072 0.463 . . . . 0.0 111.564 -179.705 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 2.0 p -114.28 129.36 70.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.352 -178.897 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 8.0 t30 -94.05 -38.33 11.19 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.306 0.574 . . . . 0.0 109.817 179.078 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -155.15 149.32 25.91 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.573 -0.739 . . . . 0.0 110.289 -179.72 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 7.7 p -145.93 135.25 17.36 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 CA-C-N 116.015 -0.538 . . . . 0.0 110.15 179.858 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . 0.497 ' HB ' ' CE1' ' A' ' 119' ' ' TYR . 2.3 m -126.37 119.74 28.08 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.468 -0.333 . . . . 0.0 110.232 179.62 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 106' ' ' ILE . . . . . 0.601 HD11 ' HA2' ' A' ' 116' ' ' GLY . 20.1 tt -108.24 143.42 18.67 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-O 120.808 0.337 . . . . 0.0 110.512 179.991 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 36.4 tp -129.39 135.39 48.63 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.713 -179.713 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -94.42 116.62 29.01 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 109.833 -0.432 . . . . 0.0 109.833 179.045 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . 0.401 ' O ' ' HG2' ' A' ' 115' ' ' LYS . 14.1 t70 -84.46 134.06 34.46 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.194 0.521 . . . . 0.0 110.87 -179.676 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 11.2 mmmm -117.77 24.22 11.2 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.742 -0.663 . . . . 0.0 109.703 179.915 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 11.6 t80 -106.87 10.77 30.55 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.208 0.528 . . . . 0.0 110.237 -179.02 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 93.79 6.83 61.88 Favored Glycine 0 N--CA 1.449 -0.461 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.697 179.396 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 27.8 mt-30 -95.47 157.61 35.93 Favored Pre-proline 0 C--N 1.323 -0.586 0 N-CA-C 109.752 -0.462 . . . . 0.0 109.752 179.89 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 11.0 Cg_endo -56.16 117.83 4.54 Favored 'Trans proline' 0 N--CA 1.462 -0.348 0 C-N-CA 122.237 1.958 . . . . 0.0 110.811 178.458 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . 0.401 ' HG2' ' O ' ' A' ' 109' ' ' ASP . 47.2 mttt -76.88 172.46 13.1 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 109.63 -0.507 . . . . 0.0 109.63 -179.289 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . 0.601 ' HA2' HD11 ' A' ' 106' ' ' ILE . . . 98.08 0.67 58.52 Favored Glycine 0 N--CA 1.446 -0.693 0 C-N-CA 120.115 -1.041 . . . . 0.0 112.599 179.596 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 1.8 t80 -52.99 119.28 4.48 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 121.018 0.437 . . . . 0.0 110.08 179.423 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -145.24 177.06 9.08 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.992 -178.845 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 119' ' ' TYR . . . . . 0.497 ' CE1' ' HB ' ' A' ' 105' ' ' THR . 49.9 p90 -158.34 133.91 8.86 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.606 -0.725 . . . . 0.0 109.059 178.905 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . 0.449 HG22 HD11 ' A' ' 77' ' ' ILE . 6.8 m -108.97 143.22 19.61 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.659 0 N-CA-C 109.666 -0.494 . . . . 0.0 109.666 178.895 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . 0.404 ' HB2' HG12 ' A' ' 72' ' ' VAL . 7.4 pt-20 -127.7 153.7 46.19 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.43 -0.35 . . . . 0.0 110.753 -179.903 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 8.4 t80 -151.97 169.57 21.99 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.297 179.318 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 3.0 t -89.52 -48.1 14.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 120.844 0.354 . . . . 0.0 111.376 -179.59 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -69.76 127.88 34.46 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.876 0.37 . . . . 0.0 110.86 -179.248 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 2.5 mp -68.03 -33.17 59.54 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.314 -179.075 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -58.09 -42.12 84.93 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.839 0.352 . . . . 0.0 111.465 -179.991 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -56.94 -56.47 21.33 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.171 -179.777 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 8.9 p -68.56 -28.32 39.79 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.363 -179.527 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 3.5 tt0 -63.01 -39.25 94.19 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.977 0.418 . . . . 0.0 110.453 -179.905 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 41.2 m-80 -77.7 -29.66 51.45 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.266 0.555 . . . . 0.0 109.797 179.096 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 131' ' ' ALA . . . . . 0.443 ' O ' ' HB2' ' A' ' 135' ' ' ASN . . . -67.65 -49.6 62.04 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.422 -0.808 . . . . 0.0 111.161 179.829 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 4.4 pp -66.38 -13.27 60.4 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.886 0.374 . . . . 0.0 111.555 -179.578 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 3.9 tp -89.06 -49.9 6.48 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.153 0.501 . . . . 0.0 109.986 179.036 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 25.3 mt -126.69 100.91 6.4 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.057 179.729 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 135' ' ' ASN . . . . . 0.443 ' HB2' ' O ' ' A' ' 131' ' ' ALA . 0.2 OUTLIER -150.62 -58.28 0.18 Allowed 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.239 0.542 . . . . 0.0 111.628 -179.293 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 4.6 pt-20 -77.5 85.98 3.86 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.8 -0.636 . . . . 0.0 111.67 -178.98 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 23.9 m -134.44 -58.88 0.83 Allowed 'General case' 0 N--CA 1.448 -0.526 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.117 179.248 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 6.8 tm-20 -155.02 128.37 8.4 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.906 0.384 . . . . 0.0 111.002 179.646 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -143.45 111.59 6.19 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 178.269 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 140' ' ' HIS . . . . . 0.482 ' HD1' ' CD ' ' A' ' 90' ' ' GLU . 1.7 t60 61.01 28.8 18.57 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.97 0.414 . . . . 0.0 110.7 -179.833 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 85.39 0.94 88.22 Favored Glycine 0 N--CA 1.449 -0.499 0 C-N-CA 120.978 -0.629 . . . . 0.0 113.043 179.779 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 142' ' ' ARG . . . . . 0.41 ' HD3' ' OD1' ' A' ' 83' ' ' ASP . 1.4 mpt_? -117.52 163.66 16.08 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 117.147 0.473 . . . . 0.0 110.868 179.928 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 2.1 pt20 -110.69 121.8 46.22 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 116.256 -0.429 . . . . 0.0 109.932 179.799 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . 0.453 HD23 HG13 ' A' ' 82' ' ' VAL . 0.5 OUTLIER -106.46 178.78 4.46 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.992 -179.025 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 6.1 tttt -115.44 121.78 43.77 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.088 -0.505 . . . . 0.0 109.859 178.893 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 146' ' ' VAL . . . . . 0.428 ' HA ' ' O ' ' A' ' 78' ' ' TYR . 96.9 t -120.98 126.9 75.77 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-O 121.094 0.473 . . . . 0.0 111.212 -179.712 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 39.7 m -134.61 151.73 51.27 Favored 'General case' 0 C--N 1.319 -0.743 0 N-CA-C 109.582 -0.525 . . . . 0.0 109.582 178.91 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -65.0 131.4 46.49 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.128 0.49 . . . . 0.0 111.46 -179.101 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 21.0 ttpt -93.48 80.29 4.35 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 121.363 0.601 . . . . 0.0 109.813 179.611 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 21.5 tpt180 . . . . . 0 C--N 1.321 -0.646 0 CA-C-N 115.346 -0.843 . . . . 0.0 109.483 179.236 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.453 -0.317 0 CA-C-O 120.732 0.301 . . . . 0.0 110.665 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 46.6 tp -72.75 90.1 1.39 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.346 179.699 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 51.2 ttt85 -154.43 147.13 24.25 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.064 -179.817 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 15.7 mt-10 -81.73 29.92 0.38 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.033 0.444 . . . . 0.0 111.111 -179.877 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 13.9 ptt? -83.64 1.83 40.44 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.277 0.56 . . . . 0.0 110.142 -179.924 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 38.6 mt-30 -71.4 -17.01 62.43 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.751 -179.793 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -78.31 -11.62 59.95 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.242 179.374 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 35.5 ttpt -77.8 -0.09 25.81 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.718 -0.674 . . . . 0.0 110.246 179.717 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 8.1 p -59.49 -26.03 33.12 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.237 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.901 179.883 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 25.7 mt-10 -67.37 -24.95 65.75 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.72 179.571 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 4.3 ttmt -98.81 -34.59 10.43 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.454 179.192 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 9.1 mm-40 -66.1 -16.04 63.6 Favored 'General case' 0 C--N 1.333 -0.112 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.22 179.781 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -64.53 -25.44 67.99 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.178 0.513 . . . . 0.0 109.785 178.694 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -97.41 12.04 65.02 Favored Glycine 0 N--CA 1.45 -0.378 0 N-CA-C 110.709 -0.956 . . . . 0.0 110.709 179.044 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.324 -0.533 0 CA-C-N 115.256 -0.472 . . . . 0.0 109.942 179.777 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.455 -0.177 0 CA-C-O 120.908 0.385 . . . . 0.0 110.575 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -74.47 -2.13 24.25 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.466 -179.922 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 22.5 tp60 -118.98 -49.37 2.42 Favored 'General case' 0 N--CA 1.451 -0.404 0 CA-C-O 120.593 0.235 . . . . 0.0 111.315 179.876 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -84.59 -52.68 5.93 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.881 0.372 . . . . 0.0 111.92 -178.549 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . 0.405 ' O ' HG23 ' A' ' 72' ' ' VAL . 1.3 tp10 -69.62 -30.67 68.45 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.989 0.423 . . . . 0.0 110.615 -179.387 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 50.9 tptt -55.81 -33.65 64.62 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.714 179.908 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 54.4 mt-10 -58.85 -25.7 63.51 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-O 121.02 0.438 . . . . 0.0 111.31 179.943 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 4.4 tp10 -93.82 -40.21 10.31 Favored 'General case' 0 N--CA 1.449 -0.517 0 N-CA-C 109.711 -0.477 . . . . 0.0 109.711 178.786 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.405 HG23 ' O ' ' A' ' 68' ' ' GLU . 61.8 t -63.01 -43.45 99.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 115.706 -0.679 . . . . 0.0 112.658 -178.804 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 9.0 p-10 -70.81 -18.89 62.73 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-O 121.154 0.502 . . . . 0.0 110.894 -179.365 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 49.1 m -97.79 -8.69 27.94 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.051 178.272 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -111.41 48.31 0.95 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.562 -0.744 . . . . 0.0 110.11 -179.368 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . 0.466 ' OG ' ' HE2' ' A' ' 149' ' ' LYS . 0.1 OUTLIER -129.95 172.76 11.37 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.921 -0.581 . . . . 0.0 111.26 179.86 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -131.01 138.14 54.2 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-N 115.847 -0.615 . . . . 0.0 109.573 178.434 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 57.2 t80 -96.64 125.32 41.03 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.405 -179.485 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.419 HG21 ' HE2' ' A' ' 95' ' ' PHE . 2.9 t -104.8 118.41 52.09 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.391 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.843 -179.405 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -124.46 168.18 16.64 Favored Glycine 0 N--CA 1.449 -0.472 0 N-CA-C 110.936 -0.866 . . . . 0.0 110.936 179.521 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 2.4 m-20 59.42 34.75 22.81 Favored 'General case' 0 N--CA 1.474 0.746 0 CA-C-O 120.834 0.35 . . . . 0.0 111.279 -179.39 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.405 ' H ' HG23 ' A' ' 82' ' ' VAL . 2.2 t -76.4 163.51 3.91 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.724 0 CA-C-N 115.616 -0.72 . . . . 0.0 110.652 -178.975 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . 0.706 ' OD2' ' HB2' ' A' ' 142' ' ' ARG . 0.5 OUTLIER -63.48 137.66 58.22 Favored 'General case' 0 CA--C 1.515 -0.369 0 N-CA-C 109.67 -0.492 . . . . 0.0 109.67 179.015 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 37.2 p90 -66.17 -8.79 26.33 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.07 -179.768 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -120.41 20.54 11.87 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.038 -179.805 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -86.48 146.34 26.44 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.817 0.342 . . . . 0.0 111.052 -179.97 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . 0.428 ' O ' ' HG2' ' A' ' 90' ' ' GLU . 17.7 p -109.73 155.0 42.2 Favored Pre-proline 0 C--N 1.323 -0.57 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.412 179.841 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . 0.479 ' HD3' HD13 ' A' ' 106' ' ' ILE . 18.3 Cg_endo -59.05 -38.88 84.9 Favored 'Trans proline' 0 C--N 1.345 0.372 0 C-N-CA 122.709 2.272 . . . . 0.0 112.929 -178.928 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 24.3 mt-10 -62.36 -50.57 71.04 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.766 -0.652 . . . . 0.0 112.348 -178.496 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . 0.428 ' HG2' ' O ' ' A' ' 87' ' ' THR . 11.1 pt-20 -66.31 -16.73 64.28 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.672 0.273 . . . . 0.0 111.535 -178.972 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 56.0 t -86.44 -47.23 16.39 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 CA-C-O 120.93 0.395 . . . . 0.0 110.495 -179.904 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -71.7 -33.39 68.73 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.791 -178.576 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 1.2 pp0? -77.09 -29.03 54.77 Favored 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 120.378 -0.529 . . . . 0.0 111.33 -178.759 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 2.9 m80 -76.7 -40.31 49.19 Favored 'General case' 0 C--N 1.327 -0.376 0 C-N-CA 120.725 -0.39 . . . . 0.0 110.809 -179.635 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . 0.419 ' HE2' HG21 ' A' ' 79' ' ' VAL . 22.0 m-30 -75.61 -16.53 60.21 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.58 179.899 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . 0.633 ' HA ' ' O ' ' A' ' 99' ' ' GLY . 2.7 tt0 -66.89 -21.77 65.99 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-N 115.982 -0.553 . . . . 0.0 110.391 179.22 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 46.7 m -66.14 -24.26 66.63 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-N 115.905 -0.588 . . . . 0.0 110.074 179.015 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 2.6 m -100.59 -48.84 4.39 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.635 -0.711 . . . . 0.0 109.497 179.042 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . 0.633 ' O ' ' HA ' ' A' ' 96' ' ' GLN . . . -142.18 138.4 8.5 Favored Glycine 0 N--CA 1.446 -0.666 0 N-CA-C 111.41 -0.676 . . . . 0.0 111.41 179.766 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . 0.404 ' HB ' ' CZ ' ' A' ' 122' ' ' PHE . 0.2 OUTLIER -59.81 148.36 34.81 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.735 0.267 . . . . 0.0 111.413 -179.934 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 2.1 p -119.88 129.28 75.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.216 -179.237 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 58.2 t30 -100.42 -43.19 6.32 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.863 0.363 . . . . 0.0 110.182 178.986 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -139.77 148.6 42.45 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.392 179.996 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 5.9 p -148.07 134.33 12.45 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-N 115.856 -0.611 . . . . 0.0 109.854 179.286 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 2.8 m -126.01 122.89 37.17 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 116.479 -0.328 . . . . 0.0 110.341 179.554 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 106' ' ' ILE . . . . . 0.479 HD13 ' HD3' ' A' ' 88' ' ' PRO . 20.3 tt -112.02 148.0 15.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 120.895 0.379 . . . . 0.0 111.136 -179.61 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 27.5 tp -136.5 128.19 28.94 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.156 178.997 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -90.06 120.69 31.47 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 109.848 -0.427 . . . . 0.0 109.848 179.315 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . 0.455 ' O ' ' HG2' ' A' ' 115' ' ' LYS . 12.8 t70 -79.53 145.1 33.36 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.087 0.47 . . . . 0.0 111.088 -179.992 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . 0.406 ' HD3' ' C ' ' A' ' 109' ' ' ASP . 0.0 OUTLIER -131.59 23.83 4.72 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.8 -0.636 . . . . 0.0 109.286 179.161 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 4.8 t80 -106.62 -5.4 18.7 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.428 -179.126 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 108.39 12.56 21.25 Favored Glycine 0 CA--C 1.519 0.287 0 C-N-CA 120.979 -0.629 . . . . 0.0 112.86 -179.956 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 113' ' ' GLN . . . . . 0.412 ' HB3' ' HD2' ' A' ' 114' ' ' PRO . 22.6 mt-30 -99.84 159.19 30.56 Favored Pre-proline 0 C--N 1.323 -0.563 0 N-CA-C 109.662 -0.496 . . . . 0.0 109.662 179.701 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 114' ' ' PRO . . . . . 0.412 ' HD2' ' HB3' ' A' ' 113' ' ' GLN . 19.3 Cg_endo -58.85 110.04 0.61 Allowed 'Trans proline' 0 C--N 1.346 0.44 0 C-N-CA 122.233 1.955 . . . . 0.0 110.863 178.645 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . 0.455 ' HG2' ' O ' ' A' ' 109' ' ' ASP . 30.5 mttt -69.6 170.9 9.83 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.553 -178.616 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . 0.415 ' HA2' HD11 ' A' ' 106' ' ' ILE . . . 101.46 4.71 52.7 Favored Glycine 0 N--CA 1.446 -0.646 0 C-N-CA 120.514 -0.851 . . . . 0.0 111.877 -179.841 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 34.1 m-85 -53.01 117.89 3.32 Favored 'General case' 0 C--O 1.232 0.167 0 C-N-CA 122.338 0.255 . . . . 0.0 110.492 179.671 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -149.18 171.54 16.28 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 121.0 0.429 . . . . 0.0 111.13 -179.314 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 17.2 p90 -154.96 132.58 11.31 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 115.501 -0.772 . . . . 0.0 109.645 178.411 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 8.5 m -108.06 142.83 19.71 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 N-CA-C 109.726 -0.472 . . . . 0.0 109.726 179.735 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . 0.424 ' HB3' ' HB3' ' A' ' 76' ' ' SER . 4.5 pt-20 -130.92 153.42 49.18 Favored 'General case' 0 C--O 1.238 0.5 0 CA-C-O 120.944 0.402 . . . . 0.0 111.235 179.987 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 122' ' ' PHE . . . . . 0.404 ' CZ ' ' HB ' ' A' ' 100' ' ' THR . 11.5 t80 -148.26 172.67 13.99 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.644 -0.707 . . . . 0.0 110.095 179.834 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 6.3 t -89.37 -41.86 14.09 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-O 121.028 0.442 . . . . 0.0 111.192 -179.742 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 38.7 mm-40 -69.96 128.92 38.02 Favored 'General case' 0 C--O 1.236 0.392 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.937 -179.83 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 2.7 mp -74.57 -33.95 33.78 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.177 -179.869 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -59.85 -37.28 78.81 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.435 179.633 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -63.56 -56.49 15.56 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.641 -0.709 . . . . 0.0 111.256 -179.789 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 11.0 p -65.77 -28.06 43.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.367 -179.367 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 5.9 tt0 -60.38 -43.93 96.12 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-O 121.006 0.431 . . . . 0.0 110.371 179.447 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 92.5 m-20 -72.48 -31.57 65.5 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.053 -0.522 . . . . 0.0 110.05 179.699 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -67.53 -42.86 82.07 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.51 -0.768 . . . . 0.0 111.636 -179.857 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 4.1 pp -74.15 -17.67 60.89 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.915 0.388 . . . . 0.0 110.914 179.976 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 6.2 tp -83.8 -56.39 3.73 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.673 179.939 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 54.1 mt -125.38 103.18 7.77 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.642 -0.254 . . . . 0.0 111.44 -179.113 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 2.4 m-20 -154.49 -53.19 0.1 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.885 0.374 . . . . 0.0 111.15 178.764 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 3.9 pt-20 -75.82 98.22 4.11 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.464 0.65 . . . . 0.0 111.08 -179.888 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 43.3 m -145.92 -57.54 0.31 Allowed 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.669 -0.696 . . . . 0.0 109.821 178.865 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 24.4 tt0 -163.17 130.05 3.44 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 109.436 -0.579 . . . . 0.0 109.436 178.954 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -148.46 122.31 9.34 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 108.603 -0.888 . . . . 0.0 108.603 179.677 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 140' ' ' HIS . . . . . 0.651 ' HB3' ' OD2' ' A' ' 83' ' ' ASP . 5.0 t60 64.43 3.16 1.77 Allowed 'General case' 0 N--CA 1.471 0.623 0 O-C-N 123.544 0.528 . . . . 0.0 111.723 179.005 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 109.65 -9.93 32.56 Favored Glycine 0 N--CA 1.446 -0.637 0 C-N-CA 121.123 -0.56 . . . . 0.0 112.127 -179.704 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 142' ' ' ARG . . . . . 0.706 ' HB2' ' OD2' ' A' ' 83' ' ' ASP . 1.0 OUTLIER -111.7 170.98 7.76 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.154 0.502 . . . . 0.0 110.375 179.876 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 7.4 pt20 -113.0 129.67 56.41 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 179.303 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -113.91 173.27 6.51 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-O 120.907 0.384 . . . . 0.0 110.474 -179.645 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 8.8 ttpt -113.23 118.02 33.5 Favored 'General case' 0 C--N 1.318 -0.775 0 N-CA-C 109.428 -0.582 . . . . 0.0 109.428 179.278 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 96.7 t -114.42 116.95 54.1 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.659 0 CA-C-O 120.756 0.312 . . . . 0.0 110.431 -179.909 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 25.7 m -127.12 146.38 50.41 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 109.393 -0.595 . . . . 0.0 109.393 179.674 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -56.85 130.6 46.46 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 120.978 0.418 . . . . 0.0 111.501 -179.234 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 149' ' ' LYS . . . . . 0.466 ' HE2' ' OG ' ' A' ' 76' ' ' SER . 18.0 ttpt -93.2 63.11 3.59 Favored 'General case' 0 N--CA 1.451 -0.378 0 N-CA-C 108.622 -0.881 . . . . 0.0 108.622 179.508 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 16.4 tpt180 . . . . . 0 C--N 1.321 -0.657 0 CA-C-O 121.31 0.576 . . . . 0.0 110.25 -179.867 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.237 0.444 0 CA-C-O 120.891 0.377 . . . . 0.0 111.547 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 16.2 tp -72.11 80.42 0.96 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.422 -0.808 . . . . 0.0 111.015 179.862 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . 0.402 ' C ' ' H ' ' A' ' 45' ' ' MET . 0.8 OUTLIER -126.6 148.93 49.72 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 115.765 -0.652 . . . . 0.0 109.391 179.449 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -75.98 23.87 0.13 Allowed 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.088 0.471 . . . . 0.0 111.847 -179.58 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' MET . . . . . 0.402 ' H ' ' C ' ' A' ' 43' ' ' ARG . 16.6 ptt? -95.8 5.93 50.13 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.053 0.454 . . . . 0.0 110.127 179.754 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 40.5 mt-30 -67.22 -8.5 32.05 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.409 -179.264 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -82.7 -11.74 58.1 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.483 0.658 . . . . 0.0 109.994 178.722 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . 0.486 ' O ' ' HG2' ' A' ' 52' ' ' GLU . 13.5 ttpp -78.51 5.82 9.97 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.257 -0.883 . . . . 0.0 110.398 -179.806 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 12.6 p -58.04 -24.65 24.25 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.123 -179.866 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 32.0 mt-10 -65.13 -27.8 68.99 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 121.154 0.502 . . . . 0.0 110.247 179.042 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 12.8 mtmt -98.59 -33.7 10.87 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.238 178.711 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . 0.486 ' HG2' ' O ' ' A' ' 48' ' ' LYS . 38.1 mm-40 -83.31 12.14 5.76 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.807 -0.633 . . . . 0.0 111.651 -179.731 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 10.5 ptp -62.03 -30.64 71.1 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-O 120.717 0.294 . . . . 0.0 110.651 179.679 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -96.91 3.96 62.81 Favored Glycine 0 N--CA 1.449 -0.434 0 N-CA-C 111.05 -0.82 . . . . 0.0 111.05 178.474 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.326 -0.441 0 CA-C-O 121.406 0.622 . . . . 0.0 110.389 -179.722 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . 0.476 ' O ' ' HB3' ' A' ' 68' ' ' GLU . . . . . . . . 0 CA--C 1.522 -0.131 0 CA-C-O 121.101 0.477 . . . . 0.0 110.223 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -77.59 3.22 14.26 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-O 121.18 0.514 . . . . 0.0 111.21 -179.795 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 16.5 tp60 -121.81 -45.86 2.26 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.794 178.928 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -87.45 -48.9 7.58 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.513 -0.312 . . . . 0.0 111.343 -179.835 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . 0.476 ' HB3' ' O ' ' A' ' 64' ' ' ALA . 3.0 tp10 -72.54 -31.37 65.25 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 121.114 0.483 . . . . 0.0 109.92 179.795 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . 0.41 ' HE3' ' OE2' ' A' ' 121' ' ' GLU . 0.0 OUTLIER -55.11 -29.98 58.77 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.814 -0.63 . . . . 0.0 111.581 179.726 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 95.4 mt-10 -60.64 -21.48 62.81 Favored 'General case' 0 C--N 1.332 -0.182 0 O-C-N 123.525 0.516 . . . . 0.0 110.787 179.656 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . 0.553 ' O ' ' HD3' ' A' ' 75' ' ' ARG . 36.0 tp10 -98.68 -43.49 6.79 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 109.435 -0.58 . . . . 0.0 109.435 177.432 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.433 HG23 ' O ' ' A' ' 68' ' ' GLU . 21.8 t -60.24 -42.22 89.66 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.244 0 CA-C-N 115.699 -0.682 . . . . 0.0 112.655 -178.613 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 23.4 p-10 -66.93 -18.37 65.35 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-O 121.045 0.45 . . . . 0.0 111.041 -179.928 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . 0.43 ' C ' ' HD2' ' A' ' 75' ' ' ARG . 28.8 t -101.64 -3.86 27.58 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 121.334 0.588 . . . . 0.0 110.125 179.018 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . 0.553 ' HD3' ' O ' ' A' ' 71' ' ' GLU . 2.6 mpt_? -115.93 49.06 1.14 Allowed 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.694 0.759 . . . . 0.0 109.631 -179.796 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . 0.479 ' OG ' ' HE2' ' A' ' 149' ' ' LYS . 0.4 OUTLIER -130.38 175.15 9.19 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 115.057 -0.974 . . . . 0.0 110.153 179.958 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -133.96 137.1 52.85 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 N-CA-C 109.977 -0.379 . . . . 0.0 109.977 178.179 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 83.9 t80 -94.82 126.52 40.2 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 109.644 -0.502 . . . . 0.0 109.644 179.877 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.426 HG21 ' HE2' ' A' ' 95' ' ' PHE . 4.0 t -105.95 115.36 47.49 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.138 -179.013 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -118.08 169.32 13.3 Favored Glycine 0 N--CA 1.447 -0.606 0 N-CA-C 110.863 -0.895 . . . . 0.0 110.863 179.255 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 1.6 m-20 59.08 37.8 24.13 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-O 121.177 0.513 . . . . 0.0 110.936 -179.566 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.422 HG22 HG12 ' A' ' 79' ' ' VAL . 2.5 t -80.84 162.25 3.65 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.884 -179.319 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . 0.537 ' OD2' ' HD2' ' A' ' 142' ' ' ARG . 9.7 t0 -66.23 135.43 54.46 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 109.607 -0.516 . . . . 0.0 109.607 179.225 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 36.5 p90 -63.96 -14.25 52.44 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.075 -0.511 . . . . 0.0 112.005 -178.616 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -114.19 14.85 18.24 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.72 0.295 . . . . 0.0 111.456 179.753 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' CYS . . . . . 0.49 ' SG ' ' HB2' ' A' ' 140' ' ' HIS . 0.8 OUTLIER -78.1 148.91 33.99 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.103 0.478 . . . . 0.0 111.281 -179.795 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . 0.501 ' O ' ' HG2' ' A' ' 90' ' ' GLU . 0.2 OUTLIER -110.67 149.71 40.7 Favored Pre-proline 0 C--N 1.325 -0.462 0 CA-C-N 115.743 -0.662 . . . . 0.0 109.921 179.114 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . 0.477 ' HD3' HD13 ' A' ' 106' ' ' ILE . 11.5 Cg_endo -55.32 -38.33 93.87 Favored 'Trans proline' 0 C--N 1.347 0.458 0 C-N-CA 122.83 2.353 . . . . 0.0 112.842 -179.039 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . 0.453 ' O ' ' HG3' ' A' ' 92' ' ' GLN . 3.2 mp0 -62.94 -52.14 64.2 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.485 -0.325 . . . . 0.0 111.802 -179.199 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . 0.501 ' HG2' ' O ' ' A' ' 87' ' ' THR . 6.0 pt-20 -61.04 -20.31 62.4 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-O 120.862 0.363 . . . . 0.0 111.519 -178.806 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 55.5 t -84.61 -47.21 17.45 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.674 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.739 -179.152 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 92' ' ' GLN . . . . . 0.453 ' HG3' ' O ' ' A' ' 89' ' ' GLU . 0.8 OUTLIER -72.17 -33.2 67.51 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.319 -0.401 . . . . 0.0 111.757 -178.423 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -78.04 -27.42 48.75 Favored 'General case' 0 N--CA 1.467 0.384 0 C-N-CA 120.237 -0.585 . . . . 0.0 111.53 -178.919 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 94' ' ' HIS . . . . . 0.492 ' HB2' ' O ' ' A' ' 90' ' ' GLU . 0.2 OUTLIER -75.12 -42.33 56.64 Favored 'General case' 0 C--N 1.325 -0.464 0 C-N-CA 120.819 -0.352 . . . . 0.0 110.721 -179.856 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . 0.426 ' HE2' HG21 ' A' ' 79' ' ' VAL . 20.3 m-30 -76.47 -18.9 58.53 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.464 179.931 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . 0.649 ' HA ' ' O ' ' A' ' 99' ' ' GLY . 0.9 OUTLIER -62.4 -22.09 65.88 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.397 179.342 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 21.5 t -62.91 -28.57 70.15 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.364 179.475 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 5.5 m -97.91 -40.7 8.36 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.23 179.837 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . 0.649 ' O ' ' HA ' ' A' ' 96' ' ' GLN . . . -151.28 141.86 8.99 Favored Glycine 0 N--CA 1.449 -0.484 0 N-CA-C 111.424 -0.671 . . . . 0.0 111.424 179.69 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . 0.419 ' HB ' ' CE1' ' A' ' 122' ' ' PHE . 0.2 OUTLIER -62.22 154.5 27.32 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.104 0.478 . . . . 0.0 112.09 -179.471 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 2.1 p -118.03 131.19 71.51 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-N 115.747 -0.66 . . . . 0.0 110.91 -179.685 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 26.1 t30 -97.91 -45.0 6.46 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.152 0.501 . . . . 0.0 109.695 179.123 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -142.75 157.32 44.76 Favored 'General case' 0 C--O 1.235 0.318 0 CA-C-N 115.676 -0.693 . . . . 0.0 109.991 179.196 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 7.2 p -155.29 137.59 6.43 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 CA-C-N 115.82 -0.627 . . . . 0.0 109.974 179.59 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . 0.479 ' HB ' ' CE1' ' A' ' 119' ' ' TYR . 3.5 m -131.59 128.29 38.89 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 109.732 -0.47 . . . . 0.0 109.732 179.317 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 106' ' ' ILE . . . . . 0.56 HD11 ' HA2' ' A' ' 116' ' ' GLY . 20.3 tt -113.27 137.15 47.31 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-O 121.3 0.571 . . . . 0.0 111.205 -179.804 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 35.0 tp -118.91 124.5 47.24 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.777 -0.647 . . . . 0.0 109.896 179.646 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -90.79 113.62 25.8 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 110.144 -0.317 . . . . 0.0 110.144 179.445 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . 0.419 ' O ' ' HG2' ' A' ' 115' ' ' LYS . 13.1 t70 -72.76 139.73 47.31 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.152 0.501 . . . . 0.0 111.253 -179.469 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -129.61 33.93 4.4 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 115.638 -0.71 . . . . 0.0 109.434 178.751 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 2.6 t80 -118.21 -4.31 10.97 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.618 -179.69 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 110.19 6.98 27.28 Favored Glycine 0 CA--C 1.52 0.353 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.833 179.936 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 113' ' ' GLN . . . . . 0.431 ' HB3' ' HD2' ' A' ' 114' ' ' PRO . 19.0 mt-30 -96.8 161.05 27.82 Favored Pre-proline 0 C--N 1.324 -0.513 0 N-CA-C 109.464 -0.569 . . . . 0.0 109.464 179.951 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 114' ' ' PRO . . . . . 0.431 ' HD2' ' HB3' ' A' ' 113' ' ' GLN . 19.5 Cg_endo -59.75 115.15 2.41 Favored 'Trans proline' 0 C--N 1.347 0.454 0 C-N-CA 122.039 1.826 . . . . 0.0 111.13 178.582 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . 0.419 ' HG2' ' O ' ' A' ' 109' ' ' ASP . 53.1 mttt -72.72 172.19 11.18 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 120.771 0.319 . . . . 0.0 110.246 -179.014 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . 0.56 ' HA2' HD11 ' A' ' 106' ' ' ILE . . . 101.4 3.89 53.29 Favored Glycine 0 N--CA 1.444 -0.781 0 C-N-CA 120.175 -1.012 . . . . 0.0 112.227 179.712 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 26.8 m-85 -52.73 112.66 0.88 Allowed 'General case' 0 N--CA 1.463 0.196 0 N-CA-C 110.094 -0.336 . . . . 0.0 110.094 179.49 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -141.37 174.25 10.72 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 121.191 0.52 . . . . 0.0 111.523 -178.61 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 119' ' ' TYR . . . . . 0.479 ' CE1' ' HB ' ' A' ' 105' ' ' THR . 48.5 p90 -156.48 129.59 7.98 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.34 -0.845 . . . . 0.0 109.81 179.202 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 13.9 m -105.92 142.94 17.78 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.686 0 N-CA-C 109.254 -0.646 . . . . 0.0 109.254 178.976 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . 0.41 ' OE2' ' HE3' ' A' ' 69' ' ' LYS . 7.1 pt-20 -129.92 150.23 51.3 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 120.765 0.317 . . . . 0.0 111.745 -179.68 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 122' ' ' PHE . . . . . 0.419 ' CE1' ' HB ' ' A' ' 100' ' ' THR . 11.5 t80 -145.89 172.44 13.34 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.706 -0.679 . . . . 0.0 109.308 178.796 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 2.9 t -92.64 -57.26 4.45 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 CA-C-O 120.782 0.325 . . . . 0.0 111.281 -178.979 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 93.0 mt-10 -62.65 118.07 7.14 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.451 -179.813 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 2.1 mp -57.29 -32.31 40.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 115.566 -0.743 . . . . 0.0 110.964 -179.435 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 17.6 t70 -53.35 -45.37 69.13 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.374 179.42 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -61.93 -54.82 36.61 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.758 -0.655 . . . . 0.0 111.691 -179.361 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 12.1 p -65.94 -29.65 47.52 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 C-N-CA 120.894 -0.322 . . . . 0.0 111.256 -179.249 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 129' ' ' GLN . . . . . 0.418 ' O ' ' HG ' ' A' ' 132' ' ' LEU . 9.6 tt0 -61.25 -48.59 80.75 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.178 0.513 . . . . 0.0 110.116 179.123 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 87.2 m-20 -69.29 -29.96 67.94 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.721 -0.672 . . . . 0.0 109.717 179.713 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 131' ' ' ALA . . . . . 0.451 ' O ' ' HB2' ' A' ' 135' ' ' ASN . . . -66.86 -52.18 46.63 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.618 -0.719 . . . . 0.0 111.089 179.66 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 132' ' ' LEU . . . . . 0.418 ' HG ' ' O ' ' A' ' 129' ' ' GLN . 4.0 pp -64.94 -23.92 67.37 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.79 0.328 . . . . 0.0 110.636 179.978 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 1.6 tp -72.0 -55.61 7.12 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.204 0.526 . . . . 0.0 110.058 179.597 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 49.4 mt -120.13 101.8 8.08 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.648 -0.705 . . . . 0.0 109.558 179.568 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 135' ' ' ASN . . . . . 0.451 ' HB2' ' O ' ' A' ' 131' ' ' ALA . 0.5 OUTLIER -146.68 -71.26 0.24 Allowed 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 120.87 0.367 . . . . 0.0 111.155 -178.976 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 7.5 pt-20 -69.91 95.12 0.9 Allowed 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.649 0.738 . . . . 0.0 111.849 -179.034 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 8.9 m -137.17 -59.53 0.69 Allowed 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.374 -0.83 . . . . 0.0 109.536 178.92 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 7.4 tt0 -165.4 130.84 2.56 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 109.525 -0.546 . . . . 0.0 109.525 179.222 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -146.0 118.04 8.28 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 109.672 -0.492 . . . . 0.0 109.672 -179.939 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 140' ' ' HIS . . . . . 0.49 ' HB2' ' SG ' ' A' ' 86' ' ' CYS . 3.2 t60 68.77 1.23 2.99 Favored 'General case' 0 N--CA 1.469 0.509 0 O-C-N 123.508 0.505 . . . . 0.0 111.393 178.971 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 113.52 -9.38 24.11 Favored Glycine 0 N--CA 1.447 -0.622 0 C-N-CA 121.038 -0.601 . . . . 0.0 111.743 -179.129 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 142' ' ' ARG . . . . . 0.537 ' HD2' ' OD2' ' A' ' 83' ' ' ASP . 0.0 OUTLIER -111.29 170.88 7.82 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 109.874 -0.417 . . . . 0.0 109.874 179.785 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 13.2 pt20 -115.75 121.45 42.5 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 109.217 -0.66 . . . . 0.0 109.217 178.705 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -99.08 175.65 5.83 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.066 -178.748 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 3.8 tttt -117.1 122.69 44.84 Favored 'General case' 0 C--N 1.317 -0.805 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 179.16 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 146' ' ' VAL . . . . . 0.415 HG21 ' OD1' ' A' ' 135' ' ' ASN . 96.2 t -117.49 137.51 51.17 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.652 0 CA-C-O 121.242 0.544 . . . . 0.0 111.409 -178.971 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 23.6 t -139.13 144.18 38.54 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.845 -0.616 . . . . 0.0 109.516 179.314 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -63.14 128.89 37.93 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 120.714 0.292 . . . . 0.0 110.277 179.47 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 149' ' ' LYS . . . . . 0.479 ' HE2' ' OG ' ' A' ' 76' ' ' SER . 28.3 ttpt -89.15 76.63 7.68 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 121.3 0.571 . . . . 0.0 109.76 -179.643 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 23.9 tpt180 . . . . . 0 C--N 1.324 -0.529 0 CA-C-N 115.654 -0.703 . . . . 0.0 109.802 179.539 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.423 0 N-CA-C 110.066 -0.346 . . . . 0.0 110.066 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 27.4 tp -69.26 90.93 0.51 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.101 0.477 . . . . 0.0 109.896 179.252 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 53.5 ttm-85 -153.69 -6.34 0.17 Allowed 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.861 -0.609 . . . . 0.0 111.177 -178.88 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 17.1 mt-10 65.2 19.71 11.78 Favored 'General case' 0 N--CA 1.468 0.471 0 CA-C-O 121.149 0.499 . . . . 0.0 110.662 -178.767 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 26.5 ptm -83.61 1.35 42.65 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.848 -0.615 . . . . 0.0 110.382 -179.88 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 30.6 mt-30 -72.39 -20.9 61.36 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.147 0.498 . . . . 0.0 110.116 179.72 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -76.5 -8.54 57.4 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 121.555 0.693 . . . . 0.0 109.965 178.788 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 21.6 ttmt -79.26 1.44 24.85 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.321 -0.854 . . . . 0.0 110.499 -179.91 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 7.4 p -58.28 -23.64 22.55 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.251 0 CA-C-N 115.781 -0.645 . . . . 0.0 111.102 179.632 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -63.42 -26.37 68.7 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.512 179.526 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 24.5 mtmt -101.97 -41.52 6.43 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.872 179.444 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 62.6 mm-40 -62.36 -16.65 55.75 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.969 -0.559 . . . . 0.0 111.522 -179.572 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 10.0 ptp -63.32 -25.41 68.29 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.978 0.418 . . . . 0.0 110.042 178.794 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -98.17 -5.08 57.35 Favored Glycine 0 N--CA 1.448 -0.542 0 N-CA-C 110.943 -0.863 . . . . 0.0 110.943 179.0 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.324 -0.519 0 CA-C-O 121.099 0.476 . . . . 0.0 110.154 -179.779 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.456 -0.154 0 CA-C-O 120.82 0.343 . . . . 0.0 110.832 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -76.47 -1.62 28.05 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.09 0.471 . . . . 0.0 110.931 179.802 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 7.0 tp60 -118.05 -51.27 2.45 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.64 179.507 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -83.08 -61.65 1.8 Allowed 'General case' 0 C--N 1.331 -0.201 0 N-CA-C 111.871 0.323 . . . . 0.0 111.871 -179.092 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -60.88 -29.7 69.7 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-O 120.976 0.417 . . . . 0.0 110.671 -179.384 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 51.5 tptt -56.11 -31.35 63.19 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.83 -0.623 . . . . 0.0 111.206 179.582 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 18.7 mt-10 -63.3 -21.15 66.07 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-O 121.18 0.514 . . . . 0.0 111.074 -179.797 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . 0.426 ' O ' ' HD2' ' A' ' 75' ' ' ARG . 13.5 tp10 -94.65 -42.96 8.51 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 115.675 -0.693 . . . . 0.0 109.172 177.98 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.539 HG12 ' HB2' ' A' ' 121' ' ' GLU . 47.9 t -62.34 -43.29 97.93 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-N 115.181 -0.918 . . . . 0.0 112.552 -178.924 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 17.2 p-10 -71.55 -19.68 62.13 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-O 121.025 0.441 . . . . 0.0 111.613 -178.958 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . 0.582 ' OG ' ' HD3' ' A' ' 150' ' ' ARG . 44.4 t -96.65 -7.33 34.46 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 109.604 -0.517 . . . . 0.0 109.604 178.796 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . 0.426 ' HD2' ' O ' ' A' ' 71' ' ' GLU . 0.0 OUTLIER -114.47 40.94 2.42 Favored 'General case' 0 N--CA 1.452 -0.361 0 CA-C-N 115.505 -0.77 . . . . 0.0 110.185 -179.367 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . 0.451 ' OG ' ' HE2' ' A' ' 149' ' ' LYS . 0.3 OUTLIER -120.11 174.6 6.39 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.708 179.509 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 6.5 pt -132.3 139.64 49.62 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.262 178.341 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' TYR . . . . . 0.405 ' O ' ' HA ' ' A' ' 146' ' ' VAL . 16.7 t80 -92.58 119.84 32.43 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.615 -0.72 . . . . 0.0 109.761 179.895 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 7.2 t -104.79 109.36 27.34 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-N 116.53 -0.304 . . . . 0.0 110.184 179.86 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -117.82 166.94 12.73 Favored Glycine 0 N--CA 1.448 -0.523 0 C-N-CA 120.815 -0.707 . . . . 0.0 112.278 -179.281 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 3.0 m120 57.01 44.13 23.32 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-O 121.314 0.578 . . . . 0.0 110.853 -179.818 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.429 HG12 ' H ' ' A' ' 83' ' ' ASP . 2.4 t -82.68 167.91 1.9 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 CA-C-N 115.236 -0.893 . . . . 0.0 110.368 -179.361 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . 0.509 ' HB3' ' SG ' ' A' ' 86' ' ' CYS . 24.7 t70 -68.71 140.97 55.41 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.855 0.36 . . . . 0.0 110.337 179.625 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 28.3 p90 -65.49 -12.66 54.69 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.831 -0.622 . . . . 0.0 112.521 -178.694 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -117.85 10.79 13.33 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.617 0.246 . . . . 0.0 111.492 -179.981 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' CYS . . . . . 0.509 ' SG ' ' HB3' ' A' ' 83' ' ' ASP . 0.9 OUTLIER -73.9 144.52 45.33 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.044 0.449 . . . . 0.0 111.001 -179.995 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . 0.539 ' O ' ' HG2' ' A' ' 90' ' ' GLU . 5.6 p -108.24 157.54 36.07 Favored Pre-proline 0 C--N 1.327 -0.377 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.233 179.379 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 20.8 Cg_endo -60.53 -39.84 61.79 Favored 'Trans proline' 0 C--N 1.344 0.328 0 C-N-CA 122.399 2.066 . . . . 0.0 113.366 -178.979 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . 0.431 ' O ' ' HG2' ' A' ' 93' ' ' GLN . 7.9 mm-40 -64.16 -46.1 85.55 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 112.323 0.49 . . . . 0.0 112.323 -178.603 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . 0.539 ' HG2' ' O ' ' A' ' 87' ' ' THR . 9.8 pt-20 -65.79 -18.29 65.23 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-O 121.028 0.442 . . . . 0.0 111.432 -179.25 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 52.1 t -87.44 -47.36 15.85 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.83 -179.135 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 1.7 pp0? -68.79 -35.44 77.03 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.511 -0.313 . . . . 0.0 111.496 -178.581 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . 0.431 ' HG2' ' O ' ' A' ' 89' ' ' GLU . 3.5 pt20 -77.17 -29.89 54.66 Favored 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 120.372 -0.531 . . . . 0.0 111.337 -179.05 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -69.3 -41.68 76.46 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.853 0.358 . . . . 0.0 110.71 179.931 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 17.0 m-30 -82.47 -13.48 56.65 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 116.387 -0.37 . . . . 0.0 110.968 -179.557 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . 0.577 ' HA ' ' O ' ' A' ' 99' ' ' GLY . 37.3 tt0 -64.33 -23.94 67.47 Favored 'General case' 0 C--O 1.234 0.252 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.483 -179.86 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 15.2 m -67.12 -28.15 67.92 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.712 179.576 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 5.3 m -94.35 -41.62 9.32 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.144 -0.48 . . . . 0.0 109.978 179.542 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . 0.577 ' O ' ' HA ' ' A' ' 96' ' ' GLN . . . -150.55 144.26 11.63 Favored Glycine 0 N--CA 1.445 -0.745 0 CA-C-N 115.864 -0.607 . . . . 0.0 111.701 179.807 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -63.18 146.87 52.44 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 121.029 0.442 . . . . 0.0 111.48 -179.829 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 1.3 p -120.23 128.68 75.99 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.342 -179.878 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 27.2 t-20 -96.98 -46.97 5.99 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.687 0.28 . . . . 0.0 110.669 -179.999 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 2.6 tpt180 -137.44 148.33 46.04 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.571 -179.643 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 7.5 p -148.15 137.83 16.28 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-O 121.004 0.43 . . . . 0.0 110.638 179.265 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 2.3 m -130.24 129.44 43.34 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 116.008 -0.542 . . . . 0.0 109.983 178.961 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 106' ' ' ILE . . . . . 0.557 HD11 ' HA2' ' A' ' 116' ' ' GLY . 20.5 tt -114.63 148.04 17.66 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-O 120.995 0.426 . . . . 0.0 110.899 -179.494 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 9.1 tp -129.82 140.29 51.05 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.131 179.759 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -105.8 114.3 28.38 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.511 -0.313 . . . . 0.0 110.248 179.552 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . 0.415 ' O ' ' HG2' ' A' ' 115' ' ' LYS . 7.5 t70 -75.85 142.64 42.14 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.396 -0.365 . . . . 0.0 110.952 -179.818 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 2.6 mppt? -127.13 20.4 6.89 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.281 0.563 . . . . 0.0 109.906 179.015 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 36.0 t80 -100.92 -6.79 24.13 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.467 -0.788 . . . . 0.0 110.23 -179.608 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 106.36 11.61 26.99 Favored Glycine 0 N--CA 1.448 -0.534 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.443 -179.966 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 113' ' ' GLN . . . . . 0.443 ' HB3' ' HD2' ' A' ' 114' ' ' PRO . 24.5 mt-30 -97.1 160.86 28.04 Favored Pre-proline 0 C--O 1.239 0.535 0 N-CA-C 109.455 -0.572 . . . . 0.0 109.455 -179.972 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 114' ' ' PRO . . . . . 0.443 ' HD2' ' HB3' ' A' ' 113' ' ' GLN . 16.8 Cg_endo -58.7 113.77 1.71 Allowed 'Trans proline' 0 C--N 1.347 0.492 0 C-N-CA 122.207 1.938 . . . . 0.0 111.277 178.628 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . 0.415 ' HG2' ' O ' ' A' ' 109' ' ' ASP . 9.6 mttp -78.57 179.74 6.91 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.144 -179.226 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . 0.557 ' HA2' HD11 ' A' ' 106' ' ' ILE . . . 92.55 2.83 67.24 Favored Glycine 0 N--CA 1.444 -0.804 0 C-N-CA 120.081 -1.057 . . . . 0.0 111.462 179.978 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 5.1 t80 -55.67 124.59 17.91 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.725 0.298 . . . . 0.0 110.393 179.78 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -149.44 171.2 16.96 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.627 -179.374 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 44.9 p90 -152.4 130.41 11.82 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-N 115.656 -0.702 . . . . 0.0 109.204 178.782 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 13.7 m -108.56 142.49 21.04 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.139 179.905 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . 0.539 ' HB2' HG12 ' A' ' 72' ' ' VAL . 1.3 pt-20 -131.55 154.34 48.91 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 120.923 0.392 . . . . 0.0 111.192 179.637 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 12.1 t80 -146.88 167.61 23.5 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.587 -0.733 . . . . 0.0 110.363 179.689 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 11.0 t -84.45 -41.21 15.97 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-O 120.901 0.381 . . . . 0.0 111.565 -179.432 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 33.3 mm-40 -76.56 131.34 38.89 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.152 -179.429 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 2.1 mp -73.27 -34.53 44.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.018 -179.46 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 17.5 t70 -58.38 -36.1 73.0 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.204 0.526 . . . . 0.0 111.058 -179.763 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -64.13 -57.7 8.81 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.735 -0.666 . . . . 0.0 111.271 -179.893 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 10.9 p -65.27 -27.71 42.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.554 -0.293 . . . . 0.0 111.287 -179.52 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 7.1 tt0 -60.02 -46.77 88.39 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.887 0.375 . . . . 0.0 110.246 179.83 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 50.7 m-80 -74.96 -24.26 58.43 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.143 179.873 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -68.98 -51.78 35.81 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.608 179.344 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 3.8 pp -67.55 -16.89 64.43 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.988 0.423 . . . . 0.0 111.057 179.881 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 1.1 tp -77.41 -53.08 8.09 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.003 179.324 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 87.9 mt -126.36 102.83 7.33 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.742 -0.663 . . . . 0.0 109.687 179.568 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -147.52 -67.02 0.26 Allowed 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.166 0.508 . . . . 0.0 111.948 -178.931 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 4.5 pt-20 -74.12 95.04 2.5 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.629 0.728 . . . . 0.0 111.857 -178.819 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 5.9 m -141.21 -59.75 0.49 Allowed 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.692 -0.686 . . . . 0.0 110.134 178.801 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -154.21 121.36 5.68 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 109.935 -0.395 . . . . 0.0 109.935 179.841 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -141.97 117.04 9.99 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 109.459 -0.571 . . . . 0.0 109.459 179.744 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 140' ' ' HIS . . . . . 0.422 ' HB2' ' SG ' ' A' ' 86' ' ' CYS . 2.2 t60 64.52 21.09 12.36 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-O 120.99 0.424 . . . . 0.0 110.78 179.869 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 86.55 -1.84 87.27 Favored Glycine 0 N--CA 1.449 -0.469 0 C-N-CA 120.715 -0.755 . . . . 0.0 111.533 -179.084 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 1.4 mpt_? -116.17 178.88 4.16 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 109.663 -0.495 . . . . 0.0 109.663 -179.68 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -122.5 141.41 51.68 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-O 120.818 0.342 . . . . 0.0 110.268 179.41 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -123.98 178.72 5.15 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 115.968 -0.56 . . . . 0.0 109.971 -179.821 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -120.81 120.3 35.17 Favored 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 109.595 -0.52 . . . . 0.0 109.595 179.444 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 146' ' ' VAL . . . . . 0.405 ' HA ' ' O ' ' A' ' 78' ' ' TYR . 73.1 t -115.32 129.92 70.76 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-O 120.951 0.405 . . . . 0.0 111.063 -179.092 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 1.6 m -134.22 148.02 50.8 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 179.109 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -61.96 129.47 41.05 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 120.658 0.266 . . . . 0.0 111.246 -179.83 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 149' ' ' LYS . . . . . 0.451 ' HE2' ' OG ' ' A' ' 76' ' ' SER . 25.8 ttpt -90.39 62.19 5.25 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.919 0.866 . . . . 0.0 108.758 179.528 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 150' ' ' ARG . . . . . 0.582 ' HD3' ' OG ' ' A' ' 74' ' ' SER . 0.0 OUTLIER . . . . . 0 C--N 1.321 -0.631 0 CA-C-N 114.959 -1.019 . . . . 0.0 110.064 -179.729 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.454 -0.269 0 N-CA-C 110.127 -0.323 . . . . 0.0 110.127 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 63.9 tp -72.81 91.42 1.5 Allowed 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 109.623 -0.51 . . . . 0.0 109.623 179.06 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . 0.448 ' HD2' ' SD ' ' A' ' 45' ' ' MET . 13.5 ttm-85 -119.28 -16.1 9.07 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.96 -0.564 . . . . 0.0 111.161 -179.292 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 60.07 29.45 19.01 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 121.375 0.607 . . . . 0.0 110.021 -179.317 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' MET . . . . . 0.448 ' SD ' ' HD2' ' A' ' 43' ' ' ARG . 19.9 ptt? -99.63 12.56 36.22 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.182 -0.917 . . . . 0.0 111.167 -179.69 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 9.9 mm100 -71.81 -20.89 61.78 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 120.853 0.359 . . . . 0.0 110.898 -179.361 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -71.77 -14.5 62.01 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.302 0.572 . . . . 0.0 109.866 178.381 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 34.1 ttpt -82.78 7.22 15.7 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.694 -0.684 . . . . 0.0 109.445 178.826 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 7.3 p -57.2 -20.62 13.26 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.202 0 CA-C-N 115.693 -0.685 . . . . 0.0 111.623 -179.923 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 12.7 mm-40 -64.06 -33.23 75.28 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.431 0.634 . . . . 0.0 109.573 178.705 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 23.1 mtmt -97.42 -31.1 12.54 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.247 -0.888 . . . . 0.0 110.827 179.316 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 20.1 mm-40 -88.04 18.48 4.22 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.592 -179.548 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 7.9 ptm -64.76 -30.37 71.38 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.894 0.378 . . . . 0.0 110.813 179.971 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -94.07 -4.86 62.8 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.771 -0.728 . . . . 0.0 111.445 178.883 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.328 -0.343 0 CA-C-O 121.218 0.532 . . . . 0.0 110.166 -179.61 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.457 -0.092 0 CA-C-O 120.874 0.369 . . . . 0.0 110.45 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -75.13 -1.37 22.76 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.967 -0.56 . . . . 0.0 111.684 -179.615 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -118.97 -40.17 2.87 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.873 179.988 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -93.69 -58.97 2.11 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 112.203 0.445 . . . . 0.0 112.203 -179.408 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . 0.53 ' O ' HG23 ' A' ' 72' ' ' VAL . 2.4 tp10 -66.59 -29.34 69.37 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.611 -0.268 . . . . 0.0 110.997 -178.993 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 45.1 tptt -56.36 -27.88 57.39 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.027 179.715 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 24.1 mt-10 -59.23 -34.83 72.67 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-O 120.83 0.347 . . . . 0.0 110.504 179.274 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 6.8 tp10 -89.07 -41.32 12.38 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.173 179.214 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.53 HG23 ' O ' ' A' ' 68' ' ' GLU . 22.1 t -62.68 -42.02 94.5 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.444 0 N-CA-C 112.073 0.397 . . . . 0.0 112.073 -178.964 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 25.4 t0 -66.28 -20.11 66.01 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-O 121.6 0.714 . . . . 0.0 110.192 179.76 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 16.3 m -100.61 -12.95 18.79 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 114.972 -1.013 . . . . 0.0 110.871 179.998 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -109.21 47.39 0.92 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.485 -179.199 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . 0.409 ' HB3' ' HB3' ' A' ' 121' ' ' GLU . 0.0 OUTLIER -126.14 170.13 12.11 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.644 179.783 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -133.24 133.62 57.99 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 N-CA-C 109.832 -0.433 . . . . 0.0 109.832 178.851 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 22.4 t80 -88.5 124.67 34.22 Favored 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 109.497 -0.557 . . . . 0.0 109.497 179.952 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 5.2 t -105.89 111.11 33.66 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-N 116.519 -0.31 . . . . 0.0 110.297 179.861 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -117.04 170.57 13.47 Favored Glycine 0 N--CA 1.447 -0.621 0 N-CA-C 111.574 -0.61 . . . . 0.0 111.574 -179.982 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 3.9 m-20 55.91 43.29 27.68 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-O 121.238 0.542 . . . . 0.0 110.933 -179.099 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 2.5 t -85.49 166.38 2.05 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 CA-C-N 115.646 -0.706 . . . . 0.0 110.561 -179.505 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . 0.542 ' OD2' ' HD2' ' A' ' 142' ' ' ARG . 14.7 t70 -69.68 141.34 53.58 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.042 0.448 . . . . 0.0 110.392 179.978 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 14.5 p90 -64.0 -23.04 67.18 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.763 -0.653 . . . . 0.0 112.322 -178.575 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -107.13 16.01 24.57 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 120.874 0.368 . . . . 0.0 111.162 -179.27 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' CYS . . . . . 0.422 ' SG ' ' HB3' ' A' ' 83' ' ' ASP . 0.8 OUTLIER -79.84 145.43 32.76 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 121.207 0.527 . . . . 0.0 110.954 179.971 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . 0.405 ' O ' ' HG2' ' A' ' 90' ' ' GLU . 13.2 p -111.25 153.77 43.89 Favored Pre-proline 0 C--N 1.324 -0.524 0 CA-C-N 115.509 -0.769 . . . . 0.0 110.315 179.553 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . 0.525 ' HD3' HD13 ' A' ' 106' ' ' ILE . 16.6 Cg_endo -56.43 -37.7 96.67 Favored 'Trans proline' 0 C--N 1.344 0.336 0 C-N-CA 122.855 2.37 . . . . 0.0 112.556 -179.311 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . 0.481 ' O ' ' HG2' ' A' ' 93' ' ' GLN . 0.0 OUTLIER -63.5 -52.26 62.03 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.9 -0.591 . . . . 0.0 111.886 -178.937 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . 0.406 ' O ' ' HB2' ' A' ' 94' ' ' HIS . 7.9 pt-20 -65.23 -15.3 62.33 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.763 0.316 . . . . 0.0 111.429 -178.475 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 61.7 t -89.65 -46.25 15.17 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 CA-C-N 116.63 -0.259 . . . . 0.0 110.873 -179.806 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 1.7 pt20 -72.35 -34.2 67.84 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 111.817 0.302 . . . . 0.0 111.817 -178.45 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . 0.481 ' HG2' ' O ' ' A' ' 89' ' ' GLU . 26.0 pt20 -80.59 -22.72 40.42 Favored 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 120.33 -0.548 . . . . 0.0 111.249 -179.157 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 94' ' ' HIS . . . . . 0.406 ' HB2' ' O ' ' A' ' 90' ' ' GLU . 0.3 OUTLIER -75.31 -32.42 60.96 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.952 0.405 . . . . 0.0 110.498 179.331 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 23.3 m-30 -89.68 -8.08 53.19 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.175 -179.266 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . 0.555 ' HA ' ' O ' ' A' ' 99' ' ' GLY . 1.3 tt0 -66.49 -22.54 66.19 Favored 'General case' 0 C--O 1.232 0.148 0 CA-C-O 121.163 0.506 . . . . 0.0 109.978 -179.694 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 1.2 m -63.36 -30.71 71.79 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.459 -0.791 . . . . 0.0 110.642 179.147 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 17.4 m -97.27 -46.03 6.27 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.397 179.63 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . 0.555 ' O ' ' HA ' ' A' ' 96' ' ' GLN . . . -144.92 143.35 11.81 Favored Glycine 0 N--CA 1.442 -0.95 0 C-N-CA 120.908 -0.663 . . . . 0.0 111.869 -179.892 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . 0.406 ' HB ' ' CE1' ' A' ' 122' ' ' PHE . 0.2 OUTLIER -66.06 145.65 55.6 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 120.574 0.226 . . . . 0.0 111.096 -179.872 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 2.5 p -111.09 129.51 66.23 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-O 120.957 0.408 . . . . 0.0 111.25 -179.335 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . 0.535 ' OD1' ' HD2' ' A' ' 103' ' ' ARG . 26.0 t-20 -100.88 -45.17 5.53 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 109.868 -0.419 . . . . 0.0 109.868 179.327 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 103' ' ' ARG . . . . . 0.535 ' HD2' ' OD1' ' A' ' 102' ' ' ASN . 0.0 OUTLIER -138.44 151.9 47.86 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.156 -0.475 . . . . 0.0 109.972 178.776 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 4.0 p -151.44 119.52 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-O 121.142 0.496 . . . . 0.0 110.299 179.144 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . 0.428 ' HB ' ' CE1' ' A' ' 119' ' ' TYR . 1.2 m -112.27 120.12 40.66 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.116 179.655 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 106' ' ' ILE . . . . . 0.525 HD13 ' HD3' ' A' ' 88' ' ' PRO . 21.5 tt -108.06 146.38 14.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-O 121.025 0.44 . . . . 0.0 111.166 -179.903 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 26.0 tp -131.93 136.22 47.21 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.213 179.458 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -101.83 116.33 32.48 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 116.544 -0.298 . . . . 0.0 110.533 179.749 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . 0.456 ' O ' ' HG2' ' A' ' 115' ' ' LYS . 12.3 t70 -83.76 136.2 34.25 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.026 0.441 . . . . 0.0 111.155 -179.766 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -126.56 27.42 6.12 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 116.148 -0.478 . . . . 0.0 109.896 179.4 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 10.0 t80 -108.23 -2.01 19.7 Favored 'General case' 0 N--CA 1.45 -0.451 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.282 -179.36 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 114.45 3.2 22.63 Favored Glycine 0 N--CA 1.449 -0.434 0 C-N-CA 120.399 -0.905 . . . . 0.0 112.995 179.617 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 26.6 mt-30 -98.18 156.57 35.7 Favored Pre-proline 0 C--N 1.321 -0.645 0 N-CA-C 109.671 -0.492 . . . . 0.0 109.671 179.858 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 14.2 Cg_endo -57.37 126.71 22.85 Favored 'Trans proline' 0 C--N 1.349 0.566 0 C-N-CA 122.194 1.929 . . . . 0.0 110.894 178.798 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . 0.456 ' HG2' ' O ' ' A' ' 109' ' ' ASP . 10.7 mttp -82.67 177.55 8.64 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 110.008 -0.368 . . . . 0.0 110.008 -179.732 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . 0.456 ' HA2' HD11 ' A' ' 106' ' ' ILE . . . 94.78 2.91 62.66 Favored Glycine 0 N--CA 1.444 -0.774 0 C-N-CA 120.157 -1.02 . . . . 0.0 112.349 179.419 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 9.9 m-30 -55.84 117.73 3.94 Favored 'General case' 0 C--N 1.332 -0.194 0 N-CA-C 110.163 -0.31 . . . . 0.0 110.163 179.992 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -147.03 174.69 11.31 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-O 120.935 0.398 . . . . 0.0 111.145 -179.144 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 119' ' ' TYR . . . . . 0.428 ' CE1' ' HB ' ' A' ' 105' ' ' THR . 36.1 p90 -152.91 134.09 14.19 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.687 -0.688 . . . . 0.0 109.182 178.674 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 14.6 m -107.91 136.64 42.66 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 N-CA-C 109.42 -0.585 . . . . 0.0 109.42 178.906 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . 0.491 ' HB2' HG12 ' A' ' 72' ' ' VAL . 10.7 pt-20 -122.61 152.25 40.64 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 120.619 0.247 . . . . 0.0 110.755 -179.728 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 122' ' ' PHE . . . . . 0.406 ' CE1' ' HB ' ' A' ' 100' ' ' THR . 11.9 t80 -148.4 170.07 18.79 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.028 -0.533 . . . . 0.0 109.961 179.421 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 21.4 t -87.49 -50.09 14.08 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-O 120.975 0.417 . . . . 0.0 111.568 -179.452 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 29.0 mt-10 -70.22 134.26 47.87 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.385 -179.128 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 2.6 mp -73.23 -30.97 32.58 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.59 -179.621 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 5.7 t70 -57.24 -40.45 77.59 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.892 -179.771 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -64.04 -54.95 26.13 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.708 -0.678 . . . . 0.0 111.402 -179.413 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 7.3 p -65.59 -30.58 50.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.447 -0.342 . . . . 0.0 111.193 -179.498 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 20.4 tt0 -59.98 -45.82 91.44 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-O 120.939 0.4 . . . . 0.0 110.361 179.539 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 82.8 m-20 -71.25 -32.61 68.94 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.183 179.701 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 131' ' ' ALA . . . . . 0.429 ' O ' ' HB2' ' A' ' 135' ' ' ASN . . . -66.32 -48.06 71.53 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.85 -0.614 . . . . 0.0 111.382 -179.927 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 4.2 pp -71.24 -16.87 62.51 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.784 0.326 . . . . 0.0 110.943 -179.734 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 5.5 tp -82.1 -48.96 10.74 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.068 -179.85 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 79.2 mt -136.98 104.06 5.34 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.398 -0.365 . . . . 0.0 110.503 -179.815 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 135' ' ' ASN . . . . . 0.429 ' HB2' ' O ' ' A' ' 131' ' ' ALA . 1.8 m-20 -152.33 -52.87 0.12 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.564 -0.289 . . . . 0.0 111.54 -179.743 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 5.2 pt-20 -73.83 89.27 1.83 Allowed 'General case' 0 C--N 1.33 -0.283 0 CA-C-O 121.528 0.68 . . . . 0.0 111.039 -179.658 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 6.7 m -130.78 -61.94 0.93 Allowed 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.548 -0.751 . . . . 0.0 110.51 179.672 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 8.0 tm-20 -162.16 127.21 3.36 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.22 -0.445 . . . . 0.0 109.813 -179.867 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -142.35 119.69 11.58 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.929 -0.578 . . . . 0.0 109.616 179.466 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 140' ' ' HIS . . . . . 0.42 ' HB2' ' SG ' ' A' ' 86' ' ' CYS . 3.7 t60 63.75 12.74 6.89 Favored 'General case' 0 N--CA 1.466 0.333 0 C-N-CA 122.717 0.407 . . . . 0.0 111.413 179.594 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 103.76 -8.42 50.79 Favored Glycine 0 N--CA 1.45 -0.398 0 C-N-CA 120.633 -0.794 . . . . 0.0 112.755 -179.59 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 142' ' ' ARG . . . . . 0.542 ' HD2' ' OD2' ' A' ' 83' ' ' ASP . 0.0 OUTLIER -116.2 169.77 9.03 Favored 'General case' 0 C--N 1.324 -0.543 0 O-C-N 122.602 -0.352 . . . . 0.0 110.843 -179.436 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 7.8 pt20 -110.93 125.72 53.97 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 109.544 -0.539 . . . . 0.0 109.544 179.046 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -104.92 177.35 4.87 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 120.734 0.302 . . . . 0.0 111.179 -179.277 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 145' ' ' LYS . . . . . 0.558 ' HE2' ' OG ' ' A' ' 147' ' ' SER . 0.1 OUTLIER -118.04 122.95 44.46 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 109.459 -0.571 . . . . 0.0 109.459 179.305 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 89.0 t -114.18 121.64 66.7 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-O 120.837 0.351 . . . . 0.0 111.226 -179.785 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 147' ' ' SER . . . . . 0.558 ' OG ' ' HE2' ' A' ' 145' ' ' LYS . 0.6 OUTLIER -118.63 141.77 48.28 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.007 179.68 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -67.6 123.51 20.66 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.722 0.296 . . . . 0.0 110.537 179.885 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 15.7 tttp -86.0 74.29 10.15 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.332 0.586 . . . . 0.0 110.312 -179.051 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 11.6 tpt85 . . . . . 0 C--N 1.323 -0.558 0 N-CA-C 109.105 -0.702 . . . . 0.0 109.105 178.944 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.234 0.268 0 N-CA-C 109.846 -0.427 . . . . 0.0 109.846 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 57.4 tp -73.87 91.39 1.97 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.314 0.578 . . . . 0.0 110.234 179.33 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . 0.677 ' HB3' ' SD ' ' A' ' 45' ' ' MET . 49.5 ttt85 -155.87 156.27 34.36 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.785 -0.643 . . . . 0.0 109.785 -179.31 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 2.0 pt-20 -79.56 39.55 0.41 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.803 0.811 . . . . 0.0 110.016 178.669 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' MET . . . . . 0.677 ' SD ' ' HB3' ' A' ' 43' ' ' ARG . 6.1 ptm -95.36 9.97 37.96 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 114.815 -1.084 . . . . 0.0 110.989 -179.26 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 22.0 mm-40 -69.87 -20.43 63.4 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.251 0.548 . . . . 0.0 110.459 -179.774 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -82.37 -3.26 55.17 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.664 179.173 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 24.0 ttpp -81.87 -4.19 55.94 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.501 -179.794 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 9.9 p -61.85 -22.28 28.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 121.347 0.594 . . . . 0.0 110.238 179.549 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -67.83 -17.9 64.66 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.657 -0.701 . . . . 0.0 110.044 178.619 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 29.4 mtmt -103.86 -41.15 5.98 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.205 -0.907 . . . . 0.0 110.616 179.741 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 8.4 mt-10 -78.82 6.28 9.44 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.901 0.381 . . . . 0.0 111.24 179.752 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -72.74 -32.61 65.81 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 121.315 0.579 . . . . 0.0 109.526 178.142 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -89.37 -9.6 66.81 Favored Glycine 0 N--CA 1.445 -0.703 0 N-CA-C 110.429 -1.068 . . . . 0.0 110.429 179.034 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.322 -0.612 0 CA-C-N 114.654 -0.773 . . . . 0.0 109.838 179.868 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . 0.434 ' O ' ' HB3' ' A' ' 68' ' ' GLU . . . . . . . . 0 C--O 1.227 -0.112 0 CA-C-O 121.312 0.577 . . . . 0.0 110.1 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -81.56 1.76 32.26 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.733 179.814 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 24.3 tp60 -123.4 -50.88 1.87 Allowed 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.723 -0.671 . . . . 0.0 110.569 179.577 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -82.89 -57.85 3.12 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.545 -179.634 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . 0.434 ' HB3' ' O ' ' A' ' 64' ' ' ALA . 28.4 tt0 -64.06 -29.73 70.85 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 121.129 0.49 . . . . 0.0 110.587 -179.817 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 39.4 tptt -57.24 -30.14 64.37 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.785 -0.643 . . . . 0.0 111.265 179.955 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 7.2 mt-10 -61.42 -22.54 65.11 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-O 121.261 0.553 . . . . 0.0 111.25 179.998 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . 0.546 ' O ' ' HD3' ' A' ' 75' ' ' ARG . 42.7 tp10 -97.84 -43.35 7.16 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 115.881 -0.6 . . . . 0.0 109.536 178.481 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.434 HG12 ' HB2' ' A' ' 121' ' ' GLU . 45.3 t -61.84 -40.22 86.24 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-N 115.597 -0.729 . . . . 0.0 112.776 -178.815 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 16.1 p-10 -72.79 -14.21 61.48 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-O 120.742 0.306 . . . . 0.0 111.792 -178.709 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 48.0 t -106.37 -2.02 22.66 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.004 178.323 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . 0.546 ' HD3' ' O ' ' A' ' 71' ' ' GLU . 2.8 mpt_? -116.68 41.16 2.75 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.609 0.719 . . . . 0.0 109.331 -179.74 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -120.73 171.17 8.79 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.223 -0.899 . . . . 0.0 110.474 179.906 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.414 HD11 HG22 ' A' ' 120' ' ' VAL . 0.8 OUTLIER -131.4 136.15 58.05 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 N-CA-C 109.74 -0.467 . . . . 0.0 109.74 178.603 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 79.2 t80 -93.05 124.06 36.75 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.286 -179.142 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.472 HG21 ' HE2' ' A' ' 95' ' ' PHE . 3.4 t -104.5 112.92 40.01 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.808 -179.708 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -119.24 167.69 13.3 Favored Glycine 0 N--CA 1.447 -0.599 0 N-CA-C 111.18 -0.768 . . . . 0.0 111.18 179.479 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 5.3 m-20 61.77 36.71 16.11 Favored 'General case' 0 N--CA 1.472 0.625 0 CA-C-O 121.218 0.532 . . . . 0.0 110.488 -179.702 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 2.5 t -78.55 164.03 3.48 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-N 115.624 -0.716 . . . . 0.0 111.116 -178.897 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . 0.545 ' OD2' ' HD3' ' A' ' 142' ' ' ARG . 10.8 t0 -68.06 136.58 54.01 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.996 -0.547 . . . . 0.0 109.61 179.313 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 25.7 p90 -64.98 -13.89 58.83 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.118 -0.492 . . . . 0.0 112.1 -179.253 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -113.28 14.21 19.26 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.773 0.321 . . . . 0.0 111.24 179.586 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' CYS . . . . . 0.458 ' SG ' ' HB2' ' A' ' 140' ' ' HIS . 0.8 OUTLIER -78.47 150.11 33.05 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.067 0.461 . . . . 0.0 111.521 -179.389 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 5.3 p -111.47 150.91 42.84 Favored Pre-proline 0 C--N 1.323 -0.55 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.259 179.099 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . 0.441 ' HD3' HD13 ' A' ' 106' ' ' ILE . 16.9 Cg_endo -57.89 -35.03 99.01 Favored 'Trans proline' 0 C--N 1.342 0.235 0 C-N-CA 122.462 2.108 . . . . 0.0 111.566 -179.716 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 66.8 mm-40 -64.36 -53.45 48.46 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.549 -0.75 . . . . 0.0 111.89 -179.429 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 -64.16 -18.37 64.4 Favored 'General case' 0 C--N 1.333 -0.133 0 CA-C-O 120.901 0.381 . . . . 0.0 111.472 -178.225 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 55.0 t -83.71 -49.06 16.79 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.518 -179.884 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 92' ' ' GLN . . . . . 0.417 ' O ' ' HB2' ' A' ' 96' ' ' GLN . 2.8 pt20 -73.38 -32.47 64.5 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.472 -0.331 . . . . 0.0 111.611 -178.479 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 7.1 pt20 -77.25 -28.29 53.57 Favored 'General case' 0 C--N 1.33 -0.261 0 C-N-CA 120.618 -0.433 . . . . 0.0 111.048 -179.118 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 60.9 t-80 -74.95 -44.48 48.21 Favored 'General case' 0 CA--C 1.519 -0.248 0 CA-C-O 121.085 0.469 . . . . 0.0 110.165 179.536 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . 0.472 ' HE2' HG21 ' A' ' 79' ' ' VAL . 20.5 m-30 -73.45 -17.78 61.2 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.866 -0.607 . . . . 0.0 110.517 -179.2 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . 0.492 ' HA ' ' O ' ' A' ' 99' ' ' GLY . 7.7 tt0 -64.61 -25.29 67.9 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.494 -0.775 . . . . 0.0 110.631 179.521 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 48.8 m -61.0 -32.18 71.77 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.514 179.682 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 18.2 m -92.35 -50.23 5.75 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.176 0.512 . . . . 0.0 110.078 179.42 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . 0.492 ' O ' ' HA ' ' A' ' 96' ' ' GLN . . . -137.77 133.7 6.53 Favored Glycine 0 N--CA 1.443 -0.854 0 C-N-CA 120.659 -0.782 . . . . 0.0 111.91 179.783 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -59.33 140.0 56.48 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.029 0.443 . . . . 0.0 110.686 179.975 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 2.8 p -105.51 140.18 24.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 115.876 -0.602 . . . . 0.0 112.171 -178.058 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 9.1 t30 -101.95 -50.56 3.63 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 109.431 -0.581 . . . . 0.0 109.431 178.125 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 9.0 mmm180 -141.8 158.32 43.94 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.386 179.698 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 6.6 p -151.54 127.57 1.83 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.104 179.566 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . 0.416 ' HB ' ' CE1' ' A' ' 119' ' ' TYR . 1.8 m -117.9 119.17 34.04 Favored 'General case' 0 C--N 1.321 -0.669 0 O-C-N 122.263 -0.273 . . . . 0.0 110.441 -179.984 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 106' ' ' ILE . . . . . 0.441 HD13 ' HD3' ' A' ' 88' ' ' PRO . 18.6 tt -107.16 146.64 13.19 Favored 'Isoleucine or valine' 0 C--O 1.235 0.327 0 CA-C-O 120.959 0.409 . . . . 0.0 111.04 -179.592 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 60.4 tp -135.69 126.24 26.97 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.858 -0.61 . . . . 0.0 109.948 179.12 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -89.2 120.02 30.21 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 116.517 -0.311 . . . . 0.0 110.499 179.83 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . 0.543 ' O ' ' HG2' ' A' ' 115' ' ' LYS . 16.8 t70 -81.08 136.9 35.99 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.014 0.435 . . . . 0.0 110.829 -179.883 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -124.93 25.86 7.21 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.896 -0.593 . . . . 0.0 109.763 179.556 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 24.6 t80 -105.99 -3.87 21.19 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.059 -179.483 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 106.83 10.9 27.62 Favored Glycine 0 N--CA 1.449 -0.493 0 C-N-CA 120.678 -0.772 . . . . 0.0 112.536 -179.582 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 113' ' ' GLN . . . . . 0.417 ' HB3' ' HD2' ' A' ' 114' ' ' PRO . 20.9 mt-30 -99.8 159.36 30.14 Favored Pre-proline 0 C--N 1.325 -0.471 0 N-CA-C 109.509 -0.552 . . . . 0.0 109.509 179.388 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 114' ' ' PRO . . . . . 0.417 ' HD2' ' HB3' ' A' ' 113' ' ' GLN . 11.4 Cg_endo -55.77 115.67 2.62 Favored 'Trans proline' 0 C--N 1.344 0.327 0 C-N-CA 122.307 2.005 . . . . 0.0 110.835 178.584 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . 0.543 ' HG2' ' O ' ' A' ' 109' ' ' ASP . 54.9 mttt -75.52 172.27 12.83 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.044 -178.467 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . 0.42 ' HA2' HD11 ' A' ' 106' ' ' ILE . . . 98.55 7.81 55.32 Favored Glycine 0 N--CA 1.444 -0.767 0 C-N-CA 120.351 -0.928 . . . . 0.0 112.286 179.902 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 30.2 m-85 -53.27 115.48 1.92 Allowed 'General case' 0 C--N 1.334 -0.097 0 N-CA-C 110.146 -0.316 . . . . 0.0 110.146 179.749 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -146.23 175.53 10.44 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-O 121.034 0.445 . . . . 0.0 111.165 -179.168 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 119' ' ' TYR . . . . . 0.416 ' CE1' ' HB ' ' A' ' 105' ' ' THR . 51.7 p90 -160.08 135.64 8.29 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.581 -0.736 . . . . 0.0 109.234 178.799 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . 0.414 HG22 HD11 ' A' ' 77' ' ' ILE . 17.4 m -105.55 142.0 19.62 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.727 0 N-CA-C 109.69 -0.485 . . . . 0.0 109.69 179.344 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . 0.434 ' HB2' HG12 ' A' ' 72' ' ' VAL . 5.8 pt-20 -127.1 152.94 46.64 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.157 -179.417 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 15.4 t80 -156.46 166.99 31.82 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.476 179.163 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 3.8 t -84.37 -47.61 17.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 120.921 0.391 . . . . 0.0 111.627 -179.317 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 74.9 mm-40 -66.33 126.45 28.82 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.32 -179.394 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 2.5 mp -70.23 -32.92 52.41 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.02 -179.926 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 4.8 t70 -62.66 -36.64 83.5 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.505 179.884 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -61.3 -55.44 31.8 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.636 179.724 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 11.3 p -67.12 -28.86 44.12 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.756 179.729 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 7.0 tt0 -58.56 -46.53 86.68 Favored 'General case' 0 N--CA 1.462 0.165 0 CA-C-O 121.11 0.481 . . . . 0.0 110.399 179.223 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 46.2 m-80 -70.83 -31.16 67.78 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.878 -0.601 . . . . 0.0 109.985 179.913 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -68.03 -48.41 65.76 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.665 -0.698 . . . . 0.0 111.833 -179.537 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 3.8 pp -69.93 -18.97 63.4 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.943 0.401 . . . . 0.0 110.92 -179.666 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 5.4 tp -80.03 -49.91 11.12 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.765 179.858 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 79.1 mt -134.61 107.81 7.7 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.477 -0.329 . . . . 0.0 110.967 -179.609 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 2.8 m-20 -159.81 -52.53 0.06 Allowed 'General case' 0 N--CA 1.465 0.303 0 CA-C-O 121.181 0.515 . . . . 0.0 110.998 179.757 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 4.6 pt-20 -74.73 80.06 2.05 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.433 0.635 . . . . 0.0 111.205 -179.735 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 6.8 m -133.78 -60.58 0.82 Allowed 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.672 -0.695 . . . . 0.0 111.0 179.573 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 1.6 tp10 -150.97 121.25 7.28 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-O 120.532 0.206 . . . . 0.0 110.516 -179.325 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -141.93 111.43 6.55 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 109.867 -0.42 . . . . 0.0 109.867 179.237 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 140' ' ' HIS . . . . . 0.458 ' HB2' ' SG ' ' A' ' 86' ' ' CYS . 2.4 t60 67.34 18.27 10.2 Favored 'General case' 0 N--CA 1.468 0.425 0 CA-C-O 121.142 0.496 . . . . 0.0 110.402 179.582 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 88.9 4.14 75.72 Favored Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.869 -0.681 . . . . 0.0 111.54 -179.212 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 142' ' ' ARG . . . . . 0.545 ' HD3' ' OD2' ' A' ' 83' ' ' ASP . 4.3 mpt_? -121.28 166.49 13.95 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 109.825 -0.435 . . . . 0.0 109.825 179.499 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 18.7 pt20 -110.99 140.08 45.81 Favored 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 109.863 -0.421 . . . . 0.0 109.863 179.2 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -125.6 174.98 7.88 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.547 -179.549 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 15.6 ttpt -111.32 118.79 36.82 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.255 179.791 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 85.9 t -113.37 118.53 58.38 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-O 120.992 0.425 . . . . 0.0 110.005 179.276 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 66.3 m -127.49 143.36 51.2 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 116.116 -0.493 . . . . 0.0 109.921 -179.89 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -59.13 133.49 56.14 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.058 0.456 . . . . 0.0 111.888 -178.747 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 12.1 ttpp -96.0 78.29 3.18 Favored 'General case' 0 N--CA 1.449 -0.476 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.205 179.607 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 21.5 tpt180 . . . . . 0 C--N 1.322 -0.615 0 N-CA-C 109.293 -0.632 . . . . 0.0 109.293 179.329 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.235 0.319 0 N-CA-C 110.05 -0.352 . . . . 0.0 110.05 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 50.7 tp -72.45 94.32 1.64 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.095 0.474 . . . . 0.0 109.825 179.472 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 16.8 ttm180 -149.03 149.58 31.36 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.764 -0.653 . . . . 0.0 109.576 -179.71 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 10.4 tt0 -79.97 48.79 1.0 Allowed 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.272 0.558 . . . . 0.0 110.824 -179.508 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 6.4 ptm -107.35 12.31 28.19 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.441 179.674 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 19.7 mm-40 -69.63 -20.8 63.6 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.056 0.455 . . . . 0.0 111.212 -179.261 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -79.71 -5.44 55.23 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.25 178.913 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 37.1 ttpt -85.34 1.73 47.22 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.78 -0.645 . . . . 0.0 109.775 179.614 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 5.8 p -58.32 -19.44 13.59 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.432 0 CA-C-N 115.261 -0.882 . . . . 0.0 111.094 179.447 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 29.6 mt-10 -70.65 -19.9 62.76 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-O 121.207 0.527 . . . . 0.0 110.369 179.173 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 5.2 mtmt -101.63 -42.52 6.18 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.995 -0.548 . . . . 0.0 109.905 178.749 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 22.0 mt-10 -61.37 -26.6 67.94 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.854 179.391 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 19.5 ptt? -66.55 -16.53 64.22 Favored 'General case' 0 C--O 1.227 -0.116 0 CA-C-O 121.372 0.606 . . . . 0.0 110.024 178.668 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -98.67 -7.93 55.04 Favored Glycine 0 N--CA 1.445 -0.725 0 N-CA-C 110.612 -0.995 . . . . 0.0 110.612 178.509 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.318 -0.785 0 CA-C-O 121.144 0.497 . . . . 0.0 110.055 -179.871 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.453 -0.302 0 CA-C-O 120.879 0.371 . . . . 0.0 110.584 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -81.88 -1.64 48.42 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.993 179.867 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 22.9 tp60 -119.87 -44.75 2.51 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.565 -0.289 . . . . 0.0 111.337 179.811 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -90.86 -61.18 1.73 Allowed 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 120.844 0.354 . . . . 0.0 111.252 -179.415 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . 0.468 ' O ' HG23 ' A' ' 72' ' ' VAL . 0.6 OUTLIER -61.94 -27.86 69.13 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.969 -0.56 . . . . 0.0 111.125 -179.313 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 19.4 tptp -58.4 -29.55 66.14 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.405 -179.727 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 17.7 mt-10 -66.27 -20.39 66.09 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-O 121.396 0.617 . . . . 0.0 110.605 179.722 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . 0.445 ' O ' ' HD2' ' A' ' 75' ' ' ARG . 5.5 tp10 -95.28 -39.88 9.83 Favored 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 109.091 -0.707 . . . . 0.0 109.091 177.176 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.468 HG23 ' O ' ' A' ' 68' ' ' GLU . 54.9 t -63.97 -42.64 96.39 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.374 0 CA-C-N 115.606 -0.724 . . . . 0.0 112.491 -179.464 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 14.5 p-10 -70.69 -18.18 62.82 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-O 120.949 0.404 . . . . 0.0 110.898 -179.076 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 33.6 t -97.41 -13.47 21.8 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.188 178.633 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . 0.445 ' HD2' ' O ' ' A' ' 71' ' ' GLU . 0.0 OUTLIER -106.04 44.95 1.0 Allowed 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.775 -0.648 . . . . 0.0 109.961 -179.498 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . 0.459 ' CB ' ' HB3' ' A' ' 121' ' ' GLU . 0.3 OUTLIER -124.53 170.99 10.36 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.47 -0.786 . . . . 0.0 110.689 179.971 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.436 HD13 ' HB1' ' A' ' 131' ' ' ALA . 6.7 pt -132.15 135.15 58.73 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.772 0 CA-C-N 115.803 -0.635 . . . . 0.0 109.35 178.445 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 69.6 t80 -91.91 123.04 34.99 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 116.341 -0.39 . . . . 0.0 109.994 -179.883 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 4.6 t -102.78 111.48 32.71 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.493 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.223 -179.516 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -121.42 169.69 14.55 Favored Glycine 0 N--CA 1.447 -0.602 0 C-N-CA 120.828 -0.701 . . . . 0.0 111.57 179.858 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 4.2 m-20 61.01 37.66 17.89 Favored 'General case' 0 N--CA 1.469 0.514 0 CA-C-O 121.251 0.548 . . . . 0.0 110.431 -179.882 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 2.5 t -83.52 164.31 2.72 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-N 115.358 -0.837 . . . . 0.0 110.804 -179.01 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . 0.732 ' OD2' ' HB2' ' A' ' 142' ' ' ARG . 0.1 OUTLIER -66.17 137.3 56.91 Favored 'General case' 0 CA--C 1.517 -0.323 0 N-CA-C 109.707 -0.479 . . . . 0.0 109.707 179.288 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 24.6 p90 -65.64 -8.06 18.43 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 120.917 0.389 . . . . 0.0 111.379 -179.878 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -118.51 19.52 13.29 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.14 -179.743 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -87.01 143.88 27.14 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.707 179.971 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . 0.436 ' O ' ' HG2' ' A' ' 90' ' ' GLU . 20.7 p -107.79 148.9 38.25 Favored Pre-proline 0 C--N 1.326 -0.429 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.425 179.572 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . 0.545 ' HD3' HD13 ' A' ' 106' ' ' ILE . 11.7 Cg_endo -54.81 -39.65 88.83 Favored 'Trans proline' 0 C--N 1.344 0.339 0 C-N-CA 123.089 2.526 . . . . 0.0 112.977 -179.198 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 3.2 mp0 -65.1 -41.73 94.7 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 112.498 0.555 . . . . 0.0 112.498 -178.486 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . 0.485 ' O ' ' HB2' ' A' ' 94' ' ' HIS . 8.0 pt-20 -73.98 -14.8 61.09 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.97 0.414 . . . . 0.0 111.024 -178.977 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.424 HG23 ' O ' ' A' ' 87' ' ' THR . 74.5 t -88.52 -48.35 14.92 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.89 -179.561 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -69.0 -34.13 74.8 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.545 -178.333 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 7.6 pt20 -78.11 -28.97 48.7 Favored 'General case' 0 C--N 1.327 -0.384 0 C-N-CA 120.556 -0.457 . . . . 0.0 111.24 -178.854 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 94' ' ' HIS . . . . . 0.485 ' HB2' ' O ' ' A' ' 90' ' ' GLU . 1.8 t-80 -73.39 -32.19 64.33 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.97 0.414 . . . . 0.0 110.828 -179.664 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 21.4 m-30 -87.7 -11.69 47.54 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.144 179.543 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 26.4 tt0 -62.74 -27.64 69.41 Favored 'General case' 0 C--O 1.234 0.237 0 CA-C-N 115.538 -0.755 . . . . 0.0 110.343 -179.957 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 12.7 m -63.96 -35.5 80.89 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.233 179.085 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 3.8 m -85.29 -52.75 5.68 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.883 -0.599 . . . . 0.0 109.532 179.159 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -140.57 128.16 3.71 Favored Glycine 0 N--CA 1.441 -0.979 0 CA-C-N 115.684 -0.689 . . . . 0.0 111.689 179.752 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . 0.444 ' H ' HG22 ' A' ' 100' ' ' THR . 0.1 OUTLIER -57.33 136.25 56.55 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.853 0.359 . . . . 0.0 110.101 179.418 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 2.0 p -102.01 130.33 51.94 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-N 116.048 -0.524 . . . . 0.0 112.073 -177.913 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . 0.457 ' HB2' ' CD1' ' A' ' 122' ' ' PHE . 29.2 t-20 -99.85 -43.78 6.3 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 109.53 -0.544 . . . . 0.0 109.53 178.449 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 103' ' ' ARG . . . . . 0.431 ' HD3' ' OD1' ' A' ' 102' ' ' ASN . 1.5 mpt_? -135.7 151.24 49.98 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.328 179.657 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 6.1 p -155.46 129.82 1.39 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.552 -0.295 . . . . 0.0 110.211 179.28 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -127.49 124.8 39.19 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.492 -0.322 . . . . 0.0 110.248 179.472 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 106' ' ' ILE . . . . . 0.548 HD11 ' HA2' ' A' ' 116' ' ' GLY . 20.8 tt -109.26 149.06 12.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 120.857 0.36 . . . . 0.0 111.014 -179.89 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 13.8 tp -130.14 136.22 49.05 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.002 -0.544 . . . . 0.0 109.991 179.516 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -100.8 111.35 23.55 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.488 179.9 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . 0.416 ' O ' ' HG2' ' A' ' 115' ' ' LYS . 23.1 t70 -76.73 146.91 37.68 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.188 0.518 . . . . 0.0 111.13 -179.618 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 3.3 mppt? -135.15 22.99 3.5 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.267 179.446 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 19.0 t80 -107.58 -3.89 18.88 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.222 0.534 . . . . 0.0 110.157 -179.544 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 114.78 0.62 22.96 Favored Glycine 0 N--CA 1.449 -0.474 0 C-N-CA 120.816 -0.707 . . . . 0.0 112.766 179.835 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 26.6 mt-30 -88.35 154.59 51.53 Favored Pre-proline 0 C--N 1.329 -0.315 0 N-CA-C 109.361 -0.607 . . . . 0.0 109.361 179.679 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 14.5 Cg_endo -58.45 115.92 2.88 Favored 'Trans proline' 0 N--CA 1.462 -0.378 0 C-N-CA 122.013 1.809 . . . . 0.0 111.444 178.917 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . 0.416 ' HG2' ' O ' ' A' ' 109' ' ' ASP . 60.0 mttt -70.86 167.06 19.77 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 109.558 -0.534 . . . . 0.0 109.558 -179.485 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . 0.548 ' HA2' HD11 ' A' ' 106' ' ' ILE . . . 105.59 1.83 40.36 Favored Glycine 0 N--CA 1.447 -0.607 0 C-N-CA 120.073 -1.061 . . . . 0.0 112.197 179.914 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 32.4 m-85 -53.69 115.61 2.07 Favored 'General case' 0 C--N 1.333 -0.138 0 N-CA-C 110.269 -0.271 . . . . 0.0 110.269 179.46 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -143.41 173.01 12.0 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 120.915 0.388 . . . . 0.0 111.006 -179.162 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 51.9 p90 -155.21 130.09 9.35 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 115.847 -0.615 . . . . 0.0 109.765 178.681 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 18.6 m -107.21 141.27 22.85 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 N-CA-C 109.695 -0.483 . . . . 0.0 109.695 179.178 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . 0.459 ' HB3' ' CB ' ' A' ' 76' ' ' SER . 1.4 pt-20 -132.04 157.05 45.16 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.916 0.388 . . . . 0.0 111.17 179.723 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 122' ' ' PHE . . . . . 0.457 ' CD1' ' HB2' ' A' ' 102' ' ' ASN . 22.2 t80 -152.29 170.88 18.95 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.535 -0.757 . . . . 0.0 109.771 179.91 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 20.4 t -84.26 -51.6 13.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-O 120.969 0.414 . . . . 0.0 110.461 179.852 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 4.7 mm-40 -60.53 129.66 42.69 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.852 -0.613 . . . . 0.0 111.132 179.886 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 2.9 mp -73.9 -31.03 29.58 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 N-CA-C 109.327 -0.62 . . . . 0.0 109.327 179.516 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -60.53 -37.97 82.92 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.342 179.26 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -60.8 -56.33 22.52 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.537 -0.756 . . . . 0.0 111.107 -179.976 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 11.3 p -67.19 -30.13 48.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.442 -179.654 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 30.1 tt0 -61.31 -44.78 96.64 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 121.038 0.447 . . . . 0.0 110.436 179.653 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 37.9 m-80 -72.3 -29.11 63.55 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.055 -0.52 . . . . 0.0 109.994 179.601 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 131' ' ' ALA . . . . . 0.436 ' HB1' HD13 ' A' ' 77' ' ' ILE . . . -69.53 -51.65 33.66 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.476 -0.784 . . . . 0.0 111.305 -179.939 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 4.2 pp -65.59 -23.34 66.81 Favored 'General case' 0 N--CA 1.462 0.142 0 CA-C-O 120.794 0.33 . . . . 0.0 110.681 -179.824 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 5.7 tp -73.37 -56.48 5.01 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.961 0.41 . . . . 0.0 110.228 179.595 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 69.1 mt -122.71 104.2 9.16 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.007 -0.542 . . . . 0.0 109.79 179.826 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 135' ' ' ASN . . . . . 0.43 ' HB2' ' O ' ' A' ' 131' ' ' ALA . 0.5 OUTLIER -148.4 -66.84 0.24 Allowed 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.15 0.5 . . . . 0.0 111.122 -179.186 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 5.6 pt-20 -73.68 106.29 5.37 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.563 -0.744 . . . . 0.0 111.414 -179.466 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 21.3 m -150.09 -59.13 0.19 Allowed 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.706 -0.679 . . . . 0.0 109.599 178.997 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 4.9 tt0 -161.55 120.96 2.5 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.813 -0.63 . . . . 0.0 109.572 178.946 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -139.35 123.18 17.63 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 -179.982 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 140' ' ' HIS . . . . . 0.621 ' HB3' ' OD2' ' A' ' 83' ' ' ASP . 6.9 t60 59.07 12.4 2.42 Favored 'General case' 0 CA--C 1.54 0.562 0 O-C-N 123.555 0.534 . . . . 0.0 111.553 179.28 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 101.36 -6.4 55.75 Favored Glycine 0 N--CA 1.449 -0.443 0 C-N-CA 120.904 -0.665 . . . . 0.0 112.754 -179.918 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 142' ' ' ARG . . . . . 0.732 ' HB2' ' OD2' ' A' ' 83' ' ' ASP . 8.0 mpt_? -113.43 173.42 6.42 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 117.023 0.412 . . . . 0.0 110.418 179.58 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 17.4 pt20 -116.87 114.16 23.49 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.093 0.473 . . . . 0.0 109.759 179.531 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -97.97 175.13 6.24 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.174 -179.15 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 6.4 ttpt -117.51 120.81 39.22 Favored 'General case' 0 N--CA 1.45 -0.457 0 CA-C-N 115.905 -0.589 . . . . 0.0 109.495 179.052 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 93.5 t -113.36 119.96 62.07 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.738 0 CA-C-O 120.898 0.38 . . . . 0.0 110.653 -179.635 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 58.2 m -123.25 141.68 51.72 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 116.195 -0.457 . . . . 0.0 109.801 -179.849 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -59.86 128.8 38.67 Favored 'General case' 0 C--O 1.236 0.378 0 CA-C-O 120.828 0.347 . . . . 0.0 111.277 -179.64 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 149' ' ' LYS . . . . . 0.429 ' HE2' ' OG ' ' A' ' 76' ' ' SER . 21.9 ttpt -91.94 67.8 5.25 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.384 0.611 . . . . 0.0 109.999 -179.601 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 24.7 tpt180 . . . . . 0 C--N 1.324 -0.537 0 CA-C-O 121.236 0.541 . . . . 0.0 109.611 179.104 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 18.6 mmt . . . . . 0 N--CA 1.48 1.069 0 N-CA-C 110.224 -0.287 . . . . 0.0 110.224 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 90.47 -61.64 3.18 Favored Glycine 0 N--CA 1.447 -0.598 0 C-N-CA 120.658 -0.782 . . . . 0.0 111.623 -179.711 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 2.2 m -67.35 148.02 52.18 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 120.667 0.27 . . . . 0.0 110.404 179.333 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -82.18 -59.68 2.47 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 120.723 0.297 . . . . 0.0 110.624 -179.896 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 11.4 t60 -160.11 118.1 2.62 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.306 179.88 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 19.1 p-80 -59.64 139.54 57.12 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.925 179.492 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 36.7 m80 -115.37 -155.1 0.56 Allowed 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.343 -0.389 . . . . 0.0 110.232 -179.926 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -134.34 133.1 40.29 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.968 0.413 . . . . 0.0 111.071 179.866 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 31.8 t-80 -121.89 103.25 8.71 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 109.606 -0.516 . . . . 0.0 109.606 179.291 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 3.1 t60 -65.2 122.99 18.37 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.495 -179.818 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -79.21 151.72 31.06 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.252 -179.317 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 35.6 m -92.68 132.48 36.88 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.005 -0.543 . . . . 0.0 109.919 178.824 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -78.79 109.12 2.78 Favored Glycine 0 N--CA 1.448 -0.506 0 C-N-CA 120.691 -0.766 . . . . 0.0 112.491 -179.657 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 42.5 mt -85.41 167.57 15.4 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 120.883 0.373 . . . . 0.0 110.555 179.53 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 12.9 m -95.37 144.44 27.82 Favored Pre-proline 0 C--N 1.325 -0.49 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.498 179.565 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_endo -68.88 145.71 63.17 Favored 'Trans proline' 0 C--O 1.234 0.304 0 C-N-CA 122.681 2.254 . . . . 0.0 112.292 -179.99 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . 0.426 HH11 ' HD3' ' A' ' 17' ' ' ARG . 6.1 ttt180 -92.09 87.81 6.29 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.287 179.95 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -76.85 86.76 0.96 Allowed Glycine 0 N--CA 1.449 -0.454 0 C-N-CA 120.801 -0.714 . . . . 0.0 111.695 179.68 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 6.0 m -148.13 144.92 28.13 Favored 'General case' 0 C--N 1.323 -0.557 0 O-C-N 122.813 -0.228 . . . . 0.0 110.58 -179.932 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 18.8 p-80 -130.67 111.19 11.96 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 109.729 -0.471 . . . . 0.0 109.729 178.842 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 45.8 mtt -148.98 174.63 12.07 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.174 -179.122 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 145.94 129.0 2.02 Favored Glycine 0 N--CA 1.445 -0.729 0 C-N-CA 120.901 -0.666 . . . . 0.0 112.338 179.564 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 2.8 m -92.32 138.78 31.23 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 120.717 0.294 . . . . 0.0 110.29 179.565 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -101.55 136.62 41.09 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.065 179.897 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 85.1 mt -105.11 120.84 42.5 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 120.983 0.42 . . . . 0.0 111.17 -179.404 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 23.3 mt-10 -93.8 129.46 40.16 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.781 -0.645 . . . . 0.0 109.932 179.372 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -83.56 120.91 26.53 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 110.183 -0.303 . . . . 0.0 110.183 179.694 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 25.8 ptm -163.85 -178.58 5.77 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.159 -179.482 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 37.5 tttm -66.79 136.55 55.63 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.085 179.524 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 16.3 pttm -72.27 144.56 48.35 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 109.719 -0.474 . . . . 0.0 109.719 179.256 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 65.0 mtt180 -114.5 171.36 7.67 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-O 120.962 0.41 . . . . 0.0 110.506 -179.71 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -75.06 97.23 3.38 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.699 -0.682 . . . . 0.0 109.58 179.411 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 20.5 pttp -66.13 118.85 10.45 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.363 0.602 . . . . 0.0 111.35 -179.452 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -96.79 -22.6 16.85 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.61 179.354 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.413 HG12 ' N ' ' A' ' 36' ' ' GLU . 11.5 tt -95.61 161.47 2.64 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 CA-C-N 115.813 -0.63 . . . . 0.0 110.725 -179.717 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . 0.413 ' N ' HG12 ' A' ' 35' ' ' ILE . 2.7 pt-20 -72.17 152.47 42.25 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.514 179.313 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -123.6 163.31 21.27 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 109.942 -0.392 . . . . 0.0 109.942 -179.94 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 22.2 mm-40 -79.57 79.6 6.03 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.28 0.562 . . . . 0.0 111.106 -179.424 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -123.42 110.19 14.81 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.781 -0.645 . . . . 0.0 109.777 179.296 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -78.45 106.44 2.32 Favored Glycine 0 N--CA 1.449 -0.498 0 C-N-CA 120.947 -0.644 . . . . 0.0 113.221 -179.187 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -112.54 -170.11 1.6 Allowed 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 109.772 -0.455 . . . . 0.0 109.772 179.128 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 56.8 tp -71.8 97.02 1.71 Allowed 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.177 0.513 . . . . 0.0 110.35 179.547 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . 0.422 ' C ' ' H ' ' A' ' 45' ' ' MET . 0.7 OUTLIER -150.13 147.92 28.34 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.655 -0.702 . . . . 0.0 109.582 -179.986 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -73.79 20.35 0.1 Allowed 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.623 -179.723 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' MET . . . . . 0.422 ' H ' ' C ' ' A' ' 43' ' ' ARG . 19.5 ptt? -83.86 8.1 15.98 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.026 0.441 . . . . 0.0 110.63 -179.854 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 87.7 mt-30 -66.1 -22.75 66.41 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.179 0.514 . . . . 0.0 110.477 179.361 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -80.37 -7.43 59.09 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.149 0.499 . . . . 0.0 110.681 179.648 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 18.7 ttmm -77.91 -6.28 53.81 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.539 -179.795 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 14.8 p -56.2 -28.57 25.83 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.32 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.596 -179.474 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 26.7 mt-10 -62.22 -31.36 71.89 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.91 0.386 . . . . 0.0 111.294 -179.359 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 37.6 mtmt -96.68 -41.18 8.63 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.609 -179.966 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 27.6 mm-40 -61.39 -29.6 70.02 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.71 -179.502 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 15.2 ptt? -62.62 -24.9 67.83 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-O 120.87 0.367 . . . . 0.0 110.629 179.797 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -94.3 -9.48 59.14 Favored Glycine 0 N--CA 1.447 -0.598 0 C-N-CA 120.699 -0.762 . . . . 0.0 111.483 179.463 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -110.79 17.05 20.98 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 120.909 0.385 . . . . 0.0 110.747 -179.753 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.417 HG12 ' HB2' ' A' ' 60' ' ' SER . 18.0 m -64.31 -13.71 14.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.376 179.797 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 92.6 mt-30 -78.83 -10.98 59.97 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.902 0.382 . . . . 0.0 110.39 179.232 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 26.8 t70 -127.38 -52.39 1.38 Allowed 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.474 179.92 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 7.6 m -71.71 -75.29 0.13 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.241 179.899 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . 0.417 ' HB2' HG12 ' A' ' 56' ' ' VAL . 0.4 OUTLIER -79.61 39.91 0.43 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.172 0.51 . . . . 0.0 111.135 -179.827 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 45.5 p -80.78 -33.61 34.78 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.597 -179.44 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 1.3 m -67.51 -25.17 65.71 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.958 -0.565 . . . . 0.0 111.006 179.949 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -62.39 -27.61 69.2 Favored 'General case' 0 N--CA 1.449 -0.477 0 CA-C-N 115.771 -0.65 . . . . 0.0 110.492 179.794 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -69.63 -33.41 72.59 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.213 179.454 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -74.6 -0.08 16.63 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.048 0.452 . . . . 0.0 111.14 179.909 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 21.9 tp60 -119.47 -48.69 2.39 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.998 179.698 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -89.36 -52.94 4.78 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.864 0.364 . . . . 0.0 111.904 -179.236 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . 0.45 ' O ' HG23 ' A' ' 72' ' ' VAL . 6.4 tt0 -68.68 -26.1 65.13 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.143 0.497 . . . . 0.0 110.549 -179.094 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 51.2 tptt -58.91 -27.89 65.69 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.886 179.511 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 52.6 mt-10 -63.76 -21.94 66.66 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-O 121.443 0.64 . . . . 0.0 110.99 179.758 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . 0.522 ' O ' ' HD3' ' A' ' 75' ' ' ARG . 13.2 tp10 -94.8 -44.56 7.71 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 115.521 -0.763 . . . . 0.0 108.951 178.307 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.596 HG12 ' HB2' ' A' ' 121' ' ' GLU . 26.7 t -62.78 -40.45 88.69 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-N 115.351 -0.84 . . . . 0.0 112.883 -178.496 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 9.9 p-10 -70.86 -20.83 62.49 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-O 121.091 0.472 . . . . 0.0 111.64 -178.933 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 18.0 m -100.89 -5.05 26.61 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-O 121.335 0.588 . . . . 0.0 110.192 179.888 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . 0.522 ' HD3' ' O ' ' A' ' 71' ' ' GLU . 1.9 mpt_? -113.9 39.43 2.7 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.593 -0.73 . . . . 0.0 109.545 -179.92 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -119.26 173.83 6.71 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.381 -0.827 . . . . 0.0 110.886 -179.926 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.416 HD13 ' HB1' ' A' ' 131' ' ' ALA . 7.0 pt -133.31 140.41 47.03 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.067 178.585 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 71.0 t80 -96.53 126.52 41.77 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 109.624 -0.51 . . . . 0.0 109.624 179.815 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 5.1 t -108.09 114.33 46.23 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.983 -179.381 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -120.38 169.45 14.06 Favored Glycine 0 N--CA 1.448 -0.513 0 N-CA-C 111.192 -0.763 . . . . 0.0 111.192 179.36 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 93.8 m-20 60.06 38.66 20.47 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-O 121.073 0.463 . . . . 0.0 110.754 -179.712 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 2.4 t -81.82 164.44 2.91 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.753 -179.145 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . 0.414 ' O ' ' HB2' ' A' ' 86' ' ' CYS . 9.7 t70 -67.3 137.01 55.75 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 109.676 -0.491 . . . . 0.0 109.676 179.414 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 30.5 p90 -64.27 -18.46 64.59 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.897 -178.647 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -113.23 24.92 11.81 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 121.037 0.446 . . . . 0.0 110.747 179.851 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' CYS . . . . . 0.414 ' HB2' ' O ' ' A' ' 83' ' ' ASP . 0.1 OUTLIER -85.85 156.45 20.55 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.397 0.618 . . . . 0.0 111.549 -179.966 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . 0.483 ' O ' ' HG2' ' A' ' 90' ' ' GLU . 0.0 OUTLIER -119.31 146.64 41.35 Favored Pre-proline 0 C--N 1.322 -0.601 0 CA-C-N 115.432 -0.804 . . . . 0.0 110.343 -179.941 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . 0.566 ' HD3' HD13 ' A' ' 106' ' ' ILE . 15.0 Cg_endo -56.7 -40.2 86.04 Favored 'Trans proline' 0 C--N 1.344 0.319 0 C-N-CA 122.83 2.353 . . . . 0.0 112.734 -178.867 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 60.1 mm-40 -60.42 -50.49 73.36 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.531 -179.097 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . 0.719 ' O ' ' HB2' ' A' ' 94' ' ' HIS . 6.6 pt-20 -63.91 -24.6 67.8 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.624 -0.262 . . . . 0.0 111.143 -178.706 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 70.0 t -80.76 -48.66 19.3 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.04 -179.343 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 2.3 pt20 -70.92 -34.03 71.12 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 112.1 0.407 . . . . 0.0 112.1 -178.167 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 18.5 pt20 -79.19 -23.8 43.61 Favored 'General case' 0 C--N 1.329 -0.285 0 C-N-CA 120.496 -0.481 . . . . 0.0 110.896 -179.502 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' HIS . . . . . 0.719 ' HB2' ' O ' ' A' ' 90' ' ' GLU . 0.4 OUTLIER -74.48 -43.66 55.0 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.048 0.452 . . . . 0.0 110.067 179.684 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 21.8 m-30 -78.17 -12.52 60.0 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.521 -179.873 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . 0.603 ' HA ' ' O ' ' A' ' 99' ' ' GLY . 15.8 tt0 -65.08 -19.72 66.13 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.378 -179.959 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 12.3 m -66.54 -26.82 67.32 Favored 'General case' 0 N--CA 1.451 -0.401 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.272 179.217 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 5.9 m -97.02 -42.97 7.64 Favored 'General case' 0 N--CA 1.453 -0.324 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.168 179.365 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . 0.603 ' O ' ' HA ' ' A' ' 96' ' ' GLN . . . -150.65 142.16 9.35 Favored Glycine 0 N--CA 1.445 -0.712 0 C-N-CA 120.875 -0.679 . . . . 0.0 111.768 179.855 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . 0.417 ' HB ' ' CZ ' ' A' ' 122' ' ' PHE . 0.2 OUTLIER -62.68 150.03 42.09 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 120.937 0.398 . . . . 0.0 111.524 -179.924 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 2.2 p -119.54 129.26 75.55 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.754 -179.762 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 55.7 t30 -98.24 -39.51 8.81 Favored 'General case' 0 N--CA 1.463 0.175 0 CA-C-O 121.145 0.498 . . . . 0.0 110.274 179.385 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 2.2 tpt180 -145.93 153.29 40.66 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.223 -179.883 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 5.8 p -151.22 133.09 5.39 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.07 179.763 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 1.5 m -121.27 122.88 40.89 Favored 'General case' 0 C--N 1.32 -0.674 0 N-CA-C 110.129 -0.323 . . . . 0.0 110.129 179.612 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' ILE . . . . . 0.566 HD13 ' HD3' ' A' ' 88' ' ' PRO . 21.0 tt -113.49 144.36 21.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 120.935 0.398 . . . . 0.0 110.729 -179.514 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 27.0 tp -132.45 128.7 38.02 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.305 179.662 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -86.91 114.56 23.65 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.715 179.7 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . 0.423 ' O ' ' HG2' ' A' ' 115' ' ' LYS . 15.0 t70 -75.39 140.93 43.28 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.872 0.367 . . . . 0.0 110.796 -179.74 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -132.31 28.7 4.36 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 109.352 -0.61 . . . . 0.0 109.352 179.159 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 5.1 t80 -109.82 -2.37 17.32 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.589 -0.732 . . . . 0.0 109.707 179.919 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 106.89 6.29 34.81 Favored Glycine 0 N--CA 1.448 -0.51 0 CA-C-N 115.527 -0.76 . . . . 0.0 112.52 179.98 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 36.3 mt-30 -94.87 158.74 34.61 Favored Pre-proline 0 C--N 1.324 -0.511 0 N-CA-C 109.407 -0.59 . . . . 0.0 109.407 179.593 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 15.2 Cg_endo -58.11 119.3 6.47 Favored 'Trans proline' 0 C--N 1.345 0.388 0 C-N-CA 122.105 1.87 . . . . 0.0 110.88 178.886 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . 0.423 ' HG2' ' O ' ' A' ' 109' ' ' ASP . 58.3 mttt -74.4 173.37 10.38 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 109.976 -0.379 . . . . 0.0 109.976 -179.499 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . 0.529 ' HA2' HD11 ' A' ' 106' ' ' ILE . . . 98.32 3.27 57.68 Favored Glycine 0 N--CA 1.443 -0.844 0 C-N-CA 120.178 -1.01 . . . . 0.0 112.165 179.626 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 5.2 m-30 -54.82 117.56 3.51 Favored 'General case' 0 N--CA 1.463 0.206 0 N-CA-C 110.188 -0.301 . . . . 0.0 110.188 179.582 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -147.29 168.42 21.79 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.046 0.45 . . . . 0.0 111.451 -178.811 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 34.5 p90 -148.24 129.84 14.98 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.643 -0.708 . . . . 0.0 109.722 178.41 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 6.4 m -105.3 145.95 12.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 N-CA-C 109.742 -0.466 . . . . 0.0 109.742 179.781 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . 0.596 ' HB2' HG12 ' A' ' 72' ' ' VAL . 6.1 pt-20 -133.9 152.58 51.91 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 120.657 0.265 . . . . 0.0 111.005 -179.701 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' PHE . . . . . 0.417 ' CZ ' ' HB ' ' A' ' 100' ' ' THR . 13.0 t80 -148.64 167.01 26.6 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.124 179.525 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 10.1 t -83.44 -41.92 17.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.488 -0.324 . . . . 0.0 111.535 -179.286 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 43.6 mm-40 -74.02 132.12 42.06 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.121 0.486 . . . . 0.0 111.593 -179.087 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 2.4 mp -74.71 -35.51 37.44 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.444 -179.657 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -59.25 -33.49 71.1 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.151 0.5 . . . . 0.0 110.937 -179.692 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -65.56 -54.97 20.52 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.926 179.958 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 10.3 p -66.49 -29.6 47.06 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.804 -179.564 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 8.3 tt0 -60.39 -42.62 96.28 Favored 'General case' 0 C--N 1.333 -0.142 0 CA-C-O 120.909 0.385 . . . . 0.0 110.431 179.619 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 29.3 m-80 -73.59 -31.0 63.35 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.119 179.282 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . 0.416 ' HB1' HD13 ' A' ' 77' ' ' ILE . . . -67.93 -52.44 36.08 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.664 -0.698 . . . . 0.0 111.274 -179.885 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 4.0 pp -64.23 -22.22 66.87 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.85 0.357 . . . . 0.0 111.015 -179.802 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 5.5 tp -77.55 -55.72 5.13 Favored 'General case' 0 N--CA 1.451 -0.403 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.46 179.556 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 33.7 mt -123.74 103.04 8.14 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.078 -179.836 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -145.42 -71.25 0.26 Allowed 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 120.788 0.328 . . . . 0.0 111.56 -179.316 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 4.1 pt-20 -66.61 110.35 3.16 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.268 0.556 . . . . 0.0 111.268 -179.224 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 14.0 m -153.45 -58.14 0.13 Allowed 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.787 -0.642 . . . . 0.0 109.726 179.334 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -163.88 122.15 1.88 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.1 -0.5 . . . . 0.0 109.978 179.174 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -138.83 115.61 10.74 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 109.189 -0.671 . . . . 0.0 109.189 179.425 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 3.3 t60 64.83 16.45 10.47 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-O 120.896 0.379 . . . . 0.0 110.853 179.883 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 91.39 6.28 66.42 Favored Glycine 0 N--CA 1.448 -0.522 0 C-N-CA 120.893 -0.67 . . . . 0.0 111.761 -179.034 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -119.99 160.45 22.73 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 110.204 -0.295 . . . . 0.0 110.204 179.794 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 14.2 pt20 -108.22 126.5 52.87 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 109.443 -0.577 . . . . 0.0 109.443 178.573 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -112.47 175.43 5.44 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.688 -179.553 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 78.4 tttt -116.97 124.04 48.41 Favored 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 109.461 -0.57 . . . . 0.0 109.461 178.73 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 99.1 t -116.01 125.24 73.03 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.639 0 CA-C-O 120.941 0.4 . . . . 0.0 110.448 179.862 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 11.9 t -127.36 149.58 49.99 Favored 'General case' 0 N--CA 1.447 -0.624 0 N-CA-C 109.583 -0.525 . . . . 0.0 109.583 179.927 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -65.58 127.26 31.17 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.55 -0.295 . . . . 0.0 110.964 -179.829 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 19.9 ttpt -91.2 66.42 5.66 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.376 0.607 . . . . 0.0 109.683 179.88 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 150' ' ' ARG . . . . . 0.491 ' C ' ' HD2' ' A' ' 150' ' ' ARG . 0.0 OUTLIER -88.9 76.16 7.95 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 109.439 -0.578 . . . . 0.0 109.439 179.819 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 8.2 t -62.33 133.84 55.65 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.456 -0.793 . . . . 0.0 111.015 -179.799 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 152' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 -175.68 175.6 2.03 Favored 'General case' 0 C--O 1.235 0.326 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.039 179.995 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 7.7 pt -81.04 153.41 72.22 Favored Pre-proline 0 C--N 1.323 -0.564 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.951 -179.806 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 6.7 Cg_exo -74.08 73.24 3.81 Favored 'Trans proline' 0 C--N 1.346 0.443 0 C-N-CA 123.032 2.488 . . . . 0.0 111.832 179.436 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.443 -0.862 0 N-CA-C 110.803 -0.919 . . . . 0.0 110.803 -179.879 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.481 1.103 0 CA-C-O 120.669 0.271 . . . . 0.0 110.614 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 133.24 158.8 8.88 Favored Glycine 0 N--CA 1.447 -0.624 0 C-N-CA 120.793 -0.718 . . . . 0.0 111.666 179.71 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 8.4 t -155.25 132.98 11.31 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 120.781 0.324 . . . . 0.0 110.214 -179.965 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -100.83 159.12 15.45 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.132 179.289 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 80.1 m-70 -133.8 155.27 50.12 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 110.417 -0.216 . . . . 0.0 110.417 -179.585 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 2.7 t60 -162.27 131.5 4.37 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.478 179.765 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 34.7 m80 -93.4 -179.79 5.16 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.009 0.433 . . . . 0.0 111.271 -179.623 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 27.7 m80 -144.24 167.66 21.9 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.774 -0.648 . . . . 0.0 109.413 179.387 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 5.7 t60 -150.55 141.18 22.62 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.965 0.412 . . . . 0.0 111.034 -179.781 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 5.2 p80 -144.04 130.04 19.5 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.087 179.645 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 1.2 m -127.26 142.34 51.49 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.557 -179.627 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 15.1 m -126.74 127.2 44.72 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 110.068 -0.345 . . . . 0.0 110.068 179.825 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -81.89 172.46 53.07 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.989 -0.624 . . . . 0.0 113.242 -178.852 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 74.2 mt -103.64 -178.53 3.69 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 120.694 0.283 . . . . 0.0 110.765 -179.776 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 16.1 m -123.9 152.96 67.16 Favored Pre-proline 0 C--N 1.326 -0.417 0 CA-C-N 116.444 -0.344 . . . . 0.0 111.32 -179.719 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -75.31 -171.76 1.1 Allowed 'Trans proline' 0 C--N 1.345 0.378 0 C-N-CA 123.047 2.498 . . . . 0.0 112.499 179.802 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 4.7 mtp85 -130.07 146.97 51.76 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.509 -179.249 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -103.46 168.93 17.93 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 121.09 -0.576 . . . . 0.0 111.716 179.583 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -129.28 160.2 33.74 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.766 0.317 . . . . 0.0 110.824 -179.685 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 8.9 p-80 -131.79 161.33 33.15 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.54 179.616 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -131.78 -178.41 4.87 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.459 -0.337 . . . . 0.0 110.74 179.998 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -157.99 174.48 35.28 Favored Glycine 0 N--CA 1.452 -0.263 0 N-CA-C 111.601 -0.6 . . . . 0.0 111.601 -179.957 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 39.7 m -132.81 157.74 44.23 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 120.912 0.386 . . . . 0.0 111.259 -179.704 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 15.9 p-10 -106.27 -151.91 0.46 Allowed 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.839 -0.618 . . . . 0.0 110.551 179.865 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -148.04 167.69 24.3 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-O 120.651 0.263 . . . . 0.0 110.596 179.88 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 30.1 mt-10 -101.18 -172.81 2.23 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.076 -179.755 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 44.7 t0 -85.27 162.26 19.2 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.692 179.865 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 28.2 ptm -94.29 168.44 10.9 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.851 -179.491 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 21.8 pttm -86.43 -178.14 6.36 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.041 179.971 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -98.02 172.62 7.51 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.967 0.413 . . . . 0.0 111.105 -179.528 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 67.3 ttt180 -114.32 153.26 30.07 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.104 -179.552 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 48.1 tp -62.07 133.28 55.09 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-O 120.937 0.398 . . . . 0.0 110.59 179.342 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 49.0 tttm -130.72 119.31 22.17 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.003 179.839 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 4.6 tp10 -120.06 149.94 41.38 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.965 -0.562 . . . . 0.0 110.315 -179.662 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 19.0 tt -101.07 147.67 7.87 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 CA-C-N 115.877 -0.601 . . . . 0.0 109.943 179.778 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 3.7 mm-40 -125.73 -169.64 2.04 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-O 120.766 0.317 . . . . 0.0 110.868 -179.686 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 4.8 pt-20 -135.32 147.28 49.11 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.741 -0.663 . . . . 0.0 109.272 179.577 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -142.56 149.1 38.61 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.091 0.472 . . . . 0.0 111.361 -178.78 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -122.18 -28.46 4.36 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.516 -0.766 . . . . 0.0 110.271 179.333 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 77.57 98.59 0.2 Allowed Glycine 0 C--N 1.334 0.422 0 CA-C-N 116.011 -0.541 . . . . 0.0 112.634 179.407 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -160.0 -172.22 3.54 Favored 'General case' 0 C--N 1.328 -0.359 0 O-C-N 122.891 -0.182 . . . . 0.0 110.623 179.074 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 64.7 tp -75.33 92.63 2.8 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-O 121.225 0.536 . . . . 0.0 110.569 179.696 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . 0.409 ' HB3' ' SD ' ' A' ' 45' ' ' MET . 4.3 ttp180 -155.84 159.73 39.62 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.836 -0.62 . . . . 0.0 109.675 -179.673 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 16.9 mt-10 -86.17 23.47 1.53 Allowed 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.371 0.605 . . . . 0.0 111.185 179.91 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' MET . . . . . 0.409 ' SD ' ' HB3' ' A' ' 43' ' ' ARG . 6.4 ptm -83.56 14.18 3.98 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.061 179.39 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 45.4 mt-30 -73.23 -27.53 61.65 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.837 -0.619 . . . . 0.0 109.713 179.408 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -75.8 -12.27 60.14 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.509 -0.769 . . . . 0.0 110.146 179.136 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 3.4 tmmt? -74.89 -2.62 27.69 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.214 -0.903 . . . . 0.0 110.21 179.681 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 8.1 p -60.5 -23.95 29.96 Favored 'Isoleucine or valine' 0 C--O 1.235 0.302 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.831 179.337 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 26.1 mm-40 -59.46 -27.28 65.95 Favored 'General case' 0 N--CA 1.457 -0.087 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.285 179.187 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 12.7 mtmm -97.85 -37.25 9.91 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.945 -0.571 . . . . 0.0 110.441 178.455 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -59.38 -22.32 61.19 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.687 -179.748 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 17.9 ptt? -58.47 -23.09 56.83 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.767 0.317 . . . . 0.0 110.859 179.814 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -105.86 4.37 39.18 Favored Glycine 0 N--CA 1.447 -0.592 0 C-N-CA 120.668 -0.777 . . . . 0.0 111.711 179.258 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -129.11 21.76 5.74 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.139 0.495 . . . . 0.0 110.635 -179.829 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 15.2 m -63.46 -9.83 5.7 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.272 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.666 -179.845 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 84.5 mt-30 -81.81 -9.19 59.68 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.539 179.546 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 17.3 t70 -132.58 -51.89 0.93 Allowed 'General case' 0 CA--C 1.531 0.217 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.44 179.372 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 4.5 m -67.31 -56.57 9.21 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.069 0.462 . . . . 0.0 111.874 -179.591 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -102.29 25.99 8.27 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.602 -178.736 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 2.4 t -72.57 -29.9 63.93 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 120.993 0.425 . . . . 0.0 110.178 -179.738 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -66.4 -26.46 67.25 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.257 179.681 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 2.9 m -64.22 -26.74 68.64 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.106 0.479 . . . . 0.0 110.436 -179.979 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -72.31 -31.11 65.41 Favored 'General case' 0 N--CA 1.453 -0.318 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.175 179.242 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -76.12 0.82 17.51 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.984 0.421 . . . . 0.0 111.243 179.826 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 57.1 tp60 -120.44 -50.52 2.22 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.972 179.679 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -85.04 -57.18 3.2 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 111.927 0.343 . . . . 0.0 111.927 -179.384 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 2.1 tp10 -63.09 -29.23 70.65 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-O 121.344 0.592 . . . . 0.0 110.211 -179.62 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 52.7 tptt -58.98 -28.59 66.49 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.459 -0.792 . . . . 0.0 111.251 179.453 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 63.4 mt-10 -62.43 -24.32 67.36 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-O 120.906 0.384 . . . . 0.0 111.174 -179.786 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 11.9 tp10 -96.83 -35.69 10.86 Favored 'General case' 0 C--N 1.318 -0.797 0 N-CA-C 109.841 -0.429 . . . . 0.0 109.841 178.423 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.526 HG12 ' HB2' ' A' ' 121' ' ' GLU . 57.5 t -65.98 -42.31 91.5 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.878 -179.337 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 24.9 p-10 -71.33 -14.71 62.28 Favored 'General case' 0 N--CA 1.466 0.325 0 CA-C-O 121.118 0.485 . . . . 0.0 110.864 -179.726 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . 0.415 ' OG ' ' HD3' ' A' ' 75' ' ' ARG . 12.4 p -97.89 -14.61 20.59 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.093 178.894 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . 0.476 ' CZ ' HG12 ' A' ' 125' ' ' ILE . 0.1 OUTLIER -111.23 46.47 1.08 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.423 -0.808 . . . . 0.0 110.401 -178.85 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -122.25 172.42 8.31 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.456 179.921 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.544 HD13 ' HB1' ' A' ' 131' ' ' ALA . 10.4 pt -130.83 140.71 48.02 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.61 179.394 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 87.2 t80 -95.54 123.07 38.91 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.839 -0.619 . . . . 0.0 109.836 179.908 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 3.9 t -106.48 113.18 42.43 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.849 -179.426 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -120.45 165.68 13.79 Favored Glycine 0 N--CA 1.448 -0.516 0 C-N-CA 120.937 -0.649 . . . . 0.0 111.801 179.938 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 2.6 m-20 61.79 39.44 13.96 Favored 'General case' 0 N--CA 1.471 0.598 0 CA-C-O 121.112 0.482 . . . . 0.0 111.014 -179.602 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 2.3 t -81.4 162.99 3.39 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.693 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.331 -179.417 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . 0.729 ' OD2' ' HB2' ' A' ' 142' ' ' ARG . 0.3 OUTLIER -63.87 138.52 58.51 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 109.845 -0.428 . . . . 0.0 109.845 179.445 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 30.5 p90 -62.67 -12.44 23.55 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.107 -0.497 . . . . 0.0 112.057 -179.443 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -123.24 27.74 7.41 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.744 0.307 . . . . 0.0 110.948 -179.485 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -86.08 147.55 26.12 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 116.444 -0.344 . . . . 0.0 110.783 -179.975 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . 0.487 ' HB ' ' OE1' ' A' ' 89' ' ' GLU . 15.5 p -108.88 146.82 34.59 Favored Pre-proline 0 C--N 1.325 -0.487 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.894 179.658 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . 0.428 ' HD3' HD13 ' A' ' 106' ' ' ILE . 16.1 Cg_endo -57.41 -37.43 97.45 Favored 'Trans proline' 0 C--N 1.344 0.29 0 C-N-CA 122.663 2.242 . . . . 0.0 113.2 -179.083 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . 0.487 ' OE1' ' HB ' ' A' ' 87' ' ' THR . 5.4 mp0 -64.75 -47.46 78.12 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.912 -178.347 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . 0.416 ' HG2' ' O ' ' A' ' 87' ' ' THR . 7.4 pt-20 -67.01 -24.19 66.0 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.843 0.354 . . . . 0.0 111.157 -178.958 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 75.0 t -79.97 -47.99 20.91 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.96 -179.535 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -69.43 -33.76 73.44 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.569 -0.287 . . . . 0.0 111.593 -178.356 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 11.1 pt20 -76.65 -30.17 56.72 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 120.516 -0.474 . . . . 0.0 111.143 -179.176 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 8.1 t60 -73.13 -40.04 65.23 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.053 0.454 . . . . 0.0 109.976 179.898 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 18.6 m-30 -78.35 -14.57 59.35 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.301 179.751 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . 0.595 ' HA ' ' O ' ' A' ' 99' ' ' GLY . 28.2 tt0 -67.57 -20.85 65.44 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.401 -0.818 . . . . 0.0 110.257 179.699 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 5.1 m -69.18 -23.09 63.88 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.648 -0.706 . . . . 0.0 110.173 179.241 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 26.5 m -99.91 -42.17 6.9 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.76 -0.655 . . . . 0.0 110.324 179.276 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . 0.595 ' O ' ' HA ' ' A' ' 96' ' ' GLN . . . -150.63 144.72 12.18 Favored Glycine 0 N--CA 1.442 -0.95 0 CA-C-N 115.906 -0.588 . . . . 0.0 111.84 179.897 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -63.25 146.5 53.29 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 120.993 0.425 . . . . 0.0 111.304 179.857 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 2.0 p -115.73 126.47 73.28 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.777 -179.533 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 5.5 t30 -94.57 -39.07 10.57 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 121.179 0.514 . . . . 0.0 110.047 179.309 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 3.0 tpt180 -150.01 151.98 34.17 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.121 -179.872 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 4.0 p -148.59 128.97 4.53 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-O 121.09 0.472 . . . . 0.0 110.122 179.483 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . 0.596 ' HB ' ' CE1' ' A' ' 119' ' ' TYR . 4.9 m -121.47 122.38 39.63 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 116.473 -0.33 . . . . 0.0 110.573 179.845 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' ILE . . . . . 0.566 HD11 ' HA2' ' A' ' 116' ' ' GLY . 19.6 tt -108.87 148.54 12.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 O-C-N 123.206 0.316 . . . . 0.0 110.408 179.741 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 17.6 tp -136.75 124.89 22.99 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.386 -179.914 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -89.0 117.37 27.97 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 120.81 0.338 . . . . 0.0 110.651 179.434 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 4.7 t70 -77.94 139.64 39.21 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.698 0.285 . . . . 0.0 110.762 179.596 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -123.34 32.6 5.6 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 121.061 0.457 . . . . 0.0 110.261 179.274 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 1.7 t80 -113.73 -3.06 13.57 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.302 -179.889 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 106.65 6.7 35.06 Favored Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 120.828 -0.701 . . . . 0.0 112.738 -179.565 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' GLN . . . . . 0.415 ' HB3' ' HD2' ' A' ' 114' ' ' PRO . 27.5 mt-30 -92.02 158.81 38.96 Favored Pre-proline 0 C--N 1.323 -0.568 0 N-CA-C 109.564 -0.532 . . . . 0.0 109.564 -179.939 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' PRO . . . . . 0.415 ' HD2' ' HB3' ' A' ' 113' ' ' GLN . 18.0 Cg_endo -59.7 106.45 0.32 Allowed 'Trans proline' 0 C--N 1.347 0.466 0 C-N-CA 122.411 2.074 . . . . 0.0 111.528 179.148 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 5.2 mttp -68.3 175.46 3.29 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.07 -0.513 . . . . 0.0 110.588 -179.475 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . 0.566 ' HA2' HD11 ' A' ' 106' ' ' ILE . . . 98.51 4.02 57.28 Favored Glycine 0 N--CA 1.441 -0.993 0 C-N-CA 120.04 -1.076 . . . . 0.0 111.658 -179.628 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 30.0 m-85 -52.82 116.06 2.14 Favored 'General case' 0 CA--C 1.521 -0.152 0 O-C-N 123.776 0.339 . . . . 0.0 110.364 179.86 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -144.05 176.19 9.48 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 121.057 0.456 . . . . 0.0 111.236 -179.255 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' TYR . . . . . 0.596 ' CE1' ' HB ' ' A' ' 105' ' ' THR . 50.0 p90 -159.93 137.34 9.64 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.497 -0.774 . . . . 0.0 109.171 178.93 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 10.9 m -111.01 143.57 20.63 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 178.925 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . 0.526 ' HB2' HG12 ' A' ' 72' ' ' VAL . 4.4 pt-20 -128.8 157.05 42.56 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 116.562 -0.29 . . . . 0.0 111.054 -179.207 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' PHE . . . . . 0.415 ' O ' ' HA ' ' A' ' 72' ' ' VAL . 11.9 t80 -161.37 168.99 22.85 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 109.691 -0.485 . . . . 0.0 109.691 179.491 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 1.8 t -85.54 -48.38 16.21 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-O 120.921 0.391 . . . . 0.0 111.342 -179.182 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 11.0 mt-10 -62.44 130.31 44.6 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.956 -0.565 . . . . 0.0 111.795 -178.971 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . 0.476 HG12 ' CZ ' ' A' ' 75' ' ' ARG . 2.3 mp -76.06 -32.4 23.0 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.468 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.63 -179.795 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 13.2 t70 -60.43 -39.49 87.64 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.102 0.477 . . . . 0.0 110.232 179.333 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -61.36 -53.64 54.04 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.523 -0.762 . . . . 0.0 111.545 179.963 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 7.3 p -68.74 -28.11 38.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.127 -179.511 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 25.5 tt0 -58.86 -47.6 84.32 Favored 'General case' 0 C--N 1.334 -0.096 0 CA-C-O 121.023 0.439 . . . . 0.0 110.32 179.629 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 76.8 m-20 -70.9 -33.29 70.42 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.741 -0.663 . . . . 0.0 109.864 179.533 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . 0.544 ' HB1' HD13 ' A' ' 77' ' ' ILE . . . -66.06 -40.52 90.98 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.542 -0.754 . . . . 0.0 112.219 -179.408 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 3.9 pp -79.49 -16.84 55.35 Favored 'General case' 0 C--N 1.329 -0.325 0 O-C-N 122.128 -0.358 . . . . 0.0 110.959 179.905 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 5.2 tp -86.12 -50.15 7.23 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.283 -179.529 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 28.3 mt -132.47 112.68 12.33 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.501 -0.318 . . . . 0.0 110.944 -179.208 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 3.5 m-20 -168.95 -49.41 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.336 179.664 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 1.9 pt-20 -75.09 79.48 2.25 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.58 -0.737 . . . . 0.0 111.206 179.737 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 6.5 m -135.4 -59.93 0.76 Allowed 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.912 -0.586 . . . . 0.0 110.188 179.224 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 7.9 tm-20 -149.31 128.05 12.48 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 109.606 -0.516 . . . . 0.0 109.606 179.959 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -149.78 121.04 7.82 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 179.329 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 140' ' ' HIS . . . . . 0.662 ' HB3' ' OD2' ' A' ' 83' ' ' ASP . 5.4 t60 60.83 13.47 4.46 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-O 121.076 0.465 . . . . 0.0 111.614 178.742 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 98.58 -6.11 60.7 Favored Glycine 0 N--CA 1.447 -0.611 0 C-N-CA 120.803 -0.713 . . . . 0.0 112.216 -179.621 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 142' ' ' ARG . . . . . 0.729 ' HB2' ' OD2' ' A' ' 83' ' ' ASP . 2.1 mpt_? -114.01 -169.32 1.5 Allowed 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.008 0.432 . . . . 0.0 110.187 179.347 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 15.3 pt20 -131.65 138.74 48.88 Favored 'General case' 0 C--N 1.319 -0.754 0 N-CA-C 109.254 -0.647 . . . . 0.0 109.254 178.796 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -123.2 177.79 5.41 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-N 115.867 -0.606 . . . . 0.0 109.935 -179.528 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 1.7 tmtp? -117.27 121.8 42.17 Favored 'General case' 0 C--N 1.315 -0.907 0 N-CA-C 109.588 -0.523 . . . . 0.0 109.588 179.09 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 98.8 t -114.82 119.78 62.61 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-O 120.827 0.346 . . . . 0.0 110.911 -179.427 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 5.1 t -122.09 153.15 39.05 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.022 179.665 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -70.83 125.61 27.33 Favored 'General case' 0 N--CA 1.445 -0.713 0 CA-C-O 120.858 0.361 . . . . 0.0 111.187 179.956 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 18.9 ttpp -90.88 68.95 6.38 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.502 0.668 . . . . 0.0 109.29 179.909 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 13.0 tpt180 -84.92 90.18 7.74 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.731 -0.668 . . . . 0.0 109.965 -179.999 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 6.8 t -74.29 129.8 38.49 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.581 -0.736 . . . . 0.0 109.658 179.69 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 152' ' ' ASN . . . . . . . . . . . . . 28.6 t-20 -174.89 148.23 1.04 Allowed 'General case' 0 C--O 1.235 0.309 0 CA-C-N 116.184 -0.462 . . . . 0.0 109.971 -179.029 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 11.5 pt -68.66 145.45 97.01 Favored Pre-proline 0 CA--C 1.533 0.303 0 O-C-N 123.186 0.304 . . . . 0.0 111.184 -179.806 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 25.9 Cg_exo -63.31 122.91 11.25 Favored 'Trans proline' 0 C--O 1.235 0.373 0 C-N-CA 122.5 2.133 . . . . 0.0 111.965 179.211 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.246 0.874 0 CA-C-O 118.686 -1.063 . . . . 0.0 111.84 179.996 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.7 ttp . . . . . 0 N--CA 1.48 1.072 0 N-CA-C 110.06 -0.348 . . . . 0.0 110.06 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 99.81 172.54 30.4 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.589 -0.815 . . . . 0.0 111.807 179.953 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 3.3 p -142.19 152.69 43.38 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.971 0.386 . . . . 0.0 111.15 -179.583 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -134.3 141.62 47.0 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 109.724 -0.473 . . . . 0.0 109.724 179.605 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -127.56 3.41 6.18 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.667 0.27 . . . . 0.0 111.167 -179.563 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 2.0 p80 -76.43 143.39 40.61 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 116.367 -0.378 . . . . 0.0 111.077 -179.732 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 15.3 p-80 -90.74 -176.5 4.72 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 109.966 -0.383 . . . . 0.0 109.966 179.287 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 49.9 m80 -126.13 173.33 9.31 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.648 0.261 . . . . 0.0 110.953 -179.406 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 52.3 p-80 -153.72 158.39 40.94 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.008 -0.542 . . . . 0.0 109.715 179.501 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -146.22 131.77 18.78 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 120.815 0.341 . . . . 0.0 111.003 -179.764 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 14.5 m -155.95 138.71 15.19 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.268 -0.424 . . . . 0.0 109.971 179.501 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 23.5 m -132.39 139.15 47.97 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.744 0.306 . . . . 0.0 110.816 179.336 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -116.55 118.48 4.19 Favored Glycine 0 N--CA 1.447 -0.6 0 C-N-CA 120.924 -0.655 . . . . 0.0 112.248 -179.502 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -141.64 179.22 6.95 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 109.669 -0.493 . . . . 0.0 109.669 179.678 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 4.7 p -104.94 126.75 30.29 Favored Pre-proline 0 C--N 1.323 -0.557 0 N-CA-C 110.35 -0.241 . . . . 0.0 110.35 179.727 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -70.75 90.2 0.62 Allowed 'Trans proline' 0 N--CA 1.462 -0.324 0 C-N-CA 122.475 2.116 . . . . 0.0 111.383 179.036 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 82.6 mtt-85 -74.9 143.96 43.54 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.617 -0.72 . . . . 0.0 110.403 -179.488 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 153.11 -171.58 32.08 Favored Glycine 0 N--CA 1.444 -0.81 0 C-N-CA 120.654 -0.784 . . . . 0.0 112.261 179.868 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -138.78 174.07 10.91 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 109.907 -0.405 . . . . 0.0 109.907 179.888 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 14.9 m170 -97.33 138.45 34.78 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 120.683 0.278 . . . . 0.0 110.384 179.447 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 28.6 ttt -142.77 132.29 23.7 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 120.984 0.421 . . . . 0.0 110.537 -179.864 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -153.3 -151.45 5.72 Favored Glycine 0 N--CA 1.448 -0.503 0 C-N-CA 120.852 -0.689 . . . . 0.0 111.927 179.847 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -73.96 86.26 1.79 Allowed 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.014 0.435 . . . . 0.0 110.793 -179.915 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 24.1 t0 -82.19 -42.18 19.34 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.928 179.916 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 32.3 mt -118.53 143.43 46.75 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.276 179.942 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -74.09 -171.65 1.18 Allowed 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.696 0.284 . . . . 0.0 110.971 -179.997 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -61.26 -54.97 37.3 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.41 -178.752 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 1.9 mmm 54.14 48.69 20.39 Favored 'General case' 0 N--CA 1.466 0.33 0 O-C-N 123.639 0.587 . . . . 0.0 110.964 -179.597 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 94.8 mttt -69.22 126.82 30.98 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.721 -0.672 . . . . 0.0 111.247 -179.383 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 68.1 tttt -93.76 127.67 39.61 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 121.002 0.43 . . . . 0.0 109.883 179.367 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 18.6 ptt180 -121.62 176.49 5.68 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.116 -179.941 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 35.7 mt -98.01 130.73 44.83 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 120.864 0.364 . . . . 0.0 111.04 -179.685 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 12.5 tmtt? -135.72 60.56 1.68 Allowed 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 179.071 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 35.3 mt-10 -81.94 78.48 8.64 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.933 -0.576 . . . . 0.0 109.865 179.878 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 40.5 mm -113.9 101.5 12.54 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.336 179.972 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 28.5 mt-10 -120.91 88.14 2.88 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.925 -0.579 . . . . 0.0 110.011 179.793 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -158.46 123.83 4.39 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.323 0.583 . . . . 0.0 111.667 -179.72 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -131.14 155.3 47.23 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.468 -0.787 . . . . 0.0 110.043 179.413 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.404 ' HB3' ' SD ' ' A' ' 45' ' ' MET . . . -150.43 169.42 21.5 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 109.817 -0.438 . . . . 0.0 109.817 -179.792 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -144.95 69.23 0.4 Allowed Glycine 0 N--CA 1.449 -0.438 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.564 -179.628 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -152.8 -177.23 6.13 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 110.374 -0.232 . . . . 0.0 110.374 179.713 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 29.4 tp -73.81 84.43 1.67 Allowed 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.226 0.536 . . . . 0.0 110.387 179.741 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 17.0 tpt180 -130.8 151.83 50.8 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.161 -179.623 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 26.8 mm-40 -82.45 19.49 1.24 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.301 -179.825 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' MET . . . . . 0.404 ' SD ' ' HB3' ' A' ' 39' ' ' ALA . 11.9 ptm -83.7 4.37 29.0 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.735 -179.431 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 43.5 mt-30 -66.19 -22.03 66.33 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.945 -0.571 . . . . 0.0 110.578 179.911 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -78.89 -8.69 59.07 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.601 -0.727 . . . . 0.0 111.446 -179.763 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . 0.462 ' O ' ' HG2' ' A' ' 52' ' ' GLU . 10.3 ttpt -78.23 -6.31 54.54 Favored 'General case' 0 C--O 1.234 0.28 0 CA-C-O 120.991 0.424 . . . . 0.0 110.345 -179.869 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 8.4 p -59.32 -25.65 31.4 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.325 0 CA-C-N 115.936 -0.575 . . . . 0.0 111.581 -179.48 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 39.5 mt-10 -61.47 -30.61 70.71 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 121.008 0.432 . . . . 0.0 110.922 -179.876 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 15.3 mtmm -95.83 -36.27 11.19 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.244 -179.532 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . 0.462 ' HG2' ' O ' ' A' ' 48' ' ' LYS . 3.0 mm-40 -75.63 -16.99 60.14 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.936 -178.337 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 25.7 ptm -64.47 -24.11 67.51 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.178 0.513 . . . . 0.0 110.117 178.731 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -97.83 1.06 59.49 Favored Glycine 0 N--CA 1.446 -0.69 0 N-CA-C 110.885 -0.886 . . . . 0.0 110.885 178.595 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -121.23 21.23 11.22 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.235 0.54 . . . . 0.0 110.215 179.931 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 13.6 m -65.88 -8.62 6.78 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 115.739 -0.664 . . . . 0.0 111.809 -179.664 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 23.1 mm-40 -83.67 -7.93 59.39 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 121.142 0.496 . . . . 0.0 109.937 179.756 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -129.73 -53.07 1.15 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.432 -0.804 . . . . 0.0 110.602 -179.804 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 8.0 m -68.75 -62.86 1.2 Allowed 'General case' 0 CA--C 1.531 0.243 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.241 179.954 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -91.23 30.45 1.25 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.213 0.53 . . . . 0.0 110.95 -179.822 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 22.8 t -77.32 -31.24 54.49 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.955 -178.938 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -63.62 -24.52 67.83 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.024 0.44 . . . . 0.0 111.37 -179.941 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 47.1 m -62.28 -25.73 68.01 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.927 -0.578 . . . . 0.0 110.836 179.931 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -70.05 -31.46 69.09 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.53 179.358 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -80.59 5.75 14.54 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.012 0.434 . . . . 0.0 111.136 -179.762 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 49.7 tp60 -125.16 -40.38 2.15 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.448 -0.342 . . . . 0.0 111.006 179.616 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -94.1 -53.45 3.96 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.917 0.389 . . . . 0.0 111.341 179.826 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 3.2 tp10 -70.12 -30.36 67.53 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.032 -179.421 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.11 -25.76 64.11 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.542 -179.886 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 39.9 mt-10 -62.98 -23.77 67.59 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.186 0.517 . . . . 0.0 110.925 179.883 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . 0.608 ' O ' ' HD3' ' A' ' 75' ' ' ARG . 8.3 tp10 -96.66 -43.59 7.49 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.992 -0.549 . . . . 0.0 109.572 178.225 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.427 HG22 ' HA ' ' A' ' 123' ' ' VAL . 41.3 t -61.15 -44.13 97.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 115.467 -0.788 . . . . 0.0 112.459 -178.709 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 8.5 p-10 -63.29 -27.57 69.42 Favored 'General case' 0 N--CA 1.471 0.624 0 N-CA-C 111.921 0.341 . . . . 0.0 111.921 -179.31 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 40.0 t -95.54 -2.27 48.84 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-O 120.909 0.385 . . . . 0.0 110.741 179.772 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . 0.608 ' HD3' ' O ' ' A' ' 71' ' ' GLU . 2.2 mpt_? -115.26 46.95 1.37 Allowed 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.389 0.614 . . . . 0.0 109.582 -179.473 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -125.43 174.48 8.16 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.188 -0.914 . . . . 0.0 110.436 179.874 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.479 HG23 HG23 ' A' ' 128' ' ' VAL . 7.4 pt -131.02 140.48 48.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-O 120.742 0.306 . . . . 0.0 110.794 179.141 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 13.7 t80 -92.75 118.72 31.38 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.616 -0.72 . . . . 0.0 109.361 179.636 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.419 HG21 ' HE2' ' A' ' 95' ' ' PHE . 6.8 t -104.01 109.51 27.46 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-N 116.332 -0.395 . . . . 0.0 109.974 179.452 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -118.03 165.85 12.74 Favored Glycine 0 N--CA 1.447 -0.576 0 C-N-CA 120.773 -0.727 . . . . 0.0 111.995 -179.262 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 9.9 m120 59.21 41.12 20.69 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-O 121.043 0.449 . . . . 0.0 110.741 -179.621 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.422 HG12 ' H ' ' A' ' 83' ' ' ASP . 2.1 t -80.02 167.56 2.15 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-N 115.566 -0.743 . . . . 0.0 110.41 -179.172 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . 0.46 ' OD1' ' HD3' ' A' ' 142' ' ' ARG . 33.0 t70 -75.03 141.34 43.91 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.043 0.449 . . . . 0.0 110.627 179.901 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 29.2 p90 -63.09 -17.02 61.84 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.673 -0.694 . . . . 0.0 112.613 -178.743 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -110.42 8.27 23.13 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.828 0.346 . . . . 0.0 111.481 -179.592 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' CYS . . . . . 0.499 ' SG ' ' HB2' ' A' ' 140' ' ' HIS . 1.0 OUTLIER -73.27 142.42 47.22 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.154 0.502 . . . . 0.0 111.299 -179.893 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . 0.506 ' O ' ' HG2' ' A' ' 90' ' ' GLU . 12.2 p -109.73 154.12 42.64 Favored Pre-proline 0 C--N 1.322 -0.602 0 CA-C-N 115.464 -0.789 . . . . 0.0 109.856 178.997 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . 0.559 ' O ' ' HG2' ' A' ' 92' ' ' GLN . 14.0 Cg_endo -57.25 -36.83 99.07 Favored 'Trans proline' 0 C--O 1.233 0.236 0 C-N-CA 122.391 2.061 . . . . 0.0 112.274 -179.726 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . 0.443 ' O ' ' HG2' ' A' ' 93' ' ' GLN . 28.2 mp0 -62.93 -51.51 66.64 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.781 -179.42 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . 0.506 ' HG2' ' O ' ' A' ' 87' ' ' THR . 8.3 pt-20 -63.96 -22.68 67.03 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.615 0.245 . . . . 0.0 111.344 -178.751 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 66.5 t -82.98 -48.05 17.97 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.521 -179.583 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . 0.559 ' HG2' ' O ' ' A' ' 88' ' ' PRO . 16.4 pt20 -71.86 -33.56 68.51 Favored 'General case' 0 N--CA 1.465 0.284 0 N-CA-C 111.881 0.326 . . . . 0.0 111.881 -178.397 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . 0.443 ' HG2' ' O ' ' A' ' 89' ' ' GLU . 0.8 OUTLIER -77.27 -27.87 53.29 Favored 'General case' 0 C--N 1.329 -0.32 0 C-N-CA 120.464 -0.494 . . . . 0.0 110.636 -179.515 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' HIS . . . . . 0.495 ' HB2' ' O ' ' A' ' 90' ' ' GLU . 0.1 OUTLIER -71.9 -43.33 65.52 Favored 'General case' 0 CA--C 1.517 -0.295 0 CA-C-O 121.11 0.481 . . . . 0.0 110.276 179.719 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . 0.419 ' HE2' HG21 ' A' ' 79' ' ' VAL . 21.0 m-30 -79.13 -15.36 58.25 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.93 -179.453 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . 0.507 ' HA ' ' O ' ' A' ' 99' ' ' GLY . 33.6 tt0 -64.64 -23.5 67.28 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.558 179.967 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 13.4 m -65.72 -33.41 75.8 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.409 179.454 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 11.1 m -94.95 -40.78 9.5 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.368 179.871 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . 0.507 ' O ' ' HA ' ' A' ' 96' ' ' GLN . . . -146.46 130.39 3.66 Favored Glycine 0 N--CA 1.444 -0.829 0 C-N-CA 120.688 -0.768 . . . . 0.0 111.742 -179.916 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . 0.421 ' HB ' ' CZ ' ' A' ' 122' ' ' PHE . 0.2 OUTLIER -58.56 146.45 35.7 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 120.984 0.421 . . . . 0.0 111.539 179.894 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 2.4 p -111.99 131.43 63.43 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.112 -179.133 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 23.1 t-20 -99.19 -45.02 6.04 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 178.566 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 18.5 mmt180 -141.55 150.23 41.84 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-N 115.509 -0.769 . . . . 0.0 110.088 179.473 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 6.1 p -146.17 136.53 18.2 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-O 121.013 0.435 . . . . 0.0 110.191 179.385 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . 0.516 ' HB ' ' CE1' ' A' ' 119' ' ' TYR . 1.4 m -128.15 129.4 46.47 Favored 'General case' 0 C--N 1.319 -0.722 0 N-CA-C 109.731 -0.47 . . . . 0.0 109.731 179.309 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' ILE . . . . . 0.537 HD13 ' HD3' ' A' ' 88' ' ' PRO . 20.1 tt -120.47 147.47 24.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-O 120.953 0.406 . . . . 0.0 111.294 -179.298 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 15.3 tp -133.11 143.52 49.34 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.25 179.361 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -104.5 119.34 38.76 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 120.588 0.232 . . . . 0.0 110.662 179.463 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 8.5 t70 -80.08 130.41 35.23 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.992 0.425 . . . . 0.0 111.245 -179.76 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 10.8 mmmm -114.66 20.51 15.23 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.272 -179.799 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 63.9 t80 -98.68 -11.26 22.18 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.491 0.662 . . . . 0.0 109.913 -179.446 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 111.15 8.56 23.49 Favored Glycine 0 N--CA 1.448 -0.534 0 CA-C-N 115.557 -0.747 . . . . 0.0 112.394 -179.269 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' GLN . . . . . 0.443 ' HB3' ' HD2' ' A' ' 114' ' ' PRO . 24.4 mt-30 -94.42 160.58 31.44 Favored Pre-proline 0 C--N 1.323 -0.553 0 N-CA-C 109.188 -0.671 . . . . 0.0 109.188 179.663 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' PRO . . . . . 0.443 ' HD2' ' HB3' ' A' ' 113' ' ' GLN . 14.4 Cg_endo -57.37 114.2 1.84 Allowed 'Trans proline' 0 C--N 1.346 0.415 0 C-N-CA 122.357 2.038 . . . . 0.0 111.686 179.119 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 6.3 mttp -76.98 179.3 6.3 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.403 -179.897 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . 0.498 ' HA2' HD11 ' A' ' 106' ' ' ILE . . . 94.99 1.45 63.1 Favored Glycine 0 N--CA 1.445 -0.718 0 C-N-CA 120.056 -1.068 . . . . 0.0 111.488 -179.884 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 6.8 t80 -53.74 117.31 3.06 Favored 'General case' 0 C--O 1.234 0.278 0 O-C-N 123.806 0.357 . . . . 0.0 110.125 179.744 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -145.32 175.34 10.37 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.781 -179.356 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' TYR . . . . . 0.516 ' CE1' ' HB ' ' A' ' 105' ' ' THR . 51.7 p90 -157.48 134.16 9.93 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.561 -0.745 . . . . 0.0 109.292 179.047 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 14.7 m -110.49 140.15 30.88 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 N-CA-C 109.766 -0.457 . . . . 0.0 109.766 179.705 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . 0.422 ' HB2' HG12 ' A' ' 72' ' ' VAL . 7.9 pt-20 -124.45 154.22 40.81 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 116.596 -0.275 . . . . 0.0 110.642 -179.993 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 122' ' ' PHE . . . . . 0.421 ' CZ ' ' HB ' ' A' ' 100' ' ' THR . 11.0 t80 -149.29 164.84 33.71 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.203 179.94 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . 0.427 ' HA ' HG22 ' A' ' 72' ' ' VAL . 11.8 t -81.56 -42.64 19.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.317 -179.579 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 81.9 mt-10 -76.38 138.73 40.6 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.043 0.449 . . . . 0.0 111.171 -179.541 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 2.5 mp -75.87 -30.55 21.2 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-N 115.745 -0.661 . . . . 0.0 110.029 179.572 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -54.15 -47.21 72.18 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 115.802 -0.636 . . . . 0.0 111.17 179.596 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -56.26 -58.0 9.84 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.396 -0.82 . . . . 0.0 111.488 -179.362 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . 0.479 HG23 HG23 ' A' ' 77' ' ' ILE . 8.9 p -66.04 -32.8 59.73 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-N 116.31 -0.404 . . . . 0.0 111.676 -179.049 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 44.9 tt0 -60.99 -41.11 95.85 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.817 0.341 . . . . 0.0 110.88 -179.579 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 94.4 m-20 -79.4 -28.9 41.83 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.148 0.499 . . . . 0.0 110.01 179.36 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -70.12 -39.13 75.63 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.651 -0.704 . . . . 0.0 112.045 -179.414 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 4.2 pp -75.89 -11.47 59.97 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.938 0.399 . . . . 0.0 110.809 -179.901 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -88.84 -58.94 2.37 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.841 -0.618 . . . . 0.0 111.063 -179.923 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 75.8 mt -125.53 108.27 11.44 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.681 -178.864 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 2.8 m-20 -162.99 -50.66 0.04 OUTLIER 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.771 -0.65 . . . . 0.0 110.801 179.876 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 5.0 pt-20 -73.35 85.11 1.45 Allowed 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.779 -0.646 . . . . 0.0 111.448 -179.917 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 6.3 m -137.97 -59.32 0.65 Allowed 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.58 -0.736 . . . . 0.0 110.154 179.091 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 22.7 tt0 -153.79 127.94 9.04 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.217 -179.816 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -145.57 115.61 7.42 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 108.764 -0.828 . . . . 0.0 108.764 179.101 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 140' ' ' HIS . . . . . 0.499 ' HB2' ' SG ' ' A' ' 86' ' ' CYS . 2.8 t60 65.83 21.09 11.47 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-O 121.058 0.456 . . . . 0.0 110.373 -179.596 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 87.53 4.4 80.13 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.213 -179.601 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 142' ' ' ARG . . . . . 0.46 ' HD3' ' OD1' ' A' ' 83' ' ' ASP . 0.8 OUTLIER -125.66 165.19 19.02 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 109.945 -0.391 . . . . 0.0 109.945 179.838 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 12.9 pt20 -107.85 139.61 42.18 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-O 120.982 0.42 . . . . 0.0 110.697 179.656 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -121.68 178.08 4.99 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.037 -179.97 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 28.5 ttpt -116.22 122.41 44.93 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 109.912 -0.403 . . . . 0.0 109.912 179.063 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 95.7 t -113.92 123.13 69.28 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-O 120.968 0.413 . . . . 0.0 110.525 179.713 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 30.5 t -125.05 149.37 47.86 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 109.507 -0.553 . . . . 0.0 109.507 179.892 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -68.83 127.55 33.48 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 110.56 -0.163 . . . . 0.0 110.56 179.687 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 64.8 tttp -90.94 83.15 5.62 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.294 0.569 . . . . 0.0 110.505 -179.74 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 23.8 tpt180 -96.32 98.69 10.48 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 115.741 -0.663 . . . . 0.0 109.36 179.01 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 4.9 t -103.03 127.46 50.27 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.083 179.867 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 152' ' ' ASN . . . . . . . . . . . . . 5.2 t-20 -169.69 153.76 5.14 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.227 -179.857 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 153' ' ' ILE . . . . . 0.432 ' HA ' ' HD3' ' A' ' 154' ' ' PRO . 8.9 pt -62.24 127.98 90.42 Favored Pre-proline 0 C--N 1.327 -0.402 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.075 179.727 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 154' ' ' PRO . . . . . 0.432 ' HD3' ' HA ' ' A' ' 153' ' ' ILE . 4.3 Cg_exo -75.32 74.13 4.27 Favored 'Trans proline' 0 C--N 1.345 0.373 0 C-N-CA 122.559 2.173 . . . . 0.0 112.494 179.787 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 0.98 0 CA-C-O 118.924 -0.931 . . . . 0.0 111.331 179.874 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 15.3 tpt . . . . . 0 N--CA 1.482 1.163 0 CA-C-O 120.66 0.267 . . . . 0.0 110.669 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -131.5 -171.47 12.86 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.855 -0.688 . . . . 0.0 111.722 179.869 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 40.2 m 60.37 45.65 10.86 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-O 121.395 0.617 . . . . 0.0 111.062 179.936 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 1.1 m -89.33 170.76 10.29 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.381 -0.827 . . . . 0.0 110.532 179.953 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 37.4 m170 -73.77 143.47 46.03 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.74 0.305 . . . . 0.0 110.588 179.835 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 41.7 m-70 -101.03 -61.58 1.35 Allowed 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.398 -0.365 . . . . 0.0 111.262 -179.318 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 1.3 p-80 -162.06 157.06 22.9 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.746 0.307 . . . . 0.0 111.19 -178.735 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 33.0 p80 -167.38 142.62 3.98 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 109.193 -0.669 . . . . 0.0 109.193 178.865 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 19.2 p80 -165.12 150.82 9.69 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.024 0.44 . . . . 0.0 110.972 179.992 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 29.9 t-80 -138.99 145.16 39.36 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.661 -0.7 . . . . 0.0 109.375 179.407 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 1.2 p -126.77 148.58 49.9 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 120.853 0.358 . . . . 0.0 111.251 -179.879 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -102.2 172.39 6.92 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.619 179.667 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -88.91 -167.54 43.17 Favored Glycine 0 CA--C 1.518 0.234 0 C-N-CA 120.709 -0.757 . . . . 0.0 112.325 179.863 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 2.0 pt? -138.5 161.87 35.96 Favored 'General case' 0 C--N 1.326 -0.415 0 O-C-N 122.576 -0.367 . . . . 0.0 110.509 -179.904 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 1.6 p -134.04 102.37 12.16 Favored Pre-proline 0 C--N 1.325 -0.496 0 CA-C-O 121.391 0.615 . . . . 0.0 110.543 -179.825 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 94.5 Cg_endo -89.95 -176.85 1.24 Allowed 'Trans proline' 0 N--CA 1.456 -0.734 0 C-N-CA 122.818 2.345 . . . . 0.0 112.582 179.79 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 32.8 mtp180 -109.18 124.18 50.42 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.364 179.628 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -92.4 -167.79 39.78 Favored Glycine 0 N--CA 1.445 -0.749 0 C-N-CA 120.638 -0.792 . . . . 0.0 112.695 -179.621 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 51.3 m -151.21 146.87 26.39 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 110.273 -0.269 . . . . 0.0 110.273 179.661 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 9.3 p-80 -99.5 166.2 11.27 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.5 -179.857 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 31.9 mtt -83.46 152.03 25.17 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.607 -0.27 . . . . 0.0 110.389 -179.732 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -177.78 162.11 29.66 Favored Glycine 0 N--CA 1.447 -0.604 0 C-N-CA 120.773 -0.727 . . . . 0.0 111.883 -179.977 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -144.93 160.3 41.54 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.756 0.278 . . . . 0.0 110.634 -179.958 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 30.9 t0 -116.37 164.75 14.07 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.459 -0.337 . . . . 0.0 110.212 -179.863 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -105.83 -156.95 0.59 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.634 -0.257 . . . . 0.0 111.128 -179.385 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 15.9 pt-20 -129.96 -172.68 2.84 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.882 0.373 . . . . 0.0 111.102 -179.727 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 26.8 t70 -153.4 148.83 27.14 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.414 -179.681 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 21.3 ttt -120.69 136.97 54.7 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 109.734 -0.469 . . . . 0.0 109.734 179.505 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 20.5 tptt -129.53 154.92 46.56 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.757 0.313 . . . . 0.0 111.739 -179.033 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 96.9 mttt -130.77 169.2 16.02 Favored 'General case' 0 C--O 1.235 0.308 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.251 179.636 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 5.2 ptp180 -165.53 139.75 4.72 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 116.541 -0.3 . . . . 0.0 110.712 179.765 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -144.93 156.68 44.11 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 110.209 -0.293 . . . . 0.0 110.209 179.68 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 16.1 ttmt -151.21 114.7 4.86 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.907 0.384 . . . . 0.0 111.032 -179.97 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 6.4 mt-10 -128.66 84.13 2.21 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.059 179.381 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 39.2 pt -129.23 147.37 33.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 116.712 -0.222 . . . . 0.0 111.484 -179.055 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 22.1 mm-40 43.89 62.82 1.8 Allowed 'General case' 0 N--CA 1.468 0.473 0 O-C-N 124.249 0.968 . . . . 0.0 112.824 178.891 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 10.7 tt0 -82.75 -17.12 45.39 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.257 0.551 . . . . 0.0 109.936 179.732 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -130.06 110.26 11.49 Favored 'General case' 0 C--O 1.236 0.348 0 CA-C-N 115.619 -0.718 . . . . 0.0 110.995 -179.743 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -161.43 122.29 2.76 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.877 179.797 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 165.33 138.89 2.52 Favored Glycine 0 N--CA 1.449 -0.464 0 C-N-CA 120.876 -0.678 . . . . 0.0 112.234 179.693 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -164.1 -164.06 0.83 Allowed 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 110.085 -0.339 . . . . 0.0 110.085 -179.75 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 18.6 tp -81.56 85.88 6.45 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.17 0.51 . . . . 0.0 110.067 179.622 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 13.4 tpp180 -145.95 132.36 19.65 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.899 -0.591 . . . . 0.0 109.652 179.96 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 3.3 tp10 -82.79 39.26 0.61 Allowed 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.559 0.695 . . . . 0.0 110.911 -179.742 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 17.6 ptt? -87.83 11.66 14.98 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.656 -0.702 . . . . 0.0 109.538 179.089 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 19.4 mm-40 -66.87 -22.5 65.98 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.277 -0.874 . . . . 0.0 111.101 -179.682 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -68.8 -14.4 63.0 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 121.348 0.594 . . . . 0.0 110.6 179.54 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 20.2 ttpp -83.24 1.05 42.73 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.589 -0.732 . . . . 0.0 110.33 179.814 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 8.3 p -59.48 -26.2 33.6 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.205 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.971 -179.912 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 26.6 mt-10 -67.14 -24.67 65.93 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 115.912 -0.586 . . . . 0.0 110.344 179.534 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 11.4 mtmm -97.22 -29.74 13.4 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.579 -0.737 . . . . 0.0 110.594 179.331 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 38.0 mm-40 -80.96 -5.32 57.36 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.677 -179.661 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 10.7 ptp -62.33 -30.83 71.44 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.891 0.377 . . . . 0.0 110.652 -179.932 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -91.55 3.89 79.17 Favored Glycine 0 N--CA 1.447 -0.594 0 C-N-CA 120.722 -0.751 . . . . 0.0 111.319 178.838 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -130.41 26.66 5.08 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.432 -0.384 . . . . 0.0 110.275 -179.802 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 18.4 m -71.03 -4.33 4.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 120.773 0.32 . . . . 0.0 111.497 -179.489 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 28.7 mt-30 -94.25 -4.17 49.35 Favored 'General case' 0 CA--C 1.505 -0.785 0 N-CA-C 108.108 -1.071 . . . . 0.0 108.108 179.778 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -124.51 -60.64 1.38 Allowed 'General case' 0 C--N 1.31 -1.113 0 CA-C-N 113.399 -1.728 . . . . 0.0 110.023 -177.239 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 10.1 m -72.75 -70.1 0.37 Allowed 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.091 -0.959 . . . . 0.0 111.844 -179.36 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -85.08 33.7 0.54 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.816 0.341 . . . . 0.0 111.455 -178.931 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 3.6 t -75.74 -27.87 58.3 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 109.675 -0.491 . . . . 0.0 109.675 -179.812 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 1.3 m -65.61 -25.83 67.56 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-O 121.238 0.542 . . . . 0.0 110.681 178.857 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 18.1 m -60.88 -28.15 68.66 Favored 'General case' 0 N--CA 1.45 -0.46 0 CA-C-N 115.63 -0.714 . . . . 0.0 110.63 179.989 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -72.62 -33.45 66.66 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.488 179.15 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -76.44 -2.12 30.45 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.25 0.548 . . . . 0.0 110.793 179.865 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 64.7 tt0 -114.39 -54.71 2.56 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.923 179.924 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -85.49 -56.09 3.69 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.793 -178.509 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . 0.458 ' O ' HG23 ' A' ' 72' ' ' VAL . 1.2 tt0 -62.65 -31.48 72.35 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.952 0.406 . . . . 0.0 110.896 -179.61 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 48.7 tptt -55.55 -30.01 59.99 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.587 -0.733 . . . . 0.0 111.299 179.937 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 99.3 mt-10 -58.63 -41.6 86.32 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.027 0.441 . . . . 0.0 110.455 179.469 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . 0.429 ' O ' ' HD2' ' A' ' 75' ' ' ARG . 7.4 tp10 -76.86 -43.37 36.38 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.057 -0.519 . . . . 0.0 109.871 179.308 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.583 HG12 ' HB2' ' A' ' 121' ' ' GLU . 43.8 t -60.75 -40.34 84.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 115.648 -0.705 . . . . 0.0 111.624 -179.241 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 7.5 t0 -68.23 -23.26 64.78 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-O 121.318 0.58 . . . . 0.0 110.723 -179.934 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 1.2 t -95.29 -9.9 31.77 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 121.686 0.755 . . . . 0.0 109.782 179.705 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . 0.429 ' HD2' ' O ' ' A' ' 71' ' ' GLU . 0.0 OUTLIER -111.75 44.77 1.32 Allowed 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.396 -0.82 . . . . 0.0 110.659 -179.259 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . 0.464 ' OG ' ' HE2' ' A' ' 149' ' ' LYS . 0.0 OUTLIER -126.92 171.69 11.07 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.818 179.367 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 13.8 pt -131.01 136.95 56.97 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-N 116.465 -0.334 . . . . 0.0 110.198 178.64 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' TYR . . . . . 0.447 ' O ' ' HA ' ' A' ' 146' ' ' VAL . 43.0 t80 -91.12 123.29 34.47 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.142 -179.896 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 10.4 t -107.04 111.92 37.72 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.658 -179.749 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -121.48 170.8 14.84 Favored Glycine 0 N--CA 1.446 -0.682 0 N-CA-C 111.362 -0.695 . . . . 0.0 111.362 179.974 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 13.1 m120 58.39 44.24 18.6 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-O 121.294 0.569 . . . . 0.0 110.441 -179.627 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.498 HG12 ' H ' ' A' ' 83' ' ' ASP . 1.7 t -90.07 172.1 1.03 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 CA-C-N 115.338 -0.846 . . . . 0.0 110.615 -179.011 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . 0.498 ' H ' HG12 ' A' ' 82' ' ' VAL . 9.2 t0 -68.74 137.25 53.91 Favored 'General case' 0 N--CA 1.451 -0.395 0 N-CA-C 109.666 -0.494 . . . . 0.0 109.666 179.476 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 34.9 p90 -61.71 -18.14 58.51 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.459 -179.28 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -118.15 20.59 13.14 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.511 -0.313 . . . . 0.0 111.332 179.942 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' CYS . . . . . 0.459 ' SG ' ' HB3' ' A' ' 83' ' ' ASP . 0.5 OUTLIER -77.16 145.25 37.83 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.984 0.421 . . . . 0.0 110.869 179.603 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . 0.474 ' O ' ' HG2' ' A' ' 90' ' ' GLU . 55.9 p -103.08 151.22 38.43 Favored Pre-proline 0 C--N 1.323 -0.57 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.261 179.637 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -61.77 -29.2 82.84 Favored 'Trans proline' 0 C--O 1.233 0.24 0 C-N-CA 122.3 2.0 . . . . 0.0 111.93 179.835 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . 0.517 ' O ' ' HG2' ' A' ' 93' ' ' GLN . 27.8 mt-10 -66.27 -53.26 38.94 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.343 -0.844 . . . . 0.0 111.933 -178.837 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . 0.474 ' HG2' ' O ' ' A' ' 87' ' ' THR . 9.2 pt-20 -61.71 -24.98 67.13 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.967 0.413 . . . . 0.0 111.24 -179.268 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 69.3 t -79.84 -48.57 20.41 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.275 -179.106 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . 0.411 ' O ' ' HB2' ' A' ' 96' ' ' GLN . 0.0 OUTLIER -70.29 -32.88 70.85 Favored 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 112.196 0.443 . . . . 0.0 112.196 -178.183 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . 0.517 ' HG2' ' O ' ' A' ' 89' ' ' GLU . 9.6 pt20 -79.79 -28.77 40.25 Favored 'General case' 0 C--N 1.325 -0.491 0 C-N-CA 120.061 -0.656 . . . . 0.0 111.19 -179.331 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 58.7 t-80 -68.92 -45.22 71.4 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.808 0.337 . . . . 0.0 110.57 179.989 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 23.9 m-85 -78.53 -11.8 59.98 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.68 -179.388 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . 0.563 ' HA ' ' O ' ' A' ' 99' ' ' GLY . 8.2 tt0 -68.9 -21.7 64.22 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 121.23 0.538 . . . . 0.0 109.958 179.802 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 4.5 m -66.52 -32.24 73.47 Favored 'General case' 0 N--CA 1.452 -0.347 0 CA-C-N 115.673 -0.694 . . . . 0.0 109.531 178.545 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 2.1 m -88.25 -47.83 8.14 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.546 -0.752 . . . . 0.0 110.075 179.575 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . 0.563 ' O ' ' HA ' ' A' ' 96' ' ' GLN . . . -147.07 142.35 10.23 Favored Glycine 0 N--CA 1.447 -0.603 0 C-N-CA 121.023 -0.608 . . . . 0.0 111.751 179.801 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -60.07 144.03 50.56 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 120.827 0.346 . . . . 0.0 111.503 -179.639 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 2.3 p -114.86 127.76 72.27 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.289 179.832 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 20.1 t-20 -95.1 -40.99 9.34 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.145 0.498 . . . . 0.0 110.098 179.649 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 3.2 tpp180 -144.87 155.91 43.72 Favored 'General case' 0 N--CA 1.45 -0.425 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.263 -179.487 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 5.7 p -154.32 133.95 3.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.109 179.804 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -126.13 127.74 46.23 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 109.736 -0.468 . . . . 0.0 109.736 179.006 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' ILE . . . . . 0.424 HD11 ' HA2' ' A' ' 116' ' ' GLY . 20.1 tt -111.04 146.07 16.54 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-O 121.017 0.437 . . . . 0.0 110.951 -179.368 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 43.3 tp -130.15 138.32 50.58 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.26 179.816 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -103.64 113.68 27.38 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 109.963 -0.384 . . . . 0.0 109.963 179.453 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 6.4 t70 -72.3 133.32 44.94 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.054 0.454 . . . . 0.0 111.367 -179.677 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 11.2 mmmt -111.31 19.22 18.5 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.722 -179.868 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 3.0 t80 -101.0 -9.93 21.0 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.973 0.416 . . . . 0.0 110.324 -179.372 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 110.83 -0.53 28.8 Favored Glycine 0 N--CA 1.449 -0.441 0 CA-C-N 115.788 -0.642 . . . . 0.0 112.227 -179.808 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 3.5 mt-30 -81.28 158.63 69.13 Favored Pre-proline 0 C--N 1.323 -0.581 0 N-CA-C 110.332 -0.247 . . . . 0.0 110.332 -179.911 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 13.5 Cg_endo -56.57 103.77 0.13 Allowed 'Trans proline' 0 C--N 1.347 0.486 0 C-N-CA 122.687 2.258 . . . . 0.0 111.319 178.419 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 7.8 mttp -68.84 176.67 2.94 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.606 -0.725 . . . . 0.0 110.776 -178.444 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . 0.424 ' HA2' HD11 ' A' ' 106' ' ' ILE . . . 99.92 4.52 55.53 Favored Glycine 0 N--CA 1.441 -0.998 0 C-N-CA 120.398 -0.906 . . . . 0.0 111.187 -179.54 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 59.2 m-85 -52.27 118.3 3.43 Favored 'General case' 0 CA--C 1.522 -0.098 0 C-N-CA 122.63 0.372 . . . . 0.0 110.121 179.401 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -146.23 176.33 9.84 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 121.052 0.453 . . . . 0.0 111.234 -178.916 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 43.5 p90 -156.56 133.95 10.7 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.418 -0.81 . . . . 0.0 109.706 179.155 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 15.7 m -108.42 142.5 20.89 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 N-CA-C 109.108 -0.701 . . . . 0.0 109.108 178.62 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . 0.583 ' HB2' HG12 ' A' ' 72' ' ' VAL . 5.9 pt-20 -131.39 156.18 46.0 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 120.927 0.394 . . . . 0.0 111.884 -178.901 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 13.8 t80 -152.08 166.64 30.99 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.796 -0.638 . . . . 0.0 109.755 179.134 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 13.0 t -83.96 -52.94 12.16 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-O 120.76 0.314 . . . . 0.0 111.242 -179.52 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 38.6 mt-10 -67.88 131.7 45.99 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.832 -179.66 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 2.2 mp -70.91 -31.07 44.25 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.88 -179.161 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -54.47 -40.48 68.47 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-O 121.15 0.5 . . . . 0.0 111.228 179.327 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -62.76 -57.05 12.29 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.837 -0.62 . . . . 0.0 111.273 -179.877 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 9.9 p -65.91 -27.97 42.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.192 -179.503 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 129' ' ' GLN . . . . . 0.432 HE21 HD11 ' A' ' 132' ' ' LEU . 18.6 tp60 -59.08 -44.58 91.92 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.902 0.382 . . . . 0.0 110.247 179.506 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 52.9 m-80 -77.31 -29.66 53.72 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.919 -0.582 . . . . 0.0 109.72 179.209 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -67.38 -41.6 84.75 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.799 -0.637 . . . . 0.0 111.342 179.821 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 132' ' ' LEU . . . . . 0.432 HD11 HE21 ' A' ' 129' ' ' GLN . 4.2 pp -77.96 -10.31 59.53 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.915 0.388 . . . . 0.0 110.605 179.482 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -86.7 -52.51 5.48 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.928 -0.578 . . . . 0.0 109.648 179.257 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 27.7 mt -117.46 102.83 9.53 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.598 -0.728 . . . . 0.0 109.647 179.919 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 135' ' ' ASN . . . . . 0.536 ' OD1' ' HB ' ' A' ' 146' ' ' VAL . 1.3 p30 -142.96 -78.1 0.23 Allowed 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 112.422 0.527 . . . . 0.0 112.422 -178.46 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -68.76 109.99 4.11 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.432 0.634 . . . . 0.0 111.549 -178.67 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 56.2 m -152.43 -61.53 0.16 Allowed 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.709 -0.678 . . . . 0.0 109.666 179.0 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 -157.76 120.36 3.84 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 116.699 -0.228 . . . . 0.0 110.943 179.225 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -140.6 116.66 10.49 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 109.555 -0.535 . . . . 0.0 109.555 179.482 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 1.3 t60 61.69 17.21 8.48 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-O 120.992 0.425 . . . . 0.0 110.863 -179.866 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 96.34 -7.38 66.36 Favored Glycine 0 N--CA 1.448 -0.556 0 C-N-CA 120.992 -0.623 . . . . 0.0 112.173 -179.76 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 3.8 mpt_? -112.26 160.61 17.47 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.938 0.399 . . . . 0.0 111.443 -179.39 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 16.3 pt20 -104.79 116.9 32.8 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 109.387 -0.597 . . . . 0.0 109.387 178.641 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . 0.452 HD23 HG13 ' A' ' 82' ' ' VAL . 0.5 OUTLIER -95.32 176.73 6.09 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.081 -179.16 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 1.8 tmtp? -117.64 120.94 39.55 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 109.679 -0.489 . . . . 0.0 109.679 179.599 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 146' ' ' VAL . . . . . 0.536 ' HB ' ' OD1' ' A' ' 135' ' ' ASN . 99.3 t -119.34 133.02 67.5 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-O 120.879 0.371 . . . . 0.0 111.26 -179.336 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 5.3 m -135.24 142.86 46.06 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.114 -0.494 . . . . 0.0 109.954 178.92 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -58.87 124.98 21.65 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.846 0.355 . . . . 0.0 110.844 179.766 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 149' ' ' LYS . . . . . 0.464 ' HE2' ' OG ' ' A' ' 76' ' ' SER . 23.7 ttpt -91.17 63.33 5.01 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.562 0.696 . . . . 0.0 109.189 -179.877 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -84.5 81.51 8.81 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.405 -0.816 . . . . 0.0 109.81 -179.872 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 13.0 t -61.24 129.03 39.28 Favored 'General case' 0 N--CA 1.45 -0.432 0 CA-C-N 115.926 -0.579 . . . . 0.0 109.614 179.204 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 152' ' ' ASN . . . . . . . . . . . . . 64.3 t30 -161.97 155.3 20.83 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 109.643 -0.503 . . . . 0.0 109.643 -179.295 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 153' ' ' ILE . . . . . 0.447 ' HA ' ' HD3' ' A' ' 154' ' ' PRO . 15.1 pt -74.68 137.25 73.86 Favored Pre-proline 0 C--N 1.322 -0.606 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.621 -179.956 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 154' ' ' PRO . . . . . 0.447 ' HD3' ' HA ' ' A' ' 153' ' ' ILE . 26.3 Cg_exo -62.65 140.48 81.21 Favored 'Trans proline' 0 C--N 1.343 0.289 0 C-N-CA 122.476 2.117 . . . . 0.0 112.111 179.729 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.244 0.746 0 CA-C-O 118.994 -0.892 . . . . 0.0 111.701 -179.647 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 37.7 mtt . . . . . 0 N--CA 1.479 0.977 0 N-CA-C 110.13 -0.322 . . . . 0.0 110.13 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 105.21 62.28 0.64 Allowed Glycine 0 N--CA 1.447 -0.568 0 C-N-CA 120.773 -0.727 . . . . 0.0 111.718 -179.311 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 2.0 m -96.94 89.48 4.86 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 120.958 0.408 . . . . 0.0 111.313 -179.261 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 1.1 m -130.66 93.34 3.41 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.119 -0.491 . . . . 0.0 109.965 179.38 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -154.03 138.48 16.77 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.681 0.277 . . . . 0.0 111.042 -179.437 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 27.3 t-80 -154.98 148.97 25.77 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 109.374 -0.602 . . . . 0.0 109.374 179.077 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 11.4 p80 -149.73 179.88 7.66 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.673 0.273 . . . . 0.0 110.539 -179.549 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 36.0 t60 -124.58 153.77 41.66 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 109.494 -0.558 . . . . 0.0 109.494 179.953 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 17.9 p-80 -83.13 156.13 23.43 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.724 0.297 . . . . 0.0 110.873 179.769 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 23.3 t-80 -105.97 142.1 36.25 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 109.836 -0.431 . . . . 0.0 109.836 179.197 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -130.02 150.63 51.21 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.327 179.644 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -134.21 152.45 51.83 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 120.899 0.38 . . . . 0.0 110.785 -179.83 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -97.48 -123.26 4.59 Favored Glycine 0 N--CA 1.448 -0.527 0 C-N-CA 120.614 -0.803 . . . . 0.0 112.541 -179.665 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -162.71 175.29 11.48 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 110.111 -0.329 . . . . 0.0 110.111 179.883 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.448 ' HA ' ' HD3' ' A' ' 16' ' ' PRO . 2.7 p -150.48 110.03 3.17 Favored Pre-proline 0 C--N 1.324 -0.518 0 CA-C-O 120.823 0.344 . . . . 0.0 110.66 179.69 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . 0.448 ' HD3' ' HA ' ' A' ' 15' ' ' VAL . 2.5 Cg_endo -84.3 -166.05 0.34 Allowed 'Trans proline' 0 N--CA 1.459 -0.547 0 C-N-CA 122.867 2.378 . . . . 0.0 111.936 179.474 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 31.1 mmm180 -113.42 -171.75 1.94 Allowed 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.407 -0.36 . . . . 0.0 110.141 179.734 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -148.31 169.4 28.96 Favored Glycine 0 N--CA 1.447 -0.605 0 C-N-CA 120.455 -0.878 . . . . 0.0 112.308 -179.798 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 2.3 t -144.98 170.69 15.66 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 109.956 -0.387 . . . . 0.0 109.956 -179.973 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 35.8 p-80 -160.63 144.76 13.88 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.549 -0.296 . . . . 0.0 110.379 -179.633 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . 0.573 ' HB2' ' HG3' ' A' ' 36' ' ' GLU . 6.2 tpt -146.93 177.51 9.08 Favored 'General case' 0 C--N 1.326 -0.413 0 N-CA-C 109.607 -0.516 . . . . 0.0 109.607 179.838 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . 0.436 ' H ' ' HG3' ' A' ' 21' ' ' MET . . . -104.18 81.55 0.34 Allowed Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.699 -0.763 . . . . 0.0 112.561 -179.889 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 4.7 m -63.33 141.57 58.72 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.73 0.3 . . . . 0.0 111.571 179.808 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 15.5 p-10 -115.16 -154.25 0.54 Allowed 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.464 179.625 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 1.4 mm? -80.43 135.81 36.22 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.0 0.428 . . . . 0.0 111.753 -179.18 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -134.44 -147.14 0.27 Allowed 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 109.009 -0.737 . . . . 0.0 109.009 179.276 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 28.0 t0 -91.73 157.45 16.91 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.783 0.325 . . . . 0.0 110.126 179.362 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -99.2 91.67 5.09 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 120.976 0.417 . . . . 0.0 111.155 -179.291 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.506 ' HD3' ' OG ' ' A' ' 63' ' ' SER . 0.0 OUTLIER -139.43 159.79 41.34 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.474 179.608 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 36.9 mmtt -83.0 106.39 14.78 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.323 -0.398 . . . . 0.0 110.323 179.713 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 6.3 tpp180 -162.07 128.92 3.76 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.018 -0.537 . . . . 0.0 109.975 179.967 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 51.7 tp -113.08 112.71 24.31 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.899 -179.958 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -164.78 132.84 3.29 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.215 179.198 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -108.73 128.31 54.76 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.189 -179.636 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 9.2 tt 179.31 166.11 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 115.947 -0.569 . . . . 0.0 109.694 179.334 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . 0.573 ' HG3' ' HB2' ' A' ' 21' ' ' MET . 1.3 mp0 -77.5 144.05 38.0 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.765 0.317 . . . . 0.0 110.22 179.14 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -120.07 -174.69 2.83 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.378 -178.761 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 28.5 mt-10 -125.88 -100.71 0.38 Allowed 'General case' 0 C--O 1.236 0.354 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.352 179.499 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -168.68 164.85 12.2 Favored 'General case' 0 C--O 1.235 0.313 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.269 -179.851 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 139.89 71.8 0.04 OUTLIER Glycine 0 C--N 1.332 0.358 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.953 179.655 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -113.47 -63.5 1.44 Allowed 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.742 0.306 . . . . 0.0 110.953 179.88 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 32.0 tp -79.82 79.55 6.32 Favored 'General case' 0 N--CA 1.45 -0.436 0 CA-C-O 121.796 0.808 . . . . 0.0 110.079 179.959 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 65.5 ttt180 -161.62 159.37 27.49 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 114.739 -1.119 . . . . 0.0 109.382 -179.787 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 4.5 tt0 -78.62 19.89 0.47 Allowed 'General case' 0 N--CA 1.465 0.316 0 CA-C-O 121.325 0.583 . . . . 0.0 110.922 179.988 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 13.6 ptm -88.16 6.0 38.68 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.717 -179.819 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 49.5 mt-30 -70.77 -23.03 62.32 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.581 179.999 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -75.51 -13.9 60.39 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.361 0.601 . . . . 0.0 110.623 179.33 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 6.1 ttmm -74.0 -2.28 23.48 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.683 -0.69 . . . . 0.0 111.09 -179.523 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 9.5 p -57.64 -24.4 22.33 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.275 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.155 -179.87 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 4.6 mm-40 -62.14 -27.99 69.33 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-O 121.107 0.48 . . . . 0.0 110.341 179.552 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 5.8 mtmm -106.76 -42.57 4.92 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.747 -0.66 . . . . 0.0 110.994 179.619 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 78.9 mm-40 -64.87 -6.09 7.5 Favored 'General case' 0 N--CA 1.467 0.397 0 N-CA-C 112.304 0.483 . . . . 0.0 112.304 -179.089 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 3.0 ptt? -65.76 -23.9 66.83 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.112 0.482 . . . . 0.0 109.937 178.777 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -96.78 5.42 64.06 Favored Glycine 0 N--CA 1.451 -0.332 0 N-CA-C 110.708 -0.957 . . . . 0.0 110.708 178.337 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -128.31 19.28 6.37 Favored 'General case' 0 N--CA 1.452 -0.359 0 CA-C-N 115.284 -0.458 . . . . 0.0 110.134 -179.85 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 11.8 m -67.01 -12.19 14.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-O 121.234 0.54 . . . . 0.0 110.657 -179.735 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -83.08 -4.14 58.04 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.7 179.712 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -130.83 -53.09 1.06 Allowed 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.593 -0.731 . . . . 0.0 110.304 -179.946 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 3.5 m -73.28 -71.0 0.33 Allowed 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.394 -0.821 . . . . 0.0 111.646 -179.428 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -85.06 38.16 0.7 Allowed 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.178 0.514 . . . . 0.0 111.226 -179.254 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 7.0 t -85.69 -18.59 32.71 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 109.191 -0.67 . . . . 0.0 109.191 179.243 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 2.0 m -69.42 -24.59 63.85 Favored 'General case' 0 C--O 1.234 0.286 0 CA-C-N 115.364 -0.835 . . . . 0.0 109.599 179.125 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . 0.506 ' OG ' ' HD3' ' A' ' 29' ' ' LYS . 71.9 m -58.25 -28.08 64.59 Favored 'General case' 0 N--CA 1.448 -0.559 0 CA-C-N 115.039 -0.982 . . . . 0.0 111.287 179.299 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -71.24 -31.57 67.7 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.986 0.422 . . . . 0.0 110.215 179.327 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -82.36 7.21 14.67 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.439 0.638 . . . . 0.0 110.2 179.499 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 1.1 tp-100 -124.88 -55.34 1.6 Allowed 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.705 -0.68 . . . . 0.0 111.357 -179.795 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -85.16 -51.48 6.6 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.54 -179.275 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 4.8 tp10 -72.3 -24.27 61.3 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.102 0.477 . . . . 0.0 110.312 -179.549 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 2.2 tptm -64.23 -24.64 67.74 Favored 'General case' 0 N--CA 1.453 -0.317 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.611 178.902 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -63.55 -17.75 63.14 Favored 'General case' 0 C--O 1.232 0.141 0 CA-C-O 121.543 0.687 . . . . 0.0 109.927 178.882 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . 0.464 ' O ' ' HD2' ' A' ' 75' ' ' ARG . 6.6 tp10 -97.37 -47.17 5.8 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.147 -0.933 . . . . 0.0 109.208 177.744 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 94.7 t -60.36 -39.37 80.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 115.449 -0.796 . . . . 0.0 112.332 -178.943 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 17.5 p-10 -68.8 -21.31 64.33 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-O 120.754 0.311 . . . . 0.0 111.47 -178.596 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 39.1 t -101.32 -0.07 36.27 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 109.451 -0.574 . . . . 0.0 109.451 178.66 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . 0.464 ' HD2' ' O ' ' A' ' 71' ' ' GLU . 0.0 OUTLIER -117.91 44.15 2.25 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.551 -0.75 . . . . 0.0 110.309 -179.749 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -123.43 172.25 8.85 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.675 179.499 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 8.3 pt -132.99 137.46 53.7 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 N-CA-C 109.864 -0.421 . . . . 0.0 109.864 178.604 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 85.4 t80 -96.06 125.61 40.72 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 116.148 -0.478 . . . . 0.0 109.849 -179.775 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.436 HG12 HG22 ' A' ' 82' ' ' VAL . 4.6 t -105.24 114.32 44.49 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.057 -179.346 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -117.97 168.0 12.97 Favored Glycine 0 N--CA 1.448 -0.504 0 N-CA-C 111.123 -0.791 . . . . 0.0 111.123 179.502 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 4.3 m-20 58.61 41.4 22.27 Favored 'General case' 0 N--CA 1.472 0.662 0 CA-C-O 121.118 0.485 . . . . 0.0 110.844 -179.328 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.436 HG22 HG12 ' A' ' 79' ' ' VAL . 2.0 t -85.66 166.38 2.04 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.954 -179.245 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . 0.627 ' OD2' ' HD3' ' A' ' 142' ' ' ARG . 9.9 t70 -67.83 136.63 54.42 Favored 'General case' 0 CA--C 1.519 -0.243 0 N-CA-C 109.587 -0.523 . . . . 0.0 109.587 179.526 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 32.4 p90 -62.09 -19.71 63.26 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.944 -0.571 . . . . 0.0 112.493 -178.597 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -112.71 17.61 18.95 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 120.534 0.207 . . . . 0.0 111.508 -179.382 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' CYS . . . . . 0.442 ' SG ' ' HB3' ' A' ' 83' ' ' ASP . 0.7 OUTLIER -77.51 144.58 37.57 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.196 0.522 . . . . 0.0 111.41 -179.779 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . 0.504 ' O ' ' HG2' ' A' ' 90' ' ' GLU . 20.5 p -105.44 152.92 40.04 Favored Pre-proline 0 C--N 1.323 -0.554 0 CA-C-N 115.496 -0.775 . . . . 0.0 110.008 179.222 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . 0.409 ' HD3' HD13 ' A' ' 106' ' ' ILE . 21.0 Cg_endo -61.32 -32.04 89.44 Favored 'Trans proline' 0 C--N 1.342 0.221 0 C-N-CA 122.342 2.028 . . . . 0.0 112.554 -179.071 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 12.3 mt-10 -64.54 -54.42 32.56 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.737 -0.665 . . . . 0.0 111.731 -178.862 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . 0.571 ' O ' ' HB2' ' A' ' 94' ' ' HIS . 11.3 pt-20 -60.72 -26.25 67.03 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.032 0.444 . . . . 0.0 111.299 -178.75 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 51.8 t -78.92 -48.97 20.96 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.319 -179.244 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -71.19 -32.47 68.9 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 111.794 0.294 . . . . 0.0 111.794 -178.585 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 16.7 pt20 -79.45 -25.99 41.85 Favored 'General case' 0 C--N 1.33 -0.243 0 C-N-CA 120.774 -0.37 . . . . 0.0 111.323 -179.117 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' HIS . . . . . 0.571 ' HB2' ' O ' ' A' ' 90' ' ' GLU . 2.3 t60 -76.34 -38.6 55.67 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.838 0.352 . . . . 0.0 110.414 -179.988 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 21.2 m-30 -81.23 -15.08 56.67 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.497 179.827 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . 0.538 ' HA ' ' O ' ' A' ' 99' ' ' GLY . 48.7 tt0 -65.72 -21.83 66.56 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.718 -0.674 . . . . 0.0 110.621 -179.977 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 17.3 m -68.58 -20.14 64.5 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.877 -0.602 . . . . 0.0 110.377 179.132 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 32.3 m -102.69 -46.42 4.73 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.005 179.188 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . 0.538 ' O ' ' HA ' ' A' ' 96' ' ' GLN . . . -145.2 142.29 10.66 Favored Glycine 0 N--CA 1.445 -0.76 0 N-CA-C 111.506 -0.637 . . . . 0.0 111.506 179.781 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . 0.405 ' HB ' ' CZ ' ' A' ' 122' ' ' PHE . 0.2 OUTLIER -62.29 148.37 45.21 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-O 120.889 0.376 . . . . 0.0 111.305 -179.715 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 2.4 p -117.79 130.89 71.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.916 -179.652 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 16.6 t30 -98.46 -45.56 6.08 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.292 0.568 . . . . 0.0 109.868 179.123 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -142.54 150.78 40.86 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.756 -0.656 . . . . 0.0 109.668 179.844 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 3.5 p -146.04 129.54 10.22 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 N-CA-C 109.89 -0.411 . . . . 0.0 109.89 179.734 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 7.8 m -120.48 125.98 49.24 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 110.268 -0.271 . . . . 0.0 110.268 179.924 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' ILE . . . . . 0.409 HD13 ' HD3' ' A' ' 88' ' ' PRO . 19.8 tt -112.36 146.18 17.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.434 -179.944 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 16.4 tp -131.81 132.47 43.78 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.511 179.765 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -96.85 121.59 38.88 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 116.201 -0.454 . . . . 0.0 109.867 179.208 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -88.56 136.22 33.1 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.788 0.327 . . . . 0.0 110.592 179.968 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . 0.416 ' N ' ' HD3' ' A' ' 110' ' ' LYS . 0.0 OUTLIER -121.64 21.66 10.79 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 120.986 0.422 . . . . 0.0 110.474 179.819 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 17.3 t80 -101.68 -5.34 25.13 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.26 0.552 . . . . 0.0 110.277 -179.879 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 112.42 2.21 26.1 Favored Glycine 0 N--CA 1.447 -0.631 0 C-N-CA 120.879 -0.677 . . . . 0.0 112.392 179.733 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 19.4 mt-30 -89.52 154.89 48.67 Favored Pre-proline 0 C--N 1.326 -0.424 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 179.565 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -55.23 121.54 10.1 Favored 'Trans proline' 0 N--CA 1.46 -0.441 0 C-N-CA 121.737 1.625 . . . . 0.0 110.971 178.773 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 54.6 mttt -76.64 176.1 8.7 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 -179.352 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 94.95 6.9 60.14 Favored Glycine 0 N--CA 1.446 -0.634 0 C-N-CA 120.129 -1.034 . . . . 0.0 112.355 179.648 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 4.4 m-30 -58.75 103.94 0.19 Allowed 'General case' 0 C--N 1.332 -0.169 0 N-CA-C 109.815 -0.439 . . . . 0.0 109.815 179.607 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -132.18 177.25 7.71 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-O 121.085 0.469 . . . . 0.0 111.324 -179.059 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 2.0 p90 -158.56 139.58 13.03 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.372 -0.831 . . . . 0.0 109.379 179.179 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 13.8 m -112.49 142.87 23.5 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 N-CA-C 109.555 -0.535 . . . . 0.0 109.555 178.35 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 5.0 pt-20 -129.38 150.13 50.87 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.787 -179.671 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 122' ' ' PHE . . . . . 0.405 ' CZ ' ' HB ' ' A' ' 100' ' ' THR . 16.3 t80 -151.73 168.93 23.48 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.336 179.61 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 4.1 t -82.8 -54.21 9.9 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-O 120.836 0.35 . . . . 0.0 111.496 -179.359 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 56.7 mt-10 -60.61 126.52 27.73 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.958 -0.565 . . . . 0.0 111.586 -179.105 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 2.2 mp -71.69 -33.62 49.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 115.703 -0.681 . . . . 0.0 109.864 179.567 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -60.37 -38.05 82.65 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.466 -0.788 . . . . 0.0 110.707 179.585 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -63.95 -56.13 17.42 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.783 -0.644 . . . . 0.0 111.119 -179.986 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 9.9 p -64.12 -27.77 43.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-O 120.812 0.339 . . . . 0.0 110.561 179.774 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 129' ' ' GLN . . . . . 0.421 HE21 ' HB3' ' A' ' 129' ' ' GLN . 1.7 tt0 -62.29 -47.25 85.16 Favored 'General case' 0 C--N 1.333 -0.121 0 CA-C-O 121.066 0.46 . . . . 0.0 109.876 178.853 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 88.4 m-20 -66.69 -31.95 72.95 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.337 0.589 . . . . 0.0 109.579 179.349 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . 0.438 ' O ' ' HB2' ' A' ' 135' ' ' ASN . . . -67.27 -51.93 46.97 Favored 'General case' 0 N--CA 1.452 -0.358 0 CA-C-N 115.267 -0.879 . . . . 0.0 110.986 179.684 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 4.3 pp -66.22 -21.49 66.3 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.142 0.496 . . . . 0.0 110.693 179.898 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 5.6 tp -76.78 -51.45 11.35 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.115 179.16 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 94.4 mt -125.83 99.86 6.14 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.286 179.953 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 135' ' ' ASN . . . . . 0.438 ' HB2' ' O ' ' A' ' 131' ' ' ALA . 0.4 OUTLIER -146.77 -70.1 0.25 Allowed 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.491 -179.112 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . 0.432 ' HB2' ' O ' ' A' ' 144' ' ' LEU . 9.3 pt-20 -69.86 103.21 2.14 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.601 0.715 . . . . 0.0 111.277 -179.234 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 13.1 m -152.33 -57.54 0.14 Allowed 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.831 -0.622 . . . . 0.0 109.667 179.246 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 28.8 tt0 -160.0 122.32 3.34 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.152 -179.854 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -143.64 115.28 8.15 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 109.368 -0.604 . . . . 0.0 109.368 179.62 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 2.4 t60 64.82 14.03 8.9 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-O 121.255 0.55 . . . . 0.0 110.586 -179.869 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 95.71 -0.49 63.02 Favored Glycine 0 N--CA 1.446 -0.675 0 C-N-CA 120.786 -0.721 . . . . 0.0 111.913 -179.207 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 142' ' ' ARG . . . . . 0.627 ' HD3' ' OD2' ' A' ' 83' ' ' ASP . 2.4 mpt_? -115.59 158.81 22.12 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 120.917 0.389 . . . . 0.0 110.595 179.614 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 15.3 pt20 -105.06 119.07 38.13 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 178.411 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . 0.432 ' O ' ' HB2' ' A' ' 136' ' ' GLU . 0.5 OUTLIER -103.29 176.74 5.05 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.04 -178.966 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 73.8 tttt -115.57 121.9 44.02 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 109.253 -0.647 . . . . 0.0 109.253 178.996 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 89.2 t -115.34 119.3 61.44 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-O 120.902 0.382 . . . . 0.0 111.039 -179.803 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 36.3 t -121.54 139.47 53.46 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 116.142 -0.481 . . . . 0.0 109.81 179.943 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -58.84 132.12 53.0 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 109.926 -0.398 . . . . 0.0 109.926 179.213 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 57.5 tttp -93.12 78.16 4.58 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-O 121.479 0.657 . . . . 0.0 109.942 -179.382 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 21.5 tpt180 -92.31 93.46 8.65 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 115.371 -0.831 . . . . 0.0 109.281 179.435 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 8.8 t -72.79 133.08 44.34 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.288 -0.869 . . . . 0.0 109.656 179.562 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 152' ' ' ASN . . . . . . . . . . . . . 66.6 t30 -171.84 164.52 6.45 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 109.778 -0.452 . . . . 0.0 109.778 -179.449 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 7.2 pt -71.9 144.55 88.08 Favored Pre-proline 0 C--N 1.323 -0.583 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.285 179.301 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -75.65 59.44 5.61 Favored 'Trans proline' 0 CA--C 1.53 0.289 0 C-N-CA 122.828 2.352 . . . . 0.0 112.501 179.774 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.968 0 CA-C-O 119.007 -0.885 . . . . 0.0 111.483 179.938 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.2 mpt? . . . . . 0 N--CA 1.479 1.012 0 N-CA-C 110.137 -0.32 . . . . 0.0 110.137 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -123.04 122.59 5.04 Favored Glycine 0 N--CA 1.448 -0.566 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.422 -179.699 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 1.9 m -110.68 135.06 51.86 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 110.241 -0.281 . . . . 0.0 110.241 179.803 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 53.6 m -94.5 165.82 12.35 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 121.016 0.436 . . . . 0.0 111.026 -179.712 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 2.6 p-80 -148.45 150.35 33.31 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.207 -179.547 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 1.2 t-80 -139.33 141.35 37.68 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 109.538 -0.542 . . . . 0.0 109.538 179.892 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 89.8 m-70 -138.62 164.82 28.5 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 120.78 0.324 . . . . 0.0 110.753 -179.543 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 6.3 p80 -144.54 151.75 39.56 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.008 -0.542 . . . . 0.0 109.978 179.552 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 8.6 t-80 -149.2 154.58 39.34 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 109.532 -0.544 . . . . 0.0 109.532 -179.816 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 18.7 p80 -135.02 176.1 8.98 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 110.148 -0.316 . . . . 0.0 110.148 179.899 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 44.2 m -151.96 140.28 20.44 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.878 0.371 . . . . 0.0 110.807 -179.647 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 19.4 m -127.92 138.05 52.51 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.354 179.585 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -150.51 140.54 8.03 Favored Glycine 0 N--CA 1.447 -0.574 0 N-CA-C 111.119 -0.793 . . . . 0.0 111.119 -179.97 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -128.32 163.23 25.24 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 120.88 0.371 . . . . 0.0 111.095 -179.279 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -129.3 102.84 18.37 Favored Pre-proline 0 C--N 1.322 -0.592 0 CA-C-N 115.598 -0.728 . . . . 0.0 110.653 179.764 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 76.4 Cg_endo -82.22 158.71 17.6 Favored 'Trans proline' 0 N--CA 1.459 -0.543 0 C-N-CA 122.441 2.094 . . . . 0.0 112.346 179.737 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 11.2 ptt180 -138.33 131.85 30.68 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.191 179.918 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -163.46 107.39 0.3 Allowed Glycine 0 N--CA 1.447 -0.575 0 C-N-CA 120.673 -0.775 . . . . 0.0 112.568 -179.898 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 1.1 m -85.69 143.19 28.52 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 120.72 0.295 . . . . 0.0 110.46 179.758 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 47.7 t-80 -112.51 128.79 56.44 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 109.761 -0.459 . . . . 0.0 109.761 179.587 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 12.2 ptt? -153.17 154.46 34.79 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 120.84 0.352 . . . . 0.0 111.071 -179.644 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -119.73 163.51 13.68 Favored Glycine 0 N--CA 1.447 -0.632 0 N-CA-C 111.604 -0.598 . . . . 0.0 111.604 179.523 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -145.32 172.69 12.79 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 110.268 -0.271 . . . . 0.0 110.268 -179.887 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 1.5 t0 -110.79 176.39 5.05 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 110.088 -0.338 . . . . 0.0 110.088 179.466 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 27.8 mt -131.82 -176.58 4.1 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 116.439 -0.346 . . . . 0.0 110.563 -179.236 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 5.5 tp10 -72.93 153.0 41.16 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.66 -179.757 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 -112.76 167.32 10.59 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.346 179.77 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 23.9 mmt -107.25 129.59 54.86 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.069 -179.401 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 20.4 pttm -68.53 157.74 35.36 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.06 179.948 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 13.4 tptt -122.28 157.62 31.3 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.087 -179.294 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 53.4 ttm-85 -136.59 141.79 43.31 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 109.35 -0.611 . . . . 0.0 109.35 179.171 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -105.73 163.18 12.9 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 110.06 -0.348 . . . . 0.0 110.06 179.68 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -124.4 161.24 26.39 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.481 -0.327 . . . . 0.0 110.172 179.855 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 34.2 mt-10 -99.81 177.18 5.2 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.989 0.423 . . . . 0.0 111.703 -178.392 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 24.5 pt -74.67 157.11 6.17 Favored 'Isoleucine or valine' 0 C--O 1.234 0.281 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.601 -179.271 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 8.5 mm-40 -118.3 -162.29 0.88 Allowed 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.94 -179.52 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 15.3 pt-20 -74.06 159.29 32.87 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.869 -179.378 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -144.7 -119.88 0.08 Allowed 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.508 -0.769 . . . . 0.0 109.797 179.661 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . 55.57 81.95 0.11 Allowed 'General case' 0 C--O 1.234 0.259 0 C-N-CA 122.892 0.477 . . . . 0.0 112.206 179.293 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -80.66 134.03 12.9 Favored Glycine 0 N--CA 1.45 -0.406 0 C-N-CA 120.793 -0.717 . . . . 0.0 111.834 179.918 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -98.89 175.39 5.96 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 120.725 0.298 . . . . 0.0 110.853 -179.688 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 25.4 tp -79.17 84.33 5.14 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.28 0.562 . . . . 0.0 110.52 179.562 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 31.3 ttm180 -147.12 146.92 30.09 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.843 -0.617 . . . . 0.0 109.601 179.824 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -77.97 40.49 0.33 Allowed 'General case' 0 N--CA 1.463 0.214 0 CA-C-O 121.407 0.622 . . . . 0.0 111.079 179.989 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 15.8 ptt? -92.51 6.12 48.31 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 115.771 -0.65 . . . . 0.0 110.342 -179.904 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 25.3 mt-30 -64.49 -25.27 67.92 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.942 -179.764 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -66.72 -16.43 64.22 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 121.125 0.488 . . . . 0.0 111.303 -179.875 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 24.4 ttpp -72.19 -10.01 59.21 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.564 179.976 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 5.6 p -59.99 -23.96 28.49 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.169 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.039 179.844 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 38.6 mt-10 -64.63 -21.68 66.78 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.253 0.549 . . . . 0.0 110.701 179.261 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 10.3 mtmm -102.77 -40.95 6.36 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.366 179.182 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -72.8 -3.85 27.96 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.0 -0.545 . . . . 0.0 111.723 -179.84 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -67.14 -27.65 67.48 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 109.304 -0.628 . . . . 0.0 109.304 178.392 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -89.87 2.56 82.2 Favored Glycine 0 N--CA 1.446 -0.675 0 N-CA-C 110.831 -0.908 . . . . 0.0 110.831 178.57 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -131.08 27.68 4.83 Favored 'General case' 0 N--CA 1.451 -0.376 0 CA-C-O 121.034 0.445 . . . . 0.0 110.055 -179.974 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 16.0 m -63.47 -21.8 29.34 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.287 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.456 -179.762 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 20.1 mm-40 -72.75 -9.83 59.09 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.564 0.697 . . . . 0.0 109.731 179.036 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 6.8 t70 -120.15 -60.46 1.69 Allowed 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.491 -0.777 . . . . 0.0 110.91 -179.313 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 66.4 m -69.89 -75.81 0.11 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.776 -179.546 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -79.01 41.97 0.46 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.103 0.478 . . . . 0.0 111.207 -179.278 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 36.3 p -80.91 -31.68 35.01 Favored 'General case' 0 N--CA 1.448 -0.558 0 CA-C-O 121.282 0.563 . . . . 0.0 110.096 -179.356 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -69.81 -20.66 63.44 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.529 -0.76 . . . . 0.0 111.212 179.681 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . 0.497 ' O ' ' HG2' ' A' ' 66' ' ' GLN . 3.8 m -62.07 -25.03 67.46 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.07 -179.604 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -69.92 -31.55 69.37 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.452 -0.34 . . . . 0.0 110.585 179.357 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -77.32 -1.73 31.32 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.637 -179.486 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' GLN . . . . . 0.497 ' HG2' ' O ' ' A' ' 63' ' ' SER . 8.2 pt20 -121.36 -31.23 4.11 Favored 'General case' 0 C--N 1.328 -0.353 0 C-N-CA 120.613 -0.435 . . . . 0.0 111.181 179.396 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -99.65 -57.21 2.2 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.956 0.407 . . . . 0.0 111.39 -179.932 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 5.1 tp10 -71.74 -21.39 61.76 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 120.891 0.376 . . . . 0.0 110.866 -179.317 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -63.27 -24.51 67.9 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.659 -0.246 . . . . 0.0 110.736 179.318 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 51.4 mt-10 -63.52 -23.18 67.28 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.478 0.656 . . . . 0.0 109.412 178.754 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 6.6 tp10 -94.94 -45.57 7.22 Favored 'General case' 0 N--CA 1.45 -0.466 0 CA-C-N 115.217 -0.901 . . . . 0.0 109.937 178.647 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.47 HG12 ' HB2' ' A' ' 121' ' ' GLU . 84.2 t -61.17 -42.67 94.24 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.342 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.583 -179.234 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -68.18 -21.37 64.88 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-O 121.188 0.518 . . . . 0.0 110.892 -179.6 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 11.1 t -98.49 -4.66 33.9 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.625 -0.716 . . . . 0.0 109.737 179.811 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -116.56 40.65 2.86 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.485 -0.78 . . . . 0.0 110.321 -179.499 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -119.02 170.99 8.57 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.622 179.81 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 10.4 pt -127.78 137.91 56.24 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-O 120.763 0.316 . . . . 0.0 110.357 178.982 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 76.6 t80 -92.78 116.53 29.11 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 116.023 -0.535 . . . . 0.0 109.736 -179.753 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 10.9 t -105.2 113.97 43.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-O 120.914 0.387 . . . . 0.0 110.886 -179.102 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -122.52 170.56 15.25 Favored Glycine 0 N--CA 1.449 -0.49 0 N-CA-C 111.664 -0.574 . . . . 0.0 111.664 179.833 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 5.4 m-20 58.43 40.5 24.07 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-O 121.27 0.557 . . . . 0.0 110.775 -179.929 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.465 HG13 HD23 ' A' ' 144' ' ' LEU . 2.5 t -82.83 165.18 2.59 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 CA-C-N 115.364 -0.834 . . . . 0.0 110.41 -179.408 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . 0.606 ' HB3' ' SG ' ' A' ' 86' ' ' CYS . 13.6 t0 -67.23 140.88 57.42 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 109.96 -0.385 . . . . 0.0 109.96 179.316 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 34.6 p90 -68.49 -11.77 60.28 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.703 -179.13 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -113.46 14.38 19.06 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 120.739 0.304 . . . . 0.0 111.477 -179.803 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' CYS . . . . . 0.606 ' SG ' ' HB3' ' A' ' 83' ' ' ASP . 1.2 m -81.34 150.23 28.54 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.354 0.597 . . . . 0.0 111.747 -179.594 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . 0.532 ' O ' ' HG2' ' A' ' 90' ' ' GLU . 1.2 p -116.02 155.75 47.58 Favored Pre-proline 0 C--N 1.323 -0.547 0 CA-C-N 115.513 -0.767 . . . . 0.0 109.933 179.235 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . 0.477 ' HD3' HD13 ' A' ' 106' ' ' ILE . 25.6 Cg_endo -60.51 -34.52 92.68 Favored 'Trans proline' 0 C--N 1.344 0.31 0 C-N-CA 122.464 2.109 . . . . 0.0 113.054 -178.599 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 8.4 mt-10 -63.4 -51.85 64.07 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.646 -178.94 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . 0.689 ' O ' ' HB2' ' A' ' 94' ' ' HIS . 8.8 pt-20 -61.73 -28.82 69.7 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.924 -179.201 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 79.6 t -76.96 -48.53 25.16 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.178 -179.003 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . 0.447 ' O ' ' HB2' ' A' ' 96' ' ' GLN . 0.0 OUTLIER -69.87 -32.64 71.1 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.57 -0.287 . . . . 0.0 111.474 -178.084 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 1.7 pt20 -80.97 -26.44 36.58 Favored 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 120.883 -0.327 . . . . 0.0 110.994 -179.239 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' HIS . . . . . 0.689 ' HB2' ' O ' ' A' ' 90' ' ' GLU . 0.9 OUTLIER -71.5 -39.15 71.02 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.961 0.41 . . . . 0.0 110.316 -179.777 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 15.4 m-85 -88.46 -13.98 39.02 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.974 -179.479 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . 0.476 ' HA ' ' O ' ' A' ' 99' ' ' GLY . 41.6 tt0 -63.22 -22.18 66.7 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.802 -179.904 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 35.7 m -72.74 -21.9 60.95 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.54 179.505 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 3.6 m -96.67 -44.15 7.24 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.202 0.525 . . . . 0.0 109.629 178.957 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . 0.476 ' O ' ' HA ' ' A' ' 96' ' ' GLN . . . -147.35 139.03 7.58 Favored Glycine 0 N--CA 1.442 -0.916 0 CA-C-N 115.516 -0.766 . . . . 0.0 111.229 179.529 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 2.3 m -62.73 143.14 57.75 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 120.819 0.342 . . . . 0.0 110.957 179.975 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 2.6 p -108.12 132.68 55.22 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.928 -179.365 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 10.7 t30 -93.68 -41.36 9.74 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 109.615 -0.513 . . . . 0.0 109.615 178.655 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -156.41 159.11 38.41 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.285 -0.87 . . . . 0.0 109.512 179.549 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 6.2 p -148.6 136.34 14.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-O 120.909 0.385 . . . . 0.0 110.581 -179.882 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . 0.488 ' HB ' ' CE1' ' A' ' 119' ' ' TYR . 2.0 m -122.91 130.82 53.32 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.259 178.945 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' ILE . . . . . 0.477 HD13 ' HD3' ' A' ' 88' ' ' PRO . 21.1 tt -118.73 146.11 23.8 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-O 120.703 0.287 . . . . 0.0 110.535 -179.849 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 43.2 tp -135.46 127.29 29.32 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.36 179.855 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -87.59 124.32 33.38 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.6 179.759 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -86.98 137.44 32.35 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.033 0.444 . . . . 0.0 110.774 179.807 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 5.3 mmmm -121.24 17.38 11.52 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.669 -179.616 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 5.7 t80 -101.61 -0.64 34.45 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.075 0.464 . . . . 0.0 110.706 -179.172 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 105.38 5.41 39.95 Favored Glycine 0 N--CA 1.446 -0.679 0 C-N-CA 120.654 -0.784 . . . . 0.0 112.53 179.535 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' GLN . . . . . 0.449 ' HB3' ' HD2' ' A' ' 114' ' ' PRO . 7.7 mt-30 -91.25 160.03 38.14 Favored Pre-proline 0 C--N 1.322 -0.609 0 N-CA-C 109.018 -0.734 . . . . 0.0 109.018 179.677 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' PRO . . . . . 0.449 ' HD2' ' HB3' ' A' ' 113' ' ' GLN . 14.1 Cg_endo -57.42 117.45 4.15 Favored 'Trans proline' 0 C--N 1.345 0.379 0 C-N-CA 122.038 1.825 . . . . 0.0 111.577 179.333 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 63.9 mttt -76.55 179.49 5.91 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 109.071 -0.714 . . . . 0.0 109.071 179.975 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . 0.403 ' HA2' HD11 ' A' ' 106' ' ' ILE . . . 91.64 -0.79 74.41 Favored Glycine 0 N--CA 1.448 -0.515 0 C-N-CA 120.258 -0.973 . . . . 0.0 111.869 179.69 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 2.0 t80 -54.25 121.34 8.0 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.856 0.36 . . . . 0.0 110.153 179.809 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -149.95 175.45 11.66 Favored 'General case' 0 N--CA 1.448 -0.558 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.754 -179.216 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' TYR . . . . . 0.488 ' CE1' ' HB ' ' A' ' 105' ' ' THR . 35.2 p90 -157.49 134.46 10.13 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.985 -0.552 . . . . 0.0 109.615 179.068 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 11.8 m -106.41 149.33 9.93 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 N-CA-C 109.677 -0.49 . . . . 0.0 109.677 179.385 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . 0.47 ' HB2' HG12 ' A' ' 72' ' ' VAL . 0.7 OUTLIER -133.73 156.13 48.52 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.927 -178.789 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 122' ' ' PHE . . . . . 0.462 ' O ' ' HA ' ' A' ' 72' ' ' VAL . 13.2 t80 -155.1 165.63 36.11 Favored 'General case' 0 C--N 1.333 -0.116 0 CA-C-O 120.927 0.394 . . . . 0.0 111.126 179.275 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . 0.426 ' HA ' HG22 ' A' ' 72' ' ' VAL . 12.2 t -82.14 -45.26 19.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 115.694 -0.685 . . . . 0.0 112.226 -178.869 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 20.0 mm-40 -76.26 136.88 39.66 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.12 0.486 . . . . 0.0 111.306 -178.865 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 2.7 mp -74.82 -35.89 37.87 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.675 -179.493 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -55.79 -38.79 70.4 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.106 179.597 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -61.5 -57.05 13.68 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.018 179.971 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 10.0 p -66.36 -29.06 45.41 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.002 -179.544 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 19.6 tt0 -61.54 -39.46 91.17 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.666 179.804 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 46.4 m-80 -78.77 -31.12 45.99 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.142 0.496 . . . . 0.0 109.706 178.738 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -66.44 -51.07 60.79 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.657 -0.701 . . . . 0.0 111.221 179.996 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 4.2 pp -65.66 -16.08 63.4 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-O 121.036 0.446 . . . . 0.0 110.859 -179.868 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 3.8 tp -84.04 -52.89 5.95 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.014 179.237 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 69.5 mt -121.41 101.4 7.6 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.915 -0.584 . . . . 0.0 109.85 179.693 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -146.66 -70.53 0.24 Allowed 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.84 0.352 . . . . 0.0 111.706 -179.331 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -70.48 105.35 3.04 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.546 0.689 . . . . 0.0 111.598 -179.051 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 15.2 m -147.59 -58.49 0.26 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.573 -0.74 . . . . 0.0 109.41 178.769 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -161.32 127.75 3.89 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.976 -0.556 . . . . 0.0 109.839 179.433 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . 0.426 ' HG ' HD21 ' A' ' 144' ' ' LEU . 0.1 OUTLIER -142.82 111.93 6.56 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.16 -0.473 . . . . 0.0 109.861 179.794 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 140' ' ' HIS . . . . . 0.442 ' HB2' ' SG ' ' A' ' 86' ' ' CYS . 1.3 t60 62.81 25.41 15.08 Favored 'General case' 0 N--CA 1.466 0.33 0 O-C-N 123.41 0.444 . . . . 0.0 110.839 179.189 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 86.66 3.45 83.74 Favored Glycine 0 N--CA 1.45 -0.429 0 C-N-CA 120.871 -0.681 . . . . 0.0 112.029 -179.57 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -116.86 170.57 8.51 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 110.072 -0.344 . . . . 0.0 110.072 179.989 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 8.1 pt20 -120.53 117.03 26.56 Favored 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 109.486 -0.561 . . . . 0.0 109.486 178.957 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . 0.465 HD23 HG13 ' A' ' 82' ' ' VAL . 0.6 OUTLIER -99.62 175.22 5.9 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.934 0.397 . . . . 0.0 111.336 -178.934 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 145' ' ' LYS . . . . . 0.517 ' HE3' ' OG ' ' A' ' 147' ' ' SER . 1.2 tmtp? -116.37 123.19 46.99 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.645 -0.707 . . . . 0.0 109.413 179.34 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 90.8 t -120.55 137.28 54.85 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-O 120.771 0.32 . . . . 0.0 110.68 -179.303 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 147' ' ' SER . . . . . 0.517 ' OG ' ' HE3' ' A' ' 145' ' ' LYS . 66.9 m -144.62 149.23 35.41 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.284 -0.417 . . . . 0.0 109.911 178.902 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -61.74 123.55 18.27 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.757 0.313 . . . . 0.0 111.338 -179.794 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 12.5 ttpp -86.86 73.67 9.92 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.498 0.666 . . . . 0.0 109.755 -179.982 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 14.1 tpt180 -83.5 96.62 8.65 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.69 -0.686 . . . . 0.0 110.716 -179.904 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 12.4 t -84.08 124.15 30.8 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 179.002 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 152' ' ' ASN . . . . . . . . . . . . . 57.0 t30 -169.29 152.55 4.98 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 110.207 -0.294 . . . . 0.0 110.207 -178.872 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 14.9 pt -76.93 150.95 81.77 Favored Pre-proline 0 C--N 1.323 -0.557 0 CA-C-N 116.155 -0.475 . . . . 0.0 109.897 179.12 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 28.1 Cg_endo -64.08 108.13 0.9 Allowed 'Trans proline' 0 C--O 1.234 0.309 0 C-N-CA 122.351 2.034 . . . . 0.0 112.198 179.859 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.914 0 CA-C-O 118.421 -1.21 . . . . 0.0 111.56 179.844 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.5 ptt? . . . . . 0 N--CA 1.479 1.009 0 CA-C-O 120.773 0.321 . . . . 0.0 110.443 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 160.26 156.23 8.08 Favored Glycine 0 N--CA 1.448 -0.522 0 N-CA-C 111.63 -0.588 . . . . 0.0 111.63 -179.687 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 18.4 m -139.25 137.67 36.13 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.852 0.326 . . . . 0.0 111.226 -179.859 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 1.2 m -129.87 145.63 51.6 Favored 'General case' 0 CA--C 1.532 0.27 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.429 179.94 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 10.8 p80 -168.29 133.05 1.7 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.451 -0.341 . . . . 0.0 110.366 179.883 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 8.8 p80 -160.84 102.29 1.31 Allowed 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.966 0.412 . . . . 0.0 111.271 -179.732 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 7.1 p80 -168.36 152.19 5.86 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.227 179.468 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 82.6 t60 -164.3 140.77 6.36 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.669 -0.242 . . . . 0.0 110.37 179.606 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 80.5 t60 -132.39 143.55 49.91 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.438 -0.346 . . . . 0.0 110.373 179.939 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 52.2 t60 -162.52 124.94 2.77 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.478 -0.328 . . . . 0.0 110.478 179.32 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 71.0 m -134.6 151.96 51.44 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.463 -0.335 . . . . 0.0 110.328 179.631 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 32.2 m -151.62 162.06 41.62 Favored 'General case' 0 C--O 1.236 0.392 0 CA-C-O 120.84 0.353 . . . . 0.0 110.873 -179.993 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -164.32 124.42 1.26 Allowed Glycine 0 N--CA 1.451 -0.31 0 N-CA-C 111.543 -0.623 . . . . 0.0 111.543 179.705 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 64.4 mt -136.21 164.36 28.25 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.91 0.386 . . . . 0.0 111.327 -179.268 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 4.2 p -150.07 124.5 4.64 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-N 115.663 -0.699 . . . . 0.0 109.752 179.365 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -75.78 -173.72 1.76 Allowed 'Trans proline' 0 C--N 1.343 0.287 0 C-N-CA 122.814 2.343 . . . . 0.0 112.917 -179.247 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 7.9 tpp85 -162.12 145.96 12.12 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.7 179.667 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -108.46 -163.45 20.81 Favored Glycine 0 N--CA 1.449 -0.436 0 C-N-CA 120.948 -0.644 . . . . 0.0 111.69 179.337 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 41.4 m -152.02 158.26 42.82 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.757 0.278 . . . . 0.0 110.288 179.59 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 13.3 p80 -146.31 131.06 17.97 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.813 0.34 . . . . 0.0 110.963 -179.989 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 1.7 tmm? -163.49 147.77 10.71 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 179.279 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -167.31 122.04 1.02 Allowed Glycine 0 N--CA 1.447 -0.614 0 C-N-CA 120.467 -0.873 . . . . 0.0 112.782 -179.873 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 3.7 p -139.76 93.6 2.68 Favored 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 108.932 -0.766 . . . . 0.0 108.932 178.907 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -91.23 178.23 6.03 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.672 -0.694 . . . . 0.0 111.999 -178.249 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 54.5 mt -136.27 159.06 42.88 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.062 -0.972 . . . . 0.0 108.395 179.41 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -113.08 116.88 30.58 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 121.091 0.472 . . . . 0.0 111.22 -179.273 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -152.24 152.47 32.24 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.496 -0.774 . . . . 0.0 109.669 -179.844 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 74.8 mtp -118.55 156.5 29.04 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 110.272 -0.27 . . . . 0.0 110.272 -179.73 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.815 ' HE2' HG11 ' A' ' 56' ' ' VAL . 0.0 OUTLIER -133.74 171.09 14.61 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.824 0.345 . . . . 0.0 111.417 -178.276 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 20.3 ptmt -105.19 9.32 34.15 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.123 0.487 . . . . 0.0 110.703 -179.921 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . 0.442 HH11 ' HD3' ' A' ' 31' ' ' ARG . 27.9 mtm180 -100.85 112.14 24.51 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.672 -179.488 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 13.2 tp -169.47 33.06 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.377 -179.899 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.448 ' HE3' ' OE2' ' A' ' 68' ' ' GLU . 0.7 OUTLIER -164.93 37.6 0.07 Allowed 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.48 0.657 . . . . 0.0 109.816 -179.262 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 5.2 mp0 -86.97 -75.47 0.4 Allowed 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.55 -0.75 . . . . 0.0 111.842 -178.315 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 11.4 pt -141.02 175.92 5.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-O 120.613 0.244 . . . . 0.0 110.875 -179.282 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 67.1 mt-10 -125.23 113.64 17.91 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 109.513 -0.551 . . . . 0.0 109.513 178.682 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 2.9 mm-40 -124.04 -77.05 0.59 Allowed 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.004 0.431 . . . . 0.0 111.772 -178.508 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 4.7 tp10 -72.32 150.85 43.16 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.998 -0.546 . . . . 0.0 111.022 -178.97 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.442 ' O ' HG21 ' A' ' 62' ' ' THR . . . -101.99 -34.61 9.28 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.186 0.517 . . . . 0.0 110.267 179.233 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 84.66 167.7 43.3 Favored Glycine 0 N--CA 1.448 -0.515 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.489 179.467 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -161.5 178.01 9.51 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 109.837 -0.431 . . . . 0.0 109.837 -179.57 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 29.0 tp -74.97 88.63 2.37 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.987 0.423 . . . . 0.0 110.079 179.734 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 20.0 ttp180 -138.74 158.42 44.26 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.249 -0.432 . . . . 0.0 109.852 -179.469 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 52.3 mt-10 -79.66 25.18 0.35 Allowed 'General case' 0 N--CA 1.464 0.267 0 CA-C-O 121.023 0.439 . . . . 0.0 111.311 -179.807 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 11.3 ptt? -79.89 4.05 17.92 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 120.811 0.338 . . . . 0.0 110.584 -178.961 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 14.2 mt-30 -71.83 -22.31 61.57 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.214 0.531 . . . . 0.0 110.011 179.424 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -78.44 -15.26 58.84 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.707 -0.679 . . . . 0.0 110.113 179.033 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . 0.531 ' O ' ' HG2' ' A' ' 52' ' ' GLU . 6.7 ttpp -76.93 2.85 13.53 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.458 -0.792 . . . . 0.0 110.309 -179.802 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 9.2 p -55.71 -24.21 16.15 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.142 0 CA-C-N 115.481 -0.781 . . . . 0.0 111.86 -179.541 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.504 ' H ' ' HG3' ' A' ' 50' ' ' GLU . 0.1 OUTLIER -60.54 -32.25 71.31 Favored 'General case' 0 CA--C 1.52 -0.195 0 CA-C-O 121.43 0.633 . . . . 0.0 109.735 179.494 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 9.0 mtmm -103.22 -40.69 6.32 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.471 -0.786 . . . . 0.0 111.354 -179.645 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . 0.531 ' HG2' ' O ' ' A' ' 48' ' ' LYS . 44.1 mm-40 -64.63 -8.4 14.19 Favored 'General case' 0 N--CA 1.468 0.469 0 N-CA-C 112.421 0.526 . . . . 0.0 112.421 -179.356 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 9.2 ptp -57.98 -33.13 68.56 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.741 0.305 . . . . 0.0 111.257 179.604 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -91.04 -19.88 41.27 Favored Glycine 0 N--CA 1.449 -0.477 0 C-N-CA 120.573 -0.822 . . . . 0.0 111.214 179.082 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -98.57 23.21 8.87 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.125 -0.538 . . . . 0.0 110.899 -179.263 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.815 HG11 ' HE2' ' A' ' 29' ' ' LYS . 15.7 m -64.95 -9.24 6.69 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.38 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.48 179.557 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 37.2 mt-30 -86.4 -2.74 58.7 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.338 0.589 . . . . 0.0 110.14 179.531 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 11.2 t70 -133.0 -52.29 0.9 Allowed 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.41 -0.813 . . . . 0.0 110.234 179.625 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 3.3 m -74.24 -63.49 1.22 Allowed 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.374 -0.83 . . . . 0.0 112.657 -179.008 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -87.88 15.21 7.42 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.522 -0.308 . . . . 0.0 111.363 -178.489 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -73.87 -26.42 60.56 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.019 0.438 . . . . 0.0 110.089 -179.905 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . 0.442 HG21 ' O ' ' A' ' 39' ' ' ALA . 0.2 OUTLIER -69.86 -23.68 63.31 Favored 'General case' 0 N--CA 1.447 -0.602 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.409 179.325 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 2.9 m -62.26 -23.07 66.48 Favored 'General case' 0 N--CA 1.448 -0.555 0 CA-C-N 115.601 -0.727 . . . . 0.0 109.939 179.814 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -71.52 -33.25 69.04 Favored 'General case' 0 N--CA 1.455 -0.184 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.047 178.812 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 1.2 m -76.15 5.35 6.94 Favored 'General case' 0 CA--C 1.533 0.299 0 CA-C-O 121.343 0.592 . . . . 0.0 110.98 179.731 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 7.3 tp-100 -124.81 -54.99 1.62 Allowed 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.916 -0.583 . . . . 0.0 110.398 179.21 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -78.89 -56.28 4.52 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.362 -179.427 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . 0.448 ' OE2' ' HE3' ' A' ' 33' ' ' LYS . 1.7 tp10 -66.32 -28.72 68.9 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-O 121.325 0.583 . . . . 0.0 109.935 179.937 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 48.8 tptt -59.96 -29.17 68.24 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.437 -0.802 . . . . 0.0 111.268 179.487 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 48.8 mt-10 -61.69 -24.04 66.5 Favored 'General case' 0 N--CA 1.463 0.207 0 CA-C-O 120.977 0.418 . . . . 0.0 110.654 179.669 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 6.9 tp10 -95.19 -39.16 10.24 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.787 -0.642 . . . . 0.0 109.711 178.814 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.51 HG12 ' HB2' ' A' ' 121' ' ' GLU . 89.4 t -63.03 -44.65 99.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 115.795 -0.639 . . . . 0.0 112.127 -179.302 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -69.22 -23.11 63.85 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-O 121.17 0.51 . . . . 0.0 110.968 -179.129 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 49.9 m -90.6 -9.65 46.27 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.451 -0.795 . . . . 0.0 109.765 179.154 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -113.98 36.06 3.85 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 114.993 -1.003 . . . . 0.0 110.005 -179.839 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -111.89 169.27 8.95 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.04 179.425 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 7.6 pt -129.28 136.48 59.37 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 N-CA-C 110.029 -0.36 . . . . 0.0 110.029 178.748 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' TYR . . . . . 0.401 ' O ' ' HA ' ' A' ' 146' ' ' VAL . 68.8 t80 -90.42 120.83 31.86 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 116.042 -0.526 . . . . 0.0 109.808 -179.706 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.418 HG12 HG22 ' A' ' 82' ' ' VAL . 6.7 t -107.46 111.63 36.61 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-O 120.832 0.348 . . . . 0.0 110.593 -179.164 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -119.26 168.67 13.46 Favored Glycine 0 N--CA 1.449 -0.486 0 N-CA-C 111.683 -0.567 . . . . 0.0 111.683 179.708 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 96.8 m-20 60.93 34.38 19.51 Favored 'General case' 0 N--CA 1.47 0.535 0 CA-C-O 120.964 0.411 . . . . 0.0 111.262 -179.792 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.418 HG22 HG12 ' A' ' 79' ' ' VAL . 2.5 t -75.8 166.38 2.76 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.597 -179.768 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 22.0 t0 -73.08 145.36 46.57 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.854 0.359 . . . . 0.0 110.34 179.714 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 3.0 p90 -66.27 -19.97 65.97 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.732 -0.667 . . . . 0.0 111.712 -178.934 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -109.84 20.12 18.37 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 111.742 0.275 . . . . 0.0 111.742 -179.323 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' CYS . . . . . 0.471 ' SG ' ' HB2' ' A' ' 140' ' ' HIS . 0.8 OUTLIER -87.84 141.71 28.38 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.07 0.462 . . . . 0.0 111.286 -179.829 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . 0.468 ' O ' ' HG2' ' A' ' 90' ' ' GLU . 41.7 p -107.1 155.61 38.97 Favored Pre-proline 0 C--N 1.328 -0.367 0 CA-C-N 115.593 -0.73 . . . . 0.0 110.343 179.562 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . 0.477 ' HD3' HD13 ' A' ' 106' ' ' ILE . 18.6 Cg_endo -59.12 -35.35 98.14 Favored 'Trans proline' 0 C--N 1.342 0.213 0 C-N-CA 122.457 2.104 . . . . 0.0 112.556 -179.576 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 28.8 mt-10 -65.02 -50.04 67.8 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.688 -0.687 . . . . 0.0 112.096 -178.861 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . 0.565 ' O ' ' HB2' ' A' ' 94' ' ' HIS . 10.9 pt-20 -67.24 -18.6 65.29 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.835 0.35 . . . . 0.0 111.193 -179.102 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 51.3 t -85.26 -49.66 15.37 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.115 -179.897 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . 0.4 ' HG2' ' O ' ' A' ' 88' ' ' PRO . 6.9 pt20 -68.81 -35.92 77.6 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.696 -0.229 . . . . 0.0 111.561 -178.098 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 16.0 pt20 -74.48 -28.71 61.13 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.939 0.4 . . . . 0.0 110.37 -179.5 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' HIS . . . . . 0.565 ' HB2' ' O ' ' A' ' 90' ' ' GLU . 0.1 OUTLIER -70.81 -42.5 70.18 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.652 -179.796 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 20.7 m-30 -80.04 -14.59 58.43 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.87 -0.604 . . . . 0.0 110.647 -179.511 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . 0.623 ' HA ' ' O ' ' A' ' 99' ' ' GLY . 10.9 tt0 -66.0 -19.15 65.76 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.131 179.513 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 13.9 m -66.84 -28.57 68.46 Favored 'General case' 0 N--CA 1.451 -0.384 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.257 178.871 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 4.9 m -100.33 -43.26 6.32 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.401 179.661 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . 0.623 ' O ' ' HA ' ' A' ' 96' ' ' GLN . . . -144.59 139.73 8.74 Favored Glycine 0 N--CA 1.447 -0.62 0 C-N-CA 120.88 -0.676 . . . . 0.0 111.904 -179.896 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -63.02 147.72 49.84 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 120.914 0.388 . . . . 0.0 111.601 -179.901 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 2.4 p -116.52 132.93 64.71 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.095 -179.458 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 27.4 t-20 -102.2 -43.64 5.66 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.068 0.461 . . . . 0.0 110.282 178.956 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . 0.401 HH11 ' HD2' ' A' ' 103' ' ' ARG . 0.2 OUTLIER -141.03 148.68 40.64 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.055 -0.521 . . . . 0.0 109.888 -179.872 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 4.5 p -146.94 134.99 15.12 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 N-CA-C 109.936 -0.394 . . . . 0.0 109.936 179.197 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . 0.459 ' HB ' ' CE1' ' A' ' 119' ' ' TYR . 0.7 OUTLIER -128.16 126.13 40.45 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.236 179.376 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' ILE . . . . . 0.506 HD11 ' HA2' ' A' ' 116' ' ' GLY . 18.6 tt -112.55 148.3 15.69 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-O 120.862 0.363 . . . . 0.0 110.867 -179.941 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 18.0 tp -136.83 129.96 31.11 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.155 179.56 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -88.42 123.24 32.77 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 109.708 -0.479 . . . . 0.0 109.708 179.542 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . 0.417 ' O ' ' HB2' ' A' ' 110' ' ' LYS . 29.2 t70 -70.93 -80.17 0.06 Allowed 'General case' 0 CA--C 1.531 0.247 0 N-CA-C 112.628 0.603 . . . . 0.0 112.628 -178.239 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . 0.417 ' HB2' ' O ' ' A' ' 109' ' ' ASP . 1.7 mtpp 70.34 20.66 6.03 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 122.828 0.451 . . . . 0.0 111.621 -179.901 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 6.6 t80 -115.41 17.92 16.24 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-O 121.274 0.559 . . . . 0.0 109.955 -179.749 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 103.99 0.37 45.02 Favored Glycine 0 N--CA 1.449 -0.5 0 C-N-CA 120.768 -0.729 . . . . 0.0 112.158 179.952 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 4.3 mt-30 -111.34 157.72 38.24 Favored Pre-proline 0 C--N 1.322 -0.596 0 N-CA-C 109.588 -0.523 . . . . 0.0 109.588 179.599 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -59.77 129.7 31.84 Favored 'Trans proline' 0 N--CA 1.462 -0.335 0 C-N-CA 122.124 1.883 . . . . 0.0 111.366 178.827 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 15.6 mttp -82.8 -179.41 7.43 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 109.196 -0.668 . . . . 0.0 109.196 179.963 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . 0.506 ' HA2' HD11 ' A' ' 106' ' ' ILE . . . 92.36 2.53 68.02 Favored Glycine 0 N--CA 1.446 -0.645 0 C-N-CA 120.064 -1.065 . . . . 0.0 112.32 179.168 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 2.2 t80 -54.51 119.52 5.36 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-O 120.732 0.301 . . . . 0.0 110.278 179.793 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -146.56 177.89 8.71 Favored 'General case' 0 N--CA 1.45 -0.427 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.846 -179.316 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' TYR . . . . . 0.459 ' CE1' ' HB ' ' A' ' 105' ' ' THR . 43.6 p90 -161.1 134.84 6.75 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.521 -0.763 . . . . 0.0 109.225 179.045 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 15.1 m -108.74 147.07 13.69 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 N-CA-C 109.529 -0.545 . . . . 0.0 109.529 178.824 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . 0.51 ' HB2' HG12 ' A' ' 72' ' ' VAL . 7.2 pt-20 -131.7 155.91 46.82 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 116.389 -0.368 . . . . 0.0 111.022 -179.217 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 122' ' ' PHE . . . . . 0.446 ' O ' ' HA ' ' A' ' 72' ' ' VAL . 10.8 t80 -157.2 166.66 32.59 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.147 -179.943 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 5.1 t -84.82 -49.23 15.99 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-O 120.854 0.359 . . . . 0.0 111.708 -178.995 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 47.8 mm-40 -66.27 127.87 33.91 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.002 -0.545 . . . . 0.0 111.844 -178.608 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 2.3 mp -72.05 -29.4 32.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 115.6 -0.727 . . . . 0.0 109.643 179.516 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 16.7 t70 -58.1 -42.25 85.29 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.265 -0.88 . . . . 0.0 110.56 179.322 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -64.81 -52.98 53.9 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.731 -0.668 . . . . 0.0 111.532 -179.597 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 8.8 p -65.85 -27.05 40.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 116.636 -0.256 . . . . 0.0 111.43 -179.27 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 24.4 tt0 -60.31 -48.52 81.4 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.806 0.336 . . . . 0.0 110.404 179.898 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 86.6 m-20 -69.61 -32.41 71.11 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 121.021 0.439 . . . . 0.0 110.248 179.611 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . 0.421 ' O ' ' HB2' ' A' ' 135' ' ' ASN . . . -64.84 -53.16 51.13 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.604 -0.725 . . . . 0.0 111.254 -179.787 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 4.1 pp -65.23 -23.94 67.21 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.9 0.381 . . . . 0.0 110.888 -179.796 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 5.6 tp -76.42 -54.34 6.87 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.652 179.699 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 26.9 mt -122.38 103.04 8.47 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.091 -0.504 . . . . 0.0 109.878 -179.998 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 135' ' ' ASN . . . . . 0.421 ' HB2' ' O ' ' A' ' 131' ' ' ALA . 0.2 OUTLIER -150.23 -66.87 0.2 Allowed 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 120.977 0.418 . . . . 0.0 111.551 -179.22 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 3.3 pt-20 -69.73 101.18 1.63 Allowed 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.882 -0.599 . . . . 0.0 111.417 -179.188 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 23.7 m -151.31 -59.32 0.17 Allowed 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.909 -0.587 . . . . 0.0 109.966 178.93 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 6.0 tm-20 -154.78 127.68 8.17 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.457 179.755 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -147.72 111.27 4.98 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 178.774 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 140' ' ' HIS . . . . . 0.471 ' HB2' ' SG ' ' A' ' 86' ' ' CYS . 2.1 t60 64.6 28.22 13.25 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-O 121.241 0.543 . . . . 0.0 109.725 -179.585 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 79.23 1.27 85.5 Favored Glycine 0 CA--C 1.52 0.371 0 C-N-CA 121.012 -0.613 . . . . 0.0 112.485 -179.353 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 7.3 mpt_? -113.11 170.94 7.85 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 120.662 0.267 . . . . 0.0 110.437 -179.907 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 12.7 pt20 -115.11 137.55 51.89 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.114 -0.494 . . . . 0.0 109.83 179.162 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -125.58 174.48 8.22 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.135 179.951 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 76.7 tttt -116.91 122.33 44.0 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 109.775 -0.454 . . . . 0.0 109.775 179.371 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 146' ' ' VAL . . . . . 0.401 ' HA ' ' O ' ' A' ' 78' ' ' TYR . 77.6 t -115.88 125.21 72.93 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-O 120.843 0.354 . . . . 0.0 110.739 179.811 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 5.4 t -126.87 148.46 50.0 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 109.848 -0.427 . . . . 0.0 109.848 179.944 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -66.62 122.66 18.11 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.595 -0.275 . . . . 0.0 110.636 -179.737 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 14.0 ttpp -88.14 61.99 6.55 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.456 0.646 . . . . 0.0 109.63 -179.823 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -82.42 77.94 9.13 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.806 -0.634 . . . . 0.0 109.561 179.453 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 2.9 t -70.84 129.21 38.49 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-N 115.116 -0.947 . . . . 0.0 110.95 179.972 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 152' ' ' ASN . . . . . . . . . . . . . 6.8 t-20 -171.45 156.97 4.69 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.198 -0.455 . . . . 0.0 109.984 179.748 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 8.3 pt -60.72 151.04 73.76 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-O 120.841 0.353 . . . . 0.0 111.421 179.966 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 96.1 Cg_endo -78.78 48.5 2.8 Favored 'Trans proline' 0 CA--C 1.53 0.278 0 C-N-CA 123.201 2.601 . . . . 0.0 112.695 179.929 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.934 0 CA-C-O 118.842 -0.976 . . . . 0.0 111.973 -179.95 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.5 mpt? . . . . . 0 N--CA 1.478 0.925 0 N-CA-C 109.791 -0.448 . . . . 0.0 109.791 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -159.61 152.46 23.39 Favored Glycine 0 N--CA 1.447 -0.614 0 C-N-CA 120.654 -0.784 . . . . 0.0 112.219 -179.465 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -114.62 150.66 34.75 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 110.172 -0.307 . . . . 0.0 110.172 179.929 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 2.1 p -143.64 137.9 28.61 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.559 -0.291 . . . . 0.0 110.715 -179.946 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -149.06 138.48 21.67 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.597 -0.274 . . . . 0.0 110.599 179.417 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 39.9 m80 -94.47 163.71 13.29 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.914 -179.701 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 7.1 p80 -173.55 153.19 2.26 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.758 -0.656 . . . . 0.0 109.673 179.713 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 38.0 t-80 -143.53 134.43 25.39 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 120.789 0.328 . . . . 0.0 110.341 179.808 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 4.9 t-80 -144.43 119.43 10.01 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 109.421 -0.585 . . . . 0.0 109.421 179.596 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 17.1 t-80 -112.7 111.16 21.76 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 120.869 0.366 . . . . 0.0 111.228 -179.286 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 4.0 m -67.83 152.78 45.03 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.933 -0.576 . . . . 0.0 109.648 178.728 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 15.6 m -134.04 114.44 13.2 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-O 120.99 0.424 . . . . 0.0 110.906 -179.123 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -100.15 -162.59 28.56 Favored Glycine 0 N--CA 1.444 -0.828 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.245 179.95 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -131.67 159.29 38.77 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 110.402 -0.222 . . . . 0.0 110.402 -179.828 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 2.4 p -130.94 119.11 17.82 Favored Pre-proline 0 C--N 1.325 -0.477 0 CA-C-O 121.028 0.442 . . . . 0.0 110.892 179.821 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 70.0 Cg_endo -77.87 120.37 5.05 Favored 'Trans proline' 0 N--CA 1.458 -0.571 0 C-N-CA 122.65 2.234 . . . . 0.0 111.491 178.948 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 1.1 tpm_? -119.0 145.72 45.61 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.25 -179.357 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -138.65 121.5 2.16 Favored Glycine 0 N--CA 1.45 -0.425 0 C-N-CA 121.12 -0.562 . . . . 0.0 111.892 179.841 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 4.7 m -82.32 140.57 33.49 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 120.847 0.356 . . . . 0.0 111.051 -179.445 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 54.2 t-80 -90.48 140.99 29.21 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.188 -179.972 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 19.2 ptt? -137.16 -179.19 5.57 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.776 -179.624 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 148.59 119.99 1.07 Allowed Glycine 0 N--CA 1.45 -0.373 0 N-CA-C 111.723 -0.551 . . . . 0.0 111.723 -179.93 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 1.2 m -109.16 123.4 49.14 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 120.783 0.325 . . . . 0.0 111.383 -179.516 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 36.9 t0 -87.97 153.47 21.26 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.021 179.738 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 3.0 tp -114.63 139.9 49.25 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 116.683 -0.235 . . . . 0.0 110.866 -179.018 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 23.5 mm-40 -68.37 131.92 46.15 Favored 'General case' 0 C--N 1.332 -0.177 0 N-CA-C 110.347 -0.242 . . . . 0.0 110.347 179.593 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -109.0 141.07 41.64 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.982 -179.531 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 32.6 tpp -144.06 127.77 17.18 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.546 179.679 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 19.5 mmtp -131.3 166.13 21.88 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.606 -0.27 . . . . 0.0 110.721 -179.615 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 1.3 ptmm? -157.8 -175.08 5.17 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.27 179.52 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 12.4 ptt180 -150.82 174.17 13.38 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 109.654 -0.498 . . . . 0.0 109.654 179.504 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.497 HD22 ' HA ' ' A' ' 32' ' ' LEU . 0.4 OUTLIER -150.67 144.74 25.39 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.682 0.277 . . . . 0.0 110.377 -179.534 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 17.7 ttmm -100.81 125.0 47.28 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.71 -179.957 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 32.3 tt0 -84.61 126.0 32.96 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.136 179.453 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 10.6 pt -135.67 130.3 49.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-O 120.816 0.341 . . . . 0.0 110.982 -179.904 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 6.4 tp10 -147.37 153.54 39.78 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.521 -0.309 . . . . 0.0 110.414 179.549 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 1.5 mm-40 -114.4 176.08 5.2 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.004 0.43 . . . . 0.0 111.506 -179.443 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 7.9 mt-10 -115.49 145.98 42.1 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.643 -0.708 . . . . 0.0 109.948 179.551 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -145.18 124.68 13.15 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 120.901 0.382 . . . . 0.0 111.347 -179.667 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -96.93 77.87 0.69 Allowed Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.726 -0.749 . . . . 0.0 111.895 179.687 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -141.77 177.43 8.18 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 110.467 -0.198 . . . . 0.0 110.467 -179.245 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 37.9 tp -74.29 84.32 1.91 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.08 0.467 . . . . 0.0 109.897 179.346 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . 0.528 ' NE ' ' HA ' ' A' ' 43' ' ' ARG . 1.5 tpm_? -132.63 142.3 49.05 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.746 -179.376 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 21.5 mp0 -77.27 47.04 0.54 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.249 0.547 . . . . 0.0 110.278 179.252 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 9.1 ptt? -108.65 -0.41 20.18 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.498 -179.548 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 24.6 mt-30 -59.86 -22.68 62.62 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-O 120.889 0.376 . . . . 0.0 111.325 -179.048 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -68.03 -16.96 64.26 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.787 -179.914 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 3.4 ptmm? -73.82 3.59 6.39 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-O 120.635 0.255 . . . . 0.0 111.323 -179.383 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 11.0 p -54.73 -25.09 14.61 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.25 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.307 179.63 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -59.46 -37.03 77.1 Favored 'General case' 0 C--N 1.334 -0.095 0 CA-C-O 121.185 0.517 . . . . 0.0 110.152 179.134 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 10.7 mtmm -85.57 -41.14 15.53 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.804 -0.634 . . . . 0.0 110.328 -179.369 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 16.9 mm-40 -60.33 -38.05 82.53 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.519 -0.764 . . . . 0.0 111.991 -179.013 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 17.3 ptp -64.67 -25.94 68.17 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.679 0.276 . . . . 0.0 110.973 -179.607 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -95.61 -9.94 57.17 Favored Glycine 0 N--CA 1.448 -0.514 0 C-N-CA 120.812 -0.709 . . . . 0.0 111.539 179.433 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -112.86 23.79 13.08 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.029 0.442 . . . . 0.0 110.629 -179.458 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 7.7 m -64.18 -14.36 15.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.835 -179.863 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 17.7 mm-40 -81.09 -11.59 59.46 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.838 0.352 . . . . 0.0 110.544 179.561 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -121.61 -51.97 2.04 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.105 -179.785 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 13.6 m -72.76 -71.8 0.28 Allowed 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.011 -0.541 . . . . 0.0 111.295 -179.959 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -83.56 32.33 0.46 Allowed 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.798 -178.861 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 1.4 t -80.23 -31.38 38.58 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 121.042 0.449 . . . . 0.0 109.948 -179.57 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -66.47 -25.68 66.83 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.914 -0.585 . . . . 0.0 111.212 179.777 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 1.4 m -61.15 -24.53 66.36 Favored 'General case' 0 N--CA 1.449 -0.495 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.079 -179.653 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -71.7 -31.24 66.55 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.527 -0.306 . . . . 0.0 110.483 179.026 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -76.98 4.3 10.32 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.321 0.582 . . . . 0.0 110.605 179.772 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 46.3 tp60 -122.5 -54.9 1.86 Allowed 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.811 -0.632 . . . . 0.0 110.524 179.277 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -79.8 -54.42 5.86 Favored 'General case' 0 C--N 1.326 -0.413 0 N-CA-C 112.174 0.435 . . . . 0.0 112.174 -178.603 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 14.0 tp10 -69.58 -27.1 64.83 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.069 0.461 . . . . 0.0 110.963 -179.224 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 15.5 tptp -59.9 -27.2 66.52 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.995 179.303 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 94.8 mt-10 -62.74 -22.28 66.43 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-O 121.375 0.607 . . . . 0.0 111.009 179.583 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . 0.446 ' O ' ' HD2' ' A' ' 75' ' ' ARG . 7.0 tp10 -96.97 -40.01 9.09 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 115.727 -0.669 . . . . 0.0 109.596 178.007 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.436 HG12 ' HB2' ' A' ' 121' ' ' GLU . 59.0 t -65.27 -37.89 81.25 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-N 115.728 -0.669 . . . . 0.0 112.586 -179.034 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . 0.469 ' OD2' HG21 ' A' ' 151' ' ' THR . 6.5 p-10 -72.98 -17.13 61.49 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-O 120.889 0.376 . . . . 0.0 111.148 -179.227 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -97.77 -18.56 18.72 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.964 -0.562 . . . . 0.0 109.952 177.831 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . 0.446 ' HD2' ' O ' ' A' ' 71' ' ' GLU . 0.0 OUTLIER -103.05 49.76 0.83 Allowed 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.353 -179.334 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . 0.49 ' HB3' ' HB3' ' A' ' 121' ' ' GLU . 0.0 OUTLIER -128.04 170.57 12.76 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.542 -0.754 . . . . 0.0 110.313 179.703 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 4.8 pt -134.98 137.33 50.8 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.787 0 N-CA-C 109.795 -0.446 . . . . 0.0 109.795 178.88 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 67.0 t80 -95.81 128.18 42.48 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.151 -179.58 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 2.7 t -105.18 111.8 36.13 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.362 -179.861 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -116.93 162.98 12.57 Favored Glycine 0 N--CA 1.449 -0.498 0 C-N-CA 120.925 -0.655 . . . . 0.0 111.599 -179.859 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 9.9 m120 60.28 42.45 15.02 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-O 121.32 0.581 . . . . 0.0 110.542 -179.559 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.545 HG12 ' H ' ' A' ' 83' ' ' ASP . 2.0 t -83.26 172.9 1.0 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.656 0 CA-C-N 115.521 -0.763 . . . . 0.0 110.31 -179.375 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . 0.651 ' OD2' ' HD3' ' A' ' 142' ' ' ARG . 11.6 t0 -73.62 135.4 43.82 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 109.756 -0.461 . . . . 0.0 109.756 179.451 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 5.4 p90 -60.77 -21.4 63.01 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.88 -0.6 . . . . 0.0 111.924 -179.662 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -110.85 19.19 18.81 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.774 0.321 . . . . 0.0 111.237 -179.855 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' CYS . . . . . 0.442 ' SG ' ' HB3' ' A' ' 83' ' ' ASP . 0.5 OUTLIER -80.64 148.32 30.3 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.375 0.607 . . . . 0.0 110.993 -179.898 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . 0.531 ' O ' ' HG2' ' A' ' 90' ' ' GLU . 40.1 p -109.97 152.38 43.0 Favored Pre-proline 0 C--N 1.321 -0.649 0 CA-C-N 115.338 -0.846 . . . . 0.0 110.194 179.409 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . 0.408 ' HD3' HD13 ' A' ' 106' ' ' ILE . 18.8 Cg_endo -60.14 -32.39 94.52 Favored 'Trans proline' 0 C--N 1.344 0.338 0 C-N-CA 122.414 2.076 . . . . 0.0 112.593 -179.543 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 7.8 mm-40 -64.6 -53.09 53.21 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.731 -0.668 . . . . 0.0 111.96 -179.165 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . 0.531 ' HG2' ' O ' ' A' ' 87' ' ' THR . 10.7 pt-20 -62.42 -23.93 67.13 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.966 0.412 . . . . 0.0 111.413 -178.904 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 76.6 t -79.86 -48.78 20.16 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.059 -179.86 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . 0.427 ' O ' ' HB2' ' A' ' 96' ' ' GLN . 1.6 pp0? -71.97 -33.63 68.32 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.708 -0.224 . . . . 0.0 111.372 -178.455 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 8.6 pt20 -74.21 -31.79 62.76 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.911 0.386 . . . . 0.0 111.068 -179.475 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 65.0 t-80 -73.79 -41.85 61.82 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.734 -179.431 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 18.1 m-30 -78.19 -12.97 60.03 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.124 -179.162 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . 0.545 ' HA ' ' O ' ' A' ' 99' ' ' GLY . 7.5 tt0 -70.06 -20.17 63.24 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.687 -0.688 . . . . 0.0 109.988 179.669 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 1.4 m -65.17 -36.41 84.14 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.496 -0.775 . . . . 0.0 110.692 179.555 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 0.2 OUTLIER -89.81 -46.43 8.59 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.304 -179.988 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . 0.545 ' O ' ' HA ' ' A' ' 96' ' ' GLN . . . -144.27 145.21 14.55 Favored Glycine 0 N--CA 1.445 -0.766 0 C-N-CA 120.672 -0.775 . . . . 0.0 111.801 179.792 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -64.12 145.91 55.12 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 121.033 0.444 . . . . 0.0 111.337 -179.781 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 1.2 p -118.65 121.79 67.86 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.259 -179.949 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . 0.482 ' OD1' ' HG2' ' A' ' 103' ' ' ARG . 26.6 t-20 -91.07 -44.83 9.04 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 109.859 -0.423 . . . . 0.0 109.859 179.733 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . 0.482 ' HG2' ' OD1' ' A' ' 102' ' ' ASN . 10.3 mmm180 -136.99 149.16 47.34 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.534 179.967 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 4.0 p -148.2 131.39 7.9 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.587 0 CA-C-N 115.919 -0.582 . . . . 0.0 109.473 179.711 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . 0.419 ' HB ' ' CE1' ' A' ' 119' ' ' TYR . 0.7 OUTLIER -124.89 126.53 45.68 Favored 'General case' 0 C--N 1.32 -0.69 0 N-CA-C 110.08 -0.341 . . . . 0.0 110.08 179.237 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' ILE . . . . . 0.502 HD11 ' HA2' ' A' ' 116' ' ' GLY . 21.1 tt -113.26 143.62 22.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-O 120.895 0.379 . . . . 0.0 110.889 -179.598 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 51.4 tp -129.66 127.75 41.17 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.062 179.372 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -94.76 114.65 26.58 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.546 -0.297 . . . . 0.0 110.411 179.73 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . 0.468 ' C ' ' HD2' ' A' ' 110' ' ' LYS . 3.1 t70 -75.24 134.07 41.23 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.771 0.32 . . . . 0.0 110.899 -179.948 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . 0.468 ' HD2' ' C ' ' A' ' 109' ' ' ASP . 8.0 mmmm -116.66 30.17 7.5 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 120.94 0.4 . . . . 0.0 110.094 -179.906 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 8.5 t80 -112.72 -2.85 14.37 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.848 0.356 . . . . 0.0 110.81 -179.6 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 108.33 8.78 28.53 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.844 -0.693 . . . . 0.0 113.141 179.717 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 30.2 mt-30 -94.58 157.18 37.55 Favored Pre-proline 0 C--N 1.322 -0.596 0 N-CA-C 109.646 -0.502 . . . . 0.0 109.646 179.84 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -58.64 105.59 0.23 Allowed 'Trans proline' 0 C--N 1.348 0.502 0 C-N-CA 122.216 1.944 . . . . 0.0 110.819 178.998 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . 0.415 ' HG2' ' O ' ' A' ' 109' ' ' ASP . 3.3 mttp -68.22 177.34 2.32 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.68 -179.074 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . 0.502 ' HA2' HD11 ' A' ' 106' ' ' ILE . . . 99.54 2.93 56.46 Favored Glycine 0 N--CA 1.445 -0.729 0 C-N-CA 120.339 -0.934 . . . . 0.0 111.308 -179.73 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 39.9 m-85 -53.13 117.55 3.09 Favored 'General case' 0 C--N 1.331 -0.205 0 O-C-N 123.821 0.366 . . . . 0.0 110.097 179.505 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -147.15 173.49 12.46 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 121.154 0.502 . . . . 0.0 111.205 -179.099 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' TYR . . . . . 0.419 ' CE1' ' HB ' ' A' ' 105' ' ' THR . 39.2 p90 -156.14 134.6 11.58 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 115.436 -0.802 . . . . 0.0 109.0 178.642 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 14.4 m -109.43 139.24 33.18 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 N-CA-C 109.319 -0.623 . . . . 0.0 109.319 179.055 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . 0.49 ' HB3' ' HB3' ' A' ' 76' ' ' SER . 9.0 pt-20 -127.67 154.6 45.1 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 120.921 0.391 . . . . 0.0 111.334 -179.684 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 122' ' ' PHE . . . . . 0.412 ' O ' ' HA ' ' A' ' 72' ' ' VAL . 17.6 t80 -154.56 171.14 19.91 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.748 -0.66 . . . . 0.0 109.819 -179.821 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 3.8 t -84.65 -52.01 13.06 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-O 120.772 0.32 . . . . 0.0 111.551 -179.463 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -62.43 132.7 53.42 Favored 'General case' 0 C--O 1.236 0.346 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.674 -179.032 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 2.3 mp -76.04 -32.45 23.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 115.937 -0.574 . . . . 0.0 109.629 179.463 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 6.4 t70 -58.67 -39.16 79.88 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.358 -0.837 . . . . 0.0 110.632 179.324 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -62.59 -57.56 10.66 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.781 -0.645 . . . . 0.0 111.118 -179.829 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 7.6 p -65.2 -29.48 47.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.428 -0.351 . . . . 0.0 111.371 -179.449 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 40.6 tt0 -59.24 -47.17 86.36 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.284 0.564 . . . . 0.0 110.673 179.752 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 44.7 m-80 -70.68 -31.24 68.06 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.804 -0.635 . . . . 0.0 110.029 179.608 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -68.47 -47.91 65.87 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.58 -0.736 . . . . 0.0 111.672 -179.601 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 4.1 pp -68.02 -24.0 65.06 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.74 0.305 . . . . 0.0 110.9 -179.746 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 5.4 tp -74.24 -53.45 9.74 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.722 -179.354 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 61.9 mt -131.64 98.41 4.48 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 112.087 0.403 . . . . 0.0 112.087 -178.939 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 3.4 m-20 -149.9 -52.25 0.15 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.318 179.111 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 2.9 pt-20 -73.03 93.55 1.78 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.619 0.723 . . . . 0.0 110.708 179.614 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 4.6 m -142.38 -59.85 0.45 Allowed 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.544 -0.753 . . . . 0.0 110.354 179.376 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -156.47 127.41 6.86 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.216 179.894 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -146.95 122.99 10.77 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 109.481 -0.562 . . . . 0.0 109.481 179.691 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 2.0 t60 63.93 17.34 10.5 Favored 'General case' 0 N--CA 1.465 0.306 0 C-N-CA 122.71 0.404 . . . . 0.0 111.015 179.59 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 93.39 -1.59 69.73 Favored Glycine 0 N--CA 1.443 -0.843 0 C-N-CA 120.77 -0.728 . . . . 0.0 112.366 -179.465 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 142' ' ' ARG . . . . . 0.651 ' HD3' ' OD2' ' A' ' 83' ' ' ASP . 4.3 mpt_? -121.38 -173.7 2.68 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 110.127 -0.323 . . . . 0.0 110.127 179.861 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 20.7 pt20 -124.12 150.98 44.46 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 120.794 0.331 . . . . 0.0 110.402 179.735 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -133.54 177.89 7.35 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.472 -179.783 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 42.0 tttt -117.72 123.46 46.09 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 109.793 -0.447 . . . . 0.0 109.793 178.449 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 82.8 t -117.61 121.52 67.68 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-O 120.982 0.42 . . . . 0.0 110.451 179.875 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 56.8 m -127.44 147.63 50.29 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 116.33 -0.396 . . . . 0.0 110.185 179.51 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -65.23 126.79 29.25 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.903 0.382 . . . . 0.0 111.133 -179.479 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 19.8 ttpp -89.38 55.45 3.26 Favored 'General case' 0 N--CA 1.448 -0.533 0 CA-C-O 121.463 0.649 . . . . 0.0 109.302 -179.807 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.99 84.74 2.26 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.781 -0.645 . . . . 0.0 109.909 179.912 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 151' ' ' THR . . . . . 0.469 HG21 ' OD2' ' A' ' 73' ' ' ASP . 11.1 t -67.04 139.75 57.63 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.564 -0.744 . . . . 0.0 110.248 179.58 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 152' ' ' ASN . . . . . . . . . . . . . 7.5 t-20 -177.22 167.07 2.38 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 109.166 -0.679 . . . . 0.0 109.166 -179.915 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 14.1 pt -74.87 119.85 78.78 Favored Pre-proline 0 C--N 1.323 -0.562 0 CA-C-O 120.919 0.39 . . . . 0.0 110.09 179.588 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -60.36 124.17 14.6 Favored 'Trans proline' 0 C--O 1.236 0.421 0 C-N-CA 122.758 2.305 . . . . 0.0 112.929 -178.71 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.246 0.9 0 CA-C-O 118.869 -0.962 . . . . 0.0 111.63 179.554 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 59.1 tpp . . . . . 0 N--CA 1.481 1.094 0 CA-C-O 120.662 0.268 . . . . 0.0 110.324 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 124.78 122.26 2.63 Favored Glycine 0 N--CA 1.448 -0.562 0 C-N-CA 120.915 -0.659 . . . . 0.0 111.871 -179.725 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 1.1 m -65.72 -59.32 4.03 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 120.951 0.405 . . . . 0.0 110.78 -179.89 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -78.02 100.98 6.71 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.104 0.478 . . . . 0.0 110.287 179.826 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 46.8 p-80 -124.48 114.94 20.11 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.48 -179.519 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -137.38 109.52 7.26 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.113 179.867 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 2.2 t60 60.91 37.52 18.32 Favored 'General case' 0 N--CA 1.464 0.262 0 O-C-N 123.497 0.498 . . . . 0.0 110.703 179.516 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 28.0 t-80 -107.79 75.2 0.99 Allowed 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.146 0.498 . . . . 0.0 111.018 -178.997 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 15.2 p80 -78.04 167.25 21.74 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.882 179.674 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 8.7 m170 -98.14 165.22 11.99 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.648 -179.965 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 5.0 m -87.6 87.82 7.5 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 120.795 0.331 . . . . 0.0 110.466 179.459 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 3.4 t -167.64 152.93 7.11 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.176 -0.466 . . . . 0.0 109.839 179.455 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -174.61 -179.69 45.37 Favored Glycine 0 N--CA 1.444 -0.827 0 C-N-CA 120.936 -0.649 . . . . 0.0 111.75 -179.976 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 19.6 tp -131.24 121.49 24.87 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 110.08 -0.341 . . . . 0.0 110.08 179.922 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 6.6 p -91.82 127.27 50.62 Favored Pre-proline 0 C--N 1.321 -0.642 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.745 -179.957 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -71.23 155.31 60.98 Favored 'Trans proline' 0 C--N 1.346 0.418 0 C-N-CA 122.383 2.056 . . . . 0.0 111.833 179.207 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 25.3 ptt180 -72.54 137.71 46.43 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.099 0.476 . . . . 0.0 110.62 -179.883 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -177.1 72.92 0.08 OUTLIER Glycine 0 N--CA 1.445 -0.71 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.094 -179.46 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 16.1 m -123.65 139.67 53.77 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 110.348 -0.242 . . . . 0.0 110.348 179.872 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 48.9 p-80 -159.57 132.97 7.08 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 109.835 -0.432 . . . . 0.0 109.835 -179.757 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 51.2 ttp -166.53 104.65 0.61 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.845 0.355 . . . . 0.0 110.686 -179.848 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -147.87 51.53 0.56 Allowed Glycine 0 N--CA 1.448 -0.503 0 C-N-CA 120.813 -0.708 . . . . 0.0 112.001 179.737 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 24.5 m -133.89 129.83 36.95 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 110.535 -0.172 . . . . 0.0 110.535 -179.775 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -116.61 142.25 47.14 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 109.873 -0.418 . . . . 0.0 109.873 179.565 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 39.3 mt -113.83 168.56 9.68 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.581 -179.204 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 17.7 mm-40 -76.9 -178.04 4.69 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.515 179.458 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -148.53 -172.67 4.14 Favored 'General case' 0 C--N 1.325 -0.465 0 C-N-CA 121.125 -0.23 . . . . 0.0 110.901 -179.868 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 22.2 ptp -79.48 154.68 28.71 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.503 179.717 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 2.3 mtmm -95.18 148.09 22.76 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.5 -0.318 . . . . 0.0 110.274 179.6 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -68.84 174.01 4.78 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.923 -0.58 . . . . 0.0 111.618 -179.782 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 2.6 tmt_? -62.26 142.47 57.7 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.123 179.596 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 1.3 mm? -59.78 102.32 0.15 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.103 0.478 . . . . 0.0 110.867 179.811 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 23.7 tptm -170.94 91.26 0.15 Allowed 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.349 -0.841 . . . . 0.0 108.79 -179.852 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 24.9 mm-40 -100.57 -77.19 0.54 Allowed 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.34 -179.028 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 16.8 mm 58.8 53.16 0.3 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.185 0 CA-C-O 121.745 0.784 . . . . 0.0 109.544 -179.101 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 61.1 mm-40 -111.96 143.96 42.08 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.375 -0.829 . . . . 0.0 109.883 -179.672 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 77.9 mt-10 -79.4 76.12 5.98 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.204 0.526 . . . . 0.0 110.657 179.99 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 32.7 mt-10 -76.23 152.91 36.42 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.604 -0.725 . . . . 0.0 110.507 -179.817 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -107.72 168.08 9.51 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.076 -179.127 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -72.36 128.7 13.68 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.865 -0.683 . . . . 0.0 112.348 179.999 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -156.97 168.94 25.99 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 110.291 -0.263 . . . . 0.0 110.291 -179.697 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 14.4 tp -75.21 77.23 2.34 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.395 0.617 . . . . 0.0 109.84 178.955 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . 0.406 ' C ' ' H ' ' A' ' 45' ' ' MET . 29.0 ttt180 -136.33 145.67 45.71 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.127 -179.333 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -75.45 37.32 0.13 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.23 0.538 . . . . 0.0 111.199 179.97 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' MET . . . . . 0.406 ' H ' ' C ' ' A' ' 43' ' ' ARG . 22.1 ptt? -100.29 8.38 43.76 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.05 -179.843 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 73.2 mm-40 -66.07 -26.5 67.52 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.368 179.753 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -72.86 -8.4 55.37 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.832 -0.622 . . . . 0.0 111.345 179.953 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 13.5 ttpt -75.14 -8.5 56.74 Favored 'General case' 0 C--O 1.236 0.363 0 CA-C-O 121.19 0.519 . . . . 0.0 110.04 179.947 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 9.9 p -58.86 -25.04 28.02 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.204 0 CA-C-N 115.747 -0.66 . . . . 0.0 111.122 179.646 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -61.1 -27.18 68.18 Favored 'General case' 0 C--N 1.333 -0.131 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.019 179.794 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 11.8 mtmt -101.55 -35.47 9.14 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.398 179.903 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 76.5 mm-40 -70.38 -21.32 62.88 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.591 -0.277 . . . . 0.0 111.188 179.986 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 13.7 ptp -62.8 -29.36 70.65 Favored 'General case' 0 N--CA 1.462 0.169 0 CA-C-O 120.829 0.347 . . . . 0.0 110.435 179.566 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -90.66 -10.97 62.69 Favored Glycine 0 N--CA 1.447 -0.602 0 N-CA-C 111.008 -0.837 . . . . 0.0 111.008 178.909 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -105.22 14.2 29.39 Favored 'General case' 0 N--CA 1.448 -0.529 0 CA-C-O 120.805 0.336 . . . . 0.0 110.431 -179.838 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 26.8 m -62.46 -16.17 16.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.904 179.473 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 26.9 mt-30 -79.24 -3.77 47.44 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 121.42 0.628 . . . . 0.0 109.887 179.223 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 7.1 t0 -132.02 -63.16 0.82 Allowed 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.43 -0.804 . . . . 0.0 110.333 179.836 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 5.0 m -59.49 -61.61 2.49 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.728 -0.669 . . . . 0.0 111.655 -179.604 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -94.8 25.16 4.22 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.819 -0.628 . . . . 0.0 111.589 -178.934 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 5.7 t -76.9 -26.14 53.79 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 120.966 0.412 . . . . 0.0 110.664 -179.583 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 1.3 m -67.9 -23.75 65.14 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-O 121.105 0.479 . . . . 0.0 110.276 179.49 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 18.8 m -63.42 -27.36 69.24 Favored 'General case' 0 N--CA 1.449 -0.495 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.446 179.676 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -68.53 -33.48 74.19 Favored 'General case' 0 N--CA 1.452 -0.328 0 N-CA-C 109.61 -0.515 . . . . 0.0 109.61 179.08 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -76.4 4.12 9.66 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.225 0.536 . . . . 0.0 110.521 179.312 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 46.4 tt0 -118.27 -52.55 2.38 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.607 179.674 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -85.98 -57.82 2.89 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.812 -179.488 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 3.7 tp10 -63.79 -27.51 69.24 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 120.838 0.352 . . . . 0.0 110.751 -179.717 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 2.3 tptm -61.0 -23.72 65.6 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.199 179.952 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 35.1 mt-10 -62.1 -23.97 66.84 Favored 'General case' 0 N--CA 1.461 0.12 0 CA-C-O 121.176 0.512 . . . . 0.0 110.496 179.02 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 7.2 tp10 -95.46 -38.71 10.34 Favored 'General case' 0 C--N 1.319 -0.751 0 N-CA-C 109.212 -0.662 . . . . 0.0 109.212 177.747 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.447 HG22 ' HA ' ' A' ' 123' ' ' VAL . 58.4 t -65.04 -42.18 93.93 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.331 0 CA-C-N 115.913 -0.585 . . . . 0.0 112.191 -179.209 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 51.3 p30 -69.4 -15.21 63.25 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-O 121.125 0.488 . . . . 0.0 111.057 -179.223 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 24.5 m -105.51 -3.88 21.93 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.54 179.826 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -116.19 47.77 1.35 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.652 -0.704 . . . . 0.0 110.255 -179.193 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -126.3 172.81 9.79 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.866 -179.839 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 8.7 pt -131.17 136.75 57.19 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 N-CA-C 109.92 -0.4 . . . . 0.0 109.92 178.392 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' TYR . . . . . 0.536 ' O ' ' HA ' ' A' ' 146' ' ' VAL . 36.8 t80 -91.63 124.3 35.68 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.62 -179.465 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.495 HG13 HG22 ' A' ' 146' ' ' VAL . 6.9 t -105.98 110.23 30.62 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 N-CA-C 110.103 -0.332 . . . . 0.0 110.103 179.759 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -118.4 167.24 12.95 Favored Glycine 0 N--CA 1.45 -0.37 0 N-CA-C 111.745 -0.542 . . . . 0.0 111.745 -179.857 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 4.6 m-20 59.25 40.77 21.03 Favored 'General case' 0 N--CA 1.468 0.471 0 CA-C-O 121.289 0.566 . . . . 0.0 110.794 -179.583 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.444 HG12 ' H ' ' A' ' 83' ' ' ASP . 2.1 t -83.46 169.1 1.61 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-N 115.354 -0.839 . . . . 0.0 109.851 -179.471 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . 0.477 ' HB3' ' SG ' ' A' ' 86' ' ' CYS . 29.8 t70 -73.2 143.14 47.28 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 120.901 0.381 . . . . 0.0 110.73 179.916 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 34.1 p90 -64.77 -13.53 55.61 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.799 -0.637 . . . . 0.0 112.549 -178.693 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -117.21 15.95 14.91 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.81 0.338 . . . . 0.0 111.019 179.923 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' CYS . . . . . 0.477 ' SG ' ' HB3' ' A' ' 83' ' ' ASP . 1.0 OUTLIER -78.68 142.55 37.05 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.113 0.483 . . . . 0.0 110.885 179.945 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . 0.482 ' O ' ' HG2' ' A' ' 90' ' ' GLU . 70.2 p -106.12 155.41 38.55 Favored Pre-proline 0 C--N 1.321 -0.672 0 CA-C-N 115.444 -0.798 . . . . 0.0 110.272 -179.994 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 20.8 Cg_endo -61.46 -29.29 84.88 Favored 'Trans proline' 0 C--N 1.344 0.32 0 C-N-CA 122.219 1.946 . . . . 0.0 112.401 -179.788 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 14.0 mt-10 -65.31 -55.3 19.07 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.665 -179.073 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . 0.482 ' HG2' ' O ' ' A' ' 87' ' ' THR . 9.6 pt-20 -60.89 -25.53 66.78 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.921 0.391 . . . . 0.0 111.258 -178.634 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 69.2 t -78.24 -47.37 24.62 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.274 -179.286 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . 0.471 ' O ' ' HB2' ' A' ' 96' ' ' GLN . 13.9 pt20 -74.0 -31.75 63.1 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 112.172 0.434 . . . . 0.0 112.172 -178.212 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 1.5 pp0? -77.53 -27.85 51.8 Favored 'General case' 0 N--CA 1.467 0.419 0 C-N-CA 120.305 -0.558 . . . . 0.0 111.743 -179.155 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 1.5 m-70 -71.71 -44.46 64.14 Favored 'General case' 0 C--N 1.328 -0.349 0 C-N-CA 120.832 -0.347 . . . . 0.0 111.009 -179.571 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 23.0 m-85 -81.18 -11.72 59.36 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.682 0.277 . . . . 0.0 110.884 -179.707 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . 0.471 ' HB2' ' O ' ' A' ' 92' ' ' GLN . 43.3 tt0 -62.64 -28.56 70.0 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.002 -0.544 . . . . 0.0 110.59 -179.483 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 12.1 m -64.85 -38.95 92.7 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.305 179.263 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 6.1 m -81.01 -40.01 24.96 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.005 179.321 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . 0.456 ' O ' ' HA ' ' A' ' 96' ' ' GLN . . . -153.8 129.37 2.64 Favored Glycine 0 N--CA 1.442 -0.91 0 CA-C-N 115.76 -0.655 . . . . 0.0 111.516 179.487 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . 0.424 HG22 ' H ' ' A' ' 100' ' ' THR . 0.6 OUTLIER -58.97 140.84 55.18 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.259 0.552 . . . . 0.0 110.748 179.868 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.443 HG11 ' HB2' ' A' ' 92' ' ' GLN . 1.3 p -107.55 128.37 62.73 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 115.754 -0.657 . . . . 0.0 111.996 -178.057 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . 0.489 ' O ' ' HD2' ' A' ' 103' ' ' ARG . 6.3 t30 -86.39 -53.36 5.05 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 109.229 -0.656 . . . . 0.0 109.229 178.553 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . 0.489 ' HD2' ' O ' ' A' ' 102' ' ' ASN . 3.4 mpt_? -138.93 153.49 48.24 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 116.001 -0.545 . . . . 0.0 109.62 179.963 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 4.8 p -142.74 126.93 15.22 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 N-CA-C 109.787 -0.449 . . . . 0.0 109.787 179.669 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . 0.409 ' O ' ' HA ' ' A' ' 118' ' ' ALA . 0.8 OUTLIER -114.75 127.19 55.6 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 110.308 -0.256 . . . . 0.0 110.308 179.847 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 20.0 tt -117.8 144.55 25.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-O 120.708 0.29 . . . . 0.0 110.597 -179.77 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 26.6 tp -133.45 121.97 23.01 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.557 179.84 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -84.09 114.53 21.82 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.543 -0.299 . . . . 0.0 110.318 179.258 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -78.54 134.21 37.29 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.182 0.515 . . . . 0.0 111.516 -179.698 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -119.94 22.85 11.33 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.167 179.33 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 4.0 t80 -101.07 1.39 39.35 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.113 -179.56 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 100.87 12.15 38.08 Favored Glycine 0 N--CA 1.449 -0.455 0 C-N-CA 120.796 -0.716 . . . . 0.0 112.361 179.898 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 7.2 mt-30 -100.11 157.61 33.53 Favored Pre-proline 0 C--N 1.325 -0.485 0 N-CA-C 109.37 -0.604 . . . . 0.0 109.37 179.372 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -58.53 112.76 1.29 Allowed 'Trans proline' 0 C--N 1.345 0.37 0 C-N-CA 122.433 2.089 . . . . 0.0 111.488 178.889 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 7.9 mttp -69.58 176.87 3.23 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.662 -179.745 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 99.06 2.96 56.93 Favored Glycine 0 N--CA 1.439 -1.139 0 C-N-CA 120.164 -1.017 . . . . 0.0 111.768 -179.801 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 29.1 m-85 -54.95 113.35 1.31 Allowed 'General case' 0 C--O 1.231 0.118 0 N-CA-C 110.12 -0.326 . . . . 0.0 110.12 179.53 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . 0.409 ' HA ' ' O ' ' A' ' 105' ' ' THR . . . -144.59 173.07 12.14 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 120.931 0.396 . . . . 0.0 110.87 -178.977 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 2.3 p90 -157.75 136.75 11.59 Favored 'General case' 0 N--CA 1.445 -0.676 0 CA-C-N 115.891 -0.595 . . . . 0.0 109.552 178.874 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 15.0 m -105.91 140.7 23.16 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 N-CA-C 109.489 -0.56 . . . . 0.0 109.489 178.985 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . 0.414 ' HB2' HG12 ' A' ' 72' ' ' VAL . 6.4 pt-20 -126.4 154.2 43.93 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.045 -179.287 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 122' ' ' PHE . . . . . 0.436 ' O ' ' HA ' ' A' ' 72' ' ' VAL . 14.3 t80 -154.65 167.87 28.7 Favored 'General case' 0 C--O 1.226 -0.15 0 CA-C-O 120.796 0.331 . . . . 0.0 110.637 179.306 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . 0.447 ' HA ' HG22 ' A' ' 72' ' ' VAL . 6.3 t -82.73 -50.32 15.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 115.715 -0.675 . . . . 0.0 111.626 -179.126 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 33.1 mt-10 -70.97 137.42 49.12 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.044 -0.526 . . . . 0.0 111.934 -178.748 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 2.9 mp -74.99 -32.46 27.17 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.313 179.707 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 37.8 t70 -58.0 -43.54 86.67 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-O 120.982 0.42 . . . . 0.0 111.003 -179.833 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -58.05 -57.37 13.15 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.872 -0.604 . . . . 0.0 111.471 -179.682 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 12.2 p -67.62 -29.52 45.6 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 116.477 -0.329 . . . . 0.0 111.608 -179.177 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 129' ' ' GLN . . . . . 0.455 ' O ' ' HG ' ' A' ' 132' ' ' LEU . 29.4 tt0 -63.16 -46.43 87.2 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.901 0.381 . . . . 0.0 110.308 179.889 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 48.6 m-80 -72.02 -27.15 62.53 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.216 0.532 . . . . 0.0 109.688 179.125 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -72.15 -40.73 67.8 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.561 -0.745 . . . . 0.0 111.317 179.892 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 132' ' ' LEU . . . . . 0.584 ' HA ' ' ND2' ' A' ' 135' ' ' ASN . 4.4 pp -74.7 -19.1 60.39 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.924 0.392 . . . . 0.0 110.789 179.861 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 5.3 tp -76.34 -47.48 23.31 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.383 -179.906 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 40.1 mt -126.19 95.28 4.34 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.973 -0.558 . . . . 0.0 109.818 179.959 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 135' ' ' ASN . . . . . 0.584 ' ND2' ' HA ' ' A' ' 132' ' ' LEU . 2.8 p30 -135.75 -74.74 0.45 Allowed 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 112.431 0.53 . . . . 0.0 112.431 -179.083 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 5.8 pt-20 -69.25 100.57 1.33 Allowed 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.505 0.669 . . . . 0.0 111.632 -178.708 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 26.5 m -142.68 -58.3 0.44 Allowed 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.577 -0.738 . . . . 0.0 109.929 178.815 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 3.0 tm-20 -162.17 124.51 2.85 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.151 -0.477 . . . . 0.0 109.961 179.491 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -144.51 119.11 9.75 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 109.374 -0.602 . . . . 0.0 109.374 179.448 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 2.5 t60 64.67 20.52 12.16 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-O 121.108 0.48 . . . . 0.0 110.386 179.541 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 85.15 5.61 85.48 Favored Glycine 0 N--CA 1.448 -0.543 0 C-N-CA 120.922 -0.656 . . . . 0.0 112.149 -179.303 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -120.34 173.33 7.2 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 109.98 -0.378 . . . . 0.0 109.98 179.994 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 10.3 pt20 -118.84 125.43 49.52 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 109.761 -0.459 . . . . 0.0 109.761 179.271 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -110.36 178.3 4.43 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.86 -178.9 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -118.67 118.64 32.2 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 109.394 -0.595 . . . . 0.0 109.394 179.22 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 146' ' ' VAL . . . . . 0.536 ' HA ' ' O ' ' A' ' 78' ' ' TYR . 42.0 t -122.03 119.56 58.91 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-O 120.753 0.311 . . . . 0.0 111.144 -179.065 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 60.0 m -124.16 152.49 42.77 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 109.901 -0.407 . . . . 0.0 109.901 179.499 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -61.49 130.31 45.4 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.939 0.399 . . . . 0.0 110.796 179.984 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 42.7 tttp -92.94 71.19 4.69 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 109.079 -0.711 . . . . 0.0 109.079 179.958 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 150' ' ' ARG . . . . . 0.407 HH11 ' HD2' ' A' ' 150' ' ' ARG . 3.6 tpt180 -90.79 86.74 6.42 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.679 -0.692 . . . . 0.0 110.034 -179.563 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 9.0 t -68.01 138.14 55.63 Favored 'General case' 0 N--CA 1.447 -0.591 0 CA-C-N 115.66 -0.7 . . . . 0.0 109.927 179.659 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 152' ' ' ASN . . . . . . . . . . . . . 64.3 t30 -168.55 152.5 5.76 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 109.066 -0.716 . . . . 0.0 109.066 -179.779 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 18.8 pt -63.73 139.01 97.55 Favored Pre-proline 0 C--N 1.327 -0.381 0 O-C-N 123.153 0.283 . . . . 0.0 110.869 179.951 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 28.5 Cg_endo -63.82 115.89 3.35 Favored 'Trans proline' 0 CA--C 1.528 0.22 0 C-N-CA 122.891 2.394 . . . . 0.0 112.676 -179.824 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.255 1.427 0 CA-C-O 118.241 -1.31 . . . . 0.0 111.365 179.822 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 68.3 mtt . . . . . 0 N--CA 1.482 1.172 0 CA-C-O 120.77 0.319 . . . . 0.0 110.732 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 100.52 117.58 4.13 Favored Glycine 0 N--CA 1.449 -0.452 0 C-N-CA 120.915 -0.66 . . . . 0.0 111.933 179.872 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 36.5 m -129.9 128.04 41.39 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 122.665 -0.314 . . . . 0.0 111.146 -179.604 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -122.49 137.23 54.94 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.328 -0.396 . . . . 0.0 109.971 179.682 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 12.7 p-80 -155.35 125.09 6.48 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.582 -0.281 . . . . 0.0 110.735 -179.39 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -164.27 112.88 1.15 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.444 -0.344 . . . . 0.0 111.074 179.559 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 2.7 p80 -164.24 138.95 5.7 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.96 -0.564 . . . . 0.0 109.906 179.763 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 51.7 p-80 -169.12 136.96 1.9 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.818 0.342 . . . . 0.0 110.612 179.418 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 20.6 p80 -146.9 151.5 37.14 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.684 -179.505 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 72.4 t60 -161.26 115.51 2.02 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.221 -0.445 . . . . 0.0 109.851 179.235 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 2.7 p -134.12 131.72 39.05 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 120.568 0.223 . . . . 0.0 111.124 -179.391 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 19.0 m -157.97 -178.24 7.16 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 110.03 -0.359 . . . . 0.0 110.03 179.772 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 131.3 78.56 0.17 Allowed Glycine 0 N--CA 1.45 -0.432 0 C-N-CA 120.308 -0.949 . . . . 0.0 113.334 179.324 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 33.4 tp -157.15 132.55 9.15 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 120.657 0.265 . . . . 0.0 110.517 179.153 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 2.8 m -137.24 149.95 67.51 Favored Pre-proline 0 C--N 1.327 -0.375 0 CA-C-N 116.485 -0.325 . . . . 0.0 110.256 179.692 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 89.7 Cg_endo -83.19 178.7 5.64 Favored 'Trans proline' 0 C--O 1.238 0.499 0 C-N-CA 122.781 2.321 . . . . 0.0 112.688 179.545 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 37.4 ttm180 -164.94 158.09 16.75 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.196 -179.797 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 143.12 123.26 1.77 Allowed Glycine 0 C--N 1.331 0.284 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.743 179.205 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 62.4 m -155.63 143.23 19.59 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 110.207 -0.294 . . . . 0.0 110.207 179.202 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -158.72 128.12 5.63 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.576 -0.283 . . . . 0.0 110.463 -179.563 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -170.04 170.93 7.28 Favored 'General case' 0 C--O 1.236 0.344 0 O-C-N 123.103 0.252 . . . . 0.0 110.935 179.817 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 162.88 162.05 13.17 Favored Glycine 0 C--N 1.33 0.228 0 C-N-CA 120.843 -0.694 . . . . 0.0 112.422 179.656 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 19.3 m -157.7 154.9 29.03 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 116.778 0.289 . . . . 0.0 110.517 179.874 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -143.93 169.68 17.34 Favored 'General case' 0 C--O 1.235 0.331 0 CA-C-N 116.576 -0.284 . . . . 0.0 110.388 179.855 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 29.3 tp -153.76 147.73 25.55 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-O 120.7 0.285 . . . . 0.0 110.896 -179.898 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 14.7 tt0 -108.27 154.38 21.88 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.383 -0.372 . . . . 0.0 110.615 179.686 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 14.5 p-10 -114.99 -168.0 1.32 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.516 -0.311 . . . . 0.0 110.878 -179.83 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 46.2 ttm -156.53 142.89 18.32 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-N 116.506 -0.316 . . . . 0.0 110.559 -179.584 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -118.71 168.87 10.32 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.621 0.248 . . . . 0.0 110.671 179.329 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 51.0 mttt -132.34 172.76 12.04 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.465 -0.334 . . . . 0.0 110.88 -179.654 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 86.3 mtt180 -132.56 172.98 11.8 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.992 -179.613 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 16.5 mt -102.77 -160.47 0.78 Allowed 'General case' 0 C--O 1.236 0.344 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.046 179.858 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.524 ' NZ ' ' HG3' ' A' ' 36' ' ' GLU . 35.2 mtpt -124.58 -178.01 4.0 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.633 -0.258 . . . . 0.0 110.733 179.92 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 15.7 mm-40 -101.38 56.1 0.84 Allowed 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.504 -0.316 . . . . 0.0 111.144 -179.215 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 4.3 pt 30.78 85.38 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.48 1.05 0 C-N-CA 124.406 1.082 . . . . 0.0 113.134 179.764 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . 0.524 ' HG3' ' NZ ' ' A' ' 33' ' ' LYS . 9.1 mm-40 -78.96 -76.28 0.21 Allowed 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.48 -0.782 . . . . 0.0 112.042 -178.828 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 24.2 mt-10 59.9 73.04 0.5 Allowed 'General case' 0 N--CA 1.466 0.327 0 O-C-N 123.473 0.483 . . . . 0.0 111.167 -179.158 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . 0.414 ' H ' ' HG3' ' A' ' 38' ' ' GLU . 1.1 pp20? -81.96 173.49 12.16 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.939 179.975 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -94.53 -66.8 0.89 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.784 0.326 . . . . 0.0 111.188 -179.138 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 116.75 96.79 1.96 Allowed Glycine 0 N--CA 1.449 -0.488 0 C-N-CA 120.629 -0.796 . . . . 0.0 113.042 179.763 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -104.09 -172.34 2.09 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 110.107 -0.331 . . . . 0.0 110.107 179.229 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 20.2 tp -83.75 79.39 9.48 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.147 0.499 . . . . 0.0 110.297 179.919 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 28.6 ttm180 -144.22 140.79 29.48 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.797 -0.638 . . . . 0.0 109.632 179.781 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . 0.409 ' H ' ' CD ' ' A' ' 44' ' ' GLU . 0.7 OUTLIER -71.97 84.08 0.96 Allowed 'General case' 0 C--O 1.235 0.305 0 CA-C-O 120.972 0.415 . . . . 0.0 110.112 179.398 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 14.9 ptt? -132.53 12.05 4.48 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.772 -179.244 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 1.7 mp0 -65.57 -11.64 45.91 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.834 -178.929 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -70.31 -17.43 63.08 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.963 0.411 . . . . 0.0 111.331 179.852 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 19.3 pttp -70.71 -13.22 61.99 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.49 -179.411 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 5.3 p -65.11 -20.53 27.72 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.317 0 CA-C-O 121.208 0.528 . . . . 0.0 110.952 -179.66 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 49.3 mt-10 -82.5 -12.0 58.09 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.284 179.673 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 28.7 ttmt -107.43 -32.71 7.62 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.18 0.514 . . . . 0.0 109.682 179.228 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 71.1 mt-10 -78.74 7.54 6.8 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.548 -0.751 . . . . 0.0 111.265 179.754 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -62.3 -29.21 70.27 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 109.944 -0.391 . . . . 0.0 109.944 178.988 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -96.78 3.27 62.69 Favored Glycine 0 N--CA 1.449 -0.449 0 N-CA-C 110.733 -0.947 . . . . 0.0 110.733 178.526 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -101.47 23.3 11.28 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.113 0.482 . . . . 0.0 110.321 -179.388 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 10.8 m -65.72 -17.63 22.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.762 179.58 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 10.1 mm-40 -105.28 14.24 29.25 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.066 179.057 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -125.82 -59.39 1.35 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.968 -179.729 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 64.7 m -109.86 -45.08 3.69 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 111.978 0.362 . . . . 0.0 111.978 -179.062 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -79.85 29.77 0.26 Allowed 'General case' 0 CA--C 1.533 0.323 0 N-CA-C 112.243 0.46 . . . . 0.0 112.243 -178.884 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 7.7 m -92.46 -29.17 16.39 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.935 0.398 . . . . 0.0 110.454 179.932 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -65.19 -22.8 66.95 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.883 -0.599 . . . . 0.0 111.46 -179.562 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -66.89 -31.08 71.44 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.111 0.481 . . . . 0.0 110.431 179.324 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -70.22 -36.23 74.4 Favored 'General case' 0 C--O 1.232 0.153 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.799 -179.932 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -78.24 6.19 8.71 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.374 -0.376 . . . . 0.0 111.179 179.754 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 4.2 tp-100 -119.43 -51.63 2.29 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.494 179.763 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -82.1 -62.1 1.72 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.364 -179.432 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . 0.501 ' O ' HG23 ' A' ' 72' ' ' VAL . 0.7 OUTLIER -58.52 -33.89 70.36 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.464 -179.101 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 32.6 tptt -53.25 -34.21 56.25 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 116.198 -0.455 . . . . 0.0 112.165 -179.577 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 2.5 mm-40 -61.0 -34.68 75.19 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.042 0.448 . . . . 0.0 110.764 -179.793 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 10.2 tp10 -88.42 -38.19 15.26 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.493 179.829 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.501 HG23 ' O ' ' A' ' 68' ' ' GLU . 61.4 t -64.7 -41.84 93.35 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.059 -179.589 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 4.6 t70 -68.04 -33.19 74.12 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.333 -179.357 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . 0.45 ' HB2' ' HE ' ' A' ' 150' ' ' ARG . 11.5 p -82.47 -17.25 45.89 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 121.284 0.564 . . . . 0.0 109.964 179.908 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -101.79 48.19 0.89 Allowed 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.836 0.827 . . . . 0.0 108.849 178.717 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . 0.426 ' HB3' ' HE3' ' A' ' 149' ' ' LYS . 28.0 t -125.0 158.8 32.78 Favored 'General case' 0 N--CA 1.446 -0.643 0 CA-C-N 114.726 -1.125 . . . . 0.0 110.22 -179.085 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 5.4 pt -126.94 134.8 65.37 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.138 178.895 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 61.2 t80 -92.19 130.27 37.94 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.323 -179.668 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.42 HG21 ' HE2' ' A' ' 95' ' ' PHE . 8.0 t -104.23 108.2 24.14 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.742 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.35 -179.947 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -112.88 170.24 13.32 Favored Glycine 0 N--CA 1.442 -0.961 0 N-CA-C 111.022 -0.831 . . . . 0.0 111.022 179.468 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 9.9 m-20 58.51 38.5 25.45 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-N 116.97 0.385 . . . . 0.0 110.557 -179.76 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.505 HG12 ' H ' ' A' ' 83' ' ' ASP . 1.4 t -79.35 171.81 1.23 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.971 -178.993 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . 0.562 ' OD1' ' HD2' ' A' ' 142' ' ' ARG . 30.2 t70 -81.24 141.71 33.87 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.287 -0.415 . . . . 0.0 109.906 179.476 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 55.2 p90 -65.01 -16.3 63.28 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 112.708 0.633 . . . . 0.0 112.708 -178.113 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -110.22 9.26 23.84 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.698 0.285 . . . . 0.0 111.327 -179.953 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' CYS . . . . . 0.432 ' SG ' ' HB2' ' A' ' 140' ' ' HIS . 0.9 OUTLIER -73.88 135.7 43.36 Favored 'General case' 0 C--O 1.235 0.294 0 CA-C-O 121.118 0.485 . . . . 0.0 111.336 179.888 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . 0.582 ' O ' ' HG2' ' A' ' 90' ' ' GLU . 9.0 p -103.01 153.16 38.49 Favored Pre-proline 0 C--N 1.324 -0.514 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.19 179.337 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 15.2 Cg_endo -58.82 -37.86 91.64 Favored 'Trans proline' 0 CA--C 1.531 0.335 0 C-N-CA 122.48 2.12 . . . . 0.0 112.827 -179.426 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 7.5 mp0 -63.79 -46.3 85.83 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.756 -179.361 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . 0.582 ' HG2' ' O ' ' A' ' 87' ' ' THR . 7.7 pt-20 -65.65 -26.4 67.79 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.807 0.337 . . . . 0.0 111.069 -179.114 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 62.2 t -74.61 -55.51 11.74 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.874 -179.953 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 2.7 pt20 -62.51 -36.12 81.54 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 112.405 0.52 . . . . 0.0 112.405 -178.516 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 2.9 pt20 -76.35 -24.07 54.22 Favored 'General case' 0 N--CA 1.463 0.185 0 C-N-CA 120.792 -0.363 . . . . 0.0 111.605 -178.947 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -80.02 -39.25 30.3 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.856 0.36 . . . . 0.0 111.193 -179.494 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . 0.42 ' HE2' HG21 ' A' ' 79' ' ' VAL . 21.1 m-30 -81.3 -17.92 47.62 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.955 -179.22 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . 0.53 ' HA ' ' O ' ' A' ' 99' ' ' GLY . 1.9 tt0 -61.36 -23.78 66.01 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.801 179.702 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 2.7 m -63.11 -31.21 72.3 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.641 -0.708 . . . . 0.0 110.594 179.47 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 27.7 m -99.61 -44.96 5.95 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.213 179.547 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . 0.53 ' O ' ' HA ' ' A' ' 96' ' ' GLN . . . -141.52 132.24 5.2 Favored Glycine 0 N--CA 1.446 -0.646 0 C-N-CA 120.793 -0.718 . . . . 0.0 112.012 -179.815 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 2.5 m -68.0 147.23 52.69 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 120.728 0.299 . . . . 0.0 110.481 179.905 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 2.0 p -125.9 135.2 64.62 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-O 120.832 0.349 . . . . 0.0 111.325 -179.088 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 28.3 t-20 -104.78 -43.78 5.02 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.298 179.268 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 5.3 mpt_? -119.4 137.15 53.94 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.345 -0.388 . . . . 0.0 109.999 179.539 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 12.3 p -144.47 145.84 20.99 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.109 -179.948 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . 0.581 ' HB ' ' CE2' ' A' ' 119' ' ' TYR . 4.2 m -146.13 137.83 24.9 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 110.036 -0.357 . . . . 0.0 110.036 179.358 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 14.9 tt -121.38 144.96 28.74 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-O 120.824 0.345 . . . . 0.0 110.631 -179.78 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 18.6 tp -123.22 127.64 48.89 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 116.438 -0.346 . . . . 0.0 110.469 -179.959 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -90.1 121.69 32.39 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.378 179.162 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 20.5 t70 -92.76 144.39 25.34 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 120.98 0.419 . . . . 0.0 111.174 -179.69 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -135.81 30.53 3.1 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 179.131 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 40.0 t80 -111.5 -12.24 13.99 Favored 'General case' 0 N--CA 1.452 -0.329 0 CA-C-N 115.19 -0.914 . . . . 0.0 110.029 -179.253 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 112.17 9.49 19.97 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.706 -179.466 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 32.6 mt-30 -91.81 157.59 41.29 Favored Pre-proline 0 C--N 1.325 -0.497 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 179.256 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 13.9 Cg_endo -58.1 99.09 0.09 OUTLIER 'Trans proline' 0 C--N 1.345 0.388 0 C-N-CA 122.095 1.863 . . . . 0.0 111.713 179.024 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 73.9 mttt -58.5 163.3 3.22 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.624 -0.717 . . . . 0.0 111.122 -179.196 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 102.55 6.12 47.57 Favored Glycine 0 N--CA 1.445 -0.75 0 C-N-CA 120.705 -0.76 . . . . 0.0 112.015 -179.811 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 46.5 m-85 -51.96 119.36 4.21 Favored 'General case' 0 CA--C 1.519 -0.236 0 CA-C-O 120.585 0.231 . . . . 0.0 110.473 179.56 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -146.79 172.94 12.87 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-O 121.034 0.445 . . . . 0.0 111.028 -179.136 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' TYR . . . . . 0.581 ' CE2' ' HB ' ' A' ' 105' ' ' THR . 50.5 p90 -154.2 148.75 26.28 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 115.791 -0.64 . . . . 0.0 109.471 179.02 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 30.6 m -124.64 136.31 61.07 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-N 116.476 -0.329 . . . . 0.0 110.314 179.566 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . 0.411 ' HB3' ' HB2' ' A' ' 76' ' ' SER . 10.2 pt-20 -128.38 149.09 50.69 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 120.898 0.38 . . . . 0.0 111.06 -179.844 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 7.7 t80 -148.87 167.96 24.3 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.535 -179.942 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 8.0 t -82.62 -42.27 18.19 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.177 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.446 -179.501 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -71.15 126.91 30.86 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.327 0.584 . . . . 0.0 111.292 -179.165 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . 0.408 HD12 ' H ' ' A' ' 125' ' ' ILE . 4.7 mp -67.87 -44.11 85.55 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-N 115.244 -0.889 . . . . 0.0 111.262 -178.845 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . 0.445 ' HA ' ' HB3' ' A' ' 129' ' ' GLN . 0.2 OUTLIER -62.34 -27.58 69.15 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.574 -0.284 . . . . 0.0 111.698 -179.132 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -63.66 -57.95 8.43 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.893 0.378 . . . . 0.0 110.23 179.423 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 11.5 p -69.26 -27.09 33.39 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 116.343 -0.389 . . . . 0.0 110.726 179.748 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 129' ' ' GLN . . . . . 0.445 ' HB3' ' HA ' ' A' ' 126' ' ' ASP . 16.1 tt0 -62.24 -45.4 93.48 Favored 'General case' 0 C--N 1.333 -0.121 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.493 179.504 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 37.6 m-80 -73.4 -26.84 61.15 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.246 0.546 . . . . 0.0 109.914 179.417 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . 0.451 ' O ' ' HB2' ' A' ' 135' ' ' ASN . . . -69.62 -49.72 51.2 Favored 'General case' 0 N--CA 1.45 -0.456 0 CA-C-N 115.661 -0.699 . . . . 0.0 110.792 179.623 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 3.9 pp -65.74 -16.08 63.44 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-O 120.884 0.373 . . . . 0.0 111.223 179.99 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 51.2 tp -82.39 -54.19 5.41 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.014 179.344 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 89.8 mt -120.43 93.64 4.11 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.298 179.827 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 135' ' ' ASN . . . . . 0.499 ' HB3' HG21 ' A' ' 146' ' ' VAL . 0.2 OUTLIER -145.98 -57.31 0.3 Allowed 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.978 -0.556 . . . . 0.0 111.054 -179.522 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . 0.418 ' HG2' ' H ' ' A' ' 136' ' ' GLU . 1.2 pt-20 -73.44 87.71 1.58 Allowed 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.854 -0.612 . . . . 0.0 111.19 -179.462 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 6.6 m -138.28 -65.87 0.5 Allowed 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.21 179.278 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 6.2 tm-20 -157.96 136.22 10.96 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.309 -179.576 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -152.23 119.23 5.83 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 109.071 -0.715 . . . . 0.0 109.071 179.181 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 140' ' ' HIS . . . . . 0.432 ' HB2' ' SG ' ' A' ' 86' ' ' CYS . 2.2 t60 65.45 19.07 11.51 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-O 121.147 0.499 . . . . 0.0 110.658 179.63 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 88.78 -5.84 84.21 Favored Glycine 0 N--CA 1.447 -0.589 0 C-N-CA 120.864 -0.684 . . . . 0.0 111.814 -179.189 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 142' ' ' ARG . . . . . 0.562 ' HD2' ' OD1' ' A' ' 83' ' ' ASP . 0.0 OUTLIER -108.1 175.56 5.43 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 120.798 0.332 . . . . 0.0 110.154 -179.676 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 10.8 pt20 -113.9 148.94 35.9 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 109.584 -0.525 . . . . 0.0 109.584 179.257 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -137.12 175.23 9.8 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 120.789 0.328 . . . . 0.0 110.897 -179.905 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 84.0 tttt -123.96 127.46 47.99 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.758 -0.655 . . . . 0.0 109.77 -179.873 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 146' ' ' VAL . . . . . 0.499 HG21 ' HB3' ' A' ' 135' ' ' ASN . 99.2 t -115.72 126.42 73.24 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 CA-C-O 120.801 0.334 . . . . 0.0 110.975 -179.073 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 3.8 m -121.81 153.27 38.56 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.673 -179.69 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -74.84 117.17 16.38 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.721 0.296 . . . . 0.0 110.489 179.386 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 149' ' ' LYS . . . . . 0.426 ' HE3' ' HB3' ' A' ' 76' ' ' SER . 11.6 ttpp -92.97 47.48 1.28 Allowed 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.728 -179.232 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 150' ' ' ARG . . . . . 0.45 ' HE ' ' HB2' ' A' ' 74' ' ' SER . 0.0 OUTLIER -74.46 95.66 2.77 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 109.892 -0.41 . . . . 0.0 109.892 179.517 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 13.5 t -62.31 144.4 55.72 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.836 -179.815 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 152' ' ' ASN . . . . . . . . . . . . . 1.9 t-20 -163.85 -165.65 1.05 Allowed 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.769 -0.65 . . . . 0.0 109.459 -179.762 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 19.0 pt -112.4 150.94 43.36 Favored Pre-proline 0 C--N 1.325 -0.496 0 N-CA-C 110.284 -0.265 . . . . 0.0 110.284 179.787 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -60.14 101.64 0.16 Allowed 'Trans proline' 0 C--N 1.346 0.422 0 C-N-CA 122.776 2.317 . . . . 0.0 112.171 179.733 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.244 0 CA-C-O 118.309 -1.273 . . . . 0.0 111.046 -179.661 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 19.7 mmt . . . . . 0 N--CA 1.48 1.047 0 N-CA-C 110.071 -0.344 . . . . 0.0 110.071 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 122.56 120.19 2.61 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 121.003 -0.618 . . . . 0.0 112.112 179.914 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 66.7 m -115.09 152.98 31.57 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 120.68 0.276 . . . . 0.0 110.708 -179.932 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -126.14 158.48 35.41 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.612 -179.575 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 2.5 t60 -146.78 139.51 25.14 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.646 0.26 . . . . 0.0 110.507 -179.944 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 19.3 p80 -150.83 168.57 24.04 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.782 0.325 . . . . 0.0 111.014 -179.444 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 6.8 p80 -155.41 173.53 16.53 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.144 -0.48 . . . . 0.0 109.979 179.93 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 28.4 p80 -144.93 174.23 11.2 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 110.167 -0.309 . . . . 0.0 110.167 179.558 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 30.4 p-80 -101.16 178.61 4.61 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.896 0.379 . . . . 0.0 111.374 -179.143 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 10.5 p-80 -146.54 141.18 26.74 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.316 -179.957 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 2.4 m -138.13 154.07 49.21 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.661 0.267 . . . . 0.0 111.056 -179.981 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 42.2 m -149.59 -178.83 6.66 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.511 -0.313 . . . . 0.0 110.613 -179.738 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -168.51 156.39 27.8 Favored Glycine 0 C--N 1.331 0.269 0 C-N-CA 121.02 -0.609 . . . . 0.0 112.281 179.809 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 69.1 mt -103.09 173.47 6.29 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.689 0.281 . . . . 0.0 110.856 -179.987 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 24.4 m -123.42 161.03 47.85 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-N 116.663 -0.244 . . . . 0.0 111.021 179.963 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_exo -78.65 -177.35 3.83 Favored 'Trans proline' 0 C--N 1.35 0.625 0 C-N-CA 123.167 2.578 . . . . 0.0 112.561 179.885 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 53.9 mtm180 -126.14 -172.49 2.63 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.657 -179.624 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -147.42 168.5 28.45 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.89 -0.672 . . . . 0.0 111.755 179.767 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 1.4 m -125.27 178.56 5.52 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.742 0.271 . . . . 0.0 110.894 -179.877 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -155.24 144.06 20.67 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 109.977 -0.379 . . . . 0.0 109.977 179.804 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -138.47 164.51 29.19 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 110.355 -0.239 . . . . 0.0 110.355 -179.928 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -116.14 -158.49 11.5 Favored Glycine 0 N--CA 1.449 -0.45 0 C-N-CA 120.682 -0.77 . . . . 0.0 113.067 -179.702 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 6.6 m -131.2 179.94 5.72 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 120.812 0.339 . . . . 0.0 110.846 -179.644 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 8.6 p-10 -106.77 164.99 11.65 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.824 -179.812 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 3.1 tt -148.41 123.09 9.86 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 109.576 -0.527 . . . . 0.0 109.576 -179.947 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.424 ' HG2' ' H ' ' A' ' 26' ' ' GLU . 1.7 pt-20 -76.39 121.37 22.94 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.1 0.476 . . . . 0.0 112.049 -178.969 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 5.2 t70 -133.22 -159.52 0.97 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.601 -0.727 . . . . 0.0 109.463 179.319 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 23.6 ttp -155.47 3.02 0.18 Allowed 'General case' 0 CA--C 1.536 0.418 0 N-CA-C 112.251 0.463 . . . . 0.0 112.251 -179.525 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 27.6 mmtp -94.83 127.54 40.91 Favored 'General case' 0 C--N 1.327 -0.371 0 O-C-N 122.015 -0.428 . . . . 0.0 111.484 -179.812 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 49.0 mtmt -143.02 124.44 14.72 Favored 'General case' 0 C--O 1.238 0.462 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.195 179.637 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -177.07 14.25 0.0 OUTLIER 'General case' 0 CA--C 1.536 0.415 0 N-CA-C 111.887 0.328 . . . . 0.0 111.887 -179.733 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 34.1 mt -129.65 -179.38 5.15 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.789 0.328 . . . . 0.0 110.909 -179.235 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -162.99 31.77 0.1 Allowed 'General case' 0 CA--C 1.532 0.28 0 O-C-N 122.203 -0.311 . . . . 0.0 111.433 -179.992 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 1.5 pm0 -117.33 -175.3 2.78 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.895 0.379 . . . . 0.0 111.27 -179.331 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -133.37 130.41 57.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 115.618 -0.719 . . . . 0.0 109.564 178.979 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . 0.656 ' CD ' ' HA ' ' A' ' 62' ' ' THR . 0.0 OUTLIER -139.61 -159.74 0.99 Allowed 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 116.613 -0.267 . . . . 0.0 110.85 -178.987 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 -135.66 168.23 19.66 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.914 0.388 . . . . 0.0 110.91 179.523 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -68.44 127.27 32.37 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.505 -0.771 . . . . 0.0 111.272 -179.229 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -145.83 38.67 1.11 Allowed 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.971 0.415 . . . . 0.0 110.799 179.741 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -107.49 151.25 16.92 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.821 -0.704 . . . . 0.0 112.133 -179.705 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -145.98 162.38 37.96 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.59 0.233 . . . . 0.0 110.471 -179.778 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 12.1 tp -77.5 86.07 3.86 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.247 0.546 . . . . 0.0 110.369 -179.811 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 22.0 ttm-85 -148.43 149.65 32.1 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.031 -179.636 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -79.76 56.11 2.2 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.582 0.706 . . . . 0.0 110.485 -179.86 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 27.4 ptm -106.54 12.62 29.3 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.42 -0.809 . . . . 0.0 109.968 179.752 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 28.9 mm-40 -73.91 -26.45 60.53 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.531 -179.307 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -70.29 -6.37 34.54 Favored 'General case' 0 C--O 1.236 0.347 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.679 179.501 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 13.9 ttpp -86.57 2.1 49.34 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.207 179.599 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 8.3 p -55.74 -30.32 27.16 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.331 0 CA-C-N 116.052 -0.522 . . . . 0.0 112.005 -179.233 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 17.1 pt-20 -67.19 -28.45 68.11 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.862 0.363 . . . . 0.0 110.9 -179.928 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 37.4 mttm -86.63 -32.55 20.52 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 109.342 -0.614 . . . . 0.0 109.342 179.515 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 15.8 mm-40 -77.23 -3.62 40.61 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.691 -0.686 . . . . 0.0 111.197 -179.427 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 21.3 ttt -59.11 -38.58 79.91 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.174 0.511 . . . . 0.0 110.064 179.059 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -88.57 1.75 84.15 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.678 -0.772 . . . . 0.0 112.125 179.72 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -127.39 29.75 5.49 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 121.252 0.548 . . . . 0.0 110.937 -179.693 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 6.8 m -64.33 -17.44 21.05 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.206 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.937 179.704 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 5.5 mp0 -101.67 12.76 36.61 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.634 179.557 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 21.2 t70 -130.61 -54.06 1.08 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.588 -0.278 . . . . 0.0 111.43 179.724 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -99.36 -37.46 9.23 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 112.259 0.466 . . . . 0.0 112.259 -179.314 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -98.06 20.07 12.94 Favored 'General case' 0 C--O 1.237 0.399 0 N-CA-C 111.768 0.285 . . . . 0.0 111.768 -178.609 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -71.95 -17.25 62.09 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 111.818 0.303 . . . . 0.0 111.818 -179.594 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . 0.656 ' HA ' ' CD ' ' A' ' 36' ' ' GLU . 0.7 OUTLIER -56.64 -19.2 15.1 Favored 'General case' 0 CA--C 1.533 0.301 0 N-CA-C 112.693 0.627 . . . . 0.0 112.693 -179.095 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -69.52 -16.01 63.36 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.354 -0.384 . . . . 0.0 110.884 179.499 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -75.54 -48.9 20.44 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.588 -179.42 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 4.3 m -81.21 -4.95 57.1 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 120.894 0.378 . . . . 0.0 111.511 -179.18 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 20.1 tp60 -111.94 -65.52 1.17 Allowed 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 112.171 0.434 . . . . 0.0 112.171 -179.947 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -77.7 -54.58 6.2 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.774 0.321 . . . . 0.0 111.802 -178.276 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . 0.455 ' O ' HG23 ' A' ' 72' ' ' VAL . 1.0 OUTLIER -62.05 -25.86 67.92 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.323 -0.398 . . . . 0.0 110.756 -179.518 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . 0.432 ' HG3' ' OD2' ' A' ' 73' ' ' ASP . 0.1 OUTLIER -49.48 -42.91 44.67 Favored 'General case' 0 C--O 1.232 0.139 0 CA-C-N 115.998 -0.546 . . . . 0.0 112.036 -179.293 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 28.2 mt-10 -52.23 -35.84 50.66 Favored 'General case' 0 N--CA 1.465 0.301 0 O-C-N 123.696 0.622 . . . . 0.0 112.138 -179.243 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 5.7 tp10 -83.52 -32.96 25.62 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 116.564 -0.289 . . . . 0.0 111.56 -178.755 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.528 ' HA ' ' O ' ' A' ' 122' ' ' PHE . 0.6 OUTLIER -69.05 -40.95 81.4 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 116.583 -0.28 . . . . 0.0 111.518 -178.786 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . 0.432 ' OD2' ' HG3' ' A' ' 69' ' ' LYS . 0.8 OUTLIER -83.53 -11.44 57.41 Favored 'General case' 0 N--CA 1.463 0.204 0 C-N-CA 119.819 -0.753 . . . . 0.0 111.353 -179.961 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 46.4 m -87.28 -20.23 27.13 Favored 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 176.729 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -116.66 53.86 0.87 Allowed 'General case' 0 N--CA 1.454 -0.269 0 CA-C-N 115.108 -0.951 . . . . 0.0 110.468 -179.969 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -124.24 159.57 29.87 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 120.942 0.401 . . . . 0.0 110.606 179.368 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 4.5 pt -127.29 138.18 55.56 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.231 179.048 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 34.7 t80 -104.4 126.96 51.96 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 116.128 -0.487 . . . . 0.0 109.841 -179.697 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.427 HG12 HG22 ' A' ' 82' ' ' VAL . 4.6 t -98.89 112.65 31.54 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 CA-C-O 121.072 0.463 . . . . 0.0 110.464 -179.718 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -111.02 153.28 17.25 Favored Glycine 0 N--CA 1.444 -0.78 0 CA-C-N 115.74 -0.663 . . . . 0.0 111.793 179.864 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 11.2 m-80 61.01 53.08 3.8 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-O 121.083 0.468 . . . . 0.0 110.621 -179.643 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.427 HG22 HG12 ' A' ' 79' ' ' VAL . 1.1 t -89.46 169.08 1.43 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.221 -179.693 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . 0.511 ' OD1' ' HD2' ' A' ' 142' ' ' ARG . 28.4 t70 -73.99 140.35 45.43 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.877 0.37 . . . . 0.0 110.403 -179.958 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 1.1 p90 -63.97 -25.71 68.26 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.794 -0.639 . . . . 0.0 111.905 -178.907 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -96.72 10.43 38.74 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.728 0.299 . . . . 0.0 111.443 -179.595 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' CYS . . . . . 0.44 ' HB2' ' O ' ' A' ' 83' ' ' ASP . 0.8 OUTLIER -84.64 149.31 25.93 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.152 0.501 . . . . 0.0 111.15 179.823 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . 0.472 ' O ' ' HG2' ' A' ' 90' ' ' GLU . 2.5 p -120.18 157.73 52.48 Favored Pre-proline 0 C--N 1.322 -0.622 0 CA-C-N 115.73 -0.668 . . . . 0.0 109.949 179.4 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -59.09 -36.56 95.9 Favored 'Trans proline' 0 C--N 1.345 0.392 0 C-N-CA 122.366 2.044 . . . . 0.0 112.647 -179.009 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . 0.424 ' O ' ' HG3' ' A' ' 92' ' ' GLN . 56.2 mp0 -63.83 -53.11 55.9 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.67 -179.176 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . 0.472 ' HG2' ' O ' ' A' ' 87' ' ' THR . 8.9 pt-20 -62.92 -24.71 67.98 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.79 0.328 . . . . 0.0 111.853 -178.743 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 52.5 t -78.3 -49.3 21.4 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.587 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.917 -179.932 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . 0.424 ' HG3' ' O ' ' A' ' 89' ' ' GLU . 0.0 OUTLIER -67.8 -37.59 82.2 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 112.382 0.512 . . . . 0.0 112.382 -178.582 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -71.86 -26.34 62.31 Favored 'General case' 0 N--CA 1.464 0.231 0 C-N-CA 120.836 -0.346 . . . . 0.0 111.325 -179.258 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 1.6 m80 -79.26 -37.34 38.18 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.064 0.459 . . . . 0.0 110.671 179.96 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 16.7 m-30 -81.26 -14.75 57.11 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.402 -179.631 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . 0.544 ' HA ' ' O ' ' A' ' 99' ' ' GLY . 52.4 tt0 -64.1 -23.22 67.24 Favored 'General case' 0 C--N 1.333 -0.113 0 CA-C-N 115.94 -0.573 . . . . 0.0 109.898 179.215 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 1.1 m -68.79 -26.25 65.11 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.229 178.942 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 5.6 m -91.6 -47.37 7.43 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 178.864 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . 0.544 ' O ' ' HA ' ' A' ' 96' ' ' GLN . . . -150.16 143.24 10.47 Favored Glycine 0 N--CA 1.443 -0.896 0 CA-C-N 115.485 -0.779 . . . . 0.0 111.155 179.344 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . 0.518 ' HB ' ' CZ ' ' A' ' 122' ' ' PHE . 0.9 OUTLIER -62.09 139.22 58.46 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 116.881 0.34 . . . . 0.0 110.565 -179.832 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.43 HG23 ' HB ' ' A' ' 120' ' ' VAL . 7.6 p -101.78 145.26 11.97 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 116.308 -0.406 . . . . 0.0 111.424 -179.275 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . 0.472 ' HB3' ' O ' ' A' ' 121' ' ' GLU . 17.9 t30 -113.74 -62.05 1.65 Allowed 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 109.687 -0.486 . . . . 0.0 109.687 178.789 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 1.2 mpp_? -120.62 145.62 47.21 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.107 179.236 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 5.4 p -137.12 128.92 42.67 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-O 121.238 0.542 . . . . 0.0 110.611 179.776 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 2.8 m -129.53 134.41 47.75 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.243 179.455 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 10.6 tt -125.02 148.9 29.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 120.697 0.284 . . . . 0.0 110.674 -179.718 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 30.2 tp -134.01 118.92 18.37 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.084 -0.507 . . . . 0.0 109.979 179.351 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -89.27 109.77 20.62 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 120.716 0.294 . . . . 0.0 110.31 179.502 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -74.03 146.89 43.38 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.15 -179.785 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 7.2 mptt -133.04 31.65 3.84 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.898 -0.592 . . . . 0.0 109.442 178.906 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -120.3 -3.69 9.98 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.628 -179.153 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 115.32 9.48 13.05 Favored Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.147 -1.025 . . . . 0.0 114.101 179.256 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 36.7 mt-30 -98.18 155.07 37.37 Favored Pre-proline 0 C--N 1.323 -0.562 0 CA-C-N 117.467 0.633 . . . . 0.0 109.382 179.206 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -53.65 98.84 0.05 OUTLIER 'Trans proline' 0 C--N 1.348 0.523 0 C-N-CA 122.887 2.392 . . . . 0.0 111.598 178.859 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 86.2 mttt -59.39 151.75 23.0 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.408 -0.815 . . . . 0.0 111.195 -179.302 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 110.36 6.22 27.58 Favored Glycine 0 N--CA 1.447 -0.625 0 C-N-CA 120.368 -0.92 . . . . 0.0 112.468 -179.698 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 51.8 m-85 -51.89 119.13 3.95 Favored 'General case' 0 CA--C 1.521 -0.169 0 CA-C-O 120.592 0.234 . . . . 0.0 110.425 179.185 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -143.49 161.65 37.87 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-O 120.806 0.336 . . . . 0.0 110.859 -179.263 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 15.1 p90 -151.19 145.26 25.29 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 109.517 -0.549 . . . . 0.0 109.517 178.878 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . 0.43 ' HB ' HG23 ' A' ' 101' ' ' VAL . 28.3 m -124.28 144.1 35.31 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.363 -179.794 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . 0.472 ' O ' ' HB3' ' A' ' 102' ' ' ASN . 7.4 pt-20 -124.56 144.57 50.06 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.703 -179.851 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 122' ' ' PHE . . . . . 0.528 ' O ' ' HA ' ' A' ' 72' ' ' VAL . 4.8 t80 -140.73 168.54 19.55 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.19 -0.459 . . . . 0.0 109.898 179.496 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -99.59 -24.77 4.07 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.241 0 N-CA-C 112.092 0.405 . . . . 0.0 112.092 -178.798 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 59.9 mm-40 -85.3 119.52 25.76 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.92 0.39 . . . . 0.0 110.496 -179.826 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 15.0 mt -64.48 -42.49 95.38 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 115.68 -0.691 . . . . 0.0 111.495 -179.132 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -57.48 -42.43 82.61 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.777 0.322 . . . . 0.0 111.599 -179.56 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -60.34 -51.86 67.71 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.634 -179.358 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 3.4 p -68.44 -24.26 29.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-O 120.856 0.36 . . . . 0.0 111.081 -179.328 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 45.3 tt0 -63.87 -41.44 97.76 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.747 179.921 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 19.7 t-20 -66.63 -33.89 76.65 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.046 179.972 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . 0.571 ' O ' ' HB2' ' A' ' 135' ' ' ASN . . . -73.05 -25.29 60.88 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.532 179.543 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 132' ' ' LEU . . . . . 0.443 HD13 ' HA ' ' A' ' 132' ' ' LEU . 0.2 OUTLIER -74.35 -25.78 59.73 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.233 0.539 . . . . 0.0 109.943 179.034 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 26.3 tp -81.26 -58.17 3.17 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.305 -0.862 . . . . 0.0 110.554 -179.643 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . 0.4 HD23 ' HA ' ' A' ' 134' ' ' LEU . 22.6 mt -127.78 121.14 29.44 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.314 -179.922 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 135' ' ' ASN . . . . . 0.571 ' HB2' ' O ' ' A' ' 131' ' ' ALA . 3.2 t30 -169.33 -53.72 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.163 0.506 . . . . 0.0 110.303 -179.915 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -80.04 71.27 6.76 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.814 -0.63 . . . . 0.0 111.06 179.997 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 2.3 p -112.65 -74.67 0.62 Allowed 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.362 179.012 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 24.3 tt0 -157.68 124.31 4.92 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.183 179.888 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -135.3 126.81 28.73 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 109.493 -0.558 . . . . 0.0 109.493 179.83 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 1.9 t60 64.79 22.16 12.5 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-O 121.331 0.586 . . . . 0.0 110.097 -179.697 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 84.04 -1.14 89.12 Favored Glycine 0 N--CA 1.448 -0.514 0 CA-C-N 115.758 -0.655 . . . . 0.0 112.415 -179.691 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 142' ' ' ARG . . . . . 0.511 ' HD2' ' OD1' ' A' ' 83' ' ' ASP . 0.0 OUTLIER -113.36 154.79 26.32 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.644 0.259 . . . . 0.0 110.323 -179.513 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 7.6 pt20 -95.86 146.64 24.4 Favored 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 109.499 -0.556 . . . . 0.0 109.499 178.75 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -141.05 -179.74 6.26 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.788 0.328 . . . . 0.0 110.608 -179.105 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -126.17 142.33 51.57 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.956 -0.566 . . . . 0.0 110.123 179.793 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 92.3 t -129.11 110.63 21.01 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 N-CA-C 109.789 -0.449 . . . . 0.0 109.789 -179.925 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -108.51 154.3 22.11 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.611 -179.614 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -76.02 116.43 16.71 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.02 0.438 . . . . 0.0 110.524 -179.91 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 3.6 ttpm? -86.51 68.89 10.32 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.974 -0.557 . . . . 0.0 109.684 179.927 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 150' ' ' ARG . . . . . 0.402 HH11 ' HD3' ' A' ' 150' ' ' ARG . 9.6 tpt180 -77.24 96.84 4.65 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.08 -179.392 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 95.4 m -71.1 103.99 2.9 Favored 'General case' 0 N--CA 1.453 -0.315 0 N-CA-C 109.671 -0.492 . . . . 0.0 109.671 178.738 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 152' ' ' ASN . . . . . . . . . . . . . 12.3 t-20 -148.83 151.51 34.88 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.773 -179.03 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 48.2 pt -77.04 151.46 81.79 Favored Pre-proline 0 C--N 1.324 -0.519 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.356 179.579 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 16.6 Cg_exo -66.96 99.96 0.49 Allowed 'Trans proline' 0 N--CA 1.462 -0.359 0 C-N-CA 122.438 2.092 . . . . 0.0 111.422 179.633 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.242 0 CA-C-O 118.312 -1.271 . . . . 0.0 111.456 -179.948 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 20.7 mmt . . . . . 0 N--CA 1.479 1.009 0 N-CA-C 109.882 -0.414 . . . . 0.0 109.882 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 119.0 168.82 14.2 Favored Glycine 0 N--CA 1.45 -0.427 0 C-N-CA 120.818 -0.706 . . . . 0.0 112.044 179.877 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 75.6 m -148.51 156.65 42.73 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 120.881 0.372 . . . . 0.0 110.858 -179.977 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -119.33 169.88 9.6 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.352 179.808 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 22.2 t60 -148.98 136.7 20.49 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 109.719 -0.474 . . . . 0.0 109.719 179.832 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -131.97 174.46 10.15 Favored 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 121.275 -0.17 . . . . 0.0 110.635 179.745 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 48.5 p-80 -149.23 169.12 21.48 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.392 0.139 . . . . 0.0 110.926 -179.714 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 1.8 p80 -160.66 173.52 15.34 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.585 -179.628 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 17.0 p-80 -150.26 163.69 37.63 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.549 -0.296 . . . . 0.0 110.473 -179.926 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 24.0 p-80 -145.56 152.36 39.59 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.844 -0.162 . . . . 0.0 110.606 179.623 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 2.4 m -109.05 -179.2 3.78 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.477 -0.329 . . . . 0.0 110.752 -179.742 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 8.5 t -146.92 166.02 28.01 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 109.879 -0.415 . . . . 0.0 109.879 179.824 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -158.86 167.03 34.68 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.916 -0.659 . . . . 0.0 112.414 -179.649 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 90.8 mt -132.81 175.31 9.46 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.712 0.291 . . . . 0.0 110.733 -179.809 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 17.3 m -127.23 155.76 75.77 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.667 -179.682 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 69.3 Cg_endo -74.59 -177.79 3.6 Favored 'Trans proline' 0 C--N 1.346 0.435 0 C-N-CA 122.762 2.308 . . . . 0.0 112.731 179.82 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 79.8 mtm180 -124.71 176.34 6.64 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.051 -179.744 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -136.81 150.65 20.65 Favored Glycine 0 N--CA 1.448 -0.535 0 C-N-CA 120.902 -0.666 . . . . 0.0 112.149 -179.776 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 1.4 m -106.74 155.08 20.07 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 110.4 -0.222 . . . . 0.0 110.4 -179.67 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 6.6 m170 -112.8 169.24 9.05 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.724 0.297 . . . . 0.0 110.891 -179.8 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 1.3 pmm? -147.53 172.94 13.19 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.183 -0.462 . . . . 0.0 109.994 -179.985 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -141.71 -176.75 16.23 Favored Glycine 0 N--CA 1.453 -0.226 0 C-N-CA 120.94 -0.648 . . . . 0.0 111.946 179.903 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 19.3 m -121.32 161.17 22.52 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.802 0.334 . . . . 0.0 111.019 -179.832 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -94.2 177.9 5.81 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.994 179.928 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 22.9 tp -157.57 147.5 20.47 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 109.358 -0.608 . . . . 0.0 109.358 179.763 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 13.5 mt-10 -101.34 126.59 48.11 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.038 0.447 . . . . 0.0 111.535 -179.558 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . 0.44 ' OD1' ' HG2' ' A' ' 29' ' ' LYS . 4.8 t70 -140.86 -167.77 2.44 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.78 -0.645 . . . . 0.0 109.488 178.992 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 85.9 mtp -130.31 -9.29 4.21 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 111.619 0.229 . . . . 0.0 111.619 -179.417 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.44 ' HG2' ' OD1' ' A' ' 27' ' ' ASP . 0.3 OUTLIER -63.04 133.5 54.63 Favored 'General case' 0 N--CA 1.466 0.356 0 CA-C-N 116.52 -0.309 . . . . 0.0 111.451 -179.473 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . 0.457 ' O ' ' HB2' ' A' ' 31' ' ' ARG . 25.6 mttt -159.23 104.48 1.67 Allowed 'General case' 0 C--O 1.236 0.361 0 CA-C-N 116.385 -0.37 . . . . 0.0 111.03 -179.975 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . 0.623 ' NE ' ' HA ' ' A' ' 31' ' ' ARG . 0.0 OUTLIER 172.17 23.6 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.506 0 O-C-N 123.584 0.552 . . . . 0.0 111.696 179.111 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.499 ' HB2' ' HB2' ' A' ' 64' ' ' ALA . 32.8 mt -134.37 168.16 19.41 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.747 0.308 . . . . 0.0 111.134 -179.464 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 2.3 ttmt -157.13 41.78 0.33 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.094 0.474 . . . . 0.0 110.085 -179.759 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -102.46 174.13 6.04 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.155 -178.718 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.447 HG12 HH11 ' A' ' 103' ' ' ARG . 0.0 OUTLIER -136.41 106.12 5.11 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.206 0 N-CA-C 108.919 -0.771 . . . . 0.0 108.919 179.144 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . 0.539 ' OE1' ' HB2' ' A' ' 61' ' ' SER . 0.2 OUTLIER -142.61 -171.58 3.45 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 121.036 0.445 . . . . 0.0 111.421 -178.381 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 64.0 mt-10 -120.87 -173.57 2.63 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.881 -179.822 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 3.2 mp0 -70.62 144.92 51.0 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.544 -179.833 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -155.96 24.78 0.38 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.902 -179.965 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -111.92 154.71 16.63 Favored Glycine 0 N--CA 1.449 -0.463 0 C-N-CA 120.814 -0.708 . . . . 0.0 112.674 -179.303 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -140.75 168.06 20.69 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 110.035 -0.358 . . . . 0.0 110.035 -179.683 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 11.2 tp -85.21 76.85 10.13 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 121.126 0.488 . . . . 0.0 110.399 -179.942 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 23.0 ttt180 -136.6 158.48 44.35 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.683 -179.942 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -82.83 56.34 3.38 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.709 179.957 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -119.49 17.97 12.86 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.343 0.592 . . . . 0.0 110.552 179.68 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 37.9 mm-40 -70.1 -22.83 62.99 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.758 -0.655 . . . . 0.0 110.835 -179.594 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -65.21 -14.59 61.02 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.966 -179.868 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 6.4 ttpp -77.05 -7.77 56.28 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.574 -0.284 . . . . 0.0 111.195 -179.718 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 10.6 p -59.37 -27.65 37.49 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.267 0 CA-C-O 120.98 0.419 . . . . 0.0 111.12 -179.895 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 26.8 mt-10 -66.88 -24.44 66.12 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.943 -0.572 . . . . 0.0 110.363 179.921 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 35.6 ttmt -99.24 -35.38 9.99 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.765 -0.652 . . . . 0.0 109.815 179.235 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 60.3 mm-40 -77.48 2.24 16.82 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.724 -0.671 . . . . 0.0 111.286 -179.965 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 20.0 ptt? -62.76 -28.87 70.27 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.158 0.504 . . . . 0.0 110.245 179.594 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -89.78 0.41 79.66 Favored Glycine 0 N--CA 1.445 -0.732 0 C-N-CA 120.737 -0.744 . . . . 0.0 111.448 179.321 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -125.48 32.96 5.22 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.269 0.557 . . . . 0.0 110.137 -179.763 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 5.8 m -64.52 -11.44 10.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 115.593 -0.731 . . . . 0.0 111.588 -179.668 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 14.1 mp0 -89.67 3.34 52.97 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.717 179.594 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 38.3 t70 -142.82 -44.17 0.31 Allowed 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 112.141 0.422 . . . . 0.0 112.141 -179.903 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 2.6 m -86.77 -26.76 23.98 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 120.788 0.328 . . . . 0.0 111.769 -179.303 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 11.4 t -127.23 22.03 6.64 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 120.942 0.401 . . . . 0.0 110.444 -179.526 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . 0.539 ' HB2' ' OE1' ' A' ' 36' ' ' GLU . 0.3 OUTLIER -67.88 -29.86 69.07 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.091 -179.332 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . 0.508 ' HA ' ' OE2' ' A' ' 36' ' ' GLU . 1.3 m -54.59 -23.04 15.17 Favored 'General case' 0 CA--C 1.532 0.275 0 CA-C-N 116.037 -0.529 . . . . 0.0 112.028 -179.39 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 4.2 m -66.79 -17.29 64.8 Favored 'General case' 0 N--CA 1.452 -0.352 0 CA-C-O 120.735 0.302 . . . . 0.0 110.708 179.568 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . 0.499 ' HB2' ' HB2' ' A' ' 32' ' ' LEU . . . -78.03 -47.94 17.26 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.979 0.419 . . . . 0.0 110.686 179.728 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 4.9 m -75.71 -4.52 40.81 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.696 -179.61 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 21.8 tp60 -114.72 -60.69 1.85 Allowed 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 111.962 0.356 . . . . 0.0 111.962 179.936 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -79.91 -56.29 4.36 Favored 'General case' 0 C--N 1.331 -0.215 0 N-CA-C 112.187 0.44 . . . . 0.0 112.187 -178.322 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . 0.62 ' O ' HG23 ' A' ' 72' ' ' VAL . 1.4 tp10 -59.17 -33.51 71.02 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.304 -179.575 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . 0.559 ' HG3' ' OD2' ' A' ' 73' ' ' ASP . 23.5 tptp -50.85 -33.83 25.41 Favored 'General case' 0 N--CA 1.462 0.155 0 CA-C-N 115.422 -0.808 . . . . 0.0 111.875 -179.364 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 34.5 mt-10 -49.38 -39.2 31.44 Favored 'General case' 0 N--CA 1.465 0.277 0 O-C-N 123.551 0.532 . . . . 0.0 111.583 179.911 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 7.7 tp10 -94.99 -31.46 13.62 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.251 -179.438 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.62 HG23 ' O ' ' A' ' 68' ' ' GLU . 22.9 t -58.17 -54.68 29.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 N-CA-C 112.453 0.538 . . . . 0.0 112.453 -178.084 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . 0.559 ' OD2' ' HG3' ' A' ' 69' ' ' LYS . 3.3 p30 -84.58 0.47 49.93 Favored 'General case' 0 N--CA 1.462 0.164 0 C-N-CA 119.676 -0.81 . . . . 0.0 111.588 -179.419 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 6.1 m -91.11 -27.25 18.68 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 108.318 -0.993 . . . . 0.0 108.318 175.562 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -106.54 59.61 0.64 Allowed 'General case' 0 N--CA 1.449 -0.5 0 CA-C-N 114.916 -1.038 . . . . 0.0 109.565 179.701 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -132.36 161.27 34.0 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.848 -179.908 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.421 HG22 HD23 ' A' ' 132' ' ' LEU . 15.1 pt -119.68 136.98 55.05 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.312 179.293 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 56.1 t80 -101.15 128.0 47.44 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 179.432 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 2.7 t -108.73 117.75 54.83 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.683 0 CA-C-O 121.074 0.464 . . . . 0.0 111.413 -178.711 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -113.44 164.41 12.05 Favored Glycine 0 N--CA 1.445 -0.719 0 N-CA-C 111.115 -0.794 . . . . 0.0 111.115 179.421 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 2.7 m-20 61.88 44.19 8.65 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-O 121.011 0.434 . . . . 0.0 110.941 179.943 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 10.7 t -85.43 154.27 3.5 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.5 -179.82 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . 0.576 ' HB3' ' SG ' ' A' ' 86' ' ' CYS . 0.8 OUTLIER -72.33 134.66 45.61 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.13 179.51 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 48.7 p90 -63.9 -16.34 61.19 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 113.057 0.762 . . . . 0.0 113.057 -178.015 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -96.46 4.37 52.16 Favored 'General case' 0 C--N 1.324 -0.52 0 C-N-CA 121.054 -0.258 . . . . 0.0 111.665 -179.151 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' CYS . . . . . 0.576 ' SG ' ' HB3' ' A' ' 83' ' ' ASP . 89.6 m -81.18 156.66 25.58 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 121.207 0.527 . . . . 0.0 111.285 179.974 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 48.7 p -124.12 152.74 67.63 Favored Pre-proline 0 C--N 1.325 -0.494 0 CA-C-N 115.616 -0.72 . . . . 0.0 109.637 178.996 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -58.77 -23.07 64.89 Favored 'Trans proline' 0 C--N 1.342 0.226 0 C-N-CA 122.469 2.113 . . . . 0.0 112.599 -179.258 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 34.1 mt-10 -69.96 -58.69 3.55 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.955 -179.811 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -65.12 -23.49 67.16 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.096 0.474 . . . . 0.0 111.008 -179.462 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 6.2 t -72.28 -52.56 23.46 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.667 0 CA-C-N 115.791 -0.64 . . . . 0.0 111.163 -179.967 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 8.7 pt20 -68.69 -36.26 78.25 Favored 'General case' 0 CA--C 1.532 0.258 0 N-CA-C 112.451 0.538 . . . . 0.0 112.451 -178.207 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -68.48 -31.11 70.16 Favored 'General case' 0 C--O 1.234 0.269 0 C-N-CA 120.733 -0.387 . . . . 0.0 111.329 -178.834 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 3.6 m80 -70.33 -38.64 74.93 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.104 0.478 . . . . 0.0 109.729 179.386 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 8.2 m-30 -74.14 -30.76 62.43 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.72 -0.673 . . . . 0.0 109.828 179.765 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . 0.582 ' HA ' ' O ' ' A' ' 99' ' ' GLY . 29.0 tt0 -62.99 -17.66 62.41 Favored 'General case' 0 C--O 1.231 0.131 0 CA-C-N 115.448 -0.796 . . . . 0.0 111.183 -179.79 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 5.2 m -76.09 -22.88 55.08 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.179 0.514 . . . . 0.0 109.878 179.165 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 24.8 m -98.24 -46.03 5.97 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.729 -0.668 . . . . 0.0 109.81 179.42 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . 0.582 ' O ' ' HA ' ' A' ' 96' ' ' GLN . . . -148.49 152.68 24.7 Favored Glycine 0 N--CA 1.449 -0.496 0 N-CA-C 111.546 -0.622 . . . . 0.0 111.546 179.538 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . 0.554 ' HB ' ' CZ ' ' A' ' 122' ' ' PHE . 0.2 OUTLIER -66.96 146.82 53.98 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 116.799 0.3 . . . . 0.0 110.635 179.918 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.482 HG23 ' HB ' ' A' ' 120' ' ' VAL . 2.7 p -117.21 137.72 50.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 121.015 0.436 . . . . 0.0 111.695 -178.659 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 24.1 t30 -99.13 -64.26 1.05 Allowed 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 109.487 -0.56 . . . . 0.0 109.487 179.331 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . 0.447 HH11 HG12 ' A' ' 35' ' ' ILE . 0.9 OUTLIER -122.88 149.18 44.55 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.486 179.44 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 7.9 p -136.28 139.94 44.57 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.018 179.677 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . 0.588 ' HB ' ' CE1' ' A' ' 119' ' ' TYR . 4.0 m -138.19 140.69 39.89 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 109.59 -0.522 . . . . 0.0 109.59 179.304 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 20.6 tt -134.03 143.79 37.37 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 O-C-N 123.289 0.368 . . . . 0.0 110.446 -179.733 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 20.4 tp -127.09 134.55 50.23 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 120.998 0.428 . . . . 0.0 111.201 -179.804 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -101.62 114.77 29.1 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.595 179.256 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . 0.516 ' O ' ' HE2' ' A' ' 115' ' ' LYS . 17.3 t70 -85.44 148.54 25.94 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.397 -179.94 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 4.0 mppt? -128.6 23.31 5.86 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.861 179.956 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 3.8 t80 -110.52 -9.71 14.56 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.792 0.33 . . . . 0.0 110.904 -179.721 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 123.6 -3.54 9.4 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.251 -0.976 . . . . 0.0 113.465 179.327 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 34.1 mt-30 -79.22 154.82 77.18 Favored Pre-proline 0 C--N 1.326 -0.44 0 CA-C-N 117.215 0.507 . . . . 0.0 109.787 179.694 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 10.6 Cg_endo -55.72 101.64 0.09 OUTLIER 'Trans proline' 0 C--N 1.346 0.422 0 C-N-CA 122.533 2.155 . . . . 0.0 111.992 179.261 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . 0.516 ' HE2' ' O ' ' A' ' 109' ' ' ASP . 85.9 mttt -61.32 147.45 44.64 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.464 -0.789 . . . . 0.0 110.844 -179.778 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 109.76 11.45 21.0 Favored Glycine 0 N--CA 1.447 -0.627 0 C-N-CA 120.125 -1.035 . . . . 0.0 113.076 179.943 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 32.2 m-85 -54.47 116.69 2.79 Favored 'General case' 0 N--CA 1.465 0.278 0 N-CA-C 109.766 -0.457 . . . . 0.0 109.766 179.032 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -138.83 166.39 24.55 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 121.271 0.558 . . . . 0.0 111.826 -178.591 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 119' ' ' TYR . . . . . 0.588 ' CE1' ' HB ' ' A' ' 105' ' ' THR . 41.4 p90 -157.8 147.73 20.29 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.081 -0.963 . . . . 0.0 109.052 179.085 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . 0.482 ' HB ' HG23 ' A' ' 101' ' ' VAL . 29.8 m -125.59 136.58 60.4 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-N 116.643 -0.253 . . . . 0.0 110.702 -179.944 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 4.2 pt-20 -115.78 152.59 32.99 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.993 179.923 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 122' ' ' PHE . . . . . 0.554 ' CZ ' ' HB ' ' A' ' 100' ' ' THR . 8.7 t80 -152.2 167.14 29.54 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.253 -0.431 . . . . 0.0 109.935 179.498 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . 0.477 HG22 HG22 ' A' ' 72' ' ' VAL . 4.5 t -89.07 -38.63 11.6 Favored 'Isoleucine or valine' 0 C--O 1.236 0.354 0 CA-C-O 121.036 0.446 . . . . 0.0 111.392 -179.402 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 63.6 mm-40 -76.8 127.32 32.54 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.363 -179.368 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 32.4 mt -70.81 -38.37 72.45 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-N 115.593 -0.73 . . . . 0.0 111.426 -179.442 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -61.06 -38.52 86.48 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.383 -0.371 . . . . 0.0 111.697 -179.035 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -61.38 -55.8 27.43 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.213 -179.573 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 11.9 p -67.4 -27.77 39.9 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.173 -179.497 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 52.6 tt0 -61.3 -45.51 94.16 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.929 0.395 . . . . 0.0 110.788 179.937 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -64.54 -34.13 77.53 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.908 -179.726 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -77.55 -23.26 50.11 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.178 179.908 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 132' ' ' LEU . . . . . 0.421 HD23 HG22 ' A' ' 77' ' ' ILE . 0.4 OUTLIER -80.47 -15.78 55.92 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-O 121.358 0.599 . . . . 0.0 110.164 179.833 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 5.1 mp -96.62 -58.9 1.93 Allowed 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.771 179.661 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 78.9 mt -117.38 107.5 14.44 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.664 -179.435 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 65.8 t30 -166.51 -50.96 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.599 -179.799 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . 0.502 ' HB3' HG23 ' A' ' 146' ' ' VAL . 4.0 pt-20 -72.46 87.33 1.18 Allowed 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.299 0.571 . . . . 0.0 111.102 -179.618 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -131.21 -70.29 0.6 Allowed 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.393 179.845 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 2.9 tm-20 -150.11 132.93 15.99 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.228 -179.788 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -143.61 112.46 6.6 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.695 -0.684 . . . . 0.0 109.469 179.483 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 2.0 t60 62.37 27.72 16.51 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.208 179.49 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 90.0 -10.0 75.44 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.821 -0.704 . . . . 0.0 112.42 179.75 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 142' ' ' ARG . . . . . 0.427 HH11 ' HD3' ' A' ' 142' ' ' ARG . 0.4 OUTLIER -109.39 176.33 5.12 Favored 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 110.134 -0.321 . . . . 0.0 110.134 -179.886 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 5.0 pt20 -125.48 141.09 52.24 Favored 'General case' 0 C--N 1.319 -0.722 0 N-CA-C 109.891 -0.411 . . . . 0.0 109.891 179.195 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -125.3 173.83 8.55 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.467 -178.99 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -115.34 126.11 54.04 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.271 -0.422 . . . . 0.0 109.991 179.586 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 146' ' ' VAL . . . . . 0.502 HG23 ' HB3' ' A' ' 136' ' ' GLU . 94.1 t -104.47 117.18 49.63 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 CA-C-N 115.877 -0.601 . . . . 0.0 109.994 -179.743 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -117.2 156.17 28.15 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.39 -179.589 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -80.19 115.9 19.99 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 109.986 -0.376 . . . . 0.0 109.986 179.713 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 11.5 ttpp -88.52 52.9 2.55 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.219 0.533 . . . . 0.0 109.955 -179.73 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -76.13 96.13 3.8 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.804 -0.635 . . . . 0.0 110.48 -179.583 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 6.8 t -65.53 145.0 56.63 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.992 -0.549 . . . . 0.0 109.935 179.135 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 152' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 -168.7 179.42 4.25 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 109.001 -0.74 . . . . 0.0 109.001 -179.346 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 20.8 pt -96.56 154.8 38.41 Favored Pre-proline 0 C--N 1.317 -0.836 0 N-CA-C 109.451 -0.574 . . . . 0.0 109.451 179.228 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -74.88 58.7 4.89 Favored 'Trans proline' 0 C--O 1.235 0.372 0 C-N-CA 122.621 2.214 . . . . 0.0 112.141 179.62 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.048 0 CA-C-O 118.34 -1.256 . . . . 0.0 111.242 -179.769 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 63.4 mtt . . . . . 0 N--CA 1.481 1.104 0 N-CA-C 110.046 -0.353 . . . . 0.0 110.046 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 136.4 165.16 10.46 Favored Glycine 0 N--CA 1.445 -0.711 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.362 179.773 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -145.19 96.38 2.83 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-O 121.089 0.471 . . . . 0.0 110.126 179.339 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -84.49 140.72 31.28 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.969 -179.44 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 25.1 m-70 -117.17 147.07 42.78 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.554 179.779 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 2.4 t60 -123.68 118.03 26.33 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.158 -179.494 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -166.8 144.28 4.92 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.465 0.174 . . . . 0.0 111.025 -179.611 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 8.5 p80 -155.85 159.2 39.15 Favored 'General case' 0 N--CA 1.464 0.231 0 N-CA-C 109.653 -0.499 . . . . 0.0 109.653 179.637 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 30.1 t60 -158.21 145.57 18.06 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.534 0.207 . . . . 0.0 111.074 -179.267 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 25.7 p80 -148.76 136.46 20.57 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 116.438 -0.346 . . . . 0.0 110.494 179.232 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -159.08 137.32 10.6 Favored 'General case' 0 C--O 1.235 0.335 0 CA-C-N 116.511 -0.313 . . . . 0.0 110.709 -179.791 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 2.7 t -160.06 177.39 10.77 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.094 179.745 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 135.6 145.08 5.05 Favored Glycine 0 N--CA 1.449 -0.456 0 C-N-CA 120.802 -0.713 . . . . 0.0 112.814 179.516 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 1.8 pt? -151.24 148.38 28.14 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 109.744 -0.465 . . . . 0.0 109.744 179.593 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 22.0 t -126.41 107.95 23.76 Favored Pre-proline 0 C--N 1.328 -0.351 0 CA-C-N 116.711 -0.222 . . . . 0.0 110.991 -179.431 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 6.4 Cg_exo -74.18 171.66 17.56 Favored 'Trans proline' 0 C--N 1.345 0.365 0 C-N-CA 122.732 2.288 . . . . 0.0 112.211 179.527 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -132.48 125.24 30.2 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.463 -0.335 . . . . 0.0 110.217 179.76 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -160.88 98.45 0.17 Allowed Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.428 -0.891 . . . . 0.0 112.888 179.976 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 19.6 m -143.69 126.94 16.63 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 120.938 0.399 . . . . 0.0 110.02 179.152 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 1.8 t-80 -122.75 120.07 32.53 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.084 -179.756 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 26.7 ptm -136.74 164.11 29.02 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.226 -0.443 . . . . 0.0 109.996 -179.898 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 146.86 155.44 6.54 Favored Glycine 0 N--CA 1.447 -0.606 0 C-N-CA 120.316 -0.945 . . . . 0.0 112.79 179.602 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -153.04 81.62 1.2 Allowed 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.264 0.554 . . . . 0.0 109.731 179.599 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -101.51 115.88 31.51 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.147 -179.974 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.449 ' HA ' ' OE1' ' A' ' 66' ' ' GLN . 33.1 tp -129.02 91.96 3.3 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.751 -179.46 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 24.9 tt0 -175.86 128.34 0.24 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.882 -0.599 . . . . 0.0 109.82 179.4 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 18.5 t0 -85.99 152.63 22.77 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 120.782 0.325 . . . . 0.0 110.367 179.805 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 35.6 mtm -130.79 -13.7 3.65 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.612 -179.344 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 9.4 tppt? -170.12 133.95 1.2 Allowed 'General case' 0 C--N 1.332 -0.16 0 CA-C-O 120.968 0.413 . . . . 0.0 111.199 -179.293 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 62.0 tttt -78.53 70.11 4.82 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.169 179.348 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 2.4 tpt180 -132.05 131.27 42.29 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.433 -179.659 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.537 ' HA ' ' HB2' ' A' ' 64' ' ' ALA . 0.4 OUTLIER -126.64 115.29 19.24 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.052 179.783 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.447 ' HB3' ' H ' ' A' ' 34' ' ' GLU . 23.0 tptt -149.85 -87.34 0.08 Allowed 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.606 -0.27 . . . . 0.0 110.886 -179.637 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.447 ' H ' ' HB3' ' A' ' 33' ' ' LYS . 48.8 mm-40 -123.88 -155.15 0.65 Allowed 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 109.742 -0.466 . . . . 0.0 109.742 -179.405 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 13.1 pt -140.83 135.78 34.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.744 -0.207 . . . . 0.0 110.767 179.632 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 6.0 tp10 -140.29 -115.28 0.13 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.809 -0.178 . . . . 0.0 111.0 179.859 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 33.6 mt-10 -122.43 157.29 32.24 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-O 121.223 0.535 . . . . 0.0 111.867 -178.552 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . 0.473 ' H ' ' CD ' ' A' ' 38' ' ' GLU . 0.4 OUTLIER -87.75 121.76 30.56 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.846 -0.615 . . . . 0.0 110.53 179.618 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -132.51 82.18 1.99 Allowed 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.414 179.494 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -142.9 138.17 8.16 Favored Glycine 0 N--CA 1.444 -0.775 0 C-N-CA 120.669 -0.777 . . . . 0.0 112.255 -179.604 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -164.85 168.56 17.6 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 109.215 -0.661 . . . . 0.0 109.215 179.678 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 24.4 tp -74.86 82.76 2.16 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.405 0.622 . . . . 0.0 110.456 179.649 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 9.5 ttp180 -143.03 141.87 31.43 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.688 -0.687 . . . . 0.0 109.676 179.617 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -76.07 41.82 0.24 Allowed 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 121.139 0.495 . . . . 0.0 111.152 -179.749 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 10.9 ptt? -98.6 5.25 47.94 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.853 -0.612 . . . . 0.0 109.644 179.752 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 84.0 mt-30 -71.43 -20.95 62.04 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.351 -0.84 . . . . 0.0 111.383 -178.811 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -69.26 -17.51 63.76 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.214 0.531 . . . . 0.0 110.602 179.861 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . 0.556 ' O ' ' HG2' ' A' ' 52' ' ' GLU . 20.4 ttpp -72.99 1.48 8.78 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.572 -0.74 . . . . 0.0 110.885 179.72 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 8.1 p -55.38 -27.05 20.0 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.311 0 CA-C-N 116.463 -0.335 . . . . 0.0 111.601 -179.648 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 20.8 mt-10 -64.02 -19.9 65.53 Favored 'General case' 0 N--CA 1.463 0.19 0 CA-C-O 121.337 0.589 . . . . 0.0 110.248 179.377 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 13.1 mtmt -107.95 -37.66 6.03 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.598 -0.728 . . . . 0.0 110.904 178.749 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . 0.556 ' HG2' ' O ' ' A' ' 48' ' ' LYS . 9.2 mm-40 -62.77 -21.64 66.0 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 116.681 -0.236 . . . . 0.0 111.276 179.879 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 4.7 ppp? -59.36 -23.59 62.67 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-O 120.895 0.379 . . . . 0.0 110.994 179.573 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -94.53 -5.14 61.87 Favored Glycine 0 C--O 1.227 -0.324 0 C-N-CA 121.062 -0.59 . . . . 0.0 111.677 179.28 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -121.96 24.08 9.74 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.335 0.588 . . . . 0.0 110.079 -179.798 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 20.8 m -66.4 -11.42 13.03 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 115.799 -0.637 . . . . 0.0 111.817 -179.458 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 72.6 mt-30 -84.29 -9.61 58.34 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.258 0.552 . . . . 0.0 109.955 179.15 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 6.6 t70 -119.94 -55.01 2.11 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.362 -0.835 . . . . 0.0 110.246 -179.778 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 17.9 m -77.86 -72.35 0.37 Allowed 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.297 -0.865 . . . . 0.0 111.915 -178.834 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -79.36 29.33 0.23 Allowed 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 112.617 0.599 . . . . 0.0 112.617 -178.315 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -88.85 -39.99 13.45 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 109.327 -0.62 . . . . 0.0 109.327 179.066 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -59.9 -18.9 48.37 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.287 -0.87 . . . . 0.0 112.262 -179.559 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -63.6 -26.95 68.92 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 121.197 0.522 . . . . 0.0 110.343 179.221 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . 0.537 ' HB2' ' HA ' ' A' ' 32' ' ' LEU . . . -65.16 -29.99 70.87 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.28 179.102 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -77.57 0.87 21.38 Favored 'General case' 0 N--CA 1.453 -0.316 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.806 -179.868 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' GLN . . . . . 0.449 ' OE1' ' HA ' ' A' ' 25' ' ' LEU . 6.3 tp-100 -118.52 -50.49 2.43 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.441 179.502 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -82.58 -64.5 1.16 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.14 -0.482 . . . . 0.0 112.043 -179.15 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . 0.434 ' O ' HG23 ' A' ' 72' ' ' VAL . 26.0 tp10 -63.83 -26.67 68.72 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.707 0.289 . . . . 0.0 111.466 -178.775 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 36.2 tptt -58.02 -28.12 64.17 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.514 -0.312 . . . . 0.0 111.01 179.842 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 83.1 mt-10 -63.26 -21.35 66.18 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-O 121.388 0.613 . . . . 0.0 110.763 179.354 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . 0.521 ' O ' ' HD2' ' A' ' 75' ' ' ARG . 5.7 tp10 -97.49 -41.23 8.28 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.418 -0.81 . . . . 0.0 109.316 178.158 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.469 HG12 ' HB2' ' A' ' 121' ' ' GLU . 42.2 t -62.29 -40.13 86.68 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.379 0 CA-C-N 115.927 -0.578 . . . . 0.0 112.192 -179.25 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . 0.425 ' OD2' HG21 ' A' ' 151' ' ' THR . 12.9 p-10 -74.83 -14.19 60.66 Favored 'General case' 0 N--CA 1.466 0.375 0 CA-C-O 121.035 0.445 . . . . 0.0 110.867 -179.705 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 45.6 t -99.79 -12.98 19.45 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 121.504 0.669 . . . . 0.0 109.445 177.888 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . 0.521 ' HD2' ' O ' ' A' ' 71' ' ' GLU . 0.0 OUTLIER -107.66 41.05 1.58 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.054 -179.401 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -121.04 169.79 10.15 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 115.649 -0.705 . . . . 0.0 110.492 179.795 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -131.86 136.18 57.37 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 N-CA-C 109.616 -0.513 . . . . 0.0 109.616 178.433 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 71.3 t80 -91.79 123.27 35.05 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.409 -0.359 . . . . 0.0 110.278 -179.617 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 6.4 t -103.96 111.07 32.17 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.286 -179.615 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -119.95 169.66 13.96 Favored Glycine 0 N--CA 1.449 -0.48 0 C-N-CA 120.908 -0.663 . . . . 0.0 111.74 179.896 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 15.2 m120 61.48 35.62 17.5 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-O 121.102 0.477 . . . . 0.0 110.623 -179.742 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 2.1 t -79.79 165.85 2.71 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.674 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.65 -179.125 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -70.42 142.81 51.99 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 110.017 -0.364 . . . . 0.0 110.017 179.35 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 38.2 p90 -67.12 -13.47 61.98 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 112.03 0.381 . . . . 0.0 112.03 -178.723 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -114.06 16.78 18.1 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.787 0.327 . . . . 0.0 111.025 -179.968 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' CYS . . . . . 0.467 ' SG ' ' HB2' ' A' ' 140' ' ' HIS . 0.7 OUTLIER -82.16 142.1 32.5 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.132 0.491 . . . . 0.0 111.164 -179.927 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . 0.549 ' O ' ' HG2' ' A' ' 90' ' ' GLU . 23.1 p -106.29 154.48 39.72 Favored Pre-proline 0 C--N 1.327 -0.406 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.548 179.705 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . 0.462 ' HD3' HD13 ' A' ' 106' ' ' ILE . 18.2 Cg_endo -59.19 -35.13 98.22 Favored 'Trans proline' 0 C--N 1.344 0.328 0 C-N-CA 122.769 2.313 . . . . 0.0 112.794 -179.355 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -65.51 -50.62 64.6 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.909 -0.587 . . . . 0.0 112.144 -178.705 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . 0.549 ' HG2' ' O ' ' A' ' 87' ' ' THR . 10.5 pt-20 -61.97 -24.78 67.22 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.888 0.375 . . . . 0.0 111.444 -178.806 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 76.1 t -81.2 -47.78 19.68 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.926 -178.761 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -71.5 -31.11 66.72 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.581 -178.627 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 3.7 pp0? -80.33 -27.91 38.26 Favored 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 120.383 -0.527 . . . . 0.0 111.252 -179.124 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 50.2 t-80 -77.44 -34.13 54.62 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.987 0.423 . . . . 0.0 110.479 -179.792 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 22.5 m-30 -84.38 -10.21 57.76 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.611 -179.987 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . 0.453 ' HA ' ' O ' ' A' ' 99' ' ' GLY . 14.8 tt0 -65.83 -25.4 67.2 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.488 -0.778 . . . . 0.0 109.979 179.804 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 3.6 m -62.95 -30.03 71.25 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.646 -0.706 . . . . 0.0 110.48 179.123 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 3.5 m -92.55 -49.67 6.0 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.346 179.951 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . 0.453 ' O ' ' HA ' ' A' ' 96' ' ' GLN . . . -145.41 144.24 12.8 Favored Glycine 0 N--CA 1.449 -0.473 0 C-N-CA 120.824 -0.703 . . . . 0.0 111.701 179.829 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . 0.454 ' HB ' ' CZ ' ' A' ' 122' ' ' PHE . 0.2 OUTLIER -64.26 143.81 57.61 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-O 120.837 0.351 . . . . 0.0 110.69 179.945 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 1.7 p -110.72 126.45 68.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.077 -179.387 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 24.8 t-20 -90.91 -50.14 6.04 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 109.455 -0.572 . . . . 0.0 109.455 179.026 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -138.75 156.08 47.67 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.954 -0.567 . . . . 0.0 109.726 179.169 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 5.4 p -152.28 125.73 1.27 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.262 179.972 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 2.6 m -118.14 126.3 51.95 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 110.007 -0.368 . . . . 0.0 110.007 179.795 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' ILE . . . . . 0.503 HD11 ' HA2' ' A' ' 116' ' ' GLY . 20.9 tt -110.68 145.4 17.09 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-O 120.962 0.411 . . . . 0.0 110.794 179.816 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 32.6 tp -129.2 130.3 46.14 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.576 179.934 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -91.83 119.54 31.72 Favored 'General case' 0 N--CA 1.45 -0.47 0 CA-C-N 116.495 -0.32 . . . . 0.0 110.386 179.235 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . 0.437 ' O ' ' HG2' ' A' ' 115' ' ' LYS . 16.4 t70 -85.46 139.14 31.75 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.086 0.47 . . . . 0.0 110.633 179.917 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.3 23.49 5.98 Favored 'General case' 0 C--N 1.319 -0.749 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 179.113 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 1.1 t80 -103.82 1.79 31.97 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.542 -178.927 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 103.86 7.85 40.75 Favored Glycine 0 N--CA 1.448 -0.554 0 C-N-CA 121.066 -0.588 . . . . 0.0 112.701 179.527 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 18.3 mt-30 -98.56 158.19 32.97 Favored Pre-proline 0 C--N 1.324 -0.507 0 N-CA-C 109.489 -0.56 . . . . 0.0 109.489 179.581 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -59.26 118.91 5.87 Favored 'Trans proline' 0 C--N 1.346 0.403 0 C-N-CA 122.12 1.88 . . . . 0.0 111.169 178.665 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . 0.437 ' HG2' ' O ' ' A' ' 109' ' ' ASP . 60.1 mttt -72.93 173.74 8.82 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 109.892 -0.41 . . . . 0.0 109.892 -179.441 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . 0.503 ' HA2' HD11 ' A' ' 106' ' ' ILE . . . 100.28 2.53 55.72 Favored Glycine 0 N--CA 1.444 -0.788 0 C-N-CA 120.309 -0.948 . . . . 0.0 112.326 179.406 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 29.8 m-85 -52.48 115.2 1.65 Allowed 'General case' 0 C--N 1.333 -0.14 0 N-CA-C 110.117 -0.327 . . . . 0.0 110.117 179.445 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -144.6 175.36 10.2 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 121.087 0.47 . . . . 0.0 111.223 -178.913 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 50.8 p90 -159.26 137.75 10.73 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.58 -0.737 . . . . 0.0 109.506 179.002 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 11.3 m -110.31 140.66 28.39 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 N-CA-C 109.446 -0.576 . . . . 0.0 109.446 179.118 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . 0.469 ' HB2' HG12 ' A' ' 72' ' ' VAL . 4.9 pt-20 -126.02 151.57 46.92 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.487 -0.324 . . . . 0.0 110.812 179.887 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 122' ' ' PHE . . . . . 0.454 ' CZ ' ' HB ' ' A' ' 100' ' ' THR . 10.6 t80 -148.87 167.14 26.48 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.662 179.965 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 37.7 t -84.05 -45.37 18.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 115.765 -0.652 . . . . 0.0 111.741 -179.19 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 34.2 mm-40 -73.54 137.03 44.12 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.785 0.326 . . . . 0.0 110.669 -179.24 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 2.9 mp -77.42 -34.83 21.26 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.702 -179.59 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -59.28 -36.23 75.19 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.186 0.517 . . . . 0.0 111.203 -179.786 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -62.95 -57.71 9.81 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.354 -179.818 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 10.7 p -65.03 -28.7 45.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.532 -0.304 . . . . 0.0 111.271 -179.403 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 50.2 tt0 -61.49 -43.35 99.01 Favored 'General case' 0 C--N 1.334 -0.095 0 CA-C-O 120.973 0.416 . . . . 0.0 110.23 179.602 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 46.4 m-80 -72.17 -29.98 64.54 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 121.223 0.535 . . . . 0.0 109.951 179.477 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -67.97 -50.88 53.12 Favored 'General case' 0 N--CA 1.453 -0.285 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.989 179.827 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 4.1 pp -67.41 -17.31 64.67 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.986 0.422 . . . . 0.0 110.882 -179.965 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 1.4 tp -78.06 -50.49 11.96 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.506 -179.965 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 76.5 mt -135.2 104.25 5.83 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.15 179.916 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -148.64 -56.59 0.21 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.243 0.544 . . . . 0.0 111.344 -179.035 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 3.8 pt-20 -75.24 92.6 2.75 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.667 -0.697 . . . . 0.0 111.437 -179.39 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 2.5 m -140.04 -59.31 0.55 Allowed 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.005 179.276 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 11.4 tt0 -157.88 130.06 7.09 Favored 'General case' 0 N--CA 1.45 -0.438 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.482 179.413 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -148.3 120.59 8.4 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 108.82 -0.807 . . . . 0.0 108.82 179.823 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 140' ' ' HIS . . . . . 0.467 ' HB2' ' SG ' ' A' ' 86' ' ' CYS . 1.9 t60 60.48 28.08 17.73 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-O 120.87 0.367 . . . . 0.0 110.609 179.987 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 82.62 -6.0 71.54 Favored Glycine 0 CA--C 1.519 0.299 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.688 -179.845 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 1.4 mpt_? -110.94 -177.72 3.29 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.828 0.347 . . . . 0.0 110.246 -179.951 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 20.4 pt20 -123.15 141.65 51.74 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 179.077 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -125.1 175.87 7.09 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.253 179.953 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -118.06 121.27 40.17 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 109.348 -0.612 . . . . 0.0 109.348 179.61 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 96.8 t -118.73 122.64 69.93 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-O 120.71 0.29 . . . . 0.0 111.62 -178.834 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -125.77 148.26 49.15 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.041 179.196 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -63.65 130.58 44.87 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.768 0.318 . . . . 0.0 110.536 179.464 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 15.3 ttpp -91.46 67.41 5.61 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 121.351 0.596 . . . . 0.0 110.443 -179.642 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 24.3 tpt180 -81.95 100.66 9.79 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 109.366 -0.605 . . . . 0.0 109.366 179.075 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 151' ' ' THR . . . . . 0.425 HG21 ' OD2' ' A' ' 73' ' ' ASP . 6.5 t -87.88 121.32 30.16 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 116.028 -0.533 . . . . 0.0 109.985 179.96 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 152' ' ' ASN . . . . . . . . . . . . . 60.6 t30 -161.15 155.22 22.6 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 109.621 -0.511 . . . . 0.0 109.621 -179.434 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 26.1 pt -81.15 146.77 59.31 Favored Pre-proline 0 C--N 1.321 -0.653 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.105 179.613 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -60.78 -33.26 93.17 Favored 'Trans proline' 0 CA--C 1.531 0.366 0 C-N-CA 122.493 2.128 . . . . 0.0 111.984 179.767 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.246 0.859 0 CA-C-O 118.598 -1.112 . . . . 0.0 111.921 179.791 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.478 0.969 0 CA-C-O 120.81 0.338 . . . . 0.0 110.289 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 104.38 179.93 24.81 Favored Glycine 0 N--CA 1.449 -0.464 0 C-N-CA 120.614 -0.803 . . . . 0.0 112.146 179.905 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 2.0 t -164.34 179.03 7.05 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 109.709 -0.478 . . . . 0.0 109.709 -179.85 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 8.6 t -87.25 -173.27 4.32 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 120.885 0.374 . . . . 0.0 110.436 179.857 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 22.6 p-80 -146.09 137.17 24.54 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.012 -179.836 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 4.4 m-70 -143.46 136.23 27.5 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.378 -0.373 . . . . 0.0 110.527 -179.64 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 36.3 p-80 -135.65 150.21 49.54 Favored 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 109.89 -0.411 . . . . 0.0 109.89 179.113 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 57.5 t60 -123.59 145.61 48.78 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-O 120.876 0.369 . . . . 0.0 110.836 -179.2 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -113.22 136.25 52.94 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.561 -179.944 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 5.6 p80 -161.56 139.21 8.98 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.296 179.761 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 3.8 m -130.78 155.66 46.29 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.482 -0.326 . . . . 0.0 110.174 179.856 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 47.5 m -149.47 163.96 36.36 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.59 -0.277 . . . . 0.0 110.776 -179.56 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -149.44 172.23 29.48 Favored Glycine 0 N--CA 1.449 -0.469 0 C-N-CA 121.101 -0.571 . . . . 0.0 111.694 -179.897 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -142.88 125.49 15.84 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.888 0.375 . . . . 0.0 111.035 -179.964 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 39.6 t -124.78 105.92 29.56 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.567 179.776 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 91.2 Cg_endo -88.11 165.46 7.04 Favored 'Trans proline' 0 N--CA 1.458 -0.586 0 C-N-CA 122.854 2.369 . . . . 0.0 112.116 179.143 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . 0.411 HH11 ' HD3' ' A' ' 17' ' ' ARG . 0.6 OUTLIER -146.85 156.1 42.85 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 120.678 0.275 . . . . 0.0 110.453 179.431 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -92.22 -164.74 38.57 Favored Glycine 0 N--CA 1.445 -0.705 0 C-N-CA 121.092 -0.575 . . . . 0.0 112.707 -179.626 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 4.4 t -129.42 -172.45 2.75 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 110.365 -0.235 . . . . 0.0 110.365 -179.849 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 18.3 p80 -126.86 127.74 45.42 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.719 -179.884 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 26.2 ptt? -88.78 179.72 6.16 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.555 179.97 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -129.37 -160.08 10.09 Favored Glycine 0 N--CA 1.446 -0.634 0 C-N-CA 121.061 -0.59 . . . . 0.0 112.2 179.583 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 3.4 m -120.08 168.61 11.01 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 120.828 0.347 . . . . 0.0 110.894 -179.803 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 44.4 t0 -104.39 167.79 9.51 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.131 -0.486 . . . . 0.0 109.755 179.82 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 3.5 mp -122.66 150.97 41.97 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 120.743 0.306 . . . . 0.0 111.464 -178.949 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -92.43 -172.15 3.0 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.111 179.009 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 2.4 p-10 -123.81 173.44 8.16 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.656 -0.247 . . . . 0.0 110.62 -179.853 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 21.9 ttt -156.26 144.43 19.76 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.776 -179.713 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 73.9 mttt -82.77 146.46 28.97 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 110.115 -0.328 . . . . 0.0 110.115 179.368 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 43.1 mttt -117.49 176.63 5.08 Favored 'General case' 0 C--O 1.236 0.362 0 CA-C-O 121.257 0.551 . . . . 0.0 111.779 -179.084 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 22.7 mmt180 -121.37 121.32 37.36 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.394 -0.821 . . . . 0.0 110.077 179.603 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 49.5 tp -85.45 139.9 31.14 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.42 -179.119 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.454 ' HG2' ' H ' ' A' ' 34' ' ' GLU . 26.8 tttm -157.54 -157.09 0.64 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.115 178.969 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.454 ' H ' ' HG2' ' A' ' 33' ' ' LYS . 6.9 mm-40 -65.32 144.54 57.05 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.972 0.415 . . . . 0.0 111.847 -179.267 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 34.5 mm -88.64 131.54 35.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.817 -179.374 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 5.5 tp10 -126.15 175.88 7.45 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.022 179.88 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -98.64 151.72 20.39 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.952 -179.828 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 7.8 tp10 -155.61 158.71 38.8 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.911 -0.586 . . . . 0.0 109.786 179.907 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -138.94 163.51 32.14 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.836 0.351 . . . . 0.0 111.137 -179.793 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -140.57 141.81 11.75 Favored Glycine 0 N--CA 1.449 -0.47 0 C-N-CA 120.888 -0.672 . . . . 0.0 112.308 179.617 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -157.15 -170.24 3.2 Favored 'General case' 0 C--O 1.235 0.312 0 N-CA-C 110.127 -0.323 . . . . 0.0 110.127 179.944 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 41.4 tp -78.51 92.43 4.66 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.004 0.43 . . . . 0.0 110.172 179.866 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . 0.432 ' HD3' ' SD ' ' A' ' 45' ' ' MET . 57.7 ttt180 -150.86 143.06 24.15 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.455 -179.738 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 63.3 mt-10 -81.68 39.8 0.56 Allowed 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.956 -0.566 . . . . 0.0 110.757 -179.952 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' MET . . . . . 0.432 ' SD ' ' HD3' ' A' ' 43' ' ' ARG . 17.5 ptt? -97.35 14.85 24.76 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.262 0.554 . . . . 0.0 110.141 -179.611 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 51.5 mt-30 -69.09 -28.93 66.94 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.591 -0.731 . . . . 0.0 110.492 -179.826 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -70.79 -3.01 16.62 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.781 -0.645 . . . . 0.0 111.713 -179.519 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 33.6 ttpt -84.29 -3.25 58.11 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.557 179.871 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 8.9 p -57.97 -28.71 34.37 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.266 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.364 -179.874 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.432 ' O ' ' HG2' ' A' ' 53' ' ' MET . 29.4 mt-10 -67.01 -20.13 65.82 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 121.245 0.545 . . . . 0.0 110.65 179.944 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 10.6 ttmt -98.5 -41.46 7.76 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.895 -0.593 . . . . 0.0 109.627 178.996 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -63.99 -21.63 66.58 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.651 -0.704 . . . . 0.0 111.0 179.629 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' MET . . . . . 0.432 ' HG2' ' O ' ' A' ' 50' ' ' GLU . 8.3 ptt? -61.63 -27.36 68.61 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 120.973 0.416 . . . . 0.0 110.577 179.502 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -98.97 10.72 62.19 Favored Glycine 0 N--CA 1.449 -0.453 0 N-CA-C 111.144 -0.782 . . . . 0.0 111.144 178.965 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -134.7 19.68 3.56 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.383 -0.408 . . . . 0.0 110.406 179.94 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 18.1 m -65.64 -15.4 18.62 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.411 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.796 -179.888 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 14.5 mp0 -80.22 -2.58 45.55 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.489 0.661 . . . . 0.0 110.442 179.343 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -134.24 -59.47 0.83 Allowed 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.424 -0.807 . . . . 0.0 110.22 179.62 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 4.6 m -65.09 -67.85 0.41 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.589 -179.433 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -86.76 21.83 2.12 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.972 -178.705 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 3.2 t -71.56 -28.14 63.65 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 120.874 0.368 . . . . 0.0 110.926 -179.243 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -65.84 -15.52 62.98 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 112.005 0.372 . . . . 0.0 112.005 -179.502 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 93.6 p -68.31 -25.85 65.33 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.018 0.437 . . . . 0.0 110.112 179.51 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -69.21 -32.57 71.92 Favored 'General case' 0 N--CA 1.453 -0.321 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.341 179.886 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -76.21 -2.56 31.87 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.117 0.484 . . . . 0.0 111.085 179.515 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 35.3 tt0 -117.44 -50.66 2.53 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.208 -179.817 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -86.59 -58.31 2.66 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 112.105 0.409 . . . . 0.0 112.105 -178.675 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . 0.443 ' O ' HG23 ' A' ' 72' ' ' VAL . 2.9 tp10 -62.7 -31.0 71.82 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.587 -179.489 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 39.4 tptt -58.6 -28.67 65.81 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.976 -0.556 . . . . 0.0 111.169 179.87 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 49.1 mt-10 -61.98 -23.07 66.17 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-O 120.974 0.416 . . . . 0.0 111.151 -179.854 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 6.8 tp10 -97.77 -38.93 9.28 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 116.067 -0.515 . . . . 0.0 109.729 178.743 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.443 HG23 ' O ' ' A' ' 68' ' ' GLU . 46.6 t -65.01 -37.15 79.52 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-N 115.687 -0.688 . . . . 0.0 112.415 -178.907 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 52.1 p-10 -74.09 -16.11 61.03 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-O 120.951 0.405 . . . . 0.0 110.886 -179.526 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 42.3 t -101.8 -6.72 23.27 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.954 -0.566 . . . . 0.0 109.857 178.359 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -112.69 42.79 1.78 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.348 0.594 . . . . 0.0 109.96 -179.382 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -122.14 171.95 8.62 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.692 -0.686 . . . . 0.0 110.25 179.71 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.449 HD11 HG22 ' A' ' 120' ' ' VAL . 1.0 OUTLIER -132.02 139.05 51.23 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 N-CA-C 109.987 -0.375 . . . . 0.0 109.987 178.341 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' TYR . . . . . 0.428 ' O ' ' HA ' ' A' ' 146' ' ' VAL . 25.0 t80 -90.13 124.06 34.49 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.868 -0.606 . . . . 0.0 109.929 179.939 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 6.2 t -108.3 109.11 27.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.515 -0.311 . . . . 0.0 110.405 179.461 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -118.62 170.15 13.69 Favored Glycine 0 N--CA 1.447 -0.567 0 C-N-CA 120.996 -0.621 . . . . 0.0 111.7 -179.9 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 92.2 m-20 56.51 42.56 27.17 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-O 121.015 0.436 . . . . 0.0 110.829 -179.477 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.453 HG13 HD23 ' A' ' 144' ' ' LEU . 2.3 t -81.98 165.14 2.69 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-N 115.862 -0.608 . . . . 0.0 111.048 -178.998 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . 0.478 ' HB3' ' SG ' ' A' ' 86' ' ' CYS . 37.3 t70 -68.2 137.81 55.11 Favored 'General case' 0 CA--C 1.519 -0.212 0 N-CA-C 109.871 -0.418 . . . . 0.0 109.871 179.597 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 18.1 p90 -66.59 -10.07 41.8 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.901 -178.87 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -118.94 19.43 13.03 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.001 0.429 . . . . 0.0 110.719 179.521 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' CYS . . . . . 0.478 ' SG ' ' HB3' ' A' ' 83' ' ' ASP . 0.7 OUTLIER -79.45 149.28 31.61 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.966 180.0 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . 0.483 ' O ' ' HG2' ' A' ' 90' ' ' GLU . 2.9 p -112.61 145.92 33.94 Favored Pre-proline 0 C--N 1.326 -0.441 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.659 179.226 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . 0.445 ' HD3' HD13 ' A' ' 106' ' ' ILE . 11.2 Cg_endo -54.29 -42.56 66.45 Favored 'Trans proline' 0 C--N 1.344 0.311 0 C-N-CA 122.942 2.428 . . . . 0.0 113.039 -178.996 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -62.05 -45.7 92.41 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.302 -0.408 . . . . 0.0 112.011 -179.429 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . 0.628 ' O ' ' HB2' ' A' ' 94' ' ' HIS . 4.8 pt-20 -67.68 -21.76 65.32 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.723 0.297 . . . . 0.0 111.24 -178.765 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.42 HG23 ' O ' ' A' ' 87' ' ' THR . 76.2 t -82.17 -48.31 18.42 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.734 -179.108 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 2.4 pt20 -71.54 -31.33 66.9 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.441 -0.345 . . . . 0.0 111.451 -178.258 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -80.13 -26.59 39.35 Favored 'General case' 0 C--N 1.327 -0.386 0 C-N-CA 120.53 -0.468 . . . . 0.0 110.586 -179.793 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' HIS . . . . . 0.628 ' HB2' ' O ' ' A' ' 90' ' ' GLU . 0.1 OUTLIER -72.17 -42.1 66.27 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.994 0.426 . . . . 0.0 110.483 -179.959 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 19.9 m-30 -80.63 -15.33 56.84 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.377 179.913 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . 0.544 ' HA ' ' O ' ' A' ' 99' ' ' GLY . 30.1 tt0 -62.77 -28.85 70.27 Favored 'General case' 0 CA--C 1.523 -0.065 0 CA-C-N 115.549 -0.75 . . . . 0.0 109.607 178.704 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 14.2 m -63.4 -23.05 67.24 Favored 'General case' 0 CA--C 1.533 0.291 0 CA-C-N 115.491 -0.777 . . . . 0.0 110.852 179.302 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 7.4 m -100.2 -43.97 6.12 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.169 -0.469 . . . . 0.0 109.807 179.044 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . 0.544 ' O ' ' HA ' ' A' ' 96' ' ' GLN . . . -150.19 139.31 7.25 Favored Glycine 0 N--CA 1.444 -0.81 0 N-CA-C 111.071 -0.811 . . . . 0.0 111.071 179.491 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -60.41 149.92 32.51 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 121.072 0.463 . . . . 0.0 111.564 -179.705 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 2.0 p -114.28 129.36 70.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.352 -178.897 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 8.0 t30 -94.05 -38.33 11.19 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.306 0.574 . . . . 0.0 109.817 179.078 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -155.15 149.32 25.91 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.573 -0.739 . . . . 0.0 110.289 -179.72 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 7.7 p -145.93 135.25 17.36 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 CA-C-N 116.015 -0.538 . . . . 0.0 110.15 179.858 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . 0.497 ' HB ' ' CE1' ' A' ' 119' ' ' TYR . 2.3 m -126.37 119.74 28.08 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.468 -0.333 . . . . 0.0 110.232 179.62 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' ILE . . . . . 0.601 HD11 ' HA2' ' A' ' 116' ' ' GLY . 20.1 tt -108.24 143.42 18.67 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-O 120.808 0.337 . . . . 0.0 110.512 179.991 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 36.4 tp -129.39 135.39 48.63 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.713 -179.713 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -94.42 116.62 29.01 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 109.833 -0.432 . . . . 0.0 109.833 179.045 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . 0.401 ' O ' ' HG2' ' A' ' 115' ' ' LYS . 14.1 t70 -84.46 134.06 34.46 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.194 0.521 . . . . 0.0 110.87 -179.676 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 11.2 mmmm -117.77 24.22 11.2 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.742 -0.663 . . . . 0.0 109.703 179.915 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 11.6 t80 -106.87 10.77 30.55 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.208 0.528 . . . . 0.0 110.237 -179.02 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 93.79 6.83 61.88 Favored Glycine 0 N--CA 1.449 -0.461 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.697 179.396 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 27.8 mt-30 -95.47 157.61 35.93 Favored Pre-proline 0 C--N 1.323 -0.586 0 N-CA-C 109.752 -0.462 . . . . 0.0 109.752 179.89 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 11.0 Cg_endo -56.16 117.83 4.54 Favored 'Trans proline' 0 N--CA 1.462 -0.348 0 C-N-CA 122.237 1.958 . . . . 0.0 110.811 178.458 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . 0.401 ' HG2' ' O ' ' A' ' 109' ' ' ASP . 47.2 mttt -76.88 172.46 13.1 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 109.63 -0.507 . . . . 0.0 109.63 -179.289 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . 0.601 ' HA2' HD11 ' A' ' 106' ' ' ILE . . . 98.08 0.67 58.52 Favored Glycine 0 N--CA 1.446 -0.693 0 C-N-CA 120.115 -1.041 . . . . 0.0 112.599 179.596 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 1.8 t80 -52.99 119.28 4.48 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 121.018 0.437 . . . . 0.0 110.08 179.423 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -145.24 177.06 9.08 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.992 -178.845 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 119' ' ' TYR . . . . . 0.497 ' CE1' ' HB ' ' A' ' 105' ' ' THR . 49.9 p90 -158.34 133.91 8.86 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.606 -0.725 . . . . 0.0 109.059 178.905 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . 0.449 HG22 HD11 ' A' ' 77' ' ' ILE . 6.8 m -108.97 143.22 19.61 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.659 0 N-CA-C 109.666 -0.494 . . . . 0.0 109.666 178.895 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . 0.404 ' HB2' HG12 ' A' ' 72' ' ' VAL . 7.4 pt-20 -127.7 153.7 46.19 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.43 -0.35 . . . . 0.0 110.753 -179.903 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 8.4 t80 -151.97 169.57 21.99 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.297 179.318 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 3.0 t -89.52 -48.1 14.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 120.844 0.354 . . . . 0.0 111.376 -179.59 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -69.76 127.88 34.46 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.876 0.37 . . . . 0.0 110.86 -179.248 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 2.5 mp -68.03 -33.17 59.54 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.314 -179.075 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -58.09 -42.12 84.93 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.839 0.352 . . . . 0.0 111.465 -179.991 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -56.94 -56.47 21.33 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.171 -179.777 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 8.9 p -68.56 -28.32 39.79 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.363 -179.527 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 3.5 tt0 -63.01 -39.25 94.19 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.977 0.418 . . . . 0.0 110.453 -179.905 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 41.2 m-80 -77.7 -29.66 51.45 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.266 0.555 . . . . 0.0 109.797 179.096 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . 0.443 ' O ' ' HB2' ' A' ' 135' ' ' ASN . . . -67.65 -49.6 62.04 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.422 -0.808 . . . . 0.0 111.161 179.829 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 4.4 pp -66.38 -13.27 60.4 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.886 0.374 . . . . 0.0 111.555 -179.578 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 3.9 tp -89.06 -49.9 6.48 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.153 0.501 . . . . 0.0 109.986 179.036 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 25.3 mt -126.69 100.91 6.4 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.057 179.729 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 135' ' ' ASN . . . . . 0.443 ' HB2' ' O ' ' A' ' 131' ' ' ALA . 0.2 OUTLIER -150.62 -58.28 0.18 Allowed 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.239 0.542 . . . . 0.0 111.628 -179.293 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 4.6 pt-20 -77.5 85.98 3.86 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.8 -0.636 . . . . 0.0 111.67 -178.98 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 23.9 m -134.44 -58.88 0.83 Allowed 'General case' 0 N--CA 1.448 -0.526 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.117 179.248 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 6.8 tm-20 -155.02 128.37 8.4 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.906 0.384 . . . . 0.0 111.002 179.646 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -143.45 111.59 6.19 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 178.269 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 140' ' ' HIS . . . . . 0.482 ' HD1' ' CD ' ' A' ' 90' ' ' GLU . 1.7 t60 61.01 28.8 18.57 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.97 0.414 . . . . 0.0 110.7 -179.833 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 85.39 0.94 88.22 Favored Glycine 0 N--CA 1.449 -0.499 0 C-N-CA 120.978 -0.629 . . . . 0.0 113.043 179.779 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 142' ' ' ARG . . . . . 0.41 ' HD3' ' OD1' ' A' ' 83' ' ' ASP . 1.4 mpt_? -117.52 163.66 16.08 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 117.147 0.473 . . . . 0.0 110.868 179.928 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 2.1 pt20 -110.69 121.8 46.22 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 116.256 -0.429 . . . . 0.0 109.932 179.799 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . 0.453 HD23 HG13 ' A' ' 82' ' ' VAL . 0.5 OUTLIER -106.46 178.78 4.46 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.992 -179.025 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 6.1 tttt -115.44 121.78 43.77 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.088 -0.505 . . . . 0.0 109.859 178.893 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 146' ' ' VAL . . . . . 0.428 ' HA ' ' O ' ' A' ' 78' ' ' TYR . 96.9 t -120.98 126.9 75.77 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-O 121.094 0.473 . . . . 0.0 111.212 -179.712 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 39.7 m -134.61 151.73 51.27 Favored 'General case' 0 C--N 1.319 -0.743 0 N-CA-C 109.582 -0.525 . . . . 0.0 109.582 178.91 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -65.0 131.4 46.49 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.128 0.49 . . . . 0.0 111.46 -179.101 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 21.0 ttpt -93.48 80.29 4.35 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 121.363 0.601 . . . . 0.0 109.813 179.611 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 21.5 tpt180 -93.64 104.65 16.74 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.346 -0.843 . . . . 0.0 109.483 179.236 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 9.6 t -89.07 136.97 32.73 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 116.083 -0.508 . . . . 0.0 109.803 179.262 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 152' ' ' ASN . . . . . . . . . . . . . 59.8 t30 -172.51 154.87 3.24 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 108.89 -0.782 . . . . 0.0 108.89 -179.864 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 24.1 pt -71.39 139.23 84.1 Favored Pre-proline 0 C--N 1.32 -0.705 0 CA-C-O 120.635 0.255 . . . . 0.0 110.375 179.763 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 20.7 Cg_endo -61.9 119.16 6.14 Favored 'Trans proline' 0 N--CA 1.462 -0.328 0 C-N-CA 122.549 2.166 . . . . 0.0 112.169 179.954 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.063 0 CA-C-O 118.822 -0.988 . . . . 0.0 111.397 179.994 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.2 mpp? . . . . . 0 N--CA 1.481 1.122 0 N-CA-C 110.206 -0.294 . . . . 0.0 110.206 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -139.76 138.78 9.43 Favored Glycine 0 N--CA 1.445 -0.765 0 C-N-CA 120.858 -0.687 . . . . 0.0 111.763 179.557 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 16.7 m -145.24 126.36 14.67 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 120.761 0.315 . . . . 0.0 110.2 179.985 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 46.9 m -154.45 120.42 5.26 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.709 -179.439 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -160.07 124.41 3.77 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.25 179.802 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -152.62 126.82 9.17 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.43 -0.35 . . . . 0.0 110.23 -179.948 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 6.5 p80 -141.37 147.02 37.38 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 109.964 -0.384 . . . . 0.0 109.964 179.947 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 57.4 t60 -171.8 112.93 0.33 Allowed 'General case' 0 C--N 1.328 -0.333 0 O-C-N 123.182 0.301 . . . . 0.0 111.061 -179.5 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 7.9 t-80 -167.19 114.52 0.79 Allowed 'General case' 0 N--CA 1.464 0.241 0 CA-C-O 120.723 0.297 . . . . 0.0 111.021 178.998 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 1.5 m-70 -156.76 122.04 4.67 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.671 179.954 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -129.62 147.72 51.45 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.48 -0.327 . . . . 0.0 110.595 179.159 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -147.33 164.88 31.85 Favored 'General case' 0 C--O 1.237 0.436 0 CA-C-N 116.58 -0.282 . . . . 0.0 111.051 179.852 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -174.62 161.17 30.8 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.819 -0.705 . . . . 0.0 112.561 -179.976 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 15.2 tp -118.84 140.96 49.11 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.64 0.257 . . . . 0.0 110.606 179.851 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -117.51 109.56 41.77 Favored Pre-proline 0 C--N 1.325 -0.478 0 CA-C-O 120.91 0.386 . . . . 0.0 110.586 179.421 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 87.2 Cg_endo -84.44 -175.49 2.17 Favored 'Trans proline' 0 N--CA 1.461 -0.388 0 C-N-CA 122.829 2.353 . . . . 0.0 112.913 -179.743 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -143.06 121.26 12.2 Favored 'General case' 0 N--CA 1.452 -0.343 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.114 -179.807 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 173.35 87.37 0.07 OUTLIER Glycine 0 N--CA 1.448 -0.538 0 C-N-CA 120.842 -0.695 . . . . 0.0 111.905 -179.923 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 6.0 m -138.42 157.77 45.57 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 110.305 -0.257 . . . . 0.0 110.305 179.615 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 14.4 p80 -145.24 163.12 35.41 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 116.498 -0.319 . . . . 0.0 110.207 179.475 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 3.5 mpp? -108.06 -179.04 3.78 Favored 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 109.482 -0.562 . . . . 0.0 109.482 179.336 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 132.03 93.52 0.58 Allowed Glycine 0 N--CA 1.446 -0.653 0 C-N-CA 120.228 -0.986 . . . . 0.0 112.719 179.645 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 3.4 p -131.05 99.13 4.78 Favored 'General case' 0 C--N 1.32 -0.704 0 N-CA-C 110.079 -0.341 . . . . 0.0 110.079 179.815 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -146.61 97.4 2.91 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.546 -0.297 . . . . 0.0 110.367 179.782 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 4.0 mt -165.72 -167.39 1.1 Allowed 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.925 -0.579 . . . . 0.0 109.83 179.925 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 8.7 mm-40 -80.18 179.82 7.45 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.864 0.364 . . . . 0.0 111.071 179.771 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -134.16 171.86 13.66 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.656 -178.653 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 8.8 ttm -113.18 150.55 32.12 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 178.387 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 31.8 mmmt -61.52 -79.41 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.199 0 N-CA-C 110.434 -0.21 . . . . 0.0 110.434 -179.897 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 47.5 pttt -167.93 128.47 1.37 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.97 0.414 . . . . 0.0 110.789 178.956 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -109.26 1.92 20.51 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.641 -0.709 . . . . 0.0 109.969 179.375 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 16.6 tp 60.35 70.38 0.63 Allowed 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.247 -0.888 . . . . 0.0 110.952 179.787 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 15.6 ptpt -159.49 159.25 33.26 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.797 -0.638 . . . . 0.0 109.857 179.574 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 26.7 tt0 -161.58 87.65 0.69 Allowed 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 120.839 0.352 . . . . 0.0 110.157 -179.68 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 19.3 tt -147.36 149.5 15.5 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-O 120.766 0.317 . . . . 0.0 110.566 -179.307 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -119.44 175.4 5.85 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.173 179.317 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 5.2 tt0 -144.39 -160.62 1.15 Allowed 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.396 179.869 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 4.4 mm-40 -94.15 152.44 18.74 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 116.62 -0.264 . . . . 0.0 110.395 179.916 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -70.32 158.6 35.63 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.361 -179.226 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -82.3 -158.99 24.66 Favored Glycine 0 N--CA 1.448 -0.535 0 C-N-CA 121.027 -0.606 . . . . 0.0 112.438 179.783 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -152.73 -150.8 0.35 Allowed 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 120.732 0.301 . . . . 0.0 110.665 -179.875 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 46.6 tp -72.75 90.1 1.39 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.346 179.699 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 51.2 ttt85 -154.43 147.13 24.25 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.064 -179.817 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 15.7 mt-10 -81.73 29.92 0.38 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.033 0.444 . . . . 0.0 111.111 -179.877 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 13.9 ptt? -83.64 1.83 40.44 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.277 0.56 . . . . 0.0 110.142 -179.924 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 38.6 mt-30 -71.4 -17.01 62.43 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.751 -179.793 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -78.31 -11.62 59.95 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.242 179.374 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 35.5 ttpt -77.8 -0.09 25.81 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.718 -0.674 . . . . 0.0 110.246 179.717 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 8.1 p -59.49 -26.03 33.12 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.237 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.901 179.883 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 25.7 mt-10 -67.37 -24.95 65.75 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.72 179.571 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 4.3 ttmt -98.81 -34.59 10.43 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.454 179.192 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 9.1 mm-40 -66.1 -16.04 63.6 Favored 'General case' 0 C--N 1.333 -0.112 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.22 179.781 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -64.53 -25.44 67.99 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.178 0.513 . . . . 0.0 109.785 178.694 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -97.41 12.04 65.02 Favored Glycine 0 N--CA 1.45 -0.378 0 N-CA-C 110.709 -0.956 . . . . 0.0 110.709 179.044 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -138.92 26.34 2.47 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.256 -0.472 . . . . 0.0 109.942 179.777 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 16.0 m -63.32 -20.17 25.46 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.419 0 CA-C-N 116.094 -0.503 . . . . 0.0 112.073 -179.65 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 16.4 mt-30 -80.22 -5.1 55.59 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.233 0.54 . . . . 0.0 110.437 179.534 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -123.88 -48.35 1.89 Allowed 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.534 -0.757 . . . . 0.0 110.974 -179.799 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 16.5 m -81.86 -56.98 3.63 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.735 -0.666 . . . . 0.0 112.595 -178.675 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -98.81 27.18 5.09 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.068 0.461 . . . . 0.0 111.344 -178.576 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 7.6 t -70.22 -31.54 69.01 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-O 121.157 0.503 . . . . 0.0 110.316 -179.742 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -68.52 -22.77 64.5 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.854 -0.612 . . . . 0.0 111.474 179.968 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 3.5 m -63.13 -26.91 69.04 Favored 'General case' 0 N--CA 1.449 -0.499 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.823 -179.275 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -71.72 -32.77 68.12 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.908 0.385 . . . . 0.0 110.575 179.559 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -74.47 -2.13 24.25 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.466 -179.922 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 22.5 tp60 -118.98 -49.37 2.42 Favored 'General case' 0 N--CA 1.451 -0.404 0 CA-C-O 120.593 0.235 . . . . 0.0 111.315 179.876 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -84.59 -52.68 5.93 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.881 0.372 . . . . 0.0 111.92 -178.549 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . 0.405 ' O ' HG23 ' A' ' 72' ' ' VAL . 1.3 tp10 -69.62 -30.67 68.45 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.989 0.423 . . . . 0.0 110.615 -179.387 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 50.9 tptt -55.81 -33.65 64.62 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.714 179.908 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 54.4 mt-10 -58.85 -25.7 63.51 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-O 121.02 0.438 . . . . 0.0 111.31 179.943 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 4.4 tp10 -93.82 -40.21 10.31 Favored 'General case' 0 N--CA 1.449 -0.517 0 N-CA-C 109.711 -0.477 . . . . 0.0 109.711 178.786 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.405 HG23 ' O ' ' A' ' 68' ' ' GLU . 61.8 t -63.01 -43.45 99.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 115.706 -0.679 . . . . 0.0 112.658 -178.804 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . 0.41 ' OD2' HG21 ' A' ' 151' ' ' THR . 9.0 p-10 -70.81 -18.89 62.73 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-O 121.154 0.502 . . . . 0.0 110.894 -179.365 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 49.1 m -97.79 -8.69 27.94 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.051 178.272 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -111.41 48.31 0.95 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.562 -0.744 . . . . 0.0 110.11 -179.368 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . 0.466 ' OG ' ' HE2' ' A' ' 149' ' ' LYS . 0.1 OUTLIER -129.95 172.76 11.37 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.921 -0.581 . . . . 0.0 111.26 179.86 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -131.01 138.14 54.2 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-N 115.847 -0.615 . . . . 0.0 109.573 178.434 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 57.2 t80 -96.64 125.32 41.03 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.405 -179.485 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.419 HG21 ' HE2' ' A' ' 95' ' ' PHE . 2.9 t -104.8 118.41 52.09 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.391 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.843 -179.405 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -124.46 168.18 16.64 Favored Glycine 0 N--CA 1.449 -0.472 0 N-CA-C 110.936 -0.866 . . . . 0.0 110.936 179.521 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 2.4 m-20 59.42 34.75 22.81 Favored 'General case' 0 N--CA 1.474 0.746 0 CA-C-O 120.834 0.35 . . . . 0.0 111.279 -179.39 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.405 ' H ' HG23 ' A' ' 82' ' ' VAL . 2.2 t -76.4 163.51 3.91 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.724 0 CA-C-N 115.616 -0.72 . . . . 0.0 110.652 -178.975 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . 0.706 ' OD2' ' HB2' ' A' ' 142' ' ' ARG . 0.5 OUTLIER -63.48 137.66 58.22 Favored 'General case' 0 CA--C 1.515 -0.369 0 N-CA-C 109.67 -0.492 . . . . 0.0 109.67 179.015 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 37.2 p90 -66.17 -8.79 26.33 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.07 -179.768 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -120.41 20.54 11.87 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.038 -179.805 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -86.48 146.34 26.44 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.817 0.342 . . . . 0.0 111.052 -179.97 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . 0.428 ' O ' ' HG2' ' A' ' 90' ' ' GLU . 17.7 p -109.73 155.0 42.2 Favored Pre-proline 0 C--N 1.323 -0.57 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.412 179.841 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . 0.479 ' HD3' HD13 ' A' ' 106' ' ' ILE . 18.3 Cg_endo -59.05 -38.88 84.9 Favored 'Trans proline' 0 C--N 1.345 0.372 0 C-N-CA 122.709 2.272 . . . . 0.0 112.929 -178.928 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 24.3 mt-10 -62.36 -50.57 71.04 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.766 -0.652 . . . . 0.0 112.348 -178.496 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . 0.428 ' HG2' ' O ' ' A' ' 87' ' ' THR . 11.1 pt-20 -66.31 -16.73 64.28 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.672 0.273 . . . . 0.0 111.535 -178.972 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 56.0 t -86.44 -47.23 16.39 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 CA-C-O 120.93 0.395 . . . . 0.0 110.495 -179.904 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -71.7 -33.39 68.73 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.791 -178.576 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 1.2 pp0? -77.09 -29.03 54.77 Favored 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 120.378 -0.529 . . . . 0.0 111.33 -178.759 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 2.9 m80 -76.7 -40.31 49.19 Favored 'General case' 0 C--N 1.327 -0.376 0 C-N-CA 120.725 -0.39 . . . . 0.0 110.809 -179.635 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . 0.419 ' HE2' HG21 ' A' ' 79' ' ' VAL . 22.0 m-30 -75.61 -16.53 60.21 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.58 179.899 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . 0.633 ' HA ' ' O ' ' A' ' 99' ' ' GLY . 2.7 tt0 -66.89 -21.77 65.99 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-N 115.982 -0.553 . . . . 0.0 110.391 179.22 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 46.7 m -66.14 -24.26 66.63 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-N 115.905 -0.588 . . . . 0.0 110.074 179.015 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 2.6 m -100.59 -48.84 4.39 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.635 -0.711 . . . . 0.0 109.497 179.042 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . 0.633 ' O ' ' HA ' ' A' ' 96' ' ' GLN . . . -142.18 138.4 8.5 Favored Glycine 0 N--CA 1.446 -0.666 0 N-CA-C 111.41 -0.676 . . . . 0.0 111.41 179.766 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . 0.404 ' HB ' ' CZ ' ' A' ' 122' ' ' PHE . 0.2 OUTLIER -59.81 148.36 34.81 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.735 0.267 . . . . 0.0 111.413 -179.934 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 2.1 p -119.88 129.28 75.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.216 -179.237 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 58.2 t30 -100.42 -43.19 6.32 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.863 0.363 . . . . 0.0 110.182 178.986 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -139.77 148.6 42.45 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.392 179.996 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 5.9 p -148.07 134.33 12.45 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-N 115.856 -0.611 . . . . 0.0 109.854 179.286 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 2.8 m -126.01 122.89 37.17 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 116.479 -0.328 . . . . 0.0 110.341 179.554 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 106' ' ' ILE . . . . . 0.479 HD13 ' HD3' ' A' ' 88' ' ' PRO . 20.3 tt -112.02 148.0 15.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 120.895 0.379 . . . . 0.0 111.136 -179.61 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 27.5 tp -136.5 128.19 28.94 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.156 178.997 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -90.06 120.69 31.47 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 109.848 -0.427 . . . . 0.0 109.848 179.315 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . 0.455 ' O ' ' HG2' ' A' ' 115' ' ' LYS . 12.8 t70 -79.53 145.1 33.36 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.087 0.47 . . . . 0.0 111.088 -179.992 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . 0.406 ' HD3' ' C ' ' A' ' 109' ' ' ASP . 0.0 OUTLIER -131.59 23.83 4.72 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.8 -0.636 . . . . 0.0 109.286 179.161 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 4.8 t80 -106.62 -5.4 18.7 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.428 -179.126 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 108.39 12.56 21.25 Favored Glycine 0 CA--C 1.519 0.287 0 C-N-CA 120.979 -0.629 . . . . 0.0 112.86 -179.956 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 113' ' ' GLN . . . . . 0.412 ' HB3' ' HD2' ' A' ' 114' ' ' PRO . 22.6 mt-30 -99.84 159.19 30.56 Favored Pre-proline 0 C--N 1.323 -0.563 0 N-CA-C 109.662 -0.496 . . . . 0.0 109.662 179.701 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 114' ' ' PRO . . . . . 0.412 ' HD2' ' HB3' ' A' ' 113' ' ' GLN . 19.3 Cg_endo -58.85 110.04 0.61 Allowed 'Trans proline' 0 C--N 1.346 0.44 0 C-N-CA 122.233 1.955 . . . . 0.0 110.863 178.645 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . 0.455 ' HG2' ' O ' ' A' ' 109' ' ' ASP . 30.5 mttt -69.6 170.9 9.83 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.553 -178.616 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . 0.415 ' HA2' HD11 ' A' ' 106' ' ' ILE . . . 101.46 4.71 52.7 Favored Glycine 0 N--CA 1.446 -0.646 0 C-N-CA 120.514 -0.851 . . . . 0.0 111.877 -179.841 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 34.1 m-85 -53.01 117.89 3.32 Favored 'General case' 0 C--O 1.232 0.167 0 C-N-CA 122.338 0.255 . . . . 0.0 110.492 179.671 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -149.18 171.54 16.28 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 121.0 0.429 . . . . 0.0 111.13 -179.314 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 17.2 p90 -154.96 132.58 11.31 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 115.501 -0.772 . . . . 0.0 109.645 178.411 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 8.5 m -108.06 142.83 19.71 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 N-CA-C 109.726 -0.472 . . . . 0.0 109.726 179.735 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . 0.424 ' HB3' ' HB3' ' A' ' 76' ' ' SER . 4.5 pt-20 -130.92 153.42 49.18 Favored 'General case' 0 C--O 1.238 0.5 0 CA-C-O 120.944 0.402 . . . . 0.0 111.235 179.987 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 122' ' ' PHE . . . . . 0.404 ' CZ ' ' HB ' ' A' ' 100' ' ' THR . 11.5 t80 -148.26 172.67 13.99 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.644 -0.707 . . . . 0.0 110.095 179.834 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 6.3 t -89.37 -41.86 14.09 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-O 121.028 0.442 . . . . 0.0 111.192 -179.742 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 38.7 mm-40 -69.96 128.92 38.02 Favored 'General case' 0 C--O 1.236 0.392 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.937 -179.83 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 2.7 mp -74.57 -33.95 33.78 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.177 -179.869 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -59.85 -37.28 78.81 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.435 179.633 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -63.56 -56.49 15.56 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.641 -0.709 . . . . 0.0 111.256 -179.789 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 11.0 p -65.77 -28.06 43.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.367 -179.367 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 5.9 tt0 -60.38 -43.93 96.12 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-O 121.006 0.431 . . . . 0.0 110.371 179.447 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 92.5 m-20 -72.48 -31.57 65.5 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.053 -0.522 . . . . 0.0 110.05 179.699 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -67.53 -42.86 82.07 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.51 -0.768 . . . . 0.0 111.636 -179.857 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 4.1 pp -74.15 -17.67 60.89 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.915 0.388 . . . . 0.0 110.914 179.976 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 6.2 tp -83.8 -56.39 3.73 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.673 179.939 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 54.1 mt -125.38 103.18 7.77 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.642 -0.254 . . . . 0.0 111.44 -179.113 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 2.4 m-20 -154.49 -53.19 0.1 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.885 0.374 . . . . 0.0 111.15 178.764 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 3.9 pt-20 -75.82 98.22 4.11 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.464 0.65 . . . . 0.0 111.08 -179.888 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 43.3 m -145.92 -57.54 0.31 Allowed 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.669 -0.696 . . . . 0.0 109.821 178.865 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 24.4 tt0 -163.17 130.05 3.44 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 109.436 -0.579 . . . . 0.0 109.436 178.954 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -148.46 122.31 9.34 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 108.603 -0.888 . . . . 0.0 108.603 179.677 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 140' ' ' HIS . . . . . 0.651 ' HB3' ' OD2' ' A' ' 83' ' ' ASP . 5.0 t60 64.43 3.16 1.77 Allowed 'General case' 0 N--CA 1.471 0.623 0 O-C-N 123.544 0.528 . . . . 0.0 111.723 179.005 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 109.65 -9.93 32.56 Favored Glycine 0 N--CA 1.446 -0.637 0 C-N-CA 121.123 -0.56 . . . . 0.0 112.127 -179.704 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 142' ' ' ARG . . . . . 0.706 ' HB2' ' OD2' ' A' ' 83' ' ' ASP . 1.0 OUTLIER -111.7 170.98 7.76 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.154 0.502 . . . . 0.0 110.375 179.876 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 7.4 pt20 -113.0 129.67 56.41 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 179.303 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -113.91 173.27 6.51 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-O 120.907 0.384 . . . . 0.0 110.474 -179.645 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 8.8 ttpt -113.23 118.02 33.5 Favored 'General case' 0 C--N 1.318 -0.775 0 N-CA-C 109.428 -0.582 . . . . 0.0 109.428 179.278 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 96.7 t -114.42 116.95 54.1 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.659 0 CA-C-O 120.756 0.312 . . . . 0.0 110.431 -179.909 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 25.7 m -127.12 146.38 50.41 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 109.393 -0.595 . . . . 0.0 109.393 179.674 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -56.85 130.6 46.46 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 120.978 0.418 . . . . 0.0 111.501 -179.234 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 149' ' ' LYS . . . . . 0.466 ' HE2' ' OG ' ' A' ' 76' ' ' SER . 18.0 ttpt -93.2 63.11 3.59 Favored 'General case' 0 N--CA 1.451 -0.378 0 N-CA-C 108.622 -0.881 . . . . 0.0 108.622 179.508 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 16.4 tpt180 -84.99 90.76 7.91 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 121.31 0.576 . . . . 0.0 110.25 -179.867 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 151' ' ' THR . . . . . 0.41 HG21 ' OD2' ' A' ' 73' ' ' ASP . 13.7 t -74.75 141.19 44.44 Favored 'General case' 0 N--CA 1.44 -0.927 0 N-CA-C 108.622 -0.881 . . . . 0.0 108.622 178.442 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 152' ' ' ASN . . . . . . . . . . . . . 64.3 t30 -172.04 166.34 6.19 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 120.64 0.257 . . . . 0.0 110.551 -178.953 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 23.5 pt -79.58 152.29 75.22 Favored Pre-proline 0 C--N 1.325 -0.469 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.041 179.087 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -76.02 55.95 4.67 Favored 'Trans proline' 0 C--N 1.345 0.359 0 C-N-CA 122.55 2.167 . . . . 0.0 112.478 179.917 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.166 0 CA-C-O 118.491 -1.172 . . . . 0.0 111.927 -179.71 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 5.2 mpp? . . . . . 0 N--CA 1.481 1.085 0 CA-C-O 120.792 0.33 . . . . 0.0 110.141 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 155.67 128.52 1.13 Allowed Glycine 0 N--CA 1.448 -0.552 0 C-N-CA 120.933 -0.651 . . . . 0.0 112.292 -179.608 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 31.4 m -134.95 140.29 45.59 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 110.291 -0.263 . . . . 0.0 110.291 -179.971 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 8.1 m -107.15 154.4 21.24 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 120.514 0.197 . . . . 0.0 110.532 -179.804 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 7.7 p80 -165.09 138.81 4.78 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.705 -0.225 . . . . 0.0 110.657 -179.629 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 41.9 t-80 -161.58 138.12 8.28 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.444 179.619 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 1.9 m-70 -129.4 164.66 23.16 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.172 179.374 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -145.56 142.08 28.81 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.473 -0.33 . . . . 0.0 110.684 179.81 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 12.3 p-80 -143.19 162.22 36.19 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.724 0.297 . . . . 0.0 110.929 179.721 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 46.2 t-80 -155.33 148.73 25.0 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 109.73 -0.471 . . . . 0.0 109.73 179.826 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 3.1 m -88.1 174.59 8.17 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 120.687 0.279 . . . . 0.0 111.01 179.863 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 45.3 m -120.85 -162.31 0.95 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.951 179.801 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -146.62 173.87 26.69 Favored Glycine 0 N--CA 1.449 -0.45 0 N-CA-C 111.537 -0.625 . . . . 0.0 111.537 -179.771 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 23.3 tp -60.17 137.29 58.14 Favored 'General case' 0 C--O 1.238 0.45 0 CA-C-O 120.953 0.406 . . . . 0.0 111.376 -179.591 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.447 ' HB ' ' CE ' ' A' ' 33' ' ' LYS . 10.2 m -138.86 148.48 58.25 Favored Pre-proline 0 C--N 1.324 -0.505 0 CA-C-N 115.806 -0.634 . . . . 0.0 111.038 -179.744 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 70.6 Cg_endo -76.94 131.31 12.0 Favored 'Trans proline' 0 C--N 1.346 0.438 0 C-N-CA 122.61 2.206 . . . . 0.0 110.954 178.183 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . 0.514 ' HA ' ' OE2' ' A' ' 68' ' ' GLU . 2.0 mpt_? -86.11 150.76 24.2 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.094 0.473 . . . . 0.0 111.933 -178.411 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . 0.402 ' O ' ' HB ' ' A' ' 123' ' ' VAL . . . -139.99 -149.88 5.4 Favored Glycine 0 CA--C 1.522 0.503 0 CA-C-N 115.549 -0.75 . . . . 0.0 112.129 179.198 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . 0.428 ' N ' HG12 ' A' ' 35' ' ' ILE . 0.0 OUTLIER -150.28 133.7 16.47 Favored 'General case' 0 CA--C 1.532 0.285 0 CA-C-N 116.847 0.324 . . . . 0.0 111.299 179.899 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . 0.456 ' CE1' ' HA ' ' A' ' 37' ' ' GLU . 0.2 OUTLIER -174.17 167.49 4.13 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 122.353 0.261 . . . . 0.0 110.326 179.311 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 92.8 mtp -120.7 145.78 47.12 Favored 'General case' 0 C--O 1.235 0.321 0 N-CA-C 108.751 -0.833 . . . . 0.0 108.751 178.217 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -169.73 -139.94 2.85 Favored Glycine 0 C--N 1.331 0.302 0 C-N-CA 119.939 -1.124 . . . . 0.0 113.893 -179.287 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 46.5 m -127.98 -155.8 0.72 Allowed 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 122.297 0.239 . . . . 0.0 110.749 -178.925 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 12.0 t70 -124.5 142.31 51.43 Favored 'General case' 0 C--N 1.328 -0.345 0 O-C-N 122.068 -0.395 . . . . 0.0 110.872 -179.9 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 42.9 tp -171.42 107.63 0.25 Allowed 'General case' 0 CA--C 1.532 0.259 0 CA-C-O 120.952 0.406 . . . . 0.0 110.894 -179.621 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 4.3 tt0 -94.25 131.42 39.86 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.352 179.5 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 4.1 t70 -146.12 -145.05 0.16 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.625 -0.261 . . . . 0.0 110.443 -179.944 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -70.79 161.98 29.95 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.992 0.425 . . . . 0.0 111.202 -179.874 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 44.5 mttm -99.21 108.58 21.19 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.09 -178.917 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 10.4 mptt -128.15 151.96 48.6 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.539 179.517 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -102.72 -170.19 1.77 Allowed 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.879 -0.601 . . . . 0.0 109.755 179.096 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER 63.56 68.62 0.59 Allowed 'General case' 0 N--CA 1.465 0.302 0 CA-C-O 121.255 0.55 . . . . 0.0 111.081 -179.677 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.454 ' HZ3' ' CD ' ' A' ' 68' ' ' GLU . 0.5 OUTLIER -141.74 163.66 32.3 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.734 -0.666 . . . . 0.0 109.554 179.84 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -110.88 -81.22 0.58 Allowed 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 109.879 -0.415 . . . . 0.0 109.879 179.502 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.614 HD11 HG21 ' A' ' 123' ' ' VAL . 8.6 tp -174.59 47.3 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-O 122.398 1.094 . . . . 0.0 110.643 -179.591 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 1.3 pm0 -87.14 -173.01 4.22 Favored 'General case' 0 C--N 1.314 -0.944 0 CA-C-N 115.472 -0.785 . . . . 0.0 110.607 179.964 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . 0.456 ' HA ' ' CE1' ' A' ' 20' ' ' HIS . 26.9 mt-10 -77.62 -150.89 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.662 -0.244 . . . . 0.0 111.184 -179.508 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . 0.69 ' HB3' ' OG1' ' A' ' 65' ' ' THR . 1.6 pm0 -139.82 126.7 20.77 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.72 0.295 . . . . 0.0 111.096 -179.728 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -168.21 100.76 0.44 Allowed 'General case' 0 C--O 1.232 0.155 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.82 -179.844 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 177.29 -179.72 47.95 Favored Glycine 0 N--CA 1.448 -0.519 0 N-CA-C 111.559 -0.616 . . . . 0.0 111.559 -179.787 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -149.15 170.91 17.35 Favored 'General case' 0 C--O 1.237 0.444 0 CA-C-O 120.891 0.377 . . . . 0.0 111.547 -179.596 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 16.2 tp -72.11 80.42 0.96 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.422 -0.808 . . . . 0.0 111.015 179.862 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . 0.402 ' C ' ' H ' ' A' ' 45' ' ' MET . 0.8 OUTLIER -126.6 148.93 49.72 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 115.765 -0.652 . . . . 0.0 109.391 179.449 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -75.98 23.87 0.13 Allowed 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.088 0.471 . . . . 0.0 111.847 -179.58 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' MET . . . . . 0.402 ' H ' ' C ' ' A' ' 43' ' ' ARG . 16.6 ptt? -95.8 5.93 50.13 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.053 0.454 . . . . 0.0 110.127 179.754 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 40.5 mt-30 -67.22 -8.5 32.05 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.409 -179.264 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -82.7 -11.74 58.1 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.483 0.658 . . . . 0.0 109.994 178.722 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . 0.486 ' O ' ' HG2' ' A' ' 52' ' ' GLU . 13.5 ttpp -78.51 5.82 9.97 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.257 -0.883 . . . . 0.0 110.398 -179.806 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 12.6 p -58.04 -24.65 24.25 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.123 -179.866 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 32.0 mt-10 -65.13 -27.8 68.99 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 121.154 0.502 . . . . 0.0 110.247 179.042 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 12.8 mtmt -98.59 -33.7 10.87 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.238 178.711 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . 0.486 ' HG2' ' O ' ' A' ' 48' ' ' LYS . 38.1 mm-40 -83.31 12.14 5.76 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.807 -0.633 . . . . 0.0 111.651 -179.731 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 10.5 ptp -62.03 -30.64 71.1 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-O 120.717 0.294 . . . . 0.0 110.651 179.679 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -96.91 3.96 62.81 Favored Glycine 0 N--CA 1.449 -0.434 0 N-CA-C 111.05 -0.82 . . . . 0.0 111.05 178.474 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -129.66 29.49 5.02 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.406 0.622 . . . . 0.0 110.389 -179.722 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 17.3 m -65.88 -19.73 26.15 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.483 0 CA-C-N 115.817 -0.629 . . . . 0.0 111.355 -179.548 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 45.6 mt-30 -79.55 -2.18 41.18 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.15 0.5 . . . . 0.0 111.034 179.765 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 15.8 t70 -129.84 -41.9 1.29 Allowed 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.991 179.741 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 24.0 m -90.23 -70.18 0.68 Allowed 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.91 -179.307 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -81.43 30.69 0.35 Allowed 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.3 0.571 . . . . 0.0 110.988 -179.609 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 1.8 t -77.02 -43.54 34.28 Favored 'General case' 0 N--CA 1.449 -0.516 0 CA-C-N 115.512 -0.767 . . . . 0.0 110.834 -178.898 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -56.03 -22.57 27.96 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 112.604 0.594 . . . . 0.0 112.604 -178.794 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 19.5 m -61.73 -22.56 65.49 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.381 -179.708 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . 0.476 ' O ' ' HB3' ' A' ' 68' ' ' GLU . . . -73.73 -34.69 64.88 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.101 0.477 . . . . 0.0 110.223 178.958 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . 0.69 ' OG1' ' HB3' ' A' ' 38' ' ' GLU . 0.2 OUTLIER -77.59 3.22 14.26 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-O 121.18 0.514 . . . . 0.0 111.21 -179.795 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 16.5 tp60 -121.81 -45.86 2.26 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.794 178.928 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -87.45 -48.9 7.58 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.513 -0.312 . . . . 0.0 111.343 -179.835 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . 0.514 ' OE2' ' HA ' ' A' ' 17' ' ' ARG . 3.0 tp10 -72.54 -31.37 65.25 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 121.114 0.483 . . . . 0.0 109.92 179.795 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . 0.41 ' HE3' ' OE2' ' A' ' 121' ' ' GLU . 0.0 OUTLIER -55.11 -29.98 58.77 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.814 -0.63 . . . . 0.0 111.581 179.726 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 95.4 mt-10 -60.64 -21.48 62.81 Favored 'General case' 0 C--N 1.332 -0.182 0 O-C-N 123.525 0.516 . . . . 0.0 110.787 179.656 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . 0.553 ' O ' ' HD3' ' A' ' 75' ' ' ARG . 36.0 tp10 -98.68 -43.49 6.79 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 109.435 -0.58 . . . . 0.0 109.435 177.432 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.433 HG23 ' O ' ' A' ' 68' ' ' GLU . 21.8 t -60.24 -42.22 89.66 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.244 0 CA-C-N 115.699 -0.682 . . . . 0.0 112.655 -178.613 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 23.4 p-10 -66.93 -18.37 65.35 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-O 121.045 0.45 . . . . 0.0 111.041 -179.928 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . 0.43 ' C ' ' HD2' ' A' ' 75' ' ' ARG . 28.8 t -101.64 -3.86 27.58 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 121.334 0.588 . . . . 0.0 110.125 179.018 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . 0.553 ' HD3' ' O ' ' A' ' 71' ' ' GLU . 2.6 mpt_? -115.93 49.06 1.14 Allowed 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.694 0.759 . . . . 0.0 109.631 -179.796 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . 0.479 ' OG ' ' HE2' ' A' ' 149' ' ' LYS . 0.4 OUTLIER -130.38 175.15 9.19 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 115.057 -0.974 . . . . 0.0 110.153 179.958 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -133.96 137.1 52.85 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 N-CA-C 109.977 -0.379 . . . . 0.0 109.977 178.179 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 83.9 t80 -94.82 126.52 40.2 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 109.644 -0.502 . . . . 0.0 109.644 179.877 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.426 HG21 ' HE2' ' A' ' 95' ' ' PHE . 4.0 t -105.95 115.36 47.49 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.138 -179.013 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -118.08 169.32 13.3 Favored Glycine 0 N--CA 1.447 -0.606 0 N-CA-C 110.863 -0.895 . . . . 0.0 110.863 179.255 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 1.6 m-20 59.08 37.8 24.13 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-O 121.177 0.513 . . . . 0.0 110.936 -179.566 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.422 HG22 HG12 ' A' ' 79' ' ' VAL . 2.5 t -80.84 162.25 3.65 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.884 -179.319 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . 0.537 ' OD2' ' HD2' ' A' ' 142' ' ' ARG . 9.7 t0 -66.23 135.43 54.46 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 109.607 -0.516 . . . . 0.0 109.607 179.225 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 36.5 p90 -63.96 -14.25 52.44 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.075 -0.511 . . . . 0.0 112.005 -178.616 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -114.19 14.85 18.24 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.72 0.295 . . . . 0.0 111.456 179.753 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' CYS . . . . . 0.49 ' SG ' ' HB2' ' A' ' 140' ' ' HIS . 0.8 OUTLIER -78.1 148.91 33.99 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.103 0.478 . . . . 0.0 111.281 -179.795 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . 0.501 ' O ' ' HG2' ' A' ' 90' ' ' GLU . 0.2 OUTLIER -110.67 149.71 40.7 Favored Pre-proline 0 C--N 1.325 -0.462 0 CA-C-N 115.743 -0.662 . . . . 0.0 109.921 179.114 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . 0.477 ' HD3' HD13 ' A' ' 106' ' ' ILE . 11.5 Cg_endo -55.32 -38.33 93.87 Favored 'Trans proline' 0 C--N 1.347 0.458 0 C-N-CA 122.83 2.353 . . . . 0.0 112.842 -179.039 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . 0.453 ' O ' ' HG3' ' A' ' 92' ' ' GLN . 3.2 mp0 -62.94 -52.14 64.2 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.485 -0.325 . . . . 0.0 111.802 -179.199 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . 0.501 ' HG2' ' O ' ' A' ' 87' ' ' THR . 6.0 pt-20 -61.04 -20.31 62.4 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-O 120.862 0.363 . . . . 0.0 111.519 -178.806 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 55.5 t -84.61 -47.21 17.45 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.674 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.739 -179.152 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . 0.453 ' HG3' ' O ' ' A' ' 89' ' ' GLU . 0.8 OUTLIER -72.17 -33.2 67.51 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.319 -0.401 . . . . 0.0 111.757 -178.423 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -78.04 -27.42 48.75 Favored 'General case' 0 N--CA 1.467 0.384 0 C-N-CA 120.237 -0.585 . . . . 0.0 111.53 -178.919 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' HIS . . . . . 0.492 ' HB2' ' O ' ' A' ' 90' ' ' GLU . 0.2 OUTLIER -75.12 -42.33 56.64 Favored 'General case' 0 C--N 1.325 -0.464 0 C-N-CA 120.819 -0.352 . . . . 0.0 110.721 -179.856 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . 0.426 ' HE2' HG21 ' A' ' 79' ' ' VAL . 20.3 m-30 -76.47 -18.9 58.53 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.464 179.931 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . 0.649 ' HA ' ' O ' ' A' ' 99' ' ' GLY . 0.9 OUTLIER -62.4 -22.09 65.88 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.397 179.342 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 21.5 t -62.91 -28.57 70.15 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.364 179.475 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 5.5 m -97.91 -40.7 8.36 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.23 179.837 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . 0.649 ' O ' ' HA ' ' A' ' 96' ' ' GLN . . . -151.28 141.86 8.99 Favored Glycine 0 N--CA 1.449 -0.484 0 N-CA-C 111.424 -0.671 . . . . 0.0 111.424 179.69 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . 0.419 ' HB ' ' CE1' ' A' ' 122' ' ' PHE . 0.2 OUTLIER -62.22 154.5 27.32 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.104 0.478 . . . . 0.0 112.09 -179.471 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 2.1 p -118.03 131.19 71.51 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-N 115.747 -0.66 . . . . 0.0 110.91 -179.685 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 26.1 t30 -97.91 -45.0 6.46 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.152 0.501 . . . . 0.0 109.695 179.123 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -142.75 157.32 44.76 Favored 'General case' 0 C--O 1.235 0.318 0 CA-C-N 115.676 -0.693 . . . . 0.0 109.991 179.196 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 7.2 p -155.29 137.59 6.43 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 CA-C-N 115.82 -0.627 . . . . 0.0 109.974 179.59 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . 0.479 ' HB ' ' CE1' ' A' ' 119' ' ' TYR . 3.5 m -131.59 128.29 38.89 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 109.732 -0.47 . . . . 0.0 109.732 179.317 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 106' ' ' ILE . . . . . 0.56 HD11 ' HA2' ' A' ' 116' ' ' GLY . 20.3 tt -113.27 137.15 47.31 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-O 121.3 0.571 . . . . 0.0 111.205 -179.804 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 35.0 tp -118.91 124.5 47.24 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.777 -0.647 . . . . 0.0 109.896 179.646 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -90.79 113.62 25.8 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 110.144 -0.317 . . . . 0.0 110.144 179.445 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . 0.419 ' O ' ' HG2' ' A' ' 115' ' ' LYS . 13.1 t70 -72.76 139.73 47.31 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.152 0.501 . . . . 0.0 111.253 -179.469 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -129.61 33.93 4.4 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 115.638 -0.71 . . . . 0.0 109.434 178.751 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 2.6 t80 -118.21 -4.31 10.97 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.618 -179.69 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 110.19 6.98 27.28 Favored Glycine 0 CA--C 1.52 0.353 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.833 179.936 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 113' ' ' GLN . . . . . 0.431 ' HB3' ' HD2' ' A' ' 114' ' ' PRO . 19.0 mt-30 -96.8 161.05 27.82 Favored Pre-proline 0 C--N 1.324 -0.513 0 N-CA-C 109.464 -0.569 . . . . 0.0 109.464 179.951 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 114' ' ' PRO . . . . . 0.431 ' HD2' ' HB3' ' A' ' 113' ' ' GLN . 19.5 Cg_endo -59.75 115.15 2.41 Favored 'Trans proline' 0 C--N 1.347 0.454 0 C-N-CA 122.039 1.826 . . . . 0.0 111.13 178.582 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . 0.419 ' HG2' ' O ' ' A' ' 109' ' ' ASP . 53.1 mttt -72.72 172.19 11.18 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 120.771 0.319 . . . . 0.0 110.246 -179.014 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . 0.56 ' HA2' HD11 ' A' ' 106' ' ' ILE . . . 101.4 3.89 53.29 Favored Glycine 0 N--CA 1.444 -0.781 0 C-N-CA 120.175 -1.012 . . . . 0.0 112.227 179.712 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 26.8 m-85 -52.73 112.66 0.88 Allowed 'General case' 0 N--CA 1.463 0.196 0 N-CA-C 110.094 -0.336 . . . . 0.0 110.094 179.49 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -141.37 174.25 10.72 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 121.191 0.52 . . . . 0.0 111.523 -178.61 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 119' ' ' TYR . . . . . 0.479 ' CE1' ' HB ' ' A' ' 105' ' ' THR . 48.5 p90 -156.48 129.59 7.98 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.34 -0.845 . . . . 0.0 109.81 179.202 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 13.9 m -105.92 142.94 17.78 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.686 0 N-CA-C 109.254 -0.646 . . . . 0.0 109.254 178.976 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . 0.41 ' OE2' ' HE3' ' A' ' 69' ' ' LYS . 7.1 pt-20 -129.92 150.23 51.3 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 120.765 0.317 . . . . 0.0 111.745 -179.68 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 122' ' ' PHE . . . . . 0.419 ' CE1' ' HB ' ' A' ' 100' ' ' THR . 11.5 t80 -145.89 172.44 13.34 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.706 -0.679 . . . . 0.0 109.308 178.796 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . 0.614 HG21 HD11 ' A' ' 35' ' ' ILE . 2.9 t -92.64 -57.26 4.45 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 CA-C-O 120.782 0.325 . . . . 0.0 111.281 -178.979 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 93.0 mt-10 -62.65 118.07 7.14 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.451 -179.813 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 2.1 mp -57.29 -32.31 40.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 115.566 -0.743 . . . . 0.0 110.964 -179.435 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 17.6 t70 -53.35 -45.37 69.13 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.374 179.42 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -61.93 -54.82 36.61 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.758 -0.655 . . . . 0.0 111.691 -179.361 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 12.1 p -65.94 -29.65 47.52 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 C-N-CA 120.894 -0.322 . . . . 0.0 111.256 -179.249 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 129' ' ' GLN . . . . . 0.418 ' O ' ' HG ' ' A' ' 132' ' ' LEU . 9.6 tt0 -61.25 -48.59 80.75 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.178 0.513 . . . . 0.0 110.116 179.123 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 87.2 m-20 -69.29 -29.96 67.94 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.721 -0.672 . . . . 0.0 109.717 179.713 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . 0.451 ' O ' ' HB2' ' A' ' 135' ' ' ASN . . . -66.86 -52.18 46.63 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.618 -0.719 . . . . 0.0 111.089 179.66 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 132' ' ' LEU . . . . . 0.418 ' HG ' ' O ' ' A' ' 129' ' ' GLN . 4.0 pp -64.94 -23.92 67.37 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.79 0.328 . . . . 0.0 110.636 179.978 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 1.6 tp -72.0 -55.61 7.12 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.204 0.526 . . . . 0.0 110.058 179.597 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 49.4 mt -120.13 101.8 8.08 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.648 -0.705 . . . . 0.0 109.558 179.568 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 135' ' ' ASN . . . . . 0.451 ' HB2' ' O ' ' A' ' 131' ' ' ALA . 0.5 OUTLIER -146.68 -71.26 0.24 Allowed 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 120.87 0.367 . . . . 0.0 111.155 -178.976 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 7.5 pt-20 -69.91 95.12 0.9 Allowed 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.649 0.738 . . . . 0.0 111.849 -179.034 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 8.9 m -137.17 -59.53 0.69 Allowed 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.374 -0.83 . . . . 0.0 109.536 178.92 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 7.4 tt0 -165.4 130.84 2.56 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 109.525 -0.546 . . . . 0.0 109.525 179.222 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -146.0 118.04 8.28 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 109.672 -0.492 . . . . 0.0 109.672 -179.939 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 140' ' ' HIS . . . . . 0.49 ' HB2' ' SG ' ' A' ' 86' ' ' CYS . 3.2 t60 68.77 1.23 2.99 Favored 'General case' 0 N--CA 1.469 0.509 0 O-C-N 123.508 0.505 . . . . 0.0 111.393 178.971 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 113.52 -9.38 24.11 Favored Glycine 0 N--CA 1.447 -0.622 0 C-N-CA 121.038 -0.601 . . . . 0.0 111.743 -179.129 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 142' ' ' ARG . . . . . 0.537 ' HD2' ' OD2' ' A' ' 83' ' ' ASP . 0.0 OUTLIER -111.29 170.88 7.82 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 109.874 -0.417 . . . . 0.0 109.874 179.785 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 13.2 pt20 -115.75 121.45 42.5 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 109.217 -0.66 . . . . 0.0 109.217 178.705 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -99.08 175.65 5.83 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.066 -178.748 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 3.8 tttt -117.1 122.69 44.84 Favored 'General case' 0 C--N 1.317 -0.805 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 179.16 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 146' ' ' VAL . . . . . 0.415 HG21 ' OD1' ' A' ' 135' ' ' ASN . 96.2 t -117.49 137.51 51.17 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.652 0 CA-C-O 121.242 0.544 . . . . 0.0 111.409 -178.971 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 23.6 t -139.13 144.18 38.54 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.845 -0.616 . . . . 0.0 109.516 179.314 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -63.14 128.89 37.93 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 120.714 0.292 . . . . 0.0 110.277 179.47 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 149' ' ' LYS . . . . . 0.479 ' HE2' ' OG ' ' A' ' 76' ' ' SER . 28.3 ttpt -89.15 76.63 7.68 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 121.3 0.571 . . . . 0.0 109.76 -179.643 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 23.9 tpt180 -95.01 95.42 8.59 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.654 -0.703 . . . . 0.0 109.802 179.539 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 7.0 t -84.24 137.69 33.34 Favored 'General case' 0 N--CA 1.445 -0.723 0 CA-C-N 115.375 -0.83 . . . . 0.0 109.992 179.467 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 152' ' ' ASN . . . . . . . . . . . . . 58.6 t30 -171.2 157.78 5.21 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 109.449 -0.575 . . . . 0.0 109.449 -179.721 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 25.1 pt -68.94 150.65 97.55 Favored Pre-proline 0 C--N 1.325 -0.493 0 N-CA-C 109.955 -0.387 . . . . 0.0 109.955 179.266 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_endo -66.0 83.97 0.25 Allowed 'Trans proline' 0 C--O 1.233 0.268 0 C-N-CA 122.479 2.12 . . . . 0.0 112.182 179.786 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.084 0 CA-C-O 118.181 -1.344 . . . . 0.0 111.082 179.696 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.6 ptm . . . . . 0 N--CA 1.482 1.132 0 N-CA-C 110.158 -0.312 . . . . 0.0 110.158 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 91.52 66.88 1.15 Allowed Glycine 0 N--CA 1.448 -0.534 0 C-N-CA 120.987 -0.625 . . . . 0.0 112.018 -179.887 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 25.0 m -112.88 88.38 2.81 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 121.013 0.435 . . . . 0.0 111.875 -179.39 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 10.6 t -91.9 156.1 17.71 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 109.941 -0.392 . . . . 0.0 109.941 179.09 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 14.1 p-80 -169.77 142.82 2.53 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.493 -0.321 . . . . 0.0 110.804 -179.46 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 26.3 p80 -167.96 145.26 4.25 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.197 -0.456 . . . . 0.0 109.954 179.217 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 16.3 p-80 -146.4 150.68 36.12 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.557 -0.292 . . . . 0.0 110.669 -179.859 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -142.35 -175.5 4.47 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.222 -179.943 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 8.6 p80 -163.4 151.19 13.15 Favored 'General case' 0 C--N 1.332 -0.196 0 N-CA-C 109.886 -0.413 . . . . 0.0 109.886 -179.498 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 77.4 t60 -160.57 111.51 1.85 Allowed 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 120.727 0.299 . . . . 0.0 110.812 179.35 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -80.19 168.51 19.0 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.411 179.561 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 14.4 m -154.58 119.89 5.05 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.757 0.313 . . . . 0.0 110.879 -179.782 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -86.26 123.54 6.5 Favored Glycine 0 N--CA 1.448 -0.511 0 C-N-CA 121.011 -0.614 . . . . 0.0 111.736 179.352 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 8.9 mt -92.87 131.15 38.15 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.15 0.5 . . . . 0.0 111.815 -179.433 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 2.5 p -149.14 92.78 4.25 Favored Pre-proline 0 C--N 1.322 -0.616 0 CA-C-N 115.543 -0.753 . . . . 0.0 109.919 179.031 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 16.2 Cg_exo -67.93 133.34 28.88 Favored 'Trans proline' 0 N--CA 1.464 -0.214 0 C-N-CA 122.81 2.34 . . . . 0.0 112.033 -179.6 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -118.26 120.13 36.74 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 116.322 -0.399 . . . . 0.0 109.975 179.298 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -134.61 -177.14 14.74 Favored Glycine 0 N--CA 1.447 -0.608 0 C-N-CA 120.839 -0.696 . . . . 0.0 111.766 -179.993 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 61.2 m -154.93 129.08 8.89 Favored 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 110.403 -0.221 . . . . 0.0 110.403 179.94 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 28.6 p-80 -74.0 148.68 41.82 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 109.819 -0.437 . . . . 0.0 109.819 179.461 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -87.77 148.27 24.79 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 120.813 0.339 . . . . 0.0 110.144 -179.869 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -97.94 -171.74 32.76 Favored Glycine 0 N--CA 1.446 -0.68 0 CA-C-N 115.828 -0.624 . . . . 0.0 111.911 179.817 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -139.24 150.03 45.02 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 120.615 0.245 . . . . 0.0 110.396 -179.988 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 2.4 p-10 -76.37 137.67 39.93 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.307 -0.406 . . . . 0.0 109.919 179.174 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 12.8 tp -163.41 165.34 24.03 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.191 -179.634 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 15.4 mp0 -69.23 137.82 53.47 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.901 -0.59 . . . . 0.0 109.971 179.915 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 21.6 t0 -116.34 129.05 56.06 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.576 -179.876 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 15.9 tpt -100.97 127.62 47.37 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.205 -179.703 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 1.3 ptpt -147.65 148.21 30.82 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 120.636 0.255 . . . . 0.0 110.496 179.926 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 57.1 mttp -92.24 87.92 6.27 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.272 179.875 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -138.12 -167.77 2.23 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.114 -179.987 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 83.4 mt 69.69 -170.95 0.17 Allowed 'General case' 0 C--O 1.233 0.237 0 O-C-N 123.794 0.684 . . . . 0.0 111.162 179.5 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 48.6 mtpt -122.61 146.99 46.94 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.692 -179.313 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 29.2 mt-10 -79.88 135.89 36.55 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.825 -179.365 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.457 HG23 ' OD1' ' A' ' 58' ' ' ASP . 80.1 mt -123.71 117.47 51.26 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.386 -179.698 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 16.6 tt0 -178.82 126.0 0.1 Allowed 'General case' 0 C--N 1.331 -0.211 0 O-C-N 123.442 0.464 . . . . 0.0 110.469 -179.602 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -114.59 130.66 56.8 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.038 0.447 . . . . 0.0 110.467 179.613 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 49.9 mt-10 -116.01 152.64 33.15 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.006 179.368 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -93.81 160.37 14.78 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 120.921 0.391 . . . . 0.0 111.198 -179.455 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -68.66 120.98 11.8 Favored Glycine 0 N--CA 1.446 -0.693 0 CA-C-N 115.745 -0.661 . . . . 0.0 112.343 179.982 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -144.47 172.85 12.38 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 110.066 -0.346 . . . . 0.0 110.066 179.754 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 27.4 tp -69.26 90.93 0.51 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.101 0.477 . . . . 0.0 109.896 179.252 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 53.5 ttm-85 -153.69 -6.34 0.17 Allowed 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.861 -0.609 . . . . 0.0 111.177 -178.88 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 17.1 mt-10 65.2 19.71 11.78 Favored 'General case' 0 N--CA 1.468 0.471 0 CA-C-O 121.149 0.499 . . . . 0.0 110.662 -178.767 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 26.5 ptm -83.61 1.35 42.65 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.848 -0.615 . . . . 0.0 110.382 -179.88 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 30.6 mt-30 -72.39 -20.9 61.36 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.147 0.498 . . . . 0.0 110.116 179.72 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -76.5 -8.54 57.4 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 121.555 0.693 . . . . 0.0 109.965 178.788 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 21.6 ttmt -79.26 1.44 24.85 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.321 -0.854 . . . . 0.0 110.499 -179.91 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 7.4 p -58.28 -23.64 22.55 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.251 0 CA-C-N 115.781 -0.645 . . . . 0.0 111.102 179.632 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -63.42 -26.37 68.7 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.512 179.526 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 24.5 mtmt -101.97 -41.52 6.43 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.872 179.444 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 62.6 mm-40 -62.36 -16.65 55.75 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.969 -0.559 . . . . 0.0 111.522 -179.572 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 10.0 ptp -63.32 -25.41 68.29 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.978 0.418 . . . . 0.0 110.042 178.794 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -98.17 -5.08 57.35 Favored Glycine 0 N--CA 1.448 -0.542 0 N-CA-C 110.943 -0.863 . . . . 0.0 110.943 179.0 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -109.6 13.35 23.92 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.099 0.476 . . . . 0.0 110.154 -179.779 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 28.2 m -61.64 -16.81 15.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.769 179.767 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 20.5 mm-40 -77.8 -9.03 58.82 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.997 0.427 . . . . 0.0 110.588 179.884 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.457 ' OD1' HG23 ' A' ' 35' ' ' ILE . 38.4 t70 -127.5 -58.87 1.24 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.176 179.22 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 4.8 m -65.69 -62.98 1.2 Allowed 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.8 0.809 . . . . 0.0 111.574 -179.606 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -85.15 19.42 2.22 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-N 114.95 -1.023 . . . . 0.0 111.774 -178.344 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -79.79 -33.43 40.51 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 121.028 0.442 . . . . 0.0 110.824 -179.136 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -65.33 -22.62 66.84 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 121.008 0.432 . . . . 0.0 111.663 -179.957 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -64.3 -26.82 68.66 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.113 0.482 . . . . 0.0 110.556 179.655 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -70.58 -30.13 66.75 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.832 179.582 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -76.47 -1.62 28.05 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.09 0.471 . . . . 0.0 110.931 179.802 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 7.0 tp60 -118.05 -51.27 2.45 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.64 179.507 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -83.08 -61.65 1.8 Allowed 'General case' 0 C--N 1.331 -0.201 0 N-CA-C 111.871 0.323 . . . . 0.0 111.871 -179.092 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -60.88 -29.7 69.7 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-O 120.976 0.417 . . . . 0.0 110.671 -179.384 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 51.5 tptt -56.11 -31.35 63.19 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.83 -0.623 . . . . 0.0 111.206 179.582 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 18.7 mt-10 -63.3 -21.15 66.07 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-O 121.18 0.514 . . . . 0.0 111.074 -179.797 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . 0.426 ' O ' ' HD2' ' A' ' 75' ' ' ARG . 13.5 tp10 -94.65 -42.96 8.51 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 115.675 -0.693 . . . . 0.0 109.172 177.98 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.539 HG12 ' HB2' ' A' ' 121' ' ' GLU . 47.9 t -62.34 -43.29 97.93 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-N 115.181 -0.918 . . . . 0.0 112.552 -178.924 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 17.2 p-10 -71.55 -19.68 62.13 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-O 121.025 0.441 . . . . 0.0 111.613 -178.958 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . 0.582 ' OG ' ' HD3' ' A' ' 150' ' ' ARG . 44.4 t -96.65 -7.33 34.46 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 109.604 -0.517 . . . . 0.0 109.604 178.796 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . 0.426 ' HD2' ' O ' ' A' ' 71' ' ' GLU . 0.0 OUTLIER -114.47 40.94 2.42 Favored 'General case' 0 N--CA 1.452 -0.361 0 CA-C-N 115.505 -0.77 . . . . 0.0 110.185 -179.367 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . 0.451 ' OG ' ' HE2' ' A' ' 149' ' ' LYS . 0.3 OUTLIER -120.11 174.6 6.39 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.708 179.509 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 6.5 pt -132.3 139.64 49.62 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.262 178.341 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' TYR . . . . . 0.405 ' O ' ' HA ' ' A' ' 146' ' ' VAL . 16.7 t80 -92.58 119.84 32.43 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.615 -0.72 . . . . 0.0 109.761 179.895 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 7.2 t -104.79 109.36 27.34 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-N 116.53 -0.304 . . . . 0.0 110.184 179.86 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -117.82 166.94 12.73 Favored Glycine 0 N--CA 1.448 -0.523 0 C-N-CA 120.815 -0.707 . . . . 0.0 112.278 -179.281 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 3.0 m120 57.01 44.13 23.32 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-O 121.314 0.578 . . . . 0.0 110.853 -179.818 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.429 HG12 ' H ' ' A' ' 83' ' ' ASP . 2.4 t -82.68 167.91 1.9 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 CA-C-N 115.236 -0.893 . . . . 0.0 110.368 -179.361 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . 0.509 ' HB3' ' SG ' ' A' ' 86' ' ' CYS . 24.7 t70 -68.71 140.97 55.41 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.855 0.36 . . . . 0.0 110.337 179.625 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 28.3 p90 -65.49 -12.66 54.69 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.831 -0.622 . . . . 0.0 112.521 -178.694 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -117.85 10.79 13.33 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.617 0.246 . . . . 0.0 111.492 -179.981 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' CYS . . . . . 0.509 ' SG ' ' HB3' ' A' ' 83' ' ' ASP . 0.9 OUTLIER -73.9 144.52 45.33 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.044 0.449 . . . . 0.0 111.001 -179.995 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . 0.539 ' O ' ' HG2' ' A' ' 90' ' ' GLU . 5.6 p -108.24 157.54 36.07 Favored Pre-proline 0 C--N 1.327 -0.377 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.233 179.379 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 20.8 Cg_endo -60.53 -39.84 61.79 Favored 'Trans proline' 0 C--N 1.344 0.328 0 C-N-CA 122.399 2.066 . . . . 0.0 113.366 -178.979 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . 0.431 ' O ' ' HG2' ' A' ' 93' ' ' GLN . 7.9 mm-40 -64.16 -46.1 85.55 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 112.323 0.49 . . . . 0.0 112.323 -178.603 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . 0.539 ' HG2' ' O ' ' A' ' 87' ' ' THR . 9.8 pt-20 -65.79 -18.29 65.23 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-O 121.028 0.442 . . . . 0.0 111.432 -179.25 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 52.1 t -87.44 -47.36 15.85 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.83 -179.135 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 1.7 pp0? -68.79 -35.44 77.03 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.511 -0.313 . . . . 0.0 111.496 -178.581 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . 0.431 ' HG2' ' O ' ' A' ' 89' ' ' GLU . 3.5 pt20 -77.17 -29.89 54.66 Favored 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 120.372 -0.531 . . . . 0.0 111.337 -179.05 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -69.3 -41.68 76.46 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.853 0.358 . . . . 0.0 110.71 179.931 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 17.0 m-30 -82.47 -13.48 56.65 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 116.387 -0.37 . . . . 0.0 110.968 -179.557 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . 0.577 ' HA ' ' O ' ' A' ' 99' ' ' GLY . 37.3 tt0 -64.33 -23.94 67.47 Favored 'General case' 0 C--O 1.234 0.252 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.483 -179.86 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 15.2 m -67.12 -28.15 67.92 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.712 179.576 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 5.3 m -94.35 -41.62 9.32 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.144 -0.48 . . . . 0.0 109.978 179.542 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . 0.577 ' O ' ' HA ' ' A' ' 96' ' ' GLN . . . -150.55 144.26 11.63 Favored Glycine 0 N--CA 1.445 -0.745 0 CA-C-N 115.864 -0.607 . . . . 0.0 111.701 179.807 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -63.18 146.87 52.44 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 121.029 0.442 . . . . 0.0 111.48 -179.829 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 1.3 p -120.23 128.68 75.99 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.342 -179.878 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 27.2 t-20 -96.98 -46.97 5.99 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.687 0.28 . . . . 0.0 110.669 -179.999 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 2.6 tpt180 -137.44 148.33 46.04 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.571 -179.643 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 7.5 p -148.15 137.83 16.28 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-O 121.004 0.43 . . . . 0.0 110.638 179.265 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 2.3 m -130.24 129.44 43.34 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 116.008 -0.542 . . . . 0.0 109.983 178.961 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 106' ' ' ILE . . . . . 0.557 HD11 ' HA2' ' A' ' 116' ' ' GLY . 20.5 tt -114.63 148.04 17.66 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-O 120.995 0.426 . . . . 0.0 110.899 -179.494 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 9.1 tp -129.82 140.29 51.05 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.131 179.759 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -105.8 114.3 28.38 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.511 -0.313 . . . . 0.0 110.248 179.552 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . 0.415 ' O ' ' HG2' ' A' ' 115' ' ' LYS . 7.5 t70 -75.85 142.64 42.14 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.396 -0.365 . . . . 0.0 110.952 -179.818 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 2.6 mppt? -127.13 20.4 6.89 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.281 0.563 . . . . 0.0 109.906 179.015 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 36.0 t80 -100.92 -6.79 24.13 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.467 -0.788 . . . . 0.0 110.23 -179.608 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 106.36 11.61 26.99 Favored Glycine 0 N--CA 1.448 -0.534 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.443 -179.966 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 113' ' ' GLN . . . . . 0.443 ' HB3' ' HD2' ' A' ' 114' ' ' PRO . 24.5 mt-30 -97.1 160.86 28.04 Favored Pre-proline 0 C--O 1.239 0.535 0 N-CA-C 109.455 -0.572 . . . . 0.0 109.455 -179.972 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 114' ' ' PRO . . . . . 0.443 ' HD2' ' HB3' ' A' ' 113' ' ' GLN . 16.8 Cg_endo -58.7 113.77 1.71 Allowed 'Trans proline' 0 C--N 1.347 0.492 0 C-N-CA 122.207 1.938 . . . . 0.0 111.277 178.628 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . 0.415 ' HG2' ' O ' ' A' ' 109' ' ' ASP . 9.6 mttp -78.57 179.74 6.91 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.144 -179.226 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . 0.557 ' HA2' HD11 ' A' ' 106' ' ' ILE . . . 92.55 2.83 67.24 Favored Glycine 0 N--CA 1.444 -0.804 0 C-N-CA 120.081 -1.057 . . . . 0.0 111.462 179.978 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 5.1 t80 -55.67 124.59 17.91 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.725 0.298 . . . . 0.0 110.393 179.78 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -149.44 171.2 16.96 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.627 -179.374 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 44.9 p90 -152.4 130.41 11.82 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-N 115.656 -0.702 . . . . 0.0 109.204 178.782 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 13.7 m -108.56 142.49 21.04 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.139 179.905 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . 0.539 ' HB2' HG12 ' A' ' 72' ' ' VAL . 1.3 pt-20 -131.55 154.34 48.91 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 120.923 0.392 . . . . 0.0 111.192 179.637 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 12.1 t80 -146.88 167.61 23.5 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.587 -0.733 . . . . 0.0 110.363 179.689 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 11.0 t -84.45 -41.21 15.97 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-O 120.901 0.381 . . . . 0.0 111.565 -179.432 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 33.3 mm-40 -76.56 131.34 38.89 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.152 -179.429 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 2.1 mp -73.27 -34.53 44.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.018 -179.46 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 17.5 t70 -58.38 -36.1 73.0 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.204 0.526 . . . . 0.0 111.058 -179.763 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -64.13 -57.7 8.81 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.735 -0.666 . . . . 0.0 111.271 -179.893 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 10.9 p -65.27 -27.71 42.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.554 -0.293 . . . . 0.0 111.287 -179.52 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 7.1 tt0 -60.02 -46.77 88.39 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.887 0.375 . . . . 0.0 110.246 179.83 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 50.7 m-80 -74.96 -24.26 58.43 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.143 179.873 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -68.98 -51.78 35.81 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.608 179.344 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 3.8 pp -67.55 -16.89 64.43 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.988 0.423 . . . . 0.0 111.057 179.881 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 1.1 tp -77.41 -53.08 8.09 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.003 179.324 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 87.9 mt -126.36 102.83 7.33 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.742 -0.663 . . . . 0.0 109.687 179.568 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -147.52 -67.02 0.26 Allowed 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.166 0.508 . . . . 0.0 111.948 -178.931 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 4.5 pt-20 -74.12 95.04 2.5 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.629 0.728 . . . . 0.0 111.857 -178.819 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 5.9 m -141.21 -59.75 0.49 Allowed 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.692 -0.686 . . . . 0.0 110.134 178.801 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -154.21 121.36 5.68 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 109.935 -0.395 . . . . 0.0 109.935 179.841 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -141.97 117.04 9.99 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 109.459 -0.571 . . . . 0.0 109.459 179.744 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 140' ' ' HIS . . . . . 0.422 ' HB2' ' SG ' ' A' ' 86' ' ' CYS . 2.2 t60 64.52 21.09 12.36 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-O 120.99 0.424 . . . . 0.0 110.78 179.869 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 86.55 -1.84 87.27 Favored Glycine 0 N--CA 1.449 -0.469 0 C-N-CA 120.715 -0.755 . . . . 0.0 111.533 -179.084 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 1.4 mpt_? -116.17 178.88 4.16 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 109.663 -0.495 . . . . 0.0 109.663 -179.68 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -122.5 141.41 51.68 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-O 120.818 0.342 . . . . 0.0 110.268 179.41 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -123.98 178.72 5.15 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 115.968 -0.56 . . . . 0.0 109.971 -179.821 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -120.81 120.3 35.17 Favored 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 109.595 -0.52 . . . . 0.0 109.595 179.444 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 146' ' ' VAL . . . . . 0.405 ' HA ' ' O ' ' A' ' 78' ' ' TYR . 73.1 t -115.32 129.92 70.76 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-O 120.951 0.405 . . . . 0.0 111.063 -179.092 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 1.6 m -134.22 148.02 50.8 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 179.109 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -61.96 129.47 41.05 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 120.658 0.266 . . . . 0.0 111.246 -179.83 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 149' ' ' LYS . . . . . 0.451 ' HE2' ' OG ' ' A' ' 76' ' ' SER . 25.8 ttpt -90.39 62.19 5.25 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.919 0.866 . . . . 0.0 108.758 179.528 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 150' ' ' ARG . . . . . 0.582 ' HD3' ' OG ' ' A' ' 74' ' ' SER . 0.0 OUTLIER -81.93 81.85 7.77 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 114.959 -1.019 . . . . 0.0 110.064 -179.729 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 8.7 t -69.28 122.76 19.52 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.359 179.937 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 152' ' ' ASN . . . . . . . . . . . . . 4.8 t30 -163.15 151.39 13.83 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.086 -179.88 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 13.1 pt -69.97 148.3 96.18 Favored Pre-proline 0 C--N 1.321 -0.657 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.847 179.752 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -73.0 103.76 1.65 Allowed 'Trans proline' 0 N--CA 1.464 -0.262 0 C-N-CA 122.34 2.027 . . . . 0.0 111.884 179.328 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.914 0 CA-C-O 118.757 -1.024 . . . . 0.0 111.937 -179.784 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.1 mpt? . . . . . 0 N--CA 1.48 1.038 0 N-CA-C 110.351 -0.24 . . . . 0.0 110.351 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 144.12 148.28 4.85 Favored Glycine 0 N--CA 1.449 -0.472 0 C-N-CA 120.538 -0.839 . . . . 0.0 112.459 179.886 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 8.1 m -136.13 152.0 50.37 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.615 0.245 . . . . 0.0 110.387 179.768 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 2.1 m -131.91 161.72 32.37 Favored 'General case' 0 C--O 1.237 0.398 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.601 179.85 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -157.88 121.91 4.15 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.583 179.377 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 1.3 t60 -159.99 124.87 3.92 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.506 -0.315 . . . . 0.0 110.853 -179.987 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 50.1 p-80 -148.5 156.08 42.0 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 109.55 -0.537 . . . . 0.0 109.55 179.431 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 1.5 m-70 -150.41 172.44 15.42 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 110.661 -0.126 . . . . 0.0 110.661 -179.802 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 55.5 t-80 -156.08 143.94 19.62 Favored 'General case' 0 CA--C 1.536 0.404 0 CA-C-N 116.483 -0.326 . . . . 0.0 111.129 -179.436 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 43.7 t-80 -149.92 144.97 26.23 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.455 -0.339 . . . . 0.0 110.143 179.701 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 23.2 t -133.86 166.37 22.84 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.664 -0.243 . . . . 0.0 110.642 179.958 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 70.1 m -159.16 -172.08 3.62 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 122.522 0.329 . . . . 0.0 110.635 -179.776 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 168.86 135.29 1.86 Allowed Glycine 0 C--N 1.333 0.413 0 N-CA-C 111.331 -0.708 . . . . 0.0 111.331 179.832 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 19.2 mt -138.23 143.39 40.11 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 117.136 0.468 . . . . 0.0 110.754 -179.203 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 2.4 p -138.92 113.97 8.44 Favored Pre-proline 0 CA--C 1.538 0.503 0 CA-C-O 120.771 0.32 . . . . 0.0 111.312 -179.781 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 64.1 Cg_endo -97.19 176.25 0.58 Allowed 'Trans proline' 0 N--CA 1.457 -0.645 0 C-N-CA 123.476 2.784 . . . . 0.0 113.122 179.722 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 3.5 ptm180 -157.29 149.68 22.93 Favored 'General case' 0 N--CA 1.462 0.154 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.134 179.115 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -119.03 175.77 15.84 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.963 -0.636 . . . . 0.0 112.81 -179.543 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 2.7 m -106.01 -171.52 1.92 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.784 0.326 . . . . 0.0 111.047 -179.765 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 10.4 t-80 -153.93 142.28 20.58 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.269 179.788 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -116.14 170.13 8.75 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.369 179.46 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -173.25 132.67 2.39 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 121.101 -0.571 . . . . 0.0 111.813 179.939 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 3.3 t -89.75 136.79 32.83 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.714 0.257 . . . . 0.0 110.628 -179.29 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -80.8 116.46 20.8 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.879 -179.644 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -167.21 157.31 11.07 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.543 179.703 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.5 ' HA ' HG22 ' A' ' 65' ' ' THR . 0.0 OUTLIER -159.92 176.77 11.49 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.496 179.518 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 7.1 t70 -157.83 -145.29 0.14 Allowed 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 108.295 -1.002 . . . . 0.0 108.295 179.504 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -85.13 -179.74 7.08 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 109.19 -0.67 . . . . 0.0 109.19 178.48 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 81.9 mttt -117.44 124.67 49.39 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-O 120.793 0.33 . . . . 0.0 110.685 -179.586 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 84.8 tttt -166.09 91.85 0.48 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.729 -0.669 . . . . 0.0 110.367 -179.115 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . 0.552 ' HA ' ' CB ' ' A' ' 67' ' ' ALA . 8.9 ptm180 -61.83 99.33 0.12 Allowed 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.962 -0.563 . . . . 0.0 112.157 179.781 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -157.22 147.36 20.88 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.905 179.49 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 3.8 tptt 66.07 -166.99 0.22 Allowed 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 115.244 -0.889 . . . . 0.0 112.145 179.311 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -91.08 157.47 17.22 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.008 -179.178 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.516 ' HB ' ' HB2' ' A' ' 64' ' ' ALA . 1.5 pp -124.24 152.77 30.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.245 -179.986 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . 0.632 ' HB3' ' OG ' ' A' ' 61' ' ' SER . 9.4 tp10 -139.03 -84.3 0.26 Allowed 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 120.623 -0.431 . . . . 0.0 111.777 179.556 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . 0.426 ' CD ' HH12 ' A' ' 103' ' ' ARG . 2.5 mm-40 -168.38 -57.42 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.398 0 N-CA-C 112.478 0.547 . . . . 0.0 112.478 -178.33 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -61.89 158.63 15.65 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.826 -0.625 . . . . 0.0 112.496 -178.363 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -108.74 -163.07 0.85 Allowed 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.706 -179.81 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -155.49 -154.1 6.8 Favored Glycine 0 N--CA 1.446 -0.677 0 N-CA-C 111.283 -0.727 . . . . 0.0 111.283 179.994 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -140.89 175.24 9.78 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.855 0.327 . . . . 0.0 110.127 179.937 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 63.9 tp -72.81 91.42 1.5 Allowed 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 109.623 -0.51 . . . . 0.0 109.623 179.06 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . 0.448 ' HD2' ' SD ' ' A' ' 45' ' ' MET . 13.5 ttm-85 -119.28 -16.1 9.07 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.96 -0.564 . . . . 0.0 111.161 -179.292 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 60.07 29.45 19.01 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 121.375 0.607 . . . . 0.0 110.021 -179.317 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' MET . . . . . 0.448 ' SD ' ' HD2' ' A' ' 43' ' ' ARG . 19.9 ptt? -99.63 12.56 36.22 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.182 -0.917 . . . . 0.0 111.167 -179.69 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 9.9 mm100 -71.81 -20.89 61.78 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 120.853 0.359 . . . . 0.0 110.898 -179.361 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -71.77 -14.5 62.01 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.302 0.572 . . . . 0.0 109.866 178.381 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 34.1 ttpt -82.78 7.22 15.7 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.694 -0.684 . . . . 0.0 109.445 178.826 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 7.3 p -57.2 -20.62 13.26 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.202 0 CA-C-N 115.693 -0.685 . . . . 0.0 111.623 -179.923 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 12.7 mm-40 -64.06 -33.23 75.28 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.431 0.634 . . . . 0.0 109.573 178.705 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 23.1 mtmt -97.42 -31.1 12.54 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.247 -0.888 . . . . 0.0 110.827 179.316 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 20.1 mm-40 -88.04 18.48 4.22 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.592 -179.548 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 7.9 ptm -64.76 -30.37 71.38 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.894 0.378 . . . . 0.0 110.813 179.971 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -94.07 -4.86 62.8 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.771 -0.728 . . . . 0.0 111.445 178.883 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -118.97 26.57 9.43 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.218 0.532 . . . . 0.0 110.166 -179.61 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 19.0 m -65.08 -13.89 15.71 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.263 0 CA-C-N 115.732 -0.667 . . . . 0.0 111.175 -179.706 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 5.7 mp0 -77.25 -16.99 58.78 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.585 -179.915 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -120.41 -52.8 2.14 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.89 -179.298 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 7.3 m -71.52 -70.89 0.29 Allowed 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.536 -0.756 . . . . 0.0 111.687 -179.249 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -84.57 30.11 0.57 Allowed 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.028 0.442 . . . . 0.0 111.532 -179.227 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . 0.632 ' OG ' ' HB3' ' A' ' 36' ' ' GLU . 3.8 t -75.28 -26.92 59.14 Favored 'General case' 0 N--CA 1.447 -0.578 0 N-CA-C 108.523 -0.917 . . . . 0.0 108.523 178.986 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -64.15 -19.78 65.53 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-N 115.083 -0.962 . . . . 0.0 110.904 179.216 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 69.1 m -61.23 -19.31 61.52 Favored 'General case' 0 N--CA 1.445 -0.684 0 CA-C-N 115.588 -0.733 . . . . 0.0 110.715 -179.828 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . 0.516 ' HB2' ' HB ' ' A' ' 35' ' ' ILE . . . -70.07 -37.65 75.54 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.874 0.369 . . . . 0.0 110.45 179.095 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . 0.5 HG22 ' HA ' ' A' ' 26' ' ' GLU . 0.2 OUTLIER -75.13 -1.37 22.76 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.967 -0.56 . . . . 0.0 111.684 -179.615 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -118.97 -40.17 2.87 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.873 179.988 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . 0.552 ' CB ' ' HA ' ' A' ' 31' ' ' ARG . . . -93.69 -58.97 2.11 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 112.203 0.445 . . . . 0.0 112.203 -179.408 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . 0.53 ' O ' HG23 ' A' ' 72' ' ' VAL . 2.4 tp10 -66.59 -29.34 69.37 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.611 -0.268 . . . . 0.0 110.997 -178.993 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 45.1 tptt -56.36 -27.88 57.39 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.027 179.715 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 24.1 mt-10 -59.23 -34.83 72.67 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-O 120.83 0.347 . . . . 0.0 110.504 179.274 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 6.8 tp10 -89.07 -41.32 12.38 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.173 179.214 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.53 HG23 ' O ' ' A' ' 68' ' ' GLU . 22.1 t -62.68 -42.02 94.5 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.444 0 N-CA-C 112.073 0.397 . . . . 0.0 112.073 -178.964 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . 0.532 ' OD2' HG21 ' A' ' 151' ' ' THR . 25.4 t0 -66.28 -20.11 66.01 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-O 121.6 0.714 . . . . 0.0 110.192 179.76 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 16.3 m -100.61 -12.95 18.79 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 114.972 -1.013 . . . . 0.0 110.871 179.998 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -109.21 47.39 0.92 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.485 -179.199 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . 0.409 ' HB3' ' HB3' ' A' ' 121' ' ' GLU . 0.0 OUTLIER -126.14 170.13 12.11 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.644 179.783 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -133.24 133.62 57.99 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 N-CA-C 109.832 -0.433 . . . . 0.0 109.832 178.851 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 22.4 t80 -88.5 124.67 34.22 Favored 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 109.497 -0.557 . . . . 0.0 109.497 179.952 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 5.2 t -105.89 111.11 33.66 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-N 116.519 -0.31 . . . . 0.0 110.297 179.861 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -117.04 170.57 13.47 Favored Glycine 0 N--CA 1.447 -0.621 0 N-CA-C 111.574 -0.61 . . . . 0.0 111.574 -179.982 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 3.9 m-20 55.91 43.29 27.68 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-O 121.238 0.542 . . . . 0.0 110.933 -179.099 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 2.5 t -85.49 166.38 2.05 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 CA-C-N 115.646 -0.706 . . . . 0.0 110.561 -179.505 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . 0.542 ' OD2' ' HD2' ' A' ' 142' ' ' ARG . 14.7 t70 -69.68 141.34 53.58 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.042 0.448 . . . . 0.0 110.392 179.978 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 14.5 p90 -64.0 -23.04 67.18 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.763 -0.653 . . . . 0.0 112.322 -178.575 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -107.13 16.01 24.57 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 120.874 0.368 . . . . 0.0 111.162 -179.27 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' CYS . . . . . 0.422 ' SG ' ' HB3' ' A' ' 83' ' ' ASP . 0.8 OUTLIER -79.84 145.43 32.76 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 121.207 0.527 . . . . 0.0 110.954 179.971 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . 0.405 ' O ' ' HG2' ' A' ' 90' ' ' GLU . 13.2 p -111.25 153.77 43.89 Favored Pre-proline 0 C--N 1.324 -0.524 0 CA-C-N 115.509 -0.769 . . . . 0.0 110.315 179.553 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . 0.525 ' HD3' HD13 ' A' ' 106' ' ' ILE . 16.6 Cg_endo -56.43 -37.7 96.67 Favored 'Trans proline' 0 C--N 1.344 0.336 0 C-N-CA 122.855 2.37 . . . . 0.0 112.556 -179.311 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . 0.481 ' O ' ' HG2' ' A' ' 93' ' ' GLN . 0.0 OUTLIER -63.5 -52.26 62.03 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.9 -0.591 . . . . 0.0 111.886 -178.937 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . 0.406 ' O ' ' HB2' ' A' ' 94' ' ' HIS . 7.9 pt-20 -65.23 -15.3 62.33 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.763 0.316 . . . . 0.0 111.429 -178.475 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 61.7 t -89.65 -46.25 15.17 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 CA-C-N 116.63 -0.259 . . . . 0.0 110.873 -179.806 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 1.7 pt20 -72.35 -34.2 67.84 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 111.817 0.302 . . . . 0.0 111.817 -178.45 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . 0.481 ' HG2' ' O ' ' A' ' 89' ' ' GLU . 26.0 pt20 -80.59 -22.72 40.42 Favored 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 120.33 -0.548 . . . . 0.0 111.249 -179.157 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' HIS . . . . . 0.406 ' HB2' ' O ' ' A' ' 90' ' ' GLU . 0.3 OUTLIER -75.31 -32.42 60.96 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.952 0.405 . . . . 0.0 110.498 179.331 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 23.3 m-30 -89.68 -8.08 53.19 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.175 -179.266 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . 0.555 ' HA ' ' O ' ' A' ' 99' ' ' GLY . 1.3 tt0 -66.49 -22.54 66.19 Favored 'General case' 0 C--O 1.232 0.148 0 CA-C-O 121.163 0.506 . . . . 0.0 109.978 -179.694 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 1.2 m -63.36 -30.71 71.79 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.459 -0.791 . . . . 0.0 110.642 179.147 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 17.4 m -97.27 -46.03 6.27 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.397 179.63 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . 0.555 ' O ' ' HA ' ' A' ' 96' ' ' GLN . . . -144.92 143.35 11.81 Favored Glycine 0 N--CA 1.442 -0.95 0 C-N-CA 120.908 -0.663 . . . . 0.0 111.869 -179.892 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . 0.406 ' HB ' ' CE1' ' A' ' 122' ' ' PHE . 0.2 OUTLIER -66.06 145.65 55.6 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 120.574 0.226 . . . . 0.0 111.096 -179.872 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 2.5 p -111.09 129.51 66.23 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-O 120.957 0.408 . . . . 0.0 111.25 -179.335 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . 0.535 ' OD1' ' HD2' ' A' ' 103' ' ' ARG . 26.0 t-20 -100.88 -45.17 5.53 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 109.868 -0.419 . . . . 0.0 109.868 179.327 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . 0.535 ' HD2' ' OD1' ' A' ' 102' ' ' ASN . 0.0 OUTLIER -138.44 151.9 47.86 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.156 -0.475 . . . . 0.0 109.972 178.776 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 4.0 p -151.44 119.52 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-O 121.142 0.496 . . . . 0.0 110.299 179.144 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . 0.428 ' HB ' ' CE1' ' A' ' 119' ' ' TYR . 1.2 m -112.27 120.12 40.66 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.116 179.655 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 106' ' ' ILE . . . . . 0.525 HD13 ' HD3' ' A' ' 88' ' ' PRO . 21.5 tt -108.06 146.38 14.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-O 121.025 0.44 . . . . 0.0 111.166 -179.903 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 26.0 tp -131.93 136.22 47.21 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.213 179.458 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -101.83 116.33 32.48 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 116.544 -0.298 . . . . 0.0 110.533 179.749 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . 0.456 ' O ' ' HG2' ' A' ' 115' ' ' LYS . 12.3 t70 -83.76 136.2 34.25 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.026 0.441 . . . . 0.0 111.155 -179.766 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -126.56 27.42 6.12 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 116.148 -0.478 . . . . 0.0 109.896 179.4 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 10.0 t80 -108.23 -2.01 19.7 Favored 'General case' 0 N--CA 1.45 -0.451 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.282 -179.36 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 114.45 3.2 22.63 Favored Glycine 0 N--CA 1.449 -0.434 0 C-N-CA 120.399 -0.905 . . . . 0.0 112.995 179.617 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 26.6 mt-30 -98.18 156.57 35.7 Favored Pre-proline 0 C--N 1.321 -0.645 0 N-CA-C 109.671 -0.492 . . . . 0.0 109.671 179.858 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 14.2 Cg_endo -57.37 126.71 22.85 Favored 'Trans proline' 0 C--N 1.349 0.566 0 C-N-CA 122.194 1.929 . . . . 0.0 110.894 178.798 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . 0.456 ' HG2' ' O ' ' A' ' 109' ' ' ASP . 10.7 mttp -82.67 177.55 8.64 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 110.008 -0.368 . . . . 0.0 110.008 -179.732 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . 0.456 ' HA2' HD11 ' A' ' 106' ' ' ILE . . . 94.78 2.91 62.66 Favored Glycine 0 N--CA 1.444 -0.774 0 C-N-CA 120.157 -1.02 . . . . 0.0 112.349 179.419 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 9.9 m-30 -55.84 117.73 3.94 Favored 'General case' 0 C--N 1.332 -0.194 0 N-CA-C 110.163 -0.31 . . . . 0.0 110.163 179.992 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -147.03 174.69 11.31 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-O 120.935 0.398 . . . . 0.0 111.145 -179.144 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 119' ' ' TYR . . . . . 0.428 ' CE1' ' HB ' ' A' ' 105' ' ' THR . 36.1 p90 -152.91 134.09 14.19 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.687 -0.688 . . . . 0.0 109.182 178.674 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 14.6 m -107.91 136.64 42.66 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 N-CA-C 109.42 -0.585 . . . . 0.0 109.42 178.906 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . 0.491 ' HB2' HG12 ' A' ' 72' ' ' VAL . 10.7 pt-20 -122.61 152.25 40.64 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 120.619 0.247 . . . . 0.0 110.755 -179.728 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 122' ' ' PHE . . . . . 0.406 ' CE1' ' HB ' ' A' ' 100' ' ' THR . 11.9 t80 -148.4 170.07 18.79 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.028 -0.533 . . . . 0.0 109.961 179.421 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 21.4 t -87.49 -50.09 14.08 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-O 120.975 0.417 . . . . 0.0 111.568 -179.452 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 29.0 mt-10 -70.22 134.26 47.87 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.385 -179.128 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 2.6 mp -73.23 -30.97 32.58 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.59 -179.621 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 5.7 t70 -57.24 -40.45 77.59 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.892 -179.771 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -64.04 -54.95 26.13 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.708 -0.678 . . . . 0.0 111.402 -179.413 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 7.3 p -65.59 -30.58 50.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.447 -0.342 . . . . 0.0 111.193 -179.498 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 20.4 tt0 -59.98 -45.82 91.44 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-O 120.939 0.4 . . . . 0.0 110.361 179.539 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 82.8 m-20 -71.25 -32.61 68.94 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.183 179.701 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . 0.429 ' O ' ' HB2' ' A' ' 135' ' ' ASN . . . -66.32 -48.06 71.53 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.85 -0.614 . . . . 0.0 111.382 -179.927 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 4.2 pp -71.24 -16.87 62.51 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.784 0.326 . . . . 0.0 110.943 -179.734 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 5.5 tp -82.1 -48.96 10.74 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.068 -179.85 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 79.2 mt -136.98 104.06 5.34 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.398 -0.365 . . . . 0.0 110.503 -179.815 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 135' ' ' ASN . . . . . 0.429 ' HB2' ' O ' ' A' ' 131' ' ' ALA . 1.8 m-20 -152.33 -52.87 0.12 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.564 -0.289 . . . . 0.0 111.54 -179.743 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 5.2 pt-20 -73.83 89.27 1.83 Allowed 'General case' 0 C--N 1.33 -0.283 0 CA-C-O 121.528 0.68 . . . . 0.0 111.039 -179.658 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 6.7 m -130.78 -61.94 0.93 Allowed 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.548 -0.751 . . . . 0.0 110.51 179.672 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 8.0 tm-20 -162.16 127.21 3.36 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.22 -0.445 . . . . 0.0 109.813 -179.867 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -142.35 119.69 11.58 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.929 -0.578 . . . . 0.0 109.616 179.466 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 140' ' ' HIS . . . . . 0.42 ' HB2' ' SG ' ' A' ' 86' ' ' CYS . 3.7 t60 63.75 12.74 6.89 Favored 'General case' 0 N--CA 1.466 0.333 0 C-N-CA 122.717 0.407 . . . . 0.0 111.413 179.594 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 103.76 -8.42 50.79 Favored Glycine 0 N--CA 1.45 -0.398 0 C-N-CA 120.633 -0.794 . . . . 0.0 112.755 -179.59 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 142' ' ' ARG . . . . . 0.542 ' HD2' ' OD2' ' A' ' 83' ' ' ASP . 0.0 OUTLIER -116.2 169.77 9.03 Favored 'General case' 0 C--N 1.324 -0.543 0 O-C-N 122.602 -0.352 . . . . 0.0 110.843 -179.436 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 7.8 pt20 -110.93 125.72 53.97 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 109.544 -0.539 . . . . 0.0 109.544 179.046 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -104.92 177.35 4.87 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 120.734 0.302 . . . . 0.0 111.179 -179.277 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 145' ' ' LYS . . . . . 0.558 ' HE2' ' OG ' ' A' ' 147' ' ' SER . 0.1 OUTLIER -118.04 122.95 44.46 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 109.459 -0.571 . . . . 0.0 109.459 179.305 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 89.0 t -114.18 121.64 66.7 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-O 120.837 0.351 . . . . 0.0 111.226 -179.785 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 147' ' ' SER . . . . . 0.558 ' OG ' ' HE2' ' A' ' 145' ' ' LYS . 0.6 OUTLIER -118.63 141.77 48.28 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.007 179.68 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -67.6 123.51 20.66 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.722 0.296 . . . . 0.0 110.537 179.885 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 15.7 tttp -86.0 74.29 10.15 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.332 0.586 . . . . 0.0 110.312 -179.051 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 11.6 tpt85 -91.84 100.18 12.91 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 109.105 -0.702 . . . . 0.0 109.105 178.944 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 151' ' ' THR . . . . . 0.532 HG21 ' OD2' ' A' ' 73' ' ' ASP . 6.4 t -95.52 147.63 23.35 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.329 -179.61 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 152' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 177.94 178.39 0.35 Allowed 'General case' 0 CA--C 1.514 -0.424 0 CA-C-N 116.0 -0.545 . . . . 0.0 109.891 179.636 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 11.4 pt -82.57 135.46 46.4 Favored Pre-proline 0 C--N 1.321 -0.661 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.328 179.794 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 69.8 Cg_endo -78.46 67.95 8.16 Favored 'Trans proline' 0 N--CA 1.462 -0.329 0 C-N-CA 122.638 2.225 . . . . 0.0 112.171 -179.986 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.443 -0.852 0 CA-C-O 118.128 -1.373 . . . . 0.0 111.16 179.968 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 43.8 ttp . . . . . 0 N--CA 1.478 0.967 0 CA-C-O 120.879 0.371 . . . . 0.0 110.483 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 128.34 151.09 7.42 Favored Glycine 0 N--CA 1.448 -0.559 0 C-N-CA 120.647 -0.787 . . . . 0.0 112.273 -179.92 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 14.8 m -141.25 133.77 28.42 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 109.523 -0.547 . . . . 0.0 109.523 179.455 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -148.72 159.62 43.95 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.891 0.377 . . . . 0.0 111.633 -179.141 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 9.5 p-80 -169.78 138.04 1.77 Allowed 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 115.554 -0.748 . . . . 0.0 109.75 179.588 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -162.27 150.24 14.43 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 109.446 -0.575 . . . . 0.0 109.446 -179.749 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 36.5 t-80 -161.6 125.97 3.38 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.947 0.403 . . . . 0.0 111.73 -179.477 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 48.0 p-80 -163.15 113.1 1.36 Allowed 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.541 -0.754 . . . . 0.0 109.249 178.853 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 10.9 t-80 -172.42 146.85 1.84 Allowed 'General case' 0 C--N 1.327 -0.409 0 O-C-N 122.229 -0.294 . . . . 0.0 111.078 -179.379 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 7.7 p-80 -153.93 125.98 7.83 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 109.707 -0.479 . . . . 0.0 109.707 178.054 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 3.8 p -173.27 124.12 0.4 Allowed 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.132 -179.633 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 33.9 m -152.84 149.06 27.9 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.638 -0.255 . . . . 0.0 110.357 179.887 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -175.4 -151.46 8.62 Favored Glycine 0 N--CA 1.443 -0.886 0 C-N-CA 120.625 -0.798 . . . . 0.0 112.282 179.93 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 1.8 pt? -157.8 167.67 29.36 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 -179.86 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 3.6 p -140.22 125.02 11.1 Favored Pre-proline 0 C--N 1.323 -0.572 0 CA-C-O 121.026 0.441 . . . . 0.0 111.652 -179.093 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -77.01 153.67 32.65 Favored 'Trans proline' 0 C--O 1.234 0.323 0 C-N-CA 122.509 2.139 . . . . 0.0 112.571 179.43 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . 0.443 HH11 ' HD2' ' A' ' 17' ' ' ARG . 5.9 mtm105 -86.86 156.05 20.02 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.081 0.467 . . . . 0.0 111.279 -179.648 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . 0.416 ' HA3' ' O ' ' A' ' 57' ' ' GLN . . . -177.66 -112.32 0.32 Allowed Glycine 0 N--CA 1.447 -0.569 0 CA-C-N 115.508 -0.769 . . . . 0.0 111.548 -179.799 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . 0.45 ' O ' ' HB3' ' A' ' 61' ' ' SER . 5.1 m -90.6 172.53 8.62 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 120.884 0.373 . . . . 0.0 111.269 -179.853 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 41.8 m170 -127.44 84.04 2.22 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.461 -0.336 . . . . 0.0 110.253 179.839 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 38.5 ttm -160.73 89.45 0.81 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.465 -179.489 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 143.76 -169.29 26.12 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.528 -0.844 . . . . 0.0 112.509 179.803 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 8.0 t -163.32 126.86 2.77 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 109.84 -0.43 . . . . 0.0 109.84 -179.863 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 17.4 t0 -143.08 171.29 14.26 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 110.176 -0.305 . . . . 0.0 110.176 -179.784 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 1.6 pt? -130.65 37.74 3.79 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 120.872 0.368 . . . . 0.0 110.353 -179.723 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 33.5 mt-10 67.61 74.17 0.31 Allowed 'General case' 0 C--O 1.236 0.388 0 CA-C-N 115.412 -0.813 . . . . 0.0 111.677 179.122 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . 0.595 ' HB3' HG21 ' A' ' 49' ' ' VAL . 6.1 t70 -115.28 17.01 16.77 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.477 0.656 . . . . 0.0 110.21 178.482 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 26.7 ttt -70.97 101.85 2.28 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.663 -0.699 . . . . 0.0 109.994 179.395 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 4.9 mppt? -134.18 -70.83 0.51 Allowed 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.461 -0.336 . . . . 0.0 111.763 -179.255 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . 0.412 ' O ' ' HG2' ' A' ' 53' ' ' MET . 2.0 tmtp? -74.79 133.37 41.95 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.763 0.315 . . . . 0.0 110.927 -179.13 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -113.02 140.93 47.42 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.377 -179.98 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 48.0 tp -155.88 -71.16 0.11 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.772 0.32 . . . . 0.0 110.523 179.478 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.588 ' O ' ' HA ' ' A' ' 51' ' ' LYS . 17.8 tptt -150.47 169.25 21.92 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 109.338 -0.615 . . . . 0.0 109.338 -179.865 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 1.7 pm0 -138.83 73.69 1.44 Allowed 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.147 0.499 . . . . 0.0 110.934 179.97 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 1.2 mm -130.63 2.11 2.18 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.4 0 N-CA-C 112.094 0.405 . . . . 0.0 112.094 -179.331 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 66.8 tt0 -134.8 102.06 5.13 Favored 'General case' 0 C--N 1.33 -0.26 0 O-C-N 121.776 -0.577 . . . . 0.0 112.497 -177.867 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 1.9 pm0 -116.08 150.38 37.43 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.327 -0.397 . . . . 0.0 109.993 178.833 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . 0.573 ' OE1' ' HE2' ' A' ' 48' ' ' LYS . 34.1 mt-10 -148.87 -165.31 2.24 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-O 120.902 0.382 . . . . 0.0 110.926 -179.957 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -107.97 165.43 11.47 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.448 179.449 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -86.04 112.12 3.68 Favored Glycine 0 N--CA 1.45 -0.408 0 C-N-CA 120.719 -0.753 . . . . 0.0 113.021 -179.338 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -146.35 175.89 10.19 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 109.846 -0.427 . . . . 0.0 109.846 179.425 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 57.4 tp -73.87 91.39 1.97 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.314 0.578 . . . . 0.0 110.234 179.33 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . 0.677 ' HB3' ' SD ' ' A' ' 45' ' ' MET . 49.5 ttt85 -155.87 156.27 34.36 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.785 -0.643 . . . . 0.0 109.785 -179.31 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 2.0 pt-20 -79.56 39.55 0.41 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.803 0.811 . . . . 0.0 110.016 178.669 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' MET . . . . . 0.677 ' SD ' ' HB3' ' A' ' 43' ' ' ARG . 6.1 ptm -95.36 9.97 37.96 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 114.815 -1.084 . . . . 0.0 110.989 -179.26 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 22.0 mm-40 -69.87 -20.43 63.4 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.251 0.548 . . . . 0.0 110.459 -179.774 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -82.37 -3.26 55.17 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.664 179.173 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . 0.573 ' HE2' ' OE1' ' A' ' 38' ' ' GLU . 24.0 ttpp -81.87 -4.19 55.94 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.501 -179.794 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.595 HG21 ' HB3' ' A' ' 27' ' ' ASP . 9.9 p -61.85 -22.28 28.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 121.347 0.594 . . . . 0.0 110.238 179.549 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -67.83 -17.9 64.66 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.657 -0.701 . . . . 0.0 110.044 178.619 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . 0.588 ' HA ' ' O ' ' A' ' 33' ' ' LYS . 29.4 mtmt -103.86 -41.15 5.98 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.205 -0.907 . . . . 0.0 110.616 179.741 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 8.4 mt-10 -78.82 6.28 9.44 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.901 0.381 . . . . 0.0 111.24 179.752 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' MET . . . . . 0.412 ' HG2' ' O ' ' A' ' 30' ' ' LYS . 0.0 OUTLIER -72.74 -32.61 65.81 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 121.315 0.579 . . . . 0.0 109.526 178.142 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -89.37 -9.6 66.81 Favored Glycine 0 N--CA 1.445 -0.703 0 N-CA-C 110.429 -1.068 . . . . 0.0 110.429 179.034 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -106.98 20.62 18.79 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 114.654 -0.773 . . . . 0.0 109.838 179.868 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 17.2 m -66.55 -11.35 13.08 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.397 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.005 179.928 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . 0.416 ' O ' ' HA3' ' A' ' 18' ' ' GLY . 31.7 mt-30 -88.47 1.53 54.63 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.64 0.733 . . . . 0.0 110.352 178.809 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 7.7 t70 -130.17 -51.74 1.11 Allowed 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 115.24 -0.891 . . . . 0.0 109.81 178.776 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 8.6 m -79.1 -65.08 1.04 Allowed 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.377 -0.829 . . . . 0.0 112.377 -179.146 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 8.8 t -85.45 11.44 10.42 Favored 'General case' 0 CA--C 1.531 0.218 0 N-CA-C 112.119 0.415 . . . . 0.0 112.119 -178.125 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . 0.45 ' HB3' ' O ' ' A' ' 19' ' ' SER . 0.5 OUTLIER -73.11 -20.96 60.83 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-O 121.085 0.469 . . . . 0.0 110.616 -179.967 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -69.62 -25.58 64.01 Favored 'General case' 0 N--CA 1.447 -0.581 0 CA-C-N 116.057 -0.519 . . . . 0.0 109.932 178.563 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 1.5 m -62.55 -28.09 69.62 Favored 'General case' 0 N--CA 1.448 -0.53 0 CA-C-N 115.483 -0.78 . . . . 0.0 110.722 179.774 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . 0.434 ' O ' ' HB3' ' A' ' 68' ' ' GLU . . . -68.4 -25.43 65.04 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 121.312 0.577 . . . . 0.0 110.1 178.789 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -81.56 1.76 32.26 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.733 179.814 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 24.3 tp60 -123.4 -50.88 1.87 Allowed 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.723 -0.671 . . . . 0.0 110.569 179.577 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -82.89 -57.85 3.12 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.545 -179.634 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . 0.434 ' HB3' ' O ' ' A' ' 64' ' ' ALA . 28.4 tt0 -64.06 -29.73 70.85 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 121.129 0.49 . . . . 0.0 110.587 -179.817 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 39.4 tptt -57.24 -30.14 64.37 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.785 -0.643 . . . . 0.0 111.265 179.955 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 7.2 mt-10 -61.42 -22.54 65.11 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-O 121.261 0.553 . . . . 0.0 111.25 179.998 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . 0.546 ' O ' ' HD3' ' A' ' 75' ' ' ARG . 42.7 tp10 -97.84 -43.35 7.16 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 115.881 -0.6 . . . . 0.0 109.536 178.481 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.434 HG12 ' HB2' ' A' ' 121' ' ' GLU . 45.3 t -61.84 -40.22 86.24 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-N 115.597 -0.729 . . . . 0.0 112.776 -178.815 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 16.1 p-10 -72.79 -14.21 61.48 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-O 120.742 0.306 . . . . 0.0 111.792 -178.709 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 48.0 t -106.37 -2.02 22.66 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.004 178.323 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . 0.546 ' HD3' ' O ' ' A' ' 71' ' ' GLU . 2.8 mpt_? -116.68 41.16 2.75 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.609 0.719 . . . . 0.0 109.331 -179.74 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -120.73 171.17 8.79 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.223 -0.899 . . . . 0.0 110.474 179.906 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.414 HD11 HG22 ' A' ' 120' ' ' VAL . 0.8 OUTLIER -131.4 136.15 58.05 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 N-CA-C 109.74 -0.467 . . . . 0.0 109.74 178.603 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 79.2 t80 -93.05 124.06 36.75 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.286 -179.142 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.472 HG21 ' HE2' ' A' ' 95' ' ' PHE . 3.4 t -104.5 112.92 40.01 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.808 -179.708 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -119.24 167.69 13.3 Favored Glycine 0 N--CA 1.447 -0.599 0 N-CA-C 111.18 -0.768 . . . . 0.0 111.18 179.479 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 5.3 m-20 61.77 36.71 16.11 Favored 'General case' 0 N--CA 1.472 0.625 0 CA-C-O 121.218 0.532 . . . . 0.0 110.488 -179.702 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 2.5 t -78.55 164.03 3.48 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-N 115.624 -0.716 . . . . 0.0 111.116 -178.897 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . 0.545 ' OD2' ' HD3' ' A' ' 142' ' ' ARG . 10.8 t0 -68.06 136.58 54.01 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.996 -0.547 . . . . 0.0 109.61 179.313 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 25.7 p90 -64.98 -13.89 58.83 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.118 -0.492 . . . . 0.0 112.1 -179.253 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -113.28 14.21 19.26 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.773 0.321 . . . . 0.0 111.24 179.586 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' CYS . . . . . 0.458 ' SG ' ' HB2' ' A' ' 140' ' ' HIS . 0.8 OUTLIER -78.47 150.11 33.05 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.067 0.461 . . . . 0.0 111.521 -179.389 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 5.3 p -111.47 150.91 42.84 Favored Pre-proline 0 C--N 1.323 -0.55 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.259 179.099 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . 0.441 ' HD3' HD13 ' A' ' 106' ' ' ILE . 16.9 Cg_endo -57.89 -35.03 99.01 Favored 'Trans proline' 0 C--N 1.342 0.235 0 C-N-CA 122.462 2.108 . . . . 0.0 111.566 -179.716 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 66.8 mm-40 -64.36 -53.45 48.46 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.549 -0.75 . . . . 0.0 111.89 -179.429 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 -64.16 -18.37 64.4 Favored 'General case' 0 C--N 1.333 -0.133 0 CA-C-O 120.901 0.381 . . . . 0.0 111.472 -178.225 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 55.0 t -83.71 -49.06 16.79 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.518 -179.884 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . 0.417 ' O ' ' HB2' ' A' ' 96' ' ' GLN . 2.8 pt20 -73.38 -32.47 64.5 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.472 -0.331 . . . . 0.0 111.611 -178.479 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 7.1 pt20 -77.25 -28.29 53.57 Favored 'General case' 0 C--N 1.33 -0.261 0 C-N-CA 120.618 -0.433 . . . . 0.0 111.048 -179.118 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 60.9 t-80 -74.95 -44.48 48.21 Favored 'General case' 0 CA--C 1.519 -0.248 0 CA-C-O 121.085 0.469 . . . . 0.0 110.165 179.536 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . 0.472 ' HE2' HG21 ' A' ' 79' ' ' VAL . 20.5 m-30 -73.45 -17.78 61.2 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.866 -0.607 . . . . 0.0 110.517 -179.2 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . 0.492 ' HA ' ' O ' ' A' ' 99' ' ' GLY . 7.7 tt0 -64.61 -25.29 67.9 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.494 -0.775 . . . . 0.0 110.631 179.521 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 48.8 m -61.0 -32.18 71.77 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.514 179.682 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 18.2 m -92.35 -50.23 5.75 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.176 0.512 . . . . 0.0 110.078 179.42 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . 0.492 ' O ' ' HA ' ' A' ' 96' ' ' GLN . . . -137.77 133.7 6.53 Favored Glycine 0 N--CA 1.443 -0.854 0 C-N-CA 120.659 -0.782 . . . . 0.0 111.91 179.783 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -59.33 140.0 56.48 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.029 0.443 . . . . 0.0 110.686 179.975 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 2.8 p -105.51 140.18 24.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 115.876 -0.602 . . . . 0.0 112.171 -178.058 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 9.1 t30 -101.95 -50.56 3.63 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 109.431 -0.581 . . . . 0.0 109.431 178.125 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 9.0 mmm180 -141.8 158.32 43.94 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.386 179.698 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 6.6 p -151.54 127.57 1.83 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.104 179.566 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . 0.416 ' HB ' ' CE1' ' A' ' 119' ' ' TYR . 1.8 m -117.9 119.17 34.04 Favored 'General case' 0 C--N 1.321 -0.669 0 O-C-N 122.263 -0.273 . . . . 0.0 110.441 -179.984 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 106' ' ' ILE . . . . . 0.441 HD13 ' HD3' ' A' ' 88' ' ' PRO . 18.6 tt -107.16 146.64 13.19 Favored 'Isoleucine or valine' 0 C--O 1.235 0.327 0 CA-C-O 120.959 0.409 . . . . 0.0 111.04 -179.592 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 60.4 tp -135.69 126.24 26.97 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.858 -0.61 . . . . 0.0 109.948 179.12 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -89.2 120.02 30.21 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 116.517 -0.311 . . . . 0.0 110.499 179.83 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . 0.543 ' O ' ' HG2' ' A' ' 115' ' ' LYS . 16.8 t70 -81.08 136.9 35.99 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.014 0.435 . . . . 0.0 110.829 -179.883 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -124.93 25.86 7.21 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.896 -0.593 . . . . 0.0 109.763 179.556 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 24.6 t80 -105.99 -3.87 21.19 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.059 -179.483 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 106.83 10.9 27.62 Favored Glycine 0 N--CA 1.449 -0.493 0 C-N-CA 120.678 -0.772 . . . . 0.0 112.536 -179.582 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 113' ' ' GLN . . . . . 0.417 ' HB3' ' HD2' ' A' ' 114' ' ' PRO . 20.9 mt-30 -99.8 159.36 30.14 Favored Pre-proline 0 C--N 1.325 -0.471 0 N-CA-C 109.509 -0.552 . . . . 0.0 109.509 179.388 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 114' ' ' PRO . . . . . 0.417 ' HD2' ' HB3' ' A' ' 113' ' ' GLN . 11.4 Cg_endo -55.77 115.67 2.62 Favored 'Trans proline' 0 C--N 1.344 0.327 0 C-N-CA 122.307 2.005 . . . . 0.0 110.835 178.584 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . 0.543 ' HG2' ' O ' ' A' ' 109' ' ' ASP . 54.9 mttt -75.52 172.27 12.83 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.044 -178.467 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . 0.42 ' HA2' HD11 ' A' ' 106' ' ' ILE . . . 98.55 7.81 55.32 Favored Glycine 0 N--CA 1.444 -0.767 0 C-N-CA 120.351 -0.928 . . . . 0.0 112.286 179.902 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 30.2 m-85 -53.27 115.48 1.92 Allowed 'General case' 0 C--N 1.334 -0.097 0 N-CA-C 110.146 -0.316 . . . . 0.0 110.146 179.749 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -146.23 175.53 10.44 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-O 121.034 0.445 . . . . 0.0 111.165 -179.168 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 119' ' ' TYR . . . . . 0.416 ' CE1' ' HB ' ' A' ' 105' ' ' THR . 51.7 p90 -160.08 135.64 8.29 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.581 -0.736 . . . . 0.0 109.234 178.799 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . 0.414 HG22 HD11 ' A' ' 77' ' ' ILE . 17.4 m -105.55 142.0 19.62 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.727 0 N-CA-C 109.69 -0.485 . . . . 0.0 109.69 179.344 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . 0.434 ' HB2' HG12 ' A' ' 72' ' ' VAL . 5.8 pt-20 -127.1 152.94 46.64 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.157 -179.417 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 15.4 t80 -156.46 166.99 31.82 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.476 179.163 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 3.8 t -84.37 -47.61 17.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 120.921 0.391 . . . . 0.0 111.627 -179.317 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 74.9 mm-40 -66.33 126.45 28.82 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.32 -179.394 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 2.5 mp -70.23 -32.92 52.41 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.02 -179.926 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 4.8 t70 -62.66 -36.64 83.5 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.505 179.884 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -61.3 -55.44 31.8 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.636 179.724 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 11.3 p -67.12 -28.86 44.12 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.756 179.729 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 7.0 tt0 -58.56 -46.53 86.68 Favored 'General case' 0 N--CA 1.462 0.165 0 CA-C-O 121.11 0.481 . . . . 0.0 110.399 179.223 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 46.2 m-80 -70.83 -31.16 67.78 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.878 -0.601 . . . . 0.0 109.985 179.913 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -68.03 -48.41 65.76 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.665 -0.698 . . . . 0.0 111.833 -179.537 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 3.8 pp -69.93 -18.97 63.4 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.943 0.401 . . . . 0.0 110.92 -179.666 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 5.4 tp -80.03 -49.91 11.12 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.765 179.858 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 79.1 mt -134.61 107.81 7.7 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.477 -0.329 . . . . 0.0 110.967 -179.609 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 2.8 m-20 -159.81 -52.53 0.06 Allowed 'General case' 0 N--CA 1.465 0.303 0 CA-C-O 121.181 0.515 . . . . 0.0 110.998 179.757 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 4.6 pt-20 -74.73 80.06 2.05 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.433 0.635 . . . . 0.0 111.205 -179.735 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 6.8 m -133.78 -60.58 0.82 Allowed 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.672 -0.695 . . . . 0.0 111.0 179.573 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 1.6 tp10 -150.97 121.25 7.28 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-O 120.532 0.206 . . . . 0.0 110.516 -179.325 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -141.93 111.43 6.55 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 109.867 -0.42 . . . . 0.0 109.867 179.237 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 140' ' ' HIS . . . . . 0.458 ' HB2' ' SG ' ' A' ' 86' ' ' CYS . 2.4 t60 67.34 18.27 10.2 Favored 'General case' 0 N--CA 1.468 0.425 0 CA-C-O 121.142 0.496 . . . . 0.0 110.402 179.582 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 88.9 4.14 75.72 Favored Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.869 -0.681 . . . . 0.0 111.54 -179.212 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 142' ' ' ARG . . . . . 0.545 ' HD3' ' OD2' ' A' ' 83' ' ' ASP . 4.3 mpt_? -121.28 166.49 13.95 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 109.825 -0.435 . . . . 0.0 109.825 179.499 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 18.7 pt20 -110.99 140.08 45.81 Favored 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 109.863 -0.421 . . . . 0.0 109.863 179.2 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -125.6 174.98 7.88 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.547 -179.549 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 15.6 ttpt -111.32 118.79 36.82 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.255 179.791 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 85.9 t -113.37 118.53 58.38 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-O 120.992 0.425 . . . . 0.0 110.005 179.276 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 66.3 m -127.49 143.36 51.2 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 116.116 -0.493 . . . . 0.0 109.921 -179.89 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -59.13 133.49 56.14 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.058 0.456 . . . . 0.0 111.888 -178.747 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 12.1 ttpp -96.0 78.29 3.18 Favored 'General case' 0 N--CA 1.449 -0.476 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.205 179.607 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 21.5 tpt180 -91.0 101.72 14.49 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 109.293 -0.632 . . . . 0.0 109.293 179.329 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 4.2 t -94.96 140.52 29.84 Favored 'General case' 0 N--CA 1.446 -0.666 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.777 -179.193 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 152' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 172.87 177.76 0.09 Allowed 'General case' 0 CA--C 1.516 -0.345 0 CA-C-N 115.494 -0.776 . . . . 0.0 109.484 179.632 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 16.6 pt -75.08 140.53 73.6 Favored Pre-proline 0 C--N 1.318 -0.791 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.895 179.839 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -75.95 59.98 5.98 Favored 'Trans proline' 0 CA--C 1.528 0.206 0 C-N-CA 122.949 2.432 . . . . 0.0 112.372 179.916 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.44 -1.068 0 CA-C-O 118.818 -0.99 . . . . 0.0 111.534 179.957 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.3 mpt? . . . . . 0 N--CA 1.482 1.172 0 N-CA-C 109.944 -0.391 . . . . 0.0 109.944 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 118.98 117.43 2.7 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.953 -0.641 . . . . 0.0 112.597 179.898 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -144.64 113.29 6.68 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 110.08 -0.341 . . . . 0.0 110.08 179.382 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 13.3 m -120.26 155.02 34.09 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.712 0.292 . . . . 0.0 111.364 -179.615 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 21.4 p-80 -159.39 141.54 13.57 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.586 179.971 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 35.7 t60 -155.96 139.84 16.24 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.803 0.335 . . . . 0.0 110.563 179.507 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 76.1 t60 -129.41 117.31 20.37 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.041 179.698 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 49.7 t-80 -90.0 129.06 36.37 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 120.782 0.325 . . . . 0.0 110.946 -179.734 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 8.6 p-80 -100.28 -177.7 3.6 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.821 179.926 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 4.6 p80 -136.79 174.51 10.54 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.555 0.217 . . . . 0.0 110.471 179.692 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 9.0 t -111.74 -160.82 0.73 Allowed 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.511 -0.313 . . . . 0.0 110.335 -179.483 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 14.3 m -155.7 119.34 4.43 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 109.593 -0.521 . . . . 0.0 109.593 179.363 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -169.74 156.37 27.17 Favored Glycine 0 N--CA 1.448 -0.537 0 N-CA-C 111.328 -0.709 . . . . 0.0 111.328 179.773 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 47.1 mt -135.93 98.9 4.01 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.141 0.496 . . . . 0.0 110.772 -179.78 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.401 ' O ' ' HG2' ' A' ' 17' ' ' ARG . 0.2 OUTLIER -135.47 79.83 47.02 Favored Pre-proline 0 C--N 1.323 -0.549 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.314 -179.789 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . 0.58 ' HA ' ' OE2' ' A' ' 68' ' ' GLU . 89.7 Cg_exo -45.63 115.82 1.15 Allowed 'Trans proline' 0 C--N 1.348 0.518 0 C-N-CA 123.611 2.874 . . . . 0.0 113.372 -178.844 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . 0.401 ' HG2' ' O ' ' A' ' 15' ' ' VAL . 11.8 ptm180 -156.71 177.89 10.97 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.518 -0.764 . . . . 0.0 110.653 -179.755 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -83.78 144.98 22.39 Favored Glycine 0 N--CA 1.445 -0.753 0 C-N-CA 120.685 -0.769 . . . . 0.0 111.484 178.97 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 1.6 m -98.0 139.07 34.37 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 120.714 0.292 . . . . 0.0 110.428 -179.887 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . 0.419 ' HB3' ' OG ' ' A' ' 61' ' ' SER . 36.9 t-80 -157.2 159.49 37.76 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 109.517 -0.549 . . . . 0.0 109.517 179.721 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 2.3 mpt? -66.27 156.97 32.79 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.581 -0.281 . . . . 0.0 110.923 179.64 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 177.26 -171.57 44.38 Favored Glycine 0 N--CA 1.447 -0.602 0 N-CA-C 111.097 -0.801 . . . . 0.0 111.097 -179.963 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 69.3 m -78.49 -97.85 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 116.782 0.291 . . . . 0.0 111.461 -179.888 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 13.8 p-10 -161.76 32.75 0.13 Allowed 'General case' 0 N--CA 1.464 0.245 0 CA-C-O 121.047 0.451 . . . . 0.0 111.686 -179.11 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 45.1 mt -93.85 155.4 17.21 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.82 0.343 . . . . 0.0 110.616 179.745 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.405 ' HA ' ' HB3' ' A' ' 63' ' ' SER . 27.6 mt-10 -124.15 141.35 52.13 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.175 -179.354 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 3.3 t70 -153.3 169.72 22.39 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-N 116.482 -0.327 . . . . 0.0 110.229 179.495 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -139.15 2.05 2.07 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.49 -0.323 . . . . 0.0 111.659 -179.317 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 8.5 pttm -128.73 166.22 19.39 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 110.248 -0.279 . . . . 0.0 110.248 -179.943 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . 0.593 ' HA ' ' O ' ' A' ' 53' ' ' MET . 10.0 ptpt -157.32 145.27 19.07 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 109.866 -0.42 . . . . 0.0 109.866 179.359 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 2.8 mmp_? -143.2 -68.12 0.35 Allowed 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 120.876 0.369 . . . . 0.0 110.787 -179.861 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 1.9 mm? -87.83 -167.7 1.97 Allowed 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.067 -0.515 . . . . 0.0 109.996 -179.961 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.461 ' HA ' ' O ' ' A' ' 54' ' ' GLY . 3.5 mtpm? -143.27 81.1 1.7 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.189 0.519 . . . . 0.0 110.044 179.378 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 4.0 mm-40 -111.11 -171.49 1.84 Allowed 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.1 -179.178 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 1.3 pp -149.78 161.72 4.45 Favored 'Isoleucine or valine' 0 C--O 1.233 0.217 0 C-N-CA 122.536 0.335 . . . . 0.0 110.143 179.665 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . 0.407 ' HB3' ' H ' ' A' ' 37' ' ' GLU . 17.3 mm-40 61.37 -160.63 0.3 Allowed 'General case' 0 N--CA 1.465 0.318 0 O-C-N 123.437 0.461 . . . . 0.0 111.888 179.138 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . 0.407 ' H ' ' HB3' ' A' ' 36' ' ' GLU . 34.2 mm-40 67.46 30.57 6.76 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-N 115.817 -0.629 . . . . 0.0 111.353 179.232 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . 0.407 ' H ' ' HG3' ' A' ' 38' ' ' GLU . 0.0 OUTLIER -115.4 138.01 51.44 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 121.183 0.516 . . . . 0.0 111.754 -178.929 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -151.76 165.79 33.35 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.48 -0.782 . . . . 0.0 110.142 179.737 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -140.02 67.29 0.5 Allowed Glycine 0 N--CA 1.448 -0.529 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.427 -179.907 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -140.15 172.18 13.12 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 110.05 -0.352 . . . . 0.0 110.05 179.829 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 50.7 tp -72.45 94.32 1.64 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.095 0.474 . . . . 0.0 109.825 179.472 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 16.8 ttm180 -149.03 149.58 31.36 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.764 -0.653 . . . . 0.0 109.576 -179.71 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 10.4 tt0 -79.97 48.79 1.0 Allowed 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.272 0.558 . . . . 0.0 110.824 -179.508 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 6.4 ptm -107.35 12.31 28.19 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.441 179.674 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 19.7 mm-40 -69.63 -20.8 63.6 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.056 0.455 . . . . 0.0 111.212 -179.261 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -79.71 -5.44 55.23 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.25 178.913 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 37.1 ttpt -85.34 1.73 47.22 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.78 -0.645 . . . . 0.0 109.775 179.614 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 5.8 p -58.32 -19.44 13.59 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.432 0 CA-C-N 115.261 -0.882 . . . . 0.0 111.094 179.447 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 29.6 mt-10 -70.65 -19.9 62.76 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-O 121.207 0.527 . . . . 0.0 110.369 179.173 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 5.2 mtmt -101.63 -42.52 6.18 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.995 -0.548 . . . . 0.0 109.905 178.749 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 22.0 mt-10 -61.37 -26.6 67.94 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.854 179.391 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' MET . . . . . 0.593 ' O ' ' HA ' ' A' ' 30' ' ' LYS . 19.5 ptt? -66.55 -16.53 64.22 Favored 'General case' 0 C--O 1.227 -0.116 0 CA-C-O 121.372 0.606 . . . . 0.0 110.024 178.668 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . 0.461 ' O ' ' HA ' ' A' ' 33' ' ' LYS . . . -98.67 -7.93 55.04 Favored Glycine 0 N--CA 1.445 -0.725 0 N-CA-C 110.612 -0.995 . . . . 0.0 110.612 178.509 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -114.5 18.52 16.75 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-O 121.144 0.497 . . . . 0.0 110.055 -179.871 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 32.3 m -63.71 -6.87 2.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 115.913 -0.585 . . . . 0.0 112.229 -179.154 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 97.0 mt-30 -88.17 -8.63 55.08 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.234 0.54 . . . . 0.0 110.088 179.097 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -129.33 -58.4 1.12 Allowed 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.376 -0.829 . . . . 0.0 109.681 179.315 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 1.6 m -64.6 -69.69 0.27 Allowed 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.367 -0.833 . . . . 0.0 112.039 -179.674 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 2.1 m -91.38 35.83 0.94 Allowed 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.749 -0.66 . . . . 0.0 111.893 -178.91 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . 0.419 ' OG ' ' HB3' ' A' ' 20' ' ' HIS . 0.1 OUTLIER -89.02 -21.73 23.33 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.76 0.314 . . . . 0.0 111.033 -179.535 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -69.7 -12.61 61.77 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.428 -179.672 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . 0.405 ' HB3' ' HA ' ' A' ' 26' ' ' GLU . 33.9 p -61.32 -33.47 73.66 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.445 -179.87 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -70.49 -28.08 64.7 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.584 179.828 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -81.88 -1.64 48.42 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.993 179.867 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 22.9 tp60 -119.87 -44.75 2.51 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.565 -0.289 . . . . 0.0 111.337 179.811 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -90.86 -61.18 1.73 Allowed 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 120.844 0.354 . . . . 0.0 111.252 -179.415 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . 0.58 ' OE2' ' HA ' ' A' ' 16' ' ' PRO . 0.6 OUTLIER -61.94 -27.86 69.13 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.969 -0.56 . . . . 0.0 111.125 -179.313 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 19.4 tptp -58.4 -29.55 66.14 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.405 -179.727 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 17.7 mt-10 -66.27 -20.39 66.09 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-O 121.396 0.617 . . . . 0.0 110.605 179.722 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . 0.445 ' O ' ' HD2' ' A' ' 75' ' ' ARG . 5.5 tp10 -95.28 -39.88 9.83 Favored 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 109.091 -0.707 . . . . 0.0 109.091 177.176 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.468 HG23 ' O ' ' A' ' 68' ' ' GLU . 54.9 t -63.97 -42.64 96.39 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.374 0 CA-C-N 115.606 -0.724 . . . . 0.0 112.491 -179.464 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 14.5 p-10 -70.69 -18.18 62.82 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-O 120.949 0.404 . . . . 0.0 110.898 -179.076 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 33.6 t -97.41 -13.47 21.8 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.188 178.633 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . 0.445 ' HD2' ' O ' ' A' ' 71' ' ' GLU . 0.0 OUTLIER -106.04 44.95 1.0 Allowed 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.775 -0.648 . . . . 0.0 109.961 -179.498 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . 0.459 ' CB ' ' HB3' ' A' ' 121' ' ' GLU . 0.3 OUTLIER -124.53 170.99 10.36 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.47 -0.786 . . . . 0.0 110.689 179.971 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.436 HD13 ' HB1' ' A' ' 131' ' ' ALA . 6.7 pt -132.15 135.15 58.73 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.772 0 CA-C-N 115.803 -0.635 . . . . 0.0 109.35 178.445 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 69.6 t80 -91.91 123.04 34.99 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 116.341 -0.39 . . . . 0.0 109.994 -179.883 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 4.6 t -102.78 111.48 32.71 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.493 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.223 -179.516 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -121.42 169.69 14.55 Favored Glycine 0 N--CA 1.447 -0.602 0 C-N-CA 120.828 -0.701 . . . . 0.0 111.57 179.858 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 4.2 m-20 61.01 37.66 17.89 Favored 'General case' 0 N--CA 1.469 0.514 0 CA-C-O 121.251 0.548 . . . . 0.0 110.431 -179.882 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 2.5 t -83.52 164.31 2.72 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-N 115.358 -0.837 . . . . 0.0 110.804 -179.01 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . 0.732 ' OD2' ' HB2' ' A' ' 142' ' ' ARG . 0.1 OUTLIER -66.17 137.3 56.91 Favored 'General case' 0 CA--C 1.517 -0.323 0 N-CA-C 109.707 -0.479 . . . . 0.0 109.707 179.288 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 24.6 p90 -65.64 -8.06 18.43 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 120.917 0.389 . . . . 0.0 111.379 -179.878 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -118.51 19.52 13.29 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.14 -179.743 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -87.01 143.88 27.14 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.707 179.971 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . 0.436 ' O ' ' HG2' ' A' ' 90' ' ' GLU . 20.7 p -107.79 148.9 38.25 Favored Pre-proline 0 C--N 1.326 -0.429 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.425 179.572 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . 0.545 ' HD3' HD13 ' A' ' 106' ' ' ILE . 11.7 Cg_endo -54.81 -39.65 88.83 Favored 'Trans proline' 0 C--N 1.344 0.339 0 C-N-CA 123.089 2.526 . . . . 0.0 112.977 -179.198 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 3.2 mp0 -65.1 -41.73 94.7 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 112.498 0.555 . . . . 0.0 112.498 -178.486 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . 0.485 ' O ' ' HB2' ' A' ' 94' ' ' HIS . 8.0 pt-20 -73.98 -14.8 61.09 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.97 0.414 . . . . 0.0 111.024 -178.977 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.424 HG23 ' O ' ' A' ' 87' ' ' THR . 74.5 t -88.52 -48.35 14.92 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.89 -179.561 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -69.0 -34.13 74.8 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.545 -178.333 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 7.6 pt20 -78.11 -28.97 48.7 Favored 'General case' 0 C--N 1.327 -0.384 0 C-N-CA 120.556 -0.457 . . . . 0.0 111.24 -178.854 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' HIS . . . . . 0.485 ' HB2' ' O ' ' A' ' 90' ' ' GLU . 1.8 t-80 -73.39 -32.19 64.33 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.97 0.414 . . . . 0.0 110.828 -179.664 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 21.4 m-30 -87.7 -11.69 47.54 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.144 179.543 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 26.4 tt0 -62.74 -27.64 69.41 Favored 'General case' 0 C--O 1.234 0.237 0 CA-C-N 115.538 -0.755 . . . . 0.0 110.343 -179.957 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 12.7 m -63.96 -35.5 80.89 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.233 179.085 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 3.8 m -85.29 -52.75 5.68 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.883 -0.599 . . . . 0.0 109.532 179.159 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -140.57 128.16 3.71 Favored Glycine 0 N--CA 1.441 -0.979 0 CA-C-N 115.684 -0.689 . . . . 0.0 111.689 179.752 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . 0.444 ' H ' HG22 ' A' ' 100' ' ' THR . 0.1 OUTLIER -57.33 136.25 56.55 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.853 0.359 . . . . 0.0 110.101 179.418 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 2.0 p -102.01 130.33 51.94 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-N 116.048 -0.524 . . . . 0.0 112.073 -177.913 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . 0.457 ' HB2' ' CD1' ' A' ' 122' ' ' PHE . 29.2 t-20 -99.85 -43.78 6.3 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 109.53 -0.544 . . . . 0.0 109.53 178.449 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . 0.431 ' HD3' ' OD1' ' A' ' 102' ' ' ASN . 1.5 mpt_? -135.7 151.24 49.98 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.328 179.657 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 6.1 p -155.46 129.82 1.39 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.552 -0.295 . . . . 0.0 110.211 179.28 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -127.49 124.8 39.19 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.492 -0.322 . . . . 0.0 110.248 179.472 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 106' ' ' ILE . . . . . 0.548 HD11 ' HA2' ' A' ' 116' ' ' GLY . 20.8 tt -109.26 149.06 12.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 120.857 0.36 . . . . 0.0 111.014 -179.89 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 13.8 tp -130.14 136.22 49.05 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.002 -0.544 . . . . 0.0 109.991 179.516 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -100.8 111.35 23.55 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.488 179.9 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . 0.416 ' O ' ' HG2' ' A' ' 115' ' ' LYS . 23.1 t70 -76.73 146.91 37.68 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.188 0.518 . . . . 0.0 111.13 -179.618 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 3.3 mppt? -135.15 22.99 3.5 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.267 179.446 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 19.0 t80 -107.58 -3.89 18.88 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.222 0.534 . . . . 0.0 110.157 -179.544 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 114.78 0.62 22.96 Favored Glycine 0 N--CA 1.449 -0.474 0 C-N-CA 120.816 -0.707 . . . . 0.0 112.766 179.835 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 26.6 mt-30 -88.35 154.59 51.53 Favored Pre-proline 0 C--N 1.329 -0.315 0 N-CA-C 109.361 -0.607 . . . . 0.0 109.361 179.679 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 14.5 Cg_endo -58.45 115.92 2.88 Favored 'Trans proline' 0 N--CA 1.462 -0.378 0 C-N-CA 122.013 1.809 . . . . 0.0 111.444 178.917 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . 0.416 ' HG2' ' O ' ' A' ' 109' ' ' ASP . 60.0 mttt -70.86 167.06 19.77 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 109.558 -0.534 . . . . 0.0 109.558 -179.485 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . 0.548 ' HA2' HD11 ' A' ' 106' ' ' ILE . . . 105.59 1.83 40.36 Favored Glycine 0 N--CA 1.447 -0.607 0 C-N-CA 120.073 -1.061 . . . . 0.0 112.197 179.914 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 32.4 m-85 -53.69 115.61 2.07 Favored 'General case' 0 C--N 1.333 -0.138 0 N-CA-C 110.269 -0.271 . . . . 0.0 110.269 179.46 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -143.41 173.01 12.0 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 120.915 0.388 . . . . 0.0 111.006 -179.162 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 51.9 p90 -155.21 130.09 9.35 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 115.847 -0.615 . . . . 0.0 109.765 178.681 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 18.6 m -107.21 141.27 22.85 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 N-CA-C 109.695 -0.483 . . . . 0.0 109.695 179.178 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . 0.459 ' HB3' ' CB ' ' A' ' 76' ' ' SER . 1.4 pt-20 -132.04 157.05 45.16 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.916 0.388 . . . . 0.0 111.17 179.723 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 122' ' ' PHE . . . . . 0.457 ' CD1' ' HB2' ' A' ' 102' ' ' ASN . 22.2 t80 -152.29 170.88 18.95 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.535 -0.757 . . . . 0.0 109.771 179.91 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 20.4 t -84.26 -51.6 13.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-O 120.969 0.414 . . . . 0.0 110.461 179.852 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 4.7 mm-40 -60.53 129.66 42.69 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.852 -0.613 . . . . 0.0 111.132 179.886 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 2.9 mp -73.9 -31.03 29.58 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 N-CA-C 109.327 -0.62 . . . . 0.0 109.327 179.516 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -60.53 -37.97 82.92 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.342 179.26 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -60.8 -56.33 22.52 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.537 -0.756 . . . . 0.0 111.107 -179.976 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 11.3 p -67.19 -30.13 48.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.442 -179.654 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 30.1 tt0 -61.31 -44.78 96.64 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 121.038 0.447 . . . . 0.0 110.436 179.653 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 37.9 m-80 -72.3 -29.11 63.55 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.055 -0.52 . . . . 0.0 109.994 179.601 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . 0.436 ' HB1' HD13 ' A' ' 77' ' ' ILE . . . -69.53 -51.65 33.66 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.476 -0.784 . . . . 0.0 111.305 -179.939 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 4.2 pp -65.59 -23.34 66.81 Favored 'General case' 0 N--CA 1.462 0.142 0 CA-C-O 120.794 0.33 . . . . 0.0 110.681 -179.824 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 5.7 tp -73.37 -56.48 5.01 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.961 0.41 . . . . 0.0 110.228 179.595 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 69.1 mt -122.71 104.2 9.16 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.007 -0.542 . . . . 0.0 109.79 179.826 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 135' ' ' ASN . . . . . 0.43 ' HB2' ' O ' ' A' ' 131' ' ' ALA . 0.5 OUTLIER -148.4 -66.84 0.24 Allowed 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.15 0.5 . . . . 0.0 111.122 -179.186 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 5.6 pt-20 -73.68 106.29 5.37 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.563 -0.744 . . . . 0.0 111.414 -179.466 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 21.3 m -150.09 -59.13 0.19 Allowed 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.706 -0.679 . . . . 0.0 109.599 178.997 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 4.9 tt0 -161.55 120.96 2.5 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.813 -0.63 . . . . 0.0 109.572 178.946 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -139.35 123.18 17.63 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 -179.982 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 140' ' ' HIS . . . . . 0.621 ' HB3' ' OD2' ' A' ' 83' ' ' ASP . 6.9 t60 59.07 12.4 2.42 Favored 'General case' 0 CA--C 1.54 0.562 0 O-C-N 123.555 0.534 . . . . 0.0 111.553 179.28 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 101.36 -6.4 55.75 Favored Glycine 0 N--CA 1.449 -0.443 0 C-N-CA 120.904 -0.665 . . . . 0.0 112.754 -179.918 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 142' ' ' ARG . . . . . 0.732 ' HB2' ' OD2' ' A' ' 83' ' ' ASP . 8.0 mpt_? -113.43 173.42 6.42 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 117.023 0.412 . . . . 0.0 110.418 179.58 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 17.4 pt20 -116.87 114.16 23.49 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.093 0.473 . . . . 0.0 109.759 179.531 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -97.97 175.13 6.24 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.174 -179.15 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 6.4 ttpt -117.51 120.81 39.22 Favored 'General case' 0 N--CA 1.45 -0.457 0 CA-C-N 115.905 -0.589 . . . . 0.0 109.495 179.052 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 93.5 t -113.36 119.96 62.07 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.738 0 CA-C-O 120.898 0.38 . . . . 0.0 110.653 -179.635 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 58.2 m -123.25 141.68 51.72 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 116.195 -0.457 . . . . 0.0 109.801 -179.849 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -59.86 128.8 38.67 Favored 'General case' 0 C--O 1.236 0.378 0 CA-C-O 120.828 0.347 . . . . 0.0 111.277 -179.64 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 149' ' ' LYS . . . . . 0.429 ' HE2' ' OG ' ' A' ' 76' ' ' SER . 21.9 ttpt -91.94 67.8 5.25 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.384 0.611 . . . . 0.0 109.999 -179.601 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 24.7 tpt180 -88.12 94.56 9.84 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 121.236 0.541 . . . . 0.0 109.611 179.104 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 3.0 t -83.88 129.13 34.94 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 115.615 -0.721 . . . . 0.0 109.634 179.297 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 152' ' ' ASN . . . . . . . . . . . . . 62.5 t30 -163.68 158.9 20.96 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.001 -179.661 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 19.6 pt -78.36 148.81 74.67 Favored Pre-proline 0 C--N 1.32 -0.698 0 CA-C-N 116.577 -0.283 . . . . 0.0 110.322 179.733 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 30.5 Cg_endo -63.95 103.75 0.44 Allowed 'Trans proline' 0 C--N 1.344 0.31 0 C-N-CA 122.559 2.173 . . . . 0.0 111.987 179.848 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.161 0 CA-C-O 118.025 -1.431 . . . . 0.0 111.047 -179.577 . . . . . . . . 0 0 . 1 stop_ save_